	SMILES	Target Name	Medchem: Measurement Parameter	Quantitative value	Unit
0	COC1=C2C(=O)C3=C(C(O)=C4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C4=C3O)C(=O)CO)C(=O)C2=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	0.53 - 0.74	μmol/l
1	COC1=C2C(=O)C3=C(C(O)=C4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C4=C3O)C(=O)CO)C(=O)C2=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	0.42 - 0.85	μmol/l
2	NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	IC50	8.4	µM
3	NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	IC50	34.2	µM
4	NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	IC50	8.3	µM
5	[H][C@@]12CC[C@@H](C)[C@@](O)(O1)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@]([H])(CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C2)OC)[C@H](C)C[C@@H]1CC[C@@H](O)[C@@H](C1)OC	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	1.8	%
6	COC1=C(O)C=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC(OC)=C(O)C=C2)=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	44	%
7	COC1=C(O)C=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC(OC)=C(O)C=C2)=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	19	%
8	[NH3][Pt]1([NH3])OC(=O)C2(CCC2)C(=O)O1	Cyclin-dependent kinase 7 [human]	IC50	18.1 - 21.04	μmol/l
9	[NH3][Pt]1([NH3])OC(=O)C2(CCC2)C(=O)O1	Cyclin-dependent kinase 7 [human]	IC50	31.98 - 39.71	μmol/l
10	OC1=CC(O)=C2C(=O)C=C(OC2=C1)C1=CC(O)=C(O)C=C1	Cyclin-dependent kinase 7	inhibition rate	25	%
11	[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	0.22 - 0.37	μmol/l
12	[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	0.47 - 0.56	μmol/l
13	[H].O.[Na]	Cyclin-dependent kinase 7 [human]	IC50	10.86	µM
14	CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-2.27	%
15	CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	140	nM
16	CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
17	CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	IC50	10	µM
18	CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	IC50	10	µM
19	CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	IC50	10	µM
20	CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	9.7	%
21	CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-8.8	%
22	CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	IC50	10	µM
23	CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	34	%
24	CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	17	%
25	CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1	Cyclin-dependent kinase 7;+Cyclin-H;+CDK-activating kinase assembly factor MAT1	inhibition percentage	-1	%
26	CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1	Cyclin-dependent kinase 7;+Cyclin-H	inhibition percentage	4.3	%
27	OC1=CC2=C(C[C@@H](OC(=O)C3=CC(O)=C(O)C(O)=C3)[C@H](O2)C2=CC(O)=C(O)C(O)=C2)C(O)=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	5	%
28	OC1=CC2=C(C[C@@H](OC(=O)C3=CC(O)=C(O)C(O)=C3)[C@H](O2)C2=CC(O)=C(O)C(O)=C2)C(O)=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	5	%
29	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC(=CC=N3)C3=CC=CN=C3)=C2)CC1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	10000	nM
30	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC(=CC=N3)C3=CC=CN=C3)=C2)CC1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
31	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC(=CC=N3)C3=CC=CN=C3)=C2)CC1	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	IC50	10	µM
32	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC(=CC=N3)C3=CC=CN=C3)=C2)CC1	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	IC50	10	µM
33	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC(=CC=N3)C3=CC=CN=C3)=C2)CC1	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	IC50	10	µM
34	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC(=CC=N3)C3=CC=CN=C3)=C2)CC1	Cyclin-dependent kinase 7	pIC50	4.7	
35	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC(=CC=N3)C3=CC=CN=C3)=C2)CC1	Cyclin-dependent kinase 7	pIC50	5.4	
36	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC(=CC=N3)C3=CC=CN=C3)=C2)CC1	Cyclin-dependent kinase 7;+Cyclin-H;+CDK-activating kinase assembly factor MAT1	inhibition percentage	-4	%
37	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC(=CC=N3)C3=CC=CN=C3)=C2)CC1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	0.6624	%
38	OC1=CC=C(C=C1)C1=COC2=CC(O)=CC(O)=C2C1=O	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	10	%
39	OC1=CC=C(C=C1)C1=COC2=CC(O)=CC(O)=C2C1=O	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	7	%
40	COC1=CC2=C(C=C1OCCCN1CCOCC1)C(NC1=CC=C(F)C(Cl)=C1)=NC=N2	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	610	nM
41	COC1=CC2=C(C=C1OCCCN1CCOCC1)C(NC1=CC=C(F)C(Cl)=C1)=NC=N2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-4.52	%
42	COC1=CC2=C(C=C1OCCCN1CCOCC1)C(NC1=CC=C(F)C(Cl)=C1)=NC=N2	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	10000	nM
43	COC1=CC2=C(C=C1OCCCN1CCOCC1)C(NC1=CC=C(F)C(Cl)=C1)=NC=N2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	0 - 50	%
44	COC1=CC2=C(C=C1OCCCN1CCOCC1)C(NC1=CC=C(F)C(Cl)=C1)=NC=N2	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
45	COC1=CC2=C(C=C1OCCCN1CCOCC1)C(NC1=CC=C(F)C(Cl)=C1)=NC=N2	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	inhibition percentage	20	%
46	COC1=CC2=C(C=C1OCCCN1CCOCC1)C(NC1=CC=C(F)C(Cl)=C1)=NC=N2	Cyclin-dependent kinase 7;+Cyclin-H;+CDK-activating kinase assembly factor MAT1	inhibition percentage	-8	%
47	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	26.61	%
48	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	330	nM
49	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	7.7	
50	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	Cyclin-dependent kinase 7;+Cyclin-H;+CDK-activating kinase assembly factor MAT1	inhibition percentage	85	%
51	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	86.4601 - 91.2676	%
52	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	Cyclin-dependent kinase 7	inhibition rate	70	%
53	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	Cyclin-dependent kinase 7	inhibition rate	70	%
54	CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-9.13	%
55	CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	10000	nM
56	CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	0 - 50	%
57	CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
58	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-2.56	%
59	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	10000	nM
60	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
61	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1	Cyclin-dependent kinase 7	pIC50	5.15	
62	CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1	Cyclin-dependent kinase 7	pIC50	5.4	
63	CNC(=O)C1=CC=CC=C1SC1=CC=C2C(NN=C2\C=C\C2=NC=CC=C2)=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	10000	nM
64	CNC(=O)C1=CC=CC=C1SC1=CC=C2C(NN=C2\C=C\C2=NC=CC=C2)=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
65	CNC(=O)C1=CC=CC=C1SC1=CC=C2C(NN=C2\C=C\C2=NC=CC=C2)=C1	Mating-type protein MAT-1;+Cytochrome c-type biogenesis protein CycH;+Cyclin-dependent kinase 7	inhibition percentage	-7	%
66	CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC(=CC=N3)C3=CC=CN=C3)=C2)=CC(=C1)C(F)(F)F	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	10000	nM
67	CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC(=CC=N3)C3=CC=CN=C3)=C2)=CC(=C1)C(F)(F)F	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-8.94	%
68	CS(O)(=O)=O.CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC(=CC=N3)C3=CC=CN=C3)=C2)CC1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-0.56	%
69	CC1=CN(C(=O)C=C1)C1=CC=CC=C1	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	92	%
70	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=CC=C(Br)C=C3F)C2=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	4100	nM
71	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=CC=C(Br)C=C3F)C2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-2.34	%
72	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=CC=C(Br)C=C3F)C2=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	10000	nM
73	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=CC=C(Br)C=C3F)C2=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
74	COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	57	%
75	COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	9	%
76	COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	1200	nM
77	COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-12.96	%
78	COCCOC1=C(OCCOC)C=C2C(NC3=CC(=CC=C3)C#C)=NC=NC2=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	10000	nM
79	COCCOC1=C(OCCOC)C=C2C(NC3=CC(=CC=C3)C#C)=NC=NC2=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	10000	nM
80	COCCOC1=C(OCCOC)C=C2C(NC3=CC(=CC=C3)C#C)=NC=NC2=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
81	COCCOC1=C(OCCOC)C=C2C(NC3=CC(=CC=C3)C#C)=NC=NC2=C1	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	IC50	10	µM
82	COCCOC1=C(OCCOC)C=C2C(NC3=CC(=CC=C3)C#C)=NC=NC2=C1	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	IC50	10	µM
83	COCCOC1=C(OCCOC)C=C2C(NC3=CC(=CC=C3)C#C)=NC=NC2=C1	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	IC50	10	µM
84	COCCOC1=C(OCCOC)C=C2C(NC3=CC(=CC=C3)C#C)=NC=NC2=C1	Cyclin-dependent kinase 7	pIC50	4.7	
85	COCCOC1=C(OCCOC)C=C2C(NC3=CC(=CC=C3)C#C)=NC=NC2=C1	Cyclin-dependent kinase 7	pIC50	5.4	
86	COCCOC1=C(OCCOC)C=C2C(NC3=CC(=CC=C3)C#C)=NC=NC2=C1	Cyclin-dependent kinase 7;+Cyclin-H;+CDK-activating kinase assembly factor MAT1	inhibition percentage	-1	%
87	CCOC1=CC2=C(C=C1NC(=O)\C=C\CN(C)C)C(NC1=CC(Cl)=C(OCC3=NC=CC=C3)C=C1)=C(C=N2)C#N	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	5100	nM
88	O=C1C=C(OC2=C1C=CC=C2C1=CC=CC=C1)N1CCOCC1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	28	%
89	O=C1C=C(OC2=C1C=CC=C2C1=CC=CC=C1)N1CCOCC1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	12	%
90	O=C1C=C(OC2=C1C=CC=C2C1=CC=CC=C1)N1CCOCC1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	4.65	%
91	O=C1C=C(OC2=C1C=CC=C2C1=CC=CC=C1)N1CCOCC1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	281.7	nM
92	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	Cyclin-dependent kinase 7 [Candida albicans]	IC50		
93	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	97	%
94	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	95	%
95	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	56.22	%
96	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	45	nM
97	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	155	nM
98	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	910	nM
99	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	IC50	3.1	µM
100	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	41.7	%
101	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	IC50	1.4	µM
102	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	89.1	%
103	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	3.9	%
104	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	IC50	1.1	µM
105	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	87.9	%
106	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	90.5	%
107	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	IC50	1.8	µM
108	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	21	%
109	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	12.5	%
110	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.86	µM
111	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.54	µM
112	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	62	%
113	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-0.1	%
114	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	11.8	%
115	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-6.9	%
116	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	58.5	%
117	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	Cyclin-dependent kinase 7;+Cyclin-H;+CDK-activating kinase assembly factor MAT1	inhibition percentage	90	%
118	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	Cyclin-dependent kinase 5 activator 1; CDK-activating kinase assembly factor MAT1	IC50	2.0E-9	M
119	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	Cyclin-dependent kinase 7;+Cyclin-H	IC50	5.65E-8	M
120	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	CDK-activating kinase assembly factor MAT1	IC50	1.47E-7	M
121	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	Cyclin-dependent kinase 7 [human];+cyclin H [human]	IC50	5.22E-8	M
122	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	Cyclin-H;+Cyclin-dependent kinase 7	IC50	1.06E-7	M
123	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	Cyclin-H;+Cyclin-dependent kinase 7	IC50	1.83E-7	M
124	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	Cyclin-H;+Cyclin-dependent kinase 7	IC50	3.09E-8	mol/l
125	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	Cyclin-H;+Cyclin-dependent kinase 7	IC50	4.65E-7	M
126	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	IC50	1.34E-6	M
127	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	Cyclin-H;+Cyclin-dependent kinase 7	IC50	5.99E-8	M
128	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	72	nM
129	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	Cyclin-H;+Cyclin-dependent kinase 7	IC50	2.95E-6	M
130	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	Cyclin-H;+Cyclin-dependent kinase 7	IC50	7.66E-8	M
131	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	Cyclin-H;+Cyclin-dependent kinase 7	IC50	3.4E-8	M
132	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	Cyclin-H;+Cyclin-dependent kinase 7	IC50	1.19E-7	M
133	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	Cyclin-H;+Cyclin-dependent kinase 7	IC50	5.99E-8	M
134	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.12	μM
135	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	Cyclin-H;+Cyclin-dependent kinase 7	IC50	1.97E-8	μM
136	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	Cyclin-H;+Cyclin-dependent kinase 7	IC50	3.02E-8	M
137	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	Cyclin-dependent kinase 7	IC50	0.172	μM
138	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	Cyclin-dependent kinase 7; Cyclin-H	IC50	5.07E-8	M
139	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	Cyclin-dependent kinase 7	IC50	72.1	nM
140	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	Cyclin-dependent kinase 7	IC50	1.65E-8	M
141	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	Probable cyclin-H;+Cyclin-dependent kinase 7	IC50	4.94E-8	M
142	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	Cyclin-dependent kinase 7; Cyclin-H	IC50	4.184E-8	M
143	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-dependent kinase 7;+Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	798	nM
144	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	94	%
145	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	96	%
146	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.513	µM
147	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.54	µM
148	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-dependent kinase 7 [human];+Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	IC50	0.52	µM
149	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	11.37	%
150	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-dependent kinase 7;+Cyclin-H	IC50	0.49	µM
151	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	IC50	0.5	µM
152	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	1800	nM
153	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	IC50	0.49	µM
154	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.51	µM
155	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	IC50	7.5	µM
156	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	inhibition percentage	50	%
157	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	0.8	µM
158	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	IC50	0.513	µM
159	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1.7	µM
160	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	0.8	µM
161	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	IC50	0.8	µM
162	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	IC50	0.8	µM
163	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	26	%
164	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	7.1	
165	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	IC50	0.8	µM
166	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.48	µM
167	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	0.88	µM
168	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	0.5	µM
169	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	0.88	µM
170	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.25	µM
171	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	0.5	µM
172	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-dependent kinase 7;+Cyclin-H	IC50	0.49	µM
173	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	0.48	μM
174	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-dependent kinase 7 [human]	IC50	2.5	μM
175	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-dependent kinase 7 [human]	IC50	2.5	μM
176	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-dependent kinase 7 [human]	IC50	22	μM
177	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-dependent kinase 7 [human]	IC50	22	μM
178	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-dependent kinase 7 [human]	IC50	22	μM
179	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-dependent kinase 7 [human]	IC50	5.4	μM
180	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	7.5	µM
181	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	49	µM
182	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	580	nM
183	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-H; Cyclin-dependent kinase 7	IC50	630	nM
184	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	Cyclin-dependent kinase 7	IC50	2.2	μM
185	CC[C@H](CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2)=N1	CDK-activating kinase assembly factor MAT1;+Cyclin-K; Cell division cycle 7-related protein kinase	IC50	1.789	μM
186	COC1=CC2=C(C=C1OCCCN1CCCC1)N=CN=C2OC1=C(F)C2=C(NC(C)=C2)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	10000	nM
187	COC1=CC2=C(C=C1OCCCN1CCCC1)N=CN=C2OC1=C(F)C2=C(NC(C)=C2)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
188	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CC=C2C)=CC(=N1)N1CCN(CCO)CC1	Cyclin-dependent kinase 7	pIC50	4.7	
189	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CC=C2C)=CC(=N1)N1CCN(CCO)CC1	Cyclin-dependent kinase 7	pIC50	5.4	
190	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CC=C2C)=CC(=N1)N1CCN(CCO)CC1	Cyclin-dependent kinase 7;+Cyclin-H;+CDK-activating kinase assembly factor MAT1	inhibition percentage	-2	%
191	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CC=C2C)=CC(=N1)N1CCN(CCO)CC1	Cyclin-dependent kinase 7	Ki (inhibition constant)	5.05	μM
192	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CC=C2C)=CC(=N1)N1CCN(CCO)CC1	CDK-activating kinase assembly factor MAT1;+Cytochrome c-type biogenesis protein CycH;+Cyclin-dependent kinase 7	inhibition rate	75	%
193	O=S(=O)(N1CCCNCC1)C1=CC=CC2=C1C=CN=C2	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.6	
194	COC1=CC2=C(C=C1)C1=C(N2)C(C)=NC=C1	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	IC50	10	µM
195	COC1=CC2=C(C=C1)C1=C(N2)C(C)=NC=C1	Cyclin-dependent kinase 7	inhibition percentage	79	%
196	COC1=CC2=C(C=C1)C1=C(N2)C(C)=NC=C1	Cyclin-dependent kinase 7	inhibition rate	79	%
197	CN1CC[C@H]([C@@H](O)C1)C1=C2OC(=CC(=O)C2=C(O)C=C1O)C1=C(Cl)C=CC=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	7	
198	CN1CC[C@H]([C@@H](O)C1)C1=C2OC(=CC(=O)C2=C(O)C=C1O)C1=C(Cl)C=CC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	0.11	µM
199	CN1CC[C@H]([C@@H](O)C1)C1=C2OC(=CC(=O)C2=C(O)C=C1O)C1=C(Cl)C=CC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	0.3	µM
200	CN1CC[C@H]([C@@H](O)C1)C1=C2OC(=CC(=O)C2=C(O)C=C1O)C1=C(Cl)C=CC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	400	nM
201	CN1CC[C@H]([C@@H](O)C1)C1=C2OC(=CC(=O)C2=C(O)C=C1O)C1=C(Cl)C=CC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	0.4	µM
202	COC1=CC=CC(=C1N)C1=CC(=O)C2=C(O1)C=CC=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	0.08	%
203	COC1=CC=C(C=C(C#N)C#N)C=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-3.91	%
204	CC(=O)C1=C(O)C(C)=C(O)C(CC2=C(O)C(C(=O)\C=C\C3=CC=CC=C3)=C3OC(C)(C)C=CC3=C2O)=C1O	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-17	%
205	CC(=O)C1=C(O)C(C)=C(O)C(CC2=C(O)C(C(=O)\C=C\C3=CC=CC=C3)=C3OC(C)(C)C=CC3=C2O)=C1O	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-16	%
206	COC1=C(O)C2=C(OC(=CC2=O)C2=CC=C(O)C=C2)C=C1O	Cyclin-dependent kinase 7	inhibition rate	11	%
207	NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-20	%
208	NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C	CDK-activating kinase assembly factor MAT1;+Cytochrome c-type biogenesis protein CycH;+Cyclin-dependent kinase 7	inhibition percentage	-3.7	%
209	ClC1=CC=C(NC2=NN=C(CC3=CC=NC=C3)C3=C2C=CC=C3)C=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-7.23	%
210	ClC1=CC=C(NC2=NN=C(CC3=CC=NC=C3)C3=C2C=CC=C3)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	10000	nM
211	ClC1=CC=C(NC2=NN=C(CC3=CC=NC=C3)C3=C2C=CC=C3)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
212	ClC1=CC=C(NC2=NN=C(CC3=CC=NC=C3)C3=C2C=CC=C3)C=C1	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	7	%
213	CS(=O)C1=CC=C(C=C1)C1=NC(=C(N1)C1=CC=NC=C1)C1=CC=C(F)C=C1	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	10.5	%
214	CS(=O)C1=CC=C(C=C1)C1=NC(=C(N1)C1=CC=NC=C1)C1=CC=C(F)C=C1	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-2.2	%
215	CS(=O)C1=CC=C(C=C1)C1=NC(=C(N1)C1=CC=NC=C1)C1=CC=C(F)C=C1	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	IC50	10	µM
216	CS(=O)C1=CC=C(C=C1)C1=NC(=C(N1)C1=CC=NC=C1)C1=CC=C(F)C=C1	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-7.5	%
217	CS(=O)C1=CC=C(C=C1)C1=NC(=C(N1)C1=CC=NC=C1)C1=CC=C(F)C=C1	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	3.2	%
218	O=C1C2=C3C(NN=C3C3=C1C=CC=C3)=CC=C2	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	inhibition percentage	74	%
219	O=C1C2=C3C(NN=C3C3=C1C=CC=C3)=CC=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	77	%
220	O=C1C2=C3C(NN=C3C3=C1C=CC=C3)=CC=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	64	%
221	O=C1C2=C3C(NN=C3C3=C1C=CC=C3)=CC=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	5.29	%
222	O=C1C2=C3C(NN=C3C3=C1C=CC=C3)=CC=C2	CDK-activating kinase assembly factor MAT1 [human]	inhibition percentage	67	%
223	CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	10000	nM
224	[H][C@@]12CCC(=O)[C@@]1(C)C[C@@H](OC(C)=O)C1=C2C(=O)C2=C3C(=CO2)C(=O)O[C@H](COC)[C@]13C	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	4	%
225	[H][C@@]12CCC(=O)[C@@]1(C)C[C@@H](OC(C)=O)C1=C2C(=O)C2=C3C(=CO2)C(=O)O[C@H](COC)[C@]13C	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	1	%
226	[H][C@@]12CCC(=O)[C@@]1(C)C[C@@H](OC(C)=O)C1=C2C(=O)C2=C3C(=CO2)C(=O)O[C@H](COC)[C@]13C	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	6.73	%
227	CN1C(=O)N(C2=C1C=NC1=CC=C(C=C21)C1=CC2=CC=CC=C2N=C1)C1=CC=C(C=C1)C(C)(C)C#N	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	6.3	
228	CN1C(=O)N(C2=C1C=NC1=CC=C(C=C21)C1=CC2=CC=CC=C2N=C1)C1=CC=C(C=C1)C(C)(C)C#N	Cyclin-dependent kinase 7	pIC50	5.98	
229	CN1C(=O)N(C2=C1C=NC1=CC=C(C=C21)C1=CC2=CC=CC=C2N=C1)C1=CC=C(C=C1)C(C)(C)C#N	Cyclin-dependent kinase 7	pIC50	4.91	
230	CN1C(=O)N(C2=C1C=NC1=CC=C(C=C21)C1=CC2=CC=CC=C2N=C1)C1=CC=C(C=C1)C(C)(C)C#N	Cyclin-dependent kinase 7	pIC50	6.8	
231	CN1C(=O)N(C2=C1C=NC1=CC=C(C=C21)C1=CC2=CC=CC=C2N=C1)C1=CC=C(C=C1)C(C)(C)C#N	Cyclin-dependent kinase 7	pIC50	6.3	
232	CS(=O)C1=CC=C(C=C1)C1=NC(=C(N1)C1=CC=C(F)C=C1)C1=CC=NC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-4	%
233	CS(=O)C1=CC=C(C=C1)C1=NC(=C(N1)C1=CC=C(F)C=C1)C1=CC=NC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-7	%
234	CS(=O)C1=CC=C(C=C1)C1=NC(=C(N1)C1=CC=C(F)C=C1)C1=CC=NC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	3.17	%
235	CS(=O)C1=CC=C(C=C1)C1=NC(=C(N1)C1=CC=C(F)C=C1)C1=CC=NC=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	10000	nM
236	CS(=O)C1=CC=C(C=C1)C1=NC(=C(N1)C1=CC=C(F)C=C1)C1=CC=NC=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
237	CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl	Cyclin-dependent kinase 7 [Candida albicans]	IC50		
238	CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	246	nM
239	CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.514	µM
240	CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	23	nM
241	CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl	Cyclin-dependent kinase 7;+Cyclin-H	IC50	0.4	µM
242	CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	inhibition percentage	82	%
243	CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	inhibition percentage	94	%
244	CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	IC50	0.514	µM
245	CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	875	nM
246	CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	84	%
247	CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	94	%
248	CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	110 - 300	nM
249	CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	0.3	µM
250	CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	70	nM
251	CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	400	nM
252	CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.3	µM
253	CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl	Cyclin-dependent kinase 2 [human];+Cyclin-dependent kinase 9 [human];+Cyclin-dependent-like kinase 5 [human]; Cyclin-dependent kinase 7 [human]; Cyclin-dependent kinase 1 [human]; Cyclin-dependent kinase 3 [human]	IC50	594.29	nM
254	CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl	Cyclin-dependent kinase 2 [human];+Cyclin-dependent kinase 9 [human];+Cyclin-dependent-like kinase 5 [human]; Cyclin-dependent kinase 7 [human]; Cyclin-dependent kinase 1 [human]; Cyclin-dependent kinase 3 [human]	IC50	427.26	nM
255	CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl	Cyclin-dependent kinase 2 [human];+Cyclin-dependent kinase 9 [human];+Cyclin-dependent-like kinase 5 [human]; Cyclin-dependent kinase 7 [human]; Cyclin-dependent kinase 1 [human]; Cyclin-dependent kinase 3 [human]	IC50	540.87	nM
256	CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=NC=C(C=C23)C2=CC=C(Cl)C=C2)=C1F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	inhibition percentage	10	%
257	C[C@@H](OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C(F)=CC=C1Cl	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	330	nM
258	C[C@@H](OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C(F)=CC=C1Cl	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	6.2	
259	C[C@@H](OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C(F)=CC=C1Cl	Cyclin-dependent kinase 7	pIC50	6.43	
260	C[C@@H](OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C(F)=CC=C1Cl	Cyclin-dependent kinase 7	pIC50	6.2	
261	COC1=C2C3=C(OC)C=C(O)C4=C3C(C(CC(C)OC(=O)C3=CC=CC=C3)=C(OC)C4=O)=C3C(CC(C)OC(=O)OC4=CC=C(O)C=C4)=C(OC)C(=O)C(C(O)=C1)=C23	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	0	%
262	COC1=C2C3=C(OC)C=C(O)C4=C3C(C(CC(C)OC(=O)C3=CC=CC=C3)=C(OC)C4=O)=C3C(CC(C)OC(=O)OC4=CC=C(O)C=C4)=C(OC)C(=O)C(C(O)=C1)=C23	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	10	%
263	CC(=O)C1=C(C)C2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N(C2CCCC2)C1=O	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.3	
264	CC(=O)C1=C(C)C2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N(C2CCCC2)C1=O	Cyclin-dependent kinase 7	pIC50	5.25	
265	CC(=O)C1=C(C)C2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N(C2CCCC2)C1=O	Cyclin-dependent kinase 7	pIC50	4.74	
266	CC(=O)C1=C(C)C2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N(C2CCCC2)C1=O	Cyclin-dependent kinase 7	pIC50	5.4	
267	CC(=O)C1=C(C)C2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N(C2CCCC2)C1=O	Cyclin-dependent kinase 7	pIC50	5.3	
268	CC(=O)C1=C(C)C2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N(C2CCCC2)C1=O	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	10	μM
269	CC(=O)C1=C(C)C2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N(C2CCCC2)C1=O	Cyclin-dependent kinase 7	pIC50	5	no unit
270	CC(=O)C1=C(C)C2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N(C2CCCC2)C1=O	Cyclin-H;+Cyclin-dependent kinase 7	IC50	3333	nM
271	CC(=O)C1=C(C)C2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N(C2CCCC2)C1=O	CDK-activating kinase assembly factor MAT1;+Cyclin-K; Cell division cycle 7-related protein kinase	IC50	50	μM
272	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	3300	nM
273	N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
274	CS(=O)(=O)N1CCN(CC2=CC3=NC(=NC(N4CCOCC4)=C3S2)C2=CC=CC3=C2C=NN3)CC1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	10000	nM
275	CS(=O)(=O)N1CCN(CC2=CC3=NC(=NC(N4CCOCC4)=C3S2)C2=CC=CC3=C2C=NN3)CC1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
276	CC1(C)CNC2=C1C=CC(NC(=O)C1=CC=CN=C1NCC1=CC=NC=C1)=C2	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	10000	nM
277	CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	10000	nM
278	CCOC1=CC2=C(C=C1NC(=O)\C=C\CN(C)C)C(NC1=CC(Cl)=C(F)C=C1)=C(C=N2)C#N	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	10000	nM
279	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1C=C(Cl)C(Cl)=C2	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.6	
280	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1C=C(Cl)C(Cl)=C2	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	10	µM
281	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1C=C(Cl)C(Cl)=C2	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	10	µM
282	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1C=C(Cl)C(Cl)=C2	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	Kd (dissociation constant)	10	µM
283	Cl[H].COCCOC1=C(OCCOC)C=C2C(NC3=CC(=CC=C3)C#C)=NC=NC2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-6.68	%
284	Cl[H].COCCOC1=C(OCCOC)C=C2C(NC3=CC(=CC=C3)C#C)=NC=NC2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	0 - 50	%
285	CN1C=C(C2=CC=CC=C12)C1=C(C(=O)NC1=O)C1=CN(C2CCN(CC3=CC=CC=N3)CC2)C2=CC=CC=C12	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	2600	nM
286	CN(C)C(=O)C1=CC2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N1C1CCCC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	10 - 20	μM
287	C(CN1CCCCC1)OC1=CC=C(C=C1)C1=CN2N=CC(=C2N=C1)C1=CC=NC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	16.3	%
288	C[C@@H]1CCN(C[C@@H]1N(C)C1=NC=NC2=C1C=CN2)C(=O)CC#N	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-18.78	%
289	C[C@@H]1CCN(C[C@@H]1N(C)C1=NC=NC2=C1C=CN2)C(=O)CC#N	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	10000	nM
290	C[C@@H]1CCN(C[C@@H]1N(C)C1=NC=NC2=C1C=CN2)C(=O)CC#N	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
291	C[C@@H]1CCN(C[C@@H]1N(C)C1=NC=NC2=C1C=CN2)C(=O)CC#N	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	10	μM
292	CN(C)CCCN1C=C(C2=C1C=CC=C2)C1=C(C(=O)NC1=O)C1=CNC2=C1C=CC=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	7.87	%
293	CC1=CC=C(C=C1)N1N=C(C=C1NC(=O)NC1=CC=C(OCCN2CCOCC2)C2=CC=CC=C12)C(C)(C)C	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	3100	nM
294	CC1=CC=C(C=C1)N1N=C(C=C1NC(=O)NC1=CC=C(OCCN2CCOCC2)C2=CC=CC=C12)C(C)(C)C	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	10000	nM
295	CC1=CC=C(C=C1)N1N=C(C=C1NC(=O)NC1=CC=C(OCCN2CCOCC2)C2=CC=CC=C12)C(C)(C)C	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
296	CC1=CC=C(C=C1)N1N=C(C=C1NC(=O)NC1=CC=C(OCCN2CCOCC2)C2=CC=CC=C12)C(C)(C)C	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	IC50	10	µM
297	CC1=CC=C(C=C1)N1N=C(C=C1NC(=O)NC1=CC=C(OCCN2CCOCC2)C2=CC=CC=C12)C(C)(C)C	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	IC50	10	µM
298	CC1=CC=C(C=C1)N1N=C(C=C1NC(=O)NC1=CC=C(OCCN2CCOCC2)C2=CC=CC=C12)C(C)(C)C	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	IC50	10	µM
299	CC1=CC=C(C=C1)N1N=C(C=C1NC(=O)NC1=CC=C(OCCN2CCOCC2)C2=CC=CC=C12)C(C)(C)C	Cyclin-dependent kinase 7	pIC50	4.7	
300	CC1=CC=C(C=C1)N1N=C(C=C1NC(=O)NC1=CC=C(OCCN2CCOCC2)C2=CC=CC=C12)C(C)(C)C	Cyclin-dependent kinase 7	pIC50	5.4	
301	CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C(F)=C2)=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-10.3391 - -7.233	%
302	CC1=C(SC(NC(=O)N2CCC[C@H]2C(N)=O)=N1)C1=CC(=NC=C1)C(C)(C)C(F)(F)F	Cyclin-dependent kinase 7	inhibition rate	0	%
303	CN1N=C(N)C2=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C3=C2C1=NC=N3	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	0.98	%
304	CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)OC(C)(C)C)N=C2C1=CC=C(Cl)C=C1	Bromodomain-containing protein 4 [human];+Cyclin-dependent kinase 7 [human]	inhibition rate		
305	CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)OC(C)(C)C)N=C2C1=CC=C(Cl)C=C1	Bromodomain-containing protein 4 [human];+Cyclin-dependent kinase 7 [human]	inhibition rate		
306	OC(=O)CCC(O)=O.ClC1=CC=C(NC2=NN=C(CC3=CC=NC=C3)C3=C2C=CC=C3)C=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	7	%
307	BrC1=CC=C2NC3=C(CC(=O)NC4=CC=CC=C34)C2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	4.86	%
308	CN1C=NC2=C1N=C(NCCO)N=C2NCC1=CC=CC=C1	Cyclin-dependent kinase 7 [Candida albicans]	IC50		
309	CN1C=NC2=C1N=C(NCCO)N=C2NCC1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	77	%
310	CN1C=NC2=C1N=C(NCCO)N=C2NCC1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	70	%
311	CN1C=NC2=C1N=C(NCCO)N=C2NCC1=CC=CC=C1	Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	IC50	20	µM
312	CC1=CC=C(C=C1)S(=O)(=O)\C=C\C#N	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	1.75	%
313	CC(C)(C)N1N=C(C2=C(N)N=CN=C12)C1=CC=C(Cl)C=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	8	%
314	CC(C)(C)N1N=C(C2=C(N)N=CN=C12)C1=CC=C(Cl)C=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-4	%
315	CC(C)(C)N1N=C(C2=C(N)N=CN=C12)C1=CC=C(Cl)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
316	[Cl-].COC1=C(OC)C2=C(C=C1)C1=CC=C3C=C4OCOC4=CC3=C1[N+](C)=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	8.15	%
317	CN1C(NC2=CC=C(C=C2)C(F)(F)F)=NC2=C1C=CC(OC1=CC=NC(=C1)C1=NC=C(N1)C(F)(F)F)=C2	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	10000	nM
318	[H][C@@]1(CC[C@@H](CC1)C(=O)NC1=CC=NC=C1)[C@@H](C)N	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
319	BrC1=CC=C(\C=C\CNCCNS(=O)(=O)C2=CC=CC3=C2C=CN=C3)C=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	79	%
320	BrC1=CC=C(\C=C\CNCCNS(=O)(=O)C2=CC=CC3=C2C=CN=C3)C=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	73	%
321	BrC1=CC=C(\C=C\CNCCNS(=O)(=O)C2=CC=CC3=C2C=CN=C3)C=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	17.2	%
322	BrC1=CC=C(\C=C\CNCCNS(=O)(=O)C2=CC=CC3=C2C=CN=C3)C=C1	Cyclin-dependent kinase 7 [human]	IC50	0.432	µM
323	COC1=CC2=C(C=C1OC)C(NC1=CC(Cl)=CC=C1)=NC=N2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	12	%
324	COC1=CC2=C(C=C1OC)C(NC1=CC(Cl)=CC=C1)=NC=N2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	6	%
325	COC1=CC2=C(C=C1OC)C(NC1=CC(Cl)=CC=C1)=NC=N2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	0.14	%
326	FC1=C(F)C(NC2=CC=C(I)C=C2Cl)=C(C=C1)C(=O)NOCC1CC1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	0	%
327	FC1=C(F)C(NC2=CC=C(I)C=C2Cl)=C(C=C1)C(=O)NOCC1CC1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	0	%
328	FC1=C(F)C(NC2=CC=C(I)C=C2Cl)=C(C=C1)C(=O)NOCC1CC1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	10000	nM
329	CN(C)C1CCN(CC1)C(=O)C1=CC=C(NC(=O)NC2=CC=C(C=C2)C2=NC(=NC(=N2)N2CCOCC2)N2CCOCC2)C=C1	Cyclin-dependent kinase 7	inhibition rate	14	%
330	CC1=CC(C)=C(N1)\C=C1/C(=O)NC2=CC=CC=C12	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-2.57	%
331	[H][C@@]12C[C@@H]3O[C@@]33[C@H](O)[C@]4(O[C@H]4[C@@H]4O[C@]34[C@@]1(C)CCC1=C2COC1=O)C(C)C	Cyclin-dependent kinase 7 [human]	inhibition percentage		
332	[H][C@@]12C[C@@H]3O[C@@]33[C@H](O)[C@]4(O[C@H]4[C@@H]4O[C@]34[C@@]1(C)CCC1=C2COC1=O)C(C)C	Cyclin-dependent kinase 7 [human]	inhibition percentage		
333	CN1C2=C(C=CC=C2)C2=C1C1=C(C3=C2C(=O)NC3)C2=C(C=CC=C2)N1CCC#N	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	15.45	%
334	CO[C@H]1C[C@H](C)[C@@H](OC)C2=CC(=O)C=C(NC(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1OC)C2=O	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	6	%
335	CO[C@H]1C[C@H](C)[C@@H](OC)C2=CC(=O)C=C(NC(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1OC)C2=O	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	4	%
336	CO[C@H]1C[C@H](C)[C@@H](OC)C2=CC(=O)C=C(NC(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1OC)C2=O	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-7.81	%
337	CN(C)C[C@@H]1CCN2C=C(C3=C2C=CC=C3)C2=C(C(=O)NC2=O)C2=CN(CCO1)C1=C2C=CC=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	1700	nM
338	CN(C)C[C@@H]1CCN2C=C(C3=C2C=CC=C3)C2=C(C(=O)NC2=O)C2=CN(CCO1)C1=C2C=CC=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	10000	nM
339	CN(C)C[C@@H]1CCN2C=C(C3=C2C=CC=C3)C2=C(C(=O)NC2=O)C2=CN(CCO1)C1=C2C=CC=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.6	
340	CC1=CC(NC(=O)NC2=CC=C(C=C2)C2=CC=CC3=C2C(N)=NN3)=C(F)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	2900	nM
341	CC1=CC(NC(=O)NC2=CC=C(C=C2)C2=CC=CC3=C2C(N)=NN3)=C(F)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
342	CCN1CCN(CC2=CC=C(NC3=NC=C(F)C(=N3)C3=CC4=C(N=C(C)N4C(C)C)C(F)=C3)N=C2)CC1	Cyclin-H; Cyclin-dependent kinase 7; CDK-activating kinase assembly factor MAT1	IC50	3.112	μM
343	CCN1CCN(CC2=CC=C(NC3=NC=C(F)C(=N3)C3=CC4=C(N=C(C)N4C(C)C)C(F)=C3)N=C2)CC1	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	225.9 - 667.1	nM
344	CCN1CCN(CC2=CC=C(NC3=NC=C(F)C(=N3)C3=CC4=C(N=C(C)N4C(C)C)C(F)=C3)N=C2)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	3.1	μM
345	CCN1CCN(CC2=CC=C(NC3=NC=C(F)C(=N3)C3=CC4=C(N=C(C)N4C(C)C)C(F)=C3)N=C2)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
346	CCN1CCN(CC2=CC=C(NC3=NC=C(F)C(=N3)C3=CC4=C(N=C(C)N4C(C)C)C(F)=C3)N=C2)CC1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	1596	nM
347	CCN1CCN(CC2=CC=C(NC3=NC=C(F)C(=N3)C3=CC4=C(N=C(C)N4C(C)C)C(F)=C3)N=C2)CC1	CDK-activating kinase assembly factor MAT1;+Cyclin-K; Cell division cycle 7-related protein kinase	IC50	50	μM
348	CCN1CCN(CC2=CC=C(NC3=NC=C(F)C(=N3)C3=CC4=C(N=C(C)N4C(C)C)C(F)=C3)N=C2)CC1	Cyclin-dependent kinase 7	Ki (inhibition constant)	10	μM
349	OC1=C(O)C=C(\C=C(/C#N)C(=O)NCC2=CC=CC=C2)C=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-19.77	%
350	OC(=O)C1=CC=C(NC2=NC3=C(CN=C(C4=C3C=CC(Cl)=C4)C3=C(F)C=CC=C3F)C=N2)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	10000	nM
351	OC(=O)C1=CC=C(NC2=NC3=C(CN=C(C4=C3C=CC(Cl)=C4)C3=C(F)C=CC=C3F)C=N2)C=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage		
352	OC(=O)C1=CC=C(NC2=NC3=C(CN=C(C4=C3C=CC(Cl)=C4)C3=C(F)C=CC=C3F)C=N2)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
353	OC(=O)C1=CC=C(NC2=NC3=C(CN=C(C4=C3C=CC(Cl)=C4)C3=C(F)C=CC=C3F)C=N2)C=C1	Cyclin-dependent kinase 7	pIC50	4.78	
354	OC(=O)C1=CC=C(NC2=NC3=C(CN=C(C4=C3C=CC(Cl)=C4)C3=C(F)C=CC=C3F)C=N2)C=C1	Cyclin-dependent kinase 7	pIC50	5.4	
355	COC1=C(OCCCN2CCCCC2)C=C2N=CN=C(N3CCN(CC3)C(=O)NC3=CC=C(OC(C)C)C=C3)C2=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	3100	nM
356	COC1=C(OCCCN2CCCCC2)C=C2N=CN=C(N3CCN(CC3)C(=O)NC3=CC=C(OC(C)C)C=C3)C2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-8.57	%
357	COC1=C(OCCCN2CCCCC2)C=C2N=CN=C(N3CCN(CC3)C(=O)NC3=CC=C(OC(C)C)C=C3)C2=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	10000	nM
358	COC1=C(OCCCN2CCCCC2)C=C2N=CN=C(N3CCN(CC3)C(=O)NC3=CC=C(OC(C)C)C=C3)C2=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
359	CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCNCC3)S2)O1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	58	nM
360	CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCNCC3)S2)O1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	31	nM
361	CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCNCC3)S2)O1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	6.9	
362	CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCNCC3)S2)O1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	62	nM
363	CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCNCC3)S2)O1	G1/S-specific cyclin-D3 [rat];+Cyclin-dependent kinase 7 [rat]	IC50	0.062	µM
364	CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCNCC3)S2)O1	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.062	µM
365	CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCNCC3)S2)O1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	0.0062	µM
366	CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCNCC3)S2)O1	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	IC50	62	nM
367	CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCNCC3)S2)O1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	0.062	µM
368	CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCNCC3)S2)O1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.06	µM
369	CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCNCC3)S2)O1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	0.068	µM
370	CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCNCC3)S2)O1	Cyclin-dependent kinase 7	IC50	25	nM
371	CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCNCC3)S2)O1	Cyclin-dependent kinase 2 [Haemonchus contortus];+Cyclin-dependent kinase 9 [Haemonchus contortus];+Cyclin-dependent kinase 7 [Haemonchus contortus]	inhibition percentage	70	%
372	CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCNCC3)S2)O1	Cyclin-dependent kinase 2 [Haemonchus contortus];+Cyclin-dependent kinase 9 [Haemonchus contortus];+Cyclin-dependent kinase 7 [Haemonchus contortus]	inhibition percentage		
373	CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCNCC3)S2)O1	Cyclin-dependent kinase 2 [Haemonchus contortus];+Cyclin-dependent kinase 9 [Haemonchus contortus];+Cyclin-dependent kinase 7 [Haemonchus contortus]	IC50	1.3	μM
374	CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCNCC3)S2)O1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	0.29	μM
375	CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCNCC3)S2)O1	Cyclin-dependent kinase 7	pIC50	6.48	no unit
376	CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCNCC3)S2)O1	Cyclin-H; Cyclin-dependent kinase 7	IC50	60	nM
377	CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCNCC3)S2)O1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	184	nM
378	CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCNCC3)S2)O1	Cyclin-dependent kinase 2 [human];+Cyclin-dependent kinase 9 [human];+Cyclin-dependent-like kinase 5 [human]; Cyclin-dependent kinase 7 [human]; Cyclin-dependent kinase 1 [human]; Cyclin-dependent kinase 3 [human]	inhibition rate		
379	CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCNCC3)S2)O1	Cyclin-dependent kinase 2 [human];+Cyclin-dependent kinase 9 [human];+Cyclin-dependent-like kinase 5 [human]; Cyclin-dependent kinase 7 [human]; Cyclin-dependent kinase 1 [human]; Cyclin-dependent kinase 3 [human]	inhibition rate		
380	CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCNCC3)S2)O1	Cyclin-dependent kinase 2 [human];+Cyclin-dependent kinase 9 [human];+Cyclin-dependent-like kinase 5 [human]; Cyclin-dependent kinase 7 [human]; Cyclin-dependent kinase 1 [human]; Cyclin-dependent kinase 3 [human]	IC50	609.51	nM
381	CO[C@@H](C(=O)N1CC2=C(C1)C(NC(=O)C1=CC=C(C=C1)N1CCN(C)CC1)=NN2)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	8	
382	CO[C@@H](C(=O)N1CC2=C(C1)C(NC(=O)C1=CC=C(C=C1)N1CCN(C)CC1)=NN2)C1=CC=CC=C1	Cyclin-dependent kinase 7	pIC50	7.4	
383	CO[C@@H](C(=O)N1CC2=C(C1)C(NC(=O)C1=CC=C(C=C1)N1CCN(C)CC1)=NN2)C1=CC=CC=C1	Cyclin-dependent kinase 7	pIC50	8	
384	C[C@H](O)C(=O)N1CCN(CC2=C(C)C3=NC(=NC(N4CCOCC4)=C3S2)C2=CN=C(N)N=C2)CC1	Cyclin-dependent kinase 7	inhibition rate	55	%
385	C[C@]12O[C@H](C[C@]1(O)CO)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C3C(=O)NC4)C3=C(C=CC=C3)N21	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	87	nM
386	COCCOC1=CC=C(NC2=NC=C(F)C(NC3=CC(NC(=O)C=C)=CC=C3)=N2)C=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	0	%
387	ClC1=CC=CC(Cl)=C1C(=O)NC1=CNN=C1C(=O)NC1CCNCC1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	2.8	µM
388	ClC1=CC=CC(Cl)=C1C(=O)NC1=CNN=C1C(=O)NC1CCNCC1	Cyclin-H; Cyclin-dependent kinase 7	IC50	2500	nM
389	ClC1=CC=CC(Cl)=C1C(=O)NC1=CNN=C1C(=O)NC1CCNCC1	Cyclin-dependent kinase 7 [human]	inhibition percentage	11.3	%
390	CN1N=CC2=C1N=C(N=C2NC1=C(C)C=CC(=C1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C1=CC=CN=C1	Cyclin-dependent kinase 7	Kd (dissociation constant)	24.5234	nM
391	CN1N=CC2=C1N=C(N=C2NC1=C(C)C=CC(=C1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C1=CC=CN=C1	CDK-activating kinase assembly factor MAT1	Kd (dissociation constant)	8.53255	nM
392	CC(C)N1N=C(C2=C(N)N=CN=C12)C1=CC2=C(OC(N)=N2)C=C1	Cyclin-dependent kinase 7	inhibition percentage	27	%
393	CC[C@H](NC1=NC=NC2=C1NC=N2)C1=NC2=C(C(F)=CC=C2)C(=O)N1C1=CC=CC=C1	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage	-0.67 - 1.94	%
394	CC1=CNC(=N1)C1=C(N=C(NCCNC2=CC=C(C=N2)C#N)N=C1)C1=CC=C(Cl)C=C1Cl	Cell division protein kinase 2 homolog [human]	IC50	8.8	μM
395	CN1SC(=O)N(CC2=CC=CC=C2)C1=O	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	3.15	%
396	O=C1CC2=C(NC3=C2C=C(C=C3)N(=O)=O)C2=C(N1)C=CC=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	4	%
397	O=C1CC2=C(NC3=C2C=C(C=C3)N(=O)=O)C2=C(N1)C=CC=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-2	%
398	O=C1CC2=C(NC3=C2C=C(C=C3)N(=O)=O)C2=C(N1)C=CC=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	0.14	%
399	O=C1CC2=C(NC3=C2C=C(C=C3)N(=O)=O)C2=C(N1)C=CC=C2	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
400	CN1CCN(CC1)C1=CC=C(C(=O)NC2=NNC3=CC=C(CC4=CC(F)=CC(F)=C4)C=C23)C(NC2CCOCC2)=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.9	
401	[H][C@@](CC1=CC=C(OS(=O)(=O)C2=C3C=CN=CC3=CC=C2)C=C1)(N(C)S(=O)(=O)C1=C2C=CN=CC2=CC=C1)C(=O)N1CCN(CC1)C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	0.62	%
402	COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C1=CC=CS1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	inhibition percentage	87	%
403	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	10000	nM
404	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	10000	nM
405	CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1	Cyclin-dependent kinase 7	inhibition percentage	53	%
406	OC1=CC(=CC=C1)C1=NC2=C(OC3=NC=CC=C23)C(=N1)N1CCOCC1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	7200	nM
407	OC1=CC(=CC=C1)C1=NC2=C(OC3=NC=CC=C23)C(=N1)N1CCOCC1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	0.06	%
408	OC1=CC(=CC=C1)C1=NC2=C(OC3=NC=CC=C23)C(=N1)N1CCOCC1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	10000	nM
409	CC(C)N1N=C(C2=CC3=CC(O)=CC=C3N2)C2=C1N=CN=C2N	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	5500	nM
410	CC(C)N1N=C(C2=CC3=CC(O)=CC=C3N2)C2=C1N=CN=C2N	Cyclin-dependent kinase 7	Kd (dissociation constant)	5500	nM
411	CC(C)N1C(C)=NC=C1C1=NC(NC2=CC=C(C=C2)S(C)(=O)=O)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	0.821	µM
412	COC1=C(OCCCN2CCOCC2)C=C2N=CC=C(OC3=C(F)C=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3)C2=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	3.7	nM
413	COC1=C(OCCCN2CCOCC2)C=C2N=CC=C(OC3=C(F)C=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3)C2=C1	Cyclin-H;+CDK7/Cyclin (MAT)	inhibition percentage	-53	%
414	C[C@H](NC1=NC=NC2=C1N=CN2)C1=CC2=C(C(Cl)=CC=C2)C(=O)N1C1=CC=CC=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	inhibition percentage	4	%
415	C[C@H](NC1=NC=NC2=C1N=CN2)C1=CC2=C(C(Cl)=CC=C2)C(=O)N1C1=CC=CC=C1	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage	1.26 - 4.77	%
416	CN1C=C(C2=C1C=CC=C2)C1=C(C(=O)NC1=O)C1=CN(CCCSC(N)=N)C2=C1C=CC=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	94	%
417	CN1C=C(C2=C1C=CC=C2)C1=C(C(=O)NC1=O)C1=CN(CCCSC(N)=N)C2=C1C=CC=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	94	%
418	CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	Kd (dissociation constant)	120	nM
419	O=N(=O)\C=C\C1=CC=C2OCOC2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-6.51	%
420	CC#CC(=O)N1CCC[C@H]1C1=NC(=C2N1C=CN=C2N)C1=CC=C(C=C1)C(=O)NC1=NC=CC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	7	%
421	COC1=CC2=NC=NC(NC3=CC(Br)=CC=C3)=C2C=C1OC	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	7	%
422	COC1=CC2=NC=NC(NC3=CC(Br)=CC=C3)=C2C=C1OC	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	6	%
423	COC1=CC2=NC=NC(NC3=CC(Br)=CC=C3)=C2C=C1OC	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	µM
0	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100	nM
1	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	Cyclin-dependent kinase 7	IC50	6.33	nM
2	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N1CCCC(CNC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)C1	CDK/Cyclin (CDK7);+Cyclin-H	IC50	100 - 1	nM
3	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N1CCCC(C1)NC1=NC(C2=CNC3=C2C=CC=C3)=C(Cl)C=N1	CDK/Cyclin (CDK7);+Cyclin-H	IC50	100 - 1	nM
4	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)C2=CC=C(NC(=O)\C=C\CN3CCOCC3)C=C2)N=C1C1=C2C=CC=CN2N=C1	Cyclin-dependent kinase 7	IC50	100	nM
5	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)C2=CC=C(NC(=O)\C=C\CN3CCN(CC3)C3CC3)C=C2)N=C1C1=C2C=CC=CN2N=C1	Cyclin-dependent kinase 7	IC50	100	nM
6	CCN1CCN(CC2=C(C=C(NC(=O)C3=CC(OC4=CC(N)=NC=N4)=C(C)C=C3)C=C2)C(F)(F)F)CC1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	inhibition percentage	3.9	%
7	CCN1CCN(CC2=C(C=C(NC(=O)C3=CC(OC4=CC(NC(=O)C=C)=NC=N4)=C(C)C=C3)C=C2)C(F)(F)F)CC1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	inhibition percentage	66	%
8	CCN1CCN(CC2=C(C=C(NC(=O)C3=CC(OC4=CC(NC(=O)CC)=NC=N4)=C(C)C=C3)C=C2)C(F)(F)F)CC1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	inhibition percentage	33	%
9	CCN1CCN(CC2=C(C=C(NC(=O)C3=CC(OC4=CC=NC(NC5=CN(C)N=C5)=N4)=C(C)C=C3)C=C2)C(F)(F)F)CC1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	inhibition percentage	-7.3	%
10	Cl.NC1=CC=C(C=C1)C(=O)N[C@H]1CCC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(C=N1)C1CC1	Cyclin-dependent kinase 7 [human]	IC50	100 - 1	nM
11	CNC1=NC=C(OC2=CC(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)=CC=C2)C(N)=N1	Cyclin-dependent kinase 7;+Cyclin-H	inhibition percentage	4.5	%
12	CCN(CC1=C(Cl)C2=C(NC=N2)C=C1)C1=NC=CC(NC2=NNC(=C2)C2CC2)=N1	Cyclin-dependent kinase 7;+Cyclin-H	inhibition percentage	97	%
13	FC(F)(F)C1=CN=C(NC2CCOCC2)N=C1NC1=C(NC(=O)C=C)C=CC=C1	Cyclin-dependent kinase 7	inhibition percentage	75	%
14	NC1=NC=C(C=N1)C1=NC(N2CCOCC2)=C2C=CN(CCCCCCC(=O)NO)C2=N1	Cyclin-dependent kinase 7	inhibition percentage	38	%
15	OCC1=CC=CC(=C1)C1=NC(N2CCOCC2)=C2N=CN(CCCCCCC(=O)NO)C2=N1	Cyclin-dependent kinase 7	inhibition percentage	32	%
16	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)N2CCN(CC2)C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
17	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)C2CCN(CC2)C(=O)\C=C\CN2CCOCC2)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	1	μM
18	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)C2CCN(CC2)C(=O)\C=C\CN2CCOCC2)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
19	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)C2CCN(CC2)C(=O)\C=C\CN2CCOCC2)N=C1C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
20	CN(C)C\C=C\C(=O)N1CCC(CC1)C(=O)NC1=CC(NC2=NC=C(Cl)C(=N2)C2=CNC3=CC=CC=C23)=CC=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
21	ClC1=CN=C(N[C@H]2CCC[C@H](C2)NC(=O)C2CCN(CC2)C(=O)\C=C\CN2CCOCC2)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
22	ClC1=CN=C(N[C@H]2CCC[C@@H](CN3CCN(CC3)C(=O)C=C)C2)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
23	CN(C1CCN(CC1)C(=O)C=C)[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
24	CN(C1CCN(CC1)C(=O)C=C)[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
25	ClC1=CN=C(N[C@H]2CCN(C2)C(=O)C2CCN(CC2)C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100 - 1	nM
26	ClC1=CN=C(N[C@H]2CCN(C2)C(=O)C2CCN(CC2)C(=O)\C=C\CN2CCOCC2)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100 - 1	nM
27	CN(C)C\C=C\C(=O)N1CCC(CC1)C(=O)N1CC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
28	CN(C)C\C=C\C(=O)N1CCC(CC1)C(=O)N1CC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
29	ClC1=CN=C(N[C@@H]2CCN(C2)C(=O)C2CCN(CC2)C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100 - 1	nM
30	CN(C)C\C=C\C(=O)NC1=CC=C(N=C1)C(=O)NC1=CC=CC(NC2=NC=C(Cl)C(=N2)C2=CNC3=CC=CC=C23)=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
31	CN(C)C\C=C\C(=O)NC1=CN=C(C=C1)C(=O)N[C@H]1CCC[C@H](C1)NC1=NC=C(C(=N1)C1=CNC2=CC=CC=C12)C(F)(F)F	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
32	CN(C)C\C=C\C(=O)NC1=CN=C(C=C1)C(=O)N[C@H]1CCC[C@H](C1)NC1=NC=C(C(=N1)C1=CNC2=CC=CC=C12)C(F)(F)F	CDK7/cyclinH/MAT1	IC50	100	nM
33	CN(C)C\C=C\C(=O)NC1=CC=C(N=C1)C(=O)N[C@H]1CCC[C@H](C1)NC1=NC=C(C#N)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
34	CN(C)C\C=C\C(=O)NC1=CC=C(N=C1)C(=O)N[C@H]1CCC[C@H](C1)NC1=NC=C(C#N)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
35	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NCC2=NC=C(NC(=O)C=C)C=C2)N=C1C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
36	CN(C)C\C=C\C(=O)NCC(F)(F)C(=O)N[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
37	CN(C)CC=CC(=O)NC1=CN=C(CN[C@H]2CCC[C@H](C2)NC2=NC=C(Cl)C(=N2)C2=CNC3=CC=CC=C23)C=C1	CDK7/cyclinH/MAT1	IC50	100	nM
38	CN(C)C\C=C\C(=O)NC1=CC=C(N=C1)C(=O)N[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=C2C=CNC2=CC=C1	CDK7/cyclinH/MAT1	IC50	100	nM
39	CN(C)C\C=C\C(=O)NC1=CC=C(N=C1)C(=O)N[C@H]1CCC[C@H](C1)NC1=NC=C(C)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
40	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)C2=NC=C(NC(=O)C=C)C=N2)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
41	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)C2=NC=C(NC(=O)C=C)C=N2)N=C1C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
42	CN(C)C\C=C\C(=O)NC1=CN=C(C=C1)C(=O)N[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=C2C=CN(C)C2=CC=C1	CDK7/cyclinH/MAT1	IC50	100	nM
43	CN(C)C\C=C\C(=O)NC1=CN=C(N=C1)C(=O)N[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
44	CN(C)C\C=C\C(=O)NC1=CN=C(N=C1)C(=O)N[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
45	CN(C)C\C=C\C(=O)NC1=CC=C(N=C1)C(=O)N[C@H]1CCC[C@H](C1)NC1=NC(C2C(=O)NC3=CC=CC=C23)=C(Cl)C=N1	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
46	CN(C)C\C=C\C(=O)NC1=CN(CC2(O)CCC(CC2)NC2=NC=C(Cl)C(=N2)C2=CNC3=CC=CC=C23)N=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
47	CN(C)C\C=C\C(=O)N1CCN(CC1)[C@H]1CCC[C@H](C1)NC1=NC(C2C(=O)NC3=CC=CC=C23)=C(Cl)C=N1	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
48	CN(C)C\C=C\C(=O)NC1=CN=C(CN[C@@]2(C)CCC[C@H](C2)NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)C=C1	CDK7/cyclinH/MAT1	IC50	100	nM
49	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)[C@@H]2CCCN2C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
50	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)[C@@H]2CCCN2C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
51	ClC1=CN=C(N[C@@H]2CCCN(CCN3CCN(CC3)C(=O)C=C)C2)N=C1C1=CNC2=C1C=CC=C2	CDK7/cyclinH/MAT1	IC50	100	nM
52	FC1(F)C[C@H](N(C1)C(=O)C=C)C(=O)N[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
53	FC1(F)C[C@H](N(C1)C(=O)C=C)C(=O)N[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
54	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)[C@@H]2CC[C@@H](CC2)NC(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
55	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)[C@@H]2CC[C@@H](CC2)NC(=O)C=C)N=C1C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
56	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)C2CCN(CC2)C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
57	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)C2CCN(CC2)C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
58	CC1=CC2=C(NC=C2C2=NC(N[C@@H]3CCC[C@@H](C3)N3CCN(CC3)C(=O)C=C)=NC=C2Cl)C=C1	CDK7/cyclinH/MAT1	IC50	100	nM
59	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)N2CCN(CC2)C(=O)C=C)N=C1C1=NN=C2C=CC=CN12	CDK7/cyclinH/MAT1	IC50	100	nM
60	ClC1=C(N=C(N[C@@H]2CCC[C@@H](C2)N2CC[C@@H](C2)NC(=O)C=C)N=C1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
61	COC1=CC=C2NC=C(C2=C1)C1=C(Cl)C=NC(N[C@@H]2CCC[C@@H](C2)N2CCN(CC2)C(=O)C=C)=N1	CDK7/cyclinH/MAT1	IC50	1	μM
62	ClC1=C(N=C(NC23CCC(C2)(CCC3)N2CCN(CC2)C(=O)C=C)N=C1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
63	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NCC2CCN(CC2)C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
64	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NCC2CCN(CC2)C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
65	CCC1=C(N=C(N[C@@H]2CCC[C@@](C)(C2)NC(=O)C2=CC=C(NC(=O)\C=C\CN(C)C)C=N2)N=C1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
66	ClC1=C(N=C(N[C@@]23CC[C@@](C2)(CCC3)N2CCN(CC2)C(=O)C=C)N=C1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
67	ClC1=C(N=C(N[C@]23CC[C@](C2)(CCC3)N2CCN(CC2)C(=O)C=C)N=C1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
68	ClC1=C(N=C(N[C@@H]2CCC[C@@H](C2)N2CCN(CC2=O)C(=O)C=C)N=C1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
69	ClC1=CN=C(N[C@@H]2CCC[C@H](CNC3CCN(CC3)C(=O)C=C)C2)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
70	ClC1=CN=C(N[C@@H]2CCC[C@H](CNC3CCN(CC3)C(=O)C=C)C2)N=C1C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
71	Cl.NCCCCC(=O)N1CC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
72	ClC1=C(N=C(NC2=CC=CC(NC(=O)[C@@H]3CCCNC3)=C2)N=C1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
73	ClC1=C(N=C(NC2=CC=CC(NC(=O)[C@H]3CCCNC3)=C2)N=C1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
74	ClC1=C(N=C(NC2=CC=CC(NC(=O)C3CCNCC3)=C2)N=C1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
75	NC1=CN=C(C=C1)C(=O)N[C@H]1CCC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
76	NC1=CN=C(C=C1)C(=O)N[C@H]1CCC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(C=N1)C#N	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
77	NCC(F)(F)C(=O)N[C@H]1CCC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
78	ClC1=CN=C(N[C@@H]2CCC[C@H](CN3CCN(CC3)C(=O)C=C)C2)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
79	ClC1=CN=C(NC2CCN(CC3CCN(CC3)C(=O)C=C)CC2)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
80	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)[C@@H]2C[C@@H](CN2)NC(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
81	ClC1=CN=C(N[C@H]2CC[C@@H](CC2)NC(=O)C2CCCN(C2)C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
82	ClC1=CN=C(N[C@H]2CC[C@@H](CC2)NC(=O)C2CCCN(C2)C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
83	CN(C)C\C=C\C(=O)N[C@H]1CC[C@H](CC1)C(=O)NC1=CC(NC2=NC=C(Cl)C(=N2)C2=CNC3=CC=CC=C23)=CC=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
84	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)N2CCN(CC2)C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
85	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)N2CCN(CC2)C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
86	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
87	CN([C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12)C(=O)C=C	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
88	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)CCNC(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
89	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)[C@H]2CCCN2C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
90	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)[C@H]2CCCN2C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
91	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)[C@@H]2CCCN(C2)C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
92	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)[C@@H]2CCCN(C2)C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
93	CN(C)C\C=C\C(=O)NCCC1=CC2=CC=C(NC3=NC=C(Cl)C(=N3)C3=CNC4=CC=CC=C34)C=C2N1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
94	CN(C)C\C=C\C(=O)N[C@H]1CC[C@@H](CC1)C(=O)NC1=CC(NC2=NC=C(Cl)C(=N2)C2=CNC3=CC=CC=C23)=CC=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
95	CN(C)C\C=C\C(=O)N1CCC[C@H](C1)C(=O)NC1=CC(NC2=NC=C(Cl)C(=N2)C2=CNC3=CC=CC=C23)=CC=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
96	CN(C)C\C=C\C(=O)N1CCC[C@@H](C1)C(=O)NC1=CC(NC2=NC=C(Cl)C(=N2)C2=CNC3=CC=CC=C23)=CC=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
97	[O-]S(=O)(=O)C(F)(F)F.[H][C@@]1(O)[C@]([H])(O)[C@]([H])(O[C@@]1([H])N1C=NC2=C1N=CN=C2N)C(=O)NCCCCCC(=O)[N]12CC[NH]3CC[N@H]4CC[N@@H](CC1)[Zn++]234	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	inhibition percentage	4	%
98	[O-]S(=O)(=O)C(F)(F)F.[H][C@@]1(O)[C@]([H])(O)[C@]([H])(O[C@@]1([H])N1C=NC2=C1N=CN=C2N)C(=O)NCCCCCC(=O)[N]12CC[NH]3CC[N@H]4CC[N@@H](CC1)[Zn++]234	Cyclin-dependent kinase 7	inhibition percentage	14	%
99	CN(C1=CC2=C(NC=C2)C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	inhibition percentage	16	%
100	C1CCC2=C(C1)SC1=NC=NC(NN=CC3=CNC4=CC=CC=C34)=C21	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	IC50	10	μM
101	C[C@H](NC1=NC=NC(N)=C1C#N)C1=C(C2=CC=CC=C2)C(=O)N2C=C(F)C=CC2=C1	Cyclin-dependent kinase 7 [human]	inhibition percentage	15.1	%
102	CNC(=O)C1=CC=C2NN=C(CC3=CC4=C(C=C3)N(C)N=C4)C2=C1	Cyclin-dependent kinase 7;+Cyclin-H;+CDK-activating kinase assembly factor MAT1	inhibition percentage	-13	%
103	CN1C=C(C=N1)C1=CC=C(CC2=NNC3=CC=C(C=C23)C(=O)N2CC[C@@H](O)C2)C=C1	Cyclin-dependent kinase 7;+Cyclin-H;+CDK-activating kinase assembly factor MAT1	inhibition percentage	8	%
104	CN1C=C(C=N1)C1=CC=C(CC2=NNC3=CC=C(C=C23)C(=O)N2CCOCC2)C=C1	Cyclin-dependent kinase 7;+Cyclin-H;+CDK-activating kinase assembly factor MAT1	inhibition percentage	1	%
105	CNC1=NC(NC2=CC(N)=C(C)C=C2)=NC=C1C(=O)NC1=C(C)C=CC(NC(=O)C2=CC(=CC=C2)C(F)(F)F)=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	inhibition percentage	74	%
106	NC(=O)C1=CC=C(C=C1)C1=CC=C(OC2=C3C=C(SC3=CN=C2)C2=NN=NN2)C=C1	Cyclin-dependent kinase 7;+Cyclin-H	inhibition percentage	6	%
107	NC(=O)C1=CC2=C(OC3=CC=C(Cl)C=C3)C=NC(N)=C2S1	Cyclin-dependent kinase 7;+Cyclin-H	inhibition percentage	8.1	%
108	CNC(=O)C1=C(NC2=CC=CC=C2)C2=CC(OC)=C(OC)C=C2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-8	%
109	N[C@H]1CC[C@@H](CC1)NC1=NC(NCC2=CC=C(N=C2)C2=C(O)C=CC=C2)=C2N=CN(C3CCCC3)C2=N1	Cyclin-dependent kinase 7	inhibition percentage	51.96	%
110	N[C@H]1CC[C@@H](CC1)NC1=NC(NCC2=CC=C(N=C2)C2=C(O)C=CC=C2)=C2N=CN(C3CCCC3)C2=N1	Cyclin-dependent kinase 7	inhibition percentage	82.73	%
111	ClC1=C(C=C2C(=O)NC3=CC=CC=C23)C2=C(N1)C=CC=C2	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	10 - 16	μM
112	CC(=C)CN1C(=O)C2=C(SC3=C2CCCC3)N=C1SCC(=O)C1=CC=CS1	Cyclin-dependent kinase 7	inhibition percentage	32	%
113	CCC(CC)CNC1=C(C=NC2=CC=C(C=C12)C#N)C(N)=O	Cyclin-dependent kinase 7 [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-H [human]	inhibition percentage	18	%
114	OC(=O)C(F)(F)F.CN(C)C[C@@H](NC(=O)N1CC2=C(NN=C2NC(=O)C2=CC=C(NC(=O)C=C)C=C2)C1(C)C)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
115	OC(=O)C(F)(F)F.CN(C)C[C@@H](NC(=O)N1CC2=C(NN=C2NC(=O)C2=CC=C(NC(=O)C=C)C=C2)C1(C)C)C1=CC=CC=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	9.7	nM
116	OC(=O)C(F)(F)F.CN(C)C[C@@H](NC(=O)N1CC2=C(NN=C2NC(=O)C2=CC=C(NC(=O)C=C)C=C2)C1(C)C)C1=CC=CC=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	Ki (inhibition constant)	1.9	nM
117	OC(=O)C(F)(F)F.CN(C)C[C@@H](NC(=O)N1CC2=C(NN=C2NC(=O)C2=CC=C(NC(=O)C=C)C=C2)C1(C)C)C1=CC=CC=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	53.5	nM
118	OC(=O)C(F)(F)F.CN(C)C[C@@H](NC(=O)N1CC2=C(NN=C2NC(=O)C2=CC=C(NC(=O)C=C)C=C2)C1(C)C)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	inhibition percentage		
119	OC(=O)C(F)(F)F.CN(C)C[C@@H](NC(=O)N1CC2=C(NN=C2NC(=O)C2=CC=C(NC(=O)C=C)C=C2)C1(C)C)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]; Cyclin-H [human]	inhibition percentage		
120	OC(=O)C(F)(F)F.CN(C)C[C@@H](NC(=O)N1CC2=C(NN=C2NC(=O)C2=CC=C(NC(=O)C=C)C=C2)C1(C)C)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]; Cyclin-H [human]	inhibition percentage	50	%
121	OC(=O)C(F)(F)F.CCC(=O)NC1=CC=C(C=C1)C(=O)NC1=NNC2=C1CN(C(=O)N[C@H](CN(C)C)C1=CC=CC=C1)C2(C)C	Cyclin-dependent kinase 7	IC50	100	nM
122	OC(=O)C(F)(F)F.CCC(=O)NC1=CC=C(C=C1)C(=O)NC1=NNC2=C1CN(C(=O)N[C@H](CN(C)C)C1=CC=CC=C1)C2(C)C	Cyclin-dependent kinase 7 [human]	inhibition percentage		
123	CC(C)C1=CN2C(=N1)C(C(C)=O)=C(C)C1=CN=C(NC3=CC=C(C=C3)N3CCNCC3)N=C21	Cyclin-H;+Cyclin-dependent kinase 7	IC50	94.7	nM
124	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCNCC3)N=C2N2C=C(N=C12)C(C)(C)C	Cyclin-H;+Cyclin-dependent kinase 7	IC50	204	nM
125	CC(C)C1=C2N=C(N[C@H]3CC[C@H](O)CC3)N=C(NCC3=CC=CC(NC(=O)[C@@H]4CC[C@@H](CC4)NC(=O)C=C)=C3)N2N=C1	Cyclin-dependent kinase 7	IC50	1000	nM
126	CC(C)C1=C2N=C(N[C@H]3CC[C@H](O)CC3)N=C(NCC3=CC=CC(NC(=O)[C@@H]4CC[C@@H](CC4)NC(=O)C=C)=C3)N2N=C1	Cyclin-dependent kinase 7	inhibition percentage	85	%
127	CC(C)C1=C2N=C(NC3CCOCC3)N=C(NCC3=CC=CC(NC(=O)[C@@H]4CCN4C(=O)C=C)=C3)N2N=C1	Cyclin-dependent kinase 7	IC50	300	nM
128	CC(C)C1=C2N=C(NC3CCOCC3)N=C(NCC3=CC=CC(NC(=O)[C@@H]4CCN4C(=O)C=C)=C3)N2N=C1	Cyclin-dependent kinase 7	inhibition percentage	100	%
129	CC(C)C1=C2N=C(NC3CCOCC3)N=C(NCC3=CC=CC(NC(=O)[C@@H]4CCN4C(=O)C=C)=C3)N2N=C1	Cyclin-dependent kinase 7	IC50	1	μM
130	CC(C)C1=C2N=C(OC3CCN(C)CC3)N=C(NCC3=CC=CC(NC(=O)[C@H]4CC[C@@H](CC4)NC(=O)C=C)=C3)N2N=C1	Cyclin-dependent kinase 7	IC50	300	nM
131	CC(C)C1=C2N=C(OC3CCN(C)CC3)N=C(NCC3=CC=CC(NC(=O)[C@H]4CC[C@@H](CC4)NC(=O)C=C)=C3)N2N=C1	Cyclin-dependent kinase 7	inhibition percentage	94	%
132	CC(C)C1=C2N=C(OC3CCN(C)CC3)N=C(NCC3=CC=CC(NC(=O)[C@H]4CC[C@@H](CC4)NC(=O)C=C)=C3)N2N=C1	Cyclin-dependent kinase 7	IC50	10	μM
133	CCC(=O)N[C@H]1CC[C@H](CC1)C(=O)NC1=CC(CNC2=NC(OC3CCOCC3)=NC3=C(C=NN23)C(C)C)=CC=C1	Cyclin-dependent kinase 7	IC50	300.01 - 1000	nM
134	CCC(=O)N[C@H]1CC[C@H](CC1)C(=O)NC1=CC(CNC2=NC(OC3CCOCC3)=NC3=C(C=NN23)C(C)C)=CC=C1	Cyclin-dependent kinase 7	inhibition percentage	87	%
135	CCC(=O)N[C@H]1CC[C@H](CC1)C(=O)NC1=CC(CNC2=NC(OC3CCOCC3)=NC3=C(C=NN23)C(C)C)=CC=C1	Cyclin-dependent kinase 7	IC50	1 - 10	μM
136	CC(C)C1=C2N=C(OC3CCN(C)CC3)N=C(NC3=CC=CC(NC(=O)[C@@H]4CC[C@@H](CC4)NC(=O)C=C)=C3)N2N=C1	Cyclin-dependent kinase 7	IC50	1000	nM
137	CC(C)C1=C2N=C(OC3CCN(C)CC3)N=C(NC3=CC=CC(NC(=O)[C@@H]4CC[C@@H](CC4)NC(=O)C=C)=C3)N2N=C1	Cyclin-dependent kinase 7	inhibition percentage	80	%
138	COC[C@H]1CN2C=C(C=C2C(=O)N1CC1=NC(C)=CC=C1)C1=NC(NC2=CC=NN2C)=NC=C1C	Cyclin-dependent kinase 7 [human]	IC50	19.41	μM
139	CC(C)C1=C2N=C(NC3CCCOC3)N=C(NCC3=CC=CC(NC(=O)C4CCCCN4C(=O)C=C)=C3)N2N=C1	Cyclin-dependent kinase 7	IC50	300	nM
140	CN(C)C(=O)C(=CC1=CC=C(O1)C1=NC2=C(N1C1CCCCC1)C1=C(NC=C1)N=C2)C#N	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	inhibition percentage	2	%
141	C[C@@H](O)CNC1=NC(NCC2=CC=C(C=C2)C2=CC=CC=N2)=C2NN=C(C(C)C)C2=N1	Cyclin-dependent kinase 7	IC50	2780	μM
142	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=NC(F)=C(NC(=O)\C=C\CN2CCOCC2)C=C1	Cyclin-dependent kinase 7	inhibition percentage	90	%
143	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=NC(F)=C(NC(=O)\C=C\CN2CCOCC2)C=C1	Cyclin-dependent kinase 7	IC50	0.1	μM
144	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=C(F)N=C(NC(=O)\C=C\CN2CCOCC2)C=C1	Cyclin-dependent kinase 7	inhibition percentage	99	%
145	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=C(F)N=C(NC(=O)\C=C\CN2CCOCC2)C=C1	Cyclin-dependent kinase 7	IC50	0.025 - 0.1	μM
146	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CN=CC(NC(=O)\C=C\CN2CCOCC2)=C1	Cyclin-dependent kinase 7	inhibition percentage	99	%
147	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CN=CC(NC(=O)\C=C\CN2CCOCC2)=C1	Cyclin-dependent kinase 7	IC50	0.025 - 0.1	μM
148	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CC=CC(NC(=O)\C=C\CN2CCOCC2)=C1	Cyclin-dependent kinase 7	inhibition percentage	92	%
149	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CC=CC(NC(=O)\C=C\CN2CCOCC2)=C1	Cyclin-dependent kinase 7	IC50	0.1	μM
150	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CN=C(NC(=O)\C=C\CN2CCOCC2)C(F)=C1	Cyclin-dependent kinase 7	inhibition percentage	98	%
151	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CN=C(NC(=O)\C=C\CN2CCOCC2)C(F)=C1	Cyclin-dependent kinase 7	IC50	0.025 - 0.1	μM
152	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=NC(F)=C(NC(=O)\C=C\CN2CCC(F)C2)C=C1	Cyclin-dependent kinase 7	inhibition percentage	94	%
153	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=NC(F)=C(NC(=O)\C=C\CN2CCC(F)C2)C=C1	Cyclin-dependent kinase 7	IC50	0.025 - 0.1	μM
154	COC1=C(NC(=O)C=C)C=CC(=C1)C1=CC(=CC=C1)C(C)C(=O)NC1=NNC(=C1)C1CC1	Cyclin-dependent kinase 7	inhibition percentage	94	%
155	COC1=C(NC(=O)C=C)C=CC(=C1)C1=CC(=CC=C1)C(C)C(=O)NC1=NNC(=C1)C1CC1	Cyclin-dependent kinase 7	IC50	0.1	μM
156	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CC(C)=C(NC(=O)C=C)C=C1	Cyclin-dependent kinase 7	inhibition percentage	88	%
157	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CC(C)=C(NC(=O)C=C)C=C1	Cyclin-dependent kinase 7	IC50	0.1	μM
158	COC1=C(C=CC(NC(=O)C=C)=C1)C1=CC(=CC=C1)C(C)C(=O)NC1=NNC(=C1)C1CC1	Cyclin-dependent kinase 7	inhibition percentage	91	%
159	COC1=C(C=CC(NC(=O)C=C)=C1)C1=CC(=CC=C1)C(C)C(=O)NC1=NNC(=C1)C1CC1	Cyclin-dependent kinase 7	IC50	0.1	μM
160	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CC2=C(C=C1)N(CC2)C(=O)C=C	Cyclin-dependent kinase 7	inhibition percentage	98	%
161	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CC2=C(C=C1)N(CC2)C(=O)C=C	Cyclin-dependent kinase 7	IC50	0.025	μM
162	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CN=C(NC(=O)\C=C\CN2CCC(C2)C#N)C=C1	Cyclin-dependent kinase 7	inhibition percentage	100	%
163	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CN=C(NC(=O)\C=C\CN2CCC(C2)C#N)C=C1	Cyclin-dependent kinase 7	IC50	0.025 - 0.1	μM
164	CCC1=CC(NC(=O)C(C)C2=CC=CC(=C2)C2=CC=C(NC(=O)C=C)C=C2)=NN1	Cyclin-dependent kinase 7	inhibition percentage	89	%
165	CCC1=CC(NC(=O)C(C)C2=CC=CC(=C2)C2=CC=C(NC(=O)C=C)C=C2)=NN1	Cyclin-dependent kinase 7	IC50	0.1	μM
166	CC(C(=O)NC1=NNC(=C1)C(C)(C)C)C1=CC=CC(=C1)C1=CC=C(NC(=O)C=C)C=C1	Cyclin-dependent kinase 7	inhibition percentage	62	%
167	CC(C(=O)NC1=NNC(=C1)C(C)(C)C)C1=CC=CC(=C1)C1=CC=C(NC(=O)C=C)C=C1	Cyclin-dependent kinase 7	IC50	0.1	μM
168	CCC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CC(F)=C(NC(=O)\C=C\CN(C)C)C=C1	Cyclin-dependent kinase 7	inhibition percentage	100	%
169	CCC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CC(F)=C(NC(=O)\C=C\CN(C)C)C=C1	Cyclin-dependent kinase 7	IC50	0.025	μM
170	CCN(CC)C\C=C\C(=O)NC1=C(F)C=C(C=C1)C1=CC(=CC=C1)C(C)C(=O)NC1=NNC(=C1)C1CC1	Cyclin-dependent kinase 7	inhibition percentage	100	%
171	CCN(CC)C\C=C\C(=O)NC1=C(F)C=C(C=C1)C1=CC(=CC=C1)C(C)C(=O)NC1=NNC(=C1)C1CC1	Cyclin-dependent kinase 7	IC50	0.025	μM
172	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CC(F)=C(NC(=O)\C=C\CN2CCCC2)C=C1	Cyclin-dependent kinase 7	inhibition percentage	97	%
173	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CC(F)=C(NC(=O)\C=C\CN2CCCC2)C=C1	Cyclin-dependent kinase 7	IC50	0.025 - 0.1	μM
174	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CC(F)=C(NC(=O)\C=C\CN2CCOCC2)C=C1	Cyclin-dependent kinase 7	inhibition percentage	88	%
175	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CC(F)=C(NC(=O)\C=C\CN2CCOCC2)C=C1	Cyclin-dependent kinase 7	IC50	0.1	μM
176	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=NC=C(NC(=O)\C=C\CN2CCOCC2)C=C1	Cyclin-dependent kinase 7	inhibition percentage	86	%
177	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=NC=C(NC(=O)\C=C\CN2CCOCC2)C=C1	Cyclin-dependent kinase 7	IC50	0.1	μM
178	CC(C)C(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=NC=C(NC(=O)\C=C\CN(C)C)C=C1	Cyclin-dependent kinase 7	inhibition percentage	98	%
179	CC(C)C(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=NC=C(NC(=O)\C=C\CN(C)C)C=C1	Cyclin-dependent kinase 7	IC50	0.025	μM
180	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=NC=C(NC\C=C\C(=O)N(C)C)C=C1	Cyclin-dependent kinase 7	inhibition percentage	67	%
181	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=NC=C(NC\C=C\C(=O)N(C)C)C=C1	Cyclin-dependent kinase 7	IC50	0.1	μM
182	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=NC=C(NC(=O)\C=C\CN2CCCCC2)C=C1	Cyclin-dependent kinase 7	inhibition percentage	84	%
183	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=NC=C(NC(=O)\C=C\CN2CCCCC2)C=C1	Cyclin-dependent kinase 7	IC50	0.1	μM
184	COC\C=C\C(=O)NC1=NC=C(C=C1)C1=CC(=CC=C1)C(C)C(=O)NC1=NNC(=C1)C1CC1	Cyclin-dependent kinase 7	inhibition percentage	90	%
185	COC\C=C\C(=O)NC1=NC=C(C=C1)C1=CC(=CC=C1)C(C)C(=O)NC1=NNC(=C1)C1CC1	Cyclin-dependent kinase 7	IC50	0.1	μM
186	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CN=C(NC(=O)\C=C\CN(C)C)C=C1	Cyclin-dependent kinase 7	inhibition percentage	98	%
187	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CN=C(NC(=O)\C=C\CN(C)C)C=C1	Cyclin-dependent kinase 7	IC50	0.025	μM
188	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CN=C(NC(=O)\C=C\CN2CCC(F)C2)C=C1	Cyclin-dependent kinase 7	inhibition percentage	89	%
189	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CN=C(NC(=O)\C=C\CN2CCC(F)C2)C=C1	Cyclin-dependent kinase 7	IC50	0.025	μM
190	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CN=C(NC(=O)\C=C\CN2CC[C@@H](F)C2)C=C1	Cyclin-dependent kinase 7	inhibition percentage	89 - 94	%
191	CCN(CC)C\C=C\C(=O)NC1=NC=C(C=C1)C1=CC(=CC=C1)C(C)C(=O)NC1=NNC(=C1)C1CC1	Cyclin-dependent kinase 7	inhibition percentage	95	%
192	CCN(CC)C\C=C\C(=O)NC1=NC=C(C=C1)C1=CC(=CC=C1)C(C)C(=O)NC1=NNC(=C1)C1CC1	Cyclin-dependent kinase 7	IC50	0.025	μM
193	NC1=NC=C(C=C1C1=CC2=C(C=C1)C(=O)NCC2)C1=CC=CC(=C1F)N(=O)=O	CDK-activating kinase assembly factor MAT1 [human]	inhibition percentage	75 - 90	%
194	NC1=C(C=C(C=N1)C1=CC=CC2=C1SC=N2)C1=CC2=C(C=C1)C(=O)NCC2	CDK-activating kinase assembly factor MAT1 [human]	inhibition percentage	0 - 32.9	%
195	CN(C1CC1)S(=O)(=O)C1=CC=C(C(F)=C1)C1=CN=C(N)C(=C1)C1=CC=C2C(=O)NCCC2=C1	CDK-activating kinase assembly factor MAT1 [human]	inhibition percentage	0 - 12.3	%
196	COC1=C(C=CC(NS(=O)(=O)C2CC2)=C1)C1=CN=C(N)C(=C1)C1=CC=C2C(=O)NCCC2=C1	CDK-activating kinase assembly factor MAT1 [human]	inhibition percentage	0 - 19.4	%
197	NC1=NC=C(C=C1C1=CC=C2C(=O)NCCC2=C1)C1=C(F)C=C(NS(=O)(=O)C2CC2)C=C1	CDK-activating kinase assembly factor MAT1 [human]	inhibition percentage	0 - 17.4	%
198	NC1=C(C=C(C=N1)C1=CC=C(NS(=O)(=O)C2CC2)C=C1OC1CCCCC1)C1=CC=C2C(=O)NCCC2=C1	CDK-activating kinase assembly factor MAT1 [human]	inhibition percentage	0 - 29.9	%
199	CSC1=NC(=C(N1C)C1=CC=NC(NC2=CC=C(NC(=O)C3=CC=CC(NC(=O)C=C)=C3)C=C2)=C1)C1=CC=C(F)C=C1	Cyclin-dependent kinase 7;+CDK-activating kinase assembly factor MAT1;+Cyclin-H1-1	inhibition percentage	-12	%
200	CSC1=NC(=C(N1C)C1=CC=NC(NC2=CC=C(NC(=O)C3=CC=CC(NC(=O)C=C)=C3)C=C2)=C1)C1=CC=C(F)C=C1	Cyclin-dependent kinase 7;+CDK-activating kinase assembly factor MAT1;+Cyclin-H1-1	inhibition percentage	-14	%
201	NC1=NC=C(C=N1)C1=NC(=NC(N[C@@]2(CO)CCN(C2)C(=O)OCC(F)F)=C1F)N1CCOCC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	inhibition percentage	-9	%
202	CCC(=O)NC1=C(NC2=NC(NC3=CC=C(C=C3)N3CCN(C)CC3)=NC=C2Cl)C=CC=C1	Cyclin-dependent kinase 7	inhibition percentage	3.4	%
203	FC(F)N1C=C(NC2=NC=C(Cl)C(OC3=C(NC(=O)C=C)C=CC=C3)=N2)C=N1	Cyclin-dependent kinase 7	inhibition percentage	27	%
204	COCCN1C=C(NC2=NC=C(Cl)C(OC3=C(NC(=O)C=C)C=CC=C3)=N2)C=N1	Cyclin-dependent kinase 7	inhibition percentage	83	%
205	COCCN1C=C(NC2=NC=C(Cl)C(OC3=C(NC(=O)C=C)C=CC=C3)=N2)C=N1	Cyclin-dependent kinase 7	inhibition percentage	9.5	%
206	CC1=C(SC(NC2CCCC2)=N1)C1=NC(NC2=NC=C(C=C2)N2CCN(CC2)S(C)(=O)=O)=NC=C1	Cyclin-H;+Cyclin-dependent kinase 7	Ki (inhibition constant)	2.64	μM
207	OC[C@@H]1C[C@H]2CN1C1=NC3=C(C=NN3C(NC3=CC4=C(NC(=O)CC4)C(OC\C=C\CO2)=C3)=C1)C#N	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	25	%
208	CN(C)C(=O)C1=CC2=C(N=C(NC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3)N=C2)N1C1CCCC1	Cyclin-H;+Mating-type protein MAT-1;+Cyclin-dependent kinase 7	inhibition percentage	7	%
209	CN(C)C(=O)C1=CC2=C(N=C(NC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(O)C=C4)C=C3)N=C2)N1C1CCCC1	Cyclin-H;+Mating-type protein MAT-1;+Cyclin-dependent kinase 7	inhibition percentage	-9	%
210	CC1=NNC2=NC=C(C=C12)C1=C(Cl)N=CC(N[C@@H](CO)C2=CC=CC=C2)=C1	Cyclin-dependent kinase 7	IC50	20.75	nM
211	CN(C)C(=O)C1=CC2=C(N=C(NC3=CC=C(NC(=O)CCCCCCC(=O)NO)C=C3)N=C2)N1C1CCCC1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-11	%
212	CC1=NNC2=C1C=C(C=C2)C1=C(Cl)N=CC(N[C@@H](CO)C2=CC=CC=C2)=C1	Cyclin-dependent kinase 7	IC50	5.41	nM
213	C[C@H](N1N=NC2=C1C1=CC(=CC=C1N=C2)C1=CC=C2OC=NC2=C1)C1=CC=C(F)C=C1	CDK-activating kinase assembly factor MAT1 [human]	IC50	10000	nM
214	C[C@H](N1N=NC2=C1C1=CC(=CC=C1N=C2)C1=CC=C2OC=NC2=C1)C1=CC=C(F)C=C1	CDK-activating kinase assembly factor MAT1 [human]	inhibition percentage	50	%
215	CC1=NC(=CC=C1)C(=O)N[C@H]1C[C@H](C1)N1C=NC2=C(NCC3=CC(Cl)=CC=C3)N=CN=C12	Cyclin-dependent kinase 7	IC50	319	nM
216	CC(C)N1C=NC2=C1N=C(N=C2NCC1=NC2=C(N1)C(F)=C(F)C=C2)N1CCCC[C@H]1CCO	Cyclin-dependent kinase 7 [human]	IC50	30	μM
217	CC(=O)N1CCN(CC1)[C@H]1CC[C@@H](CC1)NC1=NC=NN2C=CC(C3CCOCC3)=C12	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	56	%
218	CC(=O)N1CCN(CC1)[C@H]1CC[C@@H](CC1)NC1=NC=NN2C=CC(C3CCOCC3)=C12	Cyclin-dependent kinase 7	IC50	0.516	μM
219	CC(=O)N1CCN(CC1)[C@H]1CC[C@@H](CC1)NC1=NC=NN2C=CC(C3CCOCC3)=C12	Cyclin-dependent kinase 7	IC50	30	μM
220	CN1CCN(CC1)C1=CN=C(NC2=NC(=CC=N2)N2C(=NCC22CCCCC2)C2=CC=CC=C2)C=C1	CDK-activating kinase assembly factor MAT1	IC50	100	μM
221	CN1CCN(CC1)C1=CN=C(NC2=NC(=CC=N2)N2C(=NCC22CCCCC2)C2=COC=C2)C=C1	CDK-activating kinase assembly factor MAT1	IC50	100	μM
222	CN1CCN(CC1)C1=CN=C(NC2=NC(=CC=N2)N2C(=NCC22CCCCC2)C2=CSC=C2)C=C1	CDK-activating kinase assembly factor MAT1	IC50	100	μM
223	CN1CCN(CC1)C1=CN=C(NC2=NC(=CC=N2)N2C(=O)N(CC3=CC=CC=C3)CC22CCCCC2)C=C1	CDK-activating kinase assembly factor MAT1	IC50	100	μM
224	CN1CCN(CC1)C1=CN=C(NC2=NC(=CC=N2)N2CCNC2=O)C=C1	CDK-activating kinase assembly factor MAT1	IC50	29.4	μM
225	CN1CCN(CC1)C1=CN=C(NC2=NC(=CC=N2)N2CC(=O)NCC22CCCCC2)C=C1	CDK-activating kinase assembly factor MAT1	IC50	100	μM
226	CN1CCN(CC1)C1=CN=C(NC2=NC(=CC=N2)N2C(=O)NCC22CCCCC2)C=C1	CDK-activating kinase assembly factor MAT1	IC50	95.9	μM
227	CN1CC2(CCCCC2)N(C1=O)C1=CC=NC(NC2=NC=C(C=C2)N2CCN(C)CC2)=N1	CDK-activating kinase assembly factor MAT1	IC50	100	μM
228	FC1=C(C=C2NC=C(C2=C1)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F)C#N	Cyclin-dependent kinase 7	IC50	20	nM
229	FC1=C(C=C2NC=C(C2=C1)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F)C#N	Cyclin-dependent kinase 7	IC50	20	nM
230	CS(=O)(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-H;+Cyclin-dependent kinase 7	Kd (dissociation constant)	0.1	nM
231	CNS(=O)(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20	nM
232	CNS(=O)(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
233	C[C@H]1CNC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	Cyclin-dependent kinase 7	IC50	20	nM
234	C[C@H]1CNC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	Cyclin-dependent kinase 7	IC50	20	nM
235	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=NC=CN1	Cyclin-dependent kinase 7	IC50	20	nM
236	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=NC=CN1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
237	O[C@H]1CCN(C1)C(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20	nM
238	O[C@H]1CCN(C1)C(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	200 - 5	nM
239	O[C@@H]1CCN(C1)C(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20	nM
240	O[C@@H]1CCN(C1)C(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	200 - 5	nM
241	CC(C)(O)CN1C=C(C=N1)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
242	CC(C)(O)CN1C=C(C=N1)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
243	CS(=O)(=O)CC1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20	nM
244	CS(=O)(=O)CC1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
245	C[C@]1(O)CCN(C1)C(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20	nM
246	C[C@@]1(O)CCN(C1)C(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20	nM
247	C[C@@]1(O)CCN(C1)C(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
248	C[C@@]1(O)CCN(C1)C(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	200 - 5	nM
249	FC(F)(F)C1=C(N=C(NC2C3CCC2NC3)N=C1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7	IC50	20 - 200	nM
250	FC(F)(F)C1=C(N=C(NC2C3CCC2NC3)N=C1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7	IC50	20 - 200	nM
251	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=CC=CN=C1	Cyclin-dependent kinase 7	IC50	20	nM
252	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=CC=CN=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
253	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=CC=NC=C1	Cyclin-dependent kinase 7	IC50	20	nM
254	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=CC=NC=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
255	CN1C=C(C(C)=N1)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20	nM
256	CN1C=C(C(C)=N1)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20	nM
257	CN1N=CC(=C1C)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20	nM
258	CN1N=CC(=C1C)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
259	CS(=O)(=O)C1=C2NC=C(C2=CC=C1C#N)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
260	CS(=O)(=O)C1=C2NC=C(C2=CC=C1C#N)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100	nM
261	CS(=O)(=O)C1=C2NC=C(C2=CC=C1C#N)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
262	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=CNC(=C1)C#N	Cyclin-dependent kinase 7	IC50	20	nM
263	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=CNC(=C1)C#N	Cyclin-dependent kinase 7	IC50	20 - 200	nM
264	CC1=NC(=NN1)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20	nM
265	CC1=NC(=NN1)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	200 - 5	nM
266	FC(F)(F)C1=C(N=C(N[C@@H]2CNCC(F)(F)C2)N=C1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7	IC50	20	nM
267	FC(F)(F)C1=C(N=C(N[C@@H]2CNCC(F)(F)C2)N=C1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7	IC50	20 - 200	nM
268	CC(C)(O)CCC1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
269	CC(C)(O)CCC1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
270	CN1N=C(N=C1C)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20	nM
271	CN1N=C(N=C1C)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
272	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)N1C=CN=C1	Cyclin-dependent kinase 7	IC50	20	nM
273	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)N1C=CN=C1	Cyclin-dependent kinase 7	IC50	200 - 5	nM
274	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC(=N2)C#N	Cyclin-dependent kinase 7	IC50	20	nM
275	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC(=N2)C#N	Cyclin-dependent kinase 7	IC50	100	nM
276	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC(=N2)C#N	Cyclin-dependent kinase 7	IC50	20	nM
277	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=CC=CC(=C1)C(=O)N1CCCC1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
278	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=CC=CC(=C1)C(=O)N1CCCC1	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
279	CCC(=O)N[C@H]1CNC[C@H](C1)NC1=NC(C2=CNC3=C(C=CC=C23)S(C)(=O)=O)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	200 - 5	nM
280	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C(C#N)C(=CC=C12)C#N	Cyclin-dependent kinase 7	IC50	20	nM
281	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C(C#N)C(=CC=C12)C#N	Cyclin-dependent kinase 7	IC50	20 - 200	nM
282	CCC(=O)N[C@@H]1CNC[C@@H](C1)NC1=NC(C2=CNC3=C(C=CC=C23)S(C)(=O)=O)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
283	CCC(=O)N[C@@H]1CNC[C@@H](C1)NC1=NC(C2=CNC3=C(C=CC=C23)S(C)(=O)=O)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
284	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C(C(=CC=C12)C#N)S(C)(=O)=O	Cyclin-dependent kinase 7	IC50	20	nM
285	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C(C(=CC=C12)C#N)S(C)(=O)=O	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
286	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C(C(=CC=C12)C#N)S(C)(=O)=O	Cyclin-dependent kinase 7	IC50	20 - 200	nM
287	CS(=O)(=O)C1=C2NC=C(C2=CC=C1)C1=C(C=NC(N[C@@H]2CNC[C@@H](C2)OCC2CCN(CC2)C(=O)C=C)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
288	CS(=O)(=O)C1=C2NC=C(C2=CC=C1)C1=C(C=NC(N[C@@H]2CNC[C@@H](C2)OCC2CCN(CC2)C(=O)C=C)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
289	CS(=O)(=O)C1=C2NC=C(C2=CC=C1)C1=C(C=NC(N[C@@H]2CNC[C@@H](C2)OCC2CCN(CC2)C(=O)C=C)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
290	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C(C=CC=C12)S(C)(=O)=O	Cyclin-dependent kinase 7	IC50	20	nM
291	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C(C=CC=C12)S(C)(=O)=O	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
292	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=C(F)C=N2	Cyclin-dependent kinase 7	IC50	5	μM
293	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=C(F)C=N2	Cyclin-dependent kinase 7	IC50	200 - 5	nM
294	CSC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C#N	Cyclin-dependent kinase 7	IC50	20	nM
295	CSC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C#N	Cyclin-dependent kinase 7	IC50	20 - 200	nM
296	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=NNC2=C1C=CC(=C2)C#N	Cyclin-dependent kinase 7	IC50	20	nM
297	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=NNC2=C1C=CC(=C2)C#N	Cyclin-dependent kinase 7	IC50	20 - 200	nM
298	CC(C)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=NNC2=C1C=CC(=N2)C#N	Cyclin-dependent kinase 7	IC50	20 - 200	nM
299	CC(C)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=NNC2=C1C=CC(=N2)C#N	Cyclin-dependent kinase 7	IC50	200 - 5	nM
300	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=NNC2=C1C=CC(=N2)C#N	Cyclin-dependent kinase 7	IC50	20	nM
301	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=NNC2=C1C=CC(=N2)C#N	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
302	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=NNC2=C1C=CC(=N2)C#N	Cyclin-dependent kinase 7	IC50	20 - 200	nM
303	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C(=O)N1CCCC1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
304	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C(=O)N1CCCC1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
305	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C(=O)N1CCCC1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
306	CO[C@H]1CCN(C1)C(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
307	CO[C@H]1CCN(C1)C(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
308	CO[C@@H]1CCN(C1)C(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20	nM
309	CO[C@@H]1CCN(C1)C(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
310	CC1(O)CCN(CC1)C(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20	nM
311	CC1(O)CCN(CC1)C(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
312	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC(=N2)C#N	Cyclin-dependent kinase 7	IC50	20	nM
313	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC(=N2)C#N	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
314	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC(=N2)C#N	Cyclin-dependent kinase 7	IC50	20 - 200	nM
315	FC(F)N1C=CC(=N1)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
316	FC(F)N1C=CC(=N1)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
317	FC(F)N1C=CC(=N1)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
318	FC(F)N1C=C(C=N1)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
319	FC(F)N1C=C(C=N1)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
320	FC(F)N1C=C(C=N1)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
321	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=NNC=C1	Cyclin-dependent kinase 7	IC50	20	nM
322	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=NNC=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
323	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=NNC=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
324	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C(=O)N1CC[C@H](C1)C#N	Cyclin-dependent kinase 7	IC50	20	nM
325	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C(=O)N1CC[C@H](C1)C#N	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
326	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C(=O)N1CC[C@H](C1)C#N	Cyclin-dependent kinase 7	IC50	20 - 200	nM
327	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C(=O)N1CC[C@@H](C1)C#N	Cyclin-dependent kinase 7	IC50	20	nM
328	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C(=O)N1CC[C@@H](C1)C#N	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
329	O[C@@]1(CCN(C1)C(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
330	O[C@@]1(CCN(C1)C(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
331	O[C@]1(CCN(C1)C(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
332	O[C@]1(CCN(C1)C(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
333	FC(F)OC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C#N	Cyclin-dependent kinase 7	IC50	20 - 200	nM
334	FC(F)OC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C#N	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
335	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C(=O)N1CCC(=O)C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
336	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C(=O)N1CCC(=O)C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
337	CN1C=CC(=N1)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20	nM
338	CN1C=CC(=N1)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
339	OC(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
340	OC(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
341	O[C@H]1CN(CC1(F)F)C(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20	nM
342	O[C@H]1CN(CC1(F)F)C(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
343	CC[C@@]1(O)CCN(C1)C(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
344	CC[C@@]1(O)CCN(C1)C(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
345	OC1=NC=CC=C1C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20	nM
346	OC1=NC=CC=C1C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
347	CC1=C(C#N)C(=O)NC=C1C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20	nM
348	CC1=C(C#N)C(=O)NC=C1C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
349	FC(F)(F)C1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	20	nM
350	FC(F)(F)C1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	20	nM
351	FC(F)(F)C1=CN=C(N[C@H]2CCCNC2)N=C1C1=NNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	20	nM
352	FC(F)(F)C1=CN=C(N[C@H]2CCCNC2)N=C1C1=NNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	100	nM
353	FC(F)(F)C1=CN=C(N[C@H]2CCCNC2)N=C1C1=NNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	20 - 200	nM
354	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=CNC(=O)NC1=O	Cyclin-dependent kinase 7	IC50	20	nM
355	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=CNC(=O)NC1=O	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
356	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=CC(OC2=CC=CC=C2)=CC=C1	Cyclin-dependent kinase 7	IC50	200 - 5	nM
357	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=CC(OC2=CC=CC=C2)=CC=C1	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
358	CC(C)S(=O)(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
359	CC(C)S(=O)(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
360	CC[C@]1(O)CCN(C1)C(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
361	CC[C@]1(O)CCN(C1)C(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
362	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CN2CCS(=O)(=O)C3=C2C1=CC=C3	Cyclin-dependent kinase 7	IC50	20 - 200	nM
363	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CN2CCS(=O)(=O)C3=C2C1=CC=C3	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
364	O[C@@H]1CN(CC1(F)F)C(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20	nM
365	O[C@@H]1CN(CC1(F)F)C(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
366	CN(C)S(=O)(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20	nM
367	CN(C)S(=O)(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
368	CC(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20	nM
369	CC(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	100	nM
370	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C(C=CC=C12)S(O)(=O)=O	Cyclin-dependent kinase 7	IC50	20 - 200	nM
371	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C(C=CC=C12)S(O)=O	Cyclin-dependent kinase 7	IC50	20 - 200	nM
372	CN1CCC[C@@H](C1)NC1=NC(C2=CNC3=CC(=CC=C23)S(C)(=O)=O)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
373	CN1CCC[C@@H](C1)NC1=NC(C2=CNC3=CC(=CC=C23)S(C)(=O)=O)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
374	FCS(=O)(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20	nM
375	FCS(=O)(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
376	CCCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C(C(=CC=C12)C#N)S(C)(=O)=O	Cyclin-dependent kinase 7	IC50	20 - 200	nM
377	CCCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C(C(=CC=C12)C#N)S(C)(=O)=O	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
378	F[C@@H]1CNC[C@H](C1)NC1=NC(C2=CNC3=CC(=CC=C23)C#N)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
379	F[C@@H]1CNC[C@H](C1)NC1=NC(C2=CNC3=CC(=CC=C23)C#N)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
380	CCN1C[C@H](CC(C)(C)C1)NC1=NC(C2=CNC3=CC(=CC=C23)S(C)(=O)=O)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
381	CCN1C[C@H](CC(C)(C)C1)NC1=NC(C2=CNC3=CC(=CC=C23)S(C)(=O)=O)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
382	O[C@H]1CNC[C@H](C1)NC1=NC(C2=CNC3=CC(=CC=C23)C#N)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
383	O[C@H]1CNC[C@H](C1)NC1=NC(C2=CNC3=CC(=CC=C23)C#N)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
384	FC(F)SC1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20	nM
385	FC(F)SC1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	100	nM
386	FC(F)S(=O)(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20	nM
387	FC(F)S(=O)(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
388	CC1(C)CNC[C@H](C1)NC1=NC(C2=CNC3=CC(=CC=C23)S(C)(=O)=O)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
389	CC1(C)CNC[C@H](C1)NC1=NC(C2=CNC3=CC(=CC=C23)S(C)(=O)=O)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
390	FC(F)(F)C1=C(N=C(N[C@@H]2CCC3(CCC3)NC2)N=C1)C1=CNC2=CC(=CC=C12)C#N	Cyclin-dependent kinase 7	IC50	20	nM
391	FC(F)(F)C1=C(N=C(N[C@@H]2CCC3(CCC3)NC2)N=C1)C1=CNC2=CC(=CC=C12)C#N	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
392	FC(F)(F)C1=C(N=C(N[C@H]2CCC3(CCC3)NC2)N=C1)C1=CNC2=CC(=CC=C12)C#N	Cyclin-dependent kinase 7	IC50	20 - 200	nM
393	FC(F)(F)C1=C(N=C(N[C@H]2CCC3(CCC3)NC2)N=C1)C1=CNC2=CC(=CC=C12)C#N	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
394	FC(F)S(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20	nM
395	FC(F)S(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	100	nM
396	CS(=O)(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCN(C3)C3CC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
397	CS(=O)(=O)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCN(C3)C3CC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
398	CC1(C)CNC[C@H](C1)NC1=NC(C2=CNC3=C(C(=CC=C23)C#N)S(C)(=O)=O)=C(Cl)C=N1	Cyclin-dependent kinase 7	IC50	20	nM
399	CC1(C)CNC[C@H](C1)NC1=NC(C2=CNC3=C(C(=CC=C23)C#N)S(C)(=O)=O)=C(Cl)C=N1	Cyclin-dependent kinase 7	IC50	100	nM
400	ClC1=CN=C(N[C@H]2CCCNC2)N=C1C1=C2C=CC=CN2N=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
401	ClC1=CN=C(N[C@H]2CCCNC2)N=C1C1=C2C=CC=CN2N=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
402	ClC1=CN=C(N[C@H]2CCCNC2)N=C1C1=C2C=CC=CN2N=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
403	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	20 - 200	nM
404	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	20 - 200	nM
405	CC1=C(C2=CC=CC=C2N1)C1=C(Cl)C=NC(N[C@H]2CCCNC2)=N1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
406	CC1=C(C2=CC=CC=C2N1)C1=C(Cl)C=NC(N[C@H]2CCCNC2)=N1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
407	FC1=C2NC=C(C2=CC=C1)C1=C(Cl)C=NC(N[C@H]2CCCNC2)=N1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
408	FC1=C2NC=C(C2=CC=C1)C1=C(Cl)C=NC(N[C@H]2CCCNC2)=N1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
409	FC1=C2NC=C(C2=CC=C1)C1=C(Cl)C=NC(N[C@H]2CCCNC2)=N1	Cyclin-dependent kinase 7	IC50	20	nM
410	CC1=CC=C2NC=C(C2=C1)C1=C(Cl)C=NC(N[C@H]2CCCNC2)=N1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
411	CC1=CC=C2NC=C(C2=C1)C1=C(Cl)C=NC(N[C@H]2CCCNC2)=N1	Cyclin-dependent kinase 7	IC50	200 - 5	nM
412	FC1=CC=C2NC=C(C2=C1)C1=C(Cl)C=NC(N[C@H]2CCCNC2)=N1	Cyclin-dependent kinase 7	IC50	20	nM
413	FC1=CC=C2NC=C(C2=C1)C1=C(Cl)C=NC(N[C@H]2CCCNC2)=N1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
414	FC1=CC=C2NC=C(C2=C1)C1=C(Cl)C=NC(N[C@H]2CCCNC2)=N1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
415	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=NNC2=CC=CC=C12	Cyclin-dependent kinase 7	IC50	20 - 200	nM
416	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=NNC2=CC=CC=C12	Cyclin-dependent kinase 7	IC50	20 - 200	nM
417	CC1=C2NC=C(C2=CC=C1)C1=C(Cl)C=NC(N[C@H]2CCCNC2)=N1	Cyclin-dependent kinase 7	IC50	20	nM
418	CC1=C2NC=C(C2=CC=C1)C1=C(Cl)C=NC(N[C@H]2CCCNC2)=N1	Cyclin-dependent kinase 7	IC50	100	nM
419	CC1=C2NC=C(C2=CC=C1)C1=C(Cl)C=NC(N[C@H]2CCCNC2)=N1	Cyclin-dependent kinase 7	IC50	20	nM
420	CC1(CCCNC1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	Cyclin-dependent kinase 7	IC50	200 - 5	nM
421	CC1(CCCNC1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	Cyclin-dependent kinase 7	IC50	200 - 5	nM
422	ClC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC=NC=C12	Cyclin-dependent kinase 7	IC50	20 - 200	nM
423	ClC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC=NC=C12	Cyclin-dependent kinase 7	IC50	20 - 200	nM
424	ClC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=NC=CC=C12	Cyclin-dependent kinase 7	IC50	20	nM
425	ClC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=NC=CC=C12	Cyclin-dependent kinase 7	IC50	100	nM
426	ClC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=NC=CC=C12	Cyclin-dependent kinase 7	IC50	20 - 200	nM
427	CC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7	IC50	20 - 200	nM
428	CC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7	IC50	20 - 200	nM
429	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=NNC2=CC=C(C)C=C12	Cyclin-dependent kinase 7	IC50	200 - 5	nM
430	COCCN1C=C(C2=CC=CC=C12)C1=C(Cl)C=NC(N[C@H]2CCCNC2)=N1	Cyclin-dependent kinase 7	IC50	200 - 5	nM
431	COCCN1C=C(C2=CC=CC=C12)C1=C(Cl)C=NC(N[C@H]2CCCNC2)=N1	Cyclin-dependent kinase 7	IC50	200 - 5	nM
432	COCCN1C=C(C2=CC=CC=C12)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
433	COCCN1C=C(C2=CC=CC=C12)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	200 - 5	nM
434	CC1=C2NC=C(C2=CC=C1)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
435	CC1=C2NC=C(C2=CC=C1)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
436	C[C@@H]1CCNC[C@H]1NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
437	C[C@@H]1CCNC[C@H]1NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	Cyclin-dependent kinase 7	IC50	200 - 5	nM
438	C[C@H]1CCNC[C@H]1NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
439	FC1=C(F)C=C2C(NC=C2C2=C(Cl)C=NC(N[C@H]3CCCNC3)=N2)=C1	Cyclin-dependent kinase 7	IC50	20	nM
440	FC1=C(F)C=C2C(NC=C2C2=C(Cl)C=NC(N[C@H]3CCCNC3)=N2)=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
441	CC(C)N1C=C(C2=CC=CC=C12)C1=C(Cl)C=NC(N[C@H]2CCCNC2)=N1	Cyclin-dependent kinase 7	IC50	200 - 5	nM
442	CC(C)N1C=C(C2=CC=CC=C12)C1=C(Cl)C=NC(N[C@H]2CCCNC2)=N1	Cyclin-dependent kinase 7	IC50	200 - 5	nM
443	CCC1(CCCNC1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	Cyclin-dependent kinase 7	IC50	5	μM
444	BrC1=C(N=C(N[C@@H]2CCCNC2)N=C1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7	IC50	20	nM
445	BrC1=C(N=C(N[C@@H]2CCCNC2)N=C1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7	IC50	20	nM
446	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C(C)C=CC=C12	Cyclin-dependent kinase 7	IC50	20	nM
447	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C(C)C=CC=C12	Cyclin-dependent kinase 7	IC50	20 - 200	nM
448	CC1=C2NC=C(C2=CC=C1)C1=C(F)C=NC(N[C@H]2CCCNC2)=N1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
449	CC1=C2NC=C(C2=CC=C1)C1=C(F)C=NC(N[C@H]2CCCNC2)=N1	Cyclin-dependent kinase 7	IC50	200 - 5	nM
450	CC(C)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7	IC50	20 - 200	nM
451	CC(C)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
452	CC(C)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7	IC50	200 - 5	nM
453	CC(C)CC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C(C)C=CC=C12	Cyclin-dependent kinase 7	IC50	200 - 5	nM
454	CC(C)CC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C(C)C=CC=C12	Cyclin-dependent kinase 7	IC50	200 - 5	nM
455	CC(=O)C1=C2NC=C(C2=CC=C1)C1=C(Cl)C=NC(N[C@H]2CCCNC2)=N1	Cyclin-dependent kinase 7	IC50	20	nM
456	CC(=O)C1=C2NC=C(C2=CC=C1)C1=C(Cl)C=NC(N[C@H]2CCCNC2)=N1	Cyclin-dependent kinase 7	IC50	20	nM
457	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2F	Cyclin-dependent kinase 7	IC50	20	nM
458	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
459	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
460	CC(C)CN1CCC[C@@H](C1)NC1=NC(C2=CNC3=C2C=CC=C3)=C(Cl)C=N1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
461	CC(C)CN1CCC[C@@H](C1)NC1=NC(C2=CNC3=C2C=CC=C3)=C(Cl)C=N1	Cyclin-dependent kinase 7	IC50	200 - 5	nM
462	ClC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1N=CC=C2	Cyclin-dependent kinase 7	IC50	5	μM
463	ClC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1N=CC=C2	Cyclin-dependent kinase 7	IC50	20 - 200	nM
464	IC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	20	nM
465	IC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	20	nM
466	CC(C)N1CCC[C@@H](C1)NC1=NC(C2=CNC3=C2C=CC=C3)=C(Cl)C=N1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
467	CC(C)N1CCC[C@@H](C1)NC1=NC(C2=CNC3=C2C=CC=C3)=C(Cl)C=N1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
468	COCCN1CCC[C@@H](C1)NC1=NC(C2=CNC3=C2C=CC=C3)=C(Cl)C=N1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
469	COCCN1CCC[C@@H](C1)NC1=NC(C2=CNC3=C2C=CC=C3)=C(Cl)C=N1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
470	ClC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2N1CCOCC1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
471	ClC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2N1CCOCC1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
472	ClC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=C(C=C2)N1CCOCC1	Cyclin-dependent kinase 7	IC50	200 - 5	nM
473	ClC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=C(C=C2)N1CCOCC1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
474	FC1=CC2=C(C=C1F)C(=NN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
475	FC1=CC2=C(C=C1F)C(=NN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
476	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2C#N	Cyclin-dependent kinase 7	IC50	20	nM
477	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2C#N	Cyclin-dependent kinase 7	IC50	20	nM
478	OC(=O)C1=CC=CC2=C1NC=C2C1=C(Cl)C=NC(N[C@H]2CCCNC2)=N1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
479	OC(=O)C1=CC=CC2=C1NC=C2C1=C(Cl)C=NC(N[C@H]2CCCNC2)=N1	Cyclin-dependent kinase 7	IC50	200 - 5	nM
480	FC1=CC=CC2=C1NN=C2C1=C(Cl)C=NC(N[C@H]2CCCNC2)=N1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
481	FC1=CC=CC2=C1NN=C2C1=C(Cl)C=NC(N[C@H]2CCCNC2)=N1	Cyclin-dependent kinase 7	IC50	20	nM
482	FC1=CC=CC2=C1NN=C2C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
483	FC1=CC=CC2=C1NN=C2C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
484	N#CC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	20	nM
485	N#CC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	20	nM
486	FC(F)(F)CC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	200 - 5	nM
487	FC(F)(F)CC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	20 - 200	nM
488	ClC1=C(N=C(N[C@H]2CCC(=O)NC2)N=C1)C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	20 - 200	nM
489	ClC1=C(N=C(N[C@H]2CCC(=O)NC2)N=C1)C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
490	ClC1=C(N=C(N[C@H]2CCC(=O)NC2)N=C1)C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	200 - 5	nM
491	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=C(Cl)C=C2	Cyclin-dependent kinase 7	IC50	20	nM
492	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=C(Cl)C=C2	Cyclin-dependent kinase 7	IC50	20	nM
493	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2C1=CC=NC=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
494	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2C1=CC=NC=C1	Cyclin-dependent kinase 7	IC50	20	nM
495	CN1C=C(C=N1)C1=CC=CC2=C1NC=C2C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
496	CN1C=C(C=N1)C1=CC=CC2=C1NC=C2C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
497	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=C(Cl)N=C2	Cyclin-dependent kinase 7	IC50	20	nM
498	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=C(Cl)N=C2	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
499	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=C(Cl)N=C2	Cyclin-dependent kinase 7	IC50	20 - 200	nM
500	FC1=CC2=C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)N=C1	Cyclin-dependent kinase 7	IC50	20	nM
501	FC1=CC2=C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)N=C1	Cyclin-dependent kinase 7	IC50	100	nM
502	FC1=CC2=C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)N=C1	Cyclin-dependent kinase 7	IC50	20	nM
503	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2Cl	Cyclin-dependent kinase 7	IC50	20	nM
504	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2Cl	Cyclin-dependent kinase 7	IC50	20	nM
505	CCOP(=O)(OCC)C1=CC=CC2=C1NC=C2C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	200 - 5	nM
506	CCOP(=O)(OCC)C1=CC=CC2=C1NC=C2C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	200 - 5	nM
507	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=C(C=C2)C#N	Cyclin-dependent kinase 7	IC50	20 - 200	nM
508	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=C(C=C2)C#N	Cyclin-dependent kinase 7	IC50	200 - 5	nM
509	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2C1=CNN=C1	Cyclin-dependent kinase 7	IC50	20	nM
510	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2C1=CNN=C1	Cyclin-dependent kinase 7	IC50	100	nM
511	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2C1=CNN=C1	Cyclin-dependent kinase 7	IC50	20	nM
512	CN1C=C(C(C)=N1)C1=CC=CC2=C1NC=C2C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
513	CN1C=C(C(C)=N1)C1=CC=CC2=C1NC=C2C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
514	CC1=CN(C=N1)C1=CC=CC2=C1NC=C2C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
515	CC1=CN(C=N1)C1=CC=CC2=C1NC=C2C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
516	CNC(=O)C1=CC=CC2=C1NC=C2C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
517	CNC(=O)C1=CC=CC2=C1NC=C2C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
518	CNC(=O)C1=CC=CC2=C1NC=C2C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
519	ClC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=NNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	20	nM
520	ClC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=NNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	20 - 200	nM
521	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=C(C=C2)C1=CNN=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
522	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=C(C=C2)C1=CNN=C1	Cyclin-dependent kinase 7	IC50	200 - 5	nM
523	CN1C=C(C=N1)C1=CC2=C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)C=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
524	CN1C=C(C=N1)C1=CC2=C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)C=C1	Cyclin-dependent kinase 7	IC50	200 - 5	nM
525	CCOP(C)(=O)C1=CC=CC2=C1NC=C2C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
526	CCOP(C)(=O)C1=CC=CC2=C1NC=C2C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
527	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2C1=CC=NN=C1	Cyclin-dependent kinase 7	IC50	20	nM
528	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2C1=CC=NN=C1	Cyclin-dependent kinase 7	IC50	100	nM
529	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2C1=CC=NN=C1	Cyclin-dependent kinase 7	IC50	20	nM
530	CN1C=C(C=N1)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
531	CN1C=C(C=N1)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
532	C[C@@H]1CNC[C@H](C1)NC1=NC(C2=CNC3=C2C=CC=C3)=C(Cl)C=N1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
533	C[C@@H]1CNC[C@H](C1)NC1=NC(C2=CNC3=C2C=CC=C3)=C(Cl)C=N1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
534	CCOP(=O)(OCC)C1=CC2=C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)C=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
535	CCOP(=O)(OCC)C1=CC2=C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)C=C1	Cyclin-dependent kinase 7	IC50	200 - 5	nM
536	FC1=CC2=C(C=C1F)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
537	FC1=CC2=C(C=C1F)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
538	OC1CCC(CC1)C1=CC=CC2=C1NC=C2C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
539	OC1CCC(CC1)C1=CC=CC2=C1NC=C2C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100	nM
540	OC1CCC(CC1)C1=CC=CC2=C1NC=C2C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
541	CNC(=O)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
542	CNC(=O)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
543	CCOP(=O)(OCC)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
544	CCOP(=O)(OCC)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
545	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC(=C2)C1=CNN=C1	Cyclin-dependent kinase 7	IC50	20	nM
546	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC(=C2)C1=CNN=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
547	COC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	200 - 5	nM
548	COC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	200 - 5	nM
549	CC(C)(O)CCC1=CC=CC2=C1NC=C2C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
550	CC(C)(O)CCC1=CC=CC2=C1NC=C2C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
551	C[C@]1(O)CC[C@@H](CC1)C1=CC=CC2=C1NC=C2C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
552	C[C@@]1(O)CC[C@@H](CC1)C1=CC=CC2=C1NC=C2C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
553	C#CC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	20	nM
554	C#CC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	20	nM
555	CN1C=C(C2=C1C=CC=C2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C#C	Cyclin-dependent kinase 7	IC50	200 - 5	nM
556	CN1C=C(C2=C1C=CC=C2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C#C	Cyclin-dependent kinase 7	IC50	20 - 200	nM
557	OC1CCC(=CC1)C1=C2NC=C(C2=CC=C1)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
558	OC1CCC(=CC1)C1=C2NC=C(C2=CC=C1)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
559	FCCC1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	20 - 200	nM
560	FCCC1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	200 - 5	nM
561	O[C@H]1CC[C@H](CC1)C1=CC=CC2=C1NC=C2C1=NC(N[C@H]2CCCNC2)=NC=C1C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
562	O[C@H]1CC[C@H](CC1)C1=CC=CC2=C1NC=C2C1=NC(N[C@H]2CCCNC2)=NC=C1C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
563	CC(=O)C1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	20 - 200	nM
564	CC(=O)C1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	20 - 200	nM
565	CC1(C)CCNC[C@@H]1NC1=NC=C(C(=N1)C1=CNC2=C1C=CC=C2)C(F)(F)F	Cyclin-dependent kinase 7	IC50	200 - 5	nM
566	CC1(C)CCNC[C@@H]1NC1=NC=C(C(=N1)C1=CNC2=C1C=CC=C2)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
567	CC1(C)CCNC[C@H]1NC1=NC=C(C(=N1)C1=CNC2=C1C=CC=C2)C(F)(F)F	Cyclin-dependent kinase 7	IC50	200 - 5	nM
568	CC1(C)CCNC[C@H]1NC1=NC=C(C(=N1)C1=CNC2=C1C=CC=C2)C(F)(F)F	Cyclin-dependent kinase 7	IC50	200 - 5	nM
569	CC[C@@H]1CC[C@@H](CN1)NC1=NC=C(C(=N1)C1=CNC2=C1C=CC=C2)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
570	CC[C@@H]1CC[C@@H](CN1)NC1=NC=C(C(=N1)C1=CNC2=C1C=CC=C2)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
571	FC(F)(F)C1=C(N=C(N[C@@H]2CNCC3=CC=CC=C23)N=C1)C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	20 - 200	nM
572	FC(F)(F)C1=C(N=C(N[C@@H]2CNCC3=CC=CC=C23)N=C1)C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	200 - 5	nM
573	FC(F)(F)C1=C(N=C(N[C@H]2CNCC3=CC=CC=C23)N=C1)C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	200 - 5	nM
574	FC(F)(F)C1=C(N=C(N[C@H]2CNCC3=CC=CC=C23)N=C1)C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	200 - 5	nM
575	CC[C@H]1CC[C@@H](CN1)NC1=NC=C(C(=N1)C1=CNC2=C1C=CC=C2)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
576	CC[C@H]1CC[C@@H](CN1)NC1=NC=C(C(=N1)C1=CNC2=C1C=CC=C2)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
577	C=CC1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	20	nM
578	C=CC1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	20 - 200	nM
579	FC(F)(F)C1=CN=C(N[C@H]2CC[C@@H](NC2)C(=O)N2CCCC2)N=C1C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	20	nM
580	FC(F)(F)C1=CN=C(N[C@H]2CC[C@@H](NC2)C(=O)N2CCCC2)N=C1C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	20 - 200	nM
581	CC(O)C1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	200 - 5	nM
582	CC(O)C1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	20	nM
583	C[C@H](O)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7	IC50	200 - 5	nM
584	C[C@H](O)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7	IC50	200 - 5	nM
585	C[C@@H](O)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7	IC50	200 - 5	nM
586	C[C@@H](O)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7	IC50	200 - 5	nM
587	FC(F)(F)C1=C(N=C(N[C@H]2CCC3(CCCCC3)NC2)N=C1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7	IC50	20 - 200	nM
588	CCCCCC1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
589	CCCCCC1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
590	O[C@H]1CCN(C1)C(=O)[C@H]1CC[C@@H](CN1)NC1=NC(C2=CNC3=CC=CC=C23)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
591	O[C@H]1CCN(C1)C(=O)[C@H]1CC[C@@H](CN1)NC1=NC(C2=CNC3=CC=CC=C23)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	200 - 5	nM
592	FC(F)(F)C1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC(=C2)N1C=NC(=C1)C#N	Cyclin-dependent kinase 7	IC50	20	nM
593	FC(F)(F)C1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC(=C2)N1C=NC(=C1)C#N	Cyclin-dependent kinase 7	IC50	20 - 200	nM
594	CNC(=O)[C@H]1CNC[C@H](C1)NC1=NC(C2=CNC3=C2C=CC=C3)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
595	CNC(=O)[C@H]1CNC[C@H](C1)NC1=NC(C2=CNC3=C2C=CC=C3)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	200 - 5	nM
596	CNC(=O)[C@@H]1CNC[C@@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
597	CNC(=O)[C@@H]1CNC[C@@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
598	CNC(=O)[C@H]1CNC[C@@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
599	CNC(=O)[C@H]1CNC[C@@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
600	CNC(=O)[C@@H]1CNC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
601	CNC(=O)[C@@H]1CNC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	200 - 5	nM
602	CC(C)C1CC[C@@H](CN1)NC1=NC(C2=CNC3=CC=CC=C23)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
603	CC(C)C1CC[C@@H](CN1)NC1=NC(C2=CNC3=CC=CC=C23)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	200 - 5	nM
604	CC(C)[C@H]1CC[C@@H](CN1)NC1=NC(C2=CNC3=C2C=CC=C3)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	200 - 5	nM
605	CC(C)[C@H]1CC[C@@H](CN1)NC1=NC(C2=CNC3=C2C=CC=C3)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	200 - 5	nM
606	FC(F)(F)C1=C(N=C(N[C@@H]2CNC[C@@H](C2)C2=NN=C3C=CC=CN23)N=C1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7	IC50	20 - 200	nM
607	FC(F)(F)C1=C(N=C(N[C@@H]2CNC[C@@H](C2)C2=NN=C3C=CC=CN23)N=C1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7	IC50	20 - 200	nM
608	FC(F)(F)C1=C(N=C(N[C@H]2CNC[C@H](C2)C2=NN=C3C=CC=CN23)N=C1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7	IC50	20 - 200	nM
609	FC(F)(F)C1=C(N=C(N[C@H]2CNC[C@H](C2)C2=NN=C3C=CC=CN23)N=C1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7	IC50	200 - 5	nM
610	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC(=C2)S(C)(=O)=O	Cyclin-dependent kinase 7	IC50	20 - 200	nM
611	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC(=C2)S(C)(=O)=O	Cyclin-dependent kinase 7	IC50	200 - 5	nM
612	CN1C=C(C2=C1N=C(C=C2)C#N)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	200 - 5	nM
613	CN1C=C(C2=C1N=C(C=C2)C#N)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
614	CN1C=C(C2=C1N=C(C=C2)C#N)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	200 - 5	nM
615	CCS(=O)(=O)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
616	CCS(=O)(=O)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
617	CN1C=C(C2=C1C(=CC=C2)C#N)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
618	CN1C=C(C2=C1C(=CC=C2)C#N)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
619	CN1C=C(C2=C1C(=CC=C2)C#N)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	200 - 5	nM
620	COCN1C=C(C2=C1N=C(C=C2)C#N)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	200 - 5	nM
621	COCN1C=C(C2=C1N=C(C=C2)C#N)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
622	COCN1C=C(C2=C1N=C(C=C2)C#N)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	200 - 5	nM
623	O[C@H]1CNC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
624	O[C@H]1CNC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
625	CCN1CCC[C@@H](C1)NC1=NC(C2=CNC3=C2C=CC(=C3)C#N)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
626	CCN1CCC[C@@H](C1)NC1=NC(C2=CNC3=C2C=CC(=C3)C#N)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
627	CCN1CCC[C@@H](C1)NC1=NC(C2=CNC3=C2C=CC(=C3)C#N)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
628	C[C@H]1CCNC[C@H]1NC1=NC(C2=CNC3=C2C=CC=C3)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	200 - 5	nM
629	C[C@H]1CCNC[C@H]1NC1=NC(C2=CNC3=C2C=CC=C3)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100	nM
630	C[C@H]1CCNC[C@H]1NC1=NC(C2=CNC3=C2C=CC=C3)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
631	CCS(=O)(=O)C1=CC=CC2=C1NC=C2C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
632	CCS(=O)(=O)C1=CC=CC2=C1NC=C2C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
633	CCS(=O)(=O)C1=CC=CC2=C1NC=C2C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	200 - 5	nM
634	CS(=O)(=O)C1=C(C=CC2=C1NC=C2C1=C(Cl)C=NC(N[C@H]2CCCNC2)=N1)C#N	Cyclin-dependent kinase 7	IC50	20	nM
635	CS(=O)(=O)C1=C(C=CC2=C1NC=C2C1=C(Cl)C=NC(N[C@H]2CCCNC2)=N1)C#N	Cyclin-dependent kinase 7	IC50	100	nM
636	COCN1C=C(C2=C1C(=CC=C2)C#N)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
637	COCN1C=C(C2=C1C(=CC=C2)C#N)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
638	CN1C=C(C2=C1C(=CC=C2)S(C)(=O)=O)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
639	CN1C=C(C2=C1C(=CC=C2)S(C)(=O)=O)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
640	CNC(=O)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
641	CNC(=O)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100	nM
642	CCN1CCC[C@@H](C1)NC1=NC(C2=CNC3=C2C=CC(=C3)S(C)(=O)=O)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
643	CCN1CCC[C@@H](C1)NC1=NC(C2=CNC3=C2C=CC(=C3)S(C)(=O)=O)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
644	CNC(=O)C1=CC=CC2=C1N(COC)C=C2C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
645	CNC(=O)C1=CC=CC2=C1N(COC)C=C2C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
646	FC(F)(F)SC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	20	nM
647	FC(F)(F)SC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
648	NC1=NC2=C(C=CC=C2S1)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
649	NC1=NC2=C(C=CC=C2S1)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
650	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=CC2=C(NC=N2)C=C1	Cyclin-dependent kinase 7	IC50	20	nM
651	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=CC2=C(NC=N2)C=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
652	NC(=O)C1=CC=CC(=C1)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
653	NC(=O)C1=CC=CC(=C1)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
654	OC1=C(C=C(C=C1)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F)C#N	Cyclin-dependent kinase 7	IC50	20 - 200	nM
655	OC1=C(C=C(C=C1)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F)C#N	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
656	OCC1=CC=CC(=N1)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
657	OCC1=CC=CC(=N1)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
658	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC(C=CC1=CC=CC=C1)=C2	Cyclin-dependent kinase 7	IC50	20 - 200	nM
659	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC(C=CC1=CC=CC=C1)=C2	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
660	OCC1=CN=CC(=C1)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
661	OCC1=CN=CC(=C1)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
662	FC(F)(F)C1=NC=C2C(NC=C2C2=CC=C3C(NC=C3C3=C(C=NC(N[C@H]4CCCNC4)=N3)C(F)(F)F)=C2)=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
663	FC(F)(F)C1=NC=C2C(NC=C2C2=CC=C3C(NC=C3C3=C(C=NC(N[C@H]4CCCNC4)=N3)C(F)(F)F)=C2)=C1	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
664	CN1C=C(C=CC1=O)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
665	CN1C=C(C=CC1=O)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
666	NC1=NC2=C(C=CC=C2C=N1)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20	nM
667	NC1=NC2=C(C=CC=C2C=N1)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
668	OCC1=NC=CC=C1C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
669	OCC1=NC=CC=C1C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
670	OCCC1=CC=CC(=C1)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
671	OCCC1=CC=CC(=C1)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
672	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=CC=C2C=CN=CC2=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
673	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=CC=C2C=CN=CC2=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
674	NS(=O)(=O)C1=CC=CC(=C1)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
675	NS(=O)(=O)C1=CC=CC(=C1)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
676	CCOC1=CC=CC=C1C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
677	CCOC1=CC=CC=C1C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
678	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC(=C2)C1=NC=CN=C1	Cyclin-dependent kinase 7	IC50	20	nM
679	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC(=C2)C1=NC=CN=C1	Cyclin-dependent kinase 7	IC50	100	nM
680	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=CC2=NNC=C2C=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
681	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=CC2=NNC=C2C=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
682	NS(=O)(=O)C1=CC=C(C=C1)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
683	NS(=O)(=O)C1=CC=C(C=C1)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
684	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=CC=C2CCC(=O)NC2=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
685	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=CC=C2CCC(=O)NC2=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
686	FC1=CN=CC(=C1)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
687	FC1=CN=CC(=C1)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
688	CC1=CC=NC=C1C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
689	CC1=CC=NC=C1C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100	nM
690	CN1N=CC2=CC=C(C=C12)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
691	CN1N=CC2=CC=C(C=C12)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
692	CC(=O)NCC1=CC=CC(=C1)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
693	CC(=O)NCC1=CC=CC(=C1)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
694	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=C2C=CC=CC2=NC=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
695	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=C2C=CC=CC2=NC=C1	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
696	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=CC2=C(OCCO2)C=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
697	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=CC2=C(OCCO2)C=C1	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
698	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=CC=C2N=CSC2=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
699	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=CC=C2N=CSC2=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
700	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=C2C=CN=CC2=CC=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
701	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C1=C2C=CN=CC2=CC=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
702	FC1=CC=CC(=C1)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	200 - 5	nM
703	FC1=CC=CC(=C1)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
704	F[C@@H]1CCNC[C@H]1NC1=NC(C2=CNC3=C2C=CC(=C3)C#N)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
705	F[C@@H]1CCNC[C@H]1NC1=NC(C2=CNC3=C2C=CC(=C3)C#N)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100	nM
706	CP(C)(=O)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
707	CP(C)(=O)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
708	O[C@@H]1CCNC[C@H]1NC1=NC(C2=CNC3=C2C=CC(=C3)C#N)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
709	O[C@@H]1CCNC[C@H]1NC1=NC(C2=CNC3=C2C=CC(=C3)C#N)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
710	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2S(=O)(=O)C(C)C	Cyclin-dependent kinase 7	IC50	20 - 200	nM
711	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC=C2S(=O)(=O)C(C)C	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
712	CC1=NOC(=N1)[C@H]1CC[C@@H](CN1)NC1=NC(C2=CNC3=C2C=CC(=C3)C#N)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
713	CC1=NOC(=N1)[C@H]1CC[C@@H](CN1)NC1=NC(C2=CNC3=C2C=CC(=C3)C#N)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
714	CC1(O)CCN(C1)S(=O)(=O)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
715	CC1(O)CCN(C1)S(=O)(=O)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
716	CN(C)S(=O)(=O)C1=CC=CC2=C1NC=C2C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
717	CN(C)S(=O)(=O)C1=CC=CC2=C1NC=C2C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100	nM
718	C[C@@H]1CCNC[C@H]1NC1=NC(C2=CNC3=C2C=CC=C3)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
719	C[C@@H]1CCNC[C@H]1NC1=NC(C2=CNC3=C2C=CC=C3)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
720	C[C@H]1CCNC[C@@H]1NC1=NC(C2=CNC3=C2C=CC=C3)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
721	C[C@H]1CCNC[C@@H]1NC1=NC(C2=CNC3=C2C=CC=C3)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
722	CCP(=O)(CC)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
723	CCP(=O)(CC)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
724	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C(F)C(=CC=C12)C#N	Cyclin-dependent kinase 7	IC50	20 - 200	nM
725	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C(F)C(=CC=C12)C#N	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
726	FC(F)SC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C#N	Cyclin-dependent kinase 7	IC50	20 - 200	nM
727	FC(F)SC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=CC(=CC=C12)C#N	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
728	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=NNC2=C1C=CC=C2F	Cyclin-dependent kinase 7	IC50	20	nM
729	CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=NNC2=C1C=CC=C2F	Cyclin-dependent kinase 7	IC50	20	nM
730	CC(C)C1=C2N(C=C1)N=CN=C2N[C@H]1CC[C@@H](CC1)N1CCN(CC1)C(C)=O	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	42	%
731	CC(C)C1=C2N(C=C1)N=CN=C2N[C@H]1CC[C@@H](CC1)N1CCN(CC1)C(C)=O	Cyclin-dependent kinase 7	IC50	2.31	μM
732	CC(C)C1=C2N(C=C1)N=CN=C2N[C@H]1CC[C@@H](CC1)N1CCN(CC1)C(C)=O	Cyclin-dependent kinase 7	IC50	30	μM
733	NC1=CC=C(C=N1)C1=CC=C2N=CC3=C(N(C4CCN(CC#N)CC4)C(=O)C=N3)C2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	5	%
734	CC1=CC=C(NC2=NC(N)=C(S2)C(=O)C2=CC=C(C=C2)C#N)C=C1	CDK-activating kinase assembly factor MAT1	inhibition percentage	0 - 20	%
735	CC1=CC(OCCCC(=O)NC2=NC=C(Br)S2)=CC=C1Cl	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage	9 - 11	%
736	COCCOC1=CC2=NC=NC(NC3=CC=CC(=C3)C#C)=C2C=C1NC(=O)C1=CC=C(F)C(=C1)N(=O)=O	Cyclin-dependent kinase 7	inhibition percentage	4.5	%
737	NC1=NC=CC(C2=CC(C3=NN=CN3)=C3N=CN(C3=C2)C2=CC=NC3=C(F)C=CC(F)=C23)=C1F	Cyclin-dependent kinase 7	inhibition percentage	99.15	%
738	COC1=CC=C(C=C1)C(=O)NC1CCN(CC1)C1=NC(NC2=CC=C(F)C=C2)=CC=N1	CDK-activating kinase assembly factor MAT1 [human]	IC50	89.8	nM
739	OC(=O)C1=CC=C(C=C1C1CCCC1)C1=CNC2=NC=CC=C12	Cyclin-dependent kinase 7	inhibition percentage	44	%
740	CC(C)CN(C(=O)C1=CC=CN=C1)C1=C2NC3=CC=CC=C3N2C(=O)C2=C1C=CC=C2	Cyclin-dependent kinase 7	Kd (dissociation constant)	5	μM
741	CC(C)CN(C(=O)C1=CC=CN=C1)C1=C2NC3=CC=CC=C3N2C(=O)C2=C1C=CC=C2	Cyclin-dependent kinase 7	inhibition percentage	0	%
742	CC(C)C1=CC=C(C=C1C#CC1=CN=C2C=NC=CN12)C(=O)NC1=CC(=CC(CN2CCN(C)CC2)=C1)C(F)(F)F	Cyclin-dependent kinase 7	inhibition percentage	25	%
743	CC1=C(N=C(N[C@H]2CC[C@H](O)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage	85	%
744	CC1=C(N=C(N[C@H]2CC[C@H](O)CC2)N=C1)C1=CN=C2C=CC=CN12	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage	66	%
745	COC1=CC=C(NC(=O)C2=CC=C(NC(=O)N3CCN(CC3)C(=O)C3=C(F)C=CC(CC4=NNC(=O)C5=CC=CC=C45)=C3)C=C2)C=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	inhibition rate	0.38	%
746	Cl.CN(C)CCN1N=NN=C1SC1=CC(C)=NC2=NC(SCC3=CC=C(Cl)C=C3)=NN12	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	inhibition percentage	-15.1	%
747	CCN1CCN(CC1)C1=CC=C(NC2=C3N=CN(C4CCCC4)C3=NC(NC3CCC(N)CC3)=N2)C=N1	Cyclin-dependent kinase 7 [human]	IC50	0.082	μM
748	CN1CC2(C1)CN(C2)C1=CC=C(NC2=C3N=CN(C4CCCC4)C3=NC(NC3CCC(O)CC3)=N2)C=C1	Cyclin-dependent kinase 7 [human]	IC50	0.197	μM
749	CN1N=CC(=C1CC1CC1)C1=NC(NC2CCC(N)CC2)=NC=C1F	Cyclin-dependent kinase 7	Kd (dissociation constant)	0.31	nM
750	COC1=C(OC)C=C2C(=C1)C(=O)N(CC1CCCCC1)C1=C2C=NC2=C1C=CN2	Cyclin-dependent kinase 7	inhibition percentage	12	%
751	COC1=C(OC)C=C2C(=C1)C(=O)N(C1CCCCCCC1)C1=C2C=NC2=C1C=CN2	Cyclin-dependent kinase 7	inhibition percentage	0	%
752	COC1=C(OC)C=C2C(=C1)C(=O)N([C@@H]1CCCN(C1)C(=O)CC#N)C1=C2C=NC2=C1C=CN2	Cyclin-dependent kinase 7	inhibition percentage	27	%
753	CC[C@@H](N1C(=O)C2=CC(OC)=C(OC)C=C2C2=C1C1=C(NC=C1)N=C2)C(=O)N1CC(C1)C#N	Cyclin-dependent kinase 7	inhibition percentage	0	%
754	CN(C1=CC=CC(CNC2=C(C=NC(NC3=CC=C(OCCOCCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C=C4)C4=C(C)N=CS4)C(C)(C)C)C=C3)=N2)C(F)(F)F)=C1)S(C)(=O)=O	Cyclin-dependent kinase 7	inhibition percentage	0	%
755	COC1=CC(NC2=NC=NC(NC(=O)NC3=C(Cl)C=CC=C3Cl)=C2)=C(OC)C=C1	Cyclin-dependent kinase 7	inhibition rate	22.34	%
756	CNCCN1CCC2=C(C1)C=CC(NC1=NC=C(F)C(=N1)C1=CC3=C(N=C(C)N3C3(C)CC3)C(F)=C1)=N2	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	250.1	nM
757	CN(C)CC(=O)N1CCC2=NC(NC3=NC(=C(F)C=N3)C3=CC(F)=C4N=C(C)N(C5CC5)C4=C3)=CC=C2C1	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	573.79	nM
758	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=C(F)C=NC(NC2=CC=C3CN(CCC3=N2)C(=O)[C@@H](C)N(C)C)=N1	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	2818.63	nM
759	C[C@H](CN1CCC2=NC(NC3=NC(=C(F)C=N3)C3=CC(F)=C4N=C(C)N(C5CC5)C4=C3)=CC=C2C1)N(C)C	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	146.6	nM
760	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC3=C(CN(CC3)C(=O)CN3CCOCC3)C=C2)=NC=C1F	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	2892.62	nM
761	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC3=C(CN(CC3)C(=O)C(C)N(C)C)C=C2)=NC=C1F	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	978.09	nM
762	CC(C)N1C(C)=NC2=C1C=C(C=C2F)C1=NC(NC2=NC3=C(CN(CC3)C(=O)C=C)C=C2)=NC=C1F	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30000	nM
763	CN(C)CCOC(=O)N1CCC2=C(C1)C=CC(NC1=NC=C(F)C(=N1)C1=CC3=C(N=C(C)N3C3CC3)C(F)=C1)=N2	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	1280.02	nM
764	C[C@@H](N(C)C)C(=O)N1CCC2=C(C1)C=CC(NC1=NC=C(F)C(=N1)C1=CC3=C(N=C(C)N3C3CC3)C(F)=C1)=N2	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	563.3	nM
765	CC1=NC2=C(C=C(C=C2F)C2=NC(NC3=NC4=C(CN(CC4)C(=O)NCCO)C=C3)=NC=C2F)N1C1CC1	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	718.19	nM
766	CNCC(=O)N1CCC2=C(C1)C=CC(NC1=NC=C(F)C(=N1)C1=CC3=C(N=C(C)N3C3CCC3)C(F)=C1)=N2	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	1153.1	nM
767	CN1CCC[C@H]1C(=O)N1CCC2=C(C1)C=CC(NC1=NC=C(F)C(=N1)C1=CC3=C(N=C(C)N3C3CC3)C(F)=C1)=N2	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	650.34	nM
768	CN(C)CC(=O)N1CCC2=C(C1)C=CC(NC1=NC=C(F)C(=N1)C1=CC3=C(N=C(C)N3CC3CC3)C(F)=C1)=N2	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	1194.59	nM
769	CC1=NC2=C(C=C(C=C2F)C2=NC(NC3=NC4=C(CN(CC4)C(=O)[C@@H]4CCCN4)C=C3)=NC=C2F)N1C1CC1	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	555.53	nM
770	CN(C)CCCN1CCC2=C(C1)C=CC(NC1=NC=C(F)C(=N1)C1=CC3=C(N=C(C)N3C3CC3)C(F)=C1)=N2	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	196.4	nM
771	CN1CCC[C@@H]1CN1CCC2=C(C1)C=CC(NC1=NC=C(F)C(=N1)C1=CC3=C(N=C(C)N3C3CC3)C(F)=C1)=N2	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	104	nM
772	CC(C)N1C(C)=NC2=C1C=C(C=C2F)C1=NC(NC2=NC3=C(CN(CC#CCN(C)C)CC3)C=C2)=NC=C1F	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	279.8	nM
773	CN(C)CCCN1CCC2=C(C1)C=CC(NC1=NC=C(F)C(=N1)C1=CC3=C(N=C(C)N3C(C)(C)C)C(F)=C1)=N2	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	36.48	nM
774	CN(C)CCC(=O)N1CCC2=C(C1)C=CC(NC1=NC=C(F)C(=N1)C1=CC3=C(N=C(C)N3C(C)(C)C)C(F)=C1)=N2	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	50.13	nM
775	CN1CCO[C@@H](CN2CCC3=C(C2)C=CC(NC2=NC=C(F)C(=N2)C2=CC4=C(N=C(C)N4C(C)(C)C)C(F)=C2)=N3)C1	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	147	nM
776	CN1CCO[C@H](CN2CCC3=C(C2)C=CC(NC2=NC=C(F)C(=N2)C2=CC4=C(N=C(C)N4C(C)(C)C)C(F)=C2)=N3)C1	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	66.25	nM
777	CC1=NC2=C(C=C(C=C2F)C2=NC(NC3=NC4=C(CN(C[C@H]5CNCCO5)CC4)C=C3)=NC=C2F)N1C(C)(C)C	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	109.1	nM
778	CN1CCC[C@H]1CN1CCC2=C(C1)C=CC(NC1=NC=C(F)C(=N1)C1=CC3=C(N=C(C)N3C3CC3)C(F)=C1)=N2	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	124.1	nM
779	CN1CCN(CCN2CCC3=C(C2)C=CC(NC2=NC=C(F)C(=N2)C2=CC4=C(N=C(C)N4C(C)(C)C)C(F)=C2)=N3)CC1	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	180.8	nM
780	CN(CCO)CCN1CCC2=C(C1)C=CC(NC1=NC=C(F)C(=N1)C1=CC3=C(N=C(C)N3C(C)(C)C)C(F)=C1)=N2	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	214.6	nM
781	ClC1=C(C=C(C=C1)C1=CC=C(O1)C=C1NC(=S)NC1=O)C(=O)OCC=C	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	94	%
782	CCNC(=O)C1=CC(OC)=C2N(C[C@@H]3CN(C)CCO3)C(=NC2=C1)C1=CC=C(N=C1)N1[C@@H](C)CC[C@@H]1C	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage	-2.6	%
783	CC(C)C1=C2N=C(N=C(NCC3=CC=CC(OC4=CC=CC=C4)=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
784	CC(C)C1=C2N=C(N=C(NCC3=CC=CC(OC4=CC=CC=C4)=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
785	CC(C)C1=C2N=C(N=C(NCC3=CC=CC(OC4=CC=CC=C4)=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
786	CC(C)C1=C2N=C(N=C(NCC3=CC=CC(OC4=CC=CC=C4)=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
787	CC(C)C1=NNC2=C(NCC3=CC=C(C=C3)C3=NC=CC=C3)N=C(SCCN)N=C12	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	0.124	μM
788	CC(C)C1=NNC2=C(NCC3=CC=C(C=C3)C3=NC=CC=C3)N=C(SCCN)N=C12	Cyclin-dependent kinase 7	IC50	0.124	μM
789	CN1C(=NC2=CC(N3CCC(CO)CC3)=C(NC(=O)C3=C4N=CC=CN4N=C3)C=C12)N1CCOCC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1	inhibition percentage	-11.4	%
790	OCC1CCN(CC1)C1=C(NC(=O)C2=C3N=CC=CN3N=C2)C=C2SC(=NC2=C1)N1CCOCC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1	inhibition percentage	-2	%
791	COC1=CC=C(C=C1OC)C1=CN=C2NC=C(C#CC3=CC=CN=C3)C2=C1	Cyclin-dependent kinase 7	inhibition percentage	84	%
792	COC1=C(OC(=O)N2CCN(C)CC2)C=C2N=CC=C(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3)C2=C1	Cyclin-dependent kinase 7	IC50	1000	nM
793	O=C(\C=C1/NC2=C(NC1=O)C=CC=C2)C1=C2C=CC=CC2=CC=C1	Cyclin-H [human];+Mating-type protein MAT-1 [human];+Cyclin-dependent kinase 7 [human]	inhibition rate	5	%
794	CN1C(=CN=C1C1=CC=CC=C1C)C(=O)NC1=CC(=CC=C1C)S(N)(=O)=O	Cyclin-H; CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	inhibition percentage	-19	%
795	O=C1NCC2(CCCCC2)N2C1=CC1=CN=C(N[C@H]3CCCN[C@@H]3C3=CC=CC=C3)N=C21	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
796	O=C1NCC2(CCCCC2)N2C1=CC1=CN=C(N[C@H]3CCCN[C@@H]3C3=CC=CC=C3)N=C21	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
797	O=C(NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O)[C@@H]1CCCNC1	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
798	O=C(NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O)[C@@H]1CCCNC1	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
799	O=C1NCC2(CCCCC2)N2C1=CC1=CN=C(N[C@H]3CC[C@@H](CC3)NC3CCOCC3)N=C21	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
800	O=C1NCC2(CCCCC2)N2C1=CC1=CN=C(N[C@H]3CC[C@@H](CC3)NC3CCOCC3)N=C21	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
801	O=C1NCC2(CCCCC2)N2C1=CC1=CN=C(N[C@H]3CC[C@@H](CC3)NC3=NC=CC=C3)N=C21	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
802	O=C1NCC2(CCCCC2)N2C1=CC1=CN=C(N[C@H]3CC[C@@H](CC3)NC3=NC=CC=C3)N=C21	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
803	FC1=CN=C(N[C@H]2CC[C@@H](CC2)NC2=NC=C3C=C4N(C3=N2)C2(CCCCC2)CNC4=O)N=C1	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
804	FC1=CN=C(N[C@H]2CC[C@@H](CC2)NC2=NC=C3C=C4N(C3=N2)C2(CCCCC2)CNC4=O)N=C1	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
805	FC1=C(CN[C@H]2CC[C@@H](CC2)NC2=NC=C3C=C4N(C3=N2)C2(CCCCC2)CNC4=O)C=CC=C1	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
806	FC1=C(CN[C@H]2CC[C@@H](CC2)NC2=NC=C3C=C4N(C3=N2)C2(CCCCC2)CNC4=O)C=CC=C1	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
807	O=C1NCC2(CCCCC2)N2C1=CC1=CN=C(N[C@H]3CC[C@@H](CC3)NCC3=CN=CC=C3)N=C21	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
808	O=C1NCC2(CCCCC2)N2C1=CC1=CN=C(N[C@H]3CC[C@@H](CC3)NCC3=CN=CC=C3)N=C21	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
809	CS(=O)(=O)N[C@H]1CC[C@@H](CC1)NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
810	CS(=O)(=O)N[C@H]1CC[C@@H](CC1)NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
811	O=C1CC[C@@H](CN1)NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
812	O=C1CC[C@@H](CN1)NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
813	C[C@H]1NCCC[C@H]1C(=O)NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
814	C[C@H]1NCCC[C@H]1C(=O)NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
815	O=C(NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O)[C@@H]1CCNC1	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
816	O=C(NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O)[C@@H]1CCNC1	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
817	O=C(NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O)[C@H]1CCNC1	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
818	O=C(NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O)[C@H]1CCNC1	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
819	O=C(C[C@H]1CCCN1)NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
820	O=C(C[C@H]1CCCN1)NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
821	CN1CCN(CC1)[C@@H]1CC[C@@H](CC1)NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=S	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
822	CN1CCN(CC1)[C@@H]1CC[C@@H](CC1)NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=S	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
823	S=C1NCC2(CCCCC2)N2C1=CC1=CN=C(N[C@H]3CCCNC3)N=C21	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
824	S=C1NCC2(CCCCC2)N2C1=CC1=CN=C(N[C@H]3CCCNC3)N=C21	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
825	S=C1NCC2(CCCCC2)N2C1=CC1=CN=C(N[C@@H]3CCCNC3)N=C21	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
826	S=C1NCC2(CCCCC2)N2C1=CC1=CN=C(N[C@@H]3CCCNC3)N=C21	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
827	O=C1NCC2(CCCCC2)N2C1=CC1=CN=C(N[C@H]3CC[C@@H](CC3)N3CCOCC3)N=C21	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
828	O=C1NCC2(CCCCC2)N2C1=CC1=CN=C(N[C@H]3CC[C@@H](CC3)N3CCOCC3)N=C21	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
829	CN(C)[C@H]1CC[C@@H](CC1)NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
830	CN(C)[C@H]1CC[C@@H](CC1)NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
831	O=C1NCC2(CCCCC2)N2C1=CC1=CN=C(N[C@H]3CC[C@@H](CC3)N3CCCCC3)N=C21	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
832	O=C1NCC2(CCCCC2)N2C1=CC1=CN=C(N[C@H]3CC[C@@H](CC3)N3CCCCC3)N=C21	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
833	O=C1NCC2(CCCCC2)N2C1=CC1=CN=C(N[C@H]3CCCNC3)N=C21	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
834	O=C1NCC2(CCCCC2)N2C1=CC1=CN=C(N[C@H]3CCCNC3)N=C21	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
835	O=C1NCC2(CCCCC2)N2C1=CC1=CN=C(N[C@@H]3CCCNC3)N=C21	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
836	O=C1NCC2(CCCCC2)N2C1=CC1=CN=C(N[C@@H]3CCCNC3)N=C21	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
837	C1CCC2(CC1)CN=CC1=CC3=CN=C(N[C@@H]4CCCNC4)N=C3N21	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
838	C1CCC2(CC1)CN=CC1=CC3=CN=C(N[C@@H]4CCCNC4)N=C3N21	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
839	C[C@H]1CC[C@H](CC1)NC1=NC=C2C=C3C=NCC4(CCCCC4)N3C2=N1	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
840	C[C@H]1CC[C@H](CC1)NC1=NC=C2C=C3C=NCC4(CCCCC4)N3C2=N1	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
841	C[C@H]1CC[C@@H](CC1)NC1=NC=C2C=C3C=NCC4(CCCCC4)N3C2=N1	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
842	C[C@H]1CC[C@@H](CC1)NC1=NC=C2C=C3C=NCC4(CCCCC4)N3C2=N1	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
843	FC(F)(F)C1CCN(CC1)[C@H]1CC[C@@H](CC1)NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
844	CC(C)(C)N1CCN(CC1)[C@H]1CC[C@@H](CC1)NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
845	O=C1NCC2(CCCCC2)N2C1=CC1=CN=C(N[C@H]3CC[C@@H](CC3)N3CCN(CC3)C3CCCC3)N=C21	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
846	FC1=CC=C(C=C1)N1CCN(CC1)[C@H]1CC[C@@H](CC1)NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
847	O=C1NCC2(CCCCC2)N2C1=CC1=CN=C(N[C@H]3CC[C@@H](CC3)N3CCN(CC4CCCCC4)CC3)N=C21	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
848	O=C(C1CC1)N1CCN(CC1)[C@H]1CC[C@@H](CC1)NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
849	N[C@H]1CC[C@@H](CC1)NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
850	N[C@H]1CC[C@@H](CC1)NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
851	CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCC[C@@H]2NCCF)=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
852	COCCN[C@H]1CCC[C@@H]1NC1=NC(C2=CNC3=C2C=CC(=N3)C2=C(C)ON=C2C)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
853	COC1CCN(C1)[C@H]1CCC[C@@H]1NC1=NC(C2=CNC3=NC(=CC=C23)C2=C(C)ON=C2C)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
854	CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCC[C@@H]2NCCO)=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
855	N[C@@H]1[C@H](CC2=CC=CC=C12)NC1=NC(C2=CNC3=CC(=CC=C23)C#N)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
856	CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCC[C@H]2N2CC(F)C2)=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
857	CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=NN2)C1=C(C=NC(N[C@H]2CCC[C@@H]2N)=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
858	CC1=NSC(=N1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCC[C@@H]2N)=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
859	CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCC[C@@H]2N2CC(O)C2)=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
860	CCN[C@H]1CC[C@@H]1NC1=NC(C2=CNC3=C2C=CC(=N3)C2=C(C)ON=C2C)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
861	CP(C)(=O)C1=C2NC=C(C2=CC=C1C#N)C1=C(C=NC(N[C@H]2CCC[C@@H]2N)=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
862	CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCC[C@H]2N2CC(O)C2)=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30 - 100	nM
863	CC1=C(C(C)=NO1)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CC[C@@H]3N)=N2)C(F)(F)F)=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
864	CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCC[C@@H]2N2CC(F)(F)C2)=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	500	nM
865	CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCC[C@H]2N2CC(F)(F)C2)=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	500	nM
866	N[C@H]1CCC[C@@H]1NC1=NC(C2=CNC3=C(Cl)C(O)=CC=C23)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
867	FC(F)(F)C1=C(N=C(N[C@H]2CC[C@@H]2N2CCCC2)N=C1)C1=CNC2=CC(=CC=C12)C#N	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
868	[H][C@]12CC[C@]([H])(N1)[C@H](C2)NC1=NC(C2=CNC3=CC(=CC=C23)C2=C(C)ON=C2C)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
869	[H][C@@]12CC[C@@]([H])(N1)[C@@H](C2)NC1=NC(C2=CNC3=CC(=CC=C23)C2=C(C)ON=C2C)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30 - 100	nM
870	CC1=C(C(C)=NO1)C1=CC=C2C(=C1)N(COCC[Si](C)(C)C)C=C2C1=C(C=NC(N[C@H]2CCC[C@@H]2NC(=O)OC(C)(C)C)=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
871	COCCN[C@H]1CCC[C@@H]1NC1=NC(C2=CNC3=CC(=CC=C23)C#N)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
872	[H][C@@]12CC[N@@](CC1)C[C@H](C2)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=C(C)ON=C2C)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
873	[H][C@@]12CC[N@@](CC1)C[C@@H](C2)NC1=NC(C2=CNC3=NC(=CC=C23)C2=C(C)ON=C2C)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
874	CC1=C(C(C)=NO1)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCC[C@@H]3N3CCCC3)=N2)C(F)(F)F)=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
875	CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCC[C@@H]2N2CCCC2)=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
876	CCN[C@H]1CCC[C@@H]1NC1=NC(C2=CNC3=C2C=CC(=N3)C2=C(C)ON=C2C)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
877	CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCC[C@@H]2N2CCC2)=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
878	CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCC[C@@H]2NCC(F)F)=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
879	CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CC[C@@H]2N2CCCC2)=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
880	Cl.CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
881	Cl.CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
882	Cl.CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
883	Cl.CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
884	Cl.CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
885	Cl.CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	CDK-activating kinase assembly factor MAT1	inhibition percentage	98	%
886	Cl.CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	CDK-activating kinase assembly factor MAT1	IC50	2.36	nM
887	Cl.CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-H;+Cyclin-dependent kinase 7	Kd (dissociation constant)	0.03	nM
888	CNC(=O)C1=C(OCCCCCCCCN2C=C(COC3=C4C(=O)N(C5CCC(=O)NC5=O)C(=O)C4=CC=C3)N=N2)N=C(S1)C1=CC=NC(NC(=O)C2CC2)=C1	Cyclin-dependent kinase 7	inhibition rate	3.65	%
889	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=C(C=C1)C1=CCN(CC1)C(=O)C=C	Cyclin-dependent kinase 7	IC50	3.3	μM
890	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=C(C=C1)N1CCN(CC1)C(=O)C=C	Cyclin-dependent kinase 7	IC50	2.322 - 7.96	μM
891	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=C(N=C1)C1=CCN(CC1)C(=O)C#C	Cyclin-dependent kinase 7	IC50	0.012	μM
892	CN(C)CC=CC(=O)NC1=CC=CC(=C1)C(=O)NC1=CC=CC(NC2=NC=C(Cl)C(=N2)C2=CNC3=CC=CC=C23)=C1	Cyclin-dependent kinase 7	IC50	100 - 250	nM
893	CN(C)CC=CC(=O)NC1=CC=CC(=C1)C(=O)NC1=CC=CC(NC2=NC=C(Cl)C(=N2)C2=CNC3=CC=CC=C23)=C1	Cyclin-dependent kinase 7	IC50	100 - 250	nM
894	CN(C)CC=CC(=O)NC1=CC=CC(=C1)C(=O)NC1=CC=CC(NC2=NC=C(Cl)C(=N2)C2=CNC3=CC=CC=C23)=C1	Cyclin-dependent kinase 7	IC50	100 - 250	nM
895	CC(C)C1=C2N=C(N=C(NCC3=CC(OC4=CC(NC(=O)C=C)=CC=C4)=CC=C3)N2N=C1)N1CCC(CC1)N(C)C	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
896	CC(C)C1=C2N=C(N=C(NCC3=CC(OC4=CC(NC(=O)C=C)=CC=C4)=CC=C3)N2N=C1)N1CCC(CC1)N(C)C	Cyclin-dependent kinase 7 [human]	IC50	1	μM
897	COC1CCC(CC1)NC1=NC2=C(C=NN2C(NCC2=CC=CC=C2C2=C3C=CC(NC(=O)\C=C\CN(C)C)=CC3=CC=N2)=N1)C(C)C	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
898	COC1CCC(CC1)NC1=NC2=C(C=NN2C(NCC2=CC=CC=C2C2=C3C=CC(NC(=O)\C=C\CN(C)C)=CC3=CC=N2)=N1)C(C)C	Cyclin-dependent kinase 7 [human]	IC50	1	μM
899	COC1CCC(CC1)NC1=NC2=C(C=NN2C(NCC2=CC=CC=C2C2=C3C=CC(NC(=O)\C=C\CN(C)C)=CC3=CC=N2)=N1)C(C)C	Cyclin-dependent kinase 7 [human]	IC50	1	μM
900	COC1CCC(CC1)NC1=NC2=C(C=NN2C(NCC2=CC=CC=C2C2=C3C=CC(NC(=O)\C=C\CN(C)C)=CC3=CC=N2)=N1)C(C)C	Cyclin-dependent kinase 7 [human]	IC50	1	μM
901	CC#CC(=O)NC1=CC2=CC=NC(C3=CC=CC=C3CNC3=NC(=NC4=C(C=NN34)C(C)C)N3CCC(N)CC3)=C2C=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
902	CC#CC(=O)NC1=CC2=CC=NC(C3=CC=CC=C3CNC3=NC(=NC4=C(C=NN34)C(C)C)N3CCC(N)CC3)=C2C=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
903	CC#CC(=O)NC1=CC2=CC=NC(C3=CC=CC=C3CNC3=NC(=NC4=C(C=NN34)C(C)C)N3CCC(N)CC3)=C2C=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
904	CC#CC(=O)NC1=CC2=CC=NC(C3=CC=CC=C3CNC3=NC(=NC4=C(C=NN34)C(C)C)N3CCC(N)CC3)=C2C=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
905	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C(C)=C)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
906	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C(C)=C)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
907	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C(C)=C)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
908	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C(C)=C)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
909	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C5(CC5)C#N)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
910	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C5(CC5)C#N)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
911	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C5(CC5)C#N)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
912	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C5(CC5)C#N)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
913	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=C)=CC4=CC=N3)N2N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
914	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
915	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
916	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
917	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C5=CCCC5)=CC4=CC=N3)N2N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
918	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C5=CCCC5)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
919	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C5=CCCC5)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
920	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C5=CCCC5)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
921	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C(C)=C)=CC4=CC=N3)N2N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
922	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C(C)=C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
923	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C(C)=C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
924	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C(C)=C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
925	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=C(C)C=CC=C3C3=CC=C4C=CC=C(NC(=O)C=C)C4=N3)N2N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
926	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=C(C)C=CC=C3C3=CC=C4C=CC=C(NC(=O)C=C)C4=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
927	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=C(C)C=CC=C3C3=CC=C4C=CC=C(NC(=O)C=C)C4=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
928	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=C(C)C=CC=C3C3=CC=C4C=CC=C(NC(=O)C=C)C4=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
929	CC(C)C1=C2N=C(N=C(NCC3=CC(OC4=CC(NC(=O)C=C)=CC=C4)=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
930	CC(C)C1=C2N=C(N=C(NCC3=CC(OC4=CC(NC(=O)C=C)=CC=C4)=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
931	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=C(C)C=CC=C3C3=CC4=CC=CC(NC(=O)C(F)=C)=C4N3)N2N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
932	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=C(C)C=CC=C3C3=CC4=CC=CC(NC(=O)C(F)=C)=C4N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
933	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C(F)=C)=CC4=CC=N3)N2N=C1)N1CCNCC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
934	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C(F)=C)=CC4=CC=N3)N2N=C1)N1CCNCC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
935	CC(C)C1=C2N=C(NCC3CNCCO3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C(F)=C)=CC4=CC=N3)N2N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
936	COC1CCC(CC1)NC1=NC2=C(C=NN2C(NCC2=CC=CC=C2C2=C3C=CC(NC(=O)C(F)=C)=CC3=CC=N2)=C1)C(C)C	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100 - 1000	nM
937	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C(F)=C)=CC4=CC=N3)N2N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
938	COC1CCC(CC1)NC1=NC2=C(C=NN2C(NCC2=CC=CC=C2C2=C3C=CC(NC(=O)C(F)=C)=CC3=CC=N2)=N1)C(C)C	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100 - 1000	nM
939	CCOC1CCN(CC1)C1=NC2=C(C=NN2C(NCC2=CC=CC=C2C2=C3C=CC(NC(=O)C(F)=C)=CC3=CC=N2)=N1)C(C)C	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100 - 1000	nM
940	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C(F)=C)=CC4=CC=N3)N2N=C1)N1CCC(CC1)OC(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	1000	nM
941	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C(F)=C)=CC4=CC=N3)N2N=C1)C1=CC=CC(OC2CCNC2)=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
942	COC1CCN(CC1)C1=NC2=C(C=NN2C(NCC2=CC=CC=C2C2=C3C=CC(NC(=O)C(F)=C)=CC3=CC=N2)=N1)C(C)C	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100 - 1000	nM
943	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3OC3=CC=CC(NC(=O)C=C)=C3)N2N=C1)N1CCC(N)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
944	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3OC3=CC=CC(NC(=O)C=C)=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
945	C[C@H](C(=O)NC1=NNC(=C1)C1CC1)C1=CC=C(C=C1)C1=CCN(CC1)C(=O)C=C	Cyclin-dependent kinase 7	IC50	2.29	μM
946	CC(C)C(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=C(C=C1)C1=CCN(CC1)C(=O)C=C	Cyclin-dependent kinase 7	IC50	0.506	μM
947	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CN=C(C=C1)C1=CCN(CC1)C(=O)C=C	Cyclin-dependent kinase 7	IC50	1.3	μM
948	CC(C)C(C(=O)NC1=NNC(=C1)C1CC1)C1=CN=C(C=C1)C1=CCN(CC1)C(=O)C=C	Cyclin-dependent kinase 7	IC50	0.744	μM
949	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=C(C=C1)C1=CCCN(CC1)C(=O)C=C	Cyclin-dependent kinase 7	IC50	6.585	μM
950	C[C@H](C(=O)NC1=NNC(=C1)C1CC1)C1=CC=C(C=C1)C1CCN(CC1)C(=O)C=C	Cyclin-dependent kinase 7	IC50	2.83	μM
951	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=C(N=C1)C1CCN(CC1)C(=O)C=C	Cyclin-dependent kinase 7	IC50	10	μM
952	C[C@H](C(=O)NC1=NNC(=C1)C1CC1)C1=CC=C(C=C1)C1=CCN(CC1)C(=O)\C=C\CN(C)C	Cyclin-dependent kinase 7	IC50	0.621	μM
953	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=C(N=C1)N1CCN(CC1)C(=O)C=C	Cyclin-dependent kinase 7	IC50	2.09	μM
954	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CN=C(C=C1)C1=CCCN(C1)C(=O)C=C	Cyclin-dependent kinase 7	IC50	0.153	μM
955	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=C(N=C1)C1=CCN(C1)C(=O)C=C	Cyclin-dependent kinase 7	IC50	1.01	μM
956	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=C(N=C1)C1CCCN(C1)C(=O)C=C	Cyclin-dependent kinase 7	IC50	3.51	μM
957	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC(F)=C(C=C1)C1=CCCN(C1)C(=O)C=C	Cyclin-dependent kinase 7	IC50	0.44	μM
958	C=CC(=O)N1CCC=C(C1)C1=NC=C(CC(=O)NC2=NNC(=C2)C2CC2)C=C1	Cyclin-dependent kinase 7	IC50	1.73	μM
959	CC#CC(=O)N1CCC(=CC1)C1=NC=C(C=C1)C(C)C(=O)NC1=NNC(=C1)C1CC1	Cyclin-dependent kinase 7	IC50	1.692	μM
960	CC#CC(=O)N1CCC=C(C1)C1=NC=C(C=C1)C(C)C(=O)NC1=NNC(=C1)C1CC1	Cyclin-dependent kinase 7	IC50	2.19	μM
961	C=CC(=O)N1CC=C(C1)C1=CC=C(CC(=O)NC2=NNC(=C2)C2CC2)C=N1	Cyclin-dependent kinase 7	IC50	7.79	μM
962	COC(=O)N1CCN(CC1)[C@H]1CC[C@@H](CC1)NC1=C2C=C(C=CC2=NC=N1)C#N	Cyclin-dependent kinase 7	IC50	3.1	μM
963	CCC(=O)NC1=CC=C(C=C1)C(=O)N1CCC[C@H](C1)NC1=NC2=C(C=CC(=O)N2C(C)C)C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	30 - 100	μM
964	ClC1=CC=C2N=C(N[C@@H]3CCN(C3)C(=O)C3=CC=C(NC(=O)C=C)C=C3)N=CC2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
965	C=CC(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
966	C=CC(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
967	C=CC(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=CC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
968	C=CC(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=CC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
969	FC1=CC=C2N=C(N[C@@H]3CCN(C3)C(=O)C3=CC=C(NC(=O)C=C)C=C3)N=CC2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
970	FC1=CC=C2N=C(N[C@@H]3CCN(C3)C(=O)C3=CC=C(NC(=O)C=C)C=C3)N=CC2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
971	COC1=CC=C2N=C(N[C@@H]3CCN(C3)C(=O)C3=CC=C(NC(=O)C=C)C=C3)N=CC2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	30 - 100	μM
972	CC1=CC=C2N=C(N[C@@H]3CCN(C3)C(=O)C3=CC=C(NC(=O)C=C)C=C3)N=CC2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
973	C=CC(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC=C2C=CN=CC2=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
974	CC1=CC=C2C=NC(N[C@@H]3CCN(C3)C(=O)C3=CC=C(NC(=O)C=C)C=C3)=NC2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
975	CS(=O)(=O)C1=CC=C2C=NC(N[C@@H]3CCN(C3)C(=O)C3=CC=C(NC(=O)C=C)C=C3)=NC2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
976	CS(=O)(=O)C1=CC=C2C=NC(N[C@@H]3CCN(C3)C(=O)C3=CC=C(NC(=O)C=C)C=C3)=NC2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
977	COC1=CC=C2C=NC(N[C@@H]3CCN(C3)C(=O)C3=CC=C(NC(=O)C=C)C=C3)=NC2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
978	COC1=CC=C2C=NC(N[C@@H]3CCN(C3)C(=O)C3=CC=C(NC(=O)C=C)C=C3)=NC2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
979	FC1=CC=C2C=NC(N[C@@H]3CCN(C3)C(=O)C3=CC=C(NC(=O)C=C)C=C3)=NC2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
980	ClC1=CC=C2C=NC(N[C@@H]3CCN(C3)C(=O)C3=CC=C(NC(=O)C=C)C=C3)=NC2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
981	C=CC(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC(=CC=C2C=N1)C#N	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
982	C=CC(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC(=CC=C2C=N1)C#N	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
983	OC(=O)C1=CC=C2C=NC(N[C@@H]3CCN(C3)C(=O)C3=CC=C(NC(=O)C=C)C=C3)=NC2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
984	NC(=O)C1=CC=C2C=NC(N[C@@H]3CCN(C3)C(=O)C3=CC=C(NC(=O)C=C)C=C3)=NC2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
985	CNC(=O)C1=CC=C2C=NC(N[C@@H]3CCN(C3)C(=O)C3=CC=C(NC(=O)C=C)C=C3)=NC2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
986	CN(C)C(=O)C1=CC=C2C=NC(N[C@@H]3CCN(C3)C(=O)C3=CC=C(NC(=O)C=C)C=C3)=NC2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
987	C=CC(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=C(C=CC(=O)N2)C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
988	CC(C)N1C(=O)C=CC2=C1N=C(N[C@@H]1CCN(C1)C(=O)C1=CC=C(NC(=O)C=C)C=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
989	CC(C)N1C(=O)C=CC2=C1N=C(N[C@@H]1CCN(C1)C(=O)C1=CC=C(NC(=O)C=C)C=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
990	CCC(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
991	CCC(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
992	CCC(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=CC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
993	CCC(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=C(F)C=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
994	CCC(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=C(Cl)C=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
995	CCC(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=C(OC)C=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	30 - 100	μM
996	CCC(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=C(C)C=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
997	CCC(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC=C2C=CN=CC2=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
998	CCC(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC(OC)=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
999	CCC(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC(=CC=C2C=N1)S(C)(=O)=O	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
1000	CCC(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC(Cl)=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
1001	CCC(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC(F)=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
1002	CCC(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC(=CC=C2C=N1)C#N	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
1003	CCC(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC(=CC=C2C=N1)C(O)=O	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
1004	CCC(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC(=CC=C2C=N1)C(N)=O	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	10	μM
1005	CCC(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC(=CC=C2C=N1)C(=O)N(C)C	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
1006	CCC(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=C(C=CC(=O)N2)C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
1007	CCC(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=C(C=CC(=O)N2C(C)C)C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
1008	CCC(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=C(C=CC(=O)N2C(C)C)C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
1009	FC1=C(NC(=O)C=C)C=CC(=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
1010	FC1=C(NC(=O)C=C)C=CC(=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
1011	C=CC(=O)NC1=CC=C(C=C1)C(=O)N1CCC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	30 - 100	μM
1012	F[C@H]1CN(C[C@@H]1NC1=NC2=CC=CC=C2C=N1)C(=O)C1=CC=C(NC(=O)C=C)C=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
1013	C=CC(=O)NC1=CC=C(C=C1)C(=O)N1CC(C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	10 - 30	μM
1014	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
1015	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N1CCC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	30 - 100	μM
1016	C=CC(=O)NC1=NC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
1017	C=CC(=O)NC1=NC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
1018	CN(C)C\C=C\C(=O)NC1=C(F)C=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
1019	FC1=CC=C2N=C(N[C@@H]3CCN(C3)C(=O)C3=CC(F)=C(NC(=O)C=C)C=C3)N=CC2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
1020	O=C(NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1)C#C	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	10	μM
1021	C=CC(=O)NC1=CC=C(C=C1)C(=O)N1CCC[C@H](C1)NC1=CC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	30 - 100	μM
1022	COC1=C(NC(=O)C=C)C=CC(=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
1023	ClC1=CC=C2N=C(N[C@@H]3CCCN(C3)C(=O)C3=CC=C(NC(=O)C=C)C=C3)N=CC2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	30 - 100	μM
1024	CC1=C(NC(=O)C=C)C=CC(=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
1025	CC1=C(NC(=O)C=C)C=CC(=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
1026	COC1=C(C=CC(NC(=O)C=C)=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
1027	CN(C(=O)C=C)C1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
1028	CN(C(=O)C=C)C1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
1029	CC1=CC(=CC(F)=C1NC(=O)C=C)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	10 - 30	μM
1030	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=C(F)C=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
1031	CC#CC(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
1032	CC1=CC(NC(=O)C=C)=CC=C1C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
1033	C=CC(=O)N1CCOC2=C1C=CC(=C2)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
1034	COC1=C(NC(=O)\C=C\CN(C)C)C=CC(=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
1035	CN(C)C\C=C\C(=O)NC1=C(Cl)C=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
1036	CN(C)C\C=C\C(=O)NC1=C(C)C=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
1037	CN(C)C\C=C\C(=O)N1CCOC2=C1C=CC(=C2)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
1038	COC1=C(C=CC(NC(=O)\C=C\CN(C)C)=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
1039	CN(C)C\C=C\C(=O)N(C)C1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
1040	C=CC(=O)NC1=CC(=CC=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
1041	ClC1=C(NC(=O)C=C)C=CC(=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
1042	ClC1=C(NC(=O)C=C)C=CC(=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
1043	CN(C)C\C=C\C(=O)N1CCCC2=C1C=CC(=C2)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
1044	FC1=C2N=C(N[C@@H]3CCN(C3)C(=O)C3=CC=C(NC(=O)C=C)C=C3)N=CC2=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
1045	FC1=C2C=NC(N[C@@H]3CCN(C3)C(=O)C3=CC=C(NC(=O)C=C)C=C3)=NC2=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
1046	CC1=C(NC(=O)C=C)C=CC(=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=C(F)C=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
1047	CC1=C(NC(=O)C=C)C=CC(=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC(=CC=C2C=N1)S(C)(=O)=O	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
1048	CCC(=C)C(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
1049	C=CS(=O)(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
1050	C[C@H]1CN(C[C@@H]1NC1=NC2=CC=CC=C2C=N1)C(=O)C1=CC=C(NC(=O)C=C)C=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	10 - 30	μM
1051	FC1=CC=C2N=C(N[C@@H]3CCCN(C3)C(=O)C3=CC=C(NC(=O)C=C)C=C3)N=CC2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	30 - 100	μM
1052	FC1=CC=C2C=NC(N[C@@H]3CCCN(C3)C(=O)C3=CC=C(NC(=O)C=C)C=C3)=NC2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	30 - 100	μM
1053	COC1=CC=C2C=NC(N[C@@H]3CCCN(C3)C(=O)C3=CC=C(NC(=O)C=C)C=C3)=NC2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	30 - 100	μM
1054	COC1=CC=C2N=C(N[C@@H]3CCCN(C3)C(=O)C3=CC=C(NC(=O)C=C)C=C3)N=CC2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	30 - 100	μM
1055	CC1=CC=C2N=C(N[C@@H]3CCCN(C3)C(=O)C3=CC=C(NC(=O)C=C)C=C3)N=CC2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	30 - 100	μM
1056	CC1=CC=C2C=NC(N[C@@H]3CCCN(C3)C(=O)C3=CC=C(NC(=O)C=C)C=C3)=NC2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	30 - 100	μM
1057	CCC(=O)NC1=CC=C(C=C1)C(=O)N1CCC[C@H](C1)NC1=NC2=CC(Cl)=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	30 - 100	μM
1058	CS(=O)(=O)C1=CC=C2C=NC(N[C@@H]3CCCN(C3)C(=O)C3=CC=C(NC(=O)C=C)C=C3)=NC2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	30 - 100	μM
1059	CN(C)C(=O)C1=CC=C2C=NC(N[C@@H]3CCCN(C3)C(=O)C3=CC=C(NC(=O)C=C)C=C3)=NC2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	30 - 100	μM
1060	NC(=O)C1=CC=C2C=NC(N[C@@H]3CCCN(C3)C(=O)C3=CC=C(NC(=O)C=C)C=C3)=NC2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	10 - 30	μM
1061	OC(=O)C1=CC=C2C=NC(N[C@@H]3CCCN(C3)C(=O)C3=CC=C(NC(=O)C=C)C=C3)=NC2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	10 - 30	μM
1062	CC(C)N1C(=O)C=CC2=C1N=C(N[C@@H]1CCCN(C1)C(=O)C1=CC=C(NC(=O)C=C)C=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	30 - 100	μM
1063	C=CC(=O)NC1=CC=C(C=C1)C(=O)N1CCC[C@H](C1)NC1=NC2=C(C=CC(=O)N2)C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	30 - 100	μM
1064	CCC(=O)NC1=CC=C(C=C1)C(=O)N1CCC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	30 - 100	μM
1065	CCC(=O)NC1=CC=C(C=C1)C(=O)N1CCC[C@H](C1)NC1=CC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	30 - 100	μM
1066	CCC(=O)NC1=CC=C(C=C1)C(=O)N1CCC[C@H](C1)NC1=NC2=CC=C(Cl)C=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	30 - 100	μM
1067	CCC(=O)NC1=CC=C(C=C1)C(=O)N1CCC[C@H](C1)NC1=NC2=CC(OC)=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	30 - 100	μM
1068	CCC(=O)NC1=CC=C(C=C1)C(=O)N1CCC[C@H](C1)NC1=NC2=CC(=CC=C2C=N1)S(C)(=O)=O	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	30 - 100	μM
1069	CCC(=O)NC1=CC=C(C=C1)C(=O)N1CCC[C@H](C1)NC1=NC2=CC(F)=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	30 - 100	μM
1070	CN1C=C(C=N1)N1C=NC2=C(NCC3=NC4=C(F)C(F)=CC=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 7	inhibition rate	69	%
1071	CC1=CC(=NO1)N1C=NC2=C(NCC3=NC4=C(F)C(F)=CC=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 7	inhibition rate	69	%
1072	NC1=C(C=NN1C1=CC=CC=C1)C(=O)NCC1=CC=C(C=C1)C(=O)NCCCC1CCCCC1	Cyclin-dependent kinase 7	inhibition rate	0	%
1073	NC1=CC=CC=C1NC(=O)CC1=CC=C(NC(=O)C2=NNC=C2NC(=O)C2=C(Cl)C=CC=C2Cl)C=C1	Cyclin-dependent kinase 7; Cyclin-H1-1	IC50	1000	nM
1074	C[C@H]1COCCN1C1=NC(N2CCOC[C@H]2C)=C2N=C(SC2=N1)C1=NNC=C1	Cyclin-dependent kinase 7	inhibition rate	9	%
1075	CN1CCN(CC1)C1=CC=C(NC2=NC(NC3=C(NC(=O)C=C)C=CC=C3)=C(C=N2)C(=O)NC2=C(C)C=CC=C2Cl)C=C1	Cyclin-dependent kinase 7	inhibition rate	0	%
1076	CCC(C(=O)NC1=NC=C(CC)S1)C1=CN=CC(=C1)C1=CC(C#N)=C(NC(=O)\C=C\CN(C)C)N=C1	Cyclin-dependent kinase 7 [human]	IC50	8	nM
1077	CCC(C(=O)NC1=NC=C(CC)S1)C1=CN=CC(=C1)C1=CC(C#N)=C(NC(=O)\C=C\CN(C)C)N=C1	Cyclin-dependent kinase 7 [human]	IC50	100	nM
1078	CCC(C(=O)NC1=NC=C(CC)S1)C1=CN=CC(=C1)C1=CC(C#N)=C(NC(=O)\C=C\CN(C)C)N=C1	Cyclin-dependent kinase 7 [human]	IC50	52	nM
1079	CNC1=C(C=NC2=C1C(Cl)=CN2)C1=CC=C(C=C1)C(=O)N1CCC(CC1)N1CCOCC1	Cyclin-dependent kinase 7	inhibition rate	10	%
1080	ClC1=CNC2=C1C(NC1CCCC1)=C(C=N2)C1=CC=C(C=C1)C(=O)N1CCC(CC1)N1CCOCC1	Cyclin-dependent kinase 7	inhibition rate	7	%
1081	CC(=O)C1=C(C)C2=C(OC1=O)C=C(NC1=NC(=CC=N1)C1=CC=CN=C1)C=C2	Cyclin-H;+Cyclin-dependent kinase 7	IC50	27000	nM
1082		Cyclin-dependent kinase 7 [human]	inhibition rate		
1083		Cyclin-dependent kinase 7 [human]	inhibition rate		
1084		Cyclin-dependent kinase 7 [human]	inhibition rate		
1085	C1CNCCOC2=CC=C(C=C2)C2=CSC3=CN=C(NC4=CN(C1)N=C4)N=C23	Cyclin-dependent kinase 7	inhibition rate	30 - 70	%
1086	CC(C)(C)C1=CN=C(CSC2=CN=C(N[C@@H]3CCCN(C3)C(=O)C3=CC=C(NC(=O)C=C)C(F)=C3)S2)O1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	5540	nM
1087	CC(C)(C)C1=CN=C(CSC2=CN=C(N[C@@H]3CCCN(C3)C(=O)C3=CC=C(NC(=O)C=C)C(=C3)C(F)(F)F)S2)O1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	3490	nM
1088	CN(C)C(=O)C1=CC2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N1C12CC(C1)C2	Cyclin-H; Cyclin-dependent kinase 7	IC50	27.4	μM
1089	CN(C)C(=O)C1=CC2=C(N=C(NC3=CC=C(C=C3)N3CCN(C)CC3)N=C2)N1C12CC(C1)C2	Cyclin-H; Cyclin-dependent kinase 7	IC50	1.43	μM
1090	CN(C)C(=O)C1=CC2=C(N=C(NC3=CC=C(C=C3)N3CCNCC3)N=C2)N1C12CC(C1)C2	Cyclin-H; Cyclin-dependent kinase 7	IC50	3.41	μM
1091	CN(C)C(=O)C1=CC2=C(N=C(NC3=CC(F)=C(C=C3)N3CCNCC3)N=C2)N1C12CC(C1)C2	Cyclin-H; Cyclin-dependent kinase 7	IC50	1.14	μM
1092	CC(C)N1CCN(CC1)C1=CC=C(NC2=NC3=C(C=C(N3C34CC(C3)C4)C(=O)N(C)C)C=N2)C=C1	Cyclin-H; Cyclin-dependent kinase 7	IC50	1.52	μM
1093	CN(C)C(=O)C1=CC2=C(N=C(NC3=CC=C(C=C3)N3CC4(CNC4)C3)N=C2)N1C12CC(C1)C2	Cyclin-H; Cyclin-dependent kinase 7	IC50	4.86	μM
1094	CN(C)C(=O)C1=CC2=C(N=C(NC3=CC(F)=C(OCCN4CCCC4)C=C3)N=C2)N1C12CC(C1)C2	Cyclin-H; Cyclin-dependent kinase 7	IC50	1.66	μM
1095	CN(C)C(=O)C1=CC2=C(N=C(NC3=CC=C(C=C3)C3CCN(C)CC3)N=C2)N1C12CC(C1)C2	Cyclin-H; Cyclin-dependent kinase 7	IC50	2.06	μM
1096	CN(C)CCOC1=CC=C(NC2=NC3=C(C=C(N3C34CC(C3)C4)C(=O)N(C)C)C=N2)C=C1	Cyclin-H; Cyclin-dependent kinase 7	IC50	3.42	μM
1097	CN(C)CCOC1=C(F)C=C(NC2=NC3=C(C=C(N3C34CC(C3)C4)C(=O)N(C)C)C=N2)C=C1	Cyclin-H; Cyclin-dependent kinase 7	IC50	2.14	μM
1098	CN(C)CCOC1=C(C)C=C(NC2=NC3=C(C=C(N3C34CC(C3)C4)C(=O)N(C)C)C=N2)C=C1	Cyclin-H; Cyclin-dependent kinase 7	IC50	2.65	μM
1099	CN(C)C(=O)C1=CC2=C(N=C(NC3=CC(F)=C(C=C3)N3CCC(CC3)N3CCN(C)CC3)N=C2)N1C12CC(C1)C2	Cyclin-H; Cyclin-dependent kinase 7	IC50	2.68	μM
1100	CN(C)C(=O)C1=CC2=C(N=C(NC3=CC=C(C=C3)N3CC4(CN(C)C4)C3)N=C2)N1C12CC(C1)C2	Cyclin-H; Cyclin-dependent kinase 7	IC50	10	μM
1101	CN(C)C(=O)C1=CC2=C(N=C(NC3=CC(F)=C(C=C3)N3CC4(CN(C)C4)C3)N=C2)N1C12CC(C1)C2	Cyclin-H; Cyclin-dependent kinase 7	IC50	5.01	μM
1102	CN(C)C(=O)C1=CC2=C(N=C(NC3=CC(F)=C(C=C3)N3CCN(CCO)CC3)N=C2)N1C12CC(C1)C2	Cyclin-H; Cyclin-dependent kinase 7	IC50	0.938	μM
1103	CN(C)C(=O)C1=CC2=C(N=C(NC3CCN(CC3)S(C)(=O)=O)N=C2)N1C12CC(C1)C2	Cyclin-H; Cyclin-dependent kinase 7	IC50	8.13	μM
1104	CN(C)C(=O)C1=CC2=C(N=C(NC3=CC=C(C=C3)S(C)(=O)=O)N=C2)N1C12CC(C1)C2	Cyclin-H; Cyclin-dependent kinase 7	IC50	10	μM
1105	CC1CN(CC(C)N1)C1=CC=C(NC2=NC3=C(C=C(N3C34CC(C3)C4)C(=O)N(C)C)C=N2)C=C1	Cyclin-H; Cyclin-dependent kinase 7	IC50	5.61	μM
1106	CC1CCN(CC1)C1=CC=C(NC2=NC3=C(C=C(N3C34CC(C3)C4)C(=O)N(C)C)C=N2)C=C1	Cyclin-H; Cyclin-dependent kinase 7	IC50	5.79	μM
1107	CN1CC2(C1)CN(C2)C1=CC=C(NC2=NC3=C(C=N2)C=C(C#N)C(=O)N3C2CCCC2)C=C1	CDK-activating kinase assembly factor MAT1	IC50	2.42	μM
1108	CN(C)C(=O)C1=CC2=C(N=C(NC3CCN(CC3)S(C)(=O)=O)N=C2)N(C2CCCC2)C1=O	CDK-activating kinase assembly factor MAT1	IC50	10	μM
1109	CN(C)CCN(C)C1=CC=C(NC2=NC3=C(C=N2)C(C)=C(C(C)=O)C(=O)N3C23CC(C2)C3)C=C1	CDK-activating kinase assembly factor MAT1	IC50	0.785	μM
1110	CN1CCN(CC1)C1=CC=C(NC2=NC3=C(C=N2)C(C)=C(C(C)=O)C(=O)N3C23CC(C2)C3)C=C1	CDK-activating kinase assembly factor MAT1	IC50	2.84	μM
1111	CN1CCN(CC1)C1=CN=C(NC2=NC3=C(C=N2)C(C)=C(C(C)=O)C(=O)N3C23CC(C2)C3)C=C1	CDK-activating kinase assembly factor MAT1	IC50	10	μM
1112	CN(C)CCN(C)C1=CC=C(NC2=NC3=C(C=N2)C(C)=C(C(C)=O)C(=O)N3C2CCCC2)C=C1	CDK-activating kinase assembly factor MAT1	IC50	0.468	μM
1113	CC(=O)C1=C(C)C2=C(N=C(NC3=NC=C(OCCN4CCCC4)C=C3)N=C2)N(C2CCCC2)C1=O	CDK-activating kinase assembly factor MAT1	IC50	10	μM
1114	CN(C)CCOC1=CC=C(NC2=NC3=C(C=N2)C(C)=C(C(C)=O)C(=O)N3C2CCCC2)C=C1F	CDK-activating kinase assembly factor MAT1	IC50	1.1	μM
1115	CN(C)CCOC1=C(C)C=C(NC2=NC3=C(C=N2)C(C)=C(C(C)=O)C(=O)N3C2CCCC2)C=C1	CDK-activating kinase assembly factor MAT1	IC50	100	μM
1116	COC1=C(OCCN(C)C)C=CC(NC2=NC3=C(C=N2)C(C)=C(C(C)=O)C(=O)N3C2CCCC2)=C1	CDK-activating kinase assembly factor MAT1	IC50	1.3	μM
1117	CN(C)CCOC1=CC=C(NC2=NC3=C(C=N2)C(C)=C(C(C)=O)C(=O)N3C2CCCC2)C=C1	CDK-activating kinase assembly factor MAT1	IC50	0.64	μM
1118	CN(C)CCOC1=CN=C(NC2=NC3=C(C=N2)C=C(C#N)C(=O)N3C23CC(C2)C3)C=C1	CDK-activating kinase assembly factor MAT1	IC50	10	μM
1119	CC1CN(CC(C)N1)C1=CC=C(NC2=NC3=C(C=N2)C(C)=C(C(=O)N(C)C)C(=O)N3C2CCCC2)C=C1	CDK-activating kinase assembly factor MAT1	IC50	10	μM
1120	CN(C)C(=O)C1=C(C)C2=C(N=C(NC3CCN(CC3)S(C)(=O)=O)N=C2)N(C1=O)C12CC(C1)C2	CDK-activating kinase assembly factor MAT1	IC50	10	μM
1121	CN(C)C(=O)C1=C(C)C2=C(N=C(NC3CC4CCC3C4)N=C2)N(C1=O)C12CC(C1)C2	CDK-activating kinase assembly factor MAT1	IC50	10	μM
1122	OCCN1CCN(CC1)C1=C(F)C=C(NC2=NC3=C(C=N2)C=C(C#N)C(=O)N3C2CCCC2)C=C1	CDK-activating kinase assembly factor MAT1	IC50	0.327	μM
1123	COC1=CC(=CC(OC)=C1F)C1=CN=CC(=C1C)C1=CC=C(C=C1)N1CCNCC1	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage	89.33 - 90.54	%
1124	COC1=CC(=CC(OC)=C1OC)C1=CN=CC(=C1C)C1=CC=C(C=C1)C1CCN(C)CC1	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage	96.95 - 97.68	%
1125	COC1=CC(=CC(OC)=C1OC)C1=CN=CC(=C1C)C1=CC=C(C=C1)N1CCNCC1	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage	94.82 - 94.84	%
1126	O[C@@H]1CNCC[C@H]1CNC1=NC2=C(C=NN2C(NC2=CC=CC(=C2)C#N)=C1)C1CC1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
1127	ClC1=CC=CC(NC2=CC(N[C@H]3CCCNC3)=NC3=C(C=NN23)C2CC2)=C1	Cyclin-dependent kinase 7	IC50	100	nM
1128	Cl.FC1=CC=CC(NC2=CC(N[C@H]3CCCNC3)=NC3=C(C=NN23)C2CC2)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
1129	Cl.O[C@H]1CCNC[C@@H]1NC1=NC2=C(C=NN2C(NC2=CC(F)=CC=C2)=C1)C1CC1	Cyclin-dependent kinase 7	IC50	1000	nM
1130	Cl.O[C@@H]1CNC[C@H](C1)NC1=NC2=C(C=NN2C(NC2=CC(F)=CC=C2)=C1)C1CC1	Cyclin-dependent kinase 7	IC50	1000	nM
1131	Cl.FC1=CC=CC(NC2=CC(N[C@H]3CCCNC3)=NC3=C(C=NN23)C2CCC2)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
1132	Cl.O[C@H]1CCNC[C@@H]1NC1=NC2=C(C=NN2C(NC2=CC(F)=CC=C2)=C1)C1CCC1	Cyclin-dependent kinase 7	IC50	1000	nM
1133	ClC1=CC(CNC2=CC(N[C@H]3CCCNC3)=NC3=C(C=NN23)C#N)=CC(Cl)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
1134	FC1=CC(CNC2=CC(N[C@H]3CCCNC3)=NC3=C(C=NN23)C#N)=CC(Cl)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
1135	ClC1=CC=CC(CNC2=CC(N[C@H]3CCCNC3)=NC3=C(C=NN23)C#N)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
1136	FC1=CC=CC(CNC2=CC(N[C@H]3CCCNC3)=NC3=C(C=NN23)C#N)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
1137	CC1=CC=CC(CNC2=CC(N[C@H]3CCCNC3)=NC3=C(C=NN23)C#N)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
1138	Cl.FC1=CC=CC(CNC2=CC(N[C@H]3CCCNC3)=NC3=C(C=NN23)C2CC2)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
1139	OCCN1CCC[C@@H](C1)NC1=NC2=C(C=NN2C(NCC2=CC(F)=CC=C2)=C1)C1CC1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
1140	O[C@H]1CNCC[C@@H]1CNC1=NC2=C(C=NN2C(NC2=CC(F)=CC=C2)=C1)C1CC1	Cyclin-dependent kinase 7	IC50	100	nM
1141	O[C@H]1CNCC[C@@H]1CNC1=NC2=C(C=NN2C(NC2=CC(F)=CC(F)=C2)=C1)C1CC1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
1142	O[C@@H]1CNCC[C@H]1CNC1=NC2=C(C=NN2C(NC2=CC(F)=CC(F)=C2)=C1)C1CC1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
1143	O[C@H]1CNCC[C@@H]1CNC1=NC2=C(C=NN2C(NC2=CC(=CC=C2)C#N)=C1)C1CC1	Cyclin-dependent kinase 7	IC50	100	nM
1144	CC1=CC(NC2=CC(NC[C@H]3CCNC[C@@H]3O)=NC3=C(C=NN23)C2CC2)=CC(F)=C1	Cyclin-dependent kinase 7	IC50	100	nM
1145	O[C@H]1CNCC[C@@H]1CNC1=NC2=C(C=NN2C(NC2=CC(F)=CC=C2)=C1)C1CCC1	Cyclin-dependent kinase 7	IC50	100	nM
1146	CS(=O)(=O)C1=CC=CC(NC2=CC(NC[C@H]3CCNC[C@@H]3O)=NC3=C(C=NN23)C2CC2)=C1	Cyclin-dependent kinase 7	IC50	100	nM
1147	CC1=CC(NC2=CC(NC[C@H]3CCNC[C@@H]3O)=NC3=C(C=NN23)C2CCC2)=CC(F)=C1	Cyclin-dependent kinase 7	IC50	100	nM
1148	CC1=CC(=CC(NC2=CC(NC[C@H]3CCNC[C@@H]3O)=NC3=C(C=NN23)C2CC2)=C1)C#N	Cyclin-dependent kinase 7	IC50	100	nM
1149	O[C@H]1CNCC[C@@H]1CNC1=NC2=C(C=NN2C(NC2=CC(F)=CC(=C2)C#N)=C1)C1CCC1	Cyclin-dependent kinase 7	IC50	100	nM
1150	CC1=CC(NC2=CC(N[C@@H]3CNC[C@@H](O)C3)=NC3=C(C=NN23)C2CCC2)=CC(F)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
1151	CC1=CC(NC2=CC(O[C@H]3CCCNC3)=NC3=C(C=NN23)C2CCC2)=CC(F)=C1	Cyclin-dependent kinase 7	IC50	100	nM
1152	CC1=CC(NC2=CC(NC[C@H]3CCCNC3)=NC3=C(C=NN23)C2CCC2)=CC(F)=C1	Cyclin-dependent kinase 7	IC50	1000	nM
1153	FC1=CC(=CC(NC2=CC(OC[C@H]3CCCNC3)=NC3=C(C=NN23)C2CCC2)=C1)C#N	Cyclin-dependent kinase 7	IC50	1000	nM
1154	CC1=CC(NC2=CC(O[C@H]3CCCNC3)=NC3=C(C=NN23)C2CC2)=CC(=C1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
1155	CC1=CC(NC2=CC(N[C@H]3CCCNC3)=NC3=C(C=NN23)C2CC2)=CC(=C1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
1156	CC1=CC(NC2=CC(N[C@H]3CCCNC3)=NC3=C(C=NN23)C2CCC2)=CC(=C1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100	nM
1157	FC1=CC(NC2=CC(O[C@H]3CCCNC3)=NC3=C(C=NN23)C2CC2)=CC(=C1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
1158	FC1=CC(NC2=CC(O[C@H]3CCCNC3)=NC3=C(C=NN23)C2CCC2)=CC(=C1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100	nM
1159	CC1=CC(NC2=CC(O[C@H]3CCCNC3)=NC3=C(C=NN23)C2CCC2)=CC(=C1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100	nM
1160	CC1=CC(=CC(NC2=CC(N[C@H]3CCCNC3)=NC3=C(C=NN23)C2CC2)=C1)C#N	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
1161	CC1=CC(=CC(NC2=CC(N[C@H]3CCCNC3)=NC3=C(C=NN23)C2CCC2)=C1)C#N	Cyclin-dependent kinase 7	IC50	100	nM
1162	CC1=CC(=CC(NC2=CC(O[C@H]3CCCNC3)=NC3=C(C=NN23)C2CC2)=C1)C#N	Cyclin-dependent kinase 7	IC50	100	nM
1163	CC1=CC(=CC(NC2=CC(O[C@H]3CCCNC3)=NC3=C(C=NN23)C2CCC2)=C1)C#N	Cyclin-dependent kinase 7	IC50	100	nM
1164	ClC1=C2N=C(N[C@H]3CCCNC3)C=C(NC3=CC(Cl)=CC=C3)N2N=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
1165	FC1=CC=CC(NC2=CC(N[C@H]3CCCNC3)=NC3=C(Cl)C=NN23)=C1	Cyclin-dependent kinase 7	IC50	100	nM
1166	O[C@H]1CCNC[C@@H]1NC1=NC2=C(Cl)C=NN2C(NC2=CC(F)=CC=C2)=C1	Cyclin-dependent kinase 7	IC50	1000	nM
1167	FC1=CC=CC(NC2=CC(O[C@H]3CCCNC3)=NC3=C(C=NN23)C2CC2)=C1	Cyclin-dependent kinase 7	IC50	100	nM
1168	FC1=CC=CC(NC2=CC(N[C@H]3CCCCNC3)=NC3=C(C=NN23)C2CC2)=C1	Cyclin-dependent kinase 7	IC50	1000	nM
1169	N[C@H]1CC[C@@H](CC1)NC1=NC2=C(C=NN2C(NC2=CC(F)=CC=C2)=C1)C1CC1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
1170	N[C@H]1CC[C@H](CC1)NC1=NC2=C(C=NN2C(NC2=CC(F)=CC=C2)=C1)C1CC1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
1171	FC(F)(F)C1=CC=CC(NC2=CC(N[C@H]3CCCNC3)=NC3=C(C=NN23)C2CC2)=C1	Cyclin-dependent kinase 7	IC50	100	nM
1172	N#CC1=CC(NC2=CC(N[C@H]3CCCNC3)=NC3=C(C=NN23)C2CC2)=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
1173	FC(F)(F)CC1=CC=CC(NC2=CC(N[C@H]3CCCNC3)=NC3=C(C=NN23)C2CC2)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
1174	O[C@@H]1CNCC[C@H]1CNC1=NC2=C(C=NN2C(NC2=CC(F)=CC=C2)=C1)C1CC1	Cyclin-dependent kinase 7	IC50	100	nM
1175	O[C@@H]1CNCC[C@@H]1CNC1=NC2=C(C=NN2C(NC2=CC(F)=CC=C2)=C1)C1CC1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
1176	FC1=CC=CC(NC2=CC(NC[C@H]3CCCNC3)=NC3=C(C=NN23)C2CC2)=C1	Cyclin-dependent kinase 7	IC50	1000	nM
1177	FC1=CC=CC(NC2=CC(OC[C@H]3CCCNC3)=NC3=C(C=NN23)C2CC2)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
1178	CNC1=NC(NC2=C(OC)C=C(C=C2)S(=O)(=O)N2CCC(CC2)N2CCOCC2)=NC2=C1C(Cl)=CN2	Cyclin-dependent kinase 7	inhibition rate	2	%
1179	CNC1=NC(NC2=CC=C(C(=O)N3CCC(CC3)N3CCOCC3)C3=C2OCO3)=NC2=C1C(Cl)=CN2	Cyclin-dependent kinase 7	inhibition rate	79	%
1180	CNC1=NC(NC2=C(OC)C=C(C=C2)P2(=O)CCN(CC2)C2CCOCC2)=NC2=C1C(Cl)=CN2	Cyclin-dependent kinase 7	inhibition rate	14	%
1181	CC(C)N1C=C(C=N1)C1=NC(NC2=CC3=C(CN(CC3)C(=O)\C=C\CN(C)C)C=C2)=NC=C1C	Cyclin-dependent-like kinase 5 [human]; CDK-activating kinase assembly factor MAT1 [human]	inhibition percentage	49	%
1182	CC(C)N1C=C(C=N1)C1=NC(NC2=CC3=C(CN(CC3)C(=O)\C=C\CN(C)C)C=C2)=NC=C1C	Cyclin-D3-1 [human]; CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	5	%
1183	FC1=CC=C(CN2CCC(COC3=CN=CC(NC(=O)C4=CC(NC(=O)C5CC5)=NC=C4)=C3)CC2)C=C1	CDK-activating kinase assembly factor MAT1	inhibition rate		
1184	ClC1=CN=CC(C2=CC3=CC=CC=C3O2)=C1N1CCC2(CCNC2=O)CC1	Cyclin-H; CDK-activating kinase assembly factor MAT1	inhibition rate	50	%
1185	CC(=O)N1CCN(CC1)C1=CC=C(NC2=NC(=CC=N2)C2=CN=C3C=CC(=CN23)C2=CC=CS2)N=C1	chitobiosyldiphosphodolichol beta-mannosyltransferase;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.148	μM
1186	CC(=O)N1CCN(CC1)C1=CC=C(NC2=NC(=CC=N2)C2=CN=C3C=CC(=CN23)C2=CNN=C2)N=C1	chitobiosyldiphosphodolichol beta-mannosyltransferase;+Cyclin-dependent kinase 7	Ki (inhibition constant)	1.185	μM
1187	CC(=O)N1CCN(CC1)C1=CC=C(NC2=NC(=CC=N2)C2=CN=C3C=CC(=CN23)C2=COC=C2)N=C1	chitobiosyldiphosphodolichol beta-mannosyltransferase;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.186	μM
1188	C1CN(CCN1)C1=CN=C(NC2=NC(=CC=N2)C2=CN=C3C=CC=CN23)C=C1	chitobiosyldiphosphodolichol beta-mannosyltransferase;+Cyclin-dependent kinase 7	Ki (inhibition constant)	1.185	μM
1189	CN1CCN(CC1)C1=CN=C(NC2=NC(=CC=N2)C2=CN=C3C=CC=CN23)C=C1	chitobiosyldiphosphodolichol beta-mannosyltransferase;+Cyclin-dependent kinase 7	Ki (inhibition constant)	1.7	μM
1190	CNC1=NC(C)=C(S1)C1=NC(NC2=CC(=CC=C2)N2CCN3CCC2CC3)=NC=C1C	Cyclin-H;+Cyclin-dependent kinase 7	Ki (inhibition constant)	546	nM
1191	CN(C)C[C@@H](NC(=O)N1CC2=C(N(N=C2NC(=O)C2=CC=C(NC(=O)C=C)C=C2)C(F)F)C1(C)C)C1=CC=CC=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
1192	FC1=CN=C(NC2=CC3=C(C=C2)N(CC3)C(=O)CN2CCS(=O)(=O)CC2)N=C1C1=CN(CCC#N)N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition rate	2	%
1193	C[C@@H](NC(=O)C1=CC2=C(NC(=O)\C2=C/C2=C(C)C(C(=O)NCC#C)=C(C)N2)C=C1)C1=CC=CC=C1	Cyclin-dependent kinase 7	inhibition percentage	98.255	%
1194	C[C@@H](NC(=O)C1=CC2=C(NC(=O)\C2=C/C2=C(C)C(NC(=O)CBr)=C(C)N2)C=C1)C1=CC=CC=C1	Cyclin-dependent kinase 7	inhibition percentage	28.25	%
1195	C[C@@H](NC(=O)C1=CC2=C(NC(=O)\C2=C/C2=C(C)C(NC(=O)CBr)=C(C)N2)C=C1)C1=CC=CC=C1	Cyclin-dependent kinase 7	inhibition percentage	80.985	%
1196	C[C@@H](NC(=O)C1=CC2=C(NC(=O)\C2=C/C2=C(C)C(NC(=O)CBr)=C(C)N2)C=C1)C1=CC=CC=C1	Cyclin-dependent kinase 7	inhibition percentage	96.165	%
1197	COC(=O)CNC(=O)C1=CC2=C(CCC3=C(C=CC(NC4=C(F)C=C(F)C=C4)=C3)C2=O)C=C1	Probable serine/threonine-protein kinase cdc7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	inhibition rate	12	%
1198	COC(=O)CNC(=O)C1=CC2=C(CCC3=C(C=CC(NC4=C(F)C=C(F)C=C4)=C3)C2=O)C=C1	Probable serine/threonine-protein kinase cdc7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	inhibition rate	1	%
1199	OC(=O)CNC(=O)C1=CC2=C(CCC3=C(C=CC(NC4=C(F)C=C(F)C=C4)=C3)C2=O)C=C1	Probable serine/threonine-protein kinase cdc7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	inhibition rate	6	%
1200	OC(=O)CNC(=O)C1=CC2=C(CCC3=C(C=CC(NC4=C(F)C=C(F)C=C4)=C3)C2=O)C=C1	Probable serine/threonine-protein kinase cdc7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	inhibition rate	6	%
1201	OC(=O)CCNC(=O)C1=CC2=C(CCC3=C(C=CC(NC4=C(F)C=C(F)C=C4)=C3)C2=O)C=C1	Probable serine/threonine-protein kinase cdc7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	inhibition rate	3	%
1202	OC(=O)CCNC(=O)C1=CC2=C(CCC3=C(C=CC(NC4=C(F)C=C(F)C=C4)=C3)C2=O)C=C1	Probable serine/threonine-protein kinase cdc7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	inhibition rate	5	%
1203	OC(=O)CCCNC(=O)C1=CC2=C(CCC3=C(C=CC(NC4=C(F)C=C(F)C=C4)=C3)C2=O)C=C1	Probable serine/threonine-protein kinase cdc7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	inhibition rate	14	%
1204	OC(=O)CCCNC(=O)C1=CC2=C(CCC3=C(C=CC(NC4=C(F)C=C(F)C=C4)=C3)C2=O)C=C1	Probable serine/threonine-protein kinase cdc7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	inhibition rate	8	%
1205	NC1=C(NC2=CC3=C(C=C2)C(=O)C2=C(CC3)C=CC(=C2)C(=O)NCCC2=CN=CN2)C=CC=C1	Probable serine/threonine-protein kinase cdc7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	inhibition rate	-1	%
1206	NC1=C(NC2=CC3=C(C=C2)C(=O)C2=C(CC3)C=CC(=C2)C(=O)NCCC2=CN=CN2)C=CC=C1	Probable serine/threonine-protein kinase cdc7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	inhibition rate	8	%
1207	CCC1=C(CNC(=O)C2=C(C)C(NC(=O)C=C)=CC(=C2)C2=CC=C(N=C2)N2CCNCC2)C(=O)NC(C)=C1	Cyclin-dependent kinase 7	inhibition rate	50	%
1208	CC1=C(CN2CCN(CC2)C(=O)C2=CC3=C(O2)C(=CC=C3)C(N)=O)SC2=C1N=C(N=C2N1CCOCC1)C1=CN=C(N)N=C1	Cyclin-H; Cyclin-dependent kinase 7	IC50	3.08E-8	M
1209	COC1=CC2=C(CN(C)CC2)C=C1NC1=NC(NC2=C(CO)C=CC=C2)=C(C=N1)C(N)=O	Cyclin-dependent kinase 7	IC50	3.753	μM
1210	COC1=CC2=C(CN(C)CC2)C=C1NC1=NC=C(C(N)=O)C(NC2=C(C=CC=C2F)C(F)(F)F)=N1	Cyclin-dependent kinase 7	IC50	10	μM
1211	COC1=CC2=C(CN(C)CC2)C=C1NC1=NC(NC2=CC=CC=C2)=C(C=N1)C(N)=O	Cyclin-dependent kinase 7	IC50	1	μM
1212	COC1=CC2=C(CN(C)CC2)C=C1NC1=NC(NC2=C(F)C=CC=C2C)=C(C=N1)C(N)=O	Cyclin-dependent kinase 7	IC50	2.229	μM
1213	CC1=C(N=C(NC2=CC=C(N=C2)N2CCNCC2)N=C1)C1=CN=C2C=CC=CN12	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	0.41	μM
1214	CS(=O)(=O)N1CCN(CC1)C1=CC=C(NC2=NC(=CC=N2)C2=CN=C3C=CC(=CN23)C2=CC=CN=C2)C=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	1.694	μM
1215	CS(=O)(=O)N1CCN(CC1)C1=CC=C(NC2=NC(=CC=N2)C2=CN=C3C=CC(=CN23)C2=CC=CS2)C=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	3.968	μM
1216	CN1CCN(CC1)C1=CC=C(NC2=NC(=CC=N2)C2=CN=C3C=CC(Cl)=CN23)C=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	0.77	μM
1217	C1CN(C1)C1=CC=C(NC2=NC(=CC=N2)C2=CN=C3C=CC(=CN23)C2=CC=CC=C2)C=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	0.297	μM
1218	BrC1=CN2C(C=C1)=NC=C2C1=CC=NC(NC2=CC=C(N=C2)N2CCCC2)=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	5	μM
1219	CC(C)N1CCN(CC1)C1=CC=C(NC2=NC(=CC=N2)C2=CN=C3C=CC(Br)=CN23)C=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	0.132	μM
1220	CC(C)N1CCN(CC1)C1=CC=C(NC2=NC(=CC=N2)C2=CN=C3C=CC(=CN23)C2=CC=CC=C2)C=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	0.149	μM
1221	CCN1CCN(CC2=CC=C(NC3=NC(=CC=N3)C3=CN=C4C=CC(Br)=CN34)C=N2)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	0.168	μM
1222	CS(=O)(=O)N1CCN(CC1)C1=CC=C(NC2=NC(=CC=N2)C2=CN=C3C=CC(Br)=CN23)C=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	4.502	μM
1223	CN1CCN(CC1)C1=CC=C(NC2=NC(=CC=N2)C2=CN=C3C=CC=CN23)C=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	1.09	μM
1224	FC1=C(N=C(NC2=CC=CN=C2)N=C1)C1=CN=C2C=CC=CN12	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	2.54	μM
1225	CN1CCN(CC1)C1=CC=C(NC2=NC(=CC=N2)C2=CN=C3C=CC(Br)=CN23)C=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	2.36	μM
1226	CN1CCN(CC1)C1=CC=C(NC2=NC(=CC=N2)C2=CN=C3C=CC(=CN23)C2=CC=CC=C2)C=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	0.238	μM
1227	CN1CCN(CC1)C1=CC=C(NC2=NC(=CC=N2)C2=CN=C3C=CC(=CN23)C2=CC=CN=C2)C=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	2.725	μM
1228	CN(CC1=CN2C=CN=C2C=C1)C1=NN=C(O1)C1=CC=C(C=C1)C1=C(Cl)C=CC=C1	CDK-activating kinase assembly factor MAT1	inhibition percentage	-9	%
1229	COC1=CC=C(C=N1)C1=CC2=C(NC(=O)C3=C2N(N=N3)C2=CC=C(N3CCNCC3)C(=C2)C(F)(F)F)C=C1	Cyclin-dependent kinase 7	inhibition rate	34	%
1230	C[C@H]1CC[C@H](N1C1=C2N=CNC2=NC=N1)C1=NC2=C(C(Cl)=CC=C2)C(=O)N1C1=CC=CC(F)=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-17	%
1231	CCOC(=O)\C=C\C1=C(C=NC=C1)C1=CC=C2C=CNC2=C1	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage	24	%
1232	CNC(=O)\C=C\C1=C(C=NC=C1)C1=CC=C2C=CNC2=C1	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage	28	%
1233	CN1CCN(CC1)C1=CC=C(C=C1)C1=CC2=C(N=CN=C2S1)N1CCN(CC1)C(=O)NC1=CC=C(Cl)C(=C1)C(F)(F)F	Cyclin-dependent-like kinase 5 [human]; CDK-activating kinase assembly factor MAT1 [human]	inhibition rate	10	%
1234	CN1CCN(CC1)C1=CC=C(C=C1)C1=CC2=C(N=CN=C2S1)N1CCN(CC1)C(=O)NC1=CC=C(Cl)C(=C1)C(F)(F)F	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition rate	8	%
1235	CC(C)C1=C2C=C(C=CC2=NN1C)C1=NC(NC2=CC3=NC=NC(N4CCN(C)CC4)=C3C=C2)=NC=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	95.9	nM
1236	CC(C)C1=C2C=C(C=CC2=NN1C)C1=NC(NC2=CC3=C(C=C2)C(N2CCOCC2)=C(C(C)=O)C(=O)O3)=NC=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	78.2	nM
1237	Cl.CCN(CC)C1=NC2=CC(=CC=C2N=C1)C1=C(F)C=NC(NC2=CC=C(C=N2)N2CCNCC2)=N1	Protein atonal homolog 1;+G2/mitotic-specific cyclin-B1;+Cyclin-dependent kinase 7	IC50	393	nM
1238	CN(C)CC1=CC=C(C=C1)C1=CN=C2C=CC(CN(C)C3=NN=C(O3)C3=NC=C(C=C3C)C3=C(C)N(C)N=C3C)=CN12	CDK-activating kinase assembly factor MAT1	inhibition percentage	-13	%
1239	COC1=C(C=CC(F)=C1)C1=CC(NC2=NC=CC(C[S@@](C)(=N)=O)=C2)=NC=C1F	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	10000	nM
1240	COC1=C(C=CC(F)=C1)C1=CC(NC2=NC=CC(C[S@@](C)(=N)=O)=C2)=NC=C1F	Cyclin-dependent kinase 7	Kd (dissociation constant)	24	nM
1241	CC1=CC=CC=C1NC(=O)N1CC2=C(NN=C2NC(=O)C2(CCC2)C(C)(C)C)C1(C)C	Cyclin-dependent kinase 7	Ki (inhibition constant)	50	nM
1242	CC1=CC=CC=C1NC(=O)N1CC2=C(NN=C2NC(=O)C2(CCC2)C(C)(C)C)C1(C)C	Cyclin-dependent kinase 7	IC50	50	nM
1243	CC(C)(C)C1(CCC1)C(=O)NC1=NNC2=C1CN(C(=O)NC1=CC=CC=C1F)C2(C)C	Cyclin-dependent kinase 7	Ki (inhibition constant)	50	nM
1244	CC(C)(C)C1(CCC1)C(=O)NC1=NNC2=C1CN(C(=O)NC1=CC=CC=C1F)C2(C)C	Cyclin-dependent kinase 7	IC50	50	nM
1245	CC(C)N1C=C(C2=C1N=CC=C2)C1=C(F)C=NC(NC2=NC=C(CN3CCN(CC3)C(C)C)C=C2)=N1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	5000	nM
1246	NC(=O)C1=CC(F)=C([C@H]2CCCN(C2)C(=O)C=C)C2=C1NC1=C2CCC1	Cyclin-dependent kinase 7	inhibition percentage	14.1	%
1247	NC(=O)C1=CC(F)=C([C@@H]2CCCN(C2)C(=O)C=C)C2=C1NC1=C2CCCCC1	Cyclin-dependent kinase 7	inhibition percentage	-10.1	%
1248	NC(=O)C1=CC(F)=C([C@@H]2CCCN(C2)C(=O)C=C)C2=C1NC1=C2CC2(CC2)CC1	Cyclin-dependent kinase 7	inhibition percentage	-6	%
1249	[H][C@@]12CC[C@@H](C)C3=C(C4=C(O3)C(C=O)=C(O)C(O)=C4)C1(C)CCCC2(C)C	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	1.27	μM
1250	CC1=CC(F)=CC=C1C1=CC2=C(C=N1)N=CN2C1=CC=C(OC(F)F)C=C1	Cyclin-dependent kinase 7	inhibition rate	18	%
1251	COC1=CC=C(NC(=O)C=C)C=C1NC1=NC=CC(=C1)C1=C(N=C(N1)SC)C1=CC(NC(=O)C2=C(F)C=CC(O)=C2CN2C(=O)C3=C(C=CC=C3)C2=O)=CC=C1	Cytochrome c-type biogenesis protein CycH; CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	inhibition rate	-3	%
1252	COC1=CC=C(NC(=O)C=C)C=C1NC1=NC=CC(=C1)C1=C(N=C(N1)SC)C1=CC(NC(=O)C2=C(F)C=CC(O)=C2CN2C(=O)C3=C(C=CC=C3)C2=O)=CC=C1	Cytochrome c-type biogenesis protein CycH; CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	inhibition rate	5	%
1253	FC(F)(F)OC1=CC=C(CNC2=NS(=O)(=O)C3=CC=C(Cl)C=C3N2)C=C1	Cyclin-dependent kinase 7	inhibition rate	0	%
1254	CC1C(=O)NC2=CC3=CN=C(NC4=CC=C(C=C4)S(N)(=O)=O)N=C3N2C11CCCCC1	Cyclin-dependent kinase 7	IC50	83	nM
1255	CN1N=C(C)C2(CCCCC2)N2C1=CC1=CN=C(NC3=CC=C(C=C3)S(N)(=O)=O)N=C21	Cyclin-dependent kinase 7	IC50	723	nM
1256	O=C(N1CCNCC1)C1=CC=C(NC2=NC=C3C=C4N(C3=N2)C2(CCCCC2)CNC4=O)C=C1	Cyclin-dependent kinase 7	IC50	27	nM
1257	O=C(N1CCOCC1)C1=CC=C(NC2=NC=C3C=C4NNC(=O)C5(CCCCC5)N4C3=N2)C=C1	Cyclin-dependent kinase 7	IC50	1000	nM
1258	CN1CCN(CC1)S(=O)(=O)C1=CC=C(NC2=NC=C3C=C4C(O)NC(=O)C5(CCCCC5)N4C3=N2)C=C1	Cyclin-dependent kinase 7	IC50	118	nM
1259	CN1CCN(CC1)C(=O)C1=CC=C(NC2=NC=C3C=C4NNC(=O)C5(CCCCC5)N4C3=N2)C=C1	Cyclin-dependent kinase 7	IC50	1000	nM
1260	CN1CCN(CC1)S(=O)(=O)C1=CC=C(NC2=NC=C3C=C4NNC(=O)C5(CCCCC5)N4C3=N2)C=C1	Cyclin-dependent kinase 7	IC50	242	nM
1261	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4NN=CC5(CCCCC5)N4C3=N2)C=C1	Cyclin-dependent kinase 7	IC50	0.23	μM
1262	CN1CCN(CC1)C(=O)C1=CC=C(NC2=NC=C3C=C4C(O)NC(=O)C5(CCCCC5)N4C3=N2)C=C1	Cyclin-dependent kinase 7	IC50	615	nM
1263	FC(F)(F)C1=NC=CC(N[C@@H]2CC[C@@H](CC2)NC2=NN3C(Cl)=NN=C3C=C2)=N1	Cyclin-H;+Cyclin-dependent kinase 7	inhibition rate	0	%
1264	FC(F)(F)C1=NC=CC(N[C@@H]2CC[C@@H](CC2)NC2=NN3C(Cl)=NN=C3C=C2)=N1	Cyclin-dependent-like kinase 5;+CDK-activating kinase assembly factor MAT1	inhibition rate	10	%
1265	CC[C@H]1N(C2CCCC2)C2=NC(NC3=CC(=CC=C3)C3=NC4=C(C=CC=C4N3)C(N)=O)=NC=C2N(C)C1=O	CDK7/CycH/MAT1	inhibition rate	105.2	%
1266	CC(C)C1=CN=C2N1C=C(C=C2NC1CCN(C[C@@H]2CN(CCO2)C(=O)C=C)CC1)C(F)(F)F	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	IC50	0.00574	μM
1267	CC(C)C1=CN=C2N1C=C(C=C2NC1CCN(C[C@@H]2CN(CCO2)C(=O)C=C)CC1)C(F)(F)F	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	IC50	0.0656	μM
1268	CC(C)C1=CN=C2N1C=C(C=C2NC1CCN(C[C@@H]2CN(CCO2)C(=O)C=C)CC1)C(F)(F)F	Cyclin-dependent kinase 7	inhibition rate	65	%
1269	CC(C)C1=CN=C2N1C=C(C=C2NC1CCN(C[C@@H]2CN(CCO2)C(=O)C=C)CC1)C(F)(F)F	Cyclin-dependent kinase 7	inhibition rate	96	%
1270	NC1=C(C2=NC3=CC(=CC=C3N2)N2CCN(CC2)C(=O)CCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C(=O)NC2=CC=CC(F)=C12	CDK-activating kinase assembly factor MAT1	inhibition rate	0	%
1271	CC(C)[C@@H]1CNC(=O)C2=CC(=NN12)N1CCOC[C@H]1C	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage	6.5	%
1272	CN1N=CC2(CCCCC2)N2C1=CC1=CN=C(NC3=CC=C(C=C3)S(N)(=O)=O)N=C21	Cyclin-dependent kinase 7	IC50	875	nM
1273	CC1=NNC2=CC3=C(N=C(NC4=CC=C(C=C4)S(N)(=O)=O)N=C3)N2C11CCCCC1	Cyclin-dependent kinase 7	IC50	1000	nM
1274	CN1CCN(CC1)C(=O)C1=CC=C(NC2=NC3=C(C=C4NC(=O)CC5(CCCCC5)N34)C=N2)C=C1	Cyclin-dependent kinase 7	IC50	144	nM
1275	CC1C(=O)NC2=CC3=C(N=C(NC4=CC=C(C=C4)S(=O)(=O)N4CCN(C)CC4)N=C3)N2C11CCCCC1	Cyclin-dependent kinase 7	IC50	16	nM
1276	O=C(N1CCNCC1)C1=CC=C(NC2=NC3=C(C=C4NNC(=O)C5(CCCCC5)N34)C=N2)C=C1	Cyclin-dependent kinase 7	IC50	1000	nM
1277	CN(C)C(=O)C1=CC=C(NC2=NC3=C(C=C4NNC(=O)C5(CCCCC5)N34)C=N2)C=C1	Cyclin-dependent kinase 7	IC50	1000	nM
1278	CNC(=O)C1=CC=C(NC2=NC3=C(C=C4NNC(=O)C5(CCCCC5)N34)C=N2)C=C1	Cyclin-dependent kinase 7	IC50	1000	nM
1279	FC1=CC=C(CN2CCOC3=CC(=CC=C3C2=O)C2=CN=C3NC=CC3=C2)C=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	10	μM
1280	COC1=CC2=C(C(=O)NC(=N2)C2=CC=C(OCC(=O)NC3=CC(Cl)=C(C=C3)N3CCN(C)CC3)C=C2)C(OC)=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition rate	-2	%
1281	CN1CCC(CC1)[C@@](C)(O)C1=NC2=CC(NC3=C(F)C=C(C#N)C(=C3)N3CCOCC3)=NC=C2C=C1	CDK-activating kinase assembly factor MAT1;+Cyclin-H1-1;+Cyclin-dependent kinase 7	IC50	171	nM
1282	CN1CCC(CC1)[C@@](C)(O)C1=NC2=CC(NC3=CC(=NC=C3F)C(N)=O)=NC=C2C=C1	CDK-activating kinase assembly factor MAT1;+Cyclin-H1-1;+Cyclin-dependent kinase 7	IC50	631	nM
1283	CC(C)C1=NC=C(F)C(NC2=NC=C3C=CC(=NC3=C2)[C@](C)(O)C2CCN(C)CC2)=C1	CDK-activating kinase assembly factor MAT1;+Cyclin-H1-1;+Cyclin-dependent kinase 7	IC50	147	nM
1284	CN1CCC(CC1)[C@@](C)(O)C1=NC2=CC(NC3=CC(=NC=C3F)N3CCCC3)=NC=C2C=C1	CDK-activating kinase assembly factor MAT1;+Cyclin-H1-1;+Cyclin-dependent kinase 7	IC50	96	nM
1285	CN1CCC(CC1)[C@@](C)(O)C1=NC2=CC(NC3=C(F)C=C(C#N)C(=C3)C(F)(F)F)=NC=C2C=C1	CDK-activating kinase assembly factor MAT1;+Cyclin-H1-1;+Cyclin-dependent kinase 7	IC50	294	nM
1286	CC(C)OC1=CC(NC2=NC=C3C=CC(=NC3=C2)[C@](C)(O)C2CCN(C)CC2)=C(F)C=C1C#N	CDK-activating kinase assembly factor MAT1;+Cyclin-H1-1;+Cyclin-dependent kinase 7	IC50	161	nM
1287	CC(C)OC1=NC=C(F)C(NC2=NC=C3C=CC(=NC3=C2)[C@](C)(O)C2CCN(C)CC2)=C1	CDK-activating kinase assembly factor MAT1;+Cyclin-H1-1;+Cyclin-dependent kinase 7	IC50	362	nM
1288	CC(C)NC1=NC=C(F)C(NC2=NC=C3C=CC(=NC3=C2)[C@](C)(O)C2CCN(C)CC2)=C1	CDK-activating kinase assembly factor MAT1;+Cyclin-H1-1;+Cyclin-dependent kinase 7	IC50	784	nM
1289	CCC1=NC=C(F)C(NC2=NC=C3C=CC(=NC3=C2)[C@](C)(O)C2CCN(C)CC2)=C1	CDK-activating kinase assembly factor MAT1;+Cyclin-H1-1;+Cyclin-dependent kinase 7	IC50	194	nM
1290	CN1CCC(CC1)[C@@](C)(O)C1=CC=C2C=NC(NC3=CC(=NC=C3F)N3CCOCC3)=CC2=N1	Cyclin-H1-1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1332	nM
1291	CN1CCC(CC1)[C@@](C)(O)C1=CC=C2C=NC(NC3=CC(=NC=C3F)N3CCOCC3)=CC2=N1	CDK-activating kinase assembly factor MAT1;+Cyclin-H1-1;+Cyclin-dependent kinase 7	inhibition rate	28	%
1292	CN1CCC(CC1)[C@@](C)(O)C1=CC=C2C=NC(NC3=CC(=NC=C3F)N3CCOCC3)=CC2=N1	CDK-activating kinase assembly factor MAT1;+Cyclin-H1-1;+Cyclin-dependent kinase 7	IC50	334	nM
1293	CN1CCC(CC1)[C@@](C)(O)C1=NC2=CC(NC3=CC(OC4CCC4)=NC=C3F)=NC=C2C=C1	CDK-activating kinase assembly factor MAT1;+Cyclin-H1-1;+Cyclin-dependent kinase 7	IC50	729	nM
1294	CN1CCC(CC1)[C@@](C)(O)C1=NC2=CC(NC3=CC(=NC=C3F)C(F)(F)F)=NC=C2C=C1	CDK-activating kinase assembly factor MAT1;+Cyclin-H1-1;+Cyclin-dependent kinase 7	inhibition rate	16	%
1295	CN1CCC(CC1)[C@@](C)(O)C1=NC2=CC(NC3=CC(=NC=C3F)C(F)(F)F)=NC=C2C=C1	CDK-activating kinase assembly factor MAT1;+Cyclin-H1-1;+Cyclin-dependent kinase 7	IC50	718	nM
1296	COC1=CC(=CC(OC)=C1)C(=O)C1=CNC2=NC(NC3=C(NC(=O)C=C)C=C(C=C3)N3CCOCC3)=CC=C12	CDK-activating kinase assembly factor MAT1	inhibition rate	11	%
1297	Cl[H].N[C@H]1CCN(C1)C1=C2C=C(C=CC2=NC2=C1CCCC2)C1=CC(NC(=O)C2CC2)=NC=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	inhibition rate	75.69	%
1298	CC(C)CCOC1=C(C=NC2=C1C=NN2)C(=O)C1=CC=CC=C1	Cyclin-dependent kinase 7;+Cyclin-H	IC50	1.1	µM
1299	CN1CCN(CC1)C1=CC=C(NC2=NC=C3C=CN(C4CCCCC4)C3=N2)C=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	1.5	µM
1300	C(N1CCCCC1)C1=CC2=C(NC(=C2)C2=NNC3=CC(=CC=C23)N2C=CC=N2)C=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	2300	nM
1301	CC1=CN=NN1C1=CC=C2C(NN=C2C2=CC3=C(N2)C=CC(CN2CCCCC2)=C3)=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	420	nM
1302	OCC1=C(NN=N1)C1=CC=C2C(NN=C2C2=CC3=C(N2)C=CC(CN2CCC(F)CC2)=C3)=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	0.3	nM
1303	NCC1=C(NN=N1)C1=CC=C2C(NN=C2C2=CC3=C(N2)C=CC(CN2CCC(F)CC2)=C3)=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	0.11	nM
1304	CC[C@@H](O)[C@@H](CC)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CN=C2)=N1	Cyclin-dependent kinase 7 [human];+CDK7/Cyclin (Cyclin E) [human]	IC50	1.1	µM
1305	CC[C@@H](O)[C@H](CC)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CN=C2)=N1	Cyclin-dependent kinase 7 [human];+CDK7/Cyclin (Cyclin E) [human]	IC50	1.5	µM
1306	CC[C@H](O)[C@H](CC)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CN=C2)=N1	Cyclin-dependent kinase 7 [human];+CDK7/Cyclin (Cyclin E) [human]	IC50	1.5	µM
1307	CC[C@@H](NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CN=C2)=N1)[C@H](O)C(C)(C)C	Cyclin-dependent kinase 7 [human];+CDK7/Cyclin (Cyclin E) [human]	IC50	1.6	µM
1308	CC[C@H](NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CN=C2)=N1)[C@H](O)C(C)(C)C	Cyclin-dependent kinase 7 [human];+CDK7/Cyclin (Cyclin E) [human]	IC50	3.5	µM
1309	CC1=C(SC(N)=N1)C1=NC(NC2=CC=C(Cl)N=C2)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	1.5	µM
1310	CNC1=NC(C)=C(S1)C1=NC(NC2=CC=C(OC)N=C2)=NC=C1	Cyclin-dependent kinase 7;+Cyclin-H	Ki (inhibition constant)	0.43	µM
1311	COC1=CC=C(NC2=NC=CC(=N2)C2=C(C)N=C(N)S2)C=N1	Cyclin-dependent kinase 7;+Cyclin-H	Ki (inhibition constant)	0.71	µM
1312	CCNC1=NC(C)=C(S1)C1=NC(NC2=CC=C(OC)N=C2)=NC=C1	Cyclin-dependent kinase 7;+Cyclin-H	Ki (inhibition constant)	0.13	µM
1313	CC1=NC(C)=C(S1)C1=NC(NC2=CC=C(N=C2)N2CCCC2)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.73	µM
1314	CCN1C(=O)SC(=C1C)C1=NC(NC2=CC=C(F)C=C2)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.22	µM
1315	CCN1C(=O)SC(=C1C)C1=NC(NC2=CC=C(Cl)C=C2)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.79	µM
1316	CC1=C(SC(=O)N1)C1=NC(NC2=CC=CC(=C2)N(=O)=O)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.071	µM
1317	COC1=CC=C(C)C(NC2=NC=CC(=N2)C2=C(C)N(C)C(=O)S2)=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	2.9	µM
1318	CN1C(=O)SC(=C1C)C1=NC(NC2=CC=C(C)C(N)=C2)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.6	µM
1319	CCN1C(=O)SC(=C1C)C1=NC(NC2=CC=CC(O)=C2)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.019	µM
1320	CCN1C(=O)SC(=C1C)C1=NC(NC2=CC=C(Cl)C(C)=C2)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.97	µM
1321	CCN1C(=O)SC(=C1C)C1=NC(NC2=CC=C(C=C2)N(=O)=O)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.07	µM
1322	CC1=C(SC(=O)N1)C1=NC(NC2=CC=C(C)C(=C2)N(=O)=O)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.29	µM
1323	CC(C)CCN1C(=O)SC(=C1C)C1=NC(NC2=CC=C(Cl)C=C2)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.43	µM
1324	CC(C)CCN1C(=O)SC(=C1C)C1=NC(NC2=CN=C(Cl)C=C2)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.23	µM
1325	COC1=NC=C(NC2=NC=CC(=N2)C2=C(C)N(CCC(C)C)C(=O)S2)C=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.2	µM
1326	CN1C(=O)SC(=C1C)C1=NC(NC2=CC(=CC=C2)S(N)(=O)=O)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.039	µM
1327	CCN1C(=O)SC(=C1C)C1=NC(NC2=CC(O)=C(C)C=C2)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.017	µM
1328	CCNS(=O)(=O)C1=CC=CC(NC2=NC=CC(=N2)C2=C(C)N(C)C(=O)S2)=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	1.1	µM
1329	CN1C(=O)SC(=C1C)C1=NC(NC2=CC(CNC(C)=O)=CC=C2)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.38	µM
1330	CC(C)NS(=O)(=O)C1=CC=CC(NC2=NC=CC(=N2)C2=C(C)N(C)C(=O)S2)=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	2.7	µM
1331	CN1C(=O)SC(=C1C)C1=NC(NC2=CC(CNS(C)(=O)=O)=CC=C2)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.11	µM
1332	CN1C(=O)SC(=C1C)C1=NC(NC2=CC=C(CNC(C)=O)C=C2)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.21	µM
1333	CN1C(=O)SC(=C1C)C1=NC(NC2=CC(=C(Cl)C=C2)C(F)(F)F)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	2.3	µM
1334	CNC1=CC(NC2=NC=CC(=N2)C2=C(C)N(C)C(=O)S2)=CC(=C1)C(F)(F)F	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.8	µM
1335	COCCNS(=O)(=O)C1=CC=CC(NC2=NC=CC(=N2)C2=C(C)N(C)C(=O)S2)=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.36	µM
1336	CN1C(=O)SC(=C1C)C1=NC(NC2=CC(=CC(N)=C2)C(F)(F)F)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.073	µM
1337	CN1C(=O)SC(=C1C)C1=NC(NC2=CC(=CC=C2)S(=O)(=O)NCCO)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.37	µM
1338	CN1C(=O)SC(=C1C)C1=NC(NC2=CC=C(C=C2)S(=O)(=O)NCCO)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	1.2	µM
1339	CN1C(=O)SC(=C1C)C1=NC(NC2=CC=CC(=C2)S(=O)(=O)N2CCOCC2)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	2.6	µM
1340	CN1C(=O)SC(=C1C)C1=NC(NC2=CC(CNC(=O)C3=CC=CC=C3)=CC=C2)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	1.3	µM
1341	CN1C(=O)SC(=C1C)C1=NC(NC2=CC(NC(C)=O)=CC(=C2)C(F)(F)F)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	3.9	µM
1342	CN1C(=O)SC(=C1C)C1=NC(NC2=CC=C(N3CCNCC3)C(Cl)=C2)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.019	µM
1343	CN1C(=O)SC(=C1C)C1=NC(NC2=CC(CNS(=O)(=O)C(F)(F)F)=CC=C2)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.096	µM
1344	CN1C(=O)SC(=C1C)C1=NC(NC2=CC=CC(=C2)N2CCN(CC2)C(C)=O)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	1.1	µM
1345	CN1C(=O)SC(=C1C)C1=NC(NC2=CC=C(C)C(=C2)S(=O)(=O)N2CCOCC2)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	1.2	µM
1346	CN1C(=O)SC(=C1C)C1=NC(NC2=CC=C(C=C2)N2CCN(CC3=CC=CC=C3)CC2)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.012	µM
1347	CC1=NC(C)=C(S1)C1=NC(NC2=CC(=CC=C2)S(C)(=O)=O)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	6	
1348	CC1=C(SC(N)=N1)C1=NC(NC2=CC=C(C=C2)N2CCNCC2)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	6.4	
1349	CC1=NC(C)=C(S1)C1=NC(NC2=CC(=CC=C2)S(=O)(=O)NCCO)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.9	
1350	CNC1=NC(C)=C(S1)C1=NC(NC2=CC(=CC=C2)S(=O)(=O)NC(C)=O)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.6	
1351	CC1=NC(C)=C(S1)C1=NC(NC2=CC=C(C=C2)S(=O)(=O)NCCO)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.7	
1352	CCNC1=NC(C)=C(S1)C1=NC(NC2=CC=CC(CNS(C)(=O)=O)=C2)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	6.6	
1353	CC(=O)NS(=O)(=O)C1=CC=CC(NC2=NC=CC(=N2)C2=C(C)N=C(N)S2)=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.8	
1354	CC1=C(SC(N)=N1)C1=NC(NC2=CC(=CC=C2)S(=O)(=O)NCCO)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	6.4	
1355	COCCNC1=NC(C)=C(S1)C1=NC(NC2=CC(=CC=C2)S(N)(=O)=O)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	7.3	
1356	CNC1=NC(C)=C(S1)C1=NC(NC2=CC=C(C=C2)S(=O)(=O)NCCO)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.4	
1357	CNC1=NC(C)=C(S1)C1=NC(NC2=CC(=CC=C2)S(=O)(=O)NCCO)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	6.1	
1358	CC1=C(SC(N)=N1)C1=NC(NC2=CC=C(C=C2)S(=O)(=O)NCCO)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.7	
1359	CC1=C(SC(N)=N1)C1=NC(NC2=CC=C(C=C2)S(=O)(=O)NCC2=CC=CC=C2)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	6	
1360	CC1=C(SC(N)=N1)C1=NC(NC2=CC(=CC=C2)S(=O)(=O)N2CCOCC2)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.2	
1361	CCNC1=NC(C)=C(S1)C1=NC(NC2=CC=C(C=C2)S(=O)(=O)NCCO)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	6.7	
1362	CCNC1=NC(C)=C(S1)C1=NC(NC2=CC(=CC=C2)S(=O)(=O)NCCO)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	6.4	
1363	CC1=NC(C)=C(S1)C1=NC(NC2=CC(=C(C)C=C2)S(=O)(=O)N2CCOCC2)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.4	
1364	CCNC1=NC(C)=C(S1)C1=NC(NC2=CC(=CC=C2)S(=O)(=O)NC(C)(C)CO)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.8	
1365	CCNC1=NC(C)=C(S1)C1=NC(NC2=CC=C(C=C2)N2CCN(CC3=CC=CC=C3)CC2)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	6.7	
1366	CC1=NC(C)=C(S1)C1=NC(NC2=CC=C(Cl)N=C2)=NC=C1	Cyclin-dependent kinase 7;+Cyclin-H	Ki (inhibition constant)	1.5	µM
1367	ClC1=CC=C(NC2=NC=CC(=N2)C2=NC=CS2)C=N1	Cyclin-dependent kinase 7;+Cyclin-H	Ki (inhibition constant)	50	µM
1368	CNC1=NC(C)=C(S1)C1=NC(NC2=CC(Br)=C(C)C=C2)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.2	
1369	CNS(=O)(=O)C1=CC=CC(NC2=NC=CC(=N2)C2=C(C)N=C(C)S2)=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	6.9	
1370	CNC1=NC(C)=C(S1)C1=NC(NC2=CC=C(C=C2)S(C)(=O)=O)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.4	
1371	CNC1=NC(C)=C(S1)C1=NC(NC2=CC=C(C=C2)S(N)(=O)=O)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	6	
1372	CC(=O)NCC1=CC=C(NC2=NC=CC(=N2)C2=C(C)N=C(C)S2)C=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.8	
1373	CNC1=NC(C)=C(S1)C1=NC(NC2=CC=C(CNC(C)=O)C=C2)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	6.1	
1374	CC(=O)NCC1=CC=C(NC2=NC=CC(=N2)C2=C(C)N=C(N)S2)C=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.7	
1375	CCNC1=NC(C)=C(S1)C1=NC(NC2=CC(=CC=C2)S(=O)(=O)NC)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	7	
1376	CCNC1=NC(C)=C(S1)C1=NC(NC2=CC=C(C=C2)S(N)(=O)=O)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	7.1	
1377	CCNS(=O)(=O)C1=CC=CC(NC2=NC=CC(=N2)C2=C(C)N=C(NC)S2)=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	6	
1378	COCCNS(=O)(=O)C1=CC=CC(NC2=NC=CC(=N2)C2=C(C)N=C(C)S2)=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.3	
1379	CC1=NC(C)=C(S1)C1=NC(NC2=CC(=CC=C2)N2CCNCC2)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.7	
1380	CC1=C(SC(N)=N1)C1=NC(NC2=CC=C(C=C2)N2CCCCC2)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.8	
1381	COCCOC(=O)CC1=CC(NC2=NC=CC(=N2)C2=C(C)N=C(N)S2)=CC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.5	
1382	CC1=NC(C)=C(S1)C1=NC(NC2=CC=C(CN3CCOCC3)C=C2)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	6.6	
1383	CCNC1=NC(C)=C(S1)C1=NC(NC2=CC(=CC=C2)S(=O)(=O)NCC)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	6.1	
1384	CCN(C)C1=NC(C)=C(S1)C1=NC(NC2=CC=C(C=C2)N2CCOCC2)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.5	
1385	CNC1=NC(C)=C(S1)C1=NC(NC2=CC(=CC=C2)S(=O)(=O)NCCOC)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	6.1	
1386	CNC1=NC(C)=C(S1)C1=NC(NC2=CC(=CC=C2)N2CCNCC2)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	6.2	
1387	CNC1=NC(C)=C(S1)C1=NC(NC2=CC=CC(CC(=O)OCCOC)=C2)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.5	
1388	COC1=C(C=CC(NC2=NC=CC(=N2)C2=C(C)N=C(C)S2)=C1)N1CCOCC1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.5	
1389	CC1=NC(C)=C(S1)C1=NC(NC2=CC=CC(CNC(=O)C3=CC=CC=C3)=C2)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.3	
1390	CC1=C(SC(CO)=N1)C1=NC(NC2=CC=C(C=C2)N2CCCCC2)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.1	
1391	COCCNS(=O)(=O)C1=CC=C(NC2=NC=CC(=N2)C2=C(C)N=C(N)S2)C=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.5	
1392	COCCNS(=O)(=O)C1=CC=CC(NC2=NC=CC(=N2)C2=C(C)N=C(N)S2)=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	6.2	
1393	CC(=O)NCC1=CC=C(NC2=NC=CC(=N2)C2=C(C)N=C(S2)C2=CN=CC=C2)C=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.6	
1394	CC(=O)NCC1=CC(NC2=NC=CC(=N2)C2=C(C)N=C(S2)C2=CN=CC=C2)=CC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.4	
1395	CC1=NC(C)=C(S1)C1=NC(NC2=CC=CC(CNS(=O)(=O)C(F)(F)F)=C2)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	6.2	
1396	CCNC1=NC(C)=C(S1)C1=NC(NC2=CC=CC(CC(=O)OCCOC)=C2)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.4	
1397	COC1=C(C=CC(NC2=NC=CC(=N2)C2=C(C)N=C(N)S2)=C1)N1CCOCC1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.6	
1398	CC(=O)N1CCN(CC1)C1=CC(NC2=NC=CC(=N2)C2=C(C)N=C(C)S2)=CC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.3	
1399	CC1=C(SC(CO)=N1)C1=NC(NC2=CC(C)=C(C=C2)N2CCOCC2)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.1	
1400	CCNC1=NC(C)=C(S1)C1=NC(NC2=CC=C(C=C2)S(=O)(=O)NCCOC)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	6.2	
1401	CCNC1=NC(C)=C(S1)C1=NC(NC2=CC(=CC=C2)S(=O)(=O)NCCOC)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	6.8	
1402	CC1=C(SC(N)=N1)C1=NC(NC2=CC=CC(CNS(=O)(=O)C(F)(F)F)=C2)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	6.7	
1403	COC1=C(C=CC(NC2=NC=CC(=N2)C2=C(C)N=C(CO)S2)=C1)N1CCCCC1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.8	
1404	CC1=NC(C)=C(S1)C1=NC(NC2=CC=C(C=C2)N2CCN(CC3=CC=CC=C3)CC2)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	6.9	
1405	CNC1=NC(C)=C(S1)C1=NC(NC2=CC(=CC=C2)S(=O)(=O)NC2=CC(OC)=CC=C2)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.3	
1406	CCNC1=NC(C)=C(S1)C1=NC(NC2=CC=CC(CNS(=O)(=O)C(F)(F)F)=C2)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.2	
1407	CC1=C(SC(N)=N1)C1=NC(NC2=CC(C(N)=O)=C(C=C2)N2CCOCC2)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.2	
1408	CC(=O)N1CCN(CC1)C1=CC=C(NC2=NC=CC(=N2)C2=C(C)N=C(S2)C2=CC=CS2)C=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.8	
1409	CC(C)NC(=O)CN1CCN(CC1)C1=CC=C(NC2=NC=CC(=N2)C2=C(C)N=C(C)S2)C=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.1	
1410	CC1=C(SC(CS(=O)(=O)C2=CC=CS2)=N1)C1=NC(NC2=CC=C(C=C2)N2CCOCC2)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.5	
1411	CN(C1=NC(C)=C(S1)C1=NC(NC2=CC=C(C=C2)N2CCN(CC2)C(C)=O)=NC=C1)C1=CN=CC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.4	
1412	CN(CC1=CC=CC=C1)C1=NC(C)=C(S1)C1=NC(NC2=CC=C(C=C2)N2CCN(CC2)C(C)=O)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.8	
1413	CC(=O)N1CCN(CC1)C1=CC=C(NC2=NC=CC(=N2)C2=C(C)N=C(NCCC3=CC=CC=C3)S2)C=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.6	
1414	COC1=NC=C(NC2=NC=CC(=N2)C2=CNC3=CC=CC=C23)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	IC50	5.443	µM
1415	FC1=CC=C(NC2=NC=CC(=N2)C2=CNC3=CC=CC=C23)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	IC50	100	µM
1416	O=N(=O)C1=CC(NC2=NC=CC(=N2)C2=CNC3=CC=CC=C23)=CC=C1	Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	IC50	100	µM
1417	CN(C)C1=CC=C(NC2=NC=CC(=N2)C2=CNC3=CC=CC=C23)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	IC50	5.2264	µM
1418	CC1CN(CC(C)O1)C1=CC=C(NC2=NC=CC(=N2)C2=CNC3=CC=CC=C23)C=C1	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	IC50	6.6715	µM
1419	CC1CN(CC(C)O1)C1=CC=C(NC2=NC=CC(=N2)C2=CNC3=CC=CC=C23)C=C1	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	IC50	6.6715	µM
1420	C1CN(CCN1)C1=CC=C(NC2=NC=CC(=N2)C2=CNC3=CC=CC=C23)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	IC50	2.5284	µM
1421	CC(=O)N1CCN(CC1)C1=CC=C(NC2=NC=CC(=N2)C2=C(C)NC3=CC=CC=C23)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	IC50	6.662	µM
1422	CC(=O)N1CCN(CC1)C1=CC=C(NC2=NC=CC(=N2)C2=CNC3=C(C)C=CC=C23)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	IC50	3.471	µM
1423	C(N1CCN(CC1)C1=CC=C(NC2=NC=CC(=N2)C2=CNC3=CC=CC=C23)C=C1)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	IC50	6.042	µM
1424	CC1=NC=CC(=N1)C1=CC(=CC=C1)N1N=NC2=C1N=C(NC1=CC=C(C=C1)C1=CSN=N1)N=C2	Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	inhibition percentage	2.3	%
1425	CN(C)CC(O)COC1=CC=C(NC2=NC3=C(C=N2)N=NN3[C@H]2CC[C@H](CC2)C(O)=O)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	inhibition percentage	38.6	%
1426	CCCCNS(=O)(=O)C1=CC=CC(=C1)N1N=NC2=CN=C(NC3=CC(OC)=C(OC)C(OC)=C3)N=C12	Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	inhibition percentage	19	%
1427	CCN(CC)CCNC(=O)C1=CC=C(NC2=NC3=C(C=N2)N=NN3CC2=CC=C(C=C2)N(C)C)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	inhibition percentage		
1428	CC(C)(C)OC(=O)N1CCC(CNC2=NC3=C(C=N2)N=NN3C2=CC3=C(CCC3)C=C2)CC1	Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	inhibition percentage	28.95	%
1429	O=C(NCCCN1C=CN=C1)C1=CC=CC(NC2=NC3=C(C=N2)N=NN3C2=CC3=C(CCC3)C=C2)=C1	Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	inhibition percentage	86.59	%
1430	CCCCNS(=O)(=O)C1=CC(NC2=NC3=C(C=N2)N=NN3C2=CC=C(C=C2)C(=O)NCCN(CC)CC)=CC=C1	Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	inhibition percentage	35.35	%
1431	OC(=O)C(F)(F)F.CCN(CC)CCOC(=O)C1=CC=C(NC2=NC3=C(C=N2)N=NN3C2=CC3=C(CCC3)C=C2)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	inhibition percentage	42	%
1432	OC(=O)C(F)(F)F.O=C(NCCN1CCOCC1)C1=CC(NC2=NC=C3N=NN(C3=N2)C2=CC3=C(CCC3)C=C2)=CC=C1	Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	inhibition percentage	47.55	%
1433	CN(C)C1CCN(CC2=NC=C(NC3=NC=C(S3)C3=NC(OC4CCCCC4)=NC(C)=C3)N=C2)C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	370	nM
1434	ClC1=CC(NC2=NC=CC(=N2)C2=C3C=CNC3=CC=C2)=CC=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	50	µM
1435	CS(=O)(=O)C1=CC=CC(NC2=NC=CC(=N2)C2=CC=CC3=C2C=CN3)=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	5	µM
1436	CC1=CN=C(NC2=CC(=CC=C2)S(C)(=O)=O)N=C1C1=CC=CC2=C1C=CN2	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	5	µM
1437	CCNC(=O)CN1C=CC2=C1C=CC=C2C1=NC(NC2=CC(Cl)=CC=C2)=NC=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	50	µM
1438	COC1=C(C=CC=N1)C1=NC(NC2=CC=CC(=C2)C#N)=NC=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	50	µM
1439	COC1=C(C=CN=C1)C1=NC(NC2=CC=CC(=C2)S(C)(=O)=O)=NC=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	5	µM
1440	COC1=C(C=CC=N1)C1=NC(NC2=CC=CC(=C2)S(N)(=O)=O)=NC=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	5 - 10	µM
1441	NCCNC1=C(C=CC=N1)C1=NC(NC2=CC=CC(Cl)=C2)=NC=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	5	µM
1442	COC1=NC(OC)=C(C=C1)C1=NC(NC2=CC=CC(=C2)S(C)(=O)=O)=NC=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	50	µM
1443	NCCCNC1=C(C=CC=N1)C1=NC(NC2=CC=CC(Cl)=C2)=NC=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	5	µM
1444	OCCCNC1=C(C=CC=N1)C1=NC(NC2=CC=CC(Cl)=C2)=NC=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	5	µM
1445	CC(C)(CN)CNC1=C(C=CC=N1)C1=NC(NC2=CC=CC(Cl)=C2)=NC=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	5	µM
1446	CNCCNC1=NC=CC(=C1C)C1=NC(NC2=CC=CC(Cl)=C2)=NC=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	5	µM
1447	ClC1=CC(NC2=NC=CC(=N2)C2=C(NCCCN3C=CN=C3)N=CC=C2)=CC=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	5	µM
1448	NCCCNC1=C(C=CC=N1)C1=NC(NC2=CC=CC(=C2)C#N)=NC=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	5	µM
1449	CC(=O)NCCCNC1=NC=CC(=C1)C1=NC(NC2=CC=CC(Cl)=C2)=NC=C1C	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	5	µM
1450	CC(=O)NCCCNC1=NC=CC(=C1C)C1=NC(NC2=CC=CC(Cl)=C2)=NC=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	5	µM
1451	CC(=O)NCCCNC1=NC=CC(=C1C)C1=NC(NC2=CC=CC(=C2)N(=O)=O)=NC=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	5	µM
1452	C1CN(CCO1)C1=CC=C(C=C1)C1=CN=C2NC=C(C3=CN=CS3)C2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	86	%
1453	O=C(N1CCOCC1)C1=NC(=CS1)C1=CNC2=C1C=C(C=N2)C1CCCCC1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	85	%
1454	[H][C@]12CC[C@]([H])(C1)[C@H](CN1CCC(CC1)N1C(=O)CC3=C1C=CC=C3)C2	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	Ki (inhibition constant)	22	nM
1455	[H][C@]12CC[C@]([H])(C1)[C@@H](CN1CCC(CC1)N1C(=O)CC3=C1C=CC=C3)C2	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	Ki (inhibition constant)	27.9	nM
1456	[H][C@]12C[C@]([H])(C(CN3CCC(CC3)N3C(=O)CC4=C3C=CC=C4)CC1)C2(C)C	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	Ki (inhibition constant)	15.5	nM
1457	[H][C@@]12CC[C@](C)([C@H](C1)N1CCC(CC1)N1C(=O)CC3=C1C=CC=C3)C2(C)C	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	Ki (inhibition constant)	10000	nM
1458	CC(C)C1=NN(C2=C1C(=O)NC(CC1=CC(O)=C(CN3CCCC3)C=C1)=N2)C1=C(Cl)C=NC=C1Cl	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	100	nM
1459	C[C@@H](NC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2C2=CC(OCCO)=CC=C2)[C@@H]([C@@H](OC3=O)C2=CC=CC=C2)C2=CC=CC=C2)C(=O)NC2=CC=C(C=C2)N2CCOCC2)C2=C1C=CC(=C2)C#CCNC(N)=O)C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	39	%
1460	CC(C)C1=C2N=C(Cl)C=C(NCC3=CC=C(Cl)C=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	19	%
1461	CC(C)C1=C2N=C(Cl)C=C(NCC3=CC=C(Cl)C=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1000	nM
1462	CC(C)C1=C2N=C(Cl)C=C(NCC3=CC=C(Cl)C=C3Cl)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	18	%
1463	CC(C)C1=C2N=C(Cl)C=C(NCC3=CC=C(Cl)C=C3Cl)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	620	nM
1464	CC(C)C1=C2N=C(Cl)C=C(NCC3=CC=C(C=C3)C(F)(F)F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	25	%
1465	CC(C)C1=C2N=C(Cl)C=C(NCC3=CC=C(C=C3)C(F)(F)F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	725	nM
1466	CC(C)C1=C2N=C(NCCO)C=C(NCC3=C(F)C=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	2	%
1467	CC(C)C1=C2N=C(NCCCCN)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	87.4	%
1468	CC(C)C1=C2N=C(NCCCCN)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	225	nM
1469	CC[C@H](CO)NC1=NC2=C(C=NN2C(NCC2=CC=CC=C2F)=C1)C(C)C	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	58	%
1470	CC[C@H](CO)NC1=NC2=C(C=NN2C(NCC2=CC=CC=C2F)=C1)C(C)C	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1000	nM
1471	CC(C)C1=C2N=C(NCC(O)CO)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	12	%
1472	CC(C)C1=C2N=C(NCC(O)CO)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	155	nM
1473	CCCCCCCNC1=NC2=C(C=NN2C(NCC2=CC=CC=C2)=C1)C(C)C	Cyclin-dependent kinase 7	IC50	18	nM
1474	CC(C)C1=C2N=C(NCCC=CCCN)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-dependent kinase 7	IC50	963	nM
1475	CC(C)C1=C2N=C(NC(CO)CO)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	11	%
1476	CC(C)C1=C2N=C(NCCOCCO)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	18	nM
1477	CC(C)C1=C2N=C(NCCOCCO)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	55	nM
1478	CC(C)C1=C2N=C(Cl)C=C(N(CC3=CC=C(C=C3)S(=O)(=O)N(C)C)C(=O)OC(C)(C)C)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	37	%
1479	CC(C)C1=C2N=C(Cl)C=C(N(CC3=CC=C(C=C3)S(=O)(=O)N(C)C)C(=O)OC(C)(C)C)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	48	nM
1480	CC(C)C1=C2N=C(NCCCCCN)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	7	nM
1481	CC(C)C1=C2N=C(NCCCCCN)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	60	%
1482	CC(C)C1=C2N=C(NCCCCCN)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	564	nM
1483	CC(C)C1=C2N=C(NCCCCCCN)C=C(N[C@H](C)C3=CC=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	0	%
1484	CC(C)C1=C2N=C(NCCCCCCN)C=C(N[C@H](C)C3=CC=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	520	nM
1485	CC(C)C1=C2N=C(NCCCCCCN)C=C(N[C@@H](C)C3=CC=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	520	nM
1486	CC(C)C1=C2N=C(NCCCCCCN)C=C(N[C@@H](C)C3=CC=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	44	%
1487	CC(C)C1=C2N=C(NCCCCCCN)C=C(N[C@@H](C)C3=CC=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	6	nM
1488	CC(C)C1=C2N=C(NCCCCCCCN)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	82	%
1489	CC(C)C1=C2N=C(NCCCCCCCN)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	654	nM
1490	CC(C)C1=C2N=C(NCCCCCCC3=CC=CC=N3)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	31	%
1491	CC(C)C1=C2N=C(NCCCCCCC3=CC=CC=N3)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	604	nM
1492	CC(C)C1=C2N=C(NCCCCCCC3=CC=CN=C3)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	22	%
1493	CC(C)C1=C2N=C(NCCCCCCC3=CC=CN=C3)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1000	nM
1494	CC(C)C1=C2N=C(NCCCCCCC#N)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1000	nM
1495	CC(C)C1=C2N=C(NCCCCCCN)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1000	nM
1496	CC(C)C1=C2N=C(N[C@@H](CO)CCCCCC#N)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	10	%
1497	CC(C)C1=C2N=C(N[C@@H](CO)CCCCCC#N)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	18	nM
1498	CC(C)C1=C2N=C(NCCCCCCCN)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	92	%
1499	CC(C)C1=C2N=C(NCCCCCCCN)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	27	nM
1500	CC(C)C1=C2N=C(NCC3CCC(CN)CC3)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	76	nM
1501	CC(C)C1=C2N=C(NCC3CCC(CN)CC3)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	40	%
1502	CC(C)C1=C2N=C(NCC3CCC(CN)CC3)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1000	nM
1503	CC(C)C1=C2N=C(NCCCCCCC3=CC=CN=C3)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	27	%
1504	CC(C)C1=C2N=C(NCCCCCCC3=CC=CN=C3)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1000	nM
1505	CC(C)C1=C2N=C(NCCCCCCC3=NC=CC=C3)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	4	%
1506	CC(C)C1=C2N=C(NCCCCCCC3=NC=CC=C3)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	704	nM
1507	CC(C)C1=C2N=C(N[C@@H](CO)CCCCCN)C=C(NCC3=C(F)C=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	45	%
1508	CC(C)C1=C2N=C(N[C@@H](CO)CCCCCN)C=C(NCC3=C(F)C=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	180	nM
1509	CC(C)C1=C2N=C(NCCCCCCC3=CC=C(N)N=C3)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	19	%
1510	CC(C)C1=C2N=C(NCCCCCCC3=CC=C(N)N=C3)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1000	nM
1511	CC(C)C1=C2N=C(NCCCCCCC3=CN=CN=C3)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	34	%
1512	CC(C)C1=C2N=C(NCCCCCCC3=CN=CN=C3)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1000	nM
1513	CC(C)C1=C2N=C(N[C@@H](CO)CCCCCCN)C=C(NCC3=C(F)C=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	100	nM
1514	CC(C)C1=C2N=C(N[C@@H](CO)CCCCCCN)C=C(NCC3=C(F)C=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	66	%
1515	CC(C)C1=C2N=C(N[C@@H](CO)CCCCCCN)C=C(NCC3=C(F)C=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	60	nM
1516	CC(C)C1=C2N=C(NCCCCCCCNS(C)(=O)=O)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	37	%
1517	CC(C)C1=C2N=C(NCCCCCCCNS(C)(=O)=O)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1000	nM
1518	CC(C)C1=C2N=C(N[C@@H](CO)CCCCCCC3=CN=CN=C3)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	20	nM
1519	CC(C)C1=C2N=C(NCCCCCCC3=CC=C(N)N=C3)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	17	%
1520	CC(C)C1=C2N=C(NCCCCCCC3=CC=C(N)N=C3)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1000	nM
1521	CC(C)C1=C2N=C(N[C@@H](CO)CCCCCCCC3=CN=CC=C3)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	620	nM
1522	CC(C)C1=C2N=C(N[C@@H](CO)CCCCCCCC3=CN=CC=C3)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	23	%
1523	CC(C)C1=C2N=C(N[C@@H](CO)CCCCCCCC3=CN=CC=C3)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	520	nM
1524	CC(C)C1=C2N=C(N[C@@H](CO)CCCCCCC3=NC=CC=N3)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	55	nM
1525	CC(C)C1=C2N=C(N[C@@H](CO)CCCCCCC3=NC=CC=N3)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	44	nM
1526	CC(C)C1=C2N=C(N[C@@H](CO)CCCCCCC3=CC=C(F)N=C3)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	17	%
1527	CC(C)C1=C2N=C(N[C@@H](CO)CCCCCCC3=CC=C(F)N=C3)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	183	nM
1528	CC(C)C1=C2N=C(N[C@@H](CO)CCCCCCC3=CC=CC=N3)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	44	nM
1529	CC(C)C1=C2N=C(NC3CCC(N)CC3)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-dependent kinase 7	IC50	48	nM
1530	CC(C)C1=C2N=C(NC3CCC(N)CC3)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-dependent kinase 7	IC50	6	nM
1531	CC(C)C1=C2N=C(N[C@@H](CO)CCCCCCCC3=CN=CN=C3)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	120	nM
1532	CC(C)C1=C2N=C(N[C@@H](CO)CCCCCCCC3=CN=CN=C3)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	18	nM
1533	CC(C)C1=C2N=C(N[C@@H](CO)CCCCCCCC3=CC=C(F)N=C3)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	80	nM
1534	CC(C)C1=C2N=C(N[C@@H](CO)CCCCCCCC3=CC=C(F)N=C3)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	80	nM
1535	CC(C)C1=C2N=C(N[C@@H](CO)\C=C/CCC#CC3=CC=C(F)C=C3)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	19	%
1536	CC(C)C1=C2N=C(N[C@@H](CO)\C=C/CCC#CC3=CC=C(F)C=C3)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1000	nM
1537	CC(C)C1=C2N=C(N[C@@H](CO)CCCCCCC3=CC=C(F)N=C3)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	21	%
1538	CC(C)C1=C2N=C(N[C@@H](CO)CCCCCCC3=CC=C(F)N=C3)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1000	nM
1539	CC(C)C1=C2N=C(N[C@@H](CO)CCCCCCCC3=CC=C(F)N=C3)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	46	nM
1540	CC(C)C1=C2N=C(N[C@@H](CO)CCCCCCCC3=CC=C(F)N=C3)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	46	nM
1541	CC(C)C1=C2N=C(N[C@@H](CO)CCCCCCC3=CC=C4C=CC=CC4=N3)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	24	nM
1542	CC(C)C1=C2N=C(NC3CCC(N)CC3)C=C(NCC3=CC=C(C=C3)S(=O)(=O)N(C)C)N2N=C1	Cyclin-dependent kinase 7	IC50	1000	nM
1543	CC(C)C1=C2N=C(NCCCCCN)C=C(NCC3=CC(OS(=O)(=O)C4=C5C=CC=C(N(C)C)C5=CC=C4)=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	53	%
1544	CC(C)C1=C2N=C(NCCCCCN)C=C(NCC3=CC(OS(=O)(=O)C4=C5C=CC=C(N(C)C)C5=CC=C4)=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	30	nM
1545	CC(C)C1=C2N=C(NCCCCCCNC3=NC4=C(C=NN4C(N[C@@H](C)C4=CC=CC=C4)=C3)C(C)C)C=C(N[C@@H](C)C3=CC=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	664	nM
1546	CC(C)C1=C2N=C(NCCCCCCNC3=NC4=C(C=NN4C(N[C@@H](C)C4=CC=CC=C4)=C3)C(C)C)C=C(N[C@@H](C)C3=CC=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	9	%
1547	CC(C)C1=C2N=C(NCCCCCCNC3=NC4=C(C=NN4C(N[C@@H](C)C4=CC=CC=C4)=C3)C(C)C)C=C(N[C@@H](C)C3=CC=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	7	nM
1548	CC(C)C1=C2N=C(NCCCCCNC3=NC4=C(C=NN4C(NCC4=CC=CC=C4F)=C3)C(C)C)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	27	%
1549	CC(C)C1=C2N=C(NCCCCCNC3=NC4=C(C=NN4C(NCC4=CC=CC=C4F)=C3)C(C)C)C=C(NCC3=CC=CC=C3F)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1000	nM
1550	CC(C)C1=C2N=C(NC3CCC(CC3)NC3=NC4=C(C=NN4C(NCC4=CC=CC=C4)=C3)C(C)C)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-dependent kinase 7	IC50	43	nM
1551	NCC(NC(=O)C1=CC=C(C=C1)C1=CC=NC=C1)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1552	COC1=CC2=C(C=C1)N(C)C=C2C1=CC2=NC(Br)=CN=C2N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	7.5	
1553	C[C@@H]1CCN(C[C@@H]1C1=NC=C2C=NC3=C(C=CN3)N12)C(=O)CC#N	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1554	CC1=NC2=C(S1)C1=NC(NC3=CC=C(C=C3)N(=O)=O)=NC=C1CC2	Cyclin-dependent kinase 7 [human];+Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	Ki (inhibition constant)	4.8	µM
1555	CN(C)C1=CC=C(NC2=NC=C3CCC4=C(SC(N)=N4)C3=N2)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	Ki (inhibition constant)	0.5	µM
1556	COC(=O)C1=CC=C(NC2=NC=C3CCC4=C(SC(C)=N4)C3=N2)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	Ki (inhibition constant)	6.3	µM
1557	OC(=O)C(F)(F)F.COC1=C(NC2=NC=C3N(C)C(=O)C[C@@H]4CCCN4C3=N2)C=CC(=C1)N1CCN(C)CC1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	inhibition percentage		
1558	CC1=CC=C(NS(=O)(=O)C2=C(Cl)SC(Cl)=C2)C=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.8	µM
1559	ClC1=CC(=C(Cl)S1)S(=O)(=O)N(C(=O)CBr)C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	33.4	µM
1560	CC1=CC=C(C=C1)N(SC(Cl)(Cl)Cl)S(=O)(=O)C1=C(Cl)SC(Cl)=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.7	µM
1561	FC(F)(F)C1=CC(NS(=O)(=O)C2=CC(Cl)=C(Cl)C=C2Cl)=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.2	µM
1562	CC1=NC(=CC=C1)C1=C(NC(CC2=CC=CC(=C2)C(N)=O)=N1)C1=CC2=CC=CN=C2C=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	3.4	µM
1563	CNC1=CC=C(NC2=NC=CC(=N2)C2=C(C)N=C(C)S2)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	Ki (inhibition constant)	4240	nM
1564	CCC(C)OC1=C(C=O)C(N)=NC(NC2=CC=C(C=C2)S(N)(=O)=O)=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	890	nM
1565	CC[C@@H](C)OC1=C(C=O)C(N)=NC(NC2=CC=C(C=C2)S(N)(=O)=O)=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	710	nM
1566	CN(C)CCCC1=C(NC2=C1C(=O)CCC2)\C=C1/C(=O)NC2=C1C=C(NS(=O)(=O)C1=CC=CC=C1)C=C2	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	inhibition percentage	98.5	%
1567	COC1=CC2=C(CN[C@H](C2)C(=O)NC2=C(OCC3CCN(C)CC3)C=C(C=C2)C2=CNN=C2)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	inhibition percentage	7	%
1568	CC(C)N1C=C(N=C1C)C1=NC(NC2=CC=C(C=C2)S(=O)(=O)NCCCCCCN)=NC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1139	nM
1569	CC(C)N1C=C(N=C1C(C)C)C1=NC(NC2=CC=C(C=C2)S(=O)(=O)NCCCCCCN)=NC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	3402	nM
1570	CC(C)N1C=C(N=C1C1=CC=CC=C1)C1=NC(NC2=CC=C(C=C2)S(=O)(=O)NCCCCCCN)=NC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	3425	nM
1571	CN1C=C(N=C1C)S(=O)(=O)NC1=CC=C2NN=C(C3=CC4=CC=C(C)C=C4N3)C2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-1	%
1572	CN1C=C(N=C1C)S(=O)(=O)NC1=CC=C2NN=C(C3=CC4=CC=C(C)C=C4N3)C2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	60	%
1573	CC1=CC=C2C=C(NC2=C1)C1=NNC2=CC=C(NC3CCN(CC4=CC=CC=C4)CC3)C=C12	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	6	%
1574	CC1=CC=C2C=C(NC2=C1)C1=NNC2=CC=C(NC3CCN(CC4=CC=CC=C4)CC3)C=C12	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	72	%
1575	COC1=C(NC2=NN(C(=S)NCC3=C(Cl)C=CC=C3Cl)C(N)=N2)C=CC(=C1)N1CCN(C)CC1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	inhibition percentage	100	%
1576	COC1=C(NC2=NN(C(=O)NCC3=C(Cl)C=CC=C3Cl)C(N)=N2)C=CC(=C1)N1CCN(C)CC1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	inhibition percentage	95.6	%
1577	CN1CCN(CC1)C1=NC2=C(C=N1)C1=NN=NN1C1=C(C=CC=C1)N2CC1=CC(F)=C(F)C=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	inhibition percentage		
1578	FC1=CC=C(CN2C3=CC=CC=C3N3N=NN=C3C3=CN=C(NCC4=CC=CN=C4)N=C23)C=C1F	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	inhibition percentage		
1579	FC1=CC=C(CN2C3=CC=CC=C3N3N=NN=C3C3=CN=C(NCCN4CCOCC4)N=C23)C=C1F	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	inhibition percentage	84	%
1580	CC(C)(C)OC(=O)N1CC2=C(C1=O)C(O)=CC(O)=C2	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	0.28	µM
1581	COC(=O)C1=C(O)C=C(O)C=C1CN(C)C(=O)OC(C)(C)C	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	0.68	µM
1582	CC(C)[C@@H]1N(C(=O)OC(C)(C)C)C(=O)C2=C1C=C(O)C=C2O	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	1	µM
1583	COC(=O)C1=C(CN(C)S(=O)(=O)C2=NC=CC=C2)C=C(O)C=C1O	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	0.41	µM
1584	CC(C)C[C@@H]1N(C(=O)OC(C)(C)C)C(=O)C2=C1C=C(O)C=C2O	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	0.39	µM
1585	COC(=O)C1=C(CN(C)S(=O)(=O)C2=CC=CC=C2)C=C(O)C=C1O	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	1.29	µM
1586	COC(=O)C1=C(CN(C)S(=O)(=O)C2=C(C)ON=C2C)C=C(O)C=C1O	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	0.35	µM
1587	COC(=O)C1=C(CN(C)S(=O)(=O)C2=C(Cl)N(C)N=C2C)C=C(O)C=C1O	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	1.44	µM
1588	CC(C)(C)OC(=O)N1[C@@H](COCC2=CC=CC=C2)C2=C(C1=O)C(O)=CC(O)=C2	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	0.43	µM
1589	Cl.COC1=CC(F)=CC=C1C1=CC(NC(=O)[C@@H]2CC[C@@H](C2)NC(C)=O)=NC=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	5000	nM
1590	C[C@H]1COCCN1C1=NC(=NC(=C1)C1=NC=CC=C1)C1=CC=C(NC(=O)NCCO)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	IC50	10	µM
1591	CCNC(=O)NC1=CC=C(C=C1)C1=NC(=NC(=C1)C1=CC=CC=C1C#N)N1CCOC[C@@H]1C	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	IC50	10	µM
1592	C[C@H]1COCCN1C1=NC(=CC(=N1)C1=CC=C(NC(=O)NC2CC2)C=C1)C1=CC=CN=C1S(C)(=O)=O	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	IC50	10	µM
1593	C[C@H]1COCCN1C1=NC(=CC(=N1)C1=CC=C(NC(=O)NC2CC2)C=C1)C1=CC=CC=C1S(C)(=O)=O	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	IC50	10	µM
1594	C[C@H]1COCCN1C1=NC(=NC(=C1)C1=CC=CC=C1S(C)(=O)=O)C1=CC=C(NC(=O)NC2CC2)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	IC50	10	µM
1595	C[C@H]1COCCN1C1=NC(=CC(=N1)C1=CC=C(NC(=O)NC2CC2)C=C1)C1=CC(F)=CC=C1S(C)(=O)=O	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	IC50	10	µM
1596	C[C@H]1COCCN1C1=NC(=CC(=N1)C1=CC=C(NC(=O)N[C@H]2CCC[C@@H]2O)C=C1)C1=CC(F)=CC=C1S(C)(=O)=O	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	IC50	10	µM
1597	CCCN1C=C(C2=CC=NC=C12)C1=NC(NC2=CC=C(C=C2)N2CCNCC2)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	0.25 - 0.5	µM
1598	CCCN1C=C(C2=CC=NC=C12)C1=NC(NC2=CC(=CC=C2)N2CCNCC2)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	0.25 - 0.5	µM
1599	CCCN1C=C(C2=CC=NC=C12)C1=NC(NC2=CC=CC(=C2)C(=O)N2CCOCC2)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	0.25 - 0.5	µM
1600	CCCN1C=C(C2=CC=NC(Cl)=C12)C1=NC(NC2=CC=C(C=C2)N2CCOCC2)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	0.25 - 0.5	µM
1601	CCCN1C=C(C2=CC=NC=C12)C1=NC(NC2=CC=C(C=C2)C(=O)N2CCOCC2)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	0.25 - 0.5	µM
1602	CCCN1C=C(C2=CC=NC=C12)C1=NC(NC2=CC=C(C=C2)C(=O)N2CCNCC2)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	0.25 - 0.5	µM
1603	CCCN1C=C(C2=CC=NC=C12)C1=NC(NC2=CC=CC(=C2)C(=O)N2CCNCC2)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	0.25 - 0.5	µM
1604	CCCN1C=C(C2=CC=NC=C12)C1=NC(NC2=CC=C(C=C2)C(=O)N2CCN(CC2)C(C)=O)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	0.25 - 0.5	µM
1605	CCCN1C=C(C2=CC=NC(Cl)=C12)C1=NC(NC2=CC=C(C=C2)C(=O)N2CCN(CC2)C(C)=O)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	0.25 - 0.5	µM
1606	CCCN1C=C(C2=CC=NC(Cl)=C12)C1=NC(NC2=CC=CC(=C2)C(=O)N2CCN(CC2)C(C)=O)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	0.25 - 0.5	µM
1607	FC1=CC=C(C=C1)C1=C(OC2=CC=CC=C2C1=O)C1=CC=NC(NC2CCCCC2)=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage		
1608	C[C@H]1COC2=C3N1C=C(C#N)C(=O)C3=C(N)C(F)=C2NCCCN1C=CC=N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	inhibition percentage	35	%
1609	C[C@H]1COC2=C3N1C=C(C(O)=O)C(=O)C3=C(N)C(F)=C2NCCCN1C=CC=N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	inhibition percentage	35	%
1610	C1CN(CCN1)C1=NC(NC2=NC=C(S2)C2=CC=CC=C2)=CC=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	26	nM
1611	NCCCCC1=CN=CC(=C1)C1=CN=C(NC2=NC=CC(=C2)N2CCOCC2)S1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	10000	nM
1612	NCNC(=O)C1=CN=CC(=C1)C1=CN=C(NC2=NC=CC(=C2)N2CCC(F)CC2)S1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	350	nM
1613	CC1=CC=C(NC(=O)C2=CN=CC(=C2)C2=CN=C(NC3=CC(=CC=N3)N3CCOCC3)S2)S1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	10000	nM
1614	NCNC(=O)C1=CN=CC(=C1)C1=CN=C(NC2=NC=CC(=C2)N2CCC(F)(F)CC2)S1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	317	nM
1615	F[C@H]1C[C@H](N(C1)C1=NN2C=CC=C2C(NC2=NNC(=C2)C2CC2)=N1)C(=O)NC1=NC=CS1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	inhibition percentage	98.1	%
1616	F[C@H]1C[C@H](N(C1)C1=NN2C=CC=C2C(NC2=NNC(=C2)C2CC2)=N1)C(=O)NC1=CC=NC=N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	inhibition percentage	91.2	%
1617	F[C@H]1C[C@H](N(C1)C1=NN2C=CC=C2C(NC2=NNC(=C2)C2CC2)=N1)C(=O)NC1=CC=CN=N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	inhibition percentage	91.9	%
1618	F[C@H]1C[C@H](N(C1)C1=NN2C=CC=C2C(NC2=NNC(=C2)C2CC2)=N1)C(=O)NC1=CN=CC=N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	inhibition percentage	99.1	%
1619	F[C@H]1C[C@H](N(C1)C1=NN2C=CC=C2C(NC2=NNC(=C2)C2CC2)=N1)C(=O)NC1=CN=CN=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	inhibition percentage	93.3	%
1620	F[C@H]1C[C@H](N(C1)C1=NN2C=CC=C2C(NC2=NNC(=C2)C2CC2)=N1)C(=O)NC1=CC=NN=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	inhibition percentage	90	%
1621	CC1=CN=C(NC(=O)[C@@H]2C[C@H](F)CN2C2=NN3C=CC=C3C(NC3=NNC(=C3)C3CC3)=N2)S1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	inhibition percentage	64	%
1622	F[C@H]1C[C@H](N(C1)C1=NN2C=CC=C2C(NC2=NNC(=C2)C2CC2)=N1)C(=O)NC1=NC=C(F)S1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	inhibition percentage	97.2	%
1623	F[C@H]1C[C@H](N(C1)C1=NN2C=CC=C2C(NC2=NNC(=C2)C2CC2)=N1)C(=O)NC1=CC=C(F)N=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	inhibition percentage	98.2	%
1624	CN(C)C[C@@H](OC(=O)N1CC2=C(NN=C2NC(=O)C(C)(C)C(F)(F)F)C1(C)C)C1=CC=CC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	inhibition percentage	70	%
1625	COC1=C(C=CC=C1)C1=CC(NC2=CC=C(C=C2)S(N)(=O)=O)=NC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1626	COC1=C(C=CC=C1)C1=CC(NC2=CC=C(C=C2)S(N)(=O)=O)=NC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	10000	nM
1627	COC1=C(C=CC(F)=C1)C1=CC(NC2=CC=CC(=C2)S(=O)(=O)NC(C)(C)C)=NC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1628	NS(=O)(=O)CC1=CC(NC2=NC=NC(=N2)N2CCCC2)=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1629	COC[C@H]1CCN1C1=NC(NC2=CC=CC(CS(N)(=O)=O)=C2)=NC=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1630	NS(=O)(=O)CC1=CC(NC2=NC=NC(=N2)N2CCOCC2)=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	1000 - 10000	nM
1631	C[C@@H]1CCCN1C1=NC(NC2=CC=CC(CS(N)(=O)=O)=C2)=NC=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1632	NS(=O)(=O)CC1=CC(NC2=NC=NC(=N2)N2CCCCC2)=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1633	NS(=O)(=O)CC1=CC(NC2=NC=NC(=N2)N2CCCCC2)=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	10000	nM
1634	COC(=O)[C@H]1CCN1C1=NC=NC(NC2=CC(CS(N)(=O)=O)=CC=C2)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1635	CN1CCN(CC1)C1=NC(NC2=CC=CC(CS(N)(=O)=O)=C2)=NC=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1636	NS(=O)(=O)CC1=CC(NC2=NC=NC(=N2)N2CCNCC2)=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1637	NS(=O)(=O)CC1=CC(NC2=NC=NC(=N2)N2CCN3C=CN=C3C2)=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1638	NS(=O)(=O)CC1=CC(NC2=NC=NC(=N2)N2CCCN3N=CC=C23)=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	100 - 1000	nM
1639	NS(=O)(=O)CC1=CC(NC2=NC=NC(=N2)N2CCCN3N=CC=C23)=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1000 - 10000	nM
1640	COC[C@@H]1CCCN1C1=NC(NC2=CC=CC(CS(N)(=O)=O)=C2)=NC=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1641	NS(=O)(=O)CC1=CC(NC2=NC=NC(=N2)N2CC3=CC=CN=C3C2)=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1642	NS(=O)(=O)CC1=CC=CC(NC2=NC(=NC=N2)N2CCC[C@H]2CO)=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1643	NS(=O)(=O)CC1=CC=CC(NC2=NC(=NC=N2)N2CCC[C@@H]2CO)=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1644	NS(=O)(=O)CC1=CC=CC(NC2=NC(=NC=N2)N2CCC2C2=CC=CC=C2)=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1645	NS(=O)(=O)CC1=CC(NC2=NC=NC(=N2)N2CC3=CN=CN=C3C2)=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1646	NS(=O)(=O)CC1=CC(NC2=NC=NC(=N2)N2CCC(F)(F)CC2)=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1647	NS(=O)(=O)CC1=CC(NC2=NC=NC(=N2)N2CCCC(F)(F)C2)=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1648	NS(=O)(=O)CC1=CC(NC2=NC=NC(=N2)N2CCC3=C(C2)C=CS3)=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	1000 - 10000	nM
1649	NS(=O)(=O)CC1=CC(NC2=NC=NC(=N2)N2CCC3=C(C2)SC=N3)=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	1000 - 10000	nM
1650	NS(=O)(=O)CC1=CC(NC2=NC=NC(=N2)N2CCC3=C(C2)SC=N3)=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1000 - 10000	nM
1651	NS(=O)(=O)CC1=CC(NC2=NC=NC(=N2)N2CCC3=C(C2)C=CC=C3)=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1652	COC(=O)[C@@H]1CCCN1C1=NC=NC(NC2=CC(CS(N)(=O)=O)=CC=C2)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1653	COCC1CCCCN1C1=NC(NC2=CC=CC(CS(N)(=O)=O)=C2)=NC=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1654	COC[C@H]1CCCCN1C1=NC(NC2=CC=CC(CS(N)(=O)=O)=C2)=NC=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1655	NC(=O)[C@H]1CCCN1C1=NC=NC(NC2=CC(CS(N)(=O)=O)=CC=C2)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1656	NS(=O)(=O)CC1=CC(NC2=NC=NC(=N2)N2CCC[C@@H]2C(F)(F)F)=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1657	NS(=O)(=O)CC1=CC(NC2=NC=NC(=N2)N2CCC[C@H]2C(F)(F)F)=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1658	NS(=O)(=O)CC1=CC=CC(NC2=NC(=NC=N2)N2CCCC2CC2=CC=CC=C2)=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1659	NS(=O)(=O)CC1=CC(NC2=NC=NC(=N2)N2CCCCC2C2=CC=CC=C2)=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1660	NS(=O)(=O)CC1=CC(NC2=NC=NC(=N2)N2CCC3=C(C2)C=NC=N3)=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1661	COC[C@@H]1CC[C@@H](COC)N1C1=NC(NC2=CC=CC(CS(N)(=O)=O)=C2)=NC=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1662	COC[C@H]1CC[C@H](COC)N1C1=NC(NC2=CC=CC(CS(N)(=O)=O)=C2)=NC=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1663	NS(=O)(=O)CC1=CC=CC(NC2=NC(=NC=N2)N2CCCC2CCC2=CC=CC=C2)=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1664	NS(=O)(=O)CC1=CC=CC(NC2=NC(=NC=N2)N2CCC[C@@H]2COC2=CC=CC=C2)=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1665	CN(C)CCC1CCCCN1C1=NC(NC2=CC=CC(CS(N)(=O)=O)=C2)=NC=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	10000	nM
1666	NS(=O)(=O)CC1=CC(NC2=NC=NC(=N2)N2CCC[C@@H]2CNC2=CC=CC=C2)=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1667	NC1=CC=CC2=C1CCN(C2)C1=NC(NC2=CC=CC(CS(N)(=O)=O)=C2)=NC=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1668	NS(=O)(=O)CC1=CC=CC(NC2=NC(=NC=N2)N2CCC[C@@H]2COCC2=CC=CC=C2)=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1669	NS(=O)(=O)CC1=CC(NC2=NC=NC(=N2)N2CCC[C@@H]2CN2CCCC2)=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1670	NS(=O)(=O)CC1=CC(NC2=NC=NC(=N2)N2CCC[C@H]2CN2CCCC2)=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1671	CC(C)(C)OC(=O)NCC1CCCCN1C1=NC=NC(NC2=CC(CS(N)(=O)=O)=CC=C2)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	10000	nM
1672	CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCN(CC3)C3=NC=C(C=N3)C(=O)NO)S2)O1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1 - 10	µM
1673	CNS(=O)(=O)C1=CC=C(OC)C(NC2=CC(NC3=CC=C(Cl)C=C3)=NC=N2)=C1	CDK-activating kinase assembly factor MAT1	inhibition percentage	0	%
1674	CN1C=NC2=CC=C(NC3=C(C)C=CC(NC(=O)C4=C(N=C(N4)C(F)(F)F)C4=CC=C(F)C(F)=C4)=C3)C=C2C1=O	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	inhibition percentage	25	%
1675	CNC1=NC=C(S1)C1=CC=NC(NC2=CC=C(C=C2)S(N)(=O)=O)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Ki (inhibition constant)	54	nM
1676	CNC1=NC=C(S1)C1=CC=NC(NC2=CC=CC(=C2)S(N)(=O)=O)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Ki (inhibition constant)	40	nM
1677	CNC1=NC(C2CC2)=C(S1)C1=CC=NC(NC2=CC=CC(=C2)S(N)(=O)=O)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Ki (inhibition constant)	273	nM
1678	CNC1=NC(C2CC2)=C(S1)C1=CC=NC(NC2=CC=C(C=C2)S(N)(=O)=O)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Ki (inhibition constant)	255	nM
1679	CNC1=NC(C2CC2)=C(S1)C1=CC=NC(NC2=CC(=CC=C2)N2CCCNCC2)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Ki (inhibition constant)	464	nM
1680	CNC1=NC(C)=C(S1)C1=CC=NC(NC2=CC(=CC=C2)N2CCCNCC2)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Ki (inhibition constant)	433	nM
1681	CNC1=NC(C)=C(S1)C1=C(O)C=NC(NC2=CC(=CC=C2)N(=O)=O)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Ki (inhibition constant)	5000	nM
1682	CNC1=NC(C)=C(S1)C1=C(O)C=NC(NC2=CC=CC(=C2)S(N)(=O)=O)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Ki (inhibition constant)	5000	nM
1683	CNC1=NC(C)=C(S1)C1=C(C)C=NC(NC2=CC=CC(=C2)S(N)(=O)=O)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Ki (inhibition constant)	1176	nM
1684	CCC1=C(N=C(NC2=CC=CC(=C2)S(N)(=O)=O)N=C1)C1=C(C)N=C(NC)S1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Ki (inhibition constant)	1285	nM
1685	CNC1=NC(C)=C(S1)C1=C(C=NC(NC2=CC(=CC=C2)N2CCN(CC2)C(C)=O)=N1)C#N	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Ki (inhibition constant)	92	nM
1686	CNC1=NC(C)=C(S1)C1=C(C=NC(NC2=CC(=CC=C2)N2CCNCC2)=N1)C#N	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Ki (inhibition constant)	68	nM
1687	CNC1=NC(C)=C(S1)C1=C(C=NC(NC2=CC=C(C=C2)N2CCN(CC2)C(C)=O)=N1)C#N	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Ki (inhibition constant)	316	nM
1688	CNC1=NC(C)=C(S1)C1=C(C=NC(NC2=CC=C(C=C2)N2CCNCC2)=N1)C#N	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Ki (inhibition constant)	71	nM
1689	CNC1=NC(C)=C(S1)C1=C(C=NC(NC2=CC(=CC=C2)N2CCCCC2)=N1)C#N	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Ki (inhibition constant)	286	nM
1690	CNC1=NC(C)=C(S1)C1=C(F)C=NC(NC2=CC=CC(=C2)N2CCN(CC2)C(C)=O)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Ki (inhibition constant)	302	nM
1691	CNC1=NC(C)=C(S1)C1=C(F)C=NC(NC2=CC(=CC=C2)N2CCNCC2)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Ki (inhibition constant)	193	nM
1692	CNC1=NC(C)=C(S1)C1=C(F)C=NC(NC2=CC(=CC=C2)N2CCOCC2)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Ki (inhibition constant)	473	nM
1693	CNC1=NC(C)=C(S1)C1=C(Cl)C=NC(NC2=CC(=CC=C2)N2CCNCC2)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Ki (inhibition constant)	155	nM
1694	CNC1=NC(CC(F)(F)F)=C(S1)C1=CC=NC(NC2=CC(=CC=C2)N(=O)=O)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Ki (inhibition constant)	5000	nM
1695	CNC1=NC(CC(F)(F)F)=C(S1)C1=CC=NC(NC2=CC=CC(O)=C2)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Ki (inhibition constant)	3474	nM
1696	CNC1=NC(CC(F)(F)F)=C(S1)C1=CC=NC(NC2=CC=C(O)C=C2)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Ki (inhibition constant)	1543	nM
1697	CNC1=NC(CC(F)(F)F)=C(S1)C1=CC=NC(NC2=CC=CC(=C2)S(N)(=O)=O)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Ki (inhibition constant)	1984	nM
1698	CNC1=NC(=C(S1)C1=CC=NC(NC2=CC=CC(=C2)S(N)(=O)=O)=N1)C(F)(F)F	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Ki (inhibition constant)	47	nM
1699	CNC1=NC(=C(S1)C1=CC=NC(NC2=CC=C(C=C2)S(N)(=O)=O)=N1)C(F)(F)F	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Ki (inhibition constant)	64	nM
1700	CN1C=C(C=N1)C1=CC2=C(C=CC3=CC=C(CC(=O)NCC4=CC=CC=N4)C=C3C2=O)N=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	inhibition percentage	11.8	%
1701	CN1C=C(C=N1)C1=CC2=C(C=CC3=CC=C(CC(=O)NCC4=CC=CC=N4)C=C3C2=O)N=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	inhibition percentage	6.4	%
1702	CN1C=C(C=N1)C1=CC2=C(C=CC3=CC=C(CC(=O)NCC4=CC=CC=N4)C=C3C2=O)N=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	inhibition percentage	1	%
1703	CN(C)CC=CC(=O)NC1=CC(=CC=C1)C(=O)NC1=CC=C(NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)C=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	0.0755	nM
1704	CC(C)C1=C2N=C(OC3CCNCC3)N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1	Cyclin-dependent kinase 7	IC50	5	nM
1705	CC(C)C1=C2N=C(OC3CCN(C)CC3)N=C(NCC3=C(F)C=CC=C3)N2N=C1	Cyclin-dependent kinase 7	IC50	5 - 10	nM
1706	COC1=C(NC2=NC=C3C(=O)N4C=CN=C4N(C4=CC(NC(=O)C=C)=CC=C4)C3=N2)C=CC(=C1)N1CCC(CC1)N(C)C	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	inhibition percentage	0	%
1707	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NN(C)N=N3)N2N=C1)N1CCC2(CCCN2)CC1	Cyclin-dependent kinase 7	IC50	5	nM
1708	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CCC2(CCN2)CC1	Cyclin-dependent kinase 7	IC50	5	nM
1709	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CCCC2(CCNCC2)C1	Cyclin-dependent kinase 7	IC50	5 - 10	nM
1710	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CCCC11CCNCC1	Cyclin-dependent kinase 7	IC50	5	nM
1711	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CCC2(CCCCN2)CC1	Cyclin-dependent kinase 7	IC50	5	nM
1712	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CCC(CC1)N(C)C	Cyclin-dependent kinase 7	IC50	5	nM
1713	CNC1CCN(CC1)C1=NC2=C(C=NN2C(NCC2=C(C=CC=C2)N2C=CC=N2)=N1)C(C)C	Cyclin-dependent kinase 7	IC50	5	nM
1714	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CCC2(CCNCC2)CC1	Cyclin-dependent kinase 7	IC50	5 - 10	nM
1715	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CCC2(C1)CCCNC2	Cyclin-dependent kinase 7	IC50	5 - 10	nM
1716	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CCC11CCNC1	Cyclin-dependent kinase 7	IC50	5	nM
1717	CC(C)OC1=C(CNC2=NC(N[C@@H]3CCCNC3)=NC3=C(C=NN23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7	IC50	5 - 10	nM
1718	CC(C)C1=C2N=C(N[C@@H]3CCCNC3)N=C(NCC3=C(C=CC=C3)N3C=NC=N3)N2N=C1	Cyclin-dependent kinase 7	IC50	5	nM
1719	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CCC11CCNCC1	Cyclin-dependent kinase 7	IC50	5	nM
1720	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)S(=O)(=O)N(C)C)N2N=C1)N1CCC2(CCCN2)CC1	Cyclin-dependent kinase 7	IC50	5	nM
1721	CC(C)C1=C2N=C(N=C(NCC3=CC=CC4=NON=C34)N2N=C1)N1CCC2(CCCN2)CC1	Cyclin-dependent kinase 7	IC50	5	nM
1722	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CCC2(C1)CCNCC2	Cyclin-dependent kinase 7	IC50	5	nM
1723	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3CCCC3=O)N2N=C1)N1CCC2(CCCN2)CC1	Cyclin-dependent kinase 7	IC50	5	nM
1724	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C(=O)NCC1CCNCC1	Cyclin-dependent kinase 7	IC50	5	nM
1725	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C(=O)NCC1CNC1	Cyclin-dependent kinase 7	IC50	5	nM
1726	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C(=O)NCC1CCNC1	Cyclin-dependent kinase 7	IC50	5	nM
1727	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C(=O)NCC1CCCNC1	Cyclin-dependent kinase 7	IC50	5	nM
1728	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C(=O)NCCCCN	Cyclin-dependent kinase 7	IC50	5	nM
1729	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CCC2(C1)CCCCN2	Cyclin-dependent kinase 7	IC50	5	nM
1730	CC(C)C1=C2N=C(O[C@@H]3CCNC3)N=C(NCC3=C(C=CC=C3)N3C=CN=C3C)N2N=C1	Cyclin-dependent kinase 7	IC50	5	nM
1731	CC(C)C1=C2N=C(O[C@@H]3CCNC3)N=C(NCC3=C(C=CC=C3)N3C=CN=C3)N2N=C1	Cyclin-dependent kinase 7	IC50	5	nM
1732	CC(C)C1=C2N=C(OC3CCN(C)CC3)N=C(NCC3=C(C=CC=C3)N3C=CN=C3C)N2N=C1	Cyclin-dependent kinase 7	IC50	5	nM
1733	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CCC2(CNC2)CC1	Cyclin-dependent kinase 7	IC50	5	nM
1734	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CC2(C1)CCNC2	Cyclin-dependent kinase 7	IC50	5	nM
1735	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CCC2(CCNC2)C1	Cyclin-dependent kinase 7	IC50	5	nM
1736	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CC2(C1)CCCNC2	Cyclin-dependent kinase 7	IC50	5	nM
1737	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CCC2(CNC2)C1	Cyclin-dependent kinase 7	IC50	5	nM
1738	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CCC11CNC1	Cyclin-dependent kinase 7	IC50	5 - 10	nM
1739	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CCC2(CCNC2)CC1	Cyclin-dependent kinase 7	IC50	5 - 10	nM
1740	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CC2(CNC2)C1	Cyclin-dependent kinase 7	IC50	5 - 10	nM
1741	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CCC2(CCCN2)CC1	Cyclin-dependent kinase 7	IC50	5	nM
1742	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CC2(C1)CCNCC2	Cyclin-dependent kinase 7	IC50	5	nM
1743	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CCCC11CCNC1	Cyclin-dependent kinase 7	IC50	5 - 10	nM
1744	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CCCC2(CCCNC2)C1	Cyclin-dependent kinase 7	IC50	10 - 25	nM
1745	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CCCC2(CCCCN2)C1	Cyclin-dependent kinase 7	IC50	10 - 25	nM
1746	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CCC2(CCCN2)C1	Cyclin-dependent kinase 7	IC50	5	nM
1747	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NN=NN3C)N2N=C1)N1CCC2(CCCN2)CC1	Cyclin-dependent kinase 7	IC50	5	nM
1748	CC(C)C1=C2N=C(O[C@@H]3CCCNC3)N=C(NCC3=C(CN4CCCC4=O)C=CC=C3)N2N=C1	Cyclin-dependent kinase 7	IC50	10 - 25	nM
1749	CC(C)C1=C2N=C(O[C@@H]3CCCNC3)N=C(NCC3=C(C=CC=C3)C(N)=O)N2N=C1	Cyclin-dependent kinase 7	IC50	5	nM
1750	CC(C)C1=C2N=C(O[C@@H]3CCCNC3)N=C(NCC3=C(OC4CCC4)C=CC=C3)N2N=C1	Cyclin-dependent kinase 7	IC50	25	nM
1751	CC(C)C1=C2N=C(O[C@@H]3CCCNC3)N=C(NCC3=CC=CC=C3OC3=NC=CC=C3)N2N=C1	Cyclin-dependent kinase 7	IC50	10 - 25	nM
1752	CC(C)C1=C2N=C(O[C@@H]3CCCNC3)N=C(NCC3=CC=CC=C3S(=O)(=O)N3CCOCC3)N2N=C1	Cyclin-dependent kinase 7	IC50	5	nM
1753	CC(C)C1=C2N=C(O[C@@H]3CCCNC3)N=C(NCC3=C(Br)C=CC=C3)N2N=C1	Cyclin-dependent kinase 7	IC50	5	nM
1754	CC(C)C1=C2N=C(O[C@@H]3CCCNC3)N=C(NCC3=C(Cl)C(Cl)=CC=C3)N2N=C1	Cyclin-dependent kinase 7	IC50	10 - 25	nM
1755	CC(C)NS(=O)(=O)C1=C(CNC2=NC(O[C@@H]3CCCNC3)=NC3=C(C=NN23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7	IC50	25	nM
1756	CC(C)C1=C2N=C(O[C@@H]3CCCNC3)N=C(NCC3=C(C=CC=C3)S(=O)(=O)N3CCCC3)N2N=C1	Cyclin-dependent kinase 7	IC50	5	nM
1757	CC(C)C1=C2N=C(O[C@@H]3CCCNC3)N=C(NCC3=C(C=CC=C3)S(=O)(=O)N3CCN(C)CC3)N2N=C1	Cyclin-dependent kinase 7	IC50	5	nM
1758	CNC(=O)C1=C(CNC2=NC(O[C@@H]3CCCNC3)=NC3=C(C=NN23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7	IC50	5	nM
1759	CC(C)C1=C2N=C(O[C@@H]3CCCNC3)N=C(NCC3=C(C=CC=C3)C(=O)NC(C)C#C)N2N=C1	Cyclin-dependent kinase 7	IC50	10 - 25	nM
1760	CCCNC(=O)NC1=C(CNC2=NC(O[C@@H]3CCCNC3)=NC3=C(C=NN23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7	IC50	5	nM
1761	CC(C)C1=C2N=C(O[C@@H]3CCCNC3)N=C(NCC3=CC=CC=C3NC(=O)NC3=CC=CC=C3)N2N=C1	Cyclin-dependent kinase 7	IC50	10 - 25	nM
1762	CC(C)C1=C2N=C(O[C@@H]3CCCNC3)N=C(NCC3=CC=CC=C3NC(=O)NC3CCCCC3)N2N=C1	Cyclin-dependent kinase 7	IC50	5 - 10	nM
1763	CC(C)C1=C2N=C(O[C@@H]3CCCNC3)N=C(NCC3=CC=CC=C3NC(=O)NCC3=CC=CC=C3)N2N=C1	Cyclin-dependent kinase 7	IC50	10 - 25	nM
1764	CCNC(=O)NC1=CC=CC=C1CNC1=NC(O[C@@H]2CCCNC2)=NC2=C(C=NN12)C(C)C	Cyclin-dependent kinase 7	IC50	5	nM
1765	CC(C)COC1=CC(C)=CC=C1CNC1=NC(O[C@@H]2CCCNC2)=NC2=C(C=NN12)C(C)C	Cyclin-dependent kinase 7	IC50	25	nM
1766	CC(C)C1=C2N=C(O[C@@H]3CCCNC3)N=C(NCC3=CC=CC4=C3OCCCO4)N2N=C1	Cyclin-dependent kinase 7	IC50	10 - 25	nM
1767	CC(C)C1=C2N=C(O[C@@H]3CCCNC3)N=C(NCC3=CC=CC=C3C3=CCCCC3)N2N=C1	Cyclin-dependent kinase 7	IC50	25	nM
1768	CSC1=CC=CC=C1CNC1=NC(O[C@@H]2CCCNC2)=NC2=C(C=NN12)C(C)C	Cyclin-dependent kinase 7	IC50	5 - 10	nM
1769	CC(C)C1=C2N=C(O[C@@H]3CCCNC3)N=C(NCC3=CC=CC=C3SC3CCCC3)N2N=C1	Cyclin-dependent kinase 7	IC50	25	nM
1770	CC(C)C1=C2N=C(OC3CNCC=C3)N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1	Cyclin-dependent kinase 7	IC50	5 - 10	nM
1771	CC(C)C1=C2N=C(OC3CNCCOC3)N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1	Cyclin-dependent kinase 7	IC50	10 - 25	nM
1772	CC(C)C1=C2N=C(OCCN3CCNCC3)N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1	Cyclin-dependent kinase 7	IC50	25	nM
1773	CC(C)C1=C2N=C(O[C@@H]3CCCNC3)N=C(NCC3=C(C=CC=C3)C3CCC3)N2N=C1	Cyclin-dependent kinase 7	IC50	10 - 25	nM
1774	CC(C)C1=C2N=C(O[C@@H]3CCCNC3)N=C(NCC3=C(C=CC=C3)C3CCCC3)N2N=C1	Cyclin-dependent kinase 7	IC50	25	nM
1775	CC(C)C1=C2N=C(O[C@@H]3CCCNC3)N=C(NCC3=C(C=CC=C3)C3CC3)N2N=C1	Cyclin-dependent kinase 7	IC50	10 - 25	nM
1776	CC(C)C1=C2N=C(O[C@@H]3CCCNC3)N=C(NCC3=C(OC(C)=O)C=CC=C3)N2N=C1	Cyclin-dependent kinase 7	IC50	10 - 25	nM
1777	CCNC(=O)OC1=C(CNC2=NC(O[C@@H]3CCCNC3)=NC3=C(C=NN23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7	IC50	10 - 25	nM
1778	CC(C)C1=C2N=C(O[C@@H]3CCCNC3)N=C(NCC3=C(OS(C)(=O)=O)C=CC=C3)N2N=C1	Cyclin-dependent kinase 7	IC50	5 - 10	nM
1779	CC(C)C1=C2N=C(O[C@@H]3CCCNC3)N=C(NCC3=C(OS(=O)C(C)(C)C)C=CC=C3)N2N=C1	Cyclin-dependent kinase 7	IC50	5	nM
1780	CC(C)COC(=O)OC1=C(CNC2=NC(O[C@@H]3CCCNC3)=NC3=C(C=NN23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7	IC50	10 - 25	nM
1781	CC(C)C1=C2N=C(O[C@@H]3CCCNC3)N=C(NCC3=CC=CC=C3N=S(C)(C)=O)N2N=C1	Cyclin-dependent kinase 7	IC50	5	nM
1782	CC(C)C1=C2N=C(O[C@@H]3CCCNC3)N=C(NCC3=CC=CC=C3S(C)=O)N2N=C1	Cyclin-dependent kinase 7	IC50	10 - 25	nM
1783	CC(C)C1=C2N=C(O[C@@H]3CCCNC3)N=C(NCC3=CC=CC=C3S(C)(=O)=O)N2N=C1	Cyclin-dependent kinase 7	IC50	5	nM
1784	CC(C)C1=C2N=C(O[C@@H]3CCCNC3)N=C(NCC3=CC=CC=C3S(=O)C3CCCC3)N2N=C1	Cyclin-dependent kinase 7	IC50	10 - 25	nM
1785	CC(C)C1=C2N=C(NCCN3CCCC3)N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1	Cyclin-dependent kinase 7	IC50	25	nM
1786	CC(C)C1=C2N=C(NC3CCNC3)N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1	Cyclin-dependent kinase 7	IC50	5 - 10	nM
1787	CC(C)C1=C2N=C(NCCCN3CCOCC3)N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1	Cyclin-dependent kinase 7	IC50	25	nM
1788	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N(C)CCN1CCCC1	Cyclin-dependent kinase 7	IC50	10 - 25	nM
1789	CC(C)C1=C2N=C(NCCN3CCOCC3)N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1	Cyclin-dependent kinase 7	IC50	25	nM
1790	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CC(C1)N1CCCC1=O	Cyclin-dependent kinase 7	IC50	25	nM
1791	CC(C)C1=C2N=C(NCCOCCN)N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1	Cyclin-dependent kinase 7	IC50	10 - 25	nM
1792	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N(C)CCCN1CCCCC1	Cyclin-dependent kinase 7	IC50	25	nM
1793	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CC2CCNC2C1	Cyclin-dependent kinase 7	IC50	10 - 25	nM
1794	CC(C)C1=C2N=C(NCCN)N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1	Cyclin-dependent kinase 7	IC50	5 - 10	nM
1795	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCCC(N)C1	Cyclin-dependent kinase 7	IC50	25	nM
1796	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)C1	Cyclin-dependent kinase 7	IC50	25	nM
1797	COC(=O)C(CN)NC1=NC2=C(C=NN2C(NCC2=CC=CC=C2N2C=CC=N2)=N1)C(C)C	Cyclin-dependent kinase 7	IC50	25	nM
1798	CC(C)C1=C2N=C(S[C@@H]3CCCNC3)N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1	Cyclin-dependent kinase 7	IC50	5	nM
1799	CC(C)C1=C2N=C(SC3CCNCC3)N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1	Cyclin-dependent kinase 7	IC50	10 - 25	nM
1800	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)C(=O)N(C)CCN1CCOCC1	Cyclin-dependent kinase 7	IC50	25	nM
1801	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)C(=O)N(C)CCN1CCCC1	Cyclin-dependent kinase 7	IC50	25	nM
1802	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)C(=O)N1CCNCC1	Cyclin-dependent kinase 7	IC50	25	nM
1803	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)C(=O)NCCCN	Cyclin-dependent kinase 7	IC50	25	nM
1804	CC(C)C1=C2N=C(CNCCCN3CCOCC3)N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1	Cyclin-dependent kinase 7	IC50	25	nM
1805	CC(C)C1=C2N=C(CN(C)CCN3CCCC3)N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1	Cyclin-dependent kinase 7	IC50	25	nM
1806	CC(C)C1=C2N=C(CNCCN3CCCC3)N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1	Cyclin-dependent kinase 7	IC50	25	nM
1807	CC(C)C1=C2N=C(CNCCN3CCOCC3)N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1	Cyclin-dependent kinase 7	IC50	25	nM
1808	CC(C)C1=C2N=C(CN(C)CCCN3CCCCC3)N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1	Cyclin-dependent kinase 7	IC50	25	nM
1809	CC(C)C1=C2N=C(CN3CC(C3)N3CCCC3=O)N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1	Cyclin-dependent kinase 7	IC50	25	nM
1810	COCCN1CCN(CC2=NC3=C(C=NN3C(NCC3=CC=CC=C3N3C=CC=N3)=N2)C(C)C)CC1	Cyclin-dependent kinase 7	IC50	25	nM
1811	COC1=CC=C(NC(=S)NC(=O)C2=CN(N=C2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	1876	nM
1812	COC1=CC=C(NC(=S)NC(=O)C2=CN(N=C2C2=CC=C(C)C=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	1788	nM
1813	COC1=CC=C(NC(=S)NC(=O)C2=CN(N=C2C2=CC=C(Cl)C=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	1645	nM
1814	COC1=CC=C(NC(=S)NC(=O)C2=CN(N=C2C2=CC=C(F)C=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	1642	nM
1815	COC1=CC=C(NC(=S)NC(=O)C2=CN(N=C2C2=CC=C(OC)C=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	1423	nM
1816	Cl.CC1=C(SC(N)=N1)C1=NC(NC2=CC(=CC=C2)N(=O)=O)=NC=C1	Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	Ki (inhibition constant)	70	nM
1817	Cl.O=C1NC(=O)C2=C1C1=CN(CCCCC(=O)CCCCN3C=C2C2=CC=CN=C32)C2=NC=CC=C12	Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	inhibition percentage	14	%
1818	Cl.OC1CCCCN2C=C(C3=CC=CN=C23)C2=C(C(=O)NC2=O)C2=CN(CCCC1)C1=NC=CC=C21	Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	inhibition percentage	9	%
1819	OCCCN1C=C(C2=CC=CN=C12)C1=C(C(=O)NC1=O)C1=CC(=CC(Cl)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	inhibition percentage	41	%
1820	COC1=CC(C)=CC=C1C1=NC=NC(NC2=CC(CS(N)(=O)=O)=CC=C2)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	10000	nM
1821		Cyclin-dependent kinase 7;+Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	97	nM
1822		Cyclin-dependent kinase 7;+Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	180	nM
1823	COC1=C(Cl)C=C(Cl)C(NC2=C(C=NC3=CC(OCCCN4CCN(CCCCN)CC4)=C(OC)C=C23)C#N)=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	26	%
1824	COC1=C(Cl)C=C(Cl)C(NC2=C(C=NC3=CC(OCCCN4CCN(CCCCN)CC4)=C(OC)C=C23)C#N)=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	74	%
1825	CCN1C(SC(CNC2=CC(CCN3CCCC3)=CC=C2)C1=O)C(C#N)C(=O)NCC(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	inhibition percentage	45	%
1826	Cl.CC(C)N(CCC(=O)C1=CC2C=CC=CC2C=C1)CC1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	2.04	%
1827	Cl.C[C@@H]1CN(CCCN1S(=O)(=O)C1=C2C(C)=CN=CC2=CC=C1)C(=O)CN	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	2.04	%
1828		Cyclin-dependent kinase 7 [human];+Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	IC50	0.5	µM
1829		Cyclin-dependent kinase 7 [human];+Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	IC50	0.55	µM
1830		Cyclin-dependent kinase 7 [human];+Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	IC50	1.3	µM
1831		Cyclin-dependent kinase 7 [human];+Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	IC50	0.69	µM
1832		Cyclin-dependent kinase 7 [human];+Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	IC50	2.6	µM
1833		Cyclin-dependent kinase 7 [human];+Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	IC50	0.39	µM
1834		Cyclin-dependent kinase 7 [human];+Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	IC50	1.1	µM
1835		Cyclin-dependent kinase 7 [human];+Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	IC50	1.5	µM
1836		Cyclin-dependent kinase 7 [human];+Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	IC50	2.2	µM
1837		Cyclin-dependent kinase 7 [human];+Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	IC50	3.5	µM
1838		Cyclin-dependent kinase 7 [human];+Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	IC50	1.6	µM
1839		Cyclin-dependent kinase 7 [human];+Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	IC50	3.5	µM
1840		Cyclin-dependent kinase 7 [human];+Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	IC50	4.4	µM
1841		Cyclin-dependent kinase 7 [human];+Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	IC50	3	µM
1842		Cyclin-dependent kinase 7 [human];+Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	IC50	1.1	µM
1843		Cyclin-dependent kinase 7 [human];+Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	IC50	1.2	µM
1844		Cyclin-dependent kinase 7 [human];+Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	IC50	3.7	µM
1845		Cyclin-dependent kinase 7 [human];+Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	IC50	4.3	µM
1846		Cyclin-dependent kinase 7 [human];+Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	IC50	1.2	µM
1847		Cyclin-dependent kinase 7 [human];+Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	IC50	2.6	µM
1848		Cyclin-dependent kinase 7 [human];+Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	IC50	3.9	µM
1849		Cyclin-dependent kinase 7 [human];+Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	IC50	3.3	µM
1850		Cyclin-dependent kinase 7 [human];+Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	IC50	2.4	µM
1851		Cyclin-dependent kinase 7 [human];+Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	IC50	5.8	µM
1852		Cyclin-dependent kinase 7;+Cyclin-H	IC50	1.1	µM
1853		Cyclin-dependent kinase 7;+Cyclin-H	IC50	1.1	µM
1854		Cyclin-dependent kinase 7;+Cyclin-H	IC50	1.2	µM
1855		Cyclin-dependent kinase 7;+Cyclin-H	IC50	4.4	µM
1856		Cyclin-dependent kinase 7;+Cyclin-H	IC50	3	µM
1857		Cyclin-dependent kinase 7;+Cyclin-H	IC50	3.7	µM
1858		Cyclin-dependent kinase 7;+Cyclin-H	IC50	4.3	µM
1859	CCN(CC)CCNC(=O)C1=CC=C(C=C1)N1N=NC2=CN=C(NC3=CC=C(C=C3)C3=NN=NN3)N=C12	Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	inhibition percentage	42.71	%
1860	C1CCC(C1)N1N=NC2=CN=C(NC3=CC=C(C=C3)C3=NN=NN3)N=C12	Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	inhibition percentage	44.25	%
1861	CCN(CC)CCNC(=O)C1=CC=C(NC2=NC=C3N=NN([C@@H](CO)[C@@H](C)C4=CC=CC=C4)C3=N2)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	inhibition percentage	21	%
1862		Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	IC50	6.6715	µM
1863	[H+].CC(C)C1=C2N=C(NCC3CCC(CN)CC3)C=C(NCC3=C(F)C=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	19	%
1864	[H+].CC(C)C1=C2N=C(NCC3CCC(CN)CC3)C=C(NCC3=C(F)C=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	1000	nM
1865	CC(C)C1=C2N=C(N[C@H]3CC[C@H](N)CC3)C=C(NCC3=C(F)C=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	6	nM
1866	CC(C)C1=C2N=C(N[C@H]3CC[C@H](N)CC3)C=C(NCC3=C(F)C=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	46	%
1867	CC(C)C1=C2N=C(N[C@H]3CC[C@H](N)CC3)C=C(NCC3=C(F)C=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	48	nM
1868	CC(C)C1=C2N=C(NCC\C=C\CCN)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	79	%
1869	CC(C)C1=C2N=C(NCC\C=C\CCN)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	963	nM
1870	CC(C)C1=C2N=C(N[C@H]3CC[C@@H](CC3)NC3=NC4=C(C=NN4C(NCC4=CC=CC=C4)=C3)C(C)C)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	1	%
1871	CC(C)C1=C2N=C(N[C@H]3CC[C@@H](CC3)NC3=NC4=C(C=NN4C(NCC4=CC=CC=C4)=C3)C(C)C)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	43	nM
1872		Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	IC50	1.2	µM
1873		Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	IC50	2.6	µM
1874		Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	IC50	3.9	µM
1875		Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	IC50	3.3	µM
1876		Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	IC50	2.4	µM
1877		Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	IC50	5.8	µM
1878	CCNC1=NC(C)=C(S1)C1=NC(NC2=CC(=C(C)C=C2)S(=O)(=O)N2CCOCC2)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.9	
1879	CCNC1=NC(C)=C(S1)C1=NC(NCC2=CC=CN=C2)=NC=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	pIC50	5.2	
1880	CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=C(C=CC=C3)C3=C4CNC(=O)C4=C4C5=C(C=CC=C5)N2C4=C13)N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	inhibition percentage	0	%
1881	CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=C(C=CC=C3)C3=C4CNC(=O)C4=C4C5=C(C=CC=C5)N2C4=C13)N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]1CSSC[C@H](NC(=O)CNC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC1=O)[C@@H](C)O)C(C)C)C(=O)NCC(N)=O	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	inhibition percentage	26	%
1882	CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=C(C=CC=C3)C3=C4CNC(=O)C4=C4C5=C(C=CC=C5)N2C4=C13)N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]1CNC(=O)C[C@H](NC(=O)CNC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC1=O)[C@@H](C)O)C(C)C)C(N)=O	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	inhibition percentage	2	%
1883	COC(=O)C1=C[C-](C=C1)[Ru@]1(C#[O+])N2C3=C(C4=C2C(Br)=CC(O)=C4)C2=C(C(=O)NC2=O)C2=CC=C[N+]1=C32	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	1	%
1884	Cl[Ir+3]123(Cl)N4C5=C(C=CC=C5)C5=C4C4=C(C=CC=[N+]14)C1=C5C(=O)NC1=O.C1CC2=CCCC=C31	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	7	%
1885	C[Ir+3]123(Cl)N4C5=C(C=CC=C5)C5=C4C4=C(C=CC=[N+]14)C1=C5C(=O)NC1=O.C1CC2=CCCC=C31	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	32	%
1886	NS(=O)(=O)C1=CC=C(NC2=NC(NCC#N)=C(Br)C=N2)C=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	80 - 89	%
1887	CCCCOCC(O)CNCCNS(=O)(=O)C1=CC=C(NC2=NC(NCC#N)=C(Br)C=N2)C=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	90 - 95	%
1888	OC=O.CN(C)CCCC1=CN=C(C)C(NC2=NC3=C(CC(=S)NC4=C3C=CC(Cl)=C4)C=N2)=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	inhibition percentage	68	%
1889	CN(C)S(=O)(=O)C1=CC=C(NC2=CC(N[C@H]3CC[C@H](N)CC3)=NC3=C(C=NN23)C(C)(C)C)C=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	0.177	µM
1890	CC1=C(SC=N1)C1=NC(NC2=CN=C(Cl)C=C2)=NC=C1	Cyclin-dependent kinase 7;+Cyclin-H	Ki (inhibition constant)	7.2	µM
1891	CC1=C(SC=N1)C1=NC(NC2=CN=C(C=C2)N2CCCC2)=NC=C1	Cyclin-dependent kinase 7;+Cyclin-H	Ki (inhibition constant)	0.73	µM
1892	C1CN(CCO1)[C@H]1CC[C@@H](CC1)C1=CN=C2NC=C(C3=CN=CS3)C2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	95	%
1893	FC(F)(F)C1=CSC(=N1)C1=CNC2=NC=C(C=C12)[C@H]1CC[C@@H](CC1)N1CCOCC1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	43	%
1894	FC(F)(F)C1=CSC(=N1)C1=CNC2=NC=C(C=C12)[C@@H]1CC[C@@H](CC1)N1CCOCC1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	45	%
1895	Cl.CN1C=C(C=N1)C1=CNC2=NC=C(C=C12)[C@H]1CC[C@@H](CC1)N1CCOCC1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	86	%
1896	CN1C=C(C=N1)C1=CNC2=NC=C(C=C12)[C@@H]1CC[C@@H](CC1)N1CCOCC1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	55	%
1897	CN1C=C(C=N1)C1=CNC2=NC=C(C=C12)[C@H]1CC[C@@H](CC1)N1CCN(C)CC1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	89	%
1898	CN1C=C(C=N1)C1=CNC2=NC=C(C=C12)[C@@H]1CC[C@@H](CC1)N1CCN(C)CC1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	79	%
1899	CN1C=C(C=N1)C1=CNC2=NC=C(C=C12)[C@@H]1CC[C@@H](CC1)N1CCCOCC1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	68	%
1900	CN1C=C(C=N1)C1=CNC2=NC=C(C=C12)[C@H]1CC[C@@H](CC1)N1CCCOCC1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	88	%
1901	FC(F)N1C=C(C=N1)C1=CNC2=NC=C(C=C12)[C@H]1CC[C@@H](CC1)N1CCOCC1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	95	%
1902	CC1=CC=C(NC(=O)C2=CC=C(CNC(=O)CCl)C=C2)C=C1NC1=NC(=CC=N1)C1=CC=CN=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	inhibition percentage	14	%
1903	O=C(CC1=CC2=C(C=C(N2)C2=NNC3=CC=CN=C23)C=C1)C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	38	%
1904	O=C(CC1=CC2=C(C=C(N2)C2=NNC3=CC=CN=C23)C=C1)C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	89	%
1905	OC(=O)C(F)(F)F.COC1=CC(=CC=C1NC1=NC2=C(NC(=O)C[C@@H]3CCCN23)C=N1)N1CCN(C)CC1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	inhibition percentage		
1906	OC(=O)C(F)(F)F.COC1=CC(=CC=C1NC1=NC2=C(NC(=O)C3=C(C=CC=C3)N2C)C=N1)N1CCN(C)CC1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	inhibition percentage		
1907	NC(=O)C1=CC=C(C=C1)C1=CNC2=NC=CC(Cl)=C12	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	6.2	
1908	NC1CCCCC1NC1=NC=CC(=N1)C1=CNC2=NC=CC=C12	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	8.2	
1909	CC(C)(C)NC1=C2C(NC=C2C2=CC=CC=C2)=NC=N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1910	CC(C)(CN)CNC1=CC(=CC(F)=N1)C1=CNC2=NC=CC=C12	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	6.4	
1911	CNCC(=O)N[C@H]1CC[C@@H](CC1)NC1=NC(Cl)=CC(=N1)C1=CNC2=NC=CC=C12	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	7.4	
1912	COC1=CC=C(CNC2=CC(=CC(F)=N2)C2=CNC3=NC=CC=C23)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	6.8	
1913	ClC1=CC(=NC=N1)C1=CNC2=NC=CC=C12	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.7	
1914	OC1CCCC(C1)NC1=CC(Cl)=NC(=N1)C1=CNC2=NC=CC=C12	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1915	CS(=O)(=O)N[C@H]1CC[C@@H](CC1)NC1=CC(Cl)=NC(=N1)C1=CNC2=NC=CC=C12	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1916	NC1=C(C=NC2=C(C=NN12)C1=CC=C2OCOC2=C1)C1=CC=C(NC(=O)NC2=CC=CC(=C2)C(F)(F)F)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1917	CCN(CC)CCCNC(=O)C1=C2SC=C(C2=C(N)N=C1)C1=CC=C(NC(=O)NC2=CC=CC(C)=C2)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	6.4	
1918	CC1=CC=C(F)C(NC(=O)NC2=CC=C(C=C2)C2=COC3=C(C=NC(N)=C23)C#CCN2CCOCC2)=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1919	NC1=C2N=CC=NC2=CC=C1C1=CC=C(NC(=O)NC2=CC=CC(=C2)C(F)(F)F)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1920	CN1CCN(CC1)C1=CC=C(NC2=NC=C(Cl)C(NC3=CC=C4NN=CC4=C3)=N2)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	7.1	
1921	OC1=C(Br)C=C(\C=N\NC(=O)NC2=CC=CC=C2)C=C1Br	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.5	
1922	FC1=CC=CC(NC(=O)NC2=CC=C(C=C2)C2=CC=C3C=NNC3=C2)=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1923	CC1=CC(=O)NN=C1C1=CC=C(NC(=O)NC2=CC(=CC=C2F)C(F)(F)F)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1924	FC(F)(F)C1=CC=CC(NC(=O)NC2=CC=C(C=C2)C2=NNC(=O)C=C2)=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1925	FC1=CC=CC(NC(=O)NC2=CC=CC(=C2)C2=CC=C3C=NNC3=C2)=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1926	N[C@H](COC1=CN=CC(=C1)C1=CC=C(N)C(=C1)C(=O)C1=CC=CC=C1)CC1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.8	
1927	CN(C)C1=C2C(NN=C2N)=CC(=C1)C1=CC=NC=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	6.7	
1928	COC1=CC=C(C=C1OC)C(=O)NC1=NNC2=CC=C(C=C12)C1=CN(CC2=CC=CC=C2)N=N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	6.9	
1929	FC1=CC=C(F)C(=C1)C(=O)NC1=NNC2=CC=C(C=C12)C1=CN(CC2=CC=CC=C2)N=N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	6.7	
1930	NC(=O)C1=CC=C(C=C1N1CCCC1)C1=CC=NC=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.6	
1931	N#CC1=CC=C(C=C1NCC1=CC=CC=C1)C1=CC=NC=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1932	O=C1NCC2=C1C=CC=C2C1=CC=CS1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	4.1	
1933	CCCOC1=CC=CC(=C1)[C@@H](C)NC(=O)C1=CC=C(C=C1)C1=CC=NC=C1F	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1934	COC1=CC=CC(CNC(=O)C2=CN=C(N=C2)C2=CC=NC=C2)=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1935	CN1C=C(NC2=NC=C(Br)C(NC3=CC=CC=C3C(N)=O)=N2)C=N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	8.5	
1936	CN1C=C(NC2=NC=C(Cl)C(NC3=CC=CC=C3C(N)=O)=N2)C=N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	8.2	
1937	NC(=O)C1=CC=CC=C1NC1=NC(NC2=CC=CC=C2)=NC=C1C(F)(F)F	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	8.3	
1938	OC(=O)C1=CC=CC=C1NC1=NC=NC(NC2=CC=C(F)C=C2)=N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1939	OC(=O)C1=CC=CC=C1NC1=NC=NC(NC2=CC=C3C=NNC3=C2)=N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.8	
1940	OC(=O)C1=CC=CC=C1NC1=NC=NC(NC2=CC=CC(F)=C2)=N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.8	
1941	CCCNC(=O)C1=CC=C(NC2=NC(CC)=C3C=CNC3=N2)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1942	CCCNC(=O)C1=CC=C(NC2=NC(CCC(F)(F)F)=C3C=CNC3=N2)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1943	NC1=NC=NC2=C1C(=O)NC1=CC=CC=C1N2	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	4.5	
1944	COC1=CC(=CC=C1O)C1=CC=C2C(NC3=C(O)C=CC=C3NC2=O)=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1945	COC1=CC(=CC=C1O)C1=CC=C2C(NC3=CC=C(C=C3NC2=O)C(=O)NCC2=CC=CC(F)=C2)=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.8	
1946	ClC1=CC(NC2=NC(NC3CC3)=C3SC=CC3=N2)=CC=C1N1CCOCC1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.5	
1947	FC1=CC=C(C=C1)C(=O)NC1=CC=CC(=C1)C1NC2=CC=C3C=CC=CC3=C2C2C=CCC12	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.9	
1948	CN1C(=CC2=CC=CC=C12)C(=O)NC1=CC=C(C=C1)C1=NN(C2CCC(CC2)N2CCN(CC2)C(C)=O)C2=NC=NC(N)=C12	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.8	
1949	COCC#CC1=CC=CC2=C1CC1=C2NN=C1C1=CC=CS1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1950	CC(NC1=CN=CC(=N1)N1C=NC2=CC=C(C=C12)C#N)C1=CC=CC=C1F	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	7.5	
1951	NC1=NC2=CC=C(C=C2N1C1=NC=CS1)C#N	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1952	NC1=NC2=CC=C(C=C2N1C1=NC2=C(CCCC2)S1)C#N	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1953	COCCN(C)C(=O)C1=CC=CC(=C1)N1N=C(C=C1NC(=O)NC1=C2C=CC=CC2=CC=C1)C(C)(C)C	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1954	CC(C)(C)C1=NN(C(NC(=O)C(=O)C2=C3C=CC=CC3=CC=C2)=C1)C1=CC=C(OCC(N)=O)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1955	CN(C)CCCN(C)C(=O)C1=CC=CC(=C1)N1N=C(C=C1NC(=O)NC1=C2C=CC=CC2=CC=C1)C(C)(C)C	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1956	CC(C)(C)C1=NN(C(NC(=O)C(=O)C2=C3C=CC=CC3=CC=C2)=C1)C1=CC=CC(OCC(O)=O)=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1957	CC(C)(C)C1=NN(C(NC(=O)C(=O)C2=C3C=CC=CC3=CC=C2)=C1)C1=CC=CC(OCC(=O)NCCO)=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1958	CC(C)(C)C1=NN(C(NC(=O)C(=O)C2=C3C=CC=CC3=CC=C2)=C1)C1=CC=C(OCC(O)=O)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1959	CC(C)(C)C1=NN(C(NC(=O)C(=O)C2=C3C=CC=CC3=CC=C2)=C1)C1=CC=C(OCCC(O)=O)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1960	CC(C)(C)C1=NN(C(NC(=O)NC2=C3C=CC=CC3=CC=C2)=C1)C1=CC=CC(=C1)C(=O)NCCCCC(O)=O	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1961	CN1C=C(C2=CC3=NC(Br)=CN=C3N2)C2=CC(F)=CC=C12	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	7.2	
1962	CN1C=C(C2=CC3=NC(Br)=CN=C3N2)C2=CC=CC=C12	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	6.3	
1963	FC(F)(F)C1=CC=CC(NC(=O)NC2=C3C=CC(Cl)=CC3=NC=C2)=N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1964	FC(F)(F)C1=CC=CC(NC(=O)NC2=C3C=C(Cl)C=CC3=NC=C2)=N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1965	FC(F)(F)C1=CC=C2C(NC(=O)NC3=CC=CC(=N3)C#N)=CC=NC2=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1966	OC1=C2C=CC=C(NC(=O)NC3=CN=CC=N3)C2=CC=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1967	FC(F)OC1=CC=C2C(NC(=O)NC3=CC=CC(=N3)C(F)(F)F)=CC=NC2=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1968	CCC1=CC=C2C(NC(=O)NC3=CC=CC(=N3)C(F)(F)F)=CC=NC2=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1969	FC1=C(F)C=C2C(NC(=O)NC3=CC=CC(=N3)C(F)(F)F)=CC=NC2=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1970	FC1=C2N=CC=C(NC(=O)NC3=CC=CC(=N3)C(F)(F)F)C2=C(F)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1971	OC(=O)C1=CC=C2C=C(NC(=O)NC3=CN=C(C=N3)C#N)C=CC2=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.8	
1972	CC#CC1=CC=C2N=CC=C(NC(=O)NC3=CC=CC(=N3)C(F)(F)F)C2=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1973	CCCC1=CC=C2N=CC=C(NC(=O)NC3=CC=CC(=N3)C(F)(F)F)C2=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1974	CC(C)(C)C1=CC=C2N=C(NC2=C1)C1=NNC2=CC=CC=C12	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	6.7	
1975	CCCCN(CCC#N)C(=O)C1=CC=C2N=C(NC2=C1)C1=NNC2=CC=CC=C12	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	6.2	
1976	COC1=CC=CC(=C1)[C@@H](C)NC(=O)C1=CN=C(N=C1)C1=CC=NC=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1977	COC1=CC=CC(=C1)[C@@H](C)NC(=O)C1=C(C)N=C(S1)C1=CC=NC=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1978	COC1=CC=CC(=C1)[C@@H](C)NC(=O)C1=C(C)N=C(S1)C1=CC=NC=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1979	CC[C@@H]1C[C@@H](C[C@@H]1C1=NC=C2C=NC3=C(C=CN3)N12)NS(=O)(=O)C1CC1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1980	ON=C(C1=NC2=CC=CC=C2N1)C1=NC2=CC=CC=C2N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.5	
1981	CCOC(=O)CC1=NC2=C(N)C=CC=C2N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1982	CC(C)NC1=NC=CC(NC2=NC=C(S2)C2=CC=CC=C2)=N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.8	
1983	CC(C)NC1=NC=C(Br)C(NC2=NC=C(C)S2)=N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	6.7	
1984	CC(C)C(C)NC1=NC=C(Cl)C(NC2=NC=CS2)=N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	6	
1985	CCOC(=O)CC1=NN2C(=N1)C1=CC(Br)=CC=C1NC2=O	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.5	
1986	NC1=C2C(=CN(C3CCCC3)C2=NC=N1)C#C	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.8	
1987	CCCNC(=O)C1=CC=C(NC2=NC(NCC(F)(F)F)=C3SC=CC3=N2)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1988	CC1=CC=CC(=C1)C1=C2C(ON=C2N)=CC=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	4.3	
1989	CC(C)CC1=C2C=CNC2=NC(NC2=CC=C(N3CCOCC3)C(Cl)=C2)=N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1990	CCC1=C2C=CNC2=NC(NC2=CC=C(N3CCOCC3)C(Cl)=C2)=N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1991	O\N=C1/C2=CC=CC=C2C2=CC=C(NS(=O)(=O)C3=CC=CC(Br)=C3)C=C12	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1992	NC1=NNC2=CC=CC(=C12)C1=CC=C(F)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	4.7	
1993	CCCC(=O)NC1=NNC2=CC=C(C=C12)C1=CC=CC(F)=C1F	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.8	
1994	CCOCC(C)OC1=C2C(N)=NNC2=CC=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1995	CN(C)C1=CC=C(NC(=O)CC2NC3=CC=CC=C3NC2=O)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1996	CS(=O)(=O)C1=CC=CC(=C1)C(=O)NC1=NC2=CC=CC=C2N1CCCO	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1997	NCC1=CC(NC2=NC=NC(=N2)C2=CC=CC=C2)=CC=C1O	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
1998	CN(CC1=C2C=CC=NC2=C(O)C(Cl)=C1)C1CCCCC1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.7	
1999	C1OC2=CC=C(C=C2O1)C1=C2C=CNC2=NC=N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.3	
2000	CC(C)OC1=NNC(=O)\C1=C\C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.8	
2001	FC(F)(F)C1=CC=C(Cl)C(NC(=O)CCC(=O)N\N=C/C2=CNC3=CC=CC=C23)=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
2002	CC1=CC=NC(NC2=CC(C)=NC(=N2)C2=CC=CC=C2)=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	6.6	
2003	CC(C)(C1=CC(Br)=C(O)C(I)=C1)C1=CC(Br)=C(O)C(I)=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
2004	OC1=CC=C2N=C(NC2=C1)C1=CC=C(SC2=CC=C(C=C2)C2=NC3=CC=C(O)C=C3N2)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
2005	COC(=O)C1=C(N)N=C2C=CC=CN12	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	4.2	
2006	CCOC1=CC=C(\C=C2\SC(=N)NC2=O)C(O)=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
2007	COC1=CC=C(\C=C2\S\C(NC2=O)=N\C2=CC=CC=C2)C=C1O	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.8	
2008	CC(=O)C1=CC=CC=C1C1=C2C=CNC2=NC=N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	4.2	
2009	CC1=CC(=CC=C1F)C1=C2C=CNC2=NC=N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.2	
2010	CC1=NC2=C(SC3=C(Br)C=CC(Cl)=C23)C(=O)O1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.8	
2011	BrC1=CC=C(\C=C\C(=O)NC2=C3C=CN=CC3=CC=C2)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.8	
2012	CC1=CC=C(C)C(NC(=O)C2=C3C=CC=CC3=NC(=C2)C2=CC=CO2)=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
2013	CCOC(=O)C1=C2S\C(=C\C3=CC=CO3)C(=O)N2C(N)=C(C#N)C1C1=CC=CO1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.8	
2014	CCC1=C(NC2=NC=CN=C12)C1=CC=C(C=C1)C(C)=O	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.5	
2015	FC(F)SC1=CC=C(NC(=O)CC2=CC=C(C=C2)C2=CC=CN=C2)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	6.7	
2016	CC1=CC(=O)NN=C1C1=CC=C(NC(=O)NC2=CC(=CC=C2F)C(F)(F)F)C(Cl)=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
2017	OC1=C2N=C(NC(=O)NC3=CC=CC=C3C3=CC=CC=C3)SC2=CC=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
2018	COC1=CC=C(C=C1OC)C1=NNC2=C3C(=CC=C2)C(OC)=CC=C13	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
2019	CN1C2=CC=C(N)C=C2C(C2=CC=CC=C2)C2=CC(N)=CC=C12	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	6	
2020	NC[C@@H](O)[C@@H](O)CN1C=C(I)C2=C(N)N=CN=C12	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.8	
2021	CN(C)C1=CC=C(NC2=NNC(=C2)C2=CSC(Br)=C2)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
2022	NC1=NC=C2C=CC=C(N12)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	4.1	
2023	COC1=CC=CC(OC)=C1CNC1=C2C=C(Cl)C=CC2=NC(NC2CCCCC2)=N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.7	
2024	NC1=NC=NC2=C1C(=O)NCCN2	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	4.2	
2025	FC1=CC(CN2C=C(C3=CC=NC=C23)C2=CC=C3C(NC4=CC=C(CCOC5=CC=C(C=C5)N5CCOCC5)C=C4NC3=O)=C2)=CC(F)=C1F	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
2026	CCCCNC1=NC(N)=C(S1)C(=O)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
2027	O=C1NNC2=CC=CC(=C12)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5	
2028	CC1=CC=C(NCC2=CC=C(N=C2)C2=CC=C(F)C=C2)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
2029	CC(C)C1=CC=C2C(NC3=NC=CC(C)=C3C2=O)=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	6.6	
2030	CC(C)C1=CC(=O)NC2=C1C(=O)NN2	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	4.3	
2031	FC(F)(F)OC1=CC=C(CC(=O)N2CCC3(CC2)NCCC2=C3NC3=CC=CC=C23)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
2032	OC(=O)C1=CSC2=C1NCCNC2=O	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	4.4	
2033	CC1=CC(NC2=NC(Cl)=CC(NCC3=CC=CC=C3)=N2)=NN1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.6	
2034	CC1=CN2CC(=O)NN=C2C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	4.1	
2035	CC1=CC=C(NC2=NC3=CC=C(C=C3N2)N(=O)=O)N=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	6.7	
2036	CC(C)CON1C2=C(C(C)=NN2C)C(=O)C2=CC(Cl)=CC=C12	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
2037	CCC(=O)NC1=CC=C(C(=O)N2CCNCC2)C(O)=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	6.2	
2038	NC1=NOC2=CC=CC(=C12)C1=CC=CC(O)=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	4.7	
2039	O\N=C1\C=C(OC2=C(CC=C)C=CC=C12)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
2040	NC1=NNC2=C1SC(Cl)=N2	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	4.4	
2041	OC1=CN=C2C=CC(=CC2=C1)C1=CC=NC=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
2042	CCOC(=O)C1=C(C)N(C2=C1C=C(O)C1=CC=CC=C21)C1=CC=C(I)C=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
2043	CC(=O)NC1=CC=C(C=C1)N1N=C2C=CC(N)=NC2=N1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.6	
2044	ClC1=CC(Cl)=C2NC3=C(CN(CC3)C(=O)NC3=CC=C(C=C3)N(=O)=O)C2=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
2045	NC1=NN=C2C=NC=C(Cl)N12	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	4.5	
2046	CCN1C2=CC(N)=CC=C2C2=CC=C(N)C=C2C1(O)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
2047	NC(=O)C1=CN2C=C(N=C2C=C1)C1=CC=C(O1)N(=O)=O	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	6.2	
2048	CN1C=C(C2=CC3=NC(Br)=CN=C3N2)C2=CC(=CC=C12)C#N	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	6.6	
2049	BrC1=CC=C2C=NC(NC3=CC=NC=N3)=CC2=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	pKi	5.4	
2050	F[C@H]1C[C@H](N(C1)C1=NN2C=CC=C2C(NC2=NNC(=C2)C2CC2)=N1)C(=O)NC1=CC=CN=C1	Cyclin-dependent kinase 7 [human];+Cyclin [human];+Cyclin-dependent kinase 7 [human];+Cyclin [human]	inhibition percentage	99.2	%
2051	CC(C)(C)OC1=CC=C(C=C1)C(=O)C1=C(N)C(C#N)=C2C=CC=CN12	Cyclin-dependent kinase 7 [Candida albicans]	Ki (inhibition constant)	1.5	µM
2052	CCOC(=O)C1=CC=C(NC2=C3N=CNC3=NC(N[C@H]3CC[C@H](N)CC3)=N2)C=C1	Cyclin-dependent kinase 7 [Candida albicans]	IC50	0.5	µM
2053	Cl.N[C@H]1CC[C@@H](CC1)NC1=NC(NC2=CC=CC=C2)=C2N=CNC2=N1	Cyclin-dependent kinase 7 [Candida albicans]	IC50	2.5	µM
2054	CCOC(=O)C1=CC=CC(NC2=C3N=CNC3=NC(N[C@H]3CC[C@H](N)CC3)=N2)=C1	Cyclin-dependent kinase 7 [Candida albicans]	IC50	2	µM
2055	N[C@H]1CC[C@@H](CC1)NC1=NC(NC2=CC(Cl)=C(Cl)C=C2)=C2N=CNC2=N1	Cyclin-dependent kinase 7 [Candida albicans]	IC50	2.9	µM
2056	CCCCOC(=O)C1=CC=C(NC2=C3N=CNC3=NC(N[C@H]3CC[C@H](N)CC3)=N2)C=C1	Cyclin-dependent kinase 7 [Candida albicans]	IC50	5.6	µM
2057	CCN(CC)CCOC(=O)C1=CC=C(NC2=C3N=CNC3=NC(N[C@H]3CC[C@H](N)CC3)=N2)C=C1	Cyclin-dependent kinase 7 [Candida albicans]	IC50	4.3	µM
2058	N[C@H]1CC[C@@H](CC1)NC1=NC(NC2=CC=C(C=C2)C(=O)NC2=CC=CC=C2)=C2N=CNC2=N1	Cyclin-dependent kinase 7 [Candida albicans]	IC50	3.8	µM
2059		Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	IC50	1.1	µM
2060		Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	IC50	1.5	µM
2061		Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	IC50	2.2	µM
2062		Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	IC50	3.5	µM
2063		Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	IC50	1.6	µM
2064		Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	IC50	3.5	µM
2065	Cl.COC1=CC(F)=CC=C1C1=CC(NC(=O)[C@H]2CCC[C@H](C2)NC(C)=O)=NC=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	5000	nM
2066	COC1=CC=C(C=C1)N1N=NC2=C1N=C(CC1CCCCC1)N=C2N(C)CCN(C)[C@@H]1[C@@H](O)CC2=C1C=CC=C2	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage		
2067	CCCN([C@@H]1CCC[C@H]1N(C)C)C1=NC(CC2CCCCC2)=NC2=C1N=NN2C1=CC=C(OC)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage		
2068	COC1=CC=C(C=C1)N1N=NC2=C1N=C(CC1CCCCC1)N=C2NC[C@H](C)O	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage		
2069	COC1=CC=C(C=C1)N1N=NC2=C1N=C(CC1CCCCC1)N=C2N(C)[C@@H]1COC[C@H]1N(C)C	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage		
2070	COC1=CC=C(C=C1)N1N=NC2=C1N=C(CC1CCCCC1)N=C2N1CCCC(O)C1	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage		
2071	COC1=CC=C(C=C1)N1N=NC2=C1N=C(CC1CCCCC1)N=C2N1CCCC(CO)C1	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage		
2072	COC1=CC=C(C=C1)N1N=NC2=C1N=C(CC1CCCCC1)N=C2N(C)C(CN1CCCCC1)C1=CC=CC=C1	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage		
2073	COC1=CC=C(C=C1)N1N=NC2=C1N=C(CC1CCCCC1)N=C2NC(C)C	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage		
2074	CCC(CC)NC1=NC(CC2CCCCC2)=NC2=C1N=NN2C1=CC=C(OC)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage		
2075	COC1=CC=C(C=C1)N1N=NC2=C1N=C(CC1CCCCC1)N=C2NC(CN1N=C(C)C=C1C)CC1=CC=CC=C1	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage		
2076	COC1=CC=C(C=C1)N1N=NC2=C1N=C(CC1CCCCC1)N=C2N1CC(C1)N1CCN(CC1)C1=CC=CC=N1	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage		
2077	COC1=CC=C(C=C1)N1N=NC2=C1N=C(CC1CCCCC1)N=C2N[C@H](CO)CC(C)C	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage		
2078	CNC1=NC(C)=C(S1)C1=C(F)C=NC(NC2=CC(=CC=C2)N2CCCNCC2)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	Ki (inhibition constant)	111	nM
2079	CC(=O)N1CCN(CC1)C1=CC(NC2=NC(C3=C(C)N=C(N)S3)=C(F)C=N2)=CC=C1	Cyclin-dependent kinase 7;+Cyclin-H	Ki (inhibition constant)	1457	nM
2080	CNC1=NC(C)=C(S1)C1=C(F)C=NC(NC2=CC(=CC=C2)N2CCN(C)CC2)=N1	Cyclin-dependent kinase 7;+Cyclin-H	Ki (inhibition constant)	541	nM
2081	CN1CCN(CC1)C1=CC=CC(NC2=NC(C3=C(C)N=C(N)S3)=C(F)C=N2)=C1	Cyclin-dependent kinase 7;+Cyclin-H	Ki (inhibition constant)	476	nM
2082	CNC1=NC(C)=C(S1)C1=C(C=NC(NC2=CC=CC(=C2)S(=O)(=O)NCCOC)=N1)C#N	Cyclin-dependent kinase 7;+Cyclin-H	Ki (inhibition constant)	180	nM
2083	CNC1=NC(C)=C(S1)C1=C(F)C=NC(NC2=CC=CC(=C2)S(=O)(=O)NCCOC)=N1	Cyclin-dependent kinase 7;+Cyclin-H	Ki (inhibition constant)	30	nM
2084	CNC1=NC(C)=C(S1)C1=C(F)C=NC(NC2=CC(=C(C)C=C2)S(=O)(=O)N2CCOCC2)=N1	Cyclin-dependent kinase 7;+Cyclin-H	Ki (inhibition constant)	133	nM
2085	CNC1=NC(C)=C(S1)C1=C(C=NC(NC2=CC(=CC=C2)S(=O)(=O)N2CCN(C)CC2)=N1)C#N	Cyclin-dependent kinase 7;+Cyclin-H	Ki (inhibition constant)	24	nM
2086	CNC1=NC(C)=C(S1)C1=CC=NC(NC2=CC=CC(=C2)C(=O)N2CCOCC2)=N1	Cyclin-dependent kinase 7;+Cyclin-H	Ki (inhibition constant)	393	nM
2087	CNC1=NC(C)=C(S1)C1=C(F)C=NC(NC2=CC=CC(=C2)C(=O)NC2CCN(C)CC2)=N1	Cyclin-dependent kinase 7;+Cyclin-H	Ki (inhibition constant)	542	nM
2088	CNC1=NC(C)=C(S1)C1=C(C=NC(NC2=CC=C(C=C2)C(=O)NC2CCN(C)CC2)=N1)C#N	Cyclin-dependent kinase 7;+Cyclin-H	Ki (inhibition constant)	304	nM
2089	CNC1=NC(C)=C(S1)C1=C(C=NC(NC2=CC=CC(=C2)C(=O)NC2CCN(C)CC2)=N1)C#N	Cyclin-dependent kinase 7;+Cyclin-H	Ki (inhibition constant)	163	nM
2090	CC(C)C[C@@H]1NC(=O)C2=C3C(NC4=CC=CC=C34)=C3N(CCCCN)C4=CC=CC=C4C3=C12	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-2	%
2091	CCS(=O)(=O)C1=CC=C(C=C1)C1=CN=C2NC=C(C2=C1)C1=CC=CC(NC(=O)NC2=C(F)C=CC(=C2)C(F)(F)F)=C1	Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	inhibition percentage	-12.33	%
2092	NC1=C2C=CC=C(C3=CC=C(NC(=O)NC4=CC=CC(=C4)C(F)(F)F)C=C3)C2=CC=N1	Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	inhibition percentage	6.535	%
2093	CCN1C2=CC=NC=C2N=C1C1=C(N)N=CC(=N1)C1=CC=C(NC(=O)CNC(=O)CCCCCN2C3=C(C=C(C=C3)S([O-])(=O)=O)C(C)(C)\C2=C/C=C/C=C/C2=[N+](CC)C3=C(C=C(C=C3)S([O-])(=O)=O)C2(C)C)C=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Kd (dissociation constant)	194.2	nM
2094	CC1=C(SC(N)=N1)C1=NC(NC2=CC=CC(=C2)[N]([O-])=O)=NC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	70	nM
2095	FC(F)(F)C1=CC=C(NS(=O)(=O)C2=CC(Cl)=C(S2)N(=O)=O)C=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	2.5	µM
2096	COCCN1CCN(CC2=CC=C(C=C2)C2=C3C(=O)C4=C(C=CC=C4NC(=O)NN4CCOCC4)C3=NN2)CC1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	0.044	µM
2097	CC(=O)C1=CC(NC2=NC(=CS2)C2=C(C)N=C(C)S2)=CC=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	10000	nM
2098	CCOC1=CC=C(NC2=NC(=CS2)C2=C(C)N=C(C)S2)C=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	10000	nM
2099	CC(C)(C)OC(=O)C1CCC(CNC2=NC=C3N=NN(C3=N2)C2=CC3=C(CCC3)C=C2)CC1	Cyclin-dependent kinase 7 [human]	inhibition percentage	28.95	%
2100	CCCCNS(=O)(=O)C1=CC=CC(=C1)N1N=NC2=CC=C(NC3=CC(OC)=C(OC)C(OC)=C3)C=C12	Cyclin-dependent kinase 7 [human]	inhibition percentage	19	%
2101	CC1=NC(=CC=N1)C1=CC(=CC=C1)N1N=NC2=CC=C(NC3=CC=C(C=C3)C3=CSN=N3)C=C12	Cyclin-dependent kinase 7 [human]	inhibition percentage	2.3	%
2102	CCCCNS(=O)(=O)C1=CC=CC(NC2=NC=C3N=NN(C3=N2)C2=CC=C(C=C2)C(=O)NCCN(C)CC)=C1	Cyclin-dependent kinase 7 [human]	inhibition percentage	35.35	%
2103	CCN(CC)CCNC(=O)C1=CC=C(NC2=NC=C3N=NN(CC4=CC=C(C)C=C4)C3=N2)C=C1	Cyclin-dependent kinase 7 [human]	inhibition percentage	-11.4	%
2104	O=C(NCCN1C=CN=C1)C1=CC=C(NC2=NC=C3N=NN(C3=N2)C2=CC3=C(CCC3)C=C2)C=C1	Cyclin-dependent kinase 7 [human]	inhibition percentage	86.59	%
2105	CC1=CC=C(NCC(=O)C2=CC(=CN=C2)C2=CN=C(NC3=NC=CC(=C3)N3CCOCC3)S2)S1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	10000	nM
2106	CCCN1C=C(C2=CC=NC=C12)C1=CC=NC(NC2=CC=C(C=C2)N2CCOCC2)=N1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	0.25 - 0.5	µM
2107	CCC(O)NC1=NC(NCC2=CC=CC=C2)=C2N=CN(C(C)C)C2=N1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	200 - 500	nM
2108	CCC(O)NC1=NC(NCC2=CC=CC=C2)=C2N=CN(C(C)C)C2=N1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	510	nM
2109	CCC1(O)CC2CC[C@@H](NC(=O)C3=C(N)N=CC(=N3)C3=CC(=CC=C3)C3=CN(C)N=C3)C(C2)C1	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	50	%
2110	CC(C)C1=C2C=C(NCCCCCNC3=NC4=C(C=NN4C(NCC4=CC=CC=C4F)=C3)C(C)C)C=C(NCC3=CC=CC=C3F)N2N=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	1000	nM
2111	CC(C)C1=C2N=C(NC3CC[C@@H](CC3)NC3=NC4=C(C=NN4C(NCC4=CC=CC=C4)=C3)C(C)C)C=C(NCC3=CC=CC=C3)N2N=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	43	nM
2112	CC(C)C1=C2N=C(N[C@H](CO)CCCCCN)C=C(NCC3=CC=CC=C3F)N2N=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	180	nM
2113	CC(C)C1=C2N=C(NC(CO)CCCCCCCC3=CC=C(F)N=C3)C=C(NCC3=CC=CC=C3F)N2N=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	46	nM
2114	CC(C)C1=C2N=C(NC(CO)CCCCCCCC3=CC=C(F)N=C3)C=C(NCC3=CC=CC=C3)N2N=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	80	nM
2115	CC(C)C1=C2N=C(NC(CO)CCCCCCC3=CC=CC=N3)C=C(NCC3=CC=CC=C3)N2N=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	42	nM
2116	CC(C)C1=C2N=C(NC(CO)CCCCCCC3=CC=CC=N3)C=C(NCC3=CC=CC=C3F)N2N=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	44	nM
2117	CC(C)C1=C2N=C(NC(CO)CCCCCCC3=NC=CC=N3)C=C(NCC3=CC=CC=C3F)N2N=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	55	nM
2118	CC(C)C1=C2N=C(NC(CO)CCCCCCCC3=CN=CN=C3)C=C(NCC3=CC=CC=C3F)N2N=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	120	nM
2119	CC(C)C1=NN(C2=C1C(=O)N=C(CC1=CC=C(OCCO)C=C1)N2)C1=C(Cl)C=CC=C1Cl	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.22	µM
2120	Cl[H].COCCN1CCN(CC2=CC=C(C=C2)C2=NNC3=C2C(=O)C2=C(NC(=O)NN4CCOCC4)C=CC=C32)CC1	Cyclin-dependent kinase 7	IC50	0.05	µM
2121	CC1=CC(=NC(SC2=C(Cl)C=CC=C2)=N1)C1=CN=C(NC2=CN=C(CN3CCC[C@@H]3CO)C=N2)S1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	IC50	560	nM
2122	CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2CNC3=NC=C(Cl)C=C23)=C1F	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	10.7	%
2123	CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2CNC3=NC=C(Cl)C=C23)=C1F	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-21.9	%
2124	CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2CNC3=NC=C(Cl)C=C23)=C1F	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	14.7	%
2125	CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2CNC3=NC=C(Cl)C=C23)=C1F	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-7.7	%
2126	CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2CNC3=NC=C(Cl)C=C23)=C1F	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	IC50	10	µM
2127	CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2CNC3=NC=C(Cl)C=C23)=C1F	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	IC50	10	µM
2128	CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2CNC3=NC=C(Cl)C=C23)=C1F	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	4.1	%
2129	CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2CNC3=NC=C(Cl)C=C23)=C1F	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-12.6	%
2130	CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2CNC3=NC=C(Cl)C=C23)=C1F	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-7.4	%
2131	CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2CNC3=NC=C(Cl)C=C23)=C1F	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-26.8	%
2132	CC1CC(C)CN(C1)C1=CC=C(NC2=NC(=CC=N2)C2=CNC3=CC=CC=C23)C=C1	G1/S-specific cyclin-D3 [human];+Cyclin-dependent kinase 7 [human]	IC50	10	µM
2133	Cl[H].CC(C)N1CCN(CC1)C(=O)COC1=CC=C(C=C1)C1=NNC2=C1C(=O)C1=C2C=CC=C1NC(=O)NN1CCOCC1	Cyclin-dependent kinase 7	IC50	0.5	µM
2134	CN1C=C(C2=C1C=CC(F)=C2)C1=C(C(=O)NC1=O)C1=CC=CC(NC[C@H](O)CO)=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	Kd (dissociation constant)	0.041	µM
2135	CN1C=C(C2=C1C=CC(F)=C2)C1=C(C(=O)NC1=O)C1=CC=CC(NC[C@H](O)CO)=C1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 7	inhibition percentage	90	%
2136	CN1CCN(CC1)C1=NC(OC2=CC(F)=C3NC(C)=CC3=C2F)=NC(NC2=NNC(=C2)C2CC2)=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	inhibition percentage	44	%
2137	CN1C=C(C=N1)C1=NN(C(NC(=O)NC2=CC(=NN2C2=CC=CC=C2)C(F)(F)F)=C1C)C1=CC=CC=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1	inhibition percentage	-20.5	%
2138	COCC1=CC(CNC(=O)NC2=C(C)C(=NN2C2=CC=CC=C2)C2=CN=C(C)N=C2)=C(C=C1)C1CCC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1	inhibition percentage	3.5	%
2139	COCC1=CC(CNC(=O)NC2=C(C)C(=NN2C2=CC=CC=C2)C2=CN(C)N=C2)=C(C=C1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1	inhibition percentage	-13.5	%
2140	CCC1=C(NC(=O)C2=C(NC3=NC4=CC=C(F)C=C4N=C3)SN=C2C)C=CC=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	inhibition percentage	92	%
2141	CC(C)(C)C1=CN=C(CSC2=CC=C(NC(=O)C3CCNCC3)S2)O1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	62	nM
2142	NC1=NC(N)=C(C(OCC2CCCCC2)=N1)N(=O)=NC#N	Cyclin-dependent kinase 7;+Cyclin-H	IC50		
2143	NC(=O)N=N(=O)C1=C(N)N=C(N)N=C1OCC1CCCCC1	Cyclin-dependent kinase 7;+Cyclin-H	IC50		
2144	CC1=CC=C(C=C1)S(=O)(=O)N=N(=O)C1=C(N)N=C(N)N=C1OCC1CCCCC1	Cyclin-dependent kinase 7;+Cyclin-H	IC50		
2145	CNS(=O)(=O)C1=CC=C(NC2=NC(N)=C(C(OCC3CCCCC3)=N2)N(=O)=NC#N)C=C1	Cyclin-dependent kinase 7;+Cyclin-H	IC50	1.5	µM
2146	NC1=C(C(OCC2CCCCC2)=NC(NC2=CC=C(C=C2)S(=O)(=O)NCCO)=N1)N(=O)=NC#N	Cyclin-dependent kinase 7;+Cyclin-H	IC50	1.55	µM
2147	ClC1=CC=C(NC2=C3C=CC=CC3=C(CC3=CC=NC=C3)NN2)C=C1	Cyclin-dependent kinase 7	pIC50	4.7	
2148	ClC1=CC=C(NC2=C3C=CC=CC3=C(CC3=CC=NC=C3)NN2)C=C1	Cyclin-dependent kinase 7	pIC50	5.4	
2149	CNC1=NC(C)=C(S1)C1=NC(NC2=C(Cl)C(=CC=C2)C(=O)N2CCN(C)CC2)=NC=C1C#N	Cyclin-dependent kinase 7;+Cyclin-H	Ki (inhibition constant)	5000	nM
2150	CC(C)C1=C2N=C(O[C@@H]3CCCNC3)N=C(NCC3=C(CC4CCOC4)C=C(C)C=C3)N2N=C1	Cyclin-dependent kinase 7	IC50	25	nM
2151	CC(C)C1=C2N=C(O[C@@H]3CCCNC3)N=C(NCC3=C(CC4CCCC4)C=CC=C3)N2N=C1	Cyclin-dependent kinase 7	IC50	25	nM
2152	CC(C)C1=C2N=C(O[C@@H]3CCCNC3)N=C(NCC3=C(C=CC(F)=C3)N3CCCC3)N2N=C1	Cyclin-dependent kinase 7	IC50	5	nM
2153	[H][C@@]12CC(OC3=NC4=C(C=NN4C(NCC4=C(C=CC=C4)N4C=CC=N4)=N3)C(C)C)[C@]1([H])CNC2	Cyclin-dependent kinase 7	IC50	5	nM
2154	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CN=C3)N2N=C1)S(=O)(=O)C1CCNCC1	Cyclin-dependent kinase 7	IC50	5	nM
2155	OC(=O)C(F)(F)F.CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)C(=O)N1CC2(CNC2)C1	Cyclin-dependent kinase 7	IC50	25	nM
2156	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C(=O)N1CC(C1)N1CCC(F)(F)C1	Cyclin-dependent kinase 7	IC50	25	nM
2157	CC(C)C1=C2N=C(NC3CCCNC3)N=C(NCC3=C(C=CC=C3)N3C=CN=C3)N2N=C1	Cyclin-dependent kinase 7	IC50	5	nM
2158	CC(C)C1=C2N=C(NCC3CCNC3)N=C(NCC3=C(C=CC=C3)N3C=CN=C3)N2N=C1	Cyclin-dependent kinase 7	IC50	25	nM
2159	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CN=C3)N2N=C1)N1CCC11CCCNC1	Cyclin-dependent kinase 7	IC50	10 - 25	nM
2160	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CC(C1)N1CCC(F)(F)C1	Cyclin-dependent kinase 7	IC50	25	nM
2161	CNS(=O)(=O)C1=C(CNC2=NC(OC3CCNCC3)=NC3=C(C=NN23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7	IC50	5	nM
2162	CC(C)C1=C2N=C(NCCCN)N=C(NCC3=C(C=CC=C3)N3C=CN=C3)N2N=C1	Cyclin-dependent kinase 7	IC50	25	nM
2163	COC1=C(C=C(F)C=C1)C1=C2C=C(NC2=NC=C1)C1=CCC(CC1)N1CCN(CC(O)=O)CC1	Cyclin-dependent kinase 7	IC50	9.8	μM
2164	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)NC1=CC=CC(NC2=NC=CC(=N2)C2=CNC3=C2C=CC=C3)=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	391	nM
2165	CN(CCCNC(=O)NCCOCCOCCOCCNC(=O)CCCCC1SCC2NC(=O)NC12)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)NC1=CC=CC(NC2=NC=C(Cl)C(=N2)C2=CNC3=C2C=CC=C3)=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2166	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)NC1=CC(C)=CC(NC2=NC=C(C#N)C(=N2)C2=CNC3=C2C=CC=C3)=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2167	OC(=O)C(F)(F)F.ClC1=CC=CC=C1NC(=O)NC1=CN(N=C1)C1=CC(=CC=C1)C(=O)NCC1CCNCC1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	inhibition percentage	41	%
2168	Cl.C[C@H]1CN(CC2=CC=C(\C=C\C3=NNC4=CC(=CC=C34)[C@@H]3C[C@@]33C(=O)NC4=CC=CC=C34)C=C2)C[C@@H](C)O1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	inhibition percentage	-3	%
2169	OC(=O)C=CC(O)=O.COC1=CC=C2NC(=O)[C@@]3(C[C@H]3C3=CC=C4C(NN=C4\C=C\C4=CC=C(CN5C[C@H](C)O[C@H](C)C5)C=C4)=C3)C2=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	inhibition percentage	1	%
2170	CCOC(=O)C1=C2NC3=C([C@@H](C4=CC=C(O4)SC4=NC5=CC=CC=C5N4)C2=CN1)C(=O)CCC3	CDK/Cyclin (CDK7);+Cyclin-H	IC50	10000	nM
2171	OC1=CC=C2[N-]3C4=C(C2=C1)C1=C(C(=O)NC1=O)C1=C4[N](=CC(F)=C1)[Ru++]312([N-]=C=S)[S]3CC[S]1CC[S]2CC3	CDK7/cyclinH/MAT1 (Cyclin H) [human]	inhibition percentage	75	%
2172	OC1=CC=C2[N-]3C4=C(C2=C1)C1=C(C(=O)NC1=O)C1=C4[N](=CC(F)=C1)[Ru++]312([N-]=C=O)[S]3CC[S]1CC[S]2CC3	CDK7/cyclinH/MAT1 (Cyclin H) [human]	inhibition percentage	-14	%
2173	CN1CCN(CC2=CC=C(NC(=O)C3=NNC=C3NC3=NC4=C(C=CN4)C=N3)C=C2)CC1	Cyclin-dependent kinase 7;+Cyclin-H	IC50	0.471	µM
2174	CN1CCN(CC2=CC=C(NC(=O)C3=NNC=C3NC3=NC4=C(C=C(C)N4)C=N3)C=C2)CC1	Cyclin-dependent kinase 7;+Cyclin-H	IC50	0.583	µM
2175	CN1C(NC(=O)CCl)=NC2=CN=C3NC=CC3=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	9.5	μM
2176	CN1C(NC(=O)C=C)=NC2=CN=C3NC=CC3=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	10	μM
2177	CN(CCO)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(C=N1)C#N	CDK/Cyclin (CDK7)	IC50	100	nM
2178	NC1=C(F)C=C(C=C1)C(=O)N1CCC(CC1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100	nM
2179	CN(C)C\C=C\C(=O)NC1=C(F)C=C(C=C1)C(=O)N1CCC(CC1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100	nM
2180	CC1=C(N)C=CC(=C1)C(=O)N1CCC(CC1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100	nM
2181	CN(C)C\C=C\C(=O)NC1=C(C)C=C(C=C1)C(=O)N1CCC(CC1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100	nM
2182	CC1=C(C=CC(N)=C1)C(=O)N1CCC(CC1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100 - 100	nM
2183	CN(C)C\C=C\C(=O)NC1=CC(C)=C(C=C1)C(=O)N1CCC(CC1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100	nM
2184	CN(C)C\C=C\C(=O)NC1=CC(C)=C(C=C1)C(=O)N1CCC(CC1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100 - 100	nM
2185	NC1=CC(F)=C(C=C1)C(=O)N1CCC(CC1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100 - 100	nM
2186	CN(C)C\C=C\C(=O)NC1=CC(F)=C(C=C1)C(=O)N1CCC(CC1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100	nM
2187	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N1CCC(CC1)NC1=C(N=C(Cl)N=C1)C1=NNC=C1	CDK/Cyclin (CDK7)	IC50	1	μM
2188	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N1CCC(CC1)NC1=NC(C2=C(C)N=C(C)S2)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100 - 100	nM
2189	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N[C@@H]1CC[C@@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100	nM
2190	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N1CCC(CC1)NC1=NC(C2=C(C)ON=C2C)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	1	μM
2191	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N1CCC(CC1)NC1=NC(C2=C(C)NC3=CC=CC=C23)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100	nM
2192	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N1CCC(CC1)NC1=NC(C2=CNC=N2)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100 - 100	nM
2193	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N[C@H]1CC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100 - 100	nM
2194	CC(C)(CNC(=O)C1=CC=C(NC(=O)\C=C\CO)C=C1)CNC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	Cyclin-dependent kinase 7	IC50	1	µM
2195	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N1CCC(CC1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100	nM
2196	OC(=O)C(F)(F)F.NCCC(=O)NC1=CC(NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
2197	CN(C)C\C=C\C(=O)NCCC(=O)NC1=CC(NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)=CC=C1	CDK/Cyclin (CDK7)	IC50	100	nM
2198	OC(=O)C(F)(F)F.NCC(=O)NC1=CC(NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
2199	CN(C)C\C=C\C(=O)NCC(=O)NC1=CC(NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)=CC=C1	CDK/Cyclin (CDK7)	IC50	100	nM
2200	[H][C@]12CC[C@]([H])(C[C@@H](C1)NC1=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N1)N2C(=O)C1=CC=C(N)C=C1	CDK/Cyclin (CDK7)	IC50	1	μM
2201	[H][C@]12CC[C@]([H])(C[C@@H](C1)NC1=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N1)N2C(=O)C1=CC=C(NC(=O)\C=C\CN(C)C)C=C1	CDK/Cyclin (CDK7)	IC50	100 - 100	nM
2202	ClC1=C(N=C(NC2CC3(CC(C3)NC(=O)C3=CC=C(NC(=O)C=C)C=C3)C2)N=C1)C1=CNC2=CC=CC=C12	CDK/Cyclin (CDK7)	IC50	100 - 100	nM
2203	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N1CCC(CC1)NC1=NC(=C(Cl)C=N1)C1=CC=CN=C1	CDK/Cyclin (CDK7)	IC50	100 - 100	nM
2204	CN(C)C\C=C\C(=O)NC1=CC(CN2CCC(CC2)NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)=CC=C1	CDK/Cyclin (CDK7)	IC50	100	nM
2205	CNC\C=C\C(=O)NC1=CC=C(CN2CCC(CC2)NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)C=C1	CDK/Cyclin (CDK7)	IC50	100	nM
2206	CN(C\C=C\C(=O)NC1=CC=C(CN2CCC(CC2)NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)C=C1)CC(O)CO	CDK/Cyclin (CDK7)	IC50	100	nM
2207	CN(C)C\C=C\C(=O)NC1=CC=C(CN2CC[C@H](C2)NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)C=C1	CDK/Cyclin (CDK7)	IC50	100	nM
2208	CN(C)C\C=C\C(=O)N(C)C1=CC=C(CN2CCC(CC2)NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)C=C1	CDK/Cyclin (CDK7)	IC50	100	nM
2209	CN(C\C=C\C(=O)NC1=CC=C(CN2CCC(CC2)NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)C=C1)CC(N)=O	CDK/Cyclin (CDK7)	IC50	100	nM
2210	CN(C\C=C\C(=O)NC1=CC=C(CN2CCC(CC2)NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)C=C1)CC(O)=O	CDK/Cyclin (CDK7)	IC50	100	nM
2211	NC1=CC=C(C=C1)C(=O)N1CC[C@@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100 - 100	nM
2212	Cl.CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N[C@@H]1CNC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100	nM
2213	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N[C@H]1CNC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100	nM
2214	ClC1=C(N=C(N[C@@H]2CNC[C@H](C2)C(=O)NCC2=CC=C(NC(=O)C=C)C=C2)N=C1)C1=CNC2=CC=CC=C12	CDK/Cyclin (CDK7)	IC50	100	nM
2215	ClC1=C(N=C(N[C@@H]2CNC[C@@H](C2)C(=O)NCC2=CC=C(NC(=O)C=C)C=C2)N=C1)C1=CNC2=CC=CC=C12	CDK/Cyclin (CDK7)	IC50	100	nM
2216	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100 - 100	nM
2217	ClC1=C(N=C(N[C@@H]2CNC[C@H](C2)C(=O)NC2=CC=C(NC(=O)C=C)C=C2)N=C1)C1=CNC2=CC=CC=C12	CDK/Cyclin (CDK7)	IC50	100	nM
2218	ClC1=C(N=C(N[C@@H]2CNC[C@@H](C2)C(=O)NC2=CC=C(NC(=O)C=C)C=C2)N=C1)C1=CNC2=CC=CC=C12	CDK/Cyclin (CDK7)	IC50	100	nM
2219	Cl.CN1C[C@H](C[C@@H](C1)C(=O)NCC1=CC=C(NC(=O)C=C)C=C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100	nM
2220	Cl.CN1C[C@H](C[C@H](C1)C(=O)NCC1=CC=C(NC(=O)C=C)C=C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100 - 100	nM
2221	Cl.FC(F)(F)C(=O)NC\C=C\C(=O)NC1=CC=C(CN2CCC(CC2)NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)C=C1	CDK/Cyclin (CDK7)	IC50	100 - 100	nM
2222	NC1=CC=C(CN2CCC(CC2)NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)C=C1	Cyclin-dependent kinase 7	IC50	100 - 1	nM
2223	Cl.CS(=O)(=O)NC\C=C\C(=O)NC1=CC=C(CN2CCC(CC2)NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)C=C1	CDK/Cyclin (CDK7)	IC50	100 - 100	nM
2224	CN1C[C@H](C[C@@H](C1)C(=O)NC1=CC=C(NC(=O)C=C)C=C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100 - 100	nM
2225	CN1C[C@H](C[C@H](C1)C(=O)NC1=CC=C(NC(=O)C=C)C=C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100	nM
2226	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N[C@@H]1C[C@@H](CN(C)C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	Cyclin-dependent kinase 7	IC50	100	nM
2227	CN(C)C\C=C\C(=O)N(C)C1=CC(CN2CCC(CC2)NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)=CC=C1	CDK/Cyclin (CDK7)	IC50	100	nM
2228	COC1=CC=C(CN2C3=CC=C(NC4=NC(C5=CNC6=CC=CC=C56)=C(Cl)C=N4)C=C3N=C2C2=CC=C(N)C=C2)C=C1	CDK/Cyclin (CDK7)	IC50	100 - 100	nM
2229	COC1=CC=C(CN2C3=CC=C(NC4=NC(C5=CNC6=CC=CC=C56)=C(Cl)C=N4)C=C3N=C2C2=CC=C(NC(=O)\C=C\CN(C)C)C=C2)C=C1	CDK/Cyclin (CDK7)	IC50	100 - 100	nM
2230	CN(C)C\C=C\C(=O)NCCCCC(=O)NC1=CC(NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)=CC=C1	CDK/Cyclin (CDK7)	IC50	100	nM
2231	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N[C@H]1CC[C@H](C1)NC1=NC(C2=C(C)ON=C2C)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100 - 100	nM
2232	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N[C@H]1CC[C@H](C1)NC1=NC(=C(Cl)C=N1)C1=CC=CN=C1	CDK/Cyclin (CDK7)	IC50	100 - 100	nM
2233	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N[C@H]1CC[C@H](C1)NC1=NC(C2=NNC=C2)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	1	μM
2234	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N[C@H]1CC[C@H](C1)NC1=NC(C2=C(C)NC3=CC=CC=C23)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100	nM
2235	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N[C@H]1CC[C@H](C1)NC1=NC(C2=C(C)N=C(C)S2)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100 - 100	nM
2236	CN(C)CC=CC(=O)NC1=CC=C(C=C1)C(=O)NCC(C)(C)CNC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100 - 100	nM
2237	CC(C)(CNC(=O)C1=CC=C(NC(=O)C=CCO)C=C1)CNC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	1	μM
2238	CN(C)CC=CC(=O)NCC1=CC=C(CN2CCC(CC2)NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)C=C1	CDK/Cyclin (CDK7)	IC50	100	nM
2239	CN(C)CC=CC(=O)N(C)CC1=CC=C(CN2CCC(CC2)NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)C=C1	CDK/Cyclin (CDK7)	IC50	100	nM
2240	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)NC1CC(CN(C)C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100	nM
2241	CN(C)CCCC(=O)NC1=CC=C(CN2CCC(CC2)NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)C=C1	CDK/Cyclin (CDK7)	IC50	100 - 100	nM
2242	CC(C)(CNC(=O)C1=CC=C(N)C=C1)CNC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	1	μM
2243	NCC(=O)NC1=CC(NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)=CC=C1	CDK/Cyclin (CDK7)	IC50	100	nM
2244	CN(C)CCCC(=O)NC1=CC(NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)=CC=C1	CDK/Cyclin (CDK7)	IC50	100	nM
2245	NCCC(=O)NC1=CC(NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)=CC=C1	CDK/Cyclin (CDK7)	IC50	100	nM
2246	NCCCCC(=O)NC1=CC(NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)=CC=C1	CDK/Cyclin (CDK7)	IC50	100	nM
2247	NC1=CC=C(C=C1)C(=O)NCCCNC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100 - 100	nM
2248	NC1=CC=C(C=C1)C1=NC2=CC=C(NC3=NC(C4=CNC5=CC=CC=C45)=C(Cl)C=N3)C=C2O1	CDK/Cyclin (CDK7)	IC50	1	μM
2249	CC1=C(N=C(NC2CCN(CC2)C(=O)C2=CC=C(N)C=C2)N=C1)C1=CNC2=CC=CC=C12	CDK/Cyclin (CDK7)	IC50	100	nM
2250	NC1=CC=C(C=C1)C(=O)N1CCC(CC1)NC1=NC(C2=CNC3=NC=CC=C23)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100	nM
2251	NC1=CC=C(C=C1)C(=O)N1CCC(CC1)NC1=NC(C2=CNC3=CC=CC=C23)=C(C=N1)C1CC1	CDK/Cyclin (CDK7)	IC50	1	μM
2252	CN(C)CCCC(=O)N(C)C1=CC=CC(CN2CCC(CC2)NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)=C1	CDK/Cyclin (CDK7)	IC50	100 - 100	nM
2253	NC1=CC=C(C=C1)C(=O)N1CCC(CC1)NC1=NC(C2=CNC3=CC=CC=C23)=C(C=N1)C#N	CDK/Cyclin (CDK7)	IC50	100 - 100	nM
2254	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N1CCC(CC1)NC1=NC(C2=CNC3=CC=CC=C23)=C(C=N1)C#N	CDK/Cyclin (CDK7)	IC50	100	nM
2255	NC1=CC=C(C=C1)S(=O)(=O)N1CC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100	nM
2256	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)S(=O)(=O)N1CC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100	nM
2257	NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK/Cyclin (CDK7)	IC50	100	nM
2258	NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(C=N1)C#N	CDK/Cyclin (CDK7)	IC50	100	nM
2259	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(C=N1)C#N	CDK/Cyclin (CDK7)	IC50	100	nM
2260	CC(=O)NC1=CC=C(CN2CCC(CC2)NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)C=C1	CDK/Cyclin (CDK7)	IC50	100 - 100	nM
2261	Cl.NC1=CC=C(CN2CCC(CC2)NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)C=C1	CDK/Cyclin (CDK7)	IC50	100 - 100	nM
2262	CN(C)C\C=C\C(=O)NC1=CC=C(CN2CCC(CC2)NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)C=C1	CDK/Cyclin (CDK7)	IC50	100	nM
2263	O=C(NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(C=N1)C#N)\C=C\CN1CCOCC1	CDK/Cyclin (CDK7)	IC50	100	nM
2264	O=C(NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(C=N1)C#N)\C=C\CN1CCCC1	CDK/Cyclin (CDK7)	IC50	100	nM
2265	O=C(NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(C=N1)C#N)\C=C\CN1C=CN=C1	CDK/Cyclin (CDK7)	IC50	100	nM
2266	CN1CCN(C\C=C\C(=O)NC2=CC=C(C=C2)C(=O)N2CC[C@H](C2)NC2=NC(C3=CNC4=CC=CC=C34)=C(C=N2)C#N)CC1	CDK/Cyclin (CDK7)	IC50	100	nM
2267	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N[C@@H]1CNC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	Cyclin-dependent kinase 7	IC50	100	nM
2268	CN1C[C@H](C[C@@H](C1)C(=O)NCC1=CC=C(NC(=O)C=C)C=C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	Cyclin-dependent kinase 7	IC50	100	nM
2269	CN1C[C@H](C[C@H](C1)C(=O)NCC1=CC=C(NC(=O)C=C)C=C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	Cyclin-dependent kinase 7	IC50	100 - 1	nM
2270	FC(F)(F)C(=O)NC\C=C\C(=O)NC1=CC=C(CN2CCC(CC2)NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)C=C1	Cyclin-dependent kinase 7	IC50	100 - 1	nM
2271	CS(=O)(=O)NC\C=C\C(=O)NC1=CC=C(CN2CCC(CC2)NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)C=C1	Cyclin-dependent kinase 7	IC50	100 - 1	nM
2272	CN(C)C\C=C\C(=O)NC1=CC=C(NC(=O)N2CCCC(C2)NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)C=C1	Cyclin-dependent kinase 7	IC50	100	nM
2273	OC(=O)C(F)(F)F.CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	100 - 1	nM
2274	OC(=O)C(F)(F)F.CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N1CC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	100	nM
2275	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N1CCC(CC1)NC1=NC=C(Cl)C(=N1)C1=NNC=C1	Cyclin-dependent kinase 7	IC50	1	µM
2276	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)NCC(C)(C)CNC1=NC=C(Cl)C(=N1)C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	100 - 1	nM
2277	CN(C)C\C=C\C(=O)NC1=CC(=CC=C1)C(=O)N[C@H]1CCC(CC1)NC1=NC=C(Cl)C(=N1)C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	100	nM
2278	CN(C)C\C=C\C(=O)NCC1=CC=C(CN2CCC(CC2)NC2=NC=C(Cl)C(=N2)C2=CNC3=C2C=CC=C3)C=C1	Cyclin-dependent kinase 7	IC50	100	nM
2279	CN(C)C\C=C\C(=O)N(C)CC1=CC=C(CN2CCC(CC2)NC2=NC=C(Cl)C(=N2)C2=CNC3=C2C=CC=C3)C=C1	Cyclin-dependent kinase 7	IC50	100	nM
2280	Cl.CS(=O)(=O)NCC1=CC=C2N1N=C(N=C2N1CCOCC1)C1=CN=C(N)N=C1	Cyclin-dependent kinase 7	inhibition percentage	-36	%
2281	CNC(=O)C1=C(NC2=CC(NC3CCOCC3)=NC=C2C(F)(F)F)C=C(F)C=C1	Cyclin-dependent kinase 7	inhibition percentage	75	%
2282	C1CCC2=C(C1)SC1=NC=NC(N\N=C\C3=CNC4=C3C=CC=C4)=C21	Cyclin-dependent kinase 7 [human]	IC50	10	µM
2283	COC1=CC2=C(C=C1)C1=C(N2CC#N)C(Cl)=NC=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1	inhibition percentage	0	%
2284	CN(C)CCCNC(=O)C1=CSC2=NC(=CN12)C1=CC=C(NC(=O)NC2=NOC(=C2)C(C)(C)C)C=C1	Cyclin-dependent kinase 7 [human]	IC50	10	µM
2285	Cl.CC(C)C1=C2N=C(NC[C@]3(O)CCNC[C@H]3O)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	18	nM
2286	Cl.CC(C)C1=C2N=C(N[C@H]3CNC[C@H]3O)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	27	nM
2287	Cl.CC(C)C1=C2N=C(N[C@@H]3CNCC[C@H]3O)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	73	nM
2288	CC(C)C1=C2N=C(NC[C@]3(O)CCNC[C@H]3O)C=C(NCC3CCCCC3)N2N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	975	nM
2289	CC(C)C1=C2N=C(NCC3(CO)CCNC3)C=C(NCC3CCCCC3)N2N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	29	nM
2290	CC(C)C1=C2N=C(NCC3(CO)CCNC3)C=C(NCC3=CC=NC=C3)N2N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	44	nM
2291	ClC1=CN=C(N[C@@H]2CC[C@@H](CC2)NCC2CCCN(C2)C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100 - 1	nM
2292	CN(C)CC=CC(=O)N1CCC(CN[C@H]2CC[C@@H](CC2)NC2=NC=C(Cl)C(=N2)C2=CNC3=CC=CC=C23)CC1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2293	CN(C)CC=CC(=O)N1CCC(CN[C@H]2CC[C@H](CC2)NC2=NC=C(Cl)C(=N2)C2=CNC3=CC=CC=C23)CC1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2294	CC(=O)N(CC1CCN(CC1)C(=O)C=C)[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2295	CC(=O)N(CC1CCN(CC1)C(=O)C=C)[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2296	CS(=O)(=O)N(CC1CCN(CC1)C(=O)C=C)[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100 - 1	nM
2297	ClC1=CN=C(N[C@@H]2CC[C@@H](CC2)NC(=O)C2CCCN(C2)C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100 - 1	nM
2298	[H][C@]1(CC11CCN(CC1)C(=O)C=C)N[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2299	[H][C@]1(CC11CCN(CC1)C(=O)C=C)N[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2300	ClC1=CN=C(NC2CCCC(C2)NC2CC22CCN(CC2)C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100 - 1	nM
2301	ClC1=CN=C(N[C@@H]2CCCN(C2)C(=O)NC2CCN(CC2)C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100 - 1	nM
2302	CN(C)CC=CC(=O)N1CCCC(C1)C(=O)N[C@H]1CC[C@H](CC1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100 - 1	nM
2303	C=CC(=O)N1CCC(CC1)C(=O)N[C@H]1CCC[C@H](C1)NC1=NC=C(C2CC2)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100 - 1	nM
2304	CN(C)CC=CC(=O)N1CCC(CC1)C(=O)N[C@H]1CCC[C@H](C1)NC1=NC=C(C2CC2)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100 - 1	nM
2305	ClC1=CN=C(N[C@H]2CCC[C@@H](CNC3CCN(CC3)C(=O)C=C)C2)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2306	ClC1=CN=C(N[C@H]2CCC[C@@H](CNC3CCN(CC3)C(=O)C=C)C2)N=C1C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2307	COC(=O)N(CC1CCN(CC1)C(=O)C=C)[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100 - 1	nM
2308	CN(CC1CCN(CC1)C(=O)C=C)[C@H]1CCC[C@H](C1)NC1=NC=C(C2CC2)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100 - 1	nM
2309	CN(C)CC=CC(=O)N1CCC(CC1)C(=O)N1CCC(CC1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2310	ClC1=CN=C(NC2CCN(CC2)C(=O)C2CCN(CC2)C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2311	ClC1=CN=C(NC2CCN(CC2)C(=O)C2CCN(CC2)C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2312	ClC1=CN=C(NC2CCN(CC2)C(=O)C2CCN(CC2)C(=O)C=CCN2CCOCC2)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2313	ClC1=CN=C(NC2CCN(CC2)C(=O)C2CCN(CC2)C(=O)C=CCN2CCOCC2)N=C1C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2314	ClC1=CN=C(N[C@@H]2CCN(C2)C(=O)C2CCN(CC2)C(=O)C=CCN2CCOCC2)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100 - 1	nM
2315	ClC1=CN=C(N[C@@H]2CCN(C2)C(=O)C2CCN(CC2)C(=O)C=CCN2CCOCC2)N=C1C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2316	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)C2CCN(CC2)C(=O)C=CCN2CCN(CC2)C2CC2)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2317	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)C2CCN(CC2)C(=O)C=CCN2CCN(CC2)C2CC2)N=C1C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2318	CN(C1CN(C1)C(=O)C=C)[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2319	CN(C1CN(C1)C(=O)C=C)[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2320	CN(CC1(O)CCN(CC1)C(=O)C=C)[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100 - 1	nM
2321	CN(C)CC=CC(=O)N1CCC(CC1)C(=O)N[C@H]1CCC[C@H](C1)NC1=NC=C(C)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100 - 1	nM
2322	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)N2CCN(CC2)C(=O)C=C)N=C1C1=C2C=CC=CN2N=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2323	CN(C)CC=CC(=O)N1CCC(O)(CN(C)[C@H]2CCC[C@H](C2)NC2=NC=C(Cl)C(=N2)C2=CNC3=CC=CC=C23)CC1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2324	CN(C)CC=CC(=O)N1CCC(O)(CN(C)[C@H]2CCC[C@H](C2)NC2=NC=C(Cl)C(=N2)C2=CNC3=CC=CC=C23)CC1	CDK7/cyclinH/MAT1	IC50	100	nM
2325	C[C@@H]1CN(CCN1C(=O)C=C)[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2326	C[C@@H]1CN(CCN1C(=O)C=C)[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2327	C[C@@H]1CN(CCN1C(=O)C=CCN(C)C)[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2328	C[C@@H]1CN(CCN1C(=O)C=CCN(C)C)[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2329	ClC1=CN=C(NC2=CC(NC(=O)C34CC(C3)(C4)NC(=O)C=C)=CC=C2)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	1	μM
2330	CN(C)CC=CC(=O)N1CC(C1)N(C)[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2331	CN(C)CC=CC(=O)N1CC(C1)N(C)[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2332	C[C@H]1CN(CCN1C(=O)C=C)[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2333	C[C@H]1CN(CCN1C(=O)C=C)[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2334	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)C2=NC=C(NC(=O)C=C)C=C2)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2335	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)C2=NC=C(NC(=O)C=C)C=C2)N=C1C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2336	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)C2=CSC(CNC(=O)C=C)=N2)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2337	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)C2=CSC(CNC(=O)C=C)=N2)N=C1C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2338	CN(C)CC=CC(=O)N1CC(C)(C1)C(=O)N[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2339	CN(C)CC=CC(=O)N1CC(C)(C1)C(=O)N[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2340	CC1(CN(C1)C(=O)C=C)C(=O)N[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2341	CC1(CN(C1)C(=O)C=C)C(=O)N[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2342	CN(C)CC=CC(=O)N1CCN(CC1)[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2343	CN(C)CC=CC(=O)N1CCN(CC1)[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2344	CN(C)CC=CC(=O)NCC1=NC(=CS1)C(=O)N[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2345	CN(C)CC=CC(=O)NCC1=NC(=CS1)C(=O)N[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2346	ClC1=CN=C(N[C@H]2CCC[C@H](C2)NC(=O)C23CC(C2)(C3)NC(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	1	μM
2347	ClC1=CN=C(N[C@@H]2CCCC(C2)N2CCC(CC2)NC(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2348	ClC1=CN=C(N[C@@H]2CCCC(C2)N2CCC(CC2)NC(=O)C=C)N=C1C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2349	CN(C)CC=CC(=O)NC1CCN(CC1)C1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2350	CN(C)CC=CC(=O)NC1CCN(CC1)C1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2351	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)N2CCN(CC2)C(=O)C=CCN2CCOCC2)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2352	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)N2CCN(CC2)C(=O)C=CCN2CCOCC2)N=C1C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2353	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)C2=NC=C(NC(=O)C=CCN3CCOCC3)C=C2)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2354	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)C2=NC=C(NC(=O)C=CCN3CCOCC3)C=C2)N=C1C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2355	CN(CC1CCN(CC1)C(=O)C=C)[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=C2C=CC=CN2N=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100 - 1	nM
2356	CC(C)S(=O)(=O)C1=C(NC2=NC(N[C@@H]3CCC[C@@H](C3)N3CCN(CC3)C(=O)C=C)=NC=C2Cl)C=CC=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2357	CC(C)S(=O)(=O)C1=C(NC2=NC(N[C@@H]3CCC[C@@H](C3)N3CCN(CC3)C(=O)C=C)=NC=C2Cl)C=CC=C1	CDK7/cyclinH/MAT1	IC50	100	nM
2358	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NCC2CCN(CC2)C(=O)C=C)N=C1C1=C2C=CC=CN2N=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100 - 1	nM
2359	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NCC2CCN(CC2)C(=O)C=C)N=C1C1=C2C=CC=CN2N=C1	CDK7/cyclinH/MAT1	IC50	100	nM
2360	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NCC2CCCN(C2)C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100 - 1	nM
2361	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NCC2CCCN(C2)C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2362	ClC1=CN=C(N[C@@H]2CCC[C@H](C2)N2CCC(CC2)NC(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2363	CN(C)CC=CC(=O)NC1CCN(CC1)[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100 - 1	nM
2364	CN(C)CC=CC(=O)NC1CCN(CC1)[C@@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2365	ClC1=CN=C(N[C@@H]2CCCC(C2)N2CC(C2)NC(=O)C=C)N=C1C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2366	ClC1=CN=C(N[C@@H]2CCCC(C2)N2CCC[C@@H](C2)NC(=O)C=C)N=C1C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2367	C[C@H]1CN(CCN1[C@@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12)C(=O)C=C	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2368	[H][C@]12CC[C@@]([H])(CC(C1)NC(=O)C=C)N2[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2369	C[C@H]1CN(CCN1[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12)C(=O)C=C	CDK7/cyclinH/MAT1	IC50	100	nM
2370	CCC1=CN=C(N[C@@H]2CCC[C@@H](C2)NCC2=NC=C(NC(=O)\C=C\CN(C)C)C=C2)N=C1C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2371	CN1C=CC2=C(C=CC=C12)C1=NC(N[C@@H]2CCC[C@@H](C2)NC(=O)C2=CC=C(NC(=O)C=C)C=N2)=NC=C1Cl	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2372	FC1(CN[C@H]2CCC[C@H](C2)NC2=NC=C(Cl)C(=N2)C2=CNC3=CC=CC=C23)CCN(CC1)C(=O)C=C	CDK7/cyclinH/MAT1	IC50	100	nM
2373	CN(C)C\C=C\C(=O)NC1=CN=C(C=C1)C(=O)N[C@@]1(C)CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=C2C=CNC2=CC=C1	CDK7/cyclinH/MAT1	IC50	100	nM
2374	C[C@@]1(CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=C2C=CNC2=CC=C1)NCC1CCN(CC1)C(=O)C=C	CDK7/cyclinH/MAT1	IC50	100	nM
2375	CN(C)CC=CC(=O)N1CC[C@H](C1)N(C)[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2376	CN(C)CC=CC(=O)N1CC[C@@H](C1)N(C)[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2377	ClC1=C(N=C(N[C@@H]2CCC[C@@H](C2)NCC2CC3(C2)CCN(CC3)C(=O)C=C)N=C1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2378	CN(C)CC=CC(=O)N1CCC2(CC(CN[C@H]3CCC[C@H](C3)NC3=NC=C(Cl)C(=N3)C3=CNC4=CC=CC=C34)C2)CC1	CDK7/cyclinH/MAT1	IC50	100	nM
2379	CN(C)CC=CC(=O)N1CCC(C)(CN[C@H]2CCC[C@H](C2)NC2=NC=C(Cl)C(=N2)C2=CNC3=CC=CC=C23)CC1	CDK7/cyclinH/MAT1	IC50	100	nM
2380	CN(C)CC=CC(=O)N[C@H]1CC[C@H](CN[C@H]2CCC[C@H](C2)NC2=NC=C(Cl)C(=N2)C2=CNC3=CC=CC=C23)CC1	CDK7/cyclinH/MAT1	IC50	100	nM
2381	C[C@@H]1CN(CCN1[C@@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=C1C=CC=C2)C(=O)C=C	CDK7/cyclinH/MAT1	IC50	100	nM
2382	[H][C@]12CC[C@]([H])(C[C@@H](C1)N[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC3=CC=CC=C13)N2C(=O)C=C	CDK7/cyclinH/MAT1	IC50	100	nM
2383	CN(C)CC=CC(=O)NC1=CC=C(N=C1)C(=O)N[C@H]1CCC[C@H](C1)NC1=NC(N2C=NC3=CC=CC=C23)=C(Cl)C=N1	CDK7/cyclinH/MAT1	IC50	100	nM
2384	C[C@@H]1CN(CCN1C1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=C1C=CC=C2)C(=O)C=C	CDK7/cyclinH/MAT1	IC50	100	nM
2385	CC=CC(=O)N1CCN(CC1)C1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=C1C=CC=C2	CDK7/cyclinH/MAT1	IC50	100	nM
2386	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC2CCCN(C2)C(=O)C=C)N=C1C1=CNC2=C1C=CC=C2	CDK7/cyclinH/MAT1	IC50	100	nM
2387	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NCC2CCN(CC2)C(=O)C=C)N=C1C1=NNC2=C1C=CC=C2	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2388	CC=CC(=O)N1CCC(CN[C@H]2CCC[C@H](C2)NC2=NC=C(Cl)C(=N2)C2=CNC3=C2C=CC=C3)CC1	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2389	FC(F)(F)C1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)C2CCN(CC2)C(=O)C=C)N=C1C1=CNC2=C1C=CC=C2	CDK7/cyclinH/MAT1	IC50	100	nM
2390	CCC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)C2CCN(CC2)C(=O)C=C)N=C1C1=CNC2=C1C=CC=C2	CDK7/cyclinH/MAT1	IC50	100	nM
2391	ClC1=CN=C(N[C@@H]2CCCN(C2)C2CCN(CC2)C(=O)C=C)N=C1C1=CNC2=C1C=CC=C2	CDK7/cyclinH/MAT1	IC50	100	nM
2392	CN(C)CC=CC(=O)N1CCC(CC1)N1CCC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK7/cyclinH/MAT1	IC50	100	nM
2393	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)N2CCCN(CC2)C(=O)C=C)N=C1C1=CNC2=C1C=CC=C2	CDK7/cyclinH/MAT1	IC50	100	nM
2394	CC(C)CC=CC(=O)N1CCCN(CC1)[C@H]1CCC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK7/cyclinH/MAT1	IC50	100	nM
2395	C=CC(=O)N1CCN(CC1)[C@H]1CCC[C@H](C1)NC1=NC=C(C#N)C(=N1)C1=CNC2=C1C=CC=C2	CDK7/cyclinH/MAT1	IC50	100	nM
2396	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)N2CCN(CC2)C(=O)C=C)N=C1C1C(=O)NC2=C1C=CC=C2	CDK7/cyclinH/MAT1	IC50	1	μM
2397	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)N2CCC[C@@H](C2)NC(=O)C=C)N=C1C1=CNC2=C1C=CC=C2	CDK7/cyclinH/MAT1	IC50	100	nM
2398	ClC1=CN=C(N[C@@H]2CCC[C@H](C2)N2CCC[C@@H](C2)NC(=O)C=C)N=C1C1=CNC2=C1C=CC=C2	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2399	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NCC2=NC=C(NC(=O)C=C)C=N2)N=C1C1=CNC2=C1C=CC=C2	CDK7/cyclinH/MAT1	IC50	100	nM
2400	CN(C)CC=CC(=O)NC1=CN=C(CN[C@H]2CCC[C@H](C2)NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)N=C1	CDK7/cyclinH/MAT1	IC50	100	nM
2401	CN(C)CC=CC(=O)N1CCN(CCN2CCC[C@H](C2)NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)CC1	CDK7/cyclinH/MAT1	IC50	100	nM
2402	ClC1=C(N=C(N[C@@H]2CCC[C@@H](C2)N2CCN(CC2)C(=O)C=C)N=C1)C1=NOC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2403	ClC1=C2C(NC=C2C2=C(Cl)C=NC(N[C@@H]3CCC[C@@H](C3)N3CCN(CC3)C(=O)C=C)=N2)=CC=C1	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2404	CN(C)CC=CC(=O)N1CCN(CC1)[C@H]1CCC[C@H](C1)NC1=NC(C2=CNC3=CC=CC(Cl)=C23)=C(Cl)C=N1	CDK7/cyclinH/MAT1	IC50	100	nM
2405	ClC1=C(N=C(N[C@@H]2CCC[C@H](COC3CCN(CC3)C(=O)C=C)C2)N=C1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2406	ClC1=C(N=C(N[C@@H]2CCC[C@@H](C2)NCC2CN(C2)C(=O)C=C)N=C1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2407	FC(F)(F)C1=C(N=C(N[C@@H]2CCC[C@@H](C2)N2CCN(CC2)C(=O)C=C)N=C1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2408	CON(C)CC=CC(=O)N1CCN(CC1)[C@H]1CCC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2409	CC=CC(=O)N1CCN(CC1)[C@H]1CCC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2410	ClC1=C(N=C(N[C@@H]2CCC[C@@H](C2)N2CCN(CC2)C(=O)C=C)N=C1)C1=COC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2411	CN(C)CC=CC(=O)N1CCN(CC1)[C@H]1CCC[C@H](C1)NC1=NC(N2C=NC3=CC=CC=C23)=C(Cl)C=N1	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2412	CN(C)CC=CC(=O)N1CCN(CC1)[C@H]1CCC[C@H](C1)NC1=NC(C2=COC3=CC=CC=C23)=C(Cl)C=N1	CDK7/cyclinH/MAT1	IC50	100	nM
2413	ClC1=C(N=C(N[C@@H]2CCC[C@@H](C2)N2CCN(CC2)C(=O)C=C)N=C1)C1=CSC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2414	CN(C)CC=CC(=O)N1CCN(CC1)[C@H]1CCC[C@H](C1)NC1=NC(C2=CSC3=CC=CC=C23)=C(Cl)C=N1	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2415	COCC=CC(=O)N1CCN(CC1)[C@H]1CCC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2416	ClC1=C(N=C(N[C@@H]2CCC[C@@H](C2)N2CCN(CC2)C(=O)C=C)N=C1)C1=NSC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2417	ClC1=C(N=C(N[C@@H]2CCC[C@@H](C2)N2CCC3(CN(C3)C(=O)C=C)C2)N=C1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2418	ClC1=C(N=C(N[C@@H]2CCC[C@H](C2)N2CCC3(CN(C3)C(=O)C=C)C2)N=C1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2419	CN(C)CC=CC(=O)N1CC2(C1)CCN(C2)[C@H]1CCC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2420	CN(C)CC=CC(=O)N1CC2(C1)CCN(C2)[C@@H]1CCC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK7/cyclinH/MAT1	IC50	100	nM
2421	ClC1=C(N=C(N[C@H]2CCC[C@H](C2)N2CC3(C2)CCN(C3)C(=O)C=C)N=C1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2422	CN(C)CC=CC(=O)N1CCC2(CN(C2)[C@H]2CCC[C@H](C2)NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)C1	CDK7/cyclinH/MAT1	IC50	100	nM
2423	FC(F)(F)C1=C(N=C(N[C@@H]2CCC[C@@H](C2)NCC2CCN(CC2)C(=O)C=C)N=C1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2424	ClC1=C(N=C(N[C@@H]2CCC[C@@H](C2)N2CC3(C2)CCN(C3)C(=O)C=C)N=C1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2425	ClC1=C(N=C(N[C@@H]2CCC[C@H](C2)N2CC3(C2)CCN(CC3)C(=O)C=C)N=C1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2426	CN(C)CC=CC(=O)N1CCC2(CN(C2)[C@H]2CCC[C@H](C2)NC2=NC=C(Cl)C(=N2)C2=CNC3=C2C=CC=C3)CC1	CDK7/cyclinH/MAT1	IC50	100	nM
2427	CN1C=C(C2=CC=CC=C12)C1=C(Cl)C=NC(N[C@@H]2CCC[C@@H](C2)N2CCN(CC2)C(=O)C=C)=N1	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2428	ClC1=C(N=C(N[C@@H]2CCC[C@H](C2)N2CC3(C2)CCN(C3)C(=O)C=C)N=C1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2429	CN(C)CC=CC(=O)N1CCC2(CN(C2)[C@@H]2CCC[C@H](C2)NC2=NC=C(Cl)C(=N2)C2=CNC3=C2C=CC=C3)C1	CDK7/cyclinH/MAT1	IC50	100	nM
2430	C[C@@]1(CCC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1)N1CCN(CC1)C(=O)C=C	CDK7/cyclinH/MAT1	IC50	100	nM
2431	ClC1=C(N=C(N[C@@H]2CCC[C@@H](C2)N2C=C(NC(=O)C=C)C=N2)N=C1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2432	CCC1=C(N=C(N[C@@H]2CCC[C@@H](C2)N2CCN(CC2)C(=O)C=C)N=C1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2433	CN(C)CC=CC(=O)N1CCN(CC1)[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=NSC2=C1C=CC=C2	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2434	ClC1=CN=C(N[C@@H]2CCC[C@H](C2)N2CCOC(CNC(=O)C=C)C2)N=C1C1=CNC2=C1C=CC=C2	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2435	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)N2CCOC(CNC(=O)C=C)C2)N=C1C1=CNC2=C1C=CC=C2	CDK7/cyclinH/MAT1	IC50	100	nM
2436	CN(C)CC=CC(=O)NCC1CN(CCO1)[C@@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2437	CN(C)CC=CC(=O)NCC1CN(CCO1)[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2438	CN1C=C(C2=C1C=CC=C2)C1=NC(N[C@@H]2CCC[C@@H](C2)NCC2CCN(CC2)C(=O)C=C)=NC=C1Cl	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2439	CN(C)CC=CC(=O)N1CCC2(CN(C2)[C@@H]2CCC[C@H](C2)NC2=NC=C(Cl)C(=N2)C2=CNC3=CC=CC=C23)CC1	CDK7/cyclinH/MAT1	IC50	100	nM
2440	CN(C)CC=CC(=O)NC[C@H]1C[C@@H]1C(=O)N[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2441	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)[C@H]2C[C@@H]2CNC(=O)C=C)N=C1C1=CNC2=C1C=CC=C2	CDK7/cyclinH/MAT1	IC50	100	nM
2442	CC1=CC=CC2=C1NC=C2C1=NC(N[C@@H]2CCC[C@@H](C2)N2CCN(CC2)C(=O)C=C)=NC=C1Cl	CDK7/cyclinH/MAT1	IC50	100	nM
2443	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)N2C=C3CN(CC3=N2)C(=O)C=C)N=C1C1=CNC2=C1C=CC=C2	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2444	CN(C[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=C1C=CC=C2)C1CCN(CC1)C(=O)C=C	CDK7/cyclinH/MAT1	IC50	100	nM
2445	CCN(C[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=C1C=CC=C2)C1CCN(CC1)C(=O)C=C	CDK7/cyclinH/MAT1	IC50	100	nM
2446	CN(C)CC=CC(=O)N1CCN(CC1)[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CN(C)C2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2447	[H][C@@]12C[C@@H](CN1CCN(C2)C(=O)C=C)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2448	FC(F)(F)C1=CN=C(N[C@@H]2CCC[C@@H](C2)NCC2CCN(C2)C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2449	FC1=CC=C2NC=C(C2=C1)C1=NC(N[C@@H]2CCC[C@@H](C2)N2CCN(CC2)C(=O)C=C)=NC=C1Cl	CDK7/cyclinH/MAT1	IC50	100	nM
2450	FC(F)(F)C1CN(CCN1C(=O)C=C)[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2451	CN(C)CC=CC(=O)N1CCN(CC1C(F)(F)F)[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2452	FC(F)(F)C1CN(CCN1C(=O)C=C)[C@@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	1	μM
2453	CN(C)CC=CC(=O)N1CCN(CC1C(F)(F)F)[C@@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2454	CN(C)CC=CC(=O)N1CCN(CC1)[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=C(C)C=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2455	CN(C)CC=CC(=O)N1CCN(CC1)[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=C(F)C=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2456	CN(C)CC=CC(=O)NC[C@H]1C[C@H]1C(=O)N[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2457	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)[C@@H]2C[C@@H]2CNC(=O)C=C)N=C1C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2458	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NCC2CCN(C2)C(=O)C=C)N=C1C1=C2C=CC=CN2N=C1	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2459	C[C@@]1(CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=C2C=CC=CN2N=C1)NCC1CCN(CC1)C(=O)C=C	CDK7/cyclinH/MAT1	IC50	100	nM
2460	C[C@]1(CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=C2C=CC=CN2N=C1)NCC1CCN(CC1)C(=O)C=C	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2461	[H][C@@]12C[C@@H](CN1CCN(C2)C(=O)C=CCN(C)C)NC1=NC=C(Cl)C(=N1)C1=CNC2=C1C=CC=C2	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2462	CN(C)CC=CC(=O)N1CCC(CN[C@H]2CCC[C@H](C2)NC2=NC=C(C(=N2)C2=CNC3=CC=CC=C23)C(F)(F)F)C1	CDK7/cyclinH/MAT1	IC50	100	nM
2463	FC1=C2NC=C(C2=CC=C1)C1=C(Cl)C=NC(N[C@@H]2CCC[C@@H](C2)N2CCN(CC2)C(=O)C=C)=N1	CDK7/cyclinH/MAT1	IC50	100	nM
2464	CN(C)CC=CC(=O)N1CCC(CN[C@H]2CCC[C@H](C2)NC2=NC=C(Cl)C(=N2)C2=CNC3=CC=CC=C23)C1	CDK7/cyclinH/MAT1	IC50	100	nM
2465	ClC1=C(N=C(N[C@@H]2CCC[C@@H](C2)NCC2CCN(C2)C(=O)C=C)N=C1)C1=NNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2466	ClC1=C(N=C(N[C@@H]2CCC[C@H](C2)N2CC[C@@H](C2)NC(=O)C=C)N=C1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2467	CCC1=C(N=C(N[C@@H]2CCC[C@@H](C2)NCC2CCN(C2)C(=O)C=C)N=C1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2468	CCC1=C(N=C(N[C@@H]2CCC[C@@H](C2)NCC2CCN(C2)C(=O)C=CCN(C)C)N=C1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2469	ClC1=C(N=C(NC2CN(C2)C2CCCN(C2)C(=O)C=C)N=C1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	1	μM
2470	CN(C)CC=CC(=O)N1CCC(CN[C@H]2CCC[C@H](C2)NC2=NC(C3=C4C=CC=CN4N=C3)=C(Cl)C=N2)C1	CDK7/cyclinH/MAT1	IC50	100	nM
2471	CN(C)CC=CC(=O)NC1=CN(N=C1)[C@H]1CCC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK7/cyclinH/MAT1	IC50	100	nM
2472	CN(C)CC=CC(=O)NC1=CN=C(CN(C)[C@H]2CCC[C@H](C2)NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)C=C1	CDK7/cyclinH/MAT1	IC50	100	nM
2473	C[C@@H]1CN(CCN1[C@@H]1CCC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1)C(=O)C=CCN(C)C	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2474	C[C@@H]1CN(CCN1[C@H]1CCC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1)C(=O)C=CCN(C)C	CDK7/cyclinH/MAT1	IC50	100	nM
2475	ClC1=CN=C(N=C1N[C@@H]1CCC[C@@H](C1)N1CCN(CC1)C(=O)C=C)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	1	μM
2476	ClC1=C(N=C(N[C@@H]2CCC[C@@H](C2)N2CCC3=CC(NC(=O)C=C)=CC=C3C2=O)N=C1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2477	ClC1=C(N=C(N[C@@H]2CC[C@@H](C2)N2CCN(CC2)C(=O)C=C)N=C1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2478	ClC1=C(N=C(N[C@H]2CC[C@H](C2)N2CCN(CC2)C(=O)C=C)N=C1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2479	C[C@@]1(CCC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1)NC[C@H]1CC[C@@H](CC1)NC(=O)C=C	CDK7/cyclinH/MAT1	IC50	100	nM
2480	ClC1=C(N=C(N[C@@H]2CC[C@@H](C2)NCC2CCC(CC2)NC(=O)C=C)N=C1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2481	ClC1=C(N=C(N[C@H]2CC[C@H](C2)NCC2CCC(CC2)NC(=O)C=C)N=C1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2482	ClC1=C(N=C(N[C@@H]2CCC[C@@H](C2)N2CCN(CC2)C(=O)C=C)N=C1)C1=NNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2483	CN(C)CC=CC(=O)N1CCCC(C1)N1CC(C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	1	μM
2484	Cl.CN(C)C\C=C\C(=O)N(C)C1=CN=C(CN[C@H]2CCC[C@H](C2)NC2=NC=C(Cl)C(=N2)C2=CNC3=CC=CC=C23)C=C1	CDK7/cyclinH/MAT1	IC50	100	nM
2485	FC1(F)C[C@H](N(C1)C(=O)C=C)C(=O)N[C@H]1CCC[C@H](C1)NC1=NC(C2=NNC3=CC=CC=C23)=C(Cl)C=N1	CDK7/cyclinH/MAT1	IC50	100	nM
2486	FC1(F)C[C@H](N(C1)C(=O)C=C)C(=O)N[C@H]1CCC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(C=N1)C#N	CDK7/cyclinH/MAT1	IC50	100	nM
2487	ClC1=C(N=C(NC2=CC=C(CN[C@@H]3CCCN(C3)C(=O)C=C)C=C2)N=C1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2488	CN(C)CC=CC(=O)N1CC(F)(F)C[C@H]1C(=O)N[C@H]1CCC[C@@H](CC2=CC=C(Cl)C(=C2)C2=CNC3=CC=CC=C23)C1	CDK7/cyclinH/MAT1	IC50	100	nM
2489	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NCC2CCN(C2)C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100 - 1	nM
2490	COC1=C2NC=C(C2=CC=C1)C1=C(Cl)C=NC(N[C@@H]2CCC[C@@H](C2)N2CCN(CC2)C(=O)C=C)=N1	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2491	CN(C)CC=CC(=O)N1CC(F)(F)C[C@H]1C(=O)N[C@H]1CCC[C@@H](CC2=CC=C(C#N)C(=C2)C2=CNC3=CC=CC=C23)C1	CDK7/cyclinH/MAT1	IC50	100	nM
2492	[H][C@@]12CN(C[C@]1([H])[C@H]2CN[C@@]1(C)CCC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1)C(=O)C=C	CDK7/cyclinH/MAT1	IC50	100	nM
2493	[H][C@@]12CN(C[C@]1([H])[C@H]2CN[C@@]1(C)CCC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1)C(=O)C=CCN(C)C	CDK7/cyclinH/MAT1	IC50	100	nM
2494	Cl.CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N[C@@]1(C)CCC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(C=N1)C(F)(F)F	CDK7/cyclinH/MAT1	IC50	100	nM
2495	CN(C)CC=CC(=O)N1CCN(CC1)[C@H]1CCC[C@H](C1)NC1=NC(C2=CN=C3C=CC=CN23)=C(Cl)C=N1	CDK7/cyclinH/MAT1	IC50	100	nM
2496	FC(=C)C(=O)N1CCN(CC1)[C@H]1CCC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK7/cyclinH/MAT1	IC50	100	nM
2497	FC(=C)C(=O)NC1=CC=C(N=C1)C(=O)N[C@H]1CCC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2498	Cl.CN(C)C\C=C\C(=O)NC1=CN=C(CN[C@@]2(C)CCC[C@H](C2)NC2=NC(C3=CNC4=CC=CC=C34)=C(C=N2)C(F)(F)F)C=C1	CDK7/cyclinH/MAT1	IC50	100	nM
2499	CN(C)CC=CC(=O)N1CC(F)(F)C[C@H]1C(=O)N[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=NNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2500	ClC1=C(N=C(N[C@@H]2CCC[C@@H](C2)NCC2=NC=C(NC(=O)C=C)C=N2)N=C1)C1=NNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2501	CN(C)CC=CC(=O)NC1=CN=C(CN[C@H]2CCC[C@H](C2)NC2=NC(C3=C4C=CC=CC4=NN3)=C(Cl)C=N2)N=C1	CDK7/cyclinH/MAT1	IC50	100	nM
2502	Cl.CCC1=C(N=C(N[C@@H]2CCC[C@@](C)(C2)NC(=O)C2=CC=C(NC(=O)\C=C\CN(C)C)C=N2)N=C1)C1=C(C)NC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2503	OC(=O)C(F)(F)F.CCC1=C(N=C(N[C@@H]2CCC[C@@](C)(C2)NC(=O)C2=NC=C(NC(=O)\C=C\CN(C)C)C=C2)N=C1)C1=NNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2504	Cl.ClC1=C(N=C(N[C@@H]2CCC[C@@H](C2)N2CCN(CC2)C(=O)C=C)N=C1)C1=CN=C2C=CC=CN12	CDK7/cyclinH/MAT1	IC50	100 - 1	nM
2505	CN(C)CC=CC(=O)N1CCC[C@H](C1)NCC1=CC=C(NC2=NC=C(Cl)C(=N2)C2C=NC3=CC=CC=C23)C=C1	CDK7/cyclinH/MAT1	IC50	100	nM
2506	Cl.N[C@H]1CC[C@@H](CC1)C(=O)NC1=CC(NC2=NC(C3=CNC4=CC=CC=C34)=C(Cl)C=N2)=CC=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2507	ClC1=C(N=C(NC2=CC=CC(NC(=O)C3CCCNC3)=C2)N=C1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2508	CN(C)C\C=C\C(=O)NCCCCC(=O)N1CC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2509	FC1(CN2CCN(CC2)C(=O)C=C)CCC(CC1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2510	FC1(CN2CCN(CC2)C(=O)C=C)CCC(CC1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2511	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC2CCN(CC2)C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2512	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)N2CCC(CC2)NC(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100 - 1	nM
2513	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)N2CCC(CC2)NC(=O)C=C)N=C1C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2514	ClC1=CN=C(NC2CCC(CC2)NCC2CCN(CC2)C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2515	ClC1=CN=C(NC2CCC[C@H](C2)N2CC3=CC=C(NC(=O)C=C)C=C3C2)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2516	CN(CC1CCN(CC1)C(=O)C=C)[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2517	CN(C)CC=CC(=O)N1CC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2518	CN(C)CC=CC(=O)N1CCC(CNC2CCCC(C2)NC2=NC=C(Cl)C(=N2)C2=CNC3=CC=CC=C23)CC1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2519	ClC1=CN=C(NC2CCCC(C2)NCC2CCN(CC2)C(=O)CC=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2520	CN(C)CC=CC(=O)N1CCC(CC1)C(=O)NC1CCCC(C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2521	CN(C)CC=CC(=O)N1CCC(CC1)C(=O)NC1CCCC(C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2522	ClC1=CN=C(N[C@@H]2CCC[C@H](C2)N2CCN(CC2)C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100 - 1	nM
2523	Cl.CCC1=C(N=C(N[C@@H]2CCC[C@@](C)(C2)NC(=O)C2=CC=C(NC(=O)\C=C\CN(C)C)C=N2)N=C1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2524	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)C2CCN(CC2)C(=O)C=C)N=C1C1=C2C=CC=CN2N=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2525	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)NC(=O)C2CCN(CC2)C(=O)C=C)N=C1C1=C2C=CC=CN2N=C1	CDK7/cyclinH/MAT1	IC50	100	nM
2526	CN(C)CC=CC(=O)N1CCC(CC1)C(=O)N[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=C2C=CC=CN2N=C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2527	CN(C)CC=CC(=O)N1CCC(CC1)C(=O)N[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=C2C=CC=CN2N=C1	CDK7/cyclinH/MAT1	IC50	100	nM
2528	CN(C)CC=CC(=O)N1CCC(CC1)C(=O)N(C)[C@H]1CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2529	ClC1=CN=C(N[C@@H]2CC[C@@H](CC2)NCC2CCN(CC2)C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100 - 1	nM
2530	ClC1=CN=C(N[C@H]2CC[C@@H](CC2)N(CC2CCN(CC2)C(=O)C=C)C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	1	μM
2531	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)N2CC3(CCN(CC3)C(=O)C=C)OC2=O)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2532	ClC1=CN=C(N[C@@H]2CCC[C@@H](C2)N2CC3(CCN(CC3)C(=O)C=C)OC2=O)N=C1C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2533	O[C@@]1(CN2CCN(CC2)C(=O)C=C)CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2534	O[C@]1(CN2CCN(CC2)C(=O)C=C)CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2535	O[C@]1(CN2CCN(CC2)C(=O)C=C)CCC[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	CDK7/cyclinH/MAT1	IC50	100	nM
2536	ClC1=CN=C(N[C@@H]2CC[C@@H](CC2)NC(=O)C2CCN(CC2)C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100 - 1	nM
2537	ClC1=CN=C(N[C@H]2CC[C@@H](CC2)NCC2CCCN(C2)C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2538	ClC1=CN=C(N[C@H]2CC[C@@H](CC2)N(CC2CCCN(C2)C(=O)C=C)C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2539	ClC1=CN=C(N[C@H]2CC[C@H](CC2)N(CC2CCCN(C2)C(=O)C=C)C(=O)C=C)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	1	μM
2540	CN(C)CC=CC(=O)N1CCCC(C1)C(=O)N[C@H]1CC[C@@H](CC1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2541	CN(C)C\C=C\C(=O)N1CCCC(CN[C@H]2CC[C@@H](CC2)NC2=NC=C(Cl)C(=N2)C2=CNC3=CC=CC=C23)C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100	nM
2542	CN(C)CC=CC(=O)N1CCCC(CN[C@H]2CC[C@H](CC2)NC2=NC=C(Cl)C(=N2)C2=CNC3=CC=CC=C23)C1	Cyclin-dependent kinase 7;+Cyclin;+Cyclin-dependent kinase 7;+Cyclin	IC50	100 - 1	nM
2543	NC1=C(\N=N\C2=CC=NC=C2)C(N)=NN1	Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	IC50	14.88	µM
2544	CN1N=C(N)C(\N=N\C2=CC=NC=C2)=C1N	Cyclin-dependent kinase 7 [human];+Cyclin-H [human]	IC50	50	µM
2545	C(CN1N=NC=C1C1=CC2=C(N1)N=CC=C2)CC1=CNC2=C1C=CC=N2	Cyclin-H; Cyclin-dependent kinase 7; CDK-activating kinase assembly factor MAT1	IC50	50	μM
2546	CC1(C)OCC2=C(NC3=NNC4=CC=CC=C34)N=C(N=C12)C1=CNN=C1	Cyclin-dependent kinase 7;+Cyclin-H	inhibition percentage	14.3	%
2547	FC(F)(F)C1=CC(NC(=O)NC2=CC=C(NC3=NC(NC4=NNC(=C4)C4CC4)=CC=N3)C=C2)=CC=C1	Cyclin-dependent kinase 7;+Cyclin-H;+CDK-activating kinase assembly factor MAT1	inhibition percentage	7	%
2548	CSC1=CC=C(NC(=O)NC2=CC=C(NC3=NC(NC4=NNC(=C4)C4CC4)=CC=N3)C=C2)C=C1	Cyclin-dependent kinase 7;+Cyclin-H;+CDK-activating kinase assembly factor MAT1	inhibition percentage	26	%
2549	IC1=CC=C(OC2=C3C=C(SC3=CN=C2)C2=NN=NN2)C=C1	Cyclin-dependent kinase 7;+Cyclin-H	inhibition percentage	4.45	%
2550	CN1CCN(CCCOC2=CC=C(C=C2)N2C(=S)S\C(=C/C3=CC=C(OC4=CC=C(F)C=C4)C=C3)C2=O)CC1	Cyclin-dependent kinase 7;+Cyclin-H;+Cyclin-dependent kinase 7;+Cyclin-H	inhibition percentage	2.5	%
2551	CC(=O)N1CCC(CC1)N1C=C(NC2=NC(C3=CN=C4C=CC=CN34)=C(Cl)C=N2)C=N1	Cyclin-dependent kinase 7	IC50	0.021	μM
2552	CNC1=NC=C2C=C(C(=O)N(CCC3(F)CN(C)C3)C2=N1)C1=C(Cl)C=C(C=C1)N1C=CC=C(C)C1=O	CDK-activating kinase assembly factor MAT1	inhibition percentage	1.4	%
2553	CNC1=NC2=C(C=N1)C=C(C(=O)N2CCOC)C1=C(Cl)C=C(C=C1)N1C=NC=C(C)C1=O	CDK-activating kinase assembly factor MAT1	inhibition percentage	3.4	%
2554	CNC1=NC=C2C=C(C(=O)N(CC3OCC(N)CO3)C2=N1)C1=CC=C(C=C1Cl)C1=NC(C)=CC=C1	CDK-activating kinase assembly factor MAT1	inhibition percentage	7.7	%
2555	OC(=O)C(F)(F)F.CN(C)C[C@@H](NC(=O)N1CC2=C(NN=C2NC2=CC=C(NC(=O)C3=CC=C(NC(=O)C=C)C=C3)C=C2)C1(C)C)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
2556	OC(=O)C(F)(F)F.CN(C)C[C@@H](NC(=O)N1CC2=C(NN=C2NC2=CC=C(NC(=O)C3=CC(NC(=O)C=C)=CC=C3)C=C2)C1(C)C)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
2557	OC(=O)C(F)(F)F.CCC(=O)NC1=CC=C(C=C1)C(=O)NC1=CC=CC(NC2=NNC3=C2CN(C(=O)N[C@H](CN(C)C)C2=CC=CC=C2)C3(C)C)=C1	Cyclin-dependent kinase 7	IC50	100	nM
2558	OC(=O)C(F)(F)F.CN(C)C[C@@H](NC(=O)N1CC2=C(NN=C2NC2=CC(NC(=O)C3=CC(NC(=O)C=C)=CC=C3)=CC=C2)C1(C)C)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
2559	OC(=O)C(F)(F)F.CN(C)CCNC(=O)N1CC2=C(NC3=CC(NC(=O)C4=CC=C(NC(=O)C=C)C=C4)=CC=C3)NN=C2C1(C)C	Cyclin-dependent kinase 7	IC50	100 - 1	nM
2560	OC(=O)C(F)(F)F.CN1CCN(CC1)C(=O)N1CC2=C(NN=C2NC2=CC=CC(NC(=O)C3=CC=C(NC(=O)C=C)C=C3)=C2)C1(C)C	Cyclin-dependent kinase 7	IC50	100	nM
2561	OC(=O)C(F)(F)F.CC(CN(C)C)NC(=O)N1CC2=C(NN=C2NC2=CC(NC(=O)C3=CC=C(NC(=O)C=C)C=C3)=CC=C2)C1(C)C	Cyclin-dependent kinase 7	IC50	100	nM
2562	OC(=O)C(F)(F)F.CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)NC1=CC=CC(NC2=NNC3=C2CN(C(=O)N[C@H](CO)C2=CC=CC=C2)C3(C)C)=C1	Cyclin-dependent kinase 7	IC50	100	nM
2563	OC(=O)C(F)(F)F.CN(C)C[C@@H](NC(=O)N1CC2=C(NN=C2NC2=CC(NC(=O)C=C)=CC=C2)C1(C)C)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
2564	OC(=O)C(F)(F)F.CN(C)C[C@@H](NC(=O)N1CC2=C(NN=C2NC2=CC=C(NC(=O)C=C)C=C2)C1(C)C)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100 - 1	nM
2565	OC(=O)C(F)(F)F.CN(C)C[C@@H](NC(=O)N1CC2=C(NN=C2NC(=O)C2=CC(NC(=O)C3=CC=C(NC(=O)C=C)C=C3)=CC=C2)C1(C)C)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
2566	OC(=O)C(F)(F)F.CN(C)C[C@@H](NC(=O)N1CC2=C(NN=C2NC(=O)C2=CC(NC(=O)C=C)=CC=C2)C1(C)C)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
2567	OC(=O)C(F)(F)F.COC1=C(C=CC(NC(=O)C=C)=C1)C(=O)NC1=NNC2=C1CN(C(=O)N[C@H](CN(C)C)C1=CC=CC=C1)C2(C)C	Cyclin-dependent kinase 7	IC50	100	nM
2568	OC(=O)C(F)(F)F.COC1=C(NC(=O)C=C)C=CC(=C1)C(=O)NC1=C2CN(C(=O)N[C@H](CN(C)C)C3=CC=CC=C3)C(C)(C)C2=NN1	Cyclin-dependent kinase 7	IC50	100	nM
2569	OC(=O)C(F)(F)F.CN(C)C[C@@H](NC(=O)N1CC2=C(NN=C2NC(=O)[C@@H]2CCCN(C2)C(=O)C=C)C1(C)C)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
2570	OC(=O)C(F)(F)F.CN(C)C[C@@H](NC(=O)N1CC2=C(NN=C2NC(=O)[C@H]2CCCN(C2)C(=O)C=C)C1(C)C)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
2571	OC(=O)C(F)(F)F.CN(C)C[C@@H](NC(=O)N1CC2=C(NN=C2NC(=O)C2CCN(CC2)C(=O)C=C)C1(C)C)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
2572	OC(=O)C(F)(F)F.CN(C)C[C@@H](NC(=O)N1CC2=C(NN=C2NC(=O)C2CCC(CC2)NC(=O)C=C)C1(C)C)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
2573	OC(=O)C(F)(F)F.CN(C)C[C@@H](NC(=O)N1CC2=C(NN=C2NC2CCCN(C2)C(=O)C2=CC=C(NC(=O)C=C)C=C2)C1(C)C)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
2574	OC(=O)C(F)(F)F.CN(C)C[C@@H](NC(=O)N1CC2=C(NN=C2NC2CCN(CC2)C(=O)C2=CC=C(NC(=O)C=C)C=C2)C1(C)C)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
2575	OC(=O)C(F)(F)F.CN(C)C[C@@H](NC(=O)N1CC2=C(NN=C2N[C@@H]2CCC[C@@H](C2)NC(=O)C2=CC=C(NC(=O)C=C)C=C2)C1(C)C)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
2576	OC(=O)C(F)(F)F.CN(C)C[C@@H](NC(=O)N1CC2=C(NN=C2N[C@@H]2CCC[C@H](C2)NC(=O)C2=CC=C(NC(=O)C=C)C=C2)C1(C)C)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
2577	OC(=O)C(F)(F)F.CN(C)C[C@@H](NC(=O)N1CC2=C(NN=C2NC2CCC(CC2)NC(=O)C2=CC=C(NC(=O)C=C)C=C2)C1(C)C)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
2578	OC(=O)C(F)(F)F.CN(C)C[C@@H](NC(=O)N1CC2=C(NN=C2NC2CCN(CC2)C(=O)C=C)C1(C)C)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
2579	OC(=O)C(F)(F)F.CN(C)C[C@@H](NC(=O)N1CC2=C(NN=C2NC2CCCN(C2)C(=O)C=C)C1(C)C)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
2580	CN1CC=CCCOC2=CC=CC(=C2)C2=CC=NC(NC3=CC(C1)=CC(NC(=O)C1=CC=C(NC(=O)C=C)C=C1)=C3)=N2	Cyclin-dependent kinase 7	Kd (dissociation constant)	1	nM
2581	CN1CC=CCCOC2=CC=CC(=C2)C2=CC=NC(NC3=CC(C1)=CC(NC(=O)C1=CC=C(NC(=O)C=C)C=C1)=C3)=N2	Cyclin-dependent kinase 7	IC50	15	nM
2582	CC(O)=O.CC(C)C1=C2N=C(OC3CCN(C)CC3)N=C(NCC3=CC=CC(NC(=O)C4CCCN(C4)C(=O)C=C)=C3)N2N=C1	Cyclin-dependent kinase 7	IC50	300	nM
2583	CC(O)=O.CC(C)C1=C2N=C(OC3CCN(C)CC3)N=C(NCC3=CC=CC(NC(=O)C4CCCN(C4)C(=O)C=C)=C3)N2N=C1	Cyclin-dependent kinase 7	inhibition percentage	92	%
2584	CC(O)=O.CC(C)C1=C2N=C(OC3CCN(C)CC3)N=C(NCC3=CC=CC(NC(=O)C4CCCN(C4)C(=O)C=C)=C3)N2N=C1	Cyclin-dependent kinase 7	IC50	1 - 10	μM
2585	CC(O)=O.CC(C)C1=C2N=C(OC3CCN(C)CC3)N=C(NC3=CC=CC(NC(=O)C4=CC=C(NC(=O)C=C)C=C4)=C3)N2N=C1	Cyclin-dependent kinase 7	IC50	300	nM
2586	CC(O)=O.CC(C)C1=C2N=C(OC3CCN(C)CC3)N=C(NC3=CC=CC(NC(=O)C4=CC=C(NC(=O)C=C)C=C4)=C3)N2N=C1	Cyclin-dependent kinase 7	inhibition percentage	86	%
2587	CC(O)=O.CC(C)C1=C2N=C(OC3CCN(C)CC3)N=C(NC3=CC=CC(NC(=O)C4=CC=C(NC(=O)C=C)C=C4)=C3)N2N=C1	Cyclin-dependent kinase 7	IC50	1	μM
2588	CC1=CC=C(NC(=O)C2=CC=C(C)C(=C2)C(F)(F)F)C=C1C#CC1=NN([C@H]2CC[C@H](O)CC2)C2=NC=NC(N)=C12	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-3	%
2589	CCS(=O)(=O)C1=C(C=CC(NC2=NC(N(CC3=CC=CC=C3C#N)C3=CC(CO)=CC=C3C)=C(F)C=N2)=C1)N1CCN(C)CC1	Cyclin-dependent kinase 7 [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-H [human]	inhibition percentage	-3	%
2590	CON(C)C\C=C\C(=O)NC1=C(F)C=C(C=C1)C1=CC(=CC=C1)C(C)C(=O)NC1=NNC(=C1)C1CC1	Cyclin-dependent kinase 7	inhibition percentage	81	%
2591	CON(C)C\C=C\C(=O)NC1=C(F)C=C(C=C1)C1=CC(=CC=C1)C(C)C(=O)NC1=NNC(=C1)C1CC1	Cyclin-dependent kinase 7	IC50	0.1	μM
2592	COCCN(C)C\C=C\C(=O)NC1=C(C)C=C(C=C1C)C1=CC(=CC=C1)C(C)C(=O)NC1=NNC(=C1)C1CC1	Cyclin-dependent kinase 7	inhibition percentage	95	%
2593	COCCN(C)C\C=C\C(=O)NC1=C(C)C=C(C=C1C)C1=CC(=CC=C1)C(C)C(=O)NC1=NNC(=C1)C1CC1	Cyclin-dependent kinase 7	IC50	0.025	μM
2594	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CC(C)=C(NC(=O)\C=C\CN2C=CN=C2)C(C)=C1	Cyclin-dependent kinase 7	inhibition percentage	87	%
2595	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CC(C)=C(NC(=O)\C=C\CN2C=CN=C2)C(C)=C1	Cyclin-dependent kinase 7	IC50	0.025 - 0.1	μM
2596	COC[C@@H]1CCCN1C\C=C\C(=O)NC1=C(C)C=C(C=C1C)C1=CC(=CC=C1)C(C)C(=O)NC1=NNC(=C1)C1CC1	Cyclin-dependent kinase 7	inhibition percentage	81 - 98	%
2597	COC[C@@H]1C[C@H](F)CN1C\C=C\C(=O)NC1=NC=C(C=C1)C1=CC(=CC=C1)C(C)C(=O)NC1=NNC(=C1)C1CC1	Cyclin-dependent kinase 7	inhibition percentage	98	%
2598	COC[C@@H]1C[C@H](F)CN1C\C=C\C(=O)NC1=NC=C(C=C1)C1=CC(=CC=C1)C(C)C(=O)NC1=NNC(=C1)C1CC1	Cyclin-dependent kinase 7	IC50	0.025 - 0.1	μM
2599	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CC(F)=C(NC(=O)\C=C\CN2CC[C@H](C)C2)C=C1	Cyclin-dependent kinase 7	inhibition percentage	95	%
2600	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CC(F)=C(NC(=O)\C=C\CN2CC[C@H](C)C2)C=C1	Cyclin-dependent kinase 7	IC50	0.025 - 0.1	μM
2601	COC(=O)[C@@H]1CCCN1C\C=C\C(=O)NC1=C(C)C=C(C=C1C)C1=CC(=CC=C1)C(C)C(=O)NC1=NNC(=C1)C1CC1	Cyclin-dependent kinase 7	inhibition percentage	100	%
2602	COC(=O)[C@@H]1CCCN1C\C=C\C(=O)NC1=C(C)C=C(C=C1C)C1=CC(=CC=C1)C(C)C(=O)NC1=NNC(=C1)C1CC1	Cyclin-dependent kinase 7	IC50	0.025 - 0.1	μM
2603	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CC(C)=C(NC(=O)\C=C\CN2CCC[C@H]2CC#N)C(C)=C1	Cyclin-dependent kinase 7	inhibition percentage	99	%
2604	CC(C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CC(C)=C(NC(=O)\C=C\CN2CCC[C@H]2CC#N)C(C)=C1	Cyclin-dependent kinase 7	IC50	0.025 - 0.1	μM
2605	C[C@H](C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CC=C(NC(=O)\C=C\CN(C)C)C=C1	Cyclin-dependent kinase 7	inhibition percentage	69	%
2606	C[C@H](C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CC=C(NC(=O)\C=C\CN(C)C)C=C1	Cyclin-dependent kinase 7	IC50	0.1	μM
2607	C[C@@H](C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CC=C(NC(=O)\C=C\CN(C)C)C=C1	Cyclin-dependent kinase 7	inhibition percentage	99	%
2608	C[C@@H](C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CC=C(NC(=O)\C=C\CN(C)C)C=C1	Cyclin-dependent kinase 7	IC50	0.025 - 0.1	μM
2609	CC(C(=O)NC1=NN(C)C(=C1)C1CC1)C1=CC=CC(=C1)C1=CC=C(NC(=O)\C=C\CN(C)C)C=C1	Cyclin-dependent kinase 7	inhibition percentage	0	%
2610	C[C@@H](C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CN=C(NC(=O)\C=C\CN2CCOCC2)C=C1	Cyclin-dependent kinase 7	inhibition percentage	75	%
2611	C[C@@H](C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CN=C(NC(=O)\C=C\CN2CCOCC2)C=C1	Cyclin-dependent kinase 7	IC50	0.1	μM
2612	C[C@@H](C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CN=C(NC(=O)C=C)C=C1	Cyclin-dependent kinase 7	inhibition percentage	89	%
2613	C[C@@H](C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CN=C(NC(=O)C=C)C=C1	Cyclin-dependent kinase 7	IC50	0.1	μM
2614	C[C@H](C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CN=C(NC(=O)C=C)C=C1	Cyclin-dependent kinase 7	inhibition percentage	97	%
2615	C[C@H](C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CN=C(NC(=O)C=C)C=C1	Cyclin-dependent kinase 7	IC50	0.025	μM
2616	CNC\C=C\C(=O)NC1=C(F)N=C(C=C1)C1=CC(=CC=C1)C(C)C(=O)NC1=NNC(=C1)C1CC1	Cyclin-dependent kinase 7	inhibition percentage	94	%
2617	CNC\C=C\C(=O)NC1=C(F)N=C(C=C1)C1=CC(=CC=C1)C(C)C(=O)NC1=NNC(=C1)C1CC1	Cyclin-dependent kinase 7	IC50	0.1	μM
2618	C[C@@H](C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CN=C(NC(=O)\C=C\CN2CCCC2)C=C1	Cyclin-dependent kinase 7	inhibition percentage	100	%
2619	C[C@@H](C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CN=C(NC(=O)\C=C\CN2CCCC2)C=C1	Cyclin-dependent kinase 7	IC50	0.025	μM
2620	C[C@H](C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CN=C(NC(=O)\C=C\CN2CCCC2)C=C1	Cyclin-dependent kinase 7	inhibition percentage	78	%
2621	C[C@H](C(=O)NC1=NNC(=C1)C1CC1)C1=CC=CC(=C1)C1=CN=C(NC(=O)\C=C\CN2CCCC2)C=C1	Cyclin-dependent kinase 7	IC50	0.025	μM
2622	NC1=CC=C(C=C1)C(=O)N[C@H]1C[C@H](O)C[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2623	NC1=CC=C(C=C1)C(=O)N[C@H]1C[C@@H](F)C[C@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7 [human]	IC50	100 - 1	nM
2624	CC1=NC(=CC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=N1)N1CCN(CCNC(=O)C2=NN(N=N2)C2=CC=C(NCC(=O)NCCC#C)C=C2)CC1	Cyclin-dependent kinase 7	Ki (inhibition constant)	5.05	μM
2625	CC1=NC(=CC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=N1)N1CCN(CCOCCOCCNC(=O)C2=NN(N=N2)C2=CC=C(NCC(=O)NCCC#C)C=C2)CC1	Cyclin-dependent kinase 7	Ki (inhibition constant)	5.05	μM
2626	CC1=NC(=CC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=N1)N1CCN(CCNC(=O)[C@H](CCC2(C)N=N2)NC(=O)CCCC#C)CC1	Cyclin-dependent kinase 7	Ki (inhibition constant)	5.05	μM
2627	CC1=NC(=CC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=N1)N1CCN(CCOCCOCCNC(=O)[C@H](CCC2(C)N=N2)NC(=O)CCCC#C)CC1	Cyclin-dependent kinase 7	Ki (inhibition constant)	5.05	μM
2628	CSC1=NC(C)=C(N1)C1=CC=NC(NC2=CC=C(NC(=O)C3=CC=CC(NC(=O)C=C)=C3)C=C2)=C1	Cyclin-dependent kinase 7;+CDK-activating kinase assembly factor MAT1;+Cyclin-H1-1	inhibition percentage	11	%
2629	CSC1=NC(C)=C(N1)C1=CC=NC(NC2=CC=C(NC(=O)C3=CC=CC(NC(=O)C=C)=C3)C=C2)=C1	Cyclin-dependent kinase 7;+CDK-activating kinase assembly factor MAT1;+Cyclin-H1-1	inhibition percentage	14	%
2630	NS(=O)(=O)C1=CC=C(NC2=NC(OCC3CCCCC3)=C3C=CNC3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	4.1	μM
2631	NC1=NC(OCC2CCCCC2)=C2C=NNC2=N1	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage	16	%
2632	NS(=O)(=O)C1=CC=C(NC2=NC3=C(C=N2)N=CN3)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	75	μM
2633	NS(=O)(=O)C1=CC=C(NC2=NC(=C3N=CNC3=N2)C2=CC=CC=C2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	6.8	μM
2634	NS(=O)(=O)C1=CC=C(NC2=CC(OCC3CCCCC3)=C3N=CNC3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage	37	%
2635	NC1=NC(OCC2CCCCC2)=C2C=CNC2=N1	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage	5.1	%
2636	OC(=O)C(F)(F)F.CN1CCN(CC1)C1=CC=C(NC2=NC(NC3=C(OC(=O)C=C)C=CC=C3)=C(Cl)C=N2)C=C1	Cyclin-dependent kinase 7	inhibition percentage	0.85	%
2637	CN1C=C(N=C(NC2=CC(NC(=O)C=C)=C(C=C2)C(=O)N2CCOCC2)C1=O)C1=C(C)C(NC(=O)C2=CC=C(C=C2)C(C)(C)C)=CC=C1	Cyclin-dependent kinase 7	inhibition percentage	11	%
2638	CCC1=NC=CC(CNC2=CC(Cl)=NN3C2=NC(C)=C3C2=CC=C(OC)C(=C2)S(=O)(=O)NCCO)=C1	Cyclin-dependent kinase 7	inhibition percentage	50	%
2639	CN(C)N1CCN(CC1)C1=CN=C(NC(=O)C2=CC=CC(NC(=O)C=C)=C2)S1	Cyclin-dependent kinase 7	IC50	10000	nM
2640	CN(C)N1CCN(CC1)C1=CN=C(NC(=O)C2=CC=CC(NC(=O)C=C)=C2)S1	Cyclin-dependent kinase 7	IC50	10000	nM
2641	CN1CCN(CC2=C(C=C(C=C2)C(=O)NC2=CC(OC3CCN(CC3)C(=O)C3=CC=C(C)N=C3)=C(C)C=C2)C(F)(F)F)CC1	Cyclin-dependent kinase 7	inhibition percentage	0	%
2642	CS(=O)(=O)C1=CC=C(C=C1)N1N=C(C2=C1N=CN=C2N)C1=CC2=C(NC=C2)N=C1	Cell division protein kinase 2 homolog [human];+Cyclin-B1-1 [human]	inhibition percentage	-11	%
2643	CS(=O)(=O)C1=CC=C(C=C1)N1N=C(C2=C1N=CN=C2N)C1=CC2=C(NC=C2)N=C1	Cyclin-H [human];+MATE efflux family protein 1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	7	%
2644	COC1=C(NC(=C1)C1=CC=CN1)C=C1C(=O)N\C(=C/C)C1=O	CDK-activating kinase assembly factor MAT1	inhibition percentage	2.36 - 3.36	%
2645	COC1=C(NC2=NC=C(Cl)C(NC3=CC=CC=C3S(=O)(=O)C(C)C)=N2)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C	Cyclin-dependent kinase 7	inhibition percentage	79	%
2646	CCC(C)OC1=NC(NC2=CC=C(C=C2)S(N)(=O)=O)=NC2=C1N=CN2	Cyclin-H;+Cyclin-dependent kinase 7	IC50	2.8	μM
2647	OC[C@@H]1C[C@H]2CN1C1=NC3=C(Cl)C=NN3C(NC3=CC(OC\C=C\CO2)=C2N(CC4=CC=CC=C4)C(=O)CCC2=C3)=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	inhibition percentage	25	%
2648	FS(=O)(=O)C1=CC=C(C=C1)C(=O)N1CCN(CC1)C1=NC(=CC(NC2=NNC(=C2)C2CC2)=N1)C(=O)NCC#C	Cyclin-dependent kinase 7	inhibition percentage		
2649	FS(=O)(=O)C1=CC(CN2CCN(CC2)C2=NC(=CC(NC3=NNC(=C3)C3CC3)=N2)C(=O)NCC#C)=CC=C1	Cyclin-dependent kinase 7	inhibition percentage		
2650	CC(C)N1C=NC2=C(NC3=CC(NC(=O)C=CCN(C)C)=CC=C3)N=C(N[C@H]3CC[C@H](CC3)N(C)C)N=C12	Cyclin-H [human];+Cyclin-dependent kinase 7	IC50	121	nM
2651	[H][C@@]12CC[C@H](O)[C@@]1(C)C[C@H]1O[C@@]11[C@@]2([H])C(=O)C2=C3C(=CO2)C(=O)O[C@H](COC)[C@]13C	Cyclin-dependent kinase 7	inhibition percentage	0	%
2652	CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)CCCCN1C=C(CCCCNC(=O)CCCCCN2N=C(N)C3=C2N=NC(=C3)C2=C3C=CC=CN3N=C2C2=CC=CC=C2)N=N1)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(O)=O	Cyclin-dependent kinase 7 [human]	inhibition percentage	0	%
2653	CC1=NC(=CC=C1)C(=O)N[C@H]1C[C@H](C1)N1C=NC2=C(NCC3=CC(Br)=CC=C3)N=CN=C12	Cyclin-dependent kinase 7	IC50	359	nM
2654	CO[C@@H](C(=O)N1CC2=C(NN=C2NC(=O)C2(CCC2)[Si](C)(C)C)C1(C)C)C1=CC=CS1	Cyclin-dependent kinase 7	Ki (inhibition constant)	50	nM
2655	CC(C)(CO)[C@H](NC(=O)N1CC2=C(NN=C2NC(=O)C2(CCC2)[Si](C)(C)C)C1(C)C)C1=CC=CC=C1	Cyclin-dependent kinase 7	Ki (inhibition constant)	50	nM
2656	CC(C)(CO)[C@H](NC(=O)N1CC2=C(NN=C2NC(=O)C2(CCC2)[Si](C)(C)C)C1(C)C)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	500	nM
2657	CC(C)(CO)[C@H](NC(=O)N1CC2=C(NN=C2NC(=O)C2(CCC2)[Si](C)(C)C)C1(C)C)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	500	nM
2658	CC(C)(CO)[C@H](NC(=O)N1CC2=C(NN=C2NC(=O)C2(CCC2)[Si](C)(C)C)C1(C)C)C1=CC=CC(F)=C1	Cyclin-dependent kinase 7	Ki (inhibition constant)	50	nM
2659	CN1C(=CC2=C(Cl)C=CN=C12)C1=CC=C(C=C1)N1CCNCC1	Cyclin-dependent kinase 7	IC50	10	μM
2660	ClC1=C2C=C(NC2=NC=C1)C1=CC=C(C=C1)N1CCNCC1	Cyclin-dependent kinase 7	IC50	0.04	μM
2661	N#CC1=C2C=C(NC2=NC=C1)C1=CC=C(C=C1)N1CCNCC1	Cyclin-dependent kinase 7	IC50	0.06	μM
2662	CN1C(=CC2=C(C=CN=C12)C#N)C1=CC=C(C=C1)N1CCNCC1	Cyclin-dependent kinase 7	IC50	10	μM
2663	OC(=O)C(F)(F)F.CC1=CC=C(OC2=CC=NC3=CC(=CC=C23)C2=CN(N=C2)C2CCNCC2)C=C1	Cyclin-dependent kinase 7	inhibition percentage	4	%
2664	CN(C)CC1CCC(CC1)N1C(=O)NCC2=C1C1=CC(=CC=C1N=C2)C1=CC(Cl)=C(O)C(Cl)=C1	Cyclin-dependent kinase 7	IC50	1230	nM
2665	CC(=C)N1C(=O)N(C(C)=O)C2=CC(Br)=CN=C12	Cyclin-dependent-like kinase 5 [human];+CDK-activating kinase assembly factor MAT1 [human]	inhibition percentage	0	%
2666	CC(=C)N1C(=O)N(C(C)=O)C2=CC(Br)=CN=C12	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-8	%
2667	[H].[H].[H].[H].[H].[H].C.C.C.C.C.C.N.N.N.N.N.O.O.O.S.S	Cyclin-dependent kinase 7	IC50	132	nM
2668	[H].[H].[H].[H].[H].[H].C.C.C.C.C.C.N.N.N.N.N.O.O.O.S.S	Cyclin-dependent kinase 7	IC50	0.495	nM
2669	CN1CC[C@H]([C@@H]1O)C1=C2OC(=CC(=O)C2=C(O)C=C1O)C1=CC=CC=C1Cl	Cyclin-dependent kinase 7	Ki (inhibition constant)	10	μM
2670		Bcl-2 homologous antagonist/killer [human]; Cyclin-dependent kinase 7 [human]	IC50	0.04	μmol/l
2671		Bcl-2 homologous antagonist/killer [human]; Cyclin-dependent kinase 7 [human]	IC50	0.16	μmol/l
2672		Bcl-2 homologous antagonist/killer [human]; Cyclin-dependent kinase 7 [human]	IC50	0.02	μmol/l
2673		Bcl-2 homologous antagonist/killer [human]; Cyclin-dependent kinase 7 [human]	IC50	0.02	μmol/l
2674		Bcl-2 homologous antagonist/killer [human]; Cyclin-dependent kinase 7 [human]	IC50	0.02	μmol/l
2675		Bcl-2 homologous antagonist/killer [human]; Cyclin-dependent kinase 7 [human]	IC50	0.04	μmol/l
2676	OC[C@@H](O)[C@H](CO)NC1=NC2=CC=NN2C(NCC2=CC=CC=C2)=C1	Cyclin-dependent kinase 7 [human]	IC50	338	nM
2677	OC[C@@H](O)[C@H](CO)NC1=NC2=CC=NN2C(NCC2=CC=CC=C2)=C1	Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	152	nM
2678	OC[C@@H](O)[C@H](CO)NC1=NC2=CC=NN2C(NCC2=CC=CC=C2)=C1	Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	87	nM
2679	CC(C)C1=C2N=C(NC[C@@H]3CCNC[C@H]3O)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	925	nM
2680	CC(C)C1=C2N=C(NC[C@@H]3CCNC[C@H]3O)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	422	nM
2681	CC(C)C1=C2N=C(NC[C@@H]3CCNC[C@H]3O)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	27	nM
2682	CC(C)C1=C2N=C(NC[C@@H]3CCNC[C@H]3O)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-dependent kinase 7 [human]	Kd (dissociation constant)	1800	nM
2683		Cyclin-dependent kinase 7 [human]; Bromodomain-containing protein 4 [human]	inhibition percentage		
2684		Cyclin-dependent kinase 7 [human]; Bromodomain-containing protein 4 [human]	inhibition percentage		
2685		Cyclin-dependent kinase 7 [human]; Bromodomain-containing protein 4 [human]	inhibition percentage		
2686		Cyclin-dependent kinase 7 [human]; Bromodomain-containing protein 4 [human]	inhibition percentage		
2687		Cyclin-dependent kinase 7 [human]; Bromodomain-containing protein 4 [human]	inhibition percentage		
2688		Cyclin-dependent kinase 7 [human]; Bromodomain-containing protein 4 [human]	inhibition percentage		
2689	CCN1C=NC2=C1N=C(N=C2NCC1=NC2=C(N1)C(F)=C(F)C=C2)N1CCCC[C@H]1CCO	Cyclin-dependent kinase 7 [human]	IC50	30	μM
2690	OC(=O)C(F)(F)F.ClC1=CC=CC=C1N1C(=NN=C1C1=NC=NC=C1)[C@H]1C[C@@H](C1)N1C(=O)NC2=CC(=CC=C12)C#N	Cyclin-H;+Maturase-like protein 1;+Cyclin-dependent kinase 7	inhibition percentage	18	%
2691	FC1=CC(=CC(F)=C1)N1C=NC2=C(NCC3=NC4=C(F)C(F)=CC=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 7	inhibition percentage	54	%
2692	OCC[C@@H]1CCCCN1C1=NC(NCC2=NC3=C(F)C(F)=CC=C3N2)=C2N=CN(C2=N1)C1=CC(F)=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	30	μM
2693	CCC1=C2N=C(C=C(NCC3=NC4=C(F)C(F)=CC=C4N3)N2N=C1)N1CCCC[C@H]1CCO	Cyclin-dependent kinase 7 [human]	IC50	21.2	μM
2694	OCC[C@@H]1CCCCN1C1=NC(NCC2=NC3=CC=C(F)C(F)=C3N2)=C2N=CN(CCF)C2=N1	Cyclin-dependent kinase 7 [human]	IC50	30	μM
2695	OCC[C@@H]1CCCCN1C1=NC(NCC2=NC3=CC=C(F)C(F)=C3N2)=C2N=CN(CC(F)F)C2=N1	Cyclin-dependent kinase 7 [human]	IC50	30	μM
2696	COC1=C(C=CC(F)=C1)C1=CC=NC(NC2=CC=C(C=C2)S(=O)(=O)NC2=C(C)C(C)=NO2)=N1	Cyclin-H [human];+S-adenosylmethionine synthase 1 [human]; Cyclin-dependent kinase 7 [human]	inhibition percentage	3	%
2697	COC1=CC=CC(F)=C1C1=CC=NC(NC2=CC=C(C=C2)S(=O)(=O)NC2=C(C)C(C)=NO2)=N1	Cyclin-H [human];+S-adenosylmethionine synthase 1 [human]; Cyclin-dependent kinase 7 [human]	inhibition percentage	1	%
2698	COC1=CC=C(F)C(F)=C1C1=CC=NC(NC2=CC=C(C=C2)S(=O)(=O)NC2=C(C)C(C)=NO2)=N1	Cyclin-H [human];+S-adenosylmethionine synthase 1 [human]; Cyclin-dependent kinase 7 [human]	inhibition percentage	2	%
2699	CCOC1=C(C(F)=CC=C1)C1=CC=NC(NC2=CC=C(C=C2)S(=O)(=O)NC2=C(C)C(C)=NO2)=N1	Cyclin-H [human];+S-adenosylmethionine synthase 1 [human]; Cyclin-dependent kinase 7 [human]	inhibition percentage	0	%
2700	COC1=C(C=CC(F)=C1)C1=CC=NC(NC2=CC=C(C=C2)S(=O)(=O)NC2=NOC(C)=C2C)=N1	Cyclin-H [human];+S-adenosylmethionine synthase 1 [human]; Cyclin-dependent kinase 7 [human]	inhibition percentage	0	%
2701	COC1=CC=CC(F)=C1C1=CC=NC(NC2=CC=C(C=C2)S(=O)(=O)NC2=NC=CS2)=N1	Cyclin-H [human];+S-adenosylmethionine synthase 1 [human]; Cyclin-dependent kinase 7 [human]	inhibition percentage	0	%
2702	COC1=CC=CC(F)=C1C1=CC=NC(NC2=CC=C(C=C2)S(=O)(=O)NC2=NN=C(C)S2)=N1	Cyclin-H [human];+S-adenosylmethionine synthase 1 [human]; Cyclin-dependent kinase 7 [human]	inhibition percentage	2	%
2703	COC1=CC=C(F)C(F)=C1C1=CC=NC(NC2=CC=C(C=C2)S(=O)(=O)NC2=NN=C(C)S2)=N1	Cyclin-H [human];+S-adenosylmethionine synthase 1 [human]; Cyclin-dependent kinase 7 [human]	inhibition percentage	7	%
2704	COC1=C(C=CC=C1)C1=CC=NC(NC2=CC(CN3C=NC4=CC=CC=C34)=CC=C2)=N1	Cyclin-H [human];+S-adenosylmethionine synthase 1 [human]; Cyclin-dependent kinase 7 [human]	inhibition percentage	0	%
2705	COC1=CC=CC(F)=C1C1=CC=NC(NC2=CC(CN3C=NC4=CC=CC=C34)=CC=C2)=N1	Cyclin-H [human];+S-adenosylmethionine synthase 1 [human]; Cyclin-dependent kinase 7 [human]	inhibition percentage	0	%
2706	ClC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C(C=CC=C12)N1CCS(=O)(=O)CC1	Cyclin-dependent kinase 7	IC50	20	nM
2707	ClC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C(C=CC=C12)N1CCS(=O)(=O)CC1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
2708	CCN1CCC2=CC(NC3=NC=C(F)C(=N3)C3=CC4=C(N=C(C)N4C(C)C)C(F)=C3)=CC=C2C1	Cyclin-dependent kinase 7	inhibition percentage	14	%
2709	CN(C)[C@H]1CC[C@@H](CC1)NC1=NC=NC2=C1C(=CN2)[C@H]1CC[C@@H](CC1)C(N)=O	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	42	%
2710	FC1=CC=C(NC(=O)C2=CN=C3C=CC(=NN23)N2CCC[C@@H]2C2=CC(F)=CC=C2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage	106.02 - 110.74	%
2711	ClC1=CC(=CC=C1)C1=C2C=C(NC2=NC=C1)C(=O)NC1CC1	Cyclin-dependent kinase 7	inhibition percentage	36	%
2712	O=C(NC1CC1)C1=CC2=C(C=CN=C2N1)N1CCCC1C1=NC=CC=C1	Cyclin-dependent kinase 7	inhibition percentage	93	%
2713	CN1CCN(CCCOC2=CC=C(C=C2)N2C(=S)SC(=CC3=CC=C(OC4=CC=C(F)C=C4)C=C3)C2=O)CC1	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage	2.5	%
2714	OC(=O)C(F)(F)F.CNS(=O)(=O)C1=CC=CC(NC2=NC=NC(NC3=CC(C)=CC=C3)=C2)=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	19	%
2715	CC1=CC=C(C=C1)S(O)(=O)=O.CCS(=O)(=O)C1=C(NC2=NC=NC(NC3=NC=C(Cl)C=C3)=C2)C=C(C=C1)S(=O)(=O)NC	CDK-activating kinase assembly factor MAT1	inhibition percentage	-1	%
2716	CC1=CC=C(C=C1)S(O)(=O)=O.CCS(=O)(=O)C1=C(NC2=NC=NC(NC3=NC=C(Cl)C=C3)=C2)C=C(C=C1)S(=O)(=O)NC	CDK-activating kinase assembly factor MAT1	inhibition percentage	0	%
2717	CC(C)(OC1=CC=C(C=C1)C1=CC(=C(N)N=C1)C1=CC=C(Cl)C=C1)C(O)=O	CDK-activating kinase assembly factor MAT1;+Cytochrome c-type biogenesis protein CycH;+Cyclin-dependent kinase 7	inhibition percentage	-15.6	%
2718	CC(C)(OC1=CC=C(C=C1)C1=CC(=C(N)N=C1)C1=CC=C(Cl)C=C1)C(O)=O	Cyclin-dependent kinase 7 [human]	inhibition percentage	-21.6	%
2719	CC(C)(OC1=CC=C(C=C1)C1=CC(=C(N)N=C1)C1=CC=C(Cl)C=C1)C(O)=O	Cyclin-dependent kinase 7 [human]	inhibition percentage	8.8	%
2720	CC(C)(OC1=CC=C(C=C1)C1=CC(=C(N)N=C1)C1=CC=C(Cl)C=C1)C(O)=O	Cyclin-dependent kinase 7 [human]	inhibition percentage	22.3	%
2721	CC(C)(OC1=CC=C(C=C1)C1=CC(=C(N)N=C1)C1=CC=C(Cl)C=C1)C(O)=O	Cyclin-dependent kinase 7 [human]	inhibition percentage	24.8	%
2722	COC1=CC=C(CN2C(=O)C3=C(CCS3)N=C2SCC(=O)NC2=NC3=CC=C(C=C3S2)C(F)(F)F)C=C1	CDK-activating kinase assembly factor MAT1;+Cyclin-H1-1	inhibition percentage	-1	%
2723	COC1=CC=C(CN2C(=O)C3=C(CCS3)N=C2SCC(=O)NC2=NC3=CC=C(C=C3S2)C(F)(F)F)C=C1	CDK-activating kinase assembly factor MAT1;+Cyclin-H1-1	inhibition percentage	-2	%
2724		Cyclin-dependent kinase 7	inhibition percentage		
2725		Cyclin-dependent kinase 7	inhibition percentage		
2726	CC(C)=CCOP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12	Cyclin-H;+Cyclin-dependent kinase 7	IC50	4.568E-5	mol/l
2727	N.NC1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)C(Cl)(Cl)P(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	10	μM
2728	C[C@@H](N1CC2=C(C=C(C=C2)C2=NC(NC3CCOCC3)=NC=C2Cl)C1=O)C(=O)N[C@@H](CO)C1=CC=CC(C)=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	inhibition percentage	60	%
2729	[H][C@]12CN(C3=CC(NC4=NC(N[C@H](C)CC)=C(C)C=N4)=C(F)N=C3)[C@]([H])(CN1C)C2	Cyclin-H;+CDK-activating kinase assembly factor MAT1	inhibition percentage	13.8	%
2730		Cyclin-dependent kinase 7	inhibition percentage		
2731		Cyclin-dependent kinase 7	inhibition percentage		
2732	Cl.CCN(CC)CC(=O)NC1=CC=C(CC2=NC3=C(C(=NN3C3=C(Cl)C=C(C=C3Cl)S(N)(=O)=O)N(C)C)C(=O)N2)C=C1	Cyclin-dependent kinase 16 [human];+Cyclin-dependent kinase 13 [human];+Cyclin-dependent kinase 7 [human]; Cyclin-dependent kinase 9 [human]	IC50		
2733	Cl.CCN(CC)CC(=O)NC1=CC=C(CC2=NC3=C(C(=NN3C3=C(Cl)C=C(C=C3Cl)S(N)(=O)=O)N(C)C)C(=O)N2)C=C1	Cyclin-dependent kinase 16 [human];+Cyclin-dependent kinase 13 [human];+Cyclin-dependent kinase 7 [human]; Cyclin-dependent kinase 9 [human]	IC50	2.42E-8	M
2734	Cl.CCN(CC)CC(=O)NC1=CC=C(CC2=NC3=C(C(=NN3C3=C(Cl)C=C(C=C3Cl)S(N)(=O)=O)N(C)C)C(=O)N2)C=C1	Cyclin-dependent kinase 16 [human];+Cyclin-dependent kinase 13 [human];+Cyclin-dependent kinase 7 [human]; Cyclin-dependent kinase 9 [human]	IC50	3.731E-8	M
2735	Cl.CCN(CC)CC(=O)NC1=CC=C(CC2=NC3=C(C(=NN3C3=C(Cl)C=C(C=C3Cl)S(N)(=O)=O)N(C)C)C(=O)N2)C=C1	Cyclin-dependent kinase 16 [human];+Cyclin-dependent kinase 13 [human];+Cyclin-dependent kinase 7 [human]; Cyclin-dependent kinase 9 [human]	IC50	6.051E-9	M
2736	Cl.CCN(CC)CC(=O)NC1=CC=C(CC2=NC3=C(C(=NN3C3=C(Cl)C=C(C=C3Cl)S(N)(=O)=O)N(C)C)C(=O)N2)C=C1	Cyclin-dependent kinase 16 [human];+Cyclin-dependent kinase 13 [human];+Cyclin-dependent kinase 7 [human]; Cyclin-dependent kinase 9 [human]	IC50	3.798E-8	M
2737	Cl.CCN(CC)CC(=O)NC1=CC=C(CC2=NC3=C(C(=NN3C3=C(Cl)C=C(C=C3Cl)S(N)(=O)=O)N(C)C)C(=O)N2)C=C1	Cyclin-dependent kinase 16 [human];+Cyclin-dependent kinase 13 [human];+Cyclin-dependent kinase 7 [human]; Cyclin-dependent kinase 9 [human]	IC50	4.297E-8	M
2738	Cl.CCN(CC)CC(=O)NC1=CC=C(CC2=NC3=C(C(=NN3C3=C(Cl)C=C(C=C3Cl)S(N)(=O)=O)N(C)C)C(=O)N2)C=C1	Cyclin-dependent kinase 16 [human];+Cyclin-dependent kinase 13 [human];+Cyclin-dependent kinase 7 [human]; Cyclin-dependent kinase 9 [human]	IC50	2.131E-8	M
2739	Cl.CCN(CC)CC(=O)NC1=CC=C(CC2=NC3=C(C(=NN3C3=C(Cl)C=C(C=C3Cl)S(N)(=O)=O)N(C)C)C(=O)N2)C=C1	Cyclin-dependent kinase 16 [human];+Cyclin-dependent kinase 13 [human];+Cyclin-dependent kinase 7 [human]; Cyclin-dependent kinase 9 [human]	IC50	7.431E-8	M
2740	Cl.CCN(CC)CC(=O)NC1=CC=C(CC2=NC3=C(C(=NN3C3=C(Cl)C=C(C=C3Cl)S(N)(=O)=O)N(C)C)C(=O)N2)C=C1	Cyclin-dependent kinase 16 [human];+Cyclin-dependent kinase 13 [human];+Cyclin-dependent kinase 7 [human]; Cyclin-dependent kinase 9 [human]	IC50	1.026E-7	M
2741	Cl.CCN(CC)CC(=O)NC1=CC=C(CC2=NC3=C(C(=NN3C3=C(Cl)C=C(C=C3Cl)S(N)(=O)=O)N(C)C)C(=O)N2)C=C1	Cyclin-dependent kinase 16 [human];+Cyclin-dependent kinase 13 [human];+Cyclin-dependent kinase 7 [human]; Cyclin-dependent kinase 9 [human]	IC50	3.603E-7	M
2742	Cl.CCN(CC)CC(=O)NC1=CC=C(CC2=NC3=C(C(=NN3C3=C(Cl)C=C(C=C3Cl)S(N)(=O)=O)N(C)C)C(=O)N2)C=C1	Cyclin-dependent kinase 16 [human];+Cyclin-dependent kinase 13 [human];+Cyclin-dependent kinase 7 [human]; Cyclin-dependent kinase 9 [human]	IC50	4.183E-8	M
2743	Cl.CCN(CC)CC(=O)NC1=CC=C(CC2=NC3=C(C(=NN3C3=C(Cl)C=C(C=C3Cl)S(N)(=O)=O)N(C)C)C(=O)N2)C=C1	CDK7/cycH	IC50	5 - 50	nM
2744	Cl.CCN(CC)CC(=O)NC1=CC=C(CC2=NC3=C(C(=NN3C3=C(Cl)C=C(C=C3Cl)S(N)(=O)=O)N(C)C)C(=O)N2)C=C1	Cyclin-dependent kinase 7	inhibition percentage		
2745	Cl.COC1=CC=C(F)C(F)=C1NN	CDK7/cycH	IC50	5 - 50	nM
2746	CCOC1=C(NC(=O)NCC2=CC=CC=C2)C=C(CC2=NC3=C(C(=NN3C3=C(Cl)C=C(C=C3Cl)S(N)(=O)=O)N(C)C)C(=O)N2)C=C1	CDK7/cycH	IC50	5 - 50	nM
2747	CCSC1=C(CC2=NC3=C(C(=NN3C3=C(Cl)C=C(C=C3Cl)S(N)(=O)=O)N(C)C)C(=O)N2)C=CC(=C1)C1=CC=CC=C1	CDK7/cycH	IC50	5 - 50	nM
2748	CN(C)C1=NN(C2=C1C(=O)NC(CC1=C(C=C(C=C1)C1=CC=CC=C1)C(N)=O)=N2)C1=C(Cl)C=C(C=C1Cl)S(N)(=O)=O	CDK7/cycH	IC50	5 - 50	nM
2749	COC1=NC=C(C2=CN(CC3=CC=CC=C3)N=C2)C(OC)=C1C(O)C1=CC=C2C=CC=CC2=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	inhibition percentage	-5	%
2750	NC1=C(SC(NC2CC3CCC2C3)=N1)C(=O)C1=C(C=CC=C1)N(=O)=O	Cyclin-dependent kinase 7 [human]	inhibition percentage	70 - 79	%
2751	NC1=C(SC(NC2CC3CCC2C3)=N1)C(=O)C1=C(C=CC=C1)N(=O)=O	Cyclin-dependent kinase 7 [human]; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	555	nM
2752	N[C@H]1CC[C@@H](CC1)NC1=NC(=CC=N1)C1=CN=C2C=CC(NC3=CC=C(F)N=C3)=CN12	Cyclin-H;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.89	μM
2753	N[C@H]1CC[C@@H](CC1)NC1=NC(=CC=N1)C1=CN=C2C=CC(NCC3=CC=C(F)C=C3)=CN12	Cyclin-H;+Cyclin-dependent kinase 7	Ki (inhibition constant)	5.39	μM
2754	N[C@H]1CC[C@@H](CC1)N(C1=CC=CC=C1)C1=NC(C2=CN=C3C=CC(NC(=O)C4=CC=C(F)C=C4)=CN23)=C(F)C=N1	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage	94	%
2755	COC1=CC=C(C=N1)C1=CN2C(C=C1)=NC=C2C1=CC=NC(N[C@H]2CC[C@H](N)CC2)=N1	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage	78	%
2756	CSC1=NC2=C(C=N1)C1=NC(NC3=CC=C(C=C3)C(=O)N(C)CCN(C)C)=NC=C1CC2	Cyclin-dependent kinase 7	IC50	3.6	μM
2757	OC(=O)C(F)(F)F.CC1=NC2=C(C=C(C=C2N1C1=C2C(F)=CC=C(F)C2=NC=C1)C1=CC=NC(N)=C1F)C1=NN=CN1	Cyclin-dependent kinase 7	inhibition percentage	72	%
2758	O=C1N(C=NC2=C1C=C(C=C2)C1=C2C=CC=CC2=NC=C1)C1=CC=C(C=C1)N1CCOCC1	Cyclin-dependent kinase 7	inhibition percentage	3	%
2759	CC1=NC2=C(C(=O)N1)C(C)=C(C=C2)C1=C2C=CC=CC2=NC=C1	Cyclin-dependent kinase 7	inhibition percentage	0	%
2760	CN1C=C(C=N1)C1=CC=C(C=C1)N([C@@H]1CC[C@@H](CC1)NC1=NC=C(C=C1)C#N)C(=O)NCC1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	10	μM
2761	CN1C=C(C=N1)C1=CC=C(C=C1)S(=O)(=O)N1CCC(CC1)NC1=NC=C(C=C1)C#N	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	10	μM
2762	OC(=O)C(F)(F)F.CC1=CC(NC2=NC(=CC=N2)C2=C(N=CN2C2CCNCC2)C2=CC=C(F)C=C2)=CC(C)=C1	Cyclin-dependent kinase 7	inhibition percentage	14	%
2763	CN1N=CC(=C1CC1CC1)C1=NC(NC2CCC(N)CC2)=NC=C1	Cyclin-dependent kinase 7	Kd (dissociation constant)	1.4	nM
2764	CN1N=CC(=C1CC1CC1)C1=NC(NC2CCC(CC2)N2C=CC=N2)=NC=C1	Cyclin-dependent kinase 7	Kd (dissociation constant)	12	nM
2765	CC1=C(SC=N1)C1=CC=C(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCOCCOCCOC2=CC=C3N4C=C(N=C4SC3=C2)C2=CC=C(NC(=O)NC3=NOC(=C3)C(C)(C)C)C=C2)C(C)(C)C)C=C1	Cyclin-dependent kinase 7	inhibition percentage	15	%
2766	O=C(NCC1=C2OCCOC2=CC=C1)C1=CC=C(C=C1)C1=CC=NC=C1	Cyclin-dependent kinase 7	IC50	10	μM
2767	O=C(NCC1=C2OCCCOC2=CC=C1)C1=CC=C(C=C1)C1=CC=NC=C1	Cyclin-dependent kinase 7	IC50	10	μM
2768	CN(C)CCCOC1=CC(CNC(=O)C2=CC=C(C=C2)C2=CC=NC=C2)=CC=C1	Cyclin-dependent kinase 7	IC50	10	μM
2769	O=C(NCC1=CC=CC(OCCN2CCOCC2)=C1)C1=CC=C(C=C1)C1=CC=NC=C1	Cyclin-dependent kinase 7	IC50	10	μM
2770	COC1=CC(=CC=C1)[C@@H](C)NC(=O)C1=CC=C(C=C1)C1=CC(N)=NC=C1	Cyclin-dependent kinase 7	IC50	10	μM
2771	CCNC1=NC=CC(=C1)C1=CC=C(C=C1)C(=O)N[C@H](C)C1=CC=CC(OC)=C1	Cyclin-dependent kinase 7	IC50	10	μM
2772	COC1=CC(=CC=C1)[C@@H](C)NC(=O)C1=CC=C(C=C1)C1=CC(NCC2CC2)=NC=C1	Cyclin-dependent kinase 7	IC50	10	μM
2773	COC1=CC(=CC=C1)[C@@H](C)NC(=O)C1=CC=C(C=C1)C1=CC(NCC(C)(C)O)=NC=C1	Cyclin-dependent kinase 7	IC50	10	μM
2774	COCCNC1=NC=CC(=C1)C1=CC=C(C=C1)C(=O)N[C@H](C)C1=CC=CC(OC)=C1	Cyclin-dependent kinase 7	IC50	10	μM
2775	COCCCNC1=NC=CC(=C1)C1=CC=C(C=C1)C(=O)N[C@H](C)C1=CC=CC(OC)=C1	Cyclin-dependent kinase 7	IC50	10	μM
2776	O=C(N[C@H](CCN1CCCC1)C1=CC=CC=C1)C1=CC=C(C=C1)C1=CC=NC=C1	Cyclin-dependent kinase 7	IC50	10	μM
2777	COC1=CC(=CC=C1)[C@@H](CCN1CCCC1)NC(=O)C1=CC=C(C=C1)C1=CC=NC=C1	Cyclin-dependent kinase 7	IC50	10	μM
2778	COC1=CC(=CC=C1)[C@@H](CCO)NC(=O)C1=CC=C(C=C1)C1=CC=NC=C1	Cyclin-dependent kinase 7	IC50	10	μM
2779	COC1=CC(=CC=C1)[C@@H](CCN1CCOCC1)NC(=O)C1=CC=C(C=C1)C1=CC(F)=NC=C1	Cyclin-dependent kinase 7	IC50	10	μM
2780	CCOC1=CC(CNC(=O)C2=CC=C(C=C2)C2=CC=NC=C2)=CC=C1	Cyclin-dependent kinase 7	IC50	10	μM
2781	CCCOC1=CC(=CC=C1)[C@@H](CCN1CCCCC1)NC(=O)C1=CC=C(C=C1)C1=CC(F)=NC=C1	Cyclin-dependent kinase 7	IC50	10	μM
2782	FC1=CC(=CC=C1)[C@@H](CCN1CCCC1)NC(=O)C1=CC=C(C=C1)C1=CC(F)=NC=C1	Cyclin-dependent kinase 7	IC50	10	μM
2783	CCCOC1=CC(CNC(=O)C2=CC=C(C=C2)C2=CC=NC=C2)=CC=C1	Cyclin-dependent kinase 7	IC50	10	μM
2784	CCCOC1=CC(=CC=C1)[C@@H](CCO)NC(=O)C1=CC=C(C=C1)C1=CC(F)=NC=C1	Cyclin-dependent kinase 7	IC50	10	μM
2785	CCCOC1=CC(=CC=C1)[C@@H](CCO)NC(=O)C1=CC=C(C=C1)C1=C(F)C=NC=C1	Cyclin-dependent kinase 7	IC50	10	μM
2786	COC1=CC(=CC=C1)[C@@H](C)NC(=O)C1=CC=C(C=C1NCCN)C1=CC=NC=C1	Cyclin-dependent kinase 7	IC50	10	μM
2787	COC1=CC(=CC=C1)[C@@H](C)NC(=O)C1=CC=C(C=C1NCCCCN)C1=CC=NC=C1	Cyclin-dependent kinase 7	IC50	10	μM
2788	COC1=CC(=CC=C1)[C@@H](C)NC(=O)C1=CC=C(C=C1NCCCCN)C1=NC=NC=C1	Cyclin-dependent kinase 7	IC50	10	μM
2789	FC(F)(F)OC1=CC(CNC(=O)C2=CC=C(C=C2)C2=CC=NC=C2)=CC=C1	Cyclin-dependent kinase 7	IC50	10	μM
2790	CCCOC1=CC(=CC=C1)[C@@H](C)NC(=O)C1=CC=C(C=C1N1CC[C@@H](CN)C1)C1=NC=NC=C1	Cyclin-dependent kinase 7	IC50	10	μM
2791	CCCOC1=CC(=CC=C1)[C@@H](C)NC(=O)C1=CC=C(C=C1N1CC[C@H](CN)C1)C1=NC=NC=C1	Cyclin-dependent kinase 7	IC50	10	μM
2792	COC1=CC(=CC=C1)[C@@H](C)NC(=O)C1=CC=C(C=C1N1CCC[C@H](CN)C1)C1=NC=NC=C1	Cyclin-dependent kinase 7	IC50	10	μM
2793	COC1=CC(=CC=C1)[C@@H](C)NC(=O)C1=CC=C(C=C1N1CCC[C@@H](CN)C1)C1=NC=NC=C1	Cyclin-dependent kinase 7	IC50	7.03	μM
2794	COC1=C(OC)C(CNC(=O)C2=CC=C(C=C2)C2=CC=NC=C2)=CC=C1	Cyclin-dependent kinase 7	IC50	10	μM
2795	C[C@H]1CC2=C(CN1CCN(C)C)C=CC(NC1=NC=C(F)C(=N1)C1=CC3=C(N=C(C)N3C(C)(C)C)C(F)=C1)=N2	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	195.3	nM
2796	CN(C)CCC(=O)N1CCC2=C(C1)C=CC(NC1=NC=C(F)C(=N1)C1=CC3=C(N=C(C)N3C3CCC3)C(F)=C1)=N2	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	1817.51	nM
2797	Cl.CC1=NC2=C(C=C(C=C2F)C2=NC(NC3=NC4=C(CN(CC4)C(=O)[C@H]4CCCN4)C=C3)=NC=C2F)N1C1CC1	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	1076.14	nM
2798	Cl.CC1=NC2=C(C=C(C=C2F)C2=NC(NC3=NC4=C(CNCC4)C=C3)=NC=C2F)N1C(C)(C)C	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	20.47	nM
2799	Cl.CC(C1CC1)N1C(C)=NC2=C1C=C(C=C2F)C1=NC(NC2=NC3=C(CNCC3)C=C2)=NC=C1F	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	16.7	nM
2800	Cl.CC1=NC2=C(C=C(C=C2F)C2=NC(NC3=NC4=C(CN(C[C@@H]5CNCCO5)CC4)C=C3)=NC=C2F)N1C(C)(C)C	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	53.4	nM
2801	Cl.CNCCN1CCC2=C(C1)C=CC(NC1=NC=C(F)C(=N1)C1=CC3=C(N=C(C)N3C3CC3)C(F)=C1)=N2	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	314.7	nM
2802	Cl.CNCCN1CCC2=C(C1)C=CC(NC1=NC=C(F)C(=N1)C1=CC3=C(N=C(C)N3C(C)(C)C)C(F)=C1)=N2	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	148.7	nM
2803	CCOC1=CC(=CC=C1NC1=NC=C2N(C)C(=O)[C@@H](CC)N(CC3=CC(C)=CS3)C2=N1)C1CCN(C)CC1	Cyclin-dependent kinase 7	inhibition percentage	12	%
2804	CN1CCN(CC1)C1=CC=C(NC2=NC=C3C(C)=C(C#N)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	6	μM
2805	N=C1NC(=O)C(S1)=CC1=CC=C(O1)C1=CC=CC(=C1)N(=O)=O	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	92	%
2806	Cl.CC1NCCC2=C1C=CC(NC1=NC=C(F)C(=N1)C1=CC3=C(N=C(C)N3C(C)(C)C)C(F)=C1)=N2	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	56.98	nM
2807	Cl.CC1CC2=C(CN1)C=CC(NC1=NC=C(F)C(=N1)C1=CC3=C(N=C(C)N3C(C)(C)C)C(F)=C1)=N2	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	99.42 - 104.8	nM
2808	C[C@@H](N(C)C)C(=O)N1CCC2=C(C1)C=CC(NC1=NC=C(F)C(=N1)C1=CC3=C(N=C(C)N3CC3CC3)C(F)=C1)=N2	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	779.46	nM
2809	ClC1=NN2C(=CN=C2C(N[C@H]2CC[C@@H](CC2)NCC(=O)N2CCOCC2)=C1)C1=CC2=C(NN=C2)C=C1	Cyclin-dependent kinase 7 [human]	inhibition percentage	84	%
2810	CN1CCC(CNC2=CC(Cl)=NN3C(=CN=C23)C2=C(F)C=C3NC(NC4=CC=CC=C4)=NC3=C2)CC1	Cyclin-dependent kinase 7 [human]	inhibition percentage	39	%
2811	ClC1=NN2C(=CN=C2C(NCC2CC2)=C1)C1=CC2=C(NN=C2)C=C1	Cyclin-dependent kinase 7 [human]	inhibition percentage	32	%
2812	CC(C1CC1)N1C=NC2=C(NCC3=CC(=CC=C3)C(F)(F)F)N=C(NCCN(C)C)N=C12	Cyclin-dependent kinase 7	IC50	2.4	μM
2813	CC(C1CC1)N1C=NC2=C(NCC3=CC(=CC=C3)C(F)(F)F)N=C(NCCN(C)C)N=C12	Cyclin-H; Cyclin-dependent kinase 7	inhibition percentage	84	%
2814	O=C(NC1=C(C=C2N=C(SC2=C1)N1CCOCC1)N1CCOCC1)C1=C2N=CC=CN2N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1	inhibition percentage	-0.3	%
2815	COC1=CC(NC2=NC=C3CCCCC3=N2)=CC=C1	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage	35	%
2816	COC1=CC(NC2=NC=C3CCCCC3=N2)=CC=C1	Cyclin-H;+Cyclin-dependent kinase 7	Ki (inhibition constant)	5	μM
2817	O=N(=O)C1=CC(NC2=NC=C3CCCCC3=N2)=CC=C1	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage	24.4	%
2818	O=N(=O)C1=CC(NC2=NC=C3CCCCC3=N2)=CC=C1	Cyclin-H;+Cyclin-dependent kinase 7	Ki (inhibition constant)	5	μM
2819	CCC1=CC(NC2=NC=C3CCCCC3=N2)=CC=C1	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage	1.6	%
2820	CCC1=CC(NC2=NC=C3CCCCC3=N2)=CC=C1	Cyclin-H;+Cyclin-dependent kinase 7	Ki (inhibition constant)	5	μM
2821	CC1=CC=CC=C1NC1=NC=C2CCCCC2=N1	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage	9.5	%
2822	CC1=CC=CC=C1NC1=NC=C2CCCCC2=N1	Cyclin-H;+Cyclin-dependent kinase 7	Ki (inhibition constant)	5	μM
2823	NS(=O)(=O)C1=CC=CC(NC2=NC=C3CCCCC3=N2)=C1	Cyclin-H;+Cyclin-dependent kinase 7	Ki (inhibition constant)	1	μM
2824	OC(=O)C(F)(F)F.CN(C)C\C=C\C(=O)NC1=CC=CC(=C1)S(=O)(=O)N1CCC(CC1)NC(=O)C1=NNC=C1NC(=O)C1=C(Cl)C=CC=C1Cl	Cyclin-dependent kinase 7 [human]	inhibition percentage	50.1	%
2825	OC(=O)C(F)(F)F.CN(C)C\C=C\C(=O)NC1=CC=CC(=C1)S(=O)(=O)N1CCC(CC1)NC(=O)C1=NNC=C1NC(=O)C1=C(Cl)C=C(Cl)C=C1Cl	Cyclin-dependent kinase 7 [human]	inhibition percentage	12.1	%
2826	[H][C@]12CCC[C@]([H])(C[C@@H](C1)NC1=NC3=C(NC=C3)C(=O)N1C)N2C	CDK-activating kinase assembly factor MAT1 [human]	inhibition percentage	54	%
2827	CC(C)CC=CC(=O)NC1=CN=C(C=C1)C(=O)N[C@@]1(C)CCC[C@@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=CC=CC=C12	CDK-activating kinase assembly factor MAT1;+Cyclin-H;+Cyclin-dependent kinase 7	IC50	369	nmol/l
2828	Cl[H].CNC(=O)C[C@@H]1C[C@H]([C@@H](CN1)NC(=O)C1=CC(=C(Cl)O1)C1=C(Cl)C=NN1C)C1=CC=C(F)C(F)=C1	Cyclin-dependent kinase 7	inhibition percentage	75	%
2829	CN([C@@H]1CC2=C(C1)C=C(C=C2)C(=O)NC1=CC(=CC(=C1)N1C=NC(C)=C1)C(F)(F)F)C1=CN=CN=C1	Cyclin-dependent kinase 7	inhibition rate	31	%
2830	ClC1=C2N(C(=O)C(NC3=CC=NC=C3)=C1)C1(CCCCC1)NC2=O	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage		
2831	FC1=C(NC2=CC(Cl)=C3N(C2=O)C2(CCCCC2)NC3=O)C=CN=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage		
2832	OC1=NC=CC(NC2=CC(Cl)=C3N(C2=O)C2(CCCCC2)NC3=O)=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage		
2833	ClC1=C2N(C(=O)C(NC3=NOC=C3)=C1)C1(CCCCC1)NC2=O	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage		
2834	O[C@H]1CNC(=O)[C@H](C1)NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
2835	O[C@H]1CNC(=O)[C@H](C1)NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
2836	O[C@H]1CNC(=O)[C@@H](C1)NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
2837	O[C@H]1CNC(=O)[C@@H](C1)NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
2838	O=C1NCC2(CCCCC2)N2C1=CC1=CN=C(N[C@@H]3CCCN[C@@H]3C3=CC=CC=C3)N=C21	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
2839	O=C1NCC2(CCCCC2)N2C1=CC1=CN=C(N[C@@H]3CCCN[C@@H]3C3=CC=CC=C3)N=C21	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
2840	O=C1NCCC[C@@H]1NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
2841	O=C1NCCC[C@@H]1NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
2842	O=C1NC2=C(C[C@@H]1NC1=NC=C3C=C4N(C3=N1)C1(CCCCC1)CNC4=O)C=CC=C2	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
2843	O=C1NC2=C(C[C@@H]1NC1=NC=C3C=C4N(C3=N1)C1(CCCCC1)CNC4=O)C=CC=C2	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
2844	O=C(NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O)[C@H]1CNCC[C@H]1C1=CC=CC=C1	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
2845	O=C(NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O)[C@H]1CNCC[C@H]1C1=CC=CC=C1	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
2846	O=C(C[C@@H]1CCCN1)NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
2847	O=C(C[C@@H]1CCCN1)NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
2848	O=C(NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O)[C@H]1CNCCO1	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
2849	O=C(NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O)[C@H]1CNCCO1	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
2850	O=C(NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O)[C@H]1CNCCN1	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
2851	O=C(NC1=NC=C2C=C3N(C2=N1)C1(CCCCC1)CNC3=O)[C@H]1CNCCN1	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
2852	CS(=O)(=O)C1=CC=CC(NC2=NC=C3C=C4N(C3=N2)C2(CCCCC2)CNC4=O)=C1	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
2853	CS(=O)(=O)C1=CC=CC(NC2=NC=C3C=C4N(C3=N2)C2(CCCCC2)CNC4=O)=C1	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
2854	NS(=O)(=O)CC1=CC(NC2=NC=C3C=C4N(C3=N2)C2(CCCCC2)CNC4=O)=CC=C1	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
2855	NS(=O)(=O)CC1=CC(NC2=NC=C3C=C4N(C3=N2)C2(CCCCC2)CNC4=O)=CC=C1	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage		
2856	O=C1NCC2(CCCCC2)N2C1=CC1=CN=C(N[C@H]3CC[C@@H](CC3)N3CCN(CC3)C3CC3)N=C21	Cyclin-dependent kinase 9;+Cyclin T; Cyclin-dependent kinase 7	inhibition percentage		
2857	Cl.CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCC[C@@H]2N2CC(F)C2)=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100 - 500	nM
2858	Cl.CP(C)(=O)C1=C2NC=C(C2=CC=C1C(N)=O)C1=C(C=NC(N[C@H]2CCC[C@@H]2N)=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2859	Cl.COC1CN(C1)[C@H]1CCC[C@@H]1NC1=NC(C2=CNC3=C2C=CC(=N3)C2=C(C)ON=C2C)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2860	Cl.COC1CN(C1)[C@@H]1CCC[C@@H]1NC1=NC(C2=CNC3=C2C=CC(=N3)C2=C(C)ON=C2C)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30 - 100	nM
2861	N[C@H]1CCCC[C@@H]1NC1=NC(C2=CNC3=CC(=CC=C23)C#N)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	500	nM
2862	N[C@H]1CCC[C@@H]1NC1=NC(C2=CNC3=CC(=CC=C23)C#N)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2863	FC(F)(F)C1=C(N=C(NC[C@@H]2COCCN2)N=C1)C1=CNC2=CC(=CC=C12)C#N	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	500	nM
2864	N[C@H]1CC[C@@H]1NC1=NC(C2=CNC3=CC(=CC=C23)C#N)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2865	C[C@H]1C[C@@H](CN1)NC1=NC(C2=CNC3=CC(=CC=C23)C#N)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30 - 100	nM
2866	CC(C)N1CC[C@@H](C1)NC1=NC(C2=CNC3=CC(=CC=C23)C#N)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	500	nM
2867	O[C@H]1CNC[C@H]1NC1=NC(C2=CNC3=CC(=CC=C23)C#N)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100 - 500	nM
2868	C[C@@H]1C[C@@H](CN1)NC1=NC(C2=CNC3=CC(=CC=C23)C#N)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30 - 100	nM
2869	CN1CC[C@@H](C1)NC1=NC(C2=CNC3=CC(=CC=C23)C#N)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100 - 500	nM
2870	F[C@@H]1CNC[C@H]1NC1=NC(C2=CNC3=CC(=CC=C23)C#N)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100 - 500	nM
2871	CCO[C@@H]1CNC[C@H]1NC1=NC(C2=CNC3=CC(=CC=C23)C#N)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100 - 500	nM
2872	OC[C@@H]1C[C@H](CN1)NC1=NC(C2=CNC3=CC(=CC=C23)C#N)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100 - 500	nM
2873	FC(F)(F)C1=C(N=C(N[C@@H]2CNC[C@H]2C2=CC=C(Cl)C=C2)N=C1)C1=CNC2=CC(=CC=C12)C#N	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	500	nM
2874	[H][C@]12CC[C@]([H])(N1)[C@H](C2)NC1=NC(C2=CNC3=CC(=CC=C23)C#N)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2875	Cl.N[C@H]1CCC[C@@H]1NC1=NC(C2=CNC3=CC(=CC=C23)C2=NC=CS2)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2876	[H][C@@]12CC[C@@]([H])(N1)[C@@H](C2)NC1=NC(C2=CNC3=CC(=CC=C23)C#N)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30 - 100	nM
2877	Cl.FC(F)(F)C1=C(N=C(N[C@H]2CCC[C@@H]2N2CCOCC2)N=C1)C1=CNC2=CC(=CC=C12)C#N	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30 - 100	nM
2878	Cl.FC(F)(F)C1=C(N=C(N[C@H]2CCC[C@@H]2N2CCCC2)N=C1)C1=CNC2=CC(=CC=C12)C#N	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30 - 100	nM
2879	Cl.CN(C)[C@H]1CCC[C@@H]1NC1=NC(C2=CNC3=CC(=CC=C23)C#N)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100 - 500	nM
2880	CC1=C(C(C)=NO1)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCC[C@@H]3N)=N2)C(F)(F)F)=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2881	Cl.FC(F)(F)C1=C(N=C(N[C@H]2CC[C@@H]2N2CCOCC2)N=C1)C1=CNC2=CC(=CC=C12)C#N	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100 - 500	nM
2882	FC(F)(F)C1=C(N=C(N[C@@H]2CC[C@H]2N2CCOCC2)N=C1)C1=CNC2=CC(=CC=C12)C#N	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	500	nM
2883	Cl.COCCN[C@H]1CC[C@@H]1NC1=NC(C2=CNC3=CC(=CC=C23)C#N)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30 - 100	nM
2884	COCCN[C@@H]1CC[C@H]1NC1=NC(C2=CNC3=CC(=CC=C23)C#N)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	500	nM
2885	Cl.[H][C@]12CC[C@]([H])(N1)[C@H](C2)NC1=NC(C2=CNC3=NC(=CC=C23)C2=C(C)ON=C2C)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2886	Cl.[H][C@@]12CC[C@@]([H])(N1)[C@@H](C2)NC1=NC(C2=CNC3=NC(=CC=C23)C2=C(C)ON=C2C)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2887	Cl.FC(F)(F)C1=C(N=C(N[C@H]2CC[C@@H]2N2CCCC2)N=C1)C1=CNC2=CC(=CC=C12)C#N	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2888	Cl.FC(F)(F)C1=C(N=C(N[C@@H]2CC[C@H]2N2CCCC2)N=C1)C1=CNC2=CC(=CC=C12)C#N	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100 - 500	nM
2889	Cl.[H][C@@]12CC[C@@]([H])(N1)[C@@H](C2)NC1=NC=C(C(=N1)C1=CNC2=CC(=CC=C12)C1=C(C)ON=C1C)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30 - 100	nM
2890	Cl.CN(C)[C@H]1CC[C@@H]1NC1=NC(C2=CNC3=CC(=CC=C23)C#N)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30 - 100	nM
2891	Cl.CC(=O)N[C@H]1CC[C@@H]1NC1=NC(C2=CNC3=CC(=CC=C23)C#N)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	500	nM
2892	Cl.CCN[C@H]1CC[C@@H]1NC1=NC(C2=CNC3=CC(=CC=C23)C#N)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2893	Cl.CC(=O)N[C@H]1CCC[C@@H]1NC1=NC(C2=CNC3=CC(=CC=C23)C#N)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	500	nM
2894	Cl.CCN[C@H]1CCC[C@@H]1NC1=NC(C2=CNC3=CC(=CC=C23)C#N)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2895	Cl.CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CC[C@@H]2N)=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2896	Cl.[H][C@]12CC[C@]([H])(N1)[C@H](C2)NC1=NC=C(C(=N1)C1=CNC2=CC(=CC=C12)C1=C(C)ON=C1C)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2897	Cl.CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCC[C@@H]2N2CC[C@@H](F)C2)=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2898	Cl.CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCC[C@@H]2N2CC[C@H](F)C2)=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30 - 100	nM
2899	Cl.CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@@H]2CNC[C@H](O)C2)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2900	Cl.CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@@H]2CNC[C@H](O)C2)=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2901	Cl.CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@@H]2CNC[C@H](O)C2)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2902	Cl.CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@@H]2CNC[C@H](O)C2)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100 - 500	nM
2903	Cl.CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@@H]2CNC[C@H](O)C2)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2904	Cl.CC1(C)CNC[C@H](C1)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=NC=CS2)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2905	Cl.CC1(C)CNC[C@H](C1)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=NC=CS2)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2906	Cl.CC1(C)CNC[C@H](C1)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=NC=CS2)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2907	Cl.CC1(C)CNC[C@H](C1)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=NC=CS2)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2908	Cl.CC1(C)CNC[C@H](C1)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=NC=CS2)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2909	Cl.CC1=NSC(=N1)C1=CC=C2C(NC=C2C2=NC(N[C@H]3CCCNC3)=NC=C2C(F)(F)F)=N1	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2910	Cl.CC1=NSC(=N1)C1=CC=C2C(NC=C2C2=NC(N[C@H]3CCCNC3)=NC=C2C(F)(F)F)=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2911	Cl.CC1=NSC(=N1)C1=CC=C2C(NC=C2C2=NC(N[C@H]3CCCNC3)=NC=C2C(F)(F)F)=N1	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2912	Cl.CC1=NSC(=N1)C1=CC=C2C(NC=C2C2=NC(N[C@H]3CCCNC3)=NC=C2C(F)(F)F)=N1	Cyclin-dependent kinase 7 [human]	IC50	500 - 1	nM
2913	Cl.CC1=NSC(=N1)C1=CC=C2C(NC=C2C2=NC(N[C@H]3CCCNC3)=NC=C2C(F)(F)F)=N1	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2914	Cl.C[C@H]1CC[C@@H](CN1)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=CN=NN2C)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2915	Cl.C[C@H]1CC[C@@H](CN1)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=CN=NN2C)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2916	Cl.C[C@H]1CC[C@@H](CN1)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=CN=NN2C)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100 - 500	nM
2917	Cl.C[C@H]1CC[C@@H](CN1)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=CN=NN2C)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100 - 500	nM
2918	Cl.C[C@H]1CC[C@@H](CN1)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=CN=NN2C)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2919	Cl.C[C@@H]1CC[C@H](CN1)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=CN=NN2C)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1	μM
2920	Cl.C[C@@H]1CC[C@H](CN1)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=CN=NN2C)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2921	Cl.C[C@@H]1CC[C@H](CN1)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=CN=NN2C)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1	μM
2922	Cl.C[C@@H]1CC[C@H](CN1)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=CN=NN2C)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1	μM
2923	Cl.C[C@@H]1CC[C@H](CN1)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=CN=NN2C)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	500 - 1	nM
2924	Cl.C[C@H]1CC[C@@H](CN1)NC1=NC(C2=NNC3=C2C=CC(=N3)C2=C(C)ON=C2C)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	500 - 1	nM
2925	Cl.C[C@H]1CC[C@@H](CN1)NC1=NC(C2=NNC3=C2C=CC(=N3)C2=C(C)ON=C2C)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2926	Cl.C[C@H]1CC[C@@H](CN1)NC1=NC(C2=NNC3=C2C=CC(=N3)C2=C(C)ON=C2C)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1	μM
2927	Cl.C[C@H]1CC[C@@H](CN1)NC1=NC(C2=NNC3=C2C=CC(=N3)C2=C(C)ON=C2C)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1	μM
2928	Cl.C[C@H]1CC[C@@H](CN1)NC1=NC(C2=NNC3=C2C=CC(=N3)C2=C(C)ON=C2C)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100 - 500	nM
2929	Cl.C[C@H]1CC[C@@H](CN1)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=NN=C(C)S2)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100 - 500	nM
2930	Cl.C[C@H]1CC[C@@H](CN1)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=NN=C(C)S2)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2931	Cl.C[C@H]1CC[C@@H](CN1)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=NN=C(C)S2)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100 - 500	nM
2932	Cl.C[C@H]1CC[C@@H](CN1)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=NN=C(C)S2)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1	μM
2933	Cl.C[C@H]1CC[C@@H](CN1)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=NN=C(C)S2)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1	μM
2934	Cl.CC1=NN=C(S1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2935	Cl.CC1=NN=C(S1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2936	Cl.CC1=NN=C(S1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2937	Cl.CC1=NN=C(S1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2938	Cl.CC1=NN=C(S1)C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2939	Cl.C[C@@H]1CC[C@H](CN1)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=NN=C(C)S2)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2940	Cl.C[C@@H]1CC[C@H](CN1)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=NN=C(C)S2)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2941	Cl.C[C@@H]1CC[C@H](CN1)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=NN=C(C)S2)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2942	Cl.C[C@@H]1CC[C@H](CN1)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=NN=C(C)S2)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100 - 500	nM
2943	Cl.C[C@@H]1CC[C@H](CN1)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=NN=C(C)S2)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2944	Cl.CC1=NC(=NO1)C1=NC2=C(C=C1)C(=NN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2945	Cl.CC1=NC(=NO1)C1=NC2=C(C=C1)C(=NN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2946	Cl.CC1=NC(=NO1)C1=NC2=C(C=C1)C(=NN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2947	Cl.CC1=NC(=NO1)C1=NC2=C(C=C1)C(=NN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2948	Cl.CC1=NC(=NO1)C1=NC2=C(C=C1)C(=NN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2949	Cl.CC1=NOC=C1C1=NC2=C(C=C1)C(=NN2)C1=C(C=NC(N[C@H]2CCC(C)(C)NC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100 - 500	nM
2950	Cl.CC1=NOC=C1C1=NC2=C(C=C1)C(=NN2)C1=C(C=NC(N[C@H]2CCC(C)(C)NC2)=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2951	Cl.CC1=NOC=C1C1=NC2=C(C=C1)C(=NN2)C1=C(C=NC(N[C@H]2CCC(C)(C)NC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1	μM
2952	Cl.CC1=NOC=C1C1=NC2=C(C=C1)C(=NN2)C1=C(C=NC(N[C@H]2CCC(C)(C)NC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1	μM
2953	Cl.CC1=NOC=C1C1=NC2=C(C=C1)C(=NN2)C1=C(C=NC(N[C@H]2CCC(C)(C)NC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100 - 500	nM
2954	CC1=NN=C(S1)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2955	CC1=NN=C(S1)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2956	CC1=NN=C(S1)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100 - 500	nM
2957	CC1=NN=C(S1)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100 - 500	nM
2958	CC1=NN=C(S1)C1=CC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2959	CC1=NOC=C1C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2960	CC1=NOC=C1C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2961	CC1=NOC=C1C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2962	CC1=NOC=C1C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2963	CC1=NOC=C1C1=NC2=C(C=C1)C(=CN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2964	Cl.CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=NN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2965	Cl.CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=NN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2966	Cl.CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=NN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2967	Cl.CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=NN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100 - 500	nM
2968	Cl.CC1=C(C(C)=NO1)C1=NC2=C(C=C1)C(=NN2)C1=C(C=NC(N[C@H]2CCCNC2)=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2969	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC(=N2)C1=NC=CS1	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2970	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC(=N2)C1=NC=CS1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2971	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC(=N2)C1=NC=CS1	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2972	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC(=N2)C1=NC=CS1	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2973	FC(F)(F)C1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC(=N2)C1=NC=CS1	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2974	CO[C@H]1CNC[C@H](C1)NC1=NC(C2=CNC3=CC(=CC=C23)C2=NOC(C)=N2)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2975	CO[C@H]1CNC[C@H](C1)NC1=NC(C2=CNC3=CC(=CC=C23)C2=NOC(C)=N2)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2976	CO[C@H]1CNC[C@H](C1)NC1=NC(C2=CNC3=CC(=CC=C23)C2=NOC(C)=N2)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100 - 500	nM
2977	CO[C@H]1CNC[C@H](C1)NC1=NC(C2=CNC3=CC(=CC=C23)C2=NOC(C)=N2)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100 - 500	nM
2978	CO[C@H]1CNC[C@H](C1)NC1=NC(C2=CNC3=CC(=CC=C23)C2=NOC(C)=N2)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2979	CNC(=O)[C@@H]1C[C@H](CN(C1)C(=O)OC(C)(C)C)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=C(C)ON=C2C)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100 - 500	nM
2980	CNC(=O)[C@@H]1C[C@H](CN(C1)C(=O)OC(C)(C)C)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=C(C)ON=C2C)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2981	CNC(=O)[C@@H]1C[C@H](CN(C1)C(=O)OC(C)(C)C)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=C(C)ON=C2C)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100 - 500	nM
2982	CNC(=O)[C@@H]1C[C@H](CN(C1)C(=O)OC(C)(C)C)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=C(C)ON=C2C)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	500 - 1	nM
2983	CNC(=O)[C@@H]1C[C@H](CN(C1)C(=O)OC(C)(C)C)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=C(C)ON=C2C)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2984	Cl.CN(C)C(=O)[C@H]1CNC[C@H](C1)NC1=NC(C2=CNC3=CC(=CC=C23)C2=C(C)ON=C2C)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100 - 500	nM
2985	Cl.CN(C)C(=O)[C@H]1CNC[C@H](C1)NC1=NC(C2=CNC3=CC(=CC=C23)C2=C(C)ON=C2C)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2986	Cl.CN(C)C(=O)[C@H]1CNC[C@H](C1)NC1=NC(C2=CNC3=CC(=CC=C23)C2=C(C)ON=C2C)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100 - 500	nM
2987	Cl.CN(C)C(=O)[C@H]1CNC[C@H](C1)NC1=NC(C2=CNC3=CC(=CC=C23)C2=C(C)ON=C2C)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1	μM
2988	Cl.CN(C)C(=O)[C@H]1CNC[C@H](C1)NC1=NC(C2=CNC3=CC(=CC=C23)C2=C(C)ON=C2C)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100 - 500	nM
2989	Cl.CC1=C(C(C)=NO1)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@@H]3CNC[C@H](O)C3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7 [human]	IC50	100 - 500	nM
2990	Cl.CC1=C(C(C)=NO1)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@@H]3CNC[C@H](O)C3)=N2)C(F)(F)F)=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2991	Cl.CC1=C(C(C)=NO1)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@@H]3CNC[C@H](O)C3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2992	Cl.CC1=C(C(C)=NO1)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@@H]3CNC[C@H](O)C3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7 [human]	IC50	500 - 1	nM
2993	Cl.CC1=C(C(C)=NO1)C1=CC=C2C(NC=C2C2=C(C=NC(N[C@@H]3CNC[C@H](O)C3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7 [human]	IC50	100 - 500	nM
2994	CC(C)(C)OC(=O)N1CCC[C@H](C1)NC1=NC(C2=NN(COCC[Si](C)(C)C)C3=CC(=CC=C23)C2=NC=CS2)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2995	CC(C)(C)OC(=O)N1CCC[C@H](C1)NC1=NC(C2=NN(COCC[Si](C)(C)C)C3=CC(=CC=C23)C2=NC=CS2)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
2996	CC(C)(C)OC(=O)N1CCC[C@H](C1)NC1=NC(C2=NN(COCC[Si](C)(C)C)C3=CC(=CC=C23)C2=NC=CS2)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100 - 500	nM
2997	CC(C)(C)OC(=O)N1CCC[C@H](C1)NC1=NC(C2=NN(COCC[Si](C)(C)C)C3=CC(=CC=C23)C2=NC=CS2)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100 - 500	nM
2998	CC(C)(C)OC(=O)N1CCC[C@H](C1)NC1=NC(C2=NN(COCC[Si](C)(C)C)C3=CC(=CC=C23)C2=NC=CS2)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
2999	Cl.CN1N=NN=C1C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7 [human]	IC50	100	nM
3000	Cl.CN1N=NN=C1C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
3001	Cl.CN1N=NN=C1C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7 [human]	IC50	100 - 500	nM
3002	Cl.CN1N=NN=C1C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3003	Cl.CN1N=NN=C1C1=CC=C2C(NC=C2C2=C(C=NC(N[C@H]3CCCNC3)=N2)C(F)(F)F)=C1	Cyclin-dependent kinase 7 [human]	IC50	100	nM
3004	Cl.C[C@@H]1CC[C@H](CN1)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=C(C)ON=C2C)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
3005	Cl.C[C@@H]1CC[C@H](CN1)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=C(C)ON=C2C)=C(C=N1)C(F)(F)F	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	30	nM
3006	Cl.C[C@@H]1CC[C@H](CN1)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=C(C)ON=C2C)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100 - 500	nM
3007	Cl.C[C@@H]1CC[C@H](CN1)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=C(C)ON=C2C)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100 - 500	nM
3008	Cl.C[C@@H]1CC[C@H](CN1)NC1=NC(C2=CNC3=C2C=CC(=N3)C2=C(C)ON=C2C)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	100	nM
3009	CCCN1C(=CN=C1C1=CC=CC(=C1)C1=CC=CC(CC(N)=O)=C1)C(=O)NC1=CC(=CC=C1C)S(=O)(=O)N(C)C	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage	5	%
3010	FC1=CC2=C(NC(=O)\C2=C2/SC(NC2=O)=NC2=CC=CC=C2Cl)C=C1	Cyclin-H [human];+Mating-type protein MAT-1 [human];+Cyclin-dependent kinase 7 [human]	inhibition rate	-5	%
3011	CC(C)C1=C2N=C(NCC3CCNCC3O)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-dependent kinase 7; Apoptosis regulator, Bcl-2;+Bcl-2-like protein 1 (isoform Bcl-X(L))	inhibition percentage		
3012	CC(C)C1=C2N=C(NCC3CCNCC3O)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-dependent kinase 7	inhibition percentage		
3013	CC(C)C1=C2N=C(NCC3CCNCC3O)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-dependent kinase 7	inhibition percentage		
3014	CC(C)C1=C2N=C(NCC3CCNCC3O)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-dependent kinase 7	inhibition percentage		
3015	CC(C)C1=C2N=C(NCC3CCNCC3O)C=C(NCC3=CC=CC=C3)N2N=C1	Cyclin-dependent kinase 7	inhibition percentage		
3016		Cyclin-dependent kinase 7; Apoptosis regulator, Bcl-2;+Bcl-2-like protein 1 (isoform Bcl-X(L))	inhibition percentage		
3017	CCN1N=C(C(C(N)=O)=C1NC)C1=CC=C2SC=NC2=C1	Cyclin-H; Cyclin-dependent kinase 7	inhibition rate	50	%
3018	[H][C@]12C[C@H](O)[C@]([H])(C1)NC1=C(C(N)=O)C(=NN1C2)C1=CC=C2SC=NC2=C1	Cyclin-H; Cyclin-dependent kinase 7	inhibition rate	50	%
3019	CC(C)C1=C2N=C(N=C(NCC3=C(NC(=O)C4=CC(NC(=O)C=CCN(C)C)=CC=C4)C=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3020	CC(C)C1=C2N=C(N=C(NCC3=C(NC(=O)C4=CC(NC(=O)C=CCN(C)C)=CC=C4)C=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3021	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC=C(NC(=O)C=CCN(C)C)C4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
3022	CC(C)C1=C2N=C(N=C(NCC3=C(OC4=CC=C(NC(=O)C=CCN(C)C)C=C4)C=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3023	CC(C)C1=C2N=C(N=C(NCC3=C(OC4=CC=C(NC(=O)C=CCN(C)C)C=C4)C=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3024	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3025	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3026	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3027	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3028	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3029	CC(C)C1=C2N=C(N=C(NCC3=C4N=C(NC(=O)C=CCN(C)C)C=CC4=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3030	CC(C)C1=C2N=C(N=C(NCC3=C4N=C(NC(=O)C=CCN(C)C)C=CC4=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3031	CC(C)C1=C2N=C(N=C(NCC3=CC(OC4=CC(NC(=O)C=CCN(C)C)=C(F)C=C4)=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3032	CC(C)C1=C2N=C(N=C(NCC3=CC(OC4=CC(NC(=O)C=CCN(C)C)=C(Cl)C=C4)=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3033	CC(C)C1=C2N=C(N=C(NCC3=CC(OC4=CC(NC(=O)C=CCN(C)C)=C(Cl)C=C4)=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3034	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=CC=C(NC(=O)C=CCN(C)C)C4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3035	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=CC=C(NC(=O)C=CCN(C)C)C4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3036	CC(C)C1=C2N=C(N=C(NCC3=CC(OC4CCCN(CC4)C(=O)C=CCN(C)C)=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3037	CC(C)C1=C2N=C(N=C(NCC3=CC(OC4CCCN(CC4)C(=O)C=CCN(C)C)=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3038	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=CC(NC(=O)C=CCN(C)C)=CC=C4N3)N2N=C1)N1CCC(N)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3039	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=CC(NC(=O)C=CCN(C)C)=CC=C4N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
3040	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC=C4C=CC=C(NC(=O)C=CCN(C)C)C4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3041	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC=C4C=CC=C(NC(=O)C=CCN(C)C)C4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3042	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC=C4C=CC=C(NC(=O)C=CCN(C)C)C4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3043	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC=C4C=CC=C(NC(=O)C=CCN(C)C)C4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3044	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC=C4C=CC=C(NC(=O)C=CCN(C)C)C4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3045	CC(C)C1=C2N=C(N=C(NCC3=CC(NC4CCCN(CC4)C(=O)C=CCN(C)C)=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3046	CC(C)C1=C2N=C(N=C(NCC3=CC(NC4CCCN(CC4)C(=O)C=CCN(C)C)=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
3047	CC(C)C1=C2N=C(N=C(NCC3=CC(NC(=O)C4CCCN(CC4)C(=O)C=CCN(C)C)=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3048	CC(C)C1=C2N=C(N=C(NCC3=CC(NC(=O)C4CCCN(CC4)C(=O)C=CCN(C)C)=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
3049	CC(C)C1=C2N=C(N=C(NCC3=CC(=CC=C3)C3=CC4=CC(NC(=O)C=CCN(C)C)=CC=C4N3)N2N=C1)N1CCC(N)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3050	CC(C)C1=C2N=C(N=C(NCC3=CC(=CC=C3)C3=CC4=CC(NC(=O)C=CCN(C)C)=CC=C4N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
3051	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=C4C=C(NC(=O)C=CCN(C)C)C=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3052	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=C4C=C(NC(=O)C=CCN(C)C)C=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
3053	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=CC4=CC=CC(NC(=O)C=CCN(C)C)=C4N3)N2N=C1)N1CCC(N)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3054	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=CC4=CC=CC(NC(=O)C=CCN(C)C)=C4N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3055	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=CC4=CC=CC(NC(=O)C=CCN(C)C)=C4N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3056	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=CC4=CC=CC(NC(=O)C=CCN(C)C)=C4N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3057	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=CC4=CC=CC(NC(=O)C=CCN(C)C)=C4N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3058	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3059	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3060	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3061	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3062	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3063	CC(C)C1=C2N=C(N[C@H]3CC[C@H](O)CC3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3064	CC(C)C1=C2N=C(N[C@H]3CC[C@H](O)CC3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3065	CC(C)C1=C2N=C(N[C@H]3CC[C@H](O)CC3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3066	CC(C)C1=C2N=C(N[C@H]3CC[C@H](O)CC3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3067	CC(C)C1=C2N=C(N[C@H]3CC[C@H](O)CC3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3068	CC(C)C1=C2N=C(NCCCO)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100 - 1000	nM
3069	CC(C)C1=C2N=C(NCCCO)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3070	CC(C)C1=C2N=C(NCCCO)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3071	CC(C)C1=C2N=C(NCCCO)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3072	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCC(CO)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100 - 1000	nM
3073	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCC(CO)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3074	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCC(CO)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3075	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCC(CO)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3076	CC(C)C1=C2N=C(NCC3CCNC(=O)C3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100 - 1000	nM
3077	CC(C)C1=C2N=C(NCC3CCNC(=O)C3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3078	CC(C)C1=C2N=C(NCC3CCNC(=O)C3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3079	CC(C)C1=C2N=C(NCC3CCNC(=O)C3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3080	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCC(O)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3081	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCC(O)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3082	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCC(O)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3083	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCC(O)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3084	CC(C)C1=C2N=C(N[C@H]3CC[C@H](O)C3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3085	CC(C)C1=C2N=C(N[C@H]3CC[C@H](O)C3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3086	CC(C)C1=C2N=C(N[C@H]3CC[C@H](O)C3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3087	CC(C)C1=C2N=C(N[C@H]3CC[C@H](O)C3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3088	CC(C)C1=C2N=C(NC[C@H]3CC[C@H](O)CC3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100 - 1000	nM
3089	CC(C)C1=C2N=C(NC[C@H]3CC[C@H](O)CC3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3090	CC(C)C1=C2N=C(NC[C@H]3CC[C@H](O)CC3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3091	CC(C)C1=C2N=C(NC[C@H]3CC[C@H](O)CC3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3092	CNC1CCN(CC1)C1=NC2=C(C=NN2C(NCC2=CC=CC=C2C2=C3C=CC(NC(=O)C=CCN(C)C)=CC3=CC=N2)=N1)C(C)C	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3093	CNC1CCN(CC1)C1=NC2=C(C=NN2C(NCC2=CC=CC=C2C2=C3C=CC(NC(=O)C=CCN(C)C)=CC3=CC=N2)=N1)C(C)C	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3094	CNC1CCN(CC1)C1=NC2=C(C=NN2C(NCC2=CC=CC=C2C2=C3C=CC(NC(=O)C=CCN(C)C)=CC3=CC=N2)=N1)C(C)C	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3095	CNC1CCN(CC1)C1=NC2=C(C=NN2C(NCC2=CC=CC=C2C2=C3C=CC(NC(=O)C=CCN(C)C)=CC3=CC=N2)=N1)C(C)C	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3096	CC(C)C1=C2N=C(NCCC(C)(C)O)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3097	CC(C)C1=C2N=C(NCCC(C)(C)O)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3098	CC(C)C1=C2N=C(NCCC(C)(C)O)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3099	CC(C)C1=C2N=C(NCCC(C)(C)O)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3100	CC(C)C1=C2N=C(NC3CCC(O)CC3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3101	CC(C)C1=C2N=C(NC3CCC(O)CC3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3102	CC(C)C1=C2N=C(NC3CCC(O)CC3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3103	CC(C)C1=C2N=C(NC3CCC(O)CC3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3104	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCC(O)C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100 - 1000	nM
3105	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCC(O)C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3106	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCC(O)C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3107	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCC(O)C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3108	CC(C)C1=C2N=C(N=C(NCC3=CC(NC(=O)C4=CC(NC(=O)C=CCN(C)C)=CC=C4)=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3109	CC(C)C1=C2N=C(N=C(NCC3=CC(NC(=O)C4=CC(NC(=O)C=CCN(C)C)=CC=C4)=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
3110	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCCC(O)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100 - 1000	nM
3111	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCCC(O)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3112	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCCC(O)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3113	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCCC(O)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3114	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCC(CC1)N(C)C	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3115	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCC(CC1)N(C)C	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3116	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCC(CC1)N(C)C	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3117	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCC(CC1)N(C)C	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3118	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=C(C)C)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3119	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=C(C)C)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3120	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=C(C)C)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3121	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=C(C)C)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3122	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1C=CC(CO)=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3123	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1C=CC(CO)=N1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3124	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1C=CC(CO)=N1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3125	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1C=CC(CO)=N1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3126	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCOCC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100 - 1000	nM
3127	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCOCC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3128	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCOCC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3129	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCOCC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3130	CC(C)C1=C2N=C(NCC3CCOCC3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100 - 1000	nM
3131	CC(C)C1=C2N=C(NCC3CCOCC3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3132	CC(C)C1=C2N=C(NCC3CCOCC3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3133	CC(C)C1=C2N=C(NCC3CCOCC3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3134	CC(C)C1=C2N=C(NCC3CCNCC3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3135	CC(C)C1=C2N=C(NCC3CCNCC3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3136	CC(C)C1=C2N=C(NCC3CCNCC3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3137	CC(C)C1=C2N=C(NCC3CCNCC3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3138	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=C)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3139	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=C)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3140	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=C)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3141	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=C)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3142	CC(C)C1=C2N=C(N=C(NCC3=CC(OC4=CC(NC(=O)C=CCN(C)C)=CC=C4)=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3143	CC(C)C1=C2N=C(N=C(NCC3=CC(OC4=CC(NC(=O)C=CCN(C)C)=CC=C4)=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3144	CC=CC(=O)NC1=CC2=CC=NC(C3=CC=CC=C3CNC3=NC(=NC4=C(C=NN34)C(C)C)N3CCC(N)CC3)=C2C=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3145	CC=CC(=O)NC1=CC2=CC=NC(C3=CC=CC=C3CNC3=NC(=NC4=C(C=NN34)C(C)C)N3CCC(N)CC3)=C2C=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3146	CC=CC(=O)NC1=CC2=CC=NC(C3=CC=CC=C3CNC3=NC(=NC4=C(C=NN34)C(C)C)N3CCC(N)CC3)=C2C=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3147	CC=CC(=O)NC1=CC2=CC=NC(C3=CC=CC=C3CNC3=NC(=NC4=C(C=NN34)C(C)C)N3CCC(N)CC3)=C2C=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3148	CC(C)C1=C2N=C(NCCC3CNCCO3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3149	CC(C)C1=C2N=C(NCCC3CNCCO3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3150	CC(C)C1=C2N=C(NCCC3CNCCO3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3151	CC(C)C1=C2N=C(NCCC3CNCCO3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3152	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN5CCCCC5)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3153	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN5CCCCC5)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3154	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN5CCCCC5)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3155	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN5CCCCC5)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3156	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN5CCOCC5)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3157	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN5CCOCC5)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3158	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN5CCOCC5)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3159	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN5CCOCC5)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3160	COCC=CC(=O)NC1=CC2=CC=NC(C3=CC=CC=C3CNC3=NC(=NC4=C(C=NN34)C(C)C)N3CCC(N)CC3)=C2C=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3161	COCC=CC(=O)NC1=CC2=CC=NC(C3=CC=CC=C3CNC3=NC(=NC4=C(C=NN34)C(C)C)N3CCC(N)CC3)=C2C=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3162	COCC=CC(=O)NC1=CC2=CC=NC(C3=CC=CC=C3CNC3=NC(=NC4=C(C=NN34)C(C)C)N3CCC(N)CC3)=C2C=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3163	COCC=CC(=O)NC1=CC2=CC=NC(C3=CC=CC=C3CNC3=NC(=NC4=C(C=NN34)C(C)C)N3CCC(N)CC3)=C2C=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3164	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=NC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3165	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=NC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3166	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=NC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3167	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=NC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3168	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3C3=CC=C4C=CC=C(NC(=O)C=CCN(C)C)C4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3169	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3C3=CC=C4C=CC=C(NC(=O)C=CCN(C)C)C4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3170	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3C3=CC=C4C=CC=C(NC(=O)C=CCN(C)C)C4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3171	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3C3=CC=C4C=CC=C(NC(=O)C=CCN(C)C)C4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3172	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN5CCCC5)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3173	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN5CCCC5)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3174	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN5CCCC5)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3175	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN5CCCC5)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3176	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=CC4=C(NC(=O)C=CCN(C)C)C=CC=C4N3)N2N=C1)N1CCC(N)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3177	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=CC4=C(NC(=O)C=CCN(C)C)C=CC=C4N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3178	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=CC4=C(NC(=O)C=CCN(C)C)C=CC=C4N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3179	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=CC4=C(NC(=O)C=CCN(C)C)C=CC=C4N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3180	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=CC4=C(NC(=O)C=CCN(C)C)C=CC=C4N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3181	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCNCC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3182	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCNCC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3183	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCNCC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3184	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCNCC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3185	COC1CCN(CC1)C1=NC2=C(C=NN2C(NCC2=CC=CC=C2C2=C3C=CC(NC(=O)C=CCN(C)C)=CC3=CC=N2)=N1)C(C)C	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3186	COC1CCN(CC1)C1=NC2=C(C=NN2C(NCC2=CC=CC=C2C2=C3C=CC(NC(=O)C=CCN(C)C)=CC3=CC=N2)=N1)C(C)C	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3187	COC1CCN(CC1)C1=NC2=C(C=NN2C(NCC2=CC=CC=C2C2=C3C=CC(NC(=O)C=CCN(C)C)=CC3=CC=N2)=N1)C(C)C	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3188	COC1CCN(CC1)C1=NC2=C(C=NN2C(NCC2=CC=CC=C2C2=C3C=CC(NC(=O)C=CCN(C)C)=CC3=CC=N2)=N1)C(C)C	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3189	CC(C)C1=C2N=C(NCC3CNCCO3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3190	CC(C)C1=C2N=C(NCC3CNCCO3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3191	CC(C)C1=C2N=C(NCC3CNCCO3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3192	CC(C)C1=C2N=C(NCC3CNCCO3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3193	CC(C)C1=C2N=C(NC3CCNCC3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3194	CC(C)C1=C2N=C(NC3CCNCC3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3195	CC(C)C1=C2N=C(NC3CCNCC3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
3196	CC(C)C1=C2N=C(NC3CCNCC3)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
3197	CC=CC(=O)NC1=CC2=CC=NC(C3=CC=CC=C3CNC3=NC(NC[C@H]4CCNC[C@@H]4O)=NC4=C(C=NN34)C(C)C)=C2C=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3198	CC=CC(=O)NC1=CC2=CC=NC(C3=CC=CC=C3CNC3=NC(NC[C@H]4CCNC[C@@H]4O)=NC4=C(C=NN34)C(C)C)=C2C=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3199	CC=CC(=O)NC1=CC2=CC=NC(C3=CC=CC=C3CNC3=NC(NC[C@H]4CCNC[C@@H]4O)=NC4=C(C=NN34)C(C)C)=C2C=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3200	CC=CC(=O)NC1=CC2=CC=NC(C3=CC=CC=C3CNC3=NC(NC[C@H]4CCNC[C@@H]4O)=NC4=C(C=NN34)C(C)C)=C2C=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3201	CC=CC(=O)NC1=CC2=CC=NC(C3=CC=CC=C3CNC3=NC(NCC4CNCCO4)=NC4=C(C=NN34)C(C)C)=C2C=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3202	CC=CC(=O)NC1=CC2=CC=NC(C3=CC=CC=C3CNC3=NC(NCC4CNCCO4)=NC4=C(C=NN34)C(C)C)=C2C=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3203	CC=CC(=O)NC1=CC2=CC=NC(C3=CC=CC=C3CNC3=NC(NCC4CNCCO4)=NC4=C(C=NN34)C(C)C)=C2C=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3204	CC=CC(=O)NC1=CC2=CC=NC(C3=CC=CC=C3CNC3=NC(NCC4CNCCO4)=NC4=C(C=NN34)C(C)C)=C2C=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3205	CC=CC(=O)NC1=CC=CC2=CC=C(N=C12)C1=CC=CC(C)=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3206	CC=CC(=O)NC1=CC=CC2=CC=C(N=C12)C1=CC=CC(C)=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
3207	CC=CC(=O)NC1=CC=CC2=CC=C(N=C12)C1=CC=CC(C)=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
3208	CC=CC(=O)NC1=CC=CC2=CC=C(N=C12)C1=CC=CC(C)=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
3209	CC=CC(=O)NC1=CC2=CC=NC(C3=CC=CC=C3CNC3=NC(=NC4=C(C=NN34)C(C)C)N3CCNCC3)=C2C=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3210	CC=CC(=O)NC1=CC2=CC=NC(C3=CC=CC=C3CNC3=NC(=NC4=C(C=NN34)C(C)C)N3CCNCC3)=C2C=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3211	CC=CC(=O)NC1=CC2=CC=NC(C3=CC=CC=C3CNC3=NC(=NC4=C(C=NN34)C(C)C)N3CCNCC3)=C2C=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3212	CC=CC(=O)NC1=CC2=CC=NC(C3=CC=CC=C3CNC3=NC(=NC4=C(C=NN34)C(C)C)N3CCNCC3)=C2C=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3213	CC=CC(=O)NC1=CC2=CC=NC(C3=CC=CC=C3CNC3=CC(NC[C@H]4CCNC[C@@H]4O)=NC4=C(C=NN34)C(C)C)=C2C=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3214	CC=CC(=O)NC1=CC2=CC=NC(C3=CC=CC=C3CNC3=CC(NC[C@H]4CCNC[C@@H]4O)=NC4=C(C=NN34)C(C)C)=C2C=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3215	CC=CC(=O)NC1=CC2=CC=NC(C3=CC=CC=C3CNC3=CC(NC[C@H]4CCNC[C@@H]4O)=NC4=C(C=NN34)C(C)C)=C2C=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3216	CC=CC(=O)NC1=CC2=CC=NC(C3=CC=CC=C3CNC3=CC(NC[C@H]4CCNC[C@@H]4O)=NC4=C(C=NN34)C(C)C)=C2C=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3217	CC=CC(=O)NC1=C2NC(=CC2=CC=C1)C1=CC=CC(C)=C1CNC1=NC(NC[C@H]2CCNC[C@@H]2O)=NC2=C(C=NN12)C(C)C	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3218	CC=CC(=O)NC1=C2NC(=CC2=CC=C1)C1=CC=CC(C)=C1CNC1=NC(NC[C@H]2CCNC[C@@H]2O)=NC2=C(C=NN12)C(C)C	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3219	CC=CC(=O)NC1=C2NC(=CC2=CC=C1)C1=CC=CC(C)=C1CNC1=NC(NC[C@H]2CCNC[C@@H]2O)=NC2=C(C=NN12)C(C)C	Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
3220	CC=CC(=O)NC1=C2NC(=CC2=CC=C1)C1=CC=CC(C)=C1CNC1=NC(NC[C@H]2CCNC[C@@H]2O)=NC2=C(C=NN12)C(C)C	Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
3221	CC=CC(=O)NC1=CC=C2N(C=CC2=C1)C1=CC=CC=C1CNC1=NC(NC[C@H]2CCNC[C@@H]2O)=NC2=C(C=NN12)C(C)C	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3222	CC=CC(=O)NC1=CC=C2N(C=CC2=C1)C1=CC=CC=C1CNC1=NC(NC[C@H]2CCNC[C@@H]2O)=NC2=C(C=NN12)C(C)C	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3223	CC=CC(=O)NC1=CC=C2N(C=CC2=C1)C1=CC=CC=C1CNC1=NC(NC[C@H]2CCNC[C@@H]2O)=NC2=C(C=NN12)C(C)C	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3224	CC=CC(=O)NC1=CC=C2N(C=CC2=C1)C1=CC=CC=C1CNC1=NC(NC[C@H]2CCNC[C@@H]2O)=NC2=C(C=NN12)C(C)C	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3225	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCC(CC1)NC(=O)OC(C)(C)C	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100 - 1000	nM
3226	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCC(CC1)NC(=O)OC(C)(C)C	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3227	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCC(CC1)NC(=O)OC(C)(C)C	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3228	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN(C)C)=CC4=CC=N3)N2N=C1)N1CCC(CC1)NC(=O)OC(C)(C)C	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3229	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN5CCCCC5)=CC4=CC=N3)N2N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3230	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN5CCCCC5)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3231	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN5CCCCC5)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3232	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C=CCN5CCCCC5)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3233	CC=CC(=O)NC1=CC2=CC=NC(C3=CC=CC=C3CNC3=NC(NC[C@@H]4CNC[C@H]4O)=NC4=C(C=NN34)C(C)C)=C2C=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3234	CC=CC(=O)NC1=CC2=CC=NC(C3=CC=CC=C3CNC3=NC(NC[C@@H]4CNC[C@H]4O)=NC4=C(C=NN34)C(C)C)=C2C=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3235	CC=CC(=O)NC1=CC2=CC=NC(C3=CC=CC=C3CNC3=NC(NC[C@@H]4CNC[C@H]4O)=NC4=C(C=NN34)C(C)C)=C2C=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
3236	CC=CC(=O)NC1=CC2=CC=NC(C3=CC=CC=C3CNC3=NC(NC[C@@H]4CNC[C@H]4O)=NC4=C(C=NN34)C(C)C)=C2C=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 10	μM
3237	CC(C)C1=C2N=C(NC[C@@H]3CNC[C@H]3O)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)C(F)=C)=CC4=CC=N3)N2N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3238	CC(C)C1=C2N=C(N=C(NCC3=C(OC4CCN(CC4)C(=O)C=CCN(C)C)C=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	100	nM
3239	CC(C)C1=C2N=C(N=C(NCC3=C(OC4CCN(CC4)C(=O)C=CCN(C)C)C=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
3240	C[C@H](C(=O)NC1=NNC(=C1)C1CC1)C1=CC(F)=C(C=C1)C1=CCN(CC1)C(=O)C=C	Cyclin-dependent kinase 7	IC50	0.88	μM
3241	C[C@@H](C(=O)NC1=NNC(=C1)C1CC1)C1=CC(F)=C(C=C1)C1=CCN(CC1)C(=O)C=C	Cyclin-dependent kinase 7	IC50	5.76	μM
3242	C[C@H](C(=O)NC1=NNC(=C1)C1CC1)C1=CC=C(C=C1)C1CCC(CC1)NC(=O)C=C	Cyclin-dependent kinase 7	IC50	5.492	μM
3243	C[C@@H](C(=O)NC1=NNC(=C1)C1CC1)C1=CC=C(C=C1)C1CCC(CC1)NC(=O)C=C	Cyclin-dependent kinase 7	IC50	3.646	μM
3244	CCOC1=CC(=NC=C1Cl)N1CC(C1)N1C(=O)NC2=C1C=CC=C2	CDK-activating kinase assembly factor MAT1 [human]	IC50	1	μM
3245	CC(C)C1=C2N=C(N=C(NCC3=C(C=C(C)C=C3)N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3246	CC(C)C1=C2N=C(N=C(NCC3=C(C=C(C)C=C3)N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3247	CC(C)C1=C2N=C(N=C(NCC3=C(OC4CCN(C)CC4)C=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3248	CC(C)C1=C2N=C(N=C(NCC3=C(OC4CCN(C)CC4)C=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3249	CC(C)C1=C2N=C(N=C(NCC3=C(OC4CCN(C)CC4)C=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3250	CC(C)C1=C2N=C(N=C(NCC3=C(OC4CCN(C)CC4)C=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3251	CC(C)C1=C2N=C(N=C(NCC3=C(OC4CCN(C)CC4)C=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3252	CC(C)C1=C2N=C(N=C(NCC3=C(OC4CCN(C)CC4)C=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3253	CC(C)C1=C2N=C(N=C(NCC3=C(OC4CCN(C)CC4)C=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3254	CC(C)C1=C2N=C(N=C(NCC3=CC(N4C=CC=N4)=C(Cl)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3255	CC(C)C1=C2N=C(N=C(NCC3=CC(N4C=CC=N4)=C(Cl)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3256	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC4=C3C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3257	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC4=C3C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3258	CC(C)C1=C2N=C(N=C(NCC3=C4N(C)C(=O)CCC4=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3259	CC(C)C1=C2N=C(N=C(NCC3=C4N(C)C(=O)CCC4=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3260	CC(C)C1=C2N=C(N=C(NCC3=C4N(C)C(=O)CCC4=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3261	CC(C)C1=C2N=C(N=C(NCC3=C4N(C)C(=O)CCC4=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3262	CC(C)C1=C2N=C(N=C(NCC3=CC=CC(NC(=O)C4=CC(NC(=O)CCCN(C)C)=CC=C4)=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
3263	CC(C)C1=C2N=C(N=C(NCC3=CC=CC(NC(=O)C4=CC(NC(=O)CCCN(C)C)=CC=C4)=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3264	CC(C)C1=C2N=C(N=C(NCC3=CC=CC(NC(=O)C4=CC(NC(=O)CCCN(C)C)=CC=C4)=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3265	CC(C)C1=C2N=C(N=C(NCC3=C4N=C(C=CC4=CC=C3)C3CC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3266	CC(C)C1=C2N=C(N=C(NCC3=C4N=C(C=CC4=CC=C3)C3CC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3267	CC(C)C1=C2N=C(N=C(NCC3=C4N=C(C=CC4=CC=C3)C3CC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3268	CC(C)C1=C2N=C(N=C(NCC3=C4N=C(C=CC4=CC=C3)C3CC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3269	CC(C)C1=C2N=C(N=C(NCC3=C4N=C(C=CC4=CC=C3)C3CC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3270	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3271	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3272	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3273	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3274	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3275	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3276	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3277	CC(C)C1=C2N=C(C=C(NCC3=C(C=CC=C3)C3=CC=C4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3278	CC(C)C1=C2N=C(C=C(NCC3=C(C=CC=C3)C3=CC=C4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3279	CC(C)C1=C2N=C(C=C(NCC3=C(C=CC=C3)C3=CC=C4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3280	CC(C)C1=C2N=C(C=C(NCC3=C(C=CC=C3)C3=CC=C4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3281	CC(C)C1=C2N=C(C=C(NCC3=C(C=CC=C3)C3=CC=C4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3282	CC(C)C1=C2N=C(C=C(NCC3=C(C=CC=C3)C3=CC=C4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3283	CC(C)C1=C2N=C(C=C(NCC3=C(C=CC=C3)C3=CC=C4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3284	CC(C)C1=C2N=C(N=C(NCC3=C(OC4=NC5=C(C=CC=C5)C=C4)C=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
3285	CC(C)C1=C2N=C(N=C(NCC3=C(OC4=NC5=C(C=CC=C5)C=C4)C=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3286	CC(C)C1=C2N=C(N=C(NCC3=C(OC4=NC5=C(C=CC=C5)C=C4)C=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3287	CC(C)C1=C2N=C(N=C(NCC3=CC(=CC=C3C)N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3288	CC(C)C1=C2N=C(N=C(NCC3=CC(=CC=C3C)N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3289	CC(C)C1=C2N=C(N=C(NCC3=CC(=CC=C3C)N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3290	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3CCC4=C3C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3291	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3CCC4=C3C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3292	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3CCC4=C3C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3293	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3CCC4=C3C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3294	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC4=C(C=CC=C4)C=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3295	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC4=C(C=CC=C4)C=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3296	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC4=C(C=CC=C4)C=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3297	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC4=C(C=CC=C4)C=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3298	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC4=C(C=CC=C4)C=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3299	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=CC4=C(C=CC=C4)C=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3300	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=CC4=C(C=CC=C4)C=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3301	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=CC4=C(C=CC=C4)C=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3302	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=CC4=C(C=CC=C4)C=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3303	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=CC4=C(C=CC=C4)C=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3304	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC=CC4=C3C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3305	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC=CC4=C3C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
3306	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC=CC4=C3C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3307	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC=CC4=C3C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3308	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC=CC4=C3C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3309	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC=CC4=C3C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3310	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC4=C(C=CC=C4)N=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3311	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC4=C(C=CC=C4)N=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3312	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC4=C(C=CC=C4)N=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3313	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC4=C(C=CC=C4)N=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3314	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC4=C(C=CC=C4)N=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3315	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC4=C(C=CC=C4)N=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3316	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=N(=O)C4=C(C=CC=C4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
3317	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=N(=O)C4=C(C=CC=C4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3318	CC(C)C1=C2N=C(N=C(NCC3=C(OC4=CC=CC(NC(=O)CCCN(C)C)=C4)C=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3319	CC(C)C1=C2N=C(N=C(NCC3=CC=CC(=C3)N3CCN(C)CC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3320	CC(C)C1=C2N=C(N=C(NCC3=CC=CC(=C3)N3CCN(C)CC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3321	CC(C)C1=C2N=C(N=C(NCC3=CC=CC(OC4=CC=CC(NC(=O)CCCN(C)C)=C4)=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3322	CC(C)C1=C2N=C(N=C(NCC3=CC=CC(=C3)N3CCN(CC3)C(=O)CCCN(C)C)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
3323	CCC(=O)NC1=CC(OC2=CC(CNC3=NC(=NC4=C(C=NN34)C(C)C)N3CCC(N)CC3)=CC=C2)=CC=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3324	CCC(=O)NC1=CC(OC2=CC(CNC3=NC(=NC4=C(C=NN34)C(C)C)N3CCC(N)CC3)=CC=C2)=CC=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3325	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3NC(=O)C3=CC=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3326	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3NC(=O)C3=CC=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3327	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3NC(=O)C3=CC=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3328	CCC(=O)NC1=CC(OC2=C(CNC3=NC(=NC4=C(C=NN34)C(C)C)N3CCC(N)CC3)C=CC=C2)=CC=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3329	CCC(=O)NC1=CC(OC2=C(CNC3=NC(=NC4=C(C=NN34)C(C)C)N3CCC(N)CC3)C=CC=C2)=CC=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3330	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3NC(=O)C3=CC=CC(NC(=O)CCCN(C)C)=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3331	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3NC(=O)C3=CC=CC(NC(=O)CCCN(C)C)=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3332	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3NC(=O)C3=CC=CC(NC(=O)CCCN(C)C)=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3333	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3NC(=O)C3=CC=CC(NC(=O)CCCN(C)C)=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3334	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC=C(NC(=O)CCCN(C)C)C4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3335	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC=C(NC(=O)CCCN(C)C)C4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
3336	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC=C(NC(=O)CCCN(C)C)C4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3337	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC=C(NC(=O)CCCN(C)C)C4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3338	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC=C(NC(=O)CCCN(C)C)C4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3339	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC=C(NC(=O)CCCN(C)C)C4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3340	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC=C(NC(=O)CCCN(C)C)C4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
3341	CC(C)C1=C2N=C(N=C(NCC3=C(OC4=CC=C(NC(=O)CCCN(C)C)C=C4)C=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3342	CC(C)C1=C2N=C(N=C(NCC3=C(OC4=CC=C(NC(=O)CCCN(C)C)C=C4)C=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3343	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)CCCN(C)C)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3344	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)CCCN(C)C)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
3345	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)CCCN(C)C)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3346	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)CCCN(C)C)=CC4=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3347	CC(C)C1=C2N=C(N=C(NCC3=CC=CC(OC4=CC=C(F)C(NC(=O)CCCN(C)C)=C4)=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3348	CC(C)C1=C2N=C(N=C(NCC3=CC=CC(OC4=CC=C(F)C(NC(=O)CCCN(C)C)=C4)=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3349	CC(C)C1=C2N=C(N=C(NCC3=CC=CC(OC4=CC=C(Cl)C(NC(=O)CCCN(C)C)=C4)=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3350	CC(C)C1=C2N=C(N=C(NCC3=CC=CC(OC4=CC=C(Cl)C(NC(=O)CCCN(C)C)=C4)=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3351	CC(C)C1=C2N=C(N=C(NCC3=CC=CC4=C3N=C(NC(=O)CCCN(C)C)C=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3352	CC(C)C1=C2N=C(N=C(NCC3=CC=CC4=C3N=C(NC(=O)CCCN(C)C)C=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3353	CC(C)C1=C2N=C(N=C(NCC3=CC=CC4=C3N=C(NC(=O)CCCN(C)C)C=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3354	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC4=C(C=CC=C4)N3C)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3355	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC4=C(C=CC=C4)N3C)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3356	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC4=C(C=CC=C4)N3C)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3357	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC4=C(C=CC=C4)N3C)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3358	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC4=C(O3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3359	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC4=C(O3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3360	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC4=C(O3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3361	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC4=C(O3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3362	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC4=C(O3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3363	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC4=C(O3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3364	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3365	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3366	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3367	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3368	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3369	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=NC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3370	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC(=N3)C3=CC=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3371	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC(=N3)C3=CC=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3372	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC(=N3)C3=CC=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3373	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC(=N3)C3=CC=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3374	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC(=N3)C3=CC=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3375	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC(=N3)C3=CC=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3376	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(Br)C=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3377	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(Br)C=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3378	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(Br)C=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3379	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(C=CC4=N3)C3=CC=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3380	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(C=CC4=N3)C3=CC=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3381	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(C=CC4=N3)C3=CC=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3382	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3383	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3384	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3385	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3386	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3387	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3388	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3389	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3390	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(Cl)C=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3391	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(Cl)C=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3392	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(Cl)C=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3393	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(Cl)C=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3394	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(Cl)C=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3395	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=CC(=CC4=N3)C(F)(F)F)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3396	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=CC(=CC4=N3)C(F)(F)F)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3397	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=CC(=CC4=N3)C(F)(F)F)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3398	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=CC(=CC4=N3)C(F)(F)F)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3399	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=CC(=CC4=N3)C(F)(F)F)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3400	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=CC(=CC4=N3)C(F)(F)F)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3401	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=CC(=CC4=N3)C(F)(F)F)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3402	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(OC5=CC=CC=C5)C=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3403	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(OC5=CC=CC=C5)C=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3404	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(OC5=CC=CC=C5)C=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3405	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(OC5=CC=CC=C5)C=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3406	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(OC5=CC=CC=C5)C=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3407	CCCC1=CC2=CN(N=C2C=C1)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3408	CCCC1=CC2=CN(N=C2C=C1)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3409	CCCC1=CC2=CN(N=C2C=C1)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3410	CCCC1=CC2=CN(N=C2C=C1)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3411	CCCC1=CC2=CN(N=C2C=C1)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3412	CC(C)OC1=CC2=NN(C=C2C=C1)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3413	CC(C)OC1=CC2=NN(C=C2C=C1)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3414	CC(C)OC1=CC2=NN(C=C2C=C1)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3415	CC(C)OC1=CC2=NN(C=C2C=C1)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3416	CC(C)OC1=CC2=NN(C=C2C=C1)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3417	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(F)C=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3418	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(F)C=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3419	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(F)C=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3420	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(F)C=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3421	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(F)C=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3422	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(F)C=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3423	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(F)C=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3424	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=C4CCCCC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3425	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=C4CCCCC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3426	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=C4CCCCC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3427	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=C4CCCCC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3428	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=C4CCCCC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3429	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=C4CCCCC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3430	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CN4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3431	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CN4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3432	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CN4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3433	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CN4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3434	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CN4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3435	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(CC1)NC(C)=O	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3436	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(CC1)NC(C)=O	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3437	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(CC1)NC(C)=O	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3438	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4F)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3439	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4F)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3440	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4F)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3441	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4F)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3442	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4F)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3443	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4F)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3444	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C(F)=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3445	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C(F)=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3446	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C(F)=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3447	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C(F)=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3448	CC(C)C1=C2N=C(NC3CCOCC3)N=C(NCC3=C(C=CC=C3)C3=CC4=C(N3)C=CC=C4)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3449	CC(C)C1=C2N=C(NC3CCOCC3)N=C(NCC3=C(C=CC=C3)C3=CC4=C(N3)C=CC=C4)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3450	CC(C)C1=C2N=C(NC3CCOCC3)N=C(NCC3=C(C=CC=C3)C3=CC4=C(N3)C=CC=C4)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100 - 1000	nM
3451	CC(C)C1=C2N=C(OC3CCN(C)CC3)N=C(NCC3=C(C=CC=C3)C3=CC4=C(N3)C=CC=C4)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3452	CC(C)C1=C2N=C(OC3CCN(C)CC3)N=C(NCC3=C(C=CC=C3)C3=CC4=C(N3)C=CC=C4)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3453	CC(C)C1=C2N=C(OC3CCN(C)CC3)N=C(NCC3=C(C=CC=C3)C3=CC4=C(N3)C=CC=C4)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3454	CC(C)C1=C2N=C(OC3CCN(C)CC3)N=C(NCC3=C(C=CC=C3)C3=CC4=C(N3)C=CC=C4)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3455	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC(NC(C)=O)=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3456	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC(NC(C)=O)=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3457	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC(NC(C)=O)=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3458	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC(NC(C)=O)=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3459	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC(NC(C)=O)=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3460	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC(NC(C)=O)=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3461	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(CC1)C(N)=O	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3462	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(CC1)C(N)=O	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3463	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(CC1)C(N)=O	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100 - 1000	nM
3464	CC(C)C1=C2N=C(N=C(NCC3=CC=CC(=C3)C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3465	CC(C)C1=C2N=C(N=C(NCC3=CC=CC(=C3)C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3466	CC(C)C1=C2N=C(N=C(NCC3=CC=CC(=C3)C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3467	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C(Cl)C4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3468	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C(Cl)C4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3469	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C(Cl)C4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3470	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=C(Cl)C4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3471	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(C=CC4=N3)C#N)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3472	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(C=CC4=N3)C#N)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3473	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(C=CC4=N3)C#N)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3474	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(C=CC4=N3)C#N)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3475	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC(=C4)N(=O)=O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3476	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC(=C4)N(=O)=O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3477	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC(=C4)N(=O)=O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3478	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CN4CCCCC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3479	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CN4CCCCC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3480	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CN4CCCCC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3481	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CN4CCCCC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3482	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CN4CCCCC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3483	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(NC=N4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3484	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(NC=N4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3485	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(NC=N4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3486	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(NC=N4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3487	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CN4C=CC(F)=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3488	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CN4C=CC(F)=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3489	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CN4C=CC(F)=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3490	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CN4C=CC(F)=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3491	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CN4C=CC(F)=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3492	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCCC(N)C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3493	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCCC(N)C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3494	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=CC=C(NC(=O)CCCN(C)C)C4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3495	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=CC=C(NC(=O)CCCN(C)C)C4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3496	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=CC=C(NC(=O)CCCN(C)C)C4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3497	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(C=CC4=N3)C(C)=O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3498	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(C=CC4=N3)C(C)=O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3499	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(C=CC4=N3)C(C)=O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3500	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3CC4=C(C3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3501	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3CC4=C(C3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3502	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3CC4=C(C3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3503	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3CC4=C(C3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3504	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)(CO)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3505	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)(CO)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3506	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)(CO)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3507	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)(CO)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3508	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)(CO)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3509	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCOC(CN)C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3510	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCOC(CN)C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3511	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCOC(CN)C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3512	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCOC(CN)C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3513	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCOC(CN)C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3514	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC[C@@H](N)C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3515	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC[C@@H](N)C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3516	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4CC(=O)CCC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3517	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4CC(=O)CCC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3518	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4CC(=O)CCC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3519	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4COCCC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3520	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4COCCC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3521	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4COCCC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3522	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4COCCC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3523	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4COCCC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3524	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C(CCNC4=O)=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3525	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C(CCNC4=O)=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3526	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C(CCNC4=O)=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3527	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C(CCNC4=O)=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3528	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C(CCNC4=O)=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3529	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C(CCNC4=O)=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3530	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3CC4CCCCC4C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3531	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3CC4CCCCC4C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3532	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3CC4CCCCC4C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3533	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=CC4=C(NC=N4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3534	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=CC4=C(NC=N4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3535	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=CC4=C(NC=N4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3536	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=CC4=C(NC=N4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3537	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=CC4=C(NC=N4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3538	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(NN=C4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3539	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(NN=C4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3540	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(NN=C4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3541	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(OC(C)(C)C(=O)N4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3542	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(OC(C)(C)C(=O)N4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3543	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(OC(C)(C)C(=O)N4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3544	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=CN=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3545	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=CN=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3546	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=CN=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3547	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=CN=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3548	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=CN=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3549	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(NC(=O)N4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3550	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(NC(=O)N4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3551	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(NC(=O)N4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3552	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(NC(=O)N4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3553	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(NC(NC(=O)C5CC5)=N4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3554	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(NC(NC(=O)C5CC5)=N4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3555	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(NC(NC(=O)C5CC5)=N4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3556	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C(NC(=O)CCCN(C)C)=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3557	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C(NC(=O)CCCN(C)C)=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3558	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C(NC(=O)CCCN(C)C)=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3559	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C(NC(=O)CCCN(C)C)=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3560	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C(NC(=O)CCCN(C)C)=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3561	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C(NC(=O)C3CC3)=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3562	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C(NC(=O)C3CC3)=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3563	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C(NC(=O)C3CC3)=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3564	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C(NC(=O)C3CC3)=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3565	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C(NC(=O)C3CC3)=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3566	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C(NC(=O)C3CC3)=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3567	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C(NC(=O)C3CC3)=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3568	CC(C)CC(=O)NC1=CC=CC2=C1NC(=C2)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3569	CC(C)CC(=O)NC1=CC=CC2=C1NC(=C2)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3570	CC(C)CC(=O)NC1=CC=CC2=C1NC(=C2)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3571	CC(C)CC(=O)NC1=CC=CC2=C1NC(=C2)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3572	CC(C)CC(=O)NC1=CC=CC2=C1NC(=C2)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3573	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C(C=CC=C4NC(N)=O)=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3574	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C(C=CC=C4NC(N)=O)=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3575	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C(C=CC=C4NC(N)=O)=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3576	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C(C=CC=C4NC(N)=O)=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3577	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C(C=CC=C4NC(N)=O)=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3578	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(C=CC4=N3)C(=O)N3CCCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3579	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(C=CC4=N3)C(=O)N3CCCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3580	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(C=CC4=N3)C(=O)N3CCCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3581	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(C=CC4=N3)C(=O)N3CCCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3582	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(C=CC4=N3)C(=O)N3CCCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3583	CC(C)C(=O)N1CCC2=NN(C=C2C1)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3584	CC(C)C(=O)N1CCC2=NN(C=C2C1)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3585	CC(C)C(=O)N1CCC2=NN(C=C2C1)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3586	CC(C)C(=O)N1CCC2=NN(C=C2C1)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3587	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C(NC(=O)N(C)C)=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3588	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C(NC(=O)N(C)C)=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3589	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4CC(CCC4=N3)NC(C)=O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3590	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4CC(CCC4=N3)NC(C)=O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3591	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4CC(CCC4=N3)NC(C)=O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3592	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4CC(CCC4=N3)NC(C)=O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3593	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4CC(CCC4=N3)NC(C)=O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3594	CNC(=O)C1=CC(=CC=C1)C1=CN(N=C1)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3595	CNC(=O)C1=CC(=CC=C1)C1=CN(N=C1)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3596	CNC(=O)C1=CC(=CC=C1)C1=CN(N=C1)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3597	CNC(=O)C1=CC(=CC=C1)C1=CN(N=C1)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3598	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C(C=N3)C(=O)NC3=CC=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3599	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C(C=N3)C(=O)NC3=CC=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3600	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C(C=N3)C(=O)NC3=CC=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3601	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C(C=N3)C(=O)NC3=CC=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3602	CNC(=O)C1=CC2=C(C=C1)N=C(C=N2)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3603	CNC(=O)C1=CC2=C(C=C1)N=C(C=N2)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3604	CNC(=O)C1=CC2=C(C=C1)N=C(C=N2)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3605	CNC(=O)C1=CC2=C(C=C1)N=C(C=N2)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3606	CNC(=O)C1=CC2=C(C=C1)N=C(C=N2)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3607	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C(C=N3)C(=O)N3CCN(C)CC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3608	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C(C=N3)C(=O)N3CCN(C)CC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3609	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C(C=N3)C(=O)N3CCN(C)CC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3610	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C(C=N3)C(=O)N3CCN(C)CC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3611	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C(C=N3)C(=O)N3CCN(C)CC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3612	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C(C=N3)C(=O)NC3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3613	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C(C=N3)C(=O)NC3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3614	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C(C=N3)C(=O)NC3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3615	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C(C=N3)C(=O)NC3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3616	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C(C=N3)N3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3617	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C(C=N3)N3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3618	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C(C=N3)N3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3619	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C(C=N3)N3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3620	CNC(=O)C1=CC2=CN(N=C2C=C1F)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3621	CNC(=O)C1=CC2=CN(N=C2C=C1F)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3622	CNC(=O)C1=CC2=CN(N=C2C=C1F)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3623	CNC(=O)C1=CC2=CN(N=C2C=C1F)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3624	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(NS(C)(=O)=O)C=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3625	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(NS(C)(=O)=O)C=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3626	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(NS(C)(=O)=O)C=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3627	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(O)C=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3628	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(O)C=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3629	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(O)C=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3630	CNC(=O)C1=CC2=CN(N=C2C=C1C)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3631	CNC(=O)C1=CC2=CN(N=C2C=C1C)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3632	CNC(=O)C1=CC2=CN(N=C2C=C1C)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3633	CNC(=O)C1=CC2=CN(N=C2C=C1C)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3634	CNC(=O)C1=CC2=CN(N=C2C=C1C)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3635	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(C=CC4=N3)C(=O)NC3CC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3636	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(C=CC4=N3)C(=O)NC3CC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3637	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(C=CC4=N3)C(=O)NC3CC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3638	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(C=CC4=N3)C(=O)NC3CC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3639	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(C=CC4=N3)C(=O)NC3CC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3640	CC(C)C1=C2N=C(OC3=CC=C(C=C3)N3CCCC3)N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
3641	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C1=CC(OC2CCNC2)=CC=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3642	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C1=CC(OC2CCNC2)=CC=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3643	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C1=CC(OC2CCNC2)=CC=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3644	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C1=CC(OC2CCNC2)=CC=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3645	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C1=CC(OC2CCNC2)=CC=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3646	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C1=CC(OC2CCNC2)=CC=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3647	CC(C)C1=C2N=C(NC3=CC=CC(OC4CCNC4)=C3)N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3648	CC(C)C1=C2N=C(NC3=CC=CC(OC4CCNC4)=C3)N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3649	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C1=CC(=CC=C1)C1CCNCC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3650	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C1=CC(=CC=C1)C1CCNCC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3651	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C1=CC(=CC=C1)C1CCNCC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3652	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C1=CC=CC(=C1)N1CCNCC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3653	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C1=CC=CC(=C1)N1CCNCC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3654	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C1=CC=CC(=C1)N1CCNCC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3655	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C1=CC=C(C=C1)C1CCNCC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3656	CC(C)C1=C2N=C(NC3=CC=C(C=N3)C3CCNCC3)N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3657	CC(C)C1=C2N=C(NC3=CC=C(C=N3)C3CCNCC3)N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3658	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C1=CC=C(Cl)C(=C1)C1CCNCC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3659	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C1=CC=C(Cl)C(=C1)C1CCNCC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3660	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C1=CC=C(Cl)C(=C1)C1CCNCC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3661	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C1=CC=C(Cl)C(=C1)C1CCNCC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3662	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C1=CC=C(Cl)C(=C1)C1CCNCC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3663	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C1=CC=CC(=C1)C(=O)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3664	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C1=CC=CC(=C1)C(=O)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3665	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C1=CC=CC(=C1)C(=O)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3666	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C1=CC=CC(=C1)C(=O)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3667	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C1=CC=CC(=C1)C(=O)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3668	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C1=CC=CC(=C1)C(=O)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3669	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C1=CC=CC(=C1)C(=O)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3670	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C1=CC=C(C=C1)C(=O)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3671	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C1=CC=C(C=C1)C(=O)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3672	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C1=CC=C(C=C1)C(=O)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3673	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C1=CC=C(C=C1)C(=O)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3674	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C1=CC=C(Cl)C(OC2CCNCC2)=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3675	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C1=CC=C(Cl)C(OC2CCNCC2)=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3676	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)C1=CC=C(Cl)C(OC2CCNCC2)=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3677	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CCC(CC1)N1CCNCC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3678	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CCC(CC1)N1CCNCC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
3679	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CCC(CC1)N1CCNCC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3680	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CCC(CC1)N1CCNCC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3681	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CCC(CC1)N1CCNCC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3682	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCNC(=O)C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3683	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCNC(=O)C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3684	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCNC(=O)C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3685	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCNC(=O)C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3686	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCNC(=O)C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3687	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCNC(=O)C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3688	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(C=CC4=N3)C(=O)NC3COC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3689	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(C=CC4=N3)C(=O)NC3COC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3690	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(C=CC4=N3)C(=O)NC3COC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3691	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C4C=C(C=CC4=N3)C(=O)NC3COC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3692	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(=O)NC3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3693	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(=O)NC3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3694	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(=O)NC3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3695	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(=O)NC3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3696	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(=O)NC3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3697	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC(C(=O)NC4CCOCC4)=C(C)N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3698	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC(C(=O)NC4CCOCC4)=C(C)N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3699	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC(C(=O)NC4CCOCC4)=C(C)N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3700	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC(C(=O)NC4CCOCC4)=C(C)N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3701	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C(C=N3)N3CCN(C)CC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3702	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C(C=N3)N3CCN(C)CC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3703	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C(C=N3)N3CCN(C)CC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3704	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C(C=N3)N3CCN(C)CC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3705	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C(C=N3)N3CCNCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3706	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C(C=N3)N3CCNCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3707	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C(C=N3)N3CCNCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3708	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C(C=N3)N3CCNCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3709	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=C(C=N3)N3CCNCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3710	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC(CO)=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3711	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC(CO)=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3712	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC(CO)=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3713	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC(CO)=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3714	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC(CO)=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3715	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3716	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3717	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3718	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3719	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3720	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3721	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3722	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3723	CC(C)C1=C2N=C(N=C(N[C@@H](C)C3=CC=CC=C3N3C=C4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3724	CC(C)C1=C2N=C(N=C(N[C@@H](C)C3=CC=CC=C3N3C=C4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3725	CC(C)C1=C2N=C(N=C(N[C@@H](C)C3=CC=CC=C3N3C=C4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3726	CC(C)C1=C2N=C(N=C(N[C@@H](C)C3=CC=CC=C3N3C=C4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3727	CC(C)C1=C2N=C(N=C(N[C@@H](C)C3=CC=CC=C3N3C=C4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3728	CC(C)C1=C2N=C(N=C(N[C@@H](C)C3=CC=CC=C3N3C=C4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3729	CC(C)C1=C2N=C(N=C(N[C@@H](C)C3=CC=CC=C3N3C=C4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3730	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3731	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3732	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3733	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3734	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3735	CC(C)C1=C2N=C(N=C(NCC3=C(O)C=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3736	CC(C)C1=C2N=C(N=C(NCC3=C(O)C=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3737	CC(C)C1=C2N=C(N=C(NCC3=C(O)C=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3738	CC(C)C1=C2N=C(N=C(NCC3=C(O)C=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3739	COC1=C(CNC2=NC(=NC3=C(C=NN23)C(C)C)N2CCC(N)CC2)C(=CC=C1)C1=CC2=C(N1)C=CC=C2	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3740	COC1=C(CNC2=NC(=NC3=C(C=NN23)C(C)C)N2CCC(N)CC2)C(=CC=C1)C1=CC2=C(N1)C=CC=C2	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3741	COC1=C(CNC2=NC(=NC3=C(C=NN23)C(C)C)N2CCC(N)CC2)C(=CC=C1)C1=CC2=C(N1)C=CC=C2	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3742	COC1=C(CNC2=NC(=NC3=C(C=NN23)C(C)C)N2CCC(N)CC2)C(=CC=C1)C1=CC2=C(N1)C=CC=C2	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3743	CC(C)C1=C2N=C(N=C(N[C@@H](C)C3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3744	CC(C)C1=C2N=C(N=C(N[C@@H](C)C3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3745	CC(C)C1=C2N=C(N=C(N[C@@H](C)C3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3746	CC(C)C1=C2N=C(N=C(N[C@@H](C)C3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3747	CC(C)C1=C2N=C(N=C(N[C@H](C)C3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3748	CC(C)C1=C2N=C(N=C(N[C@H](C)C3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100 - 1000	nM
3749	CC(C)C1=C2N=C(N=C(N[C@H](C)C3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3750	CC(C)C1=C2N=C(N=C(N[C@H](C)C3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3751	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=C4C(CCNC4=O)=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3752	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=C4C(CCNC4=O)=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3753	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=C4C(CCNC4=O)=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3754	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=C4C(CCNC4=O)=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3755	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=C4C(CCNC4=O)=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3756	CC(C)C1=C2N=C(N=C(NCC3=CC(C)=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3757	CC(C)C1=C2N=C(N=C(NCC3=CC(C)=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3758	CC(C)C1=C2N=C(N=C(NCC3=CC(C)=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3759	CC(C)C1=C2N=C(N=C(NCC3=CC=C(C)C=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3760	CC(C)C1=C2N=C(N=C(NCC3=CC=C(C)C=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3761	CC(C)C1=C2N=C(N=C(NCC3=CC=C(C)C=C3C3=CC4=C(N3)C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3762	CC(C)C1=C2N=C(N=C(N[C@@H](C)C3=CC=CC=C3N3C=C(C=N3)N3CCNCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3763	CC(C)C1=C2N=C(N=C(N[C@@H](C)C3=CC=CC=C3N3C=C(C=N3)N3CCNCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3764	CC(C)C1=C2N=C(N=C(N[C@@H](C)C3=CC=CC=C3N3C=C(C=N3)N3CCNCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3765	CC(C)C1=C2N=C(N=C(N[C@@H](C)C3=CC=CC=C3N3C=C(C=N3)N3CCNCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3766	CC(C)C1=C2N=C(N=C(N[C@@H](C)C3=CC=CC=C3N3C=C(C=N3)N3CCNCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3767	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=C(C=N3)N3CCNCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3768	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=C(C=N3)N3CCNCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3769	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=C(C=N3)N3CCNCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3770	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=C(C=N3)N3CCNCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3771	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=C(C=N3)N3CCNCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3772	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3773	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3774	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3775	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3776	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3777	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3778	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3779	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NN(C=C3)C3CCNCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3780	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NN(C=C3)C3CCNCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3781	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NN(C=C3)C3CCNCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3782	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NN(C=C3)C3CCNCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3783	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NN(C=C3)C3CCNCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3784	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(=O)NC3CCNCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3785	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(=O)NC3CCNCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3786	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(=O)NC3CCNCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3787	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(=O)NC3CCNCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3788	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(=O)NC3CCNCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3789	CNC(=O)C1=NN(C=C1)C1=CC=CC(Cl)=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3790	CNC(=O)C1=NN(C=C1)C1=CC=CC(Cl)=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3791	CNC(=O)C1=NN(C=C1)C1=CC=CC(Cl)=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3792	CNC(=O)C1=NN(C=C1)C1=CC=CC(Cl)=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3793	CNC(=O)C1=NN(C=C1)C1=CC=CC(Cl)=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3794	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(=O)N3CCNCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3795	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(=O)N3CCNCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3796	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(=O)N3CCNCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3797	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(=O)N3CCNCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3798	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(=O)N3CCNCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3799	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(CC1)NC(C)=O	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3800	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(CC1)NC(C)=O	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3801	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(CC1)NC(C)=O	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3802	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(CC1)NC(C)=O	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3803	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(=O)N3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3804	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(=O)N3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3805	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(=O)N3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3806	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(=O)N3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3807	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(=O)NC3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3808	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(=O)NC3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3809	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(=O)NC3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3810	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(=O)NC3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3811	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)N3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3812	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)N3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3813	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)N3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3814	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)N3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3815	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=C(C=N3)N3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3816	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=C(C=N3)N3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3817	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=C(C=N3)N3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3818	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=C(C=N3)N3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3819	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=C(C=N3)N3CCC(C)CC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3820	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=C(C=N3)N3CCC(C)CC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3821	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=C(C=N3)N3CCC(C)CC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3822	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=C(C=N3)N3CCC(C)CC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3823	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(=O)NC3COC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3824	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(=O)NC3COC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3825	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(=O)NC3COC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3826	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(=O)NC3COC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3827	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3828	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3829	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3830	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3CCOCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3831	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(CO)=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3832	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(CO)=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3833	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(CO)=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3834	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(CO)=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3835	CC(C)C1=C2N=C(NCC3(O)CCNCC3)C=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3836	CC(C)C1=C2N=C(NCC3(O)CCNCC3)C=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3837	CC(C)C1=C2N=C(NCC3(O)CCNCC3)C=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3838	CC(C)C1=C2N=C(NCC3(O)CCNCC3)C=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3839	CC(C)C1=C2N=C(NCC3CCNCC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3840	CC(C)C1=C2N=C(NCC3CCNCC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3841	CC(C)C1=C2N=C(NCC3CCNCC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3842	CC(C)C1=C2N=C(NCC3CCNCC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3843	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3844	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3845	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3846	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3847	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3848	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7; Probable cyclin-H	IC50	0.015	μM
3849	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3850	CCC(=O)N1CCC2=NN(C=C2C1)C1=CC=CC(Cl)=C1CNC1=CC(O[C@@H]2CCCNC2)=NC2=C(C=NN12)C(C)C	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3851	CCC(=O)N1CCC2=NN(C=C2C1)C1=CC=CC(Cl)=C1CNC1=CC(O[C@@H]2CCCNC2)=NC2=C(C=NN12)C(C)C	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3852	CCC(=O)N1CCC2=NN(C=C2C1)C1=CC=CC(Cl)=C1CNC1=CC(O[C@@H]2CCCNC2)=NC2=C(C=NN12)C(C)C	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3853	CCC(=O)N1CCC2=NN(C=C2C1)C1=CC=CC(Cl)=C1CNC1=CC(O[C@@H]2CCCNC2)=NC2=C(C=NN12)C(C)C	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3854	CC(C)C1=C2N=C(NCC3(O)CCNCC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3855	CC(C)C1=C2N=C(NCC3(O)CCNCC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3856	CC(C)C1=C2N=C(NCC3(O)CCNCC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3857	CC(C)C1=C2N=C(NCC3(O)CCNCC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3858	CC(C)C1=C2N=C(OCC3CCNCC3)C=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3859	CC(C)C1=C2N=C(OCC3CCNCC3)C=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3860	CC(C)C1=C2N=C(OCC3CCNCC3)C=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3861	CC(C)C1=C2N=C(OCC3CCNCC3)C=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3862	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3C3=CC(CO)=NN3C)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3863	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3C3=CC(CO)=NN3C)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3864	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3C3=CC(CO)=NN3C)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3865	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3C3=CC(CO)=NN3C)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3866	CC(C)C1=C2N=C(OCC3CCNCC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3867	CC(C)C1=C2N=C(OCC3CCNCC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3868	CC(C)C1=C2N=C(OCC3CCNCC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3869	CC(C)C1=C2N=C(OCC3CCNCC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3870	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCC(CN)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3871	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCC(CN)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3872	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCC(CN)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3873	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCC(CN)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3874	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(CN)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3875	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(CN)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3876	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(CN)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3877	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(CN)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3878	CC(C)C1=C2N=C(OCC3CCNCC3O)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3879	CC(C)C1=C2N=C(OCC3CCNCC3O)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3880	CC(C)C1=C2N=C(OCC3CCNCC3O)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3881	CC(C)C1=C2N=C(OCC3CCNCC3O)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3882	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCC(O)(CN)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3883	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCC(O)(CN)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3884	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCC(O)(CN)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3885	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCC(O)(CN)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3886	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCC(O)(CN)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3887	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCC(O)(CN)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3888	CC(C)C1=C2N=C(N=C(NC(C)C3=CC=CC=C3N3C=CC(CO)=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3889	CC(C)C1=C2N=C(N=C(NC(C)C3=CC=CC=C3N3C=CC(CO)=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3890	CC(C)C1=C2N=C(N=C(NC(C)C3=CC=CC=C3N3C=CC(CO)=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3891	CC(C)C1=C2N=C(N=C(NC(C)C3=CC=CC=C3N3C=CC(CO)=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3892	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(CN)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3893	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(CN)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3894	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(CN)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3895	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(CN)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3896	CC(C)C1=C2N=C(NCC3CCNCC3O)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3897	CC(C)C1=C2N=C(NCC3CCNCC3O)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3898	CC(C)C1=C2N=C(NCC3CCNCC3O)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3899	CC(C)C1=C2N=C(NCC3CCNCC3O)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3900	CC(C)C1=C2N=C(NCC3CCNCC3O)N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3901	CC(C)C1=C2N=C(NCC3CCNCC3O)N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3902	CC(C)C1=C2N=C(NCC3CCNCC3O)N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3903	CC(C)C1=C2N=C(NCC3CCNCC3O)N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3904	CC(C)C1=C2N=C(NCC3CCNCC3)N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3905	CC(C)C1=C2N=C(NCC3CCNCC3)N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3906	CC(C)C1=C2N=C(NCC3CCNCC3)N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3907	CC(C)C1=C2N=C(NCC3CCNCC3)N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3908	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3909	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3910	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3911	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3912	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3913	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3914	CC(C)C1=C2N=C(NC[C@@H]3CCNC[C@H]3O)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3915	CC(C)C1=C2N=C(NC[C@@H]3CCNC[C@H]3O)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3916	CC(C)C1=C2N=C(NC[C@@H]3CCNC[C@H]3O)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3917	CC(C)C1=C2N=C(NC[C@@H]3CCNC[C@H]3O)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3918	CC(C)C1=C2N=C(OCC3CCNCC3)N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3919	CC(C)C1=C2N=C(OCC3CCNCC3)N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3920	CC(C)C1=C2N=C(OCC3CCNCC3)N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3921	CC(C)C1=C2N=C(OCC3CCNCC3)N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3922	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(O)(CN)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3923	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(O)(CN)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3924	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(O)(CN)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3925	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(O)(CN)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3926	CC(C)C1=C2N=C(NCC3(O)CCNCC3)N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3927	CC(C)C1=C2N=C(NCC3(O)CCNCC3)N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3928	CC(C)C1=C2N=C(NCC3(O)CCNCC3)N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3929	CC(C)C1=C2N=C(NCC3(O)CCNCC3)N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3930	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3931	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3932	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3933	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3934	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3935	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3C3=CC(=NN3C)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3936	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3C3=CC(=NN3C)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3937	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3C3=CC(=NN3C)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3938	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3C3=CC(=NN3C)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3939	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3C3=CC(=NN3C)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3940	CC(C)C1=C2N=C(NCC3CCNCC3)N=C(NCC3=C(C)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3941	CC(C)C1=C2N=C(NCC3CCNCC3)N=C(NCC3=C(C)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3942	CC(C)C1=C2N=C(NCC3CCNCC3)N=C(NCC3=C(C)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3943	CC(C)C1=C2N=C(NCC3CCNCC3)N=C(NCC3=C(C)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3944	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3945	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3946	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3947	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3948	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3949	CC(C)C1=C2N=C(NCCC(O)CN)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3950	CC(C)C1=C2N=C(NCCC(O)CN)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3951	CC(C)C1=C2N=C(NCCC(O)CN)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3952	CC(C)C1=C2N=C(NCCC(O)CN)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3953	CC(C)C1=C2N=C(NCCC(O)CN)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3954	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3C)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3955	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3C)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3956	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3C)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3957	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3C)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3958	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3959	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3960	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3961	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3962	CC[C@@H](N)COC1=NC2=C(C=NN2C(NCC2=CC=CC=C2C2=NC3=C(C=CC=C3)C=C2)=N1)C(C)C	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3963	CC[C@@H](N)COC1=NC2=C(C=NN2C(NCC2=CC=CC=C2C2=NC3=C(C=CC=C3)C=C2)=N1)C(C)C	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3964	CC[C@@H](N)COC1=NC2=C(C=NN2C(NCC2=CC=CC=C2C2=NC3=C(C=CC=C3)C=C2)=N1)C(C)C	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3965	CC[C@@H](N)COC1=NC2=C(C=NN2C(NCC2=CC=CC=C2C2=NC3=C(C=CC=C3)C=C2)=N1)C(C)C	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3966	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(O)(CN)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3967	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(O)(CN)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3968	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(O)(CN)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3969	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(O)(CN)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3970	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(O)(CN)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3971	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3972	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3973	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3974	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3975	CC(C)C1=C2N=C(NCC(O)CCN)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3976	CC(C)C1=C2N=C(NCC(O)CCN)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3977	CC(C)C1=C2N=C(NCC(O)CCN)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3978	CC(C)C1=C2N=C(NCC(O)CCN)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3979	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NC(=CC=C3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3980	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NC(=CC=C3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3981	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NC(=CC=C3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3982	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NC(=CC=C3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3983	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NC(=CC=C3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3984	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C#N)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3985	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C#N)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3986	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C#N)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3987	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C#N)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3988	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC4=C(C=C3)C=C(C=C4)C(C)(C)O)N2N=C1)N1CCC(O)(CN)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3989	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC4=C(C=C3)C=C(C=C4)C(C)(C)O)N2N=C1)N1CCC(O)(CN)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3990	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC4=C(C=C3)C=C(C=C4)C(C)(C)O)N2N=C1)N1CCC(O)(CN)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3991	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC4=C(C=C3)C=C(C=C4)C(C)(C)O)N2N=C1)N1CCC(O)(CN)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3992	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NN(C)C(=C3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3993	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NN(C)C(=C3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3994	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NN(C)C(=C3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3995	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NN(C)C(=C3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3996	CC(C)C1=C2N=C(NC[C@H](O)CN)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
3997	CC(C)C1=C2N=C(NC[C@H](O)CN)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
3998	CC(C)C1=C2N=C(NC[C@H](O)CN)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
3999	CC(C)C1=C2N=C(NC[C@H](O)CN)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4000	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(C)(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4001	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(C)(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4002	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(C)(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4003	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(C)(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4004	CC(C)C1=C2N=C(NCC[C@H](O)CN)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4005	CC(C)C1=C2N=C(NCC[C@H](O)CN)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4006	CC(C)C1=C2N=C(NCC[C@H](O)CN)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4007	CC(C)C1=C2N=C(NCC[C@H](O)CN)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4008	CC(C)C1=C2N=C(NC[C@@H](O)CN)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4009	CC(C)C1=C2N=C(NC[C@@H](O)CN)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4010	CC(C)C1=C2N=C(NC[C@@H](O)CN)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4011	CC(C)C1=C2N=C(NC[C@@H](O)CN)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4012	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NC=C(S3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4013	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NC=C(S3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4014	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NC=C(S3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4015	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NC=C(S3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4016	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3CC[C@@H](C3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4017	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3CC[C@@H](C3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4018	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3CC[C@@H](C3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4019	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3CC[C@@H](C3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4020	CC(C)C1=C2N=C(NCC[C@@H](O)CN)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4021	CC(C)C1=C2N=C(NCC[C@@H](O)CN)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4022	CC(C)C1=C2N=C(NCC[C@@H](O)CN)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4023	CC(C)C1=C2N=C(NCC[C@@H](O)CN)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4024	CC(C)C1=C2N=C(NCC[C@@H](O)CN)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4025	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(F)(CN)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4026	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(F)(CN)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4027	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(F)(CN)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4028	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1)N1CCC(F)(CN)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4029	CCC(O)(CC)C1=NN(C=C1)C1=CC=CC(Cl)=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4030	CCC(O)(CC)C1=NN(C=C1)C1=CC=CC(Cl)=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4031	CCC(O)(CC)C1=NN(C=C1)C1=CC=CC(Cl)=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100 - 1000	nM
4032	CCC(O)(CC)C1=NN(C=C1)C1=CC=CC(Cl)=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4033	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3CC[C@H](C3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4034	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3CC[C@H](C3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4035	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3CC[C@H](C3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4036	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3CC[C@H](C3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4037	CC(C)C1=C2N=C(N=C(NCC3=CC=CC4=C3N=C(C=C4)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4038	CC(C)C1=C2N=C(N=C(NCC3=CC=CC4=C3N=C(C=C4)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4039	CC(C)C1=C2N=C(N=C(NCC3=CC=CC4=C3N=C(C=C4)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4040	CC(C)C1=C2N=C(N=C(NCC3=CC=CC4=C3N=C(C=C4)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4041	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=C(C)C(=N3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4042	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=C(C)C(=N3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4043	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=C(C)C(=N3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4044	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=C(C)C(=N3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4045	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3Cl)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4046	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3Cl)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4047	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3Cl)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4048	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3Cl)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4049	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=CC(=NN3C)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4050	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=CC(=NN3C)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4051	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=CC(=NN3C)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4052	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=CC(=NN3C)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4053	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3C3=NN(C)C(=C3)C(C)(C)O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4054	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCCC[C@H]1CCO	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4055	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCCC[C@H]1CCO	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4056	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCCC[C@H]1CCO	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100 - 1000	nM
4057	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCCC[C@H]1CCO	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4058	CCN1CC[C@H](CNC2=NC3=C(C=NN3C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)=N2)C(C)C)[C@@H](O)C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4059	CCN1CC[C@H](CNC2=NC3=C(C=NN3C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)=N2)C(C)C)[C@@H](O)C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4060	CCN1CC[C@H](CNC2=NC3=C(C=NN3C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)=N2)C(C)C)[C@@H](O)C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4061	CCN1CC[C@H](CNC2=NC3=C(C=NN3C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)=N2)C(C)C)[C@@H](O)C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4062	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCCC[C@H]1CCO	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
4063	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCCC[C@H]1CCO	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
4064	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCCC[C@H]1CCO	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100 - 1000	nM
4065	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCCC[C@H]1CCO	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
4066	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCCC[C@H]1CO	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
4067	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCCC[C@H]1CO	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
4068	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCCC[C@H]1CO	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100 - 1000	nM
4069	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCCC[C@H]1CO	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
4070	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCCC[C@H]1CO	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
4071	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCCC[C@H]1CO	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
4072	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCCC[C@H]1CO	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100 - 1000	nM
4073	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCCC[C@H]1CO	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
4074	CC(C)C1=C2N=C(N[C@@H]3CC[C@H](O)CC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4075	CC(C)C1=C2N=C(N[C@@H]3CC[C@H](O)CC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4076	CC(C)C1=C2N=C(N[C@@H]3CC[C@H](O)CC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4077	CC(C)C1=C2N=C(N[C@@H]3CC[C@H](O)CC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4078	CC(C)C1=C2N=C(N[C@@H]3CC[C@H](O)CC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4079	CC(C)C1=C2N=C(N[C@H]3CC[C@H](O)CC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4080	CC(C)C1=C2N=C(N[C@H]3CC[C@H](O)CC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4081	CC(C)C1=C2N=C(N[C@H]3CC[C@H](O)CC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4082	CC(C)C1=C2N=C(N[C@H]3CC[C@H](O)CC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4083	CC(C)C1=C2N=C(N[C@H]3CC[C@H](O)CC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4084	CC(C)C1=C2N=C(NCC3CCOCC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
4085	CC(C)C1=C2N=C(NCC3CCOCC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4086	CC(C)C1=C2N=C(NCC3CCOCC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100 - 1000	nM
4087	CC(C)C1=C2N=C(NCC3CCOCC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4088	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCOCC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
4089	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCOCC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4090	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCOCC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4091	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCOCC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4092	CC(C)C1=C2N=C(OC3CCC(O)CC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4093	CC(C)C1=C2N=C(OC3CCC(O)CC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4094	CC(C)C1=C2N=C(OC3CCC(O)CC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4095	CC(C)C1=C2N=C(OC3CCC(O)CC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4096	CC(C)C1=C2N=C(NC3CCC(O)CC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4097	CC(C)C1=C2N=C(NC3CCC(O)CC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4098	CC(C)C1=C2N=C(NC3CCC(O)CC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4099	CC(C)C1=C2N=C(NC3CCC(O)CC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4100	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCNC[C@H]1CO	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4101	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCNC[C@H]1CO	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4102	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCNC[C@H]1CO	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4103	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCNC[C@H]1CO	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4104	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1)N1CCNC[C@H]1CO	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4105	CC(C)C1=C2N=C(O[C@@H]3CC[C@H](O)CC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4106	CC(C)C1=C2N=C(O[C@@H]3CC[C@H](O)CC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4107	CC(C)C1=C2N=C(O[C@@H]3CC[C@H](O)CC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4108	CC(C)C1=C2N=C(O[C@@H]3CC[C@H](O)CC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4109	CC(C)C1=C2N=C(O[C@H]3CC[C@H](O)CC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4110	CC(C)C1=C2N=C(O[C@H]3CC[C@H](O)CC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4111	CC(C)C1=C2N=C(O[C@H]3CC[C@H](O)CC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4112	CC(C)C1=C2N=C(O[C@H]3CC[C@H](O)CC3)N=C(NCC3=CC=CC=C3C3=NC4=C(C=CC=C4)C=C3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4113	CC(C)C1=C2N=C(NCC3CNCCO3)N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4114	CC(C)C1=C2N=C(NCC3CNCCO3)N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4115	CC(C)C1=C2N=C(NCC3CNCCO3)N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4116	CC(C)C1=C2N=C(NCC3CNCCO3)N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4117	CC(C)C1=C2N=C(NCC3CNCCO3)N=C(NCC3=CC=CC=C3C3=CC4=C(N3)C=CC=C4)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4118	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CCC2=C(C1)C=CC=N2	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4119	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CCC2=C(C1)C=CC=N2	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4120	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CCC2=C(C1)C=CC=N2	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4121	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CCC2=C(C1)C=CC=N2	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4122	CC(C)C1=C2N=C(NC3=CC=CC4=C3C=CN4)N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4123	CC(C)C1=C2N=C(NC3=CC=CC4=C3C=CN4)N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4124	CC(C)C1=C2N=C(NC3=CC=CC4=C3C=CN4)N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	1000	nM
4125	CC(C)C1=C2N=C(NC3=CNC=C3)N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
4126	CC(C)C1=C2N=C(NC3=CNC=C3)N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
4127	CC(C)C1=C2N=C(NC3=CNC=C3)N=C(NCC3=C(Cl)C=CC=C3N3C=CC(=N3)C(C)(C)O)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	1000	nM
4128	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)CCCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4129	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)CCCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
4130	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=C4C=CC(NC(=O)CCCN(C)C)=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4131	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=C4C=CC=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4132	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=C4C=CC=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4133	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)N=C(NCC3=CC=CC=C3C3=C4C=CC=CC4=CC=N3)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100 - 1000	nM
4134	CC(C)C1=C2N=C(C=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4135	CC(C)C1=C2N=C(C=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4136	CC(C)C1=C2N=C(C=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4137	CC(C)C1=C2N=C(C=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4138	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCNCC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4139	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCNCC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4140	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCNCC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4141	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCNCC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100 - 1000	nM
4142	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCNCC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4143	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCN(C)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
4144	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCN(C)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4145	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCN(C)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4146	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCC(O)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
4147	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCC(O)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4148	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCC(O)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4149	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCC(O)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4150	CC(C)C1=C2N=C(N=C(NCC3=NC=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
4151	CC(C)C1=C2N=C(N=C(NCC3=NC=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4152	CC(C)C1=C2N=C(N=C(NCC3=CC=NC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
4153	CC(C)C1=C2N=C(N=C(NCC3=CC=NC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4154	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)C(=O)N1CCC(C)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
4155	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)C(=O)NC1CCNC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100 - 1000	nM
4156	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)C(=O)NC1CCNC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
4157	CC(C)C1=C2N=C(N=C(NCC3=C4N=CC=CC4=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4158	CC(C)C1=C2N=C(N=C(NCC3=C4N=CC=CC4=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4159	CC(C)C1=C2N=C(N=C(NCC3=C4N=CC=CC4=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4160	CC(C)C1=C2N=C(N=C(NCC3=C4N(C)N=CC4=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4161	CC(C)C1=C2N=C(N=C(NCC3=C4N(C)N=CC4=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4162	CCCNC(=O)NC1=C(CNC2=NC(=NC3=C(C=NN23)C(C)C)N2CCC(N)CC2)C=CC=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4163	CCCNC(=O)NC1=C(CNC2=NC(=NC3=C(C=NN23)C(C)C)N2CCC(N)CC2)C=CC=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4164	NC1CCN(CC1)C1=NC2=C(C=NN2C(NCC2=C(C=CC=C2)N2C=CC=N2)=N1)C1CCCC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4165	NC1CCN(CC1)C1=NC2=C(C=NN2C(NCC2=C(C=CC=C2)N2C=CC=N2)=N1)C1CCCC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4166	CC(C)(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3F)N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4167	CC(C)(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3F)N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4168	CC(C)(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3F)N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4169	CNC(=O)C1=CC2=CN(N=C2C=C1)C1=C(CNC2=NC(=NC3=C(C=NN23)C(C)C)N2CCC(N)CC2)C=CC=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4170	CNC(=O)C1=CC2=CN(N=C2C=C1)C1=C(CNC2=NC(=NC3=C(C=NN23)C(C)C)N2CCC(N)CC2)C=CC=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4171	CNC(=O)C1=CC2=CN(N=C2C=C1)C1=C(CNC2=NC(=NC3=C(C=NN23)C(C)C)N2CCC(N)CC2)C=CC=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4172	CNC(=O)C1=CC2=CN(N=C2C=C1)C1=C(CNC2=NC(=NC3=C(C=NN23)C(C)C)N2CCC(N)CC2)C=CC=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4173	CNC(=O)C1=CC2=CN(N=C2C=C1)C1=C(CNC2=NC(=NC3=C(C=NN23)C(C)C)N2CCC(N)CC2)C=CC=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4174	CNC(=O)C1=CC2=CN(N=C2C=C1)C1=C(CNC2=NC(=NC3=C(C=NN23)C(C)C)N2CCC(N)CC2)C=CC=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4175	CNC(=O)C1=CC=CN=C1CNC1=NC(=NC2=C(C=NN12)C(C)(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4176	CC(C)C1=C2N=C(N=C(NCC3=CC=CC4=C3N(C)C=N4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4177	CC(C)C1=C2N=C(N=C(NCC3=CC=CC4=C3N(C)C=N4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4178	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=CC4=C(NC(=O)C4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4179	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=CC4=C(NC(=O)C4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4180	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)C3=CC4=C(NC(=O)C4)C=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4181	NC1CCN(CC1)C1=NC2=C(Br)C=NN2C(NCC2=CC=CC=C2N2C=CC=N2)=N1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4182	NC1CCN(CC1)C1=NC2=C(Br)C=NN2C(NCC2=CC=CC=C2N2C=CC=N2)=N1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4183	NC1CCN(CC1)C1=NC2=C(Br)C=NN2C(NCC2=CC=CC=C2N2C=CC=N2)=N1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4184	NC1CCN(CC1)C1=NC2=C(Br)C=NN2C(NCC2=CC=CC=C2N2C=CC=N2)=N1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4185	NC1CCN(CC1)C1=NC2=C(Br)C=NN2C(NCC2=CC=CC=C2N2C=CC=N2)=N1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4186	NC1CCN(CC1)C1=NC2=C(Br)C=NN2C(NCC2=CC=CC=C2N2C=CC=N2)=N1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4187	CNC(=O)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4188	CNC(=O)C1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4189	CNC(=O)C1=CC=CC(F)=C1CNC1=NC(=NC2=C(C=NN12)C(C)(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4190	CNC(=O)C1=CC=CC(F)=C1CNC1=NC(=NC2=C(C=NN12)C(C)(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4191	CNC(=O)C1=CC=CC(F)=C1CNC1=NC(=NC2=C(C=NN12)C(C)(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4192	CNC(=O)C1=CC=CC(F)=C1CNC1=NC(=NC2=C(C=NN12)C(C)(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4193	CC(C)C1=C2N=C(N=C(N[C@@H](C)C3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4194	CC(C)C1=C2N=C(N=C(N[C@@H](C)C3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4195	CC(C)C1=C2N=C(N=C(N[C@@H](C)C3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4196	CC(C)C1=C2N=C(N=C(N[C@@H](C)C3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4197	CC(C)C1=C2N=C(N=C(N[C@@H](C)C3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4198	CC(C)C1=C2N=C(N=C(N[C@@H](C)C3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4199	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3Br)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4200	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)C1CCNCC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4201	CC(C)(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4202	CC(C)(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4203	CC(C)(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4204	CC(C)(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4205	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)[C@H]1CC[C@H](N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4206	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)[C@H]1CC[C@H](N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4207	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCC(C)(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4208	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCC(C)(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4209	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCC(C)(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4210	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCC(C)(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4211	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCC(C)(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4212	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCC(C)(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4213	CC(C)C1=C2N=C(N=C(NCC3=CNC4=C3C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4214	NC1CCN(CC1)C1=NC2=C(Cl)C=NN2C(NCC2=C(C=CC=C2)N2C=CC=N2)=N1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4215	CC(C)C1=C2N=C(N=C(NCC3=C4C=NC=CC4=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4216	CC(C)C1=C2N=C(N=C(NCC3=C4C=NC=CC4=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4217	CC(C)C1=C2N=C(N=C(NCC3=C4C=NC=CC4=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4218	CC(C)C1=C2N=C(N=C(NCC3=CC=CC4=C3N=C(C)O4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4219	CC(C)C1=C2N=C(N=C(NCC3=CC=CC4=C3N=C(C)O4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4220	NC1CCN(CC1)C1=NC2=C(C=NN2C(NCC2=CC=CC=C2N2C=CC=N2)=N1)C#N	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4221	NC1CCN(CC1)C1=NC2=C(C=NN2C(NCC2=CC=CC=C2N2C=CC=N2)=N1)C#N	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4222	NC1CCN(CC1)C1=NC2=C(I)C=NN2C(NCC2=CC=CC=C2N2C=CC=N2)=N1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4223	NC1CCN(CC1)C1=NC2=C(I)C=NN2C(NCC2=CC=CC=C2N2C=CC=N2)=N1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4224	NC1CCN(CC1)C1=NC2=C(F)C=NN2C(NCC2=CC=CC=C2N2C=CC=N2)=N1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
4225	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4226	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4227	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4228	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4229	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4230	CC(C)C1=C2N=C(N=C(NCC3=C(Cl)C=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4231	COC1=C(CNC2=NC(=NC3=C(C=NN23)C(C)C)N2CCC(N)CC2)C(=CC=C1)N1C=CC=N1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4232	COC1=C(CNC2=NC(=NC3=C(C=NN23)C(C)C)N2CCC(N)CC2)C(=CC=C1)N1C=CC=N1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
4233	COC1=C(CNC2=NC(=NC3=C(C=NN23)C(C)C)N2CCC(N)CC2)C(=CC=C1)N1C=CC=N1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4234	COC1=C(CNC2=NC(=NC3=C(C=NN23)C(C)C)N2CCC(N)CC2)C(=CC=C1)N1C=CC=N1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4235	COC1=C(CNC2=NC(=NC3=C(C=NN23)C(C)C)N2CCC(N)CC2)C(=CC=C1)N1C=CC=N1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4236	COC1=C(CNC2=NC(=NC3=C(C=NN23)C(C)C)N2CCC(N)CC2)C(=CC=C1)N1C=CC=N1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4237	CC(C)C1=C2N=C(NC3CCNCC3)N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4238	CC(C)C1=C2N=C(NC3CCNCC3)N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
4239	CC(C)C1=C2N=C(NC3CCNCC3)N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4240	CC(C)C1=C2N=C(NC3CCNCC3)N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4241	NC1CCN(CC1)C1=NC2=C(C=NN2C(NCC2=CC=CC=C2N2C=CC=N2)=N1)C(F)(F)F	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
4242	NC1CCN(CC1)C1=NC2=C(C=NN2C(NCC2=CC=CC=C2N2C=CC=N2)=N1)C(F)(F)F	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4243	CC(C)C1=C2N=C(N=C(NCC3=C(F)C=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4244	CC(C)C1=C2N=C(N=C(NCC3=C(F)C=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4245	CC(C)C1=C2N=C(N=C(NCC3=C(F)C=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4246	CC(C)C1=C2N=C(N=C(NCC3=C(F)C=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4247	CC(C)C1=C2N=C(N=C(NCC3=C(F)C=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4248	CC(C)C1=C2N=C(N=C(NCC3=C(F)C=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4249	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4250	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4251	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4252	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4253	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4254	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4255	CC(C)C1=C2N=C(N=C(NCC3=C(C)C=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4256	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC=CS3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4257	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC=CS3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4258	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC=CS3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4259	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC=CS3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4260	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC=CO3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4261	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC=CO3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4262	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3N3C=CC=N3)C(F)(F)F)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4263	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3N3C=CC=N3)C(F)(F)F)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4264	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3N3C=CC=N3)C(F)(F)F)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4265	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3N3C=CC=N3)C(F)(F)F)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4266	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3N3C=CC=N3)C(F)(F)F)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4267	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3N3C=CC=N3)C(F)(F)F)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4268	CC(C)C1=C2N=C(N=C(NCC3=CC=CC(=C3)N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4269	CC(C)C1=C2N=C(N=C(NCC3=CC=CC(=C3)N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4270	CC(C)C1=C2N=C(N=C(NCC3=CC=CC(=C3)N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4271	CC(C)C1=C2N=C(N=C(NCC3=CC=CC(=C3)N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4272	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC=C4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4273	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC=C4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4274	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC=C4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4275	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC=C4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4276	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC=C4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4277	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC=C4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4278	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC=C4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4279	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC=C4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4280	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3C3=CC=C4C=CC=CC4=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4281	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3NC3CCN(C)CC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4282	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3NC3CCN(C)CC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4283	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3NC3CCN(C)CC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4284	CC(C)C1=C2N=C(N=C(NCC3=CC=CC(NC(=O)C4=CC=CC=C4)=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4285	CC(C)C1=C2N=C(N=C(NCC3=CC=CC(NC(=O)C4=CC=CC=C4)=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4286	CC(C)C1=C2N=C(N=C(NCC3=CC=CC(NC(=O)C4=CC=CC=C4)=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4287	CCC(O)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4288	CCC(O)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4289	CCC(O)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
4290	CCC(O)C1=C2N=C(N=C(NCC3=CC=CC=C3N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4291	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N(C)C3CCN(C)CC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4292	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N(C)C3CCN(C)CC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4293	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N(C)C3CCN(C)CC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4294	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3CCCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4295	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3CCCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4296	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3CCCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4297	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3CCCC3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4298	CCCC1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4299	CCCC1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4300	CCCC1=CC=CC=C1CNC1=NC(=NC2=C(C=NN12)C(C)C)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4301	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3OC3=CC=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4302	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3OC3=CC=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4303	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3OC3=CC=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4304	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3OC3=CC=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4305	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3OCC3=CC=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4306	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3OCC3=CC=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4307	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3OCC3=CC=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4308	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3N=CC4=C3C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4309	CC(C)C1=C2N=C(N=C(NCC3=CC=CC=C3N3N=CC4=C3C=CC=C4)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4310	CC(C)C1=C2N=C(N=C(NCC3=C4N=C(C=CC4=CC=C3)N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4311	CC(C)C1=C2N=C(N=C(NCC3=C4N=C(C=CC4=CC=C3)N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4312	CC(C)C1=C2N=C(N=C(NCC3=C4N=C(C=CC4=CC=C3)N3C=CC=N3)N2N=C1)N1CCC(N)CC1	CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7; Probable cyclin-H	IC50	0.003	μM
4313	CC(C)C1=C2N=C(N=C(NCC3=C4N=C(C=CC4=CC=C3)N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4314	CN(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
4315	CN(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4316	CC(C)C1=C2N=C(N=C(NCC3=C(NC4=CC=CC=C4)C=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4317	CC(C)C1=C2N=C(N=C(NCC3=C(NC4=CC=CC=C4)C=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4318	CC(C)C1=C2N=C(N=C(NCC3=C(NC4=CC=CC=C4)C=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4319	CC(C)C1=C2N=C(N=C(NCC3=C(NC4=CC=CC=C4)C=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4320	CC(C)C1=C2N=C(N=C(NCC3=C(SC=C3)N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4321	CC(C)C1=C2N=C(N=C(NCC3=C(SC=C3)N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4322	CC(C)C1=C2N=C(N=C(NCC3=C(SC=C3)N3C=CC=N3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4323	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N(C)C3=CC=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
4324	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N(C)C3=CC=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1 - 10	μM
4325	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N(C)C3=CC=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4326	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N(C)C3=CC=CC=C3)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4327	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N(C)C(C)=O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4328	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N(C)C(C)=O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	10	μM
4329	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N(C)C(C)=O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4330	CC(C)C1=C2N=C(N=C(NCC3=C(C=CC=C3)N(C)C(C)=O)N2N=C1)N1CCC(N)CC1	Cyclin-dependent kinase 2 [human]; Cyclin-dependent kinase 1 [human];+Cyclin-dependent kinase 7 [human];+Cyclin-dependent-like kinase 5 (isoform 2) [human]	IC50	1	μM
4331	OC(=O)C(F)(F)F.C=CC(=O)N1CCCC2=C1C=CC(=C2)C(=O)N1CC[C@H](C1)NC1=NC2=CC=CC=C2C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	IC50	0.1 - 1	μM
4332	COC1=C(Cl)C=C2NC(CNC3=C4N=CN(C5=CN(C)N=C5)C4=NC(=N3)N3CCOCC3)=NC2=C1	Cyclin-dependent kinase 7	inhibition rate	98	%
4333	COC1=CC=C(C=C1F)C1=C(N=CO1)C(=O)NCCCC1=NC=CN=C1	Cyclin-dependent kinase 7;+Cyclin homolog	inhibition percentage	7.12656 - 8.55809	%
4334	COC1=CC=C(C=C1F)C1=C(N=CO1)C(=O)NCCCC1=CC=CN=C1	Cyclin-dependent kinase 7;+Cyclin homolog	inhibition percentage	12.51 - 12.74	%
4335	COC1=CC=C(C=C1I)C1=C(N=CO1)C(=O)NCCCC1=CC(F)=CN=C1	Cyclin-dependent kinase 7;+Cyclin homolog	inhibition percentage	5.53866 - 5.79738	%
4336	COC1=CC2=C(C(O)=C1)C(=O)O[C@@H](C)C\C=C/C(=O)[C@@H](O)[C@@H](O)C1=CC=CC2=C1	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	inhibition rate	10.389	%
4337	OC(=O)C(F)(F)F.CCOC(=O)C1=C(N[C@H]2CC[C@H](CN(C)C)CC2)C2=NC(=CC=C2N=C1)C1=CC=NC=C1	Cyclin-dependent kinase 7	inhibition rate	41	%
4338	OC(=O)C(F)(F)F.CCOC(=O)C1=C(N[C@H]2CC[C@H](CN(C)C)CC2)C2=NC(=CC=C2N=C1)C1=CC=NC=C1	Cyclin-dependent kinase 7	inhibition rate	87	%
4339	COC1=CC(CN2C=NC3=C(C=C(S3)C3=C4C=CNC4=NC=C3)C2=O)=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition rate	48	%
4340	O=C(NC1=CC=C(C=C1)N1CCNCC1)C1=NNC=C1NC1=NC=NC2=C1C1=C(CCC1)S2	Cyclin-H;+Cyclin-dependent kinase 7	IC50	21.31	nM
4341		Cyclin-dependent kinase 7 [human]	inhibition rate		
4342		Cyclin-dependent kinase 7 [human]	inhibition rate		
4343	CC[C@H](N1CCNCC1)C1=CC=C(NC2=NC=C(F)C(=N2)C2=CC3=C(N=C(C)N3C(C)C)C(F)=C2)N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4344	CC[C@@H](N1CCNCC1)C1=CC=C(NC2=NC=C(F)C(=N2)C2=CC3=C(N=C(C)N3C(C)C)C(F)=C2)N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4345	CC[C@H](N1CCN(C)CC1)C1=CC=C(NC2=NC=C(F)C(=N2)C2=CC3=C(N=C(C)N3C(C)C)C(F)=C2)N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4346	CC[C@@H](N1CCN(C)CC1)C1=CC=C(NC2=NC=C(F)C(=N2)C2=CC3=C(N=C(C)N3C(C)C)C(F)=C2)N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4347	CC(C)N1C(C)=NC2=C1C=C(C=C2F)C1=NC(NC2=CC=C(C=N2)[C@H](C)C2CCN(C)CC2)=NC=C1F	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4348	CC(C)N1C(C)=NC2=C1C=C(C=C2F)C1=NC(NC2=CC=C(C=N2)[C@@H](C)C2CCN(C)CC2)=NC=C1F	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4349	CC[C@H](C1CCN(CC)CC1)C1=CC=C(NC2=NC=C(F)C(=N2)C2=CC3=C(N=C(C)N3C(C)C)C(F)=C2)N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4350	CC[C@@H](C1CCN(CC)CC1)C1=CC=C(NC2=NC=C(F)C(=N2)C2=CC3=C(N=C(C)N3C(C)C)C(F)=C2)N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4351	CC(C)N1C(C)=NC2=C1C=C(C=C2F)C1=NC(NC2=CC=C(C=N2)C(=C)C2CCNCC2)=NC=C1F	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4352	CC(C)N1C(C)=NC2=C1C=C(C=C2F)C1=NC(NC2=CC=C(C=N2)C(=C)C2CCN(C)CC2)=NC=C1F	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4353	CCN1CCN(CC1)C(=C)C1=CC=C(NC2=NC=C(F)C(=N2)C2=CC3=C(N=C(C)N3C(C)C)C(F)=C2)N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4354	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=C(F)C=NC(NC2=CC=C(C=N2)[C@H](O)C2CCNCC2)=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	0.5 - 1	μM
4355	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=C(F)C=NC(NC2=CC=C(C=N2)[C@@H](O)C2CCNCC2)=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	0.1 - 0.5	μM
4356	CCN1CCC(CC1)[C@@H](OC)C1=CC=C(NC2=NC(=C(F)C=N2)C2=CC(F)=C3N=C(C)N(C(C)C)C3=C2)N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4357	CCN1CCC(CC1)[C@H](OC)C1=CC=C(NC2=NC(=C(F)C=N2)C2=CC(F)=C3N=C(C)N(C(C)C)C3=C2)N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4358	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=C(F)C=NC(NC2=CC=C(C=N2)[C@H](O)C2CCN(C)CC2)=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	0.1 - 0.5	μM
4359	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=C(F)C=NC(NC2=CC=C(C=N2)[C@@H](O)C2CCN(C)CC2)=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	0.1 - 0.5	μM
4360	OC(=O)C(F)(F)F.CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=C(F)C=NC(NC2=NC=C(C=C3CCNCC3)C=C2)=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4361	OC(=O)C(F)(F)F.CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=C(F)C=NC(NC2=NC=C(C=C3CCN(C)CC3)C=C2)=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4362	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=C(F)C=NC(NC2=NC=C(C=C2)C(C)=C2CCNCC2)=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4363	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=C(F)C=NC(NC2=NC=C(C=C2)C(C)=C2CCN(C)CC2)=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4364	OC(=O)C(F)(F)F.CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=C(F)C=NC(NC2=NC=C(C=C3CCN(CC3)C(C)C)C=C2)=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	10 - 100	μM
4365	OC(=O)C(F)(F)F.CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=C(F)C=NC(NC2=NC=C(C=C3CCN(CC3)C3CC3)C=C2)=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4366	OC(=O)C(F)(F)F.CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=C(F)C=NC(NC2=NC=C(C=C3CCN(CCO)CC3)C=C2)=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4367	OC(=O)C(F)(F)F.COCCN1CCC(CC1)=CC1=CN=C(NC2=NC(=C(F)C=N2)C2=CC(F)=C3N=C(C)N(C(C)C)C3=C2)C=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4368	OC(=O)C(F)(F)F.CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=C(F)C=NC(NC2=NC=C(C=C3CCN(CC(F)F)CC3)C=C2)=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4369	OC(=O)C(F)(F)F.CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=C(F)C=NC(NC2=NC=C(C=C3CCN(CC(F)(F)F)CC3)C=C2)=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4370	CCN1CCC(CC1)C(OC(C)=O)C1=CC=C(NC2=NC(=C(F)C=N2)C2=CC(F)=C3N=C(C)N(C(C)C)C3=C2)N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4371	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=C(F)C=NC(NC2=NC=C(C=C2)[C@H](C)C2CCN(CC2)C(C)C)=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4372	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=C(F)C=NC(NC2=NC=C(C=C2)[C@@H](C)C2CCN(CC2)C(C)C)=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4373	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=C(F)C=NC(NC2=NC=C(C=C2)[C@H](C)C2CCN(CC2)C2CC2)=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4374	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=C(F)C=NC(NC2=NC=C(C=C2)[C@@H](C)C2CCN(CC2)C2CC2)=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4375	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=C(F)C=NC(NC2=NC=C(C=C2)[C@H](C)C2CCN(CCO)CC2)=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4376	COCCN1CCC(CC1)[C@@H](C)C1=CN=C(NC2=NC(=C(F)C=N2)C2=CC(F)=C3N=C(C)N(C(C)C)C3=C2)C=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4377	COCCN1CCC(CC1)[C@H](C)C1=CN=C(NC2=NC(=C(F)C=N2)C2=CC(F)=C3N=C(C)N(C(C)C)C3=C2)C=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4378	COCCCN1CCC(CC1)[C@@H](C)C1=CN=C(NC2=NC(=C(F)C=N2)C2=CC(F)=C3N=C(C)N(C(C)C)C3=C2)C=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4379	CC(C)CN1CCC(CC1)[C@@H](C)C1=CN=C(NC2=NC(=C(F)C=N2)C2=CC(F)=C3N=C(C)N(C(C)C)C3=C2)C=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4380	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=C(F)C=NC(NC2=NC=C(C=C2)[C@H](C)C2CCN(CC(F)(F)F)CC2)=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4381	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=C(F)C=NC(NC2=NC=C(C=C2)[C@@H](C)C2CCN(CC(F)(F)F)CC2)=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	IC50	1 - 10	μM
4382	NC1=C2N=CN([C@@H]3O[C@H](COC(=O)C4=CC=CN4)[C@@H](O)[C@H]3O)C2=NC=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition rate	19	%
4383		Bromodomain-containing protein 4 [human];+Cyclin-dependent kinase 7 [human]	inhibition rate		
4384		Bromodomain-containing protein 4 [human];+Cyclin-dependent kinase 7 [human]	inhibition rate		
4385		Bromodomain-containing protein 4 [human];+Cyclin-dependent kinase 7 [human]	inhibition rate		
4386	[H][C@@]12CC=C(C3=C4C=CN=CC4=CC=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@@H](CC[C@]12C)N(C)C	Cyclin-dependent kinase 7	inhibition rate	80	%
4387	CCN1CCN(CC1)C(=O)NC1=NC=CC(=C1)C1=CN(C2CCOCC2)C2=C1C=CN=C2	Cyclin-dependent kinase 7	inhibition rate	20.25	%
4388	COC1=C(C(N)=O)C(F)=CC(=C1)C1=C(C)C(=CN=C1)C1=CC=C(C=C1)N1CCN(CC1)C(C)C	CDK-activating kinase assembly factor MAT1	inhibition rate	-3.42 - -1.47	%
4389	COC1=C(C(N)=O)C(F)=CC(=C1)C1=C(C)C(=CN=C1)C1=CC=C(C=C1)N1C[C@H](C)N(C)[C@H](C)C1	CDK-activating kinase assembly factor MAT1	inhibition rate	3.88 - 4.5	%
4390	COC1=C(C(N)=O)C(F)=CC(=C1)C1=C(C)C(=CN=C1)C1=CC=C(C=C1)N1CCN(C)CC1	CDK-activating kinase assembly factor MAT1	inhibition rate	2.99 - 6.73	%
4391	OC(=O)C(F)(F)F.[H][C@@]12C[C@@]1(NCC2)C(=O)N1CCC2=C(C1)NC(=N2)C1=NNC2=C1C(F)=CC(=C2)C1=C(CC)C=C(O)C(F)=C1	Cyclin-dependent kinase 7	inhibition rate	82	%
4392	CCC1=CN=C(NC(=O)[C@@H](C)C2=CC=CC(=C2)C2=CC(C#N)=C(C=N2)N(C)C(=O)\C=C\CN(C)C)S1	Cyclin-dependent kinase 7 [human]	IC50	6.6	nM
4393	CCC1=CN=C(NC(=O)[C@@H](C)C2=CC=CC(=C2)C2=CC(C#N)=C(C=N2)N(C)C(=O)\C=C\CN(C)C)S1	Cyclin-dependent kinase 7 [human]	IC50	323	nM
4394	CCC1=CN=C(NC(=O)[C@@H](C)C2=CC=CC(=C2)C2=CC(C#N)=C(C=N2)N(C)C(=O)\C=C\CN(C)C)S1	Cyclin-dependent kinase 7 [human]	IC50	9.5	nM
4395	C[C@@](O)(C#CC1=CC=C(F)C(=C1)C1=CNC2=CN=C(N)N=C12)C1=NC=CS1	Cyclin-dependent kinase 7	inhibition rate	12	%
4396		Cyclin-dependent kinase 7 [human]	inhibition rate		
4397		Cyclin-dependent kinase 7 [human]	inhibition rate		
4398		Cyclin-dependent kinase 7 [human]	inhibition rate		
4399		Cyclin-dependent kinase 7 [human]	inhibition rate		
4400	OC(=O)C(F)(F)F.CC[C@H](NC1=NC(N)=NC(C)=C1C#N)C1=NC2=CC=CC(NCC3=CC=C(C=C3)C(=O)NO)=C2C(=O)N1C1=CC=CC=C1	Cyclin-H;+Cyclin-dependent kinase 7	inhibition rate	-10.6	%
4401	COC1=NN(C)C=C1NC1=NC=C(C)C(=N1)C1=CNC2=C(NC(=O)C3=C(C)N=CC=C3)C=CC=C12	Cyclin-dependent-like kinase 5;+CDK-activating kinase assembly factor MAT1	inhibition rate	66	%
4402	COC1=NN(C)C=C1NC1=NC=C(C)C(=N1)C1=CNC2=C(NC(=O)C3=C(C)N=CC=C3)C=CC=C12	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	inhibition rate	15	%
4403	C[C@@H](N1CCN(C)CC1)C(=O)NC1=C2NC=C(C2=CC=C1)C1=NC(NC(=O)C2CC2)=NC=C1C	Cyclin-dependent-like kinase 5;+CDK-activating kinase assembly factor MAT1	inhibition rate	-1	%
4404	C[C@@H](N1CCN(C)CC1)C(=O)NC1=C2NC=C(C2=CC=C1)C1=NC(NC(=O)C2CC2)=NC=C1C	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	inhibition rate	8	%
4405	FC(F)(F)C1=C(Cl)C=CC(NC(=O)NC2=CC=C3N(C4=CC=NC=C4)C(=O)C4=C(OC3=C2)N=CC=C4)=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	IC50	10	μM
4406	CC1=NC2=C(C=C(C=C2N1C1=CC=NC2=C(F)C=CC(F)=C12)C1=CC(=NC=C1)C#N)C1=NN=CN1	Cyclin-dependent kinase 7	Kd (dissociation constant)	1300	nM
4407	CN1C=C(C2=CC=CC=C12)C1=CC=NC(NC2=CC=CC(NC(=O)C=C)=C2)=N1	CDK-activating kinase assembly factor MAT1 [human];+Cytochrome c-type biogenesis protein CycH [human];+Cyclin-dependent kinase 7 [human]	inhibition rate	1.476	%
4408	CC#CC(=O)NC1=CC(NC2=NC(=CC=N2)C2=CN(C)C3=CC=CC=C23)=CC=C1	CDK-activating kinase assembly factor MAT1 [human];+Cytochrome c-type biogenesis protein CycH [human];+Cyclin-dependent kinase 7 [human]	inhibition rate	-1.2371	%
4409	CC#CC1=NC2=C(C=CC(NC3=NC(=CC=N3)C3=CN(C)C4=CC=CC=C34)=C2)C(C)(C)O1	CDK-activating kinase assembly factor MAT1 [human];+Cytochrome c-type biogenesis protein CycH [human];+Cyclin-dependent kinase 7 [human]	inhibition rate	4.4466	%
4410	COC1=CC=C2C(OC3=CN=C(CC(=O)NC4=CC5=C(C=C4)N=C(OC5(C)C)C#CC)C(OC)=C3)=CC=NC2=C1	CDK-activating kinase assembly factor MAT1 [human];+Cytochrome c-type biogenesis protein CycH [human];+Cyclin-dependent kinase 7 [human]	inhibition rate	-18.701	%
4411	OC(=O)C(F)(F)F.COC1=CC2=NC(NC3CC3)=NC(NC3CCN(CC3)C(C)C)=C2C=C1OC	Cyclin-dependent kinase 7	inhibition rate	31	%
4412	OC(CCCC(O)\C=C\C(O)C#C)CC#CC(O)C#CCCCCC(O)\C=C\CCCCCC(=O)CCCCCCCCCCCCCC(O)C(O)C#CC(O)=O	Cyclin-dependent kinase 7	IC50	9.13	μM
4413	OC(CCCC(O)\C=C\C(O)C#C)CC#CC(O)C#CCCCCC(O)\C=C\CCCC(O)C=CCCCCCCCCCCCCCC(O)C(O)C#CC(O)=O	Cyclin-dependent kinase 7	IC50	41.8	μM
4414	OC(=O)C(F)(F)F.CN(C)C[C@@H](NC(=O)N1CC2=C(NN=C2NC2=NC=CC3=CC(NC(=O)C=C)=CC=C23)C1(C)C)C1CCOCC1	Cyclin-dependent kinase 7	IC50	69	nM
4415	OC(=O)C(F)(F)F.CN(C)C[C@@H](NC(=O)N1CC2=C(NN=C2NC2=C3C=CSC3=NC(C)=N2)C1(C)C)C1CCOCC1	Cyclin-dependent kinase 7	IC50	18.5	nM
4416	CCCCOC1=C(C=NC2=NNC=C12)C(=O)C1=C(F)C=C(C)C=C1F	Cyclin-dependent kinase 7	IC50	180	nM
4417	CN1C=CC2=C(C=CC=C12)C1=NC2=C(OCC3CCNCC3)C(Cl)=CN=C2N1	Cyclin-dependent kinase 7	inhibition rate	89	%
4418	C1C[C@@H](CN1)OC1=CC2=C(C=C1)C=NC=C2C1=CN=C2NC=CC2=C1	Cyclin-dependent kinase 7	inhibition percentage	-6.1	%
4419	COC1=C(C=CC(NC2=NC=C3CC4(CCNC4=O)N(C4CCCC4)C3=N2)=C1)N1CCN(C)CC1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	10	μM
4420	CN1CC2(C1)CN(C2)C1=C(F)C=C(NC2=NC=C3CC4(CC(=O)NC4=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	10	μM
4421	CC(C)N1CC2(C1)CN(C2)C1=CC=C(NC2=NC=C3CC4(CC(=O)NC4=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	10	μM
4422	CN1CCC(CC1)C1=CC=C(NC2=NC=C3CC4(CCNC4=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	10	μM
4423	O=C1NCCC11CC2=CN=C(NC3=CC=C(OCCN4CCOCC4)C=C3)N=C2N1C1CCCC1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	10	μM
4424	CN1C=C(C=N1)C1=CC=C(NC2=NC=C3CC4(CCNC4=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	10	μM
4425	O=C1NCCC11CC2=CN=C(NC3=CC=C(OCCN4CCCC4)N=C3)N=C2N1C1CCCC1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	10	μM
4426	CN(C)[C@H]1CCN(C1)C1=C(F)C=C(NC2=NC=C3CC4(CCNC4=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	10	μM
4427	CN(C)[C@@H]1CCN(C1)C1=C(F)C=C(NC2=NC=C3CC4(CCNC4=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	10	μM
4428	CN(C)[C@H]1CCN(C1)C(=O)C1=CC=C(NC2=NC=C3CC4(CCNC4=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	10	μM
4429	CN(C)[C@@H]1CCN(C1)C(=O)C1=CC=C(NC2=NC=C3CC4(CCNC4=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	10	μM
4430	CC1CN(CC(C)N1)C1=CC=C(NC2=NC=C3CC4(CCNC4=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	10	μM
4431	CC1CN(CC(C)N1)C1=CC=C(NC2=NC=C3CC4(CC(=O)NC4=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	10	μM
4432	OC(=O)C(F)(F)F.COC1=CC2=NC(NC3CC3)=NC(NC3CCN(CC3)C(C)C)=C2C=C1OC	Cyclin-dependent kinase 7	inhibition rate	54	%
4433	CC(C)(C)C1=CN=C(CSC2=NC(N[C@@H]3CCCN(C3)C(=O)C3=CC=C(NC(=O)C=C)C=C3)=NC=C2Cl)O1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	5120	nM
4434	Cl.CN(C)C(=O)C1=CC2=C(N=C(NC3=CC=C(C=C3)N3CCN(C)CC3)N=C2)N1C12CC(C1)C2	Cyclin-H; Cyclin-dependent kinase 7	IC50	1.65	μM
4435	CN1CCN(CC1)C1=CC=C(NC2=NC=C3CN(C(=O)N(C4CCCC4)C3=N2)C2=CC=CC=C2F)C=C1F	Cyclin-H;+Cyclin-dependent kinase 7	IC50	10	μM
4436	CN1CCN(CC1)C1=CC=C(NC2=NC=C3CN(C(=O)N(C4CCCC4)C3=N2)C2=CC=CC=C2F)C=C1F	Cyclin-H;+Cyclin-dependent kinase 7	IC50	10	μM
4437	CN1CCN(CC1)C1=CC=C(NC2=NC=C3CN([C@H]4CCNC4)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	10	μM
4438	CN1CCN(CC1)C1=CC=C(NC2=NC=C3CN([C@H]4CCNC4)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	10	μM
4439	CN1CCN(CC1)C1=CC=C(NC2=NC=C3CN([C@@H]4CCNC4)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	10	μM
4440	CN1CCN(CC1)C1=CC=C(NC2=NC=C3CN([C@@H]4CCNC4)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	10	μM
4441	CN(C)CCOC1=CN=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	10	μM
4442	CN(C)CCOC1=CN=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	10	μM
4443	CN1CCN(CC1)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.229	μM
4444	CN1CCN(CC1)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.229	μM
4445	CC(C)N1CCN(CC1)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.153	μM
4446	CC(C)N1CCN(CC1)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.153	μM
4447	FC1=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=CC(=C1)N1CCNCC1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	1.12	μM
4448	FC1=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=CC(=C1)N1CCNCC1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	1.12	μM
4449	CN1CCN(CC1)C1=CC(F)=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	4.26	μM
4450	CN1CCN(CC1)C1=CC(F)=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	4.26	μM
4451	CC(C)N1CCN(CC1)C1=CC(F)=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	100	μM
4452	CC(C)N1CCN(CC1)C1=CC(F)=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	10	μM
4453	O=C1NCC[C@@]11CC2=CN=C(NC3=CC=C(N=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.34	μM
4454	O=C1NCC[C@@]11CC2=CN=C(NC3=CC=C(N=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.34	μM
4455	CN1CCN(CC1)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=N1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.402	μM
4456	CN1CCN(CC1)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=N1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.402	μM
4457	CC(C)N1CCN(CC1)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=N1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	14.7	μM
4458	CN1CCN(CC1)C1=CN=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	18.4	μM
4459	CN1CCN(CC1)C1=CN=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	18.4	μM
4460	CC(C)N1CCN(CC1)C1=CN=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	13.5	μM
4461	CC(C)N1CCN(CC1)C1=CN=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	13.5	μM
4462	CCN1CCN(CC2=CN=C(NC3=NC=C4C[C@@]5(CCNC5=O)C(=O)N(C5CCCC5)C4=N3)C=C2)CC1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	14.7	μM
4463	CCN1CCN(CC2=CN=C(NC3=NC=C4C[C@@]5(CCNC5=O)C(=O)N(C5CCCC5)C4=N3)C=C2)CC1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	14.7	μM
4464	CC1=C(C=CC(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)=C1)N1CCNCC1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.166	μM
4465	CC1=C(C=CC(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)=C1)N1CCNCC1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.166	μM
4466	CN1CCN(CC1)C1=C(C)C=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.164	μM
4467	CN1CCN(CC1)C1=C(C)C=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.164	μM
4468	CC(C)N1CCN(CC1)C1=C(C)C=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.12	μM
4469	CC(C)N1CCN(CC1)C1=C(C)C=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.12	μM
4470	COC1=C(C=CC(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)=C1)N1CCNCC1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.318	μM
4471	COC1=C(C=CC(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)=C1)N1CCNCC1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.318	μM
4472	COC1=C(C=CC(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)=C1)N1CCN(C)CC1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.157	μM
4473	COC1=C(C=CC(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)=C1)N1CCN(C)CC1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.157	μM
4474	COC1=C(C=CC(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)=C1)N1CCN(CC1)C(C)C	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.157	μM
4475	COC1=C(C=CC(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)=C1)N1CCN(CC1)C(C)C	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.157	μM
4476	CC1=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=CC(=C1)N1CCNCC1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	3.24	μM
4477	CC1=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=CC(=C1)N1CCNCC1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	3.24	μM
4478	CN1CCN(CC1)C1=CC(C)=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	2.63	μM
4479	CN1CCN(CC1)C1=CC(C)=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	2.63	μM
4480	CC(C)N1CCN(CC1)C1=CC(C)=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	3.16	μM
4481	CC(C)N1CCN(CC1)C1=CC(C)=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	3.16	μM
4482	COC1=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=CC(=C1)N1CCNCC1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	7.3	μM
4483	COC1=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=CC(=C1)N1CCNCC1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	7.3	μM
4484	COC1=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=CC(=C1)N1CCN(C)CC1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	13.9	μM
4485	COC1=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=CC(=C1)N1CCN(C)CC1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	13.9	μM
4486	COC1=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=CC(=C1)N1CCN(CC1)C(C)C	Cyclin-H;+Cyclin-dependent kinase 7	IC50	12	μM
4487	COC1=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=CC(=C1)N1CCN(CC1)C(C)C	Cyclin-H;+Cyclin-dependent kinase 7	IC50	12	μM
4488	O=C1NCC[C@@]11CC2=CN=C(NC3=CC=C(C=C3)C3=CNN=C3)N=C2N(C2CCCC2)C1=O	Cyclin-H;+Cyclin-dependent kinase 7	IC50	3.1	μM
4489	O=C1NCC[C@@]11CC2=CN=C(NC3=CC=C(C=C3)C3=CNN=C3)N=C2N(C2CCCC2)C1=O	Cyclin-H;+Cyclin-dependent kinase 7	IC50	3.1	μM
4490	CN1C=C(C=N1)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	2.82	μM
4491	CN1C=C(C=N1)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	2.82	μM
4492	CC(C)N1C=C(C=N1)C1=CN=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	100	μM
4493	CC(C)N1C=C(C=N1)C1=CN=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	100	μM
4494	CC(C)N1CC2(C1)CN(C2)C1=CN=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	26.5	μM
4495	CC(C)N1CC2(C1)CN(C2)C1=CN=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	26.5	μM
4496	O=C1NCC[C@@]11CC2=CN=C(NC3=CC=C(C=C3)N3CC4(CNC4)C3)N=C2N(C2CCCC2)C1=O	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.673	μM
4497	O=C1NCC[C@@]11CC2=CN=C(NC3=CC=C(C=C3)N3CC4(CNC4)C3)N=C2N(C2CCCC2)C1=O	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.673	μM
4498	FC1=C(C=CC(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)=C1)N1CC2(CNC2)C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.682	μM
4499	FC1=C(C=CC(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)=C1)N1CC2(CNC2)C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.682	μM
4500	CN(C)[C@H]1CCN(C1)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.505	μM
4501	CN(C)[C@H]1CCN(C1)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.505	μM
4502	CN(C)[C@@H]1CCN(C1)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=N1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.465	μM
4503	CN(C)[C@@H]1CCN(C1)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=N1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.465	μM
4504	CN(C)[C@@H]1CCN(C1)C1=C(F)C=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.126	μM
4505	CN(C)[C@@H]1CCN(C1)C1=C(F)C=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.126	μM
4506	CN(C)[C@H]1CCN(C1)C(=O)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	2.94	μM
4507	CN(C)[C@H]1CCN(C1)C(=O)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	2.94	μM
4508	CN(C)[C@H]1CCN(C1)C1=CN=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	1.13	μM
4509	CN(C)[C@H]1CCN(C1)C1=CN=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	1.13	μM
4510	CN(C)CCOC1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.321	μM
4511	CN(C)CCOC1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.321	μM
4512	O=C1NCC[C@@]11CC2=CN=C(NC3=NC=C(C=C3)N3CCC(CC3)N3CCOCC3)N=C2N(C2CCCC2)C1=O	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.229	μM
4513	O=C1NCC[C@@]11CC2=CN=C(NC3=NC=C(C=C3)N3CCC(CC3)N3CCOCC3)N=C2N(C2CCCC2)C1=O	Cyclin-H;+Cyclin-dependent kinase 7	IC50	40.9	μM
4514	O=C1NCC[C@@]11CC2=CN=C(NC3=CC=C(C=C3)N3CCC(CC3)N3CCOCC3)N=C2N(C2CCCC2)C1=O	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.153	μM
4515	O=C1NCC[C@@]11CC2=CN=C(NC3=CC=C(C=C3)N3CCC(CC3)N3CCOCC3)N=C2N(C2CCCC2)C1=O	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.591	μM
4516	O=C1NCC[C@@]11CC2=CN=C(NC3=CC=C(OCCN4CCCC4)N=C3)N=C2N(C2CCCC2)C1=O	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.166	μM
4517	O=C1NCC[C@@]11CC2=CN=C(NC3=CC=C(OCCN4CCCCC4)N=C3)N=C2N(C2CCCC2)C1=O	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.164	μM
4518	O=C1NCC[C@@]11CC2=CN=C(NC3=CC=C(N=C3)N3CCC(CC3)N3CCOCC3)N=C2N(C2CCCC2)C1=O	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.12	μM
4519	CC(C)N1C=C(C=N1)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.157	μM
4520	O=C1NCC[C@@]11CC2=CN=C(N=C2N(C2CCCC2)C1=O)N1CC2(CNC2)C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	2.63	μM
4521	CC1CN(CC(C)N1)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	3.16	μM
4522	CC1CN(CC(C)N1)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.406	μM
4523	CC(C)C1CCN(CC1)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	13.9	μM
4524	CC(C)C1CCN(CC1)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	2.97	μM
4525	O=C1NCC[C@@]11CC2=CN=C(NC3=CC=C(C=C3)N3CCN(CC3)C3CC3)N=C2N(C2CCCC2)C1=O	Cyclin-H;+Cyclin-dependent kinase 7	IC50	12	μM
4526	O=C1NCC[C@@]11CC2=CN=C(NC3=CC=C(C=C3)N3CCN(CC3)C3CC3)N=C2N(C2CCCC2)C1=O	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.276	μM
4527	CS(=O)(=O)N1CCC(CC1)NC1=NC=C2C[C@@]3(CCNC3=O)C(=O)N(C3CCCC3)C2=N1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	3.1	μM
4528	CS(=O)(=O)N1CCC(CC1)NC1=NC=C2C[C@@]3(CCNC3=O)C(=O)N(C3CCCC3)C2=N1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.215	μM
4529	CN1CCC(CC1)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	100	μM
4530	CN1CCC(CC1)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.222	μM
4531	CC(C)C1=C(F)C=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	26.5	μM
4532	CC(C)C1=C(F)C=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	10	μM
4533	CS(=O)(=O)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.673	μM
4534	CS(=O)(=O)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	1.67	μM
4535	CC(C)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.682	μM
4536	CC(C)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	10	μM
4537	OCCOC1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.505	μM
4538	OCCOC1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	3.45	μM
4539	CC(C)N1CCC(CC1)NC1=NC=C2C[C@@]3(CCNC3=O)C(=O)N(C3CCCC3)C2=N1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.465	μM
4540	CC(C)N1CCC(CC1)NC1=NC=C2C[C@@]3(CCNC3=O)C(=O)N(C3CCCC3)C2=N1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.557	μM
4541	C[C@@]1(O)CC[C@@H](CC1)NC1=NC=C2C[C@@]3(CCNC3=O)C(=O)N(C3CCCC3)C2=N1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.126	μM
4542	C[C@@]1(O)CC[C@@H](CC1)NC1=NC=C2C[C@@]3(CCNC3=O)C(=O)N(C3CCCC3)C2=N1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	10	μM
4543	OCCN1CCN(CC1)C1=C(F)C=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	1.13	μM
4544	OCCN1CCN(CC1)C1=C(F)C=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.111	μM
4545	CN1CC2(C1)CN(C2)C1=C(F)C=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.266	μM
4546	CN1CC2(C1)CN(C2)C1=C(F)C=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.162	μM
4547	CC(C)N1CC2(C1)CN(C2)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	40.9	μM
4548	CC(C)N1CC2(C1)CN(C2)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.642	μM
4549	O=C1NCC[C@@]11CC2=CN=C(N[C@H]3CC[C@@H](CC3)NC3CCOCC3)N=C2N(C2CCCC2)C1=O	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.343	μM
4550	O=C1NCC[C@@]11CC2=CN=C(N[C@H]3CC[C@@H](CC3)NC3CCOCC3)N=C2N(C2CCCC2)C1=O	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.343	μM
4551	CN1CCN(CC1)C1=C(F)C=C(NC2=NC=C3CC4(CCNC4=O)C(=O)N(C3=N2)C23CC(C2)C3)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	1.12	μM
4552	CN1CCN(CC1)C1=C(F)C=C(NC2=NC=C3CC4(CCNC4=O)C(=O)N(C3=N2)C23CC(C2)C3)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	2.34	μM
4553	FC1=C(C=CC(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C3=N2)C23CC(C2)C3)=C1)N1CCNCC1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	4.26	μM
4554	FC1=C(C=CC(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C3=N2)C23CC(C2)C3)=C1)N1CCNCC1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	1.69	μM
4555	CN1CCN(CC1)C1=C(F)C=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C3=N2)C23CC(C2)C3)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	100	μM
4556	CN1CCN(CC1)C1=C(F)C=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C3=N2)C23CC(C2)C3)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	1.17	μM
4557	CC(C)N1CCN(CC1)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C3=N2)C23CC(C2)C3)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.402	μM
4558	CC(C)N1CCN(CC1)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C3=N2)C23CC(C2)C3)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	1.68	μM
4559	CN1CCN(CC1)C1=CN=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C3=N2)C23CC(C2)C3)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	19	μM
4560	CN1CCN(CC1)C1=CN=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C3=N2)C23CC(C2)C3)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	100	μM
4561	CC(C)N1CCN(CC1)C1=CN=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C3=N2)C23CC(C2)C3)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	18.4	μM
4562	CC(C)N1CCN(CC1)C1=CN=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C3=N2)C23CC(C2)C3)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	100	μM
4563	CCN1CCN(CC2=CN=C(NC3=NC=C4C[C@@]5(CCNC5=O)C(=O)N(C4=N3)C34CC(C3)C4)C=C2)CC1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	13.5	μM
4564	CCN1CCN(CC2=CN=C(NC3=NC=C4C[C@@]5(CCNC5=O)C(=O)N(C4=N3)C34CC(C3)C4)C=C2)CC1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	100	μM
4565	CC(C)N1CCN(CC1)C1=C(F)C=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C3=N2)C23CC(C2)C3)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.318	μM
4566	CC1CN(CC(C)N1)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C3=N2)C23CC(C2)C3)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	7.3	μM
4567	CC1CN(CC(C)N1)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C3=N2)C23CC(C2)C3)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	3.77	μM
4568	CS(=O)(=O)N1CCC(CC1)NC1=NC=C2C[C@@]3(CCNC3=O)C(=O)N(C2=N1)C12CC(C1)C2	Cyclin-H;+Cyclin-dependent kinase 7	IC50	2.82	μM
4569	CS(=O)(=O)N1CCC(CC1)NC1=NC=C2C[C@@]3(CCNC3=O)C(=O)N(C2=N1)C12CC(C1)C2	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.88	μM
4570	OCCN1CCN(CC1)C1=C(F)C=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C3=N2)C23CC(C2)C3)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.321	μM
4571	OCCN1CCN(CC1)C1=C(F)C=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C3=N2)C23CC(C2)C3)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	1.24	μM
4572	FC1=C(C=CC(NC2=NC=C3C[C@]4(CCNC4=O)C(=O)N(C3=N2)C23CC(C2)C3)=C1)N1CCNCC1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.157	μM
4573	O=C1NCC[C@@]11CC2=CN=C(N[C@H]3CC[C@@H](CC3)NC3CCOCC3)N=C2N(C1=O)C12CC(C1)C2	Cyclin-H;+Cyclin-dependent kinase 7	IC50	1.5	μM
4574	O=C1NCC[C@@]11CC2=CN=C(N[C@H]3CC[C@@H](CC3)NC3CCOCC3)N=C2N(C1=O)C12CC(C1)C2	Cyclin-H;+Cyclin-dependent kinase 7	IC50	1.5	μM
4575	CN1CCN(CC1)C1CCN(CC1)C1=C(F)C=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.134	μM
4576	CN1CCN(CC1)C1CCN(CC1)C1=C(F)C=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.134	μM
4577	FC1=C(OCCN2CCCC2)C=CC(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.266	μM
4578	FC1=C(OCCN2CCCC2)C=CC(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C4CCCC4)C3=N2)=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.266	μM
4579	CN1CCN(CC1)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C3=N2)C23CC(C2)C3)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	0.34	μM
4580	CN1CCN(CC1)C1=CC=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C3=N2)C23CC(C2)C3)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	2.32	μM
4581	CN1CCN(CC1)C1CCN(CC1)C1=C(F)C=C(NC2=NC=C3C[C@@]4(CCNC4=O)C(=O)N(C3=N2)C23CC(C2)C3)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	2.94	μM
4582	CN1CCN(CC1)C1=C(F)C=C(NC2=NC=C3C[C@]4(CCNC4=O)C(=O)N(C3=N2)C23CC(C2)C3)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	3.24	μM
4583	CC(C)C1=C2N(C=C1)N=CN=C2N[C@H]1CC[C@H](CC1)N1CCN(CC1)C(=O)CCC(=O)N1CCC(CCN2CCN(CC2)C2=CC3=C(C=C2)C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage	102	%
4584	OC(=O)C(F)(F)F.O[C@@H]1CNCC[C@H]1CNC1=NC2=C(C=NN2C(NC2=CC(F)=CC(=C2)C#N)=C1)C1CC1	Cyclin-dependent kinase 7	IC50	1000	nM
4585	OC1CNCCC1COC1=NC2=C(C=NN2C(NC2=CC(F)=CC=C2)=C1)C1CC1	Cyclin-dependent kinase 7	IC50	100	nM
4586	CC1=CC(NC2=CC(OC3CNCC(O)C3)=NC3=C(C=NN23)C2CCC2)=CC(F)=C1	Cyclin-dependent kinase 7	IC50	100	nM
4587	CC(C)C1=C2N(C=C1)N=CN=C2N[C@H]1CC[C@H](CC1)N1CCN(CC1)C(C)=O	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage	80	%
4588	Cl.N[C@H]1CC[C@@H](CC1)NC1=C2SC=C(C(=O)NC3=C(F)C(NS(=O)(=O)CC4=CC=CC=C4)=CC=C3Cl)C2=NC=N1	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage	10.5	%
4589	OC(=O)CSC1=C2SC(=CC2=NC=N1)C1=CC2=CC=CC=C2S1	Cyclin-dependent kinase 7 [human]	inhibition rate	0	%
4590	OC(=O)CSC1=C2C=C(SC2=NC=N1)C1=CC2=CC=CC=C2S1	Cyclin-dependent kinase 7 [human]	inhibition rate	29	%
4591	NC1=C(NC(=O)C2=CC=C(CNC(=O)C3=NNC=C3NC(=O)C3=C(Cl)C=CC=C3Cl)C=C2)C=CC=C1	Cyclin-dependent kinase 7; Cyclin-H1-1	IC50	1000	nM
4592	NC(=O)C1=C(OCCCC2CCN(CC3=CC=C(F)C=C3)CC2)N=C(S1)C1=CC(NC(=O)C2CC2)=NC=C1	Cyclin-dependent kinase 7	IC50	300	nM
4593	OC(=O)C(F)(F)F.O=C(NC1=CC=CC=C1)C1=CC2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N1CC1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition rate	-4	%
4594	Cl.COC1=C(NC(=O)C2=CC3=CN=C(NC4=CC=C(C=N4)N4CCNCC4)N=C3N2C2CCCC2)C=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition rate	4	%
4595	FC1=C(CC2=CNC3=C2C=C(C=N3)C2=CN(N=C2)C2CCNCC2)C=CC=C1	Cyclin-dependent kinase 7	inhibition percentage	19	%
4596	CC1CCC(CC1)N1C=C(C=N1)C1=CC=C(C=C1)C1=CN=C2NC=C(C2=C1)C1=CC(NS(C)(=O)=O)=C(Cl)C(=C1)C#N	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition rate	53	%
4597	NC1=CC=CN2C(=CN=C12)C#CCNC(=O)C1=CC(Br)=C(Br)N1	cyclin H [human];+Cyclin-dependent kinase 7 [human]	inhibition rate	9.1	%
4598	CC(=O)N1CCN(CC1)C1=CC=C(NC2=NC(=CC=N2)C2=CNC3=NC=CC=C23)C=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	Ki (inhibition constant)	5	μM
4599	CN1C=C(C2=CC=CN=C12)C1=CC=NC(NC2=CC=C(C=C2)N2CCN(CC2)C(C)=O)=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	Ki (inhibition constant)	5	μM
4600	CN1CCN(CC1)C1=CC=CC(NC2=NC(=CC=N2)C2=CNC3=NC=CC=C23)=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.142	μM
4601	CN1C=C(C2=CC=CN=C12)C1=CC=NC(NC2=CC(=CC=C2)N2CCN(C)CC2)=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	Ki (inhibition constant)	5	μM
4602	CC(=O)N1CCCN(CC1)C1=CC(NC2=NC(=CC=N2)C2=CNC3=NC=CC=C23)=CC=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.029	μM
4603	CN1C=CC=C2C1=NC=C2C1=NC(NC2=CC=CC(=C2)N2CCCN(CC2)C(C)=O)=NC=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	Ki (inhibition constant)	5	μM
4604	CC(=O)N1CCN(CC1)C1=CC=C(NC2=NC(=CC=N2)C2=CNC3=CC=CN=C23)C=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	Ki (inhibition constant)	5	μM
4605	CN1CCN(CC1)C1=CC=CC(NC2=NC(=CC=N2)C2=CNC3=CC=CN=C23)=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	Ki (inhibition constant)	5	μM
4606	CC(=O)N1CCCN(CC1)C1=CC(NC2=NC(=CC=N2)C2=CNC3=CC=CN=C23)=CC=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	Ki (inhibition constant)	5	μM
4607	CC(=O)N1CCN(CC1)C1=CC=C(NC2=NC=CC(=N2)C2=CN(C3=CC=CC=C23)S(=O)(=O)C2=CC=C(C)C=C2)C=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	Ki (inhibition constant)	5	μM
4608	CC(=O)N1CCN(CC1)C1=CC=C(NC2=NC(C3=CNC4=CC=CC=C34)=C(C=N2)C#N)C=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.426	μM
4609	CN1C=C(C2=CC=CC=C12)C1=NC(NC2=CC=C(C=C2)N2CCN(CC2)C(C)=O)=NC=C1C#N	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	Ki (inhibition constant)	1.625	μM
4610	CC(=O)N1CCN(CC1)C1=CC=C(NC2=NC(C3=C(C)NC4=CC=CC=C34)=C(C=N2)C#N)C=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	Ki (inhibition constant)	0.536	μM
4611	CC(=O)N1CCN(CC1)C1=CC=C(NC2=NC(=CC=N2)C2=NNC3=CC=CC=C23)C=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	Ki (inhibition constant)	5	μM
4612	CN1N=C(C2=CC=CC=C12)C1=CC=NC(NC2=CC=C(C=C2)N2CCN(CC2)C(C)=O)=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	Ki (inhibition constant)	5	μM
4613	CC(=O)N1CCN(CC1)C1=CC=C(NC2=NC(C3=NNC4=CC=CC=C34)=C(C=N2)C#N)C=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	Ki (inhibition constant)	5	μM
4614	CC(=O)N1CCCN(CC1)C1=CC(NC2=NC(=CC=N2)C2=NNC3=CC=CC=C23)=CC=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	Ki (inhibition constant)	5	μM
4615	CNC1=NC(C)=C(S1)C1=C(C)C=NC(NC2=CC(=CC=C2)N2CCNCC2)=N1	Cyclin-H;+Cyclin-dependent kinase 7	Ki (inhibition constant)	472	nM
4616	CNC1=NC(C)=C(S1)C1=C(C)C=NC(NC2=CC(=CC=C2)N2CCCNCC2)=N1	Cyclin-H;+Cyclin-dependent kinase 7	Ki (inhibition constant)	89	nM
4617	ClC1=CN=CC(C2=CC3=CC=CC=C3S2)=C1N1CCC2(CCNC2=O)CC1	Cyclin-H; CDK-activating kinase assembly factor MAT1	inhibition rate	50	%
4618	NC(=O)C1=CC=C(C=N1)C1=C(F)C(C(=O)NC2=CNN=C2C(=O)NC2=CC=C(F)C=C2)=C(F)C=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	18000	nM
4619	CN(C)C[C@@H](NC(=O)N1CC2=C(N(C)N=C2NC(=O)C2=CC=C(NC(=O)C=C)C=N2)C1(C)C)C1=CC=CC=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100 - 1	nM
4620	CN(C)C[C@@H](NC(=O)N1CC2=C(N(N=C2NC(=O)C2=CC=C(NC(=O)C=C)C=N2)C(F)F)C1(C)C)C1=CC=CC=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4621	CN(C)C[C@@H](NC(=O)N1CC2=C(NN=C2NC(=O)C2=CC=C(NC(=O)C=C)C=N2)C1(C)C)C1=CC=CC=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4622	CN(C)C[C@@H](NC(=O)N1CC2=C(NN=C2NC(=O)C2=CC(=C(NC(=O)C=C)C=C2)C(F)(F)F)C1(C)C)C1=CC=CC=C1	Cyclin-dependent kinase 7; Cyclin-H;+CDK-activating kinase assembly factor MAT1	IC50	100	nM
4623	CN(C)CCNC(=O)C1=CC(F)=C(NC2=NC3=C(C=C(N3C3CCCC3)C(=O)N(C)C)C=N2)C=C1	Cyclin-dependent kinase 5 activator 1, p35 [human]; Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	inhibition rate	-5	%
4624	CC(C)(C)C1=CC=C(C=C1)C1=COC2=CC=C(N=C12)C1=CNN=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition rate	77	%
4625	CNC(=O)C1=C(N[C@@H]2CCN(CC3=CC=C(Cl)C=C3)[C@H](C)C2)C2=C(NC=C2)N=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	inhibition rate	15	%
4626	NC1=NC=C(C2=CC3=CC=CC=C3O2)C(N2CCC3(CCNC3=O)CC2)=C1Cl	Cyclin-dependent kinase 7; Cyclin-H	inhibition percentage	98	%
4627	COC1=CC=C(C=C1)C(=O)\C=C/NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1	Cyclin-H; Cyclin-dependent kinase 7	IC50	0.326	μM
4628	COC1=CC=C(C=C1)C(=O)\C=C/NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1	Cyclin-H; Cyclin-dependent kinase 7	Ki (inhibition constant)	0.208	μM
4629	FC1=CC=C(C=C1)C1=C2C(=NC=C1)N(N=C2C1=CC=CC=C1)C1=CC=CC=C1	Cyclin-H; Cyclin-dependent kinase 7	IC50	1.991	μM
4630	FC1=CC=C(C=C1)C1=C2C(=NC=C1)N(N=C2C1=CC=CC=C1)C1=CC=CC=C1	Cyclin-H; Cyclin-dependent kinase 7	Ki (inhibition constant)	1.272	μM
4631	COC1=CC=C(C=C1)C1=C(C#N)C(=C2C(=N1)N(N=C2C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=C(C=C1)N1CCOCC1	Cyclin-H; Cyclin-dependent kinase 7	IC50	0.318	μM
4632	COC1=CC=C(C=C1)C1=C(C#N)C(=C2C(=N1)N(N=C2C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=C(C=C1)N1CCOCC1	Cyclin-H; Cyclin-dependent kinase 7	Ki (inhibition constant)	0.203	μM
4633	COC1=CC=C(C=C1)C1=C(C#N)C(=C2C(=N1)N(N=C2C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=C(C=C1)N1CCN(C)CC1	Cyclin-H; Cyclin-dependent kinase 7	IC50	0.225	μM
4634	COC1=CC=C(C=C1)C1=C(C#N)C(=C2C(=N1)N(N=C2C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=C(C=C1)N1CCN(C)CC1	Cyclin-H; Cyclin-dependent kinase 7	Ki (inhibition constant)	0.144	μM
4635	COC1=CC=CC(F)=C1C1=NC=C2C=NN(C2=C1)C1=NC(=CC=C1)N1CC2CCC(C1)N2C	Cyclin-dependent kinase 7	IC50	910	nM
4636	CN1C=NC2=C(C=C(NC3=C(C)C=C(F)C(NC(=O)NCCC(C)(C)C)=C3)C=C2)C1=O	Cyclin-dependent kinase 7	inhibition rate	2.6	%
4637	CC(C)N1N=C(C)C(=C1C)C1=NC2=C(N1)N=CC=C2C1=CC2=C(C=C1)[C@@H](CCCC2)NC(=O)C1=NC(=NO1)C(C)(C)C	Cyclin-T2 [human];+Cyclin-dependent kinase 7 [human]	inhibition rate	-1.78	%
4638	CN1C=C(C=N1)C1=CN2C(C=C1)=NC=C2C1=CC=NC(NC2=CC=C(N=C2)N2CCN(C)CC2)=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	0.93	μM
4639	CC(=O)N1CCN(CC1)C1=NC=C(NC2=NC(C3=CN=C4C=CC=CN34)=C(F)C=N2)C=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	0.895	μM
4640	CN1CCN(CC1)C1=CC=C(NC2=NC(=CC=N2)C2=CN=C3C=CC(F)=CN23)C=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	1.715	μM
4641	CC1=C(N=C(NC2=CC=C(N=C2)N2CCOCC2)N=C1)C1=CN=C2C=CC=CN12	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	1.73	μM
4642	FC1=C(N=C(NC2=CC=C(N=C2)N2CCOCC2)N=C1)C1=CN=C2C=CC=CN12	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	1.63	μM
4643	CS(=O)(=O)N1CCN(CC1)C1=CC=C(NC2=NC(=CC=N2)C2=CN=C3C=CC(=CN23)C2=CC=CC=C2)C=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	1	μM
4644	CS(=O)(=O)N1CCN(CC1)C1=CC=C(NC2=NC(=CC=N2)C2=CN=C3C=CC(=CN23)C2=CN=CN=C2)C=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	0.89	μM
4645	CN1CCN(CC1)C1=CC=C(NC2=NC(=CC=N2)C2=CN=C3C=CC(=CN23)C2=CN=C(N)N=C2)C=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	5	μM
4646	CN1CCN(CC1)C1=CC=C(NC2=NC(=CC=N2)C2=CN=C3C=CC(=CN23)C2=CNN=C2)C=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	0.013	μM
4647	C1CCN(C1)C1=CC=C(NC2=NC(=CC=N2)C2=CN=C3C=CC(=CN23)C2=CC=CC=C2)C=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	5	μM
4648	CN1CCN(CC1)C1=CC=C(NC2=NC(C3=CN=C4C=CC(=CN34)C3=CC=CC=C3)=C(F)C=N2)C=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	0.314	μM
4649	COC(=O)N1CCC(CC1)C1=NC=C(NC2=NC(C3=CN=C4C=CC(=CN34)C3=CC=CC=C3)=C(F)C=N2)C=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	5	μM
4650	FC1=C(N=C(NC2=CC=C(N=C2)N2CCN(CCN3CCOCC3)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	0.223	μM
4651	CN1CCN(CC1)C1=CC=C(NC2=NC(=CC=N2)C2=CN=C3C=CC(C)=CN23)C=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	0.084	μM
4652	CC(C)N1CCN(CC1)C1=CC=C(NC2=NC(=CC=N2)C2=CN=C3C=CC(Cl)=CN23)C=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	0.174	μM
4653	CC(=O)N1CCN(CC1)C1=NC=C(NC2=NC(=CC=N2)C2=CN=C3C=CC(=CN23)C2=CNN=C2)C=C1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	0.262	μM
4654	CCN1CCN(CC2=CC=C(NC3=NC(=CC=N3)C3=CN=C4C=CC(=CN34)C3=CC=CC=C3)C=N2)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	0.222	μM
4655	CN(C)C1CCN(CC2=CC=C(NC3=NC(=CC=N3)C3=CN=C4C=CC(Br)=CN34)C=N2)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	0.205	μM
4656	CN1CCN(CC1)C1=CC=C(NC2=NC(=CC=N2)C2=C(C)N=C3C=CC(F)=CN23)C=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	0.56	μM
4657	CN1CCN(CC1)C1=CC=C(NC2=NC(C3=CN=C4C=CC=CN34)=C(C)C=N2)C=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	2.9	μM
4658	CN1CCN(CC1)C1=CC=C(NC2=NC(=CC=N2)C2=CN=C3C=CC(=CN23)C2=CN=CN=C2)C=N1	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	Ki (inhibition constant)	5	μM
4659	CN(C)CCNC(=O)C1=CC=C(C=C1)C1=CC=C(N1C1=C(C=CC=C1)C(F)(F)F)C1=CC=C(Cl)C=C1	Cyclin-dependent kinase 7	inhibition rate	0	%
4660	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N1CCC[C@H](C1)NC1=NC(C2=CNC3=C2C=CC=C3)=C(Br)C=N1	Cyclin-dependent kinase 7	IC50	115	nM
4661	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N1CCC[C@H](C1)NC1=NC(C2=CNC3=C2C=CC=C3)=C(C=N1)C1CC1	Cyclin-dependent kinase 7	IC50	625	nM
4662	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N1CCC[C@H](C1)NC1=NC(C2=CNC3=C2C=CC=C3)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	10000	nM
4663	CN(C)C\C=C\C(=O)NC1=CC=C(C=C1)C(=O)N1CCCC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1	Cyclin-dependent kinase 7	IC50	388	nM
4664	CN1C=NC2=CC=C(NC3=C(C)C=C(F)C(NC(=O)NCCC(C)(C)C)=C3)C(F)=C2C1=O	Cyclin-dependent kinase 7	inhibition rate	-4.5	%
4665	COC(=O)N1CCC2(C[C@H](NC3=C4N=NN([C@H]5C[C@H](O)[C@H](COS(N)(=O)=O)C5)C4=NC=N3)C3=C2C=CC=C3)CC1	Cyclin-dependent kinase 7	inhibition rate	10	%
4666		fact complex subunit spt16 [mouse];+FACT complex subunit SSRP1 [mouse]; Cyclin-dependent kinase 7 [mouse]	inhibition rate		
4667		fact complex subunit spt16 [mouse];+FACT complex subunit SSRP1 [mouse]; Cyclin-dependent kinase 7 [mouse]	inhibition rate		
4668		Cyclin-dependent kinase 7 [human]; fact complex subunit spt16 [human];+FACT complex subunit SSRP1 [human]	inhibition rate		
4669		Cyclin-dependent kinase 7 [human]; fact complex subunit spt16 [human];+FACT complex subunit SSRP1 [human]	inhibition rate		
4670		Cyclin-dependent kinase 7 [human]; fact complex subunit spt16 [human];+FACT complex subunit SSRP1 [human]	inhibition rate		
4671	COC1=CC=CC(CN2CCOC3=CC(=CC=C3C2=O)C2=CC=NC=C2)=C1	Cyclin-dependent kinase 7 [human]; Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]	inhibition percentage	11	%
4672	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=NC4=CC=CC=C4N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	343	nM
4673	CCC1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=CN4C=CC=C(C)C4=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	69	nM
4674	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=CN4C=CC=NC4=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	704	nM
4675	CCC1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=CN4C(C=CC=C4C)=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	919	nM
4676	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=CN4C=CC=CC4=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	411	nM
4677	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=NN4C=CC(=CC4=N3)C3CC3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	269	nM
4678	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=CN4C=CC=C(C)C4=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	305	nM
4679	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=CN=C4C=CC=CN34)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	179	nM
4680	CC(N)[C@H]1CC[C@@H](CC1)C(=O)NC1=C2C=C(NC2=NC=C1)C1=CSC=C1	Cyclin-dependent kinase 7	inhibition rate		
4681	NS(=O)(=O)C1=CC=C2C(NC=C2C2=NC(N[C@H]3CCCNC3)=NC=C2C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20	nM
4682	NS(=O)(=O)C1=CC=C2C(NC=C2C2=NC(N[C@H]3CCCNC3)=NC=C2C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
4683	NS(=O)(=O)C1=CC=C2C(NC=C2C2=NC(N[C@H]3CCCNC3)=NC=C2C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20	nM
4684	FC(F)(F)C1=CN=C(N[C@@H]2CCC3(CC3)NC2)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7	IC50	20	nM
4685	FC(F)(F)C1=CN=C(N[C@@H]2CCC3(CC3)NC2)N=C1C1=CNC2=CC=CC=C12	Cyclin-dependent kinase 7	IC50	20	nM
4686	CN1C(=CC=C1C1=CC=C2C(NC=C2C2=NC(N[C@H]3CCCNC3)=NC=C2C(F)(F)F)=C1)C#N	Cyclin-dependent kinase 7	IC50	20	nM
4687	CN1C(=CC=C1C1=CC=C2C(NC=C2C2=NC(N[C@H]3CCCNC3)=NC=C2C(F)(F)F)=C1)C#N	Cyclin-dependent kinase 7	IC50	20 - 200	nM
4688	CC1=NNC=C1C1=CC2=C(NC=C2C2=NC(N[C@H]3CCCNC3)=NC=C2C(F)(F)F)C=C1	Cyclin-dependent kinase 7	IC50	20	nM
4689	CC1=NNC=C1C1=CC2=C(NC=C2C2=NC(N[C@H]3CCCNC3)=NC=C2C(F)(F)F)C=C1	Cyclin-dependent kinase 7	IC50	20	nM
4690	FC(F)(F)C1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=C(C=C2)C1=CN=NC=C1	Cyclin-dependent kinase 7	IC50	20	nM
4691	FC(F)(F)C1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=C(C=C2)C1=CN=NC=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
4692	CC(C)[C@@H]1CC[C@@H](CN1)NC1=NC=CC(=N1)C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	20 - 200	nM
4693	FC(F)(F)C1=C(N=C(N[C@@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC(C#N)=C2C1=CC=NN=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
4694	FC(F)(F)C1=C(N=C(N[C@@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC(C#N)=C2C1=CC=NN=C1	Cyclin-dependent kinase 7	IC50	100	nM
4695	FC(F)(F)C1=C(N=C(N[C@@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC(C#N)=C2C1=CC=NN=C1	Cyclin-dependent kinase 7	IC50	20	nM
4696	CCC1=CN=C(N[C@@H]2CCCNC2)N=C1C1=NNC2=C1C=CC=N2	Cyclin-dependent kinase 7	IC50	20	nM
4697	CCC1=CN=C(N[C@@H]2CCCNC2)N=C1C1=NNC2=C1C=CC=N2	Cyclin-dependent kinase 7	IC50	20 - 200	nM
4698	CS(=O)(=O)C1=CC=CN2C(=NN=C12)[C@H]1CNC[C@H](C1)NC1=NC=C(C(=N1)C1=CNC2=C1C=CC=C2)C(F)(F)F	Cyclin-dependent kinase 7	IC50	200 - 5	nM
4699	CS(=O)(=O)C1=CC=CN2C(=NN=C12)[C@H]1CNC[C@H](C1)NC1=NC=C(C(=N1)C1=CNC2=C1C=CC=C2)C(F)(F)F	Cyclin-dependent kinase 7	IC50	20 - 200	nM
4700	O[C@@H]1CCNC[C@H]1NC1=NC=C(Cl)C(=N1)C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	20 - 200	nM
4701	O[C@@H]1CCNC[C@H]1NC1=NC=C(Cl)C(=N1)C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	200 - 5	nM
4702	CNC(=O)C1=CC2=C(C=C1)C(=CN2C)C1=NC(N[C@H]2CCCNC2)=NC=C1C(F)(F)F	Cyclin-dependent kinase 7	IC50	5	μM
4703	CNC(=O)C1=CC2=C(C=C1)C(=CN2C)C1=NC(N[C@H]2CCCNC2)=NC=C1C(F)(F)F	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
4704	CN1C=C(C2=C1C=C(N=C2)C(F)(F)F)C1=CC=C2C(NC=C2C2=NC(N[C@H]3CCCNC3)=NC=C2C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	20 - 200	nM
4705	CN1C=C(C2=C1C=C(N=C2)C(F)(F)F)C1=CC=C2C(NC=C2C2=NC(N[C@H]3CCCNC3)=NC=C2C(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
4706	CC(C)(C)OC(=O)N1CCC[C@@H](C1)NC1=NC=C(C(=N1)C1=CNC2=CC(=CC=C12)P(C)(C)=O)C(F)(F)F	Cyclin-dependent kinase 7	IC50	5	μM
4707	CC(C)(C)OC(=O)N1CCC[C@@H](C1)NC1=NC=C(C(=N1)C1=CNC2=CC(=CC=C12)P(C)(C)=O)C(F)(F)F	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
4708	F[C@@H]1CCNC[C@H]1NC1=NC=C(Cl)C(=N1)C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	20 - 200	nM
4709	F[C@@H]1CCNC[C@H]1NC1=NC=C(Cl)C(=N1)C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	20 - 200	nM
4710	ClC1=CN=C(NC2CN3CCC2CC3)N=C1C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	5	μM
4711	ClC1=CN=C(NC2CN3CCC2CC3)N=C1C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	200 - 5	nM
4712	ClC1=CN=C(N[C@H]2CN3CCC2CC3)N=C1C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	5	μM
4713	ClC1=CN=C(N[C@H]2CN3CCC2CC3)N=C1C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	200 - 5	nM
4714	CN1CCC[C@@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	20	nM
4715	CN1CCC[C@@H](C1)NC1=NC=C(Cl)C(=N1)C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7	IC50	20 - 200	nM
4716	ClC1=C(N=C(N[C@@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC(=C2)C#N	Cyclin-dependent kinase 7	IC50	20	nM
4717	ClC1=C(N=C(N[C@@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC(=C2)C#N	Cyclin-dependent kinase 7	IC50	100	nM
4718	ClC1=C(N=C(N[C@@H]2CCCNC2)N=C1)C1=CNC2=C1C=CC(=C2)C#N	Cyclin-dependent kinase 7	IC50	20	nM
4719	CC1=C(C=NN1)C1=CC=CC2=C1NC=C2C1=NC(N[C@@H]2CCCNC2)=NC=C1C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
4720	CC1=C(C=NN1)C1=CC=CC2=C1NC=C2C1=NC(N[C@@H]2CCCNC2)=NC=C1C(F)(F)F	Cyclin-dependent kinase 7	IC50	1000 - 5	nM
4721	CC1=C(C=NN1)C1=CC=CC2=C1NC=C2C1=NC(N[C@@H]2CCCNC2)=NC=C1C(F)(F)F	Cyclin-dependent kinase 7	IC50	20	nM
4722	CN([C@H]1CCCN(CCC#N)C1)C1=C2C(NC3=C2C=CC(=C3)C#C)=NC=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition rate	14	%
4723	C#CC1=CC2=C(C=C1)C1=C(N=CN=C1N2)N1CCC2CCN(CCC#N)CC12	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition rate	20	%
4724	C[C@@H]1CCCN1C1=C(C#N)C2=C(N)N=C(NC3=C(C)N(N=C3)[C@@H]3CCOC3)N=C2N1C	Cyclin-dependent kinase 7	inhibition percentage	36	%
4725	C[C@@H]1CCCN1C1=C(C#N)C2=C(N)N=C(NC3=C(C)N(N=C3)[C@@H]3CCOC3)N=C2N1C	Cyclin-dependent kinase 7 [human]	IC50	10	μM
4726	Cl.[H][C@@]1(CC[C@@H](CC1)C(=O)NC1=CC=NC2=C1C=C(N2)C1=CC=CC=C1)[C@H](N)C(=O)OC	Cyclin-dependent kinase 7	inhibition rate		
4727	OC(=O)C(F)(F)F.[H][C@@]1(CC[C@@H](CC1)C(=O)NC1=CC=NC2=C1C=C(N2)C1=CC=C(F)C=C1)C(C)N	Cyclin-dependent kinase 7	inhibition rate		
4728	Cl.CC(N)[C@H]1CC[C@@H](CC1)C(=O)NC1=CC=NC2=C1C=C(N2)C1=CC=C(C=C1)C#N	Cyclin-dependent kinase 7	inhibition rate		
4729	Cl.CC(N)[C@H]1CC[C@@H](CC1)C(=O)NC1=CC=NC2=C1C=C(N2)C1=CC=CC(F)=C1	Cyclin-dependent kinase 7	inhibition rate		
4730	OC(=O)C1=CC=C(C=C1C1CCCC1)C1=C2N=C(C=CN2N=C1)C1=CC=CC=C1	Cyclin-dependent kinase 7	inhibition percentage	60	%
4731	OC(=O)C1=CC=C(C=C1C1CCCC1)C1=C2C=CC=CN2N=C1	Cyclin-dependent kinase 7	inhibition percentage	50	%
4732	OC(=O)C1=CC=C(C=C1C1CCCC1)C1=C2SC=CC2=NC=N1	Cyclin-dependent kinase 7	inhibition percentage	8	%
4733	Cl[H].OC(=O)C1=CC=C(C=C1C1CCCC1)C1=NC(NC2=CC=CC=C2)=NC=C1	Cyclin-dependent kinase 7	inhibition percentage	11	%
4734	OC(=O)C1=CC=C(C=C1C1CCCC1)C1=CC=NC2=CC=C(C=C12)C1=CC=CC=C1	Cyclin-dependent kinase 7	inhibition percentage	12	%
4735	OC(=O)C1=CC=C(C=C1C1CCCC1)C1=C2N=C(NC2=NC=C1)C1=CC=CC=C1	Cyclin-dependent kinase 7	inhibition percentage	61	%
4736	CN1C(=CC2=C(C=CN=C12)C1=CC=C(C(O)=O)C(=C1)C1CCCC1)C1=CC=CC=C1	Cyclin-dependent kinase 7	inhibition percentage	11	%
4737	Cl.COC1=C(C=C(F)C=C1)C1=CC=NC2=C1C=C(N2)C1=CCN(CC1)C1CCC(CC1)C(O)=O	Cyclin-dependent kinase 7	IC50	9.8	μM
4738	COC1=C(C=C(F)C=C1)C1=CC=NC2=C1C=C(N2)C1=CCN(CC1)C1CCC(CC1)C(O)=O	Cyclin-dependent kinase 7	IC50	9.8	μM
4739	COC1=C(C=C(F)C=C1)C1=CC=NC2=C1C=C(N2)C1=CCN(CC1)C1CCC(CC(O)=O)CC1	Cyclin-dependent kinase 7	IC50	9.8	μM
4740	COC1=C(C=C(F)C=C1)C1=CC=NC2=C1C=C(N2)C1=CCN(CC1)C1CCC(CC(O)=O)CC1	Cyclin-dependent kinase 7	IC50	9.8	μM
4741	COC1=C(C=C(F)C=C1)C1=C(F)C=NC2=C1C=C(N2)C1=CCN(CC1)C1CCC(CC1)C(O)=O	Cyclin-dependent kinase 7	IC50	9.8	μM
4742	COC1=C(C=C(F)C=C1)C1=C(F)C=NC2=C1C=C(N2)C1=CCN(CC1)C1CCC(CC1)C(O)=O	Cyclin-dependent kinase 7	IC50	9.8	μM
4743	COC1=C(C=C(F)C=C1)C1=C(F)C=NC2=C1C=C(N2)C1=CCN(CC1)C1CCC(CC(O)=O)CC1	Cyclin-dependent kinase 7	IC50	9.8	μM
4744	COC1=C(C=C(F)C=C1)C1=C(F)C=NC2=C1C=C(N2)C1=CCN(CC1)C1CCC(CC(O)=O)CC1	Cyclin-dependent kinase 7	IC50	9.8	μM
4745	COC1=C(C=C(F)C=C1)C1=CC=NC2=C1C=C(N2)C1=CCC(CC1)N1CCC(CC1)C(O)=O	Cyclin-dependent kinase 7	IC50	9.8	μM
4746	Cl.COC1=C(C=C(F)C=C1)C1=CC=NC2=C1C=C(N2)C1=CCC(CC1)N1CCC(CC(O)=O)CC1	Cyclin-dependent kinase 7	IC50	9.8	μM
4747	COC1=C(C=C(F)C=C1)C1=CC=NC2=C1C=C(N2)C1=CCN(CC1)C1=CC=C(CC(O)=O)C=C1	Cyclin-dependent kinase 7	IC50	9.8	μM
4748	CCN1CCN(CC1)C1=CC=C(NC2=NC=C3SC=C(C3=N2)C2=CC(NS(C)(=O)=O)=CC=C2)C=C1	Cyclin-dependent kinase 7	inhibition percentage	47.5	%
4749	CC1=NN(CC(F)(F)F)C=C1NC1=NC=C(Br)C(NCCC2=CN=CN2)=N1	Cyclin-dependent kinase 7 [human]	inhibition rate	95.2	%
4750	C(CC1=CNC=N1)NC1=NC(NC2=CC=CC(CN3CCOCC3)=C2)=NC=C1C1CC1	Cyclin-dependent kinase 7 [human]	inhibition rate	67	%
4751	NS(=O)(=O)C1=CC=C(CNC2=NC(NC3=CC(NC(=O)N4CCCC4)=CC=C3)=NC=C2Br)C=C1	Cyclin-dependent kinase 7 [human]	inhibition rate	81	%
4752	BrC1=CN=C(NC2=CC(NC(=O)N3CCCC3)=CC=C2)N=C1NCCCNC(=O)C1CCC1	Cyclin-dependent kinase 7 [human]	inhibition rate	99.4	%
4753	CC1=NN(CC(F)(F)F)C=C1NC1=NC=C(Br)C(NCCCNC(=O)C2CCC2)=N1	Cyclin-dependent kinase 7 [human]	inhibition rate	98.8	%
4754	N[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 7 [human]	inhibition rate	79	%
4755	COC1=CC=NN2N=CC(=C12)C1=NC(=NC=C1)N(C)C	Cyclin-dependent kinase 7 [human]	inhibition rate	15	%
4756	COC1=C(NC2=NC3=C(C=N2)C=C(C(=O)N3C[C@H]2OC[C@H](N)CO2)C2=C(Cl)C=C(C=C2)C2=NC(C)=CC=C2)C=CC=C1	Cyclin-dependent kinase 7	inhibition rate	5	%
4757	CNC1=NC2=C(C=N1)C=C(C(=O)N2C[C@H]1OC[C@H](N)CO1)C1=C(Cl)C=C(C=C1)C1=NC(C)=CC=C1F	Cyclin-dependent kinase 7	inhibition rate	34	%
4758	CNC1=NC2=C(C=N1)C=C(C(=O)N2C[C@H]1OC[C@H](N)CO1)C1=C(Cl)C=C(C=C1)C1=NC=CC=C1F	Cyclin-dependent kinase 7; CDK-activating kinase assembly factor MAT1; Cyclin-H	inhibition rate	0	%
4759	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=CC=C4N(C)C=NC4=C3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	127	nM
4760	O[C@H]1CNCC[C@@H]1CNC1=NC2=C(C=NN2C(NCC2=CN3C=CC(=CC3=N2)C2=CC=CC=C2)=C1)C1CC1	Cyclin-dependent kinase 7 [human]	IC50	496	nM
4761	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=CN=C4C=CC=C(C)N34)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	436	nM
4762	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=C(C)N=C4C=C(C)C=CN34)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	3	nM
4763	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=CN4C(C)=CSC4=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	158	nM
4764	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=CN4C=C(C)C=CC4=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	117	nM
4765	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=CN4C=CC(C)=CC4=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	123	nM
4766	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=CN4C(C=CC=C4C)=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	238	nM
4767	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=CN4C=C(F)C=CC4=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	168	nM
4768	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=CN4C=C(Cl)C=CC4=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	214	nM
4769	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=CN4C=CC=C(C5CC5)C4=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	226	nM
4770	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=NC4=CC=CC=C4C=C3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	19	nM
4771	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=C(C)N4C=CC=CC4=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	40	nM
4772	[2H]C([2H])(NC1=CC(NC[C@H]2CCNC[C@@H]2O)=NC2=C(C=NN12)C(C)C)C1=CN2C=CC=CC2=N1	Cyclin-dependent kinase 7 [human]	IC50	206	nM
4773	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NC(C)C3=CN4C=CC=CC4=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	640	nM
4774	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=CC4=CC=CC=C4O3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	82	nM
4775	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=CC4=CC=CC=C4N=C3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	28	nM
4776	CC1=CC=CN2C=C(CNC3=CC(NC[C@H]4CCNC[C@@H]4O)=NC4=C(C=NN34)C3CC3)N=C12	Cyclin-dependent kinase 7 [human]	IC50	622	nM
4777	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=C(N4C=CC=CC4=N3)C(F)(F)F)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	102	nM
4778	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=C(C4CC4)N4C=CC=CC4=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	283	nM
4779	CC1=CC=CC2=NC(CNC3=CC(NC[C@H]4CCNC[C@@H]4O)=NC4=C(C=NN34)C3CC3)=CN12	Cyclin-dependent kinase 7 [human]	IC50	334	nM
4780	COC1=CC=CC2=NC(CNC3=CC(NC[C@H]4CCNC[C@@H]4O)=NC4=C(C=NN34)C3CC3)=CN12	Cyclin-dependent kinase 7 [human]	IC50	127	nM
4781	O[C@H]1CNCC[C@@H]1CNC1=NC2=C(C=NN2C(NCC2=CN3N=C(C=CC3=N2)C2CC2)=C1)C1CC1	Cyclin-dependent kinase 7 [human]	IC50	68	nM
4782	CC1=CC=CN2C=C(CNC3=CC(NC[C@H]4CCNC[C@@H]4O)=NC4=C(C=NN34)C3CCC3)N=C12	Cyclin-dependent kinase 7 [human]	IC50	196	nM
4783	O[C@H]1CNCC[C@@H]1CNC1=NC2=C(C=NN2C(NCC2=CN3C(C=CC=C3C3CC3)=N2)=C1)C1CC1	Cyclin-dependent kinase 7 [human]	IC50	274	nM
4784	CC1=CC2=NC(CNC3=CC(NC[C@H]4CCNC[C@@H]4O)=NC4=C(C=NN34)C3CC3)=CN2C(C)=C1	Cyclin-dependent kinase 7 [human]	IC50	859	nM
4785	O[C@H]1CNCC[C@@H]1CNC1=NC2=C(C=NN2C(NCC2=CN3C=C(C=C(Cl)C3=N2)C(F)(F)F)=C1)C1CC1	Cyclin-dependent kinase 7 [human]	IC50	1060	nM
4786	CCC1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=CN4C(C=CC=C4C(F)(F)F)=N3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	152	nM
4787	O[C@H]1CNCC[C@@H]1CNC1=NC2=C(C=NN2C(NCC2=CN3C=CC(=CC3=N2)C(F)(F)F)=C1)C1CC1	Cyclin-dependent kinase 7 [human]	IC50	1290	nM
4788	CN1C(CNC2=CC(NC[C@H]3CCNC[C@@H]3O)=NC3=C(C=NN23)C2CC2)=NC2=CC(F)=C(F)C=C12	Cyclin-dependent kinase 7 [human]	IC50	1150	nM
4789	O[C@H]1CNCC[C@@H]1CNC1=NC2=C(C=NN2C(NCC2=CN3C(C=CC=C3C(F)(F)F)=N2)=C1)C1CC1	Cyclin-dependent kinase 7 [human]	IC50	649	nM
4790	CCC1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=CN4C=C(C=C(C4=N3)C(F)(F)F)C3CC3)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	762	nM
0	CC1=CC(=CC2=NC(CNC3=CC(NC[C@H]4CCNC[C@@H]4O)=NC4=C(C=NN34)C3CC3)=CN12)C(F)(F)F	Cyclin-K [human]	IC50	4	nM
1	CC1=CC(=CC2=NC(CNC3=CC(NC[C@H]4CCNC[C@@H]4O)=NC4=C(C=NN34)C3CC3)=CN12)C(F)(F)F	Cyclin-dependent kinase 12 [human]	IC50	48	nM
2	CC1=CC(=CC2=NC(CNC3=CC(NC[C@H]4CCNC[C@@H]4O)=NC4=C(C=NN34)C3CC3)=CN12)C(F)(F)F	Cyclin-K [human]	IC50	48	nM
3	CC1=CC(=CC2=NC(CNC3=CC(NC[C@H]4CCNC[C@@H]4O)=NC4=C(C=NN34)C3CC3)=CN12)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1830	nM
4	CC1=CN2C=C(CNC3=CC(NC[C@H]4CCNC[C@@H]4O)=NC4=C(C=NN34)C3CC3)N=C2C=C1C(F)(F)F	Cyclin-K [human]	IC50	5.4	nM
5	CC1=CN2C=C(CNC3=CC(NC[C@H]4CCNC[C@@H]4O)=NC4=C(C=NN34)C3CC3)N=C2C=C1C(F)(F)F	Cyclin-dependent kinase 12 [human]	IC50	48	nM
6	CC1=CN2C=C(CNC3=CC(NC[C@H]4CCNC[C@@H]4O)=NC4=C(C=NN34)C3CC3)N=C2C=C1C(F)(F)F	Cyclin-K [human]	IC50	48	nM
7	CC1=CN2C=C(CNC3=CC(NC[C@H]4CCNC[C@@H]4O)=NC4=C(C=NN34)C3CC3)N=C2C=C1C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1530	nM
8	CC(C)OC1=CC=CC2=NC(CNC3=CC(NC[C@H]4CCNC[C@@H]4O)=NC4=C(C=NN34)C3CC3)=CN12	Cyclin-K [human]	IC50	9.8	nM
9	CC(C)OC1=CC=CC2=NC(CNC3=CC(NC[C@H]4CCNC[C@@H]4O)=NC4=C(C=NN34)C3CC3)=CN12	Cyclin-dependent kinase 12 [human]	IC50	46	nM
10	CC(C)OC1=CC=CC2=NC(CNC3=CC(NC[C@H]4CCNC[C@@H]4O)=NC4=C(C=NN34)C3CC3)=CN12	Cyclin-K [human]	IC50	46	nM
11	CC(C)OC1=CC=CC2=NC(CNC3=CC(NC[C@H]4CCNC[C@@H]4O)=NC4=C(C=NN34)C3CC3)=CN12	Cyclin-dependent kinase 7 [human]	IC50	650	nM
12	O[C@H]1CNCC[C@@H]1CNC1=NC2=C(C=NN2C(NCC2=CN3C=C(C=C(C3=N2)C(F)(F)F)C2CC2)=C1)C1CC1	Cyclin-K [human]	IC50	30	nM
13	O[C@H]1CNCC[C@@H]1CNC1=NC2=C(C=NN2C(NCC2=CN3C=C(C=C(C3=N2)C(F)(F)F)C2CC2)=C1)C1CC1	Cyclin-dependent kinase 12 [human]	IC50	100	nM
14	O[C@H]1CNCC[C@@H]1CNC1=NC2=C(C=NN2C(NCC2=CN3C=C(C=C(C3=N2)C(F)(F)F)C2CC2)=C1)C1CC1	Cyclin-K [human]	IC50	100	nM
15	O[C@H]1CNCC[C@@H]1CNC1=NC2=C(C=NN2C(NCC2=CN3C=C(C=C(C3=N2)C(F)(F)F)C2CC2)=C1)C1CC1	Cyclin-dependent kinase 7 [human]	IC50	974	nM
16	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=CN4C(=N3)N=C(C)C=C4C)N2N=C1	Cyclin-dependent kinase 12 [human]	IC50	21	nM
17	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=CN4C(=N3)N=C(C)C=C4C)N2N=C1	Cyclin-K [human]	IC50	21	nM
18	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=CN4C(=N3)N=C(C)C=C4C)N2N=C1	Cyclin-K [human]	IC50	340	nM
19	CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=CN4C(=N3)N=C(C)C=C4C)N2N=C1	Cyclin-dependent kinase 7 [human]	IC50	484	nM
20	C[C@@H]1NC(=O)N[C@@H]1CCCCCC(=O)NCCCCCCCCC(=O)N(CC#N)S(=O)(=O)C1=CC=C(NC2=NC(NC3=C(C(N)=O)C(F)=CC=C3)=C(Br)C=N2)C=C1	Cyclin-dependent kinase 5 activator 1, p25; Cyclin-dependent-like kinase 5	IC50	6.8	nM
21	C[C@@H]1NC(=O)N[C@@H]1CCCCCC(=O)NCCCCCCCCC(=O)N(CC#N)S(=O)(=O)C1=CC=C(NC2=NC(NC3=C(C(N)=O)C(F)=CC=C3)=C(Br)C=N2)C=C1	G2/mitotic-specific cyclin-A; Cyclin-dependent kinase 2	IC50	22.1	nM
22	C[C@@H]1NC(=O)N[C@@H]1CCCCCC(=O)NCCCCCCCCC(=O)N(CC#N)S(=O)(=O)C1=CC=C(NC2=NC(NC3=C(C(N)=O)C(F)=CC=C3)=C(Br)C=N2)C=C1	G2/mitotic-specific cyclin-B1; Cyclin-dependent kinase 1	IC50	27.8	nM
23	C[C@@H]1NC(=O)N[C@@H]1CCCCCC(=O)NCCCCCCCCC(=O)N(CC#N)S(=O)(=O)C1=CC=C(NC2=NC(NC3=C(C(N)=O)C(F)=CC=C3)=C(Br)C=N2)C=C1	G1/S-specific cyclin-D1; Cyclin-dependent kinase 4	IC50		
24	C[C@@H]1NC(=O)N[C@@H]1CCCCCC(=O)NCCCCCCCCC(=O)N(CC#N)S(=O)(=O)C1=CC=C(NC2=NC(NC3=C(C(N)=O)C(F)=CC=C3)=C(Br)C=N2)C=C1	G1/S-specific cyclin-D1; Cyclin-dependent kinase 6	IC50		
25	C[C@@H]1NC(=O)N[C@@H]1CCCCCC(=O)NCCCCCCCCC(=O)N(CC#N)S(=O)(=O)C1=CC=C(NC2=NC(NC3=C(C(N)=O)C(F)=CC=C3)=C(Br)C=N2)C=C1	Cyclin-H; Cyclin-dependent kinase 7	IC50		
26	C[C@@H]1NC(=O)N[C@@H]1CCCCCC(=O)NCCCCCCCCC(=O)N(CC#N)S(=O)(=O)C1=CC=C(NC2=NC(NC3=C(C(N)=O)C(F)=CC=C3)=C(Br)C=N2)C=C1	Cyclin-T1; Cyclin-dependent kinase 9	IC50		
27	C[C@@H]1NC(=O)N[C@@H]1CCCCCC(=O)NCCCCCCCCC(=O)N(CC#N)S(=O)(=O)C1=CC=C(NC2=NC(NC3=C(C(N)=O)C(F)=CC=C3)=C(Br)C=N2)C=C1	G1/S-specific cyclin-E1; Cyclin-dependent kinase 3	IC50		
28	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)NCC#N)=N2)C=CC=C1F	Cyclin-dependent kinase 5 activator 1, p25; Cyclin-dependent-like kinase 5	IC50	0.8	nM
29	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)NCC#N)=N2)C=CC=C1F	G2/mitotic-specific cyclin-A; Cyclin-dependent kinase 2	IC50	1.7	nM
30	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)NCC#N)=N2)C=CC=C1F	G2/mitotic-specific cyclin-B1; Cyclin-dependent kinase 1	IC50	2.2	nM
31	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)NCC#N)=N2)C=CC=C1F	G1/S-specific cyclin-E1; Cyclin-dependent kinase 3	IC50	7.7	nM
32	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)NCC#N)=N2)C=CC=C1F	Cyclin-T1; Cyclin-dependent kinase 9	IC50	14.2	nM
33	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)NCC#N)=N2)C=CC=C1F	Cyclin-H; Cyclin-dependent kinase 7	IC50	43.8	nM
34	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)NCC#N)=N2)C=CC=C1F	G1/S-specific cyclin-D1; Cyclin-dependent kinase 6	IC50	113	nM
35	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)NCC#N)=N2)C=CC=C1F	G1/S-specific cyclin-D1; Cyclin-dependent kinase 4	IC50	914	nM
36	CC(=O)N(CC#N)S(=O)(=O)C1=CC=C(NC2=NC(NC3=C(C(N)=O)C(F)=CC=C3)=C(Br)C=N2)C=C1	Cyclin-dependent kinase 5 activator 1, p25; Cyclin-dependent-like kinase 5	IC50	1.6	nM
37	CC(=O)N(CC#N)S(=O)(=O)C1=CC=C(NC2=NC(NC3=C(C(N)=O)C(F)=CC=C3)=C(Br)C=N2)C=C1	G2/mitotic-specific cyclin-A; Cyclin-dependent kinase 2	IC50	2.2	nM
38	CC(=O)N(CC#N)S(=O)(=O)C1=CC=C(NC2=NC(NC3=C(C(N)=O)C(F)=CC=C3)=C(Br)C=N2)C=C1	G2/mitotic-specific cyclin-B1; Cyclin-dependent kinase 1	IC50	3.8	nM
39	CC(=O)N(CC#N)S(=O)(=O)C1=CC=C(NC2=NC(NC3=C(C(N)=O)C(F)=CC=C3)=C(Br)C=N2)C=C1	G1/S-specific cyclin-E1; Cyclin-dependent kinase 3	IC50	11.3	nM
40	CC(=O)N(CC#N)S(=O)(=O)C1=CC=C(NC2=NC(NC3=C(C(N)=O)C(F)=CC=C3)=C(Br)C=N2)C=C1	Cyclin-T1; Cyclin-dependent kinase 9	IC50	19.2	nM
41	CC(=O)N(CC#N)S(=O)(=O)C1=CC=C(NC2=NC(NC3=C(C(N)=O)C(F)=CC=C3)=C(Br)C=N2)C=C1	Cyclin-H; Cyclin-dependent kinase 7	IC50	69.7	nM
42	CC(=O)N(CC#N)S(=O)(=O)C1=CC=C(NC2=NC(NC3=C(C(N)=O)C(F)=CC=C3)=C(Br)C=N2)C=C1	G1/S-specific cyclin-D1; Cyclin-dependent kinase 4	IC50	370	nM
43	CC(=O)N(CC#N)S(=O)(=O)C1=CC=C(NC2=NC(NC3=C(C(N)=O)C(F)=CC=C3)=C(Br)C=N2)C=C1	Cyclin-dependent kinase 2 [human]	binding rate increase		
44	CC(=O)N(CC#N)S(=O)(=O)C1=CC=C(NC2=NC(NC3=C(C(N)=O)C(F)=CC=C3)=C(Br)C=N2)C=C1	Cyclin-dependent-like kinase 5 [human]	binding rate increase		
45	CC(=O)N(CC#N)S(=O)(=O)C1=CC=C(NC2=NC(NC3=C(C(N)=O)C(F)=CC=C3)=C(Br)C=N2)C=C1	Cyclin-dependent kinase 1 [human]	binding rate increase		
46	CC(=O)N(CC#N)S(=O)(=O)C1=CC=C(NC2=NC(NC3=C(C(N)=O)C(F)=CC=C3)=C(Br)C=N2)C=C1	G1/S-specific cyclin-D1; Cyclin-dependent kinase 6	IC50	10000	nM
47	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCOCCOCCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	Cyclin-dependent kinase 5 activator 1, p25; Cyclin-dependent-like kinase 5	IC50	2.3	nM
48	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCOCCOCCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	G2/mitotic-specific cyclin-A; Cyclin-dependent kinase 2	IC50	3.5	nM
49	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCOCCOCCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	G2/mitotic-specific cyclin-B1; Cyclin-dependent kinase 1	IC50	9.7	nM
50	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCOCCOCCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	G1/S-specific cyclin-E1; Cyclin-dependent kinase 3	IC50	14.5	nM
51	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCOCCOCCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	Cyclin-T1; Cyclin-dependent kinase 9	IC50	65.3	nM
52	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCOCCOCCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	Cyclin-H; Cyclin-dependent kinase 7	IC50	211	nM
53	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCOCCOCCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	Cyclin-dependent kinase 2 [human]	binding rate increase		
54	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCOCCOCCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	Cyclin-dependent-like kinase 5 [human]	binding rate increase		
55	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCOCCOCCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	Cyclin-dependent kinase 1 [human]	binding rate increase		
56	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCOCCOCCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	G1/S-specific cyclin-D1; Cyclin-dependent kinase 4	IC50	2040	nM
57	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCOCCOCCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	G1/S-specific cyclin-D1; Cyclin-dependent kinase 6	IC50	2830	nM
58	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCOCCOCCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	Cyclin-dependent kinase 2 [human]	degradation rate increase		
59	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCOCCOCCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	Cyclin-dependent kinase 2 [human]	degradation rate increase		
60	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCOCCOCCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	Cyclin-dependent kinase 2 [human]	degradation rate increase		
61	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCOCCOCCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	Cyclin-dependent kinase 2	protein modification rate	75	%
62	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	G2/mitotic-specific cyclin-A; Cyclin-dependent kinase 2	IC50	3.1	nM
63	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	G2/mitotic-specific cyclin-B1; Cyclin-dependent kinase 1	IC50	8.5	nM
64	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	Cyclin-dependent kinase 5 activator 1, p25; Cyclin-dependent-like kinase 5	IC50	10.3	nM
65	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	G1/S-specific cyclin-E1; Cyclin-dependent kinase 3	IC50	13.4	nM
66	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	Cyclin-dependent kinase 2 [human]	degradation rate increase		
67	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	Cyclin-dependent kinase 2 [human]	degradation rate increase		
68	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	G1/S-specific cyclin-D1; Cyclin-dependent kinase 4	IC50		
69	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	G1/S-specific cyclin-D1; Cyclin-dependent kinase 6	IC50		
70	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	Cyclin-H; Cyclin-dependent kinase 7	IC50		
71	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	Cyclin-T1; Cyclin-dependent kinase 9	IC50		
72	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	G2/mitotic-specific cyclin-A; Cyclin-dependent kinase 2	IC50	8.2	nM
73	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	Cyclin-dependent kinase 5 activator 1, p25; Cyclin-dependent-like kinase 5	IC50	18.3	nM
74	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	G2/mitotic-specific cyclin-B1; Cyclin-dependent kinase 1	IC50	34.5	nM
75	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	G1/S-specific cyclin-E1; Cyclin-dependent kinase 3	IC50	34.5	nM
76	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	Cyclin-dependent kinase 2 [human]	degradation rate increase		
77	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	Cyclin-dependent kinase 2 [human]	degradation rate increase		
78	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	G1/S-specific cyclin-D1; Cyclin-dependent kinase 4	IC50		
79	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	G1/S-specific cyclin-D1; Cyclin-dependent kinase 6	IC50		
80	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	Cyclin-H; Cyclin-dependent kinase 7	IC50		
81	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	Cyclin-T1; Cyclin-dependent kinase 9	IC50		
82	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	G2/mitotic-specific cyclin-A; Cyclin-dependent kinase 2	IC50	16.9	nM
83	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	Cyclin-dependent kinase 5 activator 1, p25; Cyclin-dependent-like kinase 5	IC50	30	nM
84	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	G1/S-specific cyclin-E1; Cyclin-dependent kinase 3	IC50	47.1	nM
85	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	G2/mitotic-specific cyclin-B1; Cyclin-dependent kinase 1	IC50	48.6	nM
86	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	Cyclin-dependent kinase 2 [human]	degradation rate increase		
87	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	Cyclin-dependent kinase 2 [human]	degradation rate increase		
88	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	G1/S-specific cyclin-D1; Cyclin-dependent kinase 4	IC50		
89	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	G1/S-specific cyclin-D1; Cyclin-dependent kinase 6	IC50		
90	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	Cyclin-H; Cyclin-dependent kinase 7	IC50		
91	NC(=O)C1=C(NC2=C(Br)C=NC(NC3=CC=C(C=C3)S(=O)(=O)N(CC#N)C(=O)CCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=N2)C=CC=C1F	Cyclin-T1; Cyclin-dependent kinase 9	IC50		
92		Cyclin-dependent kinase 12 [human];+Cyclin-dependent kinase 7 [human]; Cyclin-dependent kinase 7 [human]	inhibition percentage		
93		Cyclin-dependent kinase 12 [mouse];+Cyclin-dependent kinase 13 [mouse]; Cyclin-dependent kinase 7 [mouse]	inhibition percentage		
94	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Dual specificity protein kinase TTK	IC50	0.003	μM
95	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		IC50	0.014	μM
96	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Dual specificity protein kinase TTK [human]	IC50	0.016	μM
97	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Testis-specific serine/threonine-protein kinase 1	IC50	0.035	μM
98	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		IC50	0.0397	μM
99	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		IC50	0.0424	μM
100	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		IC50	48	nM
101	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		IC50	0.0523	μM
102	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		IC50	0.0529	μM
103	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		IC50	74	nM
104	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		IC50	0.0914	μM
105	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		IC50	0.0918	μM
106	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		IC50	0.1051	μM
107	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Tyrosine-protein kinase JAK1	IC50	0.192	μM
108	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Leucine-rich repeat serine/threonine-protein kinase 2 (G2019S)	IC50	0.229	μM
109	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Leucine-rich repeat serine/threonine-protein kinase 2	IC50	0.342	μM
110	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase Chk2	IC50	0.545	μM
111	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Tyrosine-protein kinase JAK2	IC50	0.602	μM
112	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Testis-specific serine/threonine-protein kinase 2	IC50	0.944	μM
113	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Proto-oncogene tyrosine-protein kinase Src N1	IC50	1.3	μM
114	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	MAP kinase-activated protein kinase 3	IC50	1.48	μM
115	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		IC50	2.0986	μM
116	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		IC50	2.7001	μM
117	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		IC50	3.4546	μM
118	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		IC50	3.6293	μM
119	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Cytochrome P450 3A4	IC50	5	μM
120	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		IC50	7.5115	μM
121	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		IC50	10	μM
122	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		IC50	10	μM
123	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		IC50	10	μM
124	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		IC50	10	μM
125	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		IC50	10	μM
126	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		IC50	10	μM
127	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		IC50	10	μM
128	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Cytochrome P450 3A4	IC50	26	μM
129	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		body weight loss		
130	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		body weight loss		
131	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Cytochrome P450 2C8	IC50	30	μM
132	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Potassium voltage-gated channel subfamily H member 2	IC50	30	μM
133	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		CL (drug clearance)	8.8	ml/min/kg
134	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		Vdss	0.53	l/kg
135	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		MRT (mean residence time)	0.98	hour
136	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		AUC	5.29	μM*h
137	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		plasma protein-bound fraction	99	%
138	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Dual specificity protein kinase TTK [mouse]	TGI (tumor growth inhibition rate)		
139	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Epidermal growth factor receptor (T790M)	inhibition percentage	71	%
140	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Epidermal growth factor receptor (L858R);+Epidermal growth factor receptor (T790M)	inhibition percentage	80	%
141	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Ephrin type-A receptor 1	inhibition percentage	5	%
142	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Ephrin type-A receptor 2	inhibition percentage	-3	%
143	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Ephrin type-A receptor 4	inhibition percentage	2	%
144	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Ephrin type-A receptor 5	inhibition percentage	-8	%
145	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Ephrin type-A receptor 8	inhibition percentage	25	%
146	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Ephrin type-B receptor 1	inhibition percentage	9	%
147	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Ephrin type-B receptor 2	inhibition percentage	5	%
148	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Ephrin type-B receptor 3	inhibition percentage	12	%
149	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Ephrin type-B receptor 4	inhibition percentage	6	%
150	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Receptor tyrosine-protein kinase erbB-2	inhibition percentage	8	%
151	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Receptor tyrosine-protein kinase erbB-4	inhibition percentage	-16	%
152	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Tyrosine-protein kinase Fer	inhibition percentage	47	%
153	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Tyrosine-protein kinase, Fes/Fps type	inhibition percentage	20	%
154	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Fibroblast growth factor receptor 1	inhibition percentage	38	%
155	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Fibroblast growth factor receptor 2	inhibition percentage	13	%
156	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Fibroblast growth factor receptor 3	inhibition percentage	30	%
157	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Fibroblast growth factor receptor 3 (K650E)	inhibition percentage	15	%
158	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Fibroblast growth factor receptor 4	inhibition percentage	15	%
159	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Tyrosine-protein kinase Fgr	inhibition percentage	43	%
160	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Vascular endothelial growth factor receptor 1	inhibition percentage	9	%
161	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	4	%
162	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Receptor-type tyrosine-protein kinase FLT3 (D835Y)	inhibition percentage	4	%
163	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Vascular endothelial growth factor receptor 3	inhibition percentage	7	%
164	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase mTOR	inhibition percentage	2	%
165	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Tyrosine-protein kinase FRK	inhibition percentage	10	%
166	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Tyrosine-protein kinase Fyn	inhibition percentage	7	%
167	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	G protein-coupled receptor kinase 4	inhibition percentage	9	%
168	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	G protein-coupled receptor kinase 5	inhibition percentage	5	%
169	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Tyrosine-protein kinase ABL1	inhibition percentage	8	%
170	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	G protein-coupled receptor kinase 6	inhibition percentage	5	%
171	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	rhodopsin kinase	inhibition percentage	5	%
172	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Glycogen synthase kinase-3 alpha	inhibition percentage	4	%
173	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	tau-protein kinase	inhibition percentage	34	%
174	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Tyrosine-protein kinase HCK	inhibition percentage	2	%
175	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Homeodomain-interacting protein kinase 1	inhibition percentage	0	%
176	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Homeodomain-interacting protein kinase 2	inhibition percentage	11	%
177	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Homeodomain-interacting protein kinase 3	inhibition percentage	-2	%
178	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Homeodomain-interacting protein kinase 4	inhibition percentage	18	%
179	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Insulin-like growth factor 1 receptor	inhibition percentage	20	%
180	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Calcium/calmodulin-dependent protein kinase type 1	inhibition percentage	84	%
181	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Inhibitor of nuclear factor kappa-B kinase subunit beta	inhibition percentage	11	%
182	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	inhibition percentage	2	%
183	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Insulin receptor	inhibition percentage	19	%
184	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Insulin receptor-related protein	inhibition percentage	50	%
185	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Interleukin-1 receptor-associated kinase 4	inhibition percentage	3	%
186	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Tyrosine-protein kinase ITK/TSK	inhibition percentage	5	%
187	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Tyrosine-protein kinase JAK1	inhibition percentage	3	%
188	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Tyrosine-protein kinase JAK2	inhibition percentage	23	%
189	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Tyrosine-protein kinase JAK2	inhibition percentage	3	%
190	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Tyrosine-protein kinase JAK2 (V617F)	inhibition percentage	-4	%
191	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Dual specificity protein kinase TTK	inhibition percentage	100	%
192	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Tyrosine-protein kinase JAK3	inhibition percentage	-4	%
193	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Vascular endothelial growth factor receptor 2	inhibition percentage	11	%
194	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Mast/stem cell growth factor receptor Kit	inhibition percentage	1	%
195	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Mast/stem cell growth factor receptor Kit	inhibition percentage	1	%
196	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Tyrosine-protein kinase Lck	inhibition percentage	10	%
197	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Leukocyte tyrosine kinase receptor	inhibition percentage	58	%
198	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Antitoxin CcdA	inhibition percentage	4	%
199	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Toxin CcdB	inhibition percentage	33	%
200	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Dual specificity mitogen-activated protein kinase kinase 1	inhibition percentage	43	%
201	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Dual specificity mitogen-activated protein kinase kinase 2	inhibition percentage	32	%
202	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Dual specificity mitogen-activated protein kinase kinase 6	inhibition percentage	23	%
203	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Mitogen-activated protein kinase kinase kinase 8	inhibition percentage	37	%
204	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Mitogen-activated protein kinase kinase kinase 9	inhibition percentage	6	%
205	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Mitogen-activated protein kinase kinase kinase kinase 2	inhibition percentage	27	%
206	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Mitogen-activated protein kinase kinase kinase kinase 4	inhibition percentage	26	%
207	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Mitogen-activated protein kinase kinase kinase kinase 5	inhibition percentage	4	%
208	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Mitogen-activated protein kinase 1	inhibition percentage	13	%
209	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Mitogen-activated protein kinase 10	inhibition percentage	59	%
210	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Mitogen-activated protein kinase 11	inhibition percentage	11	%
211	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Mitogen-activated protein kinase 12	inhibition percentage	3	%
212	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Mitogen-activated protein kinase 13	inhibition percentage	1	%
213	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Mitogen-activated protein kinase 14	inhibition percentage	31	%
214	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Mitogen-activated protein kinase 14 direct	inhibition percentage	-14	%
215	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Mitogen-activated protein kinase 3	inhibition percentage	28	%
216	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Mitogen-activated protein kinase 8	inhibition percentage	97	%
217	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Mitogen-activated protein kinase 9	inhibition percentage	85	%
218	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	MAP kinase-activated protein kinase 2	inhibition percentage	22	%
219	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	MAP kinase-activated protein kinase 3	inhibition percentage	83	%
220	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	MAP kinase-activated protein kinase 5	inhibition percentage	3	%
221	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase MARK1	inhibition percentage	-4	%
222	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase MARK2	inhibition percentage	0	%
223	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	MAP/microtubule affinity-regulating kinase 3	inhibition percentage	3	%
224	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	MAP/microtubule affinity-regulating kinase 4	inhibition percentage	-4	%
225	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Megakaryocyte-associated tyrosine-protein kinase	inhibition percentage	9	%
226	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Maternal embryonic leucine zipper kinase	inhibition percentage	32	%
227	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Tyrosine-protein kinase Mer	inhibition percentage	4	%
228	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Hepatocyte growth factor receptor	inhibition percentage	16	%
229	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Hepatocyte growth factor receptor (M1250T)	inhibition percentage	18	%
230	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Misshapen-like kinase 1	inhibition percentage	28	%
231	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	MAP kinase-interacting serine/threonine-protein kinase 1	inhibition percentage	2	%
232	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Macrophage-stimulating protein receptor	inhibition percentage	19	%
233	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase 26	inhibition percentage	11	%
234	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Muscle, skeletal receptor tyrosine-protein kinase	inhibition percentage	19	%
235	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Myosin light chain kinase 2, skeletal/cardiac muscle	inhibition percentage	-10	%
236	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase Nek1	inhibition percentage	16	%
237	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase Nek2	inhibition percentage	-2	%
238	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase Nek4	inhibition percentage	0	%
239	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase Nek6	inhibition percentage	6	%
240	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase Nek7	inhibition percentage	-15	%
241	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase Nek9	inhibition percentage	-6	%
242	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	High affinity nerve growth factor receptor	inhibition percentage	13	%
243	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	BDNF/NT-3 growth factors receptor	inhibition percentage	8	%
244	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	NT-3 growth factor receptor	inhibition percentage	8	%
245	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase PAK 1	inhibition percentage	3	%
246	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase PAK2	inhibition percentage	6	%
247	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase PAK 3	inhibition percentage	-10	%
248	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase PAK 4	inhibition percentage	-6	%
249	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase PAK 6	inhibition percentage	9	%
250	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase PAK5	inhibition percentage	3	%
251	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	PAS domain-containing serine/threonine-protein kinase	inhibition percentage	13	%
252	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Platelet-derived growth factor receptor alpha	inhibition percentage	5	%
253	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Platelet-derived growth factor receptor alpha (D842V)	inhibition percentage	4	%
254	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Platelet-derived growth factor receptor alpha	inhibition percentage	-9	%
255	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Platelet-derived growth factor receptor alpha (V561D)	inhibition percentage	3	%
256	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Platelet-derived growth factor receptor beta	inhibition percentage	6	%
257	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	3-phosphoinositide-dependent protein kinase 1	inhibition percentage	4	%
258	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	3-phosphoinositide-dependent protein kinase 1 direct	inhibition percentage	6	%
259	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	inhibition percentage	32	%
260	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	inhibition percentage	36	%
261	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase pim-1	inhibition percentage	0	%
262	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase pim-2	inhibition percentage	15	%
263	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase N1	inhibition percentage	19	%
264	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase PLK1	inhibition percentage	4	%
265	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase PLK2	inhibition percentage	1	%
266	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase Plk3	inhibition percentage	19	%
267	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	cAMP-dependent protein kinase catalytic subunit alpha	inhibition percentage	15	%
268	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Protein kinase C alpha type	inhibition percentage	34	%
269	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Protein kinase C beta type	inhibition percentage	-2	%
270	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Protein kinase C beta type (isoform Beta-II)	inhibition percentage	43	%
271	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Protein kinase C, delta	inhibition percentage	-1	%
272	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Protein kinase C, epsilon	inhibition percentage	18	%
273	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Protein kinase C gamma type	inhibition percentage	0	%
274	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Protein kinase C, eta	inhibition percentage	7	%
275	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Protein kinase C iota type	inhibition percentage	11	%
276	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase D3	inhibition percentage	27	%
277	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Protein kinase C, theta	inhibition percentage	9	%
278	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Protein kinase C zeta type	inhibition percentage	-3	%
279	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase D1	inhibition percentage	48	%
280	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase D2	inhibition percentage	76	%
281	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	cGMP-dependent protein kinase 1	inhibition percentage	14	%
282	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	cGMP-dependent protein kinase 2	inhibition percentage	42	%
283	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	cAMP-dependent protein kinase catalytic subunit PRKX	inhibition percentage	16	%
284	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Focal adhesion kinase 1	inhibition percentage	37	%
285	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Protein-tyrosine kinase 2-beta	inhibition percentage	58	%
286	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Protein-tyrosine kinase 6	inhibition percentage	3	%
287	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	RAF proto-oncogene serine/threonine-protein kinase;+RAF proto-oncogene serine/threonine-protein kinase	inhibition percentage	33	%
288	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Proto-oncogene tyrosine-protein kinase receptor Ret	inhibition percentage	19	%
289	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Proto-oncogene tyrosine-protein kinase receptor Ret	inhibition percentage	32	%
290	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Proto-oncogene tyrosine-protein kinase receptor Ret (Y791F)	inhibition percentage	20	%
291	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Rho-associated protein kinase 1	inhibition percentage	5	%
292	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Rho-associated protein kinase 2	inhibition percentage	-2	%
293	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Proto-oncogene tyrosine-protein kinase ROS	inhibition percentage	29	%
294	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Ribosomal protein S6 kinase alpha-1	inhibition percentage	13	%
295	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Ribosomal protein S6 kinase alpha-2	inhibition percentage	-5	%
296	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Ribosomal protein S6 kinase alpha-3	inhibition percentage	80	%
297	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Ribosomal protein S6 kinase alpha-4	inhibition percentage	9	%
298	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Ribosomal protein S6 kinase alpha-5	inhibition percentage	33	%
299	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Ribosomal protein S6 kinase alpha-6	inhibition percentage	68	%
300	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Ribosomal protein S6 kinase beta-1	inhibition percentage	6	%
301	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase Sgk1	inhibition percentage	50	%
302	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase Sgk2	inhibition percentage	9	%
303	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase Sgk3	inhibition percentage	4	%
304	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase SIK2	inhibition percentage	0	%
305	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Proto-oncogene tyrosine-protein kinase Src	inhibition percentage	67	%
306	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Proto-oncogene tyrosine-protein kinase Src N1	inhibition percentage	95	%
307	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Tyrosine-protein kinase Srms	inhibition percentage	4	%
308	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	CBL-interacting serine/threonine-protein kinase 7	inhibition percentage	4	%
309	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	SRSF protein kinase 2	inhibition percentage	-6	%
310	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Testis-specific serine/threonine-protein kinase 2	inhibition percentage	81	%
311	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Testis-specific serine/threonine-protein kinase 1	inhibition percentage	96	%
312	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	SRSF protein kinase 3	inhibition percentage	0	%
313	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase 24	inhibition percentage	7	%
314	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase 25	inhibition percentage	-17	%
315	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase 3	inhibition percentage	-18	%
316	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase 4	inhibition percentage	-4	%
317	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Tyrosine-protein kinase SYK	inhibition percentage	3	%
318	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase TAO2	inhibition percentage	1	%
319	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase TBK1	inhibition percentage	2	%
320	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Angiopoietin-1 receptor	inhibition percentage	6	%
321	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Tyrosine-protein kinase TXK	inhibition percentage	5	%
322	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Non-receptor tyrosine-protein kinase TYK2	inhibition percentage	6	%
323	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Tyrosine-protein kinase receptor TYRO3	inhibition percentage	-3	%
324	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Tyrosine-protein kinase yes	inhibition percentage	46	%
325	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Tyrosine-protein kinase ZAP-70	inhibition percentage	7	%
326	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	CDK-activating kinase assembly factor MAT1	inhibition percentage	-3	%
327	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Cyclin-dependent kinase 9;+Cyclin-T1	inhibition percentage	-13	%
328	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Inhibitor of nuclear factor kappa-B kinase subunit alpha	inhibition percentage	10	%
329	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Death-associated protein kinase 1	inhibition percentage	80	%
330	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase haspin	inhibition percentage	15	%
331	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Interleukin-1 receptor-associated kinase 1	inhibition percentage	-6	%
332	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Leucine-rich repeat serine/threonine-protein kinase 2 (G2019S)	inhibition percentage	95	%
333	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Leucine-rich repeat serine/threonine-protein kinase 2	inhibition percentage	89	%
334	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	NUAK family SNF1-like kinase 1	inhibition percentage	2	%
335	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Receptor-interacting serine/threonine-protein kinase 2	inhibition percentage	9	%
336	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Tyrosine-protein kinase ABL1	inhibition percentage	10	%
337	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Tyrosine-protein kinase ABL1	inhibition percentage	14	%
338	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Tyrosine-protein kinase ABL1	inhibition percentage	12	%
339	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Tyrosine-protein kinase ABL1	inhibition percentage	17	%
340	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Tyrosine-protein kinase ABL2	inhibition percentage	-4	%
341	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Activin receptor type-1B	inhibition percentage	12	%
342	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Beta-adrenergic receptor kinase 1	inhibition percentage	8	%
343	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Beta-adrenergic receptor kinase 2	inhibition percentage	11	%
344	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	RAC-alpha serine/threonine-protein kinase	inhibition percentage	16	%
345	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	RAC-beta serine/threonine-protein kinase	inhibition percentage	80	%
346	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	RAC-gamma serine/threonine-protein kinase	inhibition percentage	34	%
347	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	5'-AMP-activated protein kinase catalytic subunit alpha-1;+5'-AMP-activated protein kinase subunit beta-1;+5'-AMP-activated protein kinase subunit gamma-1	inhibition percentage	39	%
348	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	5'-AMP-activated protein kinase catalytic subunit alpha-2;+5'-AMP-activated protein kinase subunit beta-1;+5'-AMP-activated protein kinase subunit gamma-1	inhibition percentage	15	%
349	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Aurora kinase A	inhibition percentage	70	%
350	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Aurora kinase B	inhibition percentage	21	%
351	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Aurora kinase C	inhibition percentage	-6	%
352	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Tyrosine-protein kinase receptor UFO	inhibition percentage	42	%
353	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Tyrosine-protein kinase Blk	inhibition percentage	27	%
354	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Cytoplasmic tyrosine-protein kinase BMX	inhibition percentage	16	%
355	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase B-raf	inhibition percentage	33	%
356	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase B-raf	inhibition percentage	35	%
357	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase BRSK1	inhibition percentage	2	%
358	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Tyrosine-protein kinase BTK	inhibition percentage	31	%
359	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Calcium/calmodulin-dependent protein kinase type 1D	inhibition percentage	65	%
360	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Calcium/calmodulin-dependent protein kinase type II subunit alpha	inhibition percentage	9	%
361	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Calcium/calmodulin-dependent protein kinase type II subunit beta	inhibition percentage	7	%
362	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Calcium/calmodulin-dependent protein kinase type II delta chain	inhibition percentage	31	%
363	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Calcium/calmodulin-dependent protein kinase type IV	inhibition percentage	20	%
364	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase MRCK alpha	inhibition percentage	-7	%
365	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase MRCK beta	inhibition percentage	-3	%
366	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	G2/mitotic-specific cyclin-B;+Cyclin-dependent kinase 1	inhibition percentage	3	%
367	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Cyclin-dependent kinase 2;+Cyclin-A1	inhibition percentage	-3	%
368	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Cyclin-dependent kinase 5 activator 1, p25	inhibition percentage	5	%
369	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Cyclin-dependent kinase 5 activator 1, p35	inhibition percentage	19	%
370	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase Chk1	inhibition percentage	13	%
371	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase Chk2	inhibition percentage	91	%
372	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Dual specificity protein kinase CLK1	inhibition percentage	9	%
373	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Dual specificity protein kinase CLK2	inhibition percentage	39	%
374	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Dual specificity protein kinase CLK3	inhibition percentage	26	%
375	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Macrophage colony-stimulating factor 1 receptor	inhibition percentage	35	%
376	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Tyrosine-protein kinase CSK	inhibition percentage	1	%
377	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Casein kinase I isoform alpha	inhibition percentage	0	%
378	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Casein kinase I isoform delta	inhibition percentage	8	%
379	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Casein kinase I isoform epsilon	inhibition percentage	2	%
380	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Casein kinase I isoform gamma-1	inhibition percentage	-5	%
381	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Casein kinase I isoform gamma-2	inhibition percentage	10	%
382	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Casein kinase I isoform gamma-3	inhibition percentage	12	%
383	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Casein kinase II subunit alpha	inhibition percentage	7	%
384	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Casein kinase II subunit alpha'	inhibition percentage	-7	%
385	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Death-associated protein kinase 3	inhibition percentage	23	%
386	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Serine/threonine-protein kinase DCLK2	inhibition percentage	1	%
387	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	DNA-dependent protein kinase catalytic subunit	inhibition percentage	8	%
388	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Dual specificity tyrosine-phosphorylation-regulated kinase 1A/B	inhibition percentage	3	%
389	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	inhibition percentage	-4	%
390	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Dual specificity tyrosine-phosphorylation-regulated kinase 3	inhibition percentage	4	%
391	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Dual specificity tyrosine-phosphorylation-regulated kinase 4	inhibition percentage	0	%
392	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	elongation factor-2 kinase	inhibition percentage	-1	%
393	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Epidermal growth factor receptor	inhibition percentage	0	%
394	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Epidermal growth factor receptor (L858R)	inhibition percentage	-5	%
395	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Epidermal growth factor receptor (L861Q)	inhibition percentage	3	%
396	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		inhibition rate	52.7	%
397	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		inhibition rate	24.5	%
398	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		inhibition rate	48.4	%
399	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		inhibition rate	14.7	%
400	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		inhibition rate	17.2	%
401	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		inhibition rate	34	%
402	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		inhibition rate	5.3	%
403	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		inhibition rate	43.6	%
404	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		inhibition rate	42.7	%
405	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		inhibition rate	22.9	%
406	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		inhibition rate	23.6	%
407	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		inhibition rate	18.6	%
408	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		inhibition rate	41.6	%
409	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		inhibition rate	23.2	%
410	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		inhibition rate	55.6	%
411	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		inhibition rate	71.3	%
412	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		inhibition rate	53.5	%
413	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		inhibition rate	65.5	%
414	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		inhibition rate	49	%
415	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		inhibition rate	47.7 - 76.2	%
416	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		CL (drug clearance)	2.8	ml/min/kg
417	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		CL (drug clearance)	2.8	ml/min/kg
418	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		Vdss	0.66	l/kg
419	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		MRT (mean residence time)	4.3	hour
420	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1		AUC	18.2	μM*h
421	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	neurokinin-1	inhibition rate	80	%
422	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	neurokinin-2	inhibition rate	80	%
423	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Muscarinic M1	inhibition rate	80	%
424	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Muscarinic M3	inhibition rate	80	%
425	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Bombesin	inhibition rate	80	%
426	CCC1=CC=CC(CC)=C1N1CCN2C=C(C=C2C1=O)C1=C2C=CNC2=NC(NC2=CC=C(C=C2OC)N2CCC(CC2)C(=O)N2CC3(CN(C)C3)C2)=N1	Dual specificity protein kinase TTK [mouse]	TGI (tumor growth inhibition rate)	60	%
427	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	G1/S-specific cyclin-D1; Cyclin-dependent kinase 6	IC50	0.01302	μM
428	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Cyclin-dependent kinase 4; G1/S-specific cyclin-D1	IC50	0.02599	μM
429	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Cyclin-dependent kinase 4; G1/S-specific cyclin-D3	IC50	0.05541	μM
430	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Cyclin-K; Cyclin-dependent kinase 9	IC50	0.05598	μM
431	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	G1/S-specific cyclin-D3; Cyclin-dependent kinase 6	IC50	0.1252	μM
432	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Cyclin-dependent kinase 9; Cyclin-T1	IC50	0.1935	μM
433	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Cyclin-dependent kinase 2; Cyclin-A2	IC50	0.7679	μM
434	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	0.9 - 6.9	μM
435	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	1.17	μM
436	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	1.55	μM
437	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Cyclin-dependent-like kinase 5; Cyclin-dependent kinase 5 activator 1, p35	IC50	1.858	μM
438	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Cyclin-dependent kinase 2; G1/S-specific cyclin-E	IC50	2.942	μM
439	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	3 - 3.3	μM
440	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	3.9	μM
441	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Cyclin-dependent kinase 5 activator 1, p25; Cyclin-dependent-like kinase 5	IC50	4.853	μM
442	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Cyclin-C; Cyclin-dependent kinase 3	IC50	7.663	μM
443	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	8	μM
444	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	G1/S-specific cyclin-E; Cyclin-dependent kinase 3	IC50	17.07	μM
445	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Cyclin-dependent kinase 12; Cyclin-K	IC50	17.42	μM
446	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	G1/S-specific cyclin-E; Cyclin-dependent kinase 1	IC50	19.73	μM
447	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	CDK-activating kinase assembly factor MAT1;+Cyclin-K; Cell division cycle 7-related protein kinase	IC50	30.75	μM
448	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Cyclin-dependent kinase 1; G2/mitotic-specific cyclin-B1	IC50	32.54	μM
449	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Cyclin-dependent kinase 12; Cyclin-C	IC50	36.38	μM
450	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Extracellular signal-regulated kinase 1	IC50	48.95	μM
451	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O		tumor weight decrease		
452	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O		lymphocyte count decrease		
453	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Cell division cycle 7-related protein kinase; Protein DBF4 homolog A	IC50	50	μM
454	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Cyclin-A2; Cyclin-dependent kinase 1	IC50	50	μM
455	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	RAC-alpha serine/threonine-protein kinase	IC50	50	μM
456	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Cyclin-C; Cyclin-dependent kinase 8	IC50	50	μM
457	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Dual specificity tyrosine-phosphorylation-regulated kinase 1A/B	IC50	50	μM
458	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Probable serine/threonine-protein kinase dyrk2	IC50	50	μM
459	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Homeodomain-interacting protein kinase 2	IC50	50	μM
460	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Cyclin-dependent kinase 16;+Cyclin Y	IC50	50	μM
461	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Serine/threonine-protein kinase pim-1	IC50	50	μM
462	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Cyclin-dependent kinase 4 [mouse];+Cyclin-dependent kinase 6 [mouse]; Cyclin-dependent kinase 2 [mouse]	cell count decrease		
463	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Cyclin-dependent kinase 4 [mouse];+Cyclin-dependent kinase 6 [mouse]	cell count decrease		
464	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Cyclin-dependent kinase 2 [mouse]	cell count decrease		
465	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O		cell count decrease		
466	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Cyclin-dependent kinase 4 [human]	cell count decrease		
467	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Cyclin-dependent kinase 4 [human]	cell count decrease		
468	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Cyclin-dependent kinase 4 [human]	cell count decrease		
469	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Cyclin-dependent kinase 4 [human]	cell count decrease		
470	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O	Cyclin-dependent kinase 4 [human]	cell count decrease		
471	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O		efflux ratio		
472	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O		body weight loss		
473	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O		number	1	no unit
474	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O		CLint (intrinsic clearance)	46.9	μl/min/mg protein
475	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O		CLint (intrinsic clearance)	67.8	μl/min/1e6 cells
476	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O		t1/2 (drug half life)	29.5	min
477	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O		t1/2 (drug half life)	33	min
478	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O		t1/2 (drug half life)	20.4	min
479	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O		CLint (intrinsic clearance)	33	μl/min/mg protein
480	CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(C=C3)N3CCC(CCCO)CC3)N=C2N(C2CCCC2)C1=O		t1/2 (drug half life)	42	min
481	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12		EC50	0.17	nM
482	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Receptor-interacting serine/threonine-protein kinase 1 [human]	IC50	30.9	nM
483	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Casein kinase II subunit alpha [human]	inhibition rate	0	%
484	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Casein kinase II subunit alpha' [human]	inhibition rate	17	%
485	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Megakaryocyte-associated tyrosine-protein kinase [human]	inhibition rate	8	%
486	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Death-associated protein kinase 1 [human]	inhibition rate	1	%
487	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Death-associated protein kinase 2 [human]	inhibition rate	0	%
488	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Death-associated protein kinase 3 [human]	inhibition rate	1	%
489	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase DCLK1 [human]	inhibition rate	4	%
490	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase DCLK2 [human]	inhibition rate	17	%
491	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase DCLK3 [human]	inhibition rate	2	%
492	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Discoidin domain-containing receptor 2 [human]	inhibition rate	100	%
493	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	ABL1(H396P)-phosphorylated [human]	inhibition rate	78	%
494	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Death-associated protein kinase 3 [human]	inhibition rate	9	%
495	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Myotonin-protein kinase [human]	inhibition rate	1	%
496	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase MRCK gamma [human]	inhibition rate	16	%
497	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase 17A [human]	inhibition rate	0	%
498	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase 17B [human]	inhibition rate	4	%
499	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	inhibition rate	30	%
500	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Dual specificity tyrosine-phosphorylation-regulated kinase 1B [human]	inhibition rate	10	%
501	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Dual specificity tyrosine-phosphorylation-regulated kinase 2 [human]	inhibition rate	16	%
502	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	epidermal growth factor-activated receptor [human]	inhibition rate	0	%
503	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	epidermal growth factor-activated receptor [human]	inhibition rate	0	%
504	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	ABL1(M351T)-phosphorylated [human]	inhibition rate	77	%
505	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Epidermal growth factor receptor (G719C) [human]	inhibition rate	0	%
506	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Epidermal growth factor receptor (G719S) [human]	inhibition rate	0	%
507	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	epidermal growth factor-activated receptor [human]	inhibition rate	30	%
508	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	epidermal growth factor-activated receptor [human]	inhibition rate	0	%
509	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	epidermal growth factor-activated receptor [human]	inhibition rate	0	%
510	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Epidermal growth factor receptor (L858R) [human]	inhibition rate	28	%
511	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Epidermal growth factor receptor (L858R) [human];+Epidermal growth factor receptor (T790M) [human]	inhibition rate	4	%
512	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Epidermal growth factor receptor (L861Q) [human]	inhibition rate	0	%
513	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	epidermal growth factor-activated receptor [human]	inhibition rate	0	%
514	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Epidermal growth factor receptor (T790M) [human]	inhibition rate	4	%
515	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	ABL1(Q252H)-nonphosphorylated [human]	inhibition rate	100	%
516	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Eukaryotic translation initiation factor 2-alpha kinase 1 [human]	inhibition rate	0	%
517	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Ephrin type-A receptor 1 [human]	inhibition rate	13	%
518	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Ephrin type-A receptor 2 [human]	inhibition rate	14	%
519	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Ephrin type-A receptor 3 [human]	inhibition rate	41	%
520	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Ephrin type-A receptor 4 [human]	inhibition rate	3	%
521	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Ephrin type-A receptor 5 [human]	inhibition rate	4	%
522	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Ephrin type-A receptor 6 [human]	inhibition rate	5	%
523	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Ephrin type-A receptor 7 [human]	inhibition rate	9	%
524	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Ephrin type-A receptor 8 [human]	inhibition rate	16	%
525	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Ephrin type-B receptor 1 [human]	inhibition rate	18	%
526	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	ABL1(Q252H)-phosphorylated [human]	inhibition rate	50	%
527	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Ephrin type-B receptor 2 [human]	inhibition rate	8	%
528	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Ephrin type-B receptor 3 [human]	inhibition rate	7	%
529	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Ephrin type-B receptor 4 [human]	inhibition rate	0	%
530	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Ephrin type-B receptor 6 [human]	inhibition rate	50	%
531	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Receptor tyrosine-protein kinase erbB-2 [human]	inhibition rate	46	%
532	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Receptor tyrosine-protein kinase erbB-3 [human]	inhibition rate	2	%
533	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Receptor tyrosine-protein kinase erbB-4 [human]	inhibition rate	13	%
534	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Extracellular signal-regulated kinase 1 [human]	inhibition rate	6	%
535	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Extracellular signal-regulated kinase 2 [human]	inhibition rate	6	%
536	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitogen-activated protein kinase 6 [human]	inhibition rate	8	%
537	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	ABL1(T315I)-nonphosphorylated [human]	inhibition rate	88	%
538	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitogen-activated protein kinase 4 [human]	inhibition rate	4	%
539	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitogen-activated protein kinase 7 [human]	inhibition rate	0	%
540	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitogen-activated protein kinase 15 [human]	inhibition rate	13	%
541	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Ethylene-responsive transcription factor ERN1 [human]	inhibition rate	11	%
542	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Focal adhesion kinase 1 [human]	inhibition rate	6	%
543	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Tyrosine-protein kinase Fer [human]	inhibition rate	0	%
544	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Tyrosine-protein kinase, Fes/Fps type [human]	inhibition rate	0	%
545	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Fibroblast growth factor receptor 1 [human]	inhibition rate	1	%
546	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Fibroblast growth factor receptor 2 [human]	inhibition rate	3	%
547	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Fibroblast growth factor receptor 3 [human]	inhibition rate	9	%
548	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	ABL1(T315I)-phosphorylated [human]	inhibition rate	38	%
549	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Fibroblast growth factor receptor 3 [human]	inhibition rate	17	%
550	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Fibroblast growth factor receptor 4 [human]	inhibition rate	0	%
551	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Tyrosine-protein kinase Fgr [human]	inhibition rate	3	%
552	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Vascular endothelial growth factor receptor 1 [human]	inhibition rate	2	%
553	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	90.4	%
554	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Receptor-type tyrosine-protein kinase FLT3 (D835H) [human]	inhibition rate	35	%
555	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Receptor-type tyrosine-protein kinase FLT3 (D835V) [human]	inhibition rate	34	%
556	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Receptor-type tyrosine-protein kinase FLT3 (D835Y) [human]	inhibition rate	26	%
557	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	FLT3(ITD) [human]	inhibition rate	51	%
558	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Receptor-type tyrosine-protein kinase FLT3 (D835V) [human];+FLT3(ITD) [human]	inhibition rate	10	%
559	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	ABL1(Y253F)-phosphorylated [human]	inhibition rate	0	%
560	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	FLT3(ITD) [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	18	%
561	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	64	%
562	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	74	%
563	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	24	%
564	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	FLT3-autoinhibited [human]	inhibition rate	19	%
565	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Vascular endothelial growth factor receptor 3 [human]	inhibition rate	5	%
566	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Tyrosine-protein kinase FRK [human]	inhibition rate	63	%
567	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Tyrosine-protein kinase Fyn [human]	inhibition rate	10	%
568	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Cyclin-G-associated kinase [human]	inhibition rate	1	%
569	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	ABC transporter F family member 2 [human]	inhibition rate	13	%
570	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	ABL1-nonphosphorylated [human]	inhibition rate	98.9	%
571	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Rhodopsin kinase GRK1 (C514S) [human]	inhibition rate	12	%
572	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Beta-adrenergic receptor kinase 1 [human]	inhibition rate	13	%
573	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Beta-adrenergic receptor kinase 2 [human]	inhibition rate	0	%
574	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	G protein-coupled receptor kinase 4 [human]	inhibition rate	34	%
575	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Rhodopsin kinase [human]	inhibition rate	4	%
576	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Glycogen synthase kinase-3 alpha [human]	inhibition rate	0	%
577	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	glycogen synthase kinase-3 beta [human]	inhibition rate	9	%
578	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase haspin [human]	inhibition rate	4	%
579	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Tyrosine-protein kinase HCK [human]	inhibition rate	23	%
580	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Homeodomain-interacting protein kinase 1 [human]	inhibition rate	5	%
581	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Tyrosine-protein kinase ABL2 [human]	inhibition rate	73	%
582	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Homeodomain-interacting protein kinase 2 [human]	inhibition rate	1	%
583	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Homeodomain-interacting protein kinase 3 [human]	inhibition rate	5	%
584	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Homeodomain-interacting protein kinase 4 [human]	inhibition rate	46	%
585	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitogen-activated protein kinase kinase kinase kinase 1 [human]	inhibition rate	4	%
586	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Hormonally up-regulated neu tumor-associated kinase [human]	inhibition rate	26	%
587	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Insulin-like growth factor 1 receptor [human]	inhibition rate	6	%
588	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Inhibitor of nuclear factor kappa-B kinase subunit alpha [human]	inhibition rate	4	%
589	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition rate	9	%
590	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Inhibitor of nuclear factor kappa-B kinase subunit epsilon [human]	inhibition rate	6	%
591	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Insulin receptor [human]	inhibition rate	6	%
592	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Activin receptor type-1 [human]	inhibition rate	0	%
593	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	AP2-associated protein kinase 1 [human]	inhibition rate	1	%
594	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Insulin receptor-related protein [human]	inhibition rate	0	%
595	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Interleukin-1 receptor-associated kinase 1 [human]	inhibition rate	12	%
596	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Interleukin-1 receptor-associated kinase 3 [human]	inhibition rate	0	%
597	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Interleukin-1 receptor-associated kinase 4 [human]	inhibition rate	6	%
598	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Tyrosine-protein kinase ITK/TSK [human]	inhibition rate	10	%
599	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Tyrosine-protein kinase JAK1 [human]	inhibition rate	3	%
600	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Tyrosine-protein kinase JAK1 [human]	inhibition rate	10	%
601	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Tyrosine-protein kinase JAK2 [human]	inhibition rate	24	%
602	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Tyrosine-protein kinase JAK3 [human]	inhibition rate	30	%
603	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitogen-activated protein kinase 8 [human]	inhibition rate	10	%
604	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Activin receptor type-1B [human]	inhibition rate	8	%
605	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitogen-activated protein kinase 9 [human]	inhibition rate	3	%
606	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitogen-activated protein kinase 10 [human]	inhibition rate	17	%
607	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	99.95	%
608	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mast/stem cell growth factor receptor Kit (A829P) [human]	inhibition rate	71	%
609	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mast/stem cell growth factor receptor Kit (D816H) [human]	inhibition rate	41	%
610	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mast/stem cell growth factor receptor Kit (D816V) [human]	inhibition rate	16	%
611	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	99.75	%
612	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mast/stem cell growth factor receptor Kit (V559D) [human]	inhibition rate	100	%
613	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mast/stem cell growth factor receptor Kit (V559D) [human];+Mast/stem cell growth factor receptor Kit [human]	inhibition rate	13	%
614	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mast/stem cell growth factor receptor Kit (V559D) [human];+Mast/stem cell growth factor receptor Kit [human]	inhibition rate	56	%
615	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Activin receptor type-2A [human]	inhibition rate	0	%
616	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	KIT-autoinhibited [human]	inhibition rate	33	%
617	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase LATS1 [human]	inhibition rate	1	%
618	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase LATS2 [human]	inhibition rate	0	%
619	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Proto-oncogene tyrosine-protein kinase LCK [human]	inhibition rate	47	%
620	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	LIM domain kinase 1 [human]	inhibition rate	12	%
621	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	LIM domain kinase 2 [human]	inhibition rate	29	%
622	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase STK11 [human]	inhibition rate	0	%
623	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Coiled-coil domain-containing protein 40 [human]	inhibition rate	86	%
624	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Leucine-rich repeat serine/threonine-protein kinase 2 [human]	inhibition rate	34	%
625	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Leucine-rich repeat serine/threonine-protein kinase 2 (G2019S) [human]	inhibition rate	10	%
626	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Activin receptor type-2B [human]	inhibition rate	14	%
627	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Leukocyte tyrosine kinase receptor [human]	inhibition rate	66	%
628	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Tyrosine-protein kinase Lyn [human]	inhibition rate	31	%
629	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitogen-activated protein kinase kinase kinase 13 [human]	inhibition rate	0	%
630	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase MAK [human]	inhibition rate	15	%
631	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitogen-activated protein kinase kinase kinase 1 [human]	inhibition rate	19	%
632	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitogen-activated protein kinase kinase kinase 15 [human]	inhibition rate	12	%
633	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitogen-activated protein kinase kinase kinase 2 [human]	inhibition rate	15	%
634	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitogen-activated protein kinase kinase kinase 3 [human]	inhibition rate	5	%
635	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitogen-activated protein kinase kinase kinase 4 [human]	inhibition rate	23	%
636	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitogen-activated protein kinase kinase kinase kinase 2 [human]	inhibition rate	6	%
637	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase receptor R3 [human]	inhibition rate	7	%
638	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitogen-activated protein kinase kinase kinase kinase 3 [human]	inhibition rate	12	%
639	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitogen-activated protein kinase kinase kinase kinase 4 [human]	inhibition rate	17	%
640	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitogen-activated protein kinase kinase kinase kinase 5 [human]	inhibition rate	22	%
641	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	MAP kinase-activated protein kinase 2 [human]	inhibition rate	0	%
642	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	MAP kinase-activated protein kinase 5 [human]	inhibition rate	0	%
643	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase MARK1 [human]	inhibition rate	2	%
644	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase MARK2 [human]	inhibition rate	0	%
645	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	MAP/microtubule affinity-regulating kinase 3 [human]	inhibition rate	0	%
646	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	MAP/microtubule affinity-regulating kinase 4 [human]	inhibition rate	3	%
647	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	CLIP-associating protein 1 [human]	inhibition rate	16	%
648	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Atypical kinase COQ8A, mitochondrial [human]	inhibition rate	10	%
649	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Dual specificity mitogen-activated protein kinase kinase 1 [human]	inhibition rate	5	%
650	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Dual specificity mitogen-activated protein kinase kinase 2 [human]	inhibition rate	3	%
651	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Dual specificity mitogen-activated protein kinase kinase 3 [human]	inhibition rate	19	%
652	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Dual specificity mitogen-activated protein kinase kinase 4 [human]	inhibition rate	27	%
653	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Dual specificity mitogen-activated protein kinase kinase 5 [human]	inhibition rate	47	%
654	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Dual specificity mitogen-activated protein kinase kinase 6 [human]	inhibition rate	6	%
655	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Maternal embryonic leucine zipper kinase [human]	inhibition rate	47	%
656	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Tyrosine-protein kinase Mer [human]	inhibition rate	21	%
657	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Hepatocyte growth factor receptor [human]	inhibition rate	32	%
658	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Hepatocyte growth factor receptor (M1250T) [human]	inhibition rate	6	%
659	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Atypical kinase COQ8B, mitochondrial [human]	inhibition rate	14	%
660	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Hepatocyte growth factor receptor [human]	inhibition rate	40	%
661	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Misshapen-like kinase 1 [human]	inhibition rate	20	%
662	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Dual specificity mitogen-activated protein kinase kinase 7 [human]	inhibition rate	12	%
663	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	MAP kinase-interacting serine/threonine-protein kinase 1 [human]	inhibition rate	8	%
664	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	MAP kinase-interacting serine/threonine-protein kinase 2 [human]	inhibition rate	39	%
665	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Myosin light chain kinase, smooth muscle [human]	inhibition rate	3	%
666	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitogen-activated protein kinase kinase kinase 9 [human]	inhibition rate	30	%
667	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitogen-activated protein kinase kinase kinase 10 [human]	inhibition rate	32	%
668	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitogen-activated protein kinase kinase kinase 11 [human]	inhibition rate	2	%
669	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase MRCK alpha [human]	inhibition rate	17	%
670	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	RAC-alpha serine/threonine-protein kinase [human]	inhibition rate	7	%
671	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase MRCK beta [human]	inhibition rate	9	%
672	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Hepatocyte growth factor-like [human]	inhibition rate	7	%
673	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Macrophage-stimulating protein receptor [human]	inhibition rate	11	%
674	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Histone acetyltransferase mst2 [human]	inhibition rate	3	%
675	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase 24 [human]	inhibition rate	5	%
676	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase 26 [human]	inhibition rate	2	%
677	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase mTOR [human]	inhibition rate	4	%
678	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Muscle, skeletal receptor tyrosine-protein kinase [human]	inhibition rate	76	%
679	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Myosin light chain kinase, smooth muscle [human]	inhibition rate	9	%
680	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Myosin light chain kinase 2, skeletal/cardiac muscle [human]	inhibition rate	6	%
681	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	RAC-beta serine/threonine-protein kinase [human]	inhibition rate	5	%
682	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Myosin light chain kinase family member 4 [human]	inhibition rate	14	%
683	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Myosin-IIIa [human]	inhibition rate	10	%
684	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Myosin-IIIb [human]	inhibition rate	8	%
685	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Protein NDRG1 [human]	inhibition rate	3	%
686	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Protein NDRG2 [human]	inhibition rate	14	%
687	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase Nek1 [human]	inhibition rate	2	%
688	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase Nek10 [human]	inhibition rate	16	%
689	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase Nek11 [human]	inhibition rate	2	%
690	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase Nek2 [human]	inhibition rate	0	%
691	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase Nek3 [human]	inhibition rate	24	%
692	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	RAC-gamma serine/threonine-protein kinase [human]	inhibition rate	4	%
693	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase Nek4 [human]	inhibition rate	5	%
694	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase Nek5 [human]	inhibition rate	3	%
695	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase Nek6 [human]	inhibition rate	5	%
696	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase Nek7 [human]	inhibition rate	0	%
697	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase Nek9 [human]	inhibition rate	0	%
698	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitogen-activated protein kinase kinase kinase 14 [human]	inhibition rate	18	%
699	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase NIM1 [human]	inhibition rate	1	%
700	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine kinase NLK [human]	inhibition rate	15	%
701	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase OSR1 [human]	inhibition rate	0	%
702	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitogen-activated protein kinase 14A [human]	inhibition rate	14	%
703	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	ALK tyrosine kinase receptor [human]	inhibition rate	7	%
704	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitogen-activated protein kinase 11 [human]	inhibition rate	6	%
705	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitogen-activated protein kinase 13 [human]	inhibition rate	12	%
706	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitogen-activated protein kinase 12 [human]	inhibition rate	3	%
707	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase N1 [human]	inhibition rate	3	%
708	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	serine/threonine-protein kinase pak 2 [human]	inhibition rate	25	%
709	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase PAK 3 [human]	inhibition rate	70	%
710	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase PAK 4 [human]	inhibition rate	0	%
711	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase PAK 6 [human]	inhibition rate	4	%
712	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	serine/threonine-protein kinase pak 5 [human]	inhibition rate	5	%
713	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Cyclin-dependent kinase 16 [human]	inhibition rate	11	%
714	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	ALK tyrosine kinase receptor [human]	inhibition rate	0	%
715	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Cyclin-dependent kinase 17 [human]	inhibition rate	20	%
716	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Cyclin-dependent kinase 18 [human]	inhibition rate	31	%
717	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Platelet-derived growth factor receptor alpha [human]	inhibition rate	98.2	%
718	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Platelet-derived growth factor receptor beta [human]	inhibition rate	100	%
719	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	3-phosphoinositide-dependent protein kinase 1 [human]	inhibition rate	8	%
720	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Calcium-dependent protein kinase 1 [Plasmodium falciparum]	inhibition rate	36	%
721	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Cell division control protein 2 homolog [Plasmodium falciparum]	inhibition rate	11	%
722	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Cyclin-dependent kinase 15 [human]	inhibition rate	0	%
723	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Cyclin-dependent kinase 14 [human]	inhibition rate	15	%
724	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform [human]	inhibition rate	0	%
725	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	ALK tyrosine kinase receptor [human]	inhibition rate	13	%
726	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform [human]	inhibition rate	0	%
727	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta [human]	inhibition rate	2	%
728	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition rate	26	%
729	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human]	inhibition rate	15	%
730	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (C420R) [human]	inhibition rate	10	%
731	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E542K) [human]	inhibition rate	15	%
732	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545A) [human]	inhibition rate	8	%
733	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545K) [human]	inhibition rate	19	%
734	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047L) [human]	inhibition rate	8	%
735	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047Y) [human]	inhibition rate	0	%
736	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	5'-AMP-activated protein kinase catalytic subunit alpha-1 [human]	inhibition rate	9	%
737	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human]	inhibition rate	25	%
738	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (M1043I) [human]	inhibition rate	5	%
739	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (Q546K) [human]	inhibition rate	22	%
740	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [human]	inhibition rate	51	%
741	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [human]	inhibition rate	4	%
742	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform [human]	inhibition rate	2	%
743	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Phosphatidylinositol 4-kinase beta [human]	inhibition rate	8	%
744	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	1-phosphatidylinositol 3-phosphate 5-kinase [human]	inhibition rate	37	%
745	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Lon protease homolog, mitochondrial [human]	inhibition rate	20	%
746	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase pim-2 [human]	inhibition rate	5	%
747	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	5'-AMP-activated protein kinase catalytic subunit alpha-2 [human]	inhibition rate	11	%
748	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase pim-3 [human]	inhibition rate	14	%
749	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha [human]	inhibition rate	7	%
750	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma [human]	inhibition rate	21	%
751	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta [human]	inhibition rate	6	%
752	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma [human]	inhibition rate	5	%
753	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	cAMP-dependent protein kinase catalytic subunit alpha [human]	inhibition rate	8	%
754	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	cAMP-dependent protein kinase catalytic subunit beta [human]	inhibition rate	6	%
755	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase [human]	inhibition rate	5	%
756	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase N1 [human]	inhibition rate	10	%
757	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase pkn2 [human]	inhibition rate	17	%
758	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Ankyrin repeat and protein kinase domain-containing protein 1 [human]	inhibition rate	28	%
759	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase PknB [Mycobacterium tuberculosis]	inhibition rate	0	%
760	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase PLK1 [human]	inhibition rate	4	%
761	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase PLK2 [human]	inhibition rate	9	%
762	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase Plk3 [human]	inhibition rate	12	%
763	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase Plk4 [human]	inhibition rate	0	%
764	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Protein kinase C, delta [human]	inhibition rate	6	%
765	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Protein kinase C, epsilon [human]	inhibition rate	20	%
766	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Protein kinase C, eta [human]	inhibition rate	2	%
767	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Protein kinase C iota type [human]	inhibition rate	0	%
768	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Protein kinase C, theta [human]	inhibition rate	24	%
769	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	NUAK family SNF1-like kinase 1 [human]	inhibition rate	0	%
770	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase D1 [human]	inhibition rate	2	%
771	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase D2 [human]	inhibition rate	0	%
772	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase D3 [human]	inhibition rate	3	%
773	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	cGMP-dependent protein kinase 1 [human]	inhibition rate	1	%
774	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	cGMP-dependent protein kinase 2 [human]	inhibition rate	0	%
775	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Interferon-induced, double-stranded RNA-activated protein kinase [human]	inhibition rate	12	%
776	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	cAMP-dependent protein kinase catalytic subunit PRKX [human]	inhibition rate	0	%
777	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Proline-rich protein 4 [human]	inhibition rate	40	%
778	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Protein-tyrosine kinase 2-beta [human]	inhibition rate	5	%
779	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase SIK3 [human]	inhibition rate	23	%
780	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitogen-activated protein kinase kinase kinase 5 [human]	inhibition rate	20	%
781	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	RAF proto-oncogene serine/threonine-protein kinase [human]	inhibition rate	90.9	%
782	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Proto-oncogene tyrosine-protein kinase receptor Ret [human]	inhibition rate	0	%
783	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Proto-oncogene tyrosine-protein kinase receptor Ret (M918T) [human]	inhibition rate	4	%
784	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Proto-oncogene tyrosine-protein kinase receptor Ret (V804L) [human]	inhibition rate	0	%
785	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M) [human]	inhibition rate	0	%
786	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase Rio1 [human]	inhibition rate	0	%
787	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase Rio2 [human]	inhibition rate	26	%
788	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase Rio3 [human]	inhibition rate	0	%
789	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Receptor-interacting serine/threonine-protein kinase 1 [human]	inhibition rate	100	%
790	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Receptor-interacting serine/threonine-protein kinase 2 [human]	inhibition rate	22	%
791	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitogen-activated protein kinase kinase kinase 6 [human]	inhibition rate	7	%
792	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Receptor-interacting serine/threonine-protein kinase 4 [human]	inhibition rate	3	%
793	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Dual serine/threonine and tyrosine protein kinase [human]	inhibition rate	28	%
794	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Rho-associated protein kinase 1 [human]	inhibition rate	13	%
795	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Rho-associated protein kinase 2 [human]	inhibition rate	18	%
796	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Proto-oncogene tyrosine-protein kinase ROS [human]	inhibition rate	0	%
797	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Ribosomal protein S6 kinase alpha-4 [human]	inhibition rate	5	%
798	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Ribosomal protein S6 kinase alpha-4 [human]	inhibition rate	2	%
799	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Ribosomal protein S6 kinase alpha-5 [human]	inhibition rate	0	%
800	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Ribosomal protein S6 kinase alpha-5 [human]	inhibition rate	0	%
801	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Ribosomal protein S6 kinase alpha-1 [human]	inhibition rate	10	%
802	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Aurora kinase A [human]	inhibition rate	14	%
803	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Ribosomal protein S6 kinase alpha-1 [human]	inhibition rate	1	%
804	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	9	%
805	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	9	%
806	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Ribosomal protein S6 kinase alpha-2 [human]	inhibition rate	25	%
807	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Ribosomal protein S6 kinase alpha-2 [human]	inhibition rate	7	%
808	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Ribosomal protein S6 kinase alpha-6 [human]	inhibition rate	25	%
809	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Ribosomal protein S6 kinase alpha-6 [human]	inhibition rate	0	%
810	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Ribosomal protein S6 kinase beta-1 [human]	inhibition rate	17	%
811	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	serine/threonine-protein kinase sbk1 [human]	inhibition rate	0	%
812	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase Sgk1 [human]	inhibition rate	10	%
813	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Aurora kinase B [human]	inhibition rate	28	%
814	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Uncharacterized serine/threonine-protein kinase SBK3 [human]	inhibition rate	0	%
815	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase Sgk2 [human]	inhibition rate	25	%
816	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase Sgk3 [human]	inhibition rate	17	%
817	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase SIK1 [human]	inhibition rate	11	%
818	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase SIK2 [human]	inhibition rate	7	%
819	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	STE20-like serine/threonine-protein kinase [human]	inhibition rate	29	%
820	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	NUAK family SNF1-like kinase 2 [human]	inhibition rate	2	%
821	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	SNF-related serine/threonine-protein kinase [human]	inhibition rate	0	%
822	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Proto-oncogene tyrosine-protein kinase Src [human]	inhibition rate	6	%
823	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Tyrosine-protein kinase Srms [human]	inhibition rate	46	%
824	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Aurora kinase C [human]	inhibition rate	0	%
825	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	SRSF protein kinase 1 [human]	inhibition rate	13	%
826	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	SRSF protein kinase 2 [human]	inhibition rate	27	%
827	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	SRSF protein kinase 3 [human]	inhibition rate	1	%
828	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase 16 [human]	inhibition rate	4	%
829	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase 33 [human]	inhibition rate	23	%
830	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase 35 [human]	inhibition rate	0	%
831	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase 36 [human]	inhibition rate	62	%
832	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	STE20/SPS1-related proline-alanine-rich protein kinase [human]	inhibition rate	25	%
833	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Tyrosine-protein kinase SYK [human]	inhibition rate	9	%
834	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitogen-activated protein kinase kinase kinase 7 [human]	inhibition rate	20	%
835	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	NEDD8-activating enzyme E1 regulatory subunit AXL [human]	inhibition rate	18	%
836	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase TAO1 [human]	inhibition rate	26	%
837	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase TAO2 [human]	inhibition rate	6	%
838	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase TAO3 [human]	inhibition rate	16	%
839	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase TBK1 [human]	inhibition rate	4	%
840	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Tyrosine-protein kinase Tec [human]	inhibition rate	4	%
841	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Dual specificity testis-specific protein kinase 1 [human]	inhibition rate	14	%
842	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	TGF-beta receptor type-1 [human]	inhibition rate	13	%
843	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	TGF-beta receptor type-2 [human]	inhibition rate	4	%
844	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Tyrosine-protein kinase receptor Tie-1 [human]	inhibition rate	63	%
845	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Tyrosine-protein kinase receptor Tie-2 [human]	inhibition rate	25	%
846	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	BMP-2-inducible protein kinase [human]	inhibition rate	0	%
847	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase tousled-like 1 [human]	inhibition rate	10	%
848	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase TOUSLED-like 2 [human]	inhibition rate	6	%
849	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Traf2 and NCK-interacting protein kinase [human]	inhibition rate	18	%
850	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Non-receptor tyrosine-protein kinase TNK1 [human]	inhibition rate	4	%
851	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Activated CDC42 kinase 1 [human]	inhibition rate	1	%
852	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase TNNI3K [human]	inhibition rate	23	%
853	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	High affinity nerve growth factor receptor [human]	inhibition rate	38	%
854	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	BDNF/NT-3 growth factors receptor [human]	inhibition rate	17	%
855	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	NT-3 growth factor receptor [human]	inhibition rate	17	%
856	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Transient receptor potential cation channel subfamily M member 6 [human]	inhibition rate	11	%
857	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Tyrosine-protein kinase Blk [human]	inhibition rate	24	%
858	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Testis-specific serine/threonine-protein kinase 1 [human]	inhibition rate	0	%
859	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Testis-specific serine/threonine-protein kinase 3 [human]	inhibition rate	3	%
860	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Dual specificity protein kinase TTK [human]	inhibition rate	34	%
861	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Tyrosine-protein kinase TXK [human]	inhibition rate	33	%
862	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition rate	34	%
863	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition rate	0	%
864	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Tyrosine-protein kinase receptor TYRO3 [human]	inhibition rate	5	%
865	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase ULK1 [human]	inhibition rate	16	%
866	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase ULK2 [human]	inhibition rate	7	%
867	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase ULK3 [human]	inhibition rate	29	%
868	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Bone morphogenetic protein receptor type-1A [human]	inhibition rate	3	%
869	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Vascular endothelial growth factor receptor 2 [human]	inhibition rate	30	%
870	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Phosphatidylinositol 3-kinase, Vps34 type [human]	inhibition rate	35	%
871	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase VRK2 [human]	inhibition rate	2	%
872	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitosis inhibitor protein kinase wee1 [human]	inhibition rate	8	%
873	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Wee1-like protein kinase 1-A [human]	inhibition rate	0	%
874	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase WNK1 [human]	inhibition rate	3	%
875	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase WNK2 [human]	inhibition rate	2	%
876	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase WNK3 [human]	inhibition rate	4	%
877	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase WNK4 [human]	inhibition rate	55	%
878	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase 32A [human]	inhibition rate	0	%
879	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Bone morphogenetic protein receptor type-1B [human]	inhibition rate	10	%
880	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase 32B [human]	inhibition rate	0	%
881	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase 32C [human]	inhibition rate	9	%
882	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Tyrosine-protein kinase Yes [human]	inhibition rate	0	%
883	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase 25 [human]	inhibition rate	29	%
884	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitogen-activated protein kinase kinase kinase 19 [human]	inhibition rate	35	%
885	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitogen-activated protein kinase kinase kinase 20 [human]	inhibition rate	37	%
886	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Tyrosine-protein kinase ZAP-70 [human]	inhibition rate	0	%
887	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Tyrosine-protein kinase ABL1- phosphorylated [human]	inhibition rate	79	%
888	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Calcium/calmodulin-dependent protein kinase type II delta 2 chain [human]	inhibition rate	0	%
889	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Epithelial discoidin domain-containing receptor 1 [human]	inhibition rate	99.8	%
890	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Bone morphogenetic protein receptor type-2 [human]	inhibition rate	3	%
891	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase ICK [human]	inhibition rate	21	%
892	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Cytoplasmic tyrosine-protein kinase BMX [human]	inhibition rate	13	%
893	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase B-raf [human]	inhibition rate	94	%
894	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase B-raf (V600E) [human]	inhibition rate	99.25	%
895	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Tyrosine-protein kinase ABL1(E255K)-Phosphorylated [human]	inhibition rate	70	%
896	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Protein-tyrosine kinase 6 [human]	inhibition rate	4	%
897	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase BRSK1 [human]	inhibition rate	0	%
898	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase BRSK2 [human]	inhibition rate	2	%
899	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Tyrosine-protein kinase BTK [human]	inhibition rate	0	%
900	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Mitotic checkpoint serine/threonine-protein kinase BUB1 [human]	inhibition rate	14	%
901	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Calcium/calmodulin-dependent protein kinase type 1 [human]	inhibition rate	9	%
902	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Calcium/calmodulin-dependent protein kinase type 1B [human]	inhibition rate	12	%
903	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Calcium/calmodulin-dependent protein kinase type 1D [human]	inhibition rate	4	%
904	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Calcium/calmodulin-dependent protein kinase type 1G [human]	inhibition rate	0	%
905	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Calcium/calmodulin-dependent protein kinase type II subunit alpha [human]	inhibition rate	0	%
906	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	ABL1(F317I)-nonphosphorylated [human]	inhibition rate	100	%
907	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Calcium/calmodulin-dependent protein kinase type II subunit beta [human]	inhibition rate	0	%
908	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Calcium/calmodulin-dependent protein kinase type II subunit gamma [human]	inhibition rate	2	%
909	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Calcium/calmodulin-dependent protein kinase type IV [human]	inhibition rate	3	%
910	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Calcium/calmodulin-dependent protein kinase kinase 1 [human]	inhibition rate	10	%
911	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Calcium/calmodulin-dependent protein kinase kinase 2 [human]	inhibition rate	0	%
912	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Kappa-casein [human]	inhibition rate	6	%
913	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Cyclin-dependent kinase 11B [human]	inhibition rate	8	%
914	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Cyclin-dependent kinase 11A [human]	inhibition rate	12	%
915	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Cyclin-dependent kinase 13 [human]	inhibition rate	46	%
916	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Cyclin-dependent kinase 11 [human]	inhibition rate	92.1	%
917	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	ABL1(F317I)-phosphorylated [human]	inhibition rate	68	%
918	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Cyclin-dependent kinase 2 [human]	inhibition rate	1	%
919	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Cyclin-dependent kinase 3 [human]	inhibition rate	0	%
920	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Cyclin-dependent kinase 4 [human]	inhibition rate	5	%
921	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Cyclin-dependent kinase 4 [human]; Cyclin-D1-1 [human]	inhibition rate	17	%
922	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Cyclin-dependent kinase 4 [human]; Cyclin-D3-1 [human]	inhibition rate	13	%
923	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Cyclin-dependent-like kinase 5 [human]	inhibition rate	7	%
924	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Cyclin-dependent kinase 7 [human]	inhibition rate	50	%
925	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Cyclin-dependent kinase 8 [human]	inhibition rate	100	%
926	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Cyclin-dependent kinase 9 [human]	inhibition rate	58	%
927	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Cyclin-dependent kinase-like 1 [human]	inhibition rate	5	%
928	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	ABL1(F317L)-nonphosphorylated [human]	inhibition rate	100	%
929	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Cyclin-dependent kinase-like 2 [human]	inhibition rate	100	%
930	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Cyclin-dependent kinase-like 3 [human]	inhibition rate	1	%
931	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Cyclin-dependent kinase-like 5 [human]	inhibition rate	0	%
932	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase Chk1 [human]	inhibition rate	0	%
933	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase Chk2 [human]	inhibition rate	0	%
934	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Citrate synthase, mitochondrial [human]	inhibition rate	81	%
935	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Serine/threonine-protein kinase ATG1 [human]	inhibition rate	12	%
936	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Dual specificity protein kinase CLK2 [human]	inhibition rate	1	%
937	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Dual specificity protein kinase CLK3 [human]	inhibition rate	11	%
938	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Dual specificity protein kinase CLK4 [human]	inhibition rate	7	%
939	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	ABL1(F317L)-phosphorylated [human]	inhibition rate	82	%
940	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Macrophage colony-stimulating factor 1 receptor [human]	inhibition rate	93.4	%
941	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	CSF1R-autoinhibited [human]	inhibition rate	17	%
942	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Tyrosine-protein kinase CSK [human]	inhibition rate	12	%
943	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Casein kinase I isoform alpha [human]	inhibition rate	9	%
944	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Casein kinase I isoform alpha-like [human]	inhibition rate	0	%
945	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Casein kinase I isoform delta [human]	inhibition rate	0	%
946	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Casein kinase I isoform epsilon [human]	inhibition rate	4	%
947	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Casein kinase I isoform gamma-1 [human]	inhibition rate	2	%
948	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Casein kinase I isoform gamma-2 [human]	inhibition rate	0	%
949	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	Casein kinase I isoform gamma-3 [human]	inhibition rate	7	%
950	OC(=O)C(F)(F)F.CC1=CC=C(NC(=O)N2N=CCC2C2=CC=CC=C2)C=C1C#CC1=CN=C2C=CC=NN12	ABL1(H396P)-nonphosphorylated [human]	inhibition rate	100	%
951	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Leucine-rich repeat serine/threonine-protein kinase 2 (G2019S) [human]	Kd (dissociation constant)	5.5	nM
952	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Leucine-rich repeat serine/threonine-protein kinase 2	Kd (dissociation constant)	6.6	nM
953	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Leucine-rich repeat serine/threonine-protein kinase 2 (G2019S) [human]	IC50	14	nM
954	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Leucine-rich repeat serine/threonine-protein kinase 2 [mouse]	IC50	22	nM
955	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Leucine-rich repeat serine/threonine-protein kinase 2	IC50	23	nM
956	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Leucine-rich repeat serine/threonine-protein kinase 2 [mouse]	IC50	23	nM
957	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Leucine-rich repeat serine/threonine-protein kinase 2 (G2019S) [human]	IC50	51	nM
958	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Receptor-type tyrosine-protein kinase FLT3 (D835V)	Kd (dissociation constant)	67	nM
959	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Leucine-rich repeat serine/threonine-protein kinase 2 [human]	IC50	86	nM
960	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Leucine-rich repeat serine/threonine-protein kinase 2	IC50	140	nM
961	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	Kd (dissociation constant)	430	nM
962	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 4-kinase beta	Kd (dissociation constant)	730	nM
963	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase 1 [human]	Kd (dissociation constant)	840	nM
964	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C		qualitative		
965	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase JAK2 [human]	IC50	10	μM
966	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase JAK3 [human]	IC50	10	μM
967	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase 10 [human];+Mitogen-activated protein kinase 9 [human];+Mitogen-activated protein kinase 8 [human]	IC50	10	μM
968	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Killer toxin KHS [human]	IC50	10	μM
969	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Kinase suppressor of Ras 1 [human]	IC50	10	μM
970	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Kinase suppressor of Ras 1 [human]; Connector enhancer of kinase suppressor of ras 2 [human]	IC50	10	μM
971	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase LATS1 [human]	IC50	10	μM
972	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase LATS2 [human]	IC50	10	μM
973	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Proto-oncogene tyrosine-protein kinase LCK [human]	IC50	10	μM
974	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase stk11 homolog [human]	IC50	10	μM
975	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ovarian-specific serine/threonine-protein kinase Lok [human]	IC50	10	μM
976	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Leucine-rich repeat serine/threonine-protein kinase 2 [human]	IC50	10	μM
977	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase Lyn [human]	IC50	10	μM
978	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Dual specificity mitogen-activated protein kinase kinase 1 [human]	IC50	10	μM
979	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Dual specificity mitogen-activated protein kinase kinase 2 [human]	IC50	10	μM
980	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Dual specificity mitogen-activated protein kinase kinase 3 [human]	IC50	10	μM
981	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Dual specificity mitogen-activated protein kinase kinase 4 [human]	IC50	10	μM
982	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Dual specificity mitogen-activated protein kinase kinase 5 [human]	IC50	10	μM
983	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Dual specificity mitogen-activated protein kinase kinase 6 [human]	IC50	10	μM
984	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Dual specificity mitogen-activated protein kinase kinase 7 [human]	IC50	10	μM
985	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase 15 [human]; Mitogen-activated protein kinase kinase kinase 5 [human]; Mitogen-activated protein kinase kinase kinase 6 [human]	IC50	10	μM
986	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase 2 [human]	IC50	10	μM
987	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase 3 [human]	IC50	10	μM
988	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase 4 [human]	IC50	10	μM
989	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase 5 [human]	IC50	10	μM
990	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase 6 [human]	IC50	10	μM
991	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	MAP kinase-activated protein kinase 3 [human]	IC50	10	μM
992	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase MARK1 [human]; Serine/threonine-protein kinase MARK2 [human]	IC50	10	μM
993	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase MARK2 [human]	IC50	10	μM
994	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	MAP/microtubule affinity-regulating kinase 3 [human]	IC50	10	μM
995	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	MAP/microtubule affinity-regulating kinase 3 [human]; MAP/microtubule affinity-regulating kinase 4 [human]	IC50	10	μM
996	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	MAP/microtubule affinity-regulating kinase 4 [human]	IC50	10	μM
997	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Microtubule-associated serine/threonine-protein kinase 3 [human]	IC50	10	μM
998	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Microtubule-associated serine/threonine-protein kinase 4 [human]	IC50	10	μM
999	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase 11 [human]	IC50	10	μM
1000	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mixed lineage kinase domain-like protein [human]	IC50	10	μM
1001	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase 16 [human]	IC50	10	μM
1002	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Lysine-tRNA ligase, mitochondrial [human]	IC50	10	μM
1003	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Lysine-tRNA ligase, mitochondrial [human]	IC50	10	μM
1004	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Histone acetyltransferase mst1 [human]	IC50	10	μM
1005	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Histone acetyltransferase mst1 [human]; Histone acetyltransferase mst2 [human]	IC50	10	μM
1006	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Histone acetyltransferase mst2 [human]	IC50	10	μM
1007	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase 24 [human]	IC50	10	μM
1008	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase 26 [human]	IC50	10	μM
1009	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase 26 [human]; Serine/threonine-protein kinase 25 [human]	IC50	10	μM
1010	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase 38 [human]	IC50	10	μM
1011	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Neurogenic differentiation factor 2 [human]	IC50	10	μM
1012	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Probable serine/threonine-protein kinase nek1 [human]	IC50	10	μM
1013	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Probable serine/threonine-protein kinase nek3 [human]	IC50	10	μM
1014	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase Nek4 [human]	IC50	10	μM
1015	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase Nek6 [human]; Serine/threonine-protein kinase Nek7 [human]	IC50	10	μM
1016	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase Nek7 [human]	IC50	10	μM
1017	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase Nek8 [human]	IC50	10	μM
1018	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase Nek9 [human]	IC50	10	μM
1019	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	NUAK family SNF1-like kinase 2 [human]	IC50	10	μM
1020	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase OSR1 [human]	IC50	10	μM
1021	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase 14A [human]	IC50	10	μM
1022	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase 11 [human]	IC50	10	μM
1023	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase 13 [human]	IC50	10	μM
1024	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase 12 [human]	IC50	10	μM
1025	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ribosomal protein S6 kinase beta-1 [human]	IC50	10	μM
1026	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	PAN2-PAN3 deadenylation complex subunit PAN3 [human]	IC50	10	μM
1027	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase 16 [human]; Cyclin-dependent kinase 18 [human]	IC50	10	μM
1028	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase 17 [human]	IC50	10	μM
1029	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase 18 [human]	IC50	10	μM
1030	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial [human]	IC50	10	μM
1031	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	eukaryotic translation initiation factor 2alpha kinase [human]	IC50	10	μM
1032	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase 14 [human]	IC50	10	μM
1033	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform [human]	IC50	10	μM
1034	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 4-kinase alpha [human];+Putative phosphatidylinositol 4-kinase alpha-like protein P2 [human]	IC50	10	μM
1035	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 4-kinase beta [human]	IC50	10	μM
1036	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 3-kinase catalytic subunit type 3 [human]	IC50	10	μM
1037	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [human]	IC50	10	μM
1038	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [human]	IC50	10	μM
1039	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform [human]	IC50	10	μM
1040	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [human]	IC50	10	μM
1041	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta [human]	IC50	10	μM
1042	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma [human]	IC50	10	μM
1043	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	1-phosphatidylinositol 3-phosphate 5-kinase [human]	IC50	10	μM
1044	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase PITSLRE [human]	IC50	10	μM
1045	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Protein kinase C alpha type [human];+Protein kinase C beta type [human]	IC50	10	μM
1046	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Protein kinase C, eta [human]	IC50	10	μM
1047	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Polycystin-1 [human]; Polycystin-2 [human]	IC50	10	μM
1048	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Polycystin-2 [human]	IC50	10	μM
1049	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Polycystin-3 [human]	IC50	10	μM
1050	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase N1 [human]	IC50	10	μM
1051	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Interferon-induced, double-stranded RNA-activated protein kinase [human]	IC50	10	μM
1052	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase PLK1 [human]	IC50	10	μM
1053	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase prp4 [human]	IC50	10	μM
1054	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	EKC/KEOPS complex subunit TP53RK [human]	IC50	10	μM
1055	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Protein-tyrosine kinase 2-beta [human]	IC50	10	μM
1056	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase SIK3 [human]	IC50	10	μM
1057	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Receptor-interacting serine/threonine-protein kinase 3 [human]	IC50	10	μM
1058	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Rho-associated protein kinase 1 [human];+Rho-associated protein kinase 2 [human]	IC50	10	μM
1059	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ribosomal protein S6 kinase alpha-1 [human]	IC50	10	μM
1060	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase BRSK2 [human]	IC50	10	μM
1061	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ribosomal protein S6 kinase alpha-2 [human]	IC50	10	μM
1062	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase BRSK2 [human]	IC50	10	μM
1063	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ribosomal protein S6 kinase alpha-5 [human]	IC50	10	μM
1064	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase Sgk3 [human]	IC50	10	μM
1065	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	STE20-like serine/threonine-protein kinase [human]	IC50	10	μM
1066	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase SMG1 [human]	IC50	10	μM
1067	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Myosin light chain kinase, smooth muscle [human]	IC50	10	μM
1068	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	SNF-related serine/threonine-protein kinase [human]	IC50	10	μM
1069	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Proto-oncogene tyrosine-protein kinase Src [human]	IC50	10	μM
1070	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	CBL-interacting serine/threonine-protein kinase 7 [human]	IC50	10	μM
1071	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Putative serine/threonine-protein kinase STE20-like 3 [human]	IC50	10	μM
1072	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Putative serine/threonine-protein kinase STE20-like 5 [human]	IC50	10	μM
1073	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Putative serine/threonine-protein kinase STE20-like 6 [human]	IC50	10	μM
1074	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase SYK [human]	IC50	10	μM
1075	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase SYK [human]	IC50	10	μM
1076	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase 7 [human]	IC50	10	μM
1077	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase TAO1 [human];+Serine/threonine-protein kinase TAO3 [human]	IC50	10	μM
1078	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase TAO2 [human]	IC50	10	μM
1079	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase TBK1 [human]	IC50	10	μM
1080	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	TGF-beta receptor type-2 [human]	IC50	10	μM
1081	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase tousled-like 1 [human]	IC50	10	μM
1082	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase TOUSLED-like 2 [human]	IC50	10	μM
1083	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase ULK1 [human]	IC50	10	μM
1084	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase ULK3 [human]	IC50	10	μM
1085	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Probable serine/threonine-protein kinase WNK1 [human];+Probable serine/threonine-protein kinase WNK2 [human]	IC50	10	μM
1086	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Probable serine/threonine-protein kinase WNK1 [human];+Probable serine/threonine-protein kinase WNK2 [human]; Probable serine/threonine-protein kinase WNK3 [human]	IC50	10	μM
1087	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Probable serine/threonine-protein kinase WNK1 [human];+Probable serine/threonine-protein kinase WNK2 [human]; Probable serine/threonine-protein kinase WNK4 [human]	IC50	10	μM
1088	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase 32C [human]	IC50	10	μM
1089	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase 20 [human]	IC50	10	μM
1090	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase ZAP-70 [human]	IC50	10	μM
1091	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase kinase 4 [human];+16 kDa gamma-zein [human]	IC50	10	μM
1092	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Traf2 and NCK-interacting protein kinase [human];+Zinc finger C2HC domain-containing protein 1A [human]	IC50	10	μM
1093	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Misshapen-like kinase 1 [human]	IC50	10	μM
1094	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase Abl [human];+Tyrosine-protein kinase ABL2 [human]	IC50	10	μM
1095	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Acetate kinase (peptide) [human]	IC50	10	μM
1096	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	RAC serine/threonine-protein kinase [human]	IC50	10	μM
1097	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Abhydrolase domain-containing protein AKT2 [human]	IC50	10	μM
1098	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	RAC-gamma serine/threonine-protein kinase [human]	IC50	10	μM
1099	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	5'-AMP-activated protein kinase catalytic subunit alpha-1 [human]	IC50	10	μM
1100	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	5'-AMP-activated protein kinase catalytic subunit alpha-1 [human]; 5'-AMP-activated protein kinase catalytic subunit alpha-2 [human]	IC50	10	μM
1101	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	ABC transporter L-arabinose-binding periplasmic protein [human]	IC50	10	μM
1102	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase ATR [human]	IC50	10	μM
1103	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Beta-adrenergic receptor kinase 1 [human]	IC50	10	μM
1104	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase B-raf [human]	IC50	10	μM
1105	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase BTK [human]	IC50	10	μM
1106	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Calcium/calmodulin-dependent protein kinase type 1 [human]	IC50	10	μM
1107	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Calcium/calmodulin-dependent protein kinase type 1D [human]	IC50	10	μM
1108	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Calcium/calmodulin-dependent protein kinase type II subunit alpha [human]	IC50	10	μM
1109	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Calcium/calmodulin-dependent protein kinase type II subunit beta [human]	IC50	10	μM
1110	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Calcium/calmodulin-dependent protein kinase type II subunit gamma [human]	IC50	10	μM
1111	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Calcium/calmodulin-dependent protein kinase type IV [human]	IC50	10	μM
1112	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Calcium/calmodulin-dependent protein kinase kinase 2 [human]	IC50	10	μM
1113	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Casein kinase II subunit alpha [human]	IC50	10	μM
1114	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase 1 [human]	IC50	10	μM
1115	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase 11 [human]	IC50	10	μM
1116	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase 8 [human]	IC50	10	μM
1117	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase 2 [human]	IC50	10	μM
1118	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent-like kinase 5 [human]	IC50	10	μM
1119	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase 7 [human]	IC50	10	μM
1120	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase 9 [human]	IC50	10	μM
1121	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase Chk2 [human]	IC50	10	μM
1122	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Casein kinase I isoform alpha-like [human]	IC50	10	μM
1123	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Casein kinase I isoform gamma-2 [human]	IC50	10	μM
1124	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase 8 [human]	IC50	10	μM
1125	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase CSK [human]	IC50	10	μM
1126	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Diacylglycerol kinase (peptide) [human]	IC50	10	μM
1127	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	DNA-dependent protein kinase catalytic subunit [human]	IC50	10	μM
1128	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	eukaryotic elongation factor 2 kinase [human]	IC50	10	μM
1129	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ephrin type-A receptor 1 [human]	IC50	10	μM
1130	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Extracellular signal-regulated kinase 1 [human]	IC50	10	μM
1131	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Extracellular signal-regulated kinase 2 [human]	IC50	10	μM
1132	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase 7 [human]	IC50	10	μM
1133	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase Fer [human]	IC50	10	μM
1134	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase, Fes/Fps type [human]	IC50	10	μM
1135	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase Fgr [human]	IC50	10	μM
1136	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Prostatic acid phosphatase [human]	IC50	10	μM
1137	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase Fyn [human]	IC50	10	μM
1138	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase Fyn [human]; Tyrosine-protein kinase Yes [human]; Proto-oncogene tyrosine-protein kinase Src [human]	IC50	10	μM
1139	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-G-associated kinase [human]	IC50	10	μM
1140	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase kinase 2 [human]	IC50	10	μM
1141	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	eIF-2-alpha kinase Gcn2 [human]	IC50	10	μM
1142	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	G protein-coupled receptor kinase 6 [human]	IC50	10	μM
1143	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Glycogen synthase kinase-3 alpha [human]	IC50	10	μM
1144	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	glycogen synthase kinase-3 beta [human]	IC50	10	μM
1145	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase HCK [human]	IC50	10	μM
1146	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase kinase 1 [human]	IC50	10	μM
1147	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Inhibitor of nuclear factor kappa-B kinase subunit alpha [human]	IC50	10	μM
1148	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	IC50	10	μM
1149	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Inhibitor of nuclear factor kappa-B kinase subunit epsilon [human]	IC50	10	μM
1150	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Inhibitor of nuclear factor kappa-B kinase subunit epsilon [human]; Serine/threonine-protein kinase TBK1 [human]	IC50	10	μM
1151	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Integrin-linked protein kinase [human]	IC50	10	μM
1152	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Interleukin-1 receptor-associated kinase 1 [human]	IC50	10	μM
1153	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Interleukin-1 receptor-associated kinase 3 [human]	IC50	10	μM
1154	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Interleukin-1 receptor-associated kinase 4 [human]	IC50	10	μM
1155	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase/endoribonuclease IRE1 [human]	IC50	10	μM
1156	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase ITK/TSK [human]	IC50	10	μM
1157	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase JAK1 [human]	IC50	10	μM
1158	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase JAK1 [human]	IC50	10	μM
1159	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase Abl [mouse]	inhibition rate		
1160	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Acetate kinase (peptide) [mouse]	inhibition rate		
1161	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	5'-AMP-activated serine/threonine-protein kinase catalytic subunit alpha [mouse]	inhibition rate		
1162	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	5'-AMP-activated serine/threonine-protein kinase catalytic subunit alpha [mouse]; 5'-AMP-activated protein kinase catalytic subunit alpha-2 [mouse]	inhibition rate		
1163	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	5'-AMP-activated protein kinase catalytic subunit alpha-2 [mouse]	inhibition rate		
1164	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase ATR [mouse]	inhibition rate		
1165	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	NEDD8-activating enzyme E1 regulatory subunit AXL [mouse]	inhibition rate		
1166	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase B-raf [mouse]	inhibition rate		
1167	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase BRSK1 [mouse]	inhibition rate		
1168	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase BRSK2 [mouse]	inhibition rate		
1169	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Calcium/calmodulin-dependent protein kinase type 1 [mouse]	inhibition rate		
1170	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Calcium/calmodulin-dependent protein kinase type 1B [mouse]	inhibition rate		
1171	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Calcium/calmodulin-dependent protein kinase type 1D [mouse]	inhibition rate		
1172	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Calcium/calmodulin-dependent protein kinase type 1G [mouse]	inhibition rate		
1173	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Calcium/calmodulin-dependent protein kinase type II subunit alpha [mouse]	inhibition rate		
1174	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Calcium/calmodulin-dependent protein kinase type II subunit alpha [mouse]; Calcium/calmodulin-dependent protein kinase type II subunit beta [mouse]; Calcium/calmodulin-dependent protein kinase type II subunit delta [mouse]; Calcium/calmodulin-dependent protein kinase type II subunit gamma [mouse]	inhibition rate		
1175	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Calcium/calmodulin-dependent protein kinase type II subunit beta [mouse]	inhibition rate		
1176	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Calcium/calmodulin-dependent protein kinase type II subunit delta [mouse]	inhibition rate		
1177	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Calcium/calmodulin-dependent protein kinase type II subunit gamma [mouse]	inhibition rate		
1178	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Calcium/calmodulin-dependent protein kinase type IV [mouse]	inhibition rate		
1179	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Calcium/calmodulin-dependent protein kinase kinase 1 [mouse]	inhibition rate		
1180	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Casein kinase II subunit alpha [mouse]	inhibition rate		
1181	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase 8 [mouse];+Cyclin-dependent kinase 11 [mouse]	inhibition rate		
1182	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent-like kinase 5 [mouse]	inhibition rate		
1183	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Chemoreceptor glutamine deamidase CheD [mouse]	inhibition rate		
1184	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase Chk1 [mouse]	inhibition rate		
1185	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Casein kinase I isoform gamma-2 [mouse];+Casein kinase I isoform gamma-3 [mouse];+Casein kinase I isoform gamma-1 [mouse]	inhibition rate		
1186	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase CSK [mouse]	inhibition rate		
1187	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase DCLK1 [mouse]	inhibition rate		
1188	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	eukaryotic elongation factor 2 kinase [mouse]	inhibition rate		
1189	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	epidermal growth factor-activated receptor [mouse]	inhibition rate		
1190	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ephrin type-B receptor 2 [mouse]	inhibition rate		
1191	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ephrin type-B receptor 3 [mouse]	inhibition rate		
1192	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Extracellular signal-regulated kinase 1 [mouse]	inhibition rate		
1193	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Focal adhesion kinase 1 [mouse]	inhibition rate		
1194	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase, Fes/Fps type [mouse]	inhibition rate		
1195	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase Fyn [mouse]	inhibition rate		
1196	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	D-glycerate 2-kinase [mouse]	inhibition rate		
1197	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	ABC transporter F family member 2 [mouse]	inhibition rate		
1198	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Glycogen synthase kinase-3 alpha [mouse]	inhibition rate		
1199	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	glycogen synthase kinase-3 beta [mouse]	inhibition rate		
1200	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Receptor tyrosine-protein kinase erbB-4 [mouse]	inhibition rate		
1201	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Insulin-like growth factor 1 receptor [mouse]	inhibition rate		
1202	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Inhibitor of nuclear factor kappa-B kinase subunit epsilon [mouse]; Serine/threonine-protein kinase TBK1 [mouse]	inhibition rate		
1203	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Integrin-linked protein kinase [mouse]	inhibition rate		
1204	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Insulin receptor [mouse]	inhibition rate		
1205	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Interleukin-1 receptor-associated kinase 1 [mouse]	inhibition rate		
1206	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase 8 [mouse]; Mitogen-activated protein kinase 9 [mouse]; Mitogen-activated protein kinase 10 [mouse]	inhibition rate		
1207	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase 9 [mouse]	inhibition rate		
1208	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase 10 [mouse]	inhibition rate		
1209	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Killer toxin KHS [mouse]	inhibition rate		
1210	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase LATS1 [mouse]	inhibition rate		
1211	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase stk11 homolog [mouse]	inhibition rate		
1212	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Leucine-rich repeat serine/threonine-protein kinase 2 [mouse]	inhibition rate		
1213	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Dual specificity mitogen-activated protein kinase kinase 1 [mouse]	inhibition rate		
1214	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Dual specificity mitogen-activated protein kinase kinase 1 [mouse]; Dual specificity mitogen-activated protein kinase kinase 2 [mouse]	inhibition rate		
1215	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Dual specificity mitogen-activated protein kinase kinase 4 [mouse]	inhibition rate		
1216	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Dual specificity mitogen-activated protein kinase kinase 6 [mouse]	inhibition rate		
1217	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Dual specificity mitogen-activated protein kinase kinase 7 [mouse]	inhibition rate		
1218	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase 2 [mouse];+Mitogen-activated protein kinase kinase kinase 3 [mouse]	inhibition rate		
1219	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase 4 [mouse]	inhibition rate		
1220	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase 5 [mouse];+Mitogen-activated protein kinase kinase kinase 6 [mouse]	inhibition rate		
1221	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase 5 [mouse];+Mitogen-activated protein kinase kinase kinase 6 [mouse]; Mitogen-activated protein kinase kinase kinase 7 [mouse]	inhibition rate		
1222	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase MARK1 [mouse]	inhibition rate		
1223	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase MARK2 [mouse]	inhibition rate		
1224	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	MAP/microtubule affinity-regulating kinase 3 [mouse]	inhibition rate		
1225	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	MAP/microtubule affinity-regulating kinase 3 [mouse]; Serine/threonine-protein kinase MARK1 [mouse]	inhibition rate		
1226	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase Mer [mouse];+Tyrosine-protein kinase receptor TYRO3 [mouse]	inhibition rate		
1227	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase 11 [mouse]	inhibition rate		
1228	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase 16 [mouse]	inhibition rate		
1229	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ribosomal protein S6 kinase alpha-5 [mouse]	inhibition rate		
1230	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ribosomal protein S6 kinase alpha-5 [mouse]; Ribosomal protein S6 kinase alpha-4 [mouse]	inhibition rate		
1231	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Hepatocyte growth factor-like [mouse]	inhibition rate		
1232	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Hepatocyte growth factor-like [mouse]; Histone acetyltransferase mst2 [mouse]	inhibition rate		
1233	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase 24 [mouse]	inhibition rate		
1234	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase 26 [mouse]; Serine/threonine-protein kinase 25 [mouse]	inhibition rate		
1235	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Protein NDR1 [mouse]	inhibition rate		
1236	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Neurogenic differentiation factor 2 [mouse]	inhibition rate		
1237	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase Nek1 [mouse]	inhibition rate		
1238	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase Nek7 [mouse]	inhibition rate		
1239	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase Nek9 [mouse]	inhibition rate		
1240	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	NUAK family SNF1-like kinase 1 [mouse]	inhibition rate		
1241	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase OSR1 [mouse]	inhibition rate		
1242	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ribosomal protein S6 kinase beta-1 [mouse]	inhibition rate		
1243	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase 16 [mouse]	inhibition rate		
1244	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase 16 [mouse]; Cyclin-dependent kinase 17 [mouse];+Cyclin-dependent kinase 18 [mouse]	inhibition rate		
1245	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase 17 [mouse];+Cyclin-dependent kinase 18 [mouse]	inhibition rate		
1246	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	3-phosphoinositide-dependent protein kinase 1 [mouse]	inhibition rate		
1247	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 4-kinase alpha [mouse]	inhibition rate		
1248	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 4-kinase beta [mouse]	inhibition rate		
1249	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 3-kinase catalytic subunit type 3 [mouse]	inhibition rate		
1250	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [mouse]	inhibition rate		
1251	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma [mouse]	inhibition rate		
1252	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha [mouse]	inhibition rate		
1253	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma [mouse]	inhibition rate		
1254	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	1-phosphatidylinositol 3-phosphate 5-kinase [mouse]	inhibition rate		
1255	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Protein kinase C alpha type [mouse]	inhibition rate		
1256	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Protein kinase C gamma type [mouse]	inhibition rate		
1257	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	14 kDa zinc-binding protein [mouse]	inhibition rate		
1258	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase SIK3 [mouse]	inhibition rate		
1259	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase SIK3 [mouse]; Testis-specific serine/threonine-protein kinase 3 [mouse]	inhibition rate		
1260	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Rho-associated protein kinase 1 [mouse];+Rho-associated protein kinase 2 [mouse]	inhibition rate		
1261	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ribosomal protein S6 kinase alpha-3 [mouse]; Ribosomal protein S6 kinase alpha-1 [mouse];+Ribosomal protein S6 kinase alpha-2 [mouse]	inhibition rate		
1262	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ribosomal protein S6 kinase alpha-1 [mouse];+Ribosomal protein S6 kinase alpha-2 [mouse]	inhibition rate		
1263	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ribosomal protein S6 kinase alpha-1 [mouse]	inhibition rate		
1264	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ribosomal protein S6 kinase alpha-1 [mouse]; Ribosomal protein S6 kinase alpha-3 [mouse]	inhibition rate		
1265	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	G-type lectin S-receptor-like serine/threonine-protein kinase SD1-13 [mouse]	inhibition rate		
1266	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ribosomal protein S6 kinase alpha-5 [mouse]	inhibition rate		
1267	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase Sgk3 [mouse]	inhibition rate		
1268	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	STE20-like serine/threonine-protein kinase [mouse]	inhibition rate		
1269	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase SMG1 [mouse]	inhibition rate		
1270	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	SNF-related serine/threonine-protein kinase [mouse]	inhibition rate		
1271	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	SRSF protein kinase 2 [mouse];+CBL-interacting serine/threonine-protein kinase 7 [mouse]	inhibition rate		
1272	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase SYK [mouse]	inhibition rate		
1273	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase TAO1 [mouse];+Serine/threonine-protein kinase TAO3 [mouse]	inhibition rate		
1274	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase TBK1 [mouse]	inhibition rate		
1275	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase tousled-like 1 [mouse]	inhibition rate		
1276	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	BDNF/NT-3 growth factors receptor [mouse]	inhibition rate		
1277	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Glutathione-regulated potassium-efflux system protein KefC [mouse]	inhibition rate		
1278	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase ULK3 [mouse]	inhibition rate		
1279	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase DCLK1 [mouse]	inhibition rate		
1280	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Probable serine/threonine-protein kinase WNK2 [mouse];+proenkephalin-a [mouse]	inhibition rate		
1281	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase 32B [mouse];+Serine/threonine-protein kinase 32C [mouse];+Serine/threonine-protein kinase 32A [mouse]	inhibition rate		
1282	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase 25 [mouse]	inhibition rate		
1283	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase kinase 4 [mouse];+16 kDa gamma-zein [mouse]	inhibition rate		
1284	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase kinase 4 [mouse];+16 kDa gamma-zein [mouse]; Traf2 and NCK-interacting protein kinase [mouse];+Zinc finger C2HC domain-containing protein 1A [mouse]; Misshapen-like kinase 1 [mouse]	inhibition rate		
1285	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Traf2 and NCK-interacting protein kinase [mouse];+Zinc finger C2HC domain-containing protein 1A [mouse]	inhibition rate		
1286	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Misshapen-like kinase 1 [mouse]	inhibition rate		
1287	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 4-kinase beta [human]	inhibition percentage	29	%
1288	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Interleukin-1 receptor-associated kinase 3 [human]	inhibition percentage	37	%
1289	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C		Papp (A-B)	1.2E-6	cm/s
1290	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C		BA/AB transport ratio	22	no unit
1291	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C		CL (drug clearance)	1.4	l/h/kg
1292	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C		CL (drug clearance)	3.2	l/h/kg
1293	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C		Vdss	1.8	l/kg
1294	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C		t1/2 (drug half life)	0.6	h
1295	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C		F (drug bioavailability)	96	%
1296	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C		CL (drug clearance)	4.6	l/h/kg
1297	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C		Vdss	1.1	l/kg
1298	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C		t1/2 (drug half life)	0.2	h
1299	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C		F (drug bioavailability)	1	%
1300	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Adenosine A2B receptor [human]	binding percentage	26	%
1301	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C		drug concentration	73	ng/g
1302	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C		drug concentration	1613	ng/ml
1303	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C		drug concentration	675	ng/g
1304	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C		drug concentration	1081	ng/g
1305	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C		drug concentration	100	ng/ml
1306	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C		drug concentration	1599	ng/ml
1307	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C		brain-to-plasma ratio	0.15	no unit
1308	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C		unbound brain-to-plasma ratio	0.02	no unit
1309	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C		drug concentration	17	ng/g
1310	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C		drug concentration	440	ng/ml
1311	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C		brain-to-plasma ratio	0.04	no unit
1312	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C		unbound brain-to-plasma ratio	0.014	no unit
1313	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C		brain-to-plasma ratio	0.15	no unit
1314	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C		brain-to-plasma ratio	0.65	no unit
1315	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C		unbound brain-to-plasma ratio	0.056	no unit
1316	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C		unbound brain-to-plasma ratio	0.24	no unit
1317	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	AP2-associated protein kinase 1	inhibition percentage	0	%
1318	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase ABL1-Phosphorylated	inhibition percentage	6	%
1319	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase ABL1-nonphosphorylated	inhibition percentage	34	%
1320	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase ABL1-Phosphorylated	inhibition percentage	12	%
1321	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase ABL1-nonphosphorylated	inhibition percentage	28	%
1322	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase ABL1-Phosphorylated	inhibition percentage	32	%
1323	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase ABL1-nonphosphorylated	inhibition percentage	14	%
1324	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase ABL1-Phosphorylated	inhibition percentage	1	%
1325	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase ABL1-Phosphorylated	inhibition percentage	4	%
1326	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase ABL1-nonphosphorylated	inhibition percentage	26	%
1327	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase ABL1-Phosphorylated	inhibition percentage	16	%
1328	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase ABL1-nonphosphorylated	inhibition percentage	13	%
1329	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase ABL1-Phosphorylated	inhibition percentage	33	%
1330	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase ABL1-Phosphorylated	inhibition percentage	14	%
1331	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase ABL1-nonphosphorylated	inhibition percentage	14	%
1332	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase ABL1-Phosphorylated	inhibition percentage	6	%
1333	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase ABL2	inhibition percentage	0	%
1334	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Activin receptor type-1	inhibition percentage	0	%
1335	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Activin receptor type-1B	inhibition percentage	0	%
1336	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Activin receptor type-2A	inhibition percentage	8	%
1337	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Activin receptor type-2B	inhibition percentage	3	%
1338	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase receptor R3	inhibition percentage	0	%
1339	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Atypical kinase COQ8A, mitochondrial	inhibition percentage	1	%
1340	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Atypical kinase COQ8B, mitochondrial	inhibition percentage	13	%
1341	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	RAC-alpha serine/threonine-protein kinase	inhibition percentage	0	%
1342	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	RAC-beta serine/threonine-protein kinase	inhibition percentage	14	%
1343	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	RAC-gamma serine/threonine-protein kinase	inhibition percentage	4	%
1344	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	ALK tyrosine kinase receptor	inhibition percentage	0	%
1345	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	ALK tyrosine kinase receptor	inhibition percentage	9	%
1346	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	ALK tyrosine kinase receptor	inhibition percentage	0	%
1347	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	5'-AMP-activated protein kinase catalytic subunit alpha-1	inhibition percentage	0	%
1348	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	5'-AMP-activated protein kinase catalytic subunit alpha-2	inhibition percentage	0	%
1349	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ankyrin repeat and protein kinase domain-containing protein 1	inhibition percentage	0	%
1350	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	NUAK family SNF1-like kinase 1	inhibition percentage	9	%
1351	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase 5	inhibition percentage	1	%
1352	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase 6	inhibition percentage	0	%
1353	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Aurora kinase A	inhibition percentage	15	%
1354	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Aurora kinase B	inhibition percentage	0	%
1355	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Aurora kinase C	inhibition percentage	7	%
1356	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase receptor UFO	inhibition percentage	0	%
1357	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	BMP-2-inducible protein kinase	inhibition percentage	6	%
1358	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase Blk	inhibition percentage	0	%
1359	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Bone morphogenetic protein receptor type-1A	inhibition percentage	0	%
1360	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Bone morphogenetic protein receptor type-1B	inhibition percentage	12	%
1361	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Bone morphogenetic protein receptor type-2	inhibition percentage	0	%
1362	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cytoplasmic tyrosine-protein kinase BMX	inhibition percentage	9	%
1363	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase B-raf	inhibition percentage	1	%
1364	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase B-raf (V600E)	inhibition percentage	0	%
1365	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Protein-tyrosine kinase 6	inhibition percentage	3	%
1366	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase BRSK1	inhibition percentage	10	%
1367	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase BRSK2	inhibition percentage	2	%
1368	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase BTK	inhibition percentage	43	%
1369	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitotic checkpoint serine/threonine-protein kinase BUB1	inhibition percentage	21	%
1370	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Calcium/calmodulin-dependent protein kinase type 1	inhibition percentage	0	%
1371	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Calcium/calmodulin-dependent protein kinase type 1B	inhibition percentage	8	%
1372	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Calcium/calmodulin-dependent protein kinase type 1D	inhibition percentage	0	%
1373	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Calcium/calmodulin-dependent protein kinase type 1G	inhibition percentage	0	%
1374	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Calcium/calmodulin-dependent protein kinase type II subunit alpha	inhibition percentage	0	%
1375	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Calcium/calmodulin-dependent protein kinase type II subunit beta	inhibition percentage	0	%
1376	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Calcium/calmodulin-dependent protein kinase type II subunit delta	inhibition percentage	0	%
1377	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Calcium/calmodulin-dependent protein kinase type II subunit gamma	inhibition percentage	0	%
1378	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Calcium/calmodulin-dependent protein kinase type IV	inhibition percentage	0	%
1379	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Calcium/calmodulin-dependent protein kinase kinase 1	inhibition percentage	0	%
1380	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Calcium/calmodulin-dependent protein kinase kinase 2	inhibition percentage	0	%
1381	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Peripheral plasma membrane protein CASK	inhibition percentage	2	%
1382	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase 11B	inhibition percentage	15	%
1383	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase 11A	inhibition percentage	7	%
1384	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase 13	inhibition percentage	0	%
1385	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase 11	inhibition percentage	0	%
1386	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase 2	inhibition percentage	7	%
1387	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase 3	inhibition percentage	9	%
1388	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase 4	inhibition percentage	31	%
1389	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase 4; Cyclin-dependent kinase 4	inhibition percentage	0	%
1390	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-D3-1; Cyclin-dependent kinase 4	inhibition percentage	5	%
1391	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent-like kinase 5	inhibition percentage	8	%
1392	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase 7	inhibition percentage	45	%
1393	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase 8	inhibition percentage	6	%
1394	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase 9	inhibition percentage	17	%
1395	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase-like 1	inhibition percentage	11	%
1396	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase-like 2	inhibition percentage	0	%
1397	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase-like 3	inhibition percentage	2	%
1398	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase-like 5	inhibition percentage	0	%
1399	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase Chk1	inhibition percentage	7	%
1400	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase Chk2	inhibition percentage	9	%
1401	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Citron rho-interacting kinase	inhibition percentage	3	%
1402	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Dual specificity protein kinase CLK1	inhibition percentage	34	%
1403	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Dual specificity protein kinase CLK2	inhibition percentage	11	%
1404	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Dual specificity protein kinase CLK3	inhibition percentage	8	%
1405	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Dual specificity protein kinase CLK4	inhibition percentage	10	%
1406	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Macrophage colony-stimulating factor 1 receptor	inhibition percentage	4	%
1407	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Inactive Macrophage colony-stimulating factor 1 receptor	inhibition percentage	0	%
1408	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase CSK	inhibition percentage	8	%
1409	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Casein kinase I isoform alpha	inhibition percentage	2	%
1410	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Casein kinase I isoform alpha-like	inhibition percentage	1	%
1411	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Casein kinase I isoform delta	inhibition percentage	9	%
1412	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Casein kinase I isoform epsilon	inhibition percentage	1	%
1413	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Casein kinase I isoform gamma-1	inhibition percentage	9	%
1414	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Casein kinase I isoform gamma-2	inhibition percentage	3	%
1415	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Casein kinase I isoform gamma-3	inhibition percentage	13	%
1416	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Casein kinase II subunit alpha	inhibition percentage	6	%
1417	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Casein kinase II subunit alpha'	inhibition percentage	20	%
1418	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Megakaryocyte-associated tyrosine-protein kinase	inhibition percentage	1	%
1419	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Death-associated protein kinase 1	inhibition percentage	10	%
1420	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Death-associated protein kinase 2	inhibition percentage	0	%
1421	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Death-associated protein kinase 3	inhibition percentage	0	%
1422	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase DCLK1	inhibition percentage	9	%
1423	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase DCLK2	inhibition percentage	13	%
1424	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase DCLK3	inhibition percentage	0	%
1425	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Epithelial discoidin domain-containing receptor 1	inhibition percentage	2	%
1426	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Discoidin domain-containing receptor 2	inhibition percentage	34	%
1427	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase 12	inhibition percentage	37	%
1428	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Myotonin-protein kinase	inhibition percentage	0	%
1429	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase MRCK gamma	inhibition percentage	0	%
1430	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase 17A	inhibition percentage	17	%
1431	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase 17B	inhibition percentage	8	%
1432	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Dual specificity tyrosine-phosphorylation-regulated kinase 1A/B	inhibition percentage	7	%
1433	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	inhibition percentage	0	%
1434	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Dual specificity tyrosine-phosphorylation-regulated kinase 2	inhibition percentage	0	%
1435	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Epidermal growth factor receptor	inhibition percentage	9	%
1436	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Epidermal growth factor receptor	inhibition percentage	12	%
1437	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Epidermal growth factor receptor (G719C)	inhibition percentage	0	%
1438	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Epidermal growth factor receptor (G719S)	inhibition percentage	0	%
1439	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Epidermal growth factor receptor	inhibition percentage	16	%
1440	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Epidermal growth factor receptor	inhibition percentage	6	%
1441	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Epidermal growth factor receptor	inhibition percentage	0	%
1442	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Epidermal growth factor receptor (L858R)	inhibition percentage	10	%
1443	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	epidermal growth factor-activated receptor	inhibition percentage	0	%
1444	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Epidermal growth factor receptor (L861Q)	inhibition percentage	0	%
1445	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Epidermal growth factor receptor	inhibition percentage	0	%
1446	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Epidermal growth factor receptor (T790M)	inhibition percentage	1	%
1447	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Eukaryotic translation initiation factor 2-alpha kinase 1	inhibition percentage	33	%
1448	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ephrin type-A receptor 1	inhibition percentage	0	%
1449	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ephrin type-A receptor 2	inhibition percentage	0	%
1450	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ephrin type-A receptor 3	inhibition percentage	0	%
1451	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ephrin type-A receptor 4	inhibition percentage	7	%
1452	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ephrin type-A receptor 5	inhibition percentage	12	%
1453	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ephrin type-A receptor 6	inhibition percentage	8	%
1454	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ephrin type-A receptor 7	inhibition percentage	0	%
1455	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ephrin type-A receptor 8	inhibition percentage	14	%
1456	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ephrin type-B receptor 1	inhibition percentage	3	%
1457	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ephrin type-B receptor 2	inhibition percentage	0	%
1458	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ephrin type-B receptor 3	inhibition percentage	0	%
1459	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ephrin type-B receptor 4	inhibition percentage	0	%
1460	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ephrin type-B receptor 6	inhibition percentage	0	%
1461	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Receptor tyrosine-protein kinase erbB-2	inhibition percentage	12	%
1462	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Receptor tyrosine-protein kinase erbB-3	inhibition percentage	7	%
1463	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Receptor tyrosine-protein kinase erbB-4	inhibition percentage	7	%
1464	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase 3	inhibition percentage	0	%
1465	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase 1	inhibition percentage	10	%
1466	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase 6	inhibition percentage	3	%
1467	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase 4	inhibition percentage	19	%
1468	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase 7	inhibition percentage	6	%
1469	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase 15	inhibition percentage	11	%
1470	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase/endoribonuclease IRE1	inhibition percentage	44	%
1471	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Focal adhesion kinase 1	inhibition percentage	0	%
1472	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase Fer	inhibition percentage	0	%
1473	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase, Fes/Fps type	inhibition percentage	0	%
1474	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Fibroblast growth factor receptor 1	inhibition percentage	0	%
1475	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Fibroblast growth factor receptor 2	inhibition percentage	0	%
1476	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Fibroblast growth factor receptor 3	inhibition percentage	2	%
1477	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Fibroblast growth factor receptor 3	inhibition percentage	0	%
1478	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Fibroblast growth factor receptor 4	inhibition percentage	11	%
1479	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase Fgr	inhibition percentage	1	%
1480	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Vascular endothelial growth factor receptor 1	inhibition percentage	0	%
1481	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	28	%
1482	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Receptor-type tyrosine-protein kinase FLT3 (D835H)	inhibition percentage	66	%
1483	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Receptor-type tyrosine-protein kinase FLT3 (D835V)	inhibition percentage	90	%
1484	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Receptor-type tyrosine-protein kinase FLT3 (D835Y)	inhibition percentage	73	%
1485	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Receptor-type tyrosine-protein kinase FLT3 ITD	inhibition percentage	69	%
1486	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Receptor-type tyrosine-protein kinase FLT3 ITD	inhibition percentage	98	%
1487	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Receptor-type tyrosine-protein kinase FLT3 ITD	inhibition percentage	26	%
1488	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	8	%
1489	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	74	%
1490	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	11	%
1491	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Inactive Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	17	%
1492	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Vascular endothelial growth factor receptor 3	inhibition percentage	0	%
1493	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase FRK	inhibition percentage	2	%
1494	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase Fyn	inhibition percentage	9	%
1495	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-G-associated kinase	inhibition percentage	36	%
1496	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	eIF-2-alpha kinase Gcn2	inhibition percentage	14	%
1497	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	rhodopsin kinase	inhibition percentage	7	%
1498	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	G protein-coupled receptor kinase 2	inhibition percentage	0	%
1499	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Beta-adrenergic receptor kinase 2	inhibition percentage	0	%
1500	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	G protein-coupled receptor kinase 4	inhibition percentage	9	%
1501	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	rhodopsin kinase	inhibition percentage	13	%
1502	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Glycogen synthase kinase-3 alpha	inhibition percentage	16	%
1503	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	tau-protein kinase	inhibition percentage	0	%
1504	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Putative serine/threonine-protein kinase haspin homolog	inhibition percentage	20	%
1505	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase HCK	inhibition percentage	21	%
1506	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Homeodomain-interacting protein kinase 1	inhibition percentage	10	%
1507	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Homeodomain-interacting protein kinase 2	inhibition percentage	32	%
1508	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Homeodomain-interacting protein kinase 3	inhibition percentage	3	%
1509	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Homeodomain-interacting protein kinase 4	inhibition percentage	16	%
1510	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase kinase 1	inhibition percentage	0	%
1511	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Hormonally up-regulated neu tumor-associated kinase	inhibition percentage	0	%
1512	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase ICK	inhibition percentage	35	%
1513	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Insulin-like growth factor 1 receptor	inhibition percentage	0	%
1514	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Inhibitor of nuclear factor kappa-B kinase subunit alpha	inhibition percentage	5	%
1515	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Inhibitor of nuclear factor kappa-B kinase subunit beta	inhibition percentage	4	%
1516	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	inhibition percentage	0	%
1517	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Insulin receptor	inhibition percentage	9	%
1518	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Insulin receptor-related protein	inhibition percentage	14	%
1519	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Interleukin-1 receptor-associated kinase 1	inhibition percentage	0	%
1520	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Interleukin-1 receptor-associated kinase 3	inhibition percentage	8	%
1521	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Interleukin-1 receptor-associated kinase 4	inhibition percentage	11	%
1522	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase ITK/TSK	inhibition percentage	0	%
1523	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase JAK1	inhibition percentage	9	%
1524	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase JAK1	inhibition percentage	19	%
1525	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase JAK2	inhibition percentage	17	%
1526	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase JAK3	inhibition percentage	6	%
1527	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase 8	inhibition percentage	13	%
1528	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase 9	inhibition percentage	38	%
1529	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase 10	inhibition percentage	12	%
1530	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mast/stem cell growth factor receptor Kit	inhibition percentage	2	%
1531	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mast/stem cell growth factor receptor Kit (A829P)	inhibition percentage	19	%
1532	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mast/stem cell growth factor receptor Kit (D816H)	inhibition percentage	10	%
1533	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mast/stem cell growth factor receptor Kit (D816V)	inhibition percentage	0	%
1534	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mast/stem cell growth factor receptor Kit	inhibition percentage	14	%
1535	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mast/stem cell growth factor receptor Kit (V559D)	inhibition percentage	0	%
1536	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mast/stem cell growth factor receptor Kit	inhibition percentage	10	%
1537	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mast/stem cell growth factor receptor Kit	inhibition percentage	0	%
1538	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Inactive Mast/stem cell growth factor receptor Kit	inhibition percentage	1	%
1539	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase LATS1	inhibition percentage	0	%
1540	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase LATS2	inhibition percentage	10	%
1541	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase Lck	inhibition percentage	7	%
1542	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	LIM domain kinase 1	inhibition percentage	0	%
1543	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	LIM domain kinase 2	inhibition percentage	6	%
1544	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase STK11	inhibition percentage	25	%
1545	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase 10	inhibition percentage	10	%
1546	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Leucine-rich repeat serine/threonine-protein kinase 2	inhibition percentage	97	%
1547	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Leucine-rich repeat serine/threonine-protein kinase 2 (G2019S)	inhibition percentage	79	%
1548	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Leukocyte tyrosine kinase receptor	inhibition percentage	0	%
1549	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase Lyn	inhibition percentage	0	%
1550	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase 13	inhibition percentage	22	%
1551	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase MAK	inhibition percentage	6	%
1552	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase 1	inhibition percentage	9	%
1553	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase 15	inhibition percentage	7	%
1554	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase 2	inhibition percentage	8	%
1555	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase 3	inhibition percentage	12	%
1556	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase 4	inhibition percentage	0	%
1557	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase kinase 2	inhibition percentage	11	%
1558	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase kinase 3	inhibition percentage	0	%
1559	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase kinase 4	inhibition percentage	0	%
1560	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase kinase 5	inhibition percentage	10	%
1561	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	MAP kinase-activated protein kinase 2	inhibition percentage	0	%
1562	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	MAP kinase-activated protein kinase 5	inhibition percentage	8	%
1563	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase MARK1	inhibition percentage	0	%
1564	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase MARK2	inhibition percentage	10	%
1565	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase MARK3	inhibition percentage	0	%
1566	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	MAP/microtubule affinity-regulating kinase 4	inhibition percentage	0	%
1567	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Microtubule-associated serine/threonine-protein kinase 1	inhibition percentage	1	%
1568	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Dual specificity mitogen-activated protein kinase kinase 1	inhibition percentage	10	%
1569	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Dual specificity mitogen-activated protein kinase kinase 2	inhibition percentage	10	%
1570	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Dual specificity mitogen-activated protein kinase kinase 3	inhibition percentage	9	%
1571	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Dual specificity mitogen-activated protein kinase kinase 4	inhibition percentage	12	%
1572	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Dual specificity mitogen-activated protein kinase kinase 5	inhibition percentage	19	%
1573	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Dual specificity mitogen-activated protein kinase kinase 6	inhibition percentage	7	%
1574	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Maternal embryonic leucine zipper kinase	inhibition percentage	0	%
1575	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase Mer	inhibition percentage	27	%
1576	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Hepatocyte growth factor receptor	inhibition percentage	0	%
1577	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Hepatocyte growth factor receptor (M1250T)	inhibition percentage	9	%
1578	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Hepatocyte growth factor receptor (M1250T)	inhibition percentage	11	%
1579	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Misshapen-like kinase 1	inhibition percentage	9	%
1580	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Dual specificity mitogen-activated protein kinase kinase 7	inhibition percentage	0	%
1581	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	MAP kinase-interacting serine/threonine-protein kinase 1	inhibition percentage	12	%
1582	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	MAP kinase-interacting serine/threonine-protein kinase 2	inhibition percentage	26	%
1583	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	myosin light chain kinase	inhibition percentage	11	%
1584	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase 9	inhibition percentage	2	%
1585	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase 10	inhibition percentage	0	%
1586	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase 11	inhibition percentage	0	%
1587	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase MRCK alpha (Elsevier)	inhibition percentage	3	%
1588	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase MRCK beta (Elsevier)	inhibition percentage	0	%
1589	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Hepatocyte growth factor-like	inhibition percentage	0	%
1590	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Macrophage-stimulating protein receptor	inhibition percentage	14	%
1591	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase 3	inhibition percentage	7	%
1592	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase 24	inhibition percentage	15	%
1593	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase 26	inhibition percentage	6	%
1594	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase mTOR	inhibition percentage	11	%
1595	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Muscle, skeletal receptor tyrosine-protein kinase	inhibition percentage	9	%
1596	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Myosin light chain kinase, smooth muscle	inhibition percentage	2	%
1597	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Myosin light chain kinase 2, skeletal/cardiac muscle	inhibition percentage	0	%
1598	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Myosin light chain kinase family member 4	inhibition percentage	0	%
1599	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Myosin-IIIa	inhibition percentage	6	%
1600	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Myosin-IIIb	inhibition percentage	1	%
1601	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase 38	inhibition percentage	13	%
1602	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase 38-like	inhibition percentage	14	%
1603	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase Nek1	inhibition percentage	0	%
1604	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase Nek10	inhibition percentage	0	%
1605	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase Nek11	inhibition percentage	23	%
1606	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase Nek2	inhibition percentage	4	%
1607	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase Nek3	inhibition percentage	21	%
1608	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase Nek4	inhibition percentage	6	%
1609	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase Nek5	inhibition percentage	23	%
1610	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase Nek6	inhibition percentage	3	%
1611	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase Nek7	inhibition percentage	4	%
1612	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase Nek9	inhibition percentage	0	%
1613	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase 14	inhibition percentage	6	%
1614	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase NIM1	inhibition percentage	15	%
1615	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine kinase NLK	inhibition percentage	1	%
1616	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase OSR1	inhibition percentage	0	%
1617	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase 14	inhibition percentage	0	%
1618	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase 11	inhibition percentage	0	%
1619	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase 13	inhibition percentage	13	%
1620	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase 12	inhibition percentage	4	%
1621	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase PAK 1	inhibition percentage	10	%
1622	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase PAK2	inhibition percentage	16	%
1623	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase PAK 3	inhibition percentage	0	%
1624	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase PAK 4	inhibition percentage	9	%
1625	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase PAK 6	inhibition percentage	0	%
1626	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase PAK5	inhibition percentage	4	%
1627	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase 16	inhibition percentage	0	%
1628	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase 17	inhibition percentage	9	%
1629	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase 18	inhibition percentage	8	%
1630	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Platelet-derived growth factor receptor alpha	inhibition percentage	5	%
1631	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Platelet-derived growth factor receptor beta	inhibition percentage	1	%
1632	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	3-phosphoinositide-dependent protein kinase 1	inhibition percentage	0	%
1633	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Calcium-dependent protein kinase 1 [Plasmodium falciparum]	inhibition percentage	0	%
1634	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cell division control protein 2 homolog [Plasmodium falciparum]	inhibition percentage	0	%
1635	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase 15	inhibition percentage	0	%
1636	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Cyclin-dependent kinase 14	inhibition percentage	9	%
1637	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	inhibition percentage	9	%
1638	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	inhibition percentage	2	%
1639	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	inhibition percentage	0	%
1640	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	inhibition percentage	22	%
1641	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition percentage	0	%
1642	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (C420R)	inhibition percentage	1	%
1643	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E542K)	inhibition percentage	29	%
1644	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545A)	inhibition percentage	0	%
1645	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545K)	inhibition percentage	17	%
1646	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047L)	inhibition percentage	14	%
1647	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047Y)	inhibition percentage	1	%
1648	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition percentage	21	%
1649	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (M1043I)	inhibition percentage	10	%
1650	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (Q546K)	inhibition percentage	17	%
1651	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	inhibition percentage	20	%
1652	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	inhibition percentage	3	%
1653	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	inhibition percentage	0	%
1654	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 4-kinase beta	inhibition percentage	78	%
1655	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	1-phosphatidylinositol 3-phosphate 5-kinase	inhibition percentage	7	%
1656	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase pim-1	inhibition percentage	10	%
1657	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase pim-2	inhibition percentage	0	%
1658	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase pim-3	inhibition percentage	15	%
1659	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	inhibition percentage	0	%
1660	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	inhibition percentage	46	%
1661	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta	inhibition percentage	10	%
1662	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	inhibition percentage	69	%
1663	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	cAMP-dependent protein kinase catalytic subunit alpha	inhibition percentage	0	%
1664	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	cAMP-dependent protein kinase catalytic subunit beta	inhibition percentage	7	%
1665	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	inhibition percentage	23	%
1666	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase N1	inhibition percentage	7	%
1667	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase N2	inhibition percentage	8	%
1668	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase PknB [Mycobacterium tuberculosis]	inhibition percentage	6	%
1669	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase PLK1	inhibition percentage	1	%
1670	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase PLK2	inhibition percentage	6	%
1671	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase Plk3	inhibition percentage	4	%
1672	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase Plk4	inhibition percentage	12	%
1673	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Protein kinase C, delta	inhibition percentage	0	%
1674	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Protein kinase C, epsilon	inhibition percentage	19	%
1675	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Protein kinase C, eta	inhibition percentage	4	%
1676	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Protein kinase C iota type	inhibition percentage	11	%
1677	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Protein kinase C, theta	inhibition percentage	18	%
1678	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase D1	inhibition percentage	0	%
1679	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase D2	inhibition percentage	10	%
1680	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase D3	inhibition percentage	12	%
1681	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	cGMP-dependent protein kinase 1	inhibition percentage	9	%
1682	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	cGMP-dependent protein kinase 2	inhibition percentage	9	%
1683	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Interferon-induced, double-stranded RNA-activated protein kinase	inhibition percentage	13	%
1684	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	cAMP-dependent protein kinase catalytic subunit PRKX	inhibition percentage	5	%
1685	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase prp4	inhibition percentage	0	%
1686	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Protein-tyrosine kinase 2-beta	inhibition percentage	14	%
1687	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase SIK3	inhibition percentage	1	%
1688	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	RAF proto-oncogene serine/threonine-protein kinase	inhibition percentage	0	%
1689	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Proto-oncogene tyrosine-protein kinase receptor Ret	inhibition percentage	0	%
1690	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Proto-oncogene tyrosine-protein kinase receptor Ret (M918T)	inhibition percentage	0	%
1691	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Proto-oncogene tyrosine-protein kinase receptor Ret (V804L)	inhibition percentage	0	%
1692	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M)	inhibition percentage	0	%
1693	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase Rio1	inhibition percentage	0	%
1694	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase Rio2	inhibition percentage	8	%
1695	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase Rio3	inhibition percentage	9	%
1696	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Receptor-interacting serine/threonine-protein kinase 1	inhibition percentage	0	%
1697	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Receptor-interacting serine/threonine-protein kinase 2	inhibition percentage	47	%
1698	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Receptor-interacting serine/threonine-protein kinase 4	inhibition percentage	31	%
1699	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Dual serine/threonine and tyrosine protein kinase	inhibition percentage	11	%
1700	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Rho-associated protein kinase 1	inhibition percentage	0	%
1701	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Rho-associated protein kinase 2	inhibition percentage	2	%
1702	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Proto-oncogene tyrosine-protein kinase ROS	inhibition percentage	13	%
1703	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ribosomal protein S6 kinase alpha-4	inhibition percentage	0	%
1704	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ribosomal protein S6 kinase alpha-4	inhibition percentage	33	%
1705	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ribosomal protein S6 kinase alpha-5	inhibition percentage	0	%
1706	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ribosomal protein S6 kinase alpha-5	inhibition percentage	1	%
1707	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ribosomal protein S6 kinase alpha-1	inhibition percentage	7	%
1708	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ribosomal protein S6 kinase alpha-1	inhibition percentage	26	%
1709	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ribosomal protein S6 kinase alpha-3	inhibition percentage	0	%
1710	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ribosomal protein S6 kinase alpha-3	inhibition percentage	4	%
1711	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ribosomal protein S6 kinase alpha-2	inhibition percentage	9	%
1712	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ribosomal protein S6 kinase alpha-2	inhibition percentage	13	%
1713	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ribosomal protein S6 kinase alpha-6	inhibition percentage	16	%
1714	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ribosomal protein S6 kinase alpha-6	inhibition percentage	44	%
1715	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Ribosomal protein S6 kinase beta-1	inhibition percentage	0	%
1716	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase, Sbk1	inhibition percentage	0	%
1717	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase Sgk1	inhibition percentage	0	%
1718	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Uncharacterized serine/threonine-protein kinase SBK3	inhibition percentage	19	%
1719	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase Sgk2	inhibition percentage	0	%
1720	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase Sgk3	inhibition percentage	20	%
1721	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase SIK1	inhibition percentage	7	%
1722	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase SIK2	inhibition percentage	6	%
1723	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	STE20-like serine/threonine-protein kinase	inhibition percentage	12	%
1724	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	NUAK family SNF1-like kinase 2	inhibition percentage	16	%
1725	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	SNF-related serine/threonine-protein kinase	inhibition percentage	18	%
1726	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Proto-oncogene tyrosine-protein kinase Src	inhibition percentage	0	%
1727	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase Srms	inhibition percentage	1	%
1728	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	SRSF protein kinase 1	inhibition percentage	34	%
1729	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	SRSF protein kinase 2	inhibition percentage	0	%
1730	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	SRSF protein kinase 3	inhibition percentage	0	%
1731	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase 16	inhibition percentage	0	%
1732	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase 33	inhibition percentage	6	%
1733	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase 35	inhibition percentage	4	%
1734	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase 36	inhibition percentage	0	%
1735	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	STE20/SPS1-related proline-alanine-rich protein kinase	inhibition percentage	9	%
1736	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase SYK	inhibition percentage	16	%
1737	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase 7	inhibition percentage	29	%
1738	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase TAO1	inhibition percentage	11	%
1739	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase TAO2	inhibition percentage	4	%
1740	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase TAO3	inhibition percentage	5	%
1741	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase TBK1	inhibition percentage	0	%
1742	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase Tec	inhibition percentage	0	%
1743	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Dual specificity testis-specific protein kinase 1	inhibition percentage	0	%
1744	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	TGF-beta receptor type-1	inhibition percentage	0	%
1745	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	TGF-beta receptor type-2	inhibition percentage	0	%
1746	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase receptor Tie-1	inhibition percentage	16	%
1747	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase receptor Tie-2	inhibition percentage	0	%
1748	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase tousled-like 1	inhibition percentage	22	%
1749	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase TOUSLED-like 2	inhibition percentage	0	%
1750	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Traf2 and NCK-interacting protein kinase	inhibition percentage	4	%
1751	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Non-receptor tyrosine-protein kinase TNK1	inhibition percentage	0	%
1752	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Activated CDC42 kinase 1 (Elsevier)	inhibition percentage	0	%
1753	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase TNNI3K	inhibition percentage	59	%
1754	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	High affinity nerve growth factor receptor	inhibition percentage	47	%
1755	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	BDNF/NT-3 growth factors receptor	inhibition percentage	18	%
1756	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	NT-3 growth factor receptor	inhibition percentage	21	%
1757	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Transient receptor potential cation channel subfamily M member 6	inhibition percentage	4	%
1758	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Testis-specific serine/threonine-protein kinase 1	inhibition percentage	9	%
1759	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Testis-specific serine/threonine-protein kinase 3	inhibition percentage	0	%
1760	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Dual specificity protein kinase TTK	inhibition percentage	39	%
1761	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase TXK	inhibition percentage	5	%
1762	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Non-receptor tyrosine-protein kinase TYK2	inhibition percentage	26	%
1763	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Non-receptor tyrosine-protein kinase TYK2	inhibition percentage	13	%
1764	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase receptor TYRO3	inhibition percentage	5	%
1765	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase ULK1	inhibition percentage	6	%
1766	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase ULK2	inhibition percentage	0	%
1767	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase ULK3	inhibition percentage	1	%
1768	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Vascular endothelial growth factor receptor 2	inhibition percentage	0	%
1769	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Phosphatidylinositol 3-kinase catalytic subunit type 3	inhibition percentage	0	%
1770	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase VRK2	inhibition percentage	18	%
1771	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Wee1-like protein kinase	inhibition percentage	0	%
1772	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Wee1-like protein kinase 2	inhibition percentage	0	%
1773	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Probable serine/threonine-protein kinase WNK1	inhibition percentage	0	%
1774	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Probable serine/threonine-protein kinase WNK2	inhibition percentage	14	%
1775	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Probable serine/threonine-protein kinase WNK3	inhibition percentage	11	%
1776	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Probable serine/threonine-protein kinase WNK4	inhibition percentage	4	%
1777	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase 32A	inhibition percentage	14	%
1778	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase 32B	inhibition percentage	2	%
1779	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase 32C	inhibition percentage	4	%
1780	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase yes	inhibition percentage	0	%
1781	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Serine/threonine-protein kinase 25	inhibition percentage	0	%
1782	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase 19	inhibition percentage	19	%
1783	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Mitogen-activated protein kinase kinase kinase 20	inhibition percentage	2	%
1784	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	Tyrosine-protein kinase ZAP-70	inhibition percentage	5	%
1785	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C		Papp (A-B)	4.3E-6	cm/s
1786	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C		BA/AB transport ratio	0.9	no unit
1787	CC1=NNC2=C1C=C(C=C2)C1=CN=CC(N[C@@H](CO)C2=CC=CC=C2)=N1	Cyclin-dependent kinase 9	IC50	6.04	nM
1788	CC1=NNC2=C1C=C(C=C2)C1=CN=CC(N[C@@H](CO)C2=CC=CC=C2)=N1	Cyclin-dependent kinase 7	IC50	6.04	nM
1789	CC1=NNC2=C1C=C(C=C2)C1=CN=CC(N[C@@H](CO)C2=CC=CC=C2)=N1	Cyclin-dependent kinase 2	IC50	67.44	nM
1790	CC1=NNC2=C1C=C(C=C2)C1=CN=CC(N[C@@H](CO)C2=CC=CC=C2)=N1	Cyclin-dependent kinase 4	IC50	1000	nM
1791	CC1=NNC2=C1C=C(C=C2)C1=CN=CC(N[C@@H](CO)C2=CC=CC=C2)=N1	Cyclin-dependent kinase 6	IC50	1000	nM
1792	CC1=NNC2=C1C=C(C=C2)C1=CN=CC(NC2CCCC(O)C2)=N1	Cyclin-dependent kinase 7	IC50	6.57	nM
1793	CC1=NNC2=C1C=C(C=C2)C1=CN=CC(NC2CCCC(O)C2)=N1	Cyclin-dependent kinase 2	IC50	52.86	nM
1794	CC1=NNC2=C1C=C(C=C2)C1=CN=CC(NC2CCCC(O)C2)=N1	Cyclin-dependent kinase 9	IC50	642.95	nM
1795	CC1=NNC2=C1C=C(C=C2)C1=CN=CC(NC2CCCC(O)C2)=N1	Cyclin-dependent kinase 4	IC50	1000	nM
1796	CC1=NNC2=C1C=C(C=C2)C1=CN=CC(NC2CCCC(O)C2)=N1	Cyclin-dependent kinase 6	IC50	1000	nM
1797	CC1=NNC2=C1C=C(C=C2)C1=CN=CC(N[C@@H](CO)C2=CC=CC(F)=C2)=N1	Cyclin-dependent kinase 9	IC50	9.15	nM
1798	CC1=NNC2=C1C=C(C=C2)C1=CN=CC(N[C@@H](CO)C2=CC=CC(F)=C2)=N1	Cyclin-dependent kinase 7	IC50	9.15	nM
1799	CC1=NNC2=C1C=C(C=C2)C1=CN=CC(N[C@@H](CO)C2=CC=CC(F)=C2)=N1	Cyclin-dependent kinase 2	IC50	34.48	nM
1800	CC1=NNC2=C1C=C(C=C2)C1=CN=CC(N[C@@H](CO)C2=CC=CC(F)=C2)=N1	Cyclin-dependent kinase 4	IC50	1000	nM
1801	CC1=NNC2=C1C=C(C=C2)C1=CN=CC(N[C@@H](CO)C2=CC=CC(F)=C2)=N1	Cyclin-dependent kinase 6	IC50	1000	nM
1802	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	AP2-associated protein kinase 1	IC50	12	nM
1803	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	AP2-associated protein kinase 1 [human]	IC50	51	nM
1804	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	BMP-2-inducible protein kinase	IC50	0.12	μM
1805	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Citron rho-interacting kinase	IC50	0.12	μM
1806	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	cAMP-dependent protein kinase catalytic subunit PRKX	IC50	0.326	μM
1807	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	MAP kinase-interacting serine/threonine-protein kinase 2	IC50	0.428	μM
1808	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	MAP kinase-interacting serine/threonine-protein kinase 1	IC50	0.507	μM
1809	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Protein kinase A	IC50	0.57	μM
1810	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase haspin	IC50	0.922	μM
1811	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Cyclin-G-associated kinase	IC50	1.06	μM
1812	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Protein kinase C, theta	IC50	1.33	μM
1813	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Dual specificity protein kinase CLK4	IC50	1.93	μM
1814	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Androgen receptor	IC50	6	μM
1815	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	AP2-associated protein kinase 1 [mouse]	EC50	8.3	μM
1816	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Voltage-dependent calcium channel, L-type	IC50	16	μM
1817	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	voltage-gated sodium channel	IC50	21	μM
1818	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Sodium-dependent dopamine transporter	IC50	25	μM
1819	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Sodium-dependent noradrenaline transporter	IC50	26	μM
1820	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Alpha 1B adrenoceptor	IC50	30	μM
1821	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Alpha 1D adrenoceptor	IC50	30	μM
1822	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Alpha 2A adrenoceptor	IC50	30	μM
1823	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Alpha 2C adrenoceptor	IC50	30	μM
1824	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Dopamine D1 receptor	IC50	30	μM
1825	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Histamine H1 receptor	IC50	30	μM
1826	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Histamine H2 receptor	IC50	30	μM
1827	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Muscarinic acetylcholine receptor M2	IC50	30	μM
1828	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mu opioid receptor	IC50	30	μM
1829	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Kappa opioid receptor	IC50	30	μM
1830	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	5-Hydroxytryptamine 2A receptor	IC50	10	μM
1831	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	5-Hydroxytryptamine 2B receptor	IC50	10	μM
1832	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Sodium-dependent serotonin transporter	IC50	30	μM
1833	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	acetylcholinesterase (activity)	IC50	60	μM
1834	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Amine oxidase [flavin-containing] A	IC50	30	μM
1835	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	cAMP-specific 3',5'-cAMP phosphodiesterase 4	IC50	30	μM
1836	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		latency to fall change		
1837	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		brain-to-plasma ratio	1.04	no unit
1838	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		unbount brain-to- unbound plasma ratio	0.71	no unit
1839	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		concentration (parameter)	17.7	μM
1840	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		concentration (parameter)	18.5	μM
1841	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	AP2-associated protein kinase 1 [mouse]	ED50	6	mg/kg
1842	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	AP2-associated protein kinase 1 [mouse]	phosphorylation level decrease		
1843	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	AP2-associated protein kinase 1 [mouse]	nH (Hill coefficient)	1.112	no unit
1844	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	AP2-associated protein kinase 1 [rat]	number of flinches decrease in phase II		
1845	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	AP2-associated protein kinase 1 [rat]	paw licking/biting decrease in phase II		
1846	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	AP2-associated protein kinase 1 [rat]	nociceptive threshold decrease	35	%
1847	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	AP2-associated protein kinase 1 [rat]	nociceptive threshold decrease	45	%
1848	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	AP2-associated protein kinase 1 [rat]	nociceptive threshold decrease	90	%
1849	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	AP2-associated protein kinase 1 [rat]	paw withdrawal latency decrease	113	%
1850	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		percentage of remaining compound	84	%
1851	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		percentage of remaining compound	68	%
1852	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		percentage of remaining compound	46	%
1853	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	AP2-associated protein kinase 1 [rat]	paw withdrawal threshold decrease	42	%
1854	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	AP2-associated protein kinase 1 [rat]	paw withdrawal latency decrease	49	%
1855	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		concentration (parameter)	83	μM
1856	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		concentration (parameter)	39	μM
1857	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		brain-to-plasma ratio	0.5	no unit
1858	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		unbount brain-to- unbound plasma ratio	0.7	no unit
1859	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		concentration (parameter)	1.1	μM
1860	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		concentration (parameter)	0.4	μM
1861	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		concentration (parameter)	52	μM
1862	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		concentration (parameter)	11	μM
1863	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		concentration (parameter)	0.35	μM
1864	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		concentration (parameter)	0.9	μM
1865	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		concentration (parameter)	7	μM
1866	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		concentration (parameter)	33	μM
1867	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		unbound concentration	0.01	μM
1868	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		unbound concentration	0.02	μM
1869	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		unbound concentration	0.22	μM
1870	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		unbound concentration	1.04	μM
1871	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		unbound concentration	0.01	μM
1872	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		unbound concentration	0.03	μM
1873	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		unbound concentration	0.2	μM
1874	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		unbound concentration	0.92	μM
1875	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		concentration (parameter)	34	μM
1876	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		concentration (parameter)	7.4	μM
1877	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		concentration (parameter)	84	μM
1878	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Cyclin-dependent kinase-like 3	inhibition rate	0	%
1879	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Cyclin-dependent kinase-like 5	inhibition rate	0	%
1880	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase Chk1	inhibition rate	0	%
1881	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase Chk2	inhibition rate	0	%
1882	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Casein kinase I isoform alpha (isoform 2)	inhibition rate	10	%
1883	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Casein kinase I isoform delta	inhibition rate	26	%
1884	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Casein kinase I isoform epsilon	inhibition rate	21	%
1885	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Casein kinase I isoform gamma-1	inhibition rate	4	%
1886	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Casein kinase I isoform gamma-2	inhibition rate	9	%
1887	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Casein kinase I isoform gamma-3	inhibition rate	10	%
1888	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Casein kinase II subunit alpha	inhibition rate	45	%
1889	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Casein kinase II subunit alpha'	inhibition rate	48	%
1890	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase 35	inhibition rate	4	%
1891	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase atg1	inhibition rate	47	%
1892	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Dual specificity protein kinase CLK2	inhibition rate	25	%
1893	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Dual specificity protein kinase CLK3	inhibition rate	28	%
1894	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase CSK	inhibition rate	2	%
1895	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Megakaryocyte-associated tyrosine-protein kinase	inhibition rate	0	%
1896	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Death-associated protein kinase 1	inhibition rate	65	%
1897	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Death-associated protein kinase 2	inhibition rate	14	%
1898	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Death-associated protein kinase 3	inhibition rate	46	%
1899	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase DCLK1	inhibition rate	2	%
1900	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase DCLK2	inhibition rate	0	%
1901	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase DCLK3	inhibition rate	0	%
1902	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Epithelial discoidin domain-containing receptor 1	inhibition rate	0	%
1903	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Discoidin domain-containing receptor 2	inhibition rate	0	%
1904	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Death-associated protein kinase 3	inhibition rate	58	%
1905	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Myotonin-protein kinase (isoform 1)	inhibition rate	10	%
1906	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase MRCK gamma	inhibition rate	11	%
1907	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase 17A	inhibition rate	39	%
1908	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase 17B	inhibition rate	17	%
1909	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 1A/B	inhibition rate	44	%
1910	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	inhibition rate	34	%
1911	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 2	inhibition rate	32	%
1912	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Epidermal growth factor receptor	inhibition rate	0	%
1913	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Epidermal growth factor receptor (L858R)	inhibition rate	0	%
1914	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Epidermal growth factor receptor (T790M)	inhibition rate	3	%
1915	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Epidermal growth factor receptor (L861Q)	inhibition rate	34	%
1916	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Epidermal growth factor receptor	inhibition rate	16	%
1917	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Epidermal growth factor receptor	inhibition rate	29	%
1918	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Epidermal growth factor receptor (G719C)	inhibition rate	11	%
1919	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Epidermal growth factor receptor (G719S)	inhibition rate	9	%
1920	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Epidermal growth factor receptor	inhibition rate	0	%
1921	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Epidermal growth factor receptor	inhibition rate	19	%
1922	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Epidermal growth factor receptor	inhibition rate	0	%
1923	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Ephrin type-A receptor 1	inhibition rate	13	%
1924	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Ephrin type-A receptor 2	inhibition rate	0	%
1925	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Ephrin type-A receptor 3	inhibition rate	0	%
1926	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Ephrin type-A receptor 4	inhibition rate	0	%
1927	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Ephrin type-A receptor 5	inhibition rate	0	%
1928	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Ephrin type-A receptor 6	inhibition rate	0	%
1929	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Ephrin type-A receptor 7	inhibition rate	0	%
1930	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Ephrin type-A receptor 8	inhibition rate	0	%
1931	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Ephrin type-B receptor 1	inhibition rate	0	%
1932	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Ephrin type-B receptor 2	inhibition rate	0	%
1933	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Ephrin type-B receptor 3	inhibition rate	0	%
1934	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Ephrin type-B receptor 4	inhibition rate	0	%
1935	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Ephrin type-B receptor 6	inhibition rate	0	%
1936	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	MAP kinase	inhibition rate	11	%
1937	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mitogen-activated protein kinase 1	inhibition rate	13	%
1938	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mitogen-activated protein kinase 6	inhibition rate	26	%
1939	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mitogen-activated protein kinase 4	inhibition rate	0	%
1940	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mitogen-activated protein kinase 7	inhibition rate	0	%
1941	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Extracellular signal-regulated kinase 7	inhibition rate	32	%
1942	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Focal adhesion kinase 1	inhibition rate	16	%
1943	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase Fer	inhibition rate	0	%
1944	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase, Fes/Fps type	inhibition rate	0	%
1945	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Fibroblast growth factor receptor 1	inhibition rate	0	%
1946	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Fibroblast growth factor receptor 2	inhibition rate	26	%
1947	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Fibroblast growth factor receptor 3	inhibition rate	15	%
1948	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Fibroblast growth factor receptor 3	inhibition rate	14	%
1949	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Fibroblast growth factor receptor 4	inhibition rate	12	%
1950	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase Fgr	inhibition rate	0	%
1951	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Vascular endothelial growth factor receptor 1	inhibition rate	0	%
1952	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	12	%
1953	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Receptor-type tyrosine-protein kinase FLT3 (D835H)	inhibition rate	8	%
1954	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Receptor-type tyrosine-protein kinase FLT3 (D835Y)	inhibition rate	31	%
1955	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Receptor-type tyrosine-protein kinase FLT3 (ITD)	inhibition rate	14	%
1956	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	30	%
1957	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	19	%
1958	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Vascular endothelial growth factor receptor 3	inhibition rate	0	%
1959	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Macrophage colony-stimulating factor 1 receptor	inhibition rate	0	%
1960	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase FRK	inhibition rate	8	%
1961	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase fused	inhibition rate	6	%
1962	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase Fyn	inhibition rate	4	%
1963	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mitogen-activated protein kinase kinase kinase kinase 2	inhibition rate	13	%
1964	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	eIF-2-alpha kinase Gcn2	inhibition rate	0	%
1965	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	G protein-coupled receptor kinase 4	inhibition rate	87	%
1966	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	MAP kinase-interacting serine/threonine-protein kinase 2	inhibition rate	41	%
1967	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Glycogen synthase kinase-3 alpha	inhibition rate	0	%
1968	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	tau-protein kinase	inhibition rate	0	%
1969	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase HCK	inhibition rate	7	%
1970	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Receptor tyrosine-protein kinase erbB-2	inhibition rate	0	%
1971	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Receptor tyrosine-protein kinase erbB-3	inhibition rate	51	%
1972	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Receptor tyrosine-protein kinase erbB-4	inhibition rate	15	%
1973	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase TNNI3K	inhibition rate	8	%
1974	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mitogen-activated protein kinase kinase kinase kinase 1	inhibition rate	29	%
1975	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Homeodomain-interacting protein kinase 2	inhibition rate	0	%
1976	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Homeodomain-interacting protein kinase 3	inhibition rate	0	%
1977	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Homeodomain-interacting protein kinase 4	inhibition rate	54	%
1978	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mitogen-activated protein kinase kinase kinase kinase 1	inhibition rate	0	%
1979	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Hormonally up-regulated neu tumor-associated kinase	inhibition rate	39	%
1980	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase ICK	inhibition rate	0	%
1981	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Insulin-like growth factor 1 receptor	inhibition rate	9	%
1982	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Inhibitor of nuclear factor kappa-B kinase subunit alpha	inhibition rate	0	%
1983	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Inhibitor of nuclear factor kappa-B kinase subunit beta	inhibition rate	5	%
1984	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	inhibition rate	0	%
1985	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Insulin receptor	inhibition rate	23	%
1986	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Interleukin-1 receptor-associated kinase 1	inhibition rate	0	%
1987	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Interleukin-1 receptor-associated kinase 3	inhibition rate	0	%
1988	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase/endoribonuclease IRE1	inhibition rate	12	%
1989	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Insulin receptor-related protein	inhibition rate	2	%
1990	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase ITK/TSK	inhibition rate	0	%
1991	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase JAK1	inhibition rate	0	%
1992	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase JAK1, pseudokinase	inhibition rate	0	%
1993	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase JAK2	inhibition rate	14	%
1994	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase JAK3	inhibition rate	0	%
1995	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mitogen-activated protein kinase 8	inhibition rate	6	%
1996	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mitogen-activated protein kinase 9	inhibition rate	16	%
1997	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mitogen-activated protein kinase 10	inhibition rate	0	%
1998	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Vascular endothelial growth factor receptor 2	inhibition rate	0	%
1999	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mast/stem cell growth factor receptor Kit	inhibition rate	0	%
2000	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mast/stem cell growth factor receptor Kit	inhibition rate	19	%
2001	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Kit ligand	inhibition rate	6	%
2002	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mast/stem cell growth factor receptor Kit (V559D)	inhibition rate	0	%
2003	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mast/stem cell growth factor receptor Kit (V559DT6)	inhibition rate	0	%
2004	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mast/stem cell growth factor receptor Kit (V559DV6)	inhibition rate	0	%
2005	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase LATS1	inhibition rate	59	%
2006	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase LATS2	inhibition rate	28	%
2007	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase Lck	inhibition rate	0	%
2008	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	LIM domain kinase 1	inhibition rate	0	%
2009	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	LIM domain kinase 2	inhibition rate	12	%
2010	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase STK11	inhibition rate	41	%
2011	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase 10	inhibition rate	0	%
2012	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Leukocyte tyrosine kinase receptor	inhibition rate	0	%
2013	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase Lyn	inhibition rate	0	%
2014	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mitogen-activated protein kinase kinase kinase 13	inhibition rate	11	%
2015	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase MAK	inhibition rate	0	%
2016	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	MAP kinase-activated protein kinase 2	inhibition rate	0	%
2017	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	MAP kinase-activated protein kinase 5	inhibition rate	0	%
2018	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Dual specificity mitogen-activated protein kinase kinase 1	inhibition rate	0	%
2019	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Dual specificity mitogen-activated protein kinase kinase 2	inhibition rate	0	%
2020	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Dual specificity mitogen-activated protein kinase kinase 3	inhibition rate	26	%
2021	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Dual specificity mitogen-activated protein kinase kinase 4	inhibition rate	11	%
2022	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Dual specificity mitogen-activated protein kinase kinase 6	inhibition rate	16	%
2023	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mitogen-activated protein kinase kinase kinase 1	inhibition rate	0	%
2024	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mitogen-activated protein kinase kinase kinase 15	inhibition rate	0	%
2025	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mitogen-activated protein kinase kinase kinase 2	inhibition rate	0	%
2026	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mitogen-activated protein kinase kinase kinase 3	inhibition rate	26	%
2027	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mitogen-activated protein kinase kinase kinase 4	inhibition rate	23	%
2028	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mitogen-activated protein kinase kinase kinase 5	inhibition rate	0	%
2029	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mitogen-activated protein kinase kinase kinase 6	inhibition rate	0	%
2030	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mitogen-activated protein kinase kinase kinase kinase 3	inhibition rate	0	%
2031	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mitogen-activated protein kinase kinase kinase kinase 5	inhibition rate	2	%
2032	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase MARK1	inhibition rate	0	%
2033	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase MARK2	inhibition rate	27	%
2034	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	MAP/microtubule affinity-regulating kinase 3	inhibition rate	0	%
2035	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	MAP/microtubule affinity-regulating kinase 4	inhibition rate	0	%
2036	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Microtubule-associated serine/threonine-protein kinase 1	inhibition rate	0	%
2037	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Maternal embryonic leucine zipper kinase	inhibition rate	9	%
2038	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase Mer	inhibition rate	11	%
2039	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Hepatocyte growth factor receptor	inhibition rate	16	%
2040	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Hepatocyte growth factor receptor (M1250T)	inhibition rate	11	%
2041	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Hepatocyte growth factor receptor	inhibition rate	37	%
2042	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mitogen-activated protein kinase kinase kinase 9	inhibition rate	4	%
2043	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Muscle, skeletal receptor tyrosine-protein kinase (isoform 1)	inhibition rate	2	%
2044	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mitogen-activated protein kinase kinase kinase 11	inhibition rate	0	%
2045	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase MRCK alpha	inhibition rate	27	%
2046	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase MRCK beta	inhibition rate	0	%
2047	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Lysine-tRNA ligase, mitochondrial	inhibition rate	0	%
2048	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Lysine-tRNA ligase, mitochondrial	inhibition rate	0	%
2049	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Ribosomal protein S6 kinase alpha-4	inhibition rate	8	%
2050	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Ribosomal protein S6 kinase alpha-4	inhibition rate	17	%
2051	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	SRSF protein kinase 3	inhibition rate	92.4	%
2052	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase 4	inhibition rate	0	%
2053	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase 3	inhibition rate	0	%
2054	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase 24	inhibition rate	8	%
2055	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase 26	inhibition rate	0	%
2056	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Muscle, skeletal receptor tyrosine-protein kinase	inhibition rate	0	%
2057	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Myosin-IIIa	inhibition rate	8	%
2058	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Myosin-IIIb	inhibition rate	18	%
2059	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase wee-1.3	inhibition rate	1	%
2060	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase NIM1	inhibition rate	0	%
2061	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine kinase NLK	inhibition rate	3	%
2062	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	NUAK family SNF1-like kinase 1	inhibition rate	0	%
2063	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	NUAK family SNF1-like kinase 2	inhibition rate	0	%
2064	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase OSR1	inhibition rate	26	%
2065	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase PAK 1	inhibition rate	0	%
2066	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase PAK2	inhibition rate	0	%
2067	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase PAK 3	inhibition rate	6	%
2068	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase PAK 4	inhibition rate	14	%
2069	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase PAK5	inhibition rate	23	%
2070	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase PAK 6	inhibition rate	0	%
2071	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Cyclin-dependent kinase 16	inhibition rate	18	%
2072	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Cyclin-dependent kinase 17	inhibition rate	0	%
2073	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Cyclin-dependent kinase 18	inhibition rate	0	%
2074	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Platelet-derived growth factor receptor alpha	inhibition rate	0	%
2075	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Platelet-derived growth factor receptor beta	inhibition rate	9	%
2076	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	3-phosphoinositide-dependent protein kinase 1	inhibition rate	9	%
2077	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Cyclin-dependent kinase 14	inhibition rate	0	%
2078	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Cyclin-dependent kinase 15	inhibition rate	32	%
2079	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	inhibition rate	0	%
2080	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	inhibition rate	0	%
2081	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	inhibition rate	0	%
2082	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	inhibition rate	15	%
2083	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition rate	0	%
2084	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (C420R)	inhibition rate	0	%
2085	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E542K)	inhibition rate	26	%
2086	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545A)	inhibition rate	19	%
2087	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047L)	inhibition rate	0	%
2088	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047Y)	inhibition rate	0	%
2089	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (M1043I)	inhibition rate	16	%
2090	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (Q546K)	inhibition rate	25	%
2091	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545K)	inhibition rate	1	%
2092	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	inhibition rate	0	%
2093	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	inhibition rate	0	%
2094	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	inhibition rate	0	%
2095	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Phosphatidylinositol 4-kinase beta	inhibition rate	0	%
2096	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase pim-1	inhibition rate	17	%
2097	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase pim-2	inhibition rate	14	%
2098	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase pim-3	inhibition rate	50	%
2099	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	inhibition rate	69	%
2100	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta	inhibition rate	93.8	%
2101	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	cAMP-dependent protein kinase catalytic subunit alpha	inhibition rate	60	%
2102	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	cAMP-dependent protein kinase catalytic subunit beta	inhibition rate	62	%
2103	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Protein kinase C, delta	inhibition rate	27	%
2104	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Protein kinase C, epsilon	inhibition rate	37	%
2105	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Protein kinase C, eta	inhibition rate	38	%
2106	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase D1	inhibition rate	0	%
2107	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase D2	inhibition rate	0	%
2108	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase D3	inhibition rate	0	%
2109	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	cGMP-dependent protein kinase 1	inhibition rate	51	%
2110	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	cGMP-dependent protein kinase 2	inhibition rate	63	%
2111	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase N1	inhibition rate	34	%
2112	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase N2	inhibition rate	48	%
2113	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Interferon-induced, double-stranded RNA-activated protein kinase	inhibition rate	0	%
2114	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase PLK1	inhibition rate	15	%
2115	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase PLK2	inhibition rate	14	%
2116	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase Plk3	inhibition rate	16	%
2117	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase Plk4	inhibition rate	47	%
2118	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase prp4	inhibition rate	50	%
2119	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Protein-tyrosine kinase 2-beta	inhibition rate	9	%
2120	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase SIK2	inhibition rate	0	%
2121	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase SIK3	inhibition rate	16	%
2122	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	RAF proto-oncogene serine/threonine-protein kinase	inhibition rate	22	%
2123	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Proto-oncogene tyrosine-protein kinase receptor Ret	inhibition rate	19	%
2124	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (M918T)	inhibition rate	2	%
2125	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804L)	inhibition rate	11	%
2126	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M)	inhibition rate	32	%
2127	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase Rio1	inhibition rate	92.4	%
2128	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase ABL1	inhibition rate	17	%
2129	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase Rio2	inhibition rate	3	%
2130	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase Rio3	inhibition rate	96.2	%
2131	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Receptor-interacting serine/threonine-protein kinase 1	inhibition rate	6	%
2132	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Receptor-interacting serine/threonine-protein kinase 2	inhibition rate	9	%
2133	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Rho-associated protein kinase 1	inhibition rate	14	%
2134	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Rho-associated protein kinase 2	inhibition rate	33	%
2135	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	RON, Sema domain	inhibition rate	1	%
2136	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Proto-oncogene tyrosine-protein kinase ROS	inhibition rate	0	%
2137	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Ribosomal protein S6 kinase alpha-1	inhibition rate	0	%
2138	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Ribosomal protein S6 kinase alpha-1	inhibition rate	8	%
2139	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Ribosomal protein S6 kinase alpha-3	inhibition rate	0	%
2140	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Ribosomal protein S6 kinase alpha-3	inhibition rate	7	%
2141	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Ribosomal protein S6 kinase alpha-3	inhibition rate	33	%
2142	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Ribosomal protein S6 kinase alpha-6	inhibition rate	0	%
2143	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Ribosomal protein S6 kinase alpha-6	inhibition rate	10	%
2144	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase, Sbk1	inhibition rate	19	%
2145	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Myosin light chain kinase family member 4	inhibition rate	50	%
2146	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Uncharacterized serine/threonine-protein kinase SBK3	inhibition rate	3	%
2147	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Ankyrin repeat and protein kinase domain-containing protein 1	inhibition rate	0	%
2148	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase SIK1	inhibition rate	1	%
2149	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Myosin light chain kinase 2, skeletal/cardiac muscle	inhibition rate	9	%
2150	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase Fyn	inhibition rate	0	%
2151	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Myosin light chain kinase, smooth muscle	inhibition rate	23	%
2152	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Neuronal proto-oncogene tyrosine-protein kinase Src	inhibition rate	2	%
2153	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase Srms	inhibition rate	18	%
2154	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	CBL-interacting serine/threonine-protein kinase 7	inhibition rate	88	%
2155	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	SRSF protein kinase 2	inhibition rate	12	%
2156	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase 16	inhibition rate	15	%
2157	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase 33	inhibition rate	0	%
2158	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	STE20/SPS1-related proline-alanine-rich protein kinase	inhibition rate	3	%
2159	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase SYK	inhibition rate	0	%
2160	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase TAO1	inhibition rate	6	%
2161	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase TAO2	inhibition rate	9	%
2162	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase TAO3	inhibition rate	0	%
2163	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Nuclear receptor subfamily 2 group C member 2	inhibition rate	0	%
2164	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase TBK1	inhibition rate	0	%
2165	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase Tec	inhibition rate	17	%
2166	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Dual specificity testis-specific protein kinase 1	inhibition rate	1	%
2167	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	TGF-beta receptor type-1	inhibition rate	9	%
2168	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	TGF-beta receptor type-2	inhibition rate	0	%
2169	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase receptor Tie-1	inhibition rate	0	%
2170	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase receptor Tie-2	inhibition rate	7	%
2171	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase tousled-like 1	inhibition rate	26	%
2172	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase TOUSLED-like 2	inhibition rate	9	%
2173	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Non-receptor tyrosine-protein kinase TNK1	inhibition rate	0	%
2174	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Trk system potassium uptake protein TrkA	inhibition rate	0	%
2175	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	BDNF/NT-3 growth factors receptor	inhibition rate	1	%
2176	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	NT-3 growth factor receptor	inhibition rate	0	%
2177	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Testis-specific serine/threonine-protein kinase 1	inhibition rate	0	%
2178	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Dual specificity protein kinase TTK	inhibition rate	0	%
2179	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase TXK	inhibition rate	11	%
2180	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Non-receptor tyrosine-protein kinase TYK2	inhibition rate	0	%
2181	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Non-receptor tyrosine-protein kinase TYK2 -pseudo-kinase	inhibition rate	28	%
2182	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase receptor TYRO3	inhibition rate	0	%
2183	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase ULK1	inhibition rate	17	%
2184	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase ULK2	inhibition rate	14	%
2185	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase ULK3	inhibition rate	20	%
2186	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mitosis inhibitor protein kinase wee1	inhibition rate	6	%
2187	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Wee1-like protein kinase 2	inhibition rate	11	%
2188	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase 32B	inhibition rate	6	%
2189	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase 32C	inhibition rate	0	%
2190	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase yes	inhibition rate	0	%
2191	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase 25	inhibition rate	9	%
2192	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mitogen-activated protein kinase kinase kinase 19	inhibition rate	58	%
2193	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mitogen-activated protein kinase kinase kinase 20	inhibition rate	15	%
2194	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase ZAP-70	inhibition rate	0	%
2195	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mitogen-activated protein kinase kinase kinase kinase 4	inhibition rate	3	%
2196	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Traf2 and NCK-interacting protein kinase	inhibition rate	2	%
2197	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Misshapen-like kinase 1	inhibition rate	0	%
2198	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mitogen-activated protein kinase 14A	inhibition rate	22	%
2199	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mitogen-activated protein kinase 11	inhibition rate	4	%
2200	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mitogen-activated protein kinase 13	inhibition rate	0	%
2201	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Mitogen-activated protein kinase 12	inhibition rate	0	%
2202	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase ABL1	inhibition rate	14	%
2203	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Cyclin-dependent kinase 11	inhibition rate	15	%
2204	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	AP2-associated protein kinase 1	inhibition rate	82	%
2205	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase ABL1	inhibition rate	2	%
2206	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase ABL1	inhibition rate	11	%
2207	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase ABL1	inhibition rate	8	%
2208	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase ABL1	inhibition rate	4	%
2209	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase ABL1	inhibition rate	12	%
2210	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase ABL1	inhibition rate	14	%
2211	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase ABL1	inhibition rate	11	%
2212	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Activated CDC42 kinase 1	inhibition rate	0	%
2213	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Actin-related protein 2	inhibition rate	8	%
2214	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Actin-related protein 2-B	inhibition rate	25	%
2215	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Atypical kinase COQ8A, mitochondrial	inhibition rate	12	%
2216	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Atypical kinase COQ8B, mitochondrial	inhibition rate	21	%
2217	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	RAC-alpha serine/threonine-protein kinase	inhibition rate	28	%
2218	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Abhydrolase domain-containing protein AKT2	inhibition rate	0	%
2219	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	RAC-gamma serine/threonine-protein kinase	inhibition rate	15	%
2220	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	ALK tyrosine kinase receptor	inhibition rate	9	%
2221	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase Haspin homolog ALK1	inhibition rate	0	%
2222	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase Haspin homolog ALK2	inhibition rate	0	%
2223	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	5'-AMP-activated serine/threonine-protein kinase catalytic subunit alpha 1	inhibition rate	3	%
2224	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	5'-AMP-activated serine/threonine-protein kinase catalytic subunit alpha 2	inhibition rate	0	%
2225	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Receptor-interacting serine/threonine-protein kinase 4	inhibition rate	0	%
2226	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase ABL2	inhibition rate	0	%
2227	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Aurora kinase A	inhibition rate	0	%
2228	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Aurora kinase	inhibition rate	4	%
2229	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Aurora kinase C	inhibition rate	1	%
2230	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase receptor UFO	inhibition rate	0	%
2231	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase Blk	inhibition rate	0	%
2232	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Bone morphogenetic protein receptor type-1A	inhibition rate	0	%
2233	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Bone morphogenetic protein receptor type-1B	inhibition rate	0	%
2234	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Bone morphogenetic protein receptor type-2	inhibition rate	23	%
2235	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Cytoplasmic tyrosine-protein kinase BMX	inhibition rate	6	%
2236	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase B-raf	inhibition rate	21	%
2237	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase B-raf (V600E)	inhibition rate	15	%
2238	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Protein-tyrosine kinase 6	inhibition rate	14	%
2239	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase BRSK1	inhibition rate	1	%
2240	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Serine/threonine-protein kinase BRSK2	inhibition rate	0	%
2241	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Tyrosine-protein kinase BTK	inhibition rate	0	%
2242	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Calcium/calmodulin-dependent protein kinase type 1	inhibition rate	0	%
2243	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Calcium/calmodulin-dependent protein kinase type 1G	inhibition rate	10	%
2244	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Calcium/calmodulin-dependent protein kinase type II subunit alpha	inhibition rate	8	%
2245	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Calcium/calmodulin-dependent protein kinase type II subunit beta	inhibition rate	0	%
2246	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Calcium/calmodulin-dependent protein kinase type II delta 2 chain	inhibition rate	12	%
2247	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Calcium/calmodulin-dependent protein kinase type II subunit gamma	inhibition rate	10	%
2248	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Calcium/calmodulin-dependent protein kinase type IV	inhibition rate	0	%
2249	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Calcium/calmodulin-dependent protein kinase kinase 1	inhibition rate	0	%
2250	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Calcium/calmodulin-dependent protein kinase kinase 2	inhibition rate	3	%
2251	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Myosin light chain kinase 3	inhibition rate	0	%
2252	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Cyclin-dependent kinase 11B	inhibition rate	2	%
2253	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Cyclin-dependent kinase 11A	inhibition rate	11	%
2254	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Cyclin-dependent kinase 2	inhibition rate	19	%
2255	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Cyclin-dependent kinase 3	inhibition rate	3	%
2256	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Cyclin-dependent-like kinase 5	inhibition rate	12	%
2257	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Cyclin-dependent kinase 7	inhibition rate	27	%
2258	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Cyclin-dependent kinase 8	inhibition rate	23	%
2259	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Cyclin-dependent kinase 9	inhibition rate	7	%
2260	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	Cyclin-dependent kinase-like 2	inhibition rate	0	%
2261	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		fu (fraction unbound)	2	%
2262	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		fu (fraction unbound)	4.1	%
2263	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		fu (fraction unbound)	3.8	%
2264	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	AP2-associated protein kinase 1 [rat]	number of flinches in phase I	117	no unit
2265	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1	AP2-associated protein kinase 1 [rat]	number of paw licking/ biting in phase I	18	no unit
2266	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		Papp (A-B)	1.29E-5	cm/s
2267	OC(=O)C(F)(F)F.CC(C)C[C@@H](N)C(=O)NC1=CC=C(C2=CN=CO2)C(OC(F)F)=C1		Papp (B-A)	1.13E-5	cm/s
2268	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Discoidin domain-containing receptor 2	IC50	0.75	nM
2269	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase 14A	IC50	6.2	nM
2270	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Discoidin domain-containing receptor 2	IC50	0.018	μM
2271	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Epithelial discoidin domain-containing receptor 1	IC50	0.023	μM
2272	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase 11	IC50	45.1	nM
2273	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Epithelial discoidin domain-containing receptor 1	IC50	53.3	nM
2274	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase 14A	IC50	0.125	μM
2275	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase 11	IC50	0.196	μM
2276	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Epithelial discoidin domain-containing receptor 1;+Discoidin domain-containing receptor 2;+Mitogen-activated protein kinase 11;+Mitogen-activated protein kinase 14A	qualitative		
2277	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Epithelial discoidin domain-containing receptor 1;+Discoidin domain-containing receptor 2;+Mitogen-activated protein kinase 11;+Mitogen-activated protein kinase 14A	qualitative		
2278	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Epithelial discoidin domain-containing receptor 1;+Discoidin domain-containing receptor 2;+Mitogen-activated protein kinase 11;+Mitogen-activated protein kinase 14A	qualitative		
2279	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Epithelial discoidin domain-containing receptor 1;+Discoidin domain-containing receptor 2;+Mitogen-activated protein kinase 11;+Mitogen-activated protein kinase 14A	percentage of apoptotic cells increase		
2280	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Epithelial discoidin domain-containing receptor 1;+Discoidin domain-containing receptor 2;+Mitogen-activated protein kinase 11;+Mitogen-activated protein kinase 14A	percentage of apoptotic cells increase		
2281	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Epithelial discoidin domain-containing receptor 1;+Discoidin domain-containing receptor 2;+Mitogen-activated protein kinase 11;+Mitogen-activated protein kinase 14A	percentage of apoptotic cells increase		
2282	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Epithelial discoidin domain-containing receptor 1;+Discoidin domain-containing receptor 2;+Mitogen-activated protein kinase 11;+Mitogen-activated protein kinase 14A	qualitative		
2283	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Epithelial discoidin domain-containing receptor 1;+Discoidin domain-containing receptor 2;+Mitogen-activated protein kinase 11;+Mitogen-activated protein kinase 14A	qualitative		
2284	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Epithelial discoidin domain-containing receptor 1;+Discoidin domain-containing receptor 2;+Mitogen-activated protein kinase 11;+Mitogen-activated protein kinase 14A	qualitative		
2285	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase Chk2	IC50	25	μM
2286	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Neurogenic differentiation factor 2	IC50	25	μM
2287	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	High-affinity branched-chain amino acid transport ATP-binding protein BraF	IC50	25	μM
2288	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Epithelial discoidin domain-containing receptor 1;+Discoidin domain-containing receptor 2;+Mitogen-activated protein kinase 11;+Mitogen-activated protein kinase 14A	cell lysis increase		
2289	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Epithelial discoidin domain-containing receptor 1;+Discoidin domain-containing receptor 2;+Mitogen-activated protein kinase 11;+Mitogen-activated protein kinase 14A	cell lysis increase		
2290	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Epithelial discoidin domain-containing receptor 1;+Discoidin domain-containing receptor 2;+Mitogen-activated protein kinase 11;+Mitogen-activated protein kinase 14A	cell lysis increase		
2291	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase ABL1	IC50	25	μM
2292	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Receptor-interacting serine/threonine-protein kinase 2	IC50	25	μM
2293	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Ribosomal protein S6 kinase alpha-5	IC50	25	μM
2294	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Cyclin-dependent kinase 13	inhibition percentage	0	%
2295	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Cyclin-dependent kinase 11	inhibition percentage	3	%
2296	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Cyclin-dependent kinase 2	inhibition percentage	0	%
2297	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Cyclin-dependent kinase 3	inhibition percentage	3	%
2298	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Cyclin-dependent kinase 4	inhibition percentage	1	%
2299	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Cyclin-dependent kinase 4; Cyclin-D1-1	inhibition percentage	0	%
2300	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Cyclin-dependent kinase 4; Cyclin-D3-1	inhibition percentage	1	%
2301	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Cyclin-dependent-like kinase 5	inhibition percentage	0	%
2302	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Cyclin-dependent kinase 7	inhibition percentage	4	%
2303	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Cyclin-dependent kinase 8	inhibition percentage	0	%
2304	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Cyclin-dependent kinase 9	inhibition percentage	9	%
2305	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Cyclin-dependent kinase-like 1	inhibition percentage	0	%
2306	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Cyclin-dependent kinase-like 2	inhibition percentage	0	%
2307	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Cyclin-dependent kinase-like 3	inhibition percentage	19	%
2308	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Cyclin-dependent kinase-like 5	inhibition percentage	0	%
2309	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase Chk1	inhibition percentage	0	%
2310	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase Chk2	inhibition percentage	19	%
2311	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Citrate synthase, mitochondrial	inhibition percentage	11	%
2312	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase RCK2	inhibition percentage	12	%
2313	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Dual specificity protein kinase CLK2	inhibition percentage	0	%
2314	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Dual specificity protein kinase CLK3	inhibition percentage	0	%
2315	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Dual specificity protein kinase CLK4	inhibition percentage	0	%
2316	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Macrophage colony-stimulating factor 1 receptor	inhibition percentage	8	%
2317	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Macrophage colony-stimulating factor 1 receptor	inhibition percentage	0	%
2318	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase CSK	inhibition percentage	0	%
2319	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Casein kinase I isoform alpha	inhibition percentage	0	%
2320	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Casein kinase I isoform alpha-like	inhibition percentage	0	%
2321	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Casein kinase I isoform delta	inhibition percentage	3	%
2322	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Casein kinase I isoform epsilon	inhibition percentage	9	%
2323	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Casein kinase I isoform gamma-1	inhibition percentage	5	%
2324	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Casein kinase I isoform gamma-2	inhibition percentage	5	%
2325	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Casein kinase I isoform gamma-3	inhibition percentage	2	%
2326	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Casein kinase II subunit alpha	inhibition percentage	19	%
2327	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Casein kinase II subunit alpha-2	inhibition percentage	0	%
2328	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Megakaryocyte-associated tyrosine-protein kinase	inhibition percentage	0	%
2329	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Death-associated protein kinase 1	inhibition percentage	0	%
2330	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Death-associated protein kinase 2	inhibition percentage	0	%
2331	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Death-associated protein kinase 3	inhibition percentage	0	%
2332	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase DCLK1	inhibition percentage	0	%
2333	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase DCLK2	inhibition percentage	11	%
2334	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase DCLK3	inhibition percentage	1	%
2335	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Epithelial discoidin domain-containing receptor 1	inhibition percentage	99.9	%
2336	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Discoidin domain-containing receptor 2	inhibition percentage	99.6	%
2337	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Death-associated protein kinase 3	inhibition percentage	9	%
2338	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Myotonin-protein kinase	inhibition percentage	0	%
2339	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase MRCK gamma	inhibition percentage	0	%
2340	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase 17A	inhibition percentage	28	%
2341	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase 17B	inhibition percentage	10	%
2342	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 1A/B	inhibition percentage	0	%
2343	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	inhibition percentage	32	%
2344	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 2	inhibition percentage	5	%
2345	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	epidermal growth factor-activated receptor	inhibition percentage	0	%
2346	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	epidermal growth factor-activated receptor	inhibition percentage	17	%
2347	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Epidermal growth factor receptor (G719C)	inhibition percentage	14	%
2348	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Epidermal growth factor receptor (G719S)	inhibition percentage	9	%
2349	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	epidermal growth factor-activated receptor	inhibition percentage	0	%
2350	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	epidermal growth factor-activated receptor	inhibition percentage	0	%
2351	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	epidermal growth factor-activated receptor	inhibition percentage	15	%
2352	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Epidermal growth factor receptor (L858R)	inhibition percentage	0	%
2353	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Epidermal growth factor receptor (L858R)	inhibition percentage	16	%
2354	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Epidermal growth factor receptor (L861Q)	inhibition percentage	41	%
2355	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	epidermal growth factor-activated receptor	inhibition percentage	46	%
2356	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Epidermal growth factor receptor (T790M)	inhibition percentage	0	%
2357	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Eukaryotic translation initiation factor 2-alpha kinase 1	inhibition percentage	0	%
2358	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Ephrin type-A receptor 1	inhibition percentage	0	%
2359	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Ephrin type-A receptor 2	inhibition percentage	21	%
2360	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Ephrin type-A receptor 3	inhibition percentage	0	%
2361	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Ephrin type-A receptor 4	inhibition percentage	2	%
2362	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Ephrin type-A receptor 5	inhibition percentage	0	%
2363	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Ephrin type-A receptor 6	inhibition percentage	0	%
2364	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Ephrin type-A receptor 7	inhibition percentage	0	%
2365	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Ephrin type-A receptor 8	inhibition percentage	2	%
2366	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Ephrin type-B receptor 1	inhibition percentage	0	%
2367	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Ephrin type-B receptor 2	inhibition percentage	0	%
2368	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Ephrin type-B receptor 3	inhibition percentage	0	%
2369	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Ephrin type-B receptor 4	inhibition percentage	0	%
2370	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Ephrin type-B receptor 6	inhibition percentage	13	%
2371	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Receptor tyrosine-protein kinase erbB-2	inhibition percentage	0	%
2372	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Receptor tyrosine-protein kinase erbB-3	inhibition percentage	0	%
2373	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Receptor tyrosine-protein kinase erbB-4	inhibition percentage	0	%
2374	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Extracellular signal-regulated kinase 1	inhibition percentage	0	%
2375	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Extracellular signal-regulated kinase 2	inhibition percentage	0	%
2376	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase 6	inhibition percentage	0	%
2377	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase 4	inhibition percentage	0	%
2378	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase 7	inhibition percentage	9	%
2379	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase 15	inhibition percentage	14	%
2380	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase/endoribonuclease IRE1	inhibition percentage	0	%
2381	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Focal adhesion kinase 1	inhibition percentage	0	%
2382	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase Fer	inhibition percentage	0	%
2383	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase, Fes/Fps type	inhibition percentage	0	%
2384	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Fibroblast growth factor receptor 1	inhibition percentage	0	%
2385	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Fibroblast growth factor receptor 2	inhibition percentage	22	%
2386	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Fibroblast growth factor receptor 3	inhibition percentage	0	%
2387	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Fibroblast growth factor receptor 3	inhibition percentage	11	%
2388	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Fibroblast growth factor receptor 4	inhibition percentage	0	%
2389	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase Fgr	inhibition percentage	0	%
2390	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Vascular endothelial growth factor receptor 1	inhibition percentage	0	%
2391	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Vascular endothelial growth factor receptor 3	inhibition percentage	0	%
2392	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Receptor-type tyrosine-protein kinase FLT3 (D835H)	inhibition percentage	7	%
2393	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Receptor-type tyrosine-protein kinase FLT3 (D835V)	inhibition percentage	0	%
2394	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Receptor-type tyrosine-protein kinase FLT3 (D835Y)	inhibition percentage	0	%
2395	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Receptor-type tyrosine-protein kinase FLT3 (ITD)	inhibition percentage	0	%
2396	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Receptor-type tyrosine-protein kinase FLT3 (ITD)	inhibition percentage	10	%
2397	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Receptor-type tyrosine-protein kinase FLT3 (ITD)	inhibition percentage	0	%
2398	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	0	%
2399	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	0	%
2400	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	0	%
2401	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	15	%
2402	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Vascular endothelial growth factor receptor 3	inhibition percentage	0	%
2403	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase FRK	inhibition percentage	58	%
2404	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase Fyn	inhibition percentage	10	%
2405	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Cyclin-G-associated kinase	inhibition percentage	21	%
2406	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	ABC transporter F family member 2	inhibition percentage	0	%
2407	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	rhodopsin kinase	inhibition percentage	3	%
2408	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Beta-adrenergic receptor kinase 1	inhibition percentage	19	%
2409	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Beta-adrenergic receptor kinase 2	inhibition percentage	0	%
2410	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	G protein-coupled receptor kinase 4	inhibition percentage	0	%
2411	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	rhodopsin kinase	inhibition percentage	0	%
2412	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Glycogen synthase kinase-3 alpha	inhibition percentage	57	%
2413	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	tau-protein kinase	inhibition percentage	0	%
2414	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase haspin	inhibition percentage	90.5	%
2415	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase HCK	inhibition percentage	0	%
2416	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Homeodomain-interacting protein kinase 1	inhibition percentage	4	%
2417	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Homeodomain-interacting protein kinase 2	inhibition percentage	0	%
2418	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Homeodomain-interacting protein kinase 3	inhibition percentage	0	%
2419	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Homeodomain-interacting protein kinase 4	inhibition percentage	0	%
2420	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase kinase kinase kinase 1	inhibition percentage	0	%
2421	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Hormonally up-regulated neu tumor-associated kinase	inhibition percentage	0	%
2422	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase ICK	inhibition percentage	0	%
2423	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Insulin-like growth factor 1 receptor	inhibition percentage	0	%
2424	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Inhibitor of nuclear factor kappa-B kinase subunit alpha	inhibition percentage	0	%
2425	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Inhibitor of nuclear factor kappa-B kinase subunit beta	inhibition percentage	0	%
2426	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	inhibition percentage	0	%
2427	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Insulin receptor	inhibition percentage	8	%
2428	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Insulin receptor-related protein	inhibition percentage	19	%
2429	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Interleukin-1 receptor-associated kinase 1	inhibition percentage	3	%
2430	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Interleukin-1 receptor-associated kinase 3	inhibition percentage	0	%
2431	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Interleukin-1 receptor-associated kinase 4	inhibition percentage	17	%
2432	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase ITK/TSK	inhibition percentage	0	%
2433	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase JAK1	inhibition percentage	5	%
2434	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase JAK1 pseudokinase	inhibition percentage	0	%
2435	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase JAK2	inhibition percentage	25	%
2436	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase JAK3	inhibition percentage	0	%
2437	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase 8	inhibition percentage	15	%
2438	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase 9	inhibition percentage	8	%
2439	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase 10	inhibition percentage	0	%
2440	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mast/stem cell growth factor receptor Kit	inhibition percentage	84	%
2441	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mast/stem cell growth factor receptor Kit (A829P)	inhibition percentage	65	%
2442	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mast/stem cell growth factor receptor Kit (D816H)	inhibition percentage	27	%
2443	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mast/stem cell growth factor receptor Kit (D816V)	inhibition percentage	18	%
2444	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mast/stem cell growth factor receptor Kit	inhibition percentage	60	%
2445	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mast/stem cell growth factor receptor Kit (V559D)	inhibition percentage	91.5	%
2446	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mast/stem cell growth factor receptor Kit (V559D)	inhibition percentage	0	%
2447	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mast/stem cell growth factor receptor Kit (V559D)	inhibition percentage	25	%
2448	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mast/stem cell growth factor receptor Kit	inhibition percentage	0	%
2449	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase LATS1	inhibition percentage	0	%
2450	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase LATS2	inhibition percentage	0	%
2451	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase Lck	inhibition percentage	65	%
2452	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	LIM domain kinase 1	inhibition percentage	0	%
2453	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	LIM domain kinase 2	inhibition percentage	1	%
2454	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase STK11	inhibition percentage	24	%
2455	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase 10	inhibition percentage	0	%
2456	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Leucine-rich repeat serine/threonine-protein kinase 2	inhibition percentage	1	%
2457	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Leucine-rich repeat serine/threonine-protein kinase 2 (G2019S)	inhibition percentage	0	%
2458	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Leukocyte tyrosine kinase receptor	inhibition percentage	0	%
2459	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase Lyn	inhibition percentage	17	%
2460	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase kinase kinase 13	inhibition percentage	0	%
2461	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase MAK	inhibition percentage	0	%
2462	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase kinase kinase 1	inhibition percentage	0	%
2463	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase kinase kinase 15	inhibition percentage	31	%
2464	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase kinase kinase 2	inhibition percentage	23	%
2465	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase kinase kinase 3	inhibition percentage	4	%
2466	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase kinase kinase 4	inhibition percentage	14	%
2467	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase kinase kinase kinase 2	inhibition percentage	11	%
2468	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase kinase kinase kinase 3	inhibition percentage	0	%
2469	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase kinase kinase kinase 4	inhibition percentage	0	%
2470	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase kinase kinase kinase 5	inhibition percentage	0	%
2471	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	MAP kinase-activated protein kinase 2	inhibition percentage	0	%
2472	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	MAP kinase-activated protein kinase 5	inhibition percentage	5	%
2473	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase MARK1	inhibition percentage	0	%
2474	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase MARK2	inhibition percentage	0	%
2475	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase MARK3	inhibition percentage	0	%
2476	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase MARK4	inhibition percentage	0	%
2477	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Microtubule-associated serine/threonine-protein kinase 1	inhibition percentage	0	%
2478	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Dual specificity mitogen-activated protein kinase kinase 1	inhibition percentage	6	%
2479	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Dual specificity mitogen-activated protein kinase kinase 2	inhibition percentage	0	%
2480	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Dual specificity mitogen-activated protein kinase kinase 3	inhibition percentage	5	%
2481	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Dual specificity mitogen-activated protein kinase kinase 4	inhibition percentage	16	%
2482	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Dual specificity mitogen-activated protein kinase kinase 5	inhibition percentage	0	%
2483	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Dual specificity mitogen-activated protein kinase kinase 6	inhibition percentage	0	%
2484	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Maternal embryonic leucine zipper kinase	inhibition percentage	33	%
2485	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase Mer	inhibition percentage	0	%
2486	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Hepatocyte growth factor receptor	inhibition percentage	0	%
2487	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Hepatocyte growth factor receptor (M1250T)	inhibition percentage	0	%
2488	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Hepatocyte growth factor receptor	inhibition percentage	1	%
2489	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Misshapen-like kinase 1	inhibition percentage	0	%
2490	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Dual specificity mitogen-activated protein kinase kinase 7	inhibition percentage	0	%
2491	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	MAP kinase-interacting serine/threonine-protein kinase 1	inhibition percentage	1	%
2492	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	MAP kinase-interacting serine/threonine-protein kinase 2	inhibition percentage	0	%
2493	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	myosin light chain kinase	inhibition percentage	0	%
2494	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase kinase kinase 9	inhibition percentage	0	%
2495	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase kinase kinase 10	inhibition percentage	0	%
2496	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase kinase kinase 11	inhibition percentage	6	%
2497	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase MRCK alpha	inhibition percentage	0	%
2498	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase MRCK beta	inhibition percentage	1	%
2499	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Bowman-Birk type proteinase inhibitor	inhibition percentage	0	%
2500	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Macrophage-stimulating protein receptor	inhibition percentage	0	%
2501	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase 3	inhibition percentage	0	%
2502	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase 24	inhibition percentage	13	%
2503	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase 26	inhibition percentage	14	%
2504	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase mTOR	inhibition percentage	5	%
2505	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Muscle, skeletal receptor tyrosine-protein kinase	inhibition percentage	10	%
2506	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Myosin light chain kinase, smooth muscle	inhibition percentage	11	%
2507	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Myosin light chain kinase 2, skeletal/cardiac muscle	inhibition percentage	0	%
2508	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Myosin light chain kinase family member 4	inhibition percentage	0	%
2509	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Myosin-IIIa	inhibition percentage	0	%
2510	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Myosin-IIIb	inhibition percentage	4	%
2511	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase 38	inhibition percentage	1	%
2512	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase 38-like	inhibition percentage	0	%
2513	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase Nek1	inhibition percentage	12	%
2514	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase Nek10	inhibition percentage	82	%
2515	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase Nek11	inhibition percentage	0	%
2516	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase Nek2	inhibition percentage	0	%
2517	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase Nek3	inhibition percentage	10	%
2518	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase Nek4	inhibition percentage	23	%
2519	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase Nek5	inhibition percentage	8	%
2520	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase Nek6	inhibition percentage	0	%
2521	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase Nek7	inhibition percentage	0	%
2522	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase Nek9	inhibition percentage	0	%
2523	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase kinase kinase 14	inhibition percentage	10	%
2524	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase NIM1	inhibition percentage	13	%
2525	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine kinase NLK	inhibition percentage	28	%
2526	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase OSR1	inhibition percentage	0	%
2527	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase 14A	inhibition percentage	100	%
2528	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase 11	inhibition percentage	96.6	%
2529	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase 13	inhibition percentage	0	%
2530	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase 12	inhibition percentage	1	%
2531	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase PAK 1	inhibition percentage	11	%
2532	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase PAK2	inhibition percentage	24	%
2533	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase PAK 3	inhibition percentage	0	%
2534	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase PAK 4	inhibition percentage	0	%
2535	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase PAK 6	inhibition percentage	1	%
2536	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase PAK5	inhibition percentage	0	%
2537	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Cyclin-dependent kinase 16	inhibition percentage	0	%
2538	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Cyclin-dependent kinase 17	inhibition percentage	10	%
2539	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Cyclin-dependent kinase 18	inhibition percentage	15	%
2540	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Platelet-derived growth factor receptor alpha	inhibition percentage	11	%
2541	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Platelet-derived growth factor receptor beta	inhibition percentage	0	%
2542	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	3-phosphoinositide-dependent protein kinase 1	inhibition percentage	0	%
2543	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Calcium-dependent protein kinase 1 [Plasmodium falciparum]	inhibition percentage	20	%
2544	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	23	%
2545	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Cell division control protein 2 homolog [Plasmodium falciparum]	inhibition percentage	0	%
2546	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Cyclin-dependent kinase 15	inhibition percentage	0	%
2547	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Cyclin-dependent kinase 14	inhibition percentage	0	%
2548	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	inhibition percentage	14	%
2549	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	inhibition percentage	0	%
2550	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	inhibition percentage	0	%
2551	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	inhibition percentage	6	%
2552	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition percentage	0	%
2553	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (C420R)	inhibition percentage	12	%
2554	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545A)	inhibition percentage	27	%
2555	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	55	%
2556	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545A)	inhibition percentage	0	%
2557	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545K)	inhibition percentage	14	%
2558	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047L)	inhibition percentage	8	%
2559	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047Y)	inhibition percentage	0	%
2560	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition percentage	46	%
2561	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (M1043I)	inhibition percentage	0	%
2562	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (Q546K)	inhibition percentage	15	%
2563	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	inhibition percentage	23	%
2564	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	inhibition percentage	0	%
2565	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	inhibition percentage	0	%
2566	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	45	%
2567	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Phosphatidylinositol 4-kinase beta	inhibition percentage	13	%
2568	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	1-phosphatidylinositol 3-phosphate 5-kinase	inhibition percentage	0	%
2569	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase pim-1	inhibition percentage	0	%
2570	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase pim-2	inhibition percentage	0	%
2571	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase pim-3	inhibition percentage	11	%
2572	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	inhibition percentage	0	%
2573	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	inhibition percentage	0	%
2574	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta	inhibition percentage	0	%
2575	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	inhibition percentage	0	%
2576	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	cAMP-dependent protein kinase catalytic subunit alpha	inhibition percentage	0	%
2577	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	98.8	%
2578	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	cAMP-dependent protein kinase catalytic subunit beta	inhibition percentage	0	%
2579	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	inhibition percentage	0	%
2580	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase Pkn1	inhibition percentage	0	%
2581	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase pkn2	inhibition percentage	0	%
2582	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase PknB [Mycobacterium tuberculosis]	inhibition percentage	0	%
2583	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase PLK1	inhibition percentage	14	%
2584	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase PLK2	inhibition percentage	0	%
2585	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase Plk3	inhibition percentage	7	%
2586	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase Plk4	inhibition percentage	0	%
2587	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Protein kinase C, delta	inhibition percentage	0	%
2588	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	87	%
2589	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Protein kinase C, epsilon	inhibition percentage	23	%
2590	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Protein kinase C, eta	inhibition percentage	0	%
2591	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Protein kinase C iota type	inhibition percentage	0	%
2592	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Protein kinase C, theta	inhibition percentage	20	%
2593	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase D1	inhibition percentage	11	%
2594	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase D2	inhibition percentage	0	%
2595	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase D3	inhibition percentage	9	%
2596	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	cGMP-dependent protein kinase 1	inhibition percentage	0	%
2597	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	cGMP-dependent protein kinase 2	inhibition percentage	0	%
2598	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Interferon-induced, double-stranded RNA-activated protein kinase	inhibition percentage	0	%
2599	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	88	%
2600	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	cAMP-dependent protein kinase catalytic subunit PRKX	inhibition percentage	0	%
2601	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase prp4	inhibition percentage	0	%
2602	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Protein-tyrosine kinase 2-beta	inhibition percentage	5	%
2603	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase SIK3	inhibition percentage	35	%
2604	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	RAF proto-oncogene serine/threonine-protein kinase	inhibition percentage	79	%
2605	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Proto-oncogene tyrosine-protein kinase receptor Ret	inhibition percentage	0	%
2606	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (M918T)	inhibition percentage	3	%
2607	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804L)	inhibition percentage	0	%
2608	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M)	inhibition percentage	0	%
2609	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase Rio1	inhibition percentage	0	%
2610	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	65	%
2611	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase Rio2	inhibition percentage	15	%
2612	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase Rio3	inhibition percentage	0	%
2613	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Receptor-interacting serine/threonine-protein kinase 1	inhibition percentage	2	%
2614	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Receptor-interacting serine/threonine-protein kinase 2	inhibition percentage	0	%
2615	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Receptor-interacting serine/threonine-protein kinase 4	inhibition percentage	9	%
2616	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Dual serine/threonine and tyrosine protein kinase	inhibition percentage	0	%
2617	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Rho-associated protein kinase 1	inhibition percentage	0	%
2618	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Rho-associated protein kinase 2	inhibition percentage	0	%
2619	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Proto-oncogene tyrosine-protein kinase ROS	inhibition percentage	0	%
2620	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Ribosomal protein S6 kinase alpha-4	inhibition percentage	0	%
2621	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	65	%
2622	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Ribosomal protein S6 kinase alpha-4	inhibition percentage	5	%
2623	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Ribosomal protein S6 kinase alpha-5	inhibition percentage	0	%
2624	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Ribosomal protein S6 kinase alpha-5	inhibition percentage	0	%
2625	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Ribosomal protein S6 kinase alpha-1	inhibition percentage	0	%
2626	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Ribosomal protein S6 kinase alpha-1	inhibition percentage	13	%
2627	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Ribosomal protein S6 kinase alpha-3	inhibition percentage	9	%
2628	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Ribosomal protein S6 kinase alpha-2	inhibition percentage	0	%
2629	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Ribosomal protein S6 kinase alpha-3	inhibition percentage	4	%
2630	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Ribosomal protein S6 kinase alpha-3	inhibition percentage	0	%
2631	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Ribosomal protein S6 kinase alpha-4	inhibition percentage	16	%
2632	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	97.9	%
2633	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Ribosomal protein S6 kinase alpha-4	inhibition percentage	23	%
2634	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Ribosomal protein S6 kinase beta-1	inhibition percentage	0	%
2635	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase, Sbk1	inhibition percentage	21	%
2636	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase Sgk1	inhibition percentage	2	%
2637	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Uncharacterized serine/threonine-protein kinase SBK3	inhibition percentage	0	%
2638	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase Sgk2	inhibition percentage	16	%
2639	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase Sgk3	inhibition percentage	0	%
2640	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Protein-tyrosine kinase 6	inhibition percentage	0	%
2641	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase SIK1	inhibition percentage	8	%
2642	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase Fyn	inhibition percentage	0	%
2643	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	31	%
2644	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	NUAK family SNF1-like kinase 2	inhibition percentage	0	%
2645	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	SNF-related serine/threonine-protein kinase	inhibition percentage	0	%
2646	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Neuronal proto-oncogene tyrosine-protein kinase Src	inhibition percentage	4	%
2647	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase Srms	inhibition percentage	0	%
2648	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	CBL-interacting serine/threonine-protein kinase 7	inhibition percentage	0	%
2649	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	SRSF protein kinase 2	inhibition percentage	0	%
2650	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	SRSF protein kinase 3	inhibition percentage	0	%
2651	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase 16	inhibition percentage	0	%
2652	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase 33	inhibition percentage	8	%
2653	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase 35	inhibition percentage	0	%
2654	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	8	%
2655	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase 36	inhibition percentage	2	%
2656	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	STE20/SPS1-related proline-alanine-rich protein kinase	inhibition percentage	27	%
2657	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase SYK	inhibition percentage	0	%
2658	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase kinase kinase 7	inhibition percentage	0	%
2659	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase TAO1	inhibition percentage	1	%
2660	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase TAO2	inhibition percentage	4	%
2661	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase TAO3	inhibition percentage	0	%
2662	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase TBK1	inhibition percentage	0	%
2663	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Nuclear receptor subfamily 4 group A member 3	inhibition percentage	0	%
2664	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Dual specificity testis-specific protein kinase 1	inhibition percentage	0	%
2665	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
2666	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	TGF-beta receptor type-1	inhibition percentage	0	%
2667	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	TGF-beta receptor type-2	inhibition percentage	1	%
2668	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase receptor Tie-1	inhibition percentage	3	%
2669	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase receptor Tie-2	inhibition percentage	0	%
2670	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase TOUSLED-like 2	inhibition percentage	0	%
2671	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase TOUSLED-like 2	inhibition percentage	0	%
2672	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Traf2 and NCK-interacting protein kinase	inhibition percentage	2	%
2673	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Non-receptor tyrosine-protein kinase TNK1	inhibition percentage	0	%
2674	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Activated CDC42 kinase 1	inhibition percentage	0	%
2675	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase TNNI3K	inhibition percentage	0	%
2676	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
2677	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	High affinity nerve growth factor receptor	inhibition percentage	2	%
2678	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	BDNF/NT-3 growth factors receptor	inhibition percentage	8	%
2679	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	NT-3 growth factor receptor	inhibition percentage	0	%
2680	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Transient receptor potential cation channel subfamily M member 6	inhibition percentage	0	%
2681	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Testis-specific serine/threonine-protein kinase 1	inhibition percentage	0	%
2682	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Testis-specific serine/threonine-protein kinase 3	inhibition percentage	8	%
2683	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Dual specificity protein kinase TTK	inhibition percentage	0	%
2684	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase TXK	inhibition percentage	0	%
2685	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Non-receptor tyrosine-protein kinase TYK2	inhibition percentage	51	%
2686	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Non-receptor tyrosine-protein kinase TYK2 pseudokinase	inhibition percentage	0	%
2687	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	96.1	%
2688	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase receptor TYRO3	inhibition percentage	2	%
2689	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase ULK1	inhibition percentage	0	%
2690	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase ULK2	inhibition percentage	0	%
2691	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase ULK3	inhibition percentage	13	%
2692	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Vascular endothelial growth factor receptor 2	inhibition percentage	19	%
2693	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Phosphatidylinositol 3-kinase catalytic subunit type 3	inhibition percentage	0	%
2694	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase VRK2	inhibition percentage	31	%
2695	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitosis inhibitor protein kinase wee1	inhibition percentage	0	%
2696	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Wee1-like protein kinase 1-A	inhibition percentage	0	%
2697	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase WNK1	inhibition percentage	1	%
2698	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	73	%
2699	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase WNK2	inhibition percentage	0	%
2700	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase WNK3	inhibition percentage	17	%
2701	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase WNK4	inhibition percentage	11	%
2702	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase 32A	inhibition percentage	1	%
2703	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase 32B	inhibition percentage	0	%
2704	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase 32C	inhibition percentage	0	%
2705	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase yes	inhibition percentage	0	%
2706	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase 25	inhibition percentage	10	%
2707	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase kinase kinase 19	inhibition percentage	17	%
2708	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase kinase kinase 20	inhibition percentage	62	%
2709	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase ABL2	inhibition percentage	77	%
2710	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase ZAP-70	inhibition percentage	8	%
2711	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Activin receptor type-1	inhibition percentage	0	%
2712	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Activin receptor type-1B	inhibition percentage	0	%
2713	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Activin receptor type-2A	inhibition percentage	0	%
2714	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Activin receptor type-2B	inhibition percentage	0	%
2715	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase receptor R3	inhibition percentage	0	%
2716	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Atypical kinase COQ8A, mitochondrial	inhibition percentage	2	%
2717	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Atypical kinase COQ8B, mitochondrial	inhibition percentage	23	%
2718	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	RAC-alpha serine/threonine-protein kinase	inhibition percentage	7	%
2719	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	RAC-beta serine/threonine-protein kinase	inhibition percentage	20	%
2720	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	RAC-gamma serine/threonine-protein kinase	inhibition percentage	0	%
2721	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	ALK tyrosine kinase receptor	inhibition percentage	0	%
2722	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	ALK tyrosine kinase receptor	inhibition percentage	10	%
2723	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	ALK tyrosine kinase receptor	inhibition percentage	11	%
2724	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	5'-AMP-activated protein kinase catalytic subunit alpha-1	inhibition percentage	0	%
2725	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	5'-AMP-activated protein kinase catalytic subunit alpha-2	inhibition percentage	0	%
2726	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Ankyrin repeat and protein kinase domain-containing protein 1	inhibition percentage	0	%
2727	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	NUAK family SNF1-like kinase 1	inhibition percentage	1	%
2728	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase SRK2A	inhibition percentage	9	%
2729	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase SRK2G	inhibition percentage	5	%
2730	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Aurora kinase A	inhibition percentage	0	%
2731	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	AP2-associated protein kinase 1	inhibition percentage	2	%
2732	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Aurora kinase B	inhibition percentage	0	%
2733	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Aurora kinase C	inhibition percentage	0	%
2734	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase receptor UFO	inhibition percentage	13	%
2735	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	BMP-2-inducible protein kinase	inhibition percentage	0	%
2736	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase Blk	inhibition percentage	29	%
2737	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Bone morphogenetic protein receptor type-1A	inhibition percentage	9	%
2738	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Bone morphogenetic protein receptor type-1B	inhibition percentage	8	%
2739	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Bone morphogenetic protein receptor type-2	inhibition percentage	0	%
2740	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Cytoplasmic tyrosine-protein kinase BMX	inhibition percentage	0	%
2741	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase B-raf	inhibition percentage	89	%
2742	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase B-raf	inhibition percentage	97.1	%
2743	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Protein-tyrosine kinase 6	inhibition percentage	0	%
2744	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase BRSK1	inhibition percentage	0	%
2745	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Serine/threonine-protein kinase BRSK2	inhibition percentage	0	%
2746	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Tyrosine-protein kinase BTK	inhibition percentage	0	%
2747	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Checkpoint serine/threonine-protein kinase bub1	inhibition percentage	0	%
2748	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Calcium/calmodulin-dependent protein kinase type 1	inhibition percentage	0	%
2749	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Calcium/calmodulin-dependent protein kinase type 1B	inhibition percentage	19	%
2750	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Calcium/calmodulin-dependent protein kinase type 1D	inhibition percentage	0	%
2751	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Calcium/calmodulin-dependent protein kinase type 1G	inhibition percentage	6	%
2752	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Calcium/calmodulin-dependent protein kinase type II (isoform a)	inhibition percentage	0	%
2753	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Calcium/calmodulin-dependent protein kinase type II (isoform b)	inhibition percentage	0	%
2754	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Calcium/calmodulin-dependent protein kinase type II (isoform d)	inhibition percentage	1	%
2755	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Calcium/calmodulin-dependent protein kinase type II (isoform g)	inhibition percentage	0	%
2756	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Calcium/calmodulin-dependent protein kinase type IV	inhibition percentage	25	%
2757	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Calcium/calmodulin-dependent protein kinase kinase 1	inhibition percentage	0	%
2758	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Calcium/calmodulin-dependent protein kinase kinase 2	inhibition percentage	0	%
2759	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Casein kinase II subunit alpha	inhibition percentage	11	%
2760	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Cyclin-dependent kinase 11B	inhibition percentage	9	%
2761	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Cyclin-dependent kinase 11A	inhibition percentage	7	%
2762	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Mitogen-activated protein kinase 14A	delta Tm	11.1	°C
2763	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Epithelial discoidin domain-containing receptor 1	delta Tm	7.1	°C
2764	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1	Discoidin domain-containing receptor 2	delta Tm	9.1	°C
2765	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1		percentage of remaining compound	43.6	%
2766	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC(=O)C2=CN=C3C=CC=CN23)C=C1		inhibition percentage	50	%
2767	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase 14A	IC50	0.24	μM
2768	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Epithelial discoidin domain-containing receptor 1	IC50	1.04	μM
2769	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Discoidin domain-containing receptor 2	IC50	2.06	μM
2770	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 13	inhibition percentage	0	%
2771	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 11	inhibition percentage	1	%
2772	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2	inhibition percentage	0	%
2773	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 3	inhibition percentage	0	%
2774	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 4	inhibition percentage	0	%
2775	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 4; Cyclin-D1-1	inhibition percentage	0	%
2776	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 4; Cyclin-D3-1	inhibition percentage	9	%
2777	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent-like kinase 5	inhibition percentage	0	%
2778	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 7	inhibition percentage	21	%
2779	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 8	inhibition percentage	8	%
2780	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 9	inhibition percentage	0	%
2781	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase-like 1	inhibition percentage	0	%
2782	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase-like 2	inhibition percentage	0	%
2783	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase-like 3	inhibition percentage	6	%
2784	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase-like 5	inhibition percentage	8	%
2785	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Chk1	inhibition percentage	0	%
2786	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Chk2	inhibition percentage	0	%
2787	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Citrate synthase, mitochondrial	inhibition percentage	9	%
2788	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase RCK2	inhibition percentage	0	%
2789	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Dual specificity protein kinase CLK2	inhibition percentage	0	%
2790	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Dual specificity protein kinase CLK3	inhibition percentage	0	%
2791	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Dual specificity protein kinase CLK4	inhibition percentage	6	%
2792	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Macrophage colony-stimulating factor 1 receptor	inhibition percentage	10	%
2793	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Macrophage colony-stimulating factor 1 receptor	inhibition percentage	0	%
2794	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase CSK	inhibition percentage	2	%
2795	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Casein kinase I isoform alpha	inhibition percentage	24	%
2796	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Casein kinase I isoform alpha-like	inhibition percentage	0	%
2797	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Casein kinase I isoform delta	inhibition percentage	0	%
2798	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Casein kinase I isoform epsilon	inhibition percentage	0	%
2799	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Casein kinase I isoform gamma-1	inhibition percentage	0	%
2800	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Casein kinase I isoform gamma-2	inhibition percentage	0	%
2801	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Casein kinase I isoform gamma-3	inhibition percentage	0	%
2802	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Casein kinase II subunit alpha	inhibition percentage	3	%
2803	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Casein kinase II subunit alpha-2	inhibition percentage	19	%
2804	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Megakaryocyte-associated tyrosine-protein kinase	inhibition percentage	3	%
2805	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Death-associated protein kinase 1	inhibition percentage	4	%
2806	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Death-associated protein kinase 2	inhibition percentage	0	%
2807	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Death-associated protein kinase 3	inhibition percentage	0	%
2808	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase DCLK1	inhibition percentage	5	%
2809	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase DCLK2	inhibition percentage	10	%
2810	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase DCLK3	inhibition percentage	16	%
2811	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Epithelial discoidin domain-containing receptor 1	inhibition percentage	100	%
2812	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Discoidin domain-containing receptor 2	inhibition percentage	92.3	%
2813	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Death-associated protein kinase 3	inhibition percentage	0	%
2814	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Myotonin-protein kinase	inhibition percentage	28	%
2815	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase MRCK gamma	inhibition percentage	0	%
2816	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase 17A	inhibition percentage	11	%
2817	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase 17B	inhibition percentage	0	%
2818	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 1A/B	inhibition percentage	10	%
2819	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	inhibition percentage	0	%
2820	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 2	inhibition percentage	6	%
2821	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	epidermal growth factor-activated receptor	inhibition percentage	4	%
2822	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	epidermal growth factor-activated receptor	inhibition percentage	11	%
2823	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Epidermal growth factor receptor (G719C)	inhibition percentage	13	%
2824	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Epidermal growth factor receptor (G719S)	inhibition percentage	8	%
2825	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	epidermal growth factor-activated receptor	inhibition percentage	0	%
2826	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	epidermal growth factor-activated receptor	inhibition percentage	0	%
2827	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	epidermal growth factor-activated receptor	inhibition percentage	43	%
2828	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Epidermal growth factor receptor (L858R)	inhibition percentage	0	%
2829	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Epidermal growth factor receptor (L858R)	inhibition percentage	41	%
2830	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Epidermal growth factor receptor (L861Q)	inhibition percentage	46	%
2831	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	epidermal growth factor-activated receptor	inhibition percentage	21	%
2832	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Epidermal growth factor receptor (T790M)	inhibition percentage	9	%
2833	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Eukaryotic translation initiation factor 2-alpha kinase 1	inhibition percentage	3	%
2834	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ephrin type-A receptor 1	inhibition percentage	0	%
2835	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ephrin type-A receptor 2	inhibition percentage	0	%
2836	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ephrin type-A receptor 3	inhibition percentage	1	%
2837	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ephrin type-A receptor 4	inhibition percentage	12	%
2838	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ephrin type-A receptor 5	inhibition percentage	0	%
2839	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ephrin type-A receptor 6	inhibition percentage	3	%
2840	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ephrin type-A receptor 7	inhibition percentage	0	%
2841	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ephrin type-A receptor 8	inhibition percentage	0	%
2842	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ephrin type-B receptor 1	inhibition percentage	15	%
2843	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ephrin type-B receptor 2	inhibition percentage	0	%
2844	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ephrin type-B receptor 3	inhibition percentage	0	%
2845	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ephrin type-B receptor 4	inhibition percentage	0	%
2846	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ephrin type-B receptor 6	inhibition percentage	24	%
2847	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Receptor tyrosine-protein kinase erbB-2	inhibition percentage	14	%
2848	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Receptor tyrosine-protein kinase erbB-3	inhibition percentage	12	%
2849	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Receptor tyrosine-protein kinase erbB-4	inhibition percentage	0	%
2850	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Extracellular signal-regulated kinase 1	inhibition percentage	0	%
2851	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Extracellular signal-regulated kinase 2	inhibition percentage	0	%
2852	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase 6	inhibition percentage	0	%
2853	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase 4	inhibition percentage	0	%
2854	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase 7	inhibition percentage	0	%
2855	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase 15	inhibition percentage	0	%
2856	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase/endoribonuclease IRE1	inhibition percentage	4	%
2857	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Focal adhesion kinase 1	inhibition percentage	0	%
2858	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase Fer	inhibition percentage	12	%
2859	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase, Fes/Fps type	inhibition percentage	0	%
2860	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Fibroblast growth factor receptor 1	inhibition percentage	0	%
2861	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Fibroblast growth factor receptor 2	inhibition percentage	0	%
2862	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Fibroblast growth factor receptor 3	inhibition percentage	0	%
2863	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Fibroblast growth factor receptor 3	inhibition percentage	1	%
2864	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Fibroblast growth factor receptor 4	inhibition percentage	0	%
2865	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase Fgr	inhibition percentage	16	%
2866	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Vascular endothelial growth factor receptor 1	inhibition percentage	0	%
2867	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Vascular endothelial growth factor receptor 3	inhibition percentage	2	%
2868	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Receptor-type tyrosine-protein kinase FLT3 (D835H)	inhibition percentage	33	%
2869	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Receptor-type tyrosine-protein kinase FLT3 (D835V)	inhibition percentage	0	%
2870	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Receptor-type tyrosine-protein kinase FLT3 (D835Y)	inhibition percentage	0	%
2871	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Receptor-type tyrosine-protein kinase FLT3 (ITD)	inhibition percentage	9	%
2872	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Receptor-type tyrosine-protein kinase FLT3 (ITD)	inhibition percentage	26	%
2873	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Receptor-type tyrosine-protein kinase FLT3 (ITD)	inhibition percentage	0	%
2874	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	0	%
2875	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	0	%
2876	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	0	%
2877	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	21	%
2878	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Vascular endothelial growth factor receptor 3	inhibition percentage	24	%
2879	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase FRK	inhibition percentage	0	%
2880	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase Fyn	inhibition percentage	0	%
2881	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-G-associated kinase	inhibition percentage	10	%
2882	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	ABC transporter F family member 2	inhibition percentage	9	%
2883	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	rhodopsin kinase	inhibition percentage	0	%
2884	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Beta-adrenergic receptor kinase 1	inhibition percentage	40	%
2885	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Beta-adrenergic receptor kinase 2	inhibition percentage	3	%
2886	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	G protein-coupled receptor kinase 4	inhibition percentage	6	%
2887	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	rhodopsin kinase	inhibition percentage	0	%
2888	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Glycogen synthase kinase-3 alpha	inhibition percentage	12	%
2889	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	tau-protein kinase	inhibition percentage	0	%
2890	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase haspin	inhibition percentage	11	%
2891	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase HCK	inhibition percentage	8	%
2892	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Homeodomain-interacting protein kinase 1	inhibition percentage	10	%
2893	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Homeodomain-interacting protein kinase 2	inhibition percentage	0	%
2894	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Homeodomain-interacting protein kinase 3	inhibition percentage	0	%
2895	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Homeodomain-interacting protein kinase 4	inhibition percentage	0	%
2896	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase kinase 1	inhibition percentage	15	%
2897	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Hormonally up-regulated neu tumor-associated kinase	inhibition percentage	0	%
2898	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase ICK	inhibition percentage	9	%
2899	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Insulin-like growth factor 1 receptor	inhibition percentage	0	%
2900	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Inhibitor of nuclear factor kappa-B kinase subunit alpha	inhibition percentage	0	%
2901	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Inhibitor of nuclear factor kappa-B kinase subunit beta	inhibition percentage	0	%
2902	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	inhibition percentage	4	%
2903	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Insulin receptor	inhibition percentage	8	%
2904	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Insulin receptor-related protein	inhibition percentage	6	%
2905	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Interleukin-1 receptor-associated kinase 1	inhibition percentage	6	%
2906	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Interleukin-1 receptor-associated kinase 3	inhibition percentage	9	%
2907	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Interleukin-1 receptor-associated kinase 4	inhibition percentage	27	%
2908	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ITK/TSK	inhibition percentage	0	%
2909	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase JAK1	inhibition percentage	0	%
2910	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase JAK1 pseudokinase	inhibition percentage	0	%
2911	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase JAK2	inhibition percentage	18	%
2912	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase JAK3	inhibition percentage	0	%
2913	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase 8	inhibition percentage	18	%
2914	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase 9	inhibition percentage	6	%
2915	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase 10	inhibition percentage	11	%
2916	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mast/stem cell growth factor receptor Kit	inhibition percentage	17	%
2917	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mast/stem cell growth factor receptor Kit (A829P)	inhibition percentage	0	%
2918	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mast/stem cell growth factor receptor Kit (D816H)	inhibition percentage	24	%
2919	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mast/stem cell growth factor receptor Kit (D816V)	inhibition percentage	2	%
2920	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mast/stem cell growth factor receptor Kit	inhibition percentage	2	%
2921	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mast/stem cell growth factor receptor Kit (V559D)	inhibition percentage	8	%
2922	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mast/stem cell growth factor receptor Kit (V559D)	inhibition percentage	21	%
2923	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mast/stem cell growth factor receptor Kit (V559D)	inhibition percentage	1	%
2924	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mast/stem cell growth factor receptor Kit	inhibition percentage	0	%
2925	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase LATS1	inhibition percentage	23	%
2926	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase LATS2	inhibition percentage	0	%
2927	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase Lck	inhibition percentage	17	%
2928	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	LIM domain kinase 1	inhibition percentage	6	%
2929	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	LIM domain kinase 2	inhibition percentage	0	%
2930	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase STK11	inhibition percentage	21	%
2931	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase 10	inhibition percentage	0	%
2932	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Leucine-rich repeat serine/threonine-protein kinase 2	inhibition percentage	0	%
2933	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Leucine-rich repeat serine/threonine-protein kinase 2 (G2019S)	inhibition percentage	0	%
2934	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Leukocyte tyrosine kinase receptor	inhibition percentage	0	%
2935	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase Lyn	inhibition percentage	0	%
2936	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase 13	inhibition percentage	0	%
2937	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase MAK	inhibition percentage	16	%
2938	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase 1	inhibition percentage	0	%
2939	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase 15	inhibition percentage	0	%
2940	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase 2	inhibition percentage	10	%
2941	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase 3	inhibition percentage	13	%
2942	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase 4	inhibition percentage	1	%
2943	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase kinase 2	inhibition percentage	0	%
2944	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase kinase 3	inhibition percentage	0	%
2945	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase kinase 4	inhibition percentage	0	%
2946	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase kinase 5	inhibition percentage	0	%
2947	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	MAP kinase-activated protein kinase 2	inhibition percentage	0	%
2948	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	MAP kinase-activated protein kinase 5	inhibition percentage	0	%
2949	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase MARK1	inhibition percentage	0	%
2950	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase MARK2	inhibition percentage	0	%
2951	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase MARK3	inhibition percentage	0	%
2952	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase MARK4	inhibition percentage	0	%
2953	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Microtubule-associated serine/threonine-protein kinase 1	inhibition percentage	0	%
2954	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Dual specificity mitogen-activated protein kinase kinase 1	inhibition percentage	0	%
2955	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Dual specificity mitogen-activated protein kinase kinase 2	inhibition percentage	0	%
2956	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Dual specificity mitogen-activated protein kinase kinase 3	inhibition percentage	0	%
2957	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Dual specificity mitogen-activated protein kinase kinase 4	inhibition percentage	0	%
2958	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Dual specificity mitogen-activated protein kinase kinase 5	inhibition percentage	9	%
2959	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Dual specificity mitogen-activated protein kinase kinase 6	inhibition percentage	0	%
2960	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Maternal embryonic leucine zipper kinase	inhibition percentage	0	%
2961	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase Mer	inhibition percentage	12	%
2962	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Hepatocyte growth factor receptor	inhibition percentage	0	%
2963	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Hepatocyte growth factor receptor (M1250T)	inhibition percentage	0	%
2964	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Hepatocyte growth factor receptor	inhibition percentage	0	%
2965	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Misshapen-like kinase 1	inhibition percentage	0	%
2966	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Dual specificity mitogen-activated protein kinase kinase 7	inhibition percentage	10	%
2967	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	MAP kinase-interacting serine/threonine-protein kinase 1	inhibition percentage	0	%
2968	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	MAP kinase-interacting serine/threonine-protein kinase 2	inhibition percentage	3	%
2969	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	myosin light chain kinase	inhibition percentage	15	%
2970	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase 9	inhibition percentage	0	%
2971	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase 10	inhibition percentage	0	%
2972	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase 11	inhibition percentage	11	%
2973	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase MRCK alpha	inhibition percentage	0	%
2974	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase MRCK beta	inhibition percentage	5	%
2975	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Bowman-Birk type proteinase inhibitor	inhibition percentage	0	%
2976	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Macrophage-stimulating protein receptor	inhibition percentage	15	%
2977	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase 3	inhibition percentage	0	%
2978	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase 24	inhibition percentage	3	%
2979	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase 26	inhibition percentage	0	%
2980	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase mTOR	inhibition percentage	4	%
2981	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Muscle, skeletal receptor tyrosine-protein kinase	inhibition percentage	0	%
2982	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Myosin light chain kinase, smooth muscle	inhibition percentage	4	%
2983	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Myosin light chain kinase 2, skeletal/cardiac muscle	inhibition percentage	6	%
2984	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Myosin light chain kinase family member 4	inhibition percentage	2	%
2985	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Myosin-IIIa	inhibition percentage	0	%
2986	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Myosin-IIIb	inhibition percentage	34	%
2987	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase 38	inhibition percentage	0	%
2988	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase 38-like	inhibition percentage	0	%
2989	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Nek1	inhibition percentage	0	%
2990	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Nek10	inhibition percentage	7	%
2991	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Nek11	inhibition percentage	0	%
2992	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Nek2	inhibition percentage	0	%
2993	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Nek3	inhibition percentage	4	%
2994	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Nek4	inhibition percentage	26	%
2995	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Nek5	inhibition percentage	0	%
2996	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Nek6	inhibition percentage	0	%
2997	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Nek7	inhibition percentage	0	%
2998	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Nek9	inhibition percentage	0	%
2999	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase 14	inhibition percentage	1	%
3000	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase NIM1	inhibition percentage	7	%
3001	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine kinase NLK	inhibition percentage	4	%
3002	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase OSR1	inhibition percentage	8	%
3003	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase 14A	inhibition percentage	98.5	%
3004	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase 11	inhibition percentage	80	%
3005	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase 13	inhibition percentage	13	%
3006	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase 12	inhibition percentage	2	%
3007	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase PAK 1	inhibition percentage	21	%
3008	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase PAK2	inhibition percentage	31	%
3009	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase PAK 3	inhibition percentage	0	%
3010	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase PAK 4	inhibition percentage	0	%
3011	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase PAK 6	inhibition percentage	3	%
3012	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase PAK5	inhibition percentage	4	%
3013	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 16	inhibition percentage	0	%
3014	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 17	inhibition percentage	0	%
3015	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 18	inhibition percentage	16	%
3016	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Platelet-derived growth factor receptor alpha	inhibition percentage	0	%
3017	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Platelet-derived growth factor receptor beta	inhibition percentage	0	%
3018	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	3-phosphoinositide-dependent protein kinase 1	inhibition percentage	3	%
3019	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Calcium-dependent protein kinase 1 [Plasmodium falciparum]	inhibition percentage	21	%
3020	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	26	%
3021	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cell division control protein 2 homolog [Plasmodium falciparum]	inhibition percentage	0	%
3022	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 15	inhibition percentage	0	%
3023	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 14	inhibition percentage	0	%
3024	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	inhibition percentage	11	%
3025	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	inhibition percentage	0	%
3026	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	inhibition percentage	0	%
3027	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	inhibition percentage	13	%
3028	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition percentage	0	%
3029	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (C420R)	inhibition percentage	12	%
3030	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545A)	inhibition percentage	20	%
3031	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
3032	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545A)	inhibition percentage	0	%
3033	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545K)	inhibition percentage	21	%
3034	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047L)	inhibition percentage	0	%
3035	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047Y)	inhibition percentage	10	%
3036	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition percentage	0	%
3037	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (M1043I)	inhibition percentage	9	%
3038	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (Q546K)	inhibition percentage	5	%
3039	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	inhibition percentage	19	%
3040	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	inhibition percentage	13	%
3041	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	inhibition percentage	0	%
3042	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	5	%
3043	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4-kinase beta	inhibition percentage	0	%
3044	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	1-phosphatidylinositol 3-phosphate 5-kinase	inhibition percentage	19	%
3045	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase pim-1	inhibition percentage	4	%
3046	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase pim-2	inhibition percentage	3	%
3047	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase pim-3	inhibition percentage	12	%
3048	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	inhibition percentage	0	%
3049	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	inhibition percentage	0	%
3050	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta	inhibition percentage	26	%
3051	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	inhibition percentage	0	%
3052	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	cAMP-dependent protein kinase catalytic subunit alpha	inhibition percentage	5	%
3053	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	12	%
3054	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	cAMP-dependent protein kinase catalytic subunit beta	inhibition percentage	0	%
3055	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	inhibition percentage	8	%
3056	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Pkn1	inhibition percentage	0	%
3057	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase pkn2	inhibition percentage	33	%
3058	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase PknB [Mycobacterium tuberculosis]	inhibition percentage	9	%
3059	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase PLK1	inhibition percentage	44	%
3060	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase PLK2	inhibition percentage	4	%
3061	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Plk3	inhibition percentage	11	%
3062	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Plk4	inhibition percentage	8	%
3063	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Protein kinase C, delta	inhibition percentage	0	%
3064	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	4	%
3065	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Protein kinase C, epsilon	inhibition percentage	7	%
3066	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Protein kinase C, eta	inhibition percentage	3	%
3067	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Protein kinase C iota type	inhibition percentage	0	%
3068	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Protein kinase C, theta	inhibition percentage	24	%
3069	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase D1	inhibition percentage	26	%
3070	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase D2	inhibition percentage	0	%
3071	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase D3	inhibition percentage	0	%
3072	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	cGMP-dependent protein kinase 1	inhibition percentage	0	%
3073	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	cGMP-dependent protein kinase 2	inhibition percentage	0	%
3074	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Interferon-induced, double-stranded RNA-activated protein kinase	inhibition percentage	28	%
3075	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	8	%
3076	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	cAMP-dependent protein kinase catalytic subunit PRKX	inhibition percentage	0	%
3077	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase prp4	inhibition percentage	18	%
3078	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Protein-tyrosine kinase 2-beta	inhibition percentage	21	%
3079	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase SIK3	inhibition percentage	0	%
3080	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	RAF proto-oncogene serine/threonine-protein kinase	inhibition percentage	0	%
3081	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Proto-oncogene tyrosine-protein kinase receptor Ret	inhibition percentage	0	%
3082	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (M918T)	inhibition percentage	0	%
3083	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804L)	inhibition percentage	7	%
3084	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M)	inhibition percentage	0	%
3085	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Rio1	inhibition percentage	0	%
3086	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	3	%
3087	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Rio2	inhibition percentage	0	%
3088	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Rio3	inhibition percentage	15	%
3089	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Receptor-interacting serine/threonine-protein kinase 1	inhibition percentage	0	%
3090	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Receptor-interacting serine/threonine-protein kinase 2	inhibition percentage	0	%
3091	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Receptor-interacting serine/threonine-protein kinase 4	inhibition percentage	12	%
3092	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Dual serine/threonine and tyrosine protein kinase	inhibition percentage	23	%
3093	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Rho-associated protein kinase 1	inhibition percentage	16	%
3094	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Rho-associated protein kinase 2	inhibition percentage	2	%
3095	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Proto-oncogene tyrosine-protein kinase ROS	inhibition percentage	7	%
3096	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ribosomal protein S6 kinase alpha-4	inhibition percentage	0	%
3097	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
3098	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ribosomal protein S6 kinase alpha-4	inhibition percentage	0	%
3099	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ribosomal protein S6 kinase alpha-5	inhibition percentage	9	%
3100	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ribosomal protein S6 kinase alpha-5	inhibition percentage	0	%
3101	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ribosomal protein S6 kinase alpha-1	inhibition percentage	6	%
3102	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ribosomal protein S6 kinase alpha-1	inhibition percentage	0	%
3103	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ribosomal protein S6 kinase alpha-3	inhibition percentage	0	%
3104	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ribosomal protein S6 kinase alpha-2	inhibition percentage	10	%
3105	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ribosomal protein S6 kinase alpha-3	inhibition percentage	17	%
3106	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ribosomal protein S6 kinase alpha-3	inhibition percentage	4	%
3107	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ribosomal protein S6 kinase alpha-4	inhibition percentage	8	%
3108	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	32	%
3109	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ribosomal protein S6 kinase alpha-4	inhibition percentage	1	%
3110	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ribosomal protein S6 kinase beta-1	inhibition percentage	10	%
3111	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase, Sbk1	inhibition percentage	15	%
3112	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Sgk1	inhibition percentage	0	%
3113	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Uncharacterized serine/threonine-protein kinase SBK3	inhibition percentage	0	%
3114	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Sgk2	inhibition percentage	0	%
3115	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Sgk3	inhibition percentage	0	%
3116	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Protein-tyrosine kinase 6	inhibition percentage	1	%
3117	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase SIK1	inhibition percentage	0	%
3118	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase Fyn	inhibition percentage	11	%
3119	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	6	%
3120	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	NUAK family SNF1-like kinase 2	inhibition percentage	0	%
3121	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	SNF-related serine/threonine-protein kinase	inhibition percentage	7	%
3122	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Neuronal proto-oncogene tyrosine-protein kinase Src	inhibition percentage	12	%
3123	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase Srms	inhibition percentage	0	%
3124	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	CBL-interacting serine/threonine-protein kinase 7	inhibition percentage	0	%
3125	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	SRSF protein kinase 2	inhibition percentage	0	%
3126	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	SRSF protein kinase 3	inhibition percentage	0	%
3127	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase 16	inhibition percentage	14	%
3128	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase 33	inhibition percentage	12	%
3129	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase 35	inhibition percentage	0	%
3130	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
3131	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase 36	inhibition percentage	3	%
3132	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	STE20/SPS1-related proline-alanine-rich protein kinase	inhibition percentage	14	%
3133	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase SYK	inhibition percentage	27	%
3134	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase 7	inhibition percentage	8	%
3135	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase TAO1	inhibition percentage	0	%
3136	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase TAO2	inhibition percentage	7	%
3137	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase TAO3	inhibition percentage	0	%
3138	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase TBK1	inhibition percentage	15	%
3139	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Nuclear receptor subfamily 4 group A member 3	inhibition percentage	0	%
3140	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Dual specificity testis-specific protein kinase 1	inhibition percentage	0	%
3141	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
3142	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	TGF-beta receptor type-1	inhibition percentage	0	%
3143	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	TGF-beta receptor type-2	inhibition percentage	14	%
3144	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase receptor Tie-1	inhibition percentage	3	%
3145	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase receptor Tie-2	inhibition percentage	0	%
3146	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase TOUSLED-like 2	inhibition percentage	0	%
3147	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase TOUSLED-like 2	inhibition percentage	14	%
3148	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Traf2 and NCK-interacting protein kinase	inhibition percentage	9	%
3149	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Non-receptor tyrosine-protein kinase TNK1	inhibition percentage	8	%
3150	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Activated CDC42 kinase 1	inhibition percentage	3	%
3151	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase TNNI3K	inhibition percentage	0	%
3152	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
3153	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	High affinity nerve growth factor receptor	inhibition percentage	0	%
3154	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	BDNF/NT-3 growth factors receptor	inhibition percentage	9	%
3155	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	NT-3 growth factor receptor	inhibition percentage	7	%
3156	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Transient receptor potential cation channel subfamily M member 6	inhibition percentage	0	%
3157	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Testis-specific serine/threonine-protein kinase 1	inhibition percentage	15	%
3158	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Testis-specific serine/threonine-protein kinase 3	inhibition percentage	5	%
3159	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Dual specificity protein kinase TTK	inhibition percentage	8	%
3160	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase TXK	inhibition percentage	0	%
3161	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Non-receptor tyrosine-protein kinase TYK2	inhibition percentage	42	%
3162	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Non-receptor tyrosine-protein kinase TYK2 pseudokinase	inhibition percentage	0	%
3163	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	20	%
3164	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase receptor TYRO3	inhibition percentage	0	%
3165	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase ULK1	inhibition percentage	0	%
3166	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase ULK2	inhibition percentage	0	%
3167	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase ULK3	inhibition percentage	13	%
3168	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Vascular endothelial growth factor receptor 2	inhibition percentage	8	%
3169	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 3-kinase catalytic subunit type 3	inhibition percentage	0	%
3170	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase VRK2	inhibition percentage	14	%
3171	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitosis inhibitor protein kinase wee1	inhibition percentage	0	%
3172	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Wee1-like protein kinase 1-A	inhibition percentage	0	%
3173	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase WNK1	inhibition percentage	0	%
3174	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	26	%
3175	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase WNK2	inhibition percentage	0	%
3176	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase WNK3	inhibition percentage	0	%
3177	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase WNK4	inhibition percentage	0	%
3178	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase 32A	inhibition percentage	10	%
3179	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase 32B	inhibition percentage	0	%
3180	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase 32C	inhibition percentage	17	%
3181	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase yes	inhibition percentage	8	%
3182	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase 25	inhibition percentage	6	%
3183	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase 19	inhibition percentage	6	%
3184	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase 20	inhibition percentage	24	%
3185	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ABL2	inhibition percentage	16	%
3186	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ZAP-70	inhibition percentage	0	%
3187	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Activin receptor type-1	inhibition percentage	0	%
3188	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Activin receptor type-1B	inhibition percentage	13	%
3189	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Activin receptor type-2A	inhibition percentage	0	%
3190	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Activin receptor type-2B	inhibition percentage	0	%
3191	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase receptor R3	inhibition percentage	34	%
3192	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Atypical kinase COQ8A, mitochondrial	inhibition percentage	14	%
3193	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Atypical kinase COQ8B, mitochondrial	inhibition percentage	0	%
3194	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	RAC-alpha serine/threonine-protein kinase	inhibition percentage	7	%
3195	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	RAC-beta serine/threonine-protein kinase	inhibition percentage	13	%
3196	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	RAC-gamma serine/threonine-protein kinase	inhibition percentage	26	%
3197	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	ALK tyrosine kinase receptor	inhibition percentage	0	%
3198	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	ALK tyrosine kinase receptor	inhibition percentage	0	%
3199	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	ALK tyrosine kinase receptor	inhibition percentage	1	%
3200	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	5'-AMP-activated protein kinase catalytic subunit alpha-1	inhibition percentage	0	%
3201	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	5'-AMP-activated protein kinase catalytic subunit alpha-2	inhibition percentage	0	%
3202	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ankyrin repeat and protein kinase domain-containing protein 1	inhibition percentage	0	%
3203	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	NUAK family SNF1-like kinase 1	inhibition percentage	2	%
3204	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase SRK2A	inhibition percentage	0	%
3205	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase SRK2G	inhibition percentage	0	%
3206	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Aurora kinase A	inhibition percentage	0	%
3207	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	AP2-associated protein kinase 1	inhibition percentage	15	%
3208	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Aurora kinase B	inhibition percentage	0	%
3209	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Aurora kinase C	inhibition percentage	6	%
3210	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase receptor UFO	inhibition percentage	2	%
3211	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	BMP-2-inducible protein kinase	inhibition percentage	14	%
3212	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase Blk	inhibition percentage	0	%
3213	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Bone morphogenetic protein receptor type-1A	inhibition percentage	34	%
3214	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Bone morphogenetic protein receptor type-1B	inhibition percentage	0	%
3215	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Bone morphogenetic protein receptor type-2	inhibition percentage	0	%
3216	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cytoplasmic tyrosine-protein kinase BMX	inhibition percentage	6	%
3217	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase B-raf	inhibition percentage	0	%
3218	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase B-raf	inhibition percentage	0	%
3219	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Protein-tyrosine kinase 6	inhibition percentage	0	%
3220	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase BRSK1	inhibition percentage	0	%
3221	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase BRSK2	inhibition percentage	0	%
3222	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase BTK	inhibition percentage	0	%
3223	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Checkpoint serine/threonine-protein kinase bub1	inhibition percentage	0	%
3224	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Calcium/calmodulin-dependent protein kinase type 1	inhibition percentage	5	%
3225	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Calcium/calmodulin-dependent protein kinase type 1B	inhibition percentage	23	%
3226	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Calcium/calmodulin-dependent protein kinase type 1D	inhibition percentage	7	%
3227	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Calcium/calmodulin-dependent protein kinase type 1G	inhibition percentage	0	%
3228	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Calcium/calmodulin-dependent protein kinase type II (isoform a)	inhibition percentage	0	%
3229	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Calcium/calmodulin-dependent protein kinase type II (isoform b)	inhibition percentage	0	%
3230	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Calcium/calmodulin-dependent protein kinase type II (isoform d)	inhibition percentage	4	%
3231	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Calcium/calmodulin-dependent protein kinase type II (isoform g)	inhibition percentage	0	%
3232	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Calcium/calmodulin-dependent protein kinase type IV	inhibition percentage	30	%
3233	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Calcium/calmodulin-dependent protein kinase kinase 1	inhibition percentage	0	%
3234	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Calcium/calmodulin-dependent protein kinase kinase 2	inhibition percentage	0	%
3235	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Casein kinase II subunit alpha	inhibition percentage	10	%
3236	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 11B	inhibition percentage	0	%
3237	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 11A	inhibition percentage	13	%
3238	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase 14A	delta Tm	6.6	°C
3239	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Epithelial discoidin domain-containing receptor 1	delta Tm	5.7	°C
3240	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Discoidin domain-containing receptor 2	delta Tm	6.1	°C
3241	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)C=C1		percentage of remaining compound	28.4	%
3242	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase 11	IC50	1.63	μM
3243	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase 14A	IC50	5.39	μM
3244	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Epithelial discoidin domain-containing receptor 1;+Discoidin domain-containing receptor 2;+Mitogen-activated protein kinase 11;+Mitogen-activated protein kinase 14A	qualitative		
3245	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Epithelial discoidin domain-containing receptor 1;+Discoidin domain-containing receptor 2;+Mitogen-activated protein kinase 11;+Mitogen-activated protein kinase 14A	qualitative		
3246	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Epithelial discoidin domain-containing receptor 1;+Discoidin domain-containing receptor 2;+Mitogen-activated protein kinase 11;+Mitogen-activated protein kinase 14A	qualitative		
3247	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Epithelial discoidin domain-containing receptor 1;+Discoidin domain-containing receptor 2;+Mitogen-activated protein kinase 11;+Mitogen-activated protein kinase 14A	percentage of apoptotic cells increase		
3248	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Epithelial discoidin domain-containing receptor 1;+Discoidin domain-containing receptor 2;+Mitogen-activated protein kinase 11;+Mitogen-activated protein kinase 14A	percentage of apoptotic cells increase		
3249	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Epithelial discoidin domain-containing receptor 1;+Discoidin domain-containing receptor 2;+Mitogen-activated protein kinase 11;+Mitogen-activated protein kinase 14A	percentage of apoptotic cells increase		
3250	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Discoidin domain-containing receptor 2	IC50	15.5	μM
3251	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Epithelial discoidin domain-containing receptor 1	IC50	21.9	μM
3252	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Epithelial discoidin domain-containing receptor 1;+Discoidin domain-containing receptor 2;+Mitogen-activated protein kinase 11;+Mitogen-activated protein kinase 14A	qualitative		
3253	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Epithelial discoidin domain-containing receptor 1;+Discoidin domain-containing receptor 2;+Mitogen-activated protein kinase 11;+Mitogen-activated protein kinase 14A	qualitative		
3254	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Epithelial discoidin domain-containing receptor 1;+Discoidin domain-containing receptor 2;+Mitogen-activated protein kinase 11;+Mitogen-activated protein kinase 14A	qualitative		
3255	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Epithelial discoidin domain-containing receptor 1;+Discoidin domain-containing receptor 2;+Mitogen-activated protein kinase 11;+Mitogen-activated protein kinase 14A	cell lysis increase		
3256	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Epithelial discoidin domain-containing receptor 1;+Discoidin domain-containing receptor 2;+Mitogen-activated protein kinase 11;+Mitogen-activated protein kinase 14A	cell lysis increase		
3257	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Epithelial discoidin domain-containing receptor 1;+Discoidin domain-containing receptor 2;+Mitogen-activated protein kinase 11;+Mitogen-activated protein kinase 14A	cell lysis increase		
3258	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 13	inhibition percentage	0	%
3259	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 11	inhibition percentage	10	%
3260	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2	inhibition percentage	0	%
3261	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 3	inhibition percentage	18	%
3262	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 4	inhibition percentage	9	%
3263	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 4; Cyclin-D1-1	inhibition percentage	0	%
3264	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 4; Cyclin-D3-1	inhibition percentage	0	%
3265	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent-like kinase 5	inhibition percentage	6	%
3266	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 7	inhibition percentage	0	%
3267	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 8	inhibition percentage	0	%
3268	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 9	inhibition percentage	13	%
3269	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase-like 1	inhibition percentage	29	%
3270	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase-like 2	inhibition percentage	0	%
3271	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase-like 3	inhibition percentage	4	%
3272	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase-like 5	inhibition percentage	0	%
3273	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Chk1	inhibition percentage	0	%
3274	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Chk2	inhibition percentage	0	%
3275	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Citrate synthase, mitochondrial	inhibition percentage	2	%
3276	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase RCK2	inhibition percentage	13	%
3277	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Dual specificity protein kinase CLK2	inhibition percentage	0	%
3278	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Dual specificity protein kinase CLK3	inhibition percentage	15	%
3279	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Dual specificity protein kinase CLK4	inhibition percentage	15	%
3280	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Macrophage colony-stimulating factor 1 receptor	inhibition percentage	0	%
3281	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Macrophage colony-stimulating factor 1 receptor	inhibition percentage	0	%
3282	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase CSK	inhibition percentage	9	%
3283	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Casein kinase I isoform alpha	inhibition percentage	1	%
3284	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Casein kinase I isoform alpha-like	inhibition percentage	0	%
3285	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Casein kinase I isoform delta	inhibition percentage	4	%
3286	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Casein kinase I isoform epsilon	inhibition percentage	0	%
3287	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Casein kinase I isoform gamma-1	inhibition percentage	0	%
3288	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Casein kinase I isoform gamma-2	inhibition percentage	18	%
3289	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Casein kinase I isoform gamma-3	inhibition percentage	0	%
3290	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Casein kinase II subunit alpha	inhibition percentage	6	%
3291	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Casein kinase II subunit alpha-2	inhibition percentage	15	%
3292	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Megakaryocyte-associated tyrosine-protein kinase	inhibition percentage	0	%
3293	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Death-associated protein kinase 1	inhibition percentage	8	%
3294	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Death-associated protein kinase 2	inhibition percentage	10	%
3295	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Death-associated protein kinase 3	inhibition percentage	12	%
3296	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase DCLK1	inhibition percentage	0	%
3297	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase DCLK2	inhibition percentage	5	%
3298	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase DCLK3	inhibition percentage	13	%
3299	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Epithelial discoidin domain-containing receptor 1	inhibition percentage	11	%
3300	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Discoidin domain-containing receptor 2	inhibition percentage	0	%
3301	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Death-associated protein kinase 3	inhibition percentage	0	%
3302	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Myotonin-protein kinase	inhibition percentage	0	%
3303	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase MRCK gamma	inhibition percentage	1	%
3304	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase 17A	inhibition percentage	0	%
3305	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase 17B	inhibition percentage	0	%
3306	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 1A/B	inhibition percentage	13	%
3307	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	inhibition percentage	0	%
3308	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 2	inhibition percentage	0	%
3309	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	epidermal growth factor-activated receptor	inhibition percentage	0	%
3310	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	epidermal growth factor-activated receptor	inhibition percentage	0	%
3311	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Epidermal growth factor receptor (G719C)	inhibition percentage	14	%
3312	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Epidermal growth factor receptor (G719S)	inhibition percentage	28	%
3313	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	epidermal growth factor-activated receptor	inhibition percentage	7	%
3314	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	epidermal growth factor-activated receptor	inhibition percentage	34	%
3315	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	epidermal growth factor-activated receptor	inhibition percentage	6	%
3316	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Epidermal growth factor receptor (L858R)	inhibition percentage	0	%
3317	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Epidermal growth factor receptor (L858R)	inhibition percentage	16	%
3318	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Epidermal growth factor receptor (L861Q)	inhibition percentage	0	%
3319	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	epidermal growth factor-activated receptor	inhibition percentage	0	%
3320	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Epidermal growth factor receptor (T790M)	inhibition percentage	0	%
3321	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Eukaryotic translation initiation factor 2-alpha kinase 1	inhibition percentage	19	%
3322	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ephrin type-A receptor 1	inhibition percentage	5	%
3323	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ephrin type-A receptor 2	inhibition percentage	0	%
3324	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ephrin type-A receptor 3	inhibition percentage	25	%
3325	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ephrin type-A receptor 4	inhibition percentage	24	%
3326	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ephrin type-A receptor 5	inhibition percentage	4	%
3327	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ephrin type-A receptor 6	inhibition percentage	0	%
3328	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ephrin type-A receptor 7	inhibition percentage	2	%
3329	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ephrin type-A receptor 8	inhibition percentage	0	%
3330	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ephrin type-B receptor 1	inhibition percentage	0	%
3331	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ephrin type-B receptor 2	inhibition percentage	13	%
3332	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ephrin type-B receptor 3	inhibition percentage	9	%
3333	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ephrin type-B receptor 4	inhibition percentage	4	%
3334	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ephrin type-B receptor 6	inhibition percentage	0	%
3335	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Receptor tyrosine-protein kinase erbB-2	inhibition percentage	0	%
3336	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Receptor tyrosine-protein kinase erbB-3	inhibition percentage	0	%
3337	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Receptor tyrosine-protein kinase erbB-4	inhibition percentage	39	%
3338	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Extracellular signal-regulated kinase 1	inhibition percentage	11	%
3339	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Extracellular signal-regulated kinase 2	inhibition percentage	10	%
3340	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase 6	inhibition percentage	6	%
3341	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase 4	inhibition percentage	4	%
3342	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase 7	inhibition percentage	6	%
3343	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase 15	inhibition percentage	0	%
3344	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase/endoribonuclease IRE1	inhibition percentage	0	%
3345	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Focal adhesion kinase 1	inhibition percentage	0	%
3346	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase Fer	inhibition percentage	14	%
3347	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase, Fes/Fps type	inhibition percentage	13	%
3348	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Fibroblast growth factor receptor 1	inhibition percentage	9	%
3349	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Fibroblast growth factor receptor 2	inhibition percentage	3	%
3350	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Fibroblast growth factor receptor 3	inhibition percentage	0	%
3351	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Fibroblast growth factor receptor 3	inhibition percentage	17	%
3352	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Fibroblast growth factor receptor 4	inhibition percentage	0	%
3353	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase Fgr	inhibition percentage	12	%
3354	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Vascular endothelial growth factor receptor 1	inhibition percentage	14	%
3355	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Vascular endothelial growth factor receptor 3	inhibition percentage	18	%
3356	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Receptor-type tyrosine-protein kinase FLT3 (D835H)	inhibition percentage	6	%
3357	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Receptor-type tyrosine-protein kinase FLT3 (D835V)	inhibition percentage	11	%
3358	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Receptor-type tyrosine-protein kinase FLT3 (D835Y)	inhibition percentage	7	%
3359	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Receptor-type tyrosine-protein kinase FLT3 (ITD)	inhibition percentage	20	%
3360	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Receptor-type tyrosine-protein kinase FLT3 (ITD)	inhibition percentage	0	%
3361	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Receptor-type tyrosine-protein kinase FLT3 (ITD)	inhibition percentage	0	%
3362	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	6	%
3363	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	1	%
3364	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	6	%
3365	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	3	%
3366	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Vascular endothelial growth factor receptor 3	inhibition percentage	19	%
3367	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase FRK	inhibition percentage	40	%
3368	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase Fyn	inhibition percentage	44	%
3369	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-G-associated kinase	inhibition percentage	5	%
3370	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	ABC transporter F family member 2	inhibition percentage	0	%
3371	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	rhodopsin kinase	inhibition percentage	6	%
3372	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Beta-adrenergic receptor kinase 1	inhibition percentage	28	%
3373	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Beta-adrenergic receptor kinase 2	inhibition percentage	0	%
3374	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	G protein-coupled receptor kinase 4	inhibition percentage	0	%
3375	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	rhodopsin kinase	inhibition percentage	0	%
3376	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Glycogen synthase kinase-3 alpha	inhibition percentage	0	%
3377	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	tau-protein kinase	inhibition percentage	0	%
3378	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase haspin	inhibition percentage	0	%
3379	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase HCK	inhibition percentage	0	%
3380	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Homeodomain-interacting protein kinase 1	inhibition percentage	0	%
3381	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Homeodomain-interacting protein kinase 2	inhibition percentage	0	%
3382	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Homeodomain-interacting protein kinase 3	inhibition percentage	0	%
3383	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Homeodomain-interacting protein kinase 4	inhibition percentage	0	%
3384	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase kinase 1	inhibition percentage	0	%
3385	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Hormonally up-regulated neu tumor-associated kinase	inhibition percentage	0	%
3386	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase ICK	inhibition percentage	0	%
3387	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Insulin-like growth factor 1 receptor	inhibition percentage	0	%
3388	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Inhibitor of nuclear factor kappa-B kinase subunit alpha	inhibition percentage	0	%
3389	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Inhibitor of nuclear factor kappa-B kinase subunit beta	inhibition percentage	0	%
3390	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	inhibition percentage	27	%
3391	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Insulin receptor	inhibition percentage	0	%
3392	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Insulin receptor-related protein	inhibition percentage	0	%
3393	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Interleukin-1 receptor-associated kinase 1	inhibition percentage	0	%
3394	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Interleukin-1 receptor-associated kinase 3	inhibition percentage	0	%
3395	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Interleukin-1 receptor-associated kinase 4	inhibition percentage	0	%
3396	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ITK/TSK	inhibition percentage	0	%
3397	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase JAK1	inhibition percentage	0	%
3398	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase JAK1 pseudokinase	inhibition percentage	11	%
3399	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase JAK2	inhibition percentage	0	%
3400	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase JAK3	inhibition percentage	0	%
3401	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase 8	inhibition percentage	15	%
3402	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase 9	inhibition percentage	17	%
3403	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase 10	inhibition percentage	0	%
3404	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mast/stem cell growth factor receptor Kit	inhibition percentage	11	%
3405	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mast/stem cell growth factor receptor Kit (A829P)	inhibition percentage	0	%
3406	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mast/stem cell growth factor receptor Kit (D816H)	inhibition percentage	32	%
3407	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mast/stem cell growth factor receptor Kit (D816V)	inhibition percentage	0	%
3408	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mast/stem cell growth factor receptor Kit	inhibition percentage	22	%
3409	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mast/stem cell growth factor receptor Kit (V559D)	inhibition percentage	7	%
3410	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mast/stem cell growth factor receptor Kit (V559D)	inhibition percentage	0	%
3411	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mast/stem cell growth factor receptor Kit (V559D)	inhibition percentage	0	%
3412	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mast/stem cell growth factor receptor Kit	inhibition percentage	0	%
3413	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase LATS1	inhibition percentage	0	%
3414	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase LATS2	inhibition percentage	0	%
3415	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase Lck	inhibition percentage	0	%
3416	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	LIM domain kinase 1	inhibition percentage	0	%
3417	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	LIM domain kinase 2	inhibition percentage	0	%
3418	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase STK11	inhibition percentage	0	%
3419	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase 10	inhibition percentage	0	%
3420	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Leucine-rich repeat serine/threonine-protein kinase 2	inhibition percentage	49	%
3421	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Leucine-rich repeat serine/threonine-protein kinase 2 (G2019S)	inhibition percentage	0	%
3422	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Leukocyte tyrosine kinase receptor	inhibition percentage	0	%
3423	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase Lyn	inhibition percentage	4	%
3424	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase 13	inhibition percentage	0	%
3425	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase MAK	inhibition percentage	0	%
3426	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase 1	inhibition percentage	19	%
3427	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase 15	inhibition percentage	26	%
3428	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase 2	inhibition percentage	0	%
3429	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase 3	inhibition percentage	0	%
3430	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase 4	inhibition percentage	25	%
3431	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase kinase 2	inhibition percentage	0	%
3432	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase kinase 3	inhibition percentage	25	%
3433	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase kinase 4	inhibition percentage	34	%
3434	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase kinase 5	inhibition percentage	24	%
3435	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	MAP kinase-activated protein kinase 2	inhibition percentage	0	%
3436	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	MAP kinase-activated protein kinase 5	inhibition percentage	0	%
3437	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase MARK1	inhibition percentage	26	%
3438	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase MARK2	inhibition percentage	0	%
3439	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase MARK3	inhibition percentage	0	%
3440	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase MARK4	inhibition percentage	29	%
3441	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Microtubule-associated serine/threonine-protein kinase 1	inhibition percentage	0	%
3442	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Dual specificity mitogen-activated protein kinase kinase 1	inhibition percentage	0	%
3443	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Dual specificity mitogen-activated protein kinase kinase 2	inhibition percentage	10	%
3444	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Dual specificity mitogen-activated protein kinase kinase 3	inhibition percentage	15	%
3445	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Dual specificity mitogen-activated protein kinase kinase 4	inhibition percentage	0	%
3446	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Dual specificity mitogen-activated protein kinase kinase 5	inhibition percentage	10	%
3447	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Dual specificity mitogen-activated protein kinase kinase 6	inhibition percentage	33	%
3448	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Maternal embryonic leucine zipper kinase	inhibition percentage	0	%
3449	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase Mer	inhibition percentage	9	%
3450	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Hepatocyte growth factor receptor	inhibition percentage	32	%
3451	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Hepatocyte growth factor receptor (M1250T)	inhibition percentage	13	%
3452	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Hepatocyte growth factor receptor	inhibition percentage	2	%
3453	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Misshapen-like kinase 1	inhibition percentage	15	%
3454	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Dual specificity mitogen-activated protein kinase kinase 7	inhibition percentage	0	%
3455	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	MAP kinase-interacting serine/threonine-protein kinase 1	inhibition percentage	14	%
3456	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	MAP kinase-interacting serine/threonine-protein kinase 2	inhibition percentage	0	%
3457	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	myosin light chain kinase	inhibition percentage	0	%
3458	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase 9	inhibition percentage	10	%
3459	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase 10	inhibition percentage	27	%
3460	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase 11	inhibition percentage	8	%
3461	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase MRCK alpha	inhibition percentage	0	%
3462	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase MRCK beta	inhibition percentage	10	%
3463	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Bowman-Birk type proteinase inhibitor	inhibition percentage	0	%
3464	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Macrophage-stimulating protein receptor	inhibition percentage	3	%
3465	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase 3	inhibition percentage	5	%
3466	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase 24	inhibition percentage	0	%
3467	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase 26	inhibition percentage	8	%
3468	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase mTOR	inhibition percentage	0	%
3469	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Muscle, skeletal receptor tyrosine-protein kinase	inhibition percentage	0	%
3470	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Myosin light chain kinase, smooth muscle	inhibition percentage	0	%
3471	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Myosin light chain kinase 2, skeletal/cardiac muscle	inhibition percentage	10	%
3472	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Myosin light chain kinase family member 4	inhibition percentage	0	%
3473	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Myosin-IIIa	inhibition percentage	3	%
3474	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Myosin-IIIb	inhibition percentage	0	%
3475	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase 38	inhibition percentage	17	%
3476	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase 38-like	inhibition percentage	76	%
3477	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Nek1	inhibition percentage	49	%
3478	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Nek10	inhibition percentage	0	%
3479	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Nek11	inhibition percentage	0	%
3480	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Nek2	inhibition percentage	0	%
3481	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Nek3	inhibition percentage	0	%
3482	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Nek4	inhibition percentage	0	%
3483	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Nek5	inhibition percentage	5	%
3484	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Nek6	inhibition percentage	14	%
3485	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Nek7	inhibition percentage	12	%
3486	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Nek9	inhibition percentage	0	%
3487	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase 14	inhibition percentage	17	%
3488	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase NIM1	inhibition percentage	40	%
3489	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine kinase NLK	inhibition percentage	0	%
3490	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase OSR1	inhibition percentage	0	%
3491	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase 14A	inhibition percentage	0	%
3492	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase 11	inhibition percentage	0	%
3493	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase 13	inhibition percentage	0	%
3494	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase 12	inhibition percentage	0	%
3495	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase PAK 1	inhibition percentage	0	%
3496	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase PAK2	inhibition percentage	0	%
3497	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase PAK 3	inhibition percentage	0	%
3498	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase PAK 4	inhibition percentage	0	%
3499	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase PAK 6	inhibition percentage	0	%
3500	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase PAK5	inhibition percentage	0	%
3501	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 16	inhibition percentage	0	%
3502	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 17	inhibition percentage	14	%
3503	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 18	inhibition percentage	0	%
3504	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Platelet-derived growth factor receptor alpha	inhibition percentage	9	%
3505	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Platelet-derived growth factor receptor beta	inhibition percentage	14	%
3506	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	3-phosphoinositide-dependent protein kinase 1	inhibition percentage	1	%
3507	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Calcium-dependent protein kinase 1 [Plasmodium falciparum]	inhibition percentage	0	%
3508	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	13	%
3509	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cell division control protein 2 homolog [Plasmodium falciparum]	inhibition percentage	0	%
3510	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 15	inhibition percentage	26	%
3511	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 14	inhibition percentage	0	%
3512	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	inhibition percentage	13	%
3513	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	inhibition percentage	0	%
3514	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	inhibition percentage	5	%
3515	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	inhibition percentage	19	%
3516	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition percentage	2	%
3517	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (C420R)	inhibition percentage	11	%
3518	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545A)	inhibition percentage	36	%
3519	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	12	%
3520	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545A)	inhibition percentage	0	%
3521	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545K)	inhibition percentage	47	%
3522	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047L)	inhibition percentage	24	%
3523	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047Y)	inhibition percentage	0	%
3524	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition percentage	56	%
3525	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (M1043I)	inhibition percentage	13	%
3526	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (Q546K)	inhibition percentage	40	%
3527	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	inhibition percentage	19	%
3528	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	inhibition percentage	9	%
3529	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	inhibition percentage	15	%
3530	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	5	%
3531	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4-kinase beta	inhibition percentage	0	%
3532	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	1-phosphatidylinositol 3-phosphate 5-kinase	inhibition percentage	39	%
3533	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase pim-1	inhibition percentage	5	%
3534	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase pim-2	inhibition percentage	12	%
3535	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase pim-3	inhibition percentage	0	%
3536	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	inhibition percentage	0	%
3537	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	inhibition percentage	15	%
3538	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta	inhibition percentage	0	%
3539	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	inhibition percentage	0	%
3540	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	cAMP-dependent protein kinase catalytic subunit alpha	inhibition percentage	0	%
3541	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
3542	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	cAMP-dependent protein kinase catalytic subunit beta	inhibition percentage	8	%
3543	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	inhibition percentage	26	%
3544	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Pkn1	inhibition percentage	2	%
3545	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase pkn2	inhibition percentage	5	%
3546	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase PknB [Mycobacterium tuberculosis]	inhibition percentage	10	%
3547	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase PLK1	inhibition percentage	20	%
3548	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase PLK2	inhibition percentage	1	%
3549	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Plk3	inhibition percentage	0	%
3550	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Plk4	inhibition percentage	18	%
3551	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Protein kinase C, delta	inhibition percentage	20	%
3552	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	9	%
3553	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Protein kinase C, epsilon	inhibition percentage	37	%
3554	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Protein kinase C, eta	inhibition percentage	21	%
3555	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Protein kinase C iota type	inhibition percentage	0	%
3556	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Protein kinase C, theta	inhibition percentage	10	%
3557	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase D1	inhibition percentage	9	%
3558	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase D2	inhibition percentage	8	%
3559	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase D3	inhibition percentage	0	%
3560	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	cGMP-dependent protein kinase 1	inhibition percentage	5	%
3561	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	cGMP-dependent protein kinase 2	inhibition percentage	21	%
3562	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Interferon-induced, double-stranded RNA-activated protein kinase	inhibition percentage	45	%
3563	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	1	%
3564	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	cAMP-dependent protein kinase catalytic subunit PRKX	inhibition percentage	0	%
3565	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase prp4	inhibition percentage	40	%
3566	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Protein-tyrosine kinase 2-beta	inhibition percentage	6	%
3567	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase SIK3	inhibition percentage	22	%
3568	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	RAF proto-oncogene serine/threonine-protein kinase	inhibition percentage	30	%
3569	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Proto-oncogene tyrosine-protein kinase receptor Ret	inhibition percentage	13	%
3570	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (M918T)	inhibition percentage	7	%
3571	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804L)	inhibition percentage	17	%
3572	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M)	inhibition percentage	18	%
3573	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Rio1	inhibition percentage	46	%
3574	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
3575	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Rio2	inhibition percentage	1	%
3576	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Rio3	inhibition percentage	12	%
3577	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Receptor-interacting serine/threonine-protein kinase 1	inhibition percentage	6	%
3578	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Receptor-interacting serine/threonine-protein kinase 2	inhibition percentage	41	%
3579	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Receptor-interacting serine/threonine-protein kinase 4	inhibition percentage	0	%
3580	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Dual serine/threonine and tyrosine protein kinase	inhibition percentage	20	%
3581	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Rho-associated protein kinase 1	inhibition percentage	7	%
3582	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Rho-associated protein kinase 2	inhibition percentage	0	%
3583	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Proto-oncogene tyrosine-protein kinase ROS	inhibition percentage	9	%
3584	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ribosomal protein S6 kinase alpha-4	inhibition percentage	14	%
3585	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
3586	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ribosomal protein S6 kinase alpha-4	inhibition percentage	9	%
3587	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ribosomal protein S6 kinase alpha-5	inhibition percentage	19	%
3588	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ribosomal protein S6 kinase alpha-5	inhibition percentage	5	%
3589	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ribosomal protein S6 kinase alpha-1	inhibition percentage	0	%
3590	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ribosomal protein S6 kinase alpha-1	inhibition percentage	0	%
3591	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ribosomal protein S6 kinase alpha-3	inhibition percentage	0	%
3592	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ribosomal protein S6 kinase alpha-2	inhibition percentage	0	%
3593	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ribosomal protein S6 kinase alpha-3	inhibition percentage	0	%
3594	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ribosomal protein S6 kinase alpha-3	inhibition percentage	0	%
3595	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ribosomal protein S6 kinase alpha-4	inhibition percentage	0	%
3596	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	11	%
3597	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ribosomal protein S6 kinase alpha-4	inhibition percentage	0	%
3598	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ribosomal protein S6 kinase beta-1	inhibition percentage	0	%
3599	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase, Sbk1	inhibition percentage	18	%
3600	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Sgk1	inhibition percentage	0	%
3601	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Uncharacterized serine/threonine-protein kinase SBK3	inhibition percentage	0	%
3602	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Sgk2	inhibition percentage	0	%
3603	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase Sgk3	inhibition percentage	17	%
3604	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Protein-tyrosine kinase 6	inhibition percentage	0	%
3605	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase SIK1	inhibition percentage	14	%
3606	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase Fyn	inhibition percentage	0	%
3607	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	5	%
3608	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	NUAK family SNF1-like kinase 2	inhibition percentage	0	%
3609	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	SNF-related serine/threonine-protein kinase	inhibition percentage	19	%
3610	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Neuronal proto-oncogene tyrosine-protein kinase Src	inhibition percentage	6	%
3611	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase Srms	inhibition percentage	2	%
3612	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	CBL-interacting serine/threonine-protein kinase 7	inhibition percentage	2	%
3613	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	SRSF protein kinase 2	inhibition percentage	66	%
3614	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	SRSF protein kinase 3	inhibition percentage	0	%
3615	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase 16	inhibition percentage	0	%
3616	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase 33	inhibition percentage	16	%
3617	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase 35	inhibition percentage	0	%
3618	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
3619	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase 36	inhibition percentage	3	%
3620	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	STE20/SPS1-related proline-alanine-rich protein kinase	inhibition percentage	0	%
3621	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase SYK	inhibition percentage	12	%
3622	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase 7	inhibition percentage	0	%
3623	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase TAO1	inhibition percentage	0	%
3624	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase TAO2	inhibition percentage	7	%
3625	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase TAO3	inhibition percentage	0	%
3626	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase TBK1	inhibition percentage	12	%
3627	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Nuclear receptor subfamily 4 group A member 3	inhibition percentage	0	%
3628	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Dual specificity testis-specific protein kinase 1	inhibition percentage	0	%
3629	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
3630	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	TGF-beta receptor type-1	inhibition percentage	0	%
3631	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	TGF-beta receptor type-2	inhibition percentage	7	%
3632	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase receptor Tie-1	inhibition percentage	0	%
3633	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase receptor Tie-2	inhibition percentage	27	%
3634	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase TOUSLED-like 2	inhibition percentage	6	%
3635	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase TOUSLED-like 2	inhibition percentage	18	%
3636	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Traf2 and NCK-interacting protein kinase	inhibition percentage	55	%
3637	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Non-receptor tyrosine-protein kinase TNK1	inhibition percentage	4	%
3638	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Activated CDC42 kinase 1	inhibition percentage	9	%
3639	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase TNNI3K	inhibition percentage	37	%
3640	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	16	%
3641	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	High affinity nerve growth factor receptor	inhibition percentage	0	%
3642	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	BDNF/NT-3 growth factors receptor	inhibition percentage	0	%
3643	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	NT-3 growth factor receptor	inhibition percentage	14	%
3644	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Transient receptor potential cation channel subfamily M member 6	inhibition percentage	4	%
3645	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Testis-specific serine/threonine-protein kinase 1	inhibition percentage	15	%
3646	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Testis-specific serine/threonine-protein kinase 3	inhibition percentage	0	%
3647	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Dual specificity protein kinase TTK	inhibition percentage	9	%
3648	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase TXK	inhibition percentage	23	%
3649	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Non-receptor tyrosine-protein kinase TYK2	inhibition percentage	1	%
3650	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Non-receptor tyrosine-protein kinase TYK2 pseudokinase	inhibition percentage	0	%
3651	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	12	%
3652	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase receptor TYRO3	inhibition percentage	10	%
3653	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase ULK1	inhibition percentage	0	%
3654	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase ULK2	inhibition percentage	0	%
3655	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase ULK3	inhibition percentage	1	%
3656	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Vascular endothelial growth factor receptor 2	inhibition percentage	15	%
3657	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Phosphatidylinositol 3-kinase catalytic subunit type 3	inhibition percentage	0	%
3658	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase VRK2	inhibition percentage	9	%
3659	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitosis inhibitor protein kinase wee1	inhibition percentage	28	%
3660	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Wee1-like protein kinase 1-A	inhibition percentage	0	%
3661	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase WNK1	inhibition percentage	0	%
3662	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ABL1	inhibition percentage	18	%
3663	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase WNK2	inhibition percentage	0	%
3664	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase WNK3	inhibition percentage	15	%
3665	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase WNK4	inhibition percentage	0	%
3666	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase 32A	inhibition percentage	43	%
3667	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase 32B	inhibition percentage	35	%
3668	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase 32C	inhibition percentage	0	%
3669	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase yes	inhibition percentage	2	%
3670	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase 25	inhibition percentage	10	%
3671	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase 19	inhibition percentage	8	%
3672	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase kinase kinase 20	inhibition percentage	11	%
3673	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ABL2	inhibition percentage	0	%
3674	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase ZAP-70	inhibition percentage	0	%
3675	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Activin receptor type-1	inhibition percentage	12	%
3676	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Activin receptor type-1B	inhibition percentage	6	%
3677	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Activin receptor type-2A	inhibition percentage	32	%
3678	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Activin receptor type-2B	inhibition percentage	17	%
3679	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase receptor R3	inhibition percentage	3	%
3680	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Atypical kinase COQ8A, mitochondrial	inhibition percentage	3	%
3681	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Atypical kinase COQ8B, mitochondrial	inhibition percentage	0	%
3682	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	RAC-alpha serine/threonine-protein kinase	inhibition percentage	0	%
3683	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	RAC-beta serine/threonine-protein kinase	inhibition percentage	0	%
3684	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	RAC-gamma serine/threonine-protein kinase	inhibition percentage	14	%
3685	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	ALK tyrosine kinase receptor	inhibition percentage	0	%
3686	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	ALK tyrosine kinase receptor	inhibition percentage	0	%
3687	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	ALK tyrosine kinase receptor	inhibition percentage	0	%
3688	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	5'-AMP-activated protein kinase catalytic subunit alpha-1	inhibition percentage	0	%
3689	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	5'-AMP-activated protein kinase catalytic subunit alpha-2	inhibition percentage	0	%
3690	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Ankyrin repeat and protein kinase domain-containing protein 1	inhibition percentage	20	%
3691	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	NUAK family SNF1-like kinase 1	inhibition percentage	0	%
3692	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase SRK2A	inhibition percentage	0	%
3693	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase SRK2G	inhibition percentage	0	%
3694	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Aurora kinase A	inhibition percentage	0	%
3695	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	AP2-associated protein kinase 1	inhibition percentage	10	%
3696	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Aurora kinase B	inhibition percentage	0	%
3697	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Aurora kinase C	inhibition percentage	22	%
3698	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase receptor UFO	inhibition percentage	21	%
3699	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	BMP-2-inducible protein kinase	inhibition percentage	16	%
3700	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase Blk	inhibition percentage	0	%
3701	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Bone morphogenetic protein receptor type-1A	inhibition percentage	10	%
3702	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Bone morphogenetic protein receptor type-1B	inhibition percentage	9	%
3703	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Bone morphogenetic protein receptor type-2	inhibition percentage	0	%
3704	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cytoplasmic tyrosine-protein kinase BMX	inhibition percentage	21	%
3705	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase B-raf	inhibition percentage	19	%
3706	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase B-raf	inhibition percentage	0	%
3707	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Protein-tyrosine kinase 6	inhibition percentage	24	%
3708	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase BRSK1	inhibition percentage	0	%
3709	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Serine/threonine-protein kinase BRSK2	inhibition percentage	21	%
3710	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Tyrosine-protein kinase BTK	inhibition percentage	0	%
3711	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Checkpoint serine/threonine-protein kinase bub1	inhibition percentage	0	%
3712	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Calcium/calmodulin-dependent protein kinase type 1	inhibition percentage	4	%
3713	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Calcium/calmodulin-dependent protein kinase type 1B	inhibition percentage	0	%
3714	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Calcium/calmodulin-dependent protein kinase type 1D	inhibition percentage	3	%
3715	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Calcium/calmodulin-dependent protein kinase type 1G	inhibition percentage	8	%
3716	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Calcium/calmodulin-dependent protein kinase type II (isoform a)	inhibition percentage	0	%
3717	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Calcium/calmodulin-dependent protein kinase type II (isoform b)	inhibition percentage	0	%
3718	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Calcium/calmodulin-dependent protein kinase type II (isoform d)	inhibition percentage	7	%
3719	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Calcium/calmodulin-dependent protein kinase type II (isoform g)	inhibition percentage	6	%
3720	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Calcium/calmodulin-dependent protein kinase type IV	inhibition percentage	2	%
3721	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Calcium/calmodulin-dependent protein kinase kinase 1	inhibition percentage	12	%
3722	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Calcium/calmodulin-dependent protein kinase kinase 2	inhibition percentage	22	%
3723	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Casein kinase II subunit alpha	inhibition percentage	0	%
3724	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 11B	inhibition percentage	0	%
3725	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 11A	inhibition percentage	13	%
3726	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Mitogen-activated protein kinase 14A	delta Tm	0.5	°C
3727	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Epithelial discoidin domain-containing receptor 1	delta Tm	0.3	°C
3728	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1	Discoidin domain-containing receptor 2	delta Tm	0.6	°C
3729	CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC1CCCCC1)NC(=O)C1=CC=C(CNC2=C3N=NN(C3=NC=N2)C2=CC=CC=C2)C=C1		inhibition percentage	50	%
3730	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Discoidin domain-containing receptor 2	IC50	0.032	μM
3731	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Epithelial discoidin domain-containing receptor 1	IC50	0.044	μM
3732	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase 14A	IC50	0.284	μM
3733	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 13	inhibition percentage	0	%
3734	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 11	inhibition percentage	23	%
3735	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 2	inhibition percentage	1	%
3736	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 3	inhibition percentage	0	%
3737	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 4	inhibition percentage	0	%
3738	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 4; Cyclin-D1-1	inhibition percentage	0	%
3739	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 4; Cyclin-D3-1	inhibition percentage	0	%
3740	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent-like kinase 5	inhibition percentage	8	%
3741	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 7	inhibition percentage	20	%
3742	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 8	inhibition percentage	0	%
3743	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 9	inhibition percentage	0	%
3744	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase-like 1	inhibition percentage	0	%
3745	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase-like 2	inhibition percentage	0	%
3746	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase-like 3	inhibition percentage	9	%
3747	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase-like 5	inhibition percentage	0	%
3748	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Chk1	inhibition percentage	0	%
3749	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Chk2	inhibition percentage	16	%
3750	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Citrate synthase, mitochondrial	inhibition percentage	11	%
3751	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase RCK2	inhibition percentage	0	%
3752	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Dual specificity protein kinase CLK2	inhibition percentage	0	%
3753	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Dual specificity protein kinase CLK3	inhibition percentage	0	%
3754	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Dual specificity protein kinase CLK4	inhibition percentage	0	%
3755	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Macrophage colony-stimulating factor 1 receptor	inhibition percentage	2	%
3756	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Macrophage colony-stimulating factor 1 receptor	inhibition percentage	0	%
3757	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase CSK	inhibition percentage	0	%
3758	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Casein kinase I isoform alpha	inhibition percentage	16	%
3759	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Casein kinase I isoform alpha-like	inhibition percentage	0	%
3760	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Casein kinase I isoform delta	inhibition percentage	0	%
3761	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Casein kinase I isoform epsilon	inhibition percentage	14	%
3762	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Casein kinase I isoform gamma-1	inhibition percentage	10	%
3763	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Casein kinase I isoform gamma-2	inhibition percentage	1	%
3764	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Casein kinase I isoform gamma-3	inhibition percentage	0	%
3765	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Casein kinase II subunit alpha	inhibition percentage	7	%
3766	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Casein kinase II subunit alpha-2	inhibition percentage	0	%
3767	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Megakaryocyte-associated tyrosine-protein kinase	inhibition percentage	52	%
3768	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Death-associated protein kinase 1	inhibition percentage	0	%
3769	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Death-associated protein kinase 2	inhibition percentage	0	%
3770	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Death-associated protein kinase 3	inhibition percentage	0	%
3771	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase DCLK1	inhibition percentage	0	%
3772	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase DCLK2	inhibition percentage	0	%
3773	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase DCLK3	inhibition percentage	0	%
3774	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Epithelial discoidin domain-containing receptor 1	inhibition percentage	99.7	%
3775	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Discoidin domain-containing receptor 2	inhibition percentage	98.1	%
3776	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Death-associated protein kinase 3	inhibition percentage	0	%
3777	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Myotonin-protein kinase	inhibition percentage	5	%
3778	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase MRCK gamma	inhibition percentage	0	%
3779	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase 17A	inhibition percentage	22	%
3780	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase 17B	inhibition percentage	20	%
3781	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Dual specificity tyrosine-phosphorylation-regulated kinase 1A/B	inhibition percentage	0	%
3782	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	inhibition percentage	63	%
3783	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Dual specificity tyrosine-phosphorylation-regulated kinase 2	inhibition percentage	20	%
3784	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	epidermal growth factor-activated receptor	inhibition percentage	2	%
3785	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	epidermal growth factor-activated receptor	inhibition percentage	0	%
3786	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Epidermal growth factor receptor (G719C)	inhibition percentage	26	%
3787	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Epidermal growth factor receptor (G719S)	inhibition percentage	23	%
3788	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	epidermal growth factor-activated receptor	inhibition percentage	14	%
3789	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	epidermal growth factor-activated receptor	inhibition percentage	0	%
3790	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	epidermal growth factor-activated receptor	inhibition percentage	39	%
3791	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Epidermal growth factor receptor (L858R)	inhibition percentage	7	%
3792	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Epidermal growth factor receptor (L858R)	inhibition percentage	0	%
3793	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Epidermal growth factor receptor (L861Q)	inhibition percentage	0	%
3794	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	epidermal growth factor-activated receptor	inhibition percentage	31	%
3795	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Epidermal growth factor receptor (T790M)	inhibition percentage	0	%
3796	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Eukaryotic translation initiation factor 2-alpha kinase 1	inhibition percentage	0	%
3797	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ephrin type-A receptor 1	inhibition percentage	0	%
3798	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ephrin type-A receptor 2	inhibition percentage	18	%
3799	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ephrin type-A receptor 3	inhibition percentage	0	%
3800	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ephrin type-A receptor 4	inhibition percentage	0	%
3801	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ephrin type-A receptor 5	inhibition percentage	0	%
3802	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ephrin type-A receptor 6	inhibition percentage	0	%
3803	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ephrin type-A receptor 7	inhibition percentage	0	%
3804	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ephrin type-A receptor 8	inhibition percentage	0	%
3805	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ephrin type-B receptor 1	inhibition percentage	0	%
3806	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ephrin type-B receptor 2	inhibition percentage	2	%
3807	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ephrin type-B receptor 3	inhibition percentage	0	%
3808	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ephrin type-B receptor 4	inhibition percentage	0	%
3809	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ephrin type-B receptor 6	inhibition percentage	0	%
3810	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Receptor tyrosine-protein kinase erbB-2	inhibition percentage	0	%
3811	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Receptor tyrosine-protein kinase erbB-3	inhibition percentage	1	%
3812	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Receptor tyrosine-protein kinase erbB-4	inhibition percentage	0	%
3813	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Extracellular signal-regulated kinase 1	inhibition percentage	4	%
3814	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Extracellular signal-regulated kinase 2	inhibition percentage	14	%
3815	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase 6	inhibition percentage	0	%
3816	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase 4	inhibition percentage	0	%
3817	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase 7	inhibition percentage	0	%
3818	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase 15	inhibition percentage	0	%
3819	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase/endoribonuclease IRE1	inhibition percentage	17	%
3820	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Focal adhesion kinase 1	inhibition percentage	0	%
3821	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase Fer	inhibition percentage	0	%
3822	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase, Fes/Fps type	inhibition percentage	0	%
3823	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Fibroblast growth factor receptor 1	inhibition percentage	2	%
3824	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Fibroblast growth factor receptor 2	inhibition percentage	4	%
3825	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Fibroblast growth factor receptor 3	inhibition percentage	0	%
3826	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Fibroblast growth factor receptor 3	inhibition percentage	0	%
3827	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Fibroblast growth factor receptor 4	inhibition percentage	0	%
3828	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase Fgr	inhibition percentage	0	%
3829	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Vascular endothelial growth factor receptor 1	inhibition percentage	0	%
3830	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Vascular endothelial growth factor receptor 3	inhibition percentage	0	%
3831	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Receptor-type tyrosine-protein kinase FLT3 (D835H)	inhibition percentage	39	%
3832	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Receptor-type tyrosine-protein kinase FLT3 (D835V)	inhibition percentage	0	%
3833	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Receptor-type tyrosine-protein kinase FLT3 (D835Y)	inhibition percentage	0	%
3834	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Receptor-type tyrosine-protein kinase FLT3 (ITD)	inhibition percentage	0	%
3835	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Receptor-type tyrosine-protein kinase FLT3 (ITD)	inhibition percentage	0	%
3836	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Receptor-type tyrosine-protein kinase FLT3 (ITD)	inhibition percentage	15	%
3837	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	15	%
3838	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	0	%
3839	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	0	%
3840	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	0	%
3841	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Vascular endothelial growth factor receptor 3	inhibition percentage	0	%
3842	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase FRK	inhibition percentage	0	%
3843	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase Fyn	inhibition percentage	0	%
3844	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-G-associated kinase	inhibition percentage	0	%
3845	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	ABC transporter F family member 2	inhibition percentage	0	%
3846	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	rhodopsin kinase	inhibition percentage	0	%
3847	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Beta-adrenergic receptor kinase 1	inhibition percentage	0	%
3848	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Beta-adrenergic receptor kinase 2	inhibition percentage	0	%
3849	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	G protein-coupled receptor kinase 4	inhibition percentage	26	%
3850	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	rhodopsin kinase	inhibition percentage	0	%
3851	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Glycogen synthase kinase-3 alpha	inhibition percentage	0	%
3852	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	tau-protein kinase	inhibition percentage	1	%
3853	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase haspin	inhibition percentage	38	%
3854	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase HCK	inhibition percentage	8	%
3855	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Homeodomain-interacting protein kinase 1	inhibition percentage	2	%
3856	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Homeodomain-interacting protein kinase 2	inhibition percentage	0	%
3857	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Homeodomain-interacting protein kinase 3	inhibition percentage	5	%
3858	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Homeodomain-interacting protein kinase 4	inhibition percentage	0	%
3859	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase kinase 1	inhibition percentage	0	%
3860	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Hormonally up-regulated neu tumor-associated kinase	inhibition percentage	0	%
3861	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase ICK	inhibition percentage	2	%
3862	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Insulin-like growth factor 1 receptor	inhibition percentage	0	%
3863	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Inhibitor of nuclear factor kappa-B kinase subunit alpha	inhibition percentage	0	%
3864	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Inhibitor of nuclear factor kappa-B kinase subunit beta	inhibition percentage	0	%
3865	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	inhibition percentage	0	%
3866	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Insulin receptor	inhibition percentage	0	%
3867	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Insulin receptor-related protein	inhibition percentage	0	%
3868	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Interleukin-1 receptor-associated kinase 1	inhibition percentage	0	%
3869	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Interleukin-1 receptor-associated kinase 3	inhibition percentage	16	%
3870	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Interleukin-1 receptor-associated kinase 4	inhibition percentage	0	%
3871	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ITK/TSK	inhibition percentage	0	%
3872	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase JAK1	inhibition percentage	0	%
3873	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase JAK1 pseudokinase	inhibition percentage	0	%
3874	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase JAK2	inhibition percentage	3	%
3875	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase JAK3	inhibition percentage	0	%
3876	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase 8	inhibition percentage	20	%
3877	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase 9	inhibition percentage	14	%
3878	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase 10	inhibition percentage	25	%
3879	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mast/stem cell growth factor receptor Kit	inhibition percentage	6	%
3880	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mast/stem cell growth factor receptor Kit (A829P)	inhibition percentage	0	%
3881	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mast/stem cell growth factor receptor Kit (D816H)	inhibition percentage	0	%
3882	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mast/stem cell growth factor receptor Kit (D816V)	inhibition percentage	0	%
3883	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mast/stem cell growth factor receptor Kit	inhibition percentage	0	%
3884	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mast/stem cell growth factor receptor Kit (V559D)	inhibition percentage	9	%
3885	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mast/stem cell growth factor receptor Kit (V559D)	inhibition percentage	0	%
3886	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mast/stem cell growth factor receptor Kit (V559D)	inhibition percentage	21	%
3887	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mast/stem cell growth factor receptor Kit	inhibition percentage	1	%
3888	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase LATS1	inhibition percentage	0	%
3889	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase LATS2	inhibition percentage	0	%
3890	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase Lck	inhibition percentage	0	%
3891	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	LIM domain kinase 1	inhibition percentage	0	%
3892	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	LIM domain kinase 2	inhibition percentage	0	%
3893	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase STK11	inhibition percentage	4	%
3894	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase 10	inhibition percentage	3	%
3895	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Leucine-rich repeat serine/threonine-protein kinase 2	inhibition percentage	0	%
3896	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Leucine-rich repeat serine/threonine-protein kinase 2 (G2019S)	inhibition percentage	0	%
3897	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Leukocyte tyrosine kinase receptor	inhibition percentage	15	%
3898	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase Lyn	inhibition percentage	10	%
3899	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase 13	inhibition percentage	0	%
3900	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase MAK	inhibition percentage	12	%
3901	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase 1	inhibition percentage	23	%
3902	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase 15	inhibition percentage	16	%
3903	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase 2	inhibition percentage	0	%
3904	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase 3	inhibition percentage	0	%
3905	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase 4	inhibition percentage	2	%
3906	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase kinase 2	inhibition percentage	0	%
3907	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase kinase 3	inhibition percentage	0	%
3908	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase kinase 4	inhibition percentage	0	%
3909	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase kinase 5	inhibition percentage	4	%
3910	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	MAP kinase-activated protein kinase 2	inhibition percentage	26	%
3911	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	MAP kinase-activated protein kinase 5	inhibition percentage	0	%
3912	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase MARK1	inhibition percentage	10	%
3913	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase MARK2	inhibition percentage	0	%
3914	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase MARK3	inhibition percentage	21	%
3915	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase MARK4	inhibition percentage	5	%
3916	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Microtubule-associated serine/threonine-protein kinase 1	inhibition percentage	0	%
3917	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Dual specificity mitogen-activated protein kinase kinase 1	inhibition percentage	0	%
3918	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Dual specificity mitogen-activated protein kinase kinase 2	inhibition percentage	0	%
3919	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Dual specificity mitogen-activated protein kinase kinase 3	inhibition percentage	0	%
3920	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Dual specificity mitogen-activated protein kinase kinase 4	inhibition percentage	0	%
3921	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Dual specificity mitogen-activated protein kinase kinase 5	inhibition percentage	0	%
3922	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Dual specificity mitogen-activated protein kinase kinase 6	inhibition percentage	46	%
3923	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Maternal embryonic leucine zipper kinase	inhibition percentage	67	%
3924	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase Mer	inhibition percentage	29	%
3925	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Hepatocyte growth factor receptor	inhibition percentage	0	%
3926	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Hepatocyte growth factor receptor (M1250T)	inhibition percentage	0	%
3927	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Hepatocyte growth factor receptor	inhibition percentage	0	%
3928	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Misshapen-like kinase 1	inhibition percentage	23	%
3929	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Dual specificity mitogen-activated protein kinase kinase 7	inhibition percentage	0	%
3930	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	MAP kinase-interacting serine/threonine-protein kinase 1	inhibition percentage	0	%
3931	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	MAP kinase-interacting serine/threonine-protein kinase 2	inhibition percentage	25	%
3932	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	myosin light chain kinase	inhibition percentage	43	%
3933	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase 9	inhibition percentage	0	%
3934	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase 10	inhibition percentage	6	%
3935	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase 11	inhibition percentage	0	%
3936	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase MRCK alpha	inhibition percentage	0	%
3937	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase MRCK beta	inhibition percentage	0	%
3938	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Bowman-Birk type proteinase inhibitor	inhibition percentage	10	%
3939	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Macrophage-stimulating protein receptor	inhibition percentage	1	%
3940	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase 3	inhibition percentage	9	%
3941	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase 24	inhibition percentage	0	%
3942	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase 26	inhibition percentage	0	%
3943	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase mTOR	inhibition percentage	0	%
3944	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Muscle, skeletal receptor tyrosine-protein kinase	inhibition percentage	0	%
3945	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Myosin light chain kinase, smooth muscle	inhibition percentage	0	%
3946	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Myosin light chain kinase 2, skeletal/cardiac muscle	inhibition percentage	0	%
3947	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Myosin light chain kinase family member 4	inhibition percentage	0	%
3948	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Myosin-IIIa	inhibition percentage	4	%
3949	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Myosin-IIIb	inhibition percentage	40	%
3950	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase 38	inhibition percentage	21	%
3951	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase 38-like	inhibition percentage	3	%
3952	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Nek1	inhibition percentage	48	%
3953	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Nek10	inhibition percentage	0	%
3954	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Nek11	inhibition percentage	0	%
3955	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Nek2	inhibition percentage	1	%
3956	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Nek3	inhibition percentage	0	%
3957	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Nek4	inhibition percentage	11	%
3958	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Nek5	inhibition percentage	0	%
3959	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Nek6	inhibition percentage	9	%
3960	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Nek7	inhibition percentage	0	%
3961	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Nek9	inhibition percentage	0	%
3962	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase 14	inhibition percentage	0	%
3963	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase NIM1	inhibition percentage	0	%
3964	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine kinase NLK	inhibition percentage	0	%
3965	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase OSR1	inhibition percentage	3	%
3966	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase 14A	inhibition percentage	71	%
3967	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase 11	inhibition percentage	30	%
3968	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase 13	inhibition percentage	6	%
3969	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase 12	inhibition percentage	0	%
3970	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase PAK 1	inhibition percentage	0	%
3971	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase PAK2	inhibition percentage	3	%
3972	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase PAK 3	inhibition percentage	23	%
3973	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase PAK 4	inhibition percentage	0	%
3974	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase PAK 6	inhibition percentage	0	%
3975	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase PAK5	inhibition percentage	0	%
3976	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 16	inhibition percentage	0	%
3977	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 17	inhibition percentage	0	%
3978	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 18	inhibition percentage	0	%
3979	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Platelet-derived growth factor receptor alpha	inhibition percentage	0	%
3980	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Platelet-derived growth factor receptor beta	inhibition percentage	0	%
3981	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	3-phosphoinositide-dependent protein kinase 1	inhibition percentage	0	%
3982	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Calcium-dependent protein kinase 1 [Plasmodium falciparum]	inhibition percentage	37	%
3983	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	17	%
3984	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cell division control protein 2 homolog [Plasmodium falciparum]	inhibition percentage	12	%
3985	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 15	inhibition percentage	0	%
3986	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 14	inhibition percentage	0	%
3987	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	inhibition percentage	0	%
3988	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	inhibition percentage	0	%
3989	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	inhibition percentage	0	%
3990	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	inhibition percentage	31	%
3991	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition percentage	1	%
3992	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (C420R)	inhibition percentage	0	%
3993	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545A)	inhibition percentage	0	%
3994	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
3995	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545A)	inhibition percentage	0	%
3996	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545K)	inhibition percentage	2	%
3997	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047L)	inhibition percentage	0	%
3998	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047Y)	inhibition percentage	0	%
3999	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition percentage	0	%
4000	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (M1043I)	inhibition percentage	27	%
4001	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (Q546K)	inhibition percentage	0	%
4002	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	inhibition percentage	0	%
4003	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	inhibition percentage	1	%
4004	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	inhibition percentage	15	%
4005	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	10	%
4006	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4-kinase beta	inhibition percentage	9	%
4007	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	1-phosphatidylinositol 3-phosphate 5-kinase	inhibition percentage	0	%
4008	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase pim-1	inhibition percentage	0	%
4009	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase pim-2	inhibition percentage	0	%
4010	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase pim-3	inhibition percentage	0	%
4011	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	inhibition percentage	15	%
4012	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	inhibition percentage	0	%
4013	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta	inhibition percentage	0	%
4014	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	inhibition percentage	0	%
4015	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	cAMP-dependent protein kinase catalytic subunit alpha	inhibition percentage	0	%
4016	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	18	%
4017	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	cAMP-dependent protein kinase catalytic subunit beta	inhibition percentage	0	%
4018	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	inhibition percentage	0	%
4019	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Pkn1	inhibition percentage	0	%
4020	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase pkn2	inhibition percentage	0	%
4021	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase PknB [Mycobacterium tuberculosis]	inhibition percentage	0	%
4022	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase PLK1	inhibition percentage	18	%
4023	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase PLK2	inhibition percentage	9	%
4024	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Plk3	inhibition percentage	0	%
4025	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Plk4	inhibition percentage	11	%
4026	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Protein kinase C, delta	inhibition percentage	8	%
4027	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	19	%
4028	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Protein kinase C, epsilon	inhibition percentage	0	%
4029	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Protein kinase C, eta	inhibition percentage	0	%
4030	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Protein kinase C iota type	inhibition percentage	0	%
4031	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Protein kinase C, theta	inhibition percentage	0	%
4032	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase D1	inhibition percentage	0	%
4033	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase D2	inhibition percentage	0	%
4034	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase D3	inhibition percentage	0	%
4035	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	cGMP-dependent protein kinase 1	inhibition percentage	0	%
4036	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	cGMP-dependent protein kinase 2	inhibition percentage	0	%
4037	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Interferon-induced, double-stranded RNA-activated protein kinase	inhibition percentage	0	%
4038	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	8	%
4039	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	cAMP-dependent protein kinase catalytic subunit PRKX	inhibition percentage	11	%
4040	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase prp4	inhibition percentage	26	%
4041	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Protein-tyrosine kinase 2-beta	inhibition percentage	0	%
4042	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase SIK3	inhibition percentage	0	%
4043	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	RAF proto-oncogene serine/threonine-protein kinase	inhibition percentage	9	%
4044	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Proto-oncogene tyrosine-protein kinase receptor Ret	inhibition percentage	0	%
4045	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Proto-oncogene tyrosine-protein kinase receptor Ret (M918T)	inhibition percentage	0	%
4046	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Proto-oncogene tyrosine-protein kinase receptor Ret (V804L)	inhibition percentage	4	%
4047	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M)	inhibition percentage	0	%
4048	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Rio1	inhibition percentage	12	%
4049	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
4050	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Rio2	inhibition percentage	0	%
4051	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Rio3	inhibition percentage	2	%
4052	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Receptor-interacting serine/threonine-protein kinase 1	inhibition percentage	0	%
4053	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Receptor-interacting serine/threonine-protein kinase 2	inhibition percentage	0	%
4054	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Receptor-interacting serine/threonine-protein kinase 4	inhibition percentage	0	%
4055	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Dual serine/threonine and tyrosine protein kinase	inhibition percentage	2	%
4056	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Rho-associated protein kinase 1	inhibition percentage	0	%
4057	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Rho-associated protein kinase 2	inhibition percentage	0	%
4058	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Proto-oncogene tyrosine-protein kinase ROS	inhibition percentage	3	%
4059	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ribosomal protein S6 kinase alpha-4	inhibition percentage	0	%
4060	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	1	%
4061	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ribosomal protein S6 kinase alpha-4	inhibition percentage	5	%
4062	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ribosomal protein S6 kinase alpha-5	inhibition percentage	0	%
4063	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ribosomal protein S6 kinase alpha-5	inhibition percentage	5	%
4064	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ribosomal protein S6 kinase alpha-1	inhibition percentage	6	%
4065	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ribosomal protein S6 kinase alpha-1	inhibition percentage	0	%
4066	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ribosomal protein S6 kinase alpha-3	inhibition percentage	0	%
4067	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ribosomal protein S6 kinase alpha-2	inhibition percentage	4	%
4068	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ribosomal protein S6 kinase alpha-3	inhibition percentage	2	%
4069	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ribosomal protein S6 kinase alpha-3	inhibition percentage	3	%
4070	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ribosomal protein S6 kinase alpha-4	inhibition percentage	0	%
4071	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	32	%
4072	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ribosomal protein S6 kinase alpha-4	inhibition percentage	0	%
4073	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ribosomal protein S6 kinase beta-1	inhibition percentage	0	%
4074	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase, Sbk1	inhibition percentage	0	%
4075	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Sgk1	inhibition percentage	0	%
4076	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Uncharacterized serine/threonine-protein kinase SBK3	inhibition percentage	48	%
4077	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Sgk2	inhibition percentage	0	%
4078	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Sgk3	inhibition percentage	0	%
4079	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Protein-tyrosine kinase 6	inhibition percentage	2	%
4080	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase SIK1	inhibition percentage	0	%
4081	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase Fyn	inhibition percentage	0	%
4082	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	4	%
4083	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	NUAK family SNF1-like kinase 2	inhibition percentage	0	%
4084	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	SNF-related serine/threonine-protein kinase	inhibition percentage	2	%
4085	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Neuronal proto-oncogene tyrosine-protein kinase Src	inhibition percentage	0	%
4086	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase Srms	inhibition percentage	0	%
4087	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	CBL-interacting serine/threonine-protein kinase 7	inhibition percentage	0	%
4088	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	SRSF protein kinase 2	inhibition percentage	61	%
4089	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	SRSF protein kinase 3	inhibition percentage	26	%
4090	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase 16	inhibition percentage	6	%
4091	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase 33	inhibition percentage	57	%
4092	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase 35	inhibition percentage	0	%
4093	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
4094	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase 36	inhibition percentage	4	%
4095	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	STE20/SPS1-related proline-alanine-rich protein kinase	inhibition percentage	0	%
4096	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase SYK	inhibition percentage	0	%
4097	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase 7	inhibition percentage	16	%
4098	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase TAO1	inhibition percentage	0	%
4099	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase TAO2	inhibition percentage	0	%
4100	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase TAO3	inhibition percentage	7	%
4101	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase TBK1	inhibition percentage	0	%
4102	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Nuclear receptor subfamily 4 group A member 3	inhibition percentage	0	%
4103	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Dual specificity testis-specific protein kinase 1	inhibition percentage	0	%
4104	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
4105	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	TGF-beta receptor type-1	inhibition percentage	0	%
4106	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	TGF-beta receptor type-2	inhibition percentage	4	%
4107	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase receptor Tie-1	inhibition percentage	0	%
4108	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase receptor Tie-2	inhibition percentage	0	%
4109	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase TOUSLED-like 2	inhibition percentage	0	%
4110	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase TOUSLED-like 2	inhibition percentage	0	%
4111	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Traf2 and NCK-interacting protein kinase	inhibition percentage	3	%
4112	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Non-receptor tyrosine-protein kinase TNK1	inhibition percentage	7	%
4113	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Activated CDC42 kinase 1	inhibition percentage	0	%
4114	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase TNNI3K	inhibition percentage	0	%
4115	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
4116	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	High affinity nerve growth factor receptor	inhibition percentage	0	%
4117	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	BDNF/NT-3 growth factors receptor	inhibition percentage	0	%
4118	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	NT-3 growth factor receptor	inhibition percentage	0	%
4119	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Transient receptor potential cation channel subfamily M member 6	inhibition percentage	0	%
4120	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Testis-specific serine/threonine-protein kinase 1	inhibition percentage	19	%
4121	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Testis-specific serine/threonine-protein kinase 3	inhibition percentage	0	%
4122	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Dual specificity protein kinase TTK	inhibition percentage	4	%
4123	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase TXK	inhibition percentage	6	%
4124	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Non-receptor tyrosine-protein kinase TYK2	inhibition percentage	0	%
4125	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Non-receptor tyrosine-protein kinase TYK2 pseudokinase	inhibition percentage	7	%
4126	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	26	%
4127	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase receptor TYRO3	inhibition percentage	0	%
4128	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase ULK1	inhibition percentage	0	%
4129	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase ULK2	inhibition percentage	0	%
4130	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase ULK3	inhibition percentage	0	%
4131	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Vascular endothelial growth factor receptor 2	inhibition percentage	0	%
4132	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 3-kinase catalytic subunit type 3	inhibition percentage	0	%
4133	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase VRK2	inhibition percentage	0	%
4134	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitosis inhibitor protein kinase wee1	inhibition percentage	0	%
4135	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Wee1-like protein kinase 1-A	inhibition percentage	0	%
4136	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase WNK1	inhibition percentage	0	%
4137	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
4138	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase WNK2	inhibition percentage	0	%
4139	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase WNK3	inhibition percentage	0	%
4140	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase WNK4	inhibition percentage	0	%
4141	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase 32A	inhibition percentage	3	%
4142	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase 32B	inhibition percentage	0	%
4143	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase 32C	inhibition percentage	0	%
4144	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase yes	inhibition percentage	0	%
4145	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase 25	inhibition percentage	60	%
4146	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase 19	inhibition percentage	10	%
4147	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase 20	inhibition percentage	26	%
4148	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ABL2	inhibition percentage	4	%
4149	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ZAP-70	inhibition percentage	0	%
4150	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Activin receptor type-1	inhibition percentage	0	%
4151	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Activin receptor type-1B	inhibition percentage	0	%
4152	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Activin receptor type-2A	inhibition percentage	0	%
4153	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Activin receptor type-2B	inhibition percentage	0	%
4154	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase receptor R3	inhibition percentage	0	%
4155	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Atypical kinase COQ8A, mitochondrial	inhibition percentage	1	%
4156	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Atypical kinase COQ8B, mitochondrial	inhibition percentage	0	%
4157	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	RAC-alpha serine/threonine-protein kinase	inhibition percentage	0	%
4158	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	RAC-beta serine/threonine-protein kinase	inhibition percentage	13	%
4159	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	RAC-gamma serine/threonine-protein kinase	inhibition percentage	0	%
4160	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	ALK tyrosine kinase receptor	inhibition percentage	0	%
4161	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	ALK tyrosine kinase receptor	inhibition percentage	0	%
4162	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	ALK tyrosine kinase receptor	inhibition percentage	0	%
4163	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	5'-AMP-activated protein kinase catalytic subunit alpha-1	inhibition percentage	9	%
4164	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	5'-AMP-activated protein kinase catalytic subunit alpha-2	inhibition percentage	0	%
4165	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ankyrin repeat and protein kinase domain-containing protein 1	inhibition percentage	0	%
4166	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	NUAK family SNF1-like kinase 1	inhibition percentage	0	%
4167	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase SRK2A	inhibition percentage	10	%
4168	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase SRK2G	inhibition percentage	0	%
4169	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Aurora kinase A	inhibition percentage	5	%
4170	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	AP2-associated protein kinase 1	inhibition percentage	0	%
4171	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Aurora kinase B	inhibition percentage	11	%
4172	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Aurora kinase C	inhibition percentage	7	%
4173	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase receptor UFO	inhibition percentage	4	%
4174	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	BMP-2-inducible protein kinase	inhibition percentage	5	%
4175	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase Blk	inhibition percentage	23	%
4176	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Bone morphogenetic protein receptor type-1A	inhibition percentage	4	%
4177	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Bone morphogenetic protein receptor type-1B	inhibition percentage	2	%
4178	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Bone morphogenetic protein receptor type-2	inhibition percentage	0	%
4179	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cytoplasmic tyrosine-protein kinase BMX	inhibition percentage	33	%
4180	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase B-raf	inhibition percentage	0	%
4181	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase B-raf	inhibition percentage	8	%
4182	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Protein-tyrosine kinase 6	inhibition percentage	0	%
4183	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase BRSK1	inhibition percentage	0	%
4184	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase BRSK2	inhibition percentage	14	%
4185	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase BTK	inhibition percentage	0	%
4186	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Checkpoint serine/threonine-protein kinase bub1	inhibition percentage	0	%
4187	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Calcium/calmodulin-dependent protein kinase type 1	inhibition percentage	0	%
4188	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Calcium/calmodulin-dependent protein kinase type 1B	inhibition percentage	0	%
4189	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Calcium/calmodulin-dependent protein kinase type 1D	inhibition percentage	0	%
4190	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Calcium/calmodulin-dependent protein kinase type 1G	inhibition percentage	10	%
4191	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Calcium/calmodulin-dependent protein kinase type II (isoform a)	inhibition percentage	0	%
4192	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Calcium/calmodulin-dependent protein kinase type II (isoform b)	inhibition percentage	6	%
4193	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Calcium/calmodulin-dependent protein kinase type II (isoform d)	inhibition percentage	0	%
4194	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Calcium/calmodulin-dependent protein kinase type II (isoform g)	inhibition percentage	0	%
4195	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Calcium/calmodulin-dependent protein kinase type IV	inhibition percentage	5	%
4196	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Calcium/calmodulin-dependent protein kinase kinase 1	inhibition percentage	0	%
4197	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Calcium/calmodulin-dependent protein kinase kinase 2	inhibition percentage	0	%
4198	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Casein kinase II subunit alpha	inhibition percentage	0	%
4199	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 11B	inhibition percentage	0	%
4200	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 11A	inhibition percentage	0	%
4201	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Epithelial discoidin domain-containing receptor 1	delta Tm	7.3	°C
4202	CC(NC(=O)C1=CN=C2C=CC=CN12)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Discoidin domain-containing receptor 2	delta Tm	7.9	°C
4203	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Epithelial discoidin domain-containing receptor 1	IC50	2.27	μM
4204	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase 14A	IC50	2.97	μM
4205	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Discoidin domain-containing receptor 2	IC50	7.46	μM
4206	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 13	inhibition percentage	0	%
4207	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 11	inhibition percentage	33	%
4208	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 2	inhibition percentage	0	%
4209	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 3	inhibition percentage	0	%
4210	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 4	inhibition percentage	0	%
4211	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 4; Cyclin-D1-1	inhibition percentage	0	%
4212	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 4; Cyclin-D3-1	inhibition percentage	0	%
4213	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent-like kinase 5	inhibition percentage	19	%
4214	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 7	inhibition percentage	19	%
4215	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 8	inhibition percentage	0	%
4216	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 9	inhibition percentage	3	%
4217	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase-like 1	inhibition percentage	28	%
4218	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase-like 2	inhibition percentage	0	%
4219	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase-like 3	inhibition percentage	25	%
4220	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase-like 5	inhibition percentage	2	%
4221	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Chk1	inhibition percentage	0	%
4222	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Chk2	inhibition percentage	14	%
4223	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Citrate synthase, mitochondrial	inhibition percentage	35	%
4224	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase RCK2	inhibition percentage	19	%
4225	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Dual specificity protein kinase CLK2	inhibition percentage	19	%
4226	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Dual specificity protein kinase CLK3	inhibition percentage	1	%
4227	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Dual specificity protein kinase CLK4	inhibition percentage	1	%
4228	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Macrophage colony-stimulating factor 1 receptor	inhibition percentage	0	%
4229	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Macrophage colony-stimulating factor 1 receptor	inhibition percentage	0	%
4230	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase CSK	inhibition percentage	8	%
4231	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Casein kinase I isoform alpha	inhibition percentage	0	%
4232	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Casein kinase I isoform alpha-like	inhibition percentage	7	%
4233	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Casein kinase I isoform delta	inhibition percentage	7	%
4234	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Casein kinase I isoform epsilon	inhibition percentage	0	%
4235	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Casein kinase I isoform gamma-1	inhibition percentage	0	%
4236	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Casein kinase I isoform gamma-2	inhibition percentage	0	%
4237	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Casein kinase I isoform gamma-3	inhibition percentage	0	%
4238	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Casein kinase II subunit alpha	inhibition percentage	0	%
4239	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Casein kinase II subunit alpha-2	inhibition percentage	4	%
4240	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Megakaryocyte-associated tyrosine-protein kinase	inhibition percentage	0	%
4241	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Death-associated protein kinase 1	inhibition percentage	17	%
4242	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Death-associated protein kinase 2	inhibition percentage	19	%
4243	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Death-associated protein kinase 3	inhibition percentage	26	%
4244	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase DCLK1	inhibition percentage	0	%
4245	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase DCLK2	inhibition percentage	2	%
4246	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase DCLK3	inhibition percentage	1	%
4247	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Epithelial discoidin domain-containing receptor 1	inhibition percentage	99.6	%
4248	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Discoidin domain-containing receptor 2	inhibition percentage	91.6	%
4249	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Death-associated protein kinase 3	inhibition percentage	0	%
4250	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Myotonin-protein kinase	inhibition percentage	16	%
4251	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase MRCK gamma	inhibition percentage	0	%
4252	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase 17A	inhibition percentage	0	%
4253	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase 17B	inhibition percentage	17	%
4254	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Dual specificity tyrosine-phosphorylation-regulated kinase 1A/B	inhibition percentage	12	%
4255	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	inhibition percentage	0	%
4256	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Dual specificity tyrosine-phosphorylation-regulated kinase 2	inhibition percentage	0	%
4257	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	epidermal growth factor-activated receptor	inhibition percentage	0	%
4258	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	epidermal growth factor-activated receptor	inhibition percentage	0	%
4259	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Epidermal growth factor receptor (G719C)	inhibition percentage	0	%
4260	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Epidermal growth factor receptor (G719S)	inhibition percentage	11	%
4261	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	epidermal growth factor-activated receptor	inhibition percentage	2	%
4262	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	epidermal growth factor-activated receptor	inhibition percentage	17	%
4263	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	epidermal growth factor-activated receptor	inhibition percentage	0	%
4264	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Epidermal growth factor receptor (L858R)	inhibition percentage	0	%
4265	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Epidermal growth factor receptor (L858R)	inhibition percentage	5	%
4266	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Epidermal growth factor receptor (L861Q)	inhibition percentage	0	%
4267	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	epidermal growth factor-activated receptor	inhibition percentage	0	%
4268	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Epidermal growth factor receptor (T790M)	inhibition percentage	0	%
4269	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Eukaryotic translation initiation factor 2-alpha kinase 1	inhibition percentage	0	%
4270	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ephrin type-A receptor 1	inhibition percentage	4	%
4271	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ephrin type-A receptor 2	inhibition percentage	42	%
4272	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ephrin type-A receptor 3	inhibition percentage	23	%
4273	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ephrin type-A receptor 4	inhibition percentage	5	%
4274	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ephrin type-A receptor 5	inhibition percentage	2	%
4275	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ephrin type-A receptor 6	inhibition percentage	13	%
4276	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ephrin type-A receptor 7	inhibition percentage	6	%
4277	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ephrin type-A receptor 8	inhibition percentage	0	%
4278	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ephrin type-B receptor 1	inhibition percentage	0	%
4279	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ephrin type-B receptor 2	inhibition percentage	15	%
4280	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ephrin type-B receptor 3	inhibition percentage	17	%
4281	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ephrin type-B receptor 4	inhibition percentage	0	%
4282	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ephrin type-B receptor 6	inhibition percentage	0	%
4283	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Receptor tyrosine-protein kinase erbB-2	inhibition percentage	0	%
4284	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Receptor tyrosine-protein kinase erbB-3	inhibition percentage	0	%
4285	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Receptor tyrosine-protein kinase erbB-4	inhibition percentage	19	%
4286	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Extracellular signal-regulated kinase 1	inhibition percentage	0	%
4287	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Extracellular signal-regulated kinase 2	inhibition percentage	3	%
4288	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase 6	inhibition percentage	0	%
4289	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase 4	inhibition percentage	0	%
4290	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase 7	inhibition percentage	0	%
4291	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase 15	inhibition percentage	0	%
4292	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase/endoribonuclease IRE1	inhibition percentage	4	%
4293	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Focal adhesion kinase 1	inhibition percentage	4	%
4294	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase Fer	inhibition percentage	25	%
4295	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase, Fes/Fps type	inhibition percentage	9	%
4296	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Fibroblast growth factor receptor 1	inhibition percentage	18	%
4297	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Fibroblast growth factor receptor 2	inhibition percentage	0	%
4298	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Fibroblast growth factor receptor 3	inhibition percentage	11	%
4299	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Fibroblast growth factor receptor 3	inhibition percentage	18	%
4300	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Fibroblast growth factor receptor 4	inhibition percentage	0	%
4301	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase Fgr	inhibition percentage	12	%
4302	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Vascular endothelial growth factor receptor 1	inhibition percentage	0	%
4303	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Vascular endothelial growth factor receptor 3	inhibition percentage	15	%
4304	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Receptor-type tyrosine-protein kinase FLT3 (D835H)	inhibition percentage	0	%
4305	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Receptor-type tyrosine-protein kinase FLT3 (D835V)	inhibition percentage	0	%
4306	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Receptor-type tyrosine-protein kinase FLT3 (D835Y)	inhibition percentage	0	%
4307	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Receptor-type tyrosine-protein kinase FLT3 (ITD)	inhibition percentage	0	%
4308	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Receptor-type tyrosine-protein kinase FLT3 (ITD)	inhibition percentage	0	%
4309	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Receptor-type tyrosine-protein kinase FLT3 (ITD)	inhibition percentage	0	%
4310	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	0	%
4311	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	9	%
4312	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	0	%
4313	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	2	%
4314	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Vascular endothelial growth factor receptor 3	inhibition percentage	0	%
4315	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase FRK	inhibition percentage	14	%
4316	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase Fyn	inhibition percentage	16	%
4317	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-G-associated kinase	inhibition percentage	3	%
4318	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	ABC transporter F family member 2	inhibition percentage	0	%
4319	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	rhodopsin kinase	inhibition percentage	0	%
4320	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Beta-adrenergic receptor kinase 1	inhibition percentage	0	%
4321	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Beta-adrenergic receptor kinase 2	inhibition percentage	0	%
4322	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	G protein-coupled receptor kinase 4	inhibition percentage	0	%
4323	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	rhodopsin kinase	inhibition percentage	0	%
4324	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Glycogen synthase kinase-3 alpha	inhibition percentage	3	%
4325	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	tau-protein kinase	inhibition percentage	0	%
4326	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase haspin	inhibition percentage	0	%
4327	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase HCK	inhibition percentage	0	%
4328	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Homeodomain-interacting protein kinase 1	inhibition percentage	0	%
4329	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Homeodomain-interacting protein kinase 2	inhibition percentage	0	%
4330	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Homeodomain-interacting protein kinase 3	inhibition percentage	0	%
4331	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Homeodomain-interacting protein kinase 4	inhibition percentage	0	%
4332	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase kinase 1	inhibition percentage	0	%
4333	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Hormonally up-regulated neu tumor-associated kinase	inhibition percentage	0	%
4334	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase ICK	inhibition percentage	0	%
4335	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Insulin-like growth factor 1 receptor	inhibition percentage	19	%
4336	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Inhibitor of nuclear factor kappa-B kinase subunit alpha	inhibition percentage	0	%
4337	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Inhibitor of nuclear factor kappa-B kinase subunit beta	inhibition percentage	0	%
4338	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	inhibition percentage	36	%
4339	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Insulin receptor	inhibition percentage	0	%
4340	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Insulin receptor-related protein	inhibition percentage	0	%
4341	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Interleukin-1 receptor-associated kinase 1	inhibition percentage	0	%
4342	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Interleukin-1 receptor-associated kinase 3	inhibition percentage	0	%
4343	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Interleukin-1 receptor-associated kinase 4	inhibition percentage	0	%
4344	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ITK/TSK	inhibition percentage	0	%
4345	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase JAK1	inhibition percentage	4	%
4346	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase JAK1 pseudokinase	inhibition percentage	0	%
4347	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase JAK2	inhibition percentage	0	%
4348	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase JAK3	inhibition percentage	0	%
4349	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase 8	inhibition percentage	12	%
4350	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase 9	inhibition percentage	8	%
4351	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase 10	inhibition percentage	0	%
4352	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mast/stem cell growth factor receptor Kit	inhibition percentage	0	%
4353	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mast/stem cell growth factor receptor Kit (A829P)	inhibition percentage	0	%
4354	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mast/stem cell growth factor receptor Kit (D816H)	inhibition percentage	0	%
4355	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mast/stem cell growth factor receptor Kit (D816V)	inhibition percentage	20	%
4356	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mast/stem cell growth factor receptor Kit	inhibition percentage	31	%
4357	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mast/stem cell growth factor receptor Kit (V559D)	inhibition percentage	11	%
4358	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mast/stem cell growth factor receptor Kit (V559D)	inhibition percentage	5	%
4359	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mast/stem cell growth factor receptor Kit (V559D)	inhibition percentage	11	%
4360	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mast/stem cell growth factor receptor Kit	inhibition percentage	0	%
4361	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase LATS1	inhibition percentage	0	%
4362	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase LATS2	inhibition percentage	0	%
4363	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase Lck	inhibition percentage	15	%
4364	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	LIM domain kinase 1	inhibition percentage	0	%
4365	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	LIM domain kinase 2	inhibition percentage	0	%
4366	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase STK11	inhibition percentage	0	%
4367	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase 10	inhibition percentage	0	%
4368	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Leucine-rich repeat serine/threonine-protein kinase 2	inhibition percentage	59	%
4369	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Leucine-rich repeat serine/threonine-protein kinase 2 (G2019S)	inhibition percentage	0	%
4370	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Leukocyte tyrosine kinase receptor	inhibition percentage	0	%
4371	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase Lyn	inhibition percentage	6	%
4372	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase 13	inhibition percentage	0	%
4373	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase MAK	inhibition percentage	0	%
4374	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase 1	inhibition percentage	0	%
4375	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase 15	inhibition percentage	0	%
4376	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase 2	inhibition percentage	0	%
4377	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase 3	inhibition percentage	0	%
4378	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase 4	inhibition percentage	21	%
4379	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase kinase 2	inhibition percentage	0	%
4380	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase kinase 3	inhibition percentage	30	%
4381	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase kinase 4	inhibition percentage	25	%
4382	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase kinase 5	inhibition percentage	18	%
4383	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	MAP kinase-activated protein kinase 2	inhibition percentage	0	%
4384	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	MAP kinase-activated protein kinase 5	inhibition percentage	0	%
4385	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase MARK1	inhibition percentage	28	%
4386	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase MARK2	inhibition percentage	0	%
4387	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase MARK3	inhibition percentage	54	%
4388	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase MARK4	inhibition percentage	35	%
4389	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Microtubule-associated serine/threonine-protein kinase 1	inhibition percentage	14	%
4390	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Dual specificity mitogen-activated protein kinase kinase 1	inhibition percentage	0	%
4391	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Dual specificity mitogen-activated protein kinase kinase 2	inhibition percentage	0	%
4392	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Dual specificity mitogen-activated protein kinase kinase 3	inhibition percentage	0	%
4393	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Dual specificity mitogen-activated protein kinase kinase 4	inhibition percentage	0	%
4394	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Dual specificity mitogen-activated protein kinase kinase 5	inhibition percentage	2	%
4395	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Dual specificity mitogen-activated protein kinase kinase 6	inhibition percentage	25	%
4396	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Maternal embryonic leucine zipper kinase	inhibition percentage	5	%
4397	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase Mer	inhibition percentage	0	%
4398	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Hepatocyte growth factor receptor	inhibition percentage	32	%
4399	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Hepatocyte growth factor receptor (M1250T)	inhibition percentage	20	%
4400	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Hepatocyte growth factor receptor	inhibition percentage	9	%
4401	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Misshapen-like kinase 1	inhibition percentage	0	%
4402	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Dual specificity mitogen-activated protein kinase kinase 7	inhibition percentage	0	%
4403	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	MAP kinase-interacting serine/threonine-protein kinase 1	inhibition percentage	18	%
4404	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	MAP kinase-interacting serine/threonine-protein kinase 2	inhibition percentage	0	%
4405	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	myosin light chain kinase	inhibition percentage	0	%
4406	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase 9	inhibition percentage	0	%
4407	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase 10	inhibition percentage	30	%
4408	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase 11	inhibition percentage	25	%
4409	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase MRCK alpha	inhibition percentage	0	%
4410	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase MRCK beta	inhibition percentage	0	%
4411	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Bowman-Birk type proteinase inhibitor	inhibition percentage	0	%
4412	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Macrophage-stimulating protein receptor	inhibition percentage	0	%
4413	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase 3	inhibition percentage	3	%
4414	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase 24	inhibition percentage	6	%
4415	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase 26	inhibition percentage	0	%
4416	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase mTOR	inhibition percentage	0	%
4417	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Muscle, skeletal receptor tyrosine-protein kinase	inhibition percentage	5	%
4418	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Myosin light chain kinase, smooth muscle	inhibition percentage	0	%
4419	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Myosin light chain kinase 2, skeletal/cardiac muscle	inhibition percentage	16	%
4420	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Myosin light chain kinase family member 4	inhibition percentage	6	%
4421	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Myosin-IIIa	inhibition percentage	4	%
4422	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Myosin-IIIb	inhibition percentage	0	%
4423	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase 38	inhibition percentage	3	%
4424	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase 38-like	inhibition percentage	65	%
4425	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Nek1	inhibition percentage	57	%
4426	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Nek10	inhibition percentage	0	%
4427	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Nek11	inhibition percentage	0	%
4428	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Nek2	inhibition percentage	8	%
4429	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Nek3	inhibition percentage	0	%
4430	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Nek4	inhibition percentage	0	%
4431	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Nek5	inhibition percentage	21	%
4432	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Nek6	inhibition percentage	23	%
4433	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Nek7	inhibition percentage	3	%
4434	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Nek9	inhibition percentage	0	%
4435	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase 14	inhibition percentage	0	%
4436	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase NIM1	inhibition percentage	8	%
4437	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine kinase NLK	inhibition percentage	0	%
4438	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase OSR1	inhibition percentage	0	%
4439	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase 14A	inhibition percentage	0	%
4440	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase 11	inhibition percentage	11	%
4441	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase 13	inhibition percentage	0	%
4442	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase 12	inhibition percentage	0	%
4443	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase PAK 1	inhibition percentage	14	%
4444	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase PAK2	inhibition percentage	16	%
4445	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase PAK 3	inhibition percentage	4	%
4446	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase PAK 4	inhibition percentage	10	%
4447	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase PAK 6	inhibition percentage	0	%
4448	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase PAK5	inhibition percentage	0	%
4449	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 16	inhibition percentage	0	%
4450	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 17	inhibition percentage	29	%
4451	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 18	inhibition percentage	0	%
4452	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Platelet-derived growth factor receptor alpha	inhibition percentage	0	%
4453	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Platelet-derived growth factor receptor beta	inhibition percentage	0	%
4454	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	3-phosphoinositide-dependent protein kinase 1	inhibition percentage	7	%
4455	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Calcium-dependent protein kinase 1 [Plasmodium falciparum]	inhibition percentage	5	%
4456	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
4457	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cell division control protein 2 homolog [Plasmodium falciparum]	inhibition percentage	0	%
4458	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 15	inhibition percentage	22	%
4459	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 14	inhibition percentage	1	%
4460	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	inhibition percentage	19	%
4461	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	inhibition percentage	9	%
4462	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	inhibition percentage	17	%
4463	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	inhibition percentage	3	%
4464	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition percentage	10	%
4465	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (C420R)	inhibition percentage	0	%
4466	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545A)	inhibition percentage	9	%
4467	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	1	%
4468	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545A)	inhibition percentage	0	%
4469	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545K)	inhibition percentage	23	%
4470	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047L)	inhibition percentage	27	%
4471	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047Y)	inhibition percentage	0	%
4472	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition percentage	23	%
4473	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (M1043I)	inhibition percentage	24	%
4474	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (Q546K)	inhibition percentage	18	%
4475	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	inhibition percentage	20	%
4476	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	inhibition percentage	39	%
4477	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	inhibition percentage	0	%
4478	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
4479	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4-kinase beta	inhibition percentage	0	%
4480	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	1-phosphatidylinositol 3-phosphate 5-kinase	inhibition percentage	20	%
4481	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase pim-1	inhibition percentage	10	%
4482	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase pim-2	inhibition percentage	23	%
4483	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase pim-3	inhibition percentage	1	%
4484	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	inhibition percentage	0	%
4485	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	inhibition percentage	27	%
4486	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta	inhibition percentage	0	%
4487	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	inhibition percentage	0	%
4488	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	cAMP-dependent protein kinase catalytic subunit alpha	inhibition percentage	0	%
4489	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	21	%
4490	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	cAMP-dependent protein kinase catalytic subunit beta	inhibition percentage	5	%
4491	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	inhibition percentage	40	%
4492	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Pkn1	inhibition percentage	0	%
4493	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase pkn2	inhibition percentage	0	%
4494	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase PknB [Mycobacterium tuberculosis]	inhibition percentage	0	%
4495	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase PLK1	inhibition percentage	0	%
4496	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase PLK2	inhibition percentage	0	%
4497	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Plk3	inhibition percentage	0	%
4498	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Plk4	inhibition percentage	0	%
4499	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Protein kinase C, delta	inhibition percentage	33	%
4500	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	13	%
4501	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Protein kinase C, epsilon	inhibition percentage	0	%
4502	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Protein kinase C, eta	inhibition percentage	0	%
4503	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Protein kinase C iota type	inhibition percentage	0	%
4504	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Protein kinase C, theta	inhibition percentage	14	%
4505	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase D1	inhibition percentage	1	%
4506	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase D2	inhibition percentage	23	%
4507	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase D3	inhibition percentage	0	%
4508	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	cGMP-dependent protein kinase 1	inhibition percentage	13	%
4509	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	cGMP-dependent protein kinase 2	inhibition percentage	22	%
4510	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Interferon-induced, double-stranded RNA-activated protein kinase	inhibition percentage	54	%
4511	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	18	%
4512	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	cAMP-dependent protein kinase catalytic subunit PRKX	inhibition percentage	0	%
4513	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase prp4	inhibition percentage	48	%
4514	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Protein-tyrosine kinase 2-beta	inhibition percentage	1	%
4515	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase SIK3	inhibition percentage	1	%
4516	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	RAF proto-oncogene serine/threonine-protein kinase	inhibition percentage	20	%
4517	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Proto-oncogene tyrosine-protein kinase receptor Ret	inhibition percentage	19	%
4518	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Proto-oncogene tyrosine-protein kinase receptor Ret (M918T)	inhibition percentage	0	%
4519	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Proto-oncogene tyrosine-protein kinase receptor Ret (V804L)	inhibition percentage	0	%
4520	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M)	inhibition percentage	0	%
4521	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Rio1	inhibition percentage	0	%
4522	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
4523	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Rio2	inhibition percentage	3	%
4524	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Rio3	inhibition percentage	0	%
4525	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Receptor-interacting serine/threonine-protein kinase 1	inhibition percentage	0	%
4526	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Receptor-interacting serine/threonine-protein kinase 2	inhibition percentage	16	%
4527	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Receptor-interacting serine/threonine-protein kinase 4	inhibition percentage	7	%
4528	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Dual serine/threonine and tyrosine protein kinase	inhibition percentage	0	%
4529	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Rho-associated protein kinase 1	inhibition percentage	0	%
4530	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Rho-associated protein kinase 2	inhibition percentage	0	%
4531	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Proto-oncogene tyrosine-protein kinase ROS	inhibition percentage	32	%
4532	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ribosomal protein S6 kinase alpha-4	inhibition percentage	21	%
4533	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
4534	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ribosomal protein S6 kinase alpha-4	inhibition percentage	0	%
4535	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ribosomal protein S6 kinase alpha-5	inhibition percentage	4	%
4536	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ribosomal protein S6 kinase alpha-5	inhibition percentage	0	%
4537	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ribosomal protein S6 kinase alpha-1	inhibition percentage	10	%
4538	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ribosomal protein S6 kinase alpha-1	inhibition percentage	8	%
4539	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ribosomal protein S6 kinase alpha-3	inhibition percentage	0	%
4540	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ribosomal protein S6 kinase alpha-2	inhibition percentage	0	%
4541	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ribosomal protein S6 kinase alpha-3	inhibition percentage	0	%
4542	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ribosomal protein S6 kinase alpha-3	inhibition percentage	17	%
4543	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ribosomal protein S6 kinase alpha-4	inhibition percentage	0	%
4544	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	30	%
4545	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ribosomal protein S6 kinase alpha-4	inhibition percentage	4	%
4546	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ribosomal protein S6 kinase beta-1	inhibition percentage	0	%
4547	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase, Sbk1	inhibition percentage	4	%
4548	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Sgk1	inhibition percentage	0	%
4549	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Uncharacterized serine/threonine-protein kinase SBK3	inhibition percentage	16	%
4550	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Sgk2	inhibition percentage	6	%
4551	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase Sgk3	inhibition percentage	0	%
4552	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Protein-tyrosine kinase 6	inhibition percentage	9	%
4553	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase SIK1	inhibition percentage	0	%
4554	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase Fyn	inhibition percentage	21	%
4555	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
4556	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	NUAK family SNF1-like kinase 2	inhibition percentage	0	%
4557	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	SNF-related serine/threonine-protein kinase	inhibition percentage	0	%
4558	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Neuronal proto-oncogene tyrosine-protein kinase Src	inhibition percentage	4	%
4559	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase Srms	inhibition percentage	0	%
4560	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	CBL-interacting serine/threonine-protein kinase 7	inhibition percentage	0	%
4561	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	SRSF protein kinase 2	inhibition percentage	0	%
4562	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	SRSF protein kinase 3	inhibition percentage	0	%
4563	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase 16	inhibition percentage	0	%
4564	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase 33	inhibition percentage	18	%
4565	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase 35	inhibition percentage	0	%
4566	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	36	%
4567	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase 36	inhibition percentage	0	%
4568	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	STE20/SPS1-related proline-alanine-rich protein kinase	inhibition percentage	0	%
4569	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase SYK	inhibition percentage	29	%
4570	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase 7	inhibition percentage	0	%
4571	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase TAO1	inhibition percentage	0	%
4572	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase TAO2	inhibition percentage	0	%
4573	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase TAO3	inhibition percentage	0	%
4574	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase TBK1	inhibition percentage	25	%
4575	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Nuclear receptor subfamily 4 group A member 3	inhibition percentage	0	%
4576	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Dual specificity testis-specific protein kinase 1	inhibition percentage	6	%
4577	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
4578	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	TGF-beta receptor type-1	inhibition percentage	2	%
4579	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	TGF-beta receptor type-2	inhibition percentage	0	%
4580	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase receptor Tie-1	inhibition percentage	0	%
4581	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase receptor Tie-2	inhibition percentage	22	%
4582	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase TOUSLED-like 2	inhibition percentage	31	%
4583	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase TOUSLED-like 2	inhibition percentage	12	%
4584	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Traf2 and NCK-interacting protein kinase	inhibition percentage	0	%
4585	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Non-receptor tyrosine-protein kinase TNK1	inhibition percentage	8	%
4586	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Activated CDC42 kinase 1	inhibition percentage	0	%
4587	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase TNNI3K	inhibition percentage	31	%
4588	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	1	%
4589	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	High affinity nerve growth factor receptor	inhibition percentage	0	%
4590	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	BDNF/NT-3 growth factors receptor	inhibition percentage	0	%
4591	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	NT-3 growth factor receptor	inhibition percentage	0	%
4592	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Transient receptor potential cation channel subfamily M member 6	inhibition percentage	0	%
4593	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Testis-specific serine/threonine-protein kinase 1	inhibition percentage	3	%
4594	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Testis-specific serine/threonine-protein kinase 3	inhibition percentage	9	%
4595	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Dual specificity protein kinase TTK	inhibition percentage	12	%
4596	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase TXK	inhibition percentage	26	%
4597	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Non-receptor tyrosine-protein kinase TYK2	inhibition percentage	0	%
4598	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Non-receptor tyrosine-protein kinase TYK2 pseudokinase	inhibition percentage	0	%
4599	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	32	%
4600	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase receptor TYRO3	inhibition percentage	0	%
4601	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase ULK1	inhibition percentage	0	%
4602	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase ULK2	inhibition percentage	0	%
4603	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase ULK3	inhibition percentage	2	%
4604	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Vascular endothelial growth factor receptor 2	inhibition percentage	0	%
4605	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Phosphatidylinositol 3-kinase catalytic subunit type 3	inhibition percentage	0	%
4606	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase VRK2	inhibition percentage	0	%
4607	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitosis inhibitor protein kinase wee1	inhibition percentage	25	%
4608	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Wee1-like protein kinase 1-A	inhibition percentage	6	%
4609	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase WNK1	inhibition percentage	0	%
4610	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	6	%
4611	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase WNK2	inhibition percentage	0	%
4612	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase WNK3	inhibition percentage	0	%
4613	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase WNK4	inhibition percentage	0	%
4614	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase 32A	inhibition percentage	2	%
4615	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase 32B	inhibition percentage	20	%
4616	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase 32C	inhibition percentage	0	%
4617	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase yes	inhibition percentage	0	%
4618	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase 25	inhibition percentage	0	%
4619	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase 19	inhibition percentage	0	%
4620	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase kinase kinase 20	inhibition percentage	21	%
4621	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ABL2	inhibition percentage	0	%
4622	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase ZAP-70	inhibition percentage	0	%
4623	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Activin receptor type-1	inhibition percentage	3	%
4624	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Activin receptor type-1B	inhibition percentage	16	%
4625	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Activin receptor type-2A	inhibition percentage	31	%
4626	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Activin receptor type-2B	inhibition percentage	16	%
4627	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase receptor R3	inhibition percentage	0	%
4628	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Atypical kinase COQ8A, mitochondrial	inhibition percentage	36	%
4629	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Atypical kinase COQ8B, mitochondrial	inhibition percentage	0	%
4630	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	RAC-alpha serine/threonine-protein kinase	inhibition percentage	3	%
4631	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	RAC-beta serine/threonine-protein kinase	inhibition percentage	3	%
4632	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	RAC-gamma serine/threonine-protein kinase	inhibition percentage	3	%
4633	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	ALK tyrosine kinase receptor	inhibition percentage	0	%
4634	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	ALK tyrosine kinase receptor	inhibition percentage	4	%
4635	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	ALK tyrosine kinase receptor	inhibition percentage	0	%
4636	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	5'-AMP-activated protein kinase catalytic subunit alpha-1	inhibition percentage	0	%
4637	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	5'-AMP-activated protein kinase catalytic subunit alpha-2	inhibition percentage	0	%
4638	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Ankyrin repeat and protein kinase domain-containing protein 1	inhibition percentage	0	%
4639	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	NUAK family SNF1-like kinase 1	inhibition percentage	6	%
4640	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase SRK2A	inhibition percentage	7	%
4641	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase SRK2G	inhibition percentage	0	%
4642	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Aurora kinase A	inhibition percentage	0	%
4643	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	AP2-associated protein kinase 1	inhibition percentage	4	%
4644	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Aurora kinase B	inhibition percentage	10	%
4645	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Aurora kinase C	inhibition percentage	0	%
4646	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase receptor UFO	inhibition percentage	12	%
4647	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	BMP-2-inducible protein kinase	inhibition percentage	0	%
4648	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase Blk	inhibition percentage	0	%
4649	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Bone morphogenetic protein receptor type-1A	inhibition percentage	17	%
4650	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Bone morphogenetic protein receptor type-1B	inhibition percentage	2	%
4651	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Bone morphogenetic protein receptor type-2	inhibition percentage	0	%
4652	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cytoplasmic tyrosine-protein kinase BMX	inhibition percentage	65	%
4653	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase B-raf	inhibition percentage	15	%
4654	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase B-raf	inhibition percentage	0	%
4655	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Protein-tyrosine kinase 6	inhibition percentage	11	%
4656	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase BRSK1	inhibition percentage	0	%
4657	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Serine/threonine-protein kinase BRSK2	inhibition percentage	28	%
4658	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Tyrosine-protein kinase BTK	inhibition percentage	0	%
4659	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Checkpoint serine/threonine-protein kinase bub1	inhibition percentage	0	%
4660	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Calcium/calmodulin-dependent protein kinase type 1	inhibition percentage	11	%
4661	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Calcium/calmodulin-dependent protein kinase type 1B	inhibition percentage	0	%
4662	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Calcium/calmodulin-dependent protein kinase type 1D	inhibition percentage	0	%
4663	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Calcium/calmodulin-dependent protein kinase type 1G	inhibition percentage	10	%
4664	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Calcium/calmodulin-dependent protein kinase type II (isoform a)	inhibition percentage	26	%
4665	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Calcium/calmodulin-dependent protein kinase type II (isoform b)	inhibition percentage	10	%
4666	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Calcium/calmodulin-dependent protein kinase type II (isoform d)	inhibition percentage	7	%
4667	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Calcium/calmodulin-dependent protein kinase type II (isoform g)	inhibition percentage	3	%
4668	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Calcium/calmodulin-dependent protein kinase type IV	inhibition percentage	0	%
4669	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Calcium/calmodulin-dependent protein kinase kinase 1	inhibition percentage	10	%
4670	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Calcium/calmodulin-dependent protein kinase kinase 2	inhibition percentage	10	%
4671	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Casein kinase II subunit alpha	inhibition percentage	0	%
4672	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 11B	inhibition percentage	0	%
4673	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Cyclin-dependent kinase 11A	inhibition percentage	1	%
4674	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Mitogen-activated protein kinase 14A	delta Tm	8.7	°C
4675	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Epithelial discoidin domain-containing receptor 1	delta Tm	6.1	°C
4676	CC(NC(=O)C1=C(N)N(C)N=C1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC1CCCCC1)C(=O)NC1CCCN(C1)S(C)(=O)=O	Discoidin domain-containing receptor 2	delta Tm	6.7	°C
4677	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-A2; Cyclin-dependent kinase 2	Ki (inhibition constant)	91.3	nM
4678	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	G2/mitotic-specific cyclin-B1;+Cyclin-dependent kinase 1	Ki (inhibition constant)	120	nM
4679	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-H;+Cyclin-dependent kinase 7	Ki (inhibition constant)	160	nM
4680	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 4;+G1/S-specific cyclin-D1	Ki (inhibition constant)	170	nM
4681	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	0.18	μM
4682	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	percentage of cells in G0/G1 phase	44.62	%
4683	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	percentage of cells in S phase	44.54	%
4684	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	G2/mitotic-specific cyclin-B1;+Cyclin-dependent kinase 1	IC50	265	nM
4685	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-H;+Cyclin-dependent kinase 7	IC50	265	nM
4686	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-A2; Cyclin-dependent kinase 2	IC50	323.6	nM
4687	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-A2; Cyclin-dependent kinase 2	IC50	323.6	nM
4688	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 4;+G1/S-specific cyclin-D1	IC50	342	nM
4689	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	1.42	μM
4690	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	1.54	μM
4691	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	1.65	μM
4692	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	1.8	μM
4693	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	2.01	μM
4694	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	2.06	μM
4695	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	2.03	μM
4696	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	2.14	μM
4697	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	2.13	μM
4698	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	2.17	μM
4699	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	2.2	μM
4700	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	2.2	μM
4701	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	2.25	μM
4702	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	2.26	μM
4703	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	2.43	μM
4704	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	2.47	μM
4705	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	2.46	μM
4706	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	2.5	μM
4707	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	2.58	μM
4708	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	2.72	μM
4709	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	2.68	μM
4710	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	2.73	μM
4711	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	2.74	μM
4712	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	2.84	μM
4713	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	2.8	μM
4714	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	2.84	μM
4715	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	2.83	μM
4716	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2	GI50	2.88	μM
4717	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	2.94	μM
4718	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	2.95	μM
4719	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	2.93	μM
4720	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	2.92	μM
4721	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	2.98	μM
4722	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	2.97	μM
4723	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	2.98	μM
4724	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	3.04	μM
4725	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	3.06	μM
4726	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	3.15	μM
4727	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	3.14	μM
4728	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	3.14	μM
4729	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	3.2	μM
4730	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	3.24	μM
4731	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	3.25	μM
4732	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	3.3	μM
4733	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	3.34	μM
4734	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	3.39	μM
4735	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	3.5	μM
4736	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	3.6	μM
4737	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	3.75	μM
4738	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	3.81	μM
4739	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	3.78	μM
4740	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	3.85	μM
4741	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	4.08	μM
4742	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	4.27	μM
4743	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	4.49	μM
4744	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	GI50	5.19	μM
4745	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	percentage of cells in G2/M phase	8.99	%
4746	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	percentage of early apoptotic cells	2.17	%
4747	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4748	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4749	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4750	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	19.7	μM
4751	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4752	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	16	μM
4753	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4754	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4755	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4756	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	9.94	μM
4757	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4758	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	4.86	μM
4759	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	9.93	μM
4760	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4761	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4762	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	33.2	μM
4763	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	8.95	μM
4764	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4765	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4766	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	30.2	μM
4767	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	16.3	μM
4768	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4769	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2	TGI (total growth inhibitory concentration)	100	μM
4770	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	7.69	μM
4771	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4772	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4773	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4774	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4775	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	9.48	μM
4776	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4777	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4778	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4779	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4780	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	6.47	μM
4781	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	8.11	μM
4782	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	5.88	μM
4783	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4784	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4785	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4786	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4787	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4788	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4789	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4790	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4791	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4792	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4793	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4794	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4795	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4796	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4797	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4798	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4799	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4800	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4801	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4802	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4803	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4804	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4805	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4806	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4807	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4808	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4809	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4810	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4811	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4812	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4813	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4814	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4815	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4816	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4817	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4818	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4819	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4820	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4821	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4822	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4823	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4824	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4825	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4826	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4827	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2	LC50	100	μM
4828	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4829	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4830	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4831	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4832	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4833	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4834	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4835	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4836	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4837	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4838	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4839	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4840	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	22.1	μM
4841	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4842	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4843	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	39.2	μM
4844	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4845	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4846	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4847	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	49.9	μM
4848	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	2.58	μM
4849	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4850	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	60.4	μM
4851	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	22.4	μM
4852	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	22.1	μM
4853	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	12.6	μM
4854	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	4.77	μM
4855	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4856	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4857	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4858	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	17.3	μM
4859	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4860	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	percentage of cells in sub-G1 phase	26.85	%
4861	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	percentage of late apoptotic cells	15.42	%
4862	O=C(NC1=CC(=NN1C1=CC=CC=C1)C1=CC=CC=C1)C(=NNC1=CC=CC=C1)C#N	Cyclin-dependent kinase 2 [human]	apoptotic cell percentage	26.85	%
4863	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 4;+G1/S-specific cyclin-D1	Ki (inhibition constant)	40	nM
4864	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-A2; Cyclin-dependent kinase 2	Ki (inhibition constant)	41.6	nM
4865	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 4;+G1/S-specific cyclin-D1	IC50	77	nM
4866	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	G2/mitotic-specific cyclin-B1;+Cyclin-dependent kinase 1	Ki (inhibition constant)	100	nM
4867	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-A2; Cyclin-dependent kinase 2	IC50	141.2	nM
4868	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	0.14	μM
4869	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-A2; Cyclin-dependent kinase 2	IC50	141.2	nM
4870	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	G2/mitotic-specific cyclin-B1;+Cyclin-dependent kinase 1	IC50	223	nM
4871	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	Ki (inhibition constant)	240	nM
4872	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	393	nM
4873	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	percentage of cells in G0/G1 phase	51.94	%
4874	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	0.43	μM
4875	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	percentage of cells in S phase	48.02	%
4876	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	0.75	μM
4877	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	0.82	μM
4878	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	0.85	μM
4879	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	1.21	μM
4880	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	1.22	μM
4881	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	1.45	μM
4882	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	1.46	μM
4883	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	1.54	μM
4884	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2	GI50	1.56	μM
4885	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	1.61	μM
4886	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	1.63	μM
4887	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	1.66	μM
4888	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	1.75	μM
4889	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	1.77	μM
4890	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	1.82	μM
4891	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	1.83	μM
4892	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	1.85	μM
4893	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	1.89	μM
4894	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	1.93	μM
4895	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	1.99	μM
4896	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.02	μM
4897	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.11	μM
4898	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.11	μM
4899	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.16	μM
4900	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.16	μM
4901	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.24	μM
4902	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.27	μM
4903	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.34	μM
4904	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.37	μM
4905	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.4	μM
4906	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.39	μM
4907	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.45	μM
4908	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.5	μM
4909	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.55	μM
4910	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.55	μM
4911	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.61	μM
4912	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.69	μM
4913	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.75	μM
4914	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.84	μM
4915	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.84	μM
4916	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.79	μM
4917	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.84	μM
4918	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.85	μM
4919	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.99	μM
4920	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	3.04	μM
4921	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	3.07	μM
4922	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	3.16	μM
4923	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	3.26	μM
4924	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	3.35	μM
4925	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	3.41	μM
4926	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	3.39	μM
4927	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	3.43	μM
4928	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	3.52	μM
4929	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	3.62	μM
4930	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	3.62	μM
4931	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	3.69	μM
4932	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	4.54	μM
4933	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	percentage of cells in G2/M phase	0.04	%
4934	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	percentage of early apoptotic cells	2.55	%
4935	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	20.4	μM
4936	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	25.9	μM
4937	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	5.75	μM
4938	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	12.8	μM
4939	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	13.4	μM
4940	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	8.45	μM
4941	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	13.3	μM
4942	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	17.7	μM
4943	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	13.4	μM
4944	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4945	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4946	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	5.01	μM
4947	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	77.2	μM
4948	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	3.16	μM
4949	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	8.69	μM
4950	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	17	μM
4951	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	18.3	μM
4952	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	15.6	μM
4953	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	21.8	μM
4954	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	17.2	μM
4955	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	63.8	μM
4956	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	12.1	μM
4957	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	6.39	μM
4958	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	14	μM
4959	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	2.86	μM
4960	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	10.5	μM
4961	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2	TGI (total growth inhibitory concentration)	8.72	μM
4962	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	7	μM
4963	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	8.45	μM
4964	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	16.2	μM
4965	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	9.31	μM
4966	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	13.4	μM
4967	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	8.7	μM
4968	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	20.8	μM
4969	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	11.4	μM
4970	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	5.6	μM
4971	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	53.8	μM
4972	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	11.2	μM
4973	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
4974	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	6.01	μM
4975	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4976	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4977	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4978	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4979	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4980	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4981	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4982	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4983	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4984	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	39.9	μM
4985	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	72.9	μM
4986	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	65.4	μM
4987	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4988	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	68	μM
4989	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4990	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	7.12	μM
4991	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	95.8	μM
4992	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	59.9	μM
4993	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4994	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	51.5	μM
4995	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4996	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4997	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
4998	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	38.6	μM
4999	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	64.5	μM
5000	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	49.6	μM
5001	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5002	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	49.8	μM
5003	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	52.5	μM
5004	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5005	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5006	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5007	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5008	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5009	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	13.9	μM
5010	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5011	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	94	μM
5012	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	77.9	μM
5013	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	80.6	μM
5014	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5015	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5016	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5017	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5018	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5019	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	48.7	μM
5020	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	25.6	μM
5021	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	65.3	μM
5022	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2	LC50	43.5	μM
5023	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	56.5	μM
5024	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5025	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	62.6	μM
5026	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5027	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5028	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5029	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5030	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	28.2	μM
5031	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5032	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5033	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5034	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	40.8	μM
5035	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	5.43	μM
5036	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	12.8	μM
5037	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	9.92	μM
5038	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	4.47	μM
5039	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	8.74	μM
5040	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	15.6	μM
5041	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	15.3	μM
5042	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	11.2	μM
5043	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	3.84	μM
5044	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	13.7	μM
5045	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	10.6	μM
5046	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	12.9	μM
5047	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	10.2	μM
5048	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	3.6	μM
5049	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	19.3	μM
5050	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	11.5	μM
5051	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	45.4	μM
5052	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	11.6	μM
5053	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	33.4	μM
5054	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	percentage of cells in sub-G1 phase	30.49	%
5055	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	percentage of late apoptotic cells	8.57	%
5056	FC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	apoptotic cell percentage	30.49	%
5057	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-A2; Cyclin-dependent kinase 2	Ki (inhibition constant)	19.2	nM
5058	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	G2/mitotic-specific cyclin-B1;+Cyclin-dependent kinase 1	Ki (inhibition constant)	20	nM
5059	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 4;+G1/S-specific cyclin-D1	Ki (inhibition constant)	20	nM
5060	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 4;+G1/S-specific cyclin-D1	IC50	48	nM
5061	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	G2/mitotic-specific cyclin-B1;+Cyclin-dependent kinase 1	IC50	56	nM
5062	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-A2; Cyclin-dependent kinase 2	IC50	77.94	nM
5063	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-A2; Cyclin-dependent kinase 2	IC50	77.94	nM
5064	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	Ki (inhibition constant)	80	nM
5065	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-H;+Cyclin-dependent kinase 7	IC50	130	nM
5066	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	percentage of cells in G0/G1 phase	56.19	%
5067	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	1.07	μM
5068	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	percentage of cells in S phase	41.61	%
5069	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	1.63	μM
5070	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	1.72	μM
5071	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	1.77	μM
5072	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	1.84	μM
5073	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.01	μM
5074	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.03	μM
5075	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.06	μM
5076	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.07	μM
5077	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.14	μM
5078	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.25	μM
5079	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.27	μM
5080	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.28	μM
5081	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.31	μM
5082	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.34	μM
5083	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.35	μM
5084	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.38	μM
5085	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.39	μM
5086	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.4	μM
5087	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2	GI50	2.44	μM
5088	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.44	μM
5089	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.51	μM
5090	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.51	μM
5091	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.52	μM
5092	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.64	μM
5093	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.65	μM
5094	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.65	μM
5095	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.7	μM
5096	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.71	μM
5097	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.79	μM
5098	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.84	μM
5099	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.86	μM
5100	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.86	μM
5101	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.92	μM
5102	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.96	μM
5103	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.94	μM
5104	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	3.05	μM
5105	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	3	μM
5106	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	2.99	μM
5107	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	3	μM
5108	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	3.11	μM
5109	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	3.08	μM
5110	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	3.09	μM
5111	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	3.17	μM
5112	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	3.2	μM
5113	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	3.31	μM
5114	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	3.32	μM
5115	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	3.29	μM
5116	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	3.5	μM
5117	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	3.59	μM
5118	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	3.62	μM
5119	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	3.74	μM
5120	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	3.7	μM
5121	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	3.9	μM
5122	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	4.12	μM
5123	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	4.05	μM
5124	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	GI50	4.82	μM
5125	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	percentage of cells in G2/M phase	2.2	%
5126	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	percentage of early apoptotic cells	1.81	%
5127	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5128	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5129	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5130	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5131	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5132	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5133	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5134	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5135	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5136	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	8.89	μM
5137	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5138	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	4.27	μM
5139	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	8.62	μM
5140	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5141	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5142	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5143	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	7.62	μM
5144	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5145	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5146	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5147	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	6.66	μM
5148	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5149	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5150	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	6.32	μM
5151	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5152	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5153	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5154	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5155	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5156	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5157	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5158	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5159	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	7.18	μM
5160	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	7.12	μM
5161	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	5.93	μM
5162	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5163	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5164	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5165	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5166	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5167	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5168	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5169	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5170	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5171	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5172	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5173	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5174	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5175	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5176	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5177	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5178	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5179	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5180	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5181	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5182	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5183	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5184	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5185	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5186	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5187	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5188	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5189	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5190	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5191	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5192	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5193	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5194	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5195	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5196	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5197	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5198	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5199	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5200	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5201	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5202	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5203	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5204	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5205	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5206	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2	LC50	100	μM
5207	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5208	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5209	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5210	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5211	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5212	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5213	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5214	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5215	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5216	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5217	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5218	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	LC50	100	μM
5219	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	9.38	μM
5220	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5221	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5222	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	6.67	μM
5223	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5224	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5225	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5226	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5227	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	4.49	μM
5228	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5229	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5230	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5231	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5232	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	4.51	μM
5233	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5234	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5235	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5236	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5237	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	TGI (total growth inhibitory concentration)	100	μM
5238	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	percentage of cells in sub-G1 phase	39.21	%
5239	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	percentage of late apoptotic cells	30.52	%
5240	ClC1=CC=C(NN=C(C#N)C(=O)NC2=CC(=NN2C2=CC=CC=C2)C2=CC=CC=C2)C=C1	Cyclin-dependent kinase 2 [human]	apoptotic cell percentage	39.21	%
5241	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=C(F)C=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-C; Cyclin-dependent kinase 8	IC50	0.1221	μM
5242	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=C(F)C=C(C=C1)N1CCC(CCCO)CC1)N=C2	G1/S-specific cyclin-D1; Cyclin-dependent kinase 6	IC50	0.4847	μM
5243	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=C(F)C=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 4; G1/S-specific cyclin-D1	IC50	1.266	μM
5244	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=C(F)C=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 4; G1/S-specific cyclin-D3	IC50	3.836	μM
5245	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=C(F)C=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-K; Cyclin-dependent kinase 9	IC50	7.046	μM
5246	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=C(F)C=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 2; G1/S-specific cyclin-E	IC50	7.291	μM
5247	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=C(F)C=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 9; Cyclin-T1	IC50	8.072	μM
5248	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=C(F)C=C(C=C1)N1CCC(CCCO)CC1)N=C2	G1/S-specific cyclin-D3; Cyclin-dependent kinase 6	IC50	12.62	μM
5249	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=C(F)C=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cell division cycle 7-related protein kinase; Protein DBF4 homolog A	IC50	14.58	μM
5250	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=C(F)C=C(C=C1)N1CCC(CCCO)CC1)N=C2	G1/S-specific cyclin-E; Cyclin-dependent kinase 1	IC50	14.56	μM
5251	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=C(F)C=C(C=C1)N1CCC(CCCO)CC1)N=C2	G1/S-specific cyclin-E; Cyclin-dependent kinase 3	IC50	17.16	μM
5252	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=C(F)C=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	18	μM
5253	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=C(F)C=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 2; Cyclin-A2	IC50	19.69	μM
5254	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=C(F)C=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 12; Cyclin-C	IC50	24.94	μM
5255	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=C(F)C=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-C; Cyclin-dependent kinase 3	IC50	27.07	μM
5256	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=C(F)C=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 12; Cyclin-K	IC50	28.39	μM
5257	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=C(F)C=C(C=C1)N1CCC(CCCO)CC1)N=C2	Serine/threonine-protein kinase pim-1	IC50	27.95	μM
5258	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=C(F)C=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-A2; Cyclin-dependent kinase 1	IC50	34.04	μM
5259	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=C(F)C=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	34.6	μM
5260	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=C(F)C=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	35.2	μM
5261	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=C(F)C=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent-like kinase 5; Cyclin-dependent kinase 5 activator 1, p35	IC50	38.57	μM
5262	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=C(F)C=C(C=C1)N1CCC(CCCO)CC1)N=C2	CDK-activating kinase assembly factor MAT1;+Cyclin-K; Cell division cycle 7-related protein kinase	IC50	40.73	μM
5263	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=C(F)C=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 1; G2/mitotic-specific cyclin-B1	IC50	42.1	μM
5264	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=C(F)C=C(C=C1)N1CCC(CCCO)CC1)N=C2	Extracellular signal-regulated kinase 1	IC50	47.5	μM
5265	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=C(F)C=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	50	μM
5266	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=C(F)C=C(C=C1)N1CCC(CCCO)CC1)N=C2	RAC-alpha serine/threonine-protein kinase	IC50	50	μM
5267	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=C(F)C=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 5 activator 1, p25; Cyclin-dependent-like kinase 5	IC50	50	μM
5268	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=C(F)C=C(C=C1)N1CCC(CCCO)CC1)N=C2	Dual specificity tyrosine-phosphorylation-regulated kinase 1A/B	IC50	50	μM
5269	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=C(F)C=C(C=C1)N1CCC(CCCO)CC1)N=C2	Probable serine/threonine-protein kinase dyrk2	IC50	50	μM
5270	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=C(F)C=C(C=C1)N1CCC(CCCO)CC1)N=C2	Homeodomain-interacting protein kinase 2	IC50	50	μM
5271	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=C(F)C=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 16;+Cyclin Y	IC50	50	μM
5272	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC(F)=C(C=C1)N1CCC(CCCO)CC1)N=C2	G1/S-specific cyclin-D1; Cyclin-dependent kinase 6	IC50	0.07316	μM
5273	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC(F)=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 4; G1/S-specific cyclin-D1	IC50	0.1496	μM
5274	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC(F)=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 4; G1/S-specific cyclin-D3	IC50	0.3764	μM
5275	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC(F)=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-K; Cyclin-dependent kinase 9	IC50	0.4557	μM
5276	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC(F)=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 2; G1/S-specific cyclin-E	IC50	0.5454	μM
5277	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC(F)=C(C=C1)N1CCC(CCCO)CC1)N=C2	G1/S-specific cyclin-D3; Cyclin-dependent kinase 6	IC50	0.623	μM
5278	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC(F)=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-C; Cyclin-dependent kinase 8	IC50	0.6768	μM
5279	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC(F)=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 2; Cyclin-A2	IC50	0.8103	μM
5280	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC(F)=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 9; Cyclin-T1	IC50	0.9176	μM
5281	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC(F)=C(C=C1)N1CCC(CCCO)CC1)N=C2	G1/S-specific cyclin-E; Cyclin-dependent kinase 3	IC50	1.132	μM
5282	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC(F)=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	1.6	μM
5283	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC(F)=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent-like kinase 5; Cyclin-dependent kinase 5 activator 1, p35	IC50	1.921	μM
5284	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC(F)=C(C=C1)N1CCC(CCCO)CC1)N=C2	G1/S-specific cyclin-E; Cyclin-dependent kinase 1	IC50	2.971	μM
5285	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC(F)=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 12; Cyclin-K	IC50	3.176	μM
5286	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC(F)=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	3.9	μM
5287	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC(F)=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-C; Cyclin-dependent kinase 3	IC50	3.954	μM
5288	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC(F)=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	4.1	μM
5289	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC(F)=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 1; G2/mitotic-specific cyclin-B1	IC50	4.686	μM
5290	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC(F)=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 5 activator 1, p25; Cyclin-dependent-like kinase 5	IC50	4.66	μM
5291	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC(F)=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	7.5	μM
5292	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC(F)=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cell division cycle 7-related protein kinase; Protein DBF4 homolog A	IC50	7.607	μM
5293	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC(F)=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-A2; Cyclin-dependent kinase 1	IC50	7.855	μM
5294	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC(F)=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 12; Cyclin-C	IC50	19.24	μM
5295	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC(F)=C(C=C1)N1CCC(CCCO)CC1)N=C2	CDK-activating kinase assembly factor MAT1;+Cyclin-K; Cell division cycle 7-related protein kinase	IC50	19.96	μM
5296	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC(F)=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 16;+Cyclin Y	IC50	43.84	μM
5297	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC(F)=C(C=C1)N1CCC(CCCO)CC1)N=C2	RAC-alpha serine/threonine-protein kinase	IC50	50	μM
5298	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC(F)=C(C=C1)N1CCC(CCCO)CC1)N=C2	Dual specificity tyrosine-phosphorylation-regulated kinase 1A/B	IC50	50	μM
5299	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC(F)=C(C=C1)N1CCC(CCCO)CC1)N=C2	Probable serine/threonine-protein kinase dyrk2	IC50	50	μM
5300	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC(F)=C(C=C1)N1CCC(CCCO)CC1)N=C2	Extracellular signal-regulated kinase 1	IC50	50	μM
5301	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC(F)=C(C=C1)N1CCC(CCCO)CC1)N=C2	Homeodomain-interacting protein kinase 2	IC50	50	μM
5302	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC(F)=C(C=C1)N1CCC(CCCO)CC1)N=C2	Serine/threonine-protein kinase pim-1	IC50	50	μM
5303	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCN(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 4; G1/S-specific cyclin-D1	IC50	0.0015	μM
5304	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCN(CCC(C)O)CC1)N=C2	G1/S-specific cyclin-D1; Cyclin-dependent kinase 6	IC50	0.0015	μM
5305	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCN(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 4; G1/S-specific cyclin-D3	IC50	0.002968	μM
5306	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCN(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 16;+Cyclin Y	IC50	0.00769	μM
5307	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCN(CCC(C)O)CC1)N=C2	Cyclin-K; Cyclin-dependent kinase 9	IC50	0.01014	μM
5308	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCN(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 2; Cyclin-A2	IC50	0.01299	μM
5309	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCN(CCC(C)O)CC1)N=C2	G1/S-specific cyclin-D3; Cyclin-dependent kinase 6	IC50	0.01685	μM
5310	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCN(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 2; G1/S-specific cyclin-E	IC50	0.01718	μM
5311	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCN(CCC(C)O)CC1)N=C2	Cyclin-C; Cyclin-dependent kinase 8	IC50	0.01715	μM
5312	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCN(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 9; Cyclin-T1	IC50	0.02137	μM
5313	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCN(CCC(C)O)CC1)N=C2	G1/S-specific cyclin-E; Cyclin-dependent kinase 3	IC50	0.02719	μM
5314	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCN(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 12; Cyclin-K	IC50	0.03081	μM
5315	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCN(CCC(C)O)CC1)N=C2	Cyclin-dependent-like kinase 5; Cyclin-dependent kinase 5 activator 1, p35	IC50	0.03467	μM
5316	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCN(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 1; G2/mitotic-specific cyclin-B1	IC50	0.04067	μM
5317	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCN(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	0.05	μM
5318	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCN(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	0.05	μM
5319	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCN(CCC(C)O)CC1)N=C2	Cyclin-C; Cyclin-dependent kinase 3	IC50	0.05413	μM
5320	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCN(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 5 activator 1, p25; Cyclin-dependent-like kinase 5	IC50	0.07253	μM
5321	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCN(CCC(C)O)CC1)N=C2	CDK-activating kinase assembly factor MAT1;+Cyclin-K; Cell division cycle 7-related protein kinase	IC50	0.07234	μM
5322	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCN(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	0.13	μM
5323	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCN(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	0.14	μM
5324	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCN(CCC(C)O)CC1)N=C2	G1/S-specific cyclin-E; Cyclin-dependent kinase 1	IC50	0.1732	μM
5325	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCN(CCC(C)O)CC1)N=C2	Cyclin-A2; Cyclin-dependent kinase 1	IC50	0.1797	μM
5326	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCN(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 12; Cyclin-C	IC50	0.2338	μM
5327	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCN(CCC(C)O)CC1)N=C2	Dual specificity tyrosine-phosphorylation-regulated kinase 1A/B	IC50	1.377	μM
5328	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCN(CCC(C)O)CC1)N=C2	Cell division cycle 7-related protein kinase; Protein DBF4 homolog A	IC50	1.534	μM
5329	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCN(CCC(C)O)CC1)N=C2	Extracellular signal-regulated kinase 1	IC50	4.534	μM
5330	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCN(CCC(C)O)CC1)N=C2	Probable serine/threonine-protein kinase dyrk2	IC50	4.724	μM
5331	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCN(CCC(C)O)CC1)N=C2	Homeodomain-interacting protein kinase 2	IC50	6.06	μM
5332	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCN(CCC(C)O)CC1)N=C2	Serine/threonine-protein kinase pim-1	IC50	7.186	μM
5333	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCN(CCC(C)O)CC1)N=C2	RAC-alpha serine/threonine-protein kinase	IC50	50	μM
5334	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	G1/S-specific cyclin-D1; Cyclin-dependent kinase 6	IC50	0.01248	μM
5335	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	Cyclin-dependent kinase 4; G1/S-specific cyclin-D1	IC50	0.01887	μM
5336	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	Cyclin-dependent kinase 4; G1/S-specific cyclin-D3	IC50	0.04664	μM
5337	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	Cyclin-C; Cyclin-dependent kinase 8	IC50	0.1032	μM
5338	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	G1/S-specific cyclin-D3; Cyclin-dependent kinase 6	IC50	0.1078	μM
5339	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	Cyclin-dependent kinase 2; G1/S-specific cyclin-E	IC50	0.1085	μM
5340	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	Cyclin-K; Cyclin-dependent kinase 9	IC50	0.1485	μM
5341	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	0.19	μM
5342	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	Cyclin-dependent kinase 2; Cyclin-A2	IC50	0.203	μM
5343	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	Cyclin-dependent kinase 9; Cyclin-T1	IC50	0.2643	μM
5344	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	G1/S-specific cyclin-E; Cyclin-dependent kinase 3	IC50	0.3065	μM
5345	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	0.42	μM
5346	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	Cyclin-dependent-like kinase 5; Cyclin-dependent kinase 5 activator 1, p35	IC50	0.7706	μM
5347	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	Cyclin-C; Cyclin-dependent kinase 3	IC50	0.8849	μM
5348	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	Cyclin-dependent kinase 12; Cyclin-K	IC50	1.014	μM
5349	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	G1/S-specific cyclin-E; Cyclin-dependent kinase 1	IC50	1.213	μM
5350	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	1.4 - 1.7	μM
5351	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	Cyclin-dependent kinase 5 activator 1, p25; Cyclin-dependent-like kinase 5	IC50	1.458	μM
5352	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	Cyclin-dependent kinase 1; G2/mitotic-specific cyclin-B1	IC50	1.957	μM
5353	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	2.2 - 2.34	μM
5354	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	2.2	μM
5355	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	2.5	μM
5356	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	Cyclin-dependent kinase 16;+Cyclin Y	IC50	3.845	μM
5357	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	Cyclin-dependent kinase 12; Cyclin-C	IC50	4.131	μM
5358	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	Cyclin-A2; Cyclin-dependent kinase 1	IC50	4.277	μM
5359	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	Cell division cycle 7-related protein kinase; Protein DBF4 homolog A	IC50	5.569	μM
5360	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	CDK-activating kinase assembly factor MAT1;+Cyclin-K; Cell division cycle 7-related protein kinase	IC50	7.998	μM
5361	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	Extracellular signal-regulated kinase 1	IC50	8.321	μM
5362	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	Homeodomain-interacting protein kinase 2	IC50	14.7	μM
5363	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	Dual specificity tyrosine-phosphorylation-regulated kinase 1A/B	IC50	46.77	μM
5364	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2		tumor weight decrease		
5365	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2		lymphocyte count decrease		
5366	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2		body weight loss		
5367	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	RAC-alpha serine/threonine-protein kinase	IC50	50	μM
5368	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	Probable serine/threonine-protein kinase dyrk2	IC50	50	μM
5369	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	Serine/threonine-protein kinase pim-1	IC50	50	μM
5370	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	Cyclin-dependent kinase 4 [mouse];+Cyclin-dependent kinase 6 [mouse]; Cyclin-dependent kinase 2 [mouse]	cell count decrease		
5371	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	Cyclin-dependent kinase 4 [mouse];+Cyclin-dependent kinase 6 [mouse]	cell count decrease		
5372	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2	Cyclin-dependent kinase 2 [mouse]	cell count decrease		
5373	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2		cell count decrease		
5374	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2		CLint (intrinsic clearance)	49	μl/min/1e6 cells
5375	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2		efflux ratio		
5376	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2		permeability	0.59	no unit
5377	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2		number	1	no unit
5378	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2		CLint (intrinsic clearance)	184.7	μl/min/mg protein
5379	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2		CLint (intrinsic clearance)	75.7	μl/min/1e6 cells
5380	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2		t1/2 (drug half life)	7.5	min
5381	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2		t1/2 (drug half life)	28.3	min
5382	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2		t1/2 (drug half life)	18.3	min
5383	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2		CLint (intrinsic clearance)	119	μl/min/mg protein
5384	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC(C)O)N=C2		t1/2 (drug half life)	11.6	min
5385	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-dependent kinase 4; G1/S-specific cyclin-D1	IC50	0.0015	μM
5386	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	G1/S-specific cyclin-D1; Cyclin-dependent kinase 6	IC50	0.0015	μM
5387	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-dependent kinase 4; G1/S-specific cyclin-D3	IC50	0.002253	μM
5388	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-dependent kinase 16;+Cyclin Y	IC50	0.004036	μM
5389	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-K; Cyclin-dependent kinase 9	IC50	0.007166	μM
5390	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-dependent kinase 2; G1/S-specific cyclin-E	IC50	0.007803	μM
5391	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	G1/S-specific cyclin-D3; Cyclin-dependent kinase 6	IC50	0.009659	μM
5392	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	G1/S-specific cyclin-E; Cyclin-dependent kinase 3	IC50	0.01189	μM
5393	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-dependent kinase 9; Cyclin-T1	IC50	0.01355	μM
5394	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-dependent-like kinase 5; Cyclin-dependent kinase 5 activator 1, p35	IC50	0.0159	μM
5395	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-dependent kinase 2; Cyclin-A2	IC50	0.01707	μM
5396	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-dependent kinase 12; Cyclin-K	IC50	0.02579	μM
5397	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	0.04	μM
5398	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-C; Cyclin-dependent kinase 3	IC50	0.04012	μM
5399	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	G1/S-specific cyclin-E; Cyclin-dependent kinase 1	IC50	0.04084	μM
5400	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-dependent kinase 5 activator 1, p25; Cyclin-dependent-like kinase 5	IC50	0.0523	μM
5401	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	0.07	μM
5402	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	CDK-activating kinase assembly factor MAT1;+Cyclin-K; Cell division cycle 7-related protein kinase	IC50	0.0911	μM
5403	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-dependent kinase 1; G2/mitotic-specific cyclin-B1	IC50	0.0973	μM
5404	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	0.15	μM
5405	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	0.16	μM
5406	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-A2; Cyclin-dependent kinase 1	IC50	0.2085	μM
5407	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-dependent kinase 12; Cyclin-C	IC50	0.2885	μM
5408	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-C; Cyclin-dependent kinase 8	IC50	0.3066	μM
5409	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Serine/threonine-protein kinase pim-1	IC50	0.4854	μM
5410	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cell division cycle 7-related protein kinase; Protein DBF4 homolog A	IC50	0.5374	μM
5411	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Dual specificity tyrosine-phosphorylation-regulated kinase 1A/B	IC50	1.181	μM
5412	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Probable serine/threonine-protein kinase dyrk2	IC50	2.314	μM
5413	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Extracellular signal-regulated kinase 1	IC50	2.753	μM
5414	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Homeodomain-interacting protein kinase 2	IC50	5.565	μM
5415	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	RAC-alpha serine/threonine-protein kinase	IC50	11.65	μM
5416	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCCO)CC1)N=C2	G1/S-specific cyclin-D1; Cyclin-dependent kinase 6	IC50	0.01949	μM
5417	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-K; Cyclin-dependent kinase 9	IC50	0.06747	μM
5418	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 4; G1/S-specific cyclin-D1	IC50	0.09892	μM
5419	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 9; Cyclin-T1	IC50	0.1749	μM
5420	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 4; G1/S-specific cyclin-D3	IC50	0.2612	μM
5421	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCCO)CC1)N=C2	G1/S-specific cyclin-D3; Cyclin-dependent kinase 6	IC50	0.6721	μM
5422	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	0.7	μM
5423	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 1; G2/mitotic-specific cyclin-B1	IC50	0.7215	μM
5424	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCCO)CC1)N=C2	Extracellular signal-regulated kinase 1	IC50	0.9494	μM
5425	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-C; Cyclin-dependent kinase 3	IC50	1.862	μM
5426	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	2.44	μM
5427	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	2.57	μM
5428	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCCO)CC1)N=C2	G1/S-specific cyclin-E; Cyclin-dependent kinase 1	IC50	3.037	μM
5429	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 2; Cyclin-A2	IC50	3.522	μM
5430	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 2; G1/S-specific cyclin-E	IC50	3.641	μM
5431	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent-like kinase 5; Cyclin-dependent kinase 5 activator 1, p35	IC50	3.685	μM
5432	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	4.5	μM
5433	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCCO)CC1)N=C2	Homeodomain-interacting protein kinase 2	IC50	5.577	μM
5434	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 5 activator 1, p25; Cyclin-dependent-like kinase 5	IC50	9.435	μM
5435	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCCO)CC1)N=C2	Probable serine/threonine-protein kinase dyrk2	IC50	9.242	μM
5436	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCCO)CC1)N=C2	CDK-activating kinase assembly factor MAT1;+Cyclin-K; Cell division cycle 7-related protein kinase	IC50	11.75	μM
5437	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCCO)CC1)N=C2	Dual specificity tyrosine-phosphorylation-regulated kinase 1A/B	IC50	11.75	μM
5438	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 12; Cyclin-C	IC50	25.74	μM
5439	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCCO)CC1)N=C2	G1/S-specific cyclin-E; Cyclin-dependent kinase 3	IC50	25.9	μM
5440	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-C; Cyclin-dependent kinase 8	IC50	27.29	μM
5441	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 12; Cyclin-K	IC50	28.08	μM
5442	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-dependent kinase 16;+Cyclin Y	IC50	35.86	μM
5443	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cyclin-A2; Cyclin-dependent kinase 1	IC50	39.08	μM
5444	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCCO)CC1)N=C2	Cell division cycle 7-related protein kinase; Protein DBF4 homolog A	IC50	50	μM
5445	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCCO)CC1)N=C2	RAC-alpha serine/threonine-protein kinase	IC50	50	μM
5446	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCCO)CC1)N=C2	Serine/threonine-protein kinase pim-1	IC50	50	μM
5447	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	G1/S-specific cyclin-D1; Cyclin-dependent kinase 6	IC50	0.00182	μM
5448	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-dependent kinase 4; G1/S-specific cyclin-D1	IC50	0.00314	μM
5449	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-dependent kinase 4; G1/S-specific cyclin-D3	IC50	0.00548	μM
5450	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-K; Cyclin-dependent kinase 9	IC50	0.01199	μM
5451	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	G1/S-specific cyclin-D3; Cyclin-dependent kinase 6	IC50	0.02121	μM
5452	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-dependent kinase 9; Cyclin-T1	IC50	0.0366	μM
5453	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	0.08	μM
5454	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-dependent-like kinase 5; Cyclin-dependent kinase 5 activator 1, p35	IC50	0.1132	μM
5455	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	0.16	μM
5456	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-C; Cyclin-dependent kinase 3	IC50	0.1705	μM
5457	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Homeodomain-interacting protein kinase 2	IC50	0.1869	μM
5458	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-dependent kinase 2; Cyclin-A2	IC50	0.2217	μM
5459	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-dependent kinase 2; G1/S-specific cyclin-E	IC50	0.2765	μM
5460	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	0.37	μM
5461	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-dependent kinase 5 activator 1, p25; Cyclin-dependent-like kinase 5	IC50	0.3954	μM
5462	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	0.5	μM
5463	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	G1/S-specific cyclin-E; Cyclin-dependent kinase 3	IC50	0.7003	μM
5464	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-dependent kinase 12; Cyclin-K	IC50	0.7989	μM
5465	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Probable serine/threonine-protein kinase dyrk2	IC50	1.258	μM
5466	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	G1/S-specific cyclin-E; Cyclin-dependent kinase 1	IC50	1.445	μM
5467	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-dependent kinase 1; G2/mitotic-specific cyclin-B1	IC50	2.054	μM
5468	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	CDK-activating kinase assembly factor MAT1;+Cyclin-K; Cell division cycle 7-related protein kinase	IC50	2.027	μM
5469	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-dependent kinase 12; Cyclin-C	IC50	2.849	μM
5470	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Dual specificity tyrosine-phosphorylation-regulated kinase 1A/B	IC50	3.653	μM
5471	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-A2; Cyclin-dependent kinase 1	IC50	4.206	μM
5472	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-dependent kinase 16;+Cyclin Y	IC50	4.313	μM
5473	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Serine/threonine-protein kinase pim-1	IC50	8.139	μM
5474	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cell division cycle 7-related protein kinase; Protein DBF4 homolog A	IC50	13.55	μM
5475	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Cyclin-C; Cyclin-dependent kinase 8	IC50	16.75	μM
5476	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	Extracellular signal-regulated kinase 1	IC50	22.1	μM
5477	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C(C(C)=O)=C(C)C2=C1N=C(NC1=CC=C(C=C1)N1CCNCC1)N=C2	RAC-alpha serine/threonine-protein kinase	IC50	50	μM
5478	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC1(CO)COC1)N=C2	G1/S-specific cyclin-D1; Cyclin-dependent kinase 6	IC50	0.00742	μM
5479	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC1(CO)COC1)N=C2	Cyclin-dependent kinase 4; G1/S-specific cyclin-D1	IC50	0.00885	μM
5480	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC1(CO)COC1)N=C2	Cyclin-dependent kinase 4; G1/S-specific cyclin-D3	IC50	0.02085	μM
5481	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC1(CO)COC1)N=C2	G1/S-specific cyclin-D3; Cyclin-dependent kinase 6	IC50	0.03326	μM
5482	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC1(CO)COC1)N=C2	Cyclin-C; Cyclin-dependent kinase 8	IC50	0.03786	μM
5483	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC1(CO)COC1)N=C2	Cyclin-K; Cyclin-dependent kinase 9	IC50	0.04685	μM
5484	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC1(CO)COC1)N=C2	Cyclin-dependent kinase 2; Cyclin-A2	IC50	0.04974	μM
5485	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC1(CO)COC1)N=C2	Cyclin-dependent kinase 2; G1/S-specific cyclin-E	IC50	0.07165	μM
5486	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC1(CO)COC1)N=C2	G1/S-specific cyclin-E; Cyclin-dependent kinase 3	IC50	0.09335	μM
5487	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC1(CO)COC1)N=C2	Cyclin-dependent kinase 9; Cyclin-T1	IC50	0.09253	μM
5488	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC1(CO)COC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	0.13	μM
5489	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC1(CO)COC1)N=C2	Cyclin-dependent-like kinase 5; Cyclin-dependent kinase 5 activator 1, p35	IC50	0.2546	μM
5490	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC1(CO)COC1)N=C2	Cyclin-dependent kinase 12; Cyclin-K	IC50	0.3388	μM
5491	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC1(CO)COC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	0.44	μM
5492	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC1(CO)COC1)N=C2	G1/S-specific cyclin-E; Cyclin-dependent kinase 1	IC50	0.5269	μM
5493	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC1(CO)COC1)N=C2	Cyclin-C; Cyclin-dependent kinase 3	IC50	0.5545	μM
5494	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC1(CO)COC1)N=C2	Cyclin-dependent kinase 1; G2/mitotic-specific cyclin-B1	IC50	0.6141	μM
5495	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC1(CO)COC1)N=C2	Cyclin-dependent kinase 5 activator 1, p25; Cyclin-dependent-like kinase 5	IC50	0.6525	μM
5496	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC1(CO)COC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	1.12	μM
5497	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC1(CO)COC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	1.23	μM
5498	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC1(CO)COC1)N=C2	Cyclin-A2; Cyclin-dependent kinase 1	IC50	1.356	μM
5499	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC1(CO)COC1)N=C2	Cell division cycle 7-related protein kinase; Protein DBF4 homolog A	IC50	1.979	μM
5500	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC1(CO)COC1)N=C2	Cyclin-dependent kinase 16;+Cyclin Y	IC50	2.018	μM
5501	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC1(CO)COC1)N=C2	CDK-activating kinase assembly factor MAT1;+Cyclin-K; Cell division cycle 7-related protein kinase	IC50	2.37	μM
5502	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC1(CO)COC1)N=C2	Cyclin-dependent kinase 12; Cyclin-C	IC50	2.786	μM
5503	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC1(CO)COC1)N=C2	Extracellular signal-regulated kinase 1	IC50	10.68	μM
5504	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC1(CO)COC1)N=C2	Probable serine/threonine-protein kinase dyrk2	IC50	19.71	μM
5505	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC1(CO)COC1)N=C2	Dual specificity tyrosine-phosphorylation-regulated kinase 1A/B	IC50	28.79	μM
5506	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC1(CO)COC1)N=C2	Serine/threonine-protein kinase pim-1	IC50	40.06	μM
5507	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC1(CO)COC1)N=C2	RAC-alpha serine/threonine-protein kinase	IC50	50	μM
5508	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CC1)OCC1(CO)COC1)N=C2	Homeodomain-interacting protein kinase 2	IC50	50	μM
5509	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	G1/S-specific cyclin-D1; Cyclin-dependent kinase 6	IC50	0.02735	μM
5510	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 4; G1/S-specific cyclin-D1	IC50	0.03534	μM
5511	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 4; G1/S-specific cyclin-D3	IC50	0.1231	μM
5512	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	Cyclin-K; Cyclin-dependent kinase 9	IC50	0.141	μM
5513	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	Cyclin-C; Cyclin-dependent kinase 8	IC50	0.1617	μM
5514	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 9; Cyclin-T1	IC50	0.264	μM
5515	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 2; G1/S-specific cyclin-E	IC50	0.3034	μM
5516	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	G1/S-specific cyclin-D3; Cyclin-dependent kinase 6	IC50	0.442	μM
5517	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 2; Cyclin-A2	IC50	0.4516	μM
5518	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	G1/S-specific cyclin-E; Cyclin-dependent kinase 3	IC50	0.654	μM
5519	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 12; Cyclin-K	IC50	0.9226	μM
5520	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	1.4	μM
5521	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	1.43	μM
5522	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	Cyclin-dependent-like kinase 5; Cyclin-dependent kinase 5 activator 1, p35	IC50	1.675	μM
5523	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	Cyclin-C; Cyclin-dependent kinase 3	IC50	2.101	μM
5524	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	3	μM
5525	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	G1/S-specific cyclin-E; Cyclin-dependent kinase 1	IC50	3.317	μM
5526	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	3.5 - 3.6	μM
5527	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 5 activator 1, p25; Cyclin-dependent-like kinase 5	IC50	4.414	μM
5528	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	4.5 - 5.5	μM
5529	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 12; Cyclin-C	IC50	9.598	μM
5530	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	Cell division cycle 7-related protein kinase; Protein DBF4 homolog A	IC50	9.902	μM
5531	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 4 [human]; Cyclin-dependent kinase 2 [human]	GI50	11.5	μM
5532	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 16;+Cyclin Y	IC50	13.53	μM
5533	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	Cyclin-A2; Cyclin-dependent kinase 1	IC50	14.47	μM
5534	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 1; G2/mitotic-specific cyclin-B1	IC50	16.37	μM
5535	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	CDK-activating kinase assembly factor MAT1;+Cyclin-K; Cell division cycle 7-related protein kinase	IC50	21.69	μM
5536	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	Extracellular signal-regulated kinase 1	IC50	37.82	μM
5537	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	Probable serine/threonine-protein kinase dyrk2	IC50	40.45	μM
5538	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2		body weight loss		
5539	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	RAC-alpha serine/threonine-protein kinase	IC50	50	μM
5540	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	Dual specificity tyrosine-phosphorylation-regulated kinase 1A/B	IC50	50	μM
5541	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	Homeodomain-interacting protein kinase 2	IC50	50	μM
5542	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	Serine/threonine-protein kinase pim-1	IC50	50	μM
5543	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 4 [mouse];+Cyclin-dependent kinase 6 [mouse]; Cyclin-dependent kinase 2 [mouse]	cell count decrease		
5544	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 4 [mouse];+Cyclin-dependent kinase 6 [mouse]	cell count decrease		
5545	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2	Cyclin-dependent kinase 2 [mouse]	cell count decrease		
5546	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2		cell count decrease		
5547	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2		tumor weight decrease		
5548	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2		efflux ratio		
5549	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2		lymphocyte count decrease		
5550	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2		number	4	no unit
5551	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2		CLint (intrinsic clearance)	54.5	μl/min/mg protein
5552	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2		t1/2 (drug half life)	25.4	min
5553	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2		t1/2 (drug half life)	216.8	min
5554	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2		t1/2 (drug half life)	143.4	min
5555	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2		CLint (intrinsic clearance)	40.8	μl/min/mg protein
5556	[H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1C(=O)C=CC2=C1N=C(NC1=CC=C(C=C1)N1CCC(CCC(C)O)CC1)N=C2		t1/2 (drug half life)	34	min
5557	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Casein kinase II subunit beta;+Casein kinase II subunit alpha'	Ki (inhibition constant)	4	nM
5558	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Casein kinase II subunit alpha;+Casein kinase II subunit beta	Ki (inhibition constant)	6.1	nM
5559	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Casein kinase II subunit beta;+Casein kinase II subunit alpha'	IC50	15.6	nM
5560	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Casein kinase II subunit alpha;+Casein kinase II subunit beta	IC50	19.3	nM
5561	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Casein kinase II subunit alpha [human];+Casein kinase II subunit alpha' [human]	EC50	6.19	μM
5562	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Casein kinase II subunit alpha [human];+Casein kinase II subunit alpha' [human]	phosphorylation level decrease		
5563	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Casein kinase II subunit alpha [human];+Casein kinase II subunit alpha' [human]	phosphorylation level decrease		
5564	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Casein kinase II subunit alpha [human];+Casein kinase II subunit alpha' [human]	EC50	15.94	μM
5565	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Casein kinase I isoform epsilon [human]	IC50	30	μM
5566	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Casein kinase II subunit alpha'-2 [human];+Casein kinase II subunit beta-2 [human]	inhibition rate	94.04	%
5567	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Casein kinase I isoform epsilon [human]	inhibition rate	29.86 - 29.9	%
5568	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Serine/threonine-protein kinase pim-1 [human]	inhibition rate	13.79	%
5569	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Dual specificity tyrosine-phosphorylation-regulated kinase 2 [human]	inhibition rate	13.17	%
5570	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Serine/threonine-protein kinase Chk1 [human]	inhibition rate	12.14	%
5571	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Ribosomal protein S6 kinase beta [human]	inhibition rate	11.31	%
5572	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	10.02	%
5573	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Cyclin-dependent kinase 9 [human];+Cyclin-T1 [human]	inhibition rate	8.79	%
5574	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Homeodomain-interacting protein kinase 2 [human]	inhibition rate	8.29	%
5575	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Serine/threonine-protein kinase D1 [human]	inhibition rate	7.72	%
5576	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Serine/threonine-protein kinase pim-3 [human]	inhibition rate	7.55	%
5577	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Calcium/calmodulin-dependent protein kinase type IV [human]	inhibition rate	7.34	%
5578	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	glycogen synthase kinase-3 beta [human]	inhibition rate	7.06	%
5579	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Dual specificity tyrosine-phosphorylation-regulated kinase 1B [human]	inhibition rate	7.06	%
5580	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Serine/threonine-protein kinase Chk2 [human]	inhibition rate	6.53	%
5581	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Dual specificity tyrosine-phosphorylation-regulated kinase 3 [human]	inhibition rate	5.87	%
5582	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Serine/threonine-protein kinase Nek1 [human]	inhibition rate	5.64	%
5583	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Homeodomain-interacting protein kinase 3 [human]	inhibition rate	5.52	%
5584	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Tyrosine-protein kinase receptor TYRO3 [human]	inhibition rate	4.91	%
5585	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Serine/threonine-protein kinase Nek2 [human]	inhibition rate	4.82	%
5586	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Serine/threonine-protein kinase PLK2 [human]	inhibition rate	4.5	%
5587	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Mitogen-activated protein kinase 14 [human]	inhibition rate	4.21	%
5588	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Mitogen-activated protein kinase 9 [human]	inhibition rate	4.19	%
5589	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Glycogen synthase kinase-3 alpha [human]	inhibition rate	4.02	%
5590	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Mitogen-activated protein kinase kinase kinase kinase 4 [human]	inhibition rate	3.96	%
5591	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	CDK-activating kinase assembly factor MAT1 [human];+Cytochrome c-type biogenesis protein CycH [human];+Cyclin-dependent kinase 7 [human]	inhibition rate	3.91	%
5592	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Lymphokine-activated killer T-cell-originated protein kinase [human]	inhibition rate	3.57	%
5593	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Platelet-derived growth factor receptor alpha [human]	inhibition rate	3.56	%
5594	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Serine/threonine-protein kinase 4 [human]	inhibition rate	3.51	%
5595	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Hepatocyte growth factor receptor [human]	inhibition rate	3.48	%
5596	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	epidermal growth factor-activated receptor [human]	inhibition rate	3.43	%
5597	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Serine/threonine-protein kinase Nek6 [human]	inhibition rate	3	%
5598	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Angiopoietin-1 receptor [human]	inhibition rate	2.93	%
5599	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Tyrosine-protein kinase Abl [human]	inhibition rate	2.85	%
5600	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Insulin-like growth factor 1 receptor [human]	inhibition rate	2.83	%
5601	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Mitogen-activated protein kinase 1 [human]	inhibition rate	2.78	%
5602	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Serine/threonine-protein kinase BRSK2 [human]	inhibition rate	2.51	%
5603	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	High affinity nerve growth factor receptor [human]	inhibition rate	2.33	%
5604	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition rate	2.33	%
5605	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Serine/threonine-protein kinase pim-2 [human]	inhibition rate	2.01	%
5606	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Mitogen-activated protein kinase 12 [human]	inhibition rate	1.51	%
5607	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Interleukin-1 receptor-associated kinase 4 [human]	inhibition rate	1.44	%
5608	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Fibroblast growth factor receptor 1 [human]	inhibition rate	1.42	%
5609	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Ephrin type-A receptor 2 [human]	inhibition rate	1.33	%
5610	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Tyrosine-protein kinase ITK/TSK [human]	inhibition rate	1.25	%
5611	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Rho-associated protein kinase 1 [human]	inhibition rate	1.23	%
5612	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Tyrosine-protein kinase JAK3 [human]	inhibition rate	1.03	%
5613	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Death-associated protein kinase 1 [human]	inhibition rate	0.83	%
5614	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Transcription factor PRE6 [human]	inhibition rate	0.72	%
5615	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Protein kinase C alpha type [human]	inhibition rate	0.54	%
5616	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Mitogen-activated protein kinase 11 [human]	inhibition rate	0.46	%
5617	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Cyclin-dependent kinase 6 [human]; Cyclin-D3-1 [human]	inhibition rate	0.39	%
5618	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	aspartate kinase [human];+Cell division control protein 7 [human]	inhibition rate	0.38	%
5619	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Protein-tyrosine kinase 2-beta [human]	inhibition rate	0.29	%
5620	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial [human]	inhibition rate	0.24	%
5621	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Cyclin-dependent kinase 2 [human];+Cyclin-A2 [human]	inhibition rate	0.06	%
5622	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Tyrosine-protein kinase Lck [human]	inhibition rate	0.01	%
5623	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Ribosomal protein S6 kinase alpha-1 [human]	inhibition rate	-0.23	%
5624	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Serine/threonine-protein kinase Sgk1 [human]	inhibition rate	-0.37	%
5625	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Proto-oncogene tyrosine-protein kinase Src [human]	inhibition rate	-0.44	%
5626	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Aurora kinase C [human]	inhibition rate	-0.45	%
5627	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	inhibition rate	-0.46	%
5628	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Testis-specific serine/threonine-protein kinase 1 [human]	inhibition rate	-0.5	%
5629	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Serine/threonine-protein kinase Nek7 [human]	inhibition rate	-0.82	%
5630	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Tyrosine-protein kinase CSK [human]	inhibition rate	-0.87	%
5631	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Serine/threonine-protein kinase Nek9 [human]	inhibition rate	-0.98	%
5632	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	5'-AMP-activated protein kinase catalytic subunit alpha-1 [human];+5'-AMP-activated protein kinase subunit beta-1 [human];+5'-AMP-activated protein kinase subunit gamma-1 [human]	inhibition rate	-1.68	%
5633	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Casein kinase II subunit alpha-2 [human];+Casein kinase II subunit beta-2 [human]	inhibition rate	94.21	%
5634	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	RAC-alpha serine/threonine-protein kinase [human]	inhibition rate	-1.69	%
5635	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Serine/threonine-protein kinase PLK1 [human]	inhibition rate	-1.84	%
5636	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Mitogen-activated protein kinase 13 [human]	inhibition rate	-2.02	%
5637	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Ephrin type-B receptor 4 [human]	inhibition rate	-2.08	%
5638	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Tyrosine-protein kinase SYK [human]	inhibition rate	-2.27	%
5639	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Cyclin-dependent kinase 3 [human]; G1/S-specific cyclin-E1 [human]	inhibition rate	-3.44	%
5640	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Cyclin-B1-1 [human]; Cyclin-dependent kinase 2 [human]	inhibition rate	-3.55	%
5641	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	cAMP-dependent protein kinase catalytic subunit alpha [human]	inhibition rate	-3.91	%
5642	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Serine/threonine-protein kinase N2 [human]	inhibition rate	-4.85	%
5643	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Cyclin-D3-1 [human]; Cyclin-dependent kinase 4 [human]	inhibition rate	-4.85	%
5644	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Serine/threonine-protein kinase D2 [human]	inhibition rate	-5.9	%
5645	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Aurora kinase B [human]	inhibition rate	-6.05	%
5646	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	Aurora kinase A [human]	inhibition rate	-11.86	%
5647	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	MAP kinase-activated protein kinase 2 [human]	inhibition rate	-20.46	%
5648	ClC1=CC=C(CCNC(=O)CCC(=O)NCCCCN2C=NC3=C2C(Br)=C(Br)C(Br)=C3Br)C=C1Cl	G1/S-specific cyclin-E1 [human]; Cyclin-dependent kinase 2 [human]	inhibition rate	-20.82	%
5649	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	pIC50	6.96	no unit
5650	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 4 [human]	inhibition rate	0	%
5651	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 4 [human]; Cyclin-D1-1 [human]	inhibition rate	0	%
5652	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 4 [human]; Cyclin-D3-1 [human]	inhibition rate	0	%
5653	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent-like kinase 5 [human]	inhibition rate	4	%
5654	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 7 [human]	inhibition rate	0	%
5655	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 8 [human]	inhibition rate	0	%
5656	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 9 [human]	inhibition rate	0	%
5657	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 1 [human]	inhibition rate	19	%
5658	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 2 [human]	inhibition rate	0	%
5659	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 3 [human]	inhibition rate	8	%
5660	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 5 [human]	inhibition rate	0	%
5661	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Chk1 [human]	inhibition rate	1	%
5662	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Chk2 [human]	inhibition rate	0	%
5663	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Citrate synthase, mitochondrial [human]	inhibition rate	18	%
5664	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ATG1 [human]	inhibition rate	29	%
5665	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase CLK2 [human]	inhibition rate	39	%
5666	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase CLK3 [human]	inhibition rate	0	%
5667	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase CLK4 [human]	inhibition rate	45	%
5668	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Macrophage colony-stimulating factor 1 receptor [human]	inhibition rate	0	%
5669	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	CSF1R-autoinhibited [human]	inhibition rate	1	%
5670	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase CSK [human]	inhibition rate	0	%
5671	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform alpha [human]	inhibition rate	0	%
5672	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform alpha-like [human]	inhibition rate	0	%
5673	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform delta [human]	inhibition rate	0	%
5674	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform epsilon [human]	inhibition rate	0	%
5675	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform gamma-1 [human]	inhibition rate	0	%
5676	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform gamma-2 [human]	inhibition rate	23	%
5677	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform gamma-3 [human]	inhibition rate	0	%
5678	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase II subunit alpha [human]	inhibition rate	10	%
5679	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase II subunit alpha' [human]	inhibition rate	7	%
5680	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Megakaryocyte-associated tyrosine-protein kinase [human]	inhibition rate	0	%
5681	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 1 [human]	inhibition rate	1	%
5682	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 2 [human]	inhibition rate	14	%
5683	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 3 [human]	inhibition rate	11	%
5684	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase DCLK1 [human]	inhibition rate	13	%
5685	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase DCLK2 [human]	inhibition rate	0	%
5686	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase DCLK3 [human]	inhibition rate	0	%
5687	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epithelial discoidin domain-containing receptor 1 [human]	inhibition rate	6	%
5688	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Discoidin domain-containing receptor 2 [human]	inhibition rate	0	%
5689	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 3 [human]	inhibition rate	0	%
5690	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myotonin-protein kinase [human]	inhibition rate	6	%
5691	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MRCK gamma [human]	inhibition rate	13	%
5692	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 17A [human]	inhibition rate	16	%
5693	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 17B [human]	inhibition rate	0	%
5694	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	inhibition rate	67	%
5695	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 1B [human]	inhibition rate	19	%
5696	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 2 [human]	inhibition rate	34	%
5697	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	0	%
5698	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	25	%
5699	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (G719C) [human]	inhibition rate	0	%
5700	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (G719S) [human]	inhibition rate	0	%
5701	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	13	%
5702	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	31	%
5703	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	0	%
5704	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (L858R) [human]	inhibition rate	0	%
5705	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (L858R) [human];+Epidermal growth factor receptor (T790M) [human]	inhibition rate	0	%
5706	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (L861Q) [human]	inhibition rate	0	%
5707	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	0	%
5708	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (T790M) [human]	inhibition rate	0	%
5709	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Eukaryotic translation initiation factor 2-alpha kinase 1 [human]	inhibition rate	0	%
5710	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	AP2-associated protein kinase 1 [human]	inhibition rate	0	%
5711	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 1 [human]	inhibition rate	4	%
5712	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 2 [human]	inhibition rate	1	%
5713	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 3 [human]	inhibition rate	3	%
5714	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 4 [human]	inhibition rate	3	%
5715	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 5 [human]	inhibition rate	0	%
5716	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 6 [human]	inhibition rate	6	%
5717	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 7 [human]	inhibition rate	1	%
5718	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 8 [human]	inhibition rate	0	%
5719	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 1 [human]	inhibition rate	0	%
5720	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 2 [human]	inhibition rate	7	%
5721	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 3 [human]	inhibition rate	11	%
5722	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 4 [human]	inhibition rate	0	%
5723	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 6 [human]	inhibition rate	18	%
5724	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor tyrosine-protein kinase erbB-2 [human]	inhibition rate	7	%
5725	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor tyrosine-protein kinase erbB-3 [human]	inhibition rate	0	%
5726	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor tyrosine-protein kinase erbB-4 [human]	inhibition rate	2	%
5727	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Extracellular signal-regulated kinase 1 [human]	inhibition rate	14	%
5728	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Extracellular signal-regulated kinase 2 [human]	inhibition rate	5	%
5729	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 6 [human]	inhibition rate	11	%
5730	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 4 [human]	inhibition rate	0	%
5731	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 7 [human]	inhibition rate	0	%
5732	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 15 [human]	inhibition rate	0	%
5733	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ethylene-responsive transcription factor ERN1 [human]	inhibition rate	0	%
5734	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Focal adhesion kinase 1 [human]	inhibition rate	0	%
5735	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Fer [human]	inhibition rate	0	%
5736	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase, Fes/Fps type [human]	inhibition rate	0	%
5737	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 1 [human]	inhibition rate	0	%
5738	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 2 [human]	inhibition rate	0	%
5739	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 3 [human]	inhibition rate	0	%
5740	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 3 [human]	inhibition rate	14	%
5741	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 4 [human]	inhibition rate	0	%
5742	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Fgr [human]	inhibition rate	2	%
5743	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Vascular endothelial growth factor receptor 1 [human]	inhibition rate	0	%
5744	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	0	%
5745	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835H) [human]	inhibition rate	10	%
5746	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835V) [human]	inhibition rate	21	%
5747	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835Y) [human]	inhibition rate	0	%
5748	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	FLT3(ITD) [human]	inhibition rate	0	%
5749	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835V) [human];+FLT3(ITD) [human]	inhibition rate	0	%
5750	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	FLT3(ITD) [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	0	%
5751	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	0	%
5752	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	25	%
5753	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	0	%
5754	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	FLT3-autoinhibited [human]	inhibition rate	0	%
5755	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Vascular endothelial growth factor receptor 3 [human]	inhibition rate	7	%
5756	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase FRK [human]	inhibition rate	12	%
5757	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Fyn [human]	inhibition rate	31	%
5758	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-G-associated kinase [human]	inhibition rate	6	%
5759	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABC transporter F family member 2 [human]	inhibition rate	7	%
5760	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Rhodopsin kinase GRK1 (C514S) [human]	inhibition rate	18	%
5761	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Beta-adrenergic receptor kinase 1 [human]	inhibition rate	31	%
5762	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Beta-adrenergic receptor kinase 2 [human]	inhibition rate	0	%
5763	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	G protein-coupled receptor kinase 4 [human]	inhibition rate	25	%
5764	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Rhodopsin kinase [human]	inhibition rate	0	%
5765	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Glycogen synthase kinase-3 alpha [human]	inhibition rate	6	%
5766	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	glycogen synthase kinase-3 beta [human]	inhibition rate	8	%
5767	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase haspin [human]	inhibition rate	79	%
5768	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase HCK [human]	inhibition rate	0	%
5769	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 1 [human]	inhibition rate	8	%
5770	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 2 [human]	inhibition rate	0	%
5771	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 3 [human]	inhibition rate	0	%
5772	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 4 [human]	inhibition rate	3	%
5773	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 1 [human]	inhibition rate	0	%
5774	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hormonally up-regulated neu tumor-associated kinase [human]	inhibition rate	0	%
5775	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Insulin-like growth factor 1 receptor [human]	inhibition rate	4	%
5776	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit alpha [human]	inhibition rate	14	%
5777	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition rate	0	%
5778	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit epsilon [human]	inhibition rate	0	%
5779	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Insulin receptor [human]	inhibition rate	14	%
5780	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Insulin receptor-related protein [human]	inhibition rate	0	%
5781	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Interleukin-1 receptor-associated kinase 1 [human]	inhibition rate	15	%
5782	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Interleukin-1 receptor-associated kinase 3 [human]	inhibition rate	28	%
5783	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Interleukin-1 receptor-associated kinase 4 [human]	inhibition rate	16	%
5784	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ITK/TSK [human]	inhibition rate	0	%
5785	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK1 [human]	inhibition rate	0	%
5786	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK1 [human]	inhibition rate	0	%
5787	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK2 [human]	inhibition rate	2	%
5788	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK3 [human]	inhibition rate	3	%
5789	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 8 [human]	inhibition rate	6	%
5790	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 9 [human]	inhibition rate	0	%
5791	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 10 [human]	inhibition rate	21	%
5792	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	0	%
5793	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (A829P) [human]	inhibition rate	11	%
5794	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (D816H) [human]	inhibition rate	19	%
5795	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (D816V) [human]	inhibition rate	0	%
5796	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	0	%
5797	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (V559D) [human]	inhibition rate	0	%
5798	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (V559D) [human];+Mast/stem cell growth factor receptor Kit [human]	inhibition rate	0	%
5799	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (V559D) [human];+Mast/stem cell growth factor receptor Kit [human]	inhibition rate	0	%
5800	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	KIT-autoinhibited [human]	inhibition rate	0	%
5801	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase LATS1 [human]	inhibition rate	0	%
5802	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase LATS2 [human]	inhibition rate	0	%
5803	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase LCK [human]	inhibition rate	0	%
5804	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	LIM domain kinase 1 [human]	inhibition rate	0	%
5805	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	LIM domain kinase 2 [human]	inhibition rate	4	%
5806	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase STK11 [human]	inhibition rate	0	%
5807	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Coiled-coil domain-containing protein 40 [human]	inhibition rate	4	%
5808	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Leucine-rich repeat serine/threonine-protein kinase 2 [human]	inhibition rate	0	%
5809	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Leucine-rich repeat serine/threonine-protein kinase 2 (G2019S) [human]	inhibition rate	0	%
5810	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Leukocyte tyrosine kinase receptor [human]	inhibition rate	0	%
5811	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Lyn [human]	inhibition rate	16	%
5812	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 13 [human]	inhibition rate	0	%
5813	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MAK [human]	inhibition rate	0	%
5814	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 1 [human]	inhibition rate	13	%
5815	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 15 [human]	inhibition rate	0	%
5816	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 2 [human]	inhibition rate	2	%
5817	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 3 [human]	inhibition rate	3	%
5818	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 4 [human]	inhibition rate	29	%
5819	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 2 [human]	inhibition rate	0	%
5820	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 3 [human]	inhibition rate	8	%
5821	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 4 [human]	inhibition rate	0	%
5822	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 5 [human]	inhibition rate	0	%
5823	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-activated protein kinase 2 [human]	inhibition rate	7	%
5824	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-activated protein kinase 5 [human]	inhibition rate	0	%
5825	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MARK1 [human]	inhibition rate	0	%
5826	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MARK2 [human]	inhibition rate	30	%
5827	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP/microtubule affinity-regulating kinase 3 [human]	inhibition rate	0	%
5828	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP/microtubule affinity-regulating kinase 4 [human]	inhibition rate	2	%
5829	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	CLIP-associating protein 1 [human]	inhibition rate	0	%
5830	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 1 [human]	inhibition rate	9	%
5831	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 2 [human]	inhibition rate	4	%
5832	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 3 [human]	inhibition rate	16	%
5833	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 4 [human]	inhibition rate	0	%
5834	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 5 [human]	inhibition rate	0	%
5835	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 6 [human]	inhibition rate	0	%
5836	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Maternal embryonic leucine zipper kinase [human]	inhibition rate	3	%
5837	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Mer [human]	inhibition rate	2	%
5838	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor receptor [human]	inhibition rate	4	%
5839	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor receptor (M1250T) [human]	inhibition rate	0	%
5840	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor receptor [human]	inhibition rate	0	%
5841	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Misshapen-like kinase 1 [human]	inhibition rate	10	%
5842	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 7 [human]	inhibition rate	0	%
5843	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-interacting serine/threonine-protein kinase 1 [human]	inhibition rate	11	%
5844	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-interacting serine/threonine-protein kinase 2 [human]	inhibition rate	54	%
5845	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase, smooth muscle [human]	inhibition rate	0	%
5846	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 9 [human]	inhibition rate	0	%
5847	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 10 [human]	inhibition rate	0	%
5848	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 11 [human]	inhibition rate	0	%
5849	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MRCK alpha [human]	inhibition rate	0	%
5850	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MRCK beta [human]	inhibition rate	3	%
5851	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor-like [human]	inhibition rate	2	%
5852	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Macrophage-stimulating protein receptor [human]	inhibition rate	0	%
5853	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Histone acetyltransferase mst2 [human]	inhibition rate	0	%
5854	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 24 [human]	inhibition rate	0	%
5855	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 26 [human]	inhibition rate	0	%
5856	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase mTOR [human]	inhibition rate	5	%
5857	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Muscle, skeletal receptor tyrosine-protein kinase [human]	inhibition rate	0	%
5858	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase, smooth muscle [human]	inhibition rate	3	%
5859	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase 2, skeletal/cardiac muscle [human]	inhibition rate	0	%
5860	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase family member 4 [human]	inhibition rate	0	%
5861	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ABL1(E255K)-Phosphorylated [human]	inhibition rate	7	%
5862	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin-IIIa [human]	inhibition rate	0	%
5863	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin-IIIb [human]	inhibition rate	0	%
5864	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein NDRG1 [human]	inhibition rate	7	%
5865	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein NDRG2 [human]	inhibition rate	0	%
5866	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek1 [human]	inhibition rate	0	%
5867	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek10 [human]	inhibition rate	0	%
5868	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek11 [human]	inhibition rate	0	%
5869	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek2 [human]	inhibition rate	0	%
5870	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek3 [human]	inhibition rate	18	%
5871	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek4 [human]	inhibition rate	0	%
5872	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317I)-nonphosphorylated [human]	inhibition rate	7	%
5873	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek5 [human]	inhibition rate	0	%
5874	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek6 [human]	inhibition rate	7	%
5875	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek7 [human]	inhibition rate	0	%
5876	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek9 [human]	inhibition rate	0	%
5877	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 14 [human]	inhibition rate	0	%
5878	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase NIM1 [human]	inhibition rate	5	%
5879	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine kinase NLK [human]	inhibition rate	22	%
5880	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase OSR1 [human]	inhibition rate	0	%
5881	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 14A [human]	inhibition rate	0	%
5882	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 11 [human]	inhibition rate	19	%
5883	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317I)-phosphorylated [human]	inhibition rate	0	%
5884	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 13 [human]	inhibition rate	0	%
5885	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 12 [human]	inhibition rate	10	%
5886	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase N1 [human]	inhibition rate	0	%
5887	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	serine/threonine-protein kinase pak 2 [human]	inhibition rate	0	%
5888	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PAK 3 [human]	inhibition rate	0	%
5889	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PAK 4 [human]	inhibition rate	0	%
5890	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PAK 6 [human]	inhibition rate	0	%
5891	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	serine/threonine-protein kinase pak 5 [human]	inhibition rate	30	%
5892	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 16 [human]	inhibition rate	0	%
5893	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 17 [human]	inhibition rate	0	%
5894	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317L)-nonphosphorylated [human]	inhibition rate	4	%
5895	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 18 [human]	inhibition rate	0	%
5896	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Platelet-derived growth factor receptor alpha [human]	inhibition rate	6	%
5897	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Platelet-derived growth factor receptor beta [human]	inhibition rate	0	%
5898	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	3-phosphoinositide-dependent protein kinase 1 [human]	inhibition rate	11	%
5899	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium-dependent protein kinase 1 [Plasmodium falciparum]	inhibition rate	0	%
5900	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cell division control protein 2 homolog [Plasmodium falciparum]	inhibition rate	0	%
5901	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 15 [human]	inhibition rate	0	%
5902	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 14 [human]	inhibition rate	0	%
5903	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform [human]	inhibition rate	0	%
5904	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform [human]	inhibition rate	8	%
5905	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317L)-phosphorylated [human]	inhibition rate	0	%
5906	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta [human]	inhibition rate	0	%
5907	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition rate	19	%
5908	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human]	inhibition rate	0	%
5909	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (C420R) [human]	inhibition rate	28	%
5910	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E542K) [human]	inhibition rate	57	%
5911	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545A) [human]	inhibition rate	17	%
5912	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545K) [human]	inhibition rate	0	%
5913	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047L) [human]	inhibition rate	0	%
5914	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047Y) [human]	inhibition rate	12	%
5915	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human]	inhibition rate	12	%
5916	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(H396P)-nonphosphorylated [human]	inhibition rate	20	%
5917	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (M1043I) [human]	inhibition rate	0	%
5918	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (Q546K) [human]	inhibition rate	58	%
5919	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [human]	inhibition rate	0	%
5920	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [human]	inhibition rate	0	%
5921	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform [human]	inhibition rate	0	%
5922	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-kinase beta [human]	inhibition rate	0	%
5923	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	1-phosphatidylinositol 3-phosphate 5-kinase [human]	inhibition rate	0	%
5924	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Lon protease homolog, mitochondrial [human]	inhibition rate	0	%
5925	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase pim-2 [human]	inhibition rate	8	%
5926	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase pim-3 [human]	inhibition rate	0	%
5927	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(H396P)-phosphorylated [human]	inhibition rate	18	%
5928	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha [human]	inhibition rate	0	%
5929	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma [human]	inhibition rate	26	%
5930	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta [human]	inhibition rate	0	%
5931	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma [human]	inhibition rate	0	%
5932	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cAMP-dependent protein kinase catalytic subunit alpha [human]	inhibition rate	0	%
5933	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cAMP-dependent protein kinase catalytic subunit beta [human]	inhibition rate	11	%
5934	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase [human]	inhibition rate	3	%
5935	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase N1 [human]	inhibition rate	0	%
5936	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase pkn2 [human]	inhibition rate	11	%
5937	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PknB [Mycobacterium tuberculosis]	inhibition rate	0	%
5938	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(M351T)-phosphorylated [human]	inhibition rate	2	%
5939	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PLK1 [human]	inhibition rate	0	%
5940	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PLK2 [human]	inhibition rate	0	%
5941	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Plk3 [human]	inhibition rate	9	%
5942	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Plk4 [human]	inhibition rate	8	%
5943	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, delta [human]	inhibition rate	0	%
5944	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, epsilon [human]	inhibition rate	0	%
5945	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, eta [human]	inhibition rate	0	%
5946	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C iota type [human]	inhibition rate	0	%
5947	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, theta [human]	inhibition rate	0	%
5948	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase D1 [human]	inhibition rate	0	%
5949	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(Q252H)-nonphosphorylated [human]	inhibition rate	3	%
5950	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase D2 [human]	inhibition rate	15	%
5951	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase D3 [human]	inhibition rate	3	%
5952	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cGMP-dependent protein kinase 1 [human]	inhibition rate	11	%
5953	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cGMP-dependent protein kinase 2 [human]	inhibition rate	3	%
5954	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Interferon-induced, double-stranded RNA-activated protein kinase [human]	inhibition rate	0	%
5955	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cAMP-dependent protein kinase catalytic subunit PRKX [human]	inhibition rate	8	%
5956	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proline-rich protein 4 [human]	inhibition rate	0	%
5957	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein-tyrosine kinase 2-beta [human]	inhibition rate	0	%
5958	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase SIK3 [human]	inhibition rate	6	%
5959	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	RAF proto-oncogene serine/threonine-protein kinase [human]	inhibition rate	0	%
5960	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(Q252H)-phosphorylated [human]	inhibition rate	0	%
5961	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret [human]	inhibition rate	0	%
5962	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (M918T) [human]	inhibition rate	11	%
5963	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804L) [human]	inhibition rate	15	%
5964	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M) [human]	inhibition rate	0	%
5965	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Rio1 [human]	inhibition rate	0	%
5966	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Rio2 [human]	inhibition rate	8	%
5967	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Rio3 [human]	inhibition rate	0	%
5968	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-interacting serine/threonine-protein kinase 1 [human]	inhibition rate	0	%
5969	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-interacting serine/threonine-protein kinase 2 [human]	inhibition rate	11	%
5970	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-interacting serine/threonine-protein kinase 4 [human]	inhibition rate	2	%
5971	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(T315I)-nonphosphorylated [human]	inhibition rate	0	%
5972	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual serine/threonine and tyrosine protein kinase [human]	inhibition rate	0	%
5973	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Rho-associated protein kinase 1 [human]	inhibition rate	0	%
5974	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Rho-associated protein kinase 2 [human]	inhibition rate	0	%
5975	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase ROS [human]	inhibition rate	0	%
5976	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-4 [human]	inhibition rate	1	%
5977	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-4 [human]	inhibition rate	7	%
5978	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-5 [human]	inhibition rate	0	%
5979	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-5 [human]	inhibition rate	0	%
5980	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-1 [human]	inhibition rate	23	%
5981	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-1 [human]	inhibition rate	23	%
5982	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(T315I)-phosphorylated [human]	inhibition rate	0	%
5983	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	0	%
5984	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	0	%
5985	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-2 [human]	inhibition rate	0	%
5986	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-2 [human]	inhibition rate	0	%
5987	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-6 [human]	inhibition rate	1	%
5988	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-6 [human]	inhibition rate	0	%
5989	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase beta-1 [human]	inhibition rate	0	%
5990	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	serine/threonine-protein kinase sbk1 [human]	inhibition rate	0	%
5991	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Sgk1 [human]	inhibition rate	14	%
5992	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Uncharacterized serine/threonine-protein kinase SBK3 [human]	inhibition rate	0	%
5993	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(Y253F)-phosphorylated [human]	inhibition rate	4	%
5994	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Sgk2 [human]	inhibition rate	6	%
5995	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Sgk3 [human]	inhibition rate	14	%
5996	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase SIK1 [human]	inhibition rate	0	%
5997	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase SIK2 [human]	inhibition rate	10	%
5998	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	STE20-like serine/threonine-protein kinase [human]	inhibition rate	0	%
5999	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	NUAK family SNF1-like kinase 2 [human]	inhibition rate	15	%
6000	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	SNF-related serine/threonine-protein kinase [human]	inhibition rate	7	%
6001	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase Src [human]	inhibition rate	0	%
6002	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Srms [human]	inhibition rate	0	%
6003	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	SRSF protein kinase 1 [human]	inhibition rate	6	%
6004	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1-nonphosphorylated [human]	inhibition rate	3	%
6005	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	SRSF protein kinase 2 [human]	inhibition rate	0	%
6006	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	SRSF protein kinase 3 [human]	inhibition rate	14	%
6007	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 16 [human]	inhibition rate	14	%
6008	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 33 [human]	inhibition rate	0	%
6009	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 35 [human]	inhibition rate	12	%
6010	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 36 [human]	inhibition rate	0	%
6011	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	STE20/SPS1-related proline-alanine-rich protein kinase [human]	inhibition rate	8	%
6012	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase SYK [human]	inhibition rate	0	%
6013	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 7 [human]	inhibition rate	0	%
6014	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TAO1 [human]	inhibition rate	0	%
6015	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ABL1- phosphorylated [human]	inhibition rate	4	%
6016	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TAO2 [human]	inhibition rate	0	%
6017	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TAO3 [human]	inhibition rate	52	%
6018	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TBK1 [human]	inhibition rate	8	%
6019	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Tec [human]	inhibition rate	0	%
6020	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity testis-specific protein kinase 1 [human]	inhibition rate	1	%
6021	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	TGF-beta receptor type-1 [human]	inhibition rate	0	%
6022	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	TGF-beta receptor type-2 [human]	inhibition rate	0	%
6023	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase receptor Tie-1 [human]	inhibition rate	0	%
6024	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase receptor Tie-2 [human]	inhibition rate	2	%
6025	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase tousled-like 1 [human]	inhibition rate	3	%
6026	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ABL2 [human]	inhibition rate	0	%
6027	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TOUSLED-like 2 [human]	inhibition rate	7	%
6028	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Traf2 and NCK-interacting protein kinase [human]	inhibition rate	5	%
6029	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Non-receptor tyrosine-protein kinase TNK1 [human]	inhibition rate	19	%
6030	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activated CDC42 kinase 1 [human]	inhibition rate	15	%
6031	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TNNI3K [human]	inhibition rate	1	%
6032	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	High affinity nerve growth factor receptor [human]	inhibition rate	13	%
6033	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	BDNF/NT-3 growth factors receptor [human]	inhibition rate	0	%
6034	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	NT-3 growth factor receptor [human]	inhibition rate	0	%
6035	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Transient receptor potential cation channel subfamily M member 6 [human]	inhibition rate	0	%
6036	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Testis-specific serine/threonine-protein kinase 1 [human]	inhibition rate	0	%
6037	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-1 [human]	inhibition rate	8	%
6038	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Testis-specific serine/threonine-protein kinase 3 [human]	inhibition rate	1	%
6039	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase TTK [human]	inhibition rate	19	%
6040	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase TXK [human]	inhibition rate	0	%
6041	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition rate	0	%
6042	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition rate	13	%
6043	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase receptor TYRO3 [human]	inhibition rate	21	%
6044	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ULK1 [human]	inhibition rate	3	%
6045	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ULK2 [human]	inhibition rate	26	%
6046	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ULK3 [human]	inhibition rate	0	%
6047	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Vascular endothelial growth factor receptor 2 [human]	inhibition rate	0	%
6048	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-1B [human]	inhibition rate	12	%
6049	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 3-kinase, Vps34 type [human]	inhibition rate	0	%
6050	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase VRK2 [human]	inhibition rate	0	%
6051	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitosis inhibitor protein kinase wee1 [human]	inhibition rate	0	%
6052	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Wee1-like protein kinase 1-A [human]	inhibition rate	0	%
6053	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK1 [human]	inhibition rate	2	%
6054	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK2 [human]	inhibition rate	0	%
6055	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK3 [human]	inhibition rate	0	%
6056	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK4 [human]	inhibition rate	0	%
6057	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 32A [human]	inhibition rate	0	%
6058	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 32B [human]	inhibition rate	0	%
6059	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-2A [human]	inhibition rate	9	%
6060	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 32C [human]	inhibition rate	0	%
6061	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Yes [human]	inhibition rate	11	%
6062	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 25 [human]	inhibition rate	0	%
6063	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 19 [human]	inhibition rate	5	%
6064	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 20 [human]	inhibition rate	0	%
6065	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ZAP-70 [human]	inhibition rate	0	%
6066	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-2B [human]	inhibition rate	9	%
6067	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase receptor R3 [human]	inhibition rate	11	%
6068	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Atypical kinase COQ8A, mitochondrial [human]	inhibition rate	0	%
6069	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Atypical kinase COQ8B, mitochondrial [human]	inhibition rate	32	%
6070	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	RAC-alpha serine/threonine-protein kinase [human]	inhibition rate	0	%
6071	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	RAC-beta serine/threonine-protein kinase [human]	inhibition rate	0	%
6072	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	RAC-gamma serine/threonine-protein kinase [human]	inhibition rate	7	%
6073	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ALK tyrosine kinase receptor [human]	inhibition rate	31	%
6074	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ALK tyrosine kinase receptor [human]	inhibition rate	52	%
6075	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ALK tyrosine kinase receptor [human]	inhibition rate	15	%
6076	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	5'-AMP-activated protein kinase catalytic subunit alpha-1 [human]	inhibition rate	8	%
6077	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	5'-AMP-activated protein kinase catalytic subunit alpha-2 [human]	inhibition rate	0	%
6078	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ankyrin repeat and protein kinase domain-containing protein 1 [human]	inhibition rate	19	%
6079	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	NUAK family SNF1-like kinase 1 [human]	inhibition rate	11	%
6080	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 5 [human]	inhibition rate	21	%
6081	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 6 [human]	inhibition rate	0	%
6082	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Aurora kinase A [human]	inhibition rate	13	%
6083	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Aurora kinase B [human]	inhibition rate	9	%
6084	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Aurora kinase C [human]	inhibition rate	11	%
6085	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	NEDD8-activating enzyme E1 regulatory subunit AXL [human]	inhibition rate	0	%
6086	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	BMP-2-inducible protein kinase [human]	inhibition rate	5	%
6087	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Blk [human]	inhibition rate	0	%
6088	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Bone morphogenetic protein receptor type-1A [human]	inhibition rate	9	%
6089	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Bone morphogenetic protein receptor type-1B [human]	inhibition rate	16	%
6090	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Bone morphogenetic protein receptor type-2 [human]	inhibition rate	3	%
6091	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cytoplasmic tyrosine-protein kinase BMX [human]	inhibition rate	6	%
6092	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase B-raf [human]	inhibition rate	0	%
6093	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase B-raf (V600E) [human]	inhibition rate	0	%
6094	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein-tyrosine kinase 6 [human]	inhibition rate	11	%
6095	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase BRSK1 [human]	inhibition rate	5	%
6096	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase BRSK2 [human]	inhibition rate	0	%
6097	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase BTK [human]	inhibition rate	0	%
6098	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitotic checkpoint serine/threonine-protein kinase BUB1 [human]	inhibition rate	0	%
6099	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1 [human]	inhibition rate	2	%
6100	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1B [human]	inhibition rate	18	%
6101	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1D [human]	inhibition rate	0	%
6102	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1G [human]	inhibition rate	0	%
6103	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II subunit alpha [human]	inhibition rate	10	%
6104	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II subunit beta [human]	inhibition rate	2	%
6105	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II delta 2 chain [human]	inhibition rate	0	%
6106	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II subunit gamma [human]	inhibition rate	0	%
6107	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type IV [human]	inhibition rate	0	%
6108	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase kinase 1 [human]	inhibition rate	0	%
6109	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase kinase 2 [human]	inhibition rate	0	%
6110	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Kappa-casein [human]	inhibition rate	0	%
6111	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 11B [human]	inhibition rate	0	%
6112	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 11A [human]	inhibition rate	0	%
6113	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 13 [human]	inhibition rate	0	%
6114	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 11 [human]	inhibition rate	0	%
6115	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 2 [human]	inhibition rate	0	%
6116	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 3 [human]	inhibition rate	0	%
6117	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1		CLint (intrinsic clearance)	929	μl/min/mg protein
6118	CC1CCCN1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1		CLint (intrinsic clearance)	328	μl/min/mg protein
6119	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	pIC50	6.94	no unit
6120	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 4 [human]	inhibition rate	5	%
6121	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 4 [human]; Cyclin-D1-1 [human]	inhibition rate	20	%
6122	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 4 [human]; Cyclin-D3-1 [human]	inhibition rate	38	%
6123	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent-like kinase 5 [human]	inhibition rate	3	%
6124	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 7 [human]	inhibition rate	73	%
6125	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 8 [human]	inhibition rate	0	%
6126	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 9 [human]	inhibition rate	13	%
6127	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 1 [human]	inhibition rate	38	%
6128	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 2 [human]	inhibition rate	0	%
6129	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 3 [human]	inhibition rate	15	%
6130	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 5 [human]	inhibition rate	0	%
6131	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Chk1 [human]	inhibition rate	24	%
6132	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Chk2 [human]	inhibition rate	6	%
6133	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Citrate synthase, mitochondrial [human]	inhibition rate	31	%
6134	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ATG1 [human]	inhibition rate	83	%
6135	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase CLK2 [human]	inhibition rate	84	%
6136	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase CLK3 [human]	inhibition rate	12	%
6137	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase CLK4 [human]	inhibition rate	90.1	%
6138	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Macrophage colony-stimulating factor 1 receptor [human]	inhibition rate	0	%
6139	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	CSF1R-autoinhibited [human]	inhibition rate	25	%
6140	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase CSK [human]	inhibition rate	17	%
6141	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform alpha [human]	inhibition rate	53	%
6142	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform alpha-like [human]	inhibition rate	0	%
6143	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform delta [human]	inhibition rate	29	%
6144	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform epsilon [human]	inhibition rate	51	%
6145	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform gamma-1 [human]	inhibition rate	15	%
6146	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform gamma-2 [human]	inhibition rate	36	%
6147	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform gamma-3 [human]	inhibition rate	9	%
6148	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase II subunit alpha [human]	inhibition rate	23	%
6149	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase II subunit alpha' [human]	inhibition rate	44	%
6150	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Megakaryocyte-associated tyrosine-protein kinase [human]	inhibition rate	10	%
6151	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 1 [human]	inhibition rate	29	%
6152	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 2 [human]	inhibition rate	28	%
6153	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 3 [human]	inhibition rate	21	%
6154	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase DCLK1 [human]	inhibition rate	15	%
6155	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase DCLK2 [human]	inhibition rate	13	%
6156	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase DCLK3 [human]	inhibition rate	7	%
6157	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epithelial discoidin domain-containing receptor 1 [human]	inhibition rate	0	%
6158	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Discoidin domain-containing receptor 2 [human]	inhibition rate	23	%
6159	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 3 [human]	inhibition rate	0	%
6160	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myotonin-protein kinase [human]	inhibition rate	0	%
6161	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MRCK gamma [human]	inhibition rate	8	%
6162	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 17A [human]	inhibition rate	87	%
6163	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 17B [human]	inhibition rate	7	%
6164	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	inhibition rate	97.6	%
6165	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 1B [human]	inhibition rate	92.8	%
6166	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 2 [human]	inhibition rate	85	%
6167	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	0	%
6168	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	29	%
6169	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (G719C) [human]	inhibition rate	15	%
6170	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (G719S) [human]	inhibition rate	25	%
6171	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	11	%
6172	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	5	%
6173	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	25	%
6174	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (L858R) [human]	inhibition rate	0	%
6175	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (L858R) [human];+Epidermal growth factor receptor (T790M) [human]	inhibition rate	20	%
6176	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (L861Q) [human]	inhibition rate	19	%
6177	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	3	%
6178	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (T790M) [human]	inhibition rate	24	%
6179	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Eukaryotic translation initiation factor 2-alpha kinase 1 [human]	inhibition rate	27	%
6180	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	AP2-associated protein kinase 1 [human]	inhibition rate	36	%
6181	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 1 [human]	inhibition rate	16	%
6182	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 2 [human]	inhibition rate	0	%
6183	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 3 [human]	inhibition rate	0	%
6184	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 4 [human]	inhibition rate	14	%
6185	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 5 [human]	inhibition rate	5	%
6186	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 6 [human]	inhibition rate	0	%
6187	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 7 [human]	inhibition rate	13	%
6188	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 8 [human]	inhibition rate	11	%
6189	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 1 [human]	inhibition rate	0	%
6190	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 2 [human]	inhibition rate	100	%
6191	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 3 [human]	inhibition rate	0	%
6192	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 4 [human]	inhibition rate	0	%
6193	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 6 [human]	inhibition rate	15	%
6194	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor tyrosine-protein kinase erbB-2 [human]	inhibition rate	6	%
6195	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor tyrosine-protein kinase erbB-3 [human]	inhibition rate	0	%
6196	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor tyrosine-protein kinase erbB-4 [human]	inhibition rate	19	%
6197	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Extracellular signal-regulated kinase 1 [human]	inhibition rate	17	%
6198	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Extracellular signal-regulated kinase 2 [human]	inhibition rate	0	%
6199	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 6 [human]	inhibition rate	17	%
6200	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 4 [human]	inhibition rate	7	%
6201	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 7 [human]	inhibition rate	7	%
6202	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 15 [human]	inhibition rate	26	%
6203	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ethylene-responsive transcription factor ERN1 [human]	inhibition rate	12	%
6204	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Focal adhesion kinase 1 [human]	inhibition rate	0	%
6205	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Fer [human]	inhibition rate	7	%
6206	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase, Fes/Fps type [human]	inhibition rate	0	%
6207	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 1 [human]	inhibition rate	0	%
6208	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 2 [human]	inhibition rate	0	%
6209	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 3 [human]	inhibition rate	0	%
6210	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 3 [human]	inhibition rate	17	%
6211	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 4 [human]	inhibition rate	24	%
6212	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Fgr [human]	inhibition rate	0	%
6213	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Vascular endothelial growth factor receptor 1 [human]	inhibition rate	0	%
6214	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	19	%
6215	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835H) [human]	inhibition rate	13	%
6216	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835V) [human]	inhibition rate	47	%
6217	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835Y) [human]	inhibition rate	19	%
6218	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	FLT3(ITD) [human]	inhibition rate	6	%
6219	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835V) [human];+FLT3(ITD) [human]	inhibition rate	38	%
6220	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	FLT3(ITD) [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	16	%
6221	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	2	%
6222	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	0	%
6223	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	29	%
6224	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	FLT3-autoinhibited [human]	inhibition rate	28	%
6225	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Vascular endothelial growth factor receptor 3 [human]	inhibition rate	0	%
6226	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase FRK [human]	inhibition rate	0	%
6227	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Fyn [human]	inhibition rate	0	%
6228	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-G-associated kinase [human]	inhibition rate	72	%
6229	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABC transporter F family member 2 [human]	inhibition rate	0	%
6230	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Rhodopsin kinase GRK1 (C514S) [human]	inhibition rate	26	%
6231	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Beta-adrenergic receptor kinase 1 [human]	inhibition rate	50	%
6232	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Beta-adrenergic receptor kinase 2 [human]	inhibition rate	67	%
6233	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	G protein-coupled receptor kinase 4 [human]	inhibition rate	46	%
6234	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Rhodopsin kinase [human]	inhibition rate	22	%
6235	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Glycogen synthase kinase-3 alpha [human]	inhibition rate	15	%
6236	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	glycogen synthase kinase-3 beta [human]	inhibition rate	2	%
6237	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase haspin [human]	inhibition rate	97.9	%
6238	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase HCK [human]	inhibition rate	5	%
6239	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 1 [human]	inhibition rate	60	%
6240	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 2 [human]	inhibition rate	55	%
6241	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 3 [human]	inhibition rate	39	%
6242	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 4 [human]	inhibition rate	20	%
6243	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 1 [human]	inhibition rate	1	%
6244	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hormonally up-regulated neu tumor-associated kinase [human]	inhibition rate	0	%
6245	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Insulin-like growth factor 1 receptor [human]	inhibition rate	10	%
6246	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit alpha [human]	inhibition rate	38	%
6247	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition rate	36	%
6248	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit epsilon [human]	inhibition rate	21	%
6249	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Insulin receptor [human]	inhibition rate	31	%
6250	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Insulin receptor-related protein [human]	inhibition rate	2	%
6251	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Interleukin-1 receptor-associated kinase 1 [human]	inhibition rate	0	%
6252	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Interleukin-1 receptor-associated kinase 3 [human]	inhibition rate	48	%
6253	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Interleukin-1 receptor-associated kinase 4 [human]	inhibition rate	27	%
6254	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ITK/TSK [human]	inhibition rate	7	%
6255	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK1 [human]	inhibition rate	13	%
6256	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK1 [human]	inhibition rate	38	%
6257	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK2 [human]	inhibition rate	30	%
6258	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK3 [human]	inhibition rate	16	%
6259	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 8 [human]	inhibition rate	66	%
6260	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 9 [human]	inhibition rate	40	%
6261	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 10 [human]	inhibition rate	68	%
6262	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	4	%
6263	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (A829P) [human]	inhibition rate	17	%
6264	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (D816H) [human]	inhibition rate	16	%
6265	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (D816V) [human]	inhibition rate	0	%
6266	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	33	%
6267	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (V559D) [human]	inhibition rate	11	%
6268	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (V559D) [human];+Mast/stem cell growth factor receptor Kit [human]	inhibition rate	2	%
6269	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (V559D) [human];+Mast/stem cell growth factor receptor Kit [human]	inhibition rate	21	%
6270	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	KIT-autoinhibited [human]	inhibition rate	27	%
6271	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase LATS1 [human]	inhibition rate	0	%
6272	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase LATS2 [human]	inhibition rate	17	%
6273	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase LCK [human]	inhibition rate	2	%
6274	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	LIM domain kinase 1 [human]	inhibition rate	9	%
6275	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	LIM domain kinase 2 [human]	inhibition rate	25	%
6276	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase STK11 [human]	inhibition rate	20	%
6277	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Coiled-coil domain-containing protein 40 [human]	inhibition rate	0	%
6278	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Leucine-rich repeat serine/threonine-protein kinase 2 [human]	inhibition rate	33	%
6279	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Leucine-rich repeat serine/threonine-protein kinase 2 (G2019S) [human]	inhibition rate	12	%
6280	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Leukocyte tyrosine kinase receptor [human]	inhibition rate	9	%
6281	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Lyn [human]	inhibition rate	36	%
6282	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 13 [human]	inhibition rate	38	%
6283	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MAK [human]	inhibition rate	34	%
6284	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 1 [human]	inhibition rate	17	%
6285	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 15 [human]	inhibition rate	23	%
6286	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 2 [human]	inhibition rate	19	%
6287	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 3 [human]	inhibition rate	41	%
6288	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 4 [human]	inhibition rate	12	%
6289	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 2 [human]	inhibition rate	29	%
6290	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 3 [human]	inhibition rate	0	%
6291	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 4 [human]	inhibition rate	2	%
6292	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 5 [human]	inhibition rate	10	%
6293	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-activated protein kinase 2 [human]	inhibition rate	0	%
6294	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-activated protein kinase 5 [human]	inhibition rate	31	%
6295	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MARK1 [human]	inhibition rate	8	%
6296	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MARK2 [human]	inhibition rate	0	%
6297	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP/microtubule affinity-regulating kinase 3 [human]	inhibition rate	8	%
6298	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP/microtubule affinity-regulating kinase 4 [human]	inhibition rate	0	%
6299	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	CLIP-associating protein 1 [human]	inhibition rate	18	%
6300	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 1 [human]	inhibition rate	34	%
6301	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 2 [human]	inhibition rate	0	%
6302	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 3 [human]	inhibition rate	31	%
6303	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 4 [human]	inhibition rate	12	%
6304	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 5 [human]	inhibition rate	19	%
6305	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 6 [human]	inhibition rate	0	%
6306	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Maternal embryonic leucine zipper kinase [human]	inhibition rate	67	%
6307	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Mer [human]	inhibition rate	6	%
6308	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor receptor [human]	inhibition rate	6	%
6309	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor receptor (M1250T) [human]	inhibition rate	50	%
6310	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor receptor [human]	inhibition rate	0	%
6311	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Misshapen-like kinase 1 [human]	inhibition rate	29	%
6312	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 7 [human]	inhibition rate	17	%
6313	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-interacting serine/threonine-protein kinase 1 [human]	inhibition rate	41	%
6314	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-interacting serine/threonine-protein kinase 2 [human]	inhibition rate	97.7	%
6315	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase, smooth muscle [human]	inhibition rate	2	%
6316	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 9 [human]	inhibition rate	0	%
6317	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 10 [human]	inhibition rate	0	%
6318	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 11 [human]	inhibition rate	7	%
6319	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MRCK alpha [human]	inhibition rate	2	%
6320	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MRCK beta [human]	inhibition rate	0	%
6321	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor-like [human]	inhibition rate	18	%
6322	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Macrophage-stimulating protein receptor [human]	inhibition rate	7	%
6323	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Histone acetyltransferase mst2 [human]	inhibition rate	11	%
6324	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 24 [human]	inhibition rate	11	%
6325	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 26 [human]	inhibition rate	27	%
6326	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase mTOR [human]	inhibition rate	0	%
6327	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Muscle, skeletal receptor tyrosine-protein kinase [human]	inhibition rate	20	%
6328	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase, smooth muscle [human]	inhibition rate	9	%
6329	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase 2, skeletal/cardiac muscle [human]	inhibition rate	21	%
6330	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase family member 4 [human]	inhibition rate	13	%
6331	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ABL1(E255K)-Phosphorylated [human]	inhibition rate	23	%
6332	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin-IIIa [human]	inhibition rate	12	%
6333	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin-IIIb [human]	inhibition rate	0	%
6334	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein NDRG1 [human]	inhibition rate	7	%
6335	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein NDRG2 [human]	inhibition rate	17	%
6336	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek1 [human]	inhibition rate	0	%
6337	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek10 [human]	inhibition rate	9	%
6338	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek11 [human]	inhibition rate	11	%
6339	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek2 [human]	inhibition rate	10	%
6340	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek3 [human]	inhibition rate	30	%
6341	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek4 [human]	inhibition rate	19	%
6342	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317I)-nonphosphorylated [human]	inhibition rate	41	%
6343	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek5 [human]	inhibition rate	10	%
6344	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek6 [human]	inhibition rate	0	%
6345	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek7 [human]	inhibition rate	0	%
6346	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek9 [human]	inhibition rate	0	%
6347	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 14 [human]	inhibition rate	18	%
6348	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase NIM1 [human]	inhibition rate	18	%
6349	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine kinase NLK [human]	inhibition rate	0	%
6350	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase OSR1 [human]	inhibition rate	24	%
6351	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 14A [human]	inhibition rate	0	%
6352	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 11 [human]	inhibition rate	45	%
6353	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317I)-phosphorylated [human]	inhibition rate	15	%
6354	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 13 [human]	inhibition rate	17	%
6355	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 12 [human]	inhibition rate	63	%
6356	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase N1 [human]	inhibition rate	12	%
6357	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	serine/threonine-protein kinase pak 2 [human]	inhibition rate	41	%
6358	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PAK 3 [human]	inhibition rate	6	%
6359	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PAK 4 [human]	inhibition rate	5	%
6360	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PAK 6 [human]	inhibition rate	20	%
6361	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	serine/threonine-protein kinase pak 5 [human]	inhibition rate	0	%
6362	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 16 [human]	inhibition rate	5	%
6363	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 17 [human]	inhibition rate	100	%
6364	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317L)-nonphosphorylated [human]	inhibition rate	29	%
6365	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 18 [human]	inhibition rate	0	%
6366	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Platelet-derived growth factor receptor alpha [human]	inhibition rate	17	%
6367	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Platelet-derived growth factor receptor beta [human]	inhibition rate	12	%
6368	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	3-phosphoinositide-dependent protein kinase 1 [human]	inhibition rate	0	%
6369	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium-dependent protein kinase 1 [Plasmodium falciparum]	inhibition rate	14	%
6370	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cell division control protein 2 homolog [Plasmodium falciparum]	inhibition rate	31	%
6371	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 15 [human]	inhibition rate	44	%
6372	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 14 [human]	inhibition rate	13	%
6373	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform [human]	inhibition rate	0	%
6374	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform [human]	inhibition rate	21	%
6375	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317L)-phosphorylated [human]	inhibition rate	18	%
6376	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta [human]	inhibition rate	9	%
6377	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition rate	21	%
6378	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human]	inhibition rate	20	%
6379	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (C420R) [human]	inhibition rate	12	%
6380	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E542K) [human]	inhibition rate	12	%
6381	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545A) [human]	inhibition rate	0	%
6382	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545K) [human]	inhibition rate	12	%
6383	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047L) [human]	inhibition rate	31	%
6384	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047Y) [human]	inhibition rate	9	%
6385	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human]	inhibition rate	5	%
6386	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(H396P)-nonphosphorylated [human]	inhibition rate	34	%
6387	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (M1043I) [human]	inhibition rate	0	%
6388	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (Q546K) [human]	inhibition rate	15	%
6389	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [human]	inhibition rate	35	%
6390	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [human]	inhibition rate	0	%
6391	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform [human]	inhibition rate	18	%
6392	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-kinase beta [human]	inhibition rate	81	%
6393	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	1-phosphatidylinositol 3-phosphate 5-kinase [human]	inhibition rate	0	%
6394	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Lon protease homolog, mitochondrial [human]	inhibition rate	17	%
6395	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase pim-2 [human]	inhibition rate	19	%
6396	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase pim-3 [human]	inhibition rate	19	%
6397	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(H396P)-phosphorylated [human]	inhibition rate	23	%
6398	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha [human]	inhibition rate	53	%
6399	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma [human]	inhibition rate	5	%
6400	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta [human]	inhibition rate	11	%
6401	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma [human]	inhibition rate	58	%
6402	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cAMP-dependent protein kinase catalytic subunit alpha [human]	inhibition rate	0	%
6403	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cAMP-dependent protein kinase catalytic subunit beta [human]	inhibition rate	1	%
6404	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase [human]	inhibition rate	0	%
6405	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase N1 [human]	inhibition rate	0	%
6406	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase pkn2 [human]	inhibition rate	5	%
6407	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PknB [Mycobacterium tuberculosis]	inhibition rate	13	%
6408	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(M351T)-phosphorylated [human]	inhibition rate	25	%
6409	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PLK1 [human]	inhibition rate	0	%
6410	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PLK2 [human]	inhibition rate	9	%
6411	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Plk3 [human]	inhibition rate	25	%
6412	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Plk4 [human]	inhibition rate	1	%
6413	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, delta [human]	inhibition rate	0	%
6414	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, epsilon [human]	inhibition rate	0	%
6415	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, eta [human]	inhibition rate	7	%
6416	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C iota type [human]	inhibition rate	41	%
6417	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, theta [human]	inhibition rate	0	%
6418	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase D1 [human]	inhibition rate	12	%
6419	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(Q252H)-nonphosphorylated [human]	inhibition rate	31	%
6420	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase D2 [human]	inhibition rate	18	%
6421	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase D3 [human]	inhibition rate	41	%
6422	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cGMP-dependent protein kinase 1 [human]	inhibition rate	2	%
6423	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cGMP-dependent protein kinase 2 [human]	inhibition rate	20	%
6424	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Interferon-induced, double-stranded RNA-activated protein kinase [human]	inhibition rate	0	%
6425	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cAMP-dependent protein kinase catalytic subunit PRKX [human]	inhibition rate	0	%
6426	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proline-rich protein 4 [human]	inhibition rate	47	%
6427	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein-tyrosine kinase 2-beta [human]	inhibition rate	0	%
6428	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase SIK3 [human]	inhibition rate	34	%
6429	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	RAF proto-oncogene serine/threonine-protein kinase [human]	inhibition rate	10	%
6430	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(Q252H)-phosphorylated [human]	inhibition rate	16	%
6431	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret [human]	inhibition rate	3	%
6432	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (M918T) [human]	inhibition rate	0	%
6433	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804L) [human]	inhibition rate	13	%
6434	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M) [human]	inhibition rate	16	%
6435	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Rio1 [human]	inhibition rate	38	%
6436	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Rio2 [human]	inhibition rate	10	%
6437	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Rio3 [human]	inhibition rate	0	%
6438	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-interacting serine/threonine-protein kinase 1 [human]	inhibition rate	13	%
6439	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-interacting serine/threonine-protein kinase 2 [human]	inhibition rate	5	%
6440	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-interacting serine/threonine-protein kinase 4 [human]	inhibition rate	19	%
6441	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(T315I)-nonphosphorylated [human]	inhibition rate	18	%
6442	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual serine/threonine and tyrosine protein kinase [human]	inhibition rate	6	%
6443	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Rho-associated protein kinase 1 [human]	inhibition rate	19	%
6444	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Rho-associated protein kinase 2 [human]	inhibition rate	13	%
6445	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase ROS [human]	inhibition rate	9	%
6446	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-4 [human]	inhibition rate	7	%
6447	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-4 [human]	inhibition rate	44	%
6448	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-5 [human]	inhibition rate	23	%
6449	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-5 [human]	inhibition rate	0	%
6450	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-1 [human]	inhibition rate	70	%
6451	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-1 [human]	inhibition rate	70	%
6452	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(T315I)-phosphorylated [human]	inhibition rate	2	%
6453	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	22	%
6454	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	7	%
6455	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-2 [human]	inhibition rate	4	%
6456	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-2 [human]	inhibition rate	0	%
6457	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-6 [human]	inhibition rate	23	%
6458	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-6 [human]	inhibition rate	16	%
6459	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase beta-1 [human]	inhibition rate	19	%
6460	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	serine/threonine-protein kinase sbk1 [human]	inhibition rate	22	%
6461	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Sgk1 [human]	inhibition rate	32	%
6462	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Uncharacterized serine/threonine-protein kinase SBK3 [human]	inhibition rate	11	%
6463	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(Y253F)-phosphorylated [human]	inhibition rate	23	%
6464	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Sgk2 [human]	inhibition rate	35	%
6465	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Sgk3 [human]	inhibition rate	12	%
6466	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase SIK1 [human]	inhibition rate	12	%
6467	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase SIK2 [human]	inhibition rate	0	%
6468	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	STE20-like serine/threonine-protein kinase [human]	inhibition rate	4	%
6469	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	NUAK family SNF1-like kinase 2 [human]	inhibition rate	21	%
6470	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	SNF-related serine/threonine-protein kinase [human]	inhibition rate	19	%
6471	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase Src [human]	inhibition rate	0	%
6472	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Srms [human]	inhibition rate	29	%
6473	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	SRSF protein kinase 1 [human]	inhibition rate	23	%
6474	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1-nonphosphorylated [human]	inhibition rate	14	%
6475	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	SRSF protein kinase 2 [human]	inhibition rate	7	%
6476	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	SRSF protein kinase 3 [human]	inhibition rate	32	%
6477	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 16 [human]	inhibition rate	13	%
6478	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 33 [human]	inhibition rate	0	%
6479	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 35 [human]	inhibition rate	0	%
6480	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 36 [human]	inhibition rate	0	%
6481	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	STE20/SPS1-related proline-alanine-rich protein kinase [human]	inhibition rate	38	%
6482	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase SYK [human]	inhibition rate	18	%
6483	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 7 [human]	inhibition rate	29	%
6484	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TAO1 [human]	inhibition rate	22	%
6485	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ABL1- phosphorylated [human]	inhibition rate	41	%
6486	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TAO2 [human]	inhibition rate	30	%
6487	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TAO3 [human]	inhibition rate	14	%
6488	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TBK1 [human]	inhibition rate	20	%
6489	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Tec [human]	inhibition rate	11	%
6490	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity testis-specific protein kinase 1 [human]	inhibition rate	0	%
6491	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	TGF-beta receptor type-1 [human]	inhibition rate	24	%
6492	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	TGF-beta receptor type-2 [human]	inhibition rate	40	%
6493	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase receptor Tie-1 [human]	inhibition rate	25	%
6494	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase receptor Tie-2 [human]	inhibition rate	18	%
6495	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase tousled-like 1 [human]	inhibition rate	12	%
6496	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ABL2 [human]	inhibition rate	22	%
6497	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TOUSLED-like 2 [human]	inhibition rate	0	%
6498	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Traf2 and NCK-interacting protein kinase [human]	inhibition rate	0	%
6499	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Non-receptor tyrosine-protein kinase TNK1 [human]	inhibition rate	0	%
6500	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activated CDC42 kinase 1 [human]	inhibition rate	0	%
6501	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TNNI3K [human]	inhibition rate	0	%
6502	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	High affinity nerve growth factor receptor [human]	inhibition rate	32	%
6503	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	BDNF/NT-3 growth factors receptor [human]	inhibition rate	39	%
6504	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	NT-3 growth factor receptor [human]	inhibition rate	37	%
6505	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Transient receptor potential cation channel subfamily M member 6 [human]	inhibition rate	6	%
6506	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Testis-specific serine/threonine-protein kinase 1 [human]	inhibition rate	2	%
6507	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-1 [human]	inhibition rate	0	%
6508	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Testis-specific serine/threonine-protein kinase 3 [human]	inhibition rate	8	%
6509	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase TTK [human]	inhibition rate	66	%
6510	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase TXK [human]	inhibition rate	10	%
6511	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition rate	37	%
6512	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition rate	49	%
6513	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase receptor TYRO3 [human]	inhibition rate	0	%
6514	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ULK1 [human]	inhibition rate	15	%
6515	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ULK2 [human]	inhibition rate	37	%
6516	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ULK3 [human]	inhibition rate	23	%
6517	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Vascular endothelial growth factor receptor 2 [human]	inhibition rate	8	%
6518	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-1B [human]	inhibition rate	29	%
6519	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 3-kinase, Vps34 type [human]	inhibition rate	14	%
6520	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase VRK2 [human]	inhibition rate	19	%
6521	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitosis inhibitor protein kinase wee1 [human]	inhibition rate	0	%
6522	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Wee1-like protein kinase 1-A [human]	inhibition rate	0	%
6523	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK1 [human]	inhibition rate	9	%
6524	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK2 [human]	inhibition rate	2	%
6525	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK3 [human]	inhibition rate	2	%
6526	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK4 [human]	inhibition rate	21	%
6527	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 32A [human]	inhibition rate	36	%
6528	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 32B [human]	inhibition rate	0	%
6529	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-2A [human]	inhibition rate	4	%
6530	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 32C [human]	inhibition rate	0	%
6531	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Yes [human]	inhibition rate	6	%
6532	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 25 [human]	inhibition rate	0	%
6533	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 19 [human]	inhibition rate	47	%
6534	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 20 [human]	inhibition rate	3	%
6535	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ZAP-70 [human]	inhibition rate	27	%
6536	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-2B [human]	inhibition rate	13	%
6537	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase receptor R3 [human]	inhibition rate	13	%
6538	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Atypical kinase COQ8A, mitochondrial [human]	inhibition rate	0	%
6539	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Atypical kinase COQ8B, mitochondrial [human]	inhibition rate	8	%
6540	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	RAC-alpha serine/threonine-protein kinase [human]	inhibition rate	8	%
6541	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	RAC-beta serine/threonine-protein kinase [human]	inhibition rate	0	%
6542	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	RAC-gamma serine/threonine-protein kinase [human]	inhibition rate	1	%
6543	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ALK tyrosine kinase receptor [human]	inhibition rate	18	%
6544	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ALK tyrosine kinase receptor [human]	inhibition rate	1	%
6545	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ALK tyrosine kinase receptor [human]	inhibition rate	0	%
6546	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	5'-AMP-activated protein kinase catalytic subunit alpha-1 [human]	inhibition rate	7	%
6547	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	5'-AMP-activated protein kinase catalytic subunit alpha-2 [human]	inhibition rate	16	%
6548	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ankyrin repeat and protein kinase domain-containing protein 1 [human]	inhibition rate	17	%
6549	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	NUAK family SNF1-like kinase 1 [human]	inhibition rate	10	%
6550	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 5 [human]	inhibition rate	0	%
6551	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 6 [human]	inhibition rate	43	%
6552	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Aurora kinase A [human]	inhibition rate	9	%
6553	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Aurora kinase B [human]	inhibition rate	30	%
6554	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Aurora kinase C [human]	inhibition rate	55	%
6555	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	NEDD8-activating enzyme E1 regulatory subunit AXL [human]	inhibition rate	51	%
6556	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	BMP-2-inducible protein kinase [human]	inhibition rate	17	%
6557	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Blk [human]	inhibition rate	0	%
6558	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Bone morphogenetic protein receptor type-1A [human]	inhibition rate	32	%
6559	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Bone morphogenetic protein receptor type-1B [human]	inhibition rate	40	%
6560	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Bone morphogenetic protein receptor type-2 [human]	inhibition rate	3	%
6561	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cytoplasmic tyrosine-protein kinase BMX [human]	inhibition rate	16	%
6562	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase B-raf [human]	inhibition rate	11	%
6563	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase B-raf (V600E) [human]	inhibition rate	7	%
6564	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein-tyrosine kinase 6 [human]	inhibition rate	0	%
6565	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase BRSK1 [human]	inhibition rate	2	%
6566	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase BRSK2 [human]	inhibition rate	4	%
6567	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase BTK [human]	inhibition rate	5	%
6568	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitotic checkpoint serine/threonine-protein kinase BUB1 [human]	inhibition rate	48	%
6569	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1 [human]	inhibition rate	11	%
6570	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1B [human]	inhibition rate	12	%
6571	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1D [human]	inhibition rate	5	%
6572	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1G [human]	inhibition rate	3	%
6573	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II subunit alpha [human]	inhibition rate	9	%
6574	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II subunit beta [human]	inhibition rate	20	%
6575	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II delta 2 chain [human]	inhibition rate	6	%
6576	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II subunit gamma [human]	inhibition rate	12	%
6577	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type IV [human]	inhibition rate	10	%
6578	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase kinase 1 [human]	inhibition rate	9	%
6579	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase kinase 2 [human]	inhibition rate	26	%
6580	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Kappa-casein [human]	inhibition rate	26	%
6581	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 11B [human]	inhibition rate	10	%
6582	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 11A [human]	inhibition rate	19	%
6583	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 13 [human]	inhibition rate	16	%
6584	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 11 [human]	inhibition rate	30	%
6585	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 2 [human]	inhibition rate	5	%
6586	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 3 [human]	inhibition rate	14	%
6587	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1		CLint (intrinsic clearance)	448	μl/min/mg protein
6588	C[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1		CLint (intrinsic clearance)	378	μl/min/mg protein
6589	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	pIC50	6.83	no unit
6590	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 4 [human]	inhibition rate	21	%
6591	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 4 [human]; Cyclin-D1-1 [human]	inhibition rate	12	%
6592	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 4 [human]; Cyclin-D3-1 [human]	inhibition rate	24	%
6593	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent-like kinase 5 [human]	inhibition rate	0	%
6594	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 7 [human]	inhibition rate	65	%
6595	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 8 [human]	inhibition rate	49	%
6596	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 9 [human]	inhibition rate	13	%
6597	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 1 [human]	inhibition rate	30	%
6598	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 2 [human]	inhibition rate	1	%
6599	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 3 [human]	inhibition rate	7	%
6600	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 5 [human]	inhibition rate	14	%
6601	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Chk1 [human]	inhibition rate	0	%
6602	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Chk2 [human]	inhibition rate	29	%
6603	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Citrate synthase, mitochondrial [human]	inhibition rate	4	%
6604	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ATG1 [human]	inhibition rate	84	%
6605	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase CLK2 [human]	inhibition rate	85	%
6606	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase CLK3 [human]	inhibition rate	27	%
6607	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase CLK4 [human]	inhibition rate	88	%
6608	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Macrophage colony-stimulating factor 1 receptor [human]	inhibition rate	0	%
6609	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	CSF1R-autoinhibited [human]	inhibition rate	22	%
6610	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase CSK [human]	inhibition rate	11	%
6611	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform alpha [human]	inhibition rate	39	%
6612	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform alpha-like [human]	inhibition rate	19	%
6613	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform delta [human]	inhibition rate	36	%
6614	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform epsilon [human]	inhibition rate	14	%
6615	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform gamma-1 [human]	inhibition rate	13	%
6616	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform gamma-2 [human]	inhibition rate	38	%
6617	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform gamma-3 [human]	inhibition rate	35	%
6618	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase II subunit alpha [human]	inhibition rate	11	%
6619	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase II subunit alpha' [human]	inhibition rate	40	%
6620	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Megakaryocyte-associated tyrosine-protein kinase [human]	inhibition rate	4	%
6621	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 1 [human]	inhibition rate	21	%
6622	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 2 [human]	inhibition rate	15	%
6623	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 3 [human]	inhibition rate	31	%
6624	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase DCLK1 [human]	inhibition rate	16	%
6625	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase DCLK2 [human]	inhibition rate	4	%
6626	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase DCLK3 [human]	inhibition rate	0	%
6627	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epithelial discoidin domain-containing receptor 1 [human]	inhibition rate	0	%
6628	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Discoidin domain-containing receptor 2 [human]	inhibition rate	34	%
6629	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 3 [human]	inhibition rate	25	%
6630	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myotonin-protein kinase [human]	inhibition rate	10	%
6631	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MRCK gamma [human]	inhibition rate	12	%
6632	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 17A [human]	inhibition rate	81	%
6633	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 17B [human]	inhibition rate	0	%
6634	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	inhibition rate	98.5	%
6635	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 1B [human]	inhibition rate	90.9	%
6636	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 2 [human]	inhibition rate	75	%
6637	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	0	%
6638	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	4	%
6639	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (G719C) [human]	inhibition rate	13	%
6640	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (G719S) [human]	inhibition rate	26	%
6641	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	4	%
6642	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	0	%
6643	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	24	%
6644	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (L858R) [human]	inhibition rate	7	%
6645	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (L858R) [human];+Epidermal growth factor receptor (T790M) [human]	inhibition rate	24	%
6646	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (L861Q) [human]	inhibition rate	8	%
6647	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	12	%
6648	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (T790M) [human]	inhibition rate	21	%
6649	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Eukaryotic translation initiation factor 2-alpha kinase 1 [human]	inhibition rate	21	%
6650	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	AP2-associated protein kinase 1 [human]	inhibition rate	29	%
6651	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 1 [human]	inhibition rate	0	%
6652	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 2 [human]	inhibition rate	7	%
6653	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 3 [human]	inhibition rate	39	%
6654	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 4 [human]	inhibition rate	0	%
6655	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 5 [human]	inhibition rate	6	%
6656	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 6 [human]	inhibition rate	0	%
6657	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 7 [human]	inhibition rate	16	%
6658	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 8 [human]	inhibition rate	5	%
6659	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 1 [human]	inhibition rate	3	%
6660	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 2 [human]	inhibition rate	0	%
6661	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 3 [human]	inhibition rate	0	%
6662	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 4 [human]	inhibition rate	0	%
6663	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 6 [human]	inhibition rate	7	%
6664	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor tyrosine-protein kinase erbB-2 [human]	inhibition rate	10	%
6665	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor tyrosine-protein kinase erbB-3 [human]	inhibition rate	0	%
6666	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor tyrosine-protein kinase erbB-4 [human]	inhibition rate	21	%
6667	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Extracellular signal-regulated kinase 1 [human]	inhibition rate	17	%
6668	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Extracellular signal-regulated kinase 2 [human]	inhibition rate	12	%
6669	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 6 [human]	inhibition rate	0	%
6670	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 4 [human]	inhibition rate	0	%
6671	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 7 [human]	inhibition rate	0	%
6672	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 15 [human]	inhibition rate	51	%
6673	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ethylene-responsive transcription factor ERN1 [human]	inhibition rate	0	%
6674	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Focal adhesion kinase 1 [human]	inhibition rate	0	%
6675	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Fer [human]	inhibition rate	0	%
6676	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase, Fes/Fps type [human]	inhibition rate	0	%
6677	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 1 [human]	inhibition rate	0	%
6678	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 2 [human]	inhibition rate	8	%
6679	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 3 [human]	inhibition rate	10	%
6680	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 3 [human]	inhibition rate	0	%
6681	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 4 [human]	inhibition rate	0	%
6682	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Fgr [human]	inhibition rate	0	%
6683	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Vascular endothelial growth factor receptor 1 [human]	inhibition rate	0	%
6684	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	0	%
6685	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835H) [human]	inhibition rate	0	%
6686	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835V) [human]	inhibition rate	49	%
6687	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835Y) [human]	inhibition rate	0	%
6688	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	FLT3(ITD) [human]	inhibition rate	0	%
6689	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835V) [human];+FLT3(ITD) [human]	inhibition rate	33	%
6690	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	FLT3(ITD) [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	15	%
6691	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	0	%
6692	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	1	%
6693	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	29	%
6694	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	FLT3-autoinhibited [human]	inhibition rate	22	%
6695	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Vascular endothelial growth factor receptor 3 [human]	inhibition rate	0	%
6696	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase FRK [human]	inhibition rate	0	%
6697	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Fyn [human]	inhibition rate	12	%
6698	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-G-associated kinase [human]	inhibition rate	60	%
6699	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABC transporter F family member 2 [human]	inhibition rate	22	%
6700	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Rhodopsin kinase GRK1 (C514S) [human]	inhibition rate	23	%
6701	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Beta-adrenergic receptor kinase 1 [human]	inhibition rate	43	%
6702	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Beta-adrenergic receptor kinase 2 [human]	inhibition rate	44	%
6703	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	G protein-coupled receptor kinase 4 [human]	inhibition rate	44	%
6704	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Rhodopsin kinase [human]	inhibition rate	18	%
6705	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Glycogen synthase kinase-3 alpha [human]	inhibition rate	20	%
6706	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	glycogen synthase kinase-3 beta [human]	inhibition rate	0	%
6707	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase haspin [human]	inhibition rate	98	%
6708	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase HCK [human]	inhibition rate	16	%
6709	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 1 [human]	inhibition rate	48	%
6710	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 2 [human]	inhibition rate	39	%
6711	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 3 [human]	inhibition rate	32	%
6712	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 4 [human]	inhibition rate	8	%
6713	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 1 [human]	inhibition rate	0	%
6714	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hormonally up-regulated neu tumor-associated kinase [human]	inhibition rate	0	%
6715	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Insulin-like growth factor 1 receptor [human]	inhibition rate	47	%
6716	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit alpha [human]	inhibition rate	19	%
6717	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition rate	23	%
6718	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit epsilon [human]	inhibition rate	18	%
6719	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Insulin receptor [human]	inhibition rate	28	%
6720	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Insulin receptor-related protein [human]	inhibition rate	5	%
6721	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Interleukin-1 receptor-associated kinase 1 [human]	inhibition rate	2	%
6722	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Interleukin-1 receptor-associated kinase 3 [human]	inhibition rate	48	%
6723	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Interleukin-1 receptor-associated kinase 4 [human]	inhibition rate	0	%
6724	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ITK/TSK [human]	inhibition rate	9	%
6725	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK1 [human]	inhibition rate	18	%
6726	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK1 [human]	inhibition rate	38	%
6727	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK2 [human]	inhibition rate	10	%
6728	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK3 [human]	inhibition rate	20	%
6729	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 8 [human]	inhibition rate	77	%
6730	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 9 [human]	inhibition rate	36	%
6731	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 10 [human]	inhibition rate	66	%
6732	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	0	%
6733	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (A829P) [human]	inhibition rate	15	%
6734	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (D816H) [human]	inhibition rate	21	%
6735	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (D816V) [human]	inhibition rate	6	%
6736	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	0	%
6737	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (V559D) [human]	inhibition rate	0	%
6738	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (V559D) [human];+Mast/stem cell growth factor receptor Kit [human]	inhibition rate	0	%
6739	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (V559D) [human];+Mast/stem cell growth factor receptor Kit [human]	inhibition rate	21	%
6740	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	KIT-autoinhibited [human]	inhibition rate	13	%
6741	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase LATS1 [human]	inhibition rate	0	%
6742	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase LATS2 [human]	inhibition rate	7	%
6743	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase LCK [human]	inhibition rate	7	%
6744	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	LIM domain kinase 1 [human]	inhibition rate	0	%
6745	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	LIM domain kinase 2 [human]	inhibition rate	13	%
6746	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase STK11 [human]	inhibition rate	0	%
6747	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Coiled-coil domain-containing protein 40 [human]	inhibition rate	2	%
6748	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Leucine-rich repeat serine/threonine-protein kinase 2 [human]	inhibition rate	41	%
6749	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Leucine-rich repeat serine/threonine-protein kinase 2 (G2019S) [human]	inhibition rate	37	%
6750	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Leukocyte tyrosine kinase receptor [human]	inhibition rate	7	%
6751	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Lyn [human]	inhibition rate	7	%
6752	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 13 [human]	inhibition rate	29	%
6753	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MAK [human]	inhibition rate	3	%
6754	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 1 [human]	inhibition rate	15	%
6755	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 15 [human]	inhibition rate	0	%
6756	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 2 [human]	inhibition rate	21	%
6757	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 3 [human]	inhibition rate	20	%
6758	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 4 [human]	inhibition rate	0	%
6759	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 2 [human]	inhibition rate	30	%
6760	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 3 [human]	inhibition rate	4	%
6761	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 4 [human]	inhibition rate	4	%
6762	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 5 [human]	inhibition rate	7	%
6763	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-activated protein kinase 2 [human]	inhibition rate	6	%
6764	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-activated protein kinase 5 [human]	inhibition rate	31	%
6765	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MARK1 [human]	inhibition rate	0	%
6766	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MARK2 [human]	inhibition rate	5	%
6767	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP/microtubule affinity-regulating kinase 3 [human]	inhibition rate	0	%
6768	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP/microtubule affinity-regulating kinase 4 [human]	inhibition rate	0	%
6769	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	CLIP-associating protein 1 [human]	inhibition rate	0	%
6770	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 1 [human]	inhibition rate	25	%
6771	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 2 [human]	inhibition rate	6	%
6772	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 3 [human]	inhibition rate	31	%
6773	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 4 [human]	inhibition rate	31	%
6774	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 5 [human]	inhibition rate	29	%
6775	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 6 [human]	inhibition rate	0	%
6776	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Maternal embryonic leucine zipper kinase [human]	inhibition rate	52	%
6777	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Mer [human]	inhibition rate	0	%
6778	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor receptor [human]	inhibition rate	16	%
6779	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor receptor (M1250T) [human]	inhibition rate	2	%
6780	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor receptor [human]	inhibition rate	21	%
6781	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Misshapen-like kinase 1 [human]	inhibition rate	26	%
6782	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 7 [human]	inhibition rate	0	%
6783	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-interacting serine/threonine-protein kinase 1 [human]	inhibition rate	26	%
6784	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-interacting serine/threonine-protein kinase 2 [human]	inhibition rate	89	%
6785	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase, smooth muscle [human]	inhibition rate	9	%
6786	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 9 [human]	inhibition rate	0	%
6787	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 10 [human]	inhibition rate	6	%
6788	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 11 [human]	inhibition rate	0	%
6789	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MRCK alpha [human]	inhibition rate	4	%
6790	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MRCK beta [human]	inhibition rate	6	%
6791	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor-like [human]	inhibition rate	15	%
6792	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Macrophage-stimulating protein receptor [human]	inhibition rate	0	%
6793	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Histone acetyltransferase mst2 [human]	inhibition rate	37	%
6794	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 24 [human]	inhibition rate	37	%
6795	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 26 [human]	inhibition rate	27	%
6796	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase mTOR [human]	inhibition rate	3	%
6797	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Muscle, skeletal receptor tyrosine-protein kinase [human]	inhibition rate	8	%
6798	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase, smooth muscle [human]	inhibition rate	8	%
6799	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase 2, skeletal/cardiac muscle [human]	inhibition rate	14	%
6800	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase family member 4 [human]	inhibition rate	0	%
6801	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ABL1(E255K)-Phosphorylated [human]	inhibition rate	6	%
6802	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin-IIIa [human]	inhibition rate	0	%
6803	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin-IIIb [human]	inhibition rate	0	%
6804	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein NDRG1 [human]	inhibition rate	28	%
6805	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein NDRG2 [human]	inhibition rate	0	%
6806	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek1 [human]	inhibition rate	0	%
6807	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek10 [human]	inhibition rate	4	%
6808	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek11 [human]	inhibition rate	10	%
6809	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek2 [human]	inhibition rate	13	%
6810	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek3 [human]	inhibition rate	19	%
6811	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek4 [human]	inhibition rate	17	%
6812	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317I)-nonphosphorylated [human]	inhibition rate	40	%
6813	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek5 [human]	inhibition rate	0	%
6814	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek6 [human]	inhibition rate	0	%
6815	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek7 [human]	inhibition rate	11	%
6816	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek9 [human]	inhibition rate	19	%
6817	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 14 [human]	inhibition rate	28	%
6818	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase NIM1 [human]	inhibition rate	13	%
6819	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine kinase NLK [human]	inhibition rate	30	%
6820	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase OSR1 [human]	inhibition rate	25	%
6821	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 14A [human]	inhibition rate	0	%
6822	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 11 [human]	inhibition rate	0	%
6823	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317I)-phosphorylated [human]	inhibition rate	4	%
6824	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 13 [human]	inhibition rate	7	%
6825	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 12 [human]	inhibition rate	53	%
6826	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase N1 [human]	inhibition rate	0	%
6827	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	serine/threonine-protein kinase pak 2 [human]	inhibition rate	1	%
6828	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PAK 3 [human]	inhibition rate	15	%
6829	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PAK 4 [human]	inhibition rate	0	%
6830	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PAK 6 [human]	inhibition rate	13	%
6831	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	serine/threonine-protein kinase pak 5 [human]	inhibition rate	10	%
6832	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 16 [human]	inhibition rate	6	%
6833	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 17 [human]	inhibition rate	0	%
6834	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317L)-nonphosphorylated [human]	inhibition rate	64	%
6835	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 18 [human]	inhibition rate	0	%
6836	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Platelet-derived growth factor receptor alpha [human]	inhibition rate	19	%
6837	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Platelet-derived growth factor receptor beta [human]	inhibition rate	0	%
6838	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	3-phosphoinositide-dependent protein kinase 1 [human]	inhibition rate	11	%
6839	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium-dependent protein kinase 1 [Plasmodium falciparum]	inhibition rate	15	%
6840	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cell division control protein 2 homolog [Plasmodium falciparum]	inhibition rate	16	%
6841	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 15 [human]	inhibition rate	27	%
6842	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 14 [human]	inhibition rate	0	%
6843	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform [human]	inhibition rate	0	%
6844	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform [human]	inhibition rate	28	%
6845	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317L)-phosphorylated [human]	inhibition rate	21	%
6846	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta [human]	inhibition rate	6	%
6847	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition rate	6	%
6848	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human]	inhibition rate	0	%
6849	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (C420R) [human]	inhibition rate	0	%
6850	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E542K) [human]	inhibition rate	18	%
6851	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545A) [human]	inhibition rate	12	%
6852	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545K) [human]	inhibition rate	34	%
6853	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047L) [human]	inhibition rate	25	%
6854	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047Y) [human]	inhibition rate	7	%
6855	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human]	inhibition rate	6	%
6856	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(H396P)-nonphosphorylated [human]	inhibition rate	21	%
6857	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (M1043I) [human]	inhibition rate	2	%
6858	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (Q546K) [human]	inhibition rate	21	%
6859	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [human]	inhibition rate	27	%
6860	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [human]	inhibition rate	0	%
6861	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform [human]	inhibition rate	42	%
6862	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-kinase beta [human]	inhibition rate	80	%
6863	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	1-phosphatidylinositol 3-phosphate 5-kinase [human]	inhibition rate	1	%
6864	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Lon protease homolog, mitochondrial [human]	inhibition rate	16	%
6865	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase pim-2 [human]	inhibition rate	22	%
6866	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase pim-3 [human]	inhibition rate	8	%
6867	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(H396P)-phosphorylated [human]	inhibition rate	30	%
6868	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha [human]	inhibition rate	48	%
6869	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma [human]	inhibition rate	1	%
6870	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta [human]	inhibition rate	0	%
6871	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma [human]	inhibition rate	60	%
6872	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cAMP-dependent protein kinase catalytic subunit alpha [human]	inhibition rate	0	%
6873	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cAMP-dependent protein kinase catalytic subunit beta [human]	inhibition rate	28	%
6874	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase [human]	inhibition rate	1	%
6875	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase N1 [human]	inhibition rate	16	%
6876	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase pkn2 [human]	inhibition rate	29	%
6877	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PknB [Mycobacterium tuberculosis]	inhibition rate	0	%
6878	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(M351T)-phosphorylated [human]	inhibition rate	0	%
6879	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PLK1 [human]	inhibition rate	24	%
6880	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PLK2 [human]	inhibition rate	12	%
6881	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Plk3 [human]	inhibition rate	12	%
6882	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Plk4 [human]	inhibition rate	0	%
6883	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, delta [human]	inhibition rate	0	%
6884	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, epsilon [human]	inhibition rate	0	%
6885	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, eta [human]	inhibition rate	17	%
6886	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C iota type [human]	inhibition rate	36	%
6887	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, theta [human]	inhibition rate	33	%
6888	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase D1 [human]	inhibition rate	0	%
6889	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(Q252H)-nonphosphorylated [human]	inhibition rate	19	%
6890	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase D2 [human]	inhibition rate	17	%
6891	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase D3 [human]	inhibition rate	0	%
6892	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cGMP-dependent protein kinase 1 [human]	inhibition rate	32	%
6893	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cGMP-dependent protein kinase 2 [human]	inhibition rate	19	%
6894	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Interferon-induced, double-stranded RNA-activated protein kinase [human]	inhibition rate	17	%
6895	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cAMP-dependent protein kinase catalytic subunit PRKX [human]	inhibition rate	0	%
6896	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proline-rich protein 4 [human]	inhibition rate	36	%
6897	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein-tyrosine kinase 2-beta [human]	inhibition rate	6	%
6898	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase SIK3 [human]	inhibition rate	69	%
6899	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	RAF proto-oncogene serine/threonine-protein kinase [human]	inhibition rate	0	%
6900	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(Q252H)-phosphorylated [human]	inhibition rate	2	%
6901	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret [human]	inhibition rate	30	%
6902	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (M918T) [human]	inhibition rate	0	%
6903	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804L) [human]	inhibition rate	0	%
6904	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M) [human]	inhibition rate	12	%
6905	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Rio1 [human]	inhibition rate	25	%
6906	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Rio2 [human]	inhibition rate	25	%
6907	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Rio3 [human]	inhibition rate	0	%
6908	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-interacting serine/threonine-protein kinase 1 [human]	inhibition rate	0	%
6909	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-interacting serine/threonine-protein kinase 2 [human]	inhibition rate	9	%
6910	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-interacting serine/threonine-protein kinase 4 [human]	inhibition rate	82	%
6911	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(T315I)-nonphosphorylated [human]	inhibition rate	40	%
6912	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual serine/threonine and tyrosine protein kinase [human]	inhibition rate	23	%
6913	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Rho-associated protein kinase 1 [human]	inhibition rate	14	%
6914	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Rho-associated protein kinase 2 [human]	inhibition rate	2	%
6915	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase ROS [human]	inhibition rate	1	%
6916	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-4 [human]	inhibition rate	40	%
6917	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-4 [human]	inhibition rate	42	%
6918	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-5 [human]	inhibition rate	30	%
6919	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-5 [human]	inhibition rate	0	%
6920	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-1 [human]	inhibition rate	53	%
6921	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-1 [human]	inhibition rate	53	%
6922	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(T315I)-phosphorylated [human]	inhibition rate	0	%
6923	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	26	%
6924	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	2	%
6925	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-2 [human]	inhibition rate	21	%
6926	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-2 [human]	inhibition rate	55	%
6927	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-6 [human]	inhibition rate	29	%
6928	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-6 [human]	inhibition rate	34	%
6929	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase beta-1 [human]	inhibition rate	13	%
6930	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	serine/threonine-protein kinase sbk1 [human]	inhibition rate	15	%
6931	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Sgk1 [human]	inhibition rate	42	%
6932	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Uncharacterized serine/threonine-protein kinase SBK3 [human]	inhibition rate	1	%
6933	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(Y253F)-phosphorylated [human]	inhibition rate	12	%
6934	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Sgk2 [human]	inhibition rate	19	%
6935	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Sgk3 [human]	inhibition rate	13	%
6936	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase SIK1 [human]	inhibition rate	0	%
6937	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase SIK2 [human]	inhibition rate	27	%
6938	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	STE20-like serine/threonine-protein kinase [human]	inhibition rate	13	%
6939	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	NUAK family SNF1-like kinase 2 [human]	inhibition rate	26	%
6940	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	SNF-related serine/threonine-protein kinase [human]	inhibition rate	8	%
6941	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase Src [human]	inhibition rate	8	%
6942	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Srms [human]	inhibition rate	27	%
6943	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	SRSF protein kinase 1 [human]	inhibition rate	2	%
6944	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1-nonphosphorylated [human]	inhibition rate	19	%
6945	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	SRSF protein kinase 2 [human]	inhibition rate	0	%
6946	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	SRSF protein kinase 3 [human]	inhibition rate	45	%
6947	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 16 [human]	inhibition rate	6	%
6948	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 33 [human]	inhibition rate	12	%
6949	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 35 [human]	inhibition rate	28	%
6950	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 36 [human]	inhibition rate	13	%
6951	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	STE20/SPS1-related proline-alanine-rich protein kinase [human]	inhibition rate	41	%
6952	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase SYK [human]	inhibition rate	16	%
6953	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 7 [human]	inhibition rate	19	%
6954	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TAO1 [human]	inhibition rate	17	%
6955	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ABL1- phosphorylated [human]	inhibition rate	39	%
6956	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TAO2 [human]	inhibition rate	25	%
6957	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TAO3 [human]	inhibition rate	10	%
6958	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TBK1 [human]	inhibition rate	37	%
6959	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Tec [human]	inhibition rate	10	%
6960	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity testis-specific protein kinase 1 [human]	inhibition rate	9	%
6961	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	TGF-beta receptor type-1 [human]	inhibition rate	2	%
6962	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	TGF-beta receptor type-2 [human]	inhibition rate	0	%
6963	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase receptor Tie-1 [human]	inhibition rate	0	%
6964	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase receptor Tie-2 [human]	inhibition rate	23	%
6965	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase tousled-like 1 [human]	inhibition rate	21	%
6966	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ABL2 [human]	inhibition rate	24	%
6967	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TOUSLED-like 2 [human]	inhibition rate	0	%
6968	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Traf2 and NCK-interacting protein kinase [human]	inhibition rate	10	%
6969	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Non-receptor tyrosine-protein kinase TNK1 [human]	inhibition rate	0	%
6970	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activated CDC42 kinase 1 [human]	inhibition rate	0	%
6971	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TNNI3K [human]	inhibition rate	0	%
6972	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	High affinity nerve growth factor receptor [human]	inhibition rate	39	%
6973	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	BDNF/NT-3 growth factors receptor [human]	inhibition rate	28	%
6974	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	NT-3 growth factor receptor [human]	inhibition rate	30	%
6975	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Transient receptor potential cation channel subfamily M member 6 [human]	inhibition rate	9	%
6976	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Testis-specific serine/threonine-protein kinase 1 [human]	inhibition rate	0	%
6977	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-1 [human]	inhibition rate	0	%
6978	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Testis-specific serine/threonine-protein kinase 3 [human]	inhibition rate	22	%
6979	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase TTK [human]	inhibition rate	54	%
6980	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase TXK [human]	inhibition rate	0	%
6981	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition rate	6	%
6982	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition rate	34	%
6983	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase receptor TYRO3 [human]	inhibition rate	0	%
6984	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ULK1 [human]	inhibition rate	4	%
6985	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ULK2 [human]	inhibition rate	31	%
6986	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ULK3 [human]	inhibition rate	20	%
6987	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Vascular endothelial growth factor receptor 2 [human]	inhibition rate	13	%
6988	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-1B [human]	inhibition rate	24	%
6989	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 3-kinase, Vps34 type [human]	inhibition rate	30	%
6990	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase VRK2 [human]	inhibition rate	18	%
6991	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitosis inhibitor protein kinase wee1 [human]	inhibition rate	0	%
6992	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Wee1-like protein kinase 1-A [human]	inhibition rate	13	%
6993	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK1 [human]	inhibition rate	8	%
6994	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK2 [human]	inhibition rate	0	%
6995	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK3 [human]	inhibition rate	4	%
6996	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK4 [human]	inhibition rate	0	%
6997	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 32A [human]	inhibition rate	29	%
6998	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 32B [human]	inhibition rate	11	%
6999	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-2A [human]	inhibition rate	0	%
7000	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 32C [human]	inhibition rate	17	%
7001	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Yes [human]	inhibition rate	0	%
7002	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 25 [human]	inhibition rate	0	%
7003	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 19 [human]	inhibition rate	21	%
7004	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 20 [human]	inhibition rate	0	%
7005	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ZAP-70 [human]	inhibition rate	25	%
7006	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-2B [human]	inhibition rate	0	%
7007	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase receptor R3 [human]	inhibition rate	0	%
7008	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Atypical kinase COQ8A, mitochondrial [human]	inhibition rate	0	%
7009	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Atypical kinase COQ8B, mitochondrial [human]	inhibition rate	11	%
7010	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	RAC-alpha serine/threonine-protein kinase [human]	inhibition rate	7	%
7011	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	RAC-beta serine/threonine-protein kinase [human]	inhibition rate	7	%
7012	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	RAC-gamma serine/threonine-protein kinase [human]	inhibition rate	22	%
7013	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ALK tyrosine kinase receptor [human]	inhibition rate	19	%
7014	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ALK tyrosine kinase receptor [human]	inhibition rate	9	%
7015	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ALK tyrosine kinase receptor [human]	inhibition rate	0	%
7016	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	5'-AMP-activated protein kinase catalytic subunit alpha-1 [human]	inhibition rate	1	%
7017	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	5'-AMP-activated protein kinase catalytic subunit alpha-2 [human]	inhibition rate	26	%
7018	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ankyrin repeat and protein kinase domain-containing protein 1 [human]	inhibition rate	19	%
7019	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	NUAK family SNF1-like kinase 1 [human]	inhibition rate	7	%
7020	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 5 [human]	inhibition rate	4	%
7021	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 6 [human]	inhibition rate	45	%
7022	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Aurora kinase A [human]	inhibition rate	8	%
7023	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Aurora kinase B [human]	inhibition rate	4	%
7024	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Aurora kinase C [human]	inhibition rate	2	%
7025	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	NEDD8-activating enzyme E1 regulatory subunit AXL [human]	inhibition rate	14	%
7026	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	BMP-2-inducible protein kinase [human]	inhibition rate	3	%
7027	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Blk [human]	inhibition rate	0	%
7028	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Bone morphogenetic protein receptor type-1A [human]	inhibition rate	27	%
7029	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Bone morphogenetic protein receptor type-1B [human]	inhibition rate	32	%
7030	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Bone morphogenetic protein receptor type-2 [human]	inhibition rate	10	%
7031	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cytoplasmic tyrosine-protein kinase BMX [human]	inhibition rate	0	%
7032	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase B-raf [human]	inhibition rate	25	%
7033	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase B-raf (V600E) [human]	inhibition rate	4	%
7034	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein-tyrosine kinase 6 [human]	inhibition rate	0	%
7035	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase BRSK1 [human]	inhibition rate	7	%
7036	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase BRSK2 [human]	inhibition rate	9	%
7037	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase BTK [human]	inhibition rate	10	%
7038	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitotic checkpoint serine/threonine-protein kinase BUB1 [human]	inhibition rate	29	%
7039	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1 [human]	inhibition rate	13	%
7040	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1B [human]	inhibition rate	11	%
7041	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1D [human]	inhibition rate	14	%
7042	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1G [human]	inhibition rate	9	%
7043	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II subunit alpha [human]	inhibition rate	20	%
7044	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II subunit beta [human]	inhibition rate	22	%
7045	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II delta 2 chain [human]	inhibition rate	0	%
7046	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II subunit gamma [human]	inhibition rate	6	%
7047	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type IV [human]	inhibition rate	0	%
7048	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase kinase 1 [human]	inhibition rate	13	%
7049	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase kinase 2 [human]	inhibition rate	28	%
7050	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Kappa-casein [human]	inhibition rate	16	%
7051	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 11B [human]	inhibition rate	3	%
7052	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 11A [human]	inhibition rate	15	%
7053	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 13 [human]	inhibition rate	28	%
7054	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 11 [human]	inhibition rate	3	%
7055	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 2 [human]	inhibition rate	5	%
7056	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 3 [human]	inhibition rate	6	%
7057	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1		CLint (intrinsic clearance)	184	μl/min/mg protein
7058	C[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1		CLint (intrinsic clearance)	389	μl/min/mg protein
7059	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	pIC50	7.18	no unit
7060	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 4 [human]	inhibition rate	0	%
7061	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 4 [human]; Cyclin-D1-1 [human]	inhibition rate	0	%
7062	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 4 [human]; Cyclin-D3-1 [human]	inhibition rate	8	%
7063	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent-like kinase 5 [human]	inhibition rate	0	%
7064	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 7 [human]	inhibition rate	3	%
7065	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 8 [human]	inhibition rate	0	%
7066	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 9 [human]	inhibition rate	4	%
7067	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 1 [human]	inhibition rate	11	%
7068	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 2 [human]	inhibition rate	0	%
7069	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 3 [human]	inhibition rate	0	%
7070	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 5 [human]	inhibition rate	0	%
7071	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Chk1 [human]	inhibition rate	8	%
7072	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Chk2 [human]	inhibition rate	0	%
7073	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Citrate synthase, mitochondrial [human]	inhibition rate	25	%
7074	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ATG1 [human]	inhibition rate	52	%
7075	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase CLK2 [human]	inhibition rate	38	%
7076	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase CLK3 [human]	inhibition rate	4	%
7077	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase CLK4 [human]	inhibition rate	40	%
7078	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Macrophage colony-stimulating factor 1 receptor [human]	inhibition rate	3	%
7079	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	CSF1R-autoinhibited [human]	inhibition rate	19	%
7080	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase CSK [human]	inhibition rate	0	%
7081	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform alpha [human]	inhibition rate	10	%
7082	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform alpha-like [human]	inhibition rate	0	%
7083	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform delta [human]	inhibition rate	17	%
7084	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform epsilon [human]	inhibition rate	15	%
7085	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform gamma-1 [human]	inhibition rate	2	%
7086	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform gamma-2 [human]	inhibition rate	26	%
7087	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform gamma-3 [human]	inhibition rate	14	%
7088	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase II subunit alpha [human]	inhibition rate	42	%
7089	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase II subunit alpha' [human]	inhibition rate	0	%
7090	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Megakaryocyte-associated tyrosine-protein kinase [human]	inhibition rate	20	%
7091	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 1 [human]	inhibition rate	2	%
7092	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 2 [human]	inhibition rate	0	%
7093	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 3 [human]	inhibition rate	1	%
7094	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase DCLK1 [human]	inhibition rate	18	%
7095	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase DCLK2 [human]	inhibition rate	12	%
7096	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase DCLK3 [human]	inhibition rate	1	%
7097	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epithelial discoidin domain-containing receptor 1 [human]	inhibition rate	17	%
7098	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Discoidin domain-containing receptor 2 [human]	inhibition rate	9	%
7099	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 3 [human]	inhibition rate	0	%
7100	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myotonin-protein kinase [human]	inhibition rate	1	%
7101	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MRCK gamma [human]	inhibition rate	23	%
7102	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 17A [human]	inhibition rate	0	%
7103	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 17B [human]	inhibition rate	1	%
7104	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	inhibition rate	80	%
7105	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 1B [human]	inhibition rate	66	%
7106	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 2 [human]	inhibition rate	61	%
7107	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	9	%
7108	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	34	%
7109	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (G719C) [human]	inhibition rate	0	%
7110	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (G719S) [human]	inhibition rate	0	%
7111	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	0	%
7112	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	38	%
7113	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	0	%
7114	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (L858R) [human]	inhibition rate	11	%
7115	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (L858R) [human];+Epidermal growth factor receptor (T790M) [human]	inhibition rate	0	%
7116	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (L861Q) [human]	inhibition rate	7	%
7117	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	0	%
7118	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (T790M) [human]	inhibition rate	4	%
7119	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Eukaryotic translation initiation factor 2-alpha kinase 1 [human]	inhibition rate	0	%
7120	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	AP2-associated protein kinase 1 [human]	inhibition rate	24	%
7121	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 1 [human]	inhibition rate	21	%
7122	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 2 [human]	inhibition rate	0	%
7123	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 3 [human]	inhibition rate	10	%
7124	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 4 [human]	inhibition rate	0	%
7125	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 5 [human]	inhibition rate	0	%
7126	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 6 [human]	inhibition rate	20	%
7127	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 7 [human]	inhibition rate	0	%
7128	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 8 [human]	inhibition rate	8	%
7129	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 1 [human]	inhibition rate	3	%
7130	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 2 [human]	inhibition rate	4	%
7131	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 3 [human]	inhibition rate	23	%
7132	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 4 [human]	inhibition rate	10	%
7133	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 6 [human]	inhibition rate	0	%
7134	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor tyrosine-protein kinase erbB-2 [human]	inhibition rate	6	%
7135	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor tyrosine-protein kinase erbB-3 [human]	inhibition rate	0	%
7136	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor tyrosine-protein kinase erbB-4 [human]	inhibition rate	18	%
7137	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Extracellular signal-regulated kinase 1 [human]	inhibition rate	15	%
7138	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Extracellular signal-regulated kinase 2 [human]	inhibition rate	0	%
7139	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 6 [human]	inhibition rate	26	%
7140	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 4 [human]	inhibition rate	6	%
7141	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 7 [human]	inhibition rate	0	%
7142	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 15 [human]	inhibition rate	34	%
7143	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ethylene-responsive transcription factor ERN1 [human]	inhibition rate	17	%
7144	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Focal adhesion kinase 1 [human]	inhibition rate	0	%
7145	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Fer [human]	inhibition rate	19	%
7146	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase, Fes/Fps type [human]	inhibition rate	23	%
7147	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 1 [human]	inhibition rate	13	%
7148	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 2 [human]	inhibition rate	0	%
7149	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 3 [human]	inhibition rate	0	%
7150	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 3 [human]	inhibition rate	21	%
7151	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 4 [human]	inhibition rate	0	%
7152	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Fgr [human]	inhibition rate	19	%
7153	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Vascular endothelial growth factor receptor 1 [human]	inhibition rate	0	%
7154	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	19	%
7155	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835H) [human]	inhibition rate	4	%
7156	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835V) [human]	inhibition rate	16	%
7157	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835Y) [human]	inhibition rate	39	%
7158	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	FLT3(ITD) [human]	inhibition rate	0	%
7159	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835V) [human];+FLT3(ITD) [human]	inhibition rate	18	%
7160	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	FLT3(ITD) [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	0	%
7161	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	36	%
7162	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	0	%
7163	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	0	%
7164	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	FLT3-autoinhibited [human]	inhibition rate	0	%
7165	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Vascular endothelial growth factor receptor 3 [human]	inhibition rate	10	%
7166	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase FRK [human]	inhibition rate	12	%
7167	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Fyn [human]	inhibition rate	2	%
7168	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-G-associated kinase [human]	inhibition rate	15	%
7169	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABC transporter F family member 2 [human]	inhibition rate	37	%
7170	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Rhodopsin kinase GRK1 (C514S) [human]	inhibition rate	0	%
7171	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Beta-adrenergic receptor kinase 1 [human]	inhibition rate	46	%
7172	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Beta-adrenergic receptor kinase 2 [human]	inhibition rate	87	%
7173	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	G protein-coupled receptor kinase 4 [human]	inhibition rate	2	%
7174	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Rhodopsin kinase [human]	inhibition rate	0	%
7175	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Glycogen synthase kinase-3 alpha [human]	inhibition rate	0	%
7176	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	glycogen synthase kinase-3 beta [human]	inhibition rate	25	%
7177	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase haspin [human]	inhibition rate	85	%
7178	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase HCK [human]	inhibition rate	22	%
7179	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 1 [human]	inhibition rate	2	%
7180	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 2 [human]	inhibition rate	0	%
7181	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 3 [human]	inhibition rate	3	%
7182	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 4 [human]	inhibition rate	10	%
7183	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 1 [human]	inhibition rate	0	%
7184	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hormonally up-regulated neu tumor-associated kinase [human]	inhibition rate	100	%
7185	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Insulin-like growth factor 1 receptor [human]	inhibition rate	11	%
7186	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit alpha [human]	inhibition rate	0	%
7187	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition rate	0	%
7188	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit epsilon [human]	inhibition rate	0	%
7189	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Insulin receptor [human]	inhibition rate	9	%
7190	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Insulin receptor-related protein [human]	inhibition rate	0	%
7191	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Interleukin-1 receptor-associated kinase 1 [human]	inhibition rate	1	%
7192	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Interleukin-1 receptor-associated kinase 3 [human]	inhibition rate	0	%
7193	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Interleukin-1 receptor-associated kinase 4 [human]	inhibition rate	0	%
7194	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ITK/TSK [human]	inhibition rate	0	%
7195	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK1 [human]	inhibition rate	0	%
7196	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK1 [human]	inhibition rate	0	%
7197	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK2 [human]	inhibition rate	5	%
7198	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK3 [human]	inhibition rate	0	%
7199	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 8 [human]	inhibition rate	11	%
7200	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 9 [human]	inhibition rate	5	%
7201	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 10 [human]	inhibition rate	13	%
7202	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	9	%
7203	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (A829P) [human]	inhibition rate	26	%
7204	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (D816H) [human]	inhibition rate	15	%
7205	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (D816V) [human]	inhibition rate	0	%
7206	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	8	%
7207	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (V559D) [human]	inhibition rate	0	%
7208	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (V559D) [human];+Mast/stem cell growth factor receptor Kit [human]	inhibition rate	2	%
7209	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (V559D) [human];+Mast/stem cell growth factor receptor Kit [human]	inhibition rate	26	%
7210	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	KIT-autoinhibited [human]	inhibition rate	0	%
7211	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase LATS1 [human]	inhibition rate	4	%
7212	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase LATS2 [human]	inhibition rate	0	%
7213	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase LCK [human]	inhibition rate	0	%
7214	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	LIM domain kinase 1 [human]	inhibition rate	11	%
7215	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	LIM domain kinase 2 [human]	inhibition rate	15	%
7216	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase STK11 [human]	inhibition rate	0	%
7217	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Coiled-coil domain-containing protein 40 [human]	inhibition rate	10	%
7218	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Leucine-rich repeat serine/threonine-protein kinase 2 [human]	inhibition rate	0	%
7219	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Leucine-rich repeat serine/threonine-protein kinase 2 (G2019S) [human]	inhibition rate	0	%
7220	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Leukocyte tyrosine kinase receptor [human]	inhibition rate	8	%
7221	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Lyn [human]	inhibition rate	13	%
7222	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 13 [human]	inhibition rate	0	%
7223	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MAK [human]	inhibition rate	14	%
7224	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 1 [human]	inhibition rate	0	%
7225	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 15 [human]	inhibition rate	0	%
7226	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 2 [human]	inhibition rate	8	%
7227	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 3 [human]	inhibition rate	0	%
7228	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 4 [human]	inhibition rate	22	%
7229	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 2 [human]	inhibition rate	0	%
7230	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 3 [human]	inhibition rate	0	%
7231	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 4 [human]	inhibition rate	24	%
7232	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 5 [human]	inhibition rate	21	%
7233	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-activated protein kinase 2 [human]	inhibition rate	7	%
7234	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-activated protein kinase 5 [human]	inhibition rate	6	%
7235	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MARK1 [human]	inhibition rate	0	%
7236	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MARK2 [human]	inhibition rate	0	%
7237	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP/microtubule affinity-regulating kinase 3 [human]	inhibition rate	0	%
7238	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP/microtubule affinity-regulating kinase 4 [human]	inhibition rate	0	%
7239	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	CLIP-associating protein 1 [human]	inhibition rate	0	%
7240	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 1 [human]	inhibition rate	11	%
7241	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 2 [human]	inhibition rate	12	%
7242	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 3 [human]	inhibition rate	17	%
7243	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 4 [human]	inhibition rate	0	%
7244	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 5 [human]	inhibition rate	0	%
7245	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 6 [human]	inhibition rate	0	%
7246	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Maternal embryonic leucine zipper kinase [human]	inhibition rate	0	%
7247	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Mer [human]	inhibition rate	0	%
7248	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor receptor [human]	inhibition rate	10	%
7249	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor receptor (M1250T) [human]	inhibition rate	0	%
7250	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor receptor [human]	inhibition rate	0	%
7251	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Misshapen-like kinase 1 [human]	inhibition rate	3	%
7252	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 7 [human]	inhibition rate	0	%
7253	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-interacting serine/threonine-protein kinase 1 [human]	inhibition rate	0	%
7254	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-interacting serine/threonine-protein kinase 2 [human]	inhibition rate	32	%
7255	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase, smooth muscle [human]	inhibition rate	0	%
7256	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 9 [human]	inhibition rate	22	%
7257	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 10 [human]	inhibition rate	6	%
7258	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 11 [human]	inhibition rate	5	%
7259	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MRCK alpha [human]	inhibition rate	0	%
7260	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MRCK beta [human]	inhibition rate	5	%
7261	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor-like [human]	inhibition rate	9	%
7262	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Macrophage-stimulating protein receptor [human]	inhibition rate	0	%
7263	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Histone acetyltransferase mst2 [human]	inhibition rate	7	%
7264	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 24 [human]	inhibition rate	7	%
7265	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 26 [human]	inhibition rate	0	%
7266	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase mTOR [human]	inhibition rate	23	%
7267	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Muscle, skeletal receptor tyrosine-protein kinase [human]	inhibition rate	1	%
7268	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase, smooth muscle [human]	inhibition rate	28	%
7269	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase 2, skeletal/cardiac muscle [human]	inhibition rate	2	%
7270	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase family member 4 [human]	inhibition rate	5	%
7271	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ABL1(E255K)-Phosphorylated [human]	inhibition rate	0	%
7272	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin-IIIa [human]	inhibition rate	7	%
7273	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin-IIIb [human]	inhibition rate	5	%
7274	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein NDRG1 [human]	inhibition rate	4	%
7275	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein NDRG2 [human]	inhibition rate	0	%
7276	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek1 [human]	inhibition rate	0	%
7277	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek10 [human]	inhibition rate	3	%
7278	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek11 [human]	inhibition rate	0	%
7279	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek2 [human]	inhibition rate	1	%
7280	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek3 [human]	inhibition rate	10	%
7281	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek4 [human]	inhibition rate	0	%
7282	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317I)-nonphosphorylated [human]	inhibition rate	5	%
7283	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek5 [human]	inhibition rate	0	%
7284	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek6 [human]	inhibition rate	0	%
7285	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek7 [human]	inhibition rate	0	%
7286	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek9 [human]	inhibition rate	0	%
7287	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 14 [human]	inhibition rate	0	%
7288	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase NIM1 [human]	inhibition rate	0	%
7289	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine kinase NLK [human]	inhibition rate	5	%
7290	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase OSR1 [human]	inhibition rate	0	%
7291	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 14A [human]	inhibition rate	0	%
7292	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 11 [human]	inhibition rate	1	%
7293	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317I)-phosphorylated [human]	inhibition rate	0	%
7294	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 13 [human]	inhibition rate	33	%
7295	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 12 [human]	inhibition rate	0	%
7296	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase N1 [human]	inhibition rate	0	%
7297	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	serine/threonine-protein kinase pak 2 [human]	inhibition rate	0	%
7298	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PAK 3 [human]	inhibition rate	0	%
7299	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PAK 4 [human]	inhibition rate	0	%
7300	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PAK 6 [human]	inhibition rate	0	%
7301	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	serine/threonine-protein kinase pak 5 [human]	inhibition rate	0	%
7302	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 16 [human]	inhibition rate	0	%
7303	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 17 [human]	inhibition rate	0	%
7304	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317L)-nonphosphorylated [human]	inhibition rate	0	%
7305	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 18 [human]	inhibition rate	14	%
7306	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Platelet-derived growth factor receptor alpha [human]	inhibition rate	0	%
7307	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Platelet-derived growth factor receptor beta [human]	inhibition rate	5	%
7308	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	3-phosphoinositide-dependent protein kinase 1 [human]	inhibition rate	1	%
7309	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium-dependent protein kinase 1 [Plasmodium falciparum]	inhibition rate	0	%
7310	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cell division control protein 2 homolog [Plasmodium falciparum]	inhibition rate	0	%
7311	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 15 [human]	inhibition rate	0	%
7312	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 14 [human]	inhibition rate	0	%
7313	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform [human]	inhibition rate	0	%
7314	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform [human]	inhibition rate	0	%
7315	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317L)-phosphorylated [human]	inhibition rate	0	%
7316	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta [human]	inhibition rate	15	%
7317	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition rate	18	%
7318	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human]	inhibition rate	0	%
7319	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (C420R) [human]	inhibition rate	10	%
7320	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E542K) [human]	inhibition rate	46	%
7321	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545A) [human]	inhibition rate	8	%
7322	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545K) [human]	inhibition rate	0	%
7323	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047L) [human]	inhibition rate	0	%
7324	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047Y) [human]	inhibition rate	19	%
7325	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human]	inhibition rate	0	%
7326	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(H396P)-nonphosphorylated [human]	inhibition rate	0	%
7327	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (M1043I) [human]	inhibition rate	0	%
7328	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (Q546K) [human]	inhibition rate	45	%
7329	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [human]	inhibition rate	0	%
7330	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [human]	inhibition rate	2	%
7331	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform [human]	inhibition rate	0	%
7332	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-kinase beta [human]	inhibition rate	11	%
7333	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	1-phosphatidylinositol 3-phosphate 5-kinase [human]	inhibition rate	18	%
7334	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Lon protease homolog, mitochondrial [human]	inhibition rate	0	%
7335	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase pim-2 [human]	inhibition rate	0	%
7336	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase pim-3 [human]	inhibition rate	0	%
7337	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(H396P)-phosphorylated [human]	inhibition rate	28	%
7338	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha [human]	inhibition rate	0	%
7339	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma [human]	inhibition rate	0	%
7340	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta [human]	inhibition rate	21	%
7341	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma [human]	inhibition rate	0	%
7342	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cAMP-dependent protein kinase catalytic subunit alpha [human]	inhibition rate	6	%
7343	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cAMP-dependent protein kinase catalytic subunit beta [human]	inhibition rate	6	%
7344	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase [human]	inhibition rate	0	%
7345	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase N1 [human]	inhibition rate	0	%
7346	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase pkn2 [human]	inhibition rate	0	%
7347	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PknB [Mycobacterium tuberculosis]	inhibition rate	0	%
7348	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(M351T)-phosphorylated [human]	inhibition rate	0	%
7349	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PLK1 [human]	inhibition rate	0	%
7350	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PLK2 [human]	inhibition rate	0	%
7351	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Plk3 [human]	inhibition rate	13	%
7352	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Plk4 [human]	inhibition rate	0	%
7353	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, delta [human]	inhibition rate	0	%
7354	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, epsilon [human]	inhibition rate	12	%
7355	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, eta [human]	inhibition rate	0	%
7356	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C iota type [human]	inhibition rate	0	%
7357	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, theta [human]	inhibition rate	0	%
7358	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase D1 [human]	inhibition rate	3	%
7359	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(Q252H)-nonphosphorylated [human]	inhibition rate	1	%
7360	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase D2 [human]	inhibition rate	0	%
7361	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase D3 [human]	inhibition rate	24	%
7362	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cGMP-dependent protein kinase 1 [human]	inhibition rate	10	%
7363	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cGMP-dependent protein kinase 2 [human]	inhibition rate	7	%
7364	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Interferon-induced, double-stranded RNA-activated protein kinase [human]	inhibition rate	0	%
7365	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cAMP-dependent protein kinase catalytic subunit PRKX [human]	inhibition rate	0	%
7366	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proline-rich protein 4 [human]	inhibition rate	0	%
7367	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein-tyrosine kinase 2-beta [human]	inhibition rate	5	%
7368	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase SIK3 [human]	inhibition rate	26	%
7369	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	RAF proto-oncogene serine/threonine-protein kinase [human]	inhibition rate	0	%
7370	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(Q252H)-phosphorylated [human]	inhibition rate	7	%
7371	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret [human]	inhibition rate	8	%
7372	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (M918T) [human]	inhibition rate	0	%
7373	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804L) [human]	inhibition rate	0	%
7374	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M) [human]	inhibition rate	28	%
7375	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Rio1 [human]	inhibition rate	7	%
7376	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Rio2 [human]	inhibition rate	36	%
7377	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Rio3 [human]	inhibition rate	15	%
7378	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-interacting serine/threonine-protein kinase 1 [human]	inhibition rate	5	%
7379	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-interacting serine/threonine-protein kinase 2 [human]	inhibition rate	0	%
7380	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-interacting serine/threonine-protein kinase 4 [human]	inhibition rate	0	%
7381	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(T315I)-nonphosphorylated [human]	inhibition rate	0	%
7382	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual serine/threonine and tyrosine protein kinase [human]	inhibition rate	0	%
7383	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Rho-associated protein kinase 1 [human]	inhibition rate	0	%
7384	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Rho-associated protein kinase 2 [human]	inhibition rate	0	%
7385	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase ROS [human]	inhibition rate	12	%
7386	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-4 [human]	inhibition rate	10	%
7387	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-4 [human]	inhibition rate	8	%
7388	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-5 [human]	inhibition rate	0	%
7389	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-5 [human]	inhibition rate	27	%
7390	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-1 [human]	inhibition rate	6	%
7391	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-1 [human]	inhibition rate	6	%
7392	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(T315I)-phosphorylated [human]	inhibition rate	0	%
7393	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	0	%
7394	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	0	%
7395	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-2 [human]	inhibition rate	7	%
7396	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-2 [human]	inhibition rate	9	%
7397	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-6 [human]	inhibition rate	18	%
7398	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-6 [human]	inhibition rate	8	%
7399	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase beta-1 [human]	inhibition rate	0	%
7400	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	serine/threonine-protein kinase sbk1 [human]	inhibition rate	0	%
7401	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Sgk1 [human]	inhibition rate	3	%
7402	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Uncharacterized serine/threonine-protein kinase SBK3 [human]	inhibition rate	0	%
7403	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(Y253F)-phosphorylated [human]	inhibition rate	10	%
7404	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Sgk2 [human]	inhibition rate	8	%
7405	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Sgk3 [human]	inhibition rate	11	%
7406	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase SIK1 [human]	inhibition rate	0	%
7407	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase SIK2 [human]	inhibition rate	0	%
7408	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	STE20-like serine/threonine-protein kinase [human]	inhibition rate	5	%
7409	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	NUAK family SNF1-like kinase 2 [human]	inhibition rate	12	%
7410	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	SNF-related serine/threonine-protein kinase [human]	inhibition rate	0	%
7411	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase Src [human]	inhibition rate	0	%
7412	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Srms [human]	inhibition rate	0	%
7413	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	SRSF protein kinase 1 [human]	inhibition rate	0	%
7414	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1-nonphosphorylated [human]	inhibition rate	1	%
7415	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	SRSF protein kinase 2 [human]	inhibition rate	20	%
7416	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	SRSF protein kinase 3 [human]	inhibition rate	0	%
7417	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 16 [human]	inhibition rate	0	%
7418	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 33 [human]	inhibition rate	0	%
7419	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 35 [human]	inhibition rate	0	%
7420	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 36 [human]	inhibition rate	10	%
7421	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	STE20/SPS1-related proline-alanine-rich protein kinase [human]	inhibition rate	43	%
7422	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase SYK [human]	inhibition rate	2	%
7423	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 7 [human]	inhibition rate	0	%
7424	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TAO1 [human]	inhibition rate	0	%
7425	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ABL1- phosphorylated [human]	inhibition rate	21	%
7426	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TAO2 [human]	inhibition rate	0	%
7427	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TAO3 [human]	inhibition rate	45	%
7428	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TBK1 [human]	inhibition rate	16	%
7429	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Tec [human]	inhibition rate	6	%
7430	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity testis-specific protein kinase 1 [human]	inhibition rate	33	%
7431	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	TGF-beta receptor type-1 [human]	inhibition rate	0	%
7432	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	TGF-beta receptor type-2 [human]	inhibition rate	0	%
7433	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase receptor Tie-1 [human]	inhibition rate	0	%
7434	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase receptor Tie-2 [human]	inhibition rate	0	%
7435	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase tousled-like 1 [human]	inhibition rate	0	%
7436	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ABL2 [human]	inhibition rate	3	%
7437	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TOUSLED-like 2 [human]	inhibition rate	0	%
7438	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Traf2 and NCK-interacting protein kinase [human]	inhibition rate	0	%
7439	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Non-receptor tyrosine-protein kinase TNK1 [human]	inhibition rate	13	%
7440	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activated CDC42 kinase 1 [human]	inhibition rate	21	%
7441	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TNNI3K [human]	inhibition rate	0	%
7442	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	High affinity nerve growth factor receptor [human]	inhibition rate	14	%
7443	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	BDNF/NT-3 growth factors receptor [human]	inhibition rate	0	%
7444	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	NT-3 growth factor receptor [human]	inhibition rate	0	%
7445	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Transient receptor potential cation channel subfamily M member 6 [human]	inhibition rate	0	%
7446	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Testis-specific serine/threonine-protein kinase 1 [human]	inhibition rate	0	%
7447	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-1 [human]	inhibition rate	20	%
7448	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Testis-specific serine/threonine-protein kinase 3 [human]	inhibition rate	0	%
7449	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase TTK [human]	inhibition rate	38	%
7450	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase TXK [human]	inhibition rate	27	%
7451	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition rate	0	%
7452	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition rate	0	%
7453	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase receptor TYRO3 [human]	inhibition rate	11	%
7454	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ULK1 [human]	inhibition rate	11	%
7455	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ULK2 [human]	inhibition rate	0	%
7456	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ULK3 [human]	inhibition rate	0	%
7457	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Vascular endothelial growth factor receptor 2 [human]	inhibition rate	0	%
7458	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-1B [human]	inhibition rate	0	%
7459	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 3-kinase, Vps34 type [human]	inhibition rate	0	%
7460	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase VRK2 [human]	inhibition rate	6	%
7461	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitosis inhibitor protein kinase wee1 [human]	inhibition rate	0	%
7462	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Wee1-like protein kinase 1-A [human]	inhibition rate	1	%
7463	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK1 [human]	inhibition rate	0	%
7464	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK2 [human]	inhibition rate	0	%
7465	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK3 [human]	inhibition rate	0	%
7466	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK4 [human]	inhibition rate	9	%
7467	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 32A [human]	inhibition rate	0	%
7468	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 32B [human]	inhibition rate	0	%
7469	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-2A [human]	inhibition rate	0	%
7470	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 32C [human]	inhibition rate	11	%
7471	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Yes [human]	inhibition rate	10	%
7472	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 25 [human]	inhibition rate	0	%
7473	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 19 [human]	inhibition rate	11	%
7474	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 20 [human]	inhibition rate	24	%
7475	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ZAP-70 [human]	inhibition rate	0	%
7476	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-2B [human]	inhibition rate	0	%
7477	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase receptor R3 [human]	inhibition rate	12	%
7478	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Atypical kinase COQ8A, mitochondrial [human]	inhibition rate	0	%
7479	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Atypical kinase COQ8B, mitochondrial [human]	inhibition rate	21	%
7480	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	RAC-alpha serine/threonine-protein kinase [human]	inhibition rate	0	%
7481	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	RAC-beta serine/threonine-protein kinase [human]	inhibition rate	14	%
7482	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	RAC-gamma serine/threonine-protein kinase [human]	inhibition rate	7	%
7483	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ALK tyrosine kinase receptor [human]	inhibition rate	0	%
7484	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ALK tyrosine kinase receptor [human]	inhibition rate	0	%
7485	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ALK tyrosine kinase receptor [human]	inhibition rate	0	%
7486	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	5'-AMP-activated protein kinase catalytic subunit alpha-1 [human]	inhibition rate	15	%
7487	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	5'-AMP-activated protein kinase catalytic subunit alpha-2 [human]	inhibition rate	0	%
7488	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ankyrin repeat and protein kinase domain-containing protein 1 [human]	inhibition rate	0	%
7489	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	NUAK family SNF1-like kinase 1 [human]	inhibition rate	4	%
7490	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 5 [human]	inhibition rate	17	%
7491	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 6 [human]	inhibition rate	24	%
7492	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Aurora kinase A [human]	inhibition rate	9	%
7493	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Aurora kinase B [human]	inhibition rate	0	%
7494	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Aurora kinase C [human]	inhibition rate	0	%
7495	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	NEDD8-activating enzyme E1 regulatory subunit AXL [human]	inhibition rate	13	%
7496	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	BMP-2-inducible protein kinase [human]	inhibition rate	0	%
7497	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Blk [human]	inhibition rate	0	%
7498	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Bone morphogenetic protein receptor type-1A [human]	inhibition rate	1	%
7499	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Bone morphogenetic protein receptor type-1B [human]	inhibition rate	28	%
7500	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Bone morphogenetic protein receptor type-2 [human]	inhibition rate	0	%
7501	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cytoplasmic tyrosine-protein kinase BMX [human]	inhibition rate	17	%
7502	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase B-raf [human]	inhibition rate	2	%
7503	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase B-raf (V600E) [human]	inhibition rate	0	%
7504	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein-tyrosine kinase 6 [human]	inhibition rate	11	%
7505	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase BRSK1 [human]	inhibition rate	0	%
7506	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase BRSK2 [human]	inhibition rate	0	%
7507	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase BTK [human]	inhibition rate	0	%
7508	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitotic checkpoint serine/threonine-protein kinase BUB1 [human]	inhibition rate	28	%
7509	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1 [human]	inhibition rate	0	%
7510	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1B [human]	inhibition rate	0	%
7511	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1D [human]	inhibition rate	0	%
7512	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1G [human]	inhibition rate	0	%
7513	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II subunit alpha [human]	inhibition rate	0	%
7514	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II subunit beta [human]	inhibition rate	0	%
7515	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II delta 2 chain [human]	inhibition rate	0	%
7516	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II subunit gamma [human]	inhibition rate	0	%
7517	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type IV [human]	inhibition rate	21	%
7518	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase kinase 1 [human]	inhibition rate	0	%
7519	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase kinase 2 [human]	inhibition rate	4	%
7520	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Kappa-casein [human]	inhibition rate	0	%
7521	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 11B [human]	inhibition rate	2	%
7522	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 11A [human]	inhibition rate	0	%
7523	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 13 [human]	inhibition rate	1	%
7524	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 11 [human]	inhibition rate	0	%
7525	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 2 [human]	inhibition rate	0	%
7526	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 3 [human]	inhibition rate	0	%
7527	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1		CLint (intrinsic clearance)	130	μl/min/mg protein
7528	F[C@@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1		CLint (intrinsic clearance)	296	μl/min/mg protein
7529	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	pIC50	6.87	no unit
7530	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 4 [human]	inhibition rate	25	%
7531	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 4 [human]; Cyclin-D1-1 [human]	inhibition rate	0	%
7532	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 4 [human]; Cyclin-D3-1 [human]	inhibition rate	5	%
7533	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent-like kinase 5 [human]	inhibition rate	0	%
7534	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 7 [human]	inhibition rate	41	%
7535	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 8 [human]	inhibition rate	0	%
7536	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 9 [human]	inhibition rate	4	%
7537	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 1 [human]	inhibition rate	20	%
7538	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 2 [human]	inhibition rate	1	%
7539	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 3 [human]	inhibition rate	0	%
7540	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 5 [human]	inhibition rate	0	%
7541	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Chk1 [human]	inhibition rate	0	%
7542	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Chk2 [human]	inhibition rate	2	%
7543	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Citrate synthase, mitochondrial [human]	inhibition rate	0	%
7544	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ATG1 [human]	inhibition rate	64	%
7545	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase CLK2 [human]	inhibition rate	28	%
7546	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase CLK3 [human]	inhibition rate	5	%
7547	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase CLK4 [human]	inhibition rate	78	%
7548	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Macrophage colony-stimulating factor 1 receptor [human]	inhibition rate	0	%
7549	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	CSF1R-autoinhibited [human]	inhibition rate	0	%
7550	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase CSK [human]	inhibition rate	0	%
7551	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform alpha [human]	inhibition rate	59	%
7552	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform alpha-like [human]	inhibition rate	0	%
7553	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform delta [human]	inhibition rate	64	%
7554	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform epsilon [human]	inhibition rate	53	%
7555	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform gamma-1 [human]	inhibition rate	18	%
7556	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform gamma-2 [human]	inhibition rate	2	%
7557	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform gamma-3 [human]	inhibition rate	0	%
7558	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase II subunit alpha [human]	inhibition rate	11	%
7559	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase II subunit alpha' [human]	inhibition rate	12	%
7560	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Megakaryocyte-associated tyrosine-protein kinase [human]	inhibition rate	0	%
7561	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 1 [human]	inhibition rate	4	%
7562	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 2 [human]	inhibition rate	2	%
7563	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 3 [human]	inhibition rate	0	%
7564	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase DCLK1 [human]	inhibition rate	17	%
7565	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase DCLK2 [human]	inhibition rate	6	%
7566	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase DCLK3 [human]	inhibition rate	0	%
7567	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epithelial discoidin domain-containing receptor 1 [human]	inhibition rate	0	%
7568	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Discoidin domain-containing receptor 2 [human]	inhibition rate	52	%
7569	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 3 [human]	inhibition rate	29	%
7570	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myotonin-protein kinase [human]	inhibition rate	43	%
7571	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MRCK gamma [human]	inhibition rate	0	%
7572	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 17A [human]	inhibition rate	0	%
7573	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 17B [human]	inhibition rate	0	%
7574	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	inhibition rate	98.3	%
7575	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 1B [human]	inhibition rate	82	%
7576	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 2 [human]	inhibition rate	71	%
7577	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	0	%
7578	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	2	%
7579	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (G719C) [human]	inhibition rate	12	%
7580	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (G719S) [human]	inhibition rate	7	%
7581	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	0	%
7582	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	0	%
7583	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	14	%
7584	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (L858R) [human]	inhibition rate	0	%
7585	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (L858R) [human];+Epidermal growth factor receptor (T790M) [human]	inhibition rate	11	%
7586	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (L861Q) [human]	inhibition rate	19	%
7587	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	12	%
7588	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (T790M) [human]	inhibition rate	21	%
7589	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Eukaryotic translation initiation factor 2-alpha kinase 1 [human]	inhibition rate	22	%
7590	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	AP2-associated protein kinase 1 [human]	inhibition rate	9	%
7591	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 1 [human]	inhibition rate	0	%
7592	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 2 [human]	inhibition rate	13	%
7593	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 3 [human]	inhibition rate	2	%
7594	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 4 [human]	inhibition rate	0	%
7595	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 5 [human]	inhibition rate	0	%
7596	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 6 [human]	inhibition rate	0	%
7597	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 7 [human]	inhibition rate	0	%
7598	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 8 [human]	inhibition rate	6	%
7599	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 1 [human]	inhibition rate	0	%
7600	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 2 [human]	inhibition rate	0	%
7601	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 3 [human]	inhibition rate	3	%
7602	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 4 [human]	inhibition rate	5	%
7603	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 6 [human]	inhibition rate	44	%
7604	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor tyrosine-protein kinase erbB-2 [human]	inhibition rate	16	%
7605	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor tyrosine-protein kinase erbB-3 [human]	inhibition rate	3	%
7606	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor tyrosine-protein kinase erbB-4 [human]	inhibition rate	16	%
7607	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Extracellular signal-regulated kinase 1 [human]	inhibition rate	9	%
7608	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Extracellular signal-regulated kinase 2 [human]	inhibition rate	0	%
7609	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 6 [human]	inhibition rate	2	%
7610	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 4 [human]	inhibition rate	0	%
7611	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 7 [human]	inhibition rate	0	%
7612	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 15 [human]	inhibition rate	7	%
7613	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ethylene-responsive transcription factor ERN1 [human]	inhibition rate	2	%
7614	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Focal adhesion kinase 1 [human]	inhibition rate	0	%
7615	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Fer [human]	inhibition rate	3	%
7616	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase, Fes/Fps type [human]	inhibition rate	0	%
7617	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 1 [human]	inhibition rate	0	%
7618	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 2 [human]	inhibition rate	8	%
7619	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 3 [human]	inhibition rate	16	%
7620	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 3 [human]	inhibition rate	0	%
7621	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 4 [human]	inhibition rate	0	%
7622	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Fgr [human]	inhibition rate	4	%
7623	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Vascular endothelial growth factor receptor 1 [human]	inhibition rate	1	%
7624	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	1	%
7625	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835H) [human]	inhibition rate	8	%
7626	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835V) [human]	inhibition rate	39	%
7627	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835Y) [human]	inhibition rate	3	%
7628	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	FLT3(ITD) [human]	inhibition rate	0	%
7629	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835V) [human];+FLT3(ITD) [human]	inhibition rate	25	%
7630	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	FLT3(ITD) [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	63	%
7631	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	0	%
7632	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	16	%
7633	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	10	%
7634	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	FLT3-autoinhibited [human]	inhibition rate	1	%
7635	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Vascular endothelial growth factor receptor 3 [human]	inhibition rate	8	%
7636	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase FRK [human]	inhibition rate	0	%
7637	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Fyn [human]	inhibition rate	4	%
7638	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-G-associated kinase [human]	inhibition rate	20	%
7639	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABC transporter F family member 2 [human]	inhibition rate	0	%
7640	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Rhodopsin kinase GRK1 (C514S) [human]	inhibition rate	0	%
7641	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Beta-adrenergic receptor kinase 1 [human]	inhibition rate	20	%
7642	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Beta-adrenergic receptor kinase 2 [human]	inhibition rate	34	%
7643	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	G protein-coupled receptor kinase 4 [human]	inhibition rate	25	%
7644	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Rhodopsin kinase [human]	inhibition rate	0	%
7645	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Glycogen synthase kinase-3 alpha [human]	inhibition rate	14	%
7646	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	glycogen synthase kinase-3 beta [human]	inhibition rate	0	%
7647	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase haspin [human]	inhibition rate	99.6	%
7648	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase HCK [human]	inhibition rate	2	%
7649	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 1 [human]	inhibition rate	46	%
7650	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 2 [human]	inhibition rate	2	%
7651	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 3 [human]	inhibition rate	9	%
7652	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 4 [human]	inhibition rate	67	%
7653	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 1 [human]	inhibition rate	0	%
7654	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hormonally up-regulated neu tumor-associated kinase [human]	inhibition rate	18	%
7655	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Insulin-like growth factor 1 receptor [human]	inhibition rate	19	%
7656	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit alpha [human]	inhibition rate	18	%
7657	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition rate	9	%
7658	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit epsilon [human]	inhibition rate	9	%
7659	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Insulin receptor [human]	inhibition rate	15	%
7660	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Insulin receptor-related protein [human]	inhibition rate	3	%
7661	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Interleukin-1 receptor-associated kinase 1 [human]	inhibition rate	10	%
7662	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Interleukin-1 receptor-associated kinase 3 [human]	inhibition rate	28	%
7663	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Interleukin-1 receptor-associated kinase 4 [human]	inhibition rate	4	%
7664	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ITK/TSK [human]	inhibition rate	0	%
7665	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK1 [human]	inhibition rate	0	%
7666	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK1 [human]	inhibition rate	40	%
7667	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK2 [human]	inhibition rate	6	%
7668	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK3 [human]	inhibition rate	14	%
7669	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 8 [human]	inhibition rate	15	%
7670	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 9 [human]	inhibition rate	0	%
7671	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 10 [human]	inhibition rate	40	%
7672	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	5	%
7673	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (A829P) [human]	inhibition rate	0	%
7674	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (D816H) [human]	inhibition rate	36	%
7675	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (D816V) [human]	inhibition rate	13	%
7676	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	14	%
7677	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (V559D) [human]	inhibition rate	13	%
7678	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (V559D) [human];+Mast/stem cell growth factor receptor Kit [human]	inhibition rate	0	%
7679	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (V559D) [human];+Mast/stem cell growth factor receptor Kit [human]	inhibition rate	5	%
7680	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	KIT-autoinhibited [human]	inhibition rate	100	%
7681	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase LATS1 [human]	inhibition rate	0	%
7682	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase LATS2 [human]	inhibition rate	26	%
7683	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase LCK [human]	inhibition rate	10	%
7684	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	LIM domain kinase 1 [human]	inhibition rate	19	%
7685	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	LIM domain kinase 2 [human]	inhibition rate	0	%
7686	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase STK11 [human]	inhibition rate	35	%
7687	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Coiled-coil domain-containing protein 40 [human]	inhibition rate	2	%
7688	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Leucine-rich repeat serine/threonine-protein kinase 2 [human]	inhibition rate	0	%
7689	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Leucine-rich repeat serine/threonine-protein kinase 2 (G2019S) [human]	inhibition rate	11	%
7690	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Leukocyte tyrosine kinase receptor [human]	inhibition rate	0	%
7691	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Lyn [human]	inhibition rate	1	%
7692	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 13 [human]	inhibition rate	0	%
7693	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MAK [human]	inhibition rate	22	%
7694	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 1 [human]	inhibition rate	2	%
7695	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 15 [human]	inhibition rate	17	%
7696	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 2 [human]	inhibition rate	0	%
7697	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 3 [human]	inhibition rate	0	%
7698	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 4 [human]	inhibition rate	0	%
7699	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 2 [human]	inhibition rate	6	%
7700	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 3 [human]	inhibition rate	0	%
7701	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 4 [human]	inhibition rate	0	%
7702	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 5 [human]	inhibition rate	0	%
7703	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-activated protein kinase 2 [human]	inhibition rate	61	%
7704	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-activated protein kinase 5 [human]	inhibition rate	5	%
7705	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MARK1 [human]	inhibition rate	0	%
7706	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MARK2 [human]	inhibition rate	0	%
7707	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP/microtubule affinity-regulating kinase 3 [human]	inhibition rate	43	%
7708	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP/microtubule affinity-regulating kinase 4 [human]	inhibition rate	0	%
7709	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	CLIP-associating protein 1 [human]	inhibition rate	0	%
7710	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 1 [human]	inhibition rate	6	%
7711	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 2 [human]	inhibition rate	0	%
7712	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 3 [human]	inhibition rate	33	%
7713	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 4 [human]	inhibition rate	14	%
7714	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 5 [human]	inhibition rate	31	%
7715	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 6 [human]	inhibition rate	0	%
7716	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Maternal embryonic leucine zipper kinase [human]	inhibition rate	31	%
7717	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Mer [human]	inhibition rate	0	%
7718	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor receptor [human]	inhibition rate	10	%
7719	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor receptor (M1250T) [human]	inhibition rate	0	%
7720	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor receptor [human]	inhibition rate	0	%
7721	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Misshapen-like kinase 1 [human]	inhibition rate	0	%
7722	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 7 [human]	inhibition rate	7	%
7723	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-interacting serine/threonine-protein kinase 1 [human]	inhibition rate	10	%
7724	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-interacting serine/threonine-protein kinase 2 [human]	inhibition rate	79	%
7725	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase, smooth muscle [human]	inhibition rate	12	%
7726	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 9 [human]	inhibition rate	13	%
7727	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 10 [human]	inhibition rate	8	%
7728	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 11 [human]	inhibition rate	15	%
7729	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MRCK alpha [human]	inhibition rate	16	%
7730	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MRCK beta [human]	inhibition rate	12	%
7731	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor-like [human]	inhibition rate	0	%
7732	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Macrophage-stimulating protein receptor [human]	inhibition rate	18	%
7733	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Histone acetyltransferase mst2 [human]	inhibition rate	17	%
7734	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 24 [human]	inhibition rate	17	%
7735	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 26 [human]	inhibition rate	29	%
7736	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase mTOR [human]	inhibition rate	34	%
7737	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Muscle, skeletal receptor tyrosine-protein kinase [human]	inhibition rate	0	%
7738	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase, smooth muscle [human]	inhibition rate	19	%
7739	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase 2, skeletal/cardiac muscle [human]	inhibition rate	8	%
7740	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase family member 4 [human]	inhibition rate	0	%
7741	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ABL1(E255K)-Phosphorylated [human]	inhibition rate	2	%
7742	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin-IIIa [human]	inhibition rate	5	%
7743	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin-IIIb [human]	inhibition rate	0	%
7744	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein NDRG1 [human]	inhibition rate	0	%
7745	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein NDRG2 [human]	inhibition rate	0	%
7746	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek1 [human]	inhibition rate	3	%
7747	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek10 [human]	inhibition rate	4	%
7748	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek11 [human]	inhibition rate	29	%
7749	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek2 [human]	inhibition rate	0	%
7750	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek3 [human]	inhibition rate	0	%
7751	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek4 [human]	inhibition rate	0	%
7752	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317I)-nonphosphorylated [human]	inhibition rate	1	%
7753	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek5 [human]	inhibition rate	13	%
7754	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek6 [human]	inhibition rate	0	%
7755	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek7 [human]	inhibition rate	0	%
7756	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek9 [human]	inhibition rate	0	%
7757	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 14 [human]	inhibition rate	0	%
7758	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase NIM1 [human]	inhibition rate	5	%
7759	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine kinase NLK [human]	inhibition rate	24	%
7760	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase OSR1 [human]	inhibition rate	14	%
7761	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 14A [human]	inhibition rate	0	%
7762	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 11 [human]	inhibition rate	6	%
7763	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317I)-phosphorylated [human]	inhibition rate	6	%
7764	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 13 [human]	inhibition rate	16	%
7765	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 12 [human]	inhibition rate	14	%
7766	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase N1 [human]	inhibition rate	0	%
7767	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	serine/threonine-protein kinase pak 2 [human]	inhibition rate	13	%
7768	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PAK 3 [human]	inhibition rate	0	%
7769	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PAK 4 [human]	inhibition rate	12	%
7770	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PAK 6 [human]	inhibition rate	13	%
7771	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	serine/threonine-protein kinase pak 5 [human]	inhibition rate	0	%
7772	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 16 [human]	inhibition rate	0	%
7773	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 17 [human]	inhibition rate	0	%
7774	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317L)-nonphosphorylated [human]	inhibition rate	0	%
7775	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 18 [human]	inhibition rate	0	%
7776	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Platelet-derived growth factor receptor alpha [human]	inhibition rate	10	%
7777	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Platelet-derived growth factor receptor beta [human]	inhibition rate	7	%
7778	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	3-phosphoinositide-dependent protein kinase 1 [human]	inhibition rate	3	%
7779	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium-dependent protein kinase 1 [Plasmodium falciparum]	inhibition rate	6	%
7780	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cell division control protein 2 homolog [Plasmodium falciparum]	inhibition rate	62	%
7781	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 15 [human]	inhibition rate	0	%
7782	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 14 [human]	inhibition rate	0	%
7783	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform [human]	inhibition rate	16	%
7784	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform [human]	inhibition rate	23	%
7785	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317L)-phosphorylated [human]	inhibition rate	0	%
7786	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta [human]	inhibition rate	0	%
7787	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition rate	0	%
7788	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human]	inhibition rate	0	%
7789	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (C420R) [human]	inhibition rate	0	%
7790	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E542K) [human]	inhibition rate	17	%
7791	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545A) [human]	inhibition rate	0	%
7792	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545K) [human]	inhibition rate	5	%
7793	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047L) [human]	inhibition rate	25	%
7794	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047Y) [human]	inhibition rate	44	%
7795	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human]	inhibition rate	0	%
7796	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(H396P)-nonphosphorylated [human]	inhibition rate	42	%
7797	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (M1043I) [human]	inhibition rate	9	%
7798	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (Q546K) [human]	inhibition rate	9	%
7799	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [human]	inhibition rate	0	%
7800	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [human]	inhibition rate	0	%
7801	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform [human]	inhibition rate	0	%
7802	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-kinase beta [human]	inhibition rate	0	%
7803	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	1-phosphatidylinositol 3-phosphate 5-kinase [human]	inhibition rate	28	%
7804	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Lon protease homolog, mitochondrial [human]	inhibition rate	1	%
7805	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase pim-2 [human]	inhibition rate	2	%
7806	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase pim-3 [human]	inhibition rate	21	%
7807	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(H396P)-phosphorylated [human]	inhibition rate	42	%
7808	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha [human]	inhibition rate	5	%
7809	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma [human]	inhibition rate	37	%
7810	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta [human]	inhibition rate	0	%
7811	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma [human]	inhibition rate	19	%
7812	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cAMP-dependent protein kinase catalytic subunit alpha [human]	inhibition rate	6	%
7813	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cAMP-dependent protein kinase catalytic subunit beta [human]	inhibition rate	17	%
7814	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase [human]	inhibition rate	9	%
7815	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase N1 [human]	inhibition rate	14	%
7816	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase pkn2 [human]	inhibition rate	29	%
7817	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PknB [Mycobacterium tuberculosis]	inhibition rate	2	%
7818	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(M351T)-phosphorylated [human]	inhibition rate	0	%
7819	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PLK1 [human]	inhibition rate	4	%
7820	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PLK2 [human]	inhibition rate	29	%
7821	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Plk3 [human]	inhibition rate	17	%
7822	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Plk4 [human]	inhibition rate	0	%
7823	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, delta [human]	inhibition rate	0	%
7824	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, epsilon [human]	inhibition rate	0	%
7825	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, eta [human]	inhibition rate	12	%
7826	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C iota type [human]	inhibition rate	63	%
7827	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, theta [human]	inhibition rate	26	%
7828	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase D1 [human]	inhibition rate	35	%
7829	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(Q252H)-nonphosphorylated [human]	inhibition rate	26	%
7830	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase D2 [human]	inhibition rate	26	%
7831	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase D3 [human]	inhibition rate	9	%
7832	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cGMP-dependent protein kinase 1 [human]	inhibition rate	11	%
7833	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cGMP-dependent protein kinase 2 [human]	inhibition rate	9	%
7834	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Interferon-induced, double-stranded RNA-activated protein kinase [human]	inhibition rate	0	%
7835	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cAMP-dependent protein kinase catalytic subunit PRKX [human]	inhibition rate	0	%
7836	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proline-rich protein 4 [human]	inhibition rate	18	%
7837	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein-tyrosine kinase 2-beta [human]	inhibition rate	0	%
7838	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase SIK3 [human]	inhibition rate	0	%
7839	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	RAF proto-oncogene serine/threonine-protein kinase [human]	inhibition rate	0	%
7840	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(Q252H)-phosphorylated [human]	inhibition rate	41	%
7841	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret [human]	inhibition rate	49	%
7842	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (M918T) [human]	inhibition rate	10	%
7843	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804L) [human]	inhibition rate	7	%
7844	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M) [human]	inhibition rate	0	%
7845	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Rio1 [human]	inhibition rate	9	%
7846	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Rio2 [human]	inhibition rate	64	%
7847	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Rio3 [human]	inhibition rate	19	%
7848	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-interacting serine/threonine-protein kinase 1 [human]	inhibition rate	4	%
7849	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-interacting serine/threonine-protein kinase 2 [human]	inhibition rate	0	%
7850	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-interacting serine/threonine-protein kinase 4 [human]	inhibition rate	0	%
7851	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(T315I)-nonphosphorylated [human]	inhibition rate	12	%
7852	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual serine/threonine and tyrosine protein kinase [human]	inhibition rate	0	%
7853	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Rho-associated protein kinase 1 [human]	inhibition rate	27	%
7854	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Rho-associated protein kinase 2 [human]	inhibition rate	0	%
7855	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase ROS [human]	inhibition rate	15	%
7856	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-4 [human]	inhibition rate	9	%
7857	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-4 [human]	inhibition rate	5	%
7858	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-5 [human]	inhibition rate	0	%
7859	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-5 [human]	inhibition rate	0	%
7860	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-1 [human]	inhibition rate	1	%
7861	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-1 [human]	inhibition rate	1	%
7862	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(T315I)-phosphorylated [human]	inhibition rate	0	%
7863	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	11	%
7864	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	60	%
7865	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-2 [human]	inhibition rate	15	%
7866	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-2 [human]	inhibition rate	9	%
7867	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-6 [human]	inhibition rate	0	%
7868	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-6 [human]	inhibition rate	14	%
7869	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase beta-1 [human]	inhibition rate	0	%
7870	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	serine/threonine-protein kinase sbk1 [human]	inhibition rate	17	%
7871	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Sgk1 [human]	inhibition rate	9	%
7872	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Uncharacterized serine/threonine-protein kinase SBK3 [human]	inhibition rate	0	%
7873	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(Y253F)-phosphorylated [human]	inhibition rate	47	%
7874	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Sgk2 [human]	inhibition rate	6	%
7875	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Sgk3 [human]	inhibition rate	0	%
7876	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase SIK1 [human]	inhibition rate	0	%
7877	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase SIK2 [human]	inhibition rate	13	%
7878	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	STE20-like serine/threonine-protein kinase [human]	inhibition rate	14	%
7879	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	NUAK family SNF1-like kinase 2 [human]	inhibition rate	0	%
7880	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	SNF-related serine/threonine-protein kinase [human]	inhibition rate	0	%
7881	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase Src [human]	inhibition rate	12	%
7882	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Srms [human]	inhibition rate	12	%
7883	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	SRSF protein kinase 1 [human]	inhibition rate	16	%
7884	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1-nonphosphorylated [human]	inhibition rate	9	%
7885	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	SRSF protein kinase 2 [human]	inhibition rate	38	%
7886	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	SRSF protein kinase 3 [human]	inhibition rate	34	%
7887	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 16 [human]	inhibition rate	9	%
7888	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 33 [human]	inhibition rate	100	%
7889	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 35 [human]	inhibition rate	11	%
7890	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 36 [human]	inhibition rate	38	%
7891	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	STE20/SPS1-related proline-alanine-rich protein kinase [human]	inhibition rate	5	%
7892	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase SYK [human]	inhibition rate	19	%
7893	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 7 [human]	inhibition rate	0	%
7894	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TAO1 [human]	inhibition rate	13	%
7895	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ABL1- phosphorylated [human]	inhibition rate	12	%
7896	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TAO2 [human]	inhibition rate	48	%
7897	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TAO3 [human]	inhibition rate	0	%
7898	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TBK1 [human]	inhibition rate	0	%
7899	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Tec [human]	inhibition rate	0	%
7900	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity testis-specific protein kinase 1 [human]	inhibition rate	14	%
7901	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	TGF-beta receptor type-1 [human]	inhibition rate	0	%
7902	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	TGF-beta receptor type-2 [human]	inhibition rate	14	%
7903	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase receptor Tie-1 [human]	inhibition rate	0	%
7904	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase receptor Tie-2 [human]	inhibition rate	16	%
7905	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase tousled-like 1 [human]	inhibition rate	36	%
7906	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ABL2 [human]	inhibition rate	4	%
7907	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TOUSLED-like 2 [human]	inhibition rate	0	%
7908	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Traf2 and NCK-interacting protein kinase [human]	inhibition rate	20	%
7909	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Non-receptor tyrosine-protein kinase TNK1 [human]	inhibition rate	100	%
7910	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activated CDC42 kinase 1 [human]	inhibition rate	23	%
7911	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TNNI3K [human]	inhibition rate	0	%
7912	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	High affinity nerve growth factor receptor [human]	inhibition rate	15	%
7913	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	BDNF/NT-3 growth factors receptor [human]	inhibition rate	0	%
7914	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	NT-3 growth factor receptor [human]	inhibition rate	15	%
7915	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Transient receptor potential cation channel subfamily M member 6 [human]	inhibition rate	9	%
7916	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Testis-specific serine/threonine-protein kinase 1 [human]	inhibition rate	0	%
7917	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-1 [human]	inhibition rate	15	%
7918	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Testis-specific serine/threonine-protein kinase 3 [human]	inhibition rate	12	%
7919	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase TTK [human]	inhibition rate	7	%
7920	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase TXK [human]	inhibition rate	0	%
7921	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition rate	24	%
7922	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition rate	22	%
7923	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase receptor TYRO3 [human]	inhibition rate	12	%
7924	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ULK1 [human]	inhibition rate	0	%
7925	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ULK2 [human]	inhibition rate	6	%
7926	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ULK3 [human]	inhibition rate	14	%
7927	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Vascular endothelial growth factor receptor 2 [human]	inhibition rate	0	%
7928	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-1B [human]	inhibition rate	23	%
7929	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 3-kinase, Vps34 type [human]	inhibition rate	23	%
7930	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase VRK2 [human]	inhibition rate	17	%
7931	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitosis inhibitor protein kinase wee1 [human]	inhibition rate	32	%
7932	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Wee1-like protein kinase 1-A [human]	inhibition rate	0	%
7933	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK1 [human]	inhibition rate	91.6	%
7934	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK2 [human]	inhibition rate	0	%
7935	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK3 [human]	inhibition rate	10	%
7936	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK4 [human]	inhibition rate	16	%
7937	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 32A [human]	inhibition rate	13	%
7938	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 32B [human]	inhibition rate	0	%
7939	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-2A [human]	inhibition rate	0	%
7940	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 32C [human]	inhibition rate	3	%
7941	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Yes [human]	inhibition rate	9	%
7942	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 25 [human]	inhibition rate	0	%
7943	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 19 [human]	inhibition rate	21	%
7944	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 20 [human]	inhibition rate	1	%
7945	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ZAP-70 [human]	inhibition rate	0	%
7946	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-2B [human]	inhibition rate	7	%
7947	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase receptor R3 [human]	inhibition rate	3	%
7948	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Atypical kinase COQ8A, mitochondrial [human]	inhibition rate	21	%
7949	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Atypical kinase COQ8B, mitochondrial [human]	inhibition rate	26	%
7950	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	RAC-alpha serine/threonine-protein kinase [human]	inhibition rate	3	%
7951	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	RAC-beta serine/threonine-protein kinase [human]	inhibition rate	0	%
7952	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	RAC-gamma serine/threonine-protein kinase [human]	inhibition rate	0	%
7953	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ALK tyrosine kinase receptor [human]	inhibition rate	15	%
7954	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ALK tyrosine kinase receptor [human]	inhibition rate	4	%
7955	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ALK tyrosine kinase receptor [human]	inhibition rate	26	%
7956	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	5'-AMP-activated protein kinase catalytic subunit alpha-1 [human]	inhibition rate	0	%
7957	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	5'-AMP-activated protein kinase catalytic subunit alpha-2 [human]	inhibition rate	0	%
7958	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ankyrin repeat and protein kinase domain-containing protein 1 [human]	inhibition rate	6	%
7959	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	NUAK family SNF1-like kinase 1 [human]	inhibition rate	37	%
7960	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 5 [human]	inhibition rate	1	%
7961	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 6 [human]	inhibition rate	18	%
7962	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Aurora kinase A [human]	inhibition rate	3	%
7963	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Aurora kinase B [human]	inhibition rate	23	%
7964	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Aurora kinase C [human]	inhibition rate	3	%
7965	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	NEDD8-activating enzyme E1 regulatory subunit AXL [human]	inhibition rate	3	%
7966	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	BMP-2-inducible protein kinase [human]	inhibition rate	12	%
7967	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Blk [human]	inhibition rate	0	%
7968	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Bone morphogenetic protein receptor type-1A [human]	inhibition rate	25	%
7969	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Bone morphogenetic protein receptor type-1B [human]	inhibition rate	0	%
7970	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Bone morphogenetic protein receptor type-2 [human]	inhibition rate	0	%
7971	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cytoplasmic tyrosine-protein kinase BMX [human]	inhibition rate	5	%
7972	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase B-raf [human]	inhibition rate	16	%
7973	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase B-raf (V600E) [human]	inhibition rate	8	%
7974	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein-tyrosine kinase 6 [human]	inhibition rate	5	%
7975	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase BRSK1 [human]	inhibition rate	19	%
7976	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase BRSK2 [human]	inhibition rate	0	%
7977	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase BTK [human]	inhibition rate	6	%
7978	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitotic checkpoint serine/threonine-protein kinase BUB1 [human]	inhibition rate	3	%
7979	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1 [human]	inhibition rate	12	%
7980	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1B [human]	inhibition rate	16	%
7981	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1D [human]	inhibition rate	9	%
7982	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1G [human]	inhibition rate	7	%
7983	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II subunit alpha [human]	inhibition rate	0	%
7984	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II subunit beta [human]	inhibition rate	0	%
7985	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II delta 2 chain [human]	inhibition rate	0	%
7986	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II subunit gamma [human]	inhibition rate	4	%
7987	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type IV [human]	inhibition rate	0	%
7988	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase kinase 1 [human]	inhibition rate	0	%
7989	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase kinase 2 [human]	inhibition rate	0	%
7990	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Kappa-casein [human]	inhibition rate	0	%
7991	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 11B [human]	inhibition rate	0	%
7992	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 11A [human]	inhibition rate	18	%
7993	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 13 [human]	inhibition rate	36	%
7994	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 11 [human]	inhibition rate	0	%
7995	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 2 [human]	inhibition rate	0	%
7996	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 3 [human]	inhibition rate	5	%
7997	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	kd	72.8	nM
7998	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1		CLint (intrinsic clearance)	48	μl/min/mg protein
7999	N[C@H]1CCN(C1)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1		CLint (intrinsic clearance)	199	μl/min/mg protein
8000	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	pIC50	6.94	no unit
8001	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Cyclin-dependent kinase 4 [human]	inhibition rate	5	%
8002	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Cyclin-dependent kinase 4 [human]; Cyclin-D1-1 [human]	inhibition rate	16	%
8003	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Cyclin-dependent kinase 4 [human]; Cyclin-D3-1 [human]	inhibition rate	17	%
8004	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Cyclin-dependent-like kinase 5 [human]	inhibition rate	0	%
8005	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Cyclin-dependent kinase 7 [human]	inhibition rate	39	%
8006	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Cyclin-dependent kinase 8 [human]	inhibition rate	7	%
8007	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Cyclin-dependent kinase 9 [human]	inhibition rate	9	%
8008	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Cyclin-dependent kinase-like 1 [human]	inhibition rate	27	%
8009	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Cyclin-dependent kinase-like 2 [human]	inhibition rate	0	%
8010	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Cyclin-dependent kinase-like 3 [human]	inhibition rate	14	%
8011	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Cyclin-dependent kinase-like 5 [human]	inhibition rate	14	%
8012	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase Chk1 [human]	inhibition rate	0	%
8013	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase Chk2 [human]	inhibition rate	16	%
8014	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Citrate synthase, mitochondrial [human]	inhibition rate	18	%
8015	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase ATG1 [human]	inhibition rate	85	%
8016	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Dual specificity protein kinase CLK2 [human]	inhibition rate	87	%
8017	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Dual specificity protein kinase CLK3 [human]	inhibition rate	24	%
8018	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Dual specificity protein kinase CLK4 [human]	inhibition rate	90.3	%
8019	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Macrophage colony-stimulating factor 1 receptor [human]	inhibition rate	0	%
8020	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	CSF1R-autoinhibited [human]	inhibition rate	12	%
8021	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Tyrosine-protein kinase CSK [human]	inhibition rate	1	%
8022	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Casein kinase I isoform alpha [human]	inhibition rate	57	%
8023	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Casein kinase I isoform alpha-like [human]	inhibition rate	11	%
8024	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Casein kinase I isoform delta [human]	inhibition rate	31	%
8025	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Casein kinase I isoform epsilon [human]	inhibition rate	40	%
8026	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Casein kinase I isoform gamma-1 [human]	inhibition rate	27	%
8027	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Casein kinase I isoform gamma-2 [human]	inhibition rate	0	%
8028	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Casein kinase I isoform gamma-3 [human]	inhibition rate	18	%
8029	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Casein kinase II subunit alpha [human]	inhibition rate	14	%
8030	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Casein kinase II subunit alpha' [human]	inhibition rate	31	%
8031	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Megakaryocyte-associated tyrosine-protein kinase [human]	inhibition rate	0	%
8032	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Death-associated protein kinase 1 [human]	inhibition rate	26	%
8033	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Death-associated protein kinase 2 [human]	inhibition rate	13	%
8034	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Death-associated protein kinase 3 [human]	inhibition rate	16	%
8035	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase DCLK1 [human]	inhibition rate	9	%
8036	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase DCLK2 [human]	inhibition rate	0	%
8037	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase DCLK3 [human]	inhibition rate	7	%
8038	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Epithelial discoidin domain-containing receptor 1 [human]	inhibition rate	0	%
8039	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Discoidin domain-containing receptor 2 [human]	inhibition rate	31	%
8040	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Death-associated protein kinase 3 [human]	inhibition rate	17	%
8041	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Myotonin-protein kinase [human]	inhibition rate	0	%
8042	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase MRCK gamma [human]	inhibition rate	3	%
8043	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase 17A [human]	inhibition rate	14	%
8044	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase 17B [human]	inhibition rate	0	%
8045	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	inhibition rate	98.9	%
8046	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 1B [human]	inhibition rate	98.4	%
8047	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 2 [human]	inhibition rate	75	%
8048	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	25	%
8049	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	0	%
8050	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Epidermal growth factor receptor (G719C) [human]	inhibition rate	0	%
8051	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Epidermal growth factor receptor (G719S) [human]	inhibition rate	0	%
8052	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	17	%
8053	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	17	%
8054	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	0	%
8055	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Epidermal growth factor receptor (L858R) [human]	inhibition rate	0	%
8056	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Epidermal growth factor receptor (L858R) [human];+Epidermal growth factor receptor (T790M) [human]	inhibition rate	0	%
8057	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Epidermal growth factor receptor (L861Q) [human]	inhibition rate	30	%
8058	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	0	%
8059	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Epidermal growth factor receptor (T790M) [human]	inhibition rate	0	%
8060	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Eukaryotic translation initiation factor 2-alpha kinase 1 [human]	inhibition rate	16	%
8061	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	AP2-associated protein kinase 1 [human]	inhibition rate	9	%
8062	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Ephrin type-A receptor 1 [human]	inhibition rate	11	%
8063	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Ephrin type-A receptor 2 [human]	inhibition rate	5	%
8064	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Ephrin type-A receptor 3 [human]	inhibition rate	16	%
8065	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Ephrin type-A receptor 4 [human]	inhibition rate	4	%
8066	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Ephrin type-A receptor 5 [human]	inhibition rate	0	%
8067	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Ephrin type-A receptor 6 [human]	inhibition rate	0	%
8068	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Ephrin type-A receptor 7 [human]	inhibition rate	0	%
8069	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Ephrin type-A receptor 8 [human]	inhibition rate	1	%
8070	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Ephrin type-B receptor 1 [human]	inhibition rate	0	%
8071	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Ephrin type-B receptor 2 [human]	inhibition rate	10	%
8072	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Ephrin type-B receptor 3 [human]	inhibition rate	0	%
8073	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Ephrin type-B receptor 4 [human]	inhibition rate	6	%
8074	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Ephrin type-B receptor 6 [human]	inhibition rate	20	%
8075	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Receptor tyrosine-protein kinase erbB-2 [human]	inhibition rate	6	%
8076	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Receptor tyrosine-protein kinase erbB-3 [human]	inhibition rate	0	%
8077	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Receptor tyrosine-protein kinase erbB-4 [human]	inhibition rate	35	%
8078	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Extracellular signal-regulated kinase 1 [human]	inhibition rate	0	%
8079	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Extracellular signal-regulated kinase 2 [human]	inhibition rate	0	%
8080	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitogen-activated protein kinase 6 [human]	inhibition rate	2	%
8081	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitogen-activated protein kinase 4 [human]	inhibition rate	6	%
8082	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitogen-activated protein kinase 7 [human]	inhibition rate	4	%
8083	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitogen-activated protein kinase 15 [human]	inhibition rate	17	%
8084	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Ethylene-responsive transcription factor ERN1 [human]	inhibition rate	0	%
8085	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Focal adhesion kinase 1 [human]	inhibition rate	8	%
8086	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Tyrosine-protein kinase Fer [human]	inhibition rate	8	%
8087	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Tyrosine-protein kinase, Fes/Fps type [human]	inhibition rate	7	%
8088	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Fibroblast growth factor receptor 1 [human]	inhibition rate	0	%
8089	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Fibroblast growth factor receptor 2 [human]	inhibition rate	2	%
8090	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Fibroblast growth factor receptor 3 [human]	inhibition rate	0	%
8091	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Fibroblast growth factor receptor 3 [human]	inhibition rate	18	%
8092	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Fibroblast growth factor receptor 4 [human]	inhibition rate	3	%
8093	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Tyrosine-protein kinase Fgr [human]	inhibition rate	0	%
8094	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Vascular endothelial growth factor receptor 1 [human]	inhibition rate	3	%
8095	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	2	%
8096	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835H) [human]	inhibition rate	0	%
8097	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835V) [human]	inhibition rate	34	%
8098	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835Y) [human]	inhibition rate	34	%
8099	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	FLT3(ITD) [human]	inhibition rate	18	%
8100	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835V) [human];+FLT3(ITD) [human]	inhibition rate	13	%
8101	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	FLT3(ITD) [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	5	%
8102	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	0	%
8103	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	0	%
8104	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	10	%
8105	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	FLT3-autoinhibited [human]	inhibition rate	16	%
8106	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Vascular endothelial growth factor receptor 3 [human]	inhibition rate	0	%
8107	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Tyrosine-protein kinase FRK [human]	inhibition rate	0	%
8108	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Tyrosine-protein kinase Fyn [human]	inhibition rate	2	%
8109	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Cyclin-G-associated kinase [human]	inhibition rate	48	%
8110	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	ABC transporter F family member 2 [human]	inhibition rate	4	%
8111	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Rhodopsin kinase GRK1 (C514S) [human]	inhibition rate	12	%
8112	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Beta-adrenergic receptor kinase 1 [human]	inhibition rate	50	%
8113	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Beta-adrenergic receptor kinase 2 [human]	inhibition rate	33	%
8114	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	G protein-coupled receptor kinase 4 [human]	inhibition rate	45	%
8115	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Rhodopsin kinase [human]	inhibition rate	16	%
8116	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Glycogen synthase kinase-3 alpha [human]	inhibition rate	4	%
8117	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	glycogen synthase kinase-3 beta [human]	inhibition rate	0	%
8118	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase haspin [human]	inhibition rate	98.9	%
8119	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Tyrosine-protein kinase HCK [human]	inhibition rate	0	%
8120	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Homeodomain-interacting protein kinase 1 [human]	inhibition rate	61	%
8121	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Homeodomain-interacting protein kinase 2 [human]	inhibition rate	37	%
8122	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Homeodomain-interacting protein kinase 3 [human]	inhibition rate	32	%
8123	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Homeodomain-interacting protein kinase 4 [human]	inhibition rate	23	%
8124	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 1 [human]	inhibition rate	1	%
8125	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Hormonally up-regulated neu tumor-associated kinase [human]	inhibition rate	0	%
8126	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Insulin-like growth factor 1 receptor [human]	inhibition rate	0	%
8127	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit alpha [human]	inhibition rate	31	%
8128	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition rate	47	%
8129	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit epsilon [human]	inhibition rate	4	%
8130	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Insulin receptor [human]	inhibition rate	32	%
8131	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Insulin receptor-related protein [human]	inhibition rate	3	%
8132	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Interleukin-1 receptor-associated kinase 1 [human]	inhibition rate	0	%
8133	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Interleukin-1 receptor-associated kinase 3 [human]	inhibition rate	30	%
8134	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Interleukin-1 receptor-associated kinase 4 [human]	inhibition rate	0	%
8135	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Tyrosine-protein kinase ITK/TSK [human]	inhibition rate	0	%
8136	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Tyrosine-protein kinase JAK1 [human]	inhibition rate	2	%
8137	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Tyrosine-protein kinase JAK1 [human]	inhibition rate	49	%
8138	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Tyrosine-protein kinase JAK2 [human]	inhibition rate	7	%
8139	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Tyrosine-protein kinase JAK3 [human]	inhibition rate	9	%
8140	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitogen-activated protein kinase 8 [human]	inhibition rate	33	%
8141	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitogen-activated protein kinase 9 [human]	inhibition rate	12	%
8142	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitogen-activated protein kinase 10 [human]	inhibition rate	29	%
8143	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	0	%
8144	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mast/stem cell growth factor receptor Kit (A829P) [human]	inhibition rate	5	%
8145	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mast/stem cell growth factor receptor Kit (D816H) [human]	inhibition rate	17	%
8146	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mast/stem cell growth factor receptor Kit (D816V) [human]	inhibition rate	0	%
8147	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	0	%
8148	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mast/stem cell growth factor receptor Kit (V559D) [human]	inhibition rate	0	%
8149	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mast/stem cell growth factor receptor Kit (V559D) [human];+Mast/stem cell growth factor receptor Kit [human]	inhibition rate	0	%
8150	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mast/stem cell growth factor receptor Kit (V559D) [human];+Mast/stem cell growth factor receptor Kit [human]	inhibition rate	0	%
8151	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	KIT-autoinhibited [human]	inhibition rate	5	%
8152	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase LATS1 [human]	inhibition rate	52	%
8153	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase LATS2 [human]	inhibition rate	16	%
8154	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Proto-oncogene tyrosine-protein kinase LCK [human]	inhibition rate	0	%
8155	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	LIM domain kinase 1 [human]	inhibition rate	0	%
8156	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	LIM domain kinase 2 [human]	inhibition rate	6	%
8157	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase STK11 [human]	inhibition rate	1	%
8158	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Coiled-coil domain-containing protein 40 [human]	inhibition rate	0	%
8159	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Leucine-rich repeat serine/threonine-protein kinase 2 [human]	inhibition rate	53	%
8160	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Leucine-rich repeat serine/threonine-protein kinase 2 (G2019S) [human]	inhibition rate	0	%
8161	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Leukocyte tyrosine kinase receptor [human]	inhibition rate	2	%
8162	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Tyrosine-protein kinase Lyn [human]	inhibition rate	8	%
8163	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitogen-activated protein kinase kinase kinase 13 [human]	inhibition rate	30	%
8164	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase MAK [human]	inhibition rate	54	%
8165	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitogen-activated protein kinase kinase kinase 1 [human]	inhibition rate	9	%
8166	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitogen-activated protein kinase kinase kinase 15 [human]	inhibition rate	0	%
8167	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitogen-activated protein kinase kinase kinase 2 [human]	inhibition rate	10	%
8168	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitogen-activated protein kinase kinase kinase 3 [human]	inhibition rate	53	%
8169	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitogen-activated protein kinase kinase kinase 4 [human]	inhibition rate	14	%
8170	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 2 [human]	inhibition rate	1	%
8171	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 3 [human]	inhibition rate	0	%
8172	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 4 [human]	inhibition rate	0	%
8173	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 5 [human]	inhibition rate	33	%
8174	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	MAP kinase-activated protein kinase 2 [human]	inhibition rate	0	%
8175	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	MAP kinase-activated protein kinase 5 [human]	inhibition rate	23	%
8176	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase MARK1 [human]	inhibition rate	2	%
8177	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase MARK2 [human]	inhibition rate	0	%
8178	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	MAP/microtubule affinity-regulating kinase 3 [human]	inhibition rate	18	%
8179	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	MAP/microtubule affinity-regulating kinase 4 [human]	inhibition rate	9	%
8180	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	CLIP-associating protein 1 [human]	inhibition rate	0	%
8181	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 1 [human]	inhibition rate	18	%
8182	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 2 [human]	inhibition rate	0	%
8183	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 3 [human]	inhibition rate	17	%
8184	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 4 [human]	inhibition rate	0	%
8185	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 5 [human]	inhibition rate	22	%
8186	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 6 [human]	inhibition rate	0	%
8187	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Maternal embryonic leucine zipper kinase [human]	inhibition rate	0	%
8188	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Tyrosine-protein kinase Mer [human]	inhibition rate	0	%
8189	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Hepatocyte growth factor receptor [human]	inhibition rate	0	%
8190	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Hepatocyte growth factor receptor (M1250T) [human]	inhibition rate	39	%
8191	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Hepatocyte growth factor receptor [human]	inhibition rate	13	%
8192	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Misshapen-like kinase 1 [human]	inhibition rate	8	%
8193	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 7 [human]	inhibition rate	29	%
8194	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	MAP kinase-interacting serine/threonine-protein kinase 1 [human]	inhibition rate	24	%
8195	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	MAP kinase-interacting serine/threonine-protein kinase 2 [human]	inhibition rate	51	%
8196	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Myosin light chain kinase, smooth muscle [human]	inhibition rate	4	%
8197	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitogen-activated protein kinase kinase kinase 9 [human]	inhibition rate	0	%
8198	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitogen-activated protein kinase kinase kinase 10 [human]	inhibition rate	0	%
8199	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitogen-activated protein kinase kinase kinase 11 [human]	inhibition rate	0	%
8200	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase MRCK alpha [human]	inhibition rate	13	%
8201	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase MRCK beta [human]	inhibition rate	0	%
8202	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Hepatocyte growth factor-like [human]	inhibition rate	3	%
8203	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Macrophage-stimulating protein receptor [human]	inhibition rate	29	%
8204	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Histone acetyltransferase mst2 [human]	inhibition rate	2	%
8205	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase 24 [human]	inhibition rate	2	%
8206	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase 26 [human]	inhibition rate	2	%
8207	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase mTOR [human]	inhibition rate	0	%
8208	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Muscle, skeletal receptor tyrosine-protein kinase [human]	inhibition rate	21	%
8209	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Myosin light chain kinase, smooth muscle [human]	inhibition rate	1	%
8210	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Myosin light chain kinase 2, skeletal/cardiac muscle [human]	inhibition rate	0	%
8211	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Myosin light chain kinase family member 4 [human]	inhibition rate	20	%
8212	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Tyrosine-protein kinase ABL1(E255K)-Phosphorylated [human]	inhibition rate	0	%
8213	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Myosin-IIIa [human]	inhibition rate	0	%
8214	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Myosin-IIIb [human]	inhibition rate	20	%
8215	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Protein NDRG1 [human]	inhibition rate	0	%
8216	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Protein NDRG2 [human]	inhibition rate	0	%
8217	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase Nek1 [human]	inhibition rate	0	%
8218	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase Nek10 [human]	inhibition rate	11	%
8219	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase Nek11 [human]	inhibition rate	2	%
8220	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase Nek2 [human]	inhibition rate	11	%
8221	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase Nek3 [human]	inhibition rate	24	%
8222	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase Nek4 [human]	inhibition rate	12	%
8223	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	ABL1(F317I)-nonphosphorylated [human]	inhibition rate	31	%
8224	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase Nek5 [human]	inhibition rate	0	%
8225	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase Nek6 [human]	inhibition rate	0	%
8226	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase Nek7 [human]	inhibition rate	0	%
8227	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase Nek9 [human]	inhibition rate	0	%
8228	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitogen-activated protein kinase kinase kinase 14 [human]	inhibition rate	20	%
8229	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase NIM1 [human]	inhibition rate	8	%
8230	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine kinase NLK [human]	inhibition rate	0	%
8231	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase OSR1 [human]	inhibition rate	16	%
8232	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitogen-activated protein kinase 14A [human]	inhibition rate	0	%
8233	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitogen-activated protein kinase 11 [human]	inhibition rate	0	%
8234	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	ABL1(F317I)-phosphorylated [human]	inhibition rate	0	%
8235	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitogen-activated protein kinase 13 [human]	inhibition rate	0	%
8236	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitogen-activated protein kinase 12 [human]	inhibition rate	15	%
8237	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase N1 [human]	inhibition rate	29	%
8238	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	serine/threonine-protein kinase pak 2 [human]	inhibition rate	4	%
8239	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase PAK 3 [human]	inhibition rate	0	%
8240	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase PAK 4 [human]	inhibition rate	0	%
8241	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase PAK 6 [human]	inhibition rate	7	%
8242	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	serine/threonine-protein kinase pak 5 [human]	inhibition rate	100	%
8243	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Cyclin-dependent kinase 16 [human]	inhibition rate	0	%
8244	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Cyclin-dependent kinase 17 [human]	inhibition rate	0	%
8245	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	ABL1(F317L)-nonphosphorylated [human]	inhibition rate	49	%
8246	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Cyclin-dependent kinase 18 [human]	inhibition rate	0	%
8247	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Platelet-derived growth factor receptor alpha [human]	inhibition rate	3	%
8248	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Platelet-derived growth factor receptor beta [human]	inhibition rate	0	%
8249	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	3-phosphoinositide-dependent protein kinase 1 [human]	inhibition rate	0	%
8250	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Calcium-dependent protein kinase 1 [Plasmodium falciparum]	inhibition rate	22	%
8251	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Cell division control protein 2 homolog [Plasmodium falciparum]	inhibition rate	18	%
8252	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Cyclin-dependent kinase 15 [human]	inhibition rate	0	%
8253	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Cyclin-dependent kinase 14 [human]	inhibition rate	9	%
8254	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform [human]	inhibition rate	15	%
8255	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform [human]	inhibition rate	5	%
8256	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	ABL1(F317L)-phosphorylated [human]	inhibition rate	14	%
8257	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta [human]	inhibition rate	0	%
8258	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition rate	11	%
8259	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human]	inhibition rate	0	%
8260	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (C420R) [human]	inhibition rate	0	%
8261	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E542K) [human]	inhibition rate	21	%
8262	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545A) [human]	inhibition rate	0	%
8263	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545K) [human]	inhibition rate	18	%
8264	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047L) [human]	inhibition rate	23	%
8265	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047Y) [human]	inhibition rate	2	%
8266	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human]	inhibition rate	0	%
8267	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	ABL1(H396P)-nonphosphorylated [human]	inhibition rate	19	%
8268	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (M1043I) [human]	inhibition rate	10	%
8269	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (Q546K) [human]	inhibition rate	94.9	%
8270	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [human]	inhibition rate	26	%
8271	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [human]	inhibition rate	0	%
8272	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform [human]	inhibition rate	53	%
8273	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Phosphatidylinositol 4-kinase beta [human]	inhibition rate	44	%
8274	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	1-phosphatidylinositol 3-phosphate 5-kinase [human]	inhibition rate	13	%
8275	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Lon protease homolog, mitochondrial [human]	inhibition rate	20	%
8276	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase pim-2 [human]	inhibition rate	16	%
8277	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase pim-3 [human]	inhibition rate	15	%
8278	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	ABL1(H396P)-phosphorylated [human]	inhibition rate	3	%
8279	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha [human]	inhibition rate	0	%
8280	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma [human]	inhibition rate	0	%
8281	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta [human]	inhibition rate	53	%
8282	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma [human]	inhibition rate	20	%
8283	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	cAMP-dependent protein kinase catalytic subunit alpha [human]	inhibition rate	0	%
8284	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	cAMP-dependent protein kinase catalytic subunit beta [human]	inhibition rate	4	%
8285	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase [human]	inhibition rate	0	%
8286	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase N1 [human]	inhibition rate	1	%
8287	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase pkn2 [human]	inhibition rate	6	%
8288	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase PknB [Mycobacterium tuberculosis]	inhibition rate	10	%
8289	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	ABL1(M351T)-phosphorylated [human]	inhibition rate	9	%
8290	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase PLK1 [human]	inhibition rate	16	%
8291	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase PLK2 [human]	inhibition rate	6	%
8292	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase Plk3 [human]	inhibition rate	24	%
8293	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase Plk4 [human]	inhibition rate	26	%
8294	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Protein kinase C, delta [human]	inhibition rate	0	%
8295	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Protein kinase C, epsilon [human]	inhibition rate	0	%
8296	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Protein kinase C, eta [human]	inhibition rate	0	%
8297	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Protein kinase C iota type [human]	inhibition rate	19	%
8298	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Protein kinase C, theta [human]	inhibition rate	1	%
8299	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase D1 [human]	inhibition rate	5	%
8300	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	ABL1(Q252H)-nonphosphorylated [human]	inhibition rate	20	%
8301	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase D2 [human]	inhibition rate	0	%
8302	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase D3 [human]	inhibition rate	2	%
8303	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	cGMP-dependent protein kinase 1 [human]	inhibition rate	1	%
8304	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	cGMP-dependent protein kinase 2 [human]	inhibition rate	2	%
8305	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Interferon-induced, double-stranded RNA-activated protein kinase [human]	inhibition rate	0	%
8306	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	cAMP-dependent protein kinase catalytic subunit PRKX [human]	inhibition rate	15	%
8307	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Proline-rich protein 4 [human]	inhibition rate	6	%
8308	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Protein-tyrosine kinase 2-beta [human]	inhibition rate	0	%
8309	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase SIK3 [human]	inhibition rate	12	%
8310	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	RAF proto-oncogene serine/threonine-protein kinase [human]	inhibition rate	0	%
8311	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	ABL1(Q252H)-phosphorylated [human]	inhibition rate	0	%
8312	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret [human]	inhibition rate	31	%
8313	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (M918T) [human]	inhibition rate	0	%
8314	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804L) [human]	inhibition rate	0	%
8315	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M) [human]	inhibition rate	0	%
8316	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase Rio1 [human]	inhibition rate	2	%
8317	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase Rio2 [human]	inhibition rate	8	%
8318	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase Rio3 [human]	inhibition rate	0	%
8319	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Receptor-interacting serine/threonine-protein kinase 1 [human]	inhibition rate	0	%
8320	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Receptor-interacting serine/threonine-protein kinase 2 [human]	inhibition rate	0	%
8321	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Receptor-interacting serine/threonine-protein kinase 4 [human]	inhibition rate	20	%
8322	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	ABL1(T315I)-nonphosphorylated [human]	inhibition rate	33	%
8323	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Dual serine/threonine and tyrosine protein kinase [human]	inhibition rate	3	%
8324	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Rho-associated protein kinase 1 [human]	inhibition rate	10	%
8325	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Rho-associated protein kinase 2 [human]	inhibition rate	5	%
8326	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Proto-oncogene tyrosine-protein kinase ROS [human]	inhibition rate	0	%
8327	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Ribosomal protein S6 kinase alpha-4 [human]	inhibition rate	3	%
8328	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Ribosomal protein S6 kinase alpha-4 [human]	inhibition rate	38	%
8329	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Ribosomal protein S6 kinase alpha-5 [human]	inhibition rate	0	%
8330	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Ribosomal protein S6 kinase alpha-5 [human]	inhibition rate	0	%
8331	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Ribosomal protein S6 kinase alpha-1 [human]	inhibition rate	36	%
8332	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Ribosomal protein S6 kinase alpha-1 [human]	inhibition rate	36	%
8333	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	ABL1(T315I)-phosphorylated [human]	inhibition rate	10	%
8334	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	5	%
8335	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	0	%
8336	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Ribosomal protein S6 kinase alpha-2 [human]	inhibition rate	15	%
8337	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Ribosomal protein S6 kinase alpha-2 [human]	inhibition rate	0	%
8338	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Ribosomal protein S6 kinase alpha-6 [human]	inhibition rate	18	%
8339	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Ribosomal protein S6 kinase alpha-6 [human]	inhibition rate	0	%
8340	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Ribosomal protein S6 kinase beta-1 [human]	inhibition rate	18	%
8341	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	serine/threonine-protein kinase sbk1 [human]	inhibition rate	17	%
8342	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase Sgk1 [human]	inhibition rate	27	%
8343	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Uncharacterized serine/threonine-protein kinase SBK3 [human]	inhibition rate	74	%
8344	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	ABL1(Y253F)-phosphorylated [human]	inhibition rate	15	%
8345	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase Sgk2 [human]	inhibition rate	16	%
8346	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase Sgk3 [human]	inhibition rate	0	%
8347	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase SIK1 [human]	inhibition rate	0	%
8348	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase SIK2 [human]	inhibition rate	0	%
8349	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	STE20-like serine/threonine-protein kinase [human]	inhibition rate	0	%
8350	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	NUAK family SNF1-like kinase 2 [human]	inhibition rate	11	%
8351	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	SNF-related serine/threonine-protein kinase [human]	inhibition rate	21	%
8352	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Proto-oncogene tyrosine-protein kinase Src [human]	inhibition rate	0	%
8353	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Tyrosine-protein kinase Srms [human]	inhibition rate	0	%
8354	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	SRSF protein kinase 1 [human]	inhibition rate	0	%
8355	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	ABL1-nonphosphorylated [human]	inhibition rate	12	%
8356	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	SRSF protein kinase 2 [human]	inhibition rate	0	%
8357	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	SRSF protein kinase 3 [human]	inhibition rate	44	%
8358	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase 16 [human]	inhibition rate	9	%
8359	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase 33 [human]	inhibition rate	0	%
8360	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase 35 [human]	inhibition rate	0	%
8361	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase 36 [human]	inhibition rate	12	%
8362	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	STE20/SPS1-related proline-alanine-rich protein kinase [human]	inhibition rate	0	%
8363	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Tyrosine-protein kinase SYK [human]	inhibition rate	0	%
8364	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitogen-activated protein kinase kinase kinase 7 [human]	inhibition rate	23	%
8365	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase TAO1 [human]	inhibition rate	8	%
8366	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Tyrosine-protein kinase ABL1- phosphorylated [human]	inhibition rate	19	%
8367	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase TAO2 [human]	inhibition rate	6	%
8368	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase TAO3 [human]	inhibition rate	9	%
8369	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase TBK1 [human]	inhibition rate	18	%
8370	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Tyrosine-protein kinase Tec [human]	inhibition rate	0	%
8371	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Dual specificity testis-specific protein kinase 1 [human]	inhibition rate	10	%
8372	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	TGF-beta receptor type-1 [human]	inhibition rate	0	%
8373	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	TGF-beta receptor type-2 [human]	inhibition rate	20	%
8374	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Tyrosine-protein kinase receptor Tie-1 [human]	inhibition rate	2	%
8375	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Tyrosine-protein kinase receptor Tie-2 [human]	inhibition rate	0	%
8376	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase tousled-like 1 [human]	inhibition rate	25	%
8377	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Tyrosine-protein kinase ABL2 [human]	inhibition rate	0	%
8378	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase TOUSLED-like 2 [human]	inhibition rate	0	%
8379	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Traf2 and NCK-interacting protein kinase [human]	inhibition rate	20	%
8380	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Non-receptor tyrosine-protein kinase TNK1 [human]	inhibition rate	2	%
8381	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Activated CDC42 kinase 1 [human]	inhibition rate	0	%
8382	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase TNNI3K [human]	inhibition rate	0	%
8383	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	High affinity nerve growth factor receptor [human]	inhibition rate	20	%
8384	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	BDNF/NT-3 growth factors receptor [human]	inhibition rate	16	%
8385	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	NT-3 growth factor receptor [human]	inhibition rate	27	%
8386	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Transient receptor potential cation channel subfamily M member 6 [human]	inhibition rate	10	%
8387	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Testis-specific serine/threonine-protein kinase 1 [human]	inhibition rate	0	%
8388	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Activin receptor type-1 [human]	inhibition rate	0	%
8389	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Testis-specific serine/threonine-protein kinase 3 [human]	inhibition rate	10	%
8390	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Dual specificity protein kinase TTK [human]	inhibition rate	0	%
8391	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Tyrosine-protein kinase TXK [human]	inhibition rate	0	%
8392	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition rate	36	%
8393	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition rate	68	%
8394	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Tyrosine-protein kinase receptor TYRO3 [human]	inhibition rate	0	%
8395	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase ULK1 [human]	inhibition rate	0	%
8396	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase ULK2 [human]	inhibition rate	8	%
8397	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase ULK3 [human]	inhibition rate	24	%
8398	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Vascular endothelial growth factor receptor 2 [human]	inhibition rate	4	%
8399	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Activin receptor type-1B [human]	inhibition rate	0	%
8400	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Phosphatidylinositol 3-kinase, Vps34 type [human]	inhibition rate	13	%
8401	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase VRK2 [human]	inhibition rate	4	%
8402	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitosis inhibitor protein kinase wee1 [human]	inhibition rate	0	%
8403	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Wee1-like protein kinase 1-A [human]	inhibition rate	0	%
8404	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase WNK1 [human]	inhibition rate	6	%
8405	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase WNK2 [human]	inhibition rate	0	%
8406	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase WNK3 [human]	inhibition rate	15	%
8407	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase WNK4 [human]	inhibition rate	11	%
8408	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase 32A [human]	inhibition rate	29	%
8409	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase 32B [human]	inhibition rate	0	%
8410	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Activin receptor type-2A [human]	inhibition rate	26	%
8411	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase 32C [human]	inhibition rate	0	%
8412	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Tyrosine-protein kinase Yes [human]	inhibition rate	0	%
8413	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase 25 [human]	inhibition rate	0	%
8414	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitogen-activated protein kinase kinase kinase 19 [human]	inhibition rate	25	%
8415	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitogen-activated protein kinase kinase kinase 20 [human]	inhibition rate	5	%
8416	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Tyrosine-protein kinase ZAP-70 [human]	inhibition rate	0	%
8417	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Activin receptor type-2B [human]	inhibition rate	0	%
8418	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase receptor R3 [human]	inhibition rate	9	%
8419	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Atypical kinase COQ8A, mitochondrial [human]	inhibition rate	11	%
8420	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Atypical kinase COQ8B, mitochondrial [human]	inhibition rate	19	%
8421	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	RAC-alpha serine/threonine-protein kinase [human]	inhibition rate	6	%
8422	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	RAC-beta serine/threonine-protein kinase [human]	inhibition rate	0	%
8423	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	RAC-gamma serine/threonine-protein kinase [human]	inhibition rate	2	%
8424	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	ALK tyrosine kinase receptor [human]	inhibition rate	8	%
8425	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	ALK tyrosine kinase receptor [human]	inhibition rate	0	%
8426	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	ALK tyrosine kinase receptor [human]	inhibition rate	29	%
8427	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	5'-AMP-activated protein kinase catalytic subunit alpha-1 [human]	inhibition rate	7	%
8428	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	5'-AMP-activated protein kinase catalytic subunit alpha-2 [human]	inhibition rate	10	%
8429	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Ankyrin repeat and protein kinase domain-containing protein 1 [human]	inhibition rate	0	%
8430	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	NUAK family SNF1-like kinase 1 [human]	inhibition rate	24	%
8431	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitogen-activated protein kinase kinase kinase 5 [human]	inhibition rate	0	%
8432	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitogen-activated protein kinase kinase kinase 6 [human]	inhibition rate	19	%
8433	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Aurora kinase A [human]	inhibition rate	1	%
8434	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Aurora kinase B [human]	inhibition rate	10	%
8435	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Aurora kinase C [human]	inhibition rate	10	%
8436	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	NEDD8-activating enzyme E1 regulatory subunit AXL [human]	inhibition rate	24	%
8437	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	BMP-2-inducible protein kinase [human]	inhibition rate	20	%
8438	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Tyrosine-protein kinase Blk [human]	inhibition rate	72	%
8439	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Bone morphogenetic protein receptor type-1A [human]	inhibition rate	0	%
8440	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Bone morphogenetic protein receptor type-1B [human]	inhibition rate	33	%
8441	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Bone morphogenetic protein receptor type-2 [human]	inhibition rate	1	%
8442	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Cytoplasmic tyrosine-protein kinase BMX [human]	inhibition rate	4	%
8443	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase B-raf [human]	inhibition rate	18	%
8444	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase B-raf (V600E) [human]	inhibition rate	9	%
8445	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Protein-tyrosine kinase 6 [human]	inhibition rate	0	%
8446	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase BRSK1 [human]	inhibition rate	19	%
8447	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Serine/threonine-protein kinase BRSK2 [human]	inhibition rate	11	%
8448	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Tyrosine-protein kinase BTK [human]	inhibition rate	9	%
8449	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Mitotic checkpoint serine/threonine-protein kinase BUB1 [human]	inhibition rate	37	%
8450	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1 [human]	inhibition rate	8	%
8451	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1B [human]	inhibition rate	3	%
8452	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1D [human]	inhibition rate	0	%
8453	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1G [human]	inhibition rate	10	%
8454	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II subunit alpha [human]	inhibition rate	14	%
8455	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II subunit beta [human]	inhibition rate	24	%
8456	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II delta 2 chain [human]	inhibition rate	22	%
8457	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II subunit gamma [human]	inhibition rate	36	%
8458	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Calcium/calmodulin-dependent protein kinase type IV [human]	inhibition rate	14	%
8459	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Calcium/calmodulin-dependent protein kinase kinase 1 [human]	inhibition rate	16	%
8460	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Calcium/calmodulin-dependent protein kinase kinase 2 [human]	inhibition rate	37	%
8461	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Kappa-casein [human]	inhibition rate	11	%
8462	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Cyclin-dependent kinase 11B [human]	inhibition rate	5	%
8463	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Cyclin-dependent kinase 11A [human]	inhibition rate	0	%
8464	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Cyclin-dependent kinase 13 [human]	inhibition rate	12	%
8465	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Cyclin-dependent kinase 11 [human]	inhibition rate	12	%
8466	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Cyclin-dependent kinase 2 [human]	inhibition rate	11	%
8467	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1	Cyclin-dependent kinase 3 [human]	inhibition rate	14	%
8468	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1		CLint (intrinsic clearance)	164	μl/min/mg protein
8469	CN(C)C1=NC=CC(=N1)C1=C2C=C(C)C=NN2N=C1		CLint (intrinsic clearance)	160	μl/min/mg protein
8470	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	pIC50	6.8	no unit
8471	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Cyclin-dependent kinase 4 [human]	inhibition rate	29	%
8472	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Cyclin-dependent kinase 4 [human]; Cyclin-D1-1 [human]	inhibition rate	49	%
8473	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Cyclin-dependent kinase 4 [human]; Cyclin-D3-1 [human]	inhibition rate	52	%
8474	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Cyclin-dependent-like kinase 5 [human]	inhibition rate	9	%
8475	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Cyclin-dependent kinase 7 [human]	inhibition rate	71	%
8476	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Cyclin-dependent kinase 8 [human]	inhibition rate	4	%
8477	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Cyclin-dependent kinase 9 [human]	inhibition rate	0	%
8478	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Cyclin-dependent kinase-like 1 [human]	inhibition rate	0	%
8479	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Cyclin-dependent kinase-like 2 [human]	inhibition rate	0	%
8480	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Cyclin-dependent kinase-like 3 [human]	inhibition rate	0	%
8481	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Cyclin-dependent kinase-like 5 [human]	inhibition rate	12	%
8482	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase Chk1 [human]	inhibition rate	3	%
8483	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase Chk2 [human]	inhibition rate	21	%
8484	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Citrate synthase, mitochondrial [human]	inhibition rate	14	%
8485	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase ATG1 [human]	inhibition rate	80	%
8486	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Dual specificity protein kinase CLK2 [human]	inhibition rate	69	%
8487	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Dual specificity protein kinase CLK3 [human]	inhibition rate	44	%
8488	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Dual specificity protein kinase CLK4 [human]	inhibition rate	86	%
8489	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Macrophage colony-stimulating factor 1 receptor [human]	inhibition rate	0	%
8490	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	CSF1R-autoinhibited [human]	inhibition rate	35	%
8491	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Tyrosine-protein kinase CSK [human]	inhibition rate	4	%
8492	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Casein kinase I isoform alpha [human]	inhibition rate	64	%
8493	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Casein kinase I isoform alpha-like [human]	inhibition rate	13	%
8494	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Casein kinase I isoform delta [human]	inhibition rate	43	%
8495	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Casein kinase I isoform epsilon [human]	inhibition rate	35	%
8496	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Casein kinase I isoform gamma-1 [human]	inhibition rate	19	%
8497	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Casein kinase I isoform gamma-2 [human]	inhibition rate	11	%
8498	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Casein kinase I isoform gamma-3 [human]	inhibition rate	30	%
8499	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Casein kinase II subunit alpha [human]	inhibition rate	53	%
8500	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Casein kinase II subunit alpha' [human]	inhibition rate	76	%
8501	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Megakaryocyte-associated tyrosine-protein kinase [human]	inhibition rate	50	%
8502	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Death-associated protein kinase 1 [human]	inhibition rate	8	%
8503	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Death-associated protein kinase 2 [human]	inhibition rate	11	%
8504	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Death-associated protein kinase 3 [human]	inhibition rate	9	%
8505	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase DCLK1 [human]	inhibition rate	39	%
8506	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase DCLK2 [human]	inhibition rate	5	%
8507	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase DCLK3 [human]	inhibition rate	24	%
8508	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Epithelial discoidin domain-containing receptor 1 [human]	inhibition rate	13	%
8509	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Discoidin domain-containing receptor 2 [human]	inhibition rate	16	%
8510	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Death-associated protein kinase 3 [human]	inhibition rate	33	%
8511	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Myotonin-protein kinase [human]	inhibition rate	18	%
8512	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase MRCK gamma [human]	inhibition rate	1	%
8513	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase 17A [human]	inhibition rate	0	%
8514	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase 17B [human]	inhibition rate	0	%
8515	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	inhibition rate	99.3	%
8516	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Dual specificity tyrosine-phosphorylation-regulated kinase 1B [human]	inhibition rate	93.8	%
8517	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Dual specificity tyrosine-phosphorylation-regulated kinase 2 [human]	inhibition rate	65	%
8518	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	epidermal growth factor-activated receptor [human]	inhibition rate	37	%
8519	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	epidermal growth factor-activated receptor [human]	inhibition rate	40	%
8520	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Epidermal growth factor receptor (G719C) [human]	inhibition rate	0	%
8521	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Epidermal growth factor receptor (G719S) [human]	inhibition rate	16	%
8522	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	epidermal growth factor-activated receptor [human]	inhibition rate	0	%
8523	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	epidermal growth factor-activated receptor [human]	inhibition rate	0	%
8524	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	epidermal growth factor-activated receptor [human]	inhibition rate	3	%
8525	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Epidermal growth factor receptor (L858R) [human]	inhibition rate	11	%
8526	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Epidermal growth factor receptor (L858R) [human];+Epidermal growth factor receptor (T790M) [human]	inhibition rate	23	%
8527	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Epidermal growth factor receptor (L861Q) [human]	inhibition rate	10	%
8528	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	epidermal growth factor-activated receptor [human]	inhibition rate	0	%
8529	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Epidermal growth factor receptor (T790M) [human]	inhibition rate	42	%
8530	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Eukaryotic translation initiation factor 2-alpha kinase 1 [human]	inhibition rate	31	%
8531	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	AP2-associated protein kinase 1 [human]	inhibition rate	12	%
8532	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Ephrin type-A receptor 1 [human]	inhibition rate	7	%
8533	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Ephrin type-A receptor 2 [human]	inhibition rate	0	%
8534	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Ephrin type-A receptor 3 [human]	inhibition rate	0	%
8535	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Ephrin type-A receptor 4 [human]	inhibition rate	0	%
8536	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Ephrin type-A receptor 5 [human]	inhibition rate	3	%
8537	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Ephrin type-A receptor 6 [human]	inhibition rate	2	%
8538	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Ephrin type-A receptor 7 [human]	inhibition rate	32	%
8539	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Ephrin type-A receptor 8 [human]	inhibition rate	21	%
8540	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Ephrin type-B receptor 1 [human]	inhibition rate	14	%
8541	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Ephrin type-B receptor 2 [human]	inhibition rate	8	%
8542	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Ephrin type-B receptor 3 [human]	inhibition rate	9	%
8543	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Ephrin type-B receptor 4 [human]	inhibition rate	0	%
8544	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Ephrin type-B receptor 6 [human]	inhibition rate	55	%
8545	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Receptor tyrosine-protein kinase erbB-2 [human]	inhibition rate	100	%
8546	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Receptor tyrosine-protein kinase erbB-3 [human]	inhibition rate	0	%
8547	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Receptor tyrosine-protein kinase erbB-4 [human]	inhibition rate	11	%
8548	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Extracellular signal-regulated kinase 1 [human]	inhibition rate	0	%
8549	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Extracellular signal-regulated kinase 2 [human]	inhibition rate	19	%
8550	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitogen-activated protein kinase 6 [human]	inhibition rate	7	%
8551	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitogen-activated protein kinase 4 [human]	inhibition rate	2	%
8552	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitogen-activated protein kinase 7 [human]	inhibition rate	8	%
8553	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitogen-activated protein kinase 15 [human]	inhibition rate	50	%
8554	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Ethylene-responsive transcription factor ERN1 [human]	inhibition rate	40	%
8555	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Focal adhesion kinase 1 [human]	inhibition rate	0	%
8556	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Tyrosine-protein kinase Fer [human]	inhibition rate	13	%
8557	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Tyrosine-protein kinase, Fes/Fps type [human]	inhibition rate	3	%
8558	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Fibroblast growth factor receptor 1 [human]	inhibition rate	18	%
8559	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Fibroblast growth factor receptor 2 [human]	inhibition rate	0	%
8560	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Fibroblast growth factor receptor 3 [human]	inhibition rate	0	%
8561	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Fibroblast growth factor receptor 3 [human]	inhibition rate	1	%
8562	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Fibroblast growth factor receptor 4 [human]	inhibition rate	5	%
8563	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Tyrosine-protein kinase Fgr [human]	inhibition rate	0	%
8564	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Vascular endothelial growth factor receptor 1 [human]	inhibition rate	0	%
8565	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	0	%
8566	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Receptor-type tyrosine-protein kinase FLT3 (D835H) [human]	inhibition rate	4	%
8567	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Receptor-type tyrosine-protein kinase FLT3 (D835V) [human]	inhibition rate	32	%
8568	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Receptor-type tyrosine-protein kinase FLT3 (D835Y) [human]	inhibition rate	32	%
8569	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	FLT3(ITD) [human]	inhibition rate	0	%
8570	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Receptor-type tyrosine-protein kinase FLT3 (D835V) [human];+FLT3(ITD) [human]	inhibition rate	34	%
8571	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	FLT3(ITD) [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	14	%
8572	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	13	%
8573	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	28	%
8574	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	39	%
8575	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	FLT3-autoinhibited [human]	inhibition rate	28	%
8576	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Vascular endothelial growth factor receptor 3 [human]	inhibition rate	12	%
8577	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Tyrosine-protein kinase FRK [human]	inhibition rate	3	%
8578	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Tyrosine-protein kinase Fyn [human]	inhibition rate	1	%
8579	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Cyclin-G-associated kinase [human]	inhibition rate	28	%
8580	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	ABC transporter F family member 2 [human]	inhibition rate	1	%
8581	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Rhodopsin kinase GRK1 (C514S) [human]	inhibition rate	13	%
8582	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Beta-adrenergic receptor kinase 1 [human]	inhibition rate	8	%
8583	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Beta-adrenergic receptor kinase 2 [human]	inhibition rate	14	%
8584	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	G protein-coupled receptor kinase 4 [human]	inhibition rate	12	%
8585	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Rhodopsin kinase [human]	inhibition rate	59	%
8586	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Glycogen synthase kinase-3 alpha [human]	inhibition rate	15	%
8587	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	glycogen synthase kinase-3 beta [human]	inhibition rate	23	%
8588	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase haspin [human]	inhibition rate	97.2	%
8589	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Tyrosine-protein kinase HCK [human]	inhibition rate	0	%
8590	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Homeodomain-interacting protein kinase 1 [human]	inhibition rate	56	%
8591	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Homeodomain-interacting protein kinase 2 [human]	inhibition rate	64	%
8592	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Homeodomain-interacting protein kinase 3 [human]	inhibition rate	54	%
8593	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Homeodomain-interacting protein kinase 4 [human]	inhibition rate	13	%
8594	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitogen-activated protein kinase kinase kinase kinase 1 [human]	inhibition rate	0	%
8595	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Hormonally up-regulated neu tumor-associated kinase [human]	inhibition rate	17	%
8596	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Insulin-like growth factor 1 receptor [human]	inhibition rate	11	%
8597	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Inhibitor of nuclear factor kappa-B kinase subunit alpha [human]	inhibition rate	29	%
8598	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition rate	33	%
8599	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Inhibitor of nuclear factor kappa-B kinase subunit epsilon [human]	inhibition rate	0	%
8600	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Insulin receptor [human]	inhibition rate	30	%
8601	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Insulin receptor-related protein [human]	inhibition rate	18	%
8602	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Interleukin-1 receptor-associated kinase 1 [human]	inhibition rate	35	%
8603	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Interleukin-1 receptor-associated kinase 3 [human]	inhibition rate	13	%
8604	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Interleukin-1 receptor-associated kinase 4 [human]	inhibition rate	26	%
8605	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Tyrosine-protein kinase ITK/TSK [human]	inhibition rate	12	%
8606	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Tyrosine-protein kinase JAK1 [human]	inhibition rate	6	%
8607	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Tyrosine-protein kinase JAK1 [human]	inhibition rate	33	%
8608	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Tyrosine-protein kinase JAK2 [human]	inhibition rate	20	%
8609	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Tyrosine-protein kinase JAK3 [human]	inhibition rate	7	%
8610	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitogen-activated protein kinase 8 [human]	inhibition rate	41	%
8611	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitogen-activated protein kinase 9 [human]	inhibition rate	40	%
8612	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitogen-activated protein kinase 10 [human]	inhibition rate	30	%
8613	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	31	%
8614	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mast/stem cell growth factor receptor Kit (A829P) [human]	inhibition rate	46	%
8615	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mast/stem cell growth factor receptor Kit (D816H) [human]	inhibition rate	48	%
8616	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mast/stem cell growth factor receptor Kit (D816V) [human]	inhibition rate	0	%
8617	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	15	%
8618	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mast/stem cell growth factor receptor Kit (V559D) [human]	inhibition rate	19	%
8619	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mast/stem cell growth factor receptor Kit (V559D) [human];+Mast/stem cell growth factor receptor Kit [human]	inhibition rate	8	%
8620	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mast/stem cell growth factor receptor Kit (V559D) [human];+Mast/stem cell growth factor receptor Kit [human]	inhibition rate	0	%
8621	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	KIT-autoinhibited [human]	inhibition rate	24	%
8622	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase LATS1 [human]	inhibition rate	0	%
8623	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase LATS2 [human]	inhibition rate	21	%
8624	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Proto-oncogene tyrosine-protein kinase LCK [human]	inhibition rate	15	%
8625	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	LIM domain kinase 1 [human]	inhibition rate	0	%
8626	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	LIM domain kinase 2 [human]	inhibition rate	9	%
8627	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase STK11 [human]	inhibition rate	0	%
8628	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Coiled-coil domain-containing protein 40 [human]	inhibition rate	0	%
8629	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Leucine-rich repeat serine/threonine-protein kinase 2 [human]	inhibition rate	39	%
8630	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Leucine-rich repeat serine/threonine-protein kinase 2 (G2019S) [human]	inhibition rate	29	%
8631	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Leukocyte tyrosine kinase receptor [human]	inhibition rate	3	%
8632	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Tyrosine-protein kinase Lyn [human]	inhibition rate	0	%
8633	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitogen-activated protein kinase kinase kinase 13 [human]	inhibition rate	24	%
8634	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase MAK [human]	inhibition rate	0	%
8635	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitogen-activated protein kinase kinase kinase 1 [human]	inhibition rate	0	%
8636	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitogen-activated protein kinase kinase kinase 15 [human]	inhibition rate	0	%
8637	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitogen-activated protein kinase kinase kinase 2 [human]	inhibition rate	27	%
8638	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitogen-activated protein kinase kinase kinase 3 [human]	inhibition rate	56	%
8639	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitogen-activated protein kinase kinase kinase 4 [human]	inhibition rate	0	%
8640	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitogen-activated protein kinase kinase kinase kinase 2 [human]	inhibition rate	46	%
8641	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitogen-activated protein kinase kinase kinase kinase 3 [human]	inhibition rate	0	%
8642	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitogen-activated protein kinase kinase kinase kinase 4 [human]	inhibition rate	3	%
8643	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitogen-activated protein kinase kinase kinase kinase 5 [human]	inhibition rate	0	%
8644	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	MAP kinase-activated protein kinase 2 [human]	inhibition rate	16	%
8645	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	MAP kinase-activated protein kinase 5 [human]	inhibition rate	7	%
8646	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase MARK1 [human]	inhibition rate	20	%
8647	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase MARK2 [human]	inhibition rate	0	%
8648	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	MAP/microtubule affinity-regulating kinase 3 [human]	inhibition rate	5	%
8649	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	MAP/microtubule affinity-regulating kinase 4 [human]	inhibition rate	7	%
8650	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	CLIP-associating protein 1 [human]	inhibition rate	14	%
8651	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Dual specificity mitogen-activated protein kinase kinase 1 [human]	inhibition rate	19	%
8652	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Dual specificity mitogen-activated protein kinase kinase 2 [human]	inhibition rate	35	%
8653	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Dual specificity mitogen-activated protein kinase kinase 3 [human]	inhibition rate	22	%
8654	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Dual specificity mitogen-activated protein kinase kinase 4 [human]	inhibition rate	16	%
8655	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Dual specificity mitogen-activated protein kinase kinase 5 [human]	inhibition rate	52	%
8656	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Dual specificity mitogen-activated protein kinase kinase 6 [human]	inhibition rate	1	%
8657	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Maternal embryonic leucine zipper kinase [human]	inhibition rate	0	%
8658	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Tyrosine-protein kinase Mer [human]	inhibition rate	18	%
8659	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Hepatocyte growth factor receptor [human]	inhibition rate	3	%
8660	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Hepatocyte growth factor receptor (M1250T) [human]	inhibition rate	9	%
8661	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Hepatocyte growth factor receptor [human]	inhibition rate	24	%
8662	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Misshapen-like kinase 1 [human]	inhibition rate	18	%
8663	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Dual specificity mitogen-activated protein kinase kinase 7 [human]	inhibition rate	12	%
8664	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	MAP kinase-interacting serine/threonine-protein kinase 1 [human]	inhibition rate	33	%
8665	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	MAP kinase-interacting serine/threonine-protein kinase 2 [human]	inhibition rate	54	%
8666	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Myosin light chain kinase, smooth muscle [human]	inhibition rate	0	%
8667	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitogen-activated protein kinase kinase kinase 9 [human]	inhibition rate	35	%
8668	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitogen-activated protein kinase kinase kinase 10 [human]	inhibition rate	28	%
8669	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitogen-activated protein kinase kinase kinase 11 [human]	inhibition rate	12	%
8670	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase MRCK alpha [human]	inhibition rate	17	%
8671	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase MRCK beta [human]	inhibition rate	5	%
8672	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Hepatocyte growth factor-like [human]	inhibition rate	12	%
8673	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Macrophage-stimulating protein receptor [human]	inhibition rate	2	%
8674	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Histone acetyltransferase mst2 [human]	inhibition rate	38	%
8675	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase 24 [human]	inhibition rate	32	%
8676	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase 26 [human]	inhibition rate	32	%
8677	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase mTOR [human]	inhibition rate	21	%
8678	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Muscle, skeletal receptor tyrosine-protein kinase [human]	inhibition rate	17	%
8679	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Myosin light chain kinase, smooth muscle [human]	inhibition rate	6	%
8680	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Myosin light chain kinase 2, skeletal/cardiac muscle [human]	inhibition rate	3	%
8681	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Myosin light chain kinase family member 4 [human]	inhibition rate	15	%
8682	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Tyrosine-protein kinase ABL1(E255K)-Phosphorylated [human]	inhibition rate	58	%
8683	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Myosin-IIIa [human]	inhibition rate	10	%
8684	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Myosin-IIIb [human]	inhibition rate	21	%
8685	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Protein NDRG1 [human]	inhibition rate	21	%
8686	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Protein NDRG2 [human]	inhibition rate	0	%
8687	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase Nek1 [human]	inhibition rate	0	%
8688	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase Nek10 [human]	inhibition rate	41	%
8689	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase Nek11 [human]	inhibition rate	19	%
8690	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase Nek2 [human]	inhibition rate	7	%
8691	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase Nek3 [human]	inhibition rate	0	%
8692	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase Nek4 [human]	inhibition rate	23	%
8693	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	ABL1(F317I)-nonphosphorylated [human]	inhibition rate	58	%
8694	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase Nek5 [human]	inhibition rate	5	%
8695	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase Nek6 [human]	inhibition rate	6	%
8696	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase Nek7 [human]	inhibition rate	10	%
8697	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase Nek9 [human]	inhibition rate	12	%
8698	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitogen-activated protein kinase kinase kinase 14 [human]	inhibition rate	15	%
8699	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase NIM1 [human]	inhibition rate	33	%
8700	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine kinase NLK [human]	inhibition rate	26	%
8701	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase OSR1 [human]	inhibition rate	13	%
8702	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitogen-activated protein kinase 14A [human]	inhibition rate	0	%
8703	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitogen-activated protein kinase 11 [human]	inhibition rate	3	%
8704	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	ABL1(F317I)-phosphorylated [human]	inhibition rate	31	%
8705	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitogen-activated protein kinase 13 [human]	inhibition rate	14	%
8706	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitogen-activated protein kinase 12 [human]	inhibition rate	10	%
8707	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase N1 [human]	inhibition rate	9	%
8708	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	serine/threonine-protein kinase pak 2 [human]	inhibition rate	0	%
8709	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase PAK 3 [human]	inhibition rate	0	%
8710	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase PAK 4 [human]	inhibition rate	12	%
8711	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase PAK 6 [human]	inhibition rate	2	%
8712	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	serine/threonine-protein kinase pak 5 [human]	inhibition rate	22	%
8713	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Cyclin-dependent kinase 16 [human]	inhibition rate	27	%
8714	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Cyclin-dependent kinase 17 [human]	inhibition rate	16	%
8715	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	ABL1(F317L)-nonphosphorylated [human]	inhibition rate	50	%
8716	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Cyclin-dependent kinase 18 [human]	inhibition rate	0	%
8717	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Platelet-derived growth factor receptor alpha [human]	inhibition rate	22	%
8718	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Platelet-derived growth factor receptor beta [human]	inhibition rate	10	%
8719	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	3-phosphoinositide-dependent protein kinase 1 [human]	inhibition rate	0	%
8720	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Calcium-dependent protein kinase 1 [Plasmodium falciparum]	inhibition rate	5	%
8721	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Cell division control protein 2 homolog [Plasmodium falciparum]	inhibition rate	28	%
8722	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Cyclin-dependent kinase 15 [human]	inhibition rate	17	%
8723	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Cyclin-dependent kinase 14 [human]	inhibition rate	0	%
8724	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform [human]	inhibition rate	0	%
8725	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform [human]	inhibition rate	11	%
8726	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	ABL1(F317L)-phosphorylated [human]	inhibition rate	4	%
8727	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta [human]	inhibition rate	43	%
8728	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition rate	49	%
8729	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human]	inhibition rate	29	%
8730	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (C420R) [human]	inhibition rate	42	%
8731	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E542K) [human]	inhibition rate	23	%
8732	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545A) [human]	inhibition rate	10	%
8733	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545K) [human]	inhibition rate	18	%
8734	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047L) [human]	inhibition rate	15	%
8735	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047Y) [human]	inhibition rate	50	%
8736	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human]	inhibition rate	37	%
8737	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	ABL1(H396P)-nonphosphorylated [human]	inhibition rate	27	%
8738	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (M1043I) [human]	inhibition rate	16	%
8739	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (Q546K) [human]	inhibition rate	23	%
8740	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [human]	inhibition rate	23	%
8741	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [human]	inhibition rate	50	%
8742	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform [human]	inhibition rate	61	%
8743	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Phosphatidylinositol 4-kinase beta [human]	inhibition rate	21	%
8744	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	1-phosphatidylinositol 3-phosphate 5-kinase [human]	inhibition rate	22	%
8745	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Lon protease homolog, mitochondrial [human]	inhibition rate	18	%
8746	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase pim-2 [human]	inhibition rate	13	%
8747	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase pim-3 [human]	inhibition rate	12	%
8748	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	ABL1(H396P)-phosphorylated [human]	inhibition rate	52	%
8749	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha [human]	inhibition rate	28	%
8750	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma [human]	inhibition rate	0	%
8751	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta [human]	inhibition rate	0	%
8752	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma [human]	inhibition rate	7	%
8753	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	cAMP-dependent protein kinase catalytic subunit alpha [human]	inhibition rate	17	%
8754	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	cAMP-dependent protein kinase catalytic subunit beta [human]	inhibition rate	18	%
8755	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase [human]	inhibition rate	12	%
8756	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase N1 [human]	inhibition rate	0	%
8757	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase pkn2 [human]	inhibition rate	7	%
8758	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase PknB [Mycobacterium tuberculosis]	inhibition rate	24	%
8759	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	ABL1(M351T)-phosphorylated [human]	inhibition rate	22	%
8760	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase PLK1 [human]	inhibition rate	31	%
8761	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase PLK2 [human]	inhibition rate	34	%
8762	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase Plk3 [human]	inhibition rate	34	%
8763	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase Plk4 [human]	inhibition rate	32	%
8764	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Protein kinase C, delta [human]	inhibition rate	15	%
8765	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Protein kinase C, epsilon [human]	inhibition rate	0	%
8766	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Protein kinase C, eta [human]	inhibition rate	0	%
8767	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Protein kinase C iota type [human]	inhibition rate	28	%
8768	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Protein kinase C, theta [human]	inhibition rate	25	%
8769	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase D1 [human]	inhibition rate	39	%
8770	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	ABL1(Q252H)-nonphosphorylated [human]	inhibition rate	28	%
8771	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase D2 [human]	inhibition rate	13	%
8772	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase D3 [human]	inhibition rate	0	%
8773	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	cGMP-dependent protein kinase 1 [human]	inhibition rate	19	%
8774	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	cGMP-dependent protein kinase 2 [human]	inhibition rate	31	%
8775	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Interferon-induced, double-stranded RNA-activated protein kinase [human]	inhibition rate	14	%
8776	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	cAMP-dependent protein kinase catalytic subunit PRKX [human]	inhibition rate	6	%
8777	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Proline-rich protein 4 [human]	inhibition rate	15	%
8778	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Protein-tyrosine kinase 2-beta [human]	inhibition rate	8	%
8779	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase SIK3 [human]	inhibition rate	15	%
8780	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	RAF proto-oncogene serine/threonine-protein kinase [human]	inhibition rate	33	%
8781	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	ABL1(Q252H)-phosphorylated [human]	inhibition rate	27	%
8782	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Proto-oncogene tyrosine-protein kinase receptor Ret [human]	inhibition rate	9	%
8783	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Proto-oncogene tyrosine-protein kinase receptor Ret (M918T) [human]	inhibition rate	15	%
8784	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Proto-oncogene tyrosine-protein kinase receptor Ret (V804L) [human]	inhibition rate	13	%
8785	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M) [human]	inhibition rate	7	%
8786	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase Rio1 [human]	inhibition rate	0	%
8787	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase Rio2 [human]	inhibition rate	14	%
8788	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase Rio3 [human]	inhibition rate	0	%
8789	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Receptor-interacting serine/threonine-protein kinase 1 [human]	inhibition rate	14	%
8790	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Receptor-interacting serine/threonine-protein kinase 2 [human]	inhibition rate	2	%
8791	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Receptor-interacting serine/threonine-protein kinase 4 [human]	inhibition rate	29	%
8792	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	ABL1(T315I)-nonphosphorylated [human]	inhibition rate	48	%
8793	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Dual serine/threonine and tyrosine protein kinase [human]	inhibition rate	22	%
8794	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Rho-associated protein kinase 1 [human]	inhibition rate	26	%
8795	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Rho-associated protein kinase 2 [human]	inhibition rate	0	%
8796	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Proto-oncogene tyrosine-protein kinase ROS [human]	inhibition rate	29	%
8797	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Ribosomal protein S6 kinase alpha-4 [human]	inhibition rate	20	%
8798	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Ribosomal protein S6 kinase alpha-4 [human]	inhibition rate	38	%
8799	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Ribosomal protein S6 kinase alpha-5 [human]	inhibition rate	5	%
8800	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Ribosomal protein S6 kinase alpha-5 [human]	inhibition rate	0	%
8801	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Ribosomal protein S6 kinase alpha-1 [human]	inhibition rate	13	%
8802	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Ribosomal protein S6 kinase alpha-1 [human]	inhibition rate	13	%
8803	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	ABL1(T315I)-phosphorylated [human]	inhibition rate	32	%
8804	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	30	%
8805	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	22	%
8806	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Ribosomal protein S6 kinase alpha-2 [human]	inhibition rate	17	%
8807	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Ribosomal protein S6 kinase alpha-2 [human]	inhibition rate	9	%
8808	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Ribosomal protein S6 kinase alpha-6 [human]	inhibition rate	31	%
8809	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Ribosomal protein S6 kinase alpha-6 [human]	inhibition rate	10	%
8810	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Ribosomal protein S6 kinase beta-1 [human]	inhibition rate	23	%
8811	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	serine/threonine-protein kinase sbk1 [human]	inhibition rate	3	%
8812	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase Sgk1 [human]	inhibition rate	21	%
8813	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Uncharacterized serine/threonine-protein kinase SBK3 [human]	inhibition rate	23	%
8814	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	ABL1(Y253F)-phosphorylated [human]	inhibition rate	59	%
8815	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase Sgk2 [human]	inhibition rate	19	%
8816	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase Sgk3 [human]	inhibition rate	21	%
8817	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase SIK1 [human]	inhibition rate	13	%
8818	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase SIK2 [human]	inhibition rate	0	%
8819	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	STE20-like serine/threonine-protein kinase [human]	inhibition rate	0	%
8820	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	NUAK family SNF1-like kinase 2 [human]	inhibition rate	17	%
8821	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	SNF-related serine/threonine-protein kinase [human]	inhibition rate	9	%
8822	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Proto-oncogene tyrosine-protein kinase Src [human]	inhibition rate	11	%
8823	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Tyrosine-protein kinase Srms [human]	inhibition rate	37	%
8824	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	SRSF protein kinase 1 [human]	inhibition rate	18	%
8825	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	ABL1-nonphosphorylated [human]	inhibition rate	16	%
8826	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	SRSF protein kinase 2 [human]	inhibition rate	0	%
8827	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	SRSF protein kinase 3 [human]	inhibition rate	13	%
8828	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase 16 [human]	inhibition rate	8	%
8829	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase 33 [human]	inhibition rate	15	%
8830	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase 35 [human]	inhibition rate	0	%
8831	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase 36 [human]	inhibition rate	1	%
8832	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	STE20/SPS1-related proline-alanine-rich protein kinase [human]	inhibition rate	49	%
8833	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Tyrosine-protein kinase SYK [human]	inhibition rate	22	%
8834	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitogen-activated protein kinase kinase kinase 7 [human]	inhibition rate	64	%
8835	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase TAO1 [human]	inhibition rate	41	%
8836	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Tyrosine-protein kinase ABL1- phosphorylated [human]	inhibition rate	43	%
8837	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase TAO2 [human]	inhibition rate	24	%
8838	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase TAO3 [human]	inhibition rate	32	%
8839	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase TBK1 [human]	inhibition rate	3	%
8840	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Tyrosine-protein kinase Tec [human]	inhibition rate	0	%
8841	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Dual specificity testis-specific protein kinase 1 [human]	inhibition rate	10	%
8842	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	TGF-beta receptor type-1 [human]	inhibition rate	18	%
8843	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	TGF-beta receptor type-2 [human]	inhibition rate	24	%
8844	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Tyrosine-protein kinase receptor Tie-1 [human]	inhibition rate	17	%
8845	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Tyrosine-protein kinase receptor Tie-2 [human]	inhibition rate	5	%
8846	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase tousled-like 1 [human]	inhibition rate	19	%
8847	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Tyrosine-protein kinase ABL2 [human]	inhibition rate	1	%
8848	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase TOUSLED-like 2 [human]	inhibition rate	4	%
8849	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Traf2 and NCK-interacting protein kinase [human]	inhibition rate	16	%
8850	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Non-receptor tyrosine-protein kinase TNK1 [human]	inhibition rate	0	%
8851	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Activated CDC42 kinase 1 [human]	inhibition rate	1	%
8852	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase TNNI3K [human]	inhibition rate	15	%
8853	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	High affinity nerve growth factor receptor [human]	inhibition rate	28	%
8854	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	BDNF/NT-3 growth factors receptor [human]	inhibition rate	35	%
8855	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	NT-3 growth factor receptor [human]	inhibition rate	22	%
8856	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Transient receptor potential cation channel subfamily M member 6 [human]	inhibition rate	25	%
8857	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Testis-specific serine/threonine-protein kinase 1 [human]	inhibition rate	0	%
8858	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Activin receptor type-1 [human]	inhibition rate	12	%
8859	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Testis-specific serine/threonine-protein kinase 3 [human]	inhibition rate	10	%
8860	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Dual specificity protein kinase TTK [human]	inhibition rate	26	%
8861	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Tyrosine-protein kinase TXK [human]	inhibition rate	2	%
8862	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition rate	17	%
8863	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition rate	18	%
8864	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Tyrosine-protein kinase receptor TYRO3 [human]	inhibition rate	0	%
8865	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase ULK1 [human]	inhibition rate	29	%
8866	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase ULK2 [human]	inhibition rate	26	%
8867	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase ULK3 [human]	inhibition rate	25	%
8868	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Vascular endothelial growth factor receptor 2 [human]	inhibition rate	10	%
8869	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Activin receptor type-1B [human]	inhibition rate	3	%
8870	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Phosphatidylinositol 3-kinase, Vps34 type [human]	inhibition rate	52	%
8871	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase VRK2 [human]	inhibition rate	36	%
8872	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitosis inhibitor protein kinase wee1 [human]	inhibition rate	0	%
8873	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Wee1-like protein kinase 1-A [human]	inhibition rate	15	%
8874	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase WNK1 [human]	inhibition rate	0	%
8875	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase WNK2 [human]	inhibition rate	6	%
8876	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase WNK3 [human]	inhibition rate	33	%
8877	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase WNK4 [human]	inhibition rate	23	%
8878	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase 32A [human]	inhibition rate	53	%
8879	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase 32B [human]	inhibition rate	12	%
8880	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Activin receptor type-2A [human]	inhibition rate	0	%
8881	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase 32C [human]	inhibition rate	0	%
8882	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Tyrosine-protein kinase Yes [human]	inhibition rate	12	%
8883	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase 25 [human]	inhibition rate	0	%
8884	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitogen-activated protein kinase kinase kinase 19 [human]	inhibition rate	21	%
8885	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitogen-activated protein kinase kinase kinase 20 [human]	inhibition rate	11	%
8886	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Tyrosine-protein kinase ZAP-70 [human]	inhibition rate	10	%
8887	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Activin receptor type-2B [human]	inhibition rate	0	%
8888	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase receptor R3 [human]	inhibition rate	0	%
8889	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Atypical kinase COQ8A, mitochondrial [human]	inhibition rate	0	%
8890	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Atypical kinase COQ8B, mitochondrial [human]	inhibition rate	25	%
8891	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	RAC-alpha serine/threonine-protein kinase [human]	inhibition rate	3	%
8892	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	RAC-beta serine/threonine-protein kinase [human]	inhibition rate	12	%
8893	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	RAC-gamma serine/threonine-protein kinase [human]	inhibition rate	9	%
8894	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	ALK tyrosine kinase receptor [human]	inhibition rate	27	%
8895	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	ALK tyrosine kinase receptor [human]	inhibition rate	18	%
8896	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	ALK tyrosine kinase receptor [human]	inhibition rate	4	%
8897	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	5'-AMP-activated protein kinase catalytic subunit alpha-1 [human]	inhibition rate	0	%
8898	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	5'-AMP-activated protein kinase catalytic subunit alpha-2 [human]	inhibition rate	20	%
8899	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Ankyrin repeat and protein kinase domain-containing protein 1 [human]	inhibition rate	23	%
8900	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	NUAK family SNF1-like kinase 1 [human]	inhibition rate	2	%
8901	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitogen-activated protein kinase kinase kinase 5 [human]	inhibition rate	3	%
8902	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitogen-activated protein kinase kinase kinase 6 [human]	inhibition rate	33	%
8903	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Aurora kinase A [human]	inhibition rate	51	%
8904	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Aurora kinase B [human]	inhibition rate	24	%
8905	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Aurora kinase C [human]	inhibition rate	0	%
8906	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	NEDD8-activating enzyme E1 regulatory subunit AXL [human]	inhibition rate	0	%
8907	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	BMP-2-inducible protein kinase [human]	inhibition rate	0	%
8908	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Tyrosine-protein kinase Blk [human]	inhibition rate	4	%
8909	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Bone morphogenetic protein receptor type-1A [human]	inhibition rate	0	%
8910	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Bone morphogenetic protein receptor type-1B [human]	inhibition rate	18	%
8911	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Bone morphogenetic protein receptor type-2 [human]	inhibition rate	33	%
8912	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Cytoplasmic tyrosine-protein kinase BMX [human]	inhibition rate	0	%
8913	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase B-raf [human]	inhibition rate	11	%
8914	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase B-raf (V600E) [human]	inhibition rate	14	%
8915	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Protein-tyrosine kinase 6 [human]	inhibition rate	8	%
8916	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase BRSK1 [human]	inhibition rate	0	%
8917	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Serine/threonine-protein kinase BRSK2 [human]	inhibition rate	0	%
8918	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Tyrosine-protein kinase BTK [human]	inhibition rate	32	%
8919	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Mitotic checkpoint serine/threonine-protein kinase BUB1 [human]	inhibition rate	22	%
8920	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Calcium/calmodulin-dependent protein kinase type 1 [human]	inhibition rate	32	%
8921	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Calcium/calmodulin-dependent protein kinase type 1B [human]	inhibition rate	38	%
8922	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Calcium/calmodulin-dependent protein kinase type 1D [human]	inhibition rate	20	%
8923	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Calcium/calmodulin-dependent protein kinase type 1G [human]	inhibition rate	0	%
8924	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Calcium/calmodulin-dependent protein kinase type II subunit alpha [human]	inhibition rate	8	%
8925	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Calcium/calmodulin-dependent protein kinase type II subunit beta [human]	inhibition rate	11	%
8926	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Calcium/calmodulin-dependent protein kinase type II delta 2 chain [human]	inhibition rate	0	%
8927	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Calcium/calmodulin-dependent protein kinase type II subunit gamma [human]	inhibition rate	0	%
8928	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Calcium/calmodulin-dependent protein kinase type IV [human]	inhibition rate	0	%
8929	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Calcium/calmodulin-dependent protein kinase kinase 1 [human]	inhibition rate	0	%
8930	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Calcium/calmodulin-dependent protein kinase kinase 2 [human]	inhibition rate	0	%
8931	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Kappa-casein [human]	inhibition rate	23	%
8932	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Cyclin-dependent kinase 11B [human]	inhibition rate	0	%
8933	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Cyclin-dependent kinase 11A [human]	inhibition rate	0	%
8934	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Cyclin-dependent kinase 13 [human]	inhibition rate	42	%
8935	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Cyclin-dependent kinase 11 [human]	inhibition rate	7	%
8936	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Cyclin-dependent kinase 2 [human]	inhibition rate	14	%
8937	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12	Cyclin-dependent kinase 3 [human]	inhibition rate	21	%
8938	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12		CLint (intrinsic clearance)	96	μl/min/mg protein
8939	CN(C)C1=NC=CC(=N1)C1=CN=C2N=CC=CN12		CLint (intrinsic clearance)	154	μl/min/mg protein
8940	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	pIC50	7	no unit
8941	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 4 [human]	inhibition rate	0	%
8942	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 4 [human]; Cyclin-D1-1 [human]	inhibition rate	39	%
8943	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 4 [human]; Cyclin-D3-1 [human]	inhibition rate	0	%
8944	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent-like kinase 5 [human]	inhibition rate	4	%
8945	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 7 [human]	inhibition rate	13	%
8946	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 8 [human]	inhibition rate	0	%
8947	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 9 [human]	inhibition rate	0	%
8948	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 1 [human]	inhibition rate	17	%
8949	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 2 [human]	inhibition rate	0	%
8950	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 3 [human]	inhibition rate	0	%
8951	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 5 [human]	inhibition rate	0	%
8952	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Chk1 [human]	inhibition rate	0	%
8953	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Chk2 [human]	inhibition rate	1	%
8954	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Citrate synthase, mitochondrial [human]	inhibition rate	12	%
8955	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ATG1 [human]	inhibition rate	57	%
8956	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase CLK2 [human]	inhibition rate	53	%
8957	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase CLK3 [human]	inhibition rate	16	%
8958	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase CLK4 [human]	inhibition rate	75	%
8959	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Macrophage colony-stimulating factor 1 receptor [human]	inhibition rate	7	%
8960	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	CSF1R-autoinhibited [human]	inhibition rate	0	%
8961	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase CSK [human]	inhibition rate	9	%
8962	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform alpha [human]	inhibition rate	14	%
8963	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform alpha-like [human]	inhibition rate	9	%
8964	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform delta [human]	inhibition rate	0	%
8965	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform epsilon [human]	inhibition rate	0	%
8966	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform gamma-1 [human]	inhibition rate	0	%
8967	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform gamma-2 [human]	inhibition rate	0	%
8968	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform gamma-3 [human]	inhibition rate	0	%
8969	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase II subunit alpha [human]	inhibition rate	34	%
8970	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase II subunit alpha' [human]	inhibition rate	8	%
8971	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Megakaryocyte-associated tyrosine-protein kinase [human]	inhibition rate	28	%
8972	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 1 [human]	inhibition rate	0	%
8973	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 2 [human]	inhibition rate	3	%
8974	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 3 [human]	inhibition rate	10	%
8975	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase DCLK1 [human]	inhibition rate	10	%
8976	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase DCLK2 [human]	inhibition rate	12	%
8977	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase DCLK3 [human]	inhibition rate	15	%
8978	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epithelial discoidin domain-containing receptor 1 [human]	inhibition rate	0	%
8979	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Discoidin domain-containing receptor 2 [human]	inhibition rate	4	%
8980	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 3 [human]	inhibition rate	0	%
8981	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myotonin-protein kinase [human]	inhibition rate	20	%
8982	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MRCK gamma [human]	inhibition rate	15	%
8983	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 17A [human]	inhibition rate	0	%
8984	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 17B [human]	inhibition rate	0	%
8985	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	inhibition rate	65	%
8986	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 1B [human]	inhibition rate	61	%
8987	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 2 [human]	inhibition rate	23	%
8988	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	14	%
8989	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	20	%
8990	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (G719C) [human]	inhibition rate	0	%
8991	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (G719S) [human]	inhibition rate	2	%
8992	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	9	%
8993	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	55	%
8994	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	14	%
8995	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (L858R) [human]	inhibition rate	15	%
8996	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (L858R) [human];+Epidermal growth factor receptor (T790M) [human]	inhibition rate	0	%
8997	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (L861Q) [human]	inhibition rate	27	%
8998	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	15	%
8999	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (T790M) [human]	inhibition rate	22	%
9000	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Eukaryotic translation initiation factor 2-alpha kinase 1 [human]	inhibition rate	0	%
9001	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	AP2-associated protein kinase 1 [human]	inhibition rate	0	%
9002	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 1 [human]	inhibition rate	24	%
9003	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 2 [human]	inhibition rate	18	%
9004	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 3 [human]	inhibition rate	0	%
9005	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 4 [human]	inhibition rate	0	%
9006	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 5 [human]	inhibition rate	0	%
9007	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 6 [human]	inhibition rate	11	%
9008	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 7 [human]	inhibition rate	4	%
9009	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 8 [human]	inhibition rate	7	%
9010	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 1 [human]	inhibition rate	9	%
9011	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 2 [human]	inhibition rate	16	%
9012	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 3 [human]	inhibition rate	13	%
9013	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 4 [human]	inhibition rate	7	%
9014	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 6 [human]	inhibition rate	0	%
9015	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor tyrosine-protein kinase erbB-2 [human]	inhibition rate	1	%
9016	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor tyrosine-protein kinase erbB-3 [human]	inhibition rate	0	%
9017	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor tyrosine-protein kinase erbB-4 [human]	inhibition rate	28	%
9018	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Extracellular signal-regulated kinase 1 [human]	inhibition rate	3	%
9019	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Extracellular signal-regulated kinase 2 [human]	inhibition rate	0	%
9020	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 6 [human]	inhibition rate	10	%
9021	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 4 [human]	inhibition rate	0	%
9022	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 7 [human]	inhibition rate	0	%
9023	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 15 [human]	inhibition rate	0	%
9024	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ethylene-responsive transcription factor ERN1 [human]	inhibition rate	3	%
9025	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Focal adhesion kinase 1 [human]	inhibition rate	0	%
9026	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Fer [human]	inhibition rate	35	%
9027	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase, Fes/Fps type [human]	inhibition rate	5	%
9028	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 1 [human]	inhibition rate	54	%
9029	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 2 [human]	inhibition rate	11	%
9030	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 3 [human]	inhibition rate	7	%
9031	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 3 [human]	inhibition rate	14	%
9032	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 4 [human]	inhibition rate	4	%
9033	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Fgr [human]	inhibition rate	15	%
9034	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Vascular endothelial growth factor receptor 1 [human]	inhibition rate	0	%
9035	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	37	%
9036	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835H) [human]	inhibition rate	4	%
9037	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835V) [human]	inhibition rate	16	%
9038	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835Y) [human]	inhibition rate	24	%
9039	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	FLT3(ITD) [human]	inhibition rate	0	%
9040	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835V) [human];+FLT3(ITD) [human]	inhibition rate	28	%
9041	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	FLT3(ITD) [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	0	%
9042	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	12	%
9043	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	0	%
9044	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	0	%
9045	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	FLT3-autoinhibited [human]	inhibition rate	0	%
9046	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Vascular endothelial growth factor receptor 3 [human]	inhibition rate	0	%
9047	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase FRK [human]	inhibition rate	7	%
9048	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Fyn [human]	inhibition rate	18	%
9049	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-G-associated kinase [human]	inhibition rate	0	%
9050	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABC transporter F family member 2 [human]	inhibition rate	1	%
9051	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Rhodopsin kinase GRK1 (C514S) [human]	inhibition rate	0	%
9052	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Beta-adrenergic receptor kinase 1 [human]	inhibition rate	39	%
9053	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Beta-adrenergic receptor kinase 2 [human]	inhibition rate	0	%
9054	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	G protein-coupled receptor kinase 4 [human]	inhibition rate	0	%
9055	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Rhodopsin kinase [human]	inhibition rate	7	%
9056	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Glycogen synthase kinase-3 alpha [human]	inhibition rate	0	%
9057	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	glycogen synthase kinase-3 beta [human]	inhibition rate	13	%
9058	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase haspin [human]	inhibition rate	89	%
9059	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase HCK [human]	inhibition rate	1	%
9060	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 1 [human]	inhibition rate	30	%
9061	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 2 [human]	inhibition rate	0	%
9062	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 3 [human]	inhibition rate	12	%
9063	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 4 [human]	inhibition rate	5	%
9064	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 1 [human]	inhibition rate	5	%
9065	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hormonally up-regulated neu tumor-associated kinase [human]	inhibition rate	20	%
9066	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Insulin-like growth factor 1 receptor [human]	inhibition rate	0	%
9067	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit alpha [human]	inhibition rate	1	%
9068	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition rate	0	%
9069	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit epsilon [human]	inhibition rate	0	%
9070	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Insulin receptor [human]	inhibition rate	22	%
9071	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Insulin receptor-related protein [human]	inhibition rate	0	%
9072	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Interleukin-1 receptor-associated kinase 1 [human]	inhibition rate	0	%
9073	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Interleukin-1 receptor-associated kinase 3 [human]	inhibition rate	6	%
9074	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Interleukin-1 receptor-associated kinase 4 [human]	inhibition rate	0	%
9075	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ITK/TSK [human]	inhibition rate	5	%
9076	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK1 [human]	inhibition rate	0	%
9077	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK1 [human]	inhibition rate	0	%
9078	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK2 [human]	inhibition rate	6	%
9079	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK3 [human]	inhibition rate	29	%
9080	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 8 [human]	inhibition rate	0	%
9081	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 9 [human]	inhibition rate	10	%
9082	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 10 [human]	inhibition rate	3	%
9083	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	0	%
9084	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (A829P) [human]	inhibition rate	10	%
9085	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (D816H) [human]	inhibition rate	23	%
9086	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (D816V) [human]	inhibition rate	12	%
9087	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	7	%
9088	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (V559D) [human]	inhibition rate	0	%
9089	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (V559D) [human];+Mast/stem cell growth factor receptor Kit [human]	inhibition rate	0	%
9090	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (V559D) [human];+Mast/stem cell growth factor receptor Kit [human]	inhibition rate	0	%
9091	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	KIT-autoinhibited [human]	inhibition rate	0	%
9092	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase LATS1 [human]	inhibition rate	22	%
9093	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase LATS2 [human]	inhibition rate	0	%
9094	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase LCK [human]	inhibition rate	11	%
9095	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	LIM domain kinase 1 [human]	inhibition rate	14	%
9096	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	LIM domain kinase 2 [human]	inhibition rate	5	%
9097	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase STK11 [human]	inhibition rate	0	%
9098	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Coiled-coil domain-containing protein 40 [human]	inhibition rate	0	%
9099	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Leucine-rich repeat serine/threonine-protein kinase 2 [human]	inhibition rate	0	%
9100	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Leucine-rich repeat serine/threonine-protein kinase 2 (G2019S) [human]	inhibition rate	0	%
9101	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Leukocyte tyrosine kinase receptor [human]	inhibition rate	4	%
9102	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Lyn [human]	inhibition rate	14	%
9103	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 13 [human]	inhibition rate	0	%
9104	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MAK [human]	inhibition rate	0	%
9105	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 1 [human]	inhibition rate	25	%
9106	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 15 [human]	inhibition rate	0	%
9107	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 2 [human]	inhibition rate	4	%
9108	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 3 [human]	inhibition rate	1	%
9109	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 4 [human]	inhibition rate	19	%
9110	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 2 [human]	inhibition rate	0	%
9111	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 3 [human]	inhibition rate	0	%
9112	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 4 [human]	inhibition rate	0	%
9113	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 5 [human]	inhibition rate	0	%
9114	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-activated protein kinase 2 [human]	inhibition rate	0	%
9115	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-activated protein kinase 5 [human]	inhibition rate	0	%
9116	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MARK1 [human]	inhibition rate	0	%
9117	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MARK2 [human]	inhibition rate	0	%
9118	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP/microtubule affinity-regulating kinase 3 [human]	inhibition rate	0	%
9119	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP/microtubule affinity-regulating kinase 4 [human]	inhibition rate	10	%
9120	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	CLIP-associating protein 1 [human]	inhibition rate	0	%
9121	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 1 [human]	inhibition rate	1	%
9122	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 2 [human]	inhibition rate	0	%
9123	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 3 [human]	inhibition rate	1	%
9124	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 4 [human]	inhibition rate	0	%
9125	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 5 [human]	inhibition rate	0	%
9126	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 6 [human]	inhibition rate	0	%
9127	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Maternal embryonic leucine zipper kinase [human]	inhibition rate	6	%
9128	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Mer [human]	inhibition rate	0	%
9129	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor receptor [human]	inhibition rate	0	%
9130	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor receptor (M1250T) [human]	inhibition rate	0	%
9131	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor receptor [human]	inhibition rate	0	%
9132	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Misshapen-like kinase 1 [human]	inhibition rate	0	%
9133	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 7 [human]	inhibition rate	0	%
9134	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-interacting serine/threonine-protein kinase 1 [human]	inhibition rate	0	%
9135	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-interacting serine/threonine-protein kinase 2 [human]	inhibition rate	65	%
9136	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase, smooth muscle [human]	inhibition rate	0	%
9137	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 9 [human]	inhibition rate	12	%
9138	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 10 [human]	inhibition rate	100	%
9139	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 11 [human]	inhibition rate	25	%
9140	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MRCK alpha [human]	inhibition rate	0	%
9141	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MRCK beta [human]	inhibition rate	37	%
9142	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor-like [human]	inhibition rate	11	%
9143	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Macrophage-stimulating protein receptor [human]	inhibition rate	0	%
9144	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Histone acetyltransferase mst2 [human]	inhibition rate	0	%
9145	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 24 [human]	inhibition rate	0	%
9146	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 26 [human]	inhibition rate	0	%
9147	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase mTOR [human]	inhibition rate	5	%
9148	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Muscle, skeletal receptor tyrosine-protein kinase [human]	inhibition rate	0	%
9149	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase, smooth muscle [human]	inhibition rate	0	%
9150	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase 2, skeletal/cardiac muscle [human]	inhibition rate	2	%
9151	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase family member 4 [human]	inhibition rate	0	%
9152	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ABL1(E255K)-Phosphorylated [human]	inhibition rate	2	%
9153	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin-IIIa [human]	inhibition rate	22	%
9154	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin-IIIb [human]	inhibition rate	8	%
9155	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein NDRG1 [human]	inhibition rate	0	%
9156	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein NDRG2 [human]	inhibition rate	0	%
9157	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek1 [human]	inhibition rate	0	%
9158	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek10 [human]	inhibition rate	10	%
9159	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek11 [human]	inhibition rate	0	%
9160	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek2 [human]	inhibition rate	0	%
9161	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek3 [human]	inhibition rate	0	%
9162	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek4 [human]	inhibition rate	8	%
9163	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317I)-nonphosphorylated [human]	inhibition rate	0	%
9164	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek5 [human]	inhibition rate	0	%
9165	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek6 [human]	inhibition rate	0	%
9166	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek7 [human]	inhibition rate	0	%
9167	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek9 [human]	inhibition rate	0	%
9168	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 14 [human]	inhibition rate	0	%
9169	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase NIM1 [human]	inhibition rate	0	%
9170	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine kinase NLK [human]	inhibition rate	34	%
9171	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase OSR1 [human]	inhibition rate	0	%
9172	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 14A [human]	inhibition rate	0	%
9173	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 11 [human]	inhibition rate	7	%
9174	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317I)-phosphorylated [human]	inhibition rate	0	%
9175	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 13 [human]	inhibition rate	0	%
9176	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 12 [human]	inhibition rate	0	%
9177	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase N1 [human]	inhibition rate	2	%
9178	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	serine/threonine-protein kinase pak 2 [human]	inhibition rate	0	%
9179	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PAK 3 [human]	inhibition rate	0	%
9180	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PAK 4 [human]	inhibition rate	0	%
9181	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PAK 6 [human]	inhibition rate	0	%
9182	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	serine/threonine-protein kinase pak 5 [human]	inhibition rate	0	%
9183	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 16 [human]	inhibition rate	0	%
9184	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 17 [human]	inhibition rate	10	%
9185	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317L)-nonphosphorylated [human]	inhibition rate	0	%
9186	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 18 [human]	inhibition rate	48	%
9187	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Platelet-derived growth factor receptor alpha [human]	inhibition rate	0	%
9188	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Platelet-derived growth factor receptor beta [human]	inhibition rate	5	%
9189	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	3-phosphoinositide-dependent protein kinase 1 [human]	inhibition rate	0	%
9190	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium-dependent protein kinase 1 [Plasmodium falciparum]	inhibition rate	2	%
9191	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cell division control protein 2 homolog [Plasmodium falciparum]	inhibition rate	0	%
9192	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 15 [human]	inhibition rate	0	%
9193	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 14 [human]	inhibition rate	7	%
9194	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform [human]	inhibition rate	0	%
9195	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform [human]	inhibition rate	0	%
9196	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317L)-phosphorylated [human]	inhibition rate	0	%
9197	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta [human]	inhibition rate	0	%
9198	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition rate	0	%
9199	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human]	inhibition rate	0	%
9200	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (C420R) [human]	inhibition rate	0	%
9201	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E542K) [human]	inhibition rate	32	%
9202	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545A) [human]	inhibition rate	0	%
9203	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545K) [human]	inhibition rate	0	%
9204	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047L) [human]	inhibition rate	0	%
9205	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047Y) [human]	inhibition rate	0	%
9206	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human]	inhibition rate	0	%
9207	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(H396P)-nonphosphorylated [human]	inhibition rate	24	%
9208	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (M1043I) [human]	inhibition rate	0	%
9209	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (Q546K) [human]	inhibition rate	31	%
9210	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [human]	inhibition rate	0	%
9211	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [human]	inhibition rate	0	%
9212	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform [human]	inhibition rate	0	%
9213	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-kinase beta [human]	inhibition rate	0	%
9214	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	1-phosphatidylinositol 3-phosphate 5-kinase [human]	inhibition rate	55	%
9215	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Lon protease homolog, mitochondrial [human]	inhibition rate	2	%
9216	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase pim-2 [human]	inhibition rate	0	%
9217	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase pim-3 [human]	inhibition rate	0	%
9218	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(H396P)-phosphorylated [human]	inhibition rate	5	%
9219	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha [human]	inhibition rate	0	%
9220	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma [human]	inhibition rate	23	%
9221	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta [human]	inhibition rate	43	%
9222	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma [human]	inhibition rate	0	%
9223	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cAMP-dependent protein kinase catalytic subunit alpha [human]	inhibition rate	0	%
9224	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cAMP-dependent protein kinase catalytic subunit beta [human]	inhibition rate	0	%
9225	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase [human]	inhibition rate	7	%
9226	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase N1 [human]	inhibition rate	0	%
9227	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase pkn2 [human]	inhibition rate	26	%
9228	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PknB [Mycobacterium tuberculosis]	inhibition rate	11	%
9229	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(M351T)-phosphorylated [human]	inhibition rate	0	%
9230	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PLK1 [human]	inhibition rate	16	%
9231	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PLK2 [human]	inhibition rate	1	%
9232	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Plk3 [human]	inhibition rate	0	%
9233	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Plk4 [human]	inhibition rate	0	%
9234	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, delta [human]	inhibition rate	10	%
9235	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, epsilon [human]	inhibition rate	18	%
9236	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, eta [human]	inhibition rate	11	%
9237	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C iota type [human]	inhibition rate	0	%
9238	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, theta [human]	inhibition rate	0	%
9239	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase D1 [human]	inhibition rate	5	%
9240	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(Q252H)-nonphosphorylated [human]	inhibition rate	20	%
9241	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase D2 [human]	inhibition rate	1	%
9242	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase D3 [human]	inhibition rate	0	%
9243	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cGMP-dependent protein kinase 1 [human]	inhibition rate	0	%
9244	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cGMP-dependent protein kinase 2 [human]	inhibition rate	4	%
9245	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Interferon-induced, double-stranded RNA-activated protein kinase [human]	inhibition rate	0	%
9246	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cAMP-dependent protein kinase catalytic subunit PRKX [human]	inhibition rate	0	%
9247	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proline-rich protein 4 [human]	inhibition rate	0	%
9248	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein-tyrosine kinase 2-beta [human]	inhibition rate	0	%
9249	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase SIK3 [human]	inhibition rate	0	%
9250	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	RAF proto-oncogene serine/threonine-protein kinase [human]	inhibition rate	17	%
9251	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(Q252H)-phosphorylated [human]	inhibition rate	0	%
9252	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret [human]	inhibition rate	14	%
9253	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (M918T) [human]	inhibition rate	1	%
9254	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804L) [human]	inhibition rate	0	%
9255	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M) [human]	inhibition rate	0	%
9256	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Rio1 [human]	inhibition rate	0	%
9257	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Rio2 [human]	inhibition rate	0	%
9258	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Rio3 [human]	inhibition rate	0	%
9259	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-interacting serine/threonine-protein kinase 1 [human]	inhibition rate	3	%
9260	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-interacting serine/threonine-protein kinase 2 [human]	inhibition rate	11	%
9261	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-interacting serine/threonine-protein kinase 4 [human]	inhibition rate	0	%
9262	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(T315I)-nonphosphorylated [human]	inhibition rate	0	%
9263	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual serine/threonine and tyrosine protein kinase [human]	inhibition rate	12	%
9264	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Rho-associated protein kinase 1 [human]	inhibition rate	0	%
9265	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Rho-associated protein kinase 2 [human]	inhibition rate	0	%
9266	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase ROS [human]	inhibition rate	21	%
9267	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-4 [human]	inhibition rate	0	%
9268	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-4 [human]	inhibition rate	0	%
9269	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-5 [human]	inhibition rate	0	%
9270	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-5 [human]	inhibition rate	0	%
9271	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-1 [human]	inhibition rate	0	%
9272	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-1 [human]	inhibition rate	0	%
9273	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(T315I)-phosphorylated [human]	inhibition rate	0	%
9274	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	0	%
9275	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	0	%
9276	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-2 [human]	inhibition rate	14	%
9277	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-2 [human]	inhibition rate	0	%
9278	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-6 [human]	inhibition rate	0	%
9279	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-6 [human]	inhibition rate	0	%
9280	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase beta-1 [human]	inhibition rate	0	%
9281	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	serine/threonine-protein kinase sbk1 [human]	inhibition rate	15	%
9282	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Sgk1 [human]	inhibition rate	15	%
9283	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Uncharacterized serine/threonine-protein kinase SBK3 [human]	inhibition rate	58	%
9284	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(Y253F)-phosphorylated [human]	inhibition rate	11	%
9285	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Sgk2 [human]	inhibition rate	7	%
9286	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Sgk3 [human]	inhibition rate	3	%
9287	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase SIK1 [human]	inhibition rate	0	%
9288	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase SIK2 [human]	inhibition rate	1	%
9289	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	STE20-like serine/threonine-protein kinase [human]	inhibition rate	15	%
9290	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	NUAK family SNF1-like kinase 2 [human]	inhibition rate	8	%
9291	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	SNF-related serine/threonine-protein kinase [human]	inhibition rate	0	%
9292	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase Src [human]	inhibition rate	0	%
9293	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Srms [human]	inhibition rate	0	%
9294	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	SRSF protein kinase 1 [human]	inhibition rate	0	%
9295	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1-nonphosphorylated [human]	inhibition rate	24	%
9296	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	SRSF protein kinase 2 [human]	inhibition rate	0	%
9297	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	SRSF protein kinase 3 [human]	inhibition rate	0	%
9298	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 16 [human]	inhibition rate	21	%
9299	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 33 [human]	inhibition rate	0	%
9300	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 35 [human]	inhibition rate	0	%
9301	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 36 [human]	inhibition rate	8	%
9302	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	STE20/SPS1-related proline-alanine-rich protein kinase [human]	inhibition rate	18	%
9303	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase SYK [human]	inhibition rate	24	%
9304	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 7 [human]	inhibition rate	15	%
9305	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TAO1 [human]	inhibition rate	0	%
9306	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ABL1- phosphorylated [human]	inhibition rate	0	%
9307	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TAO2 [human]	inhibition rate	0	%
9308	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TAO3 [human]	inhibition rate	39	%
9309	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TBK1 [human]	inhibition rate	9	%
9310	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Tec [human]	inhibition rate	3	%
9311	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity testis-specific protein kinase 1 [human]	inhibition rate	33	%
9312	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	TGF-beta receptor type-1 [human]	inhibition rate	0	%
9313	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	TGF-beta receptor type-2 [human]	inhibition rate	27	%
9314	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase receptor Tie-1 [human]	inhibition rate	0	%
9315	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase receptor Tie-2 [human]	inhibition rate	0	%
9316	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase tousled-like 1 [human]	inhibition rate	0	%
9317	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ABL2 [human]	inhibition rate	7	%
9318	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TOUSLED-like 2 [human]	inhibition rate	0	%
9319	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Traf2 and NCK-interacting protein kinase [human]	inhibition rate	0	%
9320	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Non-receptor tyrosine-protein kinase TNK1 [human]	inhibition rate	17	%
9321	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activated CDC42 kinase 1 [human]	inhibition rate	17	%
9322	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TNNI3K [human]	inhibition rate	0	%
9323	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	High affinity nerve growth factor receptor [human]	inhibition rate	0	%
9324	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	BDNF/NT-3 growth factors receptor [human]	inhibition rate	0	%
9325	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	NT-3 growth factor receptor [human]	inhibition rate	0	%
9326	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Transient receptor potential cation channel subfamily M member 6 [human]	inhibition rate	0	%
9327	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Testis-specific serine/threonine-protein kinase 1 [human]	inhibition rate	8	%
9328	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-1 [human]	inhibition rate	23	%
9329	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Testis-specific serine/threonine-protein kinase 3 [human]	inhibition rate	15	%
9330	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase TTK [human]	inhibition rate	36	%
9331	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase TXK [human]	inhibition rate	13	%
9332	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition rate	0	%
9333	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition rate	0	%
9334	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase receptor TYRO3 [human]	inhibition rate	7	%
9335	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ULK1 [human]	inhibition rate	21	%
9336	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ULK2 [human]	inhibition rate	4	%
9337	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ULK3 [human]	inhibition rate	6	%
9338	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Vascular endothelial growth factor receptor 2 [human]	inhibition rate	0	%
9339	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-1B [human]	inhibition rate	4	%
9340	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 3-kinase, Vps34 type [human]	inhibition rate	0	%
9341	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase VRK2 [human]	inhibition rate	0	%
9342	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitosis inhibitor protein kinase wee1 [human]	inhibition rate	0	%
9343	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Wee1-like protein kinase 1-A [human]	inhibition rate	3	%
9344	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK1 [human]	inhibition rate	0	%
9345	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK2 [human]	inhibition rate	0	%
9346	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK3 [human]	inhibition rate	0	%
9347	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK4 [human]	inhibition rate	9	%
9348	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 32A [human]	inhibition rate	0	%
9349	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 32B [human]	inhibition rate	13	%
9350	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-2A [human]	inhibition rate	0	%
9351	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 32C [human]	inhibition rate	35	%
9352	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Yes [human]	inhibition rate	6	%
9353	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 25 [human]	inhibition rate	0	%
9354	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 19 [human]	inhibition rate	5	%
9355	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 20 [human]	inhibition rate	12	%
9356	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ZAP-70 [human]	inhibition rate	0	%
9357	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-2B [human]	inhibition rate	0	%
9358	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase receptor R3 [human]	inhibition rate	32	%
9359	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Atypical kinase COQ8A, mitochondrial [human]	inhibition rate	1	%
9360	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Atypical kinase COQ8B, mitochondrial [human]	inhibition rate	16	%
9361	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	RAC-alpha serine/threonine-protein kinase [human]	inhibition rate	0	%
9362	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	RAC-beta serine/threonine-protein kinase [human]	inhibition rate	25	%
9363	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	RAC-gamma serine/threonine-protein kinase [human]	inhibition rate	17	%
9364	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ALK tyrosine kinase receptor [human]	inhibition rate	3	%
9365	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ALK tyrosine kinase receptor [human]	inhibition rate	0	%
9366	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ALK tyrosine kinase receptor [human]	inhibition rate	0	%
9367	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	5'-AMP-activated protein kinase catalytic subunit alpha-1 [human]	inhibition rate	0	%
9368	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	5'-AMP-activated protein kinase catalytic subunit alpha-2 [human]	inhibition rate	0	%
9369	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ankyrin repeat and protein kinase domain-containing protein 1 [human]	inhibition rate	5	%
9370	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	NUAK family SNF1-like kinase 1 [human]	inhibition rate	0	%
9371	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 5 [human]	inhibition rate	24	%
9372	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 6 [human]	inhibition rate	0	%
9373	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Aurora kinase A [human]	inhibition rate	10	%
9374	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Aurora kinase B [human]	inhibition rate	2	%
9375	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Aurora kinase C [human]	inhibition rate	0	%
9376	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	NEDD8-activating enzyme E1 regulatory subunit AXL [human]	inhibition rate	25	%
9377	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	BMP-2-inducible protein kinase [human]	inhibition rate	0	%
9378	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Blk [human]	inhibition rate	9	%
9379	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Bone morphogenetic protein receptor type-1A [human]	inhibition rate	17	%
9380	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Bone morphogenetic protein receptor type-1B [human]	inhibition rate	7	%
9381	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Bone morphogenetic protein receptor type-2 [human]	inhibition rate	3	%
9382	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cytoplasmic tyrosine-protein kinase BMX [human]	inhibition rate	17	%
9383	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase B-raf [human]	inhibition rate	0	%
9384	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase B-raf (V600E) [human]	inhibition rate	0	%
9385	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein-tyrosine kinase 6 [human]	inhibition rate	3	%
9386	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase BRSK1 [human]	inhibition rate	0	%
9387	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase BRSK2 [human]	inhibition rate	0	%
9388	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase BTK [human]	inhibition rate	0	%
9389	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitotic checkpoint serine/threonine-protein kinase BUB1 [human]	inhibition rate	9	%
9390	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1 [human]	inhibition rate	24	%
9391	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1B [human]	inhibition rate	0	%
9392	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1D [human]	inhibition rate	14	%
9393	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1G [human]	inhibition rate	0	%
9394	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II subunit alpha [human]	inhibition rate	9	%
9395	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II subunit beta [human]	inhibition rate	0	%
9396	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II delta 2 chain [human]	inhibition rate	0	%
9397	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II subunit gamma [human]	inhibition rate	0	%
9398	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type IV [human]	inhibition rate	36	%
9399	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase kinase 1 [human]	inhibition rate	0	%
9400	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase kinase 2 [human]	inhibition rate	0	%
9401	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Kappa-casein [human]	inhibition rate	0	%
9402	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 11B [human]	inhibition rate	6	%
9403	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 11A [human]	inhibition rate	0	%
9404	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 13 [human]	inhibition rate	0	%
9405	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 11 [human]	inhibition rate	0	%
9406	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 2 [human]	inhibition rate	0	%
9407	CN(CCCC(F)(F)F)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 3 [human]	inhibition rate	0	%
9408	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	pIC50	7.24	no unit
9409	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 4 [human]	inhibition rate	0	%
9410	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 4 [human]; Cyclin-D1-1 [human]	inhibition rate	15	%
9411	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 4 [human]; Cyclin-D3-1 [human]	inhibition rate	9	%
9412	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent-like kinase 5 [human]	inhibition rate	18	%
9413	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 7 [human]	inhibition rate	22	%
9414	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 8 [human]	inhibition rate	13	%
9415	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 9 [human]	inhibition rate	0	%
9416	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 1 [human]	inhibition rate	0	%
9417	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 2 [human]	inhibition rate	11	%
9418	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 3 [human]	inhibition rate	7	%
9419	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 5 [human]	inhibition rate	8	%
9420	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Chk1 [human]	inhibition rate	13	%
9421	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Chk2 [human]	inhibition rate	0	%
9422	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Citrate synthase, mitochondrial [human]	inhibition rate	0	%
9423	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ATG1 [human]	inhibition rate	47	%
9424	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase CLK2 [human]	inhibition rate	46	%
9425	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase CLK3 [human]	inhibition rate	16	%
9426	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase CLK4 [human]	inhibition rate	39	%
9427	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Macrophage colony-stimulating factor 1 receptor [human]	inhibition rate	9	%
9428	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	CSF1R-autoinhibited [human]	inhibition rate	31	%
9429	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase CSK [human]	inhibition rate	2	%
9430	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform alpha [human]	inhibition rate	2	%
9431	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform alpha-like [human]	inhibition rate	0	%
9432	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform delta [human]	inhibition rate	0	%
9433	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform epsilon [human]	inhibition rate	0	%
9434	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform gamma-1 [human]	inhibition rate	26	%
9435	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform gamma-2 [human]	inhibition rate	10	%
9436	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform gamma-3 [human]	inhibition rate	0	%
9437	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Casein kinase II subunit alpha [human]	inhibition rate	0	%
9438	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Casein kinase II subunit alpha' [human]	inhibition rate	0	%
9439	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Megakaryocyte-associated tyrosine-protein kinase [human]	inhibition rate	21	%
9440	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 1 [human]	inhibition rate	0	%
9441	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 2 [human]	inhibition rate	31	%
9442	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 3 [human]	inhibition rate	37	%
9443	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase DCLK1 [human]	inhibition rate	39	%
9444	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase DCLK2 [human]	inhibition rate	4	%
9445	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase DCLK3 [human]	inhibition rate	0	%
9446	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Epithelial discoidin domain-containing receptor 1 [human]	inhibition rate	11	%
9447	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Discoidin domain-containing receptor 2 [human]	inhibition rate	16	%
9448	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 3 [human]	inhibition rate	28	%
9449	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Myotonin-protein kinase [human]	inhibition rate	0	%
9450	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MRCK gamma [human]	inhibition rate	1	%
9451	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 17A [human]	inhibition rate	5	%
9452	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 17B [human]	inhibition rate	13	%
9453	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	inhibition rate	82	%
9454	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 1B [human]	inhibition rate	29	%
9455	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 2 [human]	inhibition rate	45	%
9456	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	18	%
9457	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	0	%
9458	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (G719C) [human]	inhibition rate	14	%
9459	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (G719S) [human]	inhibition rate	0	%
9460	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	18	%
9461	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	29	%
9462	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	9	%
9463	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (L858R) [human]	inhibition rate	17	%
9464	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (L858R) [human];+Epidermal growth factor receptor (T790M) [human]	inhibition rate	26	%
9465	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (L861Q) [human]	inhibition rate	0	%
9466	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	0	%
9467	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (T790M) [human]	inhibition rate	29	%
9468	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Eukaryotic translation initiation factor 2-alpha kinase 1 [human]	inhibition rate	0	%
9469	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	AP2-associated protein kinase 1 [human]	inhibition rate	11	%
9470	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 1 [human]	inhibition rate	2	%
9471	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 2 [human]	inhibition rate	20	%
9472	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 3 [human]	inhibition rate	0	%
9473	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 4 [human]	inhibition rate	0	%
9474	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 5 [human]	inhibition rate	0	%
9475	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 6 [human]	inhibition rate	18	%
9476	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 7 [human]	inhibition rate	0	%
9477	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 8 [human]	inhibition rate	0	%
9478	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 1 [human]	inhibition rate	0	%
9479	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 2 [human]	inhibition rate	0	%
9480	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 3 [human]	inhibition rate	24	%
9481	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 4 [human]	inhibition rate	8	%
9482	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 6 [human]	inhibition rate	23	%
9483	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Receptor tyrosine-protein kinase erbB-2 [human]	inhibition rate	2	%
9484	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Receptor tyrosine-protein kinase erbB-3 [human]	inhibition rate	0	%
9485	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Receptor tyrosine-protein kinase erbB-4 [human]	inhibition rate	15	%
9486	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Extracellular signal-regulated kinase 1 [human]	inhibition rate	9	%
9487	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Extracellular signal-regulated kinase 2 [human]	inhibition rate	18	%
9488	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 6 [human]	inhibition rate	8	%
9489	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 4 [human]	inhibition rate	0	%
9490	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 7 [human]	inhibition rate	1	%
9491	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 15 [human]	inhibition rate	17	%
9492	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Ethylene-responsive transcription factor ERN1 [human]	inhibition rate	45	%
9493	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Focal adhesion kinase 1 [human]	inhibition rate	0	%
9494	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Fer [human]	inhibition rate	18	%
9495	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase, Fes/Fps type [human]	inhibition rate	13	%
9496	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 1 [human]	inhibition rate	0	%
9497	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 2 [human]	inhibition rate	0	%
9498	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 3 [human]	inhibition rate	7	%
9499	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 3 [human]	inhibition rate	0	%
9500	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 4 [human]	inhibition rate	0	%
9501	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Fgr [human]	inhibition rate	12	%
9502	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Vascular endothelial growth factor receptor 1 [human]	inhibition rate	0	%
9503	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	0	%
9504	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835H) [human]	inhibition rate	14	%
9505	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835V) [human]	inhibition rate	17	%
9506	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835Y) [human]	inhibition rate	17	%
9507	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	FLT3(ITD) [human]	inhibition rate	0	%
9508	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835V) [human];+FLT3(ITD) [human]	inhibition rate	5	%
9509	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	FLT3(ITD) [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	15	%
9510	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	0	%
9511	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	25	%
9512	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	35	%
9513	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	FLT3-autoinhibited [human]	inhibition rate	28	%
9514	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Vascular endothelial growth factor receptor 3 [human]	inhibition rate	14	%
9515	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase FRK [human]	inhibition rate	0	%
9516	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Fyn [human]	inhibition rate	17	%
9517	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Cyclin-G-associated kinase [human]	inhibition rate	0	%
9518	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	ABC transporter F family member 2 [human]	inhibition rate	0	%
9519	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Rhodopsin kinase GRK1 (C514S) [human]	inhibition rate	7	%
9520	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Beta-adrenergic receptor kinase 1 [human]	inhibition rate	12	%
9521	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Beta-adrenergic receptor kinase 2 [human]	inhibition rate	0	%
9522	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	G protein-coupled receptor kinase 4 [human]	inhibition rate	0	%
9523	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Rhodopsin kinase [human]	inhibition rate	0	%
9524	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Glycogen synthase kinase-3 alpha [human]	inhibition rate	18	%
9525	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	glycogen synthase kinase-3 beta [human]	inhibition rate	7	%
9526	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase haspin [human]	inhibition rate	63	%
9527	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase HCK [human]	inhibition rate	54	%
9528	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 1 [human]	inhibition rate	25	%
9529	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 2 [human]	inhibition rate	43	%
9530	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 3 [human]	inhibition rate	35	%
9531	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 4 [human]	inhibition rate	0	%
9532	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 1 [human]	inhibition rate	0	%
9533	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Hormonally up-regulated neu tumor-associated kinase [human]	inhibition rate	0	%
9534	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Insulin-like growth factor 1 receptor [human]	inhibition rate	0	%
9535	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit alpha [human]	inhibition rate	30	%
9536	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition rate	20	%
9537	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit epsilon [human]	inhibition rate	1	%
9538	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Insulin receptor [human]	inhibition rate	19	%
9539	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Insulin receptor-related protein [human]	inhibition rate	0	%
9540	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Interleukin-1 receptor-associated kinase 1 [human]	inhibition rate	34	%
9541	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Interleukin-1 receptor-associated kinase 3 [human]	inhibition rate	0	%
9542	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Interleukin-1 receptor-associated kinase 4 [human]	inhibition rate	31	%
9543	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ITK/TSK [human]	inhibition rate	0	%
9544	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK1 [human]	inhibition rate	0	%
9545	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK1 [human]	inhibition rate	11	%
9546	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK2 [human]	inhibition rate	15	%
9547	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK3 [human]	inhibition rate	15	%
9548	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 8 [human]	inhibition rate	24	%
9549	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 9 [human]	inhibition rate	18	%
9550	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 10 [human]	inhibition rate	27	%
9551	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	0	%
9552	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (A829P) [human]	inhibition rate	17	%
9553	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (D816H) [human]	inhibition rate	28	%
9554	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (D816V) [human]	inhibition rate	9	%
9555	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	8	%
9556	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (V559D) [human]	inhibition rate	9	%
9557	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (V559D) [human];+Mast/stem cell growth factor receptor Kit [human]	inhibition rate	0	%
9558	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (V559D) [human];+Mast/stem cell growth factor receptor Kit [human]	inhibition rate	32	%
9559	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	KIT-autoinhibited [human]	inhibition rate	27	%
9560	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase LATS1 [human]	inhibition rate	0	%
9561	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase LATS2 [human]	inhibition rate	28	%
9562	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase LCK [human]	inhibition rate	24	%
9563	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	LIM domain kinase 1 [human]	inhibition rate	11	%
9564	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	LIM domain kinase 2 [human]	inhibition rate	18	%
9565	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase STK11 [human]	inhibition rate	0	%
9566	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Coiled-coil domain-containing protein 40 [human]	inhibition rate	58	%
9567	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Leucine-rich repeat serine/threonine-protein kinase 2 [human]	inhibition rate	50	%
9568	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Leucine-rich repeat serine/threonine-protein kinase 2 (G2019S) [human]	inhibition rate	0	%
9569	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Leukocyte tyrosine kinase receptor [human]	inhibition rate	45	%
9570	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Lyn [human]	inhibition rate	0	%
9571	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 13 [human]	inhibition rate	10	%
9572	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MAK [human]	inhibition rate	9	%
9573	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 1 [human]	inhibition rate	15	%
9574	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 15 [human]	inhibition rate	15	%
9575	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 2 [human]	inhibition rate	19	%
9576	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 3 [human]	inhibition rate	10	%
9577	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 4 [human]	inhibition rate	0	%
9578	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 2 [human]	inhibition rate	18	%
9579	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 3 [human]	inhibition rate	0	%
9580	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 4 [human]	inhibition rate	0	%
9581	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 5 [human]	inhibition rate	0	%
9582	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-activated protein kinase 2 [human]	inhibition rate	0	%
9583	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-activated protein kinase 5 [human]	inhibition rate	26	%
9584	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MARK1 [human]	inhibition rate	0	%
9585	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MARK2 [human]	inhibition rate	28	%
9586	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	MAP/microtubule affinity-regulating kinase 3 [human]	inhibition rate	15	%
9587	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	MAP/microtubule affinity-regulating kinase 4 [human]	inhibition rate	0	%
9588	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	CLIP-associating protein 1 [human]	inhibition rate	4	%
9589	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 1 [human]	inhibition rate	22	%
9590	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 2 [human]	inhibition rate	26	%
9591	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 3 [human]	inhibition rate	22	%
9592	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 4 [human]	inhibition rate	0	%
9593	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 5 [human]	inhibition rate	17	%
9594	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 6 [human]	inhibition rate	0	%
9595	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Maternal embryonic leucine zipper kinase [human]	inhibition rate	21	%
9596	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Mer [human]	inhibition rate	7	%
9597	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor receptor [human]	inhibition rate	3	%
9598	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor receptor (M1250T) [human]	inhibition rate	0	%
9599	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor receptor [human]	inhibition rate	0	%
9600	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Misshapen-like kinase 1 [human]	inhibition rate	20	%
9601	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 7 [human]	inhibition rate	12	%
9602	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-interacting serine/threonine-protein kinase 1 [human]	inhibition rate	38	%
9603	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-interacting serine/threonine-protein kinase 2 [human]	inhibition rate	29	%
9604	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase, smooth muscle [human]	inhibition rate	23	%
9605	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 9 [human]	inhibition rate	0	%
9606	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 10 [human]	inhibition rate	0	%
9607	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 11 [human]	inhibition rate	12	%
9608	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MRCK alpha [human]	inhibition rate	0	%
9609	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MRCK beta [human]	inhibition rate	0	%
9610	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor-like [human]	inhibition rate	45	%
9611	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Macrophage-stimulating protein receptor [human]	inhibition rate	8	%
9612	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Histone acetyltransferase mst2 [human]	inhibition rate	6	%
9613	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 24 [human]	inhibition rate	6	%
9614	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 26 [human]	inhibition rate	6	%
9615	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase mTOR [human]	inhibition rate	0	%
9616	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Muscle, skeletal receptor tyrosine-protein kinase [human]	inhibition rate	0	%
9617	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase, smooth muscle [human]	inhibition rate	2	%
9618	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase 2, skeletal/cardiac muscle [human]	inhibition rate	0	%
9619	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase family member 4 [human]	inhibition rate	0	%
9620	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ABL1(E255K)-Phosphorylated [human]	inhibition rate	34	%
9621	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Myosin-IIIa [human]	inhibition rate	0	%
9622	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Myosin-IIIb [human]	inhibition rate	0	%
9623	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Protein NDRG1 [human]	inhibition rate	10	%
9624	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Protein NDRG2 [human]	inhibition rate	0	%
9625	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek1 [human]	inhibition rate	0	%
9626	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek10 [human]	inhibition rate	17	%
9627	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek11 [human]	inhibition rate	7	%
9628	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek2 [human]	inhibition rate	17	%
9629	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek3 [human]	inhibition rate	30	%
9630	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek4 [human]	inhibition rate	7	%
9631	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317I)-nonphosphorylated [human]	inhibition rate	4	%
9632	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek5 [human]	inhibition rate	12	%
9633	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek6 [human]	inhibition rate	1	%
9634	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek7 [human]	inhibition rate	5	%
9635	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek9 [human]	inhibition rate	0	%
9636	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 14 [human]	inhibition rate	25	%
9637	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase NIM1 [human]	inhibition rate	31	%
9638	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine kinase NLK [human]	inhibition rate	26	%
9639	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase OSR1 [human]	inhibition rate	5	%
9640	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 14A [human]	inhibition rate	0	%
9641	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 11 [human]	inhibition rate	0	%
9642	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317I)-phosphorylated [human]	inhibition rate	33	%
9643	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 13 [human]	inhibition rate	4	%
9644	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 12 [human]	inhibition rate	0	%
9645	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase N1 [human]	inhibition rate	13	%
9646	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	serine/threonine-protein kinase pak 2 [human]	inhibition rate	11	%
9647	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PAK 3 [human]	inhibition rate	46	%
9648	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PAK 4 [human]	inhibition rate	20	%
9649	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PAK 6 [human]	inhibition rate	0	%
9650	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	serine/threonine-protein kinase pak 5 [human]	inhibition rate	24	%
9651	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 16 [human]	inhibition rate	4	%
9652	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 17 [human]	inhibition rate	3	%
9653	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317L)-nonphosphorylated [human]	inhibition rate	0	%
9654	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 18 [human]	inhibition rate	17	%
9655	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Platelet-derived growth factor receptor alpha [human]	inhibition rate	33	%
9656	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Platelet-derived growth factor receptor beta [human]	inhibition rate	0	%
9657	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	3-phosphoinositide-dependent protein kinase 1 [human]	inhibition rate	1	%
9658	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Calcium-dependent protein kinase 1 [Plasmodium falciparum]	inhibition rate	16	%
9659	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Cell division control protein 2 homolog [Plasmodium falciparum]	inhibition rate	26	%
9660	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 15 [human]	inhibition rate	0	%
9661	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 14 [human]	inhibition rate	8	%
9662	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform [human]	inhibition rate	0	%
9663	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform [human]	inhibition rate	31	%
9664	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317L)-phosphorylated [human]	inhibition rate	35	%
9665	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta [human]	inhibition rate	24	%
9666	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition rate	44	%
9667	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human]	inhibition rate	23	%
9668	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (C420R) [human]	inhibition rate	54	%
9669	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E542K) [human]	inhibition rate	31	%
9670	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545A) [human]	inhibition rate	41	%
9671	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545K) [human]	inhibition rate	37	%
9672	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047L) [human]	inhibition rate	0	%
9673	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047Y) [human]	inhibition rate	0	%
9674	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human]	inhibition rate	54	%
9675	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	ABL1(H396P)-nonphosphorylated [human]	inhibition rate	2	%
9676	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (M1043I) [human]	inhibition rate	15	%
9677	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (Q546K) [human]	inhibition rate	14	%
9678	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [human]	inhibition rate	8	%
9679	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [human]	inhibition rate	2	%
9680	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform [human]	inhibition rate	10	%
9681	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-kinase beta [human]	inhibition rate	0	%
9682	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	1-phosphatidylinositol 3-phosphate 5-kinase [human]	inhibition rate	0	%
9683	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Lon protease homolog, mitochondrial [human]	inhibition rate	18	%
9684	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase pim-2 [human]	inhibition rate	5	%
9685	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase pim-3 [human]	inhibition rate	6	%
9686	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	ABL1(H396P)-phosphorylated [human]	inhibition rate	20	%
9687	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha [human]	inhibition rate	0	%
9688	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma [human]	inhibition rate	7	%
9689	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta [human]	inhibition rate	0	%
9690	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma [human]	inhibition rate	5	%
9691	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	cAMP-dependent protein kinase catalytic subunit alpha [human]	inhibition rate	14	%
9692	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	cAMP-dependent protein kinase catalytic subunit beta [human]	inhibition rate	7	%
9693	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase [human]	inhibition rate	3	%
9694	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase N1 [human]	inhibition rate	0	%
9695	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase pkn2 [human]	inhibition rate	0	%
9696	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PknB [Mycobacterium tuberculosis]	inhibition rate	13	%
9697	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	ABL1(M351T)-phosphorylated [human]	inhibition rate	29	%
9698	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PLK1 [human]	inhibition rate	15	%
9699	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PLK2 [human]	inhibition rate	22	%
9700	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Plk3 [human]	inhibition rate	21	%
9701	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Plk4 [human]	inhibition rate	0	%
9702	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, delta [human]	inhibition rate	0	%
9703	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, epsilon [human]	inhibition rate	5	%
9704	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, eta [human]	inhibition rate	0	%
9705	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C iota type [human]	inhibition rate	0	%
9706	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, theta [human]	inhibition rate	0	%
9707	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase D1 [human]	inhibition rate	0	%
9708	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	ABL1(Q252H)-nonphosphorylated [human]	inhibition rate	34	%
9709	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase D2 [human]	inhibition rate	13	%
9710	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase D3 [human]	inhibition rate	15	%
9711	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	cGMP-dependent protein kinase 1 [human]	inhibition rate	7	%
9712	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	cGMP-dependent protein kinase 2 [human]	inhibition rate	0	%
9713	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Interferon-induced, double-stranded RNA-activated protein kinase [human]	inhibition rate	0	%
9714	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	cAMP-dependent protein kinase catalytic subunit PRKX [human]	inhibition rate	0	%
9715	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Proline-rich protein 4 [human]	inhibition rate	0	%
9716	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Protein-tyrosine kinase 2-beta [human]	inhibition rate	0	%
9717	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase SIK3 [human]	inhibition rate	13	%
9718	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	RAF proto-oncogene serine/threonine-protein kinase [human]	inhibition rate	4	%
9719	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	ABL1(Q252H)-phosphorylated [human]	inhibition rate	0	%
9720	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret [human]	inhibition rate	3	%
9721	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (M918T) [human]	inhibition rate	4	%
9722	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804L) [human]	inhibition rate	9	%
9723	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M) [human]	inhibition rate	0	%
9724	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Rio1 [human]	inhibition rate	0	%
9725	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Rio2 [human]	inhibition rate	22	%
9726	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Rio3 [human]	inhibition rate	0	%
9727	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Receptor-interacting serine/threonine-protein kinase 1 [human]	inhibition rate	6	%
9728	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Receptor-interacting serine/threonine-protein kinase 2 [human]	inhibition rate	0	%
9729	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Receptor-interacting serine/threonine-protein kinase 4 [human]	inhibition rate	6	%
9730	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	ABL1(T315I)-nonphosphorylated [human]	inhibition rate	6	%
9731	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Dual serine/threonine and tyrosine protein kinase [human]	inhibition rate	31	%
9732	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Rho-associated protein kinase 1 [human]	inhibition rate	0	%
9733	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Rho-associated protein kinase 2 [human]	inhibition rate	15	%
9734	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase ROS [human]	inhibition rate	13	%
9735	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-4 [human]	inhibition rate	11	%
9736	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-4 [human]	inhibition rate	15	%
9737	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-5 [human]	inhibition rate	2	%
9738	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-5 [human]	inhibition rate	11	%
9739	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-1 [human]	inhibition rate	0	%
9740	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-1 [human]	inhibition rate	0	%
9741	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	ABL1(T315I)-phosphorylated [human]	inhibition rate	32	%
9742	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	16	%
9743	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	32	%
9744	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-2 [human]	inhibition rate	0	%
9745	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-2 [human]	inhibition rate	3	%
9746	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-6 [human]	inhibition rate	17	%
9747	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-6 [human]	inhibition rate	2	%
9748	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase beta-1 [human]	inhibition rate	22	%
9749	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	serine/threonine-protein kinase sbk1 [human]	inhibition rate	34	%
9750	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Sgk1 [human]	inhibition rate	21	%
9751	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Uncharacterized serine/threonine-protein kinase SBK3 [human]	inhibition rate	26	%
9752	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	ABL1(Y253F)-phosphorylated [human]	inhibition rate	6	%
9753	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Sgk2 [human]	inhibition rate	28	%
9754	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Sgk3 [human]	inhibition rate	16	%
9755	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase SIK1 [human]	inhibition rate	0	%
9756	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase SIK2 [human]	inhibition rate	0	%
9757	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	STE20-like serine/threonine-protein kinase [human]	inhibition rate	29	%
9758	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	NUAK family SNF1-like kinase 2 [human]	inhibition rate	20	%
9759	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	SNF-related serine/threonine-protein kinase [human]	inhibition rate	0	%
9760	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase Src [human]	inhibition rate	21	%
9761	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Srms [human]	inhibition rate	19	%
9762	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	SRSF protein kinase 1 [human]	inhibition rate	5	%
9763	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	ABL1-nonphosphorylated [human]	inhibition rate	11	%
9764	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	SRSF protein kinase 2 [human]	inhibition rate	17	%
9765	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	SRSF protein kinase 3 [human]	inhibition rate	0	%
9766	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 16 [human]	inhibition rate	13	%
9767	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 33 [human]	inhibition rate	0	%
9768	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 35 [human]	inhibition rate	0	%
9769	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 36 [human]	inhibition rate	0	%
9770	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	STE20/SPS1-related proline-alanine-rich protein kinase [human]	inhibition rate	26	%
9771	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase SYK [human]	inhibition rate	24	%
9772	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 7 [human]	inhibition rate	2	%
9773	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TAO1 [human]	inhibition rate	27	%
9774	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ABL1- phosphorylated [human]	inhibition rate	18	%
9775	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TAO2 [human]	inhibition rate	21	%
9776	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TAO3 [human]	inhibition rate	22	%
9777	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TBK1 [human]	inhibition rate	14	%
9778	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Tec [human]	inhibition rate	0	%
9779	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Dual specificity testis-specific protein kinase 1 [human]	inhibition rate	0	%
9780	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	TGF-beta receptor type-1 [human]	inhibition rate	14	%
9781	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	TGF-beta receptor type-2 [human]	inhibition rate	0	%
9782	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase receptor Tie-1 [human]	inhibition rate	16	%
9783	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase receptor Tie-2 [human]	inhibition rate	0	%
9784	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase tousled-like 1 [human]	inhibition rate	8	%
9785	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ABL2 [human]	inhibition rate	0	%
9786	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TOUSLED-like 2 [human]	inhibition rate	0	%
9787	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Traf2 and NCK-interacting protein kinase [human]	inhibition rate	8	%
9788	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Non-receptor tyrosine-protein kinase TNK1 [human]	inhibition rate	0	%
9789	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Activated CDC42 kinase 1 [human]	inhibition rate	23	%
9790	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TNNI3K [human]	inhibition rate	0	%
9791	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	High affinity nerve growth factor receptor [human]	inhibition rate	3	%
9792	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	BDNF/NT-3 growth factors receptor [human]	inhibition rate	36	%
9793	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	NT-3 growth factor receptor [human]	inhibition rate	8	%
9794	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Transient receptor potential cation channel subfamily M member 6 [human]	inhibition rate	0	%
9795	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Testis-specific serine/threonine-protein kinase 1 [human]	inhibition rate	0	%
9796	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-1 [human]	inhibition rate	21	%
9797	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Testis-specific serine/threonine-protein kinase 3 [human]	inhibition rate	1	%
9798	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase TTK [human]	inhibition rate	34	%
9799	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase TXK [human]	inhibition rate	0	%
9800	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition rate	13	%
9801	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition rate	30	%
9802	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase receptor TYRO3 [human]	inhibition rate	25	%
9803	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ULK1 [human]	inhibition rate	20	%
9804	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ULK2 [human]	inhibition rate	45	%
9805	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ULK3 [human]	inhibition rate	28	%
9806	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Vascular endothelial growth factor receptor 2 [human]	inhibition rate	25	%
9807	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-1B [human]	inhibition rate	0	%
9808	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 3-kinase, Vps34 type [human]	inhibition rate	7	%
9809	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase VRK2 [human]	inhibition rate	0	%
9810	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitosis inhibitor protein kinase wee1 [human]	inhibition rate	0	%
9811	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Wee1-like protein kinase 1-A [human]	inhibition rate	2	%
9812	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK1 [human]	inhibition rate	13	%
9813	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK2 [human]	inhibition rate	18	%
9814	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK3 [human]	inhibition rate	10	%
9815	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK4 [human]	inhibition rate	9	%
9816	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 32A [human]	inhibition rate	0	%
9817	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 32B [human]	inhibition rate	0	%
9818	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-2A [human]	inhibition rate	5	%
9819	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 32C [human]	inhibition rate	13	%
9820	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Yes [human]	inhibition rate	22	%
9821	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 25 [human]	inhibition rate	0	%
9822	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 19 [human]	inhibition rate	31	%
9823	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 20 [human]	inhibition rate	4	%
9824	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ZAP-70 [human]	inhibition rate	21	%
9825	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-2B [human]	inhibition rate	5	%
9826	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase receptor R3 [human]	inhibition rate	0	%
9827	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Atypical kinase COQ8A, mitochondrial [human]	inhibition rate	4	%
9828	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Atypical kinase COQ8B, mitochondrial [human]	inhibition rate	27	%
9829	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	RAC-alpha serine/threonine-protein kinase [human]	inhibition rate	0	%
9830	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	RAC-beta serine/threonine-protein kinase [human]	inhibition rate	0	%
9831	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	RAC-gamma serine/threonine-protein kinase [human]	inhibition rate	0	%
9832	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	ALK tyrosine kinase receptor [human]	inhibition rate	10	%
9833	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	ALK tyrosine kinase receptor [human]	inhibition rate	20	%
9834	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	ALK tyrosine kinase receptor [human]	inhibition rate	41	%
9835	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	5'-AMP-activated protein kinase catalytic subunit alpha-1 [human]	inhibition rate	52	%
9836	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	5'-AMP-activated protein kinase catalytic subunit alpha-2 [human]	inhibition rate	0	%
9837	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Ankyrin repeat and protein kinase domain-containing protein 1 [human]	inhibition rate	31	%
9838	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	NUAK family SNF1-like kinase 1 [human]	inhibition rate	0	%
9839	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 5 [human]	inhibition rate	0	%
9840	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 6 [human]	inhibition rate	3	%
9841	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Aurora kinase A [human]	inhibition rate	0	%
9842	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Aurora kinase B [human]	inhibition rate	23	%
9843	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Aurora kinase C [human]	inhibition rate	0	%
9844	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	NEDD8-activating enzyme E1 regulatory subunit AXL [human]	inhibition rate	8	%
9845	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	BMP-2-inducible protein kinase [human]	inhibition rate	0	%
9846	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Blk [human]	inhibition rate	10	%
9847	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Bone morphogenetic protein receptor type-1A [human]	inhibition rate	0	%
9848	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Bone morphogenetic protein receptor type-1B [human]	inhibition rate	36	%
9849	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Bone morphogenetic protein receptor type-2 [human]	inhibition rate	26	%
9850	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Cytoplasmic tyrosine-protein kinase BMX [human]	inhibition rate	8	%
9851	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase B-raf [human]	inhibition rate	15	%
9852	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase B-raf (V600E) [human]	inhibition rate	7	%
9853	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Protein-tyrosine kinase 6 [human]	inhibition rate	1	%
9854	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase BRSK1 [human]	inhibition rate	13	%
9855	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase BRSK2 [human]	inhibition rate	0	%
9856	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase BTK [human]	inhibition rate	25	%
9857	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Mitotic checkpoint serine/threonine-protein kinase BUB1 [human]	inhibition rate	0	%
9858	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1 [human]	inhibition rate	14	%
9859	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1B [human]	inhibition rate	15	%
9860	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1D [human]	inhibition rate	22	%
9861	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1G [human]	inhibition rate	4	%
9862	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II subunit alpha [human]	inhibition rate	37	%
9863	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II subunit beta [human]	inhibition rate	35	%
9864	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II delta 2 chain [human]	inhibition rate	8	%
9865	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II subunit gamma [human]	inhibition rate	10	%
9866	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type IV [human]	inhibition rate	0	%
9867	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase kinase 1 [human]	inhibition rate	10	%
9868	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase kinase 2 [human]	inhibition rate	14	%
9869	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Kappa-casein [human]	inhibition rate	21	%
9870	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 11B [human]	inhibition rate	0	%
9871	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 11A [human]	inhibition rate	3	%
9872	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 13 [human]	inhibition rate	4	%
9873	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 11 [human]	inhibition rate	0	%
9874	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 2 [human]	inhibition rate	0	%
9875	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 3 [human]	inhibition rate	18	%
9876	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	kd	12	nM
9877	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1		CLint (intrinsic clearance)	983	μl/min/mg protein
9878	CN(C)C1=NC=C(F)C(=N1)C1=C2C=CC=NN2N=C1		CLint (intrinsic clearance)	697	μl/min/mg protein
9879	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	pIC50	7.12	no unit
9880	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1		Papp (A-B)	7.14E-5	cm/s
9881	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1		Papp (B-A)	5.87E-5	cm/s
9882	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1		AUC (0-inf)	276.4	ng*h/ml
9883	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1		CL (drug clearance)	61.6	ml/min/kg
9884	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1		MRT (mean residence time)	0.2	h
9885	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1		Cpredose	1331.5	ng/ml
9886	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1		t1/2 (drug half life)	0.2	h
9887	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1		tmax	0.03	h
9888	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1		Cmax	1082.8	ng/ml
9889	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1		AUC (0-t)	275.3	ng*h/ml
9890	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 4 [human]	inhibition rate	8	%
9891	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 4 [human]; Cyclin-D1-1 [human]	inhibition rate	0	%
9892	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 4 [human]; Cyclin-D3-1 [human]	inhibition rate	0	%
9893	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent-like kinase 5 [human]	inhibition rate	0	%
9894	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 7 [human]	inhibition rate	18	%
9895	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 8 [human]	inhibition rate	0	%
9896	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 9 [human]	inhibition rate	0	%
9897	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 1 [human]	inhibition rate	11	%
9898	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 2 [human]	inhibition rate	0	%
9899	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 3 [human]	inhibition rate	6	%
9900	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 5 [human]	inhibition rate	0	%
9901	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Chk1 [human]	inhibition rate	0	%
9902	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Chk2 [human]	inhibition rate	0	%
9903	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Citrate synthase, mitochondrial [human]	inhibition rate	14	%
9904	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ATG1 [human]	inhibition rate	92.9	%
9905	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase CLK2 [human]	inhibition rate	90.6	%
9906	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase CLK3 [human]	inhibition rate	46	%
9907	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase CLK4 [human]	inhibition rate	94.1	%
9908	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Macrophage colony-stimulating factor 1 receptor [human]	inhibition rate	0	%
9909	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	CSF1R-autoinhibited [human]	inhibition rate	0	%
9910	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase CSK [human]	inhibition rate	32	%
9911	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform alpha [human]	inhibition rate	40	%
9912	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform alpha-like [human]	inhibition rate	2	%
9913	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform delta [human]	inhibition rate	38	%
9914	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform epsilon [human]	inhibition rate	39	%
9915	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform gamma-1 [human]	inhibition rate	0	%
9916	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform gamma-2 [human]	inhibition rate	15	%
9917	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform gamma-3 [human]	inhibition rate	18	%
9918	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase II subunit alpha [human]	inhibition rate	61	%
9919	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase II subunit alpha' [human]	inhibition rate	61	%
9920	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Megakaryocyte-associated tyrosine-protein kinase [human]	inhibition rate	0	%
9921	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 1 [human]	inhibition rate	0	%
9922	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 2 [human]	inhibition rate	10	%
9923	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 3 [human]	inhibition rate	9	%
9924	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase DCLK1 [human]	inhibition rate	5	%
9925	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase DCLK2 [human]	inhibition rate	6	%
9926	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase DCLK3 [human]	inhibition rate	0	%
9927	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epithelial discoidin domain-containing receptor 1 [human]	inhibition rate	0	%
9928	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Discoidin domain-containing receptor 2 [human]	inhibition rate	0	%
9929	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 3 [human]	inhibition rate	2	%
9930	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myotonin-protein kinase [human]	inhibition rate	0	%
9931	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MRCK gamma [human]	inhibition rate	0	%
9932	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 17A [human]	inhibition rate	24	%
9933	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 17B [human]	inhibition rate	0	%
9934	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	inhibition rate	99.6	%
9935	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 1B [human]	inhibition rate	97.3	%
9936	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 2 [human]	inhibition rate	81	%
9937	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	0	%
9938	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	6	%
9939	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (G719C) [human]	inhibition rate	0	%
9940	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (G719S) [human]	inhibition rate	0	%
9941	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	0	%
9942	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	23	%
9943	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	2	%
9944	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (L858R) [human]	inhibition rate	7	%
9945	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (L858R) [human];+Epidermal growth factor receptor (T790M) [human]	inhibition rate	0	%
9946	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (L861Q) [human]	inhibition rate	10	%
9947	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	6	%
9948	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (T790M) [human]	inhibition rate	0	%
9949	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Eukaryotic translation initiation factor 2-alpha kinase 1 [human]	inhibition rate	0	%
9950	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	AP2-associated protein kinase 1 [human]	inhibition rate	25	%
9951	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 1 [human]	inhibition rate	54	%
9952	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 2 [human]	inhibition rate	15	%
9953	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 3 [human]	inhibition rate	10	%
9954	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 4 [human]	inhibition rate	1	%
9955	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 5 [human]	inhibition rate	0	%
9956	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 6 [human]	inhibition rate	7	%
9957	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 7 [human]	inhibition rate	5	%
9958	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 8 [human]	inhibition rate	0	%
9959	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 1 [human]	inhibition rate	0	%
9960	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 2 [human]	inhibition rate	29	%
9961	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 3 [human]	inhibition rate	12	%
9962	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 4 [human]	inhibition rate	0	%
9963	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 6 [human]	inhibition rate	38	%
9964	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor tyrosine-protein kinase erbB-2 [human]	inhibition rate	0	%
9965	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor tyrosine-protein kinase erbB-3 [human]	inhibition rate	13	%
9966	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor tyrosine-protein kinase erbB-4 [human]	inhibition rate	19	%
9967	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Extracellular signal-regulated kinase 1 [human]	inhibition rate	0	%
9968	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Extracellular signal-regulated kinase 2 [human]	inhibition rate	0	%
9969	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 6 [human]	inhibition rate	0	%
9970	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 4 [human]	inhibition rate	0	%
9971	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 7 [human]	inhibition rate	6	%
9972	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 15 [human]	inhibition rate	49	%
9973	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ethylene-responsive transcription factor ERN1 [human]	inhibition rate	0	%
9974	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Focal adhesion kinase 1 [human]	inhibition rate	21	%
9975	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Fer [human]	inhibition rate	3	%
9976	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase, Fes/Fps type [human]	inhibition rate	0	%
9977	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 1 [human]	inhibition rate	0	%
9978	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 2 [human]	inhibition rate	0	%
9979	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 3 [human]	inhibition rate	6	%
9980	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 3 [human]	inhibition rate	35	%
9981	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 4 [human]	inhibition rate	0	%
9982	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Fgr [human]	inhibition rate	0	%
9983	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Vascular endothelial growth factor receptor 1 [human]	inhibition rate	0	%
9984	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	2	%
9985	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835H) [human]	inhibition rate	0	%
9986	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835V) [human]	inhibition rate	5	%
9987	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835Y) [human]	inhibition rate	0	%
9988	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	FLT3(ITD) [human]	inhibition rate	15	%
9989	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835V) [human];+FLT3(ITD) [human]	inhibition rate	47	%
9990	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	FLT3(ITD) [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	1	%
9991	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	0	%
9992	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	5	%
9993	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	0	%
9994	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	FLT3-autoinhibited [human]	inhibition rate	0	%
9995	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Vascular endothelial growth factor receptor 3 [human]	inhibition rate	0	%
9996	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase FRK [human]	inhibition rate	0	%
9997	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Fyn [human]	inhibition rate	0	%
9998	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-G-associated kinase [human]	inhibition rate	18	%
9999	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABC transporter F family member 2 [human]	inhibition rate	0	%
10000	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Rhodopsin kinase GRK1 (C514S) [human]	inhibition rate	21	%
10001	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Beta-adrenergic receptor kinase 1 [human]	inhibition rate	26	%
10002	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Beta-adrenergic receptor kinase 2 [human]	inhibition rate	11	%
10003	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	G protein-coupled receptor kinase 4 [human]	inhibition rate	0	%
10004	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Rhodopsin kinase [human]	inhibition rate	0	%
10005	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Glycogen synthase kinase-3 alpha [human]	inhibition rate	7	%
10006	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	glycogen synthase kinase-3 beta [human]	inhibition rate	6	%
10007	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase haspin [human]	inhibition rate	98.5	%
10008	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase HCK [human]	inhibition rate	0	%
10009	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 1 [human]	inhibition rate	45	%
10010	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 2 [human]	inhibition rate	51	%
10011	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 3 [human]	inhibition rate	49	%
10012	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 4 [human]	inhibition rate	25	%
10013	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 1 [human]	inhibition rate	0	%
10014	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hormonally up-regulated neu tumor-associated kinase [human]	inhibition rate	0	%
10015	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Insulin-like growth factor 1 receptor [human]	inhibition rate	0	%
10016	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit alpha [human]	inhibition rate	19	%
10017	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition rate	16	%
10018	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit epsilon [human]	inhibition rate	11	%
10019	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Insulin receptor [human]	inhibition rate	21	%
10020	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Insulin receptor-related protein [human]	inhibition rate	8	%
10021	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Interleukin-1 receptor-associated kinase 1 [human]	inhibition rate	29	%
10022	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Interleukin-1 receptor-associated kinase 3 [human]	inhibition rate	0	%
10023	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Interleukin-1 receptor-associated kinase 4 [human]	inhibition rate	27	%
10024	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ITK/TSK [human]	inhibition rate	0	%
10025	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK1 [human]	inhibition rate	31	%
10026	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK1 [human]	inhibition rate	47	%
10027	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK2 [human]	inhibition rate	51	%
10028	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK3 [human]	inhibition rate	100	%
10029	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 8 [human]	inhibition rate	0	%
10030	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 9 [human]	inhibition rate	45	%
10031	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 10 [human]	inhibition rate	51	%
10032	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	0	%
10033	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (A829P) [human]	inhibition rate	19	%
10034	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (D816H) [human]	inhibition rate	40	%
10035	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (D816V) [human]	inhibition rate	40	%
10036	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	0	%
10037	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (V559D) [human]	inhibition rate	0	%
10038	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (V559D) [human];+Mast/stem cell growth factor receptor Kit [human]	inhibition rate	0	%
10039	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (V559D) [human];+Mast/stem cell growth factor receptor Kit [human]	inhibition rate	0	%
10040	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	KIT-autoinhibited [human]	inhibition rate	12	%
10041	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase LATS1 [human]	inhibition rate	0	%
10042	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase LATS2 [human]	inhibition rate	36	%
10043	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase LCK [human]	inhibition rate	7	%
10044	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	LIM domain kinase 1 [human]	inhibition rate	5	%
10045	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	LIM domain kinase 2 [human]	inhibition rate	3	%
10046	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase STK11 [human]	inhibition rate	0	%
10047	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Coiled-coil domain-containing protein 40 [human]	inhibition rate	0	%
10048	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Leucine-rich repeat serine/threonine-protein kinase 2 [human]	inhibition rate	10	%
10049	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Leucine-rich repeat serine/threonine-protein kinase 2 (G2019S) [human]	inhibition rate	31	%
10050	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Leukocyte tyrosine kinase receptor [human]	inhibition rate	8	%
10051	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Lyn [human]	inhibition rate	17	%
10052	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 13 [human]	inhibition rate	15	%
10053	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MAK [human]	inhibition rate	0	%
10054	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 1 [human]	inhibition rate	9	%
10055	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 15 [human]	inhibition rate	9	%
10056	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 2 [human]	inhibition rate	22	%
10057	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 3 [human]	inhibition rate	0	%
10058	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 4 [human]	inhibition rate	0	%
10059	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 2 [human]	inhibition rate	0	%
10060	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 3 [human]	inhibition rate	0	%
10061	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 4 [human]	inhibition rate	13	%
10062	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 5 [human]	inhibition rate	12	%
10063	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-activated protein kinase 2 [human]	inhibition rate	0	%
10064	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-activated protein kinase 5 [human]	inhibition rate	6	%
10065	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MARK1 [human]	inhibition rate	4	%
10066	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MARK2 [human]	inhibition rate	4	%
10067	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP/microtubule affinity-regulating kinase 3 [human]	inhibition rate	0	%
10068	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP/microtubule affinity-regulating kinase 4 [human]	inhibition rate	0	%
10069	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	CLIP-associating protein 1 [human]	inhibition rate	24	%
10070	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 1 [human]	inhibition rate	7	%
10071	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 2 [human]	inhibition rate	6	%
10072	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 3 [human]	inhibition rate	49	%
10073	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 4 [human]	inhibition rate	19	%
10074	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 5 [human]	inhibition rate	32	%
10075	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 6 [human]	inhibition rate	42	%
10076	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Maternal embryonic leucine zipper kinase [human]	inhibition rate	29	%
10077	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Mer [human]	inhibition rate	13	%
10078	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor receptor [human]	inhibition rate	11	%
10079	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor receptor (M1250T) [human]	inhibition rate	0	%
10080	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor receptor [human]	inhibition rate	10	%
10081	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Misshapen-like kinase 1 [human]	inhibition rate	19	%
10082	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 7 [human]	inhibition rate	0	%
10083	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-interacting serine/threonine-protein kinase 1 [human]	inhibition rate	0	%
10084	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-interacting serine/threonine-protein kinase 2 [human]	inhibition rate	72	%
10085	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase, smooth muscle [human]	inhibition rate	0	%
10086	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 9 [human]	inhibition rate	0	%
10087	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 10 [human]	inhibition rate	2	%
10088	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 11 [human]	inhibition rate	2	%
10089	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MRCK alpha [human]	inhibition rate	0	%
10090	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MRCK beta [human]	inhibition rate	0	%
10091	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor-like [human]	inhibition rate	0	%
10092	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Macrophage-stimulating protein receptor [human]	inhibition rate	0	%
10093	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Histone acetyltransferase mst2 [human]	inhibition rate	0	%
10094	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 24 [human]	inhibition rate	0	%
10095	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 26 [human]	inhibition rate	0	%
10096	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase mTOR [human]	inhibition rate	0	%
10097	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Muscle, skeletal receptor tyrosine-protein kinase [human]	inhibition rate	8	%
10098	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase, smooth muscle [human]	inhibition rate	37	%
10099	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase 2, skeletal/cardiac muscle [human]	inhibition rate	0	%
10100	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase family member 4 [human]	inhibition rate	12	%
10101	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ABL1(E255K)-Phosphorylated [human]	inhibition rate	40	%
10102	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin-IIIa [human]	inhibition rate	0	%
10103	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin-IIIb [human]	inhibition rate	0	%
10104	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein NDRG1 [human]	inhibition rate	26	%
10105	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein NDRG2 [human]	inhibition rate	15	%
10106	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek1 [human]	inhibition rate	12	%
10107	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek10 [human]	inhibition rate	0	%
10108	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek11 [human]	inhibition rate	0	%
10109	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek2 [human]	inhibition rate	0	%
10110	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek3 [human]	inhibition rate	0	%
10111	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek4 [human]	inhibition rate	2	%
10112	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317I)-nonphosphorylated [human]	inhibition rate	43	%
10113	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek5 [human]	inhibition rate	0	%
10114	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek6 [human]	inhibition rate	0	%
10115	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek7 [human]	inhibition rate	8	%
10116	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek9 [human]	inhibition rate	0	%
10117	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 14 [human]	inhibition rate	26	%
10118	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase NIM1 [human]	inhibition rate	48	%
10119	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine kinase NLK [human]	inhibition rate	0	%
10120	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase OSR1 [human]	inhibition rate	0	%
10121	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 14A [human]	inhibition rate	9	%
10122	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 11 [human]	inhibition rate	0	%
10123	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317I)-phosphorylated [human]	inhibition rate	0	%
10124	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 13 [human]	inhibition rate	0	%
10125	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 12 [human]	inhibition rate	40	%
10126	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase N1 [human]	inhibition rate	0	%
10127	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	serine/threonine-protein kinase pak 2 [human]	inhibition rate	36	%
10128	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PAK 3 [human]	inhibition rate	0	%
10129	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PAK 4 [human]	inhibition rate	0	%
10130	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PAK 6 [human]	inhibition rate	0	%
10131	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	serine/threonine-protein kinase pak 5 [human]	inhibition rate	8	%
10132	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 16 [human]	inhibition rate	0	%
10133	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 17 [human]	inhibition rate	0	%
10134	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317L)-nonphosphorylated [human]	inhibition rate	44	%
10135	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 18 [human]	inhibition rate	11	%
10136	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Platelet-derived growth factor receptor alpha [human]	inhibition rate	0	%
10137	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Platelet-derived growth factor receptor beta [human]	inhibition rate	0	%
10138	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	3-phosphoinositide-dependent protein kinase 1 [human]	inhibition rate	0	%
10139	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium-dependent protein kinase 1 [Plasmodium falciparum]	inhibition rate	0	%
10140	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cell division control protein 2 homolog [Plasmodium falciparum]	inhibition rate	0	%
10141	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 15 [human]	inhibition rate	0	%
10142	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 14 [human]	inhibition rate	11	%
10143	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform [human]	inhibition rate	0	%
10144	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform [human]	inhibition rate	14	%
10145	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317L)-phosphorylated [human]	inhibition rate	0	%
10146	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta [human]	inhibition rate	0	%
10147	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition rate	0	%
10148	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human]	inhibition rate	3	%
10149	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (C420R) [human]	inhibition rate	0	%
10150	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E542K) [human]	inhibition rate	39	%
10151	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545A) [human]	inhibition rate	0	%
10152	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545K) [human]	inhibition rate	17	%
10153	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047L) [human]	inhibition rate	27	%
10154	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047Y) [human]	inhibition rate	10	%
10155	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human]	inhibition rate	4	%
10156	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(H396P)-nonphosphorylated [human]	inhibition rate	11	%
10157	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (M1043I) [human]	inhibition rate	37	%
10158	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (Q546K) [human]	inhibition rate	39	%
10159	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [human]	inhibition rate	50	%
10160	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [human]	inhibition rate	15	%
10161	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform [human]	inhibition rate	24	%
10162	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-kinase beta [human]	inhibition rate	42	%
10163	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	1-phosphatidylinositol 3-phosphate 5-kinase [human]	inhibition rate	0	%
10164	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Lon protease homolog, mitochondrial [human]	inhibition rate	19	%
10165	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase pim-2 [human]	inhibition rate	22	%
10166	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase pim-3 [human]	inhibition rate	44	%
10167	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(H396P)-phosphorylated [human]	inhibition rate	0	%
10168	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha [human]	inhibition rate	0	%
10169	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma [human]	inhibition rate	5	%
10170	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta [human]	inhibition rate	0	%
10171	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma [human]	inhibition rate	0	%
10172	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cAMP-dependent protein kinase catalytic subunit alpha [human]	inhibition rate	0	%
10173	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cAMP-dependent protein kinase catalytic subunit beta [human]	inhibition rate	24	%
10174	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase [human]	inhibition rate	0	%
10175	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase N1 [human]	inhibition rate	2	%
10176	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase pkn2 [human]	inhibition rate	0	%
10177	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PknB [Mycobacterium tuberculosis]	inhibition rate	24	%
10178	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(M351T)-phosphorylated [human]	inhibition rate	0	%
10179	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PLK1 [human]	inhibition rate	44	%
10180	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PLK2 [human]	inhibition rate	0	%
10181	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Plk3 [human]	inhibition rate	17	%
10182	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Plk4 [human]	inhibition rate	4	%
10183	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, delta [human]	inhibition rate	0	%
10184	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, epsilon [human]	inhibition rate	0	%
10185	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, eta [human]	inhibition rate	0	%
10186	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C iota type [human]	inhibition rate	19	%
10187	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, theta [human]	inhibition rate	12	%
10188	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase D1 [human]	inhibition rate	43	%
10189	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(Q252H)-nonphosphorylated [human]	inhibition rate	40	%
10190	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase D2 [human]	inhibition rate	11	%
10191	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase D3 [human]	inhibition rate	0	%
10192	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cGMP-dependent protein kinase 1 [human]	inhibition rate	0	%
10193	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cGMP-dependent protein kinase 2 [human]	inhibition rate	0	%
10194	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Interferon-induced, double-stranded RNA-activated protein kinase [human]	inhibition rate	0	%
10195	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cAMP-dependent protein kinase catalytic subunit PRKX [human]	inhibition rate	0	%
10196	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proline-rich protein 4 [human]	inhibition rate	14	%
10197	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein-tyrosine kinase 2-beta [human]	inhibition rate	13	%
10198	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase SIK3 [human]	inhibition rate	1	%
10199	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	RAF proto-oncogene serine/threonine-protein kinase [human]	inhibition rate	0	%
10200	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(Q252H)-phosphorylated [human]	inhibition rate	8	%
10201	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret [human]	inhibition rate	9	%
10202	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (M918T) [human]	inhibition rate	3	%
10203	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804L) [human]	inhibition rate	1	%
10204	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M) [human]	inhibition rate	0	%
10205	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Rio1 [human]	inhibition rate	0	%
10206	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Rio2 [human]	inhibition rate	16	%
10207	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Rio3 [human]	inhibition rate	0	%
10208	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-interacting serine/threonine-protein kinase 1 [human]	inhibition rate	2	%
10209	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-interacting serine/threonine-protein kinase 2 [human]	inhibition rate	0	%
10210	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-interacting serine/threonine-protein kinase 4 [human]	inhibition rate	3	%
10211	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(T315I)-nonphosphorylated [human]	inhibition rate	20	%
10212	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual serine/threonine and tyrosine protein kinase [human]	inhibition rate	4	%
10213	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Rho-associated protein kinase 1 [human]	inhibition rate	0	%
10214	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Rho-associated protein kinase 2 [human]	inhibition rate	16	%
10215	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase ROS [human]	inhibition rate	0	%
10216	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-4 [human]	inhibition rate	18	%
10217	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-4 [human]	inhibition rate	16	%
10218	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-5 [human]	inhibition rate	5	%
10219	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-5 [human]	inhibition rate	2	%
10220	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-1 [human]	inhibition rate	0	%
10221	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-1 [human]	inhibition rate	0	%
10222	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(T315I)-phosphorylated [human]	inhibition rate	37	%
10223	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	18	%
10224	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	1	%
10225	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-2 [human]	inhibition rate	0	%
10226	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-2 [human]	inhibition rate	0	%
10227	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-6 [human]	inhibition rate	8	%
10228	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-6 [human]	inhibition rate	0	%
10229	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase beta-1 [human]	inhibition rate	0	%
10230	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	serine/threonine-protein kinase sbk1 [human]	inhibition rate	0	%
10231	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Sgk1 [human]	inhibition rate	31	%
10232	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Uncharacterized serine/threonine-protein kinase SBK3 [human]	inhibition rate	0	%
10233	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(Y253F)-phosphorylated [human]	inhibition rate	14	%
10234	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Sgk2 [human]	inhibition rate	25	%
10235	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Sgk3 [human]	inhibition rate	0	%
10236	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase SIK1 [human]	inhibition rate	0	%
10237	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase SIK2 [human]	inhibition rate	0	%
10238	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	STE20-like serine/threonine-protein kinase [human]	inhibition rate	0	%
10239	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	NUAK family SNF1-like kinase 2 [human]	inhibition rate	0	%
10240	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	SNF-related serine/threonine-protein kinase [human]	inhibition rate	0	%
10241	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase Src [human]	inhibition rate	0	%
10242	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Srms [human]	inhibition rate	36	%
10243	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	SRSF protein kinase 1 [human]	inhibition rate	0	%
10244	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1-nonphosphorylated [human]	inhibition rate	2	%
10245	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	SRSF protein kinase 2 [human]	inhibition rate	0	%
10246	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	SRSF protein kinase 3 [human]	inhibition rate	8	%
10247	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 16 [human]	inhibition rate	13	%
10248	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 33 [human]	inhibition rate	25	%
10249	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 35 [human]	inhibition rate	0	%
10250	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 36 [human]	inhibition rate	0	%
10251	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	STE20/SPS1-related proline-alanine-rich protein kinase [human]	inhibition rate	72	%
10252	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase SYK [human]	inhibition rate	0	%
10253	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 7 [human]	inhibition rate	3	%
10254	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TAO1 [human]	inhibition rate	6	%
10255	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ABL1- phosphorylated [human]	inhibition rate	4	%
10256	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TAO2 [human]	inhibition rate	15	%
10257	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TAO3 [human]	inhibition rate	27	%
10258	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TBK1 [human]	inhibition rate	18	%
10259	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Tec [human]	inhibition rate	10	%
10260	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity testis-specific protein kinase 1 [human]	inhibition rate	0	%
10261	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	TGF-beta receptor type-1 [human]	inhibition rate	0	%
10262	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	TGF-beta receptor type-2 [human]	inhibition rate	27	%
10263	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase receptor Tie-1 [human]	inhibition rate	0	%
10264	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase receptor Tie-2 [human]	inhibition rate	0	%
10265	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase tousled-like 1 [human]	inhibition rate	8	%
10266	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ABL2 [human]	inhibition rate	1	%
10267	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TOUSLED-like 2 [human]	inhibition rate	0	%
10268	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Traf2 and NCK-interacting protein kinase [human]	inhibition rate	0	%
10269	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Non-receptor tyrosine-protein kinase TNK1 [human]	inhibition rate	33	%
10270	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activated CDC42 kinase 1 [human]	inhibition rate	0	%
10271	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TNNI3K [human]	inhibition rate	0	%
10272	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	High affinity nerve growth factor receptor [human]	inhibition rate	32	%
10273	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	BDNF/NT-3 growth factors receptor [human]	inhibition rate	30	%
10274	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	NT-3 growth factor receptor [human]	inhibition rate	28	%
10275	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Transient receptor potential cation channel subfamily M member 6 [human]	inhibition rate	0	%
10276	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Testis-specific serine/threonine-protein kinase 1 [human]	inhibition rate	0	%
10277	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-1 [human]	inhibition rate	10	%
10278	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Testis-specific serine/threonine-protein kinase 3 [human]	inhibition rate	0	%
10279	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase TTK [human]	inhibition rate	0	%
10280	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase TXK [human]	inhibition rate	0	%
10281	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition rate	49	%
10282	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition rate	0	%
10283	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase receptor TYRO3 [human]	inhibition rate	25	%
10284	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ULK1 [human]	inhibition rate	4	%
10285	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ULK2 [human]	inhibition rate	0	%
10286	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ULK3 [human]	inhibition rate	23	%
10287	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Vascular endothelial growth factor receptor 2 [human]	inhibition rate	5	%
10288	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-1B [human]	inhibition rate	4	%
10289	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 3-kinase, Vps34 type [human]	inhibition rate	0	%
10290	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase VRK2 [human]	inhibition rate	20	%
10291	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitosis inhibitor protein kinase wee1 [human]	inhibition rate	20	%
10292	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Wee1-like protein kinase 1-A [human]	inhibition rate	0	%
10293	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK1 [human]	inhibition rate	0	%
10294	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK2 [human]	inhibition rate	63	%
10295	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK3 [human]	inhibition rate	0	%
10296	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK4 [human]	inhibition rate	41	%
10297	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 32A [human]	inhibition rate	19	%
10298	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 32B [human]	inhibition rate	0	%
10299	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-2A [human]	inhibition rate	10	%
10300	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 32C [human]	inhibition rate	0	%
10301	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Yes [human]	inhibition rate	22	%
10302	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 25 [human]	inhibition rate	10	%
10303	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 19 [human]	inhibition rate	50	%
10304	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 20 [human]	inhibition rate	0	%
10305	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ZAP-70 [human]	inhibition rate	28	%
10306	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-2B [human]	inhibition rate	15	%
10307	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase receptor R3 [human]	inhibition rate	0	%
10308	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Atypical kinase COQ8A, mitochondrial [human]	inhibition rate	12	%
10309	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Atypical kinase COQ8B, mitochondrial [human]	inhibition rate	0	%
10310	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	RAC-alpha serine/threonine-protein kinase [human]	inhibition rate	0	%
10311	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	RAC-beta serine/threonine-protein kinase [human]	inhibition rate	0	%
10312	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	RAC-gamma serine/threonine-protein kinase [human]	inhibition rate	0	%
10313	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ALK tyrosine kinase receptor [human]	inhibition rate	0	%
10314	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ALK tyrosine kinase receptor [human]	inhibition rate	29	%
10315	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ALK tyrosine kinase receptor [human]	inhibition rate	0	%
10316	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	5'-AMP-activated protein kinase catalytic subunit alpha-1 [human]	inhibition rate	0	%
10317	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	5'-AMP-activated protein kinase catalytic subunit alpha-2 [human]	inhibition rate	0	%
10318	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ankyrin repeat and protein kinase domain-containing protein 1 [human]	inhibition rate	0	%
10319	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	NUAK family SNF1-like kinase 1 [human]	inhibition rate	3	%
10320	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 5 [human]	inhibition rate	13	%
10321	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 6 [human]	inhibition rate	26	%
10322	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Aurora kinase A [human]	inhibition rate	5	%
10323	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Aurora kinase B [human]	inhibition rate	7	%
10324	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Aurora kinase C [human]	inhibition rate	0	%
10325	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	NEDD8-activating enzyme E1 regulatory subunit AXL [human]	inhibition rate	0	%
10326	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	BMP-2-inducible protein kinase [human]	inhibition rate	0	%
10327	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Blk [human]	inhibition rate	0	%
10328	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Bone morphogenetic protein receptor type-1A [human]	inhibition rate	19	%
10329	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Bone morphogenetic protein receptor type-1B [human]	inhibition rate	24	%
10330	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Bone morphogenetic protein receptor type-2 [human]	inhibition rate	1	%
10331	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cytoplasmic tyrosine-protein kinase BMX [human]	inhibition rate	13	%
10332	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase B-raf [human]	inhibition rate	26	%
10333	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase B-raf (V600E) [human]	inhibition rate	31	%
10334	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein-tyrosine kinase 6 [human]	inhibition rate	0	%
10335	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase BRSK1 [human]	inhibition rate	0	%
10336	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase BRSK2 [human]	inhibition rate	16	%
10337	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase BTK [human]	inhibition rate	15	%
10338	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitotic checkpoint serine/threonine-protein kinase BUB1 [human]	inhibition rate	26	%
10339	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1 [human]	inhibition rate	0	%
10340	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1B [human]	inhibition rate	71	%
10341	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1D [human]	inhibition rate	0	%
10342	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1G [human]	inhibition rate	8	%
10343	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II subunit alpha [human]	inhibition rate	38	%
10344	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II subunit beta [human]	inhibition rate	35	%
10345	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II delta 2 chain [human]	inhibition rate	0	%
10346	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II subunit gamma [human]	inhibition rate	0	%
10347	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type IV [human]	inhibition rate	0	%
10348	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase kinase 1 [human]	inhibition rate	22	%
10349	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase kinase 2 [human]	inhibition rate	18	%
10350	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Kappa-casein [human]	inhibition rate	10	%
10351	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 11B [human]	inhibition rate	0	%
10352	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 11A [human]	inhibition rate	8	%
10353	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 13 [human]	inhibition rate	16	%
10354	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 11 [human]	inhibition rate	0	%
10355	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 2 [human]	inhibition rate	0	%
10356	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 3 [human]	inhibition rate	22	%
10357	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	kd	85	nM
10358	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1		CLint (intrinsic clearance)	231	μl/min/mg protein
10359	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1		CLint (intrinsic clearance)	242	μl/min/mg protein
10360	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	kd	3	nM
10361	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase haspin [human]	kd	15	nM
10362	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 1B [human]	kd	56	nM
10363	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase CLK4 [human]	kd	61	nM
10364	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase CLK1 [human]	kd	70	nM
10365	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase CLK2 [human]	kd	220	nM
10366	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 2 [human]	kd	360	nM
10367	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 2 [human]	kd	1200	nM
10368	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-interacting serine/threonine-protein kinase 2 [human]	kd	1800	nM
10369	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1 [human]	kd	10000	nM
10370	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK3 [human]	kd	1800	nM
10371	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	STE20/SPS1-related proline-alanine-rich protein kinase [human]	kd	10000	nM
10372	CN(C)C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Probable serine/threonine-protein kinase WNK2 [human]	kd	10000	nM
10373	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	pIC50	7.1	no unit
10374	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 4 [human]	inhibition rate	22	%
10375	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 4 [human]; Cyclin-D1-1 [human]	inhibition rate	19	%
10376	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 4 [human]; Cyclin-D3-1 [human]	inhibition rate	32	%
10377	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent-like kinase 5 [human]	inhibition rate	1	%
10378	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 7 [human]	inhibition rate	46	%
10379	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 8 [human]	inhibition rate	0	%
10380	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 9 [human]	inhibition rate	7	%
10381	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 1 [human]	inhibition rate	41	%
10382	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 2 [human]	inhibition rate	9	%
10383	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 3 [human]	inhibition rate	7	%
10384	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase-like 5 [human]	inhibition rate	6	%
10385	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Chk1 [human]	inhibition rate	11	%
10386	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Chk2 [human]	inhibition rate	23	%
10387	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Citrate synthase, mitochondrial [human]	inhibition rate	16	%
10388	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ATG1 [human]	inhibition rate	67	%
10389	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase CLK2 [human]	inhibition rate	87	%
10390	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase CLK3 [human]	inhibition rate	46	%
10391	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase CLK4 [human]	inhibition rate	93.8	%
10392	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Macrophage colony-stimulating factor 1 receptor [human]	inhibition rate	0	%
10393	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	CSF1R-autoinhibited [human]	inhibition rate	36	%
10394	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase CSK [human]	inhibition rate	12	%
10395	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform alpha [human]	inhibition rate	86	%
10396	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform alpha-like [human]	inhibition rate	32	%
10397	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform delta [human]	inhibition rate	59	%
10398	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform epsilon [human]	inhibition rate	47	%
10399	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform gamma-1 [human]	inhibition rate	16	%
10400	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform gamma-2 [human]	inhibition rate	23	%
10401	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase I isoform gamma-3 [human]	inhibition rate	0	%
10402	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase II subunit alpha [human]	inhibition rate	60	%
10403	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Casein kinase II subunit alpha' [human]	inhibition rate	76	%
10404	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Megakaryocyte-associated tyrosine-protein kinase [human]	inhibition rate	13	%
10405	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 1 [human]	inhibition rate	21	%
10406	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 2 [human]	inhibition rate	30	%
10407	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 3 [human]	inhibition rate	27	%
10408	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase DCLK1 [human]	inhibition rate	18	%
10409	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase DCLK2 [human]	inhibition rate	22	%
10410	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase DCLK3 [human]	inhibition rate	0	%
10411	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epithelial discoidin domain-containing receptor 1 [human]	inhibition rate	18	%
10412	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Discoidin domain-containing receptor 2 [human]	inhibition rate	17	%
10413	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Death-associated protein kinase 3 [human]	inhibition rate	26	%
10414	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myotonin-protein kinase [human]	inhibition rate	2	%
10415	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MRCK gamma [human]	inhibition rate	8	%
10416	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 17A [human]	inhibition rate	0	%
10417	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 17B [human]	inhibition rate	0	%
10418	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	inhibition rate	99.3	%
10419	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 1B [human]	inhibition rate	91.7	%
10420	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 2 [human]	inhibition rate	89	%
10421	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	0	%
10422	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	11	%
10423	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (G719C) [human]	inhibition rate	0	%
10424	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (G719S) [human]	inhibition rate	0	%
10425	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	24	%
10426	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	11	%
10427	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	0	%
10428	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (L858R) [human]	inhibition rate	16	%
10429	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (L858R) [human];+Epidermal growth factor receptor (T790M) [human]	inhibition rate	35	%
10430	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (L861Q) [human]	inhibition rate	4	%
10431	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	epidermal growth factor-activated receptor [human]	inhibition rate	33	%
10432	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Epidermal growth factor receptor (T790M) [human]	inhibition rate	25	%
10433	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Eukaryotic translation initiation factor 2-alpha kinase 1 [human]	inhibition rate	51	%
10434	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	AP2-associated protein kinase 1 [human]	inhibition rate	24	%
10435	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 1 [human]	inhibition rate	11	%
10436	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 2 [human]	inhibition rate	6	%
10437	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 3 [human]	inhibition rate	32	%
10438	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 4 [human]	inhibition rate	25	%
10439	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 5 [human]	inhibition rate	1	%
10440	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 6 [human]	inhibition rate	5	%
10441	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 7 [human]	inhibition rate	7	%
10442	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-A receptor 8 [human]	inhibition rate	11	%
10443	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 1 [human]	inhibition rate	0	%
10444	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 2 [human]	inhibition rate	0	%
10445	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 3 [human]	inhibition rate	13	%
10446	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 4 [human]	inhibition rate	8	%
10447	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ephrin type-B receptor 6 [human]	inhibition rate	37	%
10448	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor tyrosine-protein kinase erbB-2 [human]	inhibition rate	14	%
10449	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor tyrosine-protein kinase erbB-3 [human]	inhibition rate	14	%
10450	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor tyrosine-protein kinase erbB-4 [human]	inhibition rate	24	%
10451	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Extracellular signal-regulated kinase 1 [human]	inhibition rate	6	%
10452	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Extracellular signal-regulated kinase 2 [human]	inhibition rate	0	%
10453	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 6 [human]	inhibition rate	8	%
10454	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 4 [human]	inhibition rate	17	%
10455	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 7 [human]	inhibition rate	13	%
10456	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 15 [human]	inhibition rate	29	%
10457	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ethylene-responsive transcription factor ERN1 [human]	inhibition rate	31	%
10458	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Focal adhesion kinase 1 [human]	inhibition rate	1	%
10459	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Fer [human]	inhibition rate	9	%
10460	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase, Fes/Fps type [human]	inhibition rate	5	%
10461	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 1 [human]	inhibition rate	0	%
10462	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 2 [human]	inhibition rate	0	%
10463	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 3 [human]	inhibition rate	0	%
10464	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 3 [human]	inhibition rate	14	%
10465	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Fibroblast growth factor receptor 4 [human]	inhibition rate	9	%
10466	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Fgr [human]	inhibition rate	0	%
10467	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Vascular endothelial growth factor receptor 1 [human]	inhibition rate	13	%
10468	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	15	%
10469	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835H) [human]	inhibition rate	36	%
10470	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835V) [human]	inhibition rate	80	%
10471	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835Y) [human]	inhibition rate	38	%
10472	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	FLT3(ITD) [human]	inhibition rate	24	%
10473	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 (D835V) [human];+FLT3(ITD) [human]	inhibition rate	71	%
10474	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	FLT3(ITD) [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	20	%
10475	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	0	%
10476	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	28	%
10477	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	18	%
10478	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	FLT3-autoinhibited [human]	inhibition rate	42	%
10479	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Vascular endothelial growth factor receptor 3 [human]	inhibition rate	8	%
10480	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase FRK [human]	inhibition rate	18	%
10481	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Fyn [human]	inhibition rate	21	%
10482	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-G-associated kinase [human]	inhibition rate	44	%
10483	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABC transporter F family member 2 [human]	inhibition rate	0	%
10484	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Rhodopsin kinase GRK1 (C514S) [human]	inhibition rate	39	%
10485	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Beta-adrenergic receptor kinase 1 [human]	inhibition rate	52	%
10486	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Beta-adrenergic receptor kinase 2 [human]	inhibition rate	71	%
10487	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	G protein-coupled receptor kinase 4 [human]	inhibition rate	19	%
10488	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Rhodopsin kinase [human]	inhibition rate	34	%
10489	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Glycogen synthase kinase-3 alpha [human]	inhibition rate	0	%
10490	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	glycogen synthase kinase-3 beta [human]	inhibition rate	23	%
10491	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase haspin [human]	inhibition rate	99.4	%
10492	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase HCK [human]	inhibition rate	10	%
10493	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 1 [human]	inhibition rate	71	%
10494	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 2 [human]	inhibition rate	46	%
10495	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 3 [human]	inhibition rate	50	%
10496	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Homeodomain-interacting protein kinase 4 [human]	inhibition rate	13	%
10497	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 1 [human]	inhibition rate	0	%
10498	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hormonally up-regulated neu tumor-associated kinase [human]	inhibition rate	8	%
10499	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Insulin-like growth factor 1 receptor [human]	inhibition rate	3	%
10500	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit alpha [human]	inhibition rate	65	%
10501	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition rate	60	%
10502	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit epsilon [human]	inhibition rate	25	%
10503	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Insulin receptor [human]	inhibition rate	27	%
10504	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Insulin receptor-related protein [human]	inhibition rate	7	%
10505	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Interleukin-1 receptor-associated kinase 1 [human]	inhibition rate	24	%
10506	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Interleukin-1 receptor-associated kinase 3 [human]	inhibition rate	64	%
10507	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Interleukin-1 receptor-associated kinase 4 [human]	inhibition rate	21	%
10508	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ITK/TSK [human]	inhibition rate	0	%
10509	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK1 [human]	inhibition rate	5	%
10510	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK1 [human]	inhibition rate	33	%
10511	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK2 [human]	inhibition rate	26	%
10512	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase JAK3 [human]	inhibition rate	32	%
10513	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 8 [human]	inhibition rate	74	%
10514	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 9 [human]	inhibition rate	56	%
10515	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 10 [human]	inhibition rate	73	%
10516	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	10	%
10517	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (A829P) [human]	inhibition rate	39	%
10518	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (D816H) [human]	inhibition rate	20	%
10519	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (D816V) [human]	inhibition rate	7	%
10520	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	30	%
10521	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (V559D) [human]	inhibition rate	22	%
10522	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (V559D) [human];+Mast/stem cell growth factor receptor Kit [human]	inhibition rate	16	%
10523	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mast/stem cell growth factor receptor Kit (V559D) [human];+Mast/stem cell growth factor receptor Kit [human]	inhibition rate	0	%
10524	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	KIT-autoinhibited [human]	inhibition rate	44	%
10525	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase LATS1 [human]	inhibition rate	12	%
10526	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase LATS2 [human]	inhibition rate	12	%
10527	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase LCK [human]	inhibition rate	1	%
10528	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	LIM domain kinase 1 [human]	inhibition rate	25	%
10529	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	LIM domain kinase 2 [human]	inhibition rate	18	%
10530	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase STK11 [human]	inhibition rate	16	%
10531	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Coiled-coil domain-containing protein 40 [human]	inhibition rate	9	%
10532	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Leucine-rich repeat serine/threonine-protein kinase 2 [human]	inhibition rate	65	%
10533	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Leucine-rich repeat serine/threonine-protein kinase 2 (G2019S) [human]	inhibition rate	79	%
10534	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Leukocyte tyrosine kinase receptor [human]	inhibition rate	2	%
10535	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Lyn [human]	inhibition rate	12	%
10536	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 13 [human]	inhibition rate	45	%
10537	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MAK [human]	inhibition rate	46	%
10538	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 1 [human]	inhibition rate	24	%
10539	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 15 [human]	inhibition rate	32	%
10540	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 2 [human]	inhibition rate	42	%
10541	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 3 [human]	inhibition rate	60	%
10542	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 4 [human]	inhibition rate	3	%
10543	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 2 [human]	inhibition rate	30	%
10544	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 3 [human]	inhibition rate	12	%
10545	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 4 [human]	inhibition rate	23	%
10546	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase kinase 5 [human]	inhibition rate	6	%
10547	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-activated protein kinase 2 [human]	inhibition rate	0	%
10548	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-activated protein kinase 5 [human]	inhibition rate	26	%
10549	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MARK1 [human]	inhibition rate	9	%
10550	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MARK2 [human]	inhibition rate	37	%
10551	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP/microtubule affinity-regulating kinase 3 [human]	inhibition rate	0	%
10552	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP/microtubule affinity-regulating kinase 4 [human]	inhibition rate	16	%
10553	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	CLIP-associating protein 1 [human]	inhibition rate	45	%
10554	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 1 [human]	inhibition rate	31	%
10555	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 2 [human]	inhibition rate	19	%
10556	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 3 [human]	inhibition rate	69	%
10557	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 4 [human]	inhibition rate	38	%
10558	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 5 [human]	inhibition rate	70	%
10559	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 6 [human]	inhibition rate	0	%
10560	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Maternal embryonic leucine zipper kinase [human]	inhibition rate	48	%
10561	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Mer [human]	inhibition rate	13	%
10562	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor receptor [human]	inhibition rate	17	%
10563	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor receptor (M1250T) [human]	inhibition rate	59	%
10564	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor receptor [human]	inhibition rate	20	%
10565	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Misshapen-like kinase 1 [human]	inhibition rate	32	%
10566	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity mitogen-activated protein kinase kinase 7 [human]	inhibition rate	28	%
10567	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-interacting serine/threonine-protein kinase 1 [human]	inhibition rate	47	%
10568	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	MAP kinase-interacting serine/threonine-protein kinase 2 [human]	inhibition rate	96.7	%
10569	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase, smooth muscle [human]	inhibition rate	0	%
10570	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 9 [human]	inhibition rate	15	%
10571	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 10 [human]	inhibition rate	0	%
10572	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 11 [human]	inhibition rate	0	%
10573	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MRCK alpha [human]	inhibition rate	0	%
10574	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase MRCK beta [human]	inhibition rate	6	%
10575	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Hepatocyte growth factor-like [human]	inhibition rate	11	%
10576	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Macrophage-stimulating protein receptor [human]	inhibition rate	40	%
10577	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Histone acetyltransferase mst2 [human]	inhibition rate	19	%
10578	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 24 [human]	inhibition rate	26	%
10579	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 26 [human]	inhibition rate	36	%
10580	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase mTOR [human]	inhibition rate	4	%
10581	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Muscle, skeletal receptor tyrosine-protein kinase [human]	inhibition rate	20	%
10582	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase, smooth muscle [human]	inhibition rate	16	%
10583	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase 2, skeletal/cardiac muscle [human]	inhibition rate	23	%
10584	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin light chain kinase family member 4 [human]	inhibition rate	22	%
10585	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ABL1(E255K)-Phosphorylated [human]	inhibition rate	37	%
10586	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin-IIIa [human]	inhibition rate	45	%
10587	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Myosin-IIIb [human]	inhibition rate	0	%
10588	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein NDRG1 [human]	inhibition rate	13	%
10589	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein NDRG2 [human]	inhibition rate	22	%
10590	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek1 [human]	inhibition rate	0	%
10591	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek10 [human]	inhibition rate	2	%
10592	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek11 [human]	inhibition rate	11	%
10593	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek2 [human]	inhibition rate	5	%
10594	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek3 [human]	inhibition rate	36	%
10595	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek4 [human]	inhibition rate	32	%
10596	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317I)-nonphosphorylated [human]	inhibition rate	48	%
10597	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek5 [human]	inhibition rate	3	%
10598	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek6 [human]	inhibition rate	6	%
10599	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek7 [human]	inhibition rate	14	%
10600	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Nek9 [human]	inhibition rate	18	%
10601	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 14 [human]	inhibition rate	56	%
10602	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase NIM1 [human]	inhibition rate	39	%
10603	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine kinase NLK [human]	inhibition rate	13	%
10604	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase OSR1 [human]	inhibition rate	38	%
10605	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 14A [human]	inhibition rate	13	%
10606	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 11 [human]	inhibition rate	0	%
10607	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317I)-phosphorylated [human]	inhibition rate	19	%
10608	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 13 [human]	inhibition rate	22	%
10609	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase 12 [human]	inhibition rate	35	%
10610	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase N1 [human]	inhibition rate	10	%
10611	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	serine/threonine-protein kinase pak 2 [human]	inhibition rate	30	%
10612	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PAK 3 [human]	inhibition rate	12	%
10613	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PAK 4 [human]	inhibition rate	4	%
10614	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PAK 6 [human]	inhibition rate	19	%
10615	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	serine/threonine-protein kinase pak 5 [human]	inhibition rate	15	%
10616	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 16 [human]	inhibition rate	3	%
10617	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 17 [human]	inhibition rate	13	%
10618	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317L)-nonphosphorylated [human]	inhibition rate	47	%
10619	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 18 [human]	inhibition rate	2	%
10620	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Platelet-derived growth factor receptor alpha [human]	inhibition rate	46	%
10621	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Platelet-derived growth factor receptor beta [human]	inhibition rate	22	%
10622	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	3-phosphoinositide-dependent protein kinase 1 [human]	inhibition rate	2	%
10623	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium-dependent protein kinase 1 [Plasmodium falciparum]	inhibition rate	65	%
10624	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cell division control protein 2 homolog [Plasmodium falciparum]	inhibition rate	28	%
10625	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 15 [human]	inhibition rate	15	%
10626	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 14 [human]	inhibition rate	12	%
10627	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform [human]	inhibition rate	15	%
10628	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform [human]	inhibition rate	25	%
10629	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(F317L)-phosphorylated [human]	inhibition rate	45	%
10630	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta [human]	inhibition rate	18	%
10631	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition rate	40	%
10632	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human]	inhibition rate	21	%
10633	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (C420R) [human]	inhibition rate	29	%
10634	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E542K) [human]	inhibition rate	14	%
10635	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545A) [human]	inhibition rate	30	%
10636	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545K) [human]	inhibition rate	14	%
10637	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047L) [human]	inhibition rate	38	%
10638	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047Y) [human]	inhibition rate	17	%
10639	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human]	inhibition rate	32	%
10640	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(H396P)-nonphosphorylated [human]	inhibition rate	34	%
10641	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (M1043I) [human]	inhibition rate	33	%
10642	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (Q546K) [human]	inhibition rate	37	%
10643	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [human]	inhibition rate	38	%
10644	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [human]	inhibition rate	31	%
10645	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform [human]	inhibition rate	26	%
10646	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-kinase beta [human]	inhibition rate	88	%
10647	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	1-phosphatidylinositol 3-phosphate 5-kinase [human]	inhibition rate	8	%
10648	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Lon protease homolog, mitochondrial [human]	inhibition rate	29	%
10649	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase pim-2 [human]	inhibition rate	36	%
10650	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase pim-3 [human]	inhibition rate	16	%
10651	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(H396P)-phosphorylated [human]	inhibition rate	30	%
10652	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha [human]	inhibition rate	0	%
10653	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma [human]	inhibition rate	25	%
10654	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta [human]	inhibition rate	42	%
10655	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma [human]	inhibition rate	40	%
10656	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cAMP-dependent protein kinase catalytic subunit alpha [human]	inhibition rate	0	%
10657	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cAMP-dependent protein kinase catalytic subunit beta [human]	inhibition rate	8	%
10658	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase [human]	inhibition rate	3	%
10659	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase N1 [human]	inhibition rate	13	%
10660	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase pkn2 [human]	inhibition rate	11	%
10661	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PknB [Mycobacterium tuberculosis]	inhibition rate	21	%
10662	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(M351T)-phosphorylated [human]	inhibition rate	52	%
10663	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PLK1 [human]	inhibition rate	28	%
10664	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase PLK2 [human]	inhibition rate	13	%
10665	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Plk3 [human]	inhibition rate	21	%
10666	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Plk4 [human]	inhibition rate	21	%
10667	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, delta [human]	inhibition rate	0	%
10668	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, epsilon [human]	inhibition rate	0	%
10669	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, eta [human]	inhibition rate	12	%
10670	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C iota type [human]	inhibition rate	42	%
10671	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein kinase C, theta [human]	inhibition rate	14	%
10672	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase D1 [human]	inhibition rate	13	%
10673	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(Q252H)-nonphosphorylated [human]	inhibition rate	39	%
10674	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase D2 [human]	inhibition rate	11	%
10675	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase D3 [human]	inhibition rate	29	%
10676	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cGMP-dependent protein kinase 1 [human]	inhibition rate	11	%
10677	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cGMP-dependent protein kinase 2 [human]	inhibition rate	18	%
10678	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Interferon-induced, double-stranded RNA-activated protein kinase [human]	inhibition rate	0	%
10679	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	cAMP-dependent protein kinase catalytic subunit PRKX [human]	inhibition rate	32	%
10680	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proline-rich protein 4 [human]	inhibition rate	16	%
10681	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein-tyrosine kinase 2-beta [human]	inhibition rate	20	%
10682	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase SIK3 [human]	inhibition rate	30	%
10683	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	RAF proto-oncogene serine/threonine-protein kinase [human]	inhibition rate	27	%
10684	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(Q252H)-phosphorylated [human]	inhibition rate	31	%
10685	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret [human]	inhibition rate	3	%
10686	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (M918T) [human]	inhibition rate	3	%
10687	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804L) [human]	inhibition rate	9	%
10688	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M) [human]	inhibition rate	0	%
10689	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Rio1 [human]	inhibition rate	64	%
10690	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Rio2 [human]	inhibition rate	39	%
10691	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Rio3 [human]	inhibition rate	7	%
10692	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-interacting serine/threonine-protein kinase 1 [human]	inhibition rate	17	%
10693	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-interacting serine/threonine-protein kinase 2 [human]	inhibition rate	22	%
10694	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Receptor-interacting serine/threonine-protein kinase 4 [human]	inhibition rate	48	%
10695	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(T315I)-nonphosphorylated [human]	inhibition rate	36	%
10696	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual serine/threonine and tyrosine protein kinase [human]	inhibition rate	21	%
10697	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Rho-associated protein kinase 1 [human]	inhibition rate	23	%
10698	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Rho-associated protein kinase 2 [human]	inhibition rate	30	%
10699	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase ROS [human]	inhibition rate	0	%
10700	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-4 [human]	inhibition rate	9	%
10701	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-4 [human]	inhibition rate	45	%
10702	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-5 [human]	inhibition rate	0	%
10703	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-5 [human]	inhibition rate	0	%
10704	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-1 [human]	inhibition rate	44	%
10705	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-1 [human]	inhibition rate	44	%
10706	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(T315I)-phosphorylated [human]	inhibition rate	26	%
10707	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	39	%
10708	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	0	%
10709	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-2 [human]	inhibition rate	5	%
10710	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-2 [human]	inhibition rate	15	%
10711	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-6 [human]	inhibition rate	42	%
10712	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase alpha-6 [human]	inhibition rate	34	%
10713	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ribosomal protein S6 kinase beta-1 [human]	inhibition rate	34	%
10714	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	serine/threonine-protein kinase sbk1 [human]	inhibition rate	35	%
10715	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Sgk1 [human]	inhibition rate	45	%
10716	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Uncharacterized serine/threonine-protein kinase SBK3 [human]	inhibition rate	29	%
10717	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1(Y253F)-phosphorylated [human]	inhibition rate	41	%
10718	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Sgk2 [human]	inhibition rate	35	%
10719	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase Sgk3 [human]	inhibition rate	29	%
10720	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase SIK1 [human]	inhibition rate	17	%
10721	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase SIK2 [human]	inhibition rate	4	%
10722	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	STE20-like serine/threonine-protein kinase [human]	inhibition rate	0	%
10723	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	NUAK family SNF1-like kinase 2 [human]	inhibition rate	36	%
10724	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	SNF-related serine/threonine-protein kinase [human]	inhibition rate	33	%
10725	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Proto-oncogene tyrosine-protein kinase Src [human]	inhibition rate	0	%
10726	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Srms [human]	inhibition rate	30	%
10727	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	SRSF protein kinase 1 [human]	inhibition rate	25	%
10728	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ABL1-nonphosphorylated [human]	inhibition rate	32	%
10729	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	SRSF protein kinase 2 [human]	inhibition rate	30	%
10730	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	SRSF protein kinase 3 [human]	inhibition rate	34	%
10731	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 16 [human]	inhibition rate	22	%
10732	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 33 [human]	inhibition rate	0	%
10733	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 35 [human]	inhibition rate	0	%
10734	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 36 [human]	inhibition rate	24	%
10735	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	STE20/SPS1-related proline-alanine-rich protein kinase [human]	inhibition rate	59	%
10736	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase SYK [human]	inhibition rate	1	%
10737	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 7 [human]	inhibition rate	49	%
10738	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TAO1 [human]	inhibition rate	42	%
10739	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ABL1- phosphorylated [human]	inhibition rate	46	%
10740	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TAO2 [human]	inhibition rate	29	%
10741	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TAO3 [human]	inhibition rate	27	%
10742	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TBK1 [human]	inhibition rate	59	%
10743	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Tec [human]	inhibition rate	1	%
10744	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity testis-specific protein kinase 1 [human]	inhibition rate	1	%
10745	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	TGF-beta receptor type-1 [human]	inhibition rate	22	%
10746	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	TGF-beta receptor type-2 [human]	inhibition rate	64	%
10747	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase receptor Tie-1 [human]	inhibition rate	0	%
10748	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase receptor Tie-2 [human]	inhibition rate	17	%
10749	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase tousled-like 1 [human]	inhibition rate	46	%
10750	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ABL2 [human]	inhibition rate	13	%
10751	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TOUSLED-like 2 [human]	inhibition rate	0	%
10752	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Traf2 and NCK-interacting protein kinase [human]	inhibition rate	28	%
10753	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Non-receptor tyrosine-protein kinase TNK1 [human]	inhibition rate	0	%
10754	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activated CDC42 kinase 1 [human]	inhibition rate	26	%
10755	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase TNNI3K [human]	inhibition rate	0	%
10756	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	High affinity nerve growth factor receptor [human]	inhibition rate	47	%
10757	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	BDNF/NT-3 growth factors receptor [human]	inhibition rate	46	%
10758	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	NT-3 growth factor receptor [human]	inhibition rate	27	%
10759	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Transient receptor potential cation channel subfamily M member 6 [human]	inhibition rate	20	%
10760	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Testis-specific serine/threonine-protein kinase 1 [human]	inhibition rate	35	%
10761	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-1 [human]	inhibition rate	36	%
10762	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Testis-specific serine/threonine-protein kinase 3 [human]	inhibition rate	2	%
10763	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Dual specificity protein kinase TTK [human]	inhibition rate	39	%
10764	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase TXK [human]	inhibition rate	0	%
10765	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition rate	36	%
10766	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition rate	34	%
10767	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase receptor TYRO3 [human]	inhibition rate	27	%
10768	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ULK1 [human]	inhibition rate	40	%
10769	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ULK2 [human]	inhibition rate	41	%
10770	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase ULK3 [human]	inhibition rate	36	%
10771	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Vascular endothelial growth factor receptor 2 [human]	inhibition rate	33	%
10772	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-1B [human]	inhibition rate	18	%
10773	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Phosphatidylinositol 3-kinase, Vps34 type [human]	inhibition rate	52	%
10774	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase VRK2 [human]	inhibition rate	26	%
10775	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitosis inhibitor protein kinase wee1 [human]	inhibition rate	8	%
10776	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Wee1-like protein kinase 1-A [human]	inhibition rate	24	%
10777	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK1 [human]	inhibition rate	0	%
10778	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK2 [human]	inhibition rate	22	%
10779	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK3 [human]	inhibition rate	32	%
10780	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase WNK4 [human]	inhibition rate	36	%
10781	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 32A [human]	inhibition rate	42	%
10782	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 32B [human]	inhibition rate	7	%
10783	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-2A [human]	inhibition rate	1	%
10784	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 32C [human]	inhibition rate	32	%
10785	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Yes [human]	inhibition rate	28	%
10786	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase 25 [human]	inhibition rate	0	%
10787	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 19 [human]	inhibition rate	39	%
10788	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 20 [human]	inhibition rate	0	%
10789	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase ZAP-70 [human]	inhibition rate	20	%
10790	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Activin receptor type-2B [human]	inhibition rate	10	%
10791	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase receptor R3 [human]	inhibition rate	0	%
10792	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Atypical kinase COQ8A, mitochondrial [human]	inhibition rate	0	%
10793	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Atypical kinase COQ8B, mitochondrial [human]	inhibition rate	0	%
10794	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	RAC-alpha serine/threonine-protein kinase [human]	inhibition rate	5	%
10795	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	RAC-beta serine/threonine-protein kinase [human]	inhibition rate	4	%
10796	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	RAC-gamma serine/threonine-protein kinase [human]	inhibition rate	14	%
10797	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ALK tyrosine kinase receptor [human]	inhibition rate	22	%
10798	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ALK tyrosine kinase receptor [human]	inhibition rate	27	%
10799	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	ALK tyrosine kinase receptor [human]	inhibition rate	60	%
10800	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	5'-AMP-activated protein kinase catalytic subunit alpha-1 [human]	inhibition rate	8	%
10801	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	5'-AMP-activated protein kinase catalytic subunit alpha-2 [human]	inhibition rate	9	%
10802	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Ankyrin repeat and protein kinase domain-containing protein 1 [human]	inhibition rate	28	%
10803	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	NUAK family SNF1-like kinase 1 [human]	inhibition rate	0	%
10804	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 5 [human]	inhibition rate	0	%
10805	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitogen-activated protein kinase kinase kinase 6 [human]	inhibition rate	39	%
10806	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Aurora kinase A [human]	inhibition rate	10	%
10807	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Aurora kinase B [human]	inhibition rate	40	%
10808	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Aurora kinase C [human]	inhibition rate	4	%
10809	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	NEDD8-activating enzyme E1 regulatory subunit AXL [human]	inhibition rate	26	%
10810	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	BMP-2-inducible protein kinase [human]	inhibition rate	39	%
10811	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase Blk [human]	inhibition rate	0	%
10812	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Bone morphogenetic protein receptor type-1A [human]	inhibition rate	12	%
10813	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Bone morphogenetic protein receptor type-1B [human]	inhibition rate	48	%
10814	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Bone morphogenetic protein receptor type-2 [human]	inhibition rate	32	%
10815	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cytoplasmic tyrosine-protein kinase BMX [human]	inhibition rate	10	%
10816	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase B-raf [human]	inhibition rate	44	%
10817	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase B-raf (V600E) [human]	inhibition rate	37	%
10818	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Protein-tyrosine kinase 6 [human]	inhibition rate	17	%
10819	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase BRSK1 [human]	inhibition rate	18	%
10820	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Serine/threonine-protein kinase BRSK2 [human]	inhibition rate	16	%
10821	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Tyrosine-protein kinase BTK [human]	inhibition rate	11	%
10822	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Mitotic checkpoint serine/threonine-protein kinase BUB1 [human]	inhibition rate	54	%
10823	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1 [human]	inhibition rate	20	%
10824	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1B [human]	inhibition rate	19	%
10825	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1D [human]	inhibition rate	11	%
10826	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type 1G [human]	inhibition rate	0	%
10827	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II subunit alpha [human]	inhibition rate	24	%
10828	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II subunit beta [human]	inhibition rate	34	%
10829	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II delta 2 chain [human]	inhibition rate	17	%
10830	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type II subunit gamma [human]	inhibition rate	9	%
10831	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase type IV [human]	inhibition rate	0	%
10832	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase kinase 1 [human]	inhibition rate	3	%
10833	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Calcium/calmodulin-dependent protein kinase kinase 2 [human]	inhibition rate	20	%
10834	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Kappa-casein [human]	inhibition rate	19	%
10835	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 11B [human]	inhibition rate	9	%
10836	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 11A [human]	inhibition rate	16	%
10837	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 13 [human]	inhibition rate	13	%
10838	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 11 [human]	inhibition rate	8	%
10839	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 2 [human]	inhibition rate	0	%
10840	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	Cyclin-dependent kinase 3 [human]	inhibition rate	26	%
10841	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	kd	64	nM
10842	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1		CLint (intrinsic clearance)	119	μl/min/mg protein
10843	C1CC2(COC2)N1C1=NC=CC(=N1)C1=C2C=CC=NN2N=C1		CLint (intrinsic clearance)	126	μl/min/mg protein
10844	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	2.523	μM
10845	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	2.673	μM
10846	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	2.774	μM
10847	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	2.817	μM
10848	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	2.937	μM
10849	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	2.931	μM
10850	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	3.154	μM
10851	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 1	Ki (inhibition constant)	10	μM
10852	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 2	Ki (inhibition constant)	10	μM
10853	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 4	Ki (inhibition constant)	10	μM
10854	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 6	Ki (inhibition constant)	10	μM
10855	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent-like kinase 5	Ki (inhibition constant)	10	μM
10856	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 7	Ki (inhibition constant)	10	μM
10857	O=C1CCCC2=C1C(C1=CN(N=N1)C1=CC=C(C=C1)N(=O)=O)C1=C(CCCC1=O)N2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.673	μM
10858	O=C1CCCC2=C1C(C1=CN(N=N1)C1=CC=C(C=C1)N(=O)=O)C1=C(CCCC1=O)N2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.838	μM
10859	O=C1CCCC2=C1C(C1=CN(N=N1)C1=CC=C(C=C1)N(=O)=O)C1=C(CCCC1=O)N2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.924	μM
10860	O=C1CCCC2=C1C(C1=CN(N=N1)C1=CC=C(C=C1)N(=O)=O)C1=C(CCCC1=O)N2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.964	μM
10861	O=C1CCCC2=C1C(C1=CN(N=N1)C1=CC=C(C=C1)N(=O)=O)C1=C(CCCC1=O)N2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.968	μM
10862	O=C1CCCC2=C1C(C1=CN(N=N1)C1=CC=C(C=C1)N(=O)=O)C1=C(CCCC1=O)N2	Cyclin-dependent kinase 2	Ki (inhibition constant)	2.146	μM
10863	O=C1CCCC2=C1C(C1=CN(N=N1)C1=CC=C(C=C1)N(=O)=O)C1=C(CCCC1=O)N2	Cyclin-dependent kinase 6	Ki (inhibition constant)	2.543	μM
10864	O=C1CCCC2=C1C(C1=CN(N=N1)C1=CC=C(C=C1)N(=O)=O)C1=C(CCCC1=O)N2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	2.586	μM
10865	O=C1CCCC2=C1C(C1=CN(N=N1)C1=CC=C(C=C1)N(=O)=O)C1=C(CCCC1=O)N2	Cyclin-dependent-like kinase 5	Ki (inhibition constant)	2.547	μM
10866	O=C1CCCC2=C1C(C1=CN(N=N1)C1=CC=C(C=C1)N(=O)=O)C1=C(CCCC1=O)N2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	2.943	μM
10867	O=C1CCCC2=C1C(C1=CN(N=N1)C1=CC=C(C=C1)N(=O)=O)C1=C(CCCC1=O)N2	Cyclin-dependent kinase 4	Ki (inhibition constant)	3.835	μM
10868	O=C1CCCC2=C1C(C1=CN(N=N1)C1=CC=C(C=C1)N(=O)=O)C1=C(CCCC1=O)N2	Cyclin-dependent kinase 1	Ki (inhibition constant)	7.037	μM
10869	O=C1CCCC2=C1C(C1=CN(N=N1)C1=CC=C(C=C1)N(=O)=O)C1=C(CCCC1=O)N2	Cyclin-dependent kinase 7	Ki (inhibition constant)	8.554	μM
10870	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.536	μM
10871	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.661	μM
10872	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 6	Ki (inhibition constant)	1.861	μM
10873	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.847	μM
10874	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.937	μM
10875	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	2.015	μM
10876	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	2.921	μM
10877	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	3.027	μM
10878	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 2	Ki (inhibition constant)	3.472	μM
10879	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 4	Ki (inhibition constant)	6.585	μM
10880	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 1	Ki (inhibition constant)	10	μM
10881	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent-like kinase 5	Ki (inhibition constant)	10	μM
10882	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 7	Ki (inhibition constant)	10	μM
10883	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.432	μM
10884	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.762	μM
10885	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.825	μM
10886	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.956	μM
10887	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	2.392	μM
10888	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	2.585	μM
10889	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 6	Ki (inhibition constant)	2.616	μM
10890	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	3.061	μM
10891	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 7	Ki (inhibition constant)	3.751	μM
10892	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent-like kinase 5	Ki (inhibition constant)	4.187	μM
10893	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 1	Ki (inhibition constant)	5.243	μM
10894	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 4	Ki (inhibition constant)	5.892	μM
10895	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 2	Ki (inhibition constant)	6.895	μM
10896	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(C)(C)CC2=O)NC2=C1C(=O)CC(C)(C)C2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.673	μM
10897	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(C)(C)CC2=O)NC2=C1C(=O)CC(C)(C)C2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.725	μM
10898	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(C)(C)CC2=O)NC2=C1C(=O)CC(C)(C)C2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.847	μM
10899	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(C)(C)CC2=O)NC2=C1C(=O)CC(C)(C)C2	Cyclin-dependent kinase 4	Ki (inhibition constant)	1.897	μM
10900	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(C)(C)CC2=O)NC2=C1C(=O)CC(C)(C)C2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.953	μM
10901	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(C)(C)CC2=O)NC2=C1C(=O)CC(C)(C)C2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	2.046	μM
10902	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(C)(C)CC2=O)NC2=C1C(=O)CC(C)(C)C2	Cyclin-dependent kinase 7	Ki (inhibition constant)	2.124	μM
10903	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(C)(C)CC2=O)NC2=C1C(=O)CC(C)(C)C2	Cyclin-dependent kinase 6	Ki (inhibition constant)	2.318	μM
10904	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(C)(C)CC2=O)NC2=C1C(=O)CC(C)(C)C2	Cyclin-dependent-like kinase 5	Ki (inhibition constant)	2.454	μM
10905	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(C)(C)CC2=O)NC2=C1C(=O)CC(C)(C)C2	Cyclin-dependent kinase 2	Ki (inhibition constant)	2.613	μM
10906	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(C)(C)CC2=O)NC2=C1C(=O)CC(C)(C)C2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	2.932	μM
10907	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(C)(C)CC2=O)NC2=C1C(=O)CC(C)(C)C2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	3.401	μM
10908	CC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(C)(C)CC2=O)NC2=C1C(=O)CC(C)(C)C2	Cyclin-dependent kinase 1	Ki (inhibition constant)	7.164	μM
10909	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.255	μM
10910	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.572	μM
10911	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.836	μM
10912	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.835	μM
10913	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.921	μM
10914	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	2.744	μM
10915	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	2.818	μM
10916	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 7	Ki (inhibition constant)	2.895	μM
10917	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent-like kinase 5	Ki (inhibition constant)	6.642	μM
10918	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 1	Ki (inhibition constant)	7.541	μM
10919	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 2	Ki (inhibition constant)	10	μM
10920	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 4	Ki (inhibition constant)	10	μM
10921	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 6	Ki (inhibition constant)	10	μM
10922	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CC(C)(C)CC2=O)NC2=C1C(=O)CC(C)(C)C2	Cyclin-dependent kinase 2	Ki (inhibition constant)	0.037	μM
10923	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CC(C)(C)CC2=O)NC2=C1C(=O)CC(C)(C)C2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.238	μM
10924	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CC(C)(C)CC2=O)NC2=C1C(=O)CC(C)(C)C2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.424	μM
10925	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CC(C)(C)CC2=O)NC2=C1C(=O)CC(C)(C)C2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.634	μM
10926	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CC(C)(C)CC2=O)NC2=C1C(=O)CC(C)(C)C2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.92	μM
10927	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CC(C)(C)CC2=O)NC2=C1C(=O)CC(C)(C)C2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.918	μM
10928	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CC(C)(C)CC2=O)NC2=C1C(=O)CC(C)(C)C2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	2.717	μM
10929	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CC(C)(C)CC2=O)NC2=C1C(=O)CC(C)(C)C2	Cyclin-dependent kinase 4	Ki (inhibition constant)	2.863	μM
10930	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CC(C)(C)CC2=O)NC2=C1C(=O)CC(C)(C)C2	Cyclin-dependent kinase 6	Ki (inhibition constant)	2.867	μM
10931	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CC(C)(C)CC2=O)NC2=C1C(=O)CC(C)(C)C2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	3.14	μM
10932	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CC(C)(C)CC2=O)NC2=C1C(=O)CC(C)(C)C2	Cyclin-dependent-like kinase 5	Ki (inhibition constant)	3.565	μM
10933	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CC(C)(C)CC2=O)NC2=C1C(=O)CC(C)(C)C2	Cyclin-dependent kinase 7	Ki (inhibition constant)	7.912	μM
10934	COC1=CC=CC=C1N1C=C(N=N1)C1C2=C(CC(C)(C)CC2=O)NC2=C1C(=O)CC(C)(C)C2	Cyclin-dependent kinase 1	Ki (inhibition constant)	8.485	μM
10935	CC1(C)CC(=O)C2=C(C1)NC1=C(C2C2=CN(N=N2)C2=CC=C(C=C2)N(=O)=O)C(=O)CC(C)(C)C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.245	μM
10936	CC1(C)CC(=O)C2=C(C1)NC1=C(C2C2=CN(N=N2)C2=CC=C(C=C2)N(=O)=O)C(=O)CC(C)(C)C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.444	μM
10937	CC1(C)CC(=O)C2=C(C1)NC1=C(C2C2=CN(N=N2)C2=CC=C(C=C2)N(=O)=O)C(=O)CC(C)(C)C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.557	μM
10938	CC1(C)CC(=O)C2=C(C1)NC1=C(C2C2=CN(N=N2)C2=CC=C(C=C2)N(=O)=O)C(=O)CC(C)(C)C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.882	μM
10939	CC1(C)CC(=O)C2=C(C1)NC1=C(C2C2=CN(N=N2)C2=CC=C(C=C2)N(=O)=O)C(=O)CC(C)(C)C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.917	μM
10940	CC1(C)CC(=O)C2=C(C1)NC1=C(C2C2=CN(N=N2)C2=CC=C(C=C2)N(=O)=O)C(=O)CC(C)(C)C1	Cyclin-dependent kinase 6	Ki (inhibition constant)	2.147	μM
10941	CC1(C)CC(=O)C2=C(C1)NC1=C(C2C2=CN(N=N2)C2=CC=C(C=C2)N(=O)=O)C(=O)CC(C)(C)C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	2.237	μM
10942	CC1(C)CC(=O)C2=C(C1)NC1=C(C2C2=CN(N=N2)C2=CC=C(C=C2)N(=O)=O)C(=O)CC(C)(C)C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	2.568	μM
10943	CC1(C)CC(=O)C2=C(C1)NC1=C(C2C2=CN(N=N2)C2=CC=C(C=C2)N(=O)=O)C(=O)CC(C)(C)C1	Cyclin-dependent kinase 2	Ki (inhibition constant)	3.242	μM
10944	CC1(C)CC(=O)C2=C(C1)NC1=C(C2C2=CN(N=N2)C2=CC=C(C=C2)N(=O)=O)C(=O)CC(C)(C)C1	Cyclin-dependent-like kinase 5	Ki (inhibition constant)	7.468	μM
10945	CC1(C)CC(=O)C2=C(C1)NC1=C(C2C2=CN(N=N2)C2=CC=C(C=C2)N(=O)=O)C(=O)CC(C)(C)C1	Cyclin-dependent kinase 1	Ki (inhibition constant)	10	μM
10946	CC1(C)CC(=O)C2=C(C1)NC1=C(C2C2=CN(N=N2)C2=CC=C(C=C2)N(=O)=O)C(=O)CC(C)(C)C1	Cyclin-dependent kinase 4	Ki (inhibition constant)	10	μM
10947	CC1(C)CC(=O)C2=C(C1)NC1=C(C2C2=CN(N=N2)C2=CC=C(C=C2)N(=O)=O)C(=O)CC(C)(C)C1	Cyclin-dependent kinase 7	Ki (inhibition constant)	10	μM
10948	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Tyrosine-protein kinase receptor UFO	IC50	41.5	nM
10949	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2		inhibition rate		
10950	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Tyrosine-protein kinase receptor UFO [human]	GI50	1.02	μM
10951	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Tyrosine-protein kinase receptor UFO	IC50	11.4	μM
10952	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2		CLint (intrinsic clearance)	129	μl/min/mg protein
10953	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2		CLint (intrinsic clearance)	44.8	μl/min/mg protein
10954	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2		Papp (A-B)	15190000	cm/s
10955	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2		Papp (B-A)	8410000	cm/s
10956	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2		AUC (0-inf)	1620	ng*h/ml
10957	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2		t1/2 (drug half life)	2.46	hour
10958	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2		tmax	0.25	hour
10959	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2		Cmax	460	ng/ml
10960	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	SRSF protein kinase 3	control percentage	84	%
10961	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	TGF-beta receptor type-1	control percentage	70	%
10962	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Tyrosine-protein kinase receptor Tie-2	control percentage	25	%
10963	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	High affinity nerve growth factor receptor	control percentage	24	%
10964	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Testis-specific serine/threonine-protein kinase 1	control percentage	50	%
10965	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Non-receptor tyrosine-protein kinase TYK2	control percentage	11	%
10966	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Serine/threonine-protein kinase ULK2	control percentage	20	%
10967	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Vascular endothelial growth factor receptor 2 (VEGFR2)	control percentage	11	%
10968	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Serine/threonine-protein kinase 32C	control percentage	75	%
10969	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Tyrosine-protein kinase ZAP-70	control percentage	62	%
10970	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Aurora kinase B	inhibition percentage	93.8	%
10971	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Tyrosine-protein kinase receptor UFO	inhibition percentage	98.9	%
10972	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Cyclin-dependent kinase 7	inhibition percentage	95.9	%
10973	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	inhibition percentage	96	%
10974	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	98.8	%
10975	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Mitogen-activated protein kinase 8	inhibition percentage	94.7	%
10976	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Mitogen-activated protein kinase 10	inhibition percentage	96	%
10977	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	MAP kinase-interacting serine/threonine-protein kinase 2	inhibition percentage	98.7	%
10978	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Serine/threonine-protein kinase Plk4	inhibition percentage	93.7	%
10979	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Proto-oncogene tyrosine-protein kinase receptor Ret	inhibition percentage	97.6	%
10980	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Ribosomal protein S6 kinase alpha-3	inhibition percentage	93.9	%
10981	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Tyrosine-protein kinase ABL1 (T315I)-phosphorylated	control percentage	1.3	%
10982	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Tyrosine-protein kinase ABL1-nonphosphorylated	control percentage	14	%
10983	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Tyrosine-protein kinase ABL1-Phosphorylated	control percentage	11	%
10984	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Activin receptor type-1B	control percentage	77	%
10985	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Atypical kinase COQ8A, mitochondrial	control percentage	100	%
10986	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	RAC serine/threonine-protein kinase	control percentage	97	%
10987	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Tyrosine-protein kinase ABL1 (E255K)-phosphorylated	control percentage	6	%
10988	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	RAC-beta serine/threonine-protein kinase	control percentage	93	%
10989	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	ALK tyrosine kinase receptor	control percentage	63	%
10990	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Aurora kinase A	control percentage	8.7	%
10991	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Aurora kinase B	control percentage	6.2	%
10992	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Tyrosine-protein kinase receptor UFO	control percentage	1.1	%
10993	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Bone morphogenetic protein receptor type-2	control percentage	58	%
10994	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Serine/threonine-protein kinase B-raf	control percentage	97	%
10995	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Serine/threonine-protein kinase B-raf (V600E)	control percentage	79	%
10996	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Tyrosine-protein kinase BTK	control percentage	100	%
10997	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Cyclin-dependent kinase 11	control percentage	70	%
10998	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Aurora kinase A	inhibition percentage	91.3	%
10999	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Cyclin-dependent kinase 2	control percentage	100	%
11000	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Cyclin-dependent kinase 3	control percentage	97	%
11001	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Cyclin-dependent kinase 7	control percentage	4.1	%
11002	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Cyclin-dependent kinase 9	control percentage	100	%
11003	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Serine/threonine-protein kinase Chk1	control percentage	66	%
11004	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Macrophage colony-stimulating factor 1 receptor	control percentage	59	%
11005	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Casein kinase I isoform delta	control percentage	100	%
11006	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Casein kinase I isoform gamma-2	control percentage	46	%
11007	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Serine/threonine-protein kinase DCLK1	control percentage	79	%
11008	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	control percentage	4	%
11009	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Epidermal growth factor receptor	control percentage	83	%
11010	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Epidermal growth factor receptor (L858R)	control percentage	76	%
11011	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Ephrin type-A receptor 2	control percentage	81	%
11012	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Receptor tyrosine-protein kinase erbB-2	control percentage	100	%
11013	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Receptor tyrosine-protein kinase erbB-4	control percentage	100	%
11014	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Extracellular signal-regulated kinase 1	control percentage	100	%
11015	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Focal adhesion kinase 1	control percentage	100	%
11016	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Fibroblast growth factor receptor 2	control percentage	20	%
11017	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Fibroblast growth factor receptor 3	control percentage	19	%
11018	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Receptor-type tyrosine-protein kinase FLT3	control percentage	1.2	%
11019	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	tau-protein kinase	control percentage	95	%
11020	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Insulin-like growth factor 1 receptor	control percentage	100	%
11021	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Inhibitor of nuclear factor kappa-B kinase subunit alpha	control percentage	72	%
11022	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Inhibitor of nuclear factor kappa-B kinase subunit beta	control percentage	86	%
11023	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Insulin receptor	control percentage	74	%
11024	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Tyrosine-protein kinase JAK2	control percentage	66	%
11025	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Tyrosine-protein kinase JAK3	control percentage	81	%
11026	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Mitogen-activated protein kinase 8	control percentage	5.3	%
11027	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Mitogen-activated protein kinase 9	control percentage	19	%
11028	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Mitogen-activated protein kinase 10	control percentage	4	%
11029	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Mast/stem cell growth factor receptor Kit	control percentage	54	%
11030	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Mast/stem cell growth factor receptor Kit (D816V)	control percentage	7.2	%
11031	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Mast/stem cell growth factor receptor Kit (V559D);+Mast/stem cell growth factor receptor Kit	control percentage	22	%
11032	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Serine/threonine-protein kinase STK11	control percentage	87	%
11033	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Mitogen-activated protein kinase kinase kinase 4	control percentage	100	%
11034	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	MAP kinase-activated protein kinase 2	control percentage	100	%
11035	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	MAP/microtubule affinity-regulating kinase 3	control percentage	76	%
11036	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Dual specificity mitogen-activated protein kinase kinase 1	control percentage	34	%
11037	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Dual specificity mitogen-activated protein kinase kinase 2	control percentage	24	%
11038	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Hepatocyte growth factor receptor	control percentage	100	%
11039	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	MAP kinase-interacting serine/threonine-protein kinase 1	control percentage	79	%
11040	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	MAP kinase-interacting serine/threonine-protein kinase 2	control percentage	1.3	%
11041	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Mitogen-activated protein kinase kinase kinase 9	control percentage	15	%
11042	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Mitogen-activated protein kinase 14	control percentage	98	%
11043	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Mitogen-activated protein kinase p38b	control percentage	100	%
11044	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Serine/threonine-protein kinase PAK 1	control percentage	77	%
11045	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Serine/threonine-protein kinase PAK2	control percentage	57	%
11046	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Serine/threonine-protein kinase PAK 4	control percentage	32	%
11047	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Cyclin-dependent kinase 16	control percentage	99	%
11048	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Platelet-derived growth factor receptor alpha	control percentage	16	%
11049	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Platelet-derived growth factor receptor beta	control percentage	12	%
11050	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	3-phosphoinositide-dependent protein kinase 1	control percentage	75	%
11051	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	control percentage	100	%
11052	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	control percentage	100	%
11053	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	control percentage	43	%
11054	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Serine/threonine-protein kinase pim-1	control percentage	79	%
11055	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Serine/threonine-protein kinase pim-2	control percentage	100	%
11056	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Serine/threonine-protein kinase pim-3	control percentage	84	%
11057	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	cAMP-dependent protein kinase catalytic subunit alpha	control percentage	98	%
11058	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Serine/threonine-protein kinase PLK1	control percentage	96	%
11059	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Serine/threonine-protein kinase Plk3	control percentage	97	%
11060	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Serine/threonine-protein kinase Plk4	control percentage	6.3	%
11061	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Protein kinase C, epsilon	control percentage	71	%
11062	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	RAF proto-oncogene serine/threonine-protein kinase	control percentage	98	%
11063	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Proto-oncogene tyrosine-protein kinase receptor Ret	control percentage	2.4	%
11064	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Serine/threonine-protein kinase Rio2	control percentage	59	%
11065	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Rho-associated protein kinase 2	control percentage	18	%
11066	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Ribosomal protein S6 kinase alpha-3	control percentage	6.1	%
11067	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	NUAK family SNF1-like kinase 2	control percentage	34	%
11068	COC1=CC=C(C=C1)N1C=C(C=N1)C1=NNC2=C1C=C(N[C@@H]1CCN(C1)C1COC1)C(Cl)=C2	Proto-oncogene tyrosine-protein kinase Src	control percentage	23	%
11069	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Epidermal growth factor receptor [human]	IC50	0.0002	μM
11070	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Epidermal growth factor receptor	IC50	0.0044	μM
11071	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Epidermal growth factor receptor	IC50	0.032	μM
11072	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Epidermal growth factor receptor	IC50	0.052	μM
11073	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Epidermal growth factor receptor	IC50	0.122	μM
11074	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Epidermal growth factor receptor [human]	GI50	0.739	μM
11075	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Epidermal growth factor receptor	IC50	1.18	μM
11076	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1		body weight loss		
11077	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1		body weight loss		
11078	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1		phosphorylation level change		
11079	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1		phosphorylation level change		
11080	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1		phosphorylation level change		
11081	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1		CLint (intrinsic clearance)	16	μl/min/1e6 cells
11082	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1		fu (fraction unbound)	7	%
11083	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1		Papp (A-B)	61000000	cm/s
11084	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1		CLint (intrinsic clearance)	49000000	μl/min/ng
11085	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Epidermal growth factor receptor [human]	retention time	82	min
11086	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Epidermal growth factor receptor [human]	TGI (tumor growth inhibition rate)	87	%
11087	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Epidermal growth factor receptor [human]	TGI (tumor growth inhibition rate)	52	%
11088	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1		phosphorylation level decrease		
11089	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1		phosphorylation level decrease		
11090	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1		phosphorylation level decrease		
11091	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1		phosphorylation level decrease		
11092	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Epidermal growth factor receptor [human]	TGI (tumor growth inhibition rate)	52	%
11093	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Mitogen-activated protein kinase kinase kinase 7	inhibition percentage	50.9 - 51	%
11094	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Tyrosine-protein kinase Lyn (isoform LYN A)	inhibition percentage	52 - 52.2	%
11095	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Tyrosine-protein kinase receptor UFO	inhibition percentage	53.7 - 54	%
11096	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Ephrin type-B receptor 1	inhibition percentage	55 - 55.1	%
11097	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Tyrosine-protein kinase Fyn	inhibition percentage	56	%
11098	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	MAP kinase-interacting serine/threonine-protein kinase 2	inhibition percentage	57 - 57.4	%
11099	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Serine/threonine-protein kinase PAK 4	inhibition percentage	57 - 57.5	%
11100	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Serine/threonine-protein kinase PAK5	inhibition percentage	58.9 - 59	%
11101	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Receptor tyrosine-protein kinase erbB-2	inhibition percentage	60	%
11102	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Tyrosine-protein kinase ABL2	inhibition percentage	61.6 - 62	%
11103	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Fibroblast growth factor receptor 3	inhibition percentage	61.9 - 62	%
11104	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Insulin-like growth factor 1 receptor	inhibition percentage	64.8 - 65	%
11105	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Tyrosine-protein kinase ABL1	inhibition percentage	66 - 66.4	%
11106	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Tyrosine-protein kinase SYK	inhibition percentage	70.8 - 71	%
11107	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	G2/mitotic-specific cyclin-B1;+Cyclin-dependent kinase 1	inhibition percentage	71 - 71.4	%
11108	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Dual specificity protein kinase CLK1	inhibition percentage	74 - 74.2	%
11109	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Serine/threonine-protein kinase TBK1	inhibition percentage	77 - 77.3	%
11110	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Tyrosine-protein kinase Lck	inhibition percentage	79.7 - 80	%
11111	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Tyrosine-protein kinase BTK	inhibition percentage	80.7 - 81	%
11112	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Interleukin-1 receptor-associated kinase 1	inhibition percentage	81.6 - 82	%
11113	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Proto-oncogene tyrosine-protein kinase Src	inhibition percentage	82	%
11114	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Serine/threonine-protein kinase 4	inhibition percentage	83	%
11115	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Tyrosine-protein kinase yes	inhibition percentage	84.6 - 85	%
11116	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Fibroblast growth factor receptor 4	inhibition percentage	85 - 85.1	%
11117	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Fibroblast growth factor receptor 1	inhibition percentage	85 - 85.2	%
11118	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Macrophage colony-stimulating factor 1 receptor	inhibition percentage	85 - 85.3	%
11119	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Dual specificity protein kinase CLK2	inhibition percentage	89 - 89.2	%
11120	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Protein-tyrosine kinase 6	inhibition percentage	89 - 89.3	%
11121	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Mitogen-activated protein kinase kinase kinase 9	inhibition percentage	89.7 - 90	%
11122	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Dual specificity protein kinase CLK4	inhibition percentage	89.7 - 90	%
11123	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Insulin receptor	inhibition percentage	90 - 90.1	%
11124	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Tyrosine-protein kinase Blk	inhibition percentage	91 - 91.3	%
11125	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Fibroblast growth factor receptor 1	inhibition percentage	91 - 91.3	%
11126	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Tyrosine-protein kinase JAK2	inhibition percentage	92 - 92.1	%
11127	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Ribosomal protein S6 kinase alpha-1	inhibition percentage	92 - 92.3	%
11128	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Insulin receptor-related protein	inhibition percentage	92.7 - 93	%
11129	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Receptor tyrosine-protein kinase erbB-4	inhibition percentage	93.9 - 94	%
11130	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Fibroblast growth factor receptor 2	inhibition percentage	94.9 - 95	%
11131	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Epidermal growth factor receptor	inhibition percentage	94.9 - 95	%
11132	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M)	inhibition percentage	95 - 95.2	%
11133	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Tyrosine-protein kinase JAK3	inhibition percentage	95.8 - 96	%
11134	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	ALK tyrosine kinase receptor	inhibition percentage	96.9 - 97	%
11135	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Focal adhesion kinase 1	inhibition percentage	97.5 - 98	%
11136	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Proto-oncogene tyrosine-protein kinase ROS	inhibition percentage	98	%
11137	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Tyrosine-protein kinase, Fes/Fps type	inhibition percentage	98 - 98.3	%
11138	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Vascular endothelial growth factor receptor 2	inhibition percentage	98.6 - 99	%
11139	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	99	%
11140	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Tyrosine-protein kinase Fer	inhibition percentage	100.9 - 101	%
11141	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Proto-oncogene tyrosine-protein kinase receptor Ret	inhibition percentage	101	%
11142	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Epidermal growth factor receptor (L858R);+Epidermal growth factor receptor (T790M)	inhibition percentage	101 - 101.4	%
11143	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M)	inhibition percentage	103.7 - 104	%
11144	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	RAC-beta serine/threonine-protein kinase	inhibition percentage	-20 - -19.6	%
11145	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	inhibition percentage	-18.5 - -18	%
11146	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Activin receptor type-1B	inhibition percentage	-18	%
11147	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Phosphatidylinositol 3-kinase regulatory subunit alpha; Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (isoform 1)	inhibition percentage	-12 - -11.9	%
11148	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Serine/threonine-protein kinase PAK2	inhibition percentage	-11 - -10.6	%
11149	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Calcium/calmodulin-dependent protein kinase type II subunit beta	inhibition percentage	-6 - -5.7	%
11150	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Serine/threonine-protein kinase pim-2	inhibition percentage	-5.1 - -5	%
11151	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Phosphatidylinositol 3-kinase regulatory subunit alpha; Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	inhibition percentage	-4.4 - -4	%
11152	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Protein kinase C, theta	inhibition percentage	-3.4 - -3	%
11153	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	elongation factor-2 kinase	inhibition percentage	-3.1 - -3	%
11154	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Casein kinase I isoform gamma-1	inhibition percentage	-1 - -0.7	%
11155	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Tyrosine-protein kinase receptor TYRO3	inhibition percentage	-0.4 - 0	%
11156	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	MAP kinase-activated protein kinase 2	inhibition percentage	-0.3 - 0	%
11157	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Cyclin-dependent kinase 8;+Cyclin-C	inhibition percentage	0.6 - 1	%
11158	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Ribosomal protein S6 kinase beta-1	inhibition percentage	0.9 - 1	%
11159	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	MAP kinase-activated protein kinase 5	inhibition percentage	1 - 1.4	%
11160	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Tyrosine-protein kinase ZAP-70	inhibition percentage	2.9 - 3	%
11161	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha	inhibition percentage	2.9 - 3	%
11162	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Serine/threonine-protein kinase mTOR	inhibition percentage	3	%
11163	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	tau-protein kinase	inhibition percentage	3	%
11164	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Discoidin domain-containing receptor 2	inhibition percentage	3 - 3.1	%
11165	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform; Phosphatidylinositol 3-kinase regulatory subunit alpha	inhibition percentage	3 - 3.3	%
11166	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Serine/threonine-protein kinase Nek2	inhibition percentage	3.7 - 4	%
11167	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Protein kinase C, epsilon	inhibition percentage	3.8 - 4	%
11168	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	SRSF protein kinase 1	inhibition percentage	5	%
11169	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	RAC-alpha serine/threonine-protein kinase	inhibition percentage	5 - 5.3	%
11170	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Rho-associated protein kinase 2	inhibition percentage	5.9 - 6	%
11171	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage	5.9 - 6	%
11172	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	cAMP-dependent protein kinase catalytic subunit alpha	inhibition percentage	6 - 6.1	%
11173	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Serine/threonine-protein kinase Sgk1	inhibition percentage	6 - 6.4	%
11174	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Glycogen synthase kinase-3 alpha	inhibition percentage	6 - 6.4	%
11175	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Macrophage-stimulating protein receptor	inhibition percentage	6.7 - 7	%
11176	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	3-phosphoinositide-dependent protein kinase 1	inhibition percentage	6.9 - 7	%
11177	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Phosphatidylinositol 3-kinase catalytic subunit type 3	inhibition percentage	7	%
11178	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Ribosomal protein S6 kinase alpha-5	inhibition percentage	7 - 7.4	%
11179	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Dual specificity tyrosine-phosphorylation-regulated kinase 2	inhibition percentage	7 - 7.5	%
11180	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Inhibitor of nuclear factor kappa-B kinase subunit beta	inhibition percentage	7.9 - 8	%
11181	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Mitogen-activated protein kinase 14	inhibition percentage	8.6 - 9	%
11182	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Protein kinase C alpha type	inhibition percentage	9	%
11183	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	v-raf-1 murine leukemia viral oncogene homolog 1	inhibition percentage	10 - 10.1	%
11184	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Serine/threonine-protein kinase haspin	inhibition percentage	10 - 10.2	%
11185	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Serine/threonine-protein kinase 17A	inhibition percentage	10 - 10.3	%
11186	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Rho-associated protein kinase 1	inhibition percentage	10 - 10.5	%
11187	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Traf2 and NCK-interacting protein kinase	inhibition percentage	10.7 - 11	%
11188	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Serine/threonine-protein kinase PLK1	inhibition percentage	11	%
11189	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Aurora kinase C	inhibition percentage	11.6 - 12	%
11190	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	cGMP-dependent protein kinase 1	inhibition percentage	13 - 13.1	%
11191	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	DNA-dependent protein kinase	inhibition percentage	13 - 13.2	%
11192	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Mitogen-activated protein kinase 1	inhibition percentage	13.8 - 14	%
11193	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Aurora kinase B	inhibition percentage	14.7 - 15	%
11194	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	TGF-beta receptor type-1	inhibition percentage	15.5 - 16	%
11195	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Ephrin type-B receptor 4	inhibition percentage	16	%
11196	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Serine/threonine-protein kinase Chk1	inhibition percentage	17.8 - 18	%
11197	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Serine/threonine-protein kinase ULK2	inhibition percentage	18 - 18.1	%
11198	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Casein kinase II subunit alpha'	inhibition percentage	18 - 18.5	%
11199	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Hepatocyte growth factor receptor	inhibition percentage	18.6 - 19	%
11200	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Calcium/calmodulin-dependent protein kinase type 1	inhibition percentage	19	%
11201	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Ephrin type-A receptor 5	inhibition percentage	19.5 - 20	%
11202	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	BDNF/NT-3 growth factors receptor	inhibition percentage	20 - 20.2	%
11203	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	myosin light chain kinase	inhibition percentage	20 - 20.2	%
11204	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Serine/threonine-protein kinase PAK 1	inhibition percentage	21 - 21.4	%
11205	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Tyrosine-protein kinase Mer	inhibition percentage	22.7 - 23	%
11206	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Cyclin-dependent kinase 9;+Cyclin-T1	inhibition percentage	23	%
11207	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Serine/threonine-protein kinase MARK1	inhibition percentage	24	%
11208	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Interleukin-1 receptor-associated kinase 4	inhibition percentage	24 - 24.4	%
11209	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Dual specificity mitogen-activated protein kinase kinase 1	inhibition percentage	24.9 - 25	%
11210	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Serine/threonine-protein kinase B-raf	inhibition percentage	25 - 25.2	%
11211	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Platelet-derived growth factor receptor beta	inhibition percentage	25 - 25.2	%
11212	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	High affinity nerve growth factor receptor	inhibition percentage	25 - 25.2	%
11213	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Mitogen-activated protein kinase 8	inhibition percentage	25.6 - 26	%
11214	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Mast/stem cell growth factor receptor Kit	inhibition percentage	25.7 - 26	%
11215	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Serine/threonine-protein kinase MARK2	inhibition percentage	26	%
11216	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Phosphatidylinositol 4-kinase beta	inhibition percentage	27.7 - 28	%
11217	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	NUAK family SNF1-like kinase 1	inhibition percentage	31 - 31.2	%
11218	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	5'-AMP-activated protein kinase catalytic subunit alpha-2;+5'-AMP-activated protein kinase subunit beta-1;+5'-AMP-activated protein kinase subunit gamma-1	inhibition percentage	31.5 - 32	%
11219	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Myotonin-protein kinase	inhibition percentage	32.7 - 33	%
11220	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Vascular endothelial growth factor receptor 1 (VEGFR1)	inhibition percentage	34.9 - 35	%
11221	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Cytoplasmic tyrosine-protein kinase BMX	inhibition percentage	37 - 37.2	%
11222	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Cyclin-dependent kinase 2;+Cyclin-A1	inhibition percentage	37 - 37.3	%
11223	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Misshapen-like kinase 1	inhibition percentage	41	%
11224	COC1=C(NC2=NC(NC3=C(C=CC=C3)P(C)(C)=O)=C(Cl)C=N2)C=C(C2=CN(C)N=C2)C(=C1)N1CCOCC1	Tyrosine-protein kinase JAK1	inhibition percentage	48	%
11225	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Calcium/calmodulin-dependent protein kinase kinase 2	IC50	65	nM
11226	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Calcium/calmodulin-dependent protein kinase kinase 2	IC50	150	nM
11227	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Calcium/calmodulin-dependent protein kinase kinase 2	IC50	700	nM
11228	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Calcium/calmodulin-dependent protein kinase kinase 1	IC50	961	nM
11229	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Calcium/calmodulin-dependent protein kinase kinase 1	inhibition percentage	81	%
11230	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Casein kinase I isoform epsilon	inhibition percentage	0	%
11231	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Casein kinase I isoform gamma-1	inhibition percentage	0	%
11232	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Casein kinase I isoform gamma-2	inhibition percentage	0	%
11233	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Casein kinase I isoform gamma-3	inhibition percentage	10	%
11234	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Casein kinase II subunit alpha	inhibition percentage	0	%
11235	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Casein kinase II subunit alpha'	inhibition percentage	0	%
11236	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Megakaryocyte-associated tyrosine-protein kinase	inhibition percentage	0	%
11237	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Death-associated protein kinase 1	inhibition percentage	0	%
11238	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Death-associated protein kinase 2	inhibition percentage	0	%
11239	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Death-associated protein kinase 3	inhibition percentage	0	%
11240	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
11241	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase DCLK1	inhibition percentage	0	%
11242	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase DCLK2	inhibition percentage	0	%
11243	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase DCLK3	inhibition percentage	0	%
11244	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Epithelial discoidin domain-containing receptor 1	inhibition percentage	0	%
11245	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Discoidin domain-containing receptor 2	inhibition percentage	0	%
11246	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Death-associated protein kinase 3	inhibition percentage	0	%
11247	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Myotonin-protein kinase	inhibition percentage	0	%
11248	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase MRCK gamma	inhibition percentage	0	%
11249	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase 17A	inhibition percentage	0	%
11250	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase 17B	inhibition percentage	0	%
11251	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
11252	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Dual specificity tyrosine-phosphorylation-regulated kinase 1A/B	inhibition percentage	8	%
11253	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	inhibition percentage	25	%
11254	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Dual specificity tyrosine-phosphorylation-regulated kinase 2	inhibition percentage	27	%
11255	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Epidermal growth factor receptor	inhibition percentage	12	%
11256	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Epidermal growth factor receptor	inhibition percentage	23	%
11257	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Epidermal growth factor receptor	inhibition percentage	0	%
11258	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Epidermal growth factor receptor	inhibition percentage	3	%
11259	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Epidermal growth factor receptor	inhibition percentage	5	%
11260	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Epidermal growth factor receptor	inhibition percentage	6	%
11261	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Epidermal growth factor receptor	inhibition percentage	0	%
11262	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
11263	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Epidermal growth factor receptor	inhibition percentage	35	%
11264	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Epidermal growth factor receptor	inhibition percentage	0	%
11265	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Epidermal growth factor receptor	inhibition percentage	23	%
11266	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Epidermal growth factor receptor	inhibition percentage	14	%
11267	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Epidermal growth factor receptor	inhibition percentage	0	%
11268	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Eukaryotic translation initiation factor 2-alpha kinase 1	inhibition percentage	0	%
11269	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Ephrin type-A receptor 1	inhibition percentage	0	%
11270	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Ephrin type-A receptor 2	inhibition percentage	0	%
11271	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Ephrin type-A receptor 3	inhibition percentage	9	%
11272	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Ephrin type-A receptor 4	inhibition percentage	4	%
11273	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
11274	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Ephrin type-A receptor 5	inhibition percentage	0	%
11275	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Ephrin type-A receptor 6	inhibition percentage	0	%
11276	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Ephrin type-A receptor 7	inhibition percentage	0	%
11277	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Ephrin type-A receptor 8	inhibition percentage	0	%
11278	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Ephrin type-B receptor 1	inhibition percentage	11	%
11279	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Ephrin type-B receptor 2	inhibition percentage	9	%
11280	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Ephrin type-B receptor 3	inhibition percentage	0	%
11281	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Ephrin type-B receptor 4	inhibition percentage	0	%
11282	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Ephrin type-B receptor 6	inhibition percentage	46	%
11283	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Receptor tyrosine-protein kinase erbB-2	inhibition percentage	16	%
11284	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase ABL1	inhibition percentage	2	%
11285	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Receptor tyrosine-protein kinase erbB-3	inhibition percentage	40	%
11286	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Receptor tyrosine-protein kinase erbB-4	inhibition percentage	0	%
11287	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase 3	inhibition percentage	0	%
11288	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase 1	inhibition percentage	0	%
11289	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase 6	inhibition percentage	0	%
11290	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase 4	inhibition percentage	0	%
11291	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase 7	inhibition percentage	0	%
11292	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase 15	inhibition percentage	15	%
11293	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase/endoribonuclease IRE1	inhibition percentage	0	%
11294	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Focal adhesion kinase 1	inhibition percentage	15	%
11295	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
11296	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase Fer	inhibition percentage	0	%
11297	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase, Fes/Fps type	inhibition percentage	0	%
11298	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Fibroblast growth factor receptor 1	inhibition percentage	1	%
11299	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Fibroblast growth factor receptor 2	inhibition percentage	14	%
11300	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Fibroblast growth factor receptor 3	inhibition percentage	0	%
11301	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Fibroblast growth factor receptor 3	inhibition percentage	13	%
11302	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Fibroblast growth factor receptor 4	inhibition percentage	0	%
11303	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase Fgr	inhibition percentage	6	%
11304	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Vascular endothelial growth factor receptor 1	inhibition percentage	0	%
11305	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	0	%
11306	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
11307	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	0	%
11308	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	56	%
11309	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	0	%
11310	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	0	%
11311	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	5	%
11312	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	26	%
11313	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	0	%
11314	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	16	%
11315	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	0	%
11316	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	14	%
11317	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
11318	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Vascular endothelial growth factor receptor 3	inhibition percentage	0	%
11319	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase FRK	inhibition percentage	0	%
11320	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase Fyn	inhibition percentage	0	%
11321	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Cyclin-G-associated kinase	inhibition percentage	26	%
11322	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	eIF-2-alpha kinase Gcn2	inhibition percentage	0	%
11323	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	rhodopsin kinase	inhibition percentage	0	%
11324	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Beta-adrenergic receptor kinase 1	inhibition percentage	31	%
11325	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Beta-adrenergic receptor kinase 2	inhibition percentage	0	%
11326	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	G protein-coupled receptor kinase 4	inhibition percentage	0	%
11327	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	rhodopsin kinase	inhibition percentage	0	%
11328	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
11329	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Glycogen synthase kinase-3 alpha	inhibition percentage	5	%
11330	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	tau-protein kinase	inhibition percentage	0	%
11331	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase haspin	inhibition percentage	22	%
11332	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase HCK	inhibition percentage	0	%
11333	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Homeodomain-interacting protein kinase 1	inhibition percentage	0	%
11334	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Homeodomain-interacting protein kinase 2	inhibition percentage	0	%
11335	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Homeodomain-interacting protein kinase 3	inhibition percentage	0	%
11336	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Homeodomain-interacting protein kinase 4	inhibition percentage	0	%
11337	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase kinase kinase kinase 1	inhibition percentage	11	%
11338	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Hormonally up-regulated neu tumor-associated kinase	inhibition percentage	0	%
11339	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase ABL1	inhibition percentage	4	%
11340	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	AP2-associated protein kinase 1	inhibition percentage	0	%
11341	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase ICK	inhibition percentage	0	%
11342	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Insulin-like growth factor 1 receptor	inhibition percentage	0	%
11343	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Inhibitor of nuclear factor kappa-B kinase subunit alpha	inhibition percentage	0	%
11344	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Inhibitor of nuclear factor kappa-B kinase subunit beta	inhibition percentage	0	%
11345	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	inhibition percentage	0	%
11346	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Insulin receptor	inhibition percentage	16	%
11347	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Insulin receptor-related protein	inhibition percentage	0	%
11348	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Interleukin-1 receptor-associated kinase 1	inhibition percentage	0	%
11349	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Interleukin-1 receptor-associated kinase 3	inhibition percentage	17	%
11350	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Interleukin-1 receptor-associated kinase 4	inhibition percentage	14	%
11351	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
11352	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase ITK/TSK	inhibition percentage	1	%
11353	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase JAK1	inhibition percentage	0	%
11354	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Interleukin-1 receptor-associated kinase 1	inhibition percentage	48	%
11355	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase JAK2	inhibition percentage	0	%
11356	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase JAK3	inhibition percentage	27	%
11357	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase 8	inhibition percentage	23	%
11358	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase 9	inhibition percentage	35	%
11359	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase 10	inhibition percentage	10	%
11360	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mast/stem cell growth factor receptor Kit	inhibition percentage	0	%
11361	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mast/stem cell growth factor receptor Kit	inhibition percentage	0	%
11362	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase ABL1	inhibition percentage	9	%
11363	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mast/stem cell growth factor receptor Kit	inhibition percentage	31	%
11364	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mast/stem cell growth factor receptor Kit	inhibition percentage	6	%
11365	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mast/stem cell growth factor receptor Kit	inhibition percentage	0	%
11366	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mast/stem cell growth factor receptor Kit	inhibition percentage	2	%
11367	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mast/stem cell growth factor receptor Kit	inhibition percentage	0	%
11368	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mast/stem cell growth factor receptor Kit	inhibition percentage	0	%
11369	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mast/stem cell growth factor receptor Kit	inhibition percentage	11	%
11370	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase LATS1	inhibition percentage	0	%
11371	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase LATS2	inhibition percentage	22	%
11372	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Proto-oncogene tyrosine-protein kinase LCK	inhibition percentage	0	%
11373	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
11374	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	LIM domain kinase 1	inhibition percentage	0	%
11375	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	LIM domain kinase 2	inhibition percentage	0	%
11376	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase STK11	inhibition percentage	15	%
11377	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Ovarian-specific serine/threonine-protein kinase Lok	inhibition percentage	0	%
11378	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Leucine-rich repeat serine/threonine-protein kinase 2	inhibition percentage	9	%
11379	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Leucine-rich repeat serine/threonine-protein kinase 2	inhibition percentage	0	%
11380	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Leukocyte tyrosine kinase receptor	inhibition percentage	0	%
11381	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase Lyn	inhibition percentage	12	%
11382	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase kinase kinase 13	inhibition percentage	56	%
11383	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase MAK	inhibition percentage	0	%
11384	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase ABL2	inhibition percentage	23	%
11385	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase kinase kinase 1	inhibition percentage	10	%
11386	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase kinase kinase 15	inhibition percentage	0	%
11387	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase kinase kinase 2	inhibition percentage	4	%
11388	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase kinase kinase 3	inhibition percentage	0	%
11389	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase kinase kinase 4	inhibition percentage	13	%
11390	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase kinase kinase kinase 2	inhibition percentage	33	%
11391	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase kinase kinase kinase 3	inhibition percentage	0	%
11392	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase kinase kinase kinase 4	inhibition percentage	0	%
11393	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase kinase kinase kinase 5	inhibition percentage	0	%
11394	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	MAP kinase-activated protein kinase 2	inhibition percentage	0	%
11395	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Activin receptor type-1	inhibition percentage	0	%
11396	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	MAP kinase-activated protein kinase 5	inhibition percentage	0	%
11397	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase MARK1	inhibition percentage	0	%
11398	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase MARK2	inhibition percentage	20	%
11399	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	MAP/microtubule affinity-regulating kinase 3	inhibition percentage	0	%
11400	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	MAP/microtubule affinity-regulating kinase 4	inhibition percentage	0	%
11401	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Microtubule-associated serine/threonine-protein kinase 1	inhibition percentage	6	%
11402	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Dual specificity mitogen-activated protein kinase kinase 1	inhibition percentage	0	%
11403	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Dual specificity mitogen-activated protein kinase kinase 2	inhibition percentage	3	%
11404	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Dual specificity mitogen-activated protein kinase kinase 3	inhibition percentage	0	%
11405	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Dual specificity mitogen-activated protein kinase kinase 4	inhibition percentage	14	%
11406	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Activin receptor type-1B	inhibition percentage	6	%
11407	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Dual specificity mitogen-activated protein kinase kinase 5	inhibition percentage	25	%
11408	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Dual specificity mitogen-activated protein kinase kinase 6	inhibition percentage	0	%
11409	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Maternal embryonic leucine zipper kinase	inhibition percentage	0	%
11410	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase Mer	inhibition percentage	5	%
11411	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase RYK	inhibition percentage	8	%
11412	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase RYK	inhibition percentage	0	%
11413	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase RYK	inhibition percentage	6	%
11414	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Misshapen-like kinase 1	inhibition percentage	0	%
11415	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Dual specificity mitogen-activated protein kinase kinase 7	inhibition percentage	0	%
11416	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	MAP kinase-interacting serine/threonine-protein kinase 1	inhibition percentage	0	%
11417	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Activin receptor type-2A	inhibition percentage	7	%
11418	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	MAP kinase-interacting serine/threonine-protein kinase 2	inhibition percentage	17	%
11419	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Myosin light chain kinase 3	inhibition percentage	0	%
11420	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase kinase kinase 9	inhibition percentage	0	%
11421	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase kinase kinase 10	inhibition percentage	10	%
11422	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase kinase kinase 11	inhibition percentage	0	%
11423	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase MRCK alpha	inhibition percentage	0	%
11424	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase MRCK beta	inhibition percentage	0	%
11425	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase 4	inhibition percentage	0	%
11426	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Macrophage-stimulating protein receptor	inhibition percentage	0	%
11427	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase 3	inhibition percentage	0	%
11428	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Activin receptor type-2B	inhibition percentage	70	%
11429	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase 24	inhibition percentage	0	%
11430	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase 26	inhibition percentage	0	%
11431	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase mTOR	inhibition percentage	0	%
11432	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Muscle, skeletal receptor tyrosine-protein kinase	inhibition percentage	0	%
11433	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Myosin light chain kinase, smooth muscle	inhibition percentage	0	%
11434	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Myosin light chain kinase 2, skeletal/cardiac muscle	inhibition percentage	18	%
11435	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Myosin light chain kinase family member 4	inhibition percentage	0	%
11436	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Myosin-IIIa	inhibition percentage	0	%
11437	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Myosin-IIIb	inhibition percentage	0	%
11438	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase 38	inhibition percentage	0	%
11439	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase receptor R3	inhibition percentage	0	%
11440	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase 38-like	inhibition percentage	0	%
11441	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Probable serine/threonine-protein kinase nek1	inhibition percentage	0	%
11442	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase Nek10	inhibition percentage	10	%
11443	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase Nek11	inhibition percentage	0	%
11444	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Probable serine/threonine-protein kinase nek2	inhibition percentage	0	%
11445	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Probable serine/threonine-protein kinase nek3	inhibition percentage	11	%
11446	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase Nek4	inhibition percentage	0	%
11447	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase Nek5	inhibition percentage	0	%
11448	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase Nek5	inhibition percentage	0	%
11449	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase Nek7	inhibition percentage	7	%
11450	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Atypical kinase COQ8A, mitochondrial	inhibition percentage	0	%
11451	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase Nek9	inhibition percentage	0	%
11452	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase kinase kinase 14	inhibition percentage	17	%
11453	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase NIM1	inhibition percentage	7	%
11454	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine kinase NLK	inhibition percentage	1	%
11455	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase OSR1	inhibition percentage	2	%
11456	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase 14A	inhibition percentage	0	%
11457	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase 11	inhibition percentage	16	%
11458	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase 13	inhibition percentage	0	%
11459	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase 12	inhibition percentage	0	%
11460	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase PAK 1	inhibition percentage	0	%
11461	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Atypical kinase COQ8B, mitochondrial	inhibition percentage	8	%
11462	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase N2	inhibition percentage	1	%
11463	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase PAK 3	inhibition percentage	0	%
11464	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase PAK 4	inhibition percentage	0	%
11465	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase PAK 6	inhibition percentage	0	%
11466	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase PAK5	inhibition percentage	0	%
11467	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Cyclin-dependent kinase 16	inhibition percentage	0	%
11468	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Cyclin-dependent kinase 17	inhibition percentage	0	%
11469	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Cyclin-dependent kinase 18	inhibition percentage	2	%
11470	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Platelet-derived growth factor receptor alpha	inhibition percentage	16	%
11471	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Platelet-derived growth factor receptor beta	inhibition percentage	10	%
11472	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	RAC serine/threonine-protein kinase	inhibition percentage	0	%
11473	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	3-phosphoinositide-dependent protein kinase 1	inhibition percentage	0	%
11474	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Calcium-dependent protein kinase 1 [Plasmodium falciparum]	inhibition percentage	0	%
11475	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Cell division control protein 2 homolog [Plasmodium falciparum]	inhibition percentage	22	%
11476	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Cyclin-dependent kinase 15	inhibition percentage	0	%
11477	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Cyclin-dependent kinase 14	inhibition percentage	0	%
11478	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	inhibition percentage	32	%
11479	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	inhibition percentage	0	%
11480	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	inhibition percentage	7	%
11481	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	inhibition percentage	5	%
11482	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition percentage	0	%
11483	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	RAC-beta serine/threonine-protein kinase	inhibition percentage	0	%
11484	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition percentage	0	%
11485	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition percentage	0	%
11486	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition percentage	0	%
11487	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition percentage	19	%
11488	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition percentage	44	%
11489	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition percentage	0	%
11490	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition percentage	13	%
11491	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition percentage	18	%
11492	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition percentage	3	%
11493	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	inhibition percentage	26	%
11494	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	RAC-gamma serine/threonine-protein kinase	inhibition percentage	0	%
11495	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	inhibition percentage	28	%
11496	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	inhibition percentage	15	%
11497	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Phosphatidylinositol 4-kinase beta	inhibition percentage	14	%
11498	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	1-phosphatidylinositol 3-phosphate 5-kinase	inhibition percentage	17	%
11499	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase pim-1	inhibition percentage	10	%
11500	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase pim-2	inhibition percentage	14	%
11501	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase pim-3	inhibition percentage	1	%
11502	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	inhibition percentage	0	%
11503	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	inhibition percentage	0	%
11504	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta	inhibition percentage	0	%
11505	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	ALK tyrosine kinase receptor	inhibition percentage	33	%
11506	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	inhibition percentage	56	%
11507	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	cAMP-dependent protein kinase catalytic subunit alpha	inhibition percentage	0	%
11508	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	cAMP-dependent protein kinase catalytic subunit beta	inhibition percentage	0	%
11509	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	inhibition percentage	0	%
11510	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase N1	inhibition percentage	2	%
11511	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase N2	inhibition percentage	0	%
11512	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Probable serine/threonine-protein kinase PknB [Mycobacterium tuberculosis]	inhibition percentage	7	%
11513	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase PLK1	inhibition percentage	12	%
11514	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase PLK2	inhibition percentage	12	%
11515	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase Plk3	inhibition percentage	0	%
11516	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	ALK tyrosine kinase receptor	inhibition percentage	0	%
11517	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase Plk4	inhibition percentage	0	%
11518	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Protein kinase C, delta	inhibition percentage	0	%
11519	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Protein kinase C, epsilon	inhibition percentage	9	%
11520	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Protein kinase C, eta	inhibition percentage	0	%
11521	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Protein kinase C iota type	inhibition percentage	0	%
11522	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Protein kinase C, theta	inhibition percentage	7	%
11523	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase D1	inhibition percentage	0	%
11524	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase D2	inhibition percentage	1	%
11525	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase D3	inhibition percentage	0	%
11526	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	cGMP-dependent protein kinase 1	inhibition percentage	5	%
11527	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	ALK tyrosine kinase receptor	inhibition percentage	0	%
11528	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	cGMP-dependent protein kinase 2	inhibition percentage	0	%
11529	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Interferon-induced, double-stranded RNA-activated protein kinase	inhibition percentage	0	%
11530	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	cAMP-dependent protein kinase catalytic subunit PRKX	inhibition percentage	15	%
11531	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase prp4	inhibition percentage	0	%
11532	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Dual specificity protein kinase splB	inhibition percentage	9	%
11533	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase SIK3	inhibition percentage	2	%
11534	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	RAF proto-oncogene serine/threonine-protein kinase	inhibition percentage	0	%
11535	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Proto-oncogene tyrosine-protein kinase receptor Ret	inhibition percentage	0	%
11536	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Proto-oncogene tyrosine-protein kinase receptor Ret	inhibition percentage	0	%
11537	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Proto-oncogene tyrosine-protein kinase receptor Ret	inhibition percentage	0	%
11538	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	5'-AMP-activated protein kinase catalytic subunit alpha-1	inhibition percentage	0	%
11539	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Proto-oncogene tyrosine-protein kinase receptor Ret	inhibition percentage	1	%
11540	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase Rio1	inhibition percentage	0	%
11541	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase Rio2	inhibition percentage	0	%
11542	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase Rio3	inhibition percentage	0	%
11543	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Inositol-pentakisphosphate 2-kinase	inhibition percentage	1	%
11544	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Receptor-interacting serine/threonine-protein kinase 2	inhibition percentage	27	%
11545	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Receptor-interacting serine/threonine-protein kinase 4	inhibition percentage	15	%
11546	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Dual serine/threonine and tyrosine protein kinase	inhibition percentage	9	%
11547	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Rho-associated protein kinase 1	inhibition percentage	0	%
11548	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Rho-associated protein kinase 2	inhibition percentage	0	%
11549	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	5'-AMP-activated protein kinase catalytic subunit alpha-2	inhibition percentage	0	%
11550	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Proto-oncogene tyrosine-protein kinase ROS	inhibition percentage	0	%
11551	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Ribosomal protein S6 kinase alpha-4	inhibition percentage	0	%
11552	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Ribosomal protein S6 kinase alpha-4	inhibition percentage	0	%
11553	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Ribosomal protein S6 kinase alpha-5	inhibition percentage	0	%
11554	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Ribosomal protein S6 kinase alpha-5	inhibition percentage	0	%
11555	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Ribosomal protein S6 kinase alpha-1	inhibition percentage	0	%
11556	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Ribosomal protein S6 kinase alpha-1	inhibition percentage	0	%
11557	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Ribosomal protein S6 kinase alpha-3	inhibition percentage	4	%
11558	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Ribosomal protein S6 kinase alpha-3	inhibition percentage	0	%
11559	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Ribosomal protein S6 kinase alpha-2	inhibition percentage	0	%
11560	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Ankyrin repeat and protein kinase domain-containing protein 1	inhibition percentage	8	%
11561	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Ribosomal protein S6 kinase alpha-2	inhibition percentage	8	%
11562	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Ribosomal protein S6 kinase alpha-6	inhibition percentage	4	%
11563	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Ribosomal protein S6 kinase alpha-6	inhibition percentage	0	%
11564	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Ribosomal protein S6 kinase beta-1	inhibition percentage	24	%
11565	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase, Sbk1	inhibition percentage	0	%
11566	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase Sgk1	inhibition percentage	0	%
11567	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Uncharacterized serine/threonine-protein kinase SBK3	inhibition percentage	2	%
11568	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase Sgk2	inhibition percentage	0	%
11569	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase Sgk3	inhibition percentage	0	%
11570	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase SIK1	inhibition percentage	0	%
11571	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	NUAK family SNF1-like kinase 1	inhibition percentage	0	%
11572	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase SIK2	inhibition percentage	0	%
11573	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	STE20-like serine/threonine-protein kinase	inhibition percentage	0	%
11574	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	NUAK family SNF1-like kinase 2	inhibition percentage	3	%
11575	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	SNF-related serine/threonine-protein kinase	inhibition percentage	0	%
11576	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Proto-oncogene tyrosine-protein kinase Src	inhibition percentage	0	%
11577	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase Srms	inhibition percentage	4	%
11578	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	SRSF protein kinase 1	inhibition percentage	3	%
11579	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	SRSF protein kinase 2	inhibition percentage	0	%
11580	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	SRSF protein kinase 3	inhibition percentage	0	%
11581	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase 16	inhibition percentage	0	%
11582	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase kinase kinase 5	inhibition percentage	0	%
11583	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase 33	inhibition percentage	1	%
11584	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase 35	inhibition percentage	0	%
11585	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase 36	inhibition percentage	0	%
11586	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	STE20/SPS1-related proline-alanine-rich protein kinase	inhibition percentage	21	%
11587	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase SYK	inhibition percentage	3	%
11588	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase kinase kinase 7	inhibition percentage	0	%
11589	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase TAO1	inhibition percentage	8	%
11590	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase TAO2	inhibition percentage	15	%
11591	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase TAO3	inhibition percentage	13	%
11592	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase TBK1	inhibition percentage	0	%
11593	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase kinase kinase 6	inhibition percentage	33	%
11594	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase Tec	inhibition percentage	7	%
11595	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Dual specificity testis-specific protein kinase 1	inhibition percentage	8	%
11596	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	TGF-beta receptor type-1	inhibition percentage	15	%
11597	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	TGF-beta receptor type-2	inhibition percentage	12	%
11598	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase receptor Tie-1	inhibition percentage	19	%
11599	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Angiopoietin-1 receptor	inhibition percentage	19	%
11600	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase tousled-like 1	inhibition percentage	0	%
11601	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase TOUSLED-like 2	inhibition percentage	0	%
11602	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Traf2 and NCK-interacting protein kinase	inhibition percentage	8	%
11603	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Non-receptor tyrosine-protein kinase TNK1	inhibition percentage	0	%
11604	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Aurora kinase A	inhibition percentage	0	%
11605	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Activated CDC42 kinase 1	inhibition percentage	0	%
11606	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase TNNI3K	inhibition percentage	0	%
11607	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	High affinity nerve growth factor receptor	inhibition percentage	13	%
11608	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	BDNF/NT-3 growth factors receptor	inhibition percentage	11	%
11609	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	NT-3 growth factor receptor	inhibition percentage	16	%
11610	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Transient receptor potential cation channel subfamily M member 6	inhibition percentage	0	%
11611	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Testis-specific serine/threonine-protein kinase 1	inhibition percentage	0	%
11612	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Testis-specific serine/threonine-protein kinase 3	inhibition percentage	36	%
11613	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Dual specificity protein kinase TTK	inhibition percentage	0	%
11614	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase TXK	inhibition percentage	21	%
11615	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Aurora kinase B	inhibition percentage	0	%
11616	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Non-receptor tyrosine-protein kinase TYK2	inhibition percentage	0	%
11617	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Non-receptor tyrosine-protein kinase TYK2	inhibition percentage	18	%
11618	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase receptor TYRO3	inhibition percentage	0	%
11619	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase ULK1	inhibition percentage	46	%
11620	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase ULK2	inhibition percentage	0	%
11621	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase ULK3	inhibition percentage	39	%
11622	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Vascular endothelial growth factor receptor 2	inhibition percentage	0	%
11623	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Phosphatidylinositol 3-kinase, Vps34 type	inhibition percentage	7	%
11624	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase VRK2	inhibition percentage	1	%
11625	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitosis inhibitor protein kinase wee1	inhibition percentage	7	%
11626	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Aurora kinase C	inhibition percentage	0	%
11627	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Wee1-like protein kinase 1-A	inhibition percentage	5	%
11628	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Probable serine/threonine-protein kinase WNK1	inhibition percentage	0	%
11629	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Probable serine/threonine-protein kinase WNK2	inhibition percentage	22	%
11630	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Probable serine/threonine-protein kinase WNK3	inhibition percentage	5	%
11631	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Probable serine/threonine-protein kinase WNK4	inhibition percentage	17	%
11632	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase 32A	inhibition percentage	0	%
11633	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase 32B	inhibition percentage	0	%
11634	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase 32C	inhibition percentage	0	%
11635	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase yes	inhibition percentage	0	%
11636	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase 25	inhibition percentage	0	%
11637	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase receptor UFO	inhibition percentage	0	%
11638	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase kinase kinase 19	inhibition percentage	30	%
11639	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitogen-activated protein kinase kinase kinase 20	inhibition percentage	18	%
11640	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase ZAP-70	inhibition percentage	0	%
11641	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	BMP-2-inducible protein kinase	inhibition percentage	0	%
11642	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase Blk	inhibition percentage	0	%
11643	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Bone morphogenetic protein receptor type-1A	inhibition percentage	8	%
11644	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Bone morphogenetic protein receptor type-1B	inhibition percentage	11	%
11645	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Bone morphogenetic protein receptor type-2	inhibition percentage	0	%
11646	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Cytoplasmic tyrosine-protein kinase BMX	inhibition percentage	0	%
11647	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase B-raf	inhibition percentage	0	%
11648	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase B-raf	inhibition percentage	0	%
11649	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Protein-tyrosine kinase 6	inhibition percentage	0	%
11650	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase BRSK1	inhibition percentage	16	%
11651	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase BRSK2	inhibition percentage	4	%
11652	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase BTK	inhibition percentage	0	%
11653	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Mitotic checkpoint serine/threonine-protein kinase BUB1	inhibition percentage	17	%
11654	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Calcium/calmodulin-dependent protein kinase type 1	inhibition percentage	0	%
11655	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Calcium/calmodulin-dependent protein kinase type 1B	inhibition percentage	8	%
11656	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Calcium/calmodulin-dependent protein kinase type 1D	inhibition percentage	0	%
11657	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Calcium/calmodulin-dependent protein kinase type 1G	inhibition percentage	0	%
11658	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Calcium/calmodulin-dependent protein kinase type II subunit alpha	inhibition percentage	0	%
11659	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Calcium/calmodulin-dependent protein kinase type II subunit beta	inhibition percentage	1	%
11660	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Calcium/calmodulin-dependent protein kinase type II delta chain	inhibition percentage	0	%
11661	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Calcium/calmodulin-dependent protein kinase type II subunit gamma	inhibition percentage	0	%
11662	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Calcium/calmodulin-dependent protein kinase type IV	inhibition percentage	0	%
11663	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Casein kinase II subunit alpha	inhibition percentage	28	%
11664	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Cyclin-dependent kinase 11B	inhibition percentage	0	%
11665	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Cyclin-dependent kinase 11A	inhibition percentage	4	%
11666	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Cyclin-dependent kinase 13	inhibition percentage	0	%
11667	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Cyclin-dependent kinase 11	inhibition percentage	27	%
11668	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Cyclin-dependent kinase 2	inhibition percentage	0	%
11669	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Cyclin-dependent kinase 3	inhibition percentage	34	%
11670	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Cyclin-dependent kinase 4	inhibition percentage	35	%
11671	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Cyclin-dependent kinase 4;+G1/S-specific cyclin-D1	inhibition percentage	4	%
11672	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	cdk4-cyclin d3	inhibition percentage	38	%
11673	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Cyclin-dependent-like kinase 5	inhibition percentage	0	%
11674	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Cyclin-dependent kinase 7	inhibition percentage	0	%
11675	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Cyclin-dependent kinase 8	inhibition percentage	0	%
11676	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Cyclin-dependent kinase 9	inhibition percentage	0	%
11677	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Cyclin-dependent kinase-like 1	inhibition percentage	0	%
11678	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Cyclin-dependent kinase-like 2	inhibition percentage	0	%
11679	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Cyclin-dependent kinase-like 3	inhibition percentage	37	%
11680	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Cyclin-dependent kinase-like 5	inhibition percentage	0	%
11681	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase Chk1	inhibition percentage	0	%
11682	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Serine/threonine-protein kinase Chk2	inhibition percentage	10	%
11683	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Citron rho-interacting kinase	inhibition percentage	0	%
11684	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
11685	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Dual specificity protein kinase CLK1	inhibition percentage	10	%
11686	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Dual specificity protein kinase CLK2	inhibition percentage	40	%
11687	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Dual specificity protein kinase CLK3	inhibition percentage	0	%
11688	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Dual specificity protein kinase CLK4	inhibition percentage	0	%
11689	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Macrophage colony-stimulating factor 1 receptor	inhibition percentage	0	%
11690	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Macrophage colony-stimulating factor 1 receptor	inhibition percentage	19	%
11691	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase CSK	inhibition percentage	0	%
11692	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Casein kinase I isoform alpha	inhibition percentage	0	%
11693	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Casein kinase I isoform alpha-like	inhibition percentage	10	%
11694	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Casein kinase I isoform delta	inhibition percentage	0	%
11695	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Tyrosine-protein kinase ABL1	inhibition percentage	0	%
11696	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Calcium/calmodulin-dependent protein kinase kinase 1	Tm (melting temperature)	15.5	°C
11697	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Calcium/calmodulin-dependent protein kinase kinase 2	Tm (melting temperature)	8.3	°C
11698	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Calcium/calmodulin-dependent protein kinase kinase 2	inhibition percentage	93	%
11699	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Calcium/calmodulin-dependent protein kinase kinase 2	inhibition percentage	54	%
11700	OC(=O)C1=C(C=C(C=C1)C1=COC2=NC=C(C=C12)C1=CC=CC=C1)C1CCCC1	Calcium/calmodulin-dependent protein kinase kinase 2	inhibition percentage	29	%
11701	[H][C@@]12CC[C@@H](C)C(=CC3=CC(O)=C(O)C(C=O)=C3O)[C@@]1(C)CCCC2(C)C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human];+Phosphatidylinositol 3-kinase regulatory subunit alpha [human]	IC50	2.62	μM
11702	[H][C@@]12CC[C@@H](C)C(=CC3=CC(O)=C(O)C(C=O)=C3O)[C@@]1(C)CCCC2(C)C	Serine/threonine-protein kinase pim-2	IC50	6.99	μM
11703	[H][C@@]12CC[C@@H](C)C(=CC3=CC(O)=C(O)C(C=O)=C3O)[C@@]1(C)CCCC2(C)C	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	13.7	μM
11704	[H][C@@]12CC[C@@H](C)C(=CC3=CC(O)=C(O)C(C=O)=C3O)[C@@]1(C)CCCC2(C)C	G1/S-specific cyclin-D3; Cyclin-dependent kinase 4	IC50	32.9	μM
11705	[H][C@@]12CC[C@@H](C)C(=CC3=CC(O)=C(O)C(C=O)=C3O)[C@@]1(C)CCCC2(C)C	Cyclin-dependent kinase 6; G1/S-specific cyclin-D3	IC50	69.1	μM
11706	[H][C@@]12CC[C@H](C)C(=CC3=CC(O)=C(O)C(C=O)=C3O)[C@@]1(C)CCCC2(C)C	Serine/threonine-protein kinase pim-2	IC50	2.79	μM
11707	[H][C@@]12CC[C@H](C)C(=CC3=CC(O)=C(O)C(C=O)=C3O)[C@@]1(C)CCCC2(C)C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human];+Phosphatidylinositol 3-kinase regulatory subunit alpha [human]	IC50	3.26	μM
11708	[H][C@@]12CC[C@H](C)C(=CC3=CC(O)=C(O)C(C=O)=C3O)[C@@]1(C)CCCC2(C)C	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	4.24	μM
11709	[H][C@@]12CC[C@H](C)C(=CC3=CC(O)=C(O)C(C=O)=C3O)[C@@]1(C)CCCC2(C)C	G1/S-specific cyclin-D3; Cyclin-dependent kinase 4	IC50	22.4	μM
11710	[H][C@@]12CC[C@H](C)C(=CC3=CC(O)=C(O)C(C=O)=C3O)[C@@]1(C)CCCC2(C)C	Cyclin-dependent kinase 6; G1/S-specific cyclin-D3	IC50	25.6	μM
11711	[H][C@@]12CC[C@H](C)C3=C(C4=C(O3)C(C=O)=C3OCOC3=C4)[C@@]1(C)CCCC2(C)C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human];+Phosphatidylinositol 3-kinase regulatory subunit alpha [human]	IC50	4.43	μM
11712	[H][C@@]12CC[C@H](C)C3=C(C4=C(O3)C(C=O)=C3OCOC3=C4)[C@@]1(C)CCCC2(C)C	Serine/threonine-protein kinase pim-2	IC50	13.8	μM
11713	[H][C@@]12CC[C@H](C)C3=C(C4=C(O3)C(C=O)=C3OCOC3=C4)[C@@]1(C)CCCC2(C)C	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	IC50	191	μM
11714	O=C1CC(CC2=C1C(C1=CN(N=N1)C1=CC=C(C=C1)N(=O)=O)C1=C(CC(CC1=O)C1=CC=CC=C1)N2)C1=CC=CC=C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.247	μM
11715	O=C1CC(CC2=C1C(C1=CN(N=N1)C1=CC=C(C=C1)N(=O)=O)C1=C(CC(CC1=O)C1=CC=CC=C1)N2)C1=CC=CC=C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.373	μM
11716	O=C1CC(CC2=C1C(C1=CN(N=N1)C1=CC=C(C=C1)N(=O)=O)C1=C(CC(CC1=O)C1=CC=CC=C1)N2)C1=CC=CC=C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.834	μM
11717	O=C1CC(CC2=C1C(C1=CN(N=N1)C1=CC=C(C=C1)N(=O)=O)C1=C(CC(CC1=O)C1=CC=CC=C1)N2)C1=CC=CC=C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.887	μM
11718	O=C1CC(CC2=C1C(C1=CN(N=N1)C1=CC=C(C=C1)N(=O)=O)C1=C(CC(CC1=O)C1=CC=CC=C1)N2)C1=CC=CC=C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.912	μM
11719	O=C1CC(CC2=C1C(C1=CN(N=N1)C1=CC=C(C=C1)N(=O)=O)C1=C(CC(CC1=O)C1=CC=CC=C1)N2)C1=CC=CC=C1	Cyclin-dependent kinase 4	Ki (inhibition constant)	2.146	μM
11720	O=C1CC(CC2=C1C(C1=CN(N=N1)C1=CC=C(C=C1)N(=O)=O)C1=C(CC(CC1=O)C1=CC=CC=C1)N2)C1=CC=CC=C1	Cyclin-dependent kinase 7	Ki (inhibition constant)	2.152	μM
11721	O=C1CC(CC2=C1C(C1=CN(N=N1)C1=CC=C(C=C1)N(=O)=O)C1=C(CC(CC1=O)C1=CC=CC=C1)N2)C1=CC=CC=C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	3.015	μM
11722	O=C1CC(CC2=C1C(C1=CN(N=N1)C1=CC=C(C=C1)N(=O)=O)C1=C(CC(CC1=O)C1=CC=CC=C1)N2)C1=CC=CC=C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	3.067	μM
11723	O=C1CC(CC2=C1C(C1=CN(N=N1)C1=CC=C(C=C1)N(=O)=O)C1=C(CC(CC1=O)C1=CC=CC=C1)N2)C1=CC=CC=C1	Cyclin-dependent-like kinase 5	Ki (inhibition constant)	3.217	μM
11724	O=C1CC(CC2=C1C(C1=CN(N=N1)C1=CC=C(C=C1)N(=O)=O)C1=C(CC(CC1=O)C1=CC=CC=C1)N2)C1=CC=CC=C1	Cyclin-dependent kinase 2	Ki (inhibition constant)	3.762	μM
11725	O=C1CC(CC2=C1C(C1=CN(N=N1)C1=CC=C(C=C1)N(=O)=O)C1=C(CC(CC1=O)C1=CC=CC=C1)N2)C1=CC=CC=C1	Cyclin-dependent kinase 1	Ki (inhibition constant)	9.373	μM
11726	O=C1CC(CC2=C1C(C1=CN(N=N1)C1=CC=C(C=C1)N(=O)=O)C1=C(CC(CC1=O)C1=CC=CC=C1)N2)C1=CC=CC=C1	Cyclin-dependent kinase 6	Ki (inhibition constant)	10	μM
11727	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 6	Ki (inhibition constant)	0.026	μM
11728	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 4	Ki (inhibition constant)	0.029	μM
11729	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	0.153	μM
11730	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	0.159	μM
11731	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	0.163	μM
11732	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	0.168	μM
11733	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	0.178	μM
11734	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	0.193	μM
11735	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 2	Ki (inhibition constant)	3.294	μM
11736	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	3.594	μM
11737	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 7	Ki (inhibition constant)	8.542	μM
11738	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 1	Ki (inhibition constant)	10	μM
11739	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent-like kinase 5	Ki (inhibition constant)	10	μM
11740	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	apoptosis fold increase	2.5 - 3.5	no unit
11741	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	apoptosis fold increase	2.5 - 3.5	no unit
11742	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	apoptosis fold increase	2.5 - 3.5	no unit
11743	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	apoptosis fold increase	2.5 - 3.5	no unit
11744	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	apoptosis fold increase	2.5 - 3.5	no unit
11745	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	apoptosis fold increase	2.5 - 3.5	no unit
11746	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2		Cmax	163.7	ng/ml
11747	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2		Cmax	32.1	ng/ml
11748	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2		AUC (0-t)	487.2	ng*h/ml
11749	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2		AUC (0-t)	493.2	ng*h/ml
11750	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2		t1/2 (drug half life)	8.1	h
11751	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2		Vz	9875.3	ml/kg
11752	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2		CL (drug clearance)	921.4	ml/h/kg
11753	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2		F (drug bioavailability)	53.4	%
11754	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	body weight loss	20	%
11755	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CCCC2=O)NC2=C1C(=O)CCC2	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	T/C (treated/control)	20	%
11756	CC1(C)CC(=O)C2=C(C1)NC1=C(C2C2=CN(N=N2)C2=CC=C(Cl)C=C2)C(=O)CC(C)(C)C1	Cyclin-dependent kinase 6	Ki (inhibition constant)	0.067	μM
11757	CC1(C)CC(=O)C2=C(C1)NC1=C(C2C2=CN(N=N2)C2=CC=C(Cl)C=C2)C(=O)CC(C)(C)C1	Cyclin-dependent kinase 4	Ki (inhibition constant)	0.079	μM
11758	CC1(C)CC(=O)C2=C(C1)NC1=C(C2C2=CN(N=N2)C2=CC=C(Cl)C=C2)C(=O)CC(C)(C)C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	0.174	μM
11759	CC1(C)CC(=O)C2=C(C1)NC1=C(C2C2=CN(N=N2)C2=CC=C(Cl)C=C2)C(=O)CC(C)(C)C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	0.183	μM
11760	CC1(C)CC(=O)C2=C(C1)NC1=C(C2C2=CN(N=N2)C2=CC=C(Cl)C=C2)C(=O)CC(C)(C)C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	0.211	μM
11761	CC1(C)CC(=O)C2=C(C1)NC1=C(C2C2=CN(N=N2)C2=CC=C(Cl)C=C2)C(=O)CC(C)(C)C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	0.337	μM
11762	CC1(C)CC(=O)C2=C(C1)NC1=C(C2C2=CN(N=N2)C2=CC=C(Cl)C=C2)C(=O)CC(C)(C)C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	0.376	μM
11763	CC1(C)CC(=O)C2=C(C1)NC1=C(C2C2=CN(N=N2)C2=CC=C(Cl)C=C2)C(=O)CC(C)(C)C1	Cyclin-dependent kinase 7	Ki (inhibition constant)	0.982	μM
11764	CC1(C)CC(=O)C2=C(C1)NC1=C(C2C2=CN(N=N2)C2=CC=C(Cl)C=C2)C(=O)CC(C)(C)C1	Cyclin-dependent-like kinase 5	Ki (inhibition constant)	2.423	μM
11765	CC1(C)CC(=O)C2=C(C1)NC1=C(C2C2=CN(N=N2)C2=CC=C(Cl)C=C2)C(=O)CC(C)(C)C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	2.814	μM
11766	CC1(C)CC(=O)C2=C(C1)NC1=C(C2C2=CN(N=N2)C2=CC=C(Cl)C=C2)C(=O)CC(C)(C)C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	2.876	μM
11767	CC1(C)CC(=O)C2=C(C1)NC1=C(C2C2=CN(N=N2)C2=CC=C(Cl)C=C2)C(=O)CC(C)(C)C1	Cyclin-dependent kinase 2	Ki (inhibition constant)	3.254	μM
11768	CC1(C)CC(=O)C2=C(C1)NC1=C(C2C2=CN(N=N2)C2=CC=C(Cl)C=C2)C(=O)CC(C)(C)C1	Cyclin-dependent kinase 1	Ki (inhibition constant)	3.512	μM
11769	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 2	Ki (inhibition constant)	0.048	μM
11770	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.693	μM
11771	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.677	μM
11772	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.773	μM
11773	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.824	μM
11774	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	1.856	μM
11775	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 6	Ki (inhibition constant)	2.373	μM
11776	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent-like kinase 5	Ki (inhibition constant)	2.402	μM
11777	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	2.441	μM
11778	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	IC50	3.055	μM
11779	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 1	Ki (inhibition constant)	6.144	μM
11780	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 4	Ki (inhibition constant)	6.249	μM
11781	ClC1=CC=C(C=C1)N1C=C(N=N1)C1C2=C(CC(CC2=O)C2=CC=CC=C2)NC2=C1C(=O)CC(C2)C1=CC=CC=C1	Cyclin-dependent kinase 7	Ki (inhibition constant)	6.367	μM
11782	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Cyclin-dependent kinase 9	pIC50	8.52	no unit
11783	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Cyclin-dependent kinase 9	pIC50	8.52	no unit
11784	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Cyclin-dependent kinase 9 [human]	pEC50	7.77	no unit
11785	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Cyclin-dependent kinase 9 [human]	pIC50	7.61	no unit
11786	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Cyclin-dependent kinase 12	pIC50	7.4	no unit
11787	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	glycogen synthase kinase-3 beta [human]	pIC50	6.58	no unit
11788	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Cyclin-dependent kinase 1	pIC50	6.53	no unit
11789	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Cyclin-dependent kinase 2	pIC50	6.45	no unit
11790	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Cyclin-dependent kinase 7	pIC50	6.33	no unit
11791	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Cyclin-dependent kinase 12	pIC50	5.71	no unit
11792	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	activated Tyrosine-protein kinase Lck	inhibition rate	12	%
11793	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Cyclin-dependent kinase 6	inhibition rate	11	%
11794	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1		CLint (intrinsic clearance)	2.3	μl/min
11795	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1		CLint (intrinsic clearance)	3	μl/min/mg protein
11796	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1		Vd (volume of distribution)	5.9	l/kg
11797	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1		CL (drug clearance)	77	ml/min/kg
11798	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1		terminal t1/2	1.7	h
11799	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Macrophage-stimulating protein receptor	inhibition rate	15	%
11800	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Serine/threonine-protein kinase mTOR	inhibition rate	-30	%
11801	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Myosin light chain kinase, smooth muscle	inhibition rate	-3	%
11802	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Serine/threonine-protein kinase Nek2	inhibition rate	13	%
11803	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	High affinity nerve growth factor receptor	inhibition rate	24	%
11804	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	NUAK family SNF1-like kinase 1	inhibition rate	11	%
11805	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Serine/threonine-protein kinase PAK 1	inhibition rate	0	%
11806	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Serine/threonine-protein kinase PAK2	inhibition rate	7	%
11807	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Serine/threonine-protein kinase PAK 4	inhibition rate	7	%
11808	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Serine/threonine-protein kinase PAK5	inhibition rate	8	%
11809	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Platelet-derived growth factor receptor beta	inhibition rate	46	%
11810	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	3-phosphoinositide-dependent protein kinase 1	inhibition rate	14	%
11811	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	inhibition rate	27	%
11812	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform p85a	inhibition rate	4	%
11813	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform p85a	inhibition rate	3	%
11814	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform p85a	inhibition rate	4	%
11815	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform p120	inhibition rate	33	%
11816	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Serine/threonine-protein kinase pim-2	inhibition rate	20	%
11817	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	inhibition rate	1	%
11818	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	inhibition rate	11	%
11819	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	inhibition rate	13	%
11820	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Serine/threonine-protein kinase PLK1	inhibition rate	25	%
11821	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	MAP kinase-activated protein kinase 5	inhibition rate	2	%
11822	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	5'-AMP-activated protein kinase catalytic subunit alpha-2	inhibition rate	-5	%
11823	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	cAMP-dependent protein kinase catalytic subunit alpha	inhibition rate	15	%
11824	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Protein kinase C alpha type	inhibition rate	8	%
11825	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Protein kinase C, epsilon	inhibition rate	2	%
11826	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Protein kinase C, theta	inhibition rate	9	%
11827	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	cGMP-dependent protein kinase 1	inhibition rate	17	%
11828	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Focal adhesion kinase 1	inhibition rate	11	%
11829	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Protein-tyrosine kinase 6	inhibition rate	-8	%
11830	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	RAF proto-oncogene serine/threonine-protein kinase	inhibition rate	36	%
11831	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Proto-oncogene tyrosine-protein kinase receptor Ret	inhibition rate	5	%
11832	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804L)	inhibition rate	-22	%
11833	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M)	inhibition rate	3	%
11834	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Rho-associated protein kinase 1	inhibition rate	-3	%
11835	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Rho-associated protein kinase 2	inhibition rate	11	%
11836	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Proto-oncogene tyrosine-protein kinase ROS	inhibition rate	4	%
11837	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Ribosomal protein S6 kinase alpha-1	inhibition rate	25	%
11838	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Ribosomal protein S6 kinase alpha-5	inhibition rate	17	%
11839	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Ribosomal protein S6 kinase beta-1	inhibition rate	4	%
11840	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Serine/threonine-protein kinase Sgk1	inhibition rate	22	%
11841	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Proto-oncogene tyrosine-protein kinase Src	inhibition rate	19	%
11842	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Proto-oncogene tyrosine-protein kinase Src	inhibition rate	16	%
11843	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	SRSF protein kinase 1	inhibition rate	-12	%
11844	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Serine/threonine-protein kinase 10	inhibition rate	4	%
11845	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Serine/threonine-protein kinase STK11	inhibition rate	30	%
11846	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Serine/threonine-protein kinase 17A	inhibition rate	9	%
11847	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Serine/threonine-protein kinase 4	inhibition rate	5	%
11848	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Serine/threonine-protein kinase TBK1	inhibition rate	13	%
11849	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	TGF-beta receptor type-1	inhibition rate	19	%
11850	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Tyrosine-protein kinase receptor TYRO3	inhibition rate	3	%
11851	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Serine/threonine-protein kinase ULK2	inhibition rate	6	%
11852	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Tyrosine-protein kinase yes	inhibition rate	13	%
11853	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Tyrosine-protein kinase ABL1	inhibition rate	6	%
11854	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Tyrosine-protein kinase ABL2	inhibition rate	4	%
11855	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Activin receptor type-1B	inhibition rate	-16	%
11856	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	RAC-alpha serine/threonine-protein kinase	inhibition rate	10	%
11857	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Tyrosine-protein kinase ABL1	inhibition rate	28	%
11858	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	ALK tyrosine kinase receptor	inhibition rate	32	%
11859	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Aurora kinase B	inhibition rate	38	%
11860	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Aurora kinase C	inhibition rate	16	%
11861	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Tyrosine-protein kinase receptor UFO	inhibition rate	6	%
11862	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Tyrosine-protein kinase Blk	inhibition rate	23	%
11863	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Cytoplasmic tyrosine-protein kinase BMX	inhibition rate	19	%
11864	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Tyrosine-protein kinase BTK	inhibition rate	7	%
11865	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Calcium/calmodulin-dependent protein kinase type 1	inhibition rate	16	%
11866	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Calcium/calmodulin-dependent protein kinase type II subunit beta	inhibition rate	21	%
11867	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	G2/mitotic-specific cyclin-B1;+Cyclin-dependent kinase 1	inhibition rate	71	%
11868	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Cyclin-dependent kinase 2;+Cyclin-A2	inhibition rate	41	%
11869	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 6	inhibition rate	11	%
11870	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	inhibition rate	63	%
11871	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Cyclin-dependent kinase 9;+Cyclin-T1	inhibition rate	99	%
11872	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Serine/threonine-protein kinase Chk1	inhibition rate	3	%
11873	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Macrophage colony-stimulating factor 1 receptor	inhibition rate	-7	%
11874	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Casein kinase I isoform gamma-1	inhibition rate	12	%
11875	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Casein kinase II subunit alpha'	inhibition rate	7	%
11876	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Discoidin domain-containing receptor 2	inhibition rate	26	%
11877	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Myotonin-protein kinase	inhibition rate	9	%
11878	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Dual specificity tyrosine-phosphorylation-regulated kinase 2	inhibition rate	7	%
11879	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	elongation factor-2 kinase	inhibition rate	19	%
11880	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Epidermal growth factor receptor	inhibition rate	-11	%
11881	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Epidermal growth factor receptor (phosphorylated) [human]	inhibition rate	-6	%
11882	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Ephrin type-A receptor 5	inhibition rate	5	%
11883	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Ephrin type-B receptor 1	inhibition rate	-1	%
11884	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Ephrin type-B receptor 4	inhibition rate	5	%
11885	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Receptor tyrosine-protein kinase erbB-4	inhibition rate	-15	%
11886	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Tyrosine-protein kinase Fer	inhibition rate	-3	%
11887	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Tyrosine-protein kinase, Fes/Fps type	inhibition rate	-1	%
11888	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Fibroblast growth factor receptor 1	inhibition rate	32 - 36	%
11889	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Fibroblast growth factor receptor 2	inhibition rate	13	%
11890	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Fibroblast growth factor receptor 3	inhibition rate	-11	%
11891	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Fibroblast growth factor receptor 4	inhibition rate	3	%
11892	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Vascular endothelial growth factor receptor 1	inhibition rate	13	%
11893	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	18	%
11894	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Tyrosine-protein kinase Fyn	inhibition rate	36	%
11895	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Glycogen synthase kinase-3 alpha	inhibition rate	12	%
11896	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	tau-protein kinase	inhibition rate	32	%
11897	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Insulin-like growth factor 1 receptor	inhibition rate	11	%
11898	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	activated Insulin-like growth factor 1 receptor	inhibition rate	10	%
11899	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Inhibitor of nuclear factor kappa-B kinase subunit beta	inhibition rate	-31	%
11900	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Insulin receptor	inhibition rate	6	%
11901	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Activated insulin receptor	inhibition rate	9	%
11902	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Insulin receptor-related protein	inhibition rate	13	%
11903	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Interleukin-1 receptor-associated kinase 4	inhibition rate	-20	%
11904	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Tyrosine-protein kinase JAK2	inhibition rate	24	%
11905	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Tyrosine-protein kinase JAK3	inhibition rate	7	%
11906	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Vascular endothelial growth factor receptor 2	inhibition rate	8	%
11907	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Mast/stem cell growth factor receptor Kit	inhibition rate	7	%
11908	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Tyrosine-protein kinase Lck	inhibition rate	18	%
11909	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Tyrosine-protein kinase Lyn	inhibition rate	30	%
11910	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Dual specificity mitogen-activated protein kinase kinase 1	inhibition rate	11	%
11911	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Dual specificity mitogen-activated protein kinase kinase 7	inhibition rate	12	%
11912	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Mitogen-activated protein kinase kinase kinase 7	inhibition rate	10	%
11913	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Mitogen-activated protein kinase kinase kinase 9	inhibition rate	23	%
11914	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Mitogen-activated protein kinase 14	inhibition rate	-5	%
11915	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Mitogen-activated protein kinase 8	inhibition rate	13	%
11916	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	MAP kinase-activated protein kinase 2	inhibition rate	3	%
11917	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Serine/threonine-protein kinase MARK1	inhibition rate	20	%
11918	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Serine/threonine-protein kinase MARK2	inhibition rate	7	%
11919	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Hepatocyte growth factor receptor	inhibition rate	-28	%
11920	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Misshapen-like kinase 1	inhibition rate	4	%
11921	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	MAP kinase-interacting serine/threonine-protein kinase 2	inhibition rate	7	%
11922	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Cyclin-dependent kinase 1	pIC50		
11923	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Cyclin-dependent kinase 2	pIC50		
11924	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N(C)C)CC1	Cyclin-dependent kinase 7	pIC50		
11925	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Cyclin-dependent kinase 9	Kd (dissociation constant)	0.213	nM
11926	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Cyclin-dependent kinase 9	pIC50	8.52	no unit
11927	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Cyclin-dependent kinase 9	pIC50	8.07	no unit
11928	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Cyclin-dependent kinase 9 [human]	pEC50	7.68	no unit
11929	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Cyclin-dependent kinase 12	pIC50	7.26	no unit
11930	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Cyclin-dependent kinase 9 [human]	pIC50	7.25	no unit
11931	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Cyclin-dependent kinase 1	pIC50	6.84	no unit
11932	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Cyclin-dependent kinase 7	pIC50	6.4	no unit
11933	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Cyclin-dependent kinase 2	pIC50	6.14	no unit
11934	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	glycogen synthase kinase-3 beta [human]	pIC50	5.81	no unit
11935	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Cyclin-dependent kinase 12	pIC50	5.55	no unit
11936	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Cyclin-dependent kinase 1	pIC50	5.15	no unit
11937	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1		metabolite formation rate		
11938	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1		metabolite formation rate		
11939	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Cyclin-dependent kinase 2	pIC50	4.92	no unit
11940	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Cyclin-dependent kinase 7	pIC50	4.79	no unit
11941	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1		metabolite formation rate		
11942	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1		metabolite formation rate		
11943	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1		metabolite formation rate		
11944	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	activated Tyrosine-protein kinase Lck	inhibition rate	-1	%
11945	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Tyrosine-protein kinase ABL2	inhibition rate	6	%
11946	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	5'-AMP-activated protein kinase catalytic subunit alpha-2;+5'-AMP-activated protein kinase subunit beta-1;+5'-AMP-activated protein kinase subunit gamma-1	inhibition rate	2	%
11947	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase B-raf	inhibition rate	12	%
11948	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	G2/mitotic-specific cyclin-B;+Cyclin-dependent kinase 1	inhibition rate	74	%
11949	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Cyclin-dependent kinase 2;+Cyclin-A1	inhibition rate	72	%
11950	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Cyclin-dependent kinase 8;+Cyclin-C	inhibition rate	0	%
11951	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	DNA-dependent protein kinase catalytic subunit	inhibition rate	5	%
11952	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Epidermal growth factor receptor (T790M)	inhibition rate	-18	%
11953	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Receptor tyrosine-protein kinase erbB-2	inhibition rate	7	%
11954	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Fibroblast growth factor receptor 1 (V561M)	inhibition rate	3	%
11955	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Tyrosine-protein kinase JAK1	inhibition rate	-6	%
11956	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Tyrosine-protein kinase Lyn (isoform LYN A)	inhibition rate	3	%
11957	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Mitogen-activated protein kinase kinase kinase 7;+TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	inhibition rate	15	%
11958	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Mitogen-activated protein kinase 1	inhibition rate	4	%
11959	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	MAP kinase-activated protein kinase 5	inhibition rate	-2	%
11960	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Phosphatidylinositol 4-kinase beta	inhibition rate	45	%
11961	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha	inhibition rate	15	%
11962	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Phosphatidylinositol 3-kinase catalytic subunit type 3 [human]	inhibition rate	3	%
11963	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition rate	18	%
11964	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	inhibition rate	-3	%
11965	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	inhibition rate	-5	%
11966	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	RAF proto-oncogene serine/threonine-protein kinase	inhibition rate	4	%
11967	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Tyrosine-protein kinase SYK	inhibition rate	0	%
11968	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Traf2 and NCK-interacting protein kinase	inhibition rate	2	%
11969	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Cyclin-dependent kinase 6	inhibition rate	14	%
11970	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1		CLint (intrinsic clearance)	26	μl/min
11971	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1		CLint (intrinsic clearance)	8	μl/min
11972	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1		CLint (intrinsic clearance)	300	μl/min/mg protein
11973	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1		Vd (volume of distribution)	8.1	l/kg
11974	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1		CL (drug clearance)	159	ml/min/kg
11975	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1		terminal t1/2	2.4	h
11976	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1		Vd (volume of distribution)	1.5	l/kg
11977	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1		CL (drug clearance)	59	ml/min/kg
11978	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1		terminal t1/2	1	h
11979	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Cyclin-dependent kinase 9	Ka (association constant)	9.42	μM-1*s-1
11980	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Cyclin-dependent kinase 9	koff	0.00201	s-1
11981	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Macrophage-stimulating protein receptor	inhibition rate	-7	%
11982	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase mTOR	inhibition rate	0	%
11983	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Myosin light chain kinase, smooth muscle	inhibition rate	8	%
11984	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase Nek2	inhibition rate	-10	%
11985	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	High affinity nerve growth factor receptor	inhibition rate	31	%
11986	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	NUAK family SNF1-like kinase 1	inhibition rate	15	%
11987	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase PAK 1	inhibition rate	10	%
11988	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase PAK2	inhibition rate	-1	%
11989	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase PAK 4	inhibition rate	4	%
11990	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase PAK5	inhibition rate	11	%
11991	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Platelet-derived growth factor receptor beta	inhibition rate	-6	%
11992	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	3-phosphoinositide-dependent protein kinase 1	inhibition rate	-12	%
11993	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	inhibition rate	18	%
11994	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform p85a	inhibition rate	9	%
11995	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform p85a	inhibition rate	0	%
11996	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform p85a	inhibition rate	2	%
11997	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform p120	inhibition rate	-2	%
11998	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase pim-2	inhibition rate	5	%
11999	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	inhibition rate	-9	%
12000	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	inhibition rate	-4	%
12001	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	inhibition rate	7	%
12002	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase PLK1	inhibition rate	8	%
12003	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	MAP kinase-activated protein kinase 5	inhibition rate	-16	%
12004	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	5'-AMP-activated protein kinase catalytic subunit alpha-2	inhibition rate	7	%
12005	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	cAMP-dependent protein kinase catalytic subunit alpha	inhibition rate	-9	%
12006	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Protein kinase C alpha type	inhibition rate	2	%
12007	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Protein kinase C, epsilon	inhibition rate	-3	%
12008	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Protein kinase C, theta	inhibition rate	5	%
12009	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	cGMP-dependent protein kinase 1	inhibition rate	4	%
12010	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Focal adhesion kinase 1	inhibition rate	9	%
12011	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Protein-tyrosine kinase 6	inhibition rate	-19	%
12012	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	RAF proto-oncogene serine/threonine-protein kinase	inhibition rate	-6	%
12013	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Proto-oncogene tyrosine-protein kinase receptor Ret	inhibition rate	-10	%
12014	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804L)	inhibition rate	-15	%
12015	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M)	inhibition rate	-15	%
12016	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Rho-associated protein kinase 1	inhibition rate	8	%
12017	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Rho-associated protein kinase 2	inhibition rate	4	%
12018	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Proto-oncogene tyrosine-protein kinase ROS	inhibition rate	1	%
12019	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Ribosomal protein S6 kinase alpha-1	inhibition rate	-1	%
12020	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Ribosomal protein S6 kinase alpha-5	inhibition rate	12	%
12021	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Ribosomal protein S6 kinase beta-1	inhibition rate	3	%
12022	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase Sgk1	inhibition rate	19	%
12023	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Proto-oncogene tyrosine-protein kinase Src	inhibition rate	5	%
12024	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Proto-oncogene tyrosine-protein kinase Src	inhibition rate	25	%
12025	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	SRSF protein kinase 1	inhibition rate	-5	%
12026	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase 10	inhibition rate	6	%
12027	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase STK11	inhibition rate	11	%
12028	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase 17A	inhibition rate	15	%
12029	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase 4	inhibition rate	3	%
12030	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase TBK1	inhibition rate	3	%
12031	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	TGF-beta receptor type-1	inhibition rate	2	%
12032	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Tyrosine-protein kinase receptor TYRO3	inhibition rate	-8	%
12033	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase ULK2	inhibition rate	4	%
12034	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Tyrosine-protein kinase yes	inhibition rate	20	%
12035	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Activin receptor type-1B	inhibition rate	-3	%
12036	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	RAC-alpha serine/threonine-protein kinase	inhibition rate	5	%
12037	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Tyrosine-protein kinase ABL1	inhibition rate	4	%
12038	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	ALK tyrosine kinase receptor	inhibition rate	7	%
12039	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Aurora kinase B	inhibition rate	-3	%
12040	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Aurora kinase C	inhibition rate	7	%
12041	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Tyrosine-protein kinase receptor UFO	inhibition rate	8	%
12042	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Tyrosine-protein kinase Blk	inhibition rate	-5	%
12043	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Cytoplasmic tyrosine-protein kinase BMX	inhibition rate	3	%
12044	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Tyrosine-protein kinase BTK	inhibition rate	3	%
12045	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Calcium/calmodulin-dependent protein kinase type 1	inhibition rate	27	%
12046	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Calcium/calmodulin-dependent protein kinase type II subunit beta	inhibition rate	3	%
12047	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	inhibition rate	57	%
12048	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Cyclin-dependent kinase 9;+Cyclin-T1	inhibition rate	99	%
12049	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase Chk1	inhibition rate	-7	%
12050	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Macrophage colony-stimulating factor 1 receptor	inhibition rate	12	%
12051	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Casein kinase I isoform gamma-1	inhibition rate	4	%
12052	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Casein kinase II subunit alpha'	inhibition rate	3	%
12053	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Discoidin domain-containing receptor 2	inhibition rate	-3	%
12054	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Myotonin-protein kinase	inhibition rate	2	%
12055	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Dual specificity tyrosine-phosphorylation-regulated kinase 2	inhibition rate	9	%
12056	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	elongation factor-2 kinase	inhibition rate	6	%
12057	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Epidermal growth factor receptor	inhibition rate	-3	%
12058	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Ephrin type-A receptor 5	inhibition rate	1	%
12059	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Ephrin type-B receptor 1	inhibition rate	1	%
12060	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Ephrin type-B receptor 4	inhibition rate	3	%
12061	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Receptor tyrosine-protein kinase erbB-4	inhibition rate	-2	%
12062	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Tyrosine-protein kinase Fer	inhibition rate	4	%
12063	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Tyrosine-protein kinase, Fes/Fps type	inhibition rate	7	%
12064	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Fibroblast growth factor receptor 1	inhibition rate	7	%
12065	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Fibroblast growth factor receptor 2	inhibition rate	2	%
12066	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Fibroblast growth factor receptor 3	inhibition rate	-1	%
12067	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Fibroblast growth factor receptor 4	inhibition rate	6	%
12068	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Vascular endothelial growth factor receptor 1	inhibition rate	-2	%
12069	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	11	%
12070	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Tyrosine-protein kinase Fyn	inhibition rate	6	%
12071	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Glycogen synthase kinase-3 alpha	inhibition rate	14	%
12072	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	tau-protein kinase	inhibition rate	20	%
12073	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Insulin-like growth factor 1 receptor	inhibition rate	9	%
12074	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Inhibitor of nuclear factor kappa-B kinase subunit beta	inhibition rate	7	%
12075	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Insulin receptor	inhibition rate	-4	%
12076	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Insulin receptor-related protein	inhibition rate	5	%
12077	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Interleukin-1 receptor-associated kinase 4	inhibition rate	-1	%
12078	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Tyrosine-protein kinase JAK2	inhibition rate	1	%
12079	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Tyrosine-protein kinase JAK3	inhibition rate	-6	%
12080	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Vascular endothelial growth factor receptor 2	inhibition rate	0	%
12081	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Mast/stem cell growth factor receptor Kit	inhibition rate	1	%
12082	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Tyrosine-protein kinase Lck	inhibition rate	7	%
12083	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Tyrosine-protein kinase ABL1	inhibition rate	3	%
12084	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Dual specificity mitogen-activated protein kinase kinase 1	inhibition rate	14	%
12085	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Mitogen-activated protein kinase kinase kinase 9	inhibition rate	-7	%
12086	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Mitogen-activated protein kinase 14	inhibition rate	-5	%
12087	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Mitogen-activated protein kinase 8	inhibition rate	7	%
12088	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	MAP kinase-activated protein kinase 2	inhibition rate	-5	%
12089	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase MARK1	inhibition rate	11	%
12090	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase MARK2	inhibition rate	7	%
12091	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Hepatocyte growth factor receptor	inhibition rate	-17	%
12092	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Misshapen-like kinase 1	inhibition rate	34	%
12093	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	MAP kinase-interacting serine/threonine-protein kinase 2	inhibition rate	6	%
12094	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Macrophage-stimulating protein receptor	inhibition rate	-2	%
12095	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase mTOR	inhibition rate	-18	%
12096	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Myosin light chain kinase, smooth muscle	inhibition rate	-1	%
12097	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase Nek2	inhibition rate	21	%
12098	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	High affinity nerve growth factor receptor	inhibition rate	14	%
12099	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	NUAK family SNF1-like kinase 1	inhibition rate	19	%
12100	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase PAK 1	inhibition rate	-3	%
12101	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase PAK2	inhibition rate	9	%
12102	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase PAK 4	inhibition rate	3	%
12103	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase PAK5	inhibition rate	-2	%
12104	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Platelet-derived growth factor receptor beta	inhibition rate	4	%
12105	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	3-phosphoinositide-dependent protein kinase 1	inhibition rate	12	%
12106	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase pim-2	inhibition rate	8	%
12107	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase PLK1	inhibition rate	-10	%
12108	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	cAMP-dependent protein kinase catalytic subunit alpha	inhibition rate	7	%
12109	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Protein kinase C alpha type	inhibition rate	15	%
12110	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Protein kinase C, epsilon	inhibition rate	8	%
12111	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Protein kinase C, theta	inhibition rate	-11	%
12112	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	cGMP-dependent protein kinase 1	inhibition rate	5	%
12113	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Focal adhesion kinase 1	inhibition rate	11	%
12114	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Protein-tyrosine kinase 6	inhibition rate	1	%
12115	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Proto-oncogene tyrosine-protein kinase receptor Ret	inhibition rate	11	%
12116	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804L)	inhibition rate	4	%
12117	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M)	inhibition rate	5	%
12118	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Rho-associated protein kinase 1	inhibition rate	-12	%
12119	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Rho-associated protein kinase 2	inhibition rate	-2	%
12120	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Proto-oncogene tyrosine-protein kinase ROS	inhibition rate	8	%
12121	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Ribosomal protein S6 kinase alpha-1	inhibition rate	7	%
12122	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Ribosomal protein S6 kinase alpha-5	inhibition rate	-2	%
12123	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Ribosomal protein S6 kinase beta-1	inhibition rate	5	%
12124	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase Sgk1	inhibition rate	6	%
12125	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Proto-oncogene tyrosine-protein kinase Src	inhibition rate	9	%
12126	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	SRSF protein kinase 1	inhibition rate	1	%
12127	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase 17A	inhibition rate	16	%
12128	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase 4	inhibition rate	6	%
12129	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase TBK1	inhibition rate	6	%
12130	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	TGF-beta receptor type-1	inhibition rate	8	%
12131	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Tyrosine-protein kinase receptor TYRO3	inhibition rate	4	%
12132	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase ULK2	inhibition rate	8	%
12133	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Tyrosine-protein kinase yes	inhibition rate	1	%
12134	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Tyrosine-protein kinase ABL1	inhibition rate	9	%
12135	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Tyrosine-protein kinase ABL2	inhibition rate	13	%
12136	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Activin receptor type-1B	inhibition rate	-13	%
12137	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	RAC-alpha serine/threonine-protein kinase	inhibition rate	7	%
12138	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Tyrosine-protein kinase ABL1	inhibition rate	21	%
12139	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	ALK tyrosine kinase receptor	inhibition rate	-5	%
12140	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Aurora kinase B	inhibition rate	8	%
12141	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Aurora kinase C	inhibition rate	21	%
12142	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Tyrosine-protein kinase receptor UFO	inhibition rate	2	%
12143	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Tyrosine-protein kinase Blk	inhibition rate	-12	%
12144	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Cytoplasmic tyrosine-protein kinase BMX	inhibition rate	10	%
12145	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Tyrosine-protein kinase BTK	inhibition rate	-1	%
12146	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Calcium/calmodulin-dependent protein kinase type 1	inhibition rate	11	%
12147	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Calcium/calmodulin-dependent protein kinase type II subunit beta	inhibition rate	18	%
12148	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	G2/mitotic-specific cyclin-B1;+Cyclin-dependent kinase 1	inhibition rate	64	%
12149	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Cyclin-dependent kinase 2;+Cyclin-A2	inhibition rate	28	%
12150	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 6	inhibition rate	14	%
12151	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	inhibition rate	55	%
12152	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Cyclin-dependent kinase 9;+Cyclin-T1	inhibition rate	99	%
12153	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase Chk1	inhibition rate	2	%
12154	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Macrophage colony-stimulating factor 1 receptor	inhibition rate	22	%
12155	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Casein kinase I isoform gamma-1	inhibition rate	13	%
12156	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Casein kinase II subunit alpha'	inhibition rate	-3	%
12157	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Discoidin domain-containing receptor 2	inhibition rate	-9	%
12158	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Myotonin-protein kinase	inhibition rate	0	%
12159	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Dual specificity tyrosine-phosphorylation-regulated kinase 2	inhibition rate	14	%
12160	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	elongation factor-2 kinase	inhibition rate	20	%
12161	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Epidermal growth factor receptor	inhibition rate	4	%
12162	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Epidermal growth factor receptor (phosphorylated) [human]	inhibition rate	-1	%
12163	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Ephrin type-A receptor 5	inhibition rate	2	%
12164	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Ephrin type-B receptor 1	inhibition rate	-27	%
12165	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Ephrin type-B receptor 4	inhibition rate	1	%
12166	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Receptor tyrosine-protein kinase erbB-4	inhibition rate	-9	%
12167	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Tyrosine-protein kinase Fer	inhibition rate	4	%
12168	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Tyrosine-protein kinase, Fes/Fps type	inhibition rate	-9	%
12169	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Fibroblast growth factor receptor 1	inhibition rate	-1 - 9	%
12170	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Fibroblast growth factor receptor 2	inhibition rate	-1	%
12171	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Fibroblast growth factor receptor 3	inhibition rate	3	%
12172	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Fibroblast growth factor receptor 4	inhibition rate	-2	%
12173	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Vascular endothelial growth factor receptor 1	inhibition rate	4	%
12174	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	0	%
12175	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Tyrosine-protein kinase Fyn	inhibition rate	14	%
12176	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Glycogen synthase kinase-3 alpha	inhibition rate	-12	%
12177	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	tau-protein kinase	inhibition rate	25	%
12178	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Insulin-like growth factor 1 receptor	inhibition rate	21	%
12179	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	activated Insulin-like growth factor 1 receptor	inhibition rate	-32	%
12180	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Inhibitor of nuclear factor kappa-B kinase subunit beta	inhibition rate	1	%
12181	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Insulin receptor	inhibition rate	20	%
12182	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Activated insulin receptor	inhibition rate	16	%
12183	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Insulin receptor-related protein	inhibition rate	-11	%
12184	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Interleukin-1 receptor-associated kinase 4	inhibition rate	7	%
12185	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Tyrosine-protein kinase JAK2	inhibition rate	-33	%
12186	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Tyrosine-protein kinase JAK3	inhibition rate	8	%
12187	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Vascular endothelial growth factor receptor 2	inhibition rate	12	%
12188	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Mast/stem cell growth factor receptor Kit	inhibition rate	2	%
12189	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Tyrosine-protein kinase Lck	inhibition rate	9	%
12190	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Tyrosine-protein kinase Lyn	inhibition rate	11	%
12191	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Dual specificity mitogen-activated protein kinase kinase 1	inhibition rate	16	%
12192	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Dual specificity mitogen-activated protein kinase kinase 7	inhibition rate	16	%
12193	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Mitogen-activated protein kinase kinase kinase 7	inhibition rate	9	%
12194	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Mitogen-activated protein kinase kinase kinase 9	inhibition rate	-7	%
12195	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Mitogen-activated protein kinase 14	inhibition rate	13	%
12196	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Mitogen-activated protein kinase 8	inhibition rate	1	%
12197	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	MAP kinase-activated protein kinase 2	inhibition rate	4	%
12198	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase MARK1	inhibition rate	14	%
12199	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Serine/threonine-protein kinase MARK2	inhibition rate	2	%
12200	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Hepatocyte growth factor receptor	inhibition rate	6	%
12201	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	Misshapen-like kinase 1	inhibition rate	18	%
12202	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCCC2)CC1	MAP kinase-interacting serine/threonine-protein kinase 2	inhibition rate	-1	%
12203	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Cyclin-dependent kinase 9	pIC50	8.52	no unit
12204	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Cyclin-dependent kinase 9	pIC50	8.22	no unit
12205	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Cyclin-dependent kinase 9 [human]	pEC50	7.68	no unit
12206	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Cyclin-dependent kinase 12	pIC50	7.29	no unit
12207	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Cyclin-dependent kinase 9 [human]	pIC50	7.13	no unit
12208	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Cyclin-dependent kinase 1	pIC50	6.56	no unit
12209	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Cyclin-dependent kinase 7	pIC50	6.33	no unit
12210	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Cyclin-dependent kinase 2	pIC50	6.12	no unit
12211	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	glycogen synthase kinase-3 beta [human]	pIC50	5.82	no unit
12212	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Cyclin-dependent kinase 12	pIC50	5.68	no unit
12213	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Cyclin-dependent kinase 2	pIC50	4.92	no unit
12214	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Cyclin-dependent kinase 7	pIC50	4.74	no unit
12215	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Cyclin-dependent kinase 1	pIC50	4.73	no unit
12216	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1		metabolite formation rate		
12217	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1		metabolite formation rate		
12218	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	activated Tyrosine-protein kinase Lck	inhibition rate	6	%
12219	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Cyclin-dependent kinase 6	inhibition rate	9	%
12220	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1		CLint (intrinsic clearance)	5.4	μl/min
12221	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1		CLint (intrinsic clearance)	3.5	μl/min
12222	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1		CLint (intrinsic clearance)	45	μl/min/mg protein
12223	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1		Vd (volume of distribution)	3.9	l/kg
12224	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1		CL (drug clearance)	91	ml/min/kg
12225	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1		terminal t1/2	1.1	h
12226	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1		Vd (volume of distribution)	1.2	l/kg
12227	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1		CL (drug clearance)	40	ml/min/kg
12228	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1		terminal t1/2	0.7	h
12229	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Macrophage-stimulating protein receptor	inhibition rate	11	%
12230	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Serine/threonine-protein kinase mTOR	inhibition rate	4	%
12231	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Myosin light chain kinase, smooth muscle	inhibition rate	7	%
12232	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Serine/threonine-protein kinase Nek2	inhibition rate	13	%
12233	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	High affinity nerve growth factor receptor	inhibition rate	1	%
12234	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	NUAK family SNF1-like kinase 1	inhibition rate	28	%
12235	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Serine/threonine-protein kinase PAK 1	inhibition rate	-3	%
12236	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Serine/threonine-protein kinase PAK2	inhibition rate	10	%
12237	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Serine/threonine-protein kinase PAK 4	inhibition rate	7	%
12238	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Serine/threonine-protein kinase PAK5	inhibition rate	17	%
12239	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Platelet-derived growth factor receptor beta	inhibition rate	14	%
12240	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	3-phosphoinositide-dependent protein kinase 1	inhibition rate	-4	%
12241	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	inhibition rate	4	%
12242	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform p85a	inhibition rate	15	%
12243	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform p85a	inhibition rate	3	%
12244	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform p85a	inhibition rate	2	%
12245	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform p120	inhibition rate	-1	%
12246	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Serine/threonine-protein kinase pim-2	inhibition rate	-6	%
12247	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	inhibition rate	7	%
12248	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	inhibition rate	7	%
12249	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	inhibition rate	-1	%
12250	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Serine/threonine-protein kinase PLK1	inhibition rate	6	%
12251	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	MAP kinase-activated protein kinase 5	inhibition rate	6	%
12252	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	5'-AMP-activated protein kinase catalytic subunit alpha-2	inhibition rate	8	%
12253	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	cAMP-dependent protein kinase catalytic subunit alpha	inhibition rate	-11	%
12254	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Protein kinase C alpha type	inhibition rate	-4	%
12255	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Protein kinase C, epsilon	inhibition rate	2	%
12256	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Protein kinase C, theta	inhibition rate	-6	%
12257	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	cGMP-dependent protein kinase 1	inhibition rate	3	%
12258	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Focal adhesion kinase 1	inhibition rate	-8	%
12259	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Protein-tyrosine kinase 6	inhibition rate	3	%
12260	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	RAF proto-oncogene serine/threonine-protein kinase	inhibition rate	21	%
12261	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Proto-oncogene tyrosine-protein kinase receptor Ret	inhibition rate	-22	%
12262	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804L)	inhibition rate	-4	%
12263	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M)	inhibition rate	-3	%
12264	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Rho-associated protein kinase 1	inhibition rate	2	%
12265	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Rho-associated protein kinase 2	inhibition rate	15	%
12266	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Proto-oncogene tyrosine-protein kinase ROS	inhibition rate	-3	%
12267	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Ribosomal protein S6 kinase alpha-1	inhibition rate	8	%
12268	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Ribosomal protein S6 kinase alpha-5	inhibition rate	14	%
12269	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Ribosomal protein S6 kinase beta-1	inhibition rate	-5	%
12270	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Serine/threonine-protein kinase Sgk1	inhibition rate	18	%
12271	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Proto-oncogene tyrosine-protein kinase Src	inhibition rate	14	%
12272	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Proto-oncogene tyrosine-protein kinase Src	inhibition rate	11	%
12273	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	SRSF protein kinase 1	inhibition rate	1	%
12274	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Serine/threonine-protein kinase 10	inhibition rate	15	%
12275	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Serine/threonine-protein kinase STK11	inhibition rate	16	%
12276	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Serine/threonine-protein kinase 17A	inhibition rate	12	%
12277	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Serine/threonine-protein kinase 4	inhibition rate	16	%
12278	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Serine/threonine-protein kinase TBK1	inhibition rate	2	%
12279	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	TGF-beta receptor type-1	inhibition rate	7	%
12280	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Tyrosine-protein kinase receptor TYRO3	inhibition rate	1	%
12281	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Serine/threonine-protein kinase ULK2	inhibition rate	-1	%
12282	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Tyrosine-protein kinase yes	inhibition rate	28	%
12283	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Tyrosine-protein kinase ABL1	inhibition rate	24	%
12284	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Tyrosine-protein kinase ABL2	inhibition rate	29	%
12285	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Activin receptor type-1B	inhibition rate	-11	%
12286	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	RAC-alpha serine/threonine-protein kinase	inhibition rate	3	%
12287	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Tyrosine-protein kinase ABL1	inhibition rate	16	%
12288	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	ALK tyrosine kinase receptor	inhibition rate	13	%
12289	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Aurora kinase B	inhibition rate	11	%
12290	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Aurora kinase C	inhibition rate	6	%
12291	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Tyrosine-protein kinase receptor UFO	inhibition rate	3	%
12292	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Tyrosine-protein kinase Blk	inhibition rate	-5	%
12293	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Cytoplasmic tyrosine-protein kinase BMX	inhibition rate	28	%
12294	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Tyrosine-protein kinase BTK	inhibition rate	10	%
12295	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Calcium/calmodulin-dependent protein kinase type 1	inhibition rate	6	%
12296	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Calcium/calmodulin-dependent protein kinase type II subunit beta	inhibition rate	4	%
12297	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	G2/mitotic-specific cyclin-B1;+Cyclin-dependent kinase 1	inhibition rate	47	%
12298	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Cyclin-dependent kinase 2;+Cyclin-A2	inhibition rate	30	%
12299	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 6	inhibition rate	9	%
12300	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	inhibition rate	50	%
12301	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Cyclin-dependent kinase 9;+Cyclin-T1	inhibition rate	99	%
12302	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Serine/threonine-protein kinase Chk1	inhibition rate	-15	%
12303	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Macrophage colony-stimulating factor 1 receptor	inhibition rate	-47	%
12304	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Casein kinase I isoform gamma-1	inhibition rate	3	%
12305	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Casein kinase II subunit alpha'	inhibition rate	-4	%
12306	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Discoidin domain-containing receptor 2	inhibition rate	-14	%
12307	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Myotonin-protein kinase	inhibition rate	13	%
12308	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Dual specificity tyrosine-phosphorylation-regulated kinase 2	inhibition rate	8	%
12309	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	elongation factor-2 kinase	inhibition rate	23	%
12310	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Epidermal growth factor receptor	inhibition rate	-11	%
12311	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Epidermal growth factor receptor (phosphorylated) [human]	inhibition rate	21	%
12312	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Ephrin type-A receptor 5	inhibition rate	-4	%
12313	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Ephrin type-B receptor 1	inhibition rate	2	%
12314	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Ephrin type-B receptor 4	inhibition rate	21	%
12315	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Receptor tyrosine-protein kinase erbB-4	inhibition rate	-2	%
12316	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Tyrosine-protein kinase Fer	inhibition rate	-11	%
12317	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Tyrosine-protein kinase, Fes/Fps type	inhibition rate	-7	%
12318	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Fibroblast growth factor receptor 1	inhibition rate	6 - 27	%
12319	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Fibroblast growth factor receptor 2	inhibition rate	5	%
12320	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Fibroblast growth factor receptor 3	inhibition rate	8	%
12321	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Fibroblast growth factor receptor 4	inhibition rate	-6	%
12322	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Vascular endothelial growth factor receptor 1	inhibition rate	7	%
12323	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	5	%
12324	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Tyrosine-protein kinase Fyn	inhibition rate	7	%
12325	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Glycogen synthase kinase-3 alpha	inhibition rate	10	%
12326	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	tau-protein kinase	inhibition rate	13	%
12327	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Insulin-like growth factor 1 receptor	inhibition rate	19	%
12328	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	activated Insulin-like growth factor 1 receptor	inhibition rate	-7	%
12329	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Inhibitor of nuclear factor kappa-B kinase subunit beta	inhibition rate	1	%
12330	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Insulin receptor	inhibition rate	5	%
12331	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Activated insulin receptor	inhibition rate	1	%
12332	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Insulin receptor-related protein	inhibition rate	7	%
12333	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Interleukin-1 receptor-associated kinase 4	inhibition rate	-30	%
12334	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Tyrosine-protein kinase JAK2	inhibition rate	-7	%
12335	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Tyrosine-protein kinase JAK3	inhibition rate	3	%
12336	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Vascular endothelial growth factor receptor 2	inhibition rate	6	%
12337	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Mast/stem cell growth factor receptor Kit	inhibition rate	1	%
12338	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Tyrosine-protein kinase Lck	inhibition rate	12	%
12339	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Tyrosine-protein kinase Lyn	inhibition rate	5	%
12340	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Dual specificity mitogen-activated protein kinase kinase 1	inhibition rate	6	%
12341	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Dual specificity mitogen-activated protein kinase kinase 7	inhibition rate	-4	%
12342	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Mitogen-activated protein kinase kinase kinase 7	inhibition rate	9	%
12343	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Mitogen-activated protein kinase kinase kinase 9	inhibition rate	8	%
12344	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Mitogen-activated protein kinase 14	inhibition rate	5	%
12345	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Mitogen-activated protein kinase 8	inhibition rate	9	%
12346	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	MAP kinase-activated protein kinase 2	inhibition rate	2	%
12347	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Serine/threonine-protein kinase MARK1	inhibition rate	-4	%
12348	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Serine/threonine-protein kinase MARK2	inhibition rate	10	%
12349	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Hepatocyte growth factor receptor	inhibition rate	9	%
12350	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	Misshapen-like kinase 1	inhibition rate	0	%
12351	CC(C)N1C=C(C=CC1=O)C1=C2C=C(NC2=NC=C1)C1CCN(CC(=O)N2CCCC2)CC1	MAP kinase-interacting serine/threonine-protein kinase 2	inhibition rate	7	%
12352	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Cyclin-dependent kinase 9	pIC50	8.52	no unit
12353	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Cyclin-dependent kinase 9	pIC50	8.38	no unit
12354	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Cyclin-dependent kinase 12	pIC50	6.93	no unit
12355	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Cyclin-dependent kinase 9 [human]	pIC50	6.7	no unit
12356	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Cyclin-dependent kinase 1	pIC50	6.69	no unit
12357	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Cyclin-dependent kinase 7	pIC50	6.52	no unit
12358	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	glycogen synthase kinase-3 beta [human]	pIC50	6.51	no unit
12359	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Cyclin-dependent kinase 9 [human]	pEC50	6.46	no unit
12360	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Cyclin-dependent kinase 12	pIC50	5.23	no unit
12361	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Cyclin-dependent kinase 1	pIC50	5.16	no unit
12362	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Cyclin-dependent kinase 2	pIC50	4.95	no unit
12363	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Cyclin-dependent kinase 7	pIC50	4.84	no unit
12364	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Cyclin-dependent kinase 2	pIC50	4.52	no unit
12365	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	activated Tyrosine-protein kinase Lck	inhibition rate	-4	%
12366	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Cyclin-dependent kinase 6	inhibition rate	44	%
12367	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1		efflux ratio	70	no unit
12368	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1		CLint (intrinsic clearance)	1	μl/min
12369	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1		CLint (intrinsic clearance)	1	μl/min
12370	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1		CLint (intrinsic clearance)	3	μl/min/mg protein
12371	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1		Vd (volume of distribution)	5.8	l/kg
12372	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1		CL (drug clearance)	17	ml/min/kg
12373	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1		terminal t1/2	11	h
12374	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Macrophage-stimulating protein receptor	inhibition rate	10	%
12375	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Serine/threonine-protein kinase mTOR	inhibition rate	-7	%
12376	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Myosin light chain kinase, smooth muscle	inhibition rate	27	%
12377	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Serine/threonine-protein kinase Nek2	inhibition rate	10	%
12378	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	High affinity nerve growth factor receptor	inhibition rate	26	%
12379	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	NUAK family SNF1-like kinase 1	inhibition rate	15	%
12380	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Serine/threonine-protein kinase PAK 1	inhibition rate	20	%
12381	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Serine/threonine-protein kinase PAK2	inhibition rate	9	%
12382	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Serine/threonine-protein kinase PAK 4	inhibition rate	2	%
12383	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Serine/threonine-protein kinase PAK5	inhibition rate	25	%
12384	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Platelet-derived growth factor receptor beta	inhibition rate	2	%
12385	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	3-phosphoinositide-dependent protein kinase 1	inhibition rate	16	%
12386	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	inhibition rate	-3	%
12387	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform p85a	inhibition rate	5	%
12388	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform p85a	inhibition rate	4	%
12389	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform p85a	inhibition rate	11	%
12390	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform p120	inhibition rate	4	%
12391	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Serine/threonine-protein kinase pim-2	inhibition rate	34	%
12392	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	inhibition rate	2	%
12393	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	inhibition rate	2	%
12394	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	inhibition rate	6	%
12395	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Serine/threonine-protein kinase PLK1	inhibition rate	6	%
12396	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	MAP kinase-activated protein kinase 5	inhibition rate	-1	%
12397	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	5'-AMP-activated protein kinase catalytic subunit alpha-2	inhibition rate	-40	%
12398	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	cAMP-dependent protein kinase catalytic subunit alpha	inhibition rate	-44	%
12399	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Protein kinase C alpha type	inhibition rate	4	%
12400	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Protein kinase C, epsilon	inhibition rate	-9	%
12401	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Protein kinase C, theta	inhibition rate	31	%
12402	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	cGMP-dependent protein kinase 1	inhibition rate	-9	%
12403	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Focal adhesion kinase 1	inhibition rate	-1	%
12404	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Protein-tyrosine kinase 6	inhibition rate	-28	%
12405	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	RAF proto-oncogene serine/threonine-protein kinase	inhibition rate	-11	%
12406	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Proto-oncogene tyrosine-protein kinase receptor Ret	inhibition rate	2	%
12407	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804L)	inhibition rate	1	%
12408	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M)	inhibition rate	0	%
12409	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Rho-associated protein kinase 1	inhibition rate	-23	%
12410	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Rho-associated protein kinase 2	inhibition rate	-2	%
12411	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Proto-oncogene tyrosine-protein kinase ROS	inhibition rate	-12	%
12412	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Ribosomal protein S6 kinase alpha-1	inhibition rate	-13	%
12413	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Ribosomal protein S6 kinase alpha-5	inhibition rate	-1	%
12414	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Ribosomal protein S6 kinase beta-1	inhibition rate	10	%
12415	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Serine/threonine-protein kinase Sgk1	inhibition rate	41	%
12416	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Proto-oncogene tyrosine-protein kinase Src	inhibition rate	0	%
12417	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Proto-oncogene tyrosine-protein kinase Src	inhibition rate	7	%
12418	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	SRSF protein kinase 1	inhibition rate	-4	%
12419	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Serine/threonine-protein kinase 10	inhibition rate	-14	%
12420	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Serine/threonine-protein kinase STK11	inhibition rate	14	%
12421	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Serine/threonine-protein kinase 17A	inhibition rate	-42	%
12422	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Serine/threonine-protein kinase 4	inhibition rate	13	%
12423	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Serine/threonine-protein kinase TBK1	inhibition rate	11	%
12424	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	TGF-beta receptor type-1	inhibition rate	6	%
12425	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Tyrosine-protein kinase receptor TYRO3	inhibition rate	-26	%
12426	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Serine/threonine-protein kinase ULK2	inhibition rate	-2	%
12427	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Tyrosine-protein kinase yes	inhibition rate	-3	%
12428	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Tyrosine-protein kinase ABL1	inhibition rate	30	%
12429	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Tyrosine-protein kinase ABL2	inhibition rate	-21	%
12430	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Activin receptor type-1B	inhibition rate	4	%
12431	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	RAC-alpha serine/threonine-protein kinase	inhibition rate	-4	%
12432	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Tyrosine-protein kinase ABL1	inhibition rate	-16	%
12433	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	ALK tyrosine kinase receptor	inhibition rate	-32	%
12434	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Aurora kinase B	inhibition rate	6	%
12435	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Aurora kinase C	inhibition rate	11	%
12436	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Tyrosine-protein kinase receptor UFO	inhibition rate	2	%
12437	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Tyrosine-protein kinase Blk	inhibition rate	-8	%
12438	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Cytoplasmic tyrosine-protein kinase BMX	inhibition rate	6	%
12439	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Tyrosine-protein kinase BTK	inhibition rate	-25	%
12440	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Calcium/calmodulin-dependent protein kinase type 1	inhibition rate	2	%
12441	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Calcium/calmodulin-dependent protein kinase type II subunit beta	inhibition rate	28	%
12442	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	G2/mitotic-specific cyclin-B1;+Cyclin-dependent kinase 1	inhibition rate	58	%
12443	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Cyclin-dependent kinase 2;+Cyclin-A2	inhibition rate	41	%
12444	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	G1/S-specific cyclin-D3;+Cyclin-dependent kinase 6	inhibition rate	44	%
12445	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Cyclin-H;+CDK-activating kinase assembly factor MAT1;+Cyclin-dependent kinase 7	inhibition rate	47	%
12446	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Cyclin-dependent kinase 9;+Cyclin-T1	inhibition rate	99	%
12447	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Serine/threonine-protein kinase Chk1	inhibition rate	10	%
12448	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Macrophage colony-stimulating factor 1 receptor	inhibition rate	6	%
12449	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Casein kinase I isoform gamma-1	inhibition rate	14	%
12450	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Casein kinase II subunit alpha'	inhibition rate	9	%
12451	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Discoidin domain-containing receptor 2	inhibition rate	-39	%
12452	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Myotonin-protein kinase	inhibition rate	14	%
12453	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Dual specificity tyrosine-phosphorylation-regulated kinase 2	inhibition rate	-6	%
12454	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	elongation factor-2 kinase	inhibition rate	-17	%
12455	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Epidermal growth factor receptor	inhibition rate	18	%
12456	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Epidermal growth factor receptor (phosphorylated) [human]	inhibition rate	-9	%
12457	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Ephrin type-A receptor 5	inhibition rate	11	%
12458	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Ephrin type-B receptor 1	inhibition rate	-13	%
12459	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Ephrin type-B receptor 4	inhibition rate	36	%
12460	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Receptor tyrosine-protein kinase erbB-4	inhibition rate	-2	%
12461	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Tyrosine-protein kinase Fer	inhibition rate	1	%
12462	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Tyrosine-protein kinase, Fes/Fps type	inhibition rate	-4	%
12463	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Fibroblast growth factor receptor 1	inhibition rate	-7 - -5	%
12464	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Fibroblast growth factor receptor 2	inhibition rate	7	%
12465	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Fibroblast growth factor receptor 3	inhibition rate	54	%
12466	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Fibroblast growth factor receptor 4	inhibition rate	14	%
12467	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Vascular endothelial growth factor receptor 1	inhibition rate	32	%
12468	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	-4	%
12469	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Tyrosine-protein kinase Fyn	inhibition rate	3	%
12470	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Glycogen synthase kinase-3 alpha	inhibition rate	60	%
12471	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	tau-protein kinase	inhibition rate	21	%
12472	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Insulin-like growth factor 1 receptor	inhibition rate	16	%
12473	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	activated Insulin-like growth factor 1 receptor	inhibition rate	-5	%
12474	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Inhibitor of nuclear factor kappa-B kinase subunit beta	inhibition rate	-22	%
12475	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Insulin receptor	inhibition rate	10	%
12476	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Activated insulin receptor	inhibition rate	6	%
12477	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Insulin receptor-related protein	inhibition rate	-20	%
12478	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Interleukin-1 receptor-associated kinase 4	inhibition rate	-10	%
12479	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Tyrosine-protein kinase JAK2	inhibition rate	15	%
12480	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Tyrosine-protein kinase JAK3	inhibition rate	6	%
12481	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Vascular endothelial growth factor receptor 2	inhibition rate	-5	%
12482	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Mast/stem cell growth factor receptor Kit	inhibition rate	1	%
12483	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Tyrosine-protein kinase Lck	inhibition rate	-3	%
12484	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Tyrosine-protein kinase Lyn	inhibition rate	20	%
12485	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Dual specificity mitogen-activated protein kinase kinase 1	inhibition rate	7	%
12486	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Dual specificity mitogen-activated protein kinase kinase 7	inhibition rate	-22	%
12487	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Mitogen-activated protein kinase kinase kinase 7	inhibition rate	-1	%
12488	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Mitogen-activated protein kinase kinase kinase 9	inhibition rate	26	%
12489	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Mitogen-activated protein kinase 14	inhibition rate	-11	%
12490	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Mitogen-activated protein kinase 8	inhibition rate	-1	%
12491	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	MAP kinase-activated protein kinase 2	inhibition rate	4	%
12492	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Serine/threonine-protein kinase MARK1	inhibition rate	42	%
12493	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Serine/threonine-protein kinase MARK2	inhibition rate	19	%
12494	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Hepatocyte growth factor receptor	inhibition rate	-18	%
12495	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	Misshapen-like kinase 1	inhibition rate	5	%
12496	COC1=CC(=CC=C1C1=C2C=C(NC2=NC=C1)C1CCNCC1)C(=O)N1CCCC1	MAP kinase-interacting serine/threonine-protein kinase 2	inhibition rate	-4	%
12497	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		percentage of cells in G2/M phase	93.32	%
12498	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		inhibition rate		
12499	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		observed parameter		
12500	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		observed parameter		
12501	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		observed parameter		
12502	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		inhibition rate		
12503	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		percentage of cells in G0/G1 phase	49.49	%
12504	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		IC50	1.6	nM
12505	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		percentage of cells in S phase	34.63	%
12506	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		IC50	2.02	nM
12507	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		IC50	2.19	nM
12508	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		IC50	2.17	nM
12509	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		percentage of early apoptotic cells increase		
12510	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		percentage of late apoptotic cells increase		
12511	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		IC50	2.76	nM
12512	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		IC50	3.12	nM
12513	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		IC50	3.15	nM
12514	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		IC50	3.53	nM
12515	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		IC50	3.62	nM
12516	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		percentage of cells in G0/G1 phase	44.51	%
12517	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		IC50	3.78	nM
12518	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		IC50	3.83	nM
12519	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		IC50	5.6	nM
12520	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		IC50	6.06	nM
12521	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		percentage of cells in S phase	32.9	%
12522	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		IC50	6.27	nM
12523	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		IC50	6.73	nM
12524	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		IC50	1.37	μM
12525	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		IC50	1.85	μM
12526	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		IC50	9.85	μM
12527	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Cytochrome P450 1A2	IC50	16.8	μM
12528	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Cytochrome P450 2D6	IC50	69.17	μM
12529	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Cytochrome P450 3A4	IC50	92.79	μM
12530	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Cytochrome P450 2C9	IC50	100	μM
12531	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Cytochrome P450 2C19	IC50	100	μM
12532	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Cytochrome P450 2D6	IC50	100	μM
12533	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Histone deacetylase 1	IC50	10	μM
12534	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Histone deacetylase 6	IC50	10	μM
12535	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		percentage of cells in G0/G1 phase	0.36	%
12536	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		percentage of cells in S phase	6.32	%
12537	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		percentage of cells in G2/M phase	15.88	%
12538	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		percentage of cells in G2/M phase	22.58	%
12539	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		CL (drug clearance)	1.73	l/h/kg
12540	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		CL (drug clearance)	1.97	l/h/kg
12541	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		Vdss	21.6	l/kg
12542	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		Vdss	17.5	l/kg
12543	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		AUC (0-24 h)	1286	μg/h/l
12544	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		AUC (0-24 h)	2113	μg/h/l
12545	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		t1/2 (drug half life)	5.58	h
12546	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		t1/2 (drug half life)	9.09	h
12547	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		Cmax	566	μg/l
12548	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		Cmax	1702	μg/l
12549	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		F (drug bioavailability)	60.9	%
12550	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Histone deacetylase 2	inhibition rate	5.8	%
12551	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Histone deacetylase 3	inhibition rate	1.4	%
12552	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Histone deacetylase 4	inhibition rate	4.5	%
12553	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Histone deacetylase 5	inhibition rate	2.6	%
12554	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Histone deacetylase 7	inhibition rate	13.1	%
12555	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Histone deacetylase 9	inhibition rate	7.5	%
12556	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Polyamine deacetylase HDAC10	inhibition rate	3.7	%
12557	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Histone deacetylase 8	inhibition rate	31.7	%
12558	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Histone deacetylase 11	inhibition rate	33.5	%
12559	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		t1/2 (drug half life)	385	min
12560	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		CLint (intrinsic clearance)	3.6	μl/min/mg protein
12561	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		t1/2 (drug half life)	231	min
12562	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		CLint (intrinsic clearance)	6	μl/min/mg protein
12563	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Beta tubulin	binding rate		
12564	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Death-associated protein kinase 1 [human]	inhibition rate	104	%
12565	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Serine/threonine-protein kinase DCLK3 [human]	inhibition rate	109	%
12566	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Discoidin domain-containing receptor 2 [human]	inhibition rate	126	%
12567	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Dual specificity tyrosine-phosphorylation-regulated kinase 2 [human]	inhibition rate	85	%
12568	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Epidermal growth factor receptor [human]	inhibition rate	77	%
12569	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Epidermal growth factor receptor (L858R) [human]	inhibition rate	104	%
12570	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Epidermal growth factor receptor (L861Q) [human]	inhibition rate	104	%
12571	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Epidermal growth factor receptor (T790M) [human]	inhibition rate	93	%
12572	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Epidermal growth factor receptor [human]	inhibition rate	113	%
12573	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Ephrin type-A receptor 2 [human]	inhibition rate	86	%
12574	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Ephrin type-A receptor 7 [human]	inhibition rate	91	%
12575	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Ephrin type-B receptor 2 [human]	inhibition rate	107	%
12576	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Ephrin type-B receptor 4 [human]	inhibition rate	91	%
12577	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Receptor tyrosine-protein kinase erbB-2 [human]	inhibition rate	85	%
12578	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Receptor tyrosine-protein kinase erbB-4 [human]	inhibition rate	102	%
12579	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Focal adhesion kinase 1 [human]	inhibition rate	101	%
12580	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Tyrosine-protein kinase Fer [human]	inhibition rate	89	%
12581	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Tyrosine-protein kinase, Fes/Fps type [human]	inhibition rate	105	%
12582	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Fibroblast growth factor receptor 1 [human]	inhibition rate	113	%
12583	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Fibroblast growth factor receptor 2 [human]	inhibition rate	108	%
12584	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Fibroblast growth factor receptor 3 [human]	inhibition rate	143	%
12585	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Fibroblast growth factor receptor 4 [human]	inhibition rate	86	%
12586	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Vascular endothelial growth factor receptor 1 [human]	inhibition rate	112	%
12587	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Receptor-type tyrosine-protein kinase FLT3 (D835Y) [human]	inhibition rate	93	%
12588	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	90	%
12589	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Vascular endothelial growth factor receptor 3 [human]	inhibition rate	99	%
12590	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Macrophage colony-stimulating factor 1 receptor [human]	inhibition rate	119	%
12591	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Tyrosine-protein kinase Fyn [human]	inhibition rate	101	%
12592	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Glycogen synthase kinase-3 beta [human]	inhibition rate	139	%
12593	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Tyrosine-protein kinase HCK [human]	inhibition rate	120	%
12594	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Homeodomain-interacting protein kinase 2 [human]	inhibition rate	120	%
12595	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Homeodomain-interacting protein kinase 3 [human]	inhibition rate	105	%
12596	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Insulin-like growth factor 1 receptor [human]	inhibition rate	117	%
12597	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Insulin-like growth factor 1 receptor [human]	inhibition rate	93	%
12598	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Inhibitor of nuclear factor kappa-B kinase subunit alpha [human]	inhibition rate	89	%
12599	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Inhibitor of nuclear factor kappa-B kinase subunit epsilon [human]	inhibition rate	86	%
12600	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Transcription factor PRE6 [human]	inhibition rate	103	%
12601	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Tyrosine-protein kinase JAK1 [human]	inhibition rate	106	%
12602	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Tyrosine-protein kinase JAK2 [human]	inhibition rate	103	%
12603	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Tyrosine-protein kinase JAK3 [human]	inhibition rate	106	%
12604	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Serine/threonine-protein kinase STK11 [human]	inhibition rate	94	%
12605	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Tyrosine-protein kinase Lyn [human]	inhibition rate	86	%
12606	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Mitogen-activated protein kinase 1 [human]	inhibition rate	121	%
12607	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Mitogen-activated protein kinase 3 [human]	inhibition rate	85	%
12608	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Dual specificity mitogen-activated protein kinase kinase 1 [human]	inhibition rate	107	%
12609	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Maternal embryonic leucine zipper kinase [human]	inhibition rate	105	%
12610	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Tyrosine-protein kinase Mer [human]	inhibition rate	99	%
12611	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Hepatocyte growth factor receptor [human]	inhibition rate	110	%
12612	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Serine/threonine-protein kinase 3 [human]	inhibition rate	121	%
12613	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Serine/threonine-protein kinase 24 [human]	inhibition rate	91	%
12614	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Serine/threonine-protein kinase mTOR [human]	inhibition rate	92	%
12615	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Serine/threonine-protein kinase Nek2 [human]	inhibition rate	85	%
12616	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Serine/threonine-protein kinase NIM1 [human]	inhibition rate	109	%
12617	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Ribosomal protein S6 kinase beta-1 [human]	inhibition rate	77	%
12618	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Serine/threonine-protein kinase PAK 1 [human]	inhibition rate	102	%
12619	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	serine/threonine-protein kinase pak 2 [human]	inhibition rate	75	%
12620	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Serine/threonine-protein kinase PAK 4 [human]	inhibition rate	90	%
12621	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Serine/threonine-protein kinase MARK2 [human]	inhibition rate	103	%
12622	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Platelet-derived growth factor receptor alpha [human]	inhibition rate	111	%
12623	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Platelet-derived growth factor receptor alpha [human]	inhibition rate	103	%
12624	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Platelet-derived growth factor receptor beta [human]	inhibition rate	108	%
12625	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	3-phosphoinositide-dependent protein kinase 1 [human]	inhibition rate	125	%
12626	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Serine/threonine-protein kinase pim-1 [human]	inhibition rate	80	%
12627	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	cAMP-dependent protein kinase catalytic subunit alpha [human]	inhibition rate	105	%
12628	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	cAMP-dependent protein kinase catalytic subunit alpha [human]	inhibition rate	89	%
12629	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	cAMP-dependent protein kinase catalytic subunit beta [human]	inhibition rate	90	%
12630	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	cAMP-dependent protein kinase catalytic subunit gamma [human]	inhibition rate	111	%
12631	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Protein kinase C alpha type [human]	inhibition rate	116	%
12632	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Protein kinase C beta type (isoform Beta-II) [human]	inhibition rate	88	%
12633	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Protein kinase C gamma type [human]	inhibition rate	95	%
12634	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Protein kinase C, delta [human]	inhibition rate	93	%
12635	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Protein kinase C, epsilon [human]	inhibition rate	104	%
12636	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Protein kinase C, eta [human]	inhibition rate	100	%
12637	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Protein kinase C iota type [human]	inhibition rate	103	%
12638	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Protein kinase C, mu [human]	inhibition rate	104	%
12639	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Protein kinase C, theta [human]	inhibition rate	107	%
12640	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Protein kinase C zeta type [human]	inhibition rate	108	%
12641	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Serine/threonine-protein kinase D2 [human]	inhibition rate	95	%
12642	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	MAP kinase-activated protein kinase 5 [human]	inhibition rate	97	%
12643	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Serine/threonine-protein kinase N2 [human]	inhibition rate	81	%
12644	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Proto-oncogene tyrosine-protein kinase receptor Ret [human]	inhibition rate	123	%
12645	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Rho-associated protein kinase 1 [human]	inhibition rate	103	%
12646	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Macrophage-stimulating protein receptor [human]	inhibition rate	90	%
12647	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Proto-oncogene tyrosine-protein kinase ROS [human]	inhibition rate	89	%
12648	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Ribosomal protein S6 kinase alpha-1 [human]	inhibition rate	119	%
12649	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	85	%
12650	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Ribosomal protein S6 kinase alpha-2 [human]	inhibition rate	87	%
12651	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Serine/threonine-protein kinase Sgk1 [human]	inhibition rate	96	%
12652	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Serine/threonine-protein kinase PLK2 [human]	inhibition rate	95	%
12653	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Tyrosine-protein kinase SYK [human]	inhibition rate	84	%
12654	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Mitogen-activated protein kinase kinase kinase 7 [human]	inhibition rate	80	%
12655	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Angiopoietin-1 receptor [human]	inhibition rate	79	%
12656	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	High affinity nerve growth factor receptor [human]	inhibition rate	108	%
12657	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	NT-3 growth factor receptor [human]	inhibition rate	93	%
12658	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition rate	84	%
12659	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Wee1-like protein kinase [human]	inhibition rate	99	%
12660	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Tyrosine-protein kinase Yes [human]	inhibition rate	87	%
12661	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Tyrosine-protein kinase ZAP-70 [human]	inhibition rate	91	%
12662	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Death-associated protein kinase 3 [human]	inhibition rate	100	%
12663	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Serine/threonine-protein kinase ATM [human]	inhibition rate	100	%
12664	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Tyrosine-protein kinase Abl [human]	inhibition rate	108	%
12665	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Serine/threonine-protein kinase ATR [human]	inhibition rate	93	%
12666	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	ATR-interacting protein [human]	inhibition rate	93	%
12667	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	DNA-dependent protein kinase catalytic subunit [human]	inhibition rate	87	%
12668	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Tyrosine-protein kinase Abl [human]	inhibition rate	97	%
12669	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	ALK tyrosine kinase receptor [human]	inhibition rate	101	%
12670	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Arginase [human]	inhibition rate	101	%
12671	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	NUAK family SNF1-like kinase 1 [human]	inhibition rate	108	%
12672	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Aurora kinase A [human]	inhibition rate	85	%
12673	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Tyrosine-protein kinase receptor UFO [human]	inhibition rate	105	%
12674	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Tyrosine-protein kinase Blk [human]	inhibition rate	85	%
12675	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Cytoplasmic tyrosine-protein kinase BMX [human]	inhibition rate	116	%
12676	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Protein-tyrosine kinase 6 [human]	inhibition rate	114	%
12677	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Tyrosine-protein kinase BTK [human]	inhibition rate	92	%
12678	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Serine/threonine-protein kinase B-raf [human]	inhibition rate	122	%
12679	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Serine/threonine-protein kinase B-raf [human]	inhibition rate	87	%
12680	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Calcium/calmodulin-dependent protein kinase type II subunit beta [human]	inhibition rate	101	%
12681	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Calcium/calmodulin-dependent protein kinase type IV [human]	inhibition rate	112	%
12682	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Cyclin-dependent kinase 1 [human]	inhibition rate	92	%
12683	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Cyclin-dependent kinase 2 [human]	inhibition rate	76	%
12684	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Cyclin-dependent kinase 3 [human]	inhibition rate	87	%
12685	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Cyclin-dependent kinase 4 [human]	inhibition rate	90	%
12686	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Cyclin-dependent-like kinase 5 [human]	inhibition rate	101	%
12687	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Cyclin-dependent kinase 6 [human]	inhibition rate	78	%
12688	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Cyclin-dependent kinase 7 [human]	inhibition rate	112	%
12689	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Cyclin-dependent kinase 9 [human]	inhibition rate	106	%
12690	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Cyclin-B [human]	inhibition rate	92	%
12691	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Cyclin-A1 [human]	inhibition rate	76	%
12692	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Cyclin-E [human]	inhibition rate	87 - 112	%
12693	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Cyclin-D3-1 [human]	inhibition rate	78 - 90	%
12694	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Cyclin-dependent kinase 5 activator 1 [human]	inhibition rate	101	%
12695	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Cyclin-H [human]	inhibition rate	112	%
12696	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	CDK-activating kinase assembly factor MAT1 [human]	inhibition rate	112	%
12697	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Cyclin-T1 [human]	inhibition rate	106	%
12698	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Serine/threonine-protein kinase Chk1 [human]	inhibition rate	79	%
12699	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Serine/threonine-protein kinase Chk2 [human]	inhibition rate	93	%
12700	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Casein kinase I isoform gamma-1 [human]	inhibition rate	105	%
12701	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Casein kinase I isoform delta [human]	inhibition rate	114	%
12702	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Casein kinase II subunit alpha [human]	inhibition rate	91	%
12703	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	109	%
12704	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	118	%
12705	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	124	%
12706	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	Tyrosine-protein kinase CSK [human]	inhibition rate	120	%
12707	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	RAF proto-oncogene serine/threonine-protein kinase [human]	inhibition rate	121	%
12708	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1	RNase E specificity factor CsrD [human]	inhibition rate	107	%
12709	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		leukocyte count	3210000000	l
12710	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		leukocyte count	6640000000	l
12711	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		neutrophil percentage	18.1	%
12712	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		neutrophil percentage	31.45	%
12713	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		lymphocyte percentage	63.45	%
12714	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		lymphocyte percentage	76.8	%
12715	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		monocyte percentage	1.15	%
12716	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		monocyte percentage	1.35	%
12717	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		eosinophil percentage	3.1	%
12718	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		eosinophil percentage	2.55	%
12719	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		Large unstained cells	0.8	%
12720	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		Large unstained cells	1.35	%
12721	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		erythrocyte count	11250000000000	l
12722	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		erythrocyte count	8660000000000	l
12723	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		hemoglobin blood level	134	g/l
12724	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		hemoglobin blood level	182	g/l
12725	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		hematocrit	28.55	%
12726	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		hematocrit	23.05	%
12727	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		mean corpuscular volume	50.85	fl
12728	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		mean corpuscular volume	53.3	fl
12729	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		mean corpuscular hemoglobin concentration	289.5	g/l
12730	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		mean corpuscular hemoglobin concentration	318	g/l
12731	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		percentage red blood cell distribution width	13.8	%
12732	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		percentage red blood cell distribution width	19	%
12733	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		platelet count	1064000000000	l
12734	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		platelet count	958000000000	l
12735	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		mean platelet volume	6.45	fl
12736	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		mean platelet volume	7.4	fl
12737	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		mean corpuscular hemoglobin	15.4	pg/cell
12738	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		mean corpuscular hemoglobin	16.15	pg/cell
12739	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		alanine aminotransferase level	33.75	U/l
12740	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		alanine aminotransferase level	38.05	U/l
12741	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		aspartate aminotransferase level	101.3	U/l
12742	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		aspartate aminotransferase level	120.85	U/l
12743	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		total protein	51.5	g/l
12744	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		total protein	47.8	g/l
12745	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		concentration (parameter)	36.95	g/l
12746	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		concentration (parameter)	34.3	g/l
12747	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		total bilirubin	1.5	μmol/l
12748	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		total bilirubin	0.8	μmol/l
12749	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		alkaline phosphatase level	186.5	U/l
12750	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		alkaline phosphatase level	93	U/l
12751	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		glucose blood level	3.96	mmol/l
12752	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		glucose blood level	5.56	mmol/l
12753	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		urea blood level	8.6	mmol/l
12754	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		urea blood level	7.7	mmol/l
12755	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		uric acid blood level	0.9	μmol/l
12756	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		uric acid blood level	2.35	μmol/l
12757	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		cholesterol level	2.15	mmol/l
12758	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		cholesterol level	2.3	mmol/l
12759	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		triacylglycerol level	2	mmol/l
12760	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		triacylglycerol level	2.4	mmol/l
12761	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		HDL-cholesterol level	1.86	mmol/l
12762	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		HDL-cholesterol level	1.89	mmol/l
12763	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		LDL-cholesterol level	0.2	mmol/l
12764	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		LDL-cholesterol level	0.28	mmol/l
12765	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		lactate dehydrogenase blood level	954	U/l
12766	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		lactate dehydrogenase blood level	1017.5	U/l
12767	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		concentration (parameter)	676.35	U/l
12768	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		concentration (parameter)	617.2	U/l
12769	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		concentration (parameter)	2509	U/l
12770	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		concentration (parameter)	2254.5	U/l
12771	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		body weight loss	12.5	%
12772	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		body weight loss	5.29	%
12773	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		body weight loss	7.21	%
12774	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		body weight loss	4.8	%
12775	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		body weight loss	7.5	%
12776	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		body weight gain	3.59	%
12777	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		body weight gain	4.02 - 6.6	%
12778	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		mortality rate	0	%
12779	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		mortality rate	0	%
12780	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		mortality rate	0	%
12781	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		mortality rate	0	%
12782	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		mortality rate	0	%
12783	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		mortality rate	0	%
12784	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		mortality rate	0	%
12785	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		inhibition rate	75.1	%
12786	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		inhibition rate	53.8	%
12787	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		inhibition rate	55 - 75.5	%
12788	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		inhibition rate	75.5	%
12789	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		inhibition rate	82.1	%
12790	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		inhibition rate	70.1	%
12791	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		inhibition rate	78.9	%
12792	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		body weight loss	1.07	%
12793	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		body weight loss	4.65	%
12794	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		body weight gain	7.07	%
12795	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		mortality rate	0	%
12796	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		mortality rate	0	%
12797	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		mortality rate	0	%
12798	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		inhibition rate	63.5	%
12799	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		inhibition rate	76.1	%
12800	COC1=CC=C(C=C1OC(C(C)C)C(=O)NO)N(C)C1=C2C=CC=CC2=NC(C)=N1		inhibition rate	78.6	%
12801	CC1=CC=CC(Cl)=C1NC(=O)N1CC2=C(NN=C2NC(=O)C2(CCC2)C(C)(C)C)C1(C)C	Cyclin-dependent kinase 7	Ki (inhibition constant)	50	nM
12802	CC1=CC=CC(Cl)=C1NC(=O)N1CC2=C(NN=C2NC(=O)C2(CCC2)C(C)(C)C)C1(C)C	Cyclin-dependent kinase 7	IC50	50	nM
12803	CC1=CC=CC(Cl)=C1NC(=O)N1CC2=C(NN=C2NC(=O)C2(CCC2)C(C)(C)C)C1(C)C	Cyclin-dependent kinase 2	Ki (inhibition constant)	300	nM
12804	CC1=CC=CC(Cl)=C1NC(=O)N1CC2=C(NN=C2NC(=O)C2(CCC2)C(C)(C)C)C1(C)C	Serine/threonine-protein kinase PLK1	Ki (inhibition constant)	5000	nM
12805	CC1=C(NC(=O)N2CC3=C(NN=C3NC(=O)C3(CCC3)C(C)(C)C)C2(C)C)C=C(F)C=C1	Cyclin-dependent kinase 7	Ki (inhibition constant)	50	nM
12806	CC1=C(NC(=O)N2CC3=C(NN=C3NC(=O)C3(CCC3)C(C)(C)C)C2(C)C)C=C(F)C=C1	Cyclin-dependent kinase 7	IC50	50	nM
12807	CC1=C(NC(=O)N2CC3=C(NN=C3NC(=O)C3(CCC3)C(C)(C)C)C2(C)C)C=C(F)C=C1	Cyclin-dependent kinase 2	Ki (inhibition constant)	300	nM
12808	CC1=C(NC(=O)N2CC3=C(NN=C3NC(=O)C3(CCC3)C(C)(C)C)C2(C)C)C=C(F)C=C1	Serine/threonine-protein kinase PLK1	Ki (inhibition constant)	5000	nM
12809	CC1=CC(NC(=O)N2CC3=C(NN=C3NC(=O)C3(CCC3)C(C)(C)C)C2(C)C)=C(C)C=C1	Cyclin-dependent kinase 7	Ki (inhibition constant)	50	nM
12810	CC1=CC(NC(=O)N2CC3=C(NN=C3NC(=O)C3(CCC3)C(C)(C)C)C2(C)C)=C(C)C=C1	Cyclin-dependent kinase 7	IC50	50	nM
12811	CC1=CC(NC(=O)N2CC3=C(NN=C3NC(=O)C3(CCC3)C(C)(C)C)C2(C)C)=C(C)C=C1	Cyclin-dependent kinase 2	Ki (inhibition constant)	300	nM
12812	CC1=CC(NC(=O)N2CC3=C(NN=C3NC(=O)C3(CCC3)C(C)(C)C)C2(C)C)=C(C)C=C1	Serine/threonine-protein kinase PLK1	Ki (inhibition constant)	5000	nM
12813	CC(C)(C)C1(CCC1)C(=O)NC1=NNC2=C1CN(C(=O)NC1=C(Cl)C=CC=C1Cl)C2(C)C	Cyclin-dependent kinase 7	Ki (inhibition constant)	50	nM
12814	CC(C)(C)C1(CCC1)C(=O)NC1=NNC2=C1CN(C(=O)NC1=C(Cl)C=CC=C1Cl)C2(C)C	Cyclin-dependent kinase 7	IC50	50	nM
12815	CC(C)(C)C1(CCC1)C(=O)NC1=NNC2=C1CN(C(=O)NC1=C(Cl)C=CC=C1Cl)C2(C)C	Cyclin-dependent kinase 2	Ki (inhibition constant)	300	nM
12816	CC(C)(C)C1(CCC1)C(=O)NC1=NNC2=C1CN(C(=O)NC1=C(Cl)C=CC=C1Cl)C2(C)C	Serine/threonine-protein kinase PLK1	Ki (inhibition constant)	5000	nM
12817	CC(C)(C)C1(CCC1)C(=O)NC1=NNC2=C1CN(C(=O)NC1=C(Cl)C=CC=C1F)C2(C)C	Cyclin-dependent kinase 7	Ki (inhibition constant)	50	nM
12818	CC(C)(C)C1(CCC1)C(=O)NC1=NNC2=C1CN(C(=O)NC1=C(Cl)C=CC=C1F)C2(C)C	Cyclin-dependent kinase 7	IC50	50	nM
12819	CC(C)(C)C1(CCC1)C(=O)NC1=NNC2=C1CN(C(=O)NC1=C(Cl)C=CC=C1F)C2(C)C	Cyclin-dependent kinase 2	Ki (inhibition constant)	300	nM
12820	CC(C)(C)C1(CCC1)C(=O)NC1=NNC2=C1CN(C(=O)NC1=C(Cl)C=CC=C1F)C2(C)C	Serine/threonine-protein kinase PLK1	Ki (inhibition constant)	5000	nM
12821	CC1=CC=CC(Br)=C1NC(=O)N1CC2=C(NN=C2NC(=O)C2(CCC2)C(C)(C)C)C1(C)C	Cyclin-dependent kinase 7	Ki (inhibition constant)	50	nM
12822	CC1=CC=CC(Br)=C1NC(=O)N1CC2=C(NN=C2NC(=O)C2(CCC2)C(C)(C)C)C1(C)C	Cyclin-dependent kinase 7	IC50	50	nM
12823	CC1=CC=CC(Br)=C1NC(=O)N1CC2=C(NN=C2NC(=O)C2(CCC2)C(C)(C)C)C1(C)C	Cyclin-dependent kinase 2	Ki (inhibition constant)	300	nM
12824	CC1=CC=CC(Br)=C1NC(=O)N1CC2=C(NN=C2NC(=O)C2(CCC2)C(C)(C)C)C1(C)C	Serine/threonine-protein kinase PLK1	Ki (inhibition constant)	5000	nM
12825	CC1=CC=C(C)C(NC(=O)N2CC3=C(NN=C3NC(=O)C3(CCC3)C(C)(C)C)C2(C)C)=C1F	Cyclin-dependent kinase 7	Ki (inhibition constant)	50	nM
12826	CC1=CC=C(C)C(NC(=O)N2CC3=C(NN=C3NC(=O)C3(CCC3)C(C)(C)C)C2(C)C)=C1F	Cyclin-dependent kinase 7	IC50	50	nM
12827	CC1=CC=C(C)C(NC(=O)N2CC3=C(NN=C3NC(=O)C3(CCC3)C(C)(C)C)C2(C)C)=C1F	Cyclin-dependent kinase 2	Ki (inhibition constant)	300	nM
12828	CC1=CC=C(C)C(NC(=O)N2CC3=C(NN=C3NC(=O)C3(CCC3)C(C)(C)C)C2(C)C)=C1F	Serine/threonine-protein kinase PLK1	Ki (inhibition constant)	5000	nM
12829	CC(C)(C)C1(CCC1)C(=O)NC1=NNC2=C1CN(C(=O)NC1=C(F)C=CC3=C1OC=C3)C2(C)C	Cyclin-dependent kinase 7	Ki (inhibition constant)	50	nM
12830	CC(C)(C)C1(CCC1)C(=O)NC1=NNC2=C1CN(C(=O)NC1=C(F)C=CC3=C1OC=C3)C2(C)C	Cyclin-dependent kinase 7	IC50	50	nM
12831	CC(C)(C)C1(CCC1)C(=O)NC1=NNC2=C1CN(C(=O)NC1=C(F)C=CC3=C1OC=C3)C2(C)C	Cyclin-dependent kinase 2	Ki (inhibition constant)	300	nM
12832	CC(C)(C)C1(CCC1)C(=O)NC1=NNC2=C1CN(C(=O)NC1=C(F)C=CC3=C1OC=C3)C2(C)C	Serine/threonine-protein kinase PLK1	Ki (inhibition constant)	5000	nM
12833	CC(C)(C)C1(CCC1)C(=O)NC1=NNC2=C1CN(C(=O)NC1=C(F)C=CC3=C1OC(Cl)=C3)C2(C)C	Cyclin-dependent kinase 7	Ki (inhibition constant)	50	nM
12834	CC(C)(C)C1(CCC1)C(=O)NC1=NNC2=C1CN(C(=O)NC1=C(F)C=CC3=C1OC(Cl)=C3)C2(C)C	Cyclin-dependent kinase 7	IC50	50	nM
12835	CC(C)(C)C1(CCC1)C(=O)NC1=NNC2=C1CN(C(=O)NC1=C(F)C=CC3=C1OC(Cl)=C3)C2(C)C	Cyclin-dependent kinase 2	Ki (inhibition constant)	300	nM
12836	CC(C)(C)C1(CCC1)C(=O)NC1=NNC2=C1CN(C(=O)NC1=C(F)C=CC3=C1OC(Cl)=C3)C2(C)C	Serine/threonine-protein kinase PLK1	Ki (inhibition constant)	5000	nM
12837	CNC1=NC(C)=C(S1)C1=NC(NC2=NC=C(C=C2)N2CCC(N)CC2)=NC=C1F	Cyclin-dependent kinase 4;+Cyclin-D1-1	Ki (inhibition constant)	0.003	μM
12838	CNC1=NC(C)=C(S1)C1=NC(NC2=NC=C(C=C2)N2CCC(N)CC2)=NC=C1F	Cyclin-dependent kinase 6;+Cyclin-D3-1	Ki (inhibition constant)	0.032	μM
12839	CNC1=NC(C)=C(S1)C1=NC(NC2=NC=C(C=C2)N2CCC(N)CC2)=NC=C1F	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	GI50	0.08	μM
12840	CNC1=NC(C)=C(S1)C1=NC(NC2=NC=C(C=C2)N2CCC(N)CC2)=NC=C1F	Cyclin-dependent kinase 2;+Cyclin-A1	Ki (inhibition constant)	0.206	μM
12841	CNC1=NC(C)=C(S1)C1=NC(NC2=NC=C(C=C2)N2CCC(N)CC2)=NC=C1F	Cyclin-dependent kinase 4 [human];+Cyclin-dependent kinase 6 [human]	GI50	0.36	μM
12842	CNC1=NC(C)=C(S1)C1=NC(NC2=NC=C(C=C2)N2CCC(N)CC2)=NC=C1F	Cyclin-H;+Cyclin-dependent kinase 7	Ki (inhibition constant)	1	μM
12843	CNC1=NC(C)=C(S1)C1=NC(NC2=NC=C(C=C2)N2CCC(N)CC2)=NC=C1F	G2/mitotic-specific cyclin-B;+Cyclin-dependent kinase 1	Ki (inhibition constant)	1	μM
12844	CNC1=NC(C)=C(S1)C1=NC(NC2=NC=C(C=C2)N2CCC(N)CC2)=NC=C1F	Cyclin-dependent kinase 9;+Cyclin-T1	Ki (inhibition constant)	1	μM
12845	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase TNNI3K [human]	IC50	100	nM
12846	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1		AUC	3.8	kg*h/l
12847	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1		t1/2 (drug half life)	5.4	h
12848	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Myosin light chain kinase 3 [human]	inhibition rate	-5	%
12849	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Myosin light chain kinase 3 [human]	inhibition rate	11	%
12850	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Mitogen-activated protein kinase kinase kinase 9 [human]	inhibition rate	20	%
12851	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Mitogen-activated protein kinase kinase kinase 9 [human]	inhibition rate	21	%
12852	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Mitogen-activated protein kinase kinase kinase 10 [human]	inhibition rate	18	%
12853	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Mitogen-activated protein kinase kinase kinase 10 [human]	inhibition rate	77	%
12854	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase MRCK alpha [human]	inhibition rate	-16	%
12855	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase MRCK alpha [human]	inhibition rate	-8	%
12856	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase MRCK beta [human]	inhibition rate	-23	%
12857	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase MRCK beta [human]	inhibition rate	-24	%
12858	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Ribosomal protein S6 kinase alpha-4 [human]	inhibition rate	3	%
12859	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Ribosomal protein S6 kinase alpha-4 [human]	inhibition rate	3	%
12860	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	SRSF protein kinase 3 [human]	inhibition rate	-34	%
12861	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	SRSF protein kinase 3 [human]	inhibition rate	-3	%
12862	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Histone acetyltransferase mst1 [human]	inhibition rate	-12	%
12863	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Histone acetyltransferase mst1 [human]	inhibition rate	-14	%
12864	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase 24 [human]	inhibition rate	1	%
12865	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase 24 [human]	inhibition rate	2	%
12866	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Muscle, skeletal receptor tyrosine-protein kinase [human]	inhibition rate	69	%
12867	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Muscle, skeletal receptor tyrosine-protein kinase [human]	inhibition rate	96	%
12868	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	NUAK family SNF1-like kinase 1 [human]	inhibition rate	4	%
12869	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	NUAK family SNF1-like kinase 1 [human]	inhibition rate	6	%
12870	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase Nek11 [human]	inhibition rate	15	%
12871	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase Nek11 [human]	inhibition rate	2	%
12872	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase Nek2 [human]	inhibition rate	-10	%
12873	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase Nek2 [human]	inhibition rate	-12	%
12874	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Probable serine/threonine-protein kinase nek3 [human]	inhibition rate	-4	%
12875	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Probable serine/threonine-protein kinase nek3 [human]	inhibition rate	-4	%
12876	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase Nek7 [human]	inhibition rate	-10	%
12877	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase Nek7 [human]	inhibition rate	-1	%
12878	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine kinase NLK [human]	inhibition rate	-1	%
12879	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine kinase NLK [human]	inhibition rate	-9	%
12880	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase N2 [human]	inhibition rate	-1	%
12881	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase N2 [human]	inhibition rate	0	%
12882	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	GTP:AMP phosphotransferase, mitochondrial [human]	inhibition rate	-37	%
12883	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	GTP:AMP phosphotransferase, mitochondrial [human]	inhibition rate	-41	%
12884	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase MARK2 alpha [human]	inhibition rate	-1	%
12885	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase MARK2 alpha [human]	inhibition rate	-5	%
12886	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	PAS domain-containing serine/threonine-protein kinase [human]	inhibition rate	-13	%
12887	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	PAS domain-containing serine/threonine-protein kinase [human]	inhibition rate	-20	%
12888	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Platelet-derived growth factor receptor alpha [human]	inhibition rate	3	%
12889	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Platelet-derived growth factor receptor alpha [human]	inhibition rate	56	%
12890	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Tyrosine-protein kinase receptor UFO [human]	inhibition rate	57	%
12891	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Tyrosine-protein kinase receptor UFO [human]	inhibition rate	90	%
12892	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Platelet-derived growth factor receptor beta [human]	inhibition rate	-9	%
12893	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Platelet-derived growth factor receptor beta [human]	inhibition rate	19	%
12894	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	3-phosphoinositide-dependent protein kinase 1 [human]	inhibition rate	-3	%
12895	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	3-phosphoinositide-dependent protein kinase 1 [human]	inhibition rate	1	%
12896	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform [human]	inhibition rate	-12	%
12897	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform [human]	inhibition rate	-13	%
12898	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase pim-1 [human]	inhibition rate	-11	%
12899	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase pim-1 [human]	inhibition rate	-3	%
12900	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase pim-2 [human]	inhibition rate	-23	%
12901	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase pim-2 [human]	inhibition rate	-4	%
12902	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	RAC-alpha serine/threonine-protein kinase [human]	inhibition rate	-19	%
12903	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	RAC-alpha serine/threonine-protein kinase [human]	inhibition rate	-31	%
12904	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	RAC-beta serine/threonine-protein kinase [human]	inhibition rate	-39	%
12905	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	RAC-beta serine/threonine-protein kinase [human]	inhibition rate	4	%
12906	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	RAC-gamma serine/threonine-protein kinase [human]	inhibition rate	14	%
12907	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	RAC-gamma serine/threonine-protein kinase [human]	inhibition rate	97	%
12908	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Protein kinase C beta type [human]	inhibition rate	-2	%
12909	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Protein kinase C beta type [human]	inhibition rate	-2	%
12910	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Protein kinase C, epsilon [human]	inhibition rate	-6	%
12911	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Protein kinase C, epsilon [human]	inhibition rate	7	%
12912	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Tyrosine-protein kinase Blk [human]	inhibition rate	10	%
12913	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Tyrosine-protein kinase Blk [human]	inhibition rate	7	%
12914	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Protein kinase C, delta [human]	inhibition rate	-10	%
12915	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Protein kinase C, delta [human]	inhibition rate	-23	%
12916	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Protein kinase C, epsilon [human]	inhibition rate	-11	%
12917	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Protein kinase C, epsilon [human]	inhibition rate	-11	%
12918	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Protein kinase C, eta [human]	inhibition rate	-37	%
12919	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Protein kinase C, eta [human]	inhibition rate	7	%
12920	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Protein kinase C gamma type [human]	inhibition rate	-4	%
12921	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Protein kinase C gamma type [human]	inhibition rate	4	%
12922	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Protein kinase C, iota [human]	inhibition rate	-4	%
12923	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Protein kinase C, iota [human]	inhibition rate	1	%
12924	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase D1 [human]	inhibition rate	-13	%
12925	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase D1 [human]	inhibition rate	-5	%
12926	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Protein kinase C, theta [human]	inhibition rate	-14	%
12927	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Protein kinase C, theta [human]	inhibition rate	-26	%
12928	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Protein kinase C zeta type [human]	inhibition rate	-1	%
12929	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Protein kinase C zeta type [human]	inhibition rate	11	%
12930	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase D2 [human]	inhibition rate	3	%
12931	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase D2 [human]	inhibition rate	6	%
12932	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	cGMP-dependent protein kinase, alpha [human]	inhibition rate	-4	%
12933	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	cGMP-dependent protein kinase, alpha [human]	inhibition rate	-8	%
12934	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Cytoplasmic tyrosine-protein kinase BMX [human]	inhibition rate	-18	%
12935	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Cytoplasmic tyrosine-protein kinase BMX [human]	inhibition rate	-6	%
12936	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	cGMP-dependent protein kinase, beta [human]	inhibition rate	1	%
12937	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	cGMP-dependent protein kinase, beta [human]	inhibition rate	4	%
12938	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase Plk3 [human]	inhibition rate	-13	%
12939	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase Plk3 [human]	inhibition rate	-17	%
12940	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase N2 [human]	inhibition rate	-13	%
12941	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase N2 [human]	inhibition rate	-9	%
12942	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	cAMP-dependent protein kinase catalytic subunit PRKX [human]	inhibition rate	-31	%
12943	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	cAMP-dependent protein kinase catalytic subunit PRKX [human]	inhibition rate	-41	%
12944	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Tyrosine-protein kinase FRK [human]	inhibition rate	72	%
12945	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Tyrosine-protein kinase FRK [human]	inhibition rate	97	%
12946	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Protein-tyrosine kinase 2-beta [human]	inhibition rate	29	%
12947	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Protein-tyrosine kinase 2-beta [human]	inhibition rate	6	%
12948	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Proto-oncogene tyrosine-protein kinase receptor Ret [human]	inhibition rate	41	%
12949	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Proto-oncogene tyrosine-protein kinase receptor Ret [human]	inhibition rate	90	%
12950	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Receptor-interacting serine/threonine-protein kinase 2 [human]	inhibition rate	52	%
12951	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Receptor-interacting serine/threonine-protein kinase 2 [human]	inhibition rate	7	%
12952	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Rho-associated protein kinase 2 [human]	inhibition rate	-7	%
12953	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Rho-associated protein kinase 2 [human]	inhibition rate	3	%
12954	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	DNA-directed RNA polymerase subunit beta [human]	inhibition rate	32	%
12955	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	DNA-directed RNA polymerase subunit beta [human]	inhibition rate	86	%
12956	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Protein-tyrosine kinase 6 [human]	inhibition rate	-1	%
12957	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Protein-tyrosine kinase 6 [human]	inhibition rate	1	%
12958	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Proto-oncogene tyrosine-protein kinase ROS [human]	inhibition rate	-9	%
12959	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Proto-oncogene tyrosine-protein kinase ROS [human]	inhibition rate	10	%
12960	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Tyrosine-protein kinase receptor TYRO3 [human]	inhibition rate	30	%
12961	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Tyrosine-protein kinase receptor TYRO3 [human]	inhibition rate	62	%
12962	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	-3	%
12963	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	0	%
12964	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Ribosomal protein S6 kinase alpha-2 [human]	inhibition rate	20	%
12965	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Ribosomal protein S6 kinase alpha-2 [human]	inhibition rate	3	%
12966	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Ribosomal protein S6 kinase alpha-6 [human]	inhibition rate	12	%
12967	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Ribosomal protein S6 kinase alpha-6 [human]	inhibition rate	14	%
12968	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Mitogen-activated protein kinase 14 [human]	inhibition rate	21	%
12969	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Mitogen-activated protein kinase 14 [human]	inhibition rate	74	%
12970	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Mitogen-activated protein kinase 11 [human]	inhibition rate	0	%
12971	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Mitogen-activated protein kinase 11 [human]	inhibition rate	37	%
12972	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Mitogen-activated protein kinase 12 [human]	inhibition rate	-1	%
12973	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Mitogen-activated protein kinase 12 [human]	inhibition rate	0	%
12974	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Mitogen-activated protein kinase 13 [human]	inhibition rate	-2	%
12975	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Mitogen-activated protein kinase 13 [human]	inhibition rate	-5	%
12976	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Kappa-stichotoxin-Sgt4a [human]	inhibition rate	-36	%
12977	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Kappa-stichotoxin-Sgt4a [human]	inhibition rate	-7	%
12978	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase BRSK1 [human]	inhibition rate	-6	%
12979	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase BRSK1 [human]	inhibition rate	-6	%
12980	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase Sgk2 [human]	inhibition rate	-10	%
12981	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase Sgk2 [human]	inhibition rate	-23	%
12982	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase Sgk3 [human]	inhibition rate	-10	%
12983	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase Sgk3 [human]	inhibition rate	-13	%
12984	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase SIK1 [human]	inhibition rate	-17	%
12985	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase SIK1 [human]	inhibition rate	-5	%
12986	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase PLK2 [human]	inhibition rate	2	%
12987	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase PLK2 [human]	inhibition rate	5	%
12988	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	CBL-interacting serine/threonine-protein kinase 7 [human]	inhibition rate	-10	%
12989	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	CBL-interacting serine/threonine-protein kinase 7 [human]	inhibition rate	-7	%
12990	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	SRSF protein kinase 2 [human]	inhibition rate	-1	%
12991	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	SRSF protein kinase 2 [human]	inhibition rate	0	%
12992	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase 33 [human]	inhibition rate	-5	%
12993	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase 33 [human]	inhibition rate	13	%
12994	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Mitogen-activated protein kinase kinase kinase 7 [human]	inhibition rate	13	%
12995	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Mitogen-activated protein kinase kinase kinase 7 [human]	inhibition rate	2	%
12996	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase TAO1 [human]	inhibition rate	12	%
12997	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase TAO1 [human]	inhibition rate	66	%
12998	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase TAO2 [human]	inhibition rate	84	%
12999	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase TAO2 [human]	inhibition rate	97	%
13000	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase BRSK2 [human]	inhibition rate	-3	%
13001	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase BRSK2 [human]	inhibition rate	-6	%
13002	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase TAO3 [human]	inhibition rate	70	%
13003	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase TAO3 [human]	inhibition rate	93	%
13004	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase TBK1 [human]	inhibition rate	2	%
13005	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase TBK1 [human]	inhibition rate	2	%
13006	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Tyrosine-protein kinase Tec [human]	inhibition rate	-3	%
13007	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Tyrosine-protein kinase Tec [human]	inhibition rate	-6	%
13008	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Angiopoietin-1 receptor [human]	inhibition rate	38	%
13009	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Angiopoietin-1 receptor [human]	inhibition rate	90	%
13010	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase TOUSLED-like 2 [human]	inhibition rate	-2	%
13011	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase TOUSLED-like 2 [human]	inhibition rate	-5	%
13012	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	High affinity nerve growth factor receptor [human]	inhibition rate	34	%
13013	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	High affinity nerve growth factor receptor [human]	inhibition rate	96	%
13014	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	BDNF/NT-3 growth factors receptor [human]	inhibition rate	33	%
13015	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	BDNF/NT-3 growth factors receptor [human]	inhibition rate	93	%
13016	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Testis-specific serine/threonine-protein kinase 1 [human]	inhibition rate	-3	%
13017	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Testis-specific serine/threonine-protein kinase 1 [human]	inhibition rate	2	%
13018	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Testis-specific serine/threonine-protein kinase 2 [human]	inhibition rate	-6	%
13019	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Testis-specific serine/threonine-protein kinase 2 [human]	inhibition rate	-7	%
13020	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Tyrosine-protein kinase TXK [human]	inhibition rate	-1	%
13021	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Tyrosine-protein kinase TXK [human]	inhibition rate	10	%
13022	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Calcium/calmodulin-dependent protein kinase type 1D [human]	inhibition rate	-15	%
13023	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Calcium/calmodulin-dependent protein kinase type 1D [human]	inhibition rate	22	%
13024	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase ULK2 [human]	inhibition rate	-1	%
13025	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase ULK2 [human]	inhibition rate	1	%
13026	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase ULK3 [human]	inhibition rate	-3	%
13027	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase ULK3 [human]	inhibition rate	4	%
13028	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase VRK2 [human]	inhibition rate	0	%
13029	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase VRK2 [human]	inhibition rate	6	%
13030	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase WNK2 [human]	inhibition rate	-2	%
13031	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase WNK2 [human]	inhibition rate	-5	%
13032	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase WNK3 [human]	inhibition rate	-3	%
13033	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase WNK3 [human]	inhibition rate	-6	%
13034	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Tyrosine-protein kinase Yes [human]	inhibition rate	15	%
13035	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Tyrosine-protein kinase Yes [human]	inhibition rate	16	%
13036	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Tyrosine-protein kinase ZAP-70 [human]	inhibition rate	34	%
13037	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Tyrosine-protein kinase ZAP-70 [human]	inhibition rate	36	%
13038	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Death-associated protein kinase 3 [human]	inhibition rate	-7	%
13039	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Death-associated protein kinase 3 [human]	inhibition rate	1	%
13040	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Receptor tyrosine-protein kinase erbB-4 [human]	inhibition rate	-6	%
13041	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Receptor tyrosine-protein kinase erbB-4 [human]	inhibition rate	1	%
13042	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Fibroblast growth factor receptor 3 [human]	inhibition rate	-21	%
13043	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Fibroblast growth factor receptor 3 [human]	inhibition rate	-29	%
13044	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Calcium/calmodulin-dependent protein kinase type II subunit beta [human]	inhibition rate	5	%
13045	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Calcium/calmodulin-dependent protein kinase type II subunit beta [human]	inhibition rate	5	%
13046	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	56	%
13047	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	80	%
13048	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Calcium/calmodulin-dependent protein kinase type II delta 2 chain [human]	inhibition rate	-1	%
13049	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Calcium/calmodulin-dependent protein kinase type II delta 2 chain [human]	inhibition rate	8	%
13050	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Tyrosine-protein kinase Abl [human]	inhibition rate	19	%
13051	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Tyrosine-protein kinase Abl [human]	inhibition rate	3	%
13052	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Calcium/calmodulin-dependent protein kinase type II subunit gamma [human]	inhibition rate	2	%
13053	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Calcium/calmodulin-dependent protein kinase type II subunit gamma [human]	inhibition rate	8	%
13054	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Calcium/calmodulin-dependent protein kinase type IV [human]	inhibition rate	-19	%
13055	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Calcium/calmodulin-dependent protein kinase type IV [human]	inhibition rate	0	%
13056	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Cyclin-B [human];+Cyclin-dependent kinase 1 [human]	inhibition rate	-5	%
13057	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Cyclin-B [human];+Cyclin-dependent kinase 1 [human]	inhibition rate	-7	%
13058	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Cyclin-dependent kinase 2 [human]; Cyclin E [human]	inhibition rate	-1	%
13059	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Cyclin-dependent kinase 2 [human]; Cyclin E [human]	inhibition rate	1	%
13060	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Cyclin E [human]; Cyclin-dependent kinase 3 [human]	inhibition rate	-10	%
13061	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Cyclin E [human]; Cyclin-dependent kinase 3 [human]	inhibition rate	-12	%
13062	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Cyclin-dependent kinase 5 activator 1, p25 [human]; Cyclin-dependent kinase 5 homolog [human]	inhibition rate	-10	%
13063	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Cyclin-dependent kinase 5 activator 1, p25 [human]; Cyclin-dependent kinase 5 homolog [human]	inhibition rate	3	%
13064	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Cyclin-dependent kinase 5 homolog [human]; Cyclin-dependent kinase 5 activator 1, p35 [human]	inhibition rate	-5	%
13065	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Cyclin-dependent kinase 5 homolog [human]; Cyclin-dependent kinase 5 activator 1, p35 [human]	inhibition rate	6	%
13066	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Cyclin-dependent kinase 6 [human];+Cyclin-D3-1 [human]	inhibition rate	-13	%
13067	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Cyclin-dependent kinase 6 [human];+Cyclin-D3-1 [human]	inhibition rate	-24	%
13068	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition rate	-13	%
13069	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition rate	3	%
13070	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Cyclin-dependent kinase 9 [human];+Cyclin-T1 [human]	inhibition rate	-10	%
13071	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Cyclin-dependent kinase 9 [human];+Cyclin-T1 [human]	inhibition rate	5	%
13072	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Casein kinase 1-like protein 1 [human]	inhibition rate	-16	%
13073	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Casein kinase 1-like protein 1 [human]	inhibition rate	-24	%
13074	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	casein kinase 1 gamma 1 [human]	inhibition rate	-3	%
13075	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	casein kinase 1 gamma 1 [human]	inhibition rate	0	%
13076	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Casein kinase I isoform gamma-2 [human]	inhibition rate	10	%
13077	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Casein kinase I isoform gamma-2 [human]	inhibition rate	9	%
13078	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Casein kinase 1 gamma 3 [human]	inhibition rate	0	%
13079	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Casein kinase 1 gamma 3 [human]	inhibition rate	3	%
13080	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Casein kinase II subunit alpha II [human]	inhibition rate	-6	%
13081	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Casein kinase II subunit alpha II [human]	inhibition rate	-8	%
13082	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	58	%
13083	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	6	%
13084	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Dual specificity protein kinase CLK2 [human]	inhibition rate	-14	%
13085	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Dual specificity protein kinase CLK2 [human]	inhibition rate	-9	%
13086	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Dual specificity protein kinase CLK3 [human]	inhibition rate	-3	%
13087	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Dual specificity protein kinase CLK3 [human]	inhibition rate	30	%
13088	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	RAF proto-oncogene serine/threonine-protein kinase [human]	inhibition rate	-14	%
13089	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	RAF proto-oncogene serine/threonine-protein kinase [human]	inhibition rate	46	%
13090	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	RNase E specificity factor CsrD [human]	inhibition rate	-11	%
13091	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	RNase E specificity factor CsrD [human]	inhibition rate	-6	%
13092	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Death-associated protein kinase 1 [human]	inhibition rate	-3	%
13093	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Death-associated protein kinase 1 [human]	inhibition rate	4	%
13094	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Death-associated protein kinase 2 [human]	inhibition rate	-6	%
13095	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Death-associated protein kinase 2 [human]	inhibition rate	3	%
13096	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase DCLK2 [human]	inhibition rate	-20	%
13097	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase DCLK2 [human]	inhibition rate	8	%
13098	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Discoidin domain-containing receptor 2 [human]	inhibition rate	73	%
13099	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Discoidin domain-containing receptor 2 [human]	inhibition rate	95	%
13100	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Myotonin-protein kinase [human]	inhibition rate	-6	%
13101	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Myotonin-protein kinase [human]	inhibition rate	-7	%
13102	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase 17A [human]	inhibition rate	-13	%
13103	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase 17A [human]	inhibition rate	-22	%
13104	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Dual specificity tyrosine-phosphorylation-regulated kinase 2 [human]	inhibition rate	-6	%
13105	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Dual specificity tyrosine-phosphorylation-regulated kinase 2 [human]	inhibition rate	-6	%
13106	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	eukaryotic elongation factor 2 kinase [human]	inhibition rate	-18	%
13107	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	eukaryotic elongation factor 2 kinase [human]	inhibition rate	-4	%
13108	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Ephrin type-A receptor 1 [human]	inhibition rate	0	%
13109	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Ephrin type-A receptor 1 [human]	inhibition rate	27	%
13110	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Ephrin type-A receptor 2 [human]	inhibition rate	40	%
13111	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Ephrin type-A receptor 2 [human]	inhibition rate	86	%
13112	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Ephrin type-A receptor 3 [human]	inhibition rate	14	%
13113	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Ephrin type-A receptor 3 [human]	inhibition rate	78	%
13114	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Ephrin type-A receptor 4 [human]	inhibition rate	3	%
13115	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Ephrin type-A receptor 4 [human]	inhibition rate	61	%
13116	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Ephrin type-A receptor 5 [human]	inhibition rate	17	%
13117	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Ephrin type-A receptor 5 [human]	inhibition rate	77	%
13118	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Ephrin type-A receptor 7 [human]	inhibition rate	25	%
13119	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Ephrin type-A receptor 7 [human]	inhibition rate	89	%
13120	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Ephrin type-A receptor 8 [human]	inhibition rate	26	%
13121	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Ephrin type-A receptor 8 [human]	inhibition rate	80	%
13122	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Ephrin type-B receptor 1 [human]	inhibition rate	4	%
13123	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Ephrin type-B receptor 1 [human]	inhibition rate	86	%
13124	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Ephrin type-B receptor 2 [human]	inhibition rate	3	%
13125	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Ephrin type-B receptor 2 [human]	inhibition rate	88	%
13126	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Ephrin type-B receptor 3 [human]	inhibition rate	63	%
13127	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Ephrin type-B receptor 3 [human]	inhibition rate	7	%
13128	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Ephrin type-B receptor 4 [human]	inhibition rate	83	%
13129	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Ephrin type-B receptor 4 [human]	inhibition rate	9	%
13130	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Focal adhesion kinase 1 [human]	inhibition rate	-7	%
13131	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Focal adhesion kinase 1 [human]	inhibition rate	1	%
13132	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Tyrosine-protein kinase Fer [human]	inhibition rate	-19	%
13133	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Tyrosine-protein kinase Fer [human]	inhibition rate	17	%
13134	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Tyrosine-protein kinase, Fes/Fps type [human]	inhibition rate	-9	%
13135	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Tyrosine-protein kinase, Fes/Fps type [human]	inhibition rate	75	%
13136	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Fibroblast growth factor receptor 1 [human]	inhibition rate	-3	%
13137	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Fibroblast growth factor receptor 1 [human]	inhibition rate	18	%
13138	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Fibroblast growth factor receptor 2 [human]	inhibition rate	-4	%
13139	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Fibroblast growth factor receptor 2 [human]	inhibition rate	-5	%
13140	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Fibroblast growth factor receptor 4 [human]	inhibition rate	-12	%
13141	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Fibroblast growth factor receptor 4 [human]	inhibition rate	-9	%
13142	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Tyrosine-protein kinase Fgr [human]	inhibition rate	-10	%
13143	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Tyrosine-protein kinase Fgr [human]	inhibition rate	-24	%
13144	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Vascular endothelial growth factor receptor 1 [human]	inhibition rate	78	%
13145	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Vascular endothelial growth factor receptor 1 [human]	inhibition rate	97	%
13146	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Vascular endothelial growth factor receptor 3 [human]	inhibition rate	114	%
13147	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Vascular endothelial growth factor receptor 3 [human]	inhibition rate	57	%
13148	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Macrophage colony-stimulating factor 1 receptor [human]	inhibition rate	30	%
13149	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Macrophage colony-stimulating factor 1 receptor [human]	inhibition rate	59	%
13150	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase mTOR [human]	inhibition rate	-10	%
13151	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase mTOR [human]	inhibition rate	-9	%
13152	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Tyrosine-protein kinase Fyn [human]	inhibition rate	11	%
13153	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Tyrosine-protein kinase Fyn [human]	inhibition rate	39	%
13154	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Mitogen-activated protein kinase kinase kinase kinase 2 [human]	inhibition rate	-10	%
13155	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Mitogen-activated protein kinase kinase kinase kinase 2 [human]	inhibition rate	19	%
13156	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	G protein-coupled receptor kinase 5 [human]	inhibition rate	-1	%
13157	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	G protein-coupled receptor kinase 5 [human]	inhibition rate	-2	%
13158	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	G protein-coupled receptor kinase 6 [human]	inhibition rate	-7	%
13159	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	G protein-coupled receptor kinase 6 [human]	inhibition rate	6	%
13160	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Rhodopsin kinase [human]	inhibition rate	-10	%
13161	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Rhodopsin kinase [human]	inhibition rate	-9	%
13162	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Glycogen synthase kinase-3 [human]	inhibition rate	-17	%
13163	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Glycogen synthase kinase-3 [human]	inhibition rate	-6	%
13164	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase haspin [human]	inhibition rate	-8	%
13165	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase haspin [human]	inhibition rate	5	%
13166	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Tyrosine-protein kinase HCK [human]	inhibition rate	-5	%
13167	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Tyrosine-protein kinase HCK [human]	inhibition rate	31	%
13168	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Homeodomain-interacting protein kinase 1 [human]	inhibition rate	-13	%
13169	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Homeodomain-interacting protein kinase 1 [human]	inhibition rate	-9	%
13170	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Homeodomain-interacting protein kinase 3 [human]	inhibition rate	-9	%
13171	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Homeodomain-interacting protein kinase 3 [human]	inhibition rate	3	%
13172	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Acetate kinase 1 [human]	inhibition rate	6	%
13173	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Acetate kinase 1 [human]	inhibition rate	8	%
13174	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Inhibitor of nuclear factor kappa-B kinase subunit alpha [human]	inhibition rate	-14	%
13175	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Inhibitor of nuclear factor kappa-B kinase subunit alpha [human]	inhibition rate	-4	%
13176	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition rate	-2	%
13177	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition rate	-2	%
13178	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Interleukin-1 receptor-associated kinase 1 [human]	inhibition rate	0	%
13179	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Interleukin-1 receptor-associated kinase 1 [human]	inhibition rate	22	%
13180	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	ATP-sensitive inward rectifier potassium channel 14 [human]	inhibition rate	-13	%
13181	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	ATP-sensitive inward rectifier potassium channel 14 [human]	inhibition rate	-14	%
13182	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Insulin receptor-related protein [human]	inhibition rate	-31	%
13183	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Insulin receptor-related protein [human]	inhibition rate	0	%
13184	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Transcription factor PRE6 [human]	inhibition rate	92	%
13185	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Transcription factor PRE6 [human]	inhibition rate	96	%
13186	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	LIM domain kinase 1 [human]	inhibition rate	6	%
13187	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	LIM domain kinase 1 [human]	inhibition rate	8	%
13188	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase stk11 homolog [human]	inhibition rate	-1	%
13189	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase stk11 homolog [human]	inhibition rate	-3	%
13190	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Ovarian-specific serine/threonine-protein kinase Lok [human]	inhibition rate	-18	%
13191	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Ovarian-specific serine/threonine-protein kinase Lok [human]	inhibition rate	13	%
13192	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Mitogen-activated protein kinase 1 [human]	inhibition rate	-11	%
13193	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Mitogen-activated protein kinase 1 [human]	inhibition rate	-32	%
13194	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Activin receptor type-1B [human]	inhibition rate	-1	%
13195	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Activin receptor type-1B [human]	inhibition rate	1	%
13196	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Mitogen-activated protein kinase 3 [human]	inhibition rate	-14	%
13197	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Mitogen-activated protein kinase 3 [human]	inhibition rate	-8	%
13198	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	MAP kinase-activated protein kinase 3 [human]	inhibition rate	-5	%
13199	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	MAP kinase-activated protein kinase 3 [human]	inhibition rate	-8	%
13200	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase MARK1 [human]	inhibition rate	-11	%
13201	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Serine/threonine-protein kinase MARK1 [human]	inhibition rate	-8	%
13202	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Meiosis-specific serine/threonine-protein kinase MEK1 [human]	inhibition rate	-4	%
13203	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Meiosis-specific serine/threonine-protein kinase MEK1 [human]	inhibition rate	-6	%
13204	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Tyrosine-protein kinase Mer [human]	inhibition rate	77	%
13205	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Tyrosine-protein kinase Mer [human]	inhibition rate	99	%
13206	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Hepatocyte growth factor receptor [human]	inhibition rate	23	%
13207	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Hepatocyte growth factor receptor [human]	inhibition rate	89	%
13208	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Misshapen-like kinase 1 [human]	inhibition rate	-9	%
13209	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Misshapen-like kinase 1 [human]	inhibition rate	1	%
13210	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Dual specificity mitogen-activated protein kinase kinase 4 [human]	inhibition rate	-11	%
13211	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Dual specificity mitogen-activated protein kinase kinase 4 [human]	inhibition rate	-6	%
13212	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Dual specificity mitogen-activated protein kinase kinase 6 [human]	inhibition rate	21	%
13213	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Dual specificity mitogen-activated protein kinase kinase 6 [human]	inhibition rate	3	%
13214	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Dual specificity mitogen-activated protein kinase kinase 7 beta [human]	inhibition rate	-13	%
13215	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Dual specificity mitogen-activated protein kinase kinase 7 beta [human]	inhibition rate	-17	%
13216	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Arginase [human]	inhibition rate	10	%
13217	Cl[H].CNC1=CC(OC2=C(Cl)C=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)C=C2Cl)=NC=N1	Arginase [human]	inhibition rate	29	%
13218	Cl[H].CCC1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC=C2	Cyclin-H;+Cyclin-dependent kinase 7	Kd (dissociation constant)	0.4	nM
13219	Cl[H].CCC1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 12;+Cyclin-K	IC50	135	nM
13220	Cl[H].CCC1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7 [human]	EC50	230	nM
13221	Cl[H].CCC1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 9;+Cyclin-T1	IC50	430	nM
13222	Cl[H].CCC1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 2;+G1/S-specific cyclin-E2	IC50	923	nM
13223	Cl[H].CCC1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC=C2		CLint (intrinsic clearance)	107	ml/min/kg
13224	Cl[H].CCC1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC=C2		Papp (A-B)	4.9E-7	cm/s
13225	Cl[H].CCC1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC=C2		CL u	473	ml/min/kg
13226	Cl[H].CCC1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC=C2		F (drug bioavailability)	2	%
13227	Cl[H].FC(F)(F)C1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC=C2	Cyclin-H;+Cyclin-dependent kinase 7	Kd (dissociation constant)	0.15	nM
13228	Cl[H].FC(F)(F)C1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 7 [human]	EC50	11	nM
13229	Cl[H].FC(F)(F)C1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 9;+Cyclin-T1	IC50	21	nM
13230	Cl[H].FC(F)(F)C1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 12;+Cyclin-K	IC50	24	nM
13231	Cl[H].FC(F)(F)C1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC=C2	Cyclin-dependent kinase 2;+G1/S-specific cyclin-E2	IC50	42	nM
13232	Cl[H].FC(F)(F)C1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC=C2		CLint (intrinsic clearance)	127	ml/min/kg
13233	Cl[H].FC(F)(F)C1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC=C2		Papp (A-B)	1.108E-5	cm/s
13234	Cl[H].FC(F)(F)C1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC=C2		CL u	568	ml/min/kg
13235	Cl[H].FC(F)(F)C1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC=C2		F (drug bioavailability)	100	%
13236	FC(F)(F)C1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC(=C2)C#N	Cyclin-H;+Cyclin-dependent kinase 7	Kd (dissociation constant)	0.09	nM
13237	FC(F)(F)C1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC(=C2)C#N	Cyclin-dependent kinase 7 [human]	EC50	36	nM
13238	FC(F)(F)C1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC(=C2)C#N	Cyclin-dependent kinase 12;+Cyclin-K	IC50	60	nM
13239	FC(F)(F)C1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC(=C2)C#N	Cyclin-dependent kinase 9;+Cyclin-T1	IC50	86	nM
13240	FC(F)(F)C1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC(=C2)C#N	Cyclin-dependent kinase 2;+G1/S-specific cyclin-E2	IC50	347	nM
13241	FC(F)(F)C1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC(=C2)C#N		CLint (intrinsic clearance)	62	ml/min/kg
13242	FC(F)(F)C1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC(=C2)C#N		Papp (A-B)	4.63E-6	cm/s
13243	FC(F)(F)C1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC(=C2)C#N		CL u	956	ml/min/kg
13244	FC(F)(F)C1=CN=C(N[C@H]2CCCNC2)N=C1C1=CNC2=C1C=CC(=C2)C#N		F (drug bioavailability)	43	%
13245	C[C@@H]1NC(=O)C2(CCCCC2)N2C1=CC1=CN=C(NC3=CC=C(C=C3)S(N)(=O)=O)N=C21	Cyclin-A1; Cyclin-dependent kinase 2	IC50	0.0043	μM
13246	C[C@@H]1NC(=O)C2(CCCCC2)N2C1=CC1=CN=C(NC3=CC=C(C=C3)S(N)(=O)=O)N=C21	Cyclin-dependent kinase 2; G1/S-specific cyclin-E	IC50	0.0048	μM
13247	C[C@@H]1NC(=O)C2(CCCCC2)N2C1=CC1=CN=C(NC3=CC=C(C=C3)S(N)(=O)=O)N=C21	Cyclin-T1; Cyclin-dependent kinase 9	IC50	0.022	μM
13248	C[C@@H]1NC(=O)C2(CCCCC2)N2C1=CC1=CN=C(NC3=CC=C(C=C3)S(N)(=O)=O)N=C21	G1/S-specific cyclin-E; Cyclin-dependent kinase 3	IC50	0.034	μM
13249	C[C@@H]1NC(=O)C2(CCCCC2)N2C1=CC1=CN=C(NC3=CC=C(C=C3)S(N)(=O)=O)N=C21	G1/S-specific cyclin-D1; Cyclin-dependent kinase 4	IC50	0.04	μM
13250	C[C@@H]1NC(=O)C2(CCCCC2)N2C1=CC1=CN=C(NC3=CC=C(C=C3)S(N)(=O)=O)N=C21	Cyclin-dependent kinase 1	IC50	0.04	μM
13251	C[C@@H]1NC(=O)C2(CCCCC2)N2C1=CC1=CN=C(NC3=CC=C(C=C3)S(N)(=O)=O)N=C21	Cyclin-dependent-like kinase 5	IC50	0.05	μM
13252	C[C@@H]1NC(=O)C2(CCCCC2)N2C1=CC1=CN=C(NC3=CC=C(C=C3)S(N)(=O)=O)N=C21	Cyclin-dependent-like kinase 5; Cyclin-dependent kinase 5 activator 1, p25	IC50	0.062	μM
13253	C[C@@H]1NC(=O)C2(CCCCC2)N2C1=CC1=CN=C(NC3=CC=C(C=C3)S(N)(=O)=O)N=C21	G1/S-specific cyclin-D3; Cyclin-dependent kinase 6	IC50	0.21	μM
13254	C[C@@H]1NC(=O)C2(CCCCC2)N2C1=CC1=CN=C(NC3=CC=C(C=C3)S(N)(=O)=O)N=C21	Cyclin-dependent kinase 7	IC50	0.8	μM
13255	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4NNC(=O)C5(CCCCC5)N4C3=N2)C=C1	Cyclin-dependent kinase 2; G1/S-specific cyclin-E	IC50	0.00056	μM
13256	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4NNC(=O)C5(CCCCC5)N4C3=N2)C=C1	Cyclin-A1; Cyclin-dependent kinase 2	IC50	0.0025	μM
13257	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4NNC(=O)C5(CCCCC5)N4C3=N2)C=C1	G1/S-specific cyclin-E; Cyclin-dependent kinase 3	IC50	0.0099	μM
13258	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4NNC(=O)C5(CCCCC5)N4C3=N2)C=C1	Cyclin-dependent-like kinase 5; Cyclin-dependent kinase 5 activator 1, p25	IC50	0.014	μM
13259	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4NNC(=O)C5(CCCCC5)N4C3=N2)C=C1	Cyclin-dependent-like kinase 5	IC50	0.017	μM
13260	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4NNC(=O)C5(CCCCC5)N4C3=N2)C=C1	Cyclin-dependent kinase 1	IC50	0.033	μM
13261	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4NNC(=O)C5(CCCCC5)N4C3=N2)C=C1	Cyclin-T1; Cyclin-dependent kinase 9	IC50	0.062	μM
13262	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4NNC(=O)C5(CCCCC5)N4C3=N2)C=C1	G1/S-specific cyclin-D1; Cyclin-dependent kinase 4	IC50	0.13	μM
13263	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4NNC(=O)C5(CCCCC5)N4C3=N2)C=C1	G1/S-specific cyclin-D3; Cyclin-dependent kinase 6	IC50	0.35	μM
13264	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4NNC(=O)C5(CCCCC5)N4C3=N2)C=C1	Cyclin-dependent kinase 7	IC50	1	μM
13265	CC1C(=O)N(C)C2=CC3=CN=C(NC4=CC=C(C=C4)S(N)(=O)=O)N=C3N2C11CCCCC1	Cyclin-A1; Cyclin-dependent kinase 2	IC50	4	nM
13266	CC1C(=O)N(C)C2=CC3=CN=C(NC4=CC=C(C=C4)S(N)(=O)=O)N=C3N2C11CCCCC1	Cyclin-dependent kinase 2; G1/S-specific cyclin-E	IC50	4	nM
13267	CC1C(=O)N(C)C2=CC3=CN=C(NC4=CC=C(C=C4)S(N)(=O)=O)N=C3N2C11CCCCC1	Cyclin-dependent-like kinase 5	IC50	15	nM
13268	CC1C(=O)N(C)C2=CC3=CN=C(NC4=CC=C(C=C4)S(N)(=O)=O)N=C3N2C11CCCCC1	Cyclin-T1; Cyclin-dependent kinase 9	IC50	21	nM
13269	CC1C(=O)N(C)C2=CC3=CN=C(NC4=CC=C(C=C4)S(N)(=O)=O)N=C3N2C11CCCCC1	G1/S-specific cyclin-E; Cyclin-dependent kinase 3	IC50	29	nM
13270	CC1C(=O)N(C)C2=CC3=CN=C(NC4=CC=C(C=C4)S(N)(=O)=O)N=C3N2C11CCCCC1	Cyclin-dependent kinase 1	IC50	33	nM
13271	CC1C(=O)N(C)C2=CC3=CN=C(NC4=CC=C(C=C4)S(N)(=O)=O)N=C3N2C11CCCCC1	G1/S-specific cyclin-D1; Cyclin-dependent kinase 4	IC50	69	nM
13272	CC1C(=O)N(C)C2=CC3=CN=C(NC4=CC=C(C=C4)S(N)(=O)=O)N=C3N2C11CCCCC1	G1/S-specific cyclin-D3; Cyclin-dependent kinase 6	IC50	186	nM
13273	CC1C(=O)N(C)C2=CC3=CN=C(NC4=CC=C(C=C4)S(N)(=O)=O)N=C3N2C11CCCCC1	Cyclin-dependent kinase 7	IC50	250	nM
13274	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4C(O)NC(=O)C5(CCCCC5)N4C3=N2)C=C1	Cyclin-A1; Cyclin-dependent kinase 2	IC50	0.00016	μM
13275	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4C(O)NC(=O)C5(CCCCC5)N4C3=N2)C=C1	Cyclin-dependent kinase 2; G1/S-specific cyclin-E	IC50	0.00034	μM
13276	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4C(O)NC(=O)C5(CCCCC5)N4C3=N2)C=C1	Cyclin-dependent-like kinase 5	IC50	0.00068	μM
13277	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4C(O)NC(=O)C5(CCCCC5)N4C3=N2)C=C1	Cyclin-dependent-like kinase 5; Cyclin-dependent kinase 5 activator 1, p25	IC50	0.0008	μM
13278	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4C(O)NC(=O)C5(CCCCC5)N4C3=N2)C=C1	G1/S-specific cyclin-E; Cyclin-dependent kinase 3	IC50	0.00094	μM
13279	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4C(O)NC(=O)C5(CCCCC5)N4C3=N2)C=C1	Cyclin-T1; Cyclin-dependent kinase 9	IC50	0.0014	μM
13280	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4C(O)NC(=O)C5(CCCCC5)N4C3=N2)C=C1	Cyclin-dependent kinase 1	IC50	0.0022	μM
13281	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4C(O)NC(=O)C5(CCCCC5)N4C3=N2)C=C1	G1/S-specific cyclin-D1; Cyclin-dependent kinase 4	IC50	0.0031	μM
13282	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4C(O)NC(=O)C5(CCCCC5)N4C3=N2)C=C1	G1/S-specific cyclin-D3; Cyclin-dependent kinase 6	IC50	0.0075	μM
13283	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4C(O)NC(=O)C5(CCCCC5)N4C3=N2)C=C1	Cyclin-dependent kinase 7	IC50	0.56	μM
13284	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4[C@H](CF)NC(=O)C5(CCCCC5)N4C3=N2)C=C1	Cyclin-A1; Cyclin-dependent kinase 2	IC50	0.0017	μM
13285	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4[C@H](CF)NC(=O)C5(CCCCC5)N4C3=N2)C=C1	Cyclin-dependent kinase 2; G1/S-specific cyclin-E	IC50	0.0027	μM
13286	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4[C@H](CF)NC(=O)C5(CCCCC5)N4C3=N2)C=C1	Cyclin-T1; Cyclin-dependent kinase 9	IC50	0.01	μM
13287	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4[C@H](CF)NC(=O)C5(CCCCC5)N4C3=N2)C=C1	Cyclin-dependent-like kinase 5	IC50	0.016	μM
13288	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4[C@H](CF)NC(=O)C5(CCCCC5)N4C3=N2)C=C1	Cyclin-dependent-like kinase 5; Cyclin-dependent kinase 5 activator 1, p25	IC50	0.017	μM
13289	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4[C@H](CF)NC(=O)C5(CCCCC5)N4C3=N2)C=C1	G1/S-specific cyclin-E; Cyclin-dependent kinase 3	IC50	0.018	μM
13290	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4[C@H](CF)NC(=O)C5(CCCCC5)N4C3=N2)C=C1	Cyclin-dependent kinase 1	IC50	0.02	μM
13291	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4[C@H](CF)NC(=O)C5(CCCCC5)N4C3=N2)C=C1	G1/S-specific cyclin-D1; Cyclin-dependent kinase 4	IC50	0.033	μM
13292	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4[C@H](CF)NC(=O)C5(CCCCC5)N4C3=N2)C=C1	G1/S-specific cyclin-D3; Cyclin-dependent kinase 6	IC50	0.15	μM
13293	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4[C@H](CF)NC(=O)C5(CCCCC5)N4C3=N2)C=C1	Cyclin-dependent kinase 7	IC50	0.84	μM
13294	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4NC(=O)CC5(CCCCC5)N4C3=N2)C=C1	Cyclin-A1; Cyclin-dependent kinase 2	IC50	0.0004	μM
13295	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4NC(=O)CC5(CCCCC5)N4C3=N2)C=C1	Cyclin-dependent kinase 2; G1/S-specific cyclin-E	IC50	0.0005	μM
13296	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4NC(=O)CC5(CCCCC5)N4C3=N2)C=C1	Cyclin-dependent-like kinase 5; Cyclin-dependent kinase 5 activator 1, p25	IC50	0.0013	μM
13297	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4NC(=O)CC5(CCCCC5)N4C3=N2)C=C1	Cyclin-dependent-like kinase 5	IC50	0.0014	μM
13298	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4NC(=O)CC5(CCCCC5)N4C3=N2)C=C1	G1/S-specific cyclin-E; Cyclin-dependent kinase 3	IC50	0.0028	μM
13299	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4NC(=O)CC5(CCCCC5)N4C3=N2)C=C1	Cyclin-dependent kinase 1	IC50	0.0037	μM
13300	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4NC(=O)CC5(CCCCC5)N4C3=N2)C=C1	Cyclin-T1; Cyclin-dependent kinase 9	IC50	0.0045	μM
13301	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4NC(=O)CC5(CCCCC5)N4C3=N2)C=C1	G1/S-specific cyclin-D1; Cyclin-dependent kinase 4	IC50	0.041	μM
13302	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4NC(=O)CC5(CCCCC5)N4C3=N2)C=C1	G1/S-specific cyclin-D3; Cyclin-dependent kinase 6	IC50	0.098	μM
13303	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4NC(=O)CC5(CCCCC5)N4C3=N2)C=C1	Cyclin-dependent kinase 7	IC50	0.2	μM
13304	CN1NC(=O)C2(CCCCC2)N2C1=CC1=CN=C(NC3=CC=C(C=C3)S(N)(=O)=O)N=C21	Cyclin-A1; Cyclin-dependent kinase 2	IC50	0.0092	μM
13305	CN1NC(=O)C2(CCCCC2)N2C1=CC1=CN=C(NC3=CC=C(C=C3)S(N)(=O)=O)N=C21	Cyclin-dependent kinase 2; G1/S-specific cyclin-E	IC50	0.013	μM
13306	CN1NC(=O)C2(CCCCC2)N2C1=CC1=CN=C(NC3=CC=C(C=C3)S(N)(=O)=O)N=C21	G1/S-specific cyclin-D1; Cyclin-dependent kinase 4	IC50	0.028	μM
13307	CN1NC(=O)C2(CCCCC2)N2C1=CC1=CN=C(NC3=CC=C(C=C3)S(N)(=O)=O)N=C21	G1/S-specific cyclin-E; Cyclin-dependent kinase 3	IC50	0.059	μM
13308	CN1NC(=O)C2(CCCCC2)N2C1=CC1=CN=C(NC3=CC=C(C=C3)S(N)(=O)=O)N=C21	Cyclin-dependent kinase 1	IC50	0.088	μM
13309	CN1NC(=O)C2(CCCCC2)N2C1=CC1=CN=C(NC3=CC=C(C=C3)S(N)(=O)=O)N=C21	Cyclin-dependent-like kinase 5	IC50	0.12	μM
13310	CN1NC(=O)C2(CCCCC2)N2C1=CC1=CN=C(NC3=CC=C(C=C3)S(N)(=O)=O)N=C21	Cyclin-dependent-like kinase 5; Cyclin-dependent kinase 5 activator 1, p25	IC50	0.14	μM
13311	CN1NC(=O)C2(CCCCC2)N2C1=CC1=CN=C(NC3=CC=C(C=C3)S(N)(=O)=O)N=C21	G1/S-specific cyclin-D3; Cyclin-dependent kinase 6	IC50	0.16	μM
13312	CN1NC(=O)C2(CCCCC2)N2C1=CC1=CN=C(NC3=CC=C(C=C3)S(N)(=O)=O)N=C21	Cyclin-T1; Cyclin-dependent kinase 9	IC50	0.18	μM
13313	CN1NC(=O)C2(CCCCC2)N2C1=CC1=CN=C(NC3=CC=C(C=C3)S(N)(=O)=O)N=C21	Cyclin-dependent kinase 7	IC50	1	μM
13314	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	IC50	0.013	μM
13315	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	IC50	0.069	μM
13316	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	IC50	0.11	μM
13317	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	IC50	0.77	μM
13318	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [human]	EC50	1.6	μM
13319	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [human]	EC50	2.1	μM
13320	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Cytochrome P450 2C8 [human]	IC50	2.3	μM
13321	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Potassium voltage-gated channel subfamily H member 2	IC50	3.1	μM
13322	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Cytochrome P450 2C9 [human]	IC50	3.4	μM
13323	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Cytochrome P450 3A4 [human]	IC50	8.35	μM
13324	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O		IC50	9.5	μM
13325	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Cytochrome P450 3A4 [human]	IC50	10	μM
13326	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O		EC50	18.1	μM
13327	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O		IC50	21.2	μM
13328	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O		IC50	30	μM
13329	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Cytochrome P450 2D6 [human]	IC50	10	μM
13330	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Cytochrome P450 1A1 [human]	IC50	10	μM
13331	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O		IC50	50	μM
13332	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O		protein expression level increase		
13333	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O		protein expression level increase		
13334	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O		protein expression level increase		
13335	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma [human]	inhibition percentage	9.94	%
13336	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Mitogen-activated protein kinase 10 [human]	inhibition percentage	9.89	%
13337	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Protein kinase C alpha type [human]	inhibition percentage	9.84	%
13338	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase 4 [human]	inhibition percentage	9.79	%
13339	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Ribosomal protein S6 kinase alpha-4 [human]	inhibition percentage	9.56	%
13340	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase MARK1 [human]	inhibition percentage	9.47	%
13341	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Ribosomal protein S6 kinase alpha-2 [human]	inhibition percentage	9.31	%
13342	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Cytochrome P450 52B1 [human]	inhibition percentage	9.15	%
13343	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Phosphatidylinositol 3-kinase (p110b/p85a) [human]	inhibition percentage	8.75	%
13344	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Ribosomal protein S6 kinase alpha-1 [human]	inhibition percentage	8.68	%
13345	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [human]	inhibition percentage	142.36	%
13346	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Tau-tubulin kinase 1 [human]	inhibition percentage	8.4	%
13347	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Platelet-derived growth factor receptor beta [human]	inhibition percentage	8.33	%
13348	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Beta-adrenergic receptor kinase 1 [human]	inhibition percentage	7.94	%
13349	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Homeodomain-interacting protein kinase 2 [human]	inhibition percentage	7.75	%
13350	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Mitogen-activated protein kinase kinase kinase 20 [human]	inhibition percentage	7.75	%
13351	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase tousled-like 1 [human]	inhibition percentage	7.42	%
13352	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Target of rapamycin complex subunit LST8 [human]	inhibition percentage	7.39	%
13353	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase pim-3 [human]	inhibition percentage	7.17	%
13354	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase Nek3 [human]	inhibition percentage	7.13	%
13355	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Mitogen-activated protein kinase kinase kinase 7 [human]	inhibition percentage	7.11	%
13356	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Sequestosome-1 [human]	inhibition percentage	7.04	%
13357	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Tyrosine-protein kinase Tec, activated [human]	inhibition percentage	6.88	%
13358	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Protein kinase C beta type 1 [human]	inhibition percentage	6.82	%
13359	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase D1 [human]	inhibition percentage	6.8	%
13360	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform [human]	inhibition percentage	6.79	%
13361	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase RCK2 [human]	inhibition percentage	6.65	%
13362	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Interleukin-1 receptor-associated kinase 1 [human]	inhibition percentage	6.59	%
13363	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Tyrosine-protein kinase TXK [human]	inhibition percentage	6.48	%
13364	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Protein kinase C gamma type [human]	inhibition percentage	6.37	%
13365	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	DNA-dependent protein kinase catalytic subunit [human]	inhibition percentage	6.06	%
13366	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Mitogen-activated protein kinase kinase kinase 9 [human]	inhibition percentage	5.93	%
13367	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Ribosomal protein S6 kinase alpha-3 [human]	inhibition percentage	5.88	%
13368	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Aurora kinase B [human]	inhibition percentage	5.84	%
13369	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Mitogen-activated protein kinase kinase kinase kinase 5 [human]	inhibition percentage	5.6	%
13370	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	BDNF/NT-3 growth factors receptor [human]	inhibition percentage	5.6	%
13371	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase TAO3 [human]	inhibition percentage	5.54	%
13372	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Mitogen-activated protein kinase kinase kinase 3 [human]	inhibition percentage	5.47	%
13373	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	1-phosphatidylinositol-3-kinase C2a [human]	inhibition percentage	5.09	%
13374	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Acetate kinase 1 [human]	inhibition percentage	5.08	%
13375	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Cyclin-dependent kinase 2 [human];+Cyclin E [human]	inhibition percentage	5.05	%
13376	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	RAC-beta serine/threonine-protein kinase [human]	inhibition percentage	5	%
13377	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase TAO1 [human]	inhibition percentage	4.97	%
13378	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase Plk4 [human]	inhibition percentage	4.63	%
13379	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase 32B [human]	inhibition percentage	4.63	%
13380	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase SIK2 [human]	inhibition percentage	4.47	%
13381	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	RAC-gamma serine/threonine-protein kinase [human]	inhibition percentage	4.4	%
13382	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Mitogen-activated protein kinase kinase kinase kinase 3 [human]	inhibition percentage	4.37	%
13383	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Vascular endothelial growth factor receptor 1 [human]	inhibition percentage	4.25	%
13384	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Rho-associated protein kinase 1 [human]	inhibition percentage	4.15	%
13385	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase D2 [human]	inhibition percentage	4.1	%
13386	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Citron Rho-interacting kinase [human]	inhibition percentage	3.99	%
13387	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Platelet-derived growth factor receptor alpha [human]	inhibition percentage	3.9	%
13388	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Tyrosine-protein kinase, Fes/Fps type [human]	inhibition percentage	3.83	%
13389	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Receptor tyrosine-protein kinase erbB-2 [human]	inhibition percentage	3.72	%
13390	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase pim-1 [human]	inhibition percentage	3.7	%
13391	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase Nek5 [human]	inhibition percentage	3.68	%
13392	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	STE20-like serine/threonine-protein kinase [human]	inhibition percentage	3.45	%
13393	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Cyclin-dependent kinase-like 4 [human]	inhibition percentage	3.37	%
13394	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase D3 [human]	inhibition percentage	3.21	%
13395	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase 35 [human]	inhibition percentage	3.13	%
13396	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase ULK3 [human]	inhibition percentage	2.94	%
13397	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	LIM domain kinase 1 [human]	inhibition percentage	2.89	%
13398	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase DCLK3 [human]	inhibition percentage	2.84	%
13399	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Calcium/calmodulin-dependent protein kinase kinase 1 [human]	inhibition percentage	2.62	%
13400	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Cyclin-dependent kinase 2 [human];+Cyclin-A2 [human]	inhibition percentage	2.15	%
13401	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Protein kinase C iota type [human]	inhibition percentage	2.07	%
13402	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial [human]	inhibition percentage	1.99	%
13403	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase TAO2 [human]	inhibition percentage	1.9	%
13404	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	cAMP-dependent protein kinase catalytic subunit beta [human]	inhibition percentage	1.77	%
13405	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Interleukin-1 receptor-associated kinase 4 [human]	inhibition percentage	1.74	%
13406	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Cyclin-dependent kinase-like 2 [human]	inhibition percentage	1.68	%
13407	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Homeodomain-interacting protein kinase 3 [human]	inhibition percentage	1.59	%
13408	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Tyrosine-protein kinase Abl [human]	inhibition percentage	1.43	%
13409	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Cell division cycle 7-related protein kinase [human];+Cyclin-B1-1 [human]	inhibition percentage	1.34	%
13410	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Protein kinase C beta type 2 [human]	inhibition percentage	1.32	%
13411	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Fibroblast growth factor receptor 4 [human]	inhibition percentage	1.26	%
13412	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase 32C [human]	inhibition percentage	1.18	%
13413	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Cyclin-dependent kinase 6 [human];+Cyclin-D3-1 [human]	inhibition percentage	1.06	%
13414	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	ABC transporter F family member 2 [human]	inhibition percentage	0.98	%
13415	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Testis-specific serine/threonine-protein kinase 4 [human]	inhibition percentage	0.96	%
13416	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	3-phosphoinositide-dependent protein kinase 1 [human]	inhibition percentage	0.81	%
13417	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase SIK3 [human]	inhibition percentage	0.49	%
13418	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Leucine-rich repeat serine/threonine-protein kinase 2 [human]	inhibition percentage	0.43	%
13419	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Inositol-pentakisphosphate 2-kinase [human]	inhibition percentage	0.41	%
13420	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase 33 [human]	inhibition percentage	0.37	%
13421	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Tau-tubulin kinase 2 [human]	inhibition percentage	0.24	%
13422	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Ephrin type-A receptor 3 [human]	inhibition percentage	0.16	%
13423	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase Nek9 [human]	inhibition percentage	0.08	%
13424	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	MAP kinase-activated protein kinase 3 [human]	inhibition percentage	0.06	%
13425	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Ephrin type-A receptor 2 [human]	inhibition percentage	-0.2	%
13426	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Bone morphogenetic protein receptor type-2 [human]	inhibition percentage	-0.29	%
13427	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase Sgk1 [human]	inhibition percentage	-0.4	%
13428	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition percentage	-0.4	%
13429	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	SRSF protein kinase 2 [human]	inhibition percentage	-0.42	%
13430	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Taste receptor type 2 member 10 [human]	inhibition percentage	-0.5	%
13431	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Angiopoietin-1 receptor [human]	inhibition percentage	-0.59	%
13432	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase OSR1 [human]	inhibition percentage	-0.63	%
13433	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	mTOR Peptidyl-prolyl cis-trans isomerase FKBP12 [human]	inhibition percentage	-0.69	%
13434	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	phosphatidylinositol 4-phosphate 5-kinase 1 alpha [human]	inhibition percentage	-0.72	%
13435	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	DNA-directed RNA polymerase subunit beta [human]	inhibition percentage	-0.83	%
13436	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Fibroblast growth factor receptor 3 [human]	inhibition percentage	-0.85	%
13437	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase ULK1 [human]	inhibition percentage	-0.93	%
13438	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Dual specificity protein kinase TTK [human]	inhibition percentage	-1.13	%
13439	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	RAC-alpha serine/threonine-protein kinase [human]	inhibition percentage	-1.27	%
13440	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Cyclin-B1-1 [human];+Cyclin-dependent kinase 1 [human]	inhibition percentage	-1.28	%
13441	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Mitogen-activated protein kinase kinase kinase kinase 4 [human]	inhibition percentage	-1.45	%
13442	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	LIM domain kinase 2 [human]	inhibition percentage	-1.46	%
13443	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase DCLK1 [human]	inhibition percentage	-1.51	%
13444	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Dual specificity mitogen-activated protein kinase kinase 2 [human]	inhibition percentage	-1.63	%
13445	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Mitosis inhibitor protein kinase wee1 [human]	inhibition percentage	-1.73	%
13446	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Maternal embryonic leucine zipper kinase [human]	inhibition percentage	-1.89	%
13447	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	cGMP-dependent protein kinase 2 [human]	inhibition percentage	-2.05	%
13448	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase PAK 4 [human]	inhibition percentage	-2.13	%
13449	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase WNK4 [human]	inhibition percentage	-2.19	%
13450	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Tyrosine-protein kinase SYK [human]	inhibition percentage	-2.21	%
13451	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Cyclin-dependent kinase 4 [human];+Cyclin-D3-1 [human]	inhibition percentage	-2.22	%
13452	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Insulin-like growth factor 1 receptor, activated [human]	inhibition percentage	-2.32	%
13453	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	cGMP-dependent protein kinase, isozyme 1 alpha [human]	inhibition percentage	-2.39	%
13454	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	TGF-beta receptor type-1 [human]	inhibition percentage	-2.46	%
13455	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Dual specificity mitogen-activated protein kinase kinase 6 [human]	inhibition percentage	-2.48	%
13456	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Mitogen-activated protein kinase 1 [human]	inhibition percentage	-2.51	%
13457	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Focal adhesion kinase 1 [human]	inhibition percentage	-2.54	%
13458	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Mitogen-activated protein kinase kinase kinase 5 [human]	inhibition percentage	-2.59	%
13459	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase ATR [human]	inhibition percentage	-2.62	%
13460	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase PAK 3 [human]	inhibition percentage	-2.64	%
13461	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase haspin [human]	inhibition percentage	-2.9	%
13462	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Mitogen-activated protein kinase kinase kinase kinase 2 [human]	inhibition percentage	-2.96	%
13463	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase BRSK2 [human]	inhibition percentage	-3.01	%
13464	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Tyrosine-protein kinase JAK3 [human]	inhibition percentage	-3.01	%
13465	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	eukaryotic translation initiation factor 2alpha kinase [human]	inhibition percentage	-3.04	%
13466	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase 10 [human]	inhibition percentage	-3.08	%
13467	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Transcription initiation factor TFIID subunit 1-like [human]	inhibition percentage	-3.35	%
13468	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase/endoribonuclease IRE1 [human]	inhibition percentage	-3.4	%
13469	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Tyrosine-protein kinase HCK [human]	inhibition percentage	-3.44	%
13470	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Transient receptor potential cation channel subfamily M member 7 [human]	inhibition percentage	-3.48	%
13471	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Mitogen-activated protein kinase 14 [human]	inhibition percentage	-3.5	%
13472	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Testis-specific serine/threonine-protein kinase 2 [human]	inhibition percentage	-3.67	%
13473	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Dual specificity protein kinase CLK2 [human]	inhibition percentage	-3.7	%
13474	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Rhodopsin kinase [human]	inhibition percentage	-3.7	%
13475	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase prp4 [human]	inhibition percentage	-3.88	%
13476	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Tyrosine-protein kinase CSK [human]	inhibition percentage	-3.99	%
13477	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase TOUSLED-like 2 [human]	inhibition percentage	-3.99	%
13478	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Alkaline protease 1 [human]	inhibition percentage	-4.08	%
13479	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase 17A [human]	inhibition percentage	-4.09	%
13480	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Fibroblast growth factor receptor 2 [human]	inhibition percentage	-4.19	%
13481	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Mitogen-activated protein kinase 12 [human]	inhibition percentage	-4.19	%
13482	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma [human]	inhibition percentage	-4.26	%
13483	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase MRCK alpha [human]	inhibition percentage	-4.49	%
13484	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Dual specificity tyrosine-phosphorylation-regulated kinase 2 [human]	inhibition percentage	-4.53	%
13485	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Tyrosine-protein kinase Mer [human]	inhibition percentage	-4.53	%
13486	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Calcium/calmodulin-dependent protein kinase type 1G [human]	inhibition percentage	-4.58	%
13487	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase PLK2 [human]	inhibition percentage	-4.65	%
13488	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase 32B [human]	inhibition percentage	-4.83	%
13489	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase Nek4 [human]	inhibition percentage	-4.88	%
13490	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Protein-tyrosine kinase 6 [human]	inhibition percentage	-4.9	%
13491	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase Chk2 [human]	inhibition percentage	-5	%
13492	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Casein kinase II subunit alpha-2 [human]	inhibition percentage	-5.03	%
13493	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	protein kinase C binding protein [human]	inhibition percentage	-5.07	%
13494	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Ephrin type-A receptor 1 [human]	inhibition percentage	-5.13	%
13495	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Wee1-like protein kinase 2 [human]	inhibition percentage	-5.28	%
13496	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	NT-3 growth factor receptor [human]	inhibition percentage	-5.29	%
13497	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Cyclin-dependent kinase-like 3 [human]	inhibition percentage	5.38	%
13498	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Ephrin type-B receptor 1 [human]	inhibition percentage	-5.41	%
13499	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Actin-regulating kinase PRK1 [human]	inhibition percentage	-5.45	%
13500	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Tyrosine-protein kinase Fer [human]	inhibition percentage	-5.48	%
13501	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Ephrin type-A receptor 8 [human]	inhibition percentage	-5.54	%
13502	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Leukocyte tyrosine kinase receptor [human]	inhibition percentage	-5.54	%
13503	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Misshapen-like kinase 1 [human]	inhibition percentage	-5.66	%
13504	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Protein kinase C gamma type [human]	inhibition percentage	-5.69	%
13505	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	PAS domain-containing serine/threonine-protein kinase [human]	inhibition percentage	-5.93	%
13506	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Cyclin-dependent-like kinase 5 [human];+Cyclin-dependent kinase 5 activator 1, p25 [human]	inhibition percentage	-5.98	%
13507	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase Nek7 [human]	inhibition percentage	-6.03	%
13508	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Inhibitor of nuclear factor kappa-B kinase subunit epsilon [human]	inhibition percentage	-6.07	%
13509	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine kinase NLK [human]	inhibition percentage	-6.13	%
13510	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase LATS2 [human]	inhibition percentage	-6.48	%
13511	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase ULK2 [human]	inhibition percentage	-6.5	%
13512	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Mitogen-activated protein kinase kinase kinase 21 [human]	inhibition percentage	-6.68	%
13513	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase 25 [human]	inhibition percentage	-6.74	%
13514	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Rho-associated protein kinase 2 [human]	inhibition percentage	-6.87	%
13515	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Calcium/calmodulin-dependent protein kinase type IV [human]	inhibition percentage	-6.89	%
13516	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase N2 [human]	inhibition percentage	-7.13	%
13517	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Insulin receptor, activated [human]	inhibition percentage	-7.18	%
13518	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	G protein-coupled receptor kinase 6 [human]	inhibition percentage	-7.2	%
13519	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Alpha-protein kinase 3 [human]	inhibition percentage	-7.23	%
13520	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Calcium/calmodulin-dependent protein kinase type II gamma chain [human]	inhibition percentage	-7.27	%
13521	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Vascular endothelial growth factor receptor 3 [human]	inhibition percentage	-7.39	%
13522	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Death-associated protein kinase 3 [human]	inhibition percentage	-7.48	%
13523	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Stress-activated protein kinase JNK-1 alpha 1 [human]	inhibition percentage	-7.54	%
13524	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Rhodopsin kinase [human]	inhibition percentage	-7.79	%
13525	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Cyclin-dependent kinase-like 1 [human]	inhibition percentage	-7.88	%
13526	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase VRK2 [human]	inhibition percentage	-7.92	%
13527	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Protein-tyrosine kinase 6 [human]	inhibition percentage	-7.93	%
13528	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase VRK1 [human]	inhibition percentage	-7.98	%
13529	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Receptor tyrosine-protein kinase erbB-4 [human]	inhibition percentage	-8.08	%
13530	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase WNK1 [human]	inhibition percentage	-8.16	%
13531	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase MARK2 alpha [human]	inhibition percentage	-8.26	%
13532	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Ephrin type-A receptor 7 [human]	inhibition percentage	-8.83	%
13533	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	serine/threonine-protein kinase pak 5 [human]	inhibition percentage	-8.38	%
13534	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Mitogen-activated protein kinase kinase kinase 11 [human]	inhibition percentage	-8.82	%
13535	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Mitogen-activated protein kinase 11 [human]	inhibition percentage	-8.93	%
13536	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Tyrosine-protein kinase Srms [human]	inhibition percentage	42.8	%
13537	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Calcium/calmodulin-dependent protein kinase type 1D [human]	inhibition percentage	-9.05	%
13538	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Acetyltransferase MAT1 [human];+Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	-9.09	%
13539	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Kit ligand [human]	inhibition percentage	-9.34	%
13540	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Cyclin-dependent kinase 12 [human];+Cyclin-K [human]	inhibition percentage	-9.55	%
13541	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	cAMP-dependent protein kinase catalytic subunit PRKX [human]	inhibition percentage	-9.67	%
13542	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase WNK2 [human]	inhibition percentage	-9.72	%
13543	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	MAP kinase-interacting serine/threonine-protein kinase 2 [human]	inhibition percentage	-9.86	%
13544	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Tyrosine-protein kinase Fyn [human]	inhibition percentage	-9.87	%
13545	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Tyrosine-protein kinase ZAP-70 [human]	inhibition percentage	-9.98	%
13546	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Myosin-IIIb [human]	inhibition percentage	-10.19	%
13547	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Phosphatidylinositol 3-kinase (p110a/p85a) [human]	inhibition percentage	39.12	%
13548	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Muscle, skeletal receptor tyrosine-protein kinase [human]	inhibition percentage	-10.44	%
13549	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase Nek2 [human]	inhibition percentage	-10.78	%
13550	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Ephrin type-B receptor 3 [human]	inhibition percentage	-10.92	%
13551	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Eukaryotic translation initiation factor 2-alpha kinase 1 [human]	inhibition percentage	-10.98	%
13552	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Cyclin-dependent kinase 16 [human];+cyclin-y [human]	inhibition percentage	-11	%
13553	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Calcium/calmodulin-dependent protein kinase type II beta chain [human]	inhibition percentage	-11.06	%
13554	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	G1/S-specific cyclin-E2 [human];+Cyclin-dependent kinase 3 [human]	inhibition percentage	-11.17	%
13555	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Myosin light chain kinase 3 [human]	inhibition percentage	-11.23	%
13556	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Cyclin-dependent kinase 17 [human];+cyclin-y [human]	inhibition percentage	-11.28	%
13557	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Mitogen-activated protein kinase 3 [human]	inhibition percentage	-11.46	%
13558	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Epithelial discoidin domain-containing receptor 1 [human]	inhibition percentage	37.4	%
13559	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	SRSF protein kinase 3 [human]	inhibition percentage	-11.522	%
13560	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Beta-adrenergic receptor kinase 2 [human]	inhibition percentage	-11.59	%
13561	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Calcium/calmodulin-dependent protein kinase type II delta chain [human]	inhibition percentage	-11.71	%
13562	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase BRSK1 [human]	inhibition percentage	-11.86	%
13563	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	G protein-coupled receptor kinase 5 [human]	inhibition percentage	-11.91	%
13564	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Pollen receptor-like kinase 2 [human]	inhibition percentage	-12.13	%
13565	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Phosphorylase b kinase gamma 1 [human]	inhibition percentage	-12.17	%
13566	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Homeodomain-interacting protein kinase 4 [human]	inhibition percentage	-12.28	%
13567	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Cyclin-dependent kinase 18 [human];+cyclin-y [human]	inhibition percentage	-12.37	%
13568	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	serine/threonine-protein kinase sbk1 [human]	inhibition percentage	-12.51	%
13569	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Mitosis inducer protein kinase cdr1 [human]	inhibition percentage	35.21	%
13570	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase Chk1 [human]	inhibition percentage	-12.58	%
13571	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Casein kinase II subunit epsilon [human]	inhibition percentage	-12.63	%
13572	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase stk11 homolog [human]	inhibition percentage	12.68	%
13573	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	NUAK family SNF1-like kinase 2 [human]	inhibition percentage	-12.91	%
13574	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase Sgk2 [human]	inhibition percentage	-13.13	%
13575	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Cyclin-dependent kinase 13 [human];+Cyclin-K [human]	inhibition percentage	-13.59	%
13576	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition percentage	-13.61	%
13577	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase A-Raf [human]	inhibition percentage	-13.8	%
13578	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase TBK1 [human]	inhibition percentage	-13.83	%
13579	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Homeodomain-interacting protein kinase 1 [human]	inhibition percentage	-14.13	%
13580	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Casein kinase I isoform alpha [human]	inhibition percentage	32.82	%
13581	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	epidermal growth factor-activated receptor [human]	inhibition percentage	-14.27	%
13582	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Insulin receptor-related protein [human]	inhibition percentage	-14.45	%
13583	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Insulin-like growth factor 1 receptor [human]	inhibition percentage	-14.6	%
13584	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase Sgk3 [human]	inhibition percentage	-15.02	%
13585	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Proto-oncogene tyrosine-protein kinase ROS [human]	inhibition percentage	-15.29	%
13586	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase PLK1 [human]	inhibition percentage	-15.68	%
13587	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase MRCK beta [human]	inhibition percentage	-15.8	%
13588	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	MAP/microtubule affinity-regulating kinase 4 [human]	inhibition percentage	-15.91	%
13589	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Cyclin-dependent kinase 9 [human];+Cyclin-T1 [human]	inhibition percentage	-16.03	%
13590	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase 17B [human]	inhibition percentage	-16.13	%
13591	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	SNF-related serine/threonine-protein kinase [human]	inhibition percentage	30.16	%
13592	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Ephrin type-A receptor 4 [human]	inhibition percentage	-16.18	%
13593	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Tyrosine-protein kinase JAK2 [human]	inhibition percentage	-16.42	%
13594	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase PAK 6 [human]	inhibition percentage	-16.43	%
13595	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Aurora kinase C [human]	inhibition percentage	-16.59	%
13596	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Dual specificity protein kinase CLK4 [human]	inhibition percentage	-16.88	%
13597	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Tyrosine-protein kinase receptor TYRO3 [human]	inhibition percentage	-17	%
13598	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Arginase [human]	inhibition percentage	-17.22	%
13599	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Dual specificity protein kinase CLK3 [human]	inhibition percentage	-17.34	%
13600	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	AP2-associated protein kinase 1 [human]	inhibition percentage	-17.4	%
13601	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Testis-specific serine/threonine-protein kinase 1 [human]	inhibition percentage	-17.58	%
13602	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	BMP-2-inducible protein kinase [human]	inhibition percentage	29.22	%
13603	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Cyclin-dependent kinase 14 [human];+cyclin-y [human]	inhibition percentage	-17.91	%
13604	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	ALK tyrosine kinase receptor [human]	inhibition percentage	-18.02	%
13605	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Tyrosine-protein kinase FRK [human]	inhibition percentage	-18.32	%
13606	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase Plk3 [human]	inhibition percentage	-18.48	%
13607	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	STE20/SPS1-related proline-alanine-rich protein kinase [human]	inhibition percentage	-19.24	%
13608	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	eukaryotic elongation factor 2 kinase [human]	inhibition percentage	-19.63	%
13609	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Cytoplasmic tyrosine-protein kinase BMX [human]	inhibition percentage	-19.87	%
13610	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Fibroblast growth factor receptor 1 [human]	inhibition percentage	-20.02	%
13611	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	5'-AMP-activated protein kinase catalytic subunit alpha-2 [human]	inhibition percentage	-20.08	%
13612	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Myosin-1 [human]	inhibition percentage	-20.2	%
13613	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition percentage	29.22	%
13614	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Mitogen-activated protein kinase kinase kinase 2 [human]	inhibition percentage	-20.25	%
13615	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Death-associated protein kinase 1 [human]	inhibition percentage	-20.45	%
13616	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	inhibition percentage	-21.01	%
13617	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Mitogen-activated protein kinase 13 [human]	inhibition percentage	-21.36	%
13618	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Myosin light chain kinase 2, skeletal/cardiac muscle [human]	inhibition percentage	-24.69	%
13619	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Neurogenic differentiation factor 2 [human]	inhibition percentage	-24.95	%
13620	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase ICK [human]	inhibition percentage	-25.04	%
13621	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	RNase E specificity factor CsrD [human]	inhibition percentage	-26.03	%
13622	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Ribosomal protein S6 kinase alpha-5 [human]	inhibition percentage	-26.08	%
13623	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Ribosomal protein S6 kinase beta-1 [human]	inhibition percentage	-26.2	%
13624	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Myotonin-protein kinase [human]	inhibition percentage	28.26	%
13625	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Ribosomal protein S6 kinase alpha-6 [human]	inhibition percentage	-27.81	%
13626	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Dual specificity tyrosine-phosphorylation-regulated kinase 1B [human]	inhibition percentage	-28.4	%
13627	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Actin-regulating kinase PRK1 [human]	inhibition percentage	-28.77	%
13628	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Tyrosine-protein kinase Fgr [human]	inhibition percentage	-28.85	%
13629	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Protein kinase C, theta [human]	inhibition percentage	-30.5	%
13630	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Histone acetyltransferase mst2 [human]	inhibition percentage	-31.2	%
13631	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase 26 [human]	inhibition percentage	-31.58	%
13632	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Tyrosine-protein kinase Lck [human]	inhibition percentage	-31.75	%
13633	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Calcium/calmodulin-dependent protein kinase type 1B [human]	inhibition percentage	-34.5	%
13634	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	MAP kinase-activated protein kinase 2 [human]	inhibition percentage	-34.81	%
13635	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase Haspin homolog ALK2 [human]	inhibition percentage	27.96	%
13636	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Calcium/calmodulin-dependent protein kinase type II alpha chain [human]	inhibition percentage	-36.55	%
13637	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Discoidin domain-containing receptor 2 [human]	inhibition percentage	-37.49	%
13638	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Tyrosine-protein kinase Lyn [human]	inhibition percentage	-38.46	%
13639	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial [human]	inhibition percentage	-39.7	%
13640	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	5'-AMP-activated protein kinase catalytic subunit alpha-1 [human]	inhibition percentage	-41.57	%
13641	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Tyrosine-protein kinase receptor UFO [human]	inhibition percentage	-45.43	%
13642	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Mitogen-activated protein kinase kinase kinase kinase 1 [human]	inhibition percentage	-46.45	%
13643	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Insulin receptor [human]	inhibition percentage	-15.57	%
13644	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Tyrosine-protein kinase Yes [human]	inhibition percentage	4.86	%
13645	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Calcium/calmodulin-dependent protein kinase type 1 [human]	inhibition percentage	-12.19	%
13646	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase MRCK gamma [human]	inhibition percentage	25.11	%
13647	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Tyrosine-protein kinase BTK [human]	inhibition percentage	-9.71	%
13648	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Laminin subunit beta-3 [human]	inhibition percentage	24.42	%
13649	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Macrophage colony-stimulating factor 1 receptor [human]	inhibition percentage	24.4	%
13650	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Casein kinase II subunit alpha'-interacting protein [human]	inhibition percentage	24.11	%
13651	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Tyrosine-protein kinase HCK [human]	inhibition percentage	23.37	%
13652	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Inhibitor of nuclear factor kappa-B kinase subunit alpha [human]	inhibition percentage	22.98	%
13653	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Death-associated protein kinase 2 [human]	inhibition percentage	22.96	%
13654	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Receptor-interacting serine/threonine-protein kinase 2 [human]	inhibition percentage	22.9	%
13655	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase WNK3 [human]	inhibition percentage	22.66	%
13656	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Casein kinase I isoform gamma-3 [human]	inhibition percentage	22.21	%
13657	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	PKG1 beta [human]	inhibition percentage	21.55	%
13658	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase 16 [human]	inhibition percentage	20.5	%
13659	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Dual specificity tyrosine-phosphorylation-regulated kinase 3 [human]	inhibition percentage	20.14	%
13660	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Traf2 and NCK-interacting protein kinase [human]	inhibition percentage	19.63	%
13661	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Calcium/calmodulin-dependent protein kinase kinase 2 [human]	inhibition percentage	19.38	%
13662	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	MAPK/MAK/MRK overlapping kinase [human]	inhibition percentage	19.36	%
13663	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Casein kinase II subunit alpha-2 [human]	inhibition percentage	19.05	%
13664	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Ephrin type-A receptor 5 [human]	inhibition percentage	18.91	%
13665	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	glycogen synthase kinase-3 beta [human]	inhibition percentage	18.87	%
13666	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Mitogen-activated protein kinase 9 [human]	inhibition percentage	18.56	%
13667	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Ephrin type-B receptor 2 [human]	inhibition percentage	18.49	%
13668	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Proto-oncogene tyrosine-protein kinase LCK [human]	inhibition percentage	18.05	%
13669	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Transcription factor PRE6 [human]	inhibition percentage	17.96	%
13670	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	RAF proto-oncogene serine/threonine-protein kinase [human]	inhibition percentage	17.88	%
13671	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase 24 [human]	inhibition percentage	17.84	%
13672	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase Nek1 [human]	inhibition percentage	17.81	%
13673	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Actin-related protein 2 [human]	inhibition percentage	17.39	%
13674	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase Nek11 [human]	inhibition percentage	16.93	%
13675	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	MAP kinase-activated protein kinase 5 [human]	inhibition percentage	16.85	%
13676	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Casein kinase I isoform delta [human]	inhibition percentage	16.36	%
13677	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Phosphatidylinositol 3-kinase (p110d/p85a) [human]	inhibition percentage	16.33	%
13678	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Peptidyl-lysine N-acetyltransferase PatZ [human]	inhibition percentage	16.02	%
13679	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Activin receptor type-1B [human]	inhibition percentage	15.83	%
13680	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Aurora kinase A [human]	inhibition percentage	15.74	%
13681	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase 38 [human]	inhibition percentage	15.74	%
13682	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Pyruvate kinase 2 [human]	inhibition percentage	15.43	%
13683	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Casein kinase I isoform gamma-1 [human]	inhibition percentage	15.27	%
13684	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Ephrin type-B receptor 4 [human]	inhibition percentage	15.17	%
13685	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Casein kinase I isoform gamma-2 [human]	inhibition percentage	14.33	%
13686	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Testis-specific serine/threonine-protein kinase 3 [human]	inhibition percentage	14.13	%
13687	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Hepatocyte growth factor receptor [human]	inhibition percentage	13.79	%
13688	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	TGF-beta receptor type-2 [human]	inhibition percentage	13.6	%
13689	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Interferon-induced, double-stranded RNA-activated protein kinase [human]	inhibition percentage	13.03	%
13690	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Tyrosine-protein kinase ITK/TSK [human]	inhibition percentage	13.02	%
13691	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase DCLK2 [human]	inhibition percentage	12.92	%
13692	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Glycogen synthase kinase-3 alpha [human]	inhibition percentage	12.7	%
13693	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase B-raf [human]	inhibition percentage	12.69	%
13694	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Mitogen-activated protein kinase kinase 3 [human]	inhibition percentage	12.62	%
13695	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Meiosis-specific serine/threonine-protein kinase MEK1 [human]	inhibition percentage	12.42	%
13696	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	NUAK family SNF1-like kinase 1 [human]	inhibition percentage	12.12	%
13697	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase MARK3 [human]	inhibition percentage	11.85	%
13698	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Mitogen-activated protein kinase kinase kinase 10 [human]	inhibition percentage	11.82	%
13699	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Phosphatidylinositol 3-kinase (p120g) [human]	inhibition percentage	11.32	%
13700	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	CBL-interacting serine/threonine-protein kinase 7 [human]	inhibition percentage	11.26	%
13701	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	High affinity nerve growth factor receptor [human]	inhibition percentage	10.99	%
13702	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase LATS1 [human]	inhibition percentage	10.53	%
13703	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Proto-oncogene tyrosine-protein kinase receptor Ret [human]	inhibition percentage	10.44	%
13704	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Serine/threonine-protein kinase pim-2 [human]	inhibition percentage	10.35	%
13705	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Cyclin-dependent-like kinase 5 [human];+Cyclin-dependent kinase 5 activator 1, p35 [human]	inhibition percentage	10.24	%
13706	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	Tyrosine-protein kinase JAK1 [human]	inhibition percentage	10.06	%
13707	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 (isoform 1) [human]	inhibition percentage	10.02	%
13708	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O		Papp (A-B)	39	nm/s
13709	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O		efflux ratio	0.5	no unit
13710	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O		Papp (B-A)	19	nm/s
13711	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O		Fmax	100	%
13712	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O		CL (drug clearance)	0.14	l/h/kg
13713	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O		Fmax	97	%
13714	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O		CL (drug clearance)	0.3	l/h/kg
13715	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(Cl)=CC=C2)=C1C#N)C(N)=O		Fmax	93	%
13716	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	IC50	0.001	μM
13717	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	IC50	0.003	μM
13718	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	IC50	0.008	μM
13719	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [human]	EC50	1.1	μM
13720	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [human]	EC50	1.8	μM
13721	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Cytochrome P450 2C8 [human]	IC50	3.1	μM
13722	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Cytochrome P450 2C9 [human]	IC50	16	μM
13723	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O		IC50	30	μM
13724	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Potassium voltage-gated channel subfamily H member 2	IC50	10	μM
13725	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Cytochrome P450 2D6 [human]	IC50	20	μM
13726	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Cytochrome P450 3A4 [human]	IC50	20	μM
13727	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Cytochrome P450 3A4 [human]	IC50	20	μM
13728	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Cytochrome P450 1A1 [human]	IC50	20	μM
13729	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O		EC50	50	μM
13730	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O		IC50	30	μM
13731	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O		IC50	30	μM
13732	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O		IC50	50	μM
13733	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma [human]	inhibition percentage	25.37	%
13734	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Mitogen-activated protein kinase 10 [human]	inhibition percentage	-12.1	%
13735	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Protein kinase C alpha type [human]	inhibition percentage	16.34	%
13736	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase 4 [human]	inhibition percentage	20.61	%
13737	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Ribosomal protein S6 kinase alpha-4 [human]	inhibition percentage	-3.96	%
13738	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase MARK1 [human]	inhibition percentage	2.52	%
13739	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Ribosomal protein S6 kinase alpha-2 [human]	inhibition percentage	10.89	%
13740	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Cytochrome P450 52B1 [human]	inhibition percentage	-11.32	%
13741	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Phosphatidylinositol 3-kinase (p110b/p85a) [human]	inhibition percentage	0.43	%
13742	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Ribosomal protein S6 kinase alpha-1 [human]	inhibition percentage	-6.03	%
13743	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [human]	inhibition percentage	142.02	%
13744	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Tau-tubulin kinase 1 [human]	inhibition percentage	-2.05	%
13745	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Platelet-derived growth factor receptor beta [human]	inhibition percentage	9.33	%
13746	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Beta-adrenergic receptor kinase 1 [human]	inhibition percentage	1.9	%
13747	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Homeodomain-interacting protein kinase 2 [human]	inhibition percentage	0.19	%
13748	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Mitogen-activated protein kinase kinase kinase 20 [human]	inhibition percentage	-4.94	%
13749	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase tousled-like 1 [human]	inhibition percentage	-0.87	%
13750	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Target of rapamycin complex subunit LST8 [human]	inhibition percentage	14.8	%
13751	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase pim-3 [human]	inhibition percentage	1.67	%
13752	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase Nek3 [human]	inhibition percentage	8.41	%
13753	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Mitogen-activated protein kinase kinase kinase 7 [human]	inhibition percentage	7.89	%
13754	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Sequestosome-1 [human]	inhibition percentage	-2.41	%
13755	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Tyrosine-protein kinase Tec, activated [human]	inhibition percentage	4.62	%
13756	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Protein kinase C beta type 1 [human]	inhibition percentage	16.52	%
13757	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase D1 [human]	inhibition percentage	12.7	%
13758	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform [human]	inhibition percentage	-0.34	%
13759	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase RCK2 [human]	inhibition percentage	3.74	%
13760	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Interleukin-1 receptor-associated kinase 1 [human]	inhibition percentage	-3.31	%
13761	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Tyrosine-protein kinase TXK [human]	inhibition percentage	-2.9	%
13762	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Protein kinase C gamma type [human]	inhibition percentage	-20.86	%
13763	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	DNA-dependent protein kinase catalytic subunit [human]	inhibition percentage	-10.68	%
13764	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Mitogen-activated protein kinase kinase kinase 9 [human]	inhibition percentage	-23.82	%
13765	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Ribosomal protein S6 kinase alpha-3 [human]	inhibition percentage	1.78	%
13766	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Aurora kinase B [human]	inhibition percentage	-23.74	%
13767	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Mitogen-activated protein kinase kinase kinase kinase 5 [human]	inhibition percentage	13.35	%
13768	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	BDNF/NT-3 growth factors receptor [human]	inhibition percentage	2.08	%
13769	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase TAO3 [human]	inhibition percentage	2.25	%
13770	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Mitogen-activated protein kinase kinase kinase 3 [human]	inhibition percentage	-3.58	%
13771	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	1-phosphatidylinositol-3-kinase C2a [human]	inhibition percentage	4.18	%
13772	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Acetate kinase 1 [human]	inhibition percentage	10.5	%
13773	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Cyclin-dependent kinase 2 [human];+Cyclin E [human]	inhibition percentage	7.13	%
13774	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	RAC-beta serine/threonine-protein kinase [human]	inhibition percentage	3.52	%
13775	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase TAO1 [human]	inhibition percentage	1.92	%
13776	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase Plk4 [human]	inhibition percentage	-8.83	%
13777	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase 32B [human]	inhibition percentage	15.9	%
13778	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase SIK2 [human]	inhibition percentage	3.68	%
13779	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	RAC-gamma serine/threonine-protein kinase [human]	inhibition percentage	9.92	%
13780	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Mitogen-activated protein kinase kinase kinase kinase 3 [human]	inhibition percentage	8.29	%
13781	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Vascular endothelial growth factor receptor 1 [human]	inhibition percentage	56.81	%
13782	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Rho-associated protein kinase 1 [human]	inhibition percentage	-2.77	%
13783	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase D2 [human]	inhibition percentage	4.37	%
13784	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Citron Rho-interacting kinase [human]	inhibition percentage	-10.67	%
13785	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Platelet-derived growth factor receptor alpha [human]	inhibition percentage	9.33	%
13786	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Tyrosine-protein kinase, Fes/Fps type [human]	inhibition percentage	-11.86	%
13787	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Receptor tyrosine-protein kinase erbB-2 [human]	inhibition percentage	8.53	%
13788	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase pim-1 [human]	inhibition percentage	-2.53	%
13789	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase Nek5 [human]	inhibition percentage	9.31	%
13790	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	STE20-like serine/threonine-protein kinase [human]	inhibition percentage	19.74	%
13791	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Cyclin-dependent kinase-like 4 [human]	inhibition percentage	12.6	%
13792	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase D3 [human]	inhibition percentage	12.64	%
13793	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase 35 [human]	inhibition percentage	9.55	%
13794	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase ULK3 [human]	inhibition percentage	0.33	%
13795	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	LIM domain kinase 1 [human]	inhibition percentage	8.64	%
13796	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase DCLK3 [human]	inhibition percentage	5.32	%
13797	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Calcium/calmodulin-dependent protein kinase kinase 1 [human]	inhibition percentage	5.03	%
13798	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Cyclin-dependent kinase 2 [human];+Cyclin-A2 [human]	inhibition percentage	-1.5	%
13799	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Protein kinase C iota type [human]	inhibition percentage	5.85	%
13800	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial [human]	inhibition percentage	9.88	%
13801	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase TAO2 [human]	inhibition percentage	10.27	%
13802	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	cAMP-dependent protein kinase catalytic subunit beta [human]	inhibition percentage	6.73	%
13803	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Interleukin-1 receptor-associated kinase 4 [human]	inhibition percentage	6.22	%
13804	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Cyclin-dependent kinase-like 2 [human]	inhibition percentage	19.42	%
13805	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Homeodomain-interacting protein kinase 3 [human]	inhibition percentage	4.32	%
13806	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Tyrosine-protein kinase Abl [human]	inhibition percentage	12.1	%
13807	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Cell division cycle 7-related protein kinase [human];+Cyclin-B1-1 [human]	inhibition percentage	3.59	%
13808	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Protein kinase C beta type 2 [human]	inhibition percentage	-1.59	%
13809	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Fibroblast growth factor receptor 4 [human]	inhibition percentage	-15.75	%
13810	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase 32C [human]	inhibition percentage	5.49	%
13811	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Cyclin-dependent kinase 6 [human];+Cyclin-D3-1 [human]	inhibition percentage	8.28	%
13812	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	ABC transporter F family member 2 [human]	inhibition percentage	-3.21	%
13813	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Testis-specific serine/threonine-protein kinase 4 [human]	inhibition percentage	23.97	%
13814	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	3-phosphoinositide-dependent protein kinase 1 [human]	inhibition percentage	-8.72	%
13815	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase SIK3 [human]	inhibition percentage	5.14	%
13816	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Leucine-rich repeat serine/threonine-protein kinase 2 [human]	inhibition percentage	12.9	%
13817	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Inositol-pentakisphosphate 2-kinase [human]	inhibition percentage	21.25	%
13818	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase 33 [human]	inhibition percentage	2.82	%
13819	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Tau-tubulin kinase 2 [human]	inhibition percentage	1.17	%
13820	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Ephrin type-A receptor 3 [human]	inhibition percentage	4.71	%
13821	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase Nek9 [human]	inhibition percentage	6.61	%
13822	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	MAP kinase-activated protein kinase 3 [human]	inhibition percentage	5.32	%
13823	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Ephrin type-A receptor 2 [human]	inhibition percentage	-0.55	%
13824	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Bone morphogenetic protein receptor type-2 [human]	inhibition percentage	4.45	%
13825	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase Sgk1 [human]	inhibition percentage	-6.56	%
13826	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition percentage	1.22	%
13827	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	SRSF protein kinase 2 [human]	inhibition percentage	-8.51	%
13828	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Taste receptor type 2 member 10 [human]	inhibition percentage	0.49	%
13829	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Angiopoietin-1 receptor [human]	inhibition percentage	12.81	%
13830	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase OSR1 [human]	inhibition percentage	-3.86	%
13831	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	mTOR Peptidyl-prolyl cis-trans isomerase FKBP12 [human]	inhibition percentage	1.38	%
13832	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	phosphatidylinositol 4-phosphate 5-kinase 1 alpha [human]	inhibition percentage	10	%
13833	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	DNA-directed RNA polymerase subunit beta [human]	inhibition percentage	0.76	%
13834	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Fibroblast growth factor receptor 3 [human]	inhibition percentage	-1	%
13835	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase ULK1 [human]	inhibition percentage	14.16	%
13836	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Dual specificity protein kinase TTK [human]	inhibition percentage	-9.1	%
13837	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	RAC-alpha serine/threonine-protein kinase [human]	inhibition percentage	-1.04	%
13838	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Cyclin-B1-1 [human];+Cyclin-dependent kinase 1 [human]	inhibition percentage	8.82	%
13839	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Mitogen-activated protein kinase kinase kinase kinase 4 [human]	inhibition percentage	-12.23	%
13840	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	LIM domain kinase 2 [human]	inhibition percentage	3.03	%
13841	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase DCLK1 [human]	inhibition percentage	12.96	%
13842	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Dual specificity mitogen-activated protein kinase kinase 2 [human]	inhibition percentage	-9.56	%
13843	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Mitosis inhibitor protein kinase wee1 [human]	inhibition percentage	5.28	%
13844	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Maternal embryonic leucine zipper kinase [human]	inhibition percentage	-11.67	%
13845	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	cGMP-dependent protein kinase 2 [human]	inhibition percentage	12.72	%
13846	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase PAK 4 [human]	inhibition percentage	1.36	%
13847	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase WNK4 [human]	inhibition percentage	11.06	%
13848	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Tyrosine-protein kinase SYK [human]	inhibition percentage	10.42	%
13849	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Cyclin-dependent kinase 4 [human];+Cyclin-D3-1 [human]	inhibition percentage	11.31	%
13850	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Insulin-like growth factor 1 receptor, activated [human]	inhibition percentage	12.02	%
13851	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	cGMP-dependent protein kinase, isozyme 1 alpha [human]	inhibition percentage	6.77	%
13852	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	TGF-beta receptor type-1 [human]	inhibition percentage	-0.85	%
13853	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Dual specificity mitogen-activated protein kinase kinase 6 [human]	inhibition percentage	-18.97	%
13854	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Mitogen-activated protein kinase 1 [human]	inhibition percentage	6.43	%
13855	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Focal adhesion kinase 1 [human]	inhibition percentage	13.32	%
13856	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Mitogen-activated protein kinase kinase kinase 5 [human]	inhibition percentage	-9.98	%
13857	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase ATR [human]	inhibition percentage	16.22	%
13858	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase PAK 3 [human]	inhibition percentage	4.13	%
13859	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase haspin [human]	inhibition percentage	14.18	%
13860	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Mitogen-activated protein kinase kinase kinase kinase 2 [human]	inhibition percentage	0.85	%
13861	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase BRSK2 [human]	inhibition percentage	3.83	%
13862	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Tyrosine-protein kinase JAK3 [human]	inhibition percentage	-14.21	%
13863	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	eukaryotic translation initiation factor 2alpha kinase [human]	inhibition percentage	3.26	%
13864	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase 10 [human]	inhibition percentage	8.13	%
13865	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Transcription initiation factor TFIID subunit 1-like [human]	inhibition percentage	-3.49	%
13866	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase/endoribonuclease IRE1 [human]	inhibition percentage	2.72	%
13867	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Tyrosine-protein kinase HCK [human]	inhibition percentage	-6.21	%
13868	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Transient receptor potential cation channel subfamily M member 7 [human]	inhibition percentage	0.08	%
13869	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Mitogen-activated protein kinase 14 [human]	inhibition percentage	2.76	%
13870	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Testis-specific serine/threonine-protein kinase 2 [human]	inhibition percentage	-1.97	%
13871	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Dual specificity protein kinase CLK2 [human]	inhibition percentage	0.07	%
13872	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Rhodopsin kinase [human]	inhibition percentage	1.52	%
13873	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase prp4 [human]	inhibition percentage	18.88	%
13874	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Tyrosine-protein kinase CSK [human]	inhibition percentage	6.94	%
13875	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase TOUSLED-like 2 [human]	inhibition percentage	8.27	%
13876	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Alkaline protease 1 [human]	inhibition percentage	5.14	%
13877	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase 17A [human]	inhibition percentage	9.65	%
13878	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Fibroblast growth factor receptor 2 [human]	inhibition percentage	9.63	%
13879	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Mitogen-activated protein kinase 12 [human]	inhibition percentage	-12.55	%
13880	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma [human]	inhibition percentage	1.51	%
13881	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase MRCK alpha [human]	inhibition percentage	-4.99	%
13882	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Dual specificity tyrosine-phosphorylation-regulated kinase 2 [human]	inhibition percentage	19.11	%
13883	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Tyrosine-protein kinase Mer [human]	inhibition percentage	10.21	%
13884	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Calcium/calmodulin-dependent protein kinase type 1G [human]	inhibition percentage	14.37	%
13885	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase PLK2 [human]	inhibition percentage	7.48	%
13886	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase 32B [human]	inhibition percentage	14.91	%
13887	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase Nek4 [human]	inhibition percentage	32.07	%
13888	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Protein-tyrosine kinase 6 [human]	inhibition percentage	8.07	%
13889	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase Chk2 [human]	inhibition percentage	5.38	%
13890	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Casein kinase II subunit alpha-2 [human]	inhibition percentage	3.34	%
13891	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	protein kinase C binding protein [human]	inhibition percentage	3.77	%
13892	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Ephrin type-A receptor 1 [human]	inhibition percentage	9.2	%
13893	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Wee1-like protein kinase 2 [human]	inhibition percentage	9.64	%
13894	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	NT-3 growth factor receptor [human]	inhibition percentage	14.82	%
13895	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Cyclin-dependent kinase-like 3 [human]	inhibition percentage	8.18	%
13896	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Ephrin type-B receptor 1 [human]	inhibition percentage	-10.48	%
13897	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Actin-regulating kinase PRK1 [human]	inhibition percentage	5.64	%
13898	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Tyrosine-protein kinase Fer [human]	inhibition percentage	5.23	%
13899	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Ephrin type-A receptor 8 [human]	inhibition percentage	-6.72	%
13900	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Leukocyte tyrosine kinase receptor [human]	inhibition percentage	-16.81	%
13901	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Misshapen-like kinase 1 [human]	inhibition percentage	3.07	%
13902	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Protein kinase C gamma type [human]	inhibition percentage	-0.39	%
13903	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	PAS domain-containing serine/threonine-protein kinase [human]	inhibition percentage	11.07	%
13904	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Cyclin-dependent-like kinase 5 [human];+Cyclin-dependent kinase 5 activator 1, p25 [human]	inhibition percentage	6.65	%
13905	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase Nek7 [human]	inhibition percentage	5.49	%
13906	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Inhibitor of nuclear factor kappa-B kinase subunit epsilon [human]	inhibition percentage	10.23	%
13907	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine kinase NLK [human]	inhibition percentage	8.59	%
13908	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase LATS2 [human]	inhibition percentage	1.83	%
13909	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase ULK2 [human]	inhibition percentage	5.46	%
13910	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Mitogen-activated protein kinase kinase kinase 21 [human]	inhibition percentage	9.6	%
13911	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase 25 [human]	inhibition percentage	3.01	%
13912	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Rho-associated protein kinase 2 [human]	inhibition percentage	-2.77	%
13913	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Calcium/calmodulin-dependent protein kinase type IV [human]	inhibition percentage	7.26	%
13914	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase N2 [human]	inhibition percentage	24.95	%
13915	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Insulin receptor, activated [human]	inhibition percentage	9.43	%
13916	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	G protein-coupled receptor kinase 6 [human]	inhibition percentage	0.16	%
13917	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Alpha-protein kinase 3 [human]	inhibition percentage	9.23	%
13918	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Calcium/calmodulin-dependent protein kinase type II gamma chain [human]	inhibition percentage	-16.51	%
13919	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Vascular endothelial growth factor receptor 3 [human]	inhibition percentage	12.93	%
13920	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Death-associated protein kinase 3 [human]	inhibition percentage	0.91	%
13921	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Stress-activated protein kinase JNK-1 alpha 1 [human]	inhibition percentage	4.24	%
13922	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Rhodopsin kinase [human]	inhibition percentage	2.75	%
13923	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Cyclin-dependent kinase-like 1 [human]	inhibition percentage	4.02	%
13924	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase VRK2 [human]	inhibition percentage	4.1	%
13925	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Protein-tyrosine kinase 6 [human]	inhibition percentage	13.36	%
13926	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase VRK1 [human]	inhibition percentage	3.04	%
13927	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Receptor tyrosine-protein kinase erbB-4 [human]	inhibition percentage	3.85	%
13928	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase WNK1 [human]	inhibition percentage	14.66	%
13929	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase MARK2 alpha [human]	inhibition percentage	6.75	%
13930	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Ephrin type-A receptor 7 [human]	inhibition percentage	2.1	%
13931	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	serine/threonine-protein kinase pak 5 [human]	inhibition percentage	1.42	%
13932	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Mitogen-activated protein kinase kinase kinase 11 [human]	inhibition percentage	21.13	%
13933	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Mitogen-activated protein kinase 11 [human]	inhibition percentage	-2.08	%
13934	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Tyrosine-protein kinase Srms [human]	inhibition percentage	26.31	%
13935	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Calcium/calmodulin-dependent protein kinase type 1D [human]	inhibition percentage	4.68	%
13936	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Acetyltransferase MAT1 [human];+Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	0.3	%
13937	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Kit ligand [human]	inhibition percentage	22.32	%
13938	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Cyclin-dependent kinase 12 [human];+Cyclin-K [human]	inhibition percentage	10.3	%
13939	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	cAMP-dependent protein kinase catalytic subunit PRKX [human]	inhibition percentage	2.66	%
13940	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase WNK2 [human]	inhibition percentage	3.31	%
13941	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	MAP kinase-interacting serine/threonine-protein kinase 2 [human]	inhibition percentage	3.39	%
13942	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Tyrosine-protein kinase Fyn [human]	inhibition percentage	-17.31	%
13943	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Tyrosine-protein kinase ZAP-70 [human]	inhibition percentage	2.99	%
13944	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Myosin-IIIb [human]	inhibition percentage	18.15	%
13945	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Phosphatidylinositol 3-kinase (p110a/p85a) [human]	inhibition percentage	30.93	%
13946	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Muscle, skeletal receptor tyrosine-protein kinase [human]	inhibition percentage	5.1	%
13947	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase Nek2 [human]	inhibition percentage	15.9	%
13948	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Ephrin type-B receptor 3 [human]	inhibition percentage	15.9	%
13949	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Eukaryotic translation initiation factor 2-alpha kinase 1 [human]	inhibition percentage	-6.26	%
13950	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Cyclin-dependent kinase 16 [human];+cyclin-y [human]	inhibition percentage	0.85	%
13951	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Calcium/calmodulin-dependent protein kinase type II beta chain [human]	inhibition percentage	8.65	%
13952	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	G1/S-specific cyclin-E2 [human];+Cyclin-dependent kinase 3 [human]	inhibition percentage	2.41	%
13953	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Myosin light chain kinase 3 [human]	inhibition percentage	-5.27	%
13954	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Cyclin-dependent kinase 17 [human];+cyclin-y [human]	inhibition percentage	0.09	%
13955	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Mitogen-activated protein kinase 3 [human]	inhibition percentage	7.74	%
13956	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Epithelial discoidin domain-containing receptor 1 [human]	inhibition percentage	11.7	%
13957	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	SRSF protein kinase 3 [human]	inhibition percentage	4.51	%
13958	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Beta-adrenergic receptor kinase 2 [human]	inhibition percentage	8.23	%
13959	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Calcium/calmodulin-dependent protein kinase type II delta chain [human]	inhibition percentage	-21.46	%
13960	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase BRSK1 [human]	inhibition percentage	-4.39	%
13961	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	G protein-coupled receptor kinase 5 [human]	inhibition percentage	-3.49	%
13962	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Pollen receptor-like kinase 2 [human]	inhibition percentage	5.02	%
13963	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Phosphorylase b kinase gamma 1 [human]	inhibition percentage	-9.06	%
13964	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Homeodomain-interacting protein kinase 4 [human]	inhibition percentage	15.73	%
13965	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Cyclin-dependent kinase 18 [human];+cyclin-y [human]	inhibition percentage	10.59	%
13966	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	serine/threonine-protein kinase sbk1 [human]	inhibition percentage	4.02	%
13967	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Mitosis inducer protein kinase cdr1 [human]	inhibition percentage	12.01	%
13968	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase Chk1 [human]	inhibition percentage	4.56	%
13969	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Casein kinase II subunit epsilon [human]	inhibition percentage	8.85	%
13970	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase stk11 homolog [human]	inhibition percentage	5.7	%
13971	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	NUAK family SNF1-like kinase 2 [human]	inhibition percentage	10.39	%
13972	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase Sgk2 [human]	inhibition percentage	-11.48	%
13973	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Cyclin-dependent kinase 13 [human];+Cyclin-K [human]	inhibition percentage	1.16	%
13974	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition percentage	-12.01	%
13975	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase A-Raf [human]	inhibition percentage	2.41	%
13976	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase TBK1 [human]	inhibition percentage	8.44	%
13977	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Homeodomain-interacting protein kinase 1 [human]	inhibition percentage	3.6	%
13978	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Casein kinase I isoform alpha [human]	inhibition percentage	3.17	%
13979	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	epidermal growth factor-activated receptor [human]	inhibition percentage	10.85	%
13980	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Insulin receptor-related protein [human]	inhibition percentage	6.25	%
13981	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Insulin-like growth factor 1 receptor [human]	inhibition percentage	-10.09	%
13982	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase Sgk3 [human]	inhibition percentage	6.09	%
13983	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Proto-oncogene tyrosine-protein kinase ROS [human]	inhibition percentage	-11.32	%
13984	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase PLK1 [human]	inhibition percentage	4.29	%
13985	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase MRCK beta [human]	inhibition percentage	-15.79	%
13986	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	MAP/microtubule affinity-regulating kinase 4 [human]	inhibition percentage	5.8	%
13987	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Cyclin-dependent kinase 9 [human];+Cyclin-T1 [human]	inhibition percentage	11.83	%
13988	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase 17B [human]	inhibition percentage	7.08	%
13989	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	SNF-related serine/threonine-protein kinase [human]	inhibition percentage	10.26	%
13990	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Ephrin type-A receptor 4 [human]	inhibition percentage	-16.84	%
13991	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Tyrosine-protein kinase JAK2 [human]	inhibition percentage	-5.62	%
13992	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase PAK 6 [human]	inhibition percentage	-5.79	%
13993	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Aurora kinase C [human]	inhibition percentage	4.64	%
13994	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Dual specificity protein kinase CLK4 [human]	inhibition percentage	18.82	%
13995	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Tyrosine-protein kinase receptor TYRO3 [human]	inhibition percentage	-32.02	%
13996	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Arginase [human]	inhibition percentage	7.75	%
13997	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Dual specificity protein kinase CLK3 [human]	inhibition percentage	2.84	%
13998	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	AP2-associated protein kinase 1 [human]	inhibition percentage	7.44	%
13999	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Testis-specific serine/threonine-protein kinase 1 [human]	inhibition percentage	14.25	%
14000	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	BMP-2-inducible protein kinase [human]	inhibition percentage	5.17	%
14001	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Cyclin-dependent kinase 14 [human];+cyclin-y [human]	inhibition percentage	18.05	%
14002	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	ALK tyrosine kinase receptor [human]	inhibition percentage	-33.12	%
14003	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Tyrosine-protein kinase FRK [human]	inhibition percentage	-14.53	%
14004	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase Plk3 [human]	inhibition percentage	-7.76	%
14005	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	STE20/SPS1-related proline-alanine-rich protein kinase [human]	inhibition percentage	5.6	%
14006	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	eukaryotic elongation factor 2 kinase [human]	inhibition percentage	5.5	%
14007	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Cytoplasmic tyrosine-protein kinase BMX [human]	inhibition percentage	3.69	%
14008	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Fibroblast growth factor receptor 1 [human]	inhibition percentage	6.44	%
14009	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	5'-AMP-activated protein kinase catalytic subunit alpha-2 [human]	inhibition percentage	-5.39	%
14010	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Myosin-1 [human]	inhibition percentage	0.32	%
14011	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition percentage	2.85	%
14012	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Mitogen-activated protein kinase kinase kinase 2 [human]	inhibition percentage	12.82	%
14013	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Death-associated protein kinase 1 [human]	inhibition percentage	-3.29	%
14014	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	inhibition percentage	4.22	%
14015	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Mitogen-activated protein kinase 13 [human]	inhibition percentage	-3.58	%
14016	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Myosin light chain kinase 2, skeletal/cardiac muscle [human]	inhibition percentage	7.84	%
14017	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Neurogenic differentiation factor 2 [human]	inhibition percentage	5.88	%
14018	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase ICK [human]	inhibition percentage	14.79	%
14019	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	RNase E specificity factor CsrD [human]	inhibition percentage	7.51	%
14020	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Ribosomal protein S6 kinase alpha-5 [human]	inhibition percentage	1.48	%
14021	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Ribosomal protein S6 kinase beta-1 [human]	inhibition percentage	4.3	%
14022	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Myotonin-protein kinase [human]	inhibition percentage	15.1	%
14023	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Ribosomal protein S6 kinase alpha-6 [human]	inhibition percentage	-6.19	%
14024	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Dual specificity tyrosine-phosphorylation-regulated kinase 1B [human]	inhibition percentage	12.05	%
14025	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Actin-regulating kinase PRK1 [human]	inhibition percentage	23.77	%
14026	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Tyrosine-protein kinase Fgr [human]	inhibition percentage	5.05	%
14027	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Protein kinase C, theta [human]	inhibition percentage	-10.11	%
14028	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Histone acetyltransferase mst2 [human]	inhibition percentage	0.08	%
14029	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase 26 [human]	inhibition percentage	5.69	%
14030	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Tyrosine-protein kinase Lck [human]	inhibition percentage	-0.68	%
14031	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Calcium/calmodulin-dependent protein kinase type 1B [human]	inhibition percentage	-7.99	%
14032	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	MAP kinase-activated protein kinase 2 [human]	inhibition percentage	5.05	%
14033	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase Haspin homolog ALK2 [human]	inhibition percentage	5.14	%
14034	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Calcium/calmodulin-dependent protein kinase type II alpha chain [human]	inhibition percentage	-13.29	%
14035	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Discoidin domain-containing receptor 2 [human]	inhibition percentage	16.27	%
14036	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Tyrosine-protein kinase Lyn [human]	inhibition percentage	12.49	%
14037	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial [human]	inhibition percentage	12.45	%
14038	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	5'-AMP-activated protein kinase catalytic subunit alpha-1 [human]	inhibition percentage	-1.91	%
14039	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Tyrosine-protein kinase receptor UFO [human]	inhibition percentage	12.63	%
14040	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Mitogen-activated protein kinase kinase kinase kinase 1 [human]	inhibition percentage	-34.19	%
14041	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Insulin receptor [human]	inhibition percentage	-2.92	%
14042	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Tyrosine-protein kinase Yes [human]	inhibition percentage	-3.76	%
14043	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Calcium/calmodulin-dependent protein kinase type 1 [human]	inhibition percentage	7.33	%
14044	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase MRCK gamma [human]	inhibition percentage	5.46	%
14045	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Tyrosine-protein kinase BTK [human]	inhibition percentage	12.82	%
14046	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Laminin subunit beta-3 [human]	inhibition percentage	-26.86	%
14047	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Macrophage colony-stimulating factor 1 receptor [human]	inhibition percentage	-5.04	%
14048	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Casein kinase II subunit alpha'-interacting protein [human]	inhibition percentage	4.66	%
14049	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Tyrosine-protein kinase HCK [human]	inhibition percentage	0.45	%
14050	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Inhibitor of nuclear factor kappa-B kinase subunit alpha [human]	inhibition percentage	3.94	%
14051	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Death-associated protein kinase 2 [human]	inhibition percentage	-6.79	%
14052	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Receptor-interacting serine/threonine-protein kinase 2 [human]	inhibition percentage	-29.87	%
14053	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase WNK3 [human]	inhibition percentage	-1.89	%
14054	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Casein kinase I isoform gamma-3 [human]	inhibition percentage	-28.46	%
14055	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	PKG1 beta [human]	inhibition percentage	8.22	%
14056	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase 16 [human]	inhibition percentage	9.54	%
14057	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Dual specificity tyrosine-phosphorylation-regulated kinase 3 [human]	inhibition percentage	7.66	%
14058	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Traf2 and NCK-interacting protein kinase [human]	inhibition percentage	-14.85	%
14059	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Calcium/calmodulin-dependent protein kinase kinase 2 [human]	inhibition percentage	11.28	%
14060	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	MAPK/MAK/MRK overlapping kinase [human]	inhibition percentage	5.44	%
14061	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Casein kinase II subunit alpha-2 [human]	inhibition percentage	-4.36	%
14062	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Ephrin type-A receptor 5 [human]	inhibition percentage	15.8	%
14063	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	glycogen synthase kinase-3 beta [human]	inhibition percentage	-0.05	%
14064	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Mitogen-activated protein kinase 9 [human]	inhibition percentage	-1.41	%
14065	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Ephrin type-B receptor 2 [human]	inhibition percentage	1.4	%
14066	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Proto-oncogene tyrosine-protein kinase LCK [human]	inhibition percentage	-0.68	%
14067	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Transcription factor PRE6 [human]	inhibition percentage	50.07	%
14068	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	RAF proto-oncogene serine/threonine-protein kinase [human]	inhibition percentage	35.96	%
14069	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase 24 [human]	inhibition percentage	1.03	%
14070	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase Nek1 [human]	inhibition percentage	24.39	%
14071	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Actin-related protein 2 [human]	inhibition percentage	1.17	%
14072	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase Nek11 [human]	inhibition percentage	7.12	%
14073	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	MAP kinase-activated protein kinase 5 [human]	inhibition percentage	23.56	%
14074	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Casein kinase I isoform delta [human]	inhibition percentage	9.07	%
14075	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Phosphatidylinositol 3-kinase (p110d/p85a) [human]	inhibition percentage	30.93	%
14076	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Peptidyl-lysine N-acetyltransferase PatZ [human]	inhibition percentage	11	%
14077	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Activin receptor type-1B [human]	inhibition percentage	-3.68	%
14078	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Aurora kinase A [human]	inhibition percentage	13.76	%
14079	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase 38 [human]	inhibition percentage	-6	%
14080	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Pyruvate kinase 2 [human]	inhibition percentage	10.72	%
14081	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Casein kinase I isoform gamma-1 [human]	inhibition percentage	8.17	%
14082	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Ephrin type-B receptor 4 [human]	inhibition percentage	11.81	%
14083	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Casein kinase I isoform gamma-2 [human]	inhibition percentage	12.38	%
14084	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Testis-specific serine/threonine-protein kinase 3 [human]	inhibition percentage	8.88	%
14085	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Hepatocyte growth factor receptor [human]	inhibition percentage	2.36	%
14086	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	TGF-beta receptor type-2 [human]	inhibition percentage	19.28	%
14087	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Interferon-induced, double-stranded RNA-activated protein kinase [human]	inhibition percentage	13.92	%
14088	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Tyrosine-protein kinase ITK/TSK [human]	inhibition percentage	9.18	%
14089	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase DCLK2 [human]	inhibition percentage	-2.01	%
14090	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Glycogen synthase kinase-3 alpha [human]	inhibition percentage	5.47	%
14091	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase B-raf [human]	inhibition percentage	23.47	%
14092	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Mitogen-activated protein kinase kinase 3 [human]	inhibition percentage	12.82	%
14093	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Meiosis-specific serine/threonine-protein kinase MEK1 [human]	inhibition percentage	21.54	%
14094	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	NUAK family SNF1-like kinase 1 [human]	inhibition percentage	4.55	%
14095	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase MARK3 [human]	inhibition percentage	-4.67	%
14096	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Mitogen-activated protein kinase kinase kinase 10 [human]	inhibition percentage	18.01	%
14097	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Phosphatidylinositol 3-kinase (p120g) [human]	inhibition percentage	14.4	%
14098	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	CBL-interacting serine/threonine-protein kinase 7 [human]	inhibition percentage	3.4	%
14099	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	High affinity nerve growth factor receptor [human]	inhibition percentage	5.32	%
14100	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase LATS1 [human]	inhibition percentage	8.31	%
14101	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Proto-oncogene tyrosine-protein kinase receptor Ret [human]	inhibition percentage	-3.56	%
14102	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Serine/threonine-protein kinase pim-2 [human]	inhibition percentage	6.42	%
14103	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Cyclin-dependent-like kinase 5 [human];+Cyclin-dependent kinase 5 activator 1, p35 [human]	inhibition percentage	-0.03	%
14104	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	Tyrosine-protein kinase JAK1 [human]	inhibition percentage	-0.44	%
14105	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 (isoform 1) [human]	inhibition percentage	-4.26	%
14106	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O		Papp (B-A)	257	nm/s
14107	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O		Fmax	100	%
14108	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O		CL (drug clearance)	2.8	l/h/kg
14109	CC[C@@H](NC1=C2C=CN=CC2=NC(C2=CC=C(C=C2)C2=C(F)C(C)=CC=C2)=C1C#N)C(O)=O		Fmax	33	%
14110	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 3	IC50	4	nM
14111	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 4	Kd (dissociation constant)	11	nM
14112	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 3	Kd (dissociation constant)	13	nM
14113	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 4	IC50	15	nM
14114	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Rio3	Kd (dissociation constant)	17	nM
14115	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 4 [human]	IC50	26	nM
14116	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 3 [human]	IC50	36	nM
14117	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 3/4	IC50	122	nM
14118	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 3	IC50	139	nM
14119	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1		IC50	413	nM
14120	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Protein kinase C, theta	Kd (dissociation constant)	1100	nM
14121	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Leucine-rich repeat serine/threonine-protein kinase 2	IC50	1390	nM
14122	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Aurora kinase A [human]	IC50	3520	nM
14123	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 4 [human];+Serine/threonine-protein kinase 3 [human]	IC50	3.7	μM
14124	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 4 [human];+Serine/threonine-protein kinase 3 [human]	IC50	5.2	μM
14125	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 4 [human];+Serine/threonine-protein kinase 3 [human]	IC50	5.8	μM
14126	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 4 [human];+Serine/threonine-protein kinase 3 [human]	IC50	7.2	μM
14127	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 4 [human];+Serine/threonine-protein kinase 3 [human]	IC50	9.4	μM
14128	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1		decrease rate		
14129	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 4 [human];+Serine/threonine-protein kinase 3 [human]	IC50	10.6	μM
14130	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase ULK3 [human]	IC50	32380	nM
14131	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	BMP-2-inducible protein kinase [human]	IC50	45000	nM
14132	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/Threonine kinase LKB1, catalytic domain [human]	IC50	45000	nM
14133	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1		concentration (parameter)	8.7	μM
14134	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1		concentration (parameter)	4.6	μM
14135	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1		Cmax	11.8	μM
14136	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1		tmax	0.25	h
14137	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1		AUC (0-t)	8.1	μmol*h/l
14138	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1		t1/2 (drug half life)	5.3	h
14139	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1		decrease rate	99	%
14140	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Calcium/calmodulin-dependent protein kinase kinase 2	inhibition rate	53	%
14141	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Peripheral plasma membrane protein CASK	inhibition rate	88	%
14142	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase 11B	inhibition rate	14	%
14143	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase 11A	inhibition rate	10	%
14144	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase 13	inhibition rate	0	%
14145	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase 11	inhibition rate	98.8	%
14146	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase 2	inhibition rate	19	%
14147	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase 3	inhibition rate	14	%
14148	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase 4	inhibition rate	74	%
14149	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase 4;+Cyclin-D1-1	inhibition rate	8	%
14150	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-D3-1;+Cyclin-dependent kinase 4	inhibition rate	48	%
14151	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent-like kinase 5	inhibition rate	5	%
14152	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase 7	inhibition rate	77	%
14153	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase 8	inhibition rate	85	%
14154	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase 9	inhibition rate	30	%
14155	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase-like 1	inhibition rate	19	%
14156	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase-like 2	inhibition rate	3	%
14157	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase-like 3	inhibition rate	0	%
14158	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase-like 5	inhibition rate	9	%
14159	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Chk1	inhibition rate	8	%
14160	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Chk2	inhibition rate	9	%
14161	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Citron rho-interacting kinase	inhibition rate	18	%
14162	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase atg1	inhibition rate	82	%
14163	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Dual specificity protein kinase CLK2	inhibition rate	83	%
14164	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Dual specificity protein kinase CLK3	inhibition rate	86	%
14165	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Dual specificity protein kinase CLK4	inhibition rate	77	%
14166	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Macrophage colony-stimulating factor 1 receptor	inhibition rate	23	%
14167	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Macrophage colony-stimulating factor 1 receptor	inhibition rate	15	%
14168	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase CSK	inhibition rate	0	%
14169	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Casein kinase I isoform alpha	inhibition rate	19	%
14170	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Casein kinase I isoform alpha-like	inhibition rate	6	%
14171	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Casein kinase I isoform delta	inhibition rate	0	%
14172	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Casein kinase I isoform epsilon	inhibition rate	63	%
14173	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Casein kinase I isoform gamma-1	inhibition rate	13	%
14174	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Casein kinase I isoform gamma-2	inhibition rate	5	%
14175	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Casein kinase I isoform gamma-3	inhibition rate	6	%
14176	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Casein kinase II subunit alpha	inhibition rate	25	%
14177	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Casein kinase II subunit alpha'	inhibition rate	35	%
14178	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Megakaryocyte-associated tyrosine-protein kinase	inhibition rate	19	%
14179	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Death-associated protein kinase 1	inhibition rate	6	%
14180	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Death-associated protein kinase 2	inhibition rate	10	%
14181	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Death-associated protein kinase 3	inhibition rate	17	%
14182	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase DCLK1	inhibition rate	22	%
14183	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase DCLK2	inhibition rate	10	%
14184	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase DCLK3	inhibition rate	61	%
14185	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Epithelial discoidin domain-containing receptor 1	inhibition rate	0	%
14186	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Discoidin domain-containing receptor 2	inhibition rate	5	%
14187	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Death-associated protein kinase 3	inhibition rate	36	%
14188	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Myotonin-protein kinase	inhibition rate	63	%
14189	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase MRCK gamma	inhibition rate	2	%
14190	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 17A	inhibition rate	14	%
14191	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 17B	inhibition rate	16	%
14192	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Dual specificity tyrosine-phosphorylation-regulated kinase 1A/B	inhibition rate	52	%
14193	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	inhibition rate	21	%
14194	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Dual specificity tyrosine-phosphorylation-regulated kinase 2	inhibition rate	30	%
14195	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	epidermal growth factor-activated receptor	inhibition rate	19	%
14196	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	epidermal growth factor-activated receptor	inhibition rate	10	%
14197	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Epidermal growth factor receptor (G719C)	inhibition rate	0	%
14198	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Epidermal growth factor receptor (G719S)	inhibition rate	0	%
14199	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	epidermal growth factor-activated receptor	inhibition rate	36	%
14200	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	epidermal growth factor-activated receptor	inhibition rate	14	%
14201	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	epidermal growth factor-activated receptor	inhibition rate	41	%
14202	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Epidermal growth factor receptor (L858R)	inhibition rate	31	%
14203	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Epidermal growth factor receptor (L858R);+Epidermal growth factor receptor (T790M)	inhibition rate	67	%
14204	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Epidermal growth factor receptor (L861Q)	inhibition rate	4	%
14205	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	epidermal growth factor-activated receptor	inhibition rate	11	%
14206	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Epidermal growth factor receptor (T790M)	inhibition rate	58	%
14207	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Eukaryotic translation initiation factor 2-alpha kinase 1	inhibition rate	4	%
14208	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ephrin type-A receptor 1	inhibition rate	11	%
14209	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ephrin type-A receptor 2	inhibition rate	0	%
14210	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ephrin type-A receptor 3	inhibition rate	29	%
14211	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ephrin type-A receptor 4	inhibition rate	3	%
14212	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ephrin type-A receptor 5	inhibition rate	0	%
14213	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ephrin type-A receptor 6	inhibition rate	3	%
14214	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ephrin type-A receptor 7	inhibition rate	5	%
14215	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ephrin type-A receptor 8	inhibition rate	5	%
14216	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ephrin type-B receptor 1	inhibition rate	6	%
14217	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ephrin type-B receptor 2	inhibition rate	0	%
14218	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ephrin type-B receptor 3	inhibition rate	0	%
14219	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ephrin type-B receptor 4	inhibition rate	5	%
14220	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ephrin type-B receptor 6	inhibition rate	50	%
14221	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Receptor tyrosine-protein kinase erbB-2	inhibition rate	0	%
14222	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Receptor tyrosine-protein kinase erbB-3	inhibition rate	31	%
14223	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Receptor tyrosine-protein kinase erbB-4	inhibition rate	23	%
14224	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Extracellular signal-regulated kinase 1	inhibition rate	2	%
14225	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Extracellular signal-regulated kinase 2	inhibition rate	1	%
14226	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase 6	inhibition rate	7	%
14227	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase 4	inhibition rate	17	%
14228	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase 7	inhibition rate	14	%
14229	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase 15	inhibition rate	93.6	%
14230	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ethylene-responsive transcription factor ERN1	inhibition rate	30	%
14231	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Focal adhesion kinase 1	inhibition rate	7	%
14232	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase Fer	inhibition rate	0	%
14233	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	(-)-endo-fenchol synthase, chloroplastic	inhibition rate	5	%
14234	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Fibroblast growth factor receptor 1	inhibition rate	76	%
14235	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Fibroblast growth factor receptor 2	inhibition rate	38	%
14236	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Fibroblast growth factor receptor 3	inhibition rate	48	%
14237	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Fibroblast growth factor receptor 3	inhibition rate	43	%
14238	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Fibroblast growth factor receptor 4	inhibition rate	11	%
14239	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase Fgr	inhibition rate	32	%
14240	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Vascular endothelial growth factor receptor 1	inhibition rate	28	%
14241	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	9	%
14242	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Receptor-type tyrosine-protein kinase FLT3 (D835H)	inhibition rate	54	%
14243	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Receptor-type tyrosine-protein kinase FLT3 (D835V)	inhibition rate	97.8	%
14244	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Receptor-type tyrosine-protein kinase FLT3 (D835Y)	inhibition rate	76	%
14245	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Receptor-type tyrosine-protein kinase FLT3 ITD	inhibition rate	28	%
14246	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	90.7	%
14247	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	94.5	%
14248	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	37	%
14249	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	54	%
14250	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	35	%
14251	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	47	%
14252	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Vascular endothelial growth factor receptor 3	inhibition rate	25	%
14253	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase FRK	inhibition rate	10	%
14254	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase Fyn	inhibition rate	12	%
14255	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-G-associated kinase	inhibition rate	67	%
14256	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	eIF-2-alpha kinase Gcn2	inhibition rate	0	%
14257	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	rhodopsin kinase	inhibition rate	58	%
14258	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Beta-adrenergic receptor kinase 1	inhibition rate	40	%
14259	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Beta-adrenergic receptor kinase 2	inhibition rate	23	%
14260	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	G protein-coupled receptor kinase 4	inhibition rate	97.2	%
14261	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	rhodopsin kinase	inhibition rate	81	%
14262	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Glycogen synthase kinase-3 alpha	inhibition rate	12	%
14263	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	tau-protein kinase	inhibition rate	21	%
14264	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase haspin	inhibition rate	83	%
14265	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase HCK	inhibition rate	3	%
14266	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Homeodomain-interacting protein kinase 1	inhibition rate	33	%
14267	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Homeodomain-interacting protein kinase 2	inhibition rate	2	%
14268	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Homeodomain-interacting protein kinase 3	inhibition rate	38	%
14269	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Homeodomain-interacting protein kinase 4	inhibition rate	10	%
14270	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase kinase 1	inhibition rate	57	%
14271	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Hormonally up-regulated neu tumor-associated kinase	inhibition rate	0	%
14272	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase ICK	inhibition rate	28	%
14273	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Insulin-like growth factor 1 receptor	inhibition rate	5	%
14274	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Inhibitor of nuclear factor kappa-B kinase subunit alpha	inhibition rate	24	%
14275	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Inhibitor of nuclear factor kappa-B kinase subunit beta	inhibition rate	20	%
14276	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	inhibition rate	72	%
14277	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Insulin receptor	inhibition rate	35	%
14278	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Insulin receptor-related protein	inhibition rate	8	%
14279	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Interleukin-1 receptor-associated kinase 1	inhibition rate	0	%
14280	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Interleukin-1 receptor-associated kinase 3	inhibition rate	7	%
14281	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Interleukin-1 receptor-associated kinase 4	inhibition rate	15	%
14282	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ITK/TSK	inhibition rate	6	%
14283	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase JAK1	inhibition rate	2	%
14284	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase JAK1	inhibition rate	2	%
14285	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase JAK2	inhibition rate	91.3	%
14286	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase JAK3	inhibition rate	96.5	%
14287	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase 8	inhibition rate	10	%
14288	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase 9	inhibition rate	17	%
14289	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase 10	inhibition rate	0	%
14290	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mast/stem cell growth factor receptor Kit	inhibition rate	3	%
14291	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mast/stem cell growth factor receptor Kit (A829P)	inhibition rate	18	%
14292	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mast/stem cell growth factor receptor Kit (D816H)	inhibition rate	53	%
14293	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mast/stem cell growth factor receptor Kit (D816V)	inhibition rate	35	%
14294	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mast/stem cell growth factor receptor Kit	inhibition rate	6	%
14295	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mast/stem cell growth factor receptor Kit (V559D)	inhibition rate	9	%
14296	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mast/stem cell growth factor receptor Kit	inhibition rate	48	%
14297	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mast/stem cell growth factor receptor Kit	inhibition rate	5	%
14298	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mast/stem cell growth factor receptor Kit	inhibition rate	0	%
14299	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase LATS1	inhibition rate	9	%
14300	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase LATS2	inhibition rate	35	%
14301	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Proto-oncogene tyrosine-protein kinase LCK	inhibition rate	27	%
14302	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	LIM domain kinase 1	inhibition rate	18	%
14303	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	LIM domain kinase 2	inhibition rate	12	%
14304	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase STK11	inhibition rate	99.7	%
14305	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ovarian-specific serine/threonine-protein kinase Lok	inhibition rate	99.15	%
14306	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Leucine-rich repeat serine/threonine-protein kinase 2	inhibition rate	91.3	%
14307	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Leucine-rich repeat serine/threonine-protein kinase 2 (G2019S)	inhibition rate	92.7	%
14308	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Leukocyte tyrosine kinase receptor	inhibition rate	1	%
14309	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase Lyn	inhibition rate	13	%
14310	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase 13	inhibition rate	38	%
14311	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase MAK	inhibition rate	3	%
14312	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase 1	inhibition rate	36	%
14313	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase 15	inhibition rate	72	%
14314	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase 2	inhibition rate	87	%
14315	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase 3	inhibition rate	82	%
14316	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase 4	inhibition rate	0	%
14317	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase kinase 2	inhibition rate	93.6	%
14318	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase kinase 3	inhibition rate	93	%
14319	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase kinase 4	inhibition rate	27	%
14320	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	AP2-associated protein kinase 1	inhibition rate	83	%
14321	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase kinase 5	inhibition rate	31	%
14322	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	MAP kinase-activated protein kinase 2	inhibition rate	0	%
14323	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	MAP kinase-activated protein kinase 5	inhibition rate	24	%
14324	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase MARK1	inhibition rate	50	%
14325	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase MARK2	inhibition rate	71	%
14326	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	MAP/microtubule affinity-regulating kinase 3	inhibition rate	99	%
14327	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	MAP/microtubule affinity-regulating kinase 4	inhibition rate	72	%
14328	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	CLIP-associating protein 1	inhibition rate	47	%
14329	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Meiosis-specific serine/threonine-protein kinase MEK1	inhibition rate	92.5	%
14330	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Dual specificity mitogen-activated protein kinase kinase 2	inhibition rate	87	%
14331	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Dual specificity mitogen-activated protein kinase kinase 3	inhibition rate	48	%
14332	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Dual specificity mitogen-activated protein kinase kinase 4	inhibition rate	52	%
14333	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Dual specificity mitogen-activated protein kinase kinase 5	inhibition rate	76	%
14334	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Dual specificity mitogen-activated protein kinase kinase 6	inhibition rate	39	%
14335	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Maternal embryonic leucine zipper kinase	inhibition rate	77	%
14336	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase Mer	inhibition rate	44	%
14337	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Hepatocyte growth factor receptor	inhibition rate	31	%
14338	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Hepatocyte growth factor receptor (M1250T)	inhibition rate	33	%
14339	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Hepatocyte growth factor receptor	inhibition rate	17	%
14340	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Misshapen-like kinase 1	inhibition rate	78	%
14341	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Dual specificity mitogen-activated protein kinase kinase 7	inhibition rate	36	%
14342	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	MAP kinase-interacting serine/threonine-protein kinase 1	inhibition rate	18	%
14343	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	MAP kinase-interacting serine/threonine-protein kinase 2	inhibition rate	45	%
14344	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Myosin light chain kinase 3	inhibition rate	0	%
14345	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase 9	inhibition rate	55	%
14346	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase 10	inhibition rate	63	%
14347	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase 11	inhibition rate	23	%
14348	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase MRCK alpha	inhibition rate	7	%
14349	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase MRCK beta	inhibition rate	0	%
14350	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Sugar transport protein MST1	inhibition rate	83	%
14351	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Macrophage-stimulating protein receptor	inhibition rate	6	%
14352	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 3	inhibition rate	98.2	%
14353	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Sugar transport protein MST3	inhibition rate	54	%
14354	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 26	inhibition rate	89	%
14355	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase mTOR	inhibition rate	2	%
14356	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Muscle, skeletal receptor tyrosine-protein kinase	inhibition rate	28	%
14357	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Myosin light chain kinase, smooth muscle	inhibition rate	58	%
14358	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Myosin light chain kinase 2, skeletal/cardiac muscle	inhibition rate	11	%
14359	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Myosin light chain kinase family member 4	inhibition rate	39	%
14360	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Myosin-IIIa	inhibition rate	44	%
14361	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Myosin-IIIb	inhibition rate	41	%
14362	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 38	inhibition rate	29	%
14363	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Neurogenic differentiation factor 2	inhibition rate	17	%
14364	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Probable serine/threonine-protein kinase nek1	inhibition rate	12	%
14365	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Nek10	inhibition rate	71	%
14366	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Nek11	inhibition rate	9	%
14367	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Nek2	inhibition rate	21	%
14368	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Probable serine/threonine-protein kinase nek3	inhibition rate	21	%
14369	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Nek4	inhibition rate	4	%
14370	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Nek5	inhibition rate	12	%
14371	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Nek6	inhibition rate	3	%
14372	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Nek7	inhibition rate	3	%
14373	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Nek9	inhibition rate	9	%
14374	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase 14	inhibition rate	90.9	%
14375	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase NIM1	inhibition rate	47	%
14376	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine kinase NLK	inhibition rate	0	%
14377	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase OSR1	inhibition rate	55	%
14378	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase 14	inhibition rate	0	%
14379	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase 11	inhibition rate	13	%
14380	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase 13	inhibition rate	4	%
14381	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase 12	inhibition rate	33	%
14382	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Actin-regulating kinase PRK1	inhibition rate	35	%
14383	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase N2	inhibition rate	47	%
14384	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	GTP:AMP phosphotransferase, mitochondrial	inhibition rate	88	%
14385	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase PAK 4	inhibition rate	75	%
14386	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase PAK 6	inhibition rate	47	%
14387	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase PAK5	inhibition rate	70	%
14388	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase 16	inhibition rate	11	%
14389	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase 17	inhibition rate	25	%
14390	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase 18	inhibition rate	3	%
14391	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Platelet-derived growth factor receptor alpha	inhibition rate	37	%
14392	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Platelet-derived growth factor receptor beta	inhibition rate	17	%
14393	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	3-phosphoinositide-dependent protein kinase 1	inhibition rate	7	%
14394	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Calcium-dependent protein kinase 1 [Plasmodium falciparum]	inhibition rate	50	%
14395	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cell division control protein 2 homolog [Plasmodium falciparum]	inhibition rate	0	%
14396	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tudor domain-containing protein 7 [Plasmodium falciparum]	inhibition rate	15	%
14397	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Thymidine kinase 1 [Plasmodium falciparum]	inhibition rate	16	%
14398	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	inhibition rate	15	%
14399	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	inhibition rate	38	%
14400	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	inhibition rate	11	%
14401	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	inhibition rate	31	%
14402	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition rate	12	%
14403	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (C420R)	inhibition rate	17	%
14404	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E542K)	inhibition rate	9	%
14405	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545A)	inhibition rate	9	%
14406	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545K)	inhibition rate	29	%
14407	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047L)	inhibition rate	16	%
14408	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047Y)	inhibition rate	31	%
14409	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition rate	22	%
14410	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (M1043I)	inhibition rate	0	%
14411	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (Q546K)	inhibition rate	27	%
14412	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	inhibition rate	10	%
14413	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	inhibition rate	43	%
14414	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	inhibition rate	69	%
14415	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4-kinase beta	inhibition rate	36	%
14416	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	1-phosphatidylinositol 3-phosphate 5-kinase	inhibition rate	8	%
14417	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase pim-1	inhibition rate	10	%
14418	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase pim-2	inhibition rate	0	%
14419	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase pim-3	inhibition rate	20	%
14420	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	inhibition rate	71	%
14421	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	inhibition rate	36	%
14422	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta	inhibition rate	90.8	%
14423	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	inhibition rate	8	%
14424	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	cAMP-dependent protein kinase catalytic subunit alpha	inhibition rate	0	%
14425	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	cAMP-dependent protein kinase catalytic subunit beta	inhibition rate	0	%
14426	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	inhibition rate	21	%
14427	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase N1	inhibition rate	82	%
14428	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase N2	inhibition rate	88	%
14429	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Probable serine/threonine-protein kinase PknB [Mycobacterium tuberculosis]	inhibition rate	80	%
14430	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase PLK1	inhibition rate	18	%
14431	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ABL1	inhibition rate	69	%
14432	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase PLK2	inhibition rate	16	%
14433	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Plk3	inhibition rate	7	%
14434	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Plk4	inhibition rate	90.8	%
14435	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Protein kinase C, delta	inhibition rate	47	%
14436	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Protein kinase C, epsilon	inhibition rate	86	%
14437	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Protein kinase C, eta	inhibition rate	59	%
14438	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Protein kinase C iota type	inhibition rate	32	%
14439	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Protein kinase C, theta	inhibition rate	100	%
14440	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase D1	inhibition rate	0	%
14441	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase D2	inhibition rate	37	%
14442	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ABL1	inhibition rate	3	%
14443	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase D3	inhibition rate	42	%
14444	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	cGMP-dependent protein kinase 1	inhibition rate	0	%
14445	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	cGMP-dependent protein kinase 2	inhibition rate	20	%
14446	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Interferon-induced, double-stranded RNA-activated protein kinase	inhibition rate	13	%
14447	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	cAMP-dependent protein kinase catalytic subunit PRKX	inhibition rate	7	%
14448	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase prp4	inhibition rate	89	%
14449	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Pyruvate kinase 2	inhibition rate	13	%
14450	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase SIK3	inhibition rate	41	%
14451	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	RAF proto-oncogene serine/threonine-protein kinase	inhibition rate	16	%
14452	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Proto-oncogene tyrosine-protein kinase receptor Ret	inhibition rate	18	%
14453	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ABL1	inhibition rate	31	%
14454	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Proto-oncogene tyrosine-protein kinase receptor Ret (M918T)	inhibition rate	13	%
14455	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Nucleolar MIF4G domain-containing protein 1 (V804L)	inhibition rate	7	%
14456	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M)	inhibition rate	28	%
14457	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Rio1	inhibition rate	95.8	%
14458	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Rio2	inhibition rate	11	%
14459	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Rio3	inhibition rate	97	%
14460	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Inositol-pentakisphosphate 2-kinase	inhibition rate	1	%
14461	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Receptor-interacting serine/threonine-protein kinase 2	inhibition rate	2	%
14462	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Receptor-interacting serine/threonine-protein kinase 4	inhibition rate	81	%
14463	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Dual serine/threonine and tyrosine protein kinase	inhibition rate	28	%
14464	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ABL1	inhibition rate	21	%
14465	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Rho-associated protein kinase 1	inhibition rate	48	%
14466	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Rho-associated protein kinase 2	inhibition rate	43	%
14467	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	DNA glycosylase/AP lyase ROS1	inhibition rate	61	%
14468	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ribosomal protein S6 kinase alpha-4	inhibition rate	0	%
14469	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ribosomal protein S6 kinase alpha-4	inhibition rate	21	%
14470	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ribosomal protein S6 kinase alpha-5	inhibition rate	1	%
14471	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ribosomal protein S6 kinase alpha-5	inhibition rate	8	%
14472	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ribosomal protein S6 kinase alpha-1	inhibition rate	35	%
14473	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ribosomal protein S6 kinase alpha-1	inhibition rate	52	%
14474	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ribosomal protein S6 kinase alpha-2	inhibition rate	83	%
14475	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ABL1	inhibition rate	28	%
14476	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ribosomal protein S6 kinase alpha-2	inhibition rate	0	%
14477	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ribosomal protein S6 kinase alpha-3	inhibition rate	40	%
14478	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ribosomal protein S6 kinase alpha-3	inhibition rate	39	%
14479	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ribosomal protein S6 kinase alpha-6	inhibition rate	92.4	%
14480	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ribosomal protein S6 kinase alpha-6	inhibition rate	57	%
14481	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ribosomal protein S6 kinase beta-1	inhibition rate	10	%
14482	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase, Sbk1	inhibition rate	56	%
14483	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Sgk1	inhibition rate	53	%
14484	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Uncharacterized serine/threonine-protein kinase SBK3	inhibition rate	15	%
14485	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Sgk2	inhibition rate	35	%
14486	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ABL1	inhibition rate	52	%
14487	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Sgk3	inhibition rate	31	%
14488	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase SIK1	inhibition rate	5	%
14489	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase SIK2	inhibition rate	44	%
14490	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase Fyn	inhibition rate	99.3	%
14491	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	NUAK family SNF1-like kinase 2	inhibition rate	99.1	%
14492	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	SNF-related serine/threonine-protein kinase	inhibition rate	4	%
14493	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Neuronal proto-oncogene tyrosine-protein kinase Src	inhibition rate	0	%
14494	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase Srms	inhibition rate	18	%
14495	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	CBL-interacting serine/threonine-protein kinase 7	inhibition rate	17	%
14496	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	SRSF protein kinase 2	inhibition rate	20	%
14497	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ABL1	inhibition rate	31	%
14498	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	SRSF protein kinase 3	inhibition rate	10	%
14499	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 16	inhibition rate	79	%
14500	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 33	inhibition rate	62	%
14501	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 35	inhibition rate	2	%
14502	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 36	inhibition rate	8	%
14503	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	STE20/SPS1-related proline-alanine-rich protein kinase	inhibition rate	32	%
14504	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase SYK	inhibition rate	15	%
14505	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase 7	inhibition rate	72	%
14506	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase TAO1	inhibition rate	95.5	%
14507	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase TAO2	inhibition rate	48	%
14508	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ABL1	inhibition rate	36	%
14509	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase TAO3	inhibition rate	86	%
14510	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase TBK1	inhibition rate	0	%
14511	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase Tec	inhibition rate	0	%
14512	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Dual specificity testis-specific protein kinase 1	inhibition rate	62	%
14513	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	TGF-beta receptor type-1	inhibition rate	46	%
14514	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	TGF-beta receptor type-2	inhibition rate	0	%
14515	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase receptor Tie-1	inhibition rate	73	%
14516	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase receptor Tie-2	inhibition rate	39	%
14517	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase tousled-like 1-B	inhibition rate	44	%
14518	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase TOUSLED-like 2	inhibition rate	21	%
14519	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ABL1	inhibition rate	22	%
14520	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Traf2 and NCK-interacting protein kinase	inhibition rate	63	%
14521	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Non-receptor tyrosine-protein kinase TNK1	inhibition rate	94.6	%
14522	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Activated CDC42 kinase 1	inhibition rate	8	%
14523	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase TNNI3K	inhibition rate	19	%
14524	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Trk system potassium uptake protein TrkA	inhibition rate	52	%
14525	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	BDNF/NT-3 growth factors receptor	inhibition rate	55	%
14526	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	NT-3 growth factor receptor	inhibition rate	34	%
14527	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Transient receptor potential cation channel subfamily M member 6	inhibition rate	0	%
14528	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Testis-specific serine/threonine-protein kinase 1	inhibition rate	0	%
14529	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Testis-specific serine/threonine-protein kinase 3	inhibition rate	4	%
14530	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ABL1	inhibition rate	79	%
14531	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Dual specificity protein kinase TTK	inhibition rate	24	%
14532	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase TXK	inhibition rate	5	%
14533	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Non-receptor tyrosine-protein kinase TYK2	inhibition rate	72	%
14534	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Non-receptor tyrosine-protein kinase TYK2	inhibition rate	52	%
14535	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase receptor TYRO3	inhibition rate	3	%
14536	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase ULK1	inhibition rate	45	%
14537	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase ULK2	inhibition rate	37	%
14538	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase ULK3	inhibition rate	97.2	%
14539	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Vascular endothelial growth factor receptor 2	inhibition rate	47	%
14540	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 3-kinase, Vps34 type	inhibition rate	25	%
14541	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ABL1	inhibition rate	35	%
14542	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase VRK2	inhibition rate	29	%
14543	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitosis inhibitor protein kinase wee1	inhibition rate	0	%
14544	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Wee1-like protein kinase 1-A	inhibition rate	8	%
14545	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase WNK1	inhibition rate	3	%
14546	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase WNK2	inhibition rate	28	%
14547	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase WNK3	inhibition rate	3	%
14548	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase WNK4	inhibition rate	14	%
14549	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 32A	inhibition rate	45	%
14550	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 32B	inhibition rate	5	%
14551	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 32C	inhibition rate	0	%
14552	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ABL1	inhibition rate	71	%
14553	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase yes	inhibition rate	14	%
14554	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 25	inhibition rate	44	%
14555	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase 19	inhibition rate	97.1	%
14556	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase 20	inhibition rate	2	%
14557	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ZAP-70	inhibition rate	5	%
14558	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ABL1	inhibition rate	47	%
14559	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ABL1	inhibition rate	30	%
14560	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ABL1	inhibition rate	8	%
14561	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ABL2	inhibition rate	5	%
14562	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Activin receptor type-1	inhibition rate	2	%
14563	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Activin receptor type-1B	inhibition rate	44	%
14564	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Activin receptor type-2A	inhibition rate	0	%
14565	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Activin receptor type-2B	inhibition rate	3	%
14566	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase receptor R3	inhibition rate	0	%
14567	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Atypical kinase COQ8A, mitochondrial	inhibition rate	0	%
14568	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Atypical kinase COQ8B, mitochondrial	inhibition rate	5	%
14569	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	RAC serine/threonine-protein kinase	inhibition rate	0	%
14570	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Abhydrolase domain-containing protein AKT2	inhibition rate	0	%
14571	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	RAC-gamma serine/threonine-protein kinase	inhibition rate	0	%
14572	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Soluble starch synthase 2-3, chloroplastic/amyloplastic	inhibition rate	31	%
14573	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Soluble starch synthase 2-3, chloroplastic/amyloplastic	inhibition rate	51	%
14574	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Soluble starch synthase 2-3, chloroplastic/amyloplastic	inhibition rate	32	%
14575	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	5'-AMP-activated protein kinase catalytic subunit alpha-1	inhibition rate	66	%
14576	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	5'-AMP-activated protein kinase catalytic subunit alpha-2	inhibition rate	43	%
14577	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ankyrin repeat and protein kinase domain-containing protein 1	inhibition rate	33	%
14578	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	NUAK family SNF1-like kinase 1	inhibition rate	91.2	%
14579	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	DASH complex subunit ASK1	inhibition rate	94.1	%
14580	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase 6	inhibition rate	79	%
14581	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Aurora kinase A	inhibition rate	99.35	%
14582	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Aurora kinase B	inhibition rate	91.4	%
14583	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Aurora kinase C	inhibition rate	79	%
14584	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	NEDD8-activating enzyme E1 regulatory subunit AXL	inhibition rate	64	%
14585	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	BMP-2-inducible protein kinase	inhibition rate	98.2	%
14586	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase Blk	inhibition rate	43	%
14587	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Bone morphogenetic protein receptor type-1A	inhibition rate	19	%
14588	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Bone morphogenetic protein receptor type-1B	inhibition rate	97	%
14589	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Bone morphogenetic protein receptor type-2	inhibition rate	30	%
14590	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cytoplasmic tyrosine-protein kinase BMX	inhibition rate	0	%
14591	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase B-raf	inhibition rate	19	%
14592	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase B-raf (V600E)	inhibition rate	3	%
14593	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Bone morphogenetic protein receptor type-2	inhibition rate	3	%
14594	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase BRSK1	inhibition rate	58	%
14595	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase BRSK2	inhibition rate	61	%
14596	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase BTK	inhibition rate	19	%
14597	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitotic checkpoint serine/threonine-protein kinase BUB1	inhibition rate	26	%
14598	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Calcium/calmodulin-dependent protein kinase type 1	inhibition rate	6	%
14599	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Calcium/calmodulin-dependent protein kinase type 1B	inhibition rate	28	%
14600	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Calcium/calmodulin-dependent protein kinase type 1D	inhibition rate	16	%
14601	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Calcium/calmodulin-dependent protein kinase type 1G	inhibition rate	24	%
14602	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Calcium/calmodulin-dependent protein kinase type II subunit alpha	inhibition rate	57	%
14603	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Calcium/calmodulin-dependent protein kinase type II subunit beta	inhibition rate	63	%
14604	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Calcium/calmodulin-dependent protein kinase type II delta chain	inhibition rate	55	%
14605	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Calcium/calmodulin-dependent protein kinase type II subunit gamma	inhibition rate	40	%
14606	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Calcium/calmodulin-dependent protein kinase type IV	inhibition rate	0	%
14607	CC(=O)NC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Calcium/calmodulin-dependent protein kinase kinase 1	inhibition rate	24	%
14608	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 3	IC50	4	nM
14609	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 4	Kd (dissociation constant)	9	nM
14610	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 4	IC50	17	nM
14611	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 3	Kd (dissociation constant)	20	nM
14612	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Rio3	Kd (dissociation constant)	70	nM
14613	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 4 [human]	IC50	80	nM
14614	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1		decrease rate		
14615	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 3 [human]	IC50	127	nM
14616	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 3/4	IC50	250	nM
14617	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 3	IC50	433	nM
14618	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1		increase rate		
14619	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1		IC50	1.2	μM
14620	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Leucine-rich repeat serine/threonine-protein kinase 2	IC50	1340	nM
14621	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Protein kinase C, theta	Kd (dissociation constant)	4800	nM
14622	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 4 [human];+Serine/threonine-protein kinase 3 [human]	IC50	4.8	μM
14623	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Aurora kinase A [human]	IC50	7440	nM
14624	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 4 [human];+Serine/threonine-protein kinase 3 [human]	IC50	8.1	μM
14625	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase ULK3 [human]	IC50	8460	nM
14626	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1		decrease rate		
14627	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1		increase rate		
14628	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 4 [human];+Serine/threonine-protein kinase 3 [human]	IC50	9.9	μM
14629	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 4 [human];+Serine/threonine-protein kinase 3 [human]	IC50	12.2	μM
14630	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 4 [human];+Serine/threonine-protein kinase 3 [human]	IC50	12.2	μM
14631	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 4 [human];+Serine/threonine-protein kinase 3 [human]	IC50	15.7	μM
14632	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	BMP-2-inducible protein kinase [human]	IC50	45000	nM
14633	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/Threonine kinase LKB1, catalytic domain [human]	IC50	45000	nM
14634	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1		concentration (parameter)	11.6	μM
14635	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1		concentration (parameter)	5.9	μM
14636	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1		Cmax	5.8	μM
14637	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1		tmax	0.25	h
14638	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1		AUC (0-t)	4.3	μmol*h/l
14639	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1		t1/2 (drug half life)	9.9	h
14640	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1		decrease rate	78	%
14641	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1		Papp (A-B)	39.8	cm/s
14642	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1		Papp (B-A)	52.7	cm/s
14643	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1		efflux ratio	1.3	no unit
14644	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Calcium/calmodulin-dependent protein kinase kinase 2	inhibition rate	29	%
14645	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Peripheral plasma membrane protein CASK	inhibition rate	81	%
14646	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase 11B	inhibition rate	2	%
14647	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase 11A	inhibition rate	10	%
14648	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase 13	inhibition rate	6	%
14649	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase 11	inhibition rate	47	%
14650	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase 2	inhibition rate	10	%
14651	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase 3	inhibition rate	12	%
14652	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase 4	inhibition rate	0	%
14653	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase 4;+Cyclin-D1-1	inhibition rate	82	%
14654	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-D3-1;+Cyclin-dependent kinase 4	inhibition rate	31	%
14655	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent-like kinase 5	inhibition rate	13	%
14656	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase 7	inhibition rate	76	%
14657	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase 8	inhibition rate	9	%
14658	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase 9	inhibition rate	8	%
14659	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase-like 1	inhibition rate	25	%
14660	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase-like 2	inhibition rate	6	%
14661	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase-like 3	inhibition rate	4	%
14662	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase-like 5	inhibition rate	4	%
14663	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Chk1	inhibition rate	0	%
14664	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Chk2	inhibition rate	11	%
14665	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Citron rho-interacting kinase	inhibition rate	4	%
14666	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase atg1	inhibition rate	68	%
14667	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Dual specificity protein kinase CLK2	inhibition rate	42	%
14668	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Dual specificity protein kinase CLK3	inhibition rate	62	%
14669	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Dual specificity protein kinase CLK4	inhibition rate	41	%
14670	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Macrophage colony-stimulating factor 1 receptor	inhibition rate	3	%
14671	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Macrophage colony-stimulating factor 1 receptor	inhibition rate	4	%
14672	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase CSK	inhibition rate	2	%
14673	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Casein kinase I isoform alpha	inhibition rate	4	%
14674	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Casein kinase I isoform alpha-like	inhibition rate	1	%
14675	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Casein kinase I isoform delta	inhibition rate	0	%
14676	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Casein kinase I isoform epsilon	inhibition rate	47	%
14677	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Casein kinase I isoform gamma-1	inhibition rate	0	%
14678	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Casein kinase I isoform gamma-2	inhibition rate	0	%
14679	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Casein kinase I isoform gamma-3	inhibition rate	17	%
14680	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Casein kinase II subunit alpha	inhibition rate	20	%
14681	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Casein kinase II subunit alpha'	inhibition rate	8	%
14682	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Megakaryocyte-associated tyrosine-protein kinase	inhibition rate	14	%
14683	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Death-associated protein kinase 1	inhibition rate	16	%
14684	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Death-associated protein kinase 2	inhibition rate	3	%
14685	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Death-associated protein kinase 3	inhibition rate	2	%
14686	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase DCLK1	inhibition rate	14	%
14687	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase DCLK2	inhibition rate	7	%
14688	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase DCLK3	inhibition rate	67	%
14689	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Epithelial discoidin domain-containing receptor 1	inhibition rate	0	%
14690	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Discoidin domain-containing receptor 2	inhibition rate	19	%
14691	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Death-associated protein kinase 3	inhibition rate	29	%
14692	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Myotonin-protein kinase	inhibition rate	27	%
14693	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase MRCK gamma	inhibition rate	1	%
14694	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 17A	inhibition rate	0	%
14695	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 17B	inhibition rate	0	%
14696	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Dual specificity tyrosine-phosphorylation-regulated kinase 1A/B	inhibition rate	57	%
14697	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	inhibition rate	44	%
14698	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Dual specificity tyrosine-phosphorylation-regulated kinase 2	inhibition rate	11	%
14699	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	epidermal growth factor-activated receptor	inhibition rate	12	%
14700	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	epidermal growth factor-activated receptor	inhibition rate	31	%
14701	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Epidermal growth factor receptor (G719C)	inhibition rate	3	%
14702	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Epidermal growth factor receptor (G719S)	inhibition rate	8	%
14703	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	epidermal growth factor-activated receptor	inhibition rate	6	%
14704	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	epidermal growth factor-activated receptor	inhibition rate	17	%
14705	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	epidermal growth factor-activated receptor	inhibition rate	8	%
14706	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Epidermal growth factor receptor (L858R)	inhibition rate	11	%
14707	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Epidermal growth factor receptor (L858R);+Epidermal growth factor receptor (T790M)	inhibition rate	69	%
14708	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Epidermal growth factor receptor (L861Q)	inhibition rate	9	%
14709	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	epidermal growth factor-activated receptor	inhibition rate	25	%
14710	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Epidermal growth factor receptor (T790M)	inhibition rate	47	%
14711	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Eukaryotic translation initiation factor 2-alpha kinase 1	inhibition rate	17	%
14712	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ephrin type-A receptor 1	inhibition rate	5	%
14713	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ephrin type-A receptor 2	inhibition rate	0	%
14714	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ephrin type-A receptor 3	inhibition rate	8	%
14715	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ephrin type-A receptor 4	inhibition rate	9	%
14716	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ephrin type-A receptor 5	inhibition rate	1	%
14717	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ephrin type-A receptor 6	inhibition rate	0	%
14718	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ephrin type-A receptor 7	inhibition rate	6	%
14719	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ephrin type-A receptor 8	inhibition rate	9	%
14720	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ephrin type-B receptor 1	inhibition rate	9	%
14721	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ephrin type-B receptor 2	inhibition rate	0	%
14722	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ephrin type-B receptor 3	inhibition rate	0	%
14723	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ephrin type-B receptor 4	inhibition rate	0	%
14724	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ephrin type-B receptor 6	inhibition rate	13	%
14725	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Receptor tyrosine-protein kinase erbB-2	inhibition rate	6	%
14726	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Receptor tyrosine-protein kinase erbB-3	inhibition rate	2	%
14727	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Receptor tyrosine-protein kinase erbB-4	inhibition rate	5	%
14728	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Extracellular signal-regulated kinase 1	inhibition rate	0	%
14729	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Extracellular signal-regulated kinase 2	inhibition rate	2	%
14730	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase 6	inhibition rate	0	%
14731	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase 4	inhibition rate	5	%
14732	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase 7	inhibition rate	1	%
14733	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase 15	inhibition rate	42	%
14734	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ethylene-responsive transcription factor ERN1	inhibition rate	52	%
14735	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Focal adhesion kinase 1	inhibition rate	0	%
14736	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase Fer	inhibition rate	0	%
14737	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	(-)-endo-fenchol synthase, chloroplastic	inhibition rate	0	%
14738	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Fibroblast growth factor receptor 1	inhibition rate	25	%
14739	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Fibroblast growth factor receptor 2	inhibition rate	54	%
14740	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Fibroblast growth factor receptor 3	inhibition rate	67	%
14741	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Fibroblast growth factor receptor 3	inhibition rate	61	%
14742	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Fibroblast growth factor receptor 4	inhibition rate	0	%
14743	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase Fgr	inhibition rate	7	%
14744	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Vascular endothelial growth factor receptor 1	inhibition rate	0	%
14745	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	0	%
14746	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Receptor-type tyrosine-protein kinase FLT3 (D835H)	inhibition rate	1	%
14747	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Receptor-type tyrosine-protein kinase FLT3 (D835V)	inhibition rate	97.5	%
14748	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Receptor-type tyrosine-protein kinase FLT3 (D835Y)	inhibition rate	25	%
14749	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Receptor-type tyrosine-protein kinase FLT3 ITD	inhibition rate	0	%
14750	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	73	%
14751	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	59	%
14752	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	24	%
14753	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	37	%
14754	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	45	%
14755	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	2	%
14756	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Vascular endothelial growth factor receptor 3	inhibition rate	0	%
14757	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase FRK	inhibition rate	0	%
14758	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase Fyn	inhibition rate	18	%
14759	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-G-associated kinase	inhibition rate	5	%
14760	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	eIF-2-alpha kinase Gcn2	inhibition rate	0	%
14761	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	rhodopsin kinase	inhibition rate	30	%
14762	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Beta-adrenergic receptor kinase 1	inhibition rate	10	%
14763	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Beta-adrenergic receptor kinase 2	inhibition rate	20	%
14764	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	G protein-coupled receptor kinase 4	inhibition rate	98.6	%
14765	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	rhodopsin kinase	inhibition rate	42	%
14766	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Glycogen synthase kinase-3 alpha	inhibition rate	0	%
14767	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	tau-protein kinase	inhibition rate	34	%
14768	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase haspin	inhibition rate	93	%
14769	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase HCK	inhibition rate	0	%
14770	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Homeodomain-interacting protein kinase 1	inhibition rate	38	%
14771	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Homeodomain-interacting protein kinase 2	inhibition rate	22	%
14772	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Homeodomain-interacting protein kinase 3	inhibition rate	76	%
14773	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Homeodomain-interacting protein kinase 4	inhibition rate	5	%
14774	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase kinase 1	inhibition rate	41	%
14775	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Hormonally up-regulated neu tumor-associated kinase	inhibition rate	0	%
14776	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase ICK	inhibition rate	29	%
14777	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Insulin-like growth factor 1 receptor	inhibition rate	1	%
14778	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Inhibitor of nuclear factor kappa-B kinase subunit alpha	inhibition rate	25	%
14779	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Inhibitor of nuclear factor kappa-B kinase subunit beta	inhibition rate	19	%
14780	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	inhibition rate	42	%
14781	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Insulin receptor	inhibition rate	19	%
14782	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Insulin receptor-related protein	inhibition rate	9	%
14783	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Interleukin-1 receptor-associated kinase 1	inhibition rate	48	%
14784	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Interleukin-1 receptor-associated kinase 3	inhibition rate	54	%
14785	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Interleukin-1 receptor-associated kinase 4	inhibition rate	52	%
14786	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ITK/TSK	inhibition rate	7	%
14787	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase JAK1	inhibition rate	0	%
14788	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase JAK1	inhibition rate	3	%
14789	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase JAK2	inhibition rate	80	%
14790	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase JAK3	inhibition rate	99.3	%
14791	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase 8	inhibition rate	15	%
14792	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase 9	inhibition rate	28	%
14793	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase 10	inhibition rate	35	%
14794	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mast/stem cell growth factor receptor Kit	inhibition rate	19	%
14795	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mast/stem cell growth factor receptor Kit (A829P)	inhibition rate	22	%
14796	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mast/stem cell growth factor receptor Kit (D816H)	inhibition rate	41	%
14797	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mast/stem cell growth factor receptor Kit (D816V)	inhibition rate	10	%
14798	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mast/stem cell growth factor receptor Kit	inhibition rate	17	%
14799	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mast/stem cell growth factor receptor Kit (V559D)	inhibition rate	14	%
14800	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mast/stem cell growth factor receptor Kit	inhibition rate	52	%
14801	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mast/stem cell growth factor receptor Kit	inhibition rate	31	%
14802	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mast/stem cell growth factor receptor Kit	inhibition rate	0	%
14803	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase LATS1	inhibition rate	64	%
14804	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase LATS2	inhibition rate	31	%
14805	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Proto-oncogene tyrosine-protein kinase LCK	inhibition rate	12	%
14806	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	LIM domain kinase 1	inhibition rate	0	%
14807	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	LIM domain kinase 2	inhibition rate	8	%
14808	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase STK11	inhibition rate	76	%
14809	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ovarian-specific serine/threonine-protein kinase Lok	inhibition rate	55	%
14810	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Leucine-rich repeat serine/threonine-protein kinase 2	inhibition rate	95	%
14811	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Leucine-rich repeat serine/threonine-protein kinase 2 (G2019S)	inhibition rate	97.1	%
14812	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Leukocyte tyrosine kinase receptor	inhibition rate	7	%
14813	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase Lyn	inhibition rate	0	%
14814	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase 13	inhibition rate	27	%
14815	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase MAK	inhibition rate	0	%
14816	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase 1	inhibition rate	37	%
14817	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase 15	inhibition rate	50	%
14818	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase 2	inhibition rate	62	%
14819	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase 3	inhibition rate	50	%
14820	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase 4	inhibition rate	0	%
14821	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase kinase 2	inhibition rate	93.8	%
14822	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase kinase 3	inhibition rate	76	%
14823	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase kinase 4	inhibition rate	17	%
14824	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	AP2-associated protein kinase 1	inhibition rate	90.4	%
14825	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase kinase 5	inhibition rate	25	%
14826	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	MAP kinase-activated protein kinase 2	inhibition rate	0	%
14827	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	MAP kinase-activated protein kinase 5	inhibition rate	6	%
14828	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase MARK1	inhibition rate	24	%
14829	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase MARK2	inhibition rate	47	%
14830	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	MAP/microtubule affinity-regulating kinase 3	inhibition rate	0	%
14831	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	MAP/microtubule affinity-regulating kinase 4	inhibition rate	27	%
14832	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	CLIP-associating protein 1	inhibition rate	9	%
14833	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Meiosis-specific serine/threonine-protein kinase MEK1	inhibition rate	86	%
14834	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Dual specificity mitogen-activated protein kinase kinase 2	inhibition rate	74	%
14835	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Dual specificity mitogen-activated protein kinase kinase 3	inhibition rate	73	%
14836	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Dual specificity mitogen-activated protein kinase kinase 4	inhibition rate	68	%
14837	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Dual specificity mitogen-activated protein kinase kinase 5	inhibition rate	69	%
14838	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Dual specificity mitogen-activated protein kinase kinase 6	inhibition rate	15	%
14839	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Maternal embryonic leucine zipper kinase	inhibition rate	51	%
14840	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase Mer	inhibition rate	35	%
14841	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Hepatocyte growth factor receptor	inhibition rate	25	%
14842	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Hepatocyte growth factor receptor (M1250T)	inhibition rate	19	%
14843	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Hepatocyte growth factor receptor	inhibition rate	30	%
14844	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Misshapen-like kinase 1	inhibition rate	88	%
14845	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Dual specificity mitogen-activated protein kinase kinase 7	inhibition rate	33	%
14846	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	MAP kinase-interacting serine/threonine-protein kinase 1	inhibition rate	21	%
14847	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	MAP kinase-interacting serine/threonine-protein kinase 2	inhibition rate	64	%
14848	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Myosin light chain kinase 3	inhibition rate	0	%
14849	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase 9	inhibition rate	17	%
14850	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase 10	inhibition rate	26	%
14851	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase 11	inhibition rate	0	%
14852	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase MRCK alpha	inhibition rate	20	%
14853	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase MRCK beta	inhibition rate	17	%
14854	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Sugar transport protein MST1	inhibition rate	43	%
14855	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Macrophage-stimulating protein receptor	inhibition rate	0	%
14856	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 3	inhibition rate	99.55	%
14857	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Sugar transport protein MST3	inhibition rate	46	%
14858	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 26	inhibition rate	72	%
14859	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase mTOR	inhibition rate	0	%
14860	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Muscle, skeletal receptor tyrosine-protein kinase	inhibition rate	14	%
14861	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Myosin light chain kinase, smooth muscle	inhibition rate	70	%
14862	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Myosin light chain kinase 2, skeletal/cardiac muscle	inhibition rate	6	%
14863	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Myosin light chain kinase family member 4	inhibition rate	24	%
14864	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Myosin-IIIa	inhibition rate	11	%
14865	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Myosin-IIIb	inhibition rate	29	%
14866	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 38	inhibition rate	24	%
14867	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Neurogenic differentiation factor 2	inhibition rate	18	%
14868	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Probable serine/threonine-protein kinase nek1	inhibition rate	6	%
14869	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Nek10	inhibition rate	90.9	%
14870	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Nek11	inhibition rate	0	%
14871	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Nek2	inhibition rate	0	%
14872	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Probable serine/threonine-protein kinase nek3	inhibition rate	35	%
14873	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Nek4	inhibition rate	0	%
14874	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Nek5	inhibition rate	0	%
14875	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Nek6	inhibition rate	0	%
14876	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Nek7	inhibition rate	1	%
14877	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Nek9	inhibition rate	4	%
14878	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase 14	inhibition rate	86	%
14879	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase NIM1	inhibition rate	43	%
14880	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine kinase NLK	inhibition rate	7	%
14881	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase OSR1	inhibition rate	58	%
14882	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase 14	inhibition rate	0	%
14883	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase 11	inhibition rate	0	%
14884	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase 13	inhibition rate	0	%
14885	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase 12	inhibition rate	13	%
14886	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Actin-regulating kinase PRK1	inhibition rate	0	%
14887	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase N2	inhibition rate	11	%
14888	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	GTP:AMP phosphotransferase, mitochondrial	inhibition rate	12	%
14889	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase PAK 4	inhibition rate	11	%
14890	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase PAK 6	inhibition rate	26	%
14891	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase PAK5	inhibition rate	29	%
14892	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase 16	inhibition rate	22	%
14893	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase 17	inhibition rate	1	%
14894	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cyclin-dependent kinase 18	inhibition rate	17	%
14895	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Platelet-derived growth factor receptor alpha	inhibition rate	27	%
14896	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Platelet-derived growth factor receptor beta	inhibition rate	16	%
14897	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	3-phosphoinositide-dependent protein kinase 1	inhibition rate	0	%
14898	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Calcium-dependent protein kinase 1 [Plasmodium falciparum]	inhibition rate	30	%
14899	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cell division control protein 2 homolog [Plasmodium falciparum]	inhibition rate	0	%
14900	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tudor domain-containing protein 7 [Plasmodium falciparum]	inhibition rate	18	%
14901	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Thymidine kinase 1 [Plasmodium falciparum]	inhibition rate	0	%
14902	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	inhibition rate	0	%
14903	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	inhibition rate	24	%
14904	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	inhibition rate	2	%
14905	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	inhibition rate	22	%
14906	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition rate	5	%
14907	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (C420R)	inhibition rate	17	%
14908	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E542K)	inhibition rate	18	%
14909	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545A)	inhibition rate	0	%
14910	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545K)	inhibition rate	29	%
14911	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047L)	inhibition rate	14	%
14912	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047Y)	inhibition rate	15	%
14913	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition rate	21	%
14914	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (M1043I)	inhibition rate	14	%
14915	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (Q546K)	inhibition rate	23	%
14916	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	inhibition rate	21	%
14917	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	inhibition rate	21	%
14918	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	inhibition rate	86	%
14919	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4-kinase beta	inhibition rate	30	%
14920	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	1-phosphatidylinositol 3-phosphate 5-kinase	inhibition rate	0	%
14921	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase pim-1	inhibition rate	0	%
14922	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase pim-2	inhibition rate	0	%
14923	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase pim-3	inhibition rate	0	%
14924	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	inhibition rate	96.6	%
14925	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	inhibition rate	49	%
14926	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta	inhibition rate	97.2	%
14927	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	inhibition rate	62	%
14928	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	cAMP-dependent protein kinase catalytic subunit alpha	inhibition rate	0	%
14929	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	cAMP-dependent protein kinase catalytic subunit beta	inhibition rate	0	%
14930	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	inhibition rate	15	%
14931	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase N1	inhibition rate	23	%
14932	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase N2	inhibition rate	35	%
14933	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Probable serine/threonine-protein kinase PknB [Mycobacterium tuberculosis]	inhibition rate	80	%
14934	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase PLK1	inhibition rate	35	%
14935	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ABL1	inhibition rate	46	%
14936	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase PLK2	inhibition rate	22	%
14937	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Plk3	inhibition rate	3	%
14938	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Plk4	inhibition rate	75	%
14939	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Protein kinase C, delta	inhibition rate	30	%
14940	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Protein kinase C, epsilon	inhibition rate	79	%
14941	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Protein kinase C, eta	inhibition rate	29	%
14942	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Protein kinase C iota type	inhibition rate	22	%
14943	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Protein kinase C, theta	inhibition rate	17	%
14944	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase D1	inhibition rate	94.1	%
14945	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase D2	inhibition rate	0	%
14946	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ABL1	inhibition rate	18	%
14947	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase D3	inhibition rate	11	%
14948	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	cGMP-dependent protein kinase 1	inhibition rate	3	%
14949	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	cGMP-dependent protein kinase 2	inhibition rate	38	%
14950	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Interferon-induced, double-stranded RNA-activated protein kinase	inhibition rate	3	%
14951	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	cAMP-dependent protein kinase catalytic subunit PRKX	inhibition rate	6	%
14952	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase prp4	inhibition rate	88	%
14953	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Pyruvate kinase 2	inhibition rate	7	%
14954	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase SIK3	inhibition rate	0	%
14955	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	RAF proto-oncogene serine/threonine-protein kinase	inhibition rate	0	%
14956	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Proto-oncogene tyrosine-protein kinase receptor Ret	inhibition rate	0	%
14957	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ABL1	inhibition rate	7	%
14958	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Proto-oncogene tyrosine-protein kinase receptor Ret (M918T)	inhibition rate	8	%
14959	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Nucleolar MIF4G domain-containing protein 1 (V804L)	inhibition rate	8	%
14960	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M)	inhibition rate	0	%
14961	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Rio1	inhibition rate	94.3	%
14962	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Rio2	inhibition rate	27	%
14963	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Rio3	inhibition rate	100	%
14964	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Inositol-pentakisphosphate 2-kinase	inhibition rate	0	%
14965	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Receptor-interacting serine/threonine-protein kinase 2	inhibition rate	0	%
14966	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Receptor-interacting serine/threonine-protein kinase 4	inhibition rate	52	%
14967	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Dual serine/threonine and tyrosine protein kinase	inhibition rate	28	%
14968	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ABL1	inhibition rate	2	%
14969	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Rho-associated protein kinase 1	inhibition rate	33	%
14970	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Rho-associated protein kinase 2	inhibition rate	41	%
14971	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	DNA glycosylase/AP lyase ROS1	inhibition rate	38	%
14972	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ribosomal protein S6 kinase alpha-4	inhibition rate	5	%
14973	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ribosomal protein S6 kinase alpha-4	inhibition rate	2	%
14974	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ribosomal protein S6 kinase alpha-5	inhibition rate	8	%
14975	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ribosomal protein S6 kinase alpha-5	inhibition rate	0	%
14976	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ribosomal protein S6 kinase alpha-1	inhibition rate	15	%
14977	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ribosomal protein S6 kinase alpha-1	inhibition rate	52	%
14978	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ribosomal protein S6 kinase alpha-2	inhibition rate	36	%
14979	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ABL1	inhibition rate	29	%
14980	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ribosomal protein S6 kinase alpha-2	inhibition rate	21	%
14981	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ribosomal protein S6 kinase alpha-3	inhibition rate	7	%
14982	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ribosomal protein S6 kinase alpha-3	inhibition rate	31	%
14983	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ribosomal protein S6 kinase alpha-6	inhibition rate	74	%
14984	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ribosomal protein S6 kinase alpha-6	inhibition rate	42	%
14985	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ribosomal protein S6 kinase beta-1	inhibition rate	6	%
14986	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase, Sbk1	inhibition rate	64	%
14987	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Sgk1	inhibition rate	34	%
14988	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Uncharacterized serine/threonine-protein kinase SBK3	inhibition rate	0	%
14989	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Sgk2	inhibition rate	6	%
14990	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ABL1	inhibition rate	68	%
14991	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase Sgk3	inhibition rate	25	%
14992	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase SIK1	inhibition rate	1	%
14993	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase SIK2	inhibition rate	30	%
14994	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase Fyn	inhibition rate	88	%
14995	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	NUAK family SNF1-like kinase 2	inhibition rate	96.8	%
14996	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	SNF-related serine/threonine-protein kinase	inhibition rate	25	%
14997	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Neuronal proto-oncogene tyrosine-protein kinase Src	inhibition rate	0	%
14998	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase Srms	inhibition rate	23	%
14999	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	CBL-interacting serine/threonine-protein kinase 7	inhibition rate	0	%
15000	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	SRSF protein kinase 2	inhibition rate	38	%
15001	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ABL1	inhibition rate	38	%
15002	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	SRSF protein kinase 3	inhibition rate	24	%
15003	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 16	inhibition rate	72	%
15004	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 33	inhibition rate	14	%
15005	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 35	inhibition rate	12	%
15006	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 36	inhibition rate	0	%
15007	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	STE20/SPS1-related proline-alanine-rich protein kinase	inhibition rate	59	%
15008	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase SYK	inhibition rate	0	%
15009	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase 7	inhibition rate	61	%
15010	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase TAO1	inhibition rate	85	%
15011	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase TAO2	inhibition rate	22	%
15012	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ABL1	inhibition rate	15	%
15013	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase TAO3	inhibition rate	61	%
15014	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase TBK1	inhibition rate	13	%
15015	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase Tec	inhibition rate	4	%
15016	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Dual specificity testis-specific protein kinase 1	inhibition rate	11	%
15017	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	TGF-beta receptor type-1	inhibition rate	11	%
15018	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	TGF-beta receptor type-2	inhibition rate	0	%
15019	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase receptor Tie-1	inhibition rate	32	%
15020	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase receptor Tie-2	inhibition rate	0	%
15021	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase tousled-like 1-B	inhibition rate	48	%
15022	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase TOUSLED-like 2	inhibition rate	31	%
15023	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ABL1	inhibition rate	50	%
15024	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Traf2 and NCK-interacting protein kinase	inhibition rate	63	%
15025	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Non-receptor tyrosine-protein kinase TNK1	inhibition rate	58	%
15026	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Activated CDC42 kinase 1	inhibition rate	0	%
15027	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase TNNI3K	inhibition rate	1	%
15028	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Trk system potassium uptake protein TrkA	inhibition rate	70	%
15029	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	BDNF/NT-3 growth factors receptor	inhibition rate	44	%
15030	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	NT-3 growth factor receptor	inhibition rate	26	%
15031	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Transient receptor potential cation channel subfamily M member 6	inhibition rate	9	%
15032	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Testis-specific serine/threonine-protein kinase 1	inhibition rate	0	%
15033	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Testis-specific serine/threonine-protein kinase 3	inhibition rate	33	%
15034	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ABL1	inhibition rate	44	%
15035	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Dual specificity protein kinase TTK	inhibition rate	35	%
15036	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase TXK	inhibition rate	0	%
15037	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Non-receptor tyrosine-protein kinase TYK2	inhibition rate	40	%
15038	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Non-receptor tyrosine-protein kinase TYK2	inhibition rate	86	%
15039	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase receptor TYRO3	inhibition rate	6	%
15040	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase ULK1	inhibition rate	45	%
15041	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase ULK2	inhibition rate	34	%
15042	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase ULK3	inhibition rate	99.55	%
15043	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Vascular endothelial growth factor receptor 2	inhibition rate	53	%
15044	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Phosphatidylinositol 3-kinase, Vps34 type	inhibition rate	34	%
15045	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ABL1	inhibition rate	76	%
15046	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase VRK2	inhibition rate	30	%
15047	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitosis inhibitor protein kinase wee1	inhibition rate	0	%
15048	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Wee1-like protein kinase 1-A	inhibition rate	8	%
15049	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase WNK1	inhibition rate	0	%
15050	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase WNK2	inhibition rate	19	%
15051	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase WNK3	inhibition rate	16	%
15052	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase WNK4	inhibition rate	23	%
15053	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 32A	inhibition rate	18	%
15054	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 32B	inhibition rate	0	%
15055	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 32C	inhibition rate	0	%
15056	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ABL1	inhibition rate	65	%
15057	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase yes	inhibition rate	0	%
15058	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 25	inhibition rate	22	%
15059	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase 19	inhibition rate	98.4	%
15060	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase 20	inhibition rate	14	%
15061	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ZAP-70	inhibition rate	9	%
15062	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ABL1	inhibition rate	34	%
15063	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ABL1	inhibition rate	39	%
15064	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ABL1	inhibition rate	38	%
15065	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase ABL2	inhibition rate	8	%
15066	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Activin receptor type-1	inhibition rate	0	%
15067	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Activin receptor type-1B	inhibition rate	0	%
15068	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Activin receptor type-2A	inhibition rate	0	%
15069	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Activin receptor type-2B	inhibition rate	0	%
15070	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase receptor R3	inhibition rate	55	%
15071	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Atypical kinase COQ8A, mitochondrial	inhibition rate	0	%
15072	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Atypical kinase COQ8B, mitochondrial	inhibition rate	3	%
15073	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	RAC serine/threonine-protein kinase	inhibition rate	0	%
15074	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Abhydrolase domain-containing protein AKT2	inhibition rate	0	%
15075	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	RAC-gamma serine/threonine-protein kinase	inhibition rate	0	%
15076	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Soluble starch synthase 2-3, chloroplastic/amyloplastic	inhibition rate	49	%
15077	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Soluble starch synthase 2-3, chloroplastic/amyloplastic	inhibition rate	16	%
15078	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Soluble starch synthase 2-3, chloroplastic/amyloplastic	inhibition rate	2	%
15079	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	5'-AMP-activated protein kinase catalytic subunit alpha-1	inhibition rate	21	%
15080	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	5'-AMP-activated protein kinase catalytic subunit alpha-2	inhibition rate	34	%
15081	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Ankyrin repeat and protein kinase domain-containing protein 1	inhibition rate	17	%
15082	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	NUAK family SNF1-like kinase 1	inhibition rate	60	%
15083	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	DASH complex subunit ASK1	inhibition rate	10	%
15084	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitogen-activated protein kinase kinase kinase 6	inhibition rate	44	%
15085	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Aurora kinase A	inhibition rate	93.3	%
15086	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Aurora kinase B	inhibition rate	76	%
15087	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Aurora kinase C	inhibition rate	77	%
15088	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	NEDD8-activating enzyme E1 regulatory subunit AXL	inhibition rate	45	%
15089	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	BMP-2-inducible protein kinase	inhibition rate	100	%
15090	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase Blk	inhibition rate	13	%
15091	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Bone morphogenetic protein receptor type-1A	inhibition rate	4	%
15092	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Bone morphogenetic protein receptor type-1B	inhibition rate	94.5	%
15093	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Bone morphogenetic protein receptor type-2	inhibition rate	0	%
15094	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Cytoplasmic tyrosine-protein kinase BMX	inhibition rate	0	%
15095	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase B-raf	inhibition rate	2	%
15096	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase B-raf (V600E)	inhibition rate	20	%
15097	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Bone morphogenetic protein receptor type-2	inhibition rate	0	%
15098	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase BRSK1	inhibition rate	23	%
15099	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase BRSK2	inhibition rate	32	%
15100	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Tyrosine-protein kinase BTK	inhibition rate	30	%
15101	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Mitotic checkpoint serine/threonine-protein kinase BUB1	inhibition rate	25	%
15102	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Calcium/calmodulin-dependent protein kinase type 1	inhibition rate	6	%
15103	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Calcium/calmodulin-dependent protein kinase type 1B	inhibition rate	19	%
15104	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Calcium/calmodulin-dependent protein kinase type 1D	inhibition rate	11	%
15105	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Calcium/calmodulin-dependent protein kinase type 1G	inhibition rate	1	%
15106	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Calcium/calmodulin-dependent protein kinase type II subunit alpha	inhibition rate	29	%
15107	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Calcium/calmodulin-dependent protein kinase type II subunit beta	inhibition rate	43	%
15108	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Calcium/calmodulin-dependent protein kinase type II delta chain	inhibition rate	45	%
15109	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Calcium/calmodulin-dependent protein kinase type II subunit gamma	inhibition rate	29	%
15110	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Calcium/calmodulin-dependent protein kinase type IV	inhibition rate	0	%
15111	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Calcium/calmodulin-dependent protein kinase kinase 1	inhibition rate	7	%
15112	OC1CCN(CC1)C1=C2C(NC=C2C2=CC=CC(Cl)=C2)=NC=N1	Serine/threonine-protein kinase 3	delta Tm	8	°C
15113	[2H]C([2H])=C([2H])C(=O)N1CCO[C@H](CN2CCC(CC2)NC2=CC(=CN3C(=CN=C23)C(C)C)C(F)(F)F)C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	IC50	0.00396	μM
15114	[2H]C([2H])=C([2H])C(=O)N1CCO[C@H](CN2CCC(CC2)NC2=CC(=CN3C(=CN=C23)C(C)C)C(F)(F)F)C1		IC50	0.00791	μM
15115	[2H]C([2H])=C([2H])C(=O)N1CCO[C@H](CN2CCC(CC2)NC2=CC(=CN3C(=CN=C23)C(C)C)C(F)(F)F)C1		IC50	0.0159	μM
15116	[2H]C([2H])=C([2H])C(=O)N1CCO[C@H](CN2CCC(CC2)NC2=CC(=CN3C(=CN=C23)C(C)C)C(F)(F)F)C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	IC50	0.0674	μM
15117	[2H]C([2H])=C([2H])C(=O)N1CCO[C@H](CN2CCC(CC2)NC2=CC(=CN3C(=CN=C23)C(C)C)C(F)(F)F)C1	Cyclin-T1 [human]; Cyclin-dependent kinase 9 [human]	IC50	1.61	μM
15118	[2H]C([2H])=C([2H])C(=O)N1CCO[C@H](CN2CCC(CC2)NC2=CC(=CN3C(=CN=C23)C(C)C)C(F)(F)F)C1		IC50	3.79	μM
15119	[2H]CC([2H])(C)C1=CN=C2N1C=C(C=C2NC1CCN(C[C@@H]2CN(CCO2)C(=O)C=C)CC1)C(F)(F)F	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	IC50	0.00625	μM
15120	[2H]CC([2H])(C)C1=CN=C2N1C=C(C=C2NC1CCN(C[C@@H]2CN(CCO2)C(=O)C=C)CC1)C(F)(F)F		IC50	0.0138	μM
15121	[2H]CC([2H])(C)C1=CN=C2N1C=C(C=C2NC1CCN(C[C@@H]2CN(CCO2)C(=O)C=C)CC1)C(F)(F)F		IC50	0.0717	μM
15122	[2H]CC([2H])(C)C1=CN=C2N1C=C(C=C2NC1CCN(C[C@@H]2CN(CCO2)C(=O)C=C)CC1)C(F)(F)F	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	IC50	0.0845	μM
15123	[2H]CC([2H])(C)C1=CN=C2N1C=C(C=C2NC1CCN(C[C@@H]2CN(CCO2)C(=O)C=C)CC1)C(F)(F)F	Cyclin-T1 [human]; Cyclin-dependent kinase 9 [human]	IC50	2.03	μM
15124	[2H]CC([2H])(C)C1=CN=C2N1C=C(C=C2NC1CCN(C[C@@H]2CN(CCO2)C(=O)C=C)CC1)C(F)(F)F		IC50	2.92	μM
15125	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Epithelial discoidin domain-containing receptor 1	IC50	10.6	nM
15126	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Epithelial discoidin domain-containing receptor 1 [human]	EC50	34.4	nM
15127	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Epithelial discoidin domain-containing receptor 1 [human]	mRNA expression level decrease		
15128	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Epithelial discoidin domain-containing receptor 1 [mouse]	mRNA expression level decrease		
15129	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Epithelial discoidin domain-containing receptor 1 [mouse]	mRNA expression level decrease		
15130	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Epithelial discoidin domain-containing receptor 1 [mouse]	mRNA expression level decrease		
15131	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Epithelial discoidin domain-containing receptor 1 [mouse]	mRNA expression level decrease		
15132	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Epithelial discoidin domain-containing receptor 1 [human]	mRNA expression level decrease		
15133	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Epithelial discoidin domain-containing receptor 1 [human]	mRNA expression level decrease		
15134	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Epithelial discoidin domain-containing receptor 1 [human]	mRNA expression level decrease		
15135	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O		t1/2 (drug half life)	0.936	h
15136	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O		AUC (0-t)	22660	ng*h/ml
15137	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O		AUC (0-inf)	22672	ng*h/ml
15138	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O		CL (drug clearance)	3.85	ml/min/kg
15139	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O		MRT (0-inf)	0.342	h
15140	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O		Vdss	81.6	ml/kg
15141	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase Chk1 [human]	inhibition percentage	15	%
15142	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase Chk2 [human]	inhibition percentage	-2	%
15143	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase Chk2 (I157T) [human]	inhibition percentage	17	%
15144	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Beta-adrenergic receptor kinase 2 [human]	inhibition percentage	10	%
15145	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase Chk2 (R145W) [human]	inhibition percentage	4	%
15146	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Casein kinase I isoform alpha [human]	inhibition percentage	-9	%
15147	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Casein kinase I isoform epsilon [human]	inhibition percentage	-2	%
15148	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Casein kinase I isoform gamma-1 [human]	inhibition percentage	11	%
15149	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Casein kinase I isoform gamma-2 [human]	inhibition percentage	20	%
15150	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Casein kinase I isoform gamma-3 [human]	inhibition percentage	-15	%
15151	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Casein kinase I isoform delta [human]	inhibition percentage	1	%
15152	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Casein kinase I	inhibition percentage	-8	%
15153	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Casein kinase II [human]	inhibition percentage	-17	%
15154	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Casein kinase II subunit alpha-1 [human]	inhibition percentage	29	%
15155	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Casein kinase II subunit alpha-2 [human]	inhibition percentage	6	%
15156	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase 35 [human]	inhibition percentage	-12	%
15157	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Dual specificity protein kinase CLK1 [human]	inhibition percentage	-4	%
15158	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Dual specificity protein kinase CLK2 [human]	inhibition percentage	13	%
15159	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Dual specificity protein kinase CLK3 [human]	inhibition percentage	4	%
15160	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Dual specificity protein kinase CLK4 [human]	inhibition percentage	-2	%
15161	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Mast/stem cell growth factor receptor Kit [human]	inhibition percentage	1	%
15162	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Mast/stem cell growth factor receptor Kit (D816V) [human]	inhibition percentage	3	%
15163	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Mast/stem cell growth factor receptor Kit (D816H) [human]	inhibition percentage	2	%
15164	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Mast/stem cell growth factor receptor Kit [human]	inhibition percentage	5	%
15165	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Mast/stem cell growth factor receptor Kit [human]	inhibition percentage	2	%
15166	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Citron Rho-interacting kinase [human]	inhibition percentage	-4	%
15167	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase CSK [human]	inhibition percentage	-18	%
15168	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	RAF proto-oncogene serine/threonine-protein kinase [human]	inhibition percentage	-23	%
15169	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase CSK [human]	inhibition percentage	5	%
15170	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Death-associated protein kinase 1 [human]	inhibition percentage	-1	%
15171	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Death-associated protein kinase 2 [human]	inhibition percentage	-3	%
15172	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase DCLK1 [human]	inhibition percentage	12	%
15173	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase DCLK2 [human]	inhibition percentage	0	%
15174	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase DCLK3 [human]	inhibition percentage	-13	%
15175	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Epithelial discoidin domain-containing receptor 1 [human]	inhibition percentage	91	%
15176	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Discoidin domain-containing receptor 2 [human]	inhibition percentage	38	%
15177	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Myotonin-protein kinase [human]	inhibition percentage	2	%
15178	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase 17A [human]	inhibition percentage	2	%
15179	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase 17B [human]	inhibition percentage	-1	%
15180	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	inhibition percentage	6	%
15181	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Dual specificity tyrosine-phosphorylation-regulated kinase 1B [human]	inhibition percentage	1	%
15182	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Ovarian-specific serine/threonine-protein kinase Lok [human]	inhibition percentage	17	%
15183	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Dual specificity tyrosine-phosphorylation-regulated kinase 3 [human]	inhibition percentage	-19	%
15184	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	eukaryotic elongation factor 2 kinase [human]	inhibition percentage	7	%
15185	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Epidermal growth factor receptor [human]	inhibition percentage	-5	%
15186	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Epidermal growth factor receptor (L858R) [human]	inhibition percentage	2	%
15187	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Epidermal growth factor receptor (L861Q) [human]	inhibition percentage	6	%
15188	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Epidermal growth factor receptor (T790M) [human]	inhibition percentage	-16	%
15189	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Epidermal growth factor receptor [human]	inhibition percentage	5	%
15190	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Ephrin type-A receptor 1 [human]	inhibition percentage	0	%
15191	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Ephrin type-A receptor 2 [human]	inhibition percentage	27	%
15192	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Ephrin type-A receptor 3 [human]	inhibition percentage	19	%
15193	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Ephrin type-A receptor 4 [human]	inhibition percentage	4	%
15194	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Ephrin type-A receptor 5 [human]	inhibition percentage	6	%
15195	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Ephrin type-A receptor 7 [human]	inhibition percentage	26	%
15196	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Ephrin type-A receptor 8 [human]	inhibition percentage	42	%
15197	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Ephrin type-B receptor 2 [human]	inhibition percentage	27	%
15198	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Ephrin type-B receptor 1 [human]	inhibition percentage	6	%
15199	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Ephrin type-B receptor 3 [human]	inhibition percentage	-8	%
15200	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Ephrin type-B receptor 4 [human]	inhibition percentage	1	%
15201	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Receptor tyrosine-protein kinase erbB-2 [human]	inhibition percentage	20	%
15202	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Receptor tyrosine-protein kinase erbB-4 [human]	inhibition percentage	2	%
15203	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Focal adhesion kinase 1 [human]	inhibition percentage	-23	%
15204	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase Fer [human]	inhibition percentage	9	%
15205	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase, Fes/Fps type [human]	inhibition percentage	5	%
15206	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Fibroblast growth factor receptor 1 [human]	inhibition percentage	22	%
15207	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Fibroblast growth factor receptor 1 (V561M) [human]	inhibition percentage	-11	%
15208	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Fibroblast growth factor receptor 2 [human]	inhibition percentage	22	%
15209	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Fibroblast growth factor receptor 2 (N549H) [human]	inhibition percentage	10	%
15210	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Fibroblast growth factor receptor 3 [human]	inhibition percentage	22	%
15211	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Fibroblast growth factor receptor 4 [human]	inhibition percentage	3	%
15212	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase Fgr [human]	inhibition percentage	1	%
15213	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Vascular endothelial growth factor receptor 1 [human]	inhibition percentage	24	%
15214	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Receptor-type tyrosine-protein kinase FLT3 (D835Y) [human]	inhibition percentage	11	%
15215	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition percentage	14	%
15216	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Vascular endothelial growth factor receptor 3 [human]	inhibition percentage	-7	%
15217	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Macrophage colony-stimulating factor 1 receptor [human]	inhibition percentage	5	%
15218	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Macrophage colony-stimulating factor 1 receptor (Y969C) [human]	inhibition percentage	7	%
15219	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase Fyn [human]	inhibition percentage	25	%
15220	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Mitogen-activated protein kinase kinase kinase kinase 2 [human]	inhibition percentage	-22	%
15221	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	eIF-2-alpha kinase Gcn2 [human]	inhibition percentage	-3	%
15222	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Beta-adrenergic receptor kinase 1 [human]	inhibition percentage	18	%
15223	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase MRCK beta [human]	inhibition percentage	-10	%
15224	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	G protein-coupled receptor kinase 5 [human]	inhibition percentage	-33	%
15225	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	G protein-coupled receptor kinase 6 [human]	inhibition percentage	7	%
15226	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Rhodopsin kinase [human]	inhibition percentage	14	%
15227	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Glycogen synthase kinase-3 alpha [human]	inhibition percentage	19	%
15228	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	glycogen synthase kinase-3 beta [human]	inhibition percentage	7	%
15229	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase haspin [human]	inhibition percentage	12	%
15230	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase HCK [human]	inhibition percentage	4	%
15231	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Activated tyrosine-protein kinase HCK [human]	inhibition percentage	-5	%
15232	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Homeodomain-interacting protein kinase 1 [human]	inhibition percentage	10	%
15233	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Homeodomain-interacting protein kinase 2 [human]	inhibition percentage	9	%
15234	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Homeodomain-interacting protein kinase 3 [human]	inhibition percentage	11	%
15235	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Homeodomain-interacting protein kinase 4 [human]	inhibition percentage	-4	%
15236	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Mitogen-activated protein kinase kinase kinase kinase 1 [human]	inhibition percentage	6	%
15237	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Eukaryotic translation initiation factor 2-alpha kinase 1 [human]	inhibition percentage	4	%
15238	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase ICK [human]	inhibition percentage	4	%
15239	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Insulin-like growth factor 1 receptor [human]	inhibition percentage	6	%
15240	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	activated Insulin-like growth factor 1 receptor [human]	inhibition percentage	-12	%
15241	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Inhibitor of nuclear factor kappa-B kinase subunit alpha [human]	inhibition percentage	15	%
15242	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition percentage	-22	%
15243	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Inhibitor of nuclear factor kappa-B kinase subunit epsilon [human]	inhibition percentage	25	%
15244	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Insulin-like receptor [human]	inhibition percentage	31	%
15245	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Activated insulin-like receptor [human]	inhibition percentage	-2	%
15246	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase/endoribonuclease IRE1 [human]	inhibition percentage	-5	%
15247	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Insulin receptor-related protein [human]	inhibition percentage	-11	%
15248	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Interleukin-1 receptor-associated kinase 1 [human]	inhibition percentage	4	%
15249	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Interleukin-1 receptor-associated kinase 4 [human]	inhibition percentage	3	%
15250	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase ITK/TSK [human]	inhibition percentage	-7	%
15251	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase JAK1 [human]	inhibition percentage	0	%
15252	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase JAK2 [human]	inhibition percentage	-19	%
15253	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase JAK3 [human]	inhibition percentage	5	%
15254	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Mitogen-activated protein kinase 8 (isoform 1) [human]	inhibition percentage	5	%
15255	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Mitogen-activated protein kinase 9 (isoform Alpha-2) [human]	inhibition percentage	13	%
15256	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Mitogen-activated protein kinase 10 [human]	inhibition percentage	-4	%
15257	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Vascular endothelial growth factor receptor 2 [human]	inhibition percentage	-11	%
15258	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase LATS1 [human]	inhibition percentage	4	%
15259	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase LATS2 [human]	inhibition percentage	6	%
15260	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase Lck [human]	inhibition percentage	36	%
15261	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	activated Tyrosine-protein kinase Lck [human]	inhibition percentage	8	%
15262	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	LIM domain kinase 1 [human]	inhibition percentage	0	%
15263	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	LIM domain kinase 2 [human]	inhibition percentage	14	%
15264	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase STK11 [human]	inhibition percentage	-9	%
15265	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial [human]	inhibition percentage	-3	%
15266	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase Lyn [human]	inhibition percentage	11	%
15267	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase Lyn	inhibition percentage	35	%
15268	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Leucine-rich repeat serine/threonine-protein kinase 2 [human]	inhibition percentage	8	%
15269	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Leukocyte tyrosine kinase receptor [human]	inhibition percentage	-5	%
15270	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase MAK [human]	inhibition percentage	-10	%
15271	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Mitogen-activated protein kinase 1 [human]	inhibition percentage	-14	%
15272	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Mitogen-activated protein kinase 2 [human]	inhibition percentage	-17	%
15273	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Mitogen-activated protein kinase 2	inhibition percentage	-3	%
15274	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Mitogen-activated protein kinase kinase kinase kinase 3 [human]	inhibition percentage	-18	%
15275	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Mitogen-activated protein kinase kinase kinase kinase 4 [human]	inhibition percentage	7	%
15276	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Mitogen-activated protein kinase kinase kinase kinase 5 [human]	inhibition percentage	-10	%
15277	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	MAP kinase-activated protein kinase 2 [human]	inhibition percentage	14	%
15278	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	MAP kinase-activated protein kinase 3 [human]	inhibition percentage	2	%
15279	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Dual specificity mitogen-activated protein kinase kinase 1 [human]	inhibition percentage	-4	%
15280	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Dual specificity mitogen-activated protein kinase kinase 2 [human]	inhibition percentage	-42	%
15281	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase MARK1 [human]	inhibition percentage	4	%
15282	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase MARK3 [human]	inhibition percentage	10	%
15283	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	MAP/microtubule affinity-regulating kinase 4 [human]	inhibition percentage	7	%
15284	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Mitogen-activated protein kinase kinase kinase 2 [human]	inhibition percentage	11	%
15285	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Mitogen-activated protein kinase kinase kinase 3 [human]	inhibition percentage	2	%
15286	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Maternal embryonic leucine zipper kinase [human]	inhibition percentage	10	%
15287	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase Mer [human]	inhibition percentage	-6	%
15288	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Hepatocyte growth factor receptor [human]	inhibition percentage	-9	%
15289	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Hepatocyte growth factor receptor [human]	inhibition percentage	-7	%
15290	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Hepatocyte growth factor receptor [human]	inhibition percentage	-1	%
15291	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Hepatocyte growth factor receptor [human]	inhibition percentage	-7	%
15292	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Hepatocyte growth factor receptor [human]	inhibition percentage	-32	%
15293	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Hepatocyte growth factor receptor [human]	inhibition percentage	-22	%
15294	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Hepatocyte growth factor receptor [human]	inhibition percentage	-4	%
15295	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Misshapen-like kinase 1 [human]	inhibition percentage	-4	%
15296	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Mitogen-activated protein kinase kinase 3 [human]	inhibition percentage	4	%
15297	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Mitogen-activated protein kinase kinase 4 [mouse]	inhibition percentage	-2	%
15298	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Mitogen-activated protein kinase kinase 6 [human]	inhibition percentage	6	%
15299	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Myosin light chain kinase, smooth muscle [human]	inhibition percentage	-8	%
15300	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	AP2-associated protein kinase 1 [human]	inhibition percentage	8	%
15301	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Mitogen-activated protein kinase kinase kinase 9 [human]	inhibition percentage	19	%
15302	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Mitogen-activated protein kinase kinase kinase 10 [human]	inhibition percentage	-2	%
15303	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Mitogen-activated protein kinase kinase kinase 11 [human]	inhibition percentage	-5	%
15304	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Mitogen-activated protein kinase kinase kinase 21 [human]	inhibition percentage	12	%
15305	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Mitogen-activated protein kinase 4 [human]	inhibition percentage	-1	%
15306	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	MAPK/MAK/MRK overlapping kinase [human]	inhibition percentage	-18	%
15307	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase MRCK alpha [human]	inhibition percentage	7	%
15308	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M) [human]	inhibition percentage	9	%
15309	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase MRCK gamma [human]	inhibition percentage	10	%
15310	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Ribosomal protein S6 kinase alpha-5 [human]	inhibition percentage	0	%
15311	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Ribosomal protein S6 kinase alpha-4 [human]	inhibition percentage	8	%
15312	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	SRSF protein kinase 3 [human]	inhibition percentage	-4	%
15313	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase 4 [human]	inhibition percentage	17	%
15314	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase 3 [human]	inhibition percentage	12	%
15315	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase 24 [human]	inhibition percentage	-4	%
15316	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase 26 [human]	inhibition percentage	-6	%
15317	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase mTOR [human]	inhibition percentage	2	%
15318	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase mTOR [human]; Peptidyl-prolyl cis-trans isomerase FKBP12 [human]	inhibition percentage	4	%
15319	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Muscle, skeletal receptor tyrosine-protein kinase [human]	inhibition percentage	3	%
15320	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Myosin light chain kinase 2, skeletal/cardiac muscle [human]	inhibition percentage	10	%
15321	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Myosin-IIIb [human]	inhibition percentage	8	%
15322	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase 38 [human]	inhibition percentage	-13	%
15323	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase 38-like [human]	inhibition percentage	6	%
15324	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase Nek1 [human]	inhibition percentage	12	%
15325	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase Nek2 [human]	inhibition percentage	-1	%
15326	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase Nek4 [human]	inhibition percentage	-1	%
15327	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase Nek3 [human]	inhibition percentage	9	%
15328	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase Nek6 [human]	inhibition percentage	8	%
15329	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase Nek7 [human]	inhibition percentage	2	%
15330	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase Nek9 [human]	inhibition percentage	10	%
15331	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase NIM1 [human]	inhibition percentage	2	%
15332	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase Nek11 [human]	inhibition percentage	5	%
15333	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine kinase NLK [human]	inhibition percentage	15	%
15334	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	NUAK family SNF1-like kinase 2 [human]	inhibition percentage	21	%
15335	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase OSR1 [human]	inhibition percentage	-7	%
15336	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Ribosomal protein S6 kinase beta-1 [human]	inhibition percentage	-12	%
15337	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase PAK 1 [human]	inhibition percentage	-21	%
15338	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	serine/threonine-protein kinase pak 2 [human]	inhibition percentage	-15	%
15339	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase PAK 4 [human]	inhibition percentage	2	%
15340	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase PAK 3 [human]	inhibition percentage	-5	%
15341	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase Abl [human]	inhibition percentage	25	%
15342	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	serine/threonine-protein kinase pak 5 [human]	inhibition percentage	-10	%
15343	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase PAK 6 [human]	inhibition percentage	-5	%
15344	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase MARK2 (isoform alpha) [human]	inhibition percentage	-5	%
15345	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	PAS domain-containing serine/threonine-protein kinase [human]	inhibition percentage	0	%
15346	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	eukaryotic translation initiation factor 2alpha kinase [human]	inhibition percentage	-2	%
15347	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Platelet-derived growth factor receptor alpha [human]	inhibition percentage	17	%
15348	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Platelet-derived growth factor receptor alpha (D842V) [human]	inhibition percentage	8	%
15349	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Platelet-derived growth factor receptor alpha (V561D) [human]	inhibition percentage	11	%
15350	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Platelet-derived growth factor receptor beta [human]	inhibition percentage	2	%
15351	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Transcription initiation factor TFIID subunit 1-like [human]	inhibition percentage	-1	%
15352	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase Abl	inhibition percentage	22	%
15353	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Mitogen-activated protein kinase kinase kinase 7 [human]	inhibition percentage	13	%
15354	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial [human]	inhibition percentage	15	%
15355	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	3-phosphoinositide-dependent protein kinase 1 [human]	inhibition percentage	-8	%
15356	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform [human]	inhibition percentage	-26	%
15357	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform [human]	inhibition percentage	10	%
15358	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase pim-1 [human]	inhibition percentage	-4	%
15359	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase pim-2 [human]	inhibition percentage	1	%
15360	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase pim-3 [human]	inhibition percentage	3	%
15361	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Protein kinase YpkA [human]	inhibition percentage	-3	%
15362	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	cAMP-dependent protein kinase catalytic subunit beta [human]	inhibition percentage	-8	%
15363	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase Abl [human]	inhibition percentage	20	%
15364	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	RAC-alpha serine/threonine-protein kinase [human]	inhibition percentage	6	%
15365	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	RAC-beta serine/threonine-protein kinase [human]	inhibition percentage	11	%
15366	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	RAC-gamma serine/threonine-protein kinase [human]	inhibition percentage	11	%
15367	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Protein kinase C alpha type [human]	inhibition percentage	-42	%
15368	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Protein kinase C beta type (isoform Beta-I) [human]	inhibition percentage	12	%
15369	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Protein kinase C beta type (isoform Beta-II) [human]	inhibition percentage	9	%
15370	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Protein kinase C gamma type [human]	inhibition percentage	32	%
15371	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Protein kinase C gamma type [human]	inhibition percentage	-12	%
15372	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Protein kinase C, epsilon [human]	inhibition percentage	-4	%
15373	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Protein kinase C, eta [human]	inhibition percentage	-3	%
15374	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase Abl [human]	inhibition percentage	33	%
15375	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Protein kinase C, tau [human]	inhibition percentage	-1	%
15376	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase D1 [human]	inhibition percentage	8	%
15377	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Protein kinase C, theta [human]	inhibition percentage	28	%
15378	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Protein kinase C zeta type [human]	inhibition percentage	-5	%
15379	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase D2 [human]	inhibition percentage	6	%
15380	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase D3 [human]	inhibition percentage	-3	%
15381	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	cGMP-dependent protein kinase 1 (isoform Alpha) [human]	inhibition percentage	-9	%
15382	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	cGMP-dependent protein kinase 1 (isoform Beta) [human]	inhibition percentage	-1	%
15383	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Interferon-induced, double-stranded RNA-activated protein kinase [human]	inhibition percentage	-2	%
15384	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase PLK1 [human]	inhibition percentage	0	%
15385	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase Abl [human]	inhibition percentage	-1	%
15386	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase Plk3 [human]	inhibition percentage	-33	%
15387	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase Plk4 [human]	inhibition percentage	-16	%
15388	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	MAP kinase-activated protein kinase 5 [human]	inhibition percentage	8	%
15389	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	cGMP-dependent protein kinase 2 [human]	inhibition percentage	6	%
15390	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase N1 [human]	inhibition percentage	-7	%
15391	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase N2 [human]	inhibition percentage	6	%
15392	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	cAMP-dependent protein kinase catalytic subunit PRKX [human]	inhibition percentage	2	%
15393	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase prp4 [human]	inhibition percentage	2	%
15394	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase FRK [human]	inhibition percentage	47	%
15395	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Protein-tyrosine kinase 2-beta [human]	inhibition percentage	9	%
15396	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase Abl [human]	inhibition percentage	14	%
15397	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Proto-oncogene tyrosine-protein kinase receptor Ret [human]	inhibition percentage	4	%
15398	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Proto-oncogene tyrosine-protein kinase receptor Ret (V804L) [human]	inhibition percentage	13	%
15399	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Testis-specific serine/threonine-protein kinase 4 [human]	inhibition percentage	5	%
15400	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tau-tubulin kinase 1 [human]	inhibition percentage	-7	%
15401	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Receptor-interacting serine/threonine-protein kinase 1 [human]	inhibition percentage	-14	%
15402	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Receptor-interacting serine/threonine-protein kinase 2 [human]	inhibition percentage	16	%
15403	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Rho-associated protein kinase 1 [human]	inhibition percentage	-11	%
15404	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Rho-associated protein kinase 2 [human]	inhibition percentage	12	%
15405	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Rho-associated protein kinase 2	inhibition percentage	10	%
15406	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Macrophage-stimulating protein receptor [human]	inhibition percentage	1	%
15407	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase Abl [human]	inhibition percentage	27	%
15408	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Proto-oncogene tyrosine-protein kinase ROS [human]	inhibition percentage	1	%
15409	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase receptor TYRO3 [human]	inhibition percentage	-8	%
15410	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Ribosomal protein S6 kinase alpha-1 [human]	inhibition percentage	42	%
15411	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Ribosomal protein S6 kinase alpha-1	inhibition percentage	-19	%
15412	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Ribosomal protein S6 kinase alpha-3 [human]	inhibition percentage	1	%
15413	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Ribosomal protein S6 kinase alpha-2 [human]	inhibition percentage	-8	%
15414	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Ribosomal protein S6 kinase alpha-6 [human]	inhibition percentage	-11	%
15415	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Mitogen-activated protein kinase 14 [human]	inhibition percentage	4	%
15416	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Mitogen-activated protein kinase 14 [human]	inhibition percentage	-5	%
15417	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Mitogen-activated protein kinase 11 [human]	inhibition percentage	-34	%
15418	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Activated CDC42 kinase 1 [human]	inhibition percentage	-2	%
15419	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase SAPK3 [human]	inhibition percentage	19	%
15420	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase SAPK4 [human]	inhibition percentage	-2	%
15421	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	serine/threonine-protein kinase sbk1 [human]	inhibition percentage	10	%
15422	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase Sgk1 [human]	inhibition percentage	-7	%
15423	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase Sgk2 [human]	inhibition percentage	-25	%
15424	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase Sgk3 [human]	inhibition percentage	1	%
15425	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase SIK1 [human]	inhibition percentage	-19	%
15426	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase SIK2 [human]	inhibition percentage	10	%
15427	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase SIK3 [human]	inhibition percentage	11	%
15428	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase Fyn [human]	inhibition percentage	5	%
15429	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Actin-related protein 2 [human]	inhibition percentage	-4	%
15430	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase PLK2 [human]	inhibition percentage	-6	%
15431	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	SNF-related serine/threonine-protein kinase [human]	inhibition percentage	-20	%
15432	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Proto-oncogene tyrosine-protein kinase Src [human]	inhibition percentage	14	%
15433	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Proto-oncogene tyrosine-protein kinase Src [human]	inhibition percentage	5	%
15434	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase Srms [human]	inhibition percentage	11	%
15435	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	CBL-interacting serine/threonine-protein kinase 7 [human]	inhibition percentage	3	%
15436	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	SRSF protein kinase 2 [human]	inhibition percentage	0	%
15437	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase 16 [human]	inhibition percentage	-3	%
15438	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase 25 [human]	inhibition percentage	1	%
15439	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase 32A [human]	inhibition percentage	12	%
15440	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	ALK tyrosine kinase receptor [human]	inhibition percentage	19	%
15441	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase 32B [human]	inhibition percentage	0	%
15442	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase 32C [human]	inhibition percentage	10	%
15443	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase 33 [human]	inhibition percentage	-10	%
15444	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	STE20/SPS1-related proline-alanine-rich protein kinase [human]	inhibition percentage	-8	%
15445	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase SYK [human]	inhibition percentage	7	%
15446	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	ATR-interacting protein [human];+Serine/threonine-protein kinase ATR [human]	inhibition percentage	6	%
15447	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	DNA-dependent protein kinase catalytic subunit [human]	inhibition percentage	1	%
15448	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase TAO1 [human]	inhibition percentage	-15	%
15449	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase TAO2 [human]	inhibition percentage	9	%
15450	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase TAO3 [human]	inhibition percentage	-28	%
15451	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase Haspin homolog ALK1 [human]	inhibition percentage	38	%
15452	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase TBK1 [human]	inhibition percentage	-2	%
15453	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Activated tyrosine-protein kinase Tec [human]	inhibition percentage	-7	%
15454	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	TGF-beta receptor type-1 [human]	inhibition percentage	-1	%
15455	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	TGF-beta receptor type-2 [human]	inhibition percentage	11	%
15456	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Angiopoietin-1 receptor [human]	inhibition percentage	1	%
15457	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Angiopoietin-1 receptor (R849W) [human]	inhibition percentage	13	%
15458	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Angiopoietin-1 receptor (Y897S) [human]	inhibition percentage	16	%
15459	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase tousled-like 1 [human]	inhibition percentage	-2	%
15460	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase TOUSLED-like 2 [human]	inhibition percentage	1	%
15461	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Traf2 and NCK-interacting protein kinase [human]	inhibition percentage	10	%
15462	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase Haspin homolog ALK2 [human]	inhibition percentage	-16	%
15463	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tribbles homolog 2 [human]	inhibition percentage	-5	%
15464	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	High affinity nerve growth factor receptor [human]	inhibition percentage	21	%
15465	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	BDNF/NT-3 growth factors receptor [human]	inhibition percentage	29	%
15466	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Testis-specific serine/threonine-protein kinase 1 [human]	inhibition percentage	13	%
15467	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Testis-specific serine/threonine-protein kinase 2 [human]	inhibition percentage	-8	%
15468	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Testis-specific serine/threonine-protein kinase 3 [human]	inhibition percentage	-2	%
15469	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Phosphatidylinositol 4-phosphate 5-kinase type-1 lambda [human]	inhibition percentage	-3	%
15470	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tau-tubulin kinase 2 [human]	inhibition percentage	-7	%
15471	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Dual specificity protein kinase TTK [human]	inhibition percentage	4	%
15472	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Activin receptor type-1B [human]	inhibition percentage	0	%
15473	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase TXK [human]	inhibition percentage	-1	%
15474	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition percentage	-1	%
15475	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase ULK1 [human]	inhibition percentage	-12	%
15476	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase ULK2 [human]	inhibition percentage	5	%
15477	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase ULK3 [human]	inhibition percentage	3	%
15478	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase VRK1 [human]	inhibition percentage	13	%
15479	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase VRK2 [human]	inhibition percentage	2	%
15480	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Mitosis inhibitor protein kinase wee1 [human]	inhibition percentage	7	%
15481	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Wee1-like protein kinase 2 [human]	inhibition percentage	-2	%
15482	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase WNK1 [human]	inhibition percentage	10	%
15483	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Bone morphogenetic protein receptor type-1B [human]	inhibition percentage	10	%
15484	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase WNK2 [human]	inhibition percentage	-19	%
15485	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase WNK3 [human]	inhibition percentage	-12	%
15486	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase WNK4 [human]	inhibition percentage	4	%
15487	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase Yes [human]	inhibition percentage	31	%
15488	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Mitogen-activated protein kinase kinase kinase 20 [human]	inhibition percentage	1	%
15489	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase ZAP-70 [human]	inhibition percentage	8	%
15490	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Death-associated protein kinase 3 [human]	inhibition percentage	-3	%
15491	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase ATM [human]	inhibition percentage	-3	%
15492	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [human];+Phosphatidylinositol 3-kinase regulatory subunit alpha [human]	inhibition percentage	-2	%
15493	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Phosphatidylinositol 3-kinase catalytic subunit p120-lambda [human]	inhibition percentage	-2	%
15494	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase ABL2 [human]	inhibition percentage	32	%
15495	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [human];+Phosphatidylinositol 3-kinase regulatory subunit alpha [human]	inhibition percentage	1	%
15496	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform;+Phosphatidylinositol 3-kinase regulatory subunit alpha	inhibition percentage	0	%
15497	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform;+PI3-kinase subunit p65-alpha	inhibition percentage	3	%
15498	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Phosphatidylinositol 3-kinase regulatory subunit alpha;+Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545K)	inhibition percentage	0	%
15499	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Phosphatidylinositol 3-kinase regulatory subunit alpha;+Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047R)	inhibition percentage	-3	%
15500	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform;+Phosphatidylinositol 3-kinase regulatory subunit beta	inhibition percentage	-2	%
15501	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform;+Phosphatidylinositol 3-kinase regulatory subunit alpha	inhibition percentage	-5	%
15502	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform;+Phosphatidylinositol 3-kinase regulatory subunit alpha	inhibition percentage	-1	%
15503	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Phosphatidylinositol 3-kinase regulatory subunit alpha;+Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E542K)	inhibition percentage	3	%
15504	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human];+Phosphatidylinositol 3-kinase regulatory subunit alpha [human]	inhibition percentage	-2	%
15505	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	5'-AMP-activated protein kinase catalytic subunit alpha-1 [human]	inhibition percentage	16	%
15506	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Phosphatidylinositol 3-kinase regulatory subunit alpha [human];+Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E542K) [human]	inhibition percentage	1	%
15507	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Phosphatidylinositol 3-kinase regulatory subunit alpha [human];+Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047R) [human]	inhibition percentage	-1	%
15508	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Phosphatidylinositol 3-kinase regulatory subunit alpha [human];+Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545K) [human]	inhibition percentage	3	%
15509	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human];+PI3-kinase subunit p65-alpha [human]	inhibition percentage	1	%
15510	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha [human]	inhibition percentage	2	%
15511	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit lambda [human]	inhibition percentage	2	%
15512	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [human]	inhibition percentage	6	%
15513	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Phosphatidylinositol 4-phosphate 5-kinase type-1 beta [human]	inhibition percentage	3	%
15514	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	5'-AMP-activated protein kinase catalytic subunit alpha-2 [human]	inhibition percentage	-2	%
15515	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase A-Raf [human]	inhibition percentage	14	%
15516	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase ABL2	inhibition percentage	39	%
15517	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	NUAK family SNF1-like kinase 1 [human]	inhibition percentage	10	%
15518	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase SRK2A [human]	inhibition percentage	-3	%
15519	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Aurora kinase A [human]	inhibition percentage	11	%
15520	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Aurora kinase B [human]	inhibition percentage	16	%
15521	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Aurora kinase C [human]	inhibition percentage	8	%
15522	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase receptor UFO [human]	inhibition percentage	15	%
15523	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	BMP-2-inducible protein kinase [human]	inhibition percentage	14	%
15524	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase Blk [human]	inhibition percentage	9	%
15525	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase Blk	inhibition percentage	17	%
15526	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Bone morphogenetic protein receptor type-2 [human]	inhibition percentage	3	%
15527	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Cytoplasmic tyrosine-protein kinase BMX [human]	inhibition percentage	0	%
15528	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Protein-tyrosine kinase 6 [human]	inhibition percentage	10	%
15529	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase BRSK1 [human]	inhibition percentage	0	%
15530	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase BRSK2 [human]	inhibition percentage	4	%
15531	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase BTK [human]	inhibition percentage	-1	%
15532	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Tyrosine-protein kinase BTK (R28H) [human]	inhibition percentage	19	%
15533	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase B-raf [human]	inhibition percentage	1	%
15534	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Dual specificity tyrosine-phosphorylation-regulated kinase 2 [human]	inhibition percentage	10	%
15535	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Serine/threonine-protein kinase B-raf [human]	inhibition percentage	7	%
15536	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Calcium/calmodulin-dependent protein kinase type 1 [human]	inhibition percentage	4	%
15537	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Calcium/calmodulin-dependent protein kinase type 1B [human]	inhibition percentage	-15	%
15538	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Calcium/calmodulin-dependent protein kinase type 1G [human]	inhibition percentage	5	%
15539	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Calcium/calmodulin-dependent protein kinase type II alpha chain [human]	inhibition percentage	6	%
15540	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Calcium/calmodulin-dependent protein kinase type II subunit beta [human]	inhibition percentage	6	%
15541	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Calcium/calmodulin-dependent protein kinase type II subunit gamma [human]	inhibition percentage	-19	%
15542	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Calcium/calmodulin-dependent protein kinase type 1D [human]	inhibition percentage	19	%
15543	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Calcium/calmodulin-dependent protein kinase type II delta chain [human]	inhibition percentage	17	%
15544	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Calcium/calmodulin-dependent protein kinase type IV [human]	inhibition percentage	-1	%
15545	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Calcium/calmodulin-dependent protein kinase kinase 1 [human]	inhibition percentage	13	%
15546	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Calcium/calmodulin-dependent protein kinase kinase 2 [human]	inhibition percentage	-3	%
15547	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Probable serine/threonine-protein kinase cdc7 [human];+G2/mitotic-specific cyclin-B1 [human]	inhibition percentage	0	%
15548	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	G2/mitotic-specific cyclin-B [human];+Cyclin-dependent kinase 1 [human]	inhibition percentage	-4	%
15549	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	G2/mitotic-specific cyclin-A [human]; Cyclin-dependent kinase 2 [human]	inhibition percentage	3	%
15550	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Cyclin-dependent kinase 2 [human]; G1/S-specific cyclin-E [human]	inhibition percentage	4	%
15551	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	G1/S-specific cyclin-E [human]; Cyclin-dependent kinase 3 [human]	inhibition percentage	9	%
15552	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Cyclin-dependent kinase 4 [human]; G1/S-specific cyclin-D3 [human]	inhibition percentage	21	%
15553	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Cyclin-dependent kinase 5 activator 1, p25 [human]; Cyclin-dependent-like kinase 5 [human]	inhibition percentage	0	%
15554	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Cyclin-dependent-like kinase 5 [human]; Cyclin-dependent kinase 5 activator 1 [human]	inhibition percentage	1	%
15555	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	G1/S-specific cyclin-D3 [human]; Cyclin-dependent kinase 6 [human]	inhibition percentage	2	%
15556	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition percentage	15	%
15557	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Cyclin-dependent kinase 9 [human];+Cyclin-T1 [human]	inhibition percentage	5	%
15558	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Cyclin-dependent kinase 12 [human]; Cyclin-K [human]	inhibition percentage	6	%
15559	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Cyclin-K [human]; Cyclin-dependent kinase 13 [human]	inhibition percentage	-4	%
15560	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Cyclin-dependent kinase 14 [human]; cyclin-y [human]	inhibition percentage	-12	%
15561	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	cyclin-y [human]; Cyclin-dependent kinase 16 [human]	inhibition percentage	-4	%
15562	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	cyclin-y [human]; Cyclin-dependent kinase 17 [human]	inhibition percentage	6	%
15563	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	cyclin-y [human]; Cyclin-dependent kinase 18 [human]	inhibition percentage	-1	%
15564	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Cyclin-dependent kinase-like 1 [human]	inhibition percentage	10	%
15565	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Cyclin-dependent kinase-like 2 [human]	inhibition percentage	-23	%
15566	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Cyclin-dependent kinase-like 3 [human]	inhibition percentage	-3	%
15567	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Cyclin-dependent kinase-like 4 [human]	inhibition percentage	1	%
15568	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Transient receptor potential cation channel subfamily M member 7 [human]	inhibition percentage	4	%
15569	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	NT-3 growth factor receptor [human]	inhibition percentage	55	%
15570	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Epithelial discoidin domain-containing receptor 1 [mouse]	observed parameter		
15571	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Epithelial discoidin domain-containing receptor 1 [mouse]	acute colitis score decrease		
15572	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Epithelial discoidin domain-containing receptor 1 [mouse]	acute colitis score decrease		
15573	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O		mRNA expression level decrease		
15574	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O		mRNA expression level decrease		
15575	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O		mRNA expression level decrease		
15576	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O		mRNA expression level decrease		
15577	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O		mRNA expression level decrease		
15578	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O		mRNA expression level decrease		
15579	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Epithelial discoidin domain-containing receptor 1 [mouse]	interleukin-6 level decrease		
15580	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Epithelial discoidin domain-containing receptor 1 [mouse]	interleukin-6 level decrease		
15581	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Epithelial discoidin domain-containing receptor 1 [mouse]	Interleukin-1 beta level decrease		
15582	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Epithelial discoidin domain-containing receptor 1 [mouse]	Interleukin-1 beta level decrease		
15583	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Epithelial discoidin domain-containing receptor 1 [mouse]	Tumor necrosis factor level decrease		
15584	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Epithelial discoidin domain-containing receptor 1 [mouse]	Tumor necrosis factor level decrease		
15585	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O		body weight loss decrease		
15586	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Epithelial discoidin domain-containing receptor 1 [mouse]	fecal occult blood score decrease		
15587	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Epithelial discoidin domain-containing receptor 1 [mouse]	colorectum length increase		
15588	CC(=O)NC1=CC=C(C=C1)N1N=C2C(=C1C1=C(C)C3=CC=C(C=C3O1)C(=O)NC1=CC=CC(=C1)C(F)(F)F)C(N)=NNC2=O	Epithelial discoidin domain-containing receptor 1 [mouse]	colorectum length increase		
15589	CC1=NNC2=CC=C(C=C12)C1=NC(N[C@@H](CO)C2=CC=C(F)C=C2)=CN=C1	Cyclin-dependent kinase 9	IC50	20.42	nM
15590	CC1=NNC2=CC=C(C=C12)C1=NC(N[C@@H](CO)C2=CC=C(F)C=C2)=CN=C1	Cyclin-dependent kinase 7	IC50	20.42	nM
15591	CC1=NNC2=CC=C(C=C12)C1=NC(N[C@@H](CO)C2=CC=C(F)C=C2)=CN=C1	Cyclin-dependent kinase 2	IC50	56.13	nM
15592	CC1=NNC2=CC=C(C=C12)C1=NC(N[C@@H](CO)C2=CC=C(F)C=C2)=CN=C1	Cyclin-dependent kinase 4	IC50	1000	nM
15593	CC1=NNC2=CC=C(C=C12)C1=NC(N[C@@H](CO)C2=CC=C(F)C=C2)=CN=C1	Cyclin-dependent kinase 6	IC50	1000	nM
15594	CC1=NNC2=CC=C(C=C12)C1=NC(NC(CO)C2=CC=CC=C2)=CN=C1	Cyclin-dependent kinase 9	IC50	14.21	nM
15595	CC1=NNC2=CC=C(C=C12)C1=NC(NC(CO)C2=CC=CC=C2)=CN=C1	Cyclin-dependent kinase 7	IC50	14.21	nM
15596	CC1=NNC2=CC=C(C=C12)C1=NC(NC(CO)C2=CC=CC=C2)=CN=C1	Cyclin-dependent kinase 2	IC50	146.85	nM
15597	CC1=NNC2=CC=C(C=C12)C1=NC(NC(CO)C2=CC=CC=C2)=CN=C1	Cyclin-dependent kinase 4	IC50	1000	nM
15598	CC1=NNC2=CC=C(C=C12)C1=NC(NC(CO)C2=CC=CC=C2)=CN=C1	Cyclin-dependent kinase 6	IC50	1000	nM
15599	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Aurora kinase A	inhibition percentage	96	%
15600	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Aurora kinase B	inhibition percentage	92	%
15601	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Bone morphogenetic protein receptor type-1A	inhibition percentage	-1.5	%
15602	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Serine/threonine-protein kinase B-raf	inhibition percentage	96	%
15603	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Cyclin-dependent kinase 2;+Cyclin-A1	inhibition percentage	101	%
15604	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Cyclin-H;+Cyclin-dependent kinase 7	inhibition percentage	64.5	%
15605	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Cyclin-dependent kinase 8;+Cyclin-C	inhibition percentage	82	%
15606	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Cyclin-dependent kinase 9;+Cyclin-T1	inhibition percentage	100	%
15607	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Casein kinase I isoform alpha	inhibition percentage	93.5	%
15608	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Casein kinase I isoform delta	inhibition percentage	98	%
15609	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Casein kinase I isoform gamma-2	inhibition percentage	96.5	%
15610	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Dual specificity protein kinase CLK2	inhibition percentage	99	%
15611	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Dual specificity protein kinase CLK3	inhibition percentage	96	%
15612	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Dual specificity protein kinase CLK4	inhibition percentage	98.5	%
15613	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Macrophage colony-stimulating factor 1 receptor	inhibition percentage	97	%
15614	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	DNA-dependent protein kinase catalytic subunit	inhibition percentage	56	%
15615	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Epidermal growth factor receptor	inhibition percentage	38	%
15616	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Epidermal growth factor receptor	inhibition percentage	85	%
15617	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Ephrin type-A receptor 7	inhibition percentage	95	%
15618	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Receptor tyrosine-protein kinase erbB-4	inhibition percentage	14	%
15619	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Tyrosine-protein kinase Fgr	inhibition percentage	98.5	%
15620	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Vascular endothelial growth factor receptor 3	inhibition percentage	95.5	%
15621	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	tau-protein kinase	inhibition percentage	100	%
15622	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Homeodomain-interacting protein kinase 1	inhibition percentage	97	%
15623	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Homeodomain-interacting protein kinase 2	inhibition percentage	98	%
15624	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Homeodomain-interacting protein kinase 4	inhibition percentage	99.5	%
15625	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Inhibitor of nuclear factor kappa-B kinase subunit beta	inhibition percentage	26	%
15626	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Mitogen-activated protein kinase 8 (isoform 1)	inhibition percentage	74	%
15627	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Mitogen-activated protein kinase 9	inhibition percentage	45	%
15628	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Mitogen-activated protein kinase 10	inhibition percentage	68.5	%
15629	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Dual specificity mitogen-activated protein kinase kinase 6	inhibition percentage	2.5	%
15630	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Mitogen-activated protein kinase kinase kinase 9	inhibition percentage	100	%
15631	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Myosin light chain kinase 3	inhibition percentage	66	%
15632	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Serine/threonine kinase NLK	inhibition percentage	98.5	%
15633	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Serine/threonine-protein kinase PAK 1	inhibition percentage	51.5	%
15634	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition percentage	98.5	%
15635	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform;+Phosphatidylinositol 3-kinase regulatory subunit beta	inhibition percentage	67.5	%
15636	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	inhibition percentage	98.5	%
15637	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	inhibition percentage	96.5	%
15638	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha	inhibition percentage	24	%
15639	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	inhibition percentage	75	%
15640	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Phosphatidylinositol 3-kinase catalytic subunit type 3	inhibition percentage	100	%
15641	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Phosphatidylinositol 4-kinase alpha	inhibition percentage	8.5	%
15642	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	inhibition percentage	94.5	%
15643	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	cAMP-dependent protein kinase type 1	inhibition percentage	32.5	%
15644	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	RAF proto-oncogene serine/threonine-protein kinase	inhibition percentage	85.5	%
15645	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	DNA-directed RNA polymerase subunit beta	inhibition percentage	95	%
15646	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Pre-mRNA-splicing factor RSE1	inhibition percentage	97.5	%
15647	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Serine/threonine-protein kinase 16	inhibition percentage	99.5	%
15648	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Tyrosine-protein kinase SYK	inhibition percentage	75	%
15649	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Mitogen-activated protein kinase kinase kinase 7;+TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	inhibition percentage	103	%
15650	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	TGF-beta receptor type-1	inhibition percentage	96.5	%
15651	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Dual specificity protein kinase TTK	inhibition percentage	32.5	%
15652	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Serine/threonine-protein kinase mTOR	inhibition percentage	12.5	%
15653	CC(C)C1CNC(=O)C2=CC(=NN12)C1=CC(NC(=O)C2CC2)=NC=C1C	Mitogen-activated protein kinase 13	inhibition percentage	100	%
15654	OC=O.CC1(C)CNC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(C=N1)C(F)(F)F	Cyclin-H;+Cyclin-dependent kinase 7	Kd (dissociation constant)	0.21	nM
15655	OC=O.CC1(C)CNC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 12;+Cyclin-K	IC50	36	nM
15656	OC=O.CC1(C)CNC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 9;+Cyclin-T1	IC50	41	nM
15657	OC=O.CC1(C)CNC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 2;+G1/S-specific cyclin-E2	IC50	52	nM
15658	OC=O.CC1(C)CNC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(C=N1)C(F)(F)F		CLint (intrinsic clearance)	120	ml/min/kg
15659	OC=O.CC1(C)CNC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(C=N1)C(F)(F)F		CL u	1477	ml/min/kg
15660	OC=O.CC1(C)CNC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(C=N1)C(F)(F)F		F (drug bioavailability)	40	%
15661	OC=O.CS(=O)(=O)C1=C2NC=C(C2=CC=C1C#N)C1=NC(N[C@H]2CCCNC2)=NC=C1C(F)(F)F	Cyclin-H;+Cyclin-dependent kinase 7	Kd (dissociation constant)	0.08	nM
15662	OC=O.CS(=O)(=O)C1=C2NC=C(C2=CC=C1C#N)C1=NC(N[C@H]2CCCNC2)=NC=C1C(F)(F)F	Cyclin-dependent kinase 7 [human]	EC50	15	nM
15663	OC=O.CS(=O)(=O)C1=C2NC=C(C2=CC=C1C#N)C1=NC(N[C@H]2CCCNC2)=NC=C1C(F)(F)F	Cyclin-dependent kinase 12;+Cyclin-K	IC50	33	nM
15664	OC=O.CS(=O)(=O)C1=C2NC=C(C2=CC=C1C#N)C1=NC(N[C@H]2CCCNC2)=NC=C1C(F)(F)F	Cyclin-dependent kinase 9;+Cyclin-T1	IC50	60	nM
15665	OC=O.CS(=O)(=O)C1=C2NC=C(C2=CC=C1C#N)C1=NC(N[C@H]2CCCNC2)=NC=C1C(F)(F)F	Cyclin-dependent kinase 2;+G1/S-specific cyclin-E2	IC50	284	nM
15666	OC=O.CS(=O)(=O)C1=C2NC=C(C2=CC=C1C#N)C1=NC(N[C@H]2CCCNC2)=NC=C1C(F)(F)F		CLint (intrinsic clearance)	38	ml/min/kg
15667	OC=O.CS(=O)(=O)C1=C2NC=C(C2=CC=C1C#N)C1=NC(N[C@H]2CCCNC2)=NC=C1C(F)(F)F		Papp (A-B)	1.86E-6	cm/s
15668	OC=O.CS(=O)(=O)C1=C2NC=C(C2=CC=C1C#N)C1=NC(N[C@H]2CCCNC2)=NC=C1C(F)(F)F		CL u	368	ml/min/kg
15669	OC=O.CS(=O)(=O)C1=C2NC=C(C2=CC=C1C#N)C1=NC(N[C@H]2CCCNC2)=NC=C1C(F)(F)F		F (drug bioavailability)	5	%
15670	OC=O.CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C(C(=CC=C12)C#N)S(C)(=O)=O	Cyclin-H;+Cyclin-dependent kinase 7	Kd (dissociation constant)	0.15	nM
15671	OC=O.CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C(C(=CC=C12)C#N)S(C)(=O)=O	Cyclin-dependent kinase 12;+Cyclin-K	IC50	215	nM
15672	OC=O.CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C(C(=CC=C12)C#N)S(C)(=O)=O	Cyclin-dependent kinase 7 [human]	EC50	287	nM
15673	OC=O.CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C(C(=CC=C12)C#N)S(C)(=O)=O	Cyclin-dependent kinase 9;+Cyclin-T1	IC50	907	nM
15674	OC=O.CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C(C(=CC=C12)C#N)S(C)(=O)=O	Cyclin-dependent kinase 2;+G1/S-specific cyclin-E2	IC50	1638	nM
15675	OC=O.CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C(C(=CC=C12)C#N)S(C)(=O)=O		CLint (intrinsic clearance)	89	ml/min/kg
15676	OC=O.CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C(C(=CC=C12)C#N)S(C)(=O)=O		Papp (A-B)	1.12E-6	cm/s
15677	OC=O.CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C(C(=CC=C12)C#N)S(C)(=O)=O		CL u	394	ml/min/kg
15678	OC=O.CCC1=C(N=C(N[C@H]2CCCNC2)N=C1)C1=CNC2=C(C(=CC=C12)C#N)S(C)(=O)=O		F (drug bioavailability)	0	%
15679	CC(C)C1=CN=C2N1C=C(C=C2NC1CCN(C[C@@H]2CN(CCO2)C(=O)C=C)CC1)[C@@H](C)F	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	IC50	0.0143	μM
15680	CC(C)C1=CN=C2N1C=C(C=C2NC1CCN(C[C@@H]2CN(CCO2)C(=O)C=C)CC1)[C@@H](C)F		IC50	0.01948	μM
15681	CC(C)C1=CN=C2N1C=C(C=C2NC1CCN(C[C@@H]2CN(CCO2)C(=O)C=C)CC1)[C@@H](C)F		IC50	0.0228	μM
15682	CC(C)C1=CN=C2N1C=C(C=C2NC1CCN(C[C@@H]2CN(CCO2)C(=O)C=C)CC1)[C@@H](C)F		IC50	0.082	μM
15683	CC(C)C1=CN=C2N1C=C(C=C2NC1CCN(C[C@@H]2CN(CCO2)C(=O)C=C)CC1)[C@@H](C)F	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	IC50	0.123	μM
15684	CC(C)C1=CN=C2N1C=C(C=C2NC1CCN(C[C@@H]2CN(CCO2)C(=O)C=C)CC1)[C@@H](C)F		IC50	0.161	μM
15685	CC(C)C1=CN=C2N1C=C(C=C2NC1CCN(C[C@@H]2CN(CCO2)C(=O)C=C)CC1)[C@@H](C)F	Cyclin-T1 [human]; Cyclin-dependent kinase 9 [human]	IC50	1.77	μM
15686	CC(C)C1=CN=C2N1C=C(C=C2NC1CCN(C[C@@H]2CN(CCO2)C(=O)C=C)CC1)[C@@H](C)F		IC50	5.73	μM
15687	CC(C)C1=CN=C2N1C=C(C=C2NC1CCN(C[C@@H]2CN(CCO2)C(=O)C=C)CC1)[C@@H](C)F		T/C (treated/control)	16.5	%
15688	CC(C)C1=CN=C2N1C=C(C=C2NC1CCN(C[C@@H]2CN(CCO2)C(=O)C=C)CC1)[C@@H](C)F		T/C (treated/control)	38	%
15689	CC(C)C1=CN=C2N1C=C(C=C2NC1CCN(C[C@@H]2CN(CCO2)C(=O)C=C)CC1)[C@H](C)F	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	IC50	0.0266	μM
15690	CC(C)C1=CN=C2N1C=C(C=C2NC1CCN(C[C@@H]2CN(CCO2)C(=O)C=C)CC1)[C@H](C)F		IC50	0.0947	μM
15691	CC(C)C1=CN=C2N1C=C(C=C2NC1CCN(C[C@@H]2CN(CCO2)C(=O)C=C)CC1)[C@H](C)F		IC50	0.162	μM
15692	CC(C)C1=CN=C2N1C=C(C=C2NC1CCN(C[C@@H]2CN(CCO2)C(=O)C=C)CC1)[C@H](C)F	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	IC50	0.256	μM
15693	CC(C)C1=CN=C2N1C=C(C=C2NC1CCN(C[C@@H]2CN(CCO2)C(=O)C=C)CC1)[C@H](C)F	Cyclin-T1 [human]; Cyclin-dependent kinase 9 [human]	IC50	3.18	μM
15694	CC(C)C1=CN=C2N1C=C(C=C2NC1CCN(C[C@@H]2CN(CCO2)C(=O)C=C)CC1)[C@H](C)F		IC50	6.36	μM
15695	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		inhibition rate		
15696	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Indoleamine 2,3-dioxygenase 1 [human]	IC50	2.16	nM
15697	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Indoleamine 2,3-dioxygenase 1	IC50	28	nM
15698	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Indoleamine 2,3-dioxygenase 2	IC50	144	nM
15699	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		IC50	56.13	μM
15700	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		IC50	61.96	μM
15701	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		IC50	83.25	μM
15702	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		mortality rate		
15703	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		body weight loss		
15704	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Potassium voltage-gated channel subfamily H member 2 [human]	IC50	30	μM
15705	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		body weight change		
15706	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Indoleamine 2,3-dioxygenase 2 [human]; Indoleamine 2,3-dioxygenase 1 [human]	TGI (tumor growth inhibition rate)		
15707	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Indoleamine 2,3-dioxygenase 2 [human]; Indoleamine 2,3-dioxygenase 1 [human]	TGI (tumor growth inhibition rate)		
15708	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Indoleamine 2,3-dioxygenase 2 [mouse];+Indoleamine 2,3-dioxygenase 1 [mouse]	protein expression level change		
15709	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Indoleamine 2,3-dioxygenase 2 [mouse];+Indoleamine 2,3-dioxygenase 1 [mouse]	mRNA expression level change		
15710	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		gene expression level change		
15711	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Tryptophan 2,3-dioxygenase (peptide)	inhibition rate		
15712	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		t1/2 (drug half life)	46.1	minute
15713	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		CLint (intrinsic clearance)	30.1	μl*min/mg
15714	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		t1/2 (drug half life)	38.6	minute
15715	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		t1/2 (drug half life)	5.66	minute
15716	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		t1/2 (drug half life)	21.2	minute
15717	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		t1/2 (drug half life)	43.2	minute
15718	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		CLint (intrinsic clearance)	36	μl*min/mg
15719	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		CLint (intrinsic clearance)	245	μl*min/mg
15720	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		CLint (intrinsic clearance)	65.3	μl*min/mg
15721	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		CLint (intrinsic clearance)	32.2	μl*min/mg
15722	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		Papp (A-B)	7.2E-6	cm/s
15723	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		Papp (B-A)	4.6E-5	cm/s
15724	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		efflux ratio	6.4	no unit
15725	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		recovery percentage	91.1	%
15726	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		recovery percentage	112	%
15727	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		fu (fraction unbound)	4.11	%
15728	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		fu (fraction unbound)	7.63	%
15729	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		fu (fraction unbound)	4.98	%
15730	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		fu (fraction unbound)	6.72	%
15731	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		fu (fraction unbound)	9.68	%
15732	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		MTD (maximum tolerated dose)	2	g/kg
15733	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Potassium voltage-gated channel subfamily H member 2 [human]	inhibition rate	1.05	%
15734	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Potassium voltage-gated channel subfamily H member 2 [human]	inhibition rate	9.89	%
15735	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Potassium voltage-gated channel subfamily H member 2 [human]	inhibition rate	7.12	%
15736	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Potassium voltage-gated channel subfamily H member 2 [human]	inhibition rate	-4.92	%
15737	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Potassium voltage-gated channel subfamily H member 2 [human]	inhibition rate	-12.12	%
15738	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Indoleamine 2,3-dioxygenase 2 [mouse];+Indoleamine 2,3-dioxygenase 1 [mouse]	TGI (tumor growth inhibition rate)	69.7	%
15739	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Indoleamine 2,3-dioxygenase 2 [mouse];+Indoleamine 2,3-dioxygenase 1 [mouse]	increase rate		
15740	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Indoleamine 2,3-dioxygenase 2 [mouse];+Indoleamine 2,3-dioxygenase 1 [mouse]	decrease rate		
15741	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Indoleamine 2,3-dioxygenase 2 [mouse];+Indoleamine 2,3-dioxygenase 1 [mouse]	increase rate		
15742	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Indoleamine 2,3-dioxygenase 2 [mouse];+Indoleamine 2,3-dioxygenase 1 [mouse]	increase rate		
15743	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Indoleamine 2,3-dioxygenase 2 [mouse];+Indoleamine 2,3-dioxygenase 1 [mouse]	increase rate		
15744	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Indoleamine 2,3-dioxygenase 2 [mouse];+Indoleamine 2,3-dioxygenase 1 [mouse]	protein expression level increase		
15745	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Indoleamine 2,3-dioxygenase 2 [mouse];+Indoleamine 2,3-dioxygenase 1 [mouse]	protein expression level increase		
15746	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Indoleamine 2,3-dioxygenase 2 [mouse];+Indoleamine 2,3-dioxygenase 1 [mouse]	protein expression level decrease		
15747	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		protein expression level decrease		
15748	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		protein expression level decrease		
15749	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Indoleamine 2,3-dioxygenase 2 [mouse];+Indoleamine 2,3-dioxygenase 1 [mouse]	decrease rate		
15750	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Indoleamine 2,3-dioxygenase 2 [mouse];+Indoleamine 2,3-dioxygenase 1 [mouse]	apoptosis rate decrease		
15751	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Indoleamine 2,3-dioxygenase 2 [mouse];+Indoleamine 2,3-dioxygenase 1 [mouse]	cell proliferation increase		
15752	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Indoleamine 2,3-dioxygenase 2 [mouse];+Indoleamine 2,3-dioxygenase 1 [mouse]	cell proliferation increase		
15753	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Indoleamine 2,3-dioxygenase 2 [mouse];+Indoleamine 2,3-dioxygenase 1 [mouse]	mRNA expression level decrease		
15754	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		mRNA expression level decrease		
15755	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		mRNA expression level decrease		
15756	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase Nek6	inhibition rate	7.15 - 7.55	%
15757	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase Nek7	inhibition rate	5.64 - 8.76	%
15758	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		inhibition rate		
15759	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		tmax	1.3	h
15760	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		t1/2 (drug half life)	0.61	h
15761	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		t1/2 (drug half life)	1.9	h
15762	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		Vdss	0.88	l/kg
15763	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		CL (drug clearance)	27.5	ml/min/kg
15764	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		F (drug bioavailability)	12	%
15765	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		AUC (0-t)	3.64	μg*h/ml
15766	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		AUC (0-t)	3.04	μg*h/ml
15767	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		AUC (0-inf)	3.95	μg*h/ml
15768	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		AUC (0-inf)	3.053	μg*h/ml
15769	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1		Cmax	1043	ng/ml
15770	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Indoleamine 2,3-dioxygenase 2 [mouse];+Indoleamine 2,3-dioxygenase 1 [mouse]	tumor volume	320	mm3
15771	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Tyrosine-protein kinase ABL2	inhibition rate	-2.23 - -1.99	%
15772	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Activator of C kinase protein 1	inhibition rate	-4.85 - -1.95	%
15773	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	RAC-alpha serine/threonine-protein kinase	inhibition rate	-11.02 - -9.87	%
15774	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	RAC-beta serine/threonine-protein kinase	inhibition rate	4.62 - 6.53	%
15775	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	RAC-gamma serine/threonine-protein kinase	inhibition rate	15.26 - 15.9	%
15776	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	ALK tyrosine kinase receptor	inhibition rate	11.59 - 12.79	%
15777	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase receptor R3	inhibition rate	9.42 - 10.33	%
15778	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Activin receptor type-1	inhibition rate	-2.56 - -1.37	%
15779	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Bone morphogenetic protein receptor type-1A	inhibition rate	-6.25 - -4.41	%
15780	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Activin receptor type-1B	inhibition rate	2.05 - 4.48	%
15781	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	TGF-beta receptor type-1	inhibition rate	-1.09 - -1.04	%
15782	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Bone morphogenetic protein receptor type-1B	inhibition rate	4.94 - 6.37	%
15783	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase A-Raf	inhibition rate	2.72 - 4.47	%
15784	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	NUAK family SNF1-like kinase 1	inhibition rate	-8.54 - -8.26	%
15785	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Mitogen-activated protein kinase kinase kinase 5	inhibition rate	-2069 - -16.15	%
15786	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Aurora kinase A	inhibition rate	7 - 7.82	%
15787	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Aurora kinase B	inhibition rate	0.19 - 0.63	%
15788	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Aurora kinase C	inhibition rate	12.67 - 13.8	%
15789	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Tyrosine-protein kinase receptor UFO	inhibition rate	17.86 - 18.15	%
15790	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Probable serine/threonine-protein kinase PBL1	inhibition rate	0.32 - 0.98	%
15791	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Bone morphogenetic protein receptor type-2	inhibition rate	5.41 - 6.51	%
15792	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Cytoplasmic tyrosine-protein kinase BMX	inhibition rate	3.57 - 6.08	%
15793	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase B-raf	inhibition rate	2.33 - 2.66	%
15794	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Protein-tyrosine kinase 6	inhibition rate	-0.83 - -0.67	%
15795	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase BRSK1	inhibition rate	12.7 - 14.24	%
15796	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase BRSK2	inhibition rate	14.05 - 14.27	%
15797	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Tyrosine-protein kinase BTK	inhibition rate	13.29 - 15.09	%
15798	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Kit ligand	inhibition rate	17.79 - 17.8	%
15799	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Tyrosine-protein kinase Mer	inhibition rate	2.04 - 2.1	%
15800	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Hepatocyte growth factor receptor	inhibition rate	17.15 - 17.8	%
15801	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Tyrosine-protein kinase CSK	inhibition rate	6.4 - 7.04	%
15802	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Calcium/calmodulin-dependent protein kinase type 1	inhibition rate	1.28 - 2.3	%
15803	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Calcium/calmodulin-dependent protein kinase type 1B	inhibition rate	5.73 - 7.71	%
15804	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Calcium/calmodulin-dependent protein kinase type 1D	inhibition rate	5.74 - 6.72	%
15805	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Calcium/calmodulin-dependent protein kinase type 1G	inhibition rate	6.11 - 10.52	%
15806	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Calcium/calmodulin-dependent protein kinase type II subunit alpha	inhibition rate	3.33 - 3.77	%
15807	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Calcium/calmodulin-dependent protein kinase type II subunit beta	inhibition rate	4.26 - 6.5	%
15808	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Calcium/calmodulin-dependent protein kinase type II subunit gamma	inhibition rate	10.94 - 18.9	%
15809	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Calcium/calmodulin-dependent protein kinase type IV	inhibition rate	-1.61 - -1.42	%
15810	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Calcium/calmodulin-dependent protein kinase kinase 1	inhibition rate	6.19 - 6.69	%
15811	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Calcium/calmodulin-dependent protein kinase kinase 2	inhibition rate	14.13 - 20.83	%
15812	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Probable serine/threonine-protein kinase cdc7;+DDK kinase regulatory subunit DBF4	inhibition rate	0.03 - 1.11	%
15813	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Cyclin-dependent kinase 1; Cyclin-A1	inhibition rate	5.03 - 5.2	%
15814	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Cyclin-dependent kinase 1; G2/mitotic-specific cyclin-B	inhibition rate	8.11 - 9.76	%
15815	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Cyclin-dependent kinase 1; Cyclin E	inhibition rate	5.73 - 6.55	%
15816	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Cyclin-dependent kinase 14; Cyclin Y	inhibition rate	-1.85 - 1.25	%
15817	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Cyclin Y; Cyclin-dependent kinase 16	inhibition rate	-2.72 - -0.37	%
15818	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Cyclin Y; Cyclin-dependent kinase 17	inhibition rate	-2.34 - -1.27	%
15819	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Cyclin Y; Cyclin-dependent kinase 18	inhibition rate	3.02 - 4.91	%
15820	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Cyclin-C;+Cyclin-dependent kinase 19	inhibition rate	-2.65 - -2	%
15821	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Cyclin-A1; Cyclin-dependent kinase 2	inhibition rate	14.45 - 15.19	%
15822	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Cyclin E; Cyclin-dependent kinase 2	inhibition rate	-5.53 - -2	%
15823	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Cyclin-dependent kinase 2; G1/S-specific cyclin-E2	inhibition rate	1.26 - 13.36	%
15824	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Cyclin-dependent kinase 2; Cyclin-O	inhibition rate	-3.45 - -2.57	%
15825	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Cyclin E; Cyclin-dependent kinase 3	inhibition rate	3.29 - 5.15	%
15826	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	G1/S-specific cyclin-E2; Cyclin-dependent kinase 3	inhibition rate	11.99 - 13.2	%
15827	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Cyclin-dependent kinase 4; Cyclin-D1-1	inhibition rate	15.84 - 18.8	%
15828	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Cyclin-D3-1; Cyclin-dependent kinase 4	inhibition rate	0.88 - 1.25	%
15829	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Cyclin-dependent kinase 5 activator 1, p25; Cyclin-dependent-like kinase 5	inhibition rate	2.41 - 3.11	%
15830	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Cyclin-dependent-like kinase 5; Cyclin-dependent kinase 5 activator 1, p35	inhibition rate	6.43 - 6.94	%
15831	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Cyclin-dependent kinase 6; Cyclin-D1-1	inhibition rate	4.9 - 5.22	%
15832	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Cyclin-D3-1; Cyclin-dependent kinase 6	inhibition rate	13.65 - 13.88	%
15833	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Cyclin-H;+Cyclin-dependent kinase 7	inhibition rate	-1.5 - -1.48	%
15834	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Cyclin-K; Cyclin-dependent kinase 9	inhibition rate	-0.6 - 1.6	%
15835	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Cyclin-dependent kinase 9; Cyclin-T1	inhibition rate	2.13 - 5.48	%
15836	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Cyclin-dependent kinase 9; Cyclin-T2	inhibition rate	-3.07 - -2.8	%
15837	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase Chk1	inhibition rate	-1.54 - -1.16	%
15838	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase Chk2	inhibition rate	-7.41 - -4.65	%
15839	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	casein kinase 1 alpha1	inhibition rate	-0.56 - 0.17	%
15840	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	casein kinase 1 alpha1L	inhibition rate	7.91 - 9.03	%
15841	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Casein kinase I isoform delta	inhibition rate	4.58 - 5.78	%
15842	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Casein kinase I isoform epsilon	inhibition rate	10.87 - 11.99	%
15843	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Casein kinase I isoform gamma-1	inhibition rate	-6.5 - -1.5	%
15844	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Casein kinase I isoform gamma-2	inhibition rate	-0.48 - 0.05	%
15845	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Casein kinase I isoform gamma-3	inhibition rate	4.6 - 6.54	%
15846	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Casein kinase II subunit alpha	inhibition rate	-2.43 - -1.31	%
15847	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Casein kinase II subunit alpha'	inhibition rate	24.44 - 25.35	%
15848	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Dual specificity protein kinase CLK1	inhibition rate	-4.54 - -3.3	%
15849	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Dual specificity protein kinase CLK2	inhibition rate	-14.35 - -13.96	%
15850	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Dual specificity protein kinase CLK3	inhibition rate	-8.67 - -0.74	%
15851	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Dual specificity protein kinase CLK4	inhibition rate	5.05 - 7.31	%
15852	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Mitogen-activated protein kinase kinase kinase 8	inhibition rate	4.22 - 5.56	%
15853	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Tyrosine-protein kinase CSK	inhibition rate	-2.38 - -0.32	%
15854	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Megakaryocyte-associated tyrosine-protein kinase	inhibition rate	23.3 - 23.35	%
15855	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Death-associated protein kinase 1	inhibition rate	3.17 - 3.38	%
15856	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Death-associated protein kinase 2	inhibition rate	4.95 - 5.42	%
15857	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase DCLK1	inhibition rate	-0.48 - 0.6	%
15858	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase DCLK2	inhibition rate	12.11 - 13.27	%
15859	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Epithelial discoidin domain-containing receptor 1	inhibition rate	17.94 - 19.21	%
15860	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Discoidin domain-containing receptor 2	inhibition rate	-11.45 - -7.7	%
15861	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Mitogen-activated protein kinase kinase kinase 12	inhibition rate	13.1 - 14.08	%
15862	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Myotonin-protein kinase	inhibition rate	-0.54 - 1.14	%
15863	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase MRCK gamma	inhibition rate	-4.47 - -4.24	%
15864	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase 17A	inhibition rate	-2.51 - 0.19	%
15865	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Dual specificity tyrosine-phosphorylation-regulated kinase 1A/B	inhibition rate	0.82 - 3.54	%
15866	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	inhibition rate	0.83 - 6.79	%
15867	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Probable serine/threonine-protein kinase dyrk2	inhibition rate	5.74 - 8.35	%
15868	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Dual specificity tyrosine-phosphorylation-regulated kinase 3	inhibition rate	-3.12 - -2.51	%
15869	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Dual specificity tyrosine-phosphorylation-regulated kinase 4	inhibition rate	-5.04 - -4.55	%
15870	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Epidermal growth factor receptor	inhibition rate	-3.31 - 1.41	%
15871	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Ephrin type-A receptor 1	inhibition rate	6.49 - 7.69	%
15872	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Ephrin type-A receptor 2	inhibition rate	2.63 - 4.06	%
15873	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Ephrin type-A receptor 3	inhibition rate	-3.4 - -2.11	%
15874	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Ephrin type-A receptor 4	inhibition rate	-2.15 - -1.99	%
15875	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Ephrin type-A receptor 5	inhibition rate	1.45 - 1.68	%
15876	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Ephrin type-A receptor 6	inhibition rate	4.99 - 5.05	%
15877	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Ephrin type-A receptor 7	inhibition rate	10 - 11.17	%
15878	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Ephrin type-A receptor 8	inhibition rate	-3.09 - -3.02	%
15879	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Ephrin type-B receptor 1	inhibition rate	3.06 - 3.49	%
15880	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Ephrin type-B receptor 2	inhibition rate	2.31 - 96.79	%
15881	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Ephrin type-B receptor 3	inhibition rate	5.62 - 5.87	%
15882	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Ephrin type-B receptor 4	inhibition rate	15.06 - 17.02	%
15883	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Receptor tyrosine-protein kinase erbB-2	inhibition rate	7.07 - 7.76	%
15884	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Receptor tyrosine-protein kinase erbB-4	inhibition rate	10.86 - 11.34	%
15885	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	MAP kinase	inhibition rate	7.12 - 7.19	%
15886	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Mitogen-activated protein kinase 1	inhibition rate	0.93 - 1.2	%
15887	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Mitogen-activated protein kinase 7	inhibition rate	0.3 - 2.94	%
15888	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Mitogen-activated protein kinase 15	inhibition rate	-15.74 - -13.18	%
15889	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase/endoribonuclease IRE1	inhibition rate	4.42 - 4.78	%
15890	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase/endoribonuclease IRE2	inhibition rate	-7.74 - -3.44	%
15891	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Protein-tyrosine kinase 2-beta	inhibition rate	0.27 - 2.51	%
15892	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Tyrosine-protein kinase Fer	inhibition rate	0.68 - 1.15	%
15893	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Tyrosine-protein kinase, Fes/Fps type	inhibition rate	0.98 - 1.09	%
15894	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Fibroblast growth factor receptor 1	inhibition rate	-5.9 - -5.89	%
15895	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Fibroblast growth factor receptor 2	inhibition rate	6.78 - 6.79	%
15896	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Fibroblast growth factor receptor 3	inhibition rate	0.16 - 1.38	%
15897	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Fibroblast growth factor receptor 4	inhibition rate	-17.54 - -14.05	%
15898	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Tyrosine-protein kinase Fgr	inhibition rate	1.98 - 4.11	%
15899	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Vascular endothelial growth factor receptor 1	inhibition rate	20.26 - 20.5	%
15900	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	13.8 - 14.71	%
15901	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Vascular endothelial growth factor receptor 3	inhibition rate	-1.08 - -0.53	%
15902	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Macrophage colony-stimulating factor 1 receptor	inhibition rate	11.72 - 13.64	%
15903	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Tyrosine-protein kinase FRK	inhibition rate	0.48 - 1.37	%
15904	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Tyrosine-protein kinase Fyn	inhibition rate	8.16 - 8.33	%
15905	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Mitogen-activated protein kinase kinase kinase kinase 2	inhibition rate	-4.12 - -3.49	%
15906	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Mitogen-activated protein kinase kinase kinase kinase 3	inhibition rate	2.96 - 3.72	%
15907	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	rhodopsin kinase	inhibition rate	-3.44 - 1.04	%
15908	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Beta-adrenergic receptor kinase 1	inhibition rate	-3.59 - -3.38	%
15909	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Beta-adrenergic receptor kinase 2	inhibition rate	-6.94 - -6.49	%
15910	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	G protein-coupled receptor kinase 4	inhibition rate	-6.55 - -5.62	%
15911	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	G protein-coupled receptor kinase 5	inhibition rate	-9.97 - -7.04	%
15912	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	G protein-coupled receptor kinase 6	inhibition rate	-4.67 - -4.46	%
15913	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	rhodopsin kinase	inhibition rate	-9.42 - -9.22	%
15914	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Glycogen synthase kinase-3 alpha	inhibition rate	-0.95 - -0.79	%
15915	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	tau-protein kinase	inhibition rate	-2.25 - 0	%
15916	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase haspin	inhibition rate	-4.27 - -0.92	%
15917	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Tyrosine-protein kinase ABL1	inhibition rate	1.12 - 6.41	%
15918	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Tyrosine-protein kinase HCK	inhibition rate	6.09 - 6.67	%
15919	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Mitogen-activated protein kinase kinase kinase kinase 4	inhibition rate	-5.38 - -2.02	%
15920	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Homeodomain-interacting protein kinase 1	inhibition rate	-14.88 - -13.77	%
15921	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Homeodomain-interacting protein kinase 2	inhibition rate	-10.65 - -6.39	%
15922	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Homeodomain-interacting protein kinase 3	inhibition rate	-10.09 - -8.38	%
15923	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Mitogen-activated protein kinase kinase kinase kinase 1	inhibition rate	-3.98 - -2.32	%
15924	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Insulin-like growth factor 1 receptor	inhibition rate	7.46 - 8.32	%
15925	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Inhibitor of nuclear factor kappa-B kinase subunit alpha	inhibition rate	-2.2 - -0.7	%
15926	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Inhibitor of nuclear factor kappa-B kinase subunit beta	inhibition rate	1.09 - 5.84	%
15927	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	inhibition rate	4.75 - 4.76	%
15928	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Insulin-like receptor	inhibition rate	-3.9 - -2.29	%
15929	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Interleukin-1 receptor-associated kinase 1	inhibition rate	-7.89 - -7.17	%
15930	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Interleukin-1 receptor-associated kinase 4	inhibition rate	1.83 - 6.84	%
15931	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Insulin receptor-related protein	inhibition rate	15.99 - 18.87	%
15932	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Tyrosine-protein kinase ITK/TSK	inhibition rate	-4.67 - -4.41	%
15933	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Tyrosine-protein kinase JAK1	inhibition rate	1.64 - 2.25	%
15934	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Tyrosine-protein kinase JAK2	inhibition rate	0.96 - 2.7	%
15935	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Tyrosine-protein kinase JAK3	inhibition rate	-5.61 - -3.13	%
15936	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Mitogen-activated protein kinase 8	inhibition rate	0.52 - 0.83	%
15937	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Mitogen-activated protein kinase 9	inhibition rate	-5.16 - -3.55	%
15938	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Mitogen-activated protein kinase 10	inhibition rate	3.67 - 5.6	%
15939	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Vascular endothelial growth factor receptor 2	inhibition rate	-3.87 - -3.45	%
15940	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Connector enhancer of kinase suppressor of ras 1	inhibition rate	12.48 - 14.54	%
15941	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Connector enhancer of kinase suppressor of ras 2	inhibition rate	4.58 - 5.22	%
15942	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase LATS1	inhibition rate	0.62 - 1.39	%
15943	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase LATS2	inhibition rate	-1.55 - 1.14	%
15944	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Tyrosine-protein kinase Lck	inhibition rate	3.97 - 4.26	%
15945	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase ICK	inhibition rate	-1.98 - -0.45	%
15946	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	LIM domain kinase 1	inhibition rate	9.64 - 10.23	%
15947	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	LIM domain kinase 2	inhibition rate	5.2 - 5.49	%
15948	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase STK11	inhibition rate	16.35 - 17.28	%
15949	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase 10	inhibition rate	-0.43 - -0.28	%
15950	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Leucine-rich repeat serine/threonine-protein kinase 2	inhibition rate	-0.22 - 2.32	%
15951	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Tyrosine-protein kinase Lyn	inhibition rate	6.3 - 7.4	%
15952	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Toxin CcdB	inhibition rate	3.68 - 8.58	%
15953	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase MAK	inhibition rate	3.99 - 8.58	%
15954	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	MAP kinase-activated protein kinase 2	inhibition rate	-1.09 - 0.05	%
15955	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	MAP kinase-activated protein kinase 3	inhibition rate	-1.47 - -0.92	%
15956	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	MAP kinase-activated protein kinase 5	inhibition rate	2.15 - 4.22	%
15957	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase MARK1	inhibition rate	-5.58 - -4.65	%
15958	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase MARK2	inhibition rate	6.51 - 8.09	%
15959	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	MAP/microtubule affinity-regulating kinase 3	inhibition rate	-6.69 - -5.68	%
15960	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	MAP/microtubule affinity-regulating kinase 4	inhibition rate	-10.52 - -8.97	%
15961	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Dual specificity mitogen-activated protein kinase kinase 1	inhibition rate	1.2 - 1.66	%
15962	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Dual specificity mitogen-activated protein kinase kinase 2	inhibition rate	0 - 3.32	%
15963	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Dual specificity mitogen-activated protein kinase kinase 3	inhibition rate	-7.11 - -2.87	%
15964	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Dual specificity mitogen-activated protein kinase kinase 5	inhibition rate	-2.83 - -0.12	%
15965	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Mitogen-activated protein kinase kinase kinase 1	inhibition rate	-12.94 - -7.4	%
15966	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Mitogen-activated protein kinase kinase kinase 2	inhibition rate	0.52 - 98.79	%
15967	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Mitogen-activated protein kinase kinase kinase 3	inhibition rate	6.21 - 91.13	%
15968	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Mitogen-activated protein kinase kinase kinase 6	inhibition rate	-10.07 - -5.17	%
15969	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Maternal embryonic leucine zipper kinase	inhibition rate	1.44 - 5.17	%
15970	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Misshapen-like kinase 1	inhibition rate	7.75 - 8.39	%
15971	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Dual specificity mitogen-activated protein kinase kinase 4	inhibition rate	-9.1 - -8.12	%
15972	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Dual specificity mitogen-activated protein kinase kinase 6	inhibition rate	-0.63 - 2.51	%
15973	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Dual specificity mitogen-activated protein kinase kinase 7	inhibition rate	-1.4 - -0.79	%
15974	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Myosin light chain kinase 3	inhibition rate	6.35 - 6.55	%
15975	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Myosin light chain kinase 2, skeletal/cardiac muscle	inhibition rate	1.9 - 5.64	%
15976	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Mitogen-activated protein kinase kinase kinase 9	inhibition rate	6.01 - 7.53	%
15977	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Mitogen-activated protein kinase kinase kinase 10	inhibition rate	12.33 - 12.48	%
15978	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Mitogen-activated protein kinase kinase kinase 11	inhibition rate	5.05 - 5.78	%
15979	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Mitogen-activated protein kinase kinase kinase 21	inhibition rate	-0.42 - 0.59	%
15980	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Mitogen-activated protein kinase 3	inhibition rate	-6.13 - -2.92	%
15981	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Mitogen-activated protein kinase 4	inhibition rate	-20.59 - -12.29	%
15982	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase MRCK alpha	inhibition rate	-3.67 - -1.56	%
15983	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase MRCK beta	inhibition rate	7.87 - 12.21	%
15984	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Ribosomal protein S6 kinase alpha-5	inhibition rate	1.63 - 1.81	%
15985	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Ribosomal protein S6 kinase alpha-4	inhibition rate	0.61 - 2.85	%
15986	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	SRSF protein kinase 3	inhibition rate	0.71 - 1.93	%
15987	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase 4	inhibition rate	-4.01 - -3.13	%
15988	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase 3	inhibition rate	7.03 - 8.08	%
15989	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase 24	inhibition rate	-21.28 - -20.62	%
15990	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase 26	inhibition rate	21.66 - 23.45	%
15991	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Muscle, skeletal receptor tyrosine-protein kinase	inhibition rate	-12.54 - -10.13	%
15992	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Myosin light chain kinase 3	inhibition rate	-5.52 - -4.95	%
15993	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Myosin light chain kinase family member 4	inhibition rate	-1.97 - -0.26	%
15994	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Myosin-IIIa	inhibition rate	0.25 - 0.89	%
15995	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Myosin-IIIb	inhibition rate	-6.83 - -6.78	%
15996	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase Nek1	inhibition rate	17.58 - 21.32	%
15997	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase Nek2	inhibition rate	-6.85 - -4.72	%
15998	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase Nek3	inhibition rate	-4.02 - -3.07	%
15999	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase Nek4	inhibition rate	1.66 - 2.82	%
16000	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase Nek5	inhibition rate	-32.72 - -32.44	%
16001	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase Nek8	inhibition rate	9.57 - 11.64	%
16002	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase Nek9	inhibition rate	3.92 - 3.97	%
16003	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase NIM1	inhibition rate	0.62 - 1.68	%
16004	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine kinase NLK	inhibition rate	-2.17 - 1.41	%
16005	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase OSR1	inhibition rate	0.75 - 5.71	%
16006	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Mitogen-activated protein kinase 14A	inhibition rate	-5.07 - -1.11	%
16007	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Mitogen-activated protein kinase 11	inhibition rate	-0.87 - 0.65	%
16008	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Mitogen-activated protein kinase 13	inhibition rate	-29.76 - -25.43	%
16009	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Mitogen-activated protein kinase 12	inhibition rate	-3.61 - -1.31	%
16010	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Ribosomal protein S6 kinase beta-1	inhibition rate	0.53 - 0.55	%
16011	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Ribosomal protein S6 kinase beta-2	inhibition rate	-3.68 - -3.19	%
16012	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase PAK 1	inhibition rate	9.09 - 12.02	%
16013	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase PAK2	inhibition rate	1.08 - 2.32	%
16014	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase PAK 3	inhibition rate	-1.24 - 0.81	%
16015	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase PAK 4	inhibition rate	-11.06 - -10.22	%
16016	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase PAK5	inhibition rate	13.23 - 14.07	%
16017	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase PAK 6	inhibition rate	23.51 - 24.82	%
16018	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	PAS domain-containing serine/threonine-protein kinase	inhibition rate	5.61 - 6.42	%
16019	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Lymphokine-activated killer T-cell-originated protein kinase	inhibition rate	1.25 - 2.19	%
16020	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Platelet-derived growth factor receptor alpha	inhibition rate	-4.48 - -2.46	%
16021	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Platelet-derived growth factor receptor beta	inhibition rate	8.17 - 10.84	%
16022	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	3-phosphoinositide-dependent protein kinase 1	inhibition rate	-0.84 - 0.05	%
16023	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Inactive tyrosine-protein kinase PEAK1	inhibition rate	5.96 - 6.76	%
16024	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	inhibition rate	18.28 - 19.07	%
16025	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	inhibition rate	12.49 - 17.98	%
16026	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase pim-1	inhibition rate	8.99 - 9.25	%
16027	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase pim-2	inhibition rate	7.58 - 8.63	%
16028	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase pim-3	inhibition rate	7.01 - 7.69	%
16029	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	cAMP-dependent protein kinase type 1	inhibition rate	9.06 - 11.34	%
16030	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	cAMP-dependent protein kinase catalytic subunit beta	inhibition rate	3.47 - 4.86	%
16031	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	cAMP-dependent protein kinase catalytic subunit gamma	inhibition rate	4.22 - 6.71	%
16032	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Protein kinase C alpha type	inhibition rate	7.34 - 8.89	%
16033	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Protein kinase C beta type (isoform Beta-I)	inhibition rate	2.62 - 2.92	%
16034	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Protein kinase C beta type (isoform Beta-II)	inhibition rate	2.31 - 5.62	%
16035	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Protein kinase C, delta	inhibition rate	5.21 - 6.63	%
16036	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Protein kinase C, epsilon	inhibition rate	3.88 - 6.17	%
16037	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Protein kinase C, eta	inhibition rate	0.82 - 1.91	%
16038	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Protein kinase C gamma type	inhibition rate	-1.46 - 1.27	%
16039	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Protein kinase C iota type	inhibition rate	-12.76 - -11.56	%
16040	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase D1	inhibition rate	-7.76 - -7.13	%
16041	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase D3	inhibition rate	7.5 - 8.24	%
16042	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Protein kinase C, theta	inhibition rate	-8.45 - -6.63	%
16043	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Protein kinase C zeta type	inhibition rate	-0.21 - 1.03	%
16044	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase D2	inhibition rate	4.46 - 5.1	%
16045	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	cGMP-dependent protein kinase 1 alpha	inhibition rate	16.98 - 18.55	%
16046	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	cGMP-dependent protein kinase 1 beta	inhibition rate	0.7 - 0.79	%
16047	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	cGMP-dependent protein kinase 2	inhibition rate	-9.21 - -2.41	%
16048	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase N1	inhibition rate	-2.4 - -1.46	%
16049	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase N2	inhibition rate	-4.07 - -3.59	%
16050	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase N3	inhibition rate	-2.92 - -1.43	%
16051	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase PLK1	inhibition rate	4.02 - 6.16	%
16052	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase PLK2	inhibition rate	-0.47 - -0.26	%
16053	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase Plk3	inhibition rate	-6.44 - -5.68	%
16054	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase Plk4	inhibition rate	1.4 - 2.69	%
16055	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	cAMP-dependent protein kinase catalytic subunit PRKX	inhibition rate	-0.54 - 1.75	%
16056	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Protein-tyrosine kinase 2-beta	inhibition rate	17.89 - 19.81	%
16057	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	RAF proto-oncogene serine/threonine-protein kinase	inhibition rate	3.22 - 3.74	%
16058	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Proto-oncogene tyrosine-protein kinase receptor Ret	inhibition rate	-14.49 - -10.67	%
16059	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Receptor-interacting serine/threonine-protein kinase 2	inhibition rate	0.22 - 3.98	%
16060	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Receptor-interacting serine/threonine-protein kinase 3	inhibition rate	-3.39 - -1.36	%
16061	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Receptor-interacting serine/threonine-protein kinase 4	inhibition rate	-1.73 - 1.9	%
16062	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Dual serine/threonine and tyrosine protein kinase	inhibition rate	-2 - -0.78	%
16063	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Rho-associated protein kinase 1	inhibition rate	4.3 - 5.13	%
16064	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Rho-associated protein kinase 2	inhibition rate	0.08 - 0.51	%
16065	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Macrophage-stimulating protein receptor	inhibition rate	-8.88 - -8.1	%
16066	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Proto-oncogene tyrosine-protein kinase ROS	inhibition rate	-2.1 - -1.05	%
16067	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Ribosomal protein S6 kinase alpha-1	inhibition rate	5.17 - 8.34	%
16068	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Ribosomal protein S6 kinase alpha-3	inhibition rate	4.91 - 7.05	%
16069	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Ribosomal protein S6 kinase alpha-2	inhibition rate	-3.88 - -1.78	%
16070	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Ribosomal protein S6 kinase alpha-6	inhibition rate	3.07 - 3.21	%
16071	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase, Sbk1	inhibition rate	-8.87 - -7.9	%
16072	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase Sgk1	inhibition rate	8.62 - 12.59	%
16073	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase Sgk2	inhibition rate	9.57 - 10.77	%
16074	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase Sgk3	inhibition rate	8.21 - 13.31	%
16075	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase SIK1	inhibition rate	1.2 - 6.37	%
16076	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase SIK2	inhibition rate	-14.7 - -5.38	%
16077	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase SIK3	inhibition rate	3.54 - 4.92	%
16078	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	STE20-like serine/threonine-protein kinase	inhibition rate	6.32 - 6.95	%
16079	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	NUAK family SNF1-like kinase 2	inhibition rate	10.5 - 12.86	%
16080	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	SNF-related serine/threonine-protein kinase	inhibition rate	-6.77 - -6.68	%
16081	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Tyrosine-protein kinase Srms	inhibition rate	14.03 - 14.82	%
16082	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	CBL-interacting serine/threonine-protein kinase 7	inhibition rate	-12.72 - -11.59	%
16083	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	SRSF protein kinase 2	inhibition rate	-1.93 - -1.51	%
16084	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Testis-specific serine/threonine-protein kinase 6	inhibition rate	5.55 - 7.65	%
16085	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase 16	inhibition rate	-21.67 - -17.38	%
16086	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Citron rho-interacting kinase	inhibition rate	-7.64 - -6.36	%
16087	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Testis-specific serine/threonine-protein kinase 1	inhibition rate	2.35 - 3.32	%
16088	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase 25	inhibition rate	2.97 - 3.91	%
16089	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase 32B	inhibition rate	-6.94 - -4.97	%
16090	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase 32C	inhibition rate	-14.48 - -10.53	%
16091	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase 33	inhibition rate	7.55 - 8.66	%
16092	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase 38	inhibition rate	-3.87 - -3.76	%
16093	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase 38-like	inhibition rate	3.07 - 3.96	%
16094	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	STE20/SPS1-related proline-alanine-rich protein kinase	inhibition rate	-1.44 - -0.68	%
16095	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Tyrosine-protein kinase SYK	inhibition rate	3.05 - 3.4	%
16096	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Mitogen-activated protein kinase kinase kinase 7	inhibition rate	-1.01 - 0.41	%
16097	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase TAO1	inhibition rate	-18.78 - -17.48	%
16098	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase TAO3	inhibition rate	-0.07 - 1.07	%
16099	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase TBK1	inhibition rate	9.08 - 11.62	%
16100	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Tyrosine-protein kinase Tec	inhibition rate	6.63 - 6.94	%
16101	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Dual specificity testis-specific protein kinase 1	inhibition rate	-12.81 - -10.19	%
16102	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Dual specificity testis-specific protein kinase 2	inhibition rate	-5.34 - -4.08	%
16103	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	TGF-beta receptor type-2	inhibition rate	-17.8 - -16.45	%
16104	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Angiopoietin-1 receptor	inhibition rate	1.05 - 1.13	%
16105	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase tousled-like 1	inhibition rate	-20.48 - -14.1	%
16106	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase TOUSLED-like 2	inhibition rate	2.54 - 3.41	%
16107	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Traf2 and NCK-interacting protein kinase	inhibition rate	20.85 - 22.5	%
16108	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	High affinity nerve growth factor receptor	inhibition rate	6.79 - 8.92	%
16109	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	BDNF/NT-3 growth factors receptor	inhibition rate	-6.78 - -2.68	%
16110	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	NT-3 growth factor receptor	inhibition rate	16.91 - 17.76	%
16111	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Testis-specific serine/threonine-protein kinase 2	inhibition rate	-6.23 - -4.88	%
16112	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Testis-specific serine/threonine-protein kinase 3	inhibition rate	5.93 - 6.56	%
16113	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Tau-tubulin kinase 1	inhibition rate	-1.17 - -0.81	%
16114	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Tau-tubulin kinase 2	inhibition rate	-12.03 - -11.6	%
16115	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Tyrosine-protein kinase TXK	inhibition rate	8.51 - 10.33	%
16116	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Leukocyte tyrosine kinase receptor	inhibition rate	9.48 - 11.92	%
16117	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Non-receptor tyrosine-protein kinase TYK2	inhibition rate	11.99 - 13.37	%
16118	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Tyrosine-protein kinase receptor TYRO3	inhibition rate	3.29 - 4.52	%
16119	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase ULK1	inhibition rate	-7.82 - -7.39	%
16120	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase ULK2	inhibition rate	-6.09 - -3.89	%
16121	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase ULK3	inhibition rate	0.26 - 0.64	%
16122	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase VRK1	inhibition rate	9.85 - 13.74	%
16123	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase VRK2	inhibition rate	-3.01 - -2.06	%
16124	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Mitosis inhibitor protein kinase wee1	inhibition rate	0.66 - 1.63	%
16125	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase WNK1	inhibition rate	9.07 - 10.39	%
16126	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase WNK2	inhibition rate	-14.82 - -14.73	%
16127	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase WNK3	inhibition rate	-0.64 - -0.34	%
16128	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Tyrosine-protein kinase yes	inhibition rate	2.01 - 2.16	%
16129	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Mitogen-activated protein kinase kinase kinase 19	inhibition rate	-2.3 - 1.69	%
16130	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Mitogen-activated protein kinase kinase kinase 20	inhibition rate	-6.56 - -6.43	%
16131	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Tyrosine-protein kinase ZAP-70	inhibition rate	2.64 - 3.74	%
16132	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Death-associated protein kinase 3	inhibition rate	-50.3 - -3.83	%
16133	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Homeodomain-interacting protein kinase 4	inhibition rate	-8.11 - -6.81	%
16134	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Mitogen-activated protein kinase kinase kinase kinase 5	inhibition rate	-3.58 - -0.46	%
16135	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase Nek11	inhibition rate	14.98 - 15.8	%
16136	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Serine/threonine-protein kinase TAO2	inhibition rate	-14.05 - -10.95	%
16137	OCCOCC1=CN(CCNC2=NON=C2\C(NO)=N\C2=CC(Br)=C(F)C=C2)N=N1	Non-receptor tyrosine-protein kinase TNK1	inhibition rate	-5.69 - -4.59	%
16138	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4[C@@H](CF)NC(=O)C5(CCCCC5)N4C3=N2)C=C1	Cyclin-A1; Cyclin-dependent kinase 2	IC50	1	nM
16139	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4[C@@H](CF)NC(=O)C5(CCCCC5)N4C3=N2)C=C1	Cyclin-dependent kinase 2; G1/S-specific cyclin-E	IC50	1	nM
16140	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4[C@@H](CF)NC(=O)C5(CCCCC5)N4C3=N2)C=C1	G1/S-specific cyclin-E; Cyclin-dependent kinase 3	IC50	6	nM
16141	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4[C@@H](CF)NC(=O)C5(CCCCC5)N4C3=N2)C=C1	Cyclin-T1; Cyclin-dependent kinase 9	IC50	11	nM
16142	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4[C@@H](CF)NC(=O)C5(CCCCC5)N4C3=N2)C=C1	Cyclin-dependent-like kinase 5	IC50	12	nM
16143	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4[C@@H](CF)NC(=O)C5(CCCCC5)N4C3=N2)C=C1	G1/S-specific cyclin-D1; Cyclin-dependent kinase 4	IC50	19	nM
16144	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4[C@@H](CF)NC(=O)C5(CCCCC5)N4C3=N2)C=C1	Cyclin-dependent kinase 1	IC50	20	nM
16145	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4[C@@H](CF)NC(=O)C5(CCCCC5)N4C3=N2)C=C1	G1/S-specific cyclin-D3; Cyclin-dependent kinase 6	IC50	45	nM
16146	NS(=O)(=O)C1=CC=C(NC2=NC=C3C=C4[C@@H](CF)NC(=O)C5(CCCCC5)N4C3=N2)C=C1	Cyclin-dependent kinase 7	IC50	682	nM
16147	CN1CCC(CC1)NS(=O)(=O)C1=CC=C(NC2=NC3=C(C=C4NC(=O)CC5(CCCCC5)N34)C=N2)C=C1	Cyclin-A1; Cyclin-dependent kinase 2	IC50	4	nM
16148	CN1CCC(CC1)NS(=O)(=O)C1=CC=C(NC2=NC3=C(C=C4NC(=O)CC5(CCCCC5)N34)C=N2)C=C1	Cyclin-dependent kinase 2; G1/S-specific cyclin-E	IC50	5	nM
16149	CN1CCC(CC1)NS(=O)(=O)C1=CC=C(NC2=NC3=C(C=C4NC(=O)CC5(CCCCC5)N34)C=N2)C=C1	Cyclin-T1; Cyclin-dependent kinase 9	IC50	5	nM
16150	CN1CCC(CC1)NS(=O)(=O)C1=CC=C(NC2=NC3=C(C=C4NC(=O)CC5(CCCCC5)N34)C=N2)C=C1	Cyclin-dependent-like kinase 5	IC50	7	nM
16151	CN1CCC(CC1)NS(=O)(=O)C1=CC=C(NC2=NC3=C(C=C4NC(=O)CC5(CCCCC5)N34)C=N2)C=C1	G1/S-specific cyclin-E; Cyclin-dependent kinase 3	IC50	23	nM
16152	CN1CCC(CC1)NS(=O)(=O)C1=CC=C(NC2=NC3=C(C=C4NC(=O)CC5(CCCCC5)N34)C=N2)C=C1	Cyclin-dependent kinase 1	IC50	31	nM
16153	CN1CCC(CC1)NS(=O)(=O)C1=CC=C(NC2=NC3=C(C=C4NC(=O)CC5(CCCCC5)N34)C=N2)C=C1	G1/S-specific cyclin-D1; Cyclin-dependent kinase 4	IC50	41	nM
16154	CN1CCC(CC1)NS(=O)(=O)C1=CC=C(NC2=NC3=C(C=C4NC(=O)CC5(CCCCC5)N34)C=N2)C=C1	G1/S-specific cyclin-D3; Cyclin-dependent kinase 6	IC50	63	nM
16155	CN1CCC(CC1)NS(=O)(=O)C1=CC=C(NC2=NC3=C(C=C4NC(=O)CC5(CCCCC5)N34)C=N2)C=C1	Cyclin-dependent kinase 7	IC50	66	nM
16156	NC(=O)C1=CC=C(NC2=NC3=C(C=C4NNC(=O)C5(CCCCC5)N34)C=N2)C=C1	Cyclin-dependent kinase 2; G1/S-specific cyclin-E	IC50	33	nM
16157	NC(=O)C1=CC=C(NC2=NC3=C(C=C4NNC(=O)C5(CCCCC5)N34)C=N2)C=C1	Cyclin-dependent-like kinase 5	IC50	78	nM
16158	NC(=O)C1=CC=C(NC2=NC3=C(C=C4NNC(=O)C5(CCCCC5)N34)C=N2)C=C1	Cyclin-A1; Cyclin-dependent kinase 2	IC50	81	nM
16159	NC(=O)C1=CC=C(NC2=NC3=C(C=C4NNC(=O)C5(CCCCC5)N34)C=N2)C=C1	G1/S-specific cyclin-E; Cyclin-dependent kinase 3	IC50	96	nM
16160	NC(=O)C1=CC=C(NC2=NC3=C(C=C4NNC(=O)C5(CCCCC5)N34)C=N2)C=C1	Cyclin-T1; Cyclin-dependent kinase 9	IC50	118	nM
16161	NC(=O)C1=CC=C(NC2=NC3=C(C=C4NNC(=O)C5(CCCCC5)N34)C=N2)C=C1	G1/S-specific cyclin-D1; Cyclin-dependent kinase 4	IC50	253	nM
16162	NC(=O)C1=CC=C(NC2=NC3=C(C=C4NNC(=O)C5(CCCCC5)N34)C=N2)C=C1	G1/S-specific cyclin-D3; Cyclin-dependent kinase 6	IC50	578	nM
16163	NC(=O)C1=CC=C(NC2=NC3=C(C=C4NNC(=O)C5(CCCCC5)N34)C=N2)C=C1	Cyclin-dependent kinase 7	IC50	579	nM
16164	NC(=O)C1=CC=C(NC2=NC3=C(C=C4NNC(=O)C5(CCCCC5)N34)C=N2)C=C1	Cyclin-dependent kinase 1	IC50	574	nM
16165	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 12	protein degradation decrease		
16166	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 12	protein degradation decrease		
16167	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 7	IC50	3000	nM
16168	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 9	IC50	3000	nM
16169	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 12	IC50	3000	nM
16170	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 1	IC50	3000	nM
16171	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 2	IC50	3000	nM
16172	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 4	IC50	3000	nM
16173	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 6	IC50	3000	nM
16174	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 13	enzyme activity decrease		
16175	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 12	protein degradation decrease		
16176	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 12	protein degradation decrease		
16177	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 7	IC50	3000	nM
16178	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 9	IC50	3000	nM
16179	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 12	IC50	3000	nM
16180	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 1	IC50	3000	nM
16181	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 2	IC50	3000	nM
16182	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 4	IC50	3000	nM
16183	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 6	IC50	3000	nM
16184	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 12; Cyclin-K	DC50 (degradation concentration)	416	nM
16185	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 12; Cyclin-K	DC50 (degradation concentration)	412	nM
16186	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 12	cell growth decrease	1.05	%
16187	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 12	cell growth decrease	6.47	%
16188	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 13	enzyme activity decrease		
16189	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 12	protein degradation decrease		
16190	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 12	protein degradation decrease		
16191	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 7	IC50	3000	nM
16192	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 9	IC50	3000	nM
16193	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 12	IC50	3000	nM
16194	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 1	IC50	3000	nM
16195	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 2	IC50	3000	nM
16196	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 4	IC50	3000	nM
16197	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 6	IC50	3000	nM
16198	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 13	enzyme activity decrease		
16199	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 12	protein degradation decrease		
16200	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 12	protein degradation decrease		
16201	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 7	IC50	3000	nM
16202	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 9	IC50	3000	nM
16203	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 12	IC50	3000	nM
16204	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 1	IC50	3000	nM
16205	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 2	IC50	3000	nM
16206	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 4	IC50	3000	nM
16207	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 6	IC50	3000	nM
16208	CC(C)N1C=NC2=C(NCC3=NC4=CC(F)=C(NCCCCCCCCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)C=C4N3)N=C(N=C12)N1CCOCC1	Cyclin-dependent kinase 13	enzyme activity decrease		
16209	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	High affinity nerve growth factor receptor	IC50	0.5	nM
16210	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	BDNF/NT-3 growth factors receptor	Ki (inhibition constant)	1	nM
16211	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	NT-3 growth factor receptor	Ki (inhibition constant)	1	nM
16212	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	High affinity nerve growth factor receptor	Ki (inhibition constant)	1	nM
16213	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	High affinity nerve growth factor receptor	IC50	1	nM
16214	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	High affinity nerve growth factor receptor	IC50	1	nM
16215	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	BDNF/NT-3 growth factors receptor	IC50	2	nM
16216	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	NT-3 growth factor receptor	IC50	2	nM
16217	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	NT-3 growth factor receptor	Ki (inhibition constant)	2	nM
16218	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	NT-3 growth factor receptor	Ki (inhibition constant)	2	nM
16219	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	NT-3 growth factor receptor	IC50	2	nM
16220	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	High affinity nerve growth factor receptor	IC50	0.002	μM
16221	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	NT-3 growth factor receptor	IC50	0.002	μM
16222	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	NT-3 growth factor receptor	phosphorylation level decrease		
16223	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1		phosphorylation level decrease		
16224	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	High affinity nerve growth factor receptor	phosphorylation level decrease		
16225	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Transcription factor ETV6;+NT-3 growth factor receptor	protein expression level decrease		
16226	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	High affinity nerve growth factor receptor	protein expression level decrease		
16227	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	High affinity nerve growth factor receptor	IC50	3	nM
16228	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	NT-3 growth factor receptor	Ki (inhibition constant)	3	nM
16229	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	BDNF/NT-3 growth factors receptor	IC50	0.003	μM
16230	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	NT-3 growth factor receptor	IC50	5	nM
16231	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	NT-3 growth factor receptor	IC50	6	nM
16232	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	BDNF/NT-3 growth factors receptor	IC50	6	nM
16233	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	NT-3 growth factor receptor	IC50	7	nM
16234	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	High affinity nerve growth factor receptor	IC50	7	nM
16235	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	High affinity nerve growth factor receptor	IC50	7	nM
16236	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	NT-3 growth factor receptor	Ki (inhibition constant)	8	nM
16237	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	NT-3 growth factor receptor	Ki (inhibition constant)	11	nM
16238	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase Mer [human]	IC50	12	nM
16239	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	High affinity nerve growth factor receptor	IC50	12	nM
16240	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Transcription factor ETV6;+NT-3 growth factor receptor	IC50	13	nM
16241	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	NT-3 growth factor receptor	IC50	15	nM
16242	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Transcription factor ETV6;+NT-3 growth factor receptor	IC50	0.015	μM
16243	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	NT-3 growth factor receptor	IC50	21	nM
16244	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	NT-3 growth factor receptor	IC50	26	nM
16245	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Transcription factor ETV6;+NT-3 growth factor receptor	percentage of cells in G0/G1 phase increase		
16246	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	High affinity nerve growth factor receptor	percentage of cells in G0/G1 phase increase		
16247	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Transcription factor ETV6;+NT-3 growth factor receptor	apoptosis rate increase		
16248	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase FRK [human]	IC50	32	nM
16249	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Ephrin type-A receptor 8 [human]	IC50	101	nM
16250	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Epithelial discoidin domain-containing receptor 1 [human]	IC50	126	nM
16251	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Mitogen-activated protein kinase kinase kinase 7 [human]	IC50	126	nM
16252	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase receptor TYRO3 [human]	IC50	138	nM
16253	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase, Fes/Fps type [human]	IC50	269	nM
16254	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1		IC50	9526	nM
16255	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	High affinity nerve growth factor receptor	protein expression level decrease		
16256	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Transcription factor ETV6;+NT-3 growth factor receptor	body weight change		
16257	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	NT-3 growth factor receptor	body weight change		
16258	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Transcription factor ETV6;+NT-3 growth factor receptor	qualitative		
16259	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	NT-3 growth factor receptor	qualitative		
16260	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1		AUC (0-t)	17941.1	ng*h/ml
16261	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1		AUC (0-t)	7084.7	ng*h/ml
16262	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1		MRT (0-24 h)	1.07	h
16263	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1		MRT (0-24 h)	2.94	h
16264	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1		tmax	0.08	h
16265	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1		tmax	2	h
16266	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1		t1/2 (drug half life)	1.5	h
16267	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1		t1/2 (drug half life)	1.78	h
16268	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1		Cmax	1800	ng/ml
16269	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1		Cmax	21265.9	ng/ml
16270	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1		CL (drug clearance)	293.5	ml/h/kg
16271	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1		CL (drug clearance)	706.9	ml/h/kg
16272	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1		F (drug bioavailability)	19.75	%
16273	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Transcription factor ETV6;+NT-3 growth factor receptor	tumor growth decrease		
16274	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	NT-3 growth factor receptor	tumor growth decrease		
16275	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Transcription factor ETV6;+NT-3 growth factor receptor	phosphorylation level decrease		
16276	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	NT-3 growth factor receptor	phosphorylation level decrease		
16277	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	eukaryotic elongation factor 2 kinase [human]	inhibition percentage	3	%
16278	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Epidermal growth factor receptor (L861Q) [human]	inhibition percentage	40	%
16279	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Ephrin type-A receptor 1 [human]	inhibition percentage	81	%
16280	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Ephrin type-A receptor 4 [human]	inhibition percentage	-2	%
16281	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Ephrin type-B receptor 3 [human]	inhibition percentage	2	%
16282	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Receptor tyrosine-protein kinase erbB-4 [human]	inhibition percentage	14	%
16283	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Fibroblast growth factor receptor 2 [human]	inhibition percentage	77	%
16284	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Fibroblast growth factor receptor 4 [human]	inhibition percentage	44	%
16285	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Receptor-type tyrosine-protein kinase FLT3 (D835Y) [human]	inhibition percentage	-12	%
16286	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Macrophage colony-stimulating factor 1 receptor [human]	inhibition percentage	71	%
16287	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Mitogen-activated protein kinase kinase kinase kinase 2 [human]	inhibition percentage	79	%
16288	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Beta-adrenergic receptor kinase 1 [human]	inhibition percentage	-9	%
16289	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	G protein-coupled receptor kinase 6 [human]	inhibition percentage	-2	%
16290	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Glycogen synthase kinase-3 beta [human]	inhibition percentage	-6	%
16291	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase HCK [human]	inhibition percentage	94	%
16292	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Homeodomain-interacting protein kinase 3 [human]	inhibition percentage	0	%
16293	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Eukaryotic translation initiation factor 2-alpha kinase 1 [human]	inhibition percentage	-10	%
16294	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Insulin-like growth factor 1 receptor [human]	inhibition percentage	2	%
16295	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Inhibitor of nuclear factor kappa-B kinase subunit epsilon [human]	inhibition percentage	4	%
16296	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase/endoribonuclease IRE1 [human]	inhibition percentage	-7	%
16297	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Interleukin-1 receptor-associated kinase 4 [human]	inhibition percentage	58	%
16298	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase JAK2 [human]	inhibition percentage	-12	%
16299	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	JNK2-alpha2 [human]	inhibition percentage	0	%
16300	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase Lck [human]	inhibition percentage	98	%
16301	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	LIM domain kinase 2 [human]	inhibition percentage	66	%
16302	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase Lyn [human]	inhibition percentage	9	%
16303	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Leukocyte tyrosine kinase receptor [human]	inhibition percentage	73	%
16304	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Mitogen-activated protein kinase 3 [human]	inhibition percentage	-12	%
16305	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Mitogen-activated protein kinase kinase kinase kinase 4 [human]	inhibition percentage	86	%
16306	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	MAP kinase-activated protein kinase 3 [human]	inhibition percentage	4	%
16307	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase MARK1 [human]	inhibition percentage	0	%
16308	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Mitogen-activated protein kinase kinase kinase 2 [human]	inhibition percentage	-3	%
16309	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Hepatocyte growth factor receptor [human]	inhibition percentage	0	%
16310	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Hepatocyte growth factor receptor [human]	inhibition percentage	-3	%
16311	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Dual specificity mitogen-activated protein kinase kinase 3 [human]	inhibition percentage	89	%
16312	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Myosin light chain kinase 3 [human]	inhibition percentage	-13	%
16313	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Mitogen-activated protein kinase kinase kinase 11 [human]	inhibition percentage	81	%
16314	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase MRCK alpha [human]	inhibition percentage	4	%
16315	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Ribosomal protein S6 kinase alpha-5 [human]	inhibition percentage	0	%
16316	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase 4 [human]	inhibition percentage	0	%
16317	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase 26 [human]	inhibition percentage	-11	%
16318	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Muscle, skeletal receptor tyrosine-protein kinase [human]	inhibition percentage	75	%
16319	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase 38-like [human]	inhibition percentage	0	%
16320	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase Nek4 [human]	inhibition percentage	89	%
16321	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase Nek7 [human]	inhibition percentage	-6	%
16322	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase Nek11 [human]	inhibition percentage	-2	%
16323	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Ribosomal protein S6 kinase beta-1 [human]	inhibition percentage	-4	%
16324	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase PAK 4 [human]	inhibition percentage	-2	%
16325	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase PAK 6 [human]	inhibition percentage	-18	%
16326	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	eukaryotic translation initiation factor 2alpha kinase [human]	inhibition percentage	92	%
16327	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Platelet-derived growth factor receptor alpha (V561D) [human]	inhibition percentage	55	%
16328	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial [human]	inhibition percentage	-5	%
16329	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform [human]	inhibition percentage	-8	%
16330	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase pim-3 [human]	inhibition percentage	-14	%
16331	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	RAC-alpha serine/threonine-protein kinase [human]	inhibition percentage	0	%
16332	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Protein kinase C alpha type [human]	inhibition percentage	18	%
16333	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Protein kinase C gamma type [human]	inhibition percentage	2	%
16334	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Protein kinase C, eta [human]	inhibition percentage	-4	%
16335	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Protein kinase C, theta [human]	inhibition percentage	6	%
16336	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase D3 [human]	inhibition percentage	-3	%
16337	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Interferon-induced, double-stranded RNA-activated protein kinase [human]	inhibition percentage	-7	%
16338	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase Plk4 [human]	inhibition percentage	-2	%
16339	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Actin-regulating kinase PRK1 [human]	inhibition percentage	-1	%
16340	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase prp4 [human]	inhibition percentage	-10	%
16341	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Proto-oncogene tyrosine-protein kinase receptor Ret [human]	inhibition percentage	71	%
16342	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Receptor-interacting serine/threonine-protein kinase 1 [human]	inhibition percentage	96	%
16343	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Rho-associated protein kinase 2 [human]	inhibition percentage	-4	%
16344	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Proto-oncogene tyrosine-protein kinase ROS [human]	inhibition percentage	64	%
16345	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Ribosomal protein S6 kinase alpha-1 [rat]	inhibition percentage	6	%
16346	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Ribosomal protein S6 kinase alpha-4 [human]	inhibition percentage	9	%
16347	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Mitogen-activated protein kinase 11 [human]	inhibition percentage	91	%
16348	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	serine/threonine-protein kinase sbk1 [human]	inhibition percentage	-11	%
16349	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase Sgk3 [human]	inhibition percentage	7	%
16350	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase SIK3 [human]	inhibition percentage	-7	%
16351	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	SNF-related serine/threonine-protein kinase [human]	inhibition percentage	-6	%
16352	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase Srms [human]	inhibition percentage	9	%
16353	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase 16 [human]	inhibition percentage	-8	%
16354	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase 32B [human]	inhibition percentage	-6	%
16355	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase SYK [human]	inhibition percentage	55	%
16356	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase TAO1 [human]	inhibition percentage	73	%
16357	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase TBK1 [human]	inhibition percentage	-7	%
16358	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	TGF-beta receptor type-2 [human]	inhibition percentage	8	%
16359	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Angiopoietin-1 receptor (Y897S) [human]	inhibition percentage	59	%
16360	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Traf2 and NCK-interacting protein kinase [human]	inhibition percentage	98	%
16361	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	BDNF/NT-3 growth factors receptor [human]	inhibition percentage	100	%
16362	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Testis-specific serine/threonine-protein kinase 2 [human]	inhibition percentage	-5	%
16363	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tau-tubulin kinase 1 [human]	inhibition percentage	3	%
16364	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase TXK [human]	inhibition percentage	-16	%
16365	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase ULK2 [human]	inhibition percentage	-2	%
16366	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase VRK2 [human]	inhibition percentage	-5	%
16367	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase WNK1 [human]	inhibition percentage	3	%
16368	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase WNK4 [human]	inhibition percentage	-12	%
16369	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase ZAP-70 [human]	inhibition percentage	-10	%
16370	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase ATR [human];+Probable serine/threonine-protein kinase atr1 [human]	inhibition percentage	5	%
16371	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform [human]	inhibition percentage	2	%
16372	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Synaptotagmin-A [mouse];+Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [mouse]	inhibition percentage	9	%
16373	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [mouse];+Phosphatidylinositol 3-kinase regulatory subunit beta [mouse]	inhibition percentage	5	%
16374	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Phosphatidylinositol 3-kinase regulatory subunit alpha [mouse];+Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E542K) [mouse]	inhibition percentage	0	%
16375	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Phosphatidylinositol 3-kinase regulatory subunit alpha [human];+Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047R) [human]	inhibition percentage	1	%
16376	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha [human]	inhibition percentage	5	%
16377	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha [human]	inhibition percentage	3	%
16378	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase Abl [human]	inhibition percentage	64	%
16379	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase Abl [human]	inhibition percentage	0	%
16380	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase Abl [human]	inhibition percentage	52	%
16381	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	ALK tyrosine kinase receptor [human]	inhibition percentage	87	%
16382	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Activin receptor type-1B [human]	inhibition percentage	0	%
16383	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	5'-AMP-activated protein kinase catalytic subunit alpha-1 [human]	inhibition percentage	0	%
16384	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Arginase [mouse]	inhibition percentage	0	%
16385	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Aurora kinase A [human]	inhibition percentage	0	%
16386	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase receptor UFO [human]	inhibition percentage	0	%
16387	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase Blk [human]	inhibition percentage	0	%
16388	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Protein-tyrosine kinase 6 [human]	inhibition percentage	56	%
16389	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase BTK [human]	inhibition percentage	0	%
16390	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase B-raf [human]	inhibition percentage	30	%
16391	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Calcium/calmodulin-dependent protein kinase type 1G [human]	inhibition percentage	-2	%
16392	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Calcium/calmodulin-dependent protein kinase type II subunit gamma [human]	inhibition percentage	0	%
16393	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Calcium/calmodulin-dependent protein kinase type IV [human]	inhibition percentage	-5	%
16394	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Cyclin-B1-1 [human];+T-cell antigen CD7 [human]	inhibition percentage	-5	%
16395	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Cyclin-dependent kinase 2 [human]; Cyclin E [human]	inhibition percentage	3	%
16396	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Cyclin-dependent kinase 5 homolog [human];+Cyclin-dependent kinase 5 activator 1, p25 [human]	inhibition percentage	4	%
16397	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	CDK-activating kinase assembly factor MAT1 [human]	inhibition percentage	-7	%
16398	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Cyclin-dependent kinase 13 [human]; Cyclin-K [human]	inhibition percentage	-19	%
16399	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Cyclin-dependent kinase 17 [human]; cyclin-y [human]	inhibition percentage	68	%
16400	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Cyclin-dependent kinase-like 2 [human]	inhibition percentage	-3	%
16401	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Transient receptor potential cation channel subfamily M member 7 [human]	inhibition percentage	-19	%
16402	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase Chk2 [human]	inhibition percentage	59	%
16403	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Casein kinase I isoform gamma-1 [human]	inhibition percentage	-2	%
16404	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	AP2-associated protein kinase 1 [human]	inhibition percentage	0	%
16405	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Casein kinase 1-like protein 1 [human]	inhibition percentage	77	%
16406	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Casein kinase II subunit alpha [human]	inhibition percentage	-2	%
16407	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Dual specificity protein kinase CLK1 [human]	inhibition percentage	-33	%
16408	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Dual specificity protein kinase CLK4 [human]	inhibition percentage	-42	%
16409	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Mast/stem cell growth factor receptor Kit (D816H) [human]	inhibition percentage	-4	%
16410	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Citron Rho-interacting kinase [human]	inhibition percentage	-13	%
16411	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase CSK [human]	inhibition percentage	76	%
16412	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase DCLK2 [human]	inhibition percentage	3	%
16413	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Discoidin domain-containing receptor 2 [human]	inhibition percentage	95	%
16414	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase 17B [human]	inhibition percentage	-20	%
16415	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Dual specificity tyrosine-phosphorylation-regulated kinase 2 [human]	inhibition percentage	-3	%
16416	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Epidermal growth factor receptor [human]	inhibition percentage	-12	%
16417	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Epidermal growth factor receptor (T790M) [human]	inhibition percentage	85	%
16418	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Ephrin type-A receptor 2 [human]	inhibition percentage	91	%
16419	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Ephrin type-A receptor 5 [human]	inhibition percentage	76	%
16420	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Ephrin type-B receptor 2 [human]	inhibition percentage	45	%
16421	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Ephrin type-B receptor 4 [human]	inhibition percentage	51	%
16422	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Focal adhesion kinase 1 [human]	inhibition percentage	94	%
16423	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Fibroblast growth factor receptor 1 [human]	inhibition percentage	93	%
16424	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Fibroblast growth factor receptor 2 (N549H) [human]	inhibition percentage	58	%
16425	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase Fgr [human]	inhibition percentage	96	%
16426	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition percentage	88	%
16427	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Macrophage colony-stimulating factor 1 receptor (Y969C) [human]	inhibition percentage	36	%
16428	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	eIF-2-alpha kinase Gcn2 [human]	inhibition percentage	-1	%
16429	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Beta-adrenergic receptor kinase 2 [human]	inhibition percentage	-1	%
16430	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Rhodopsin kinase [human]	inhibition percentage	4	%
16431	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase haspin [human]	inhibition percentage	7	%
16432	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Homeodomain-interacting protein kinase 1 [human]	inhibition percentage	83	%
16433	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Homeodomain-interacting protein kinase 4 [human]	inhibition percentage	72	%
16434	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase ICK [human]	inhibition percentage	-7	%
16435	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Inhibitor of nuclear factor kappa-B kinase subunit alpha [human]	inhibition percentage	1	%
16436	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Insulin receptor [human]	inhibition percentage	-7	%
16437	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Insulin receptor-related protein [human]	inhibition percentage	-4	%
16438	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase ITK/TSK [human]	inhibition percentage	90	%
16439	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase JAK3 [human]	inhibition percentage	2	%
16440	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Mitogen-activated protein kinase 10 [human]	inhibition percentage	8	%
16441	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase Lck [human]	inhibition percentage	79	%
16442	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase STK11 [human]	inhibition percentage	-13	%
16443	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase Lyn [mouse]	inhibition percentage	11	%
16444	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Alpha-protein kinase 3 [human]	inhibition percentage	1	%
16445	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Mitogen-activated protein kinase 3 [human]	inhibition percentage	2	%
16446	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Mitogen-activated protein kinase kinase kinase kinase 5 [human]	inhibition percentage	82	%
16447	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Mitogen-activated protein kinase kinase 1 [human]	inhibition percentage	-9	%
16448	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	MAP/microtubule affinity-regulating kinase 3 [human]	inhibition percentage	2	%
16449	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Mitogen-activated protein kinase kinase kinase 3 [human]	inhibition percentage	14	%
16450	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Hepatocyte growth factor receptor [human]	inhibition percentage	14	%
16451	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Hepatocyte growth factor receptor [human]	inhibition percentage	-20	%
16452	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Hepatocyte growth factor receptor [human]	inhibition percentage	1	%
16453	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Dual specificity mitogen-activated protein kinase kinase 4 [human]	inhibition percentage	-5	%
16454	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Mitogen-activated protein kinase kinase kinase 9 [human]	inhibition percentage	53	%
16455	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	MAP kinase-interacting serine/threonine-protein kinase 2 [human]	inhibition percentage	70	%
16456	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase MRCK beta [human]	inhibition percentage	5	%
16457	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Ribosomal protein S6 kinase alpha-4 [human]	inhibition percentage	45	%
16458	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase 3 [human]	inhibition percentage	1	%
16459	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase mTOR [human]	inhibition percentage	-1	%
16460	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Myosin light chain kinase 2, skeletal/cardiac muscle [human]	inhibition percentage	-12	%
16461	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase Nek1 [human]	inhibition percentage	-4	%
16462	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase Nek3 [human]	inhibition percentage	-4	%
16463	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase Nek9 [human]	inhibition percentage	-14	%
16464	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine kinase NLK [human]	inhibition percentage	-5	%
16465	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase PAK 1 [human]	inhibition percentage	-9	%
16466	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase PAK 3 [human]	inhibition percentage	0	%
16467	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase MARK2 [human]	inhibition percentage	-3	%
16468	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Platelet-derived growth factor receptor alpha [human]	inhibition percentage	49	%
16469	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Platelet-derived growth factor receptor beta [human]	inhibition percentage	5	%
16470	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	3-phosphoinositide-dependent protein kinase 1 [human]	inhibition percentage	-7	%
16471	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase pim-1 [human]	inhibition percentage	-4	%
16472	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	cAMP-dependent protein kinase type 1 [human]	inhibition percentage	12	%
16473	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	RAC-beta serine/threonine-protein kinase [human]	inhibition percentage	7	%
16474	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Protein kinase C beta type (isoform Beta-I) [human]	inhibition percentage	-7	%
16475	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Protein kinase C, delta [human]	inhibition percentage	-13	%
16476	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Protein kinase C iota type [human]	inhibition percentage	30	%
16477	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Protein kinase C zeta type [human]	inhibition percentage	5	%
16478	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	cGMP-dependent protein kinase, isozyme 1 alpha [human]	inhibition percentage	-17	%
16479	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase PLK1 [human]	inhibition percentage	-23	%
16480	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	MAP kinase-activated protein kinase 5 [human]	inhibition percentage	12	%
16481	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase N2 [human]	inhibition percentage	-14	%
16482	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804L) [human]	inhibition percentage	60	%
16483	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Receptor-interacting serine/threonine-protein kinase 2 [human]	inhibition percentage	64	%
16484	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Rho-associated protein kinase 2 [human]	inhibition percentage	-13	%
16485	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Ribosomal protein S6 kinase alpha-2 [human]	inhibition percentage	5	%
16486	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Mitogen-activated protein kinase 14 [human]	inhibition percentage	87	%
16487	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Mitogen-activated protein kinase 12 [human]	inhibition percentage	77	%
16488	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase Sgk1 [human]	inhibition percentage	4	%
16489	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	LRR receptor-like serine/threonine-protein kinase SIK1 [human]	inhibition percentage	-5	%
16490	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	STE20-like serine/threonine-protein kinase [human]	inhibition percentage	30	%
16491	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Neuronal proto-oncogene tyrosine-protein kinase Src [human]	inhibition percentage	98	%
16492	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	SRSF protein kinase 1 [human]	inhibition percentage	4	%
16493	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase 25 [human]	inhibition percentage	-4	%
16494	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase 32C [human]	inhibition percentage	2	%
16495	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Transcription initiation factor TFIID subunit 1-like [human]	inhibition percentage	-8	%
16496	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase TAO2 [human]	inhibition percentage	49	%
16497	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase Tec [human]	inhibition percentage	-9	%
16498	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Angiopoietin-1 receptor [human]	inhibition percentage	98	%
16499	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase tousled-like 1 [human]	inhibition percentage	-5	%
16500	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Taste receptor type 2 member 10 [human]	inhibition percentage	-13	%
16501	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	NT-3 growth factor receptor [human]	inhibition percentage	100	%
16502	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Testis-specific serine/threonine-protein kinase 3 [human]	inhibition percentage	-1	%
16503	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tau-tubulin kinase 2 [human]	inhibition percentage	-7	%
16504	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition percentage	-7	%
16505	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase ULK3 [human]	inhibition percentage	49	%
16506	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Mitosis inhibitor protein kinase wee1 [human]	inhibition percentage	-2	%
16507	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Probable serine/threonine-protein kinase WNK2 [human]	inhibition percentage	-11	%
16508	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase Yes [human]	inhibition percentage	89	%
16509	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Death-associated protein kinase 3 [human]	inhibition percentage	-3	%
16510	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	DNA-dependent protein kinase catalytic subunit [human]	inhibition percentage	7	%
16511	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [human];+Phosphatidylinositol 3-kinase regulatory subunit alpha [human]	inhibition percentage	0	%
16512	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Phosphatidylinositol 3-kinase regulatory subunit alpha [mouse];+Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545K) [mouse]	inhibition percentage	2	%
16513	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [mouse];+Phosphatidylinositol 3-kinase regulatory subunit alpha [human]	inhibition percentage	0	%
16514	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human];+Phosphatidylinositol 3-kinase regulatory subunit alpha [human]	inhibition percentage	5	%
16515	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Phosphatidylinositol 3-kinase regulatory subunit alpha [human];+Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545K) [human]	inhibition percentage	-2	%
16516	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma [human]	inhibition percentage	3	%
16517	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma [human]	inhibition percentage	-2	%
16518	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase Abl [mouse]	inhibition percentage	0	%
16519	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase Abl [human]	inhibition percentage	57	%
16520	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Activated CDC42 kinase 1 [human]	inhibition percentage	0	%
16521	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase Haspin homolog ALK1 [human]	inhibition percentage	0	%
16522	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Bone morphogenetic protein receptor type-1B [human]	inhibition percentage	0	%
16523	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	5'-AMP-activated protein kinase catalytic subunit alpha-2 [human]	inhibition percentage	0	%
16524	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	NUAK family SNF1-like kinase 1 [human]	inhibition percentage	0	%
16525	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Aurora kinase B [human]	inhibition percentage	0	%
16526	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	BMP-2-inducible protein kinase [human]	inhibition percentage	0	%
16527	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Bone morphogenetic protein receptor type-2 [human]	inhibition percentage	0	%
16528	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase BRSK1 [human]	inhibition percentage	0	%
16529	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase BTK [human]	inhibition percentage	4	%
16530	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Calcium/calmodulin-dependent protein kinase type 1 [human]	inhibition percentage	-9	%
16531	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Calcium/calmodulin-dependent protein kinase type II subunit alpha [human]	inhibition percentage	-1	%
16532	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Calcium/calmodulin-dependent protein kinase type 1D [human]	inhibition percentage	69	%
16533	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Calcium/calmodulin-dependent protein kinase kinase 1 [human]	inhibition percentage	53	%
16534	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Cyclin-B [human];+Cyclin-dependent kinase 1 [human]	inhibition percentage	4	%
16535	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Cyclin E [human]; Cyclin-dependent kinase 3 [human]	inhibition percentage	1	%
16536	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 5 homolog [human]	inhibition percentage	-2	%
16537	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Cyclin-dependent kinase 9 [human];+Cyclin-T1 [human]	inhibition percentage	-1	%
16538	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	cyclin-y [human]; Cyclin-dependent kinase 14 [human]	inhibition percentage	89	%
16539	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	cyclin-y [human]; Cyclin-dependent kinase 18 [human]	inhibition percentage	48	%
16540	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Cyclin-dependent kinase-like 3 [human]	inhibition percentage	-2	%
16541	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase Chk1 [human]	inhibition percentage	-9	%
16542	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase Chk2 [human]	inhibition percentage	72	%
16543	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Casein kinase I isoform gamma-2 [human]	inhibition percentage	1	%
16544	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Casein kinase I [human]	inhibition percentage	-21	%
16545	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Casein kinase II subunit alpha' [human]	inhibition percentage	5	%
16546	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Dual specificity protein kinase CLK2 [human]	inhibition percentage	-15	%
16547	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Mast/stem cell growth factor receptor Kit [human]	inhibition percentage	5	%
16548	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Mast/stem cell growth factor receptor Kit (V560G) [human]	inhibition percentage	83	%
16549	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Chloroplast sensor kinase, chloroplastic [human]	inhibition percentage	17	%
16550	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Death-associated protein kinase 1 [human]	inhibition percentage	-4	%
16551	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase DCLK3 [human]	inhibition percentage	15	%
16552	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Myotonin-protein kinase [human]	inhibition percentage	5	%
16553	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Dual specificity tyrosine-phosphorylation-regulated kinase 1A [human]	inhibition percentage	5	%
16554	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Dual specificity tyrosine-phosphorylation-regulated kinase 3 [human]	inhibition percentage	-4	%
16555	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Epidermal growth factor receptor (L858R) [human]	inhibition percentage	75	%
16556	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Epidermal growth factor receptor (T790M, L858R) [human]	inhibition percentage	59	%
16557	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Ephrin type-A receptor 3 [human]	inhibition percentage	82	%
16558	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Ephrin type-A receptor 7 [human]	inhibition percentage	93	%
16559	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Ephrin type-B receptor 1 [human]	inhibition percentage	78	%
16560	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Receptor tyrosine-protein kinase erbB-2 [human]	inhibition percentage	-6	%
16561	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase Fer [human]	inhibition percentage	48	%
16562	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Fibroblast growth factor receptor 1 (V561M) [human]	inhibition percentage	64	%
16563	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Fibroblast growth factor receptor 3 [human]	inhibition percentage	37	%
16564	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Vascular endothelial growth factor receptor 1 [human]	inhibition percentage	91	%
16565	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Vascular endothelial growth factor receptor 3 [human]	inhibition percentage	97	%
16566	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase Fyn [human]	inhibition percentage	94	%
16567	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	G protein-coupled receptor kinase 1 [human]	inhibition percentage	4	%
16568	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	G protein-coupled receptor kinase 5 [human]	inhibition percentage	-5	%
16569	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Glycogen synthase kinase-3 alpha [human]	inhibition percentage	42	%
16570	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase HCK [human]	inhibition percentage	97	%
16571	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Homeodomain-interacting protein kinase 2 [human]	inhibition percentage	-10	%
16572	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Mitogen-activated protein kinase kinase kinase kinase 1 [human]	inhibition percentage	72	%
16573	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Insulin-like growth factor 1 receptor [human]	inhibition percentage	-3	%
16574	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition percentage	1	%
16575	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Insulin receptor [human]	inhibition percentage	-5	%
16576	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Interleukin-1 receptor-associated kinase 1 [human]	inhibition percentage	62	%
16577	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase JAK1 [human]	inhibition percentage	46	%
16578	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Mitogen-activated protein kinase 8 (isoform 1) [human]	inhibition percentage	-26	%
16579	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Vascular endothelial growth factor receptor 2 [human]	inhibition percentage	94	%
16580	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	LIM domain kinase 1 [human]	inhibition percentage	59	%
16581	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase 10 [human]	inhibition percentage	82	%
16582	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Leucine-rich repeat serine/threonine-protein kinase 2 [human]	inhibition percentage	41	%
16583	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Mitogen-activated protein kinase 1 [human]	inhibition percentage	7	%
16584	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Mitogen-activated protein kinase kinase kinase kinase 3 [human]	inhibition percentage	-15	%
16585	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	MAP kinase-activated protein kinase 2 [human]	inhibition percentage	-18	%
16586	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Dual specificity mitogen-activated protein kinase kinase 2 [human]	inhibition percentage	44	%
16587	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	MAP/microtubule affinity-regulating kinase 4 [human]	inhibition percentage	-3	%
16588	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Maternal embryonic leucine zipper kinase [human]	inhibition percentage	3	%
16589	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Hepatocyte growth factor receptor [human]	inhibition percentage	6	%
16590	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Hepatocyte growth factor receptor [human]	inhibition percentage	23	%
16591	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Misshapen-like kinase 1 [human]	inhibition percentage	91	%
16592	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Dual specificity mitogen-activated protein kinase kinase 6 [human]	inhibition percentage	2	%
16593	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Mitogen-activated protein kinase kinase kinase 10 [human]	inhibition percentage	-2	%
16594	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	MAPK/MAK/MRK overlapping kinase [human]	inhibition percentage	-8	%
16595	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase MRCK gamma [human]	inhibition percentage	1	%
16596	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	SRSF protein kinase 3 [human]	inhibition percentage	-5	%
16597	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase 24 [human]	inhibition percentage	-5	%
16598	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase mTOR [human];+12 kDa FK506-binding protein [human]	inhibition percentage	-3	%
16599	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Myosin-IIIb [human]	inhibition percentage	-12	%
16600	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase Nek2 [human]	inhibition percentage	-5	%
16601	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase Nek6 [human]	inhibition percentage	1	%
16602	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase NIM1 [human]	inhibition percentage	-14	%
16603	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	NUAK family SNF1-like kinase 2 [human]	inhibition percentage	-6	%
16604	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	serine/threonine-protein kinase pak 2 [human]	inhibition percentage	-8	%
16605	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase PAK 4 [human]	inhibition percentage	-6	%
16606	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	PAS domain-containing serine/threonine-protein kinase [human]	inhibition percentage	-13	%
16607	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Platelet-derived growth factor receptor alpha (D842V) [human]	inhibition percentage	-2	%
16608	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial [human]	inhibition percentage	-11	%
16609	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform [human]	inhibition percentage	-11	%
16610	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase pim-2 [human]	inhibition percentage	-5	%
16611	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	cAMP-dependent protein kinase catalytic subunit beta [human]	inhibition percentage	10	%
16612	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	RAC-gamma serine/threonine-protein kinase [human]	inhibition percentage	3	%
16613	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Protein kinase C beta type (isoform Beta-II) [human]	inhibition percentage	-3	%
16614	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Protein kinase C, epsilon [human]	inhibition percentage	-1	%
16615	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase D1 [human]	inhibition percentage	-16	%
16616	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase D2 [human]	inhibition percentage	-9	%
16617	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	cGMP-dependent protein kinase, isozyme 1 beta [human]	inhibition percentage	-30	%
16618	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase Plk3 [human]	inhibition percentage	1	%
16619	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	cGMP-dependent protein kinase 2 [human]	inhibition percentage	-1	%
16620	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	cAMP-dependent protein kinase catalytic subunit PRKX [human]	inhibition percentage	-5	%
16621	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Protein-tyrosine kinase 2-beta [human]	inhibition percentage	75	%
16622	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M) [human]	inhibition percentage	51	%
16623	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Rho-associated protein kinase 1 [human]	inhibition percentage	0	%
16624	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	DNA-directed RNA polymerase subunit beta [human]	inhibition percentage	-18	%
16625	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Ribosomal protein S6 kinase alpha-1 [human]	inhibition percentage	94	%
16626	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Ribosomal protein S6 kinase alpha-3 [human]	inhibition percentage	-3	%
16627	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Mitogen-activated protein kinase 14 [human]	inhibition percentage	61	%
16628	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Mitogen-activated protein kinase 13 [human]	inhibition percentage	72	%
16629	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase Sgk2 [human]	inhibition percentage	-9	%
16630	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase SIK2 [human]	inhibition percentage	-14	%
16631	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase PLK2 [human]	inhibition percentage	4	%
16632	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Neuronal proto-oncogene tyrosine-protein kinase Src [human]	inhibition percentage	87	%
16633	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	SRSF protein kinase 2 [human]	inhibition percentage	-4	%
16634	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase 32A [human]	inhibition percentage	-12	%
16635	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase 33 [human]	inhibition percentage	-1	%
16636	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase TAO3 [human]	inhibition percentage	89	%
16637	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	TGF-beta receptor type-1 [human]	inhibition percentage	-1	%
16638	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Angiopoietin-1 receptor (R849W) [human]	inhibition percentage	97	%
16639	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase TOUSLED-like 2 [human]	inhibition percentage	3	%
16640	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	High affinity nerve growth factor receptor [human]	inhibition percentage	100	%
16641	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Testis-specific serine/threonine-protein kinase 1 [human]	inhibition percentage	13	%
16642	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Testis-specific serine/threonine-protein kinase 4 [human]	inhibition percentage	-4	%
16643	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Dual specificity protein kinase TTK [human]	inhibition percentage	-13	%
16644	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase ULK1 [human]	inhibition percentage	0	%
16645	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase VRK1 [human]	inhibition percentage	-9	%
16646	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Wee1-like protein kinase 2 [human]	inhibition percentage	-11	%
16647	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase WNK3 [human]	inhibition percentage	27	%
16648	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Mitogen-activated protein kinase kinase kinase 20 [human]	inhibition percentage	98	%
16649	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase ATM [human]	inhibition percentage	18	%
16650	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [human];+Phosphatidylinositol 3-kinase regulatory subunit alpha [human]	inhibition percentage	2	%
16651	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [mouse];+Phosphatidylinositol 3-kinase regulatory subunit alpha [mouse]	inhibition percentage	2	%
16652	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Phosphatidylinositol 3-kinase regulatory subunit alpha [mouse];+Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047R) [mouse]	inhibition percentage	-3	%
16653	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [mouse];+Phosphatidylinositol 3-kinase regulatory subunit alpha [mouse]	inhibition percentage	2	%
16654	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Phosphatidylinositol 3-kinase regulatory subunit alpha [human];+Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E542K) [human]	inhibition percentage	-1	%
16655	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Synaptotagmin-A [human];+Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human]	inhibition percentage	-1	%
16656	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [human]	inhibition percentage	1	%
16657	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase Abl [human]	inhibition percentage	58	%
16658	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase Abl [human]	inhibition percentage	56	%
16659	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Actin-related protein 2 [human]	inhibition percentage	0	%
16660	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase Haspin homolog ALK2 [human]	inhibition percentage	0	%
16661	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Arginase [human]	inhibition percentage	83	%
16662	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase A-Raf [human]	inhibition percentage	51	%
16663	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Mitogen-activated protein kinase kinase kinase 5 [human]	inhibition percentage	0	%
16664	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Aurora kinase C [human]	inhibition percentage	0	%
16665	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase Blk [human]	inhibition percentage	80	%
16666	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Cytoplasmic tyrosine-protein kinase BMX [human]	inhibition percentage	91	%
16667	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase BRSK2 [human]	inhibition percentage	-2	%
16668	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase B-raf [human]	inhibition percentage	3	%
16669	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Calcium/calmodulin-dependent protein kinase type 1B [human]	inhibition percentage	58	%
16670	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Calcium/calmodulin-dependent protein kinase type II subunit beta [human]	inhibition percentage	-13	%
16671	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Calcium/calmodulin-dependent protein kinase type II delta chain [human]	inhibition percentage	-12	%
16672	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Calcium/calmodulin-dependent protein kinase kinase 2 [human]	inhibition percentage	-15	%
16673	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Cyclin-dependent kinase 2 [human];+Cyclin-A1 [human]	inhibition percentage	-1	%
16674	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Cyclin-dependent kinase inhibitor 2A [human]; Cyclin-D3-1 [human]	inhibition percentage	27	%
16675	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Cyclin-D3-1 [human]; Cyclin-dependent kinase 6 [human]	inhibition percentage	-3	%
16676	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Cyclin-K [human]; Cyclin-dependent kinase 12 [human]	inhibition percentage	0	%
16677	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	cyclin-y [human]; Cyclin-dependent kinase 16 [human]	inhibition percentage	-17	%
16678	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Cyclin-dependent kinase-like 1 [human]	inhibition percentage	-2	%
16679	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Cyclin-dependent kinase-like 4 [human]	inhibition percentage	-7	%
16680	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase Chk2 [human]	inhibition percentage	57	%
16681	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Casein kinase I isoform epsilon [human]	inhibition percentage	70	%
16682	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Casein kinase I isoform gamma-3 [human]	inhibition percentage	9	%
16683	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Casein kinase 2 (CK2) [human]	inhibition percentage	-6	%
16684	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase 35 [human]	inhibition percentage	-7	%
16685	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Dual specificity protein kinase CLK3 [human]	inhibition percentage	1	%
16686	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Mast/stem cell growth factor receptor Kit (D816V) [human]	inhibition percentage	-3	%
16687	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Mast/stem cell growth factor receptor Kit (V654A) [human]	inhibition percentage	43	%
16688	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	RAF proto-oncogene serine/threonine-protein kinase [human]	inhibition percentage	64	%
16689	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Death-associated protein kinase 2 [human]	inhibition percentage	5	%
16690	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Serine/threonine-protein kinase 17A [human]	inhibition percentage	-8	%
16691	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Dual specificity tyrosine-phosphorylation-regulated kinase 1B [human]	inhibition percentage	-5	%
16692	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Ephrin type-A receptor 8 [human]	inhibition percentage	100	%
16693	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase, Fes/Fps type [human]	inhibition percentage	100	%
16694	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase Mer [human]	inhibition percentage	100	%
16695	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase FRK [human]	inhibition percentage	100	%
16696	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Tyrosine-protein kinase receptor TYRO3 [human]	inhibition percentage	100	%
16697	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Mitogen-activated protein kinase kinase kinase 7 [human]	inhibition percentage	100	%
16698	CC1=CC(NC(=O)NC2=CC(=NN2C2=CC=C(Cl)C=C2)C(C)(C)C)=CC=C1NC1=C2OC(C)(C)C(=O)NC2=NC=N1	Epithelial discoidin domain-containing receptor 1 [human]	inhibition percentage	99	%
16699	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Fibroblast growth factor receptor 4	IC50	56.5	nM
16700	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Fibroblast growth factor receptor 1	IC50	10000	nM
16701	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Fibroblast growth factor receptor 2	IC50	10000	nM
16702	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Fibroblast growth factor receptor 3	IC50	10000	nM
16703	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Cyclin-dependent kinase-like 2 [human]	inhibition rate	25	%
16704	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Cyclin-dependent kinase-like 3 [human]	inhibition rate	-2	%
16705	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Cyclin-dependent kinase-like 4 [human]	inhibition rate	4	%
16706	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Transient receptor potential cation channel subfamily M member 7 [human]	inhibition rate	8	%
16707	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase Chk1 [human]	inhibition rate	-7	%
16708	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase Chk2 [human]	inhibition rate	-5	%
16709	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase Chk2 (I157T) [human]	inhibition rate	-1	%
16710	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase Chk2 (R145W) [human]	inhibition rate	2	%
16711	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Casein kinase I isoform alpha [human]	inhibition rate	-7	%
16712	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Casein kinase I isoform epsilon [human]	inhibition rate	15	%
16713	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Casein kinase I isoform gamma-1 [human]	inhibition rate	3	%
16714	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Casein kinase I isoform gamma-2 [human]	inhibition rate	-11	%
16715	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Casein kinase I isoform gamma-3 [human]	inhibition rate	0	%
16716	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Casein kinase I isoform delta [human]	inhibition rate	-3	%
16717	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Casein kinase 1-like protein 1	inhibition rate	-1	%
16718	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Casein kinase 2 [human]	inhibition rate	4	%
16719	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Casein kinase II subunit alpha-1 [human]	inhibition rate	-3	%
16720	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Casein kinase II subunit alpha-1 [human]	inhibition rate	1	%
16721	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase 35 [human]	inhibition rate	13	%
16722	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Dual specificity protein kinase CLK1 [human]	inhibition rate	-8	%
16723	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Dual specificity protein kinase CLK2 [human]	inhibition rate	-9	%
16724	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Dual specificity protein kinase CLK3 [human]	inhibition rate	-13	%
16725	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Dual specificity protein kinase CLK4 [human]	inhibition rate	-8	%
16726	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	-3	%
16727	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Mast/stem cell growth factor receptor Kit (D816V) [human]	inhibition rate	0	%
16728	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Mast/stem cell growth factor receptor Kit (D816H) [human]	inhibition rate	0	%
16729	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	17	%
16730	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	5	%
16731	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Citron Rho-interacting kinase [human]	inhibition rate	-2	%
16732	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Tyrosine-protein kinase csk-1 [human]	inhibition rate	12	%
16733	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	RAF proto-oncogene serine/threonine-protein kinase [human]	inhibition rate	-6	%
16734	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Death-associated protein kinase 1 [human]	inhibition rate	-17	%
16735	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Death-associated protein kinase 2 [human]	inhibition rate	-9	%
16736	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase DCLK1 [human]	inhibition rate	1	%
16737	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase DCLK2 [human]	inhibition rate	0	%
16738	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase DCLK3 [human]	inhibition rate	17	%
16739	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Epithelial discoidin domain-containing receptor 1 [human]	inhibition rate	-1	%
16740	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Discoidin domain-containing receptor 2 [human]	inhibition rate	-5	%
16741	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Myotonin-protein kinase [human]	inhibition rate	-7	%
16742	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase 17A [human]	inhibition rate	-7	%
16743	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase 17B [human]	inhibition rate	10	%
16744	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	inhibition rate	9	%
16745	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 1B [human]	inhibition rate	-1	%
16746	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 2 [human]	inhibition rate	-6	%
16747	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 3 [human]	inhibition rate	-13	%
16748	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	eukaryotic elongation factor 2 kinase [human]	inhibition rate	3	%
16749	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	epidermal growth factor-activated receptor [human]	inhibition rate	-1	%
16750	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Epidermal growth factor receptor (L858R) [human]	inhibition rate	2	%
16751	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Epidermal growth factor receptor (L861Q) [human]	inhibition rate	23	%
16752	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Epidermal growth factor receptor (T790M) [human]	inhibition rate	-1	%
16753	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Ephrin type-A receptor 1 [human]	inhibition rate	-12	%
16754	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Ephrin type-A receptor 2 [human]	inhibition rate	-14	%
16755	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Ephrin type-A receptor 3 [human]	inhibition rate	12	%
16756	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Ephrin type-A receptor 4 [human]	inhibition rate	9	%
16757	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Ephrin type-A receptor 5 [human]	inhibition rate	4	%
16758	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Ephrin type-A receptor 7 [human]	inhibition rate	11	%
16759	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Ephrin type-A receptor 8 [human]	inhibition rate	0	%
16760	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Ephrin type-B receptor 2 [human]	inhibition rate	2	%
16761	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Ephrin type-B receptor 1 [human]	inhibition rate	-16	%
16762	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Ephrin type-B receptor 3 [human]	inhibition rate	-2	%
16763	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Ephrin type-B receptor 4 [human]	inhibition rate	2	%
16764	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Receptor tyrosine-protein kinase erbB-2 [human]	inhibition rate	-8	%
16765	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Receptor tyrosine-protein kinase erbB-4 [human]	inhibition rate	14	%
16766	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Focal adhesion kinase 1 [human]	inhibition rate	16	%
16767	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	proto-oncogene tyrosine-protein kinase FER [human]	inhibition rate	12	%
16768	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Tyrosine-protein kinase, Fes/Fps type [human]	inhibition rate	11	%
16769	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Fibroblast growth factor receptor 1 [human]	inhibition rate	-5	%
16770	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Fibroblast growth factor receptor 1 (V561M) [human]	inhibition rate	-11	%
16771	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Fibroblast growth factor receptor 2 [human]	inhibition rate	-21	%
16772	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Fibroblast growth factor receptor 2 (N549H) [human]	inhibition rate	1	%
16773	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Fibroblast growth factor receptor 3 [human]	inhibition rate	10	%
16774	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Fibroblast growth factor receptor 4 [human]	inhibition rate	59	%
16775	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Tyrosine-protein kinase Fgr [human]	inhibition rate	11	%
16776	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Vascular endothelial growth factor receptor 1 [human]	inhibition rate	7	%
16777	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Receptor-type tyrosine-protein kinase FLT3 (D835Y) [human]	inhibition rate	11	%
16778	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Vascular endothelial growth factor receptor 3 [human]	inhibition rate	10	%
16779	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Vascular endothelial growth factor receptor kdr-like [human]	inhibition rate	15	%
16780	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Macrophage colony-stimulating factor 1 receptor [human]	inhibition rate	-2	%
16781	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Macrophage colony-stimulating factor 1 receptor (Y969C) [human]	inhibition rate	13	%
16782	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Tyrosine-protein kinase Fyn [human]	inhibition rate	15	%
16783	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	glycerate 2-kinase [human]	inhibition rate	6	%
16784	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Rhodopsin kinase [human]	inhibition rate	-11	%
16785	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Beta-adrenergic receptor kinase 1 [human]	inhibition rate	-7	%
16786	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Beta-adrenergic receptor kinase 2 [human]	inhibition rate	11	%
16787	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	G protein-coupled receptor kinase 5 [human]	inhibition rate	3	%
16788	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	G protein-coupled receptor kinase 6 [human]	inhibition rate	0	%
16789	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Rhodopsin kinase [human]	inhibition rate	14	%
16790	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Glycogen synthase kinase-3 alpha [human]	inhibition rate	3	%
16791	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Glycogen synthase kinase-3 alpha [human]	inhibition rate	5	%
16792	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Putative serine/threonine-protein kinase haspin homolog [human]	inhibition rate	-1	%
16793	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Tyrosine-protein kinase HCK [human]	inhibition rate	-4	%
16794	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Homeodomain-interacting protein kinase 1 [human]	inhibition rate	-11	%
16795	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Eukaryotic translation initiation factor 2-alpha kinase 1 [human]	inhibition rate	-16	%
16796	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase ICK [human]	inhibition rate	-17	%
16797	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Insulin-like growth factor 1 receptor [human]	inhibition rate	2	%
16798	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Inhibitor of nuclear factor kappa-B kinase subunit alpha [human]	inhibition rate	6	%
16799	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition rate	-7	%
16800	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Inhibitor of nuclear factor kappa-B kinase subunit epsilon [human]	inhibition rate	6	%
16801	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Insulin receptor [human]	inhibition rate	-39	%
16802	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase/endoribonuclease IRE1 [human]	inhibition rate	23	%
16803	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Insulin receptor-related protein [human]	inhibition rate	-5	%
16804	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Interleukin-1 receptor-associated kinase 1 [human]	inhibition rate	-14	%
16805	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Interleukin-1 receptor-associated kinase 4 [human]	inhibition rate	-4	%
16806	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Tyrosine-protein kinase ITK/TSK [human]	inhibition rate	7	%
16807	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Tyrosine-protein kinase JAK1 [human]	inhibition rate	7	%
16808	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Tyrosine-protein kinase JAK3 [human]	inhibition rate	-7	%
16809	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Mitogen-activated protein kinase 8 (isoform 1) [human]	inhibition rate	14	%
16810	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	JNK2 alpha-2 [human]	inhibition rate	-11	%
16811	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Mitogen-activated protein kinase 10 [human]	inhibition rate	-16	%
16812	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Transcription factor PRE6 [human]	inhibition rate	8	%
16813	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase LATS1 [human]	inhibition rate	12	%
16814	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase LATS2 [human]	inhibition rate	-6	%
16815	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Proto-oncogene tyrosine-protein kinase LCK [human]	inhibition rate	5	%
16816	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	LIM domain kinase 1 [human]	inhibition rate	9	%
16817	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	LIM domain kinase 2 [human]	inhibition rate	5	%
16818	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase stk11 homolog [human]	inhibition rate	17	%
16819	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Coiled-coil domain-containing protein 40 [human]	inhibition rate	8	%
16820	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Tyrosine-protein kinase Lyn [human]	inhibition rate	5	%
16821	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Tyrosine-protein kinase Lyn	inhibition rate	11	%
16822	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Leucine-rich repeat serine/threonine-protein kinase 2 [human]	inhibition rate	8	%
16823	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Leukocyte tyrosine kinase receptor [human]	inhibition rate	-19	%
16824	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Alpha-protein kinase 3 [human]	inhibition rate	4	%
16825	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Mitogen-activated protein kinase 1 [human]	inhibition rate	-19	%
16826	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Mitogen-activated protein kinase 2 [human]	inhibition rate	10	%
16827	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Mitogen-activated protein kinase kinase kinase kinase 3 [human]	inhibition rate	-2	%
16828	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Mitogen-activated protein kinase kinase kinase kinase 4 [human]	inhibition rate	23	%
16829	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Mitogen-activated protein kinase kinase kinase kinase 5 [human]	inhibition rate	9	%
16830	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	MAP kinase-activated protein kinase 2 [human]	inhibition rate	-3	%
16831	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	MAP kinase-activated protein kinase 3 [human]	inhibition rate	3	%
16832	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Dual specificity mitogen-activated protein kinase kinase 1 [human]	inhibition rate	10	%
16833	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Dual specificity mitogen-activated protein kinase kinase 2 [human]	inhibition rate	2	%
16834	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase MARK1 [human]	inhibition rate	8	%
16835	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	MAP/microtubule affinity-regulating kinase 3 [human]	inhibition rate	3	%
16836	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	MAP/microtubule affinity-regulating kinase 4 [human]	inhibition rate	-2	%
16837	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Mitogen-activated protein kinase kinase kinase 2 [human]	inhibition rate	-12	%
16838	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Mitogen-activated protein kinase kinase kinase 3 [human]	inhibition rate	-2	%
16839	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Maternal embryonic leucine zipper kinase [human]	inhibition rate	16	%
16840	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Tyrosine-protein kinase Mer [human]	inhibition rate	9	%
16841	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	mesenchymal epithelial transition (MET) [human]	inhibition rate	-2	%
16842	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	mesenchymal epithelial transition (MET) [human]	inhibition rate	25	%
16843	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	mesenchymal epithelial transition (MET) [human]	inhibition rate	-2	%
16844	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	mesenchymal epithelial transition (MET) [human]	inhibition rate	21	%
16845	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	mesenchymal epithelial transition (MET) [human]	inhibition rate	16	%
16846	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	mesenchymal epithelial transition (MET) [human]	inhibition rate	18	%
16847	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	mesenchymal epithelial transition (MET) [human]	inhibition rate	18	%
16848	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Misshapen-like kinase 1 [human]	inhibition rate	13	%
16849	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Dual specificity mitogen-activated protein kinase kinase 3 [human]	inhibition rate	-6	%
16850	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Dual specificity mitogen-activated protein kinase kinase 4 [human]	inhibition rate	-10	%
16851	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Dual specificity mitogen-activated protein kinase kinase 6 [human]	inhibition rate	-3	%
16852	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Myosin light chain kinase 3 [human]	inhibition rate	6	%
16853	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Mitogen-activated protein kinase kinase kinase 9 [human]	inhibition rate	-9	%
16854	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Mitogen-activated protein kinase kinase kinase 10 [human]	inhibition rate	15	%
16855	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Mitogen-activated protein kinase kinase kinase 11 [human]	inhibition rate	14	%
16856	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Mitogen-activated protein kinase kinase kinase 21 [human]	inhibition rate	-5	%
16857	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	MAP kinase-interacting serine/threonine-protein kinase 2 [human]	inhibition rate	3	%
16858	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	MAPK/MAK/MRK overlapping kinase [human]	inhibition rate	2	%
16859	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase MRCK alpha [human]	inhibition rate	3	%
16860	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase MRCK beta [human]	inhibition rate	0	%
16861	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase MRCK gamma [human]	inhibition rate	15	%
16862	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Ribosomal protein S6 kinase alpha-5 [human]	inhibition rate	4	%
16863	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Ribosomal protein S6 kinase alpha-4 [human]	inhibition rate	-21	%
16864	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	SRSF protein kinase 3 [human]	inhibition rate	16	%
16865	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Hepatocyte growth factor-like [human]	inhibition rate	-19	%
16866	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Histone acetyltransferase mst2 [human]	inhibition rate	-1	%
16867	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase 24 [human]	inhibition rate	-7	%
16868	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase 26 [human]	inhibition rate	-4	%
16869	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase mTOR [human];+12 kDa FK506-binding protein [human]	inhibition rate	-6	%
16870	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Muscle, skeletal receptor tyrosine-protein kinase [human]	inhibition rate	-8	%
16871	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Myosin light chain kinase 2, skeletal/cardiac muscle [human]	inhibition rate	7	%
16872	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Myosin-IIIb [human]	inhibition rate	15	%
16873	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Neurogenic differentiation factor 2 [human]	inhibition rate	42	%
16874	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Probable serine/threonine-protein kinase nek1 [human]	inhibition rate	2	%
16875	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Probable serine/threonine-protein kinase nek2 [human]	inhibition rate	1	%
16876	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase Nek4 [human]	inhibition rate	20	%
16877	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Probable serine/threonine-protein kinase nek3 [human]	inhibition rate	2	%
16878	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase Nek6 [human]	inhibition rate	3	%
16879	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase Nek7 [human]	inhibition rate	-2	%
16880	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase Nek9 [human]	inhibition rate	2	%
16881	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Mitosis inducer protein kinase cdr1 [human]	inhibition rate	2	%
16882	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine kinase NLK [human]	inhibition rate	13	%
16883	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	NUAK family SNF1-like kinase 2 [human]	inhibition rate	-7	%
16884	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Oxidative stress-responsive serine-rich protein 1 [human]	inhibition rate	-4	%
16885	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Ribosomal protein S6 kinase beta-1 [human]	inhibition rate	-23	%
16886	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase PAK 1 [human]	inhibition rate	-2	%
16887	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase N2 [human]	inhibition rate	-5	%
16888	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase PAK 4 [human]	inhibition rate	1	%
16889	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	serine/threonine-protein kinase pak 5 [human]	inhibition rate	-10	%
16890	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase PAK 6 [human]	inhibition rate	-4	%
16891	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase MARK2(Par-1Balpha) [human]	inhibition rate	-7	%
16892	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	PAS domain-containing serine/threonine-protein kinase [human]	inhibition rate	0	%
16893	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	AP2-associated protein kinase 1 [human]	inhibition rate	-5	%
16894	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Platelet-derived growth factor receptor alpha [human]	inhibition rate	5	%
16895	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Platelet-derived growth factor receptor alpha (D842V) [human]	inhibition rate	6	%
16896	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Platelet-derived growth factor receptor alpha [human]	inhibition rate	2	%
16897	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Platelet-derived growth factor receptor beta [human]	inhibition rate	5	%
16898	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial [human]	inhibition rate	17	%
16899	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial [human]	inhibition rate	-2	%
16900	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	3-phosphoinositide-dependent protein kinase 1 [human]	inhibition rate	-24	%
16901	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform [human]	inhibition rate	6	%
16902	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform [human]	inhibition rate	0	%
16903	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase pim-1 [human]	inhibition rate	13	%
16904	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase pim-2 [human]	inhibition rate	24	%
16905	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase pim-3 [human]	inhibition rate	4	%
16906	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Peptidyl-lysine N-acetyltransferase PatZ [human]	inhibition rate	-4	%
16907	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	PKAC-beta [human]	inhibition rate	-3	%
16908	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	RAC-alpha serine/threonine-protein kinase [human]	inhibition rate	-15	%
16909	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	RAC-beta serine/threonine-protein kinase [human]	inhibition rate	19	%
16910	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	RAC-gamma serine/threonine-protein kinase [human]	inhibition rate	0	%
16911	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	protein kinase C binding protein [human]	inhibition rate	0	%
16912	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Protein kinase C beta type (isoform Beta-I) [human]	inhibition rate	7	%
16913	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Protein kinase C beta type (isoform Beta-II) [human]	inhibition rate	-3	%
16914	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Protein kinase C gamma type [human]	inhibition rate	11	%
16915	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Protein kinase C, epsilon [human]	inhibition rate	-4	%
16916	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Protein kinase C, eta [human]	inhibition rate	4	%
16917	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Protein kinase C, mu [human]	inhibition rate	7	%
16918	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Protein kinase C, theta [human]	inhibition rate	-11	%
16919	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Protein kinase C, zeta [human]	inhibition rate	5	%
16920	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase D2 [human]	inhibition rate	-12	%
16921	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase D3 [human]	inhibition rate	0	%
16922	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Probable serine/threonine-protein kinase fhkC [human]	inhibition rate	-5	%
16923	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Protein kinase 2 [human]	inhibition rate	11	%
16924	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Interferon-induced, double-stranded RNA-activated protein kinase [human]	inhibition rate	5	%
16925	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase PLK1 [human]	inhibition rate	3	%
16926	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase Plk3 [human]	inhibition rate	-2	%
16927	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase Plk4 [human]	inhibition rate	6	%
16928	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	MAP kinase-activated protein kinase 5 [human]	inhibition rate	-1	%
16929	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	cGMP-dependent protein kinase 2 [human]	inhibition rate	-9	%
16930	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Actin-regulating kinase PRK1 [human]	inhibition rate	2	%
16931	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase N2 [human]	inhibition rate	-6	%
16932	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	cAMP-dependent protein kinase catalytic subunit PRKX [human]	inhibition rate	-2	%
16933	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Connector enhancer of kinase suppressor of ras 3 [human]	inhibition rate	29	%
16934	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Tyrosine-protein kinase FRK [human]	inhibition rate	10	%
16935	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Protein-tyrosine kinase 2-beta [human]	inhibition rate	-5	%
16936	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Proto-oncogene tyrosine-protein kinase receptor Ret [human]	inhibition rate	-2	%
16937	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804L) [human]	inhibition rate	1	%
16938	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M) [human]	inhibition rate	3	%
16939	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Inositol-pentakisphosphate 2-kinase [human]	inhibition rate	-9	%
16940	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Receptor-interacting serine/threonine-protein kinase 2 [human]	inhibition rate	-15	%
16941	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Rho-associated protein kinase 1 [human]	inhibition rate	6	%
16942	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Rho-associated protein kinase 2 [human]	inhibition rate	21	%
16943	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Rho-associated protein kinase 2	inhibition rate	-7	%
16944	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	DNA-directed RNA polymerase subunit beta [human]	inhibition rate	-16	%
16945	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Proto-oncogene tyrosine-protein kinase ROS [human]	inhibition rate	2	%
16946	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Tyrosine-protein kinase receptor TYRO3 [human]	inhibition rate	-13	%
16947	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Ribosomal protein S6 kinase alpha-1 [human]	inhibition rate	0	%
16948	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	10	%
16949	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Ribosomal protein S6 kinase alpha-2 [human]	inhibition rate	-1	%
16950	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Ribosomal protein S6 kinase alpha-6 [human]	inhibition rate	-12	%
16951	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Mitogen-activated protein kinase 14 [human]	inhibition rate	-4	%
16952	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Mitogen-activated protein kinase 14 [human]	inhibition rate	-6	%
16953	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Mitogen-activated protein kinase 11 [human]	inhibition rate	-1	%
16954	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Mitogen-activated protein kinase 12 [human]	inhibition rate	-8	%
16955	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Mitogen-activated protein kinase 13 [human]	inhibition rate	51	%
16956	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	serine/threonine-protein kinase sbk1 [human]	inhibition rate	7	%
16957	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Kappa-stichotoxin-Sgt4a [human]	inhibition rate	2	%
16958	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase Sgk2 [human]	inhibition rate	8	%
16959	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase Sgk3 [human]	inhibition rate	-20	%
16960	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Protein-tyrosine kinase 6 [human]	inhibition rate	15	%
16961	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase SIK2 [human]	inhibition rate	-9	%
16962	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase SIK3 [human]	inhibition rate	-16	%
16963	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	STE20-like serine/threonine-protein kinase [human]	inhibition rate	7	%
16964	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase PLK2 [human]	inhibition rate	-12	%
16965	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	SNF-related serine/threonine-protein kinase [human]	inhibition rate	7	%
16966	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Neuronal proto-oncogene tyrosine-protein kinase Src [human]	inhibition rate	16	%
16967	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Neuronal proto-oncogene tyrosine-protein kinase Src [human]	inhibition rate	9	%
16968	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Tyrosine-protein kinase Srms [human]	inhibition rate	7	%
16969	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	CBL-interacting serine/threonine-protein kinase 7 [human]	inhibition rate	-4	%
16970	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	SRSF protein kinase 2 [human]	inhibition rate	-6	%
16971	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase 16 [human]	inhibition rate	-9	%
16972	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase 25 [human]	inhibition rate	10	%
16973	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase 32A [human]	inhibition rate	28	%
16974	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase 32B [human]	inhibition rate	-9	%
16975	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase 32C [human]	inhibition rate	4	%
16976	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase 33 [human]	inhibition rate	-1	%
16977	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	STE20/SPS1-related proline-alanine-rich protein kinase [human]	inhibition rate	-13	%
16978	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Tyrosine-protein kinase SYK [human]	inhibition rate	-19	%
16979	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Transcription initiation factor TFIID subunit 1-like [human]	inhibition rate	0	%
16980	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Mitogen-activated protein kinase kinase kinase 7 [human]	inhibition rate	3	%
16981	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Disease resistance protein TAO1 [human]	inhibition rate	0	%
16982	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase TAO2 [human]	inhibition rate	18	%
16983	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Cell morphogenesis protein PAG1 [human]	inhibition rate	-5	%
16984	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase TBK1 [human]	inhibition rate	-2	%
16985	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Nuclear receptor subfamily 4 group A member 3 (activated) [human]	inhibition rate	13	%
16986	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	TGF-beta receptor type-1 [human]	inhibition rate	11	%
16987	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	TGF-beta receptor type-2 [human]	inhibition rate	-5	%
16988	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Angiopoietin-1 receptor [human]	inhibition rate	53	%
16989	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Angiopoietin-1 receptor (R849W) [human]	inhibition rate	14	%
16990	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Angiopoietin-1 receptor (Y897S) [human]	inhibition rate	5	%
16991	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase tousled-like 1 [human]	inhibition rate	7	%
16992	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase TOUSLED-like 2 [human]	inhibition rate	3	%
16993	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Traf2 and NCK-interacting protein kinase [human]	inhibition rate	18	%
16994	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Agaricus bisporus lectin [human]	inhibition rate	-3	%
16995	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Taste receptor type 2 member 10 [human]	inhibition rate	-14	%
16996	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	High affinity nerve growth factor receptor [human]	inhibition rate	-27	%
16997	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	BDNF/NT-3 growth factors receptor [human]	inhibition rate	-29	%
16998	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Glutathione-regulated potassium-efflux system protein KefC [human]	inhibition rate	20	%
16999	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Testis-specific serine/threonine-protein kinase 1 [human]	inhibition rate	0	%
17000	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Testis-specific serine/threonine-protein kinase 2 [human]	inhibition rate	-3	%
17001	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Testis-specific serine/threonine-protein kinase 3 [human]	inhibition rate	16	%
17002	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Testis-specific serine/threonine-protein kinase 4 [human]	inhibition rate	8	%
17003	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Tau-tubulin kinase 1 [human]	inhibition rate	-6	%
17004	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Tau-tubulin kinase 2 [human]	inhibition rate	-2	%
17005	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	AP2-associated protein kinase 1 [mouse]	inhibition rate	-24	%
17006	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Dual specificity protein kinase TTK [human]	inhibition rate	-10	%
17007	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Tyrosine-protein kinase TXK [human]	inhibition rate	-5	%
17008	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition rate	3	%
17009	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase ULK1 [human]	inhibition rate	9	%
17010	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase ULK2 [human]	inhibition rate	16	%
17011	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase ULK3 [human]	inhibition rate	-16	%
17012	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase VRK1 [human]	inhibition rate	5	%
17013	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase VRK2 [human]	inhibition rate	-7	%
17014	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Mitosis inhibitor protein kinase wee1 [human]	inhibition rate	2	%
17015	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Wee1-like protein kinase 2 [human]	inhibition rate	11	%
17016	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	AP2-associated protein kinase 1 [human]	inhibition rate	12	%
17017	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Probable serine/threonine-protein kinase WNK1 [human]	inhibition rate	4	%
17018	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Probable serine/threonine-protein kinase WNK2 [human]	inhibition rate	14	%
17019	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Probable serine/threonine-protein kinase WNK3 [human]	inhibition rate	2	%
17020	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Probable serine/threonine-protein kinase WNK4 [human]	inhibition rate	10	%
17021	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Tyrosine-protein kinase Yes [human]	inhibition rate	5	%
17022	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Mitogen-activated protein kinase kinase kinase 20 [human]	inhibition rate	13	%
17023	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Tyrosine-protein kinase ZAP-70 [human]	inhibition rate	13	%
17024	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Death-associated protein kinase 3 [human]	inhibition rate	6	%
17025	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Myosin-1 [human]	inhibition rate	-2	%
17026	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	ATR-interacting protein [human];+Anthrax toxin receptor 1 [human]	inhibition rate	4	%
17027	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	AP2-associated protein kinase 1 [human]	inhibition rate	7	%
17028	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	DNA-dependent protein kinase catalytic subunit [human]	inhibition rate	-22	%
17029	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Phosphatidylinositol 3-kinase regulatory subunit alpha (isoform p85-alpha) [human]	inhibition rate	2	%
17030	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	1-phosphatidylinositol-3-kinase [human]	inhibition rate	7	%
17031	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [human];+Phosphatidylinositol 3-kinase regulatory subunit alpha (isoform p85-alpha) [human]	inhibition rate	6	%
17032	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform;+Phosphatidylinositol 3-kinase regulatory subunit alpha (isoform p85-alpha)	inhibition rate	1	%
17033	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase P65a;+Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition rate	-9	%
17034	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545K);+Phosphatidylinositol 3-kinase regulatory subunit alpha (isoform p85-alpha)	inhibition rate	13	%
17035	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047R);+Phosphatidylinositol 3-kinase regulatory subunit alpha (isoform p85-alpha)	inhibition rate	10	%
17036	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Probable lysine-specific histone demethylase 1;+Phosphatidylinositol 3-kinase regulatory subunit beta	inhibition rate	5	%
17037	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Probable lysine-specific histone demethylase 1;+Phosphatidylinositol 3-kinase regulatory subunit alpha (isoform p85-alpha)	inhibition rate	1	%
17038	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	AP2-associated protein kinase 1 [human]	inhibition rate	7	%
17039	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform;+Phosphatidylinositol 3-kinase regulatory subunit alpha (isoform p85-alpha)	inhibition rate	16	%
17040	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Phosphatidylinositol 3-kinase regulatory subunit alpha (isoform p85-alpha);+Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition rate	-3	%
17041	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human];+Phosphatidylinositol 3-kinase regulatory subunit alpha (isoform p85-alpha) [human]	inhibition rate	-1	%
17042	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E542K) [human];+Phosphatidylinositol 3-kinase regulatory subunit alpha (isoform p85-alpha) [human]	inhibition rate	-1	%
17043	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047R) [human];+Phosphatidylinositol 3-kinase regulatory subunit alpha (isoform p85-alpha) [human]	inhibition rate	-7	%
17044	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545K) [human];+Phosphatidylinositol 3-kinase regulatory subunit alpha (isoform p85-alpha) [human]	inhibition rate	-1	%
17045	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase P65a [human];+Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human]	inhibition rate	-4	%
17046	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	PI3KC2A [human]	inhibition rate	-1	%
17047	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	PI3KC2g [human]	inhibition rate	-4	%
17048	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	ALK tyrosine kinase receptor [human]	inhibition rate	-21	%
17049	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Agaricus bisporus lectin [human]	inhibition rate	20	%
17050	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [human]	inhibition rate	-4	%
17051	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha [human]	inhibition rate	0	%
17052	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma [human]	inhibition rate	-3	%
17053	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Calcium/calmodulin-dependent protein kinase type II subunit alpha [human]	inhibition rate	7	%
17054	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Calcium/calmodulin-dependent protein kinase type II subunit beta [human]	inhibition rate	0	%
17055	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Calcium/calmodulin-dependent protein kinase type II subunit gamma [human]	inhibition rate	-10	%
17056	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	RNase E specificity factor CsrD [human]	inhibition rate	-13	%
17057	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Epidermal growth factor receptor (L858R) [human]; Epidermal growth factor receptor (T790M) [human]	inhibition rate	2	%
17058	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	ABC transporter F family member 2 [human]	inhibition rate	26	%
17059	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Homeodomain-interacting protein kinase 2 [human]	inhibition rate	0	%
17060	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	AP2-associated protein kinase 1 [human]	inhibition rate	-3	%
17061	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Homeodomain-interacting protein kinase 3 [human]	inhibition rate	5	%
17062	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Homeodomain-interacting protein kinase 4 [human]	inhibition rate	11	%
17063	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Homeodomain-interacting protein kinase 4 [human]	inhibition rate	4	%
17064	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Nucleoprotein TPR [human]	inhibition rate	-2	%
17065	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Protein NDR1 [human]	inhibition rate	-15	%
17066	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Probable serine/threonine-protein kinase nek2 [human]	inhibition rate	1	%
17067	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	GTP:AMP phosphotransferase, mitochondrial [human]	inhibition rate	-9	%
17068	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	eukaryotic translation initiation factor 2alpha kinase [human]	inhibition rate	12	%
17069	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	protein kinase C binding protein [human]	inhibition rate	-12	%
17070	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	14 kDa zinc-binding protein [human]	inhibition rate	12	%
17071	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Activator of C kinase protein 1 [human]	inhibition rate	2	%
17072	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Ribosomal protein S6 kinase alpha-1	inhibition rate	-5	%
17073	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Tyrosine-protein kinase JAK2 [human]	inhibition rate	6	%
17074	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Mitogen-activated protein kinase 3	inhibition rate	-4	%
17075	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Tyrosine-protein kinase HCK(activated) [human]	inhibition rate	7	%
17076	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Insulin-like growth factor 1 receptor(activated) [human]	inhibition rate	19	%
17077	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Insulin receptor(activated) [human]	inhibition rate	3	%
17078	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Proto-oncogene tyrosine-protein kinase LCK(activated) [human]	inhibition rate	16	%
17079	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Actin-related protein 2 [human]	inhibition rate	-6	%
17080	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase Haspin homolog ALK1 [human]	inhibition rate	6	%
17081	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase Haspin homolog ALK2 [human]	inhibition rate	-9	%
17082	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Activin receptor type-1B [human]	inhibition rate	8	%
17083	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Bone morphogenetic protein receptor type-1B [human]	inhibition rate	-6	%
17084	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Arginase [human]	inhibition rate	-21	%
17085	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	5'-AMP-activated protein kinase catalytic subunit alpha-1 [human]	inhibition rate	-14	%
17086	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	5'-AMP-activated protein kinase catalytic subunit alpha-2 [human]	inhibition rate	-10	%
17087	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase A-Raf [human]	inhibition rate	0	%
17088	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Arginase	inhibition rate	-29	%
17089	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	NUAK family SNF1-like kinase 1 [human]	inhibition rate	-5	%
17090	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Mitogen-activated protein kinase kinase kinase 5 [human]	inhibition rate	8	%
17091	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Aurora kinase A [human]	inhibition rate	16	%
17092	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Aurora kinase B [human]	inhibition rate	11	%
17093	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Aurora kinase C [human]	inhibition rate	2	%
17094	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	NEDD8-activating enzyme E1 regulatory subunit AXL [human]	inhibition rate	10	%
17095	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	BMP-2-inducible protein kinase [human]	inhibition rate	-6	%
17096	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Tyrosine-protein kinase Blk [human]	inhibition rate	5	%
17097	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Tyrosine-protein kinase Blk	inhibition rate	2	%
17098	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Bone morphogenetic protein receptor type-2 [human]	inhibition rate	5	%
17099	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Cytoplasmic tyrosine-protein kinase BMX [human]	inhibition rate	3	%
17100	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Protein-tyrosine kinase 6 [human]	inhibition rate	-2	%
17101	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase BRSK1 [human]	inhibition rate	-13	%
17102	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase BRSK2 [human]	inhibition rate	-11	%
17103	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Tyrosine-protein kinase BTK [human]	inhibition rate	7	%
17104	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Tyrosine-protein kinase BTK (R28H) [human]	inhibition rate	7	%
17105	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase B-raf [human]	inhibition rate	13	%
17106	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Serine/threonine-protein kinase B-raf [human]	inhibition rate	19	%
17107	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Calcium/calmodulin-dependent protein kinase type 1 [human]	inhibition rate	8	%
17108	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Calcium/calmodulin-dependent protein kinase type 1B [human]	inhibition rate	2	%
17109	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Calcium/calmodulin-dependent protein kinase type 1G [human]	inhibition rate	8	%
17110	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Calcium/calmodulin-dependent protein kinase type 1D [human]	inhibition rate	38	%
17111	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Calcium/calmodulin-dependent protein kinase type II delta 1 chain [human]	inhibition rate	2	%
17112	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Calcium/calmodulin-dependent protein kinase type IV [human]	inhibition rate	-22	%
17113	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Calcium/calmodulin-dependent protein kinase kinase 1 [human]	inhibition rate	3	%
17114	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Calcium/calmodulin-dependent protein kinase kinase 2 [human]	inhibition rate	0	%
17115	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Cell division cycle 7-related protein kinase;+Cyclin-B1-1 [human]	inhibition rate	-10	%
17116	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Cyclin B [human];+Cyclin-dependent kinase 1 [human]	inhibition rate	29	%
17117	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Cyclin-dependent kinase 2 [human];+Cyclin-A1 [human]	inhibition rate	-7	%
17118	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Cyclin-dependent kinase 2 [human]; Cyclin E [human]	inhibition rate	-1	%
17119	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Cyclin E [human]; Cyclin-dependent kinase 3 [human]	inhibition rate	5	%
17120	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Cyclin-dependent kinase 4 [human]; Cyclin-D3-1 [human]	inhibition rate	-3	%
17121	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Cyclin-dependent-like kinase 5 [human];+Cyclin-dependent kinase 5 activator 1, p25 [human]	inhibition rate	2	%
17122	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Cyclin-dependent-like kinase 5 [human];+Cyclin-dependent kinase 5 activator 1, p35 [human]	inhibition rate	10	%
17123	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Cyclin-D3-1 [human]; Cyclin-dependent kinase 6 [human]	inhibition rate	-9	%
17124	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	maltose O-acetyltransferase [human];+Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	inhibition rate	10	%
17125	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Cyclin-dependent kinase 9 [human];+Cyclin-T1 [human]	inhibition rate	-6	%
17126	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Cyclin-dependent kinase 12 [human]; Cyclin-K [human]	inhibition rate	-1	%
17127	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Cyclin-K [human]; Cyclin-dependent kinase 13 [human]	inhibition rate	5	%
17128	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Cyclin-dependent kinase 14 [human]; cyclin-y [human]	inhibition rate	-7	%
17129	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	cyclin-y [human]; Cyclin-dependent kinase 16 [human]	inhibition rate	-10	%
17130	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	cyclin-y [human]; Cyclin-dependent kinase 17 [human]	inhibition rate	2	%
17131	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	cyclin-y [human]; Cyclin-dependent kinase 18 [human]	inhibition rate	-3	%
17132	COC1=CC(OC)=CC(CCC2=CN=C(NC(=O)N3CCCC4=C3N=C(C=O)C=C4)C=C2OC(C)C)=C1	Cyclin-dependent kinase-like 1 [human]	inhibition rate	4	%
17133	CC(C)C1=CC(NC2=NC=C3C=CC(=NC3=C2)[C@](C)(O)C2CCN(C)CC2)=C(F)C=C1C#N	Cyclin-dependent-like kinase 5;+Cyclin-dependent kinase 5 activator 1, p25	IC50	1	nM
17134	CC(C)C1=CC(NC2=NC=C3C=CC(=NC3=C2)[C@](C)(O)C2CCN(C)CC2)=C(F)C=C1C#N	Cyclin-dependent kinase 9;+Cyclin-T1	IC50	85	nM
17135	CC(C)C1=CC(NC2=NC=C3C=CC(=NC3=C2)[C@](C)(O)C2CCN(C)CC2)=C(F)C=C1C#N	CDK-activating kinase assembly factor MAT1;+Cyclin-H1-1;+Cyclin-dependent kinase 7	IC50	104	nM
17136	CC(C)C1=CC(NC2=NC=C3C=CC(=NC3=C2)[C@](C)(O)C2CCN(C)CC2)=C(F)C=C1C#N	Cyclin-dependent kinase 2;+Cyclin-A2	IC50	156	nM
17137	CC(C)C1=CC(NC2=NC=C3C=CC(=NC3=C2)[C@](C)(O)C2CCN(C)CC2)=C(F)C=C1C#N	Cyclin-dependent kinase 6;+Cyclin-D3-1	IC50	483	nM
17138	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4	IC50	406	nM
17139	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in G0/G1 phase	64.1	%
17140	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in G0/G1 phase	61.2	%
17141	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Receptor-type tyrosine-protein kinase FLT3	IC50	680	nM
17142	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in G0/G1 phase	53.2	%
17143	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in G0/G1 phase	66.1	%
17144	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in G0/G1 phase	64.4	%
17145	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in G0/G1 phase	64.6	%
17146	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in G0/G1 phase	60	%
17147	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in G0/G1 phase	76.3	%
17148	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in G0/G1 phase	73.7	%
17149	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in G0/G1 phase	71.6	%
17150	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in G0/G1 phase	66.3	%
17151	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in G0/G1 phase	75.1	%
17152	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in G0/G1 phase	74.6	%
17153	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in G0/G1 phase	74.6	%
17154	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	IC50	10.4	μM
17155	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	IC50	10.5	μM
17156	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in G0/G1 phase	70.9	%
17157	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in S phase	17.4	%
17158	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in S phase	19.4	%
17159	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in S phase	3.6	%
17160	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in S phase	8.5	%
17161	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in G2/M phase	10.3	%
17162	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in G2/M phase	17.5	%
17163	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in G2/M phase	22.5	%
17164	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in G2/M phase	4.2	%
17165	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in S phase	13.8	%
17166	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in S phase	15.3	%
17167	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in S phase	3.2	%
17168	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in S phase	8.4	%
17169	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in G2/M phase	17.2	%
17170	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in G2/M phase	18.4	%
17171	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in G2/M phase	4.9	%
17172	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in G2/M phase	9.1	%
17173	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in S phase	10.8	%
17174	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in S phase	11.2	%
17175	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in S phase	7	%
17176	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in S phase	9.9	%
17177	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in G2/M phase	10.6	%
17178	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in G2/M phase	18.6	%
17179	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in G2/M phase	19.8	%
17180	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in G2/M phase	22.1	%
17181	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in S phase	11.2	%
17182	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in S phase	11.3	%
17183	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in S phase	5.5	%
17184	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in S phase	8.2	%
17185	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in G2/M phase	13.8	%
17186	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in G2/M phase	18.7	%
17187	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in G2/M phase	20.7	%
17188	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in G2/M phase	7.8	%
17189	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in G0/G1 phase	10.8	%
17190	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	77	%
17191	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4	inhibition rate	93	%
17192	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	55	%
17193	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4	inhibition rate	62	%
17194	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Tyrosine-protein kinase ABL1	inhibition rate	26	%
17195	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Activin receptor type-1B	inhibition rate	-2	%
17196	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Atypical kinase COQ8A, mitochondrial	inhibition rate	-7	%
17197	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	RAC-alpha serine/threonine-protein kinase	inhibition rate	12	%
17198	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	RAC-beta serine/threonine-protein kinase	inhibition rate	11	%
17199	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	ALK tyrosine kinase receptor	inhibition rate	10	%
17200	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Aurora kinase A	inhibition rate	9	%
17201	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Aurora kinase B	inhibition rate	26	%
17202	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Tyrosine-protein kinase receptor UFO	inhibition rate	1	%
17203	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Bone morphogenetic protein receptor type-2	inhibition rate	5	%
17204	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Serine/threonine-protein kinase B-raf	inhibition rate	1	%
17205	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Tyrosine-protein kinase BTK	inhibition rate	6	%
17206	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	CDK11/Cyclin C	inhibition rate	3	%
17207	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	CDK16/cyclin Y	inhibition rate	-4	%
17208	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	CDK2/Cyclin E1	inhibition rate	-2	%
17209	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	CDK3/Cyclin E1	inhibition rate	1	%
17210	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	CDK7/cyclin H/MNAT1	inhibition rate	-8	%
17211	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	CDK9/Cyclin T1	inhibition rate	12	%
17212	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Serine/threonine-protein kinase Chk1	inhibition rate	2	%
17213	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Inhibitor of nuclear factor kappa-B kinase subunit alpha	inhibition rate	2	%
17214	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Macrophage colony-stimulating factor 1 receptor	inhibition rate	9	%
17215	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Casein kinase I isoform delta	inhibition rate	8	%
17216	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Casein kinase I isoform gamma-2	inhibition rate	5	%
17217	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Serine/threonine-protein kinase DCLK1	inhibition rate	0	%
17218	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	inhibition rate	1	%
17219	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Epidermal growth factor receptor	inhibition rate	3	%
17220	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Ephrin type-A receptor 2	inhibition rate	4	%
17221	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Receptor tyrosine-protein kinase erbB-2	inhibition rate	-12	%
17222	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Receptor tyrosine-protein kinase erbB-4	inhibition rate	4	%
17223	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Fibroblast growth factor receptor 2	inhibition rate	28	%
17224	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Fibroblast growth factor receptor 3	inhibition rate	10	%
17225	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	55	%
17226	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	tau-protein kinase	inhibition rate	14	%
17227	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	High affinity immunoglobulin gamma Fc receptor I	inhibition rate	5	%
17228	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Inhibitor of nuclear factor kappa-B kinase subunit beta	inhibition rate	34	%
17229	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Insulin receptor	inhibition rate	5	%
17230	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Tyrosine-protein kinase JAK2	inhibition rate	40	%
17231	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Tyrosine-protein kinase JAK3	inhibition rate	23	%
17232	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Vascular endothelial growth factor receptor 2	inhibition rate	14	%
17233	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mast/stem cell growth factor receptor Kit	inhibition rate	10	%
17234	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Dual specificity mitogen-activated protein kinase kinase 1	inhibition rate	-2	%
17235	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Dual specificity mitogen-activated protein kinase kinase 2	inhibition rate	3	%
17236	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase kinase kinase 9	inhibition rate	13	%
17237	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 10	inhibition rate	1	%
17238	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 11	inhibition rate	4	%
17239	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 14	inhibition rate	5	%
17240	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 3	inhibition rate	1	%
17241	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 8	inhibition rate	6	%
17242	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 9	inhibition rate	-2	%
17243	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	MAP kinase-activated protein kinase 2	inhibition rate	38	%
17244	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Serine/threonine-protein kinase MARK3	inhibition rate	5	%
17245	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Hepatocyte growth factor receptor	inhibition rate	4	%
17246	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	MAP kinase-interacting serine/threonine-protein kinase 1	inhibition rate	12	%
17247	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	MAP kinase-interacting serine/threonine-protein kinase 2	inhibition rate	62	%
17248	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	High affinity nerve growth factor receptor	inhibition rate	13	%
17249	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	NUAK family SNF1-like kinase 2	inhibition rate	-9	%
17250	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Actin-regulating kinase PRK1	inhibition rate	2	%
17251	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Serine/threonine-protein kinase PAK2/3	inhibition rate	4	%
17252	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Serine/threonine-protein kinase PAK 4	inhibition rate	4	%
17253	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Platelet-derived growth factor receptor alpha	inhibition rate	23	%
17254	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Platelet-derived growth factor receptor beta	inhibition rate	24	%
17255	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	inhibition rate	7	%
17256	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	inhibition rate	12	%
17257	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Serine/threonine-protein kinase pim-1	inhibition rate	6	%
17258	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Serine/threonine-protein kinase pim-2	inhibition rate	10	%
17259	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Serine/threonine-protein kinase pim-3	inhibition rate	1	%
17260	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Serine/threonine-protein kinase PLK1	inhibition rate	-9	%
17261	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Serine/threonine-protein kinase Plk3	inhibition rate	32	%
17262	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Serine/threonine-protein kinase Plk4	inhibition rate	3	%
17263	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	cAMP-dependent protein kinase catalytic subunit alpha	inhibition rate	1	%
17264	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Protein kinase C, epsilon	inhibition rate	3	%
17265	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Serine/threonine-protein kinase PTK2	inhibition rate	-1	%
17266	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Proto-oncogene tyrosine-protein kinase receptor Ret	inhibition rate	9	%
17267	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Rho-associated protein kinase 2	inhibition rate	8	%
17268	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Ribosomal protein S6 kinase alpha-3	inhibition rate	35	%
17269	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Proto-oncogene tyrosine-protein kinase Src	inhibition rate	11	%
17270	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Serine/threonine-protein kinase 32C	inhibition rate	4	%
17271	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Angiopoietin-1 receptor	inhibition rate	11	%
17272	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	TGF-beta receptor type-1	inhibition rate	2	%
17273	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Non-receptor tyrosine-protein kinase TYK2	inhibition rate	4	%
17274	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Serine/threonine-protein kinase ULK2	inhibition rate	4	%
17275	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Tyrosine-protein kinase ZAP-70	inhibition rate	1	%
17276	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in sub-G1 phase	17.2	%
17277	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in sub-G1 phase	5.3	%
17278	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in sub-G1 phase	5.4	%
17279	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in sub-G1 phase	7.7	%
17280	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in sub-G1 phase	17.3	%
17281	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in sub-G1 phase	4.5	%
17282	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in sub-G1 phase	4.9	%
17283	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in sub-G1 phase	6.3	%
17284	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in sub-G1 phase	12.1	%
17285	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in sub-G1 phase	4.1	%
17286	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in sub-G1 phase	4.2	%
17287	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in sub-G1 phase	6.6	%
17288	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in sub-G1 phase	11.5	%
17289	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in sub-G1 phase	2.8	%
17290	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in sub-G1 phase	3.5	%
17291	CCC1=CC=C(C=C1)N1C=NC2=CC(=CC=C12)C(=O)NC1CCCC1	Mitogen-activated protein kinase 4 [human];+Receptor-type tyrosine-protein kinase FLT3 [human]	percentage of cells in sub-G1 phase	3.9	%
17292	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Traf2 and NCK-interacting protein kinase	Ki (inhibition constant)	3	nM
17293	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Receptor-type tyrosine-protein kinase FLT3 (D835Y)	Ki (inhibition constant)	7	nM
17294	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9/Cyclin-T1	Ki (inhibition constant)	8	nM
17295	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Hepatocyte growth factor-like	Ki (inhibition constant)	9	nM
17296	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Glutathione-regulated potassium-efflux system protein KefC	Ki (inhibition constant)	10	nM
17297	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	NUAK family SNF1-like kinase 1	Ki (inhibition constant)	12	nM
17298	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD)	Ki (inhibition constant)	13	nM
17299	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Misshapen-like kinase 1	Ki (inhibition constant)	14	nM
17300	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	GI50	0.015	μM
17301	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Bifunctional protein glk	Ki (inhibition constant)	28	nM
17302	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 [human]	GI50	0.032	μM
17303	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Receptor-type tyrosine-protein kinase FLT3	Ki (inhibition constant)	46	nM
17304	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	GI50	0.07	μM
17305	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	protein expression level decrease		
17306	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	protein expression level decrease		
17307	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	protein expression level increase		
17308	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	protein expression level increase		
17309	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	protein expression level increase		
17310	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	protein expression level decrease		
17311	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	protein expression level decrease		
17312	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	protein expression level decrease		
17313	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	phosphorylation level decrease		
17314	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	phosphorylation level decrease		
17315	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	phosphorylation level decrease		
17316	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	phosphorylation level decrease		
17317	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	phosphorylation level decrease		
17318	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	GI50	0.339	μM
17319	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase inhibitor 2A	Ki (inhibition constant)	430	nM
17320	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 [human]	GI50	0.459	μM
17321	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 [human]	GI50	0.473	μM
17322	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 [human]	GI50	0.475	μM
17323	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 [human]	GI50	0.599	μM
17324	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	CDK-activating kinase assembly factor MAT1	Ki (inhibition constant)	600	nM
17325	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 [human]	GI50	0.713	μM
17326	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 1-B	Ki (inhibition constant)	1000	nM
17327	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 4/Cyclin-D1	Ki (inhibition constant)	1000	nM
17328	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 6/Cyclin-D3	Ki (inhibition constant)	1000	nM
17329	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 [human]	GI50	1.495	μM
17330	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 [human]	apoptosis rate		
17331	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1		mortality rate		
17332	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1		mortality rate		
17333	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1		observed parameter		
17334	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1		observed parameter		
17335	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	apoptosis rate	51	%
17336	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	apoptosis rate	28	%
17337	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	cells in sub-G1 phase fold increase	40	no unit
17338	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	apoptosis rate	86	%
17339	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	apoptosis rate	61	%
17340	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	cells in sub-G1 phase fold increase	40	no unit
17341	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	percentage of cells in G1 phase increase	16	%
17342	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	protein expression level decrease		
17343	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	protein expression level decrease		
17344	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	protein expression level decrease		
17345	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	phosphorylation level decrease	20	%
17346	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1		Cmax	496	ng/ml
17347	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1		Cmax	3597	ng/ml
17348	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1		tmax	1	h
17349	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1		tmax	2	h
17350	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1		AUC	1364	ng/h/ml
17351	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1		AUC	25369	ng/ml
17352	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1		AUC	906	ng/h/ml
17353	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1		t1/2 (drug half life)	0.68	h
17354	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1		t1/2 (drug half life)	1.8	h
17355	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1		t1/2 (drug half life)	6.8	h
17356	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1		CL (drug clearance)	2208	ml/h/kg
17357	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1		Vdss	1713	ml/kg
17358	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1		F (drug bioavailability)	30	%
17359	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1		F (drug bioavailability)	56	%
17360	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1		blood-to-plasma ratio	0.71	no unit
17361	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1		Papp (A-B)	6.06E-6	cm/s
17362	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1		Papp (B-A)	2.95E-5	cm/s
17363	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1		efflux ratio	4.87	no unit
17364	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1		body weight loss	15	%
17365	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1		body weight loss	15	%
17366	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1		body weight loss	15	%
17367	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	percentage tumor volume	101	%
17368	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	percentage tumor volume	102	%
17369	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	percentage tumor volume	12	%
17370	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	percentage tumor volume	12	%
17371	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	percentage tumor volume	15	%
17372	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	percentage tumor volume	16	%
17373	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	percentage tumor volume	1	%
17374	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	percentage tumor volume	1	%
17375	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	percentage tumor volume	1	%
17376	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	percentage tumor volume	22	%
17377	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	percentage tumor volume	2	%
17378	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	percentage tumor volume	2	%
17379	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	percentage tumor volume	2	%
17380	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	percentage tumor volume	32	%
17381	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	percentage tumor volume	36	%
17382	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	percentage tumor volume	3	%
17383	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	percentage tumor volume	47	%
17384	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	percentage tumor volume	4	%
17385	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	percentage tumor volume	50	%
17386	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	percentage tumor volume	5	%
17387	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	percentage tumor volume	5	%
17388	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	percentage tumor volume	5	%
17389	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	percentage tumor volume	60	%
17390	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	percentage tumor volume	66	%
17391	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	percentage tumor volume	6	%
17392	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	percentage tumor volume	75	%
17393	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	percentage tumor volume	8	%
17394	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	percentage tumor volume	9	%
17395	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	Number Of Animals With Tumor Regression	2	no unit
17396	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	Number Of Animals With Tumor Regression	7	no unit
17397	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	Number Of Animals With Tumor Regression	6	no unit
17398	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	number of animals with zero tumor volume	1	no unit
17399	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	number of animals with zero tumor volume	3	no unit
17400	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	phosphorylation level decrease		
17401	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	phosphorylation level decrease		
17402	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	phosphorylation level decrease		
17403	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	phosphorylation level decrease		
17404	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	phosphorylation level decrease		
17405	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	phosphorylation level decrease		
17406	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	protein expression level decrease		
17407	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	protein expression level decrease		
17408	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	protein expression level increase		
17409	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	protein expression level increase		
17410	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	protein expression level increase		
17411	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	protein expression level increase		
17412	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	median survival time	21	d
17413	CC1=C(N=C(NC2CCC(N)CC2)N=C1)C1=CN=C2C=CC(=CN12)C1=CC=CC=C1	Cyclin-dependent kinase 9 [human]; Receptor-type tyrosine-protein kinase FLT3 internal tandem duplication (FLT3-ITD) [human]	median survival time	27	d
17414	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Cyclin-dependent kinase 5 activator 1, p25 [human]; Cyclin-dependent-like kinase 5 [human]	inhibition rate		
17415	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Cyclin-dependent-like kinase 5 [human]; Cyclin-dependent kinase 5 activator 1 [human]	inhibition rate		
17416	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Cyclin-D3-1 [human]; Cyclin-dependent kinase 6 [human]	inhibition rate		
17417	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human];+Cyclin-dependent kinase 7 [human]	inhibition rate		
17418	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Cyclin-dependent kinase 9 [human];+Cyclin-T1 [human]	inhibition rate		
17419	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Cyclin-dependent kinase 12 [human]; Cyclin-K [human]	inhibition rate		
17420	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Cyclin-K [human]; Cyclin-dependent kinase 13 [human]	inhibition rate		
17421	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Cyclin-dependent kinase 14 [human]; cyclin-y [human]	inhibition rate		
17422	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	cyclin-y [human]; Cyclin-dependent kinase 18 [human]	inhibition rate		
17423	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Cyclin-dependent kinase-like 1 [human]	inhibition rate		
17424	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Cyclin-dependent kinase-like 2 [human]	inhibition rate		
17425	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Cyclin-dependent kinase-like 3 [human]	inhibition rate		
17426	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Cyclin-dependent kinase-like 4 [human]	inhibition rate		
17427	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Transient receptor potential cation channel subfamily M member 7 [human]	inhibition rate		
17428	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase Chk1 [human]	inhibition rate		
17429	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase Chk2 [human]	inhibition rate		
17430	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase Chk2 (I157T) [human]	inhibition rate		
17431	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase Chk2 (R145W) [human]	inhibition rate		
17432	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Casein kinase I isoform gamma-1 [human]	inhibition rate		
17433	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Casein kinase I isoform gamma-2 [human]	inhibition rate		
17434	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Casein kinase I isoform gamma-3 [human]	inhibition rate		
17435	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Casein kinase I isoform delta [human]	inhibition rate		
17436	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Casein kinase II subunit alpha-1 [human]	inhibition rate		
17437	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Casein kinase II subunit alpha-2 [human]	inhibition rate		
17438	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase 35 [human]	inhibition rate		
17439	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Dual specificity protein kinase CLK1 [human]	inhibition rate		
17440	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Dual specificity protein kinase CLK2 [human]	inhibition rate		
17441	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Dual specificity protein kinase CLK3 [human]	inhibition rate		
17442	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Dual specificity protein kinase CLK4 [human]	inhibition rate		
17443	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Mast/stem cell growth factor receptor Kit [human]	inhibition rate		
17444	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Mast/stem cell growth factor receptor Kit (D816V) [human]	inhibition rate		
17445	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Mast/stem cell growth factor receptor Kit (D816H) [human]	inhibition rate		
17446	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Mast/stem cell growth factor receptor Kit (V560G) [human]	inhibition rate		
17447	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Polyphosphoinositide phosphatase (V654A) [human]	inhibition rate		
17448	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase CSK [human]	inhibition rate		
17449	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	RAF proto-oncogene serine/threonine-protein kinase [human]	inhibition rate		
17450	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Proto-oncogene tyrosine-protein kinase Src [human]	inhibition rate		
17451	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Death-associated protein kinase 1 [human]	inhibition rate		
17452	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Death-associated protein kinase 2 [human]	inhibition rate		
17453	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase DCLK2 [human]	inhibition rate		
17454	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase DCLK3 [human]	inhibition rate		
17455	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Epithelial discoidin domain-containing receptor 1 [human]	inhibition rate		
17456	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Discoidin domain-containing receptor 2 [human]	inhibition rate		
17457	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Myotonin-protein kinase [human]	inhibition rate		
17458	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase 17A [human]	inhibition rate		
17459	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase 17B [human]	inhibition rate		
17460	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	inhibition rate		
17461	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Dual specificity tyrosine-phosphorylation-regulated kinase 1B [human]	inhibition rate		
17462	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Dual specificity tyrosine-phosphorylation-regulated kinase 2 [human]	inhibition rate		
17463	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Dual specificity tyrosine-phosphorylation-regulated kinase 3 [human]	inhibition rate		
17464	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	eukaryotic elongation factor 2 kinase [human]	inhibition rate		
17465	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Epidermal growth factor receptor [human]	inhibition rate		
17466	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Epidermal growth factor receptor (L858R) [human]	inhibition rate		
17467	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Epidermal growth factor receptor (L861Q) [human]	inhibition rate		
17468	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Epidermal growth factor receptor (T790M) [human]	inhibition rate		
17469	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Epidermal growth factor receptor (T790M,L858R) [human]	inhibition rate		
17470	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Ephrin type-A receptor 1 [human]	inhibition rate		
17471	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Ephrin type-A receptor 2 [human]	inhibition rate		
17472	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Ephrin type-A receptor 3 [human]	inhibition rate		
17473	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Ephrin type-A receptor 4 [human]	inhibition rate		
17474	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Ephrin type-A receptor 5 [human]	inhibition rate		
17475	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Ephrin type-A receptor 7 [human]	inhibition rate		
17476	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Ephrin type-A receptor 8 [human]	inhibition rate		
17477	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Ephrin type-B receptor 2 [human]	inhibition rate		
17478	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Ephrin type-B receptor 1 [human]	inhibition rate		
17479	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Ephrin type-B receptor 3 [human]	inhibition rate		
17480	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Ephrin type-B receptor 4 [human]	inhibition rate		
17481	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase PTK2 [human]	inhibition rate		
17482	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase Fer [human]	inhibition rate		
17483	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase, Fes/Fps type [human]	inhibition rate		
17484	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Fibroblast growth factor receptor 1 [human]	inhibition rate		
17485	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Fibroblast growth factor receptor 1 (V561M) [human]	inhibition rate		
17486	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Fibroblast growth factor receptor 2 [human]	inhibition rate		
17487	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Fibroblast growth factor receptor 2 (N549H) [human]	inhibition rate		
17488	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Fibroblast growth factor receptor 3 [human]	inhibition rate		
17489	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Fibroblast growth factor receptor 4 [human]	inhibition rate		
17490	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase Fgr [human]	inhibition rate		
17491	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Receptor-type tyrosine-protein kinase FLT3 (D835Y) [human]	inhibition rate		
17492	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate		
17493	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Vascular endothelial growth factor receptor 3 [human]	inhibition rate		
17494	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Macrophage colony-stimulating factor 1 receptor [human]	inhibition rate		
17495	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Macrophage colony-stimulating factor 1 receptor (Y969C) [human]	inhibition rate		
17496	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase Fyn [human]	inhibition rate		
17497	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Mitogen-activated protein kinase kinase kinase kinase 2 [human]	inhibition rate		
17498	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	eIF-2-alpha kinase Gcn2 [human]	inhibition rate		
17499	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Rhodopsin kinase [human]	inhibition rate		
17500	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Beta-adrenergic receptor kinase 1 [human]	inhibition rate		
17501	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Beta-adrenergic receptor kinase 2 [human]	inhibition rate		
17502	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	G protein-coupled receptor kinase 5 [human]	inhibition rate		
17503	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	G protein-coupled receptor kinase 6 [human]	inhibition rate		
17504	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Rhodopsin kinase [human]	inhibition rate		
17505	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Glycogen synthase kinase-3 alpha [human]	inhibition rate		
17506	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	glycogen synthase kinase-3 beta [human]	inhibition rate		
17507	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase haspin [human]	inhibition rate		
17508	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase HCK [human]	inhibition rate		
17509	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase HCK [human]	inhibition rate		
17510	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Homeodomain-interacting protein kinase 1 [human]	inhibition rate		
17511	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Homeodomain-interacting protein kinase 2 [human]	inhibition rate		
17512	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Homeodomain-interacting protein kinase 3 [human]	inhibition rate		
17513	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Homeodomain-interacting protein kinase 4 [human]	inhibition rate		
17514	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Homeodomain-interacting protein kinase 1 [human]	inhibition rate		
17515	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Eukaryotic translation initiation factor 2-alpha kinase 1 [human]	inhibition rate		
17516	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase ICK [human]	inhibition rate		
17517	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Insulin-like growth factor 1 receptor [human]	inhibition rate		
17518	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Insulin-like growth factor 1 receptor [human]	inhibition rate		
17519	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Inhibitor of nuclear factor kappa-B kinase subunit alpha [human]	inhibition rate		
17520	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition rate		
17521	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Inhibitor of nuclear factor kappa-B kinase subunit epsilon [human]	inhibition rate		
17522	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Insulin receptor [human]	inhibition rate		
17523	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Insulin receptor [human]	inhibition rate		
17524	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase/endoribonuclease IRE1 [human]	inhibition rate		
17525	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Insulin receptor-related protein [human]	inhibition rate		
17526	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Interleukin-1 receptor-associated kinase 1 [human]	inhibition rate		
17527	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Interleukin-1 receptor-associated kinase 4 [human]	inhibition rate		
17528	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase ITK/TSK [human]	inhibition rate		
17529	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase JAK1 [human]	inhibition rate		
17530	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase JAK2 [human]	inhibition rate		
17531	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase JAK3 [human]	inhibition rate		
17532	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Mitogen-activated protein kinase 8 [human]	inhibition rate		
17533	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Mitogen-activated protein kinase 9 [human]	inhibition rate		
17534	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Mitogen-activated protein kinase 10 [human]	inhibition rate		
17535	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Vascular endothelial growth factor receptor 2 [human]	inhibition rate		
17536	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Proto-oncogene tyrosine-protein kinase LCK [human]	inhibition rate		
17537	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Proto-oncogene tyrosine-protein kinase LCK [human]	inhibition rate		
17538	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	LIM domain kinase 1 [human]	inhibition rate		
17539	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	LIM domain kinase 2 [human]	inhibition rate		
17540	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase STK11 [human]	inhibition rate		
17541	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase 10 [human]	inhibition rate		
17542	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase Lyn [human]	inhibition rate		
17543	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Leucine-rich repeat serine/threonine-protein kinase 2 [human]	inhibition rate		
17544	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Leukocyte tyrosine kinase receptor [human]	inhibition rate		
17545	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase MAK [human]	inhibition rate		
17546	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Mitogen-activated protein kinase 1 [human]	inhibition rate		
17547	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Mitogen-activated protein kinase 3 [human]	inhibition rate		
17548	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Mitogen-activated protein kinase kinase kinase kinase 3 [human]	inhibition rate		
17549	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Mitogen-activated protein kinase kinase kinase kinase 4 [human]	inhibition rate		
17550	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Mitogen-activated protein kinase kinase kinase kinase 5 [human]	inhibition rate		
17551	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	MAP kinase-activated protein kinase 2 [human]	inhibition rate		
17552	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	MAP kinase-activated protein kinase 3 [human]	inhibition rate		
17553	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Dual specificity mitogen-activated protein kinase kinase 1 [human]	inhibition rate		
17554	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Dual specificity mitogen-activated protein kinase kinase 2 [human]	inhibition rate		
17555	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase MARK1 [human]	inhibition rate		
17556	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	MAP/microtubule affinity-regulating kinase 3 [human]	inhibition rate		
17557	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	MAP/microtubule affinity-regulating kinase 4 [human]	inhibition rate		
17558	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Mitogen-activated protein kinase kinase kinase 2 [human]	inhibition rate		
17559	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Mitogen-activated protein kinase kinase kinase 3 [human]	inhibition rate		
17560	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Maternal embryonic leucine zipper kinase [human]	inhibition rate		
17561	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase Mer [human]	inhibition rate		
17562	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Hepatocyte growth factor receptor [human]	inhibition rate		
17563	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Hepatocyte growth factor receptor (D1246H) [human]	inhibition rate		
17564	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Hepatocyte growth factor receptor (D1246N) [human]	inhibition rate		
17565	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Hepatocyte growth factor receptor (M1268T) [human]	inhibition rate		
17566	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Hepatocyte growth factor receptor (Y1248C) [human]	inhibition rate		
17567	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Hepatocyte growth factor receptor (Y1248D) [human]	inhibition rate		
17568	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Hepatocyte growth factor receptor (Y1248H) [human]	inhibition rate		
17569	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Misshapen-like kinase 1 [human]	inhibition rate		
17570	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Dual specificity mitogen-activated protein kinase kinase 3 [human]	inhibition rate		
17571	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Dual specificity mitogen-activated protein kinase kinase 6 [human]	inhibition rate		
17572	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Dual specificity mitogen-activated protein kinase kinase 7 [human]	inhibition rate		
17573	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Myosin light chain kinase 3 [human]	inhibition rate		
17574	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Mitogen-activated protein kinase kinase kinase 9 [human]	inhibition rate		
17575	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Mitogen-activated protein kinase kinase kinase 10 [human]	inhibition rate		
17576	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Mitogen-activated protein kinase kinase kinase 11 [human]	inhibition rate		
17577	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	MAP kinase-interacting serine/threonine-protein kinase 2 [human]	inhibition rate		
17578	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	MAPK/MAK/MRK overlapping kinase [human]	inhibition rate		
17579	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase MRCK alpha [human]	inhibition rate		
17580	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase MRCK beta [human]	inhibition rate		
17581	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Ribosomal protein S6 kinase alpha-5 [human]	inhibition rate		
17582	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Ribosomal protein S6 kinase alpha-4 [human]	inhibition rate		
17583	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	SRSF protein kinase 3 [human]	inhibition rate		
17584	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase 4 [human]	inhibition rate		
17585	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase 3 [human]	inhibition rate		
17586	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase 24 [human]	inhibition rate		
17587	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase 26 [human]	inhibition rate		
17588	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase mTOR [human]	inhibition rate		
17589	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase mTOR [human]; 12 kDa FK506-binding protein [human]	inhibition rate		
17590	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Muscle, skeletal receptor tyrosine-protein kinase [human]	inhibition rate		
17591	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Myosin light chain kinase 2, skeletal/cardiac muscle [human]	inhibition rate		
17592	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Myosin-IIIb [human]	inhibition rate		
17593	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase 38-like [human]	inhibition rate		
17594	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase Nek1 [human]	inhibition rate		
17595	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase Nek2 [human]	inhibition rate		
17596	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase Nek4 [human]	inhibition rate		
17597	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase Nek3 [human]	inhibition rate		
17598	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase Nek6 [human]	inhibition rate		
17599	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase Nek7 [human]	inhibition rate		
17600	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase Nek9 [human]	inhibition rate		
17601	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase NIM1 [human]	inhibition rate		
17602	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase Nek11 [human]	inhibition rate		
17603	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine kinase NLK [human]	inhibition rate		
17604	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	NUAK family SNF1-like kinase 2 [human]	inhibition rate		
17605	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Ribosomal protein S6 kinase beta-1 [human]	inhibition rate		
17606	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase PAK 1 [human]	inhibition rate		
17607	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase PAK2/3 [human]	inhibition rate		
17608	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase PAK 4 [human]	inhibition rate		
17609	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase PAK 3 [human]	inhibition rate		
17610	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	serine/threonine-protein kinase pak 5 [human]	inhibition rate		
17611	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase PAK 6 [human]	inhibition rate		
17612	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase MARK2 [human]	inhibition rate		
17613	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	PAS domain-containing serine/threonine-protein kinase [human]	inhibition rate		
17614	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Eukaryotic translation initiation factor 2-alpha kinase [human]	inhibition rate		
17615	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Platelet-derived growth factor receptor alpha [human]	inhibition rate		
17616	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Platelet-derived growth factor receptor alpha (D842V) [human]	inhibition rate		
17617	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Platelet-derived growth factor receptor alpha (V561D) [human]	inhibition rate		
17618	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Platelet-derived growth factor receptor beta [human]	inhibition rate		
17619	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial [human]	inhibition rate		
17620	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial [human]	inhibition rate		
17621	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	3-phosphoinositide-dependent protein kinase 1 [human]	inhibition rate		
17622	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform [human]	inhibition rate		
17623	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform [human]	inhibition rate		
17624	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase pim-1 [human]	inhibition rate		
17625	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase pim-2 [human]	inhibition rate		
17626	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase pim-3 [human]	inhibition rate		
17627	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	cAMP-dependent protein kinase catalytic subunit alpha [human]	inhibition rate		
17628	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	cAMP-dependent protein kinase catalytic subunit beta [human]	inhibition rate		
17629	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Protein kinase B alpha, catalytic domain [human]	inhibition rate		
17630	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Protein Kinase B beta, catalytic domain [human]	inhibition rate		
17631	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Protein kinase B gamma, catalytic domain [human]	inhibition rate		
17632	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Protein kinase C alpha type [human]	inhibition rate		
17633	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Protein kinase C beta type (isoform Beta-I) [human]	inhibition rate		
17634	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Protein kinase C beta type (isoform Beta-II) [human]	inhibition rate		
17635	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Protein kinase C gamma type [human]	inhibition rate		
17636	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Protein kinase C, delta [human]	inhibition rate		
17637	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Protein kinase C, epsilon [human]	inhibition rate		
17638	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Protein kinase C, eta [human]	inhibition rate		
17639	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Protein kinase C iota type [human]	inhibition rate		
17640	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase D1 [human]	inhibition rate		
17641	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Protein kinase C, theta [human]	inhibition rate		
17642	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Protein kinase C zeta type [human]	inhibition rate		
17643	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase D2 [human]	inhibition rate		
17644	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase D3 [human]	inhibition rate		
17645	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	cGMP-dependent protein kinase 1 [human]	inhibition rate		
17646	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Interferon-induced, double-stranded RNA-activated protein kinase [human]	inhibition rate		
17647	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase PLK1 [human]	inhibition rate		
17648	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase Plk3 [human]	inhibition rate		
17649	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase Plk4 [human]	inhibition rate		
17650	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	MAP kinase-activated protein kinase 5 [human]	inhibition rate		
17651	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	cGMP-dependent protein kinase 2 [human]	inhibition rate		
17652	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase N1 [human]	inhibition rate		
17653	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase N2 [human]	inhibition rate		
17654	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	cAMP-dependent protein kinase catalytic subunit PRKX [human]	inhibition rate		
17655	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase prp4 [human]	inhibition rate		
17656	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase FRK [human]	inhibition rate		
17657	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Protein-tyrosine kinase 2-beta [human]	inhibition rate		
17658	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Proto-oncogene tyrosine-protein kinase receptor Ret [human]	inhibition rate		
17659	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Proto-oncogene tyrosine-protein kinase receptor Ret (V804L) [human]	inhibition rate		
17660	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M) [human]	inhibition rate		
17661	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Receptor-interacting serine/threonine-protein kinase 1 [human]	inhibition rate		
17662	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Receptor-interacting serine/threonine-protein kinase 2 [human]	inhibition rate		
17663	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Rho-associated protein kinase 1 [human]	inhibition rate		
17664	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Rho-associated protein kinase 2 [human]	inhibition rate		
17665	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Macrophage-stimulating protein receptor [human]	inhibition rate		
17666	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Proto-oncogene tyrosine-protein kinase ROS [human]	inhibition rate		
17667	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase receptor TYRO3 [human]	inhibition rate		
17668	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Ribosomal protein S6 kinase alpha-1 [human]	inhibition rate		
17669	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate		
17670	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Ribosomal protein S6 kinase alpha-2 [human]	inhibition rate		
17671	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Ribosomal protein S6 kinase alpha-6 [human]	inhibition rate		
17672	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Mitogen-activated protein kinase 14 [human]	inhibition rate		
17673	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Mitogen-activated protein kinase 14 (T106M) [human]	inhibition rate		
17674	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Mitogen-activated protein kinase 11 [human]	inhibition rate		
17675	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase SAPK3 [human]	inhibition rate		
17676	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase SAPK4 [human]	inhibition rate		
17677	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	serine/threonine-protein kinase sbk1 [human]	inhibition rate		
17678	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase Sgk1 [human]	inhibition rate		
17679	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase Sgk2 [human]	inhibition rate		
17680	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase Sgk3 [human]	inhibition rate		
17681	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase SIK1 [human]	inhibition rate		
17682	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase SIK2 [human]	inhibition rate		
17683	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase SIK3 [human]	inhibition rate		
17684	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase 16 [human]	inhibition rate		
17685	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase 25 [human]	inhibition rate		
17686	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase 32A [human]	inhibition rate		
17687	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase 32B [human]	inhibition rate		
17688	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase 32C [human]	inhibition rate		
17689	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase 33 [human]	inhibition rate		
17690	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase SYK [human]	inhibition rate		
17691	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Transcription initiation factor TFIID subunit 1-like [human]	inhibition rate		
17692	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Mitogen-activated protein kinase kinase kinase 7 [human]	inhibition rate		
17693	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase TAO1 [human]	inhibition rate		
17694	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase TAO2 [human]	inhibition rate		
17695	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase TAO3 [human]	inhibition rate		
17696	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase TBK1 [human]	inhibition rate		
17697	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	TGF-beta receptor type-1 [human]	inhibition rate		
17698	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	TGF-beta receptor type-2 [human]	inhibition rate		
17699	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase receptor Tie-2 [human]	inhibition rate		
17700	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase receptor Tie-2 (R849W) [human]	inhibition rate		
17701	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase receptor Tie-2 (Y897S) [human]	inhibition rate		
17702	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase tousled-like 1 [human]	inhibition rate		
17703	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase TOUSLED-like 2 [human]	inhibition rate		
17704	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Traf2 and NCK-interacting protein kinase [human]	inhibition rate		
17705	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Taste receptor type 2 member 10 [human]	inhibition rate		
17706	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	High affinity nerve growth factor receptor [human]	inhibition rate		
17707	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	BDNF/NT-3 growth factors receptor [human]	inhibition rate		
17708	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	NT-3 growth factor receptor [human]	inhibition rate		
17709	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Testis-specific serine/threonine-protein kinase 1 [human]	inhibition rate		
17710	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Testis-specific serine/threonine-protein kinase 2 [human]	inhibition rate		
17711	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Testis-specific serine/threonine-protein kinase 3 [human]	inhibition rate		
17712	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Testis-specific serine/threonine-protein kinase 4 [human]	inhibition rate		
17713	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tau-tubulin kinase 1 [human]	inhibition rate		
17714	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tau-tubulin kinase 2 [human]	inhibition rate		
17715	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Dual specificity protein kinase TTK [human]	inhibition rate		
17716	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase TXK [human]	inhibition rate		
17717	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition rate		
17718	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase ULK1 [human]	inhibition rate		
17719	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase ULK2 [human]	inhibition rate		
17720	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase ULK3 [human]	inhibition rate		
17721	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase VRK1 [human]	inhibition rate		
17722	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase VRK2 [human]	inhibition rate		
17723	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Wee1-like protein kinase [human]	inhibition rate		
17724	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Wee1-like protein kinase 2 [human]	inhibition rate		
17725	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase WNK1 [human]	inhibition rate		
17726	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase WNK2 [human]	inhibition rate		
17727	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase WNK3 [human]	inhibition rate		
17728	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase Yes [human]	inhibition rate		
17729	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Mitogen-activated protein kinase kinase kinase 20 [human]	inhibition rate		
17730	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase ZAP-70 [human]	inhibition rate		
17731	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Death-associated protein kinase 3 [human]	inhibition rate		
17732	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [human]; Phosphatidylinositol 3-kinase regulatory subunit alpha [human]	inhibition rate		
17733	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Phosphatidylinositol 3-kinase regulatory subunit gamma [human]	inhibition rate		
17734	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Phosphatidylinositol 3-kinase regulatory subunit alpha [human]; Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [human]	inhibition rate		
17735	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Phosphatidylinositol 3-kinase regulatory subunit alpha [human]; Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human]	inhibition rate		
17736	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Phosphatidylinositol 3-kinase regulatory subunit alpha [human]; Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E542K) [human]	inhibition rate		
17737	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Phosphatidylinositol 3-kinase regulatory subunit alpha [human]; Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047R) [human]	inhibition rate		
17738	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Phosphatidylinositol 3-kinase regulatory subunit alpha [human]; Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545K) [human]	inhibition rate		
17739	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human]; Phosphatidylinositol 3-kinase p-65 subunit alpha [human]	inhibition rate		
17740	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha [human]	inhibition rate		
17741	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma [human]	inhibition rate		
17742	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [human]	inhibition rate		
17743	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Vascular endothelial growth factor receptor 1 [human]	inhibition rate		
17744	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	STE20-like serine/threonine-protein kinase [human]	inhibition rate		
17745	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma [human]	inhibition rate		
17746	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase PLK2 [human]	inhibition rate		
17747	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Proto-oncogene tyrosine-protein kinase Src [human]	inhibition rate		
17748	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Proto-oncogene tyrosine-protein kinase Src (T341M) [human]	inhibition rate		
17749	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase Srms [human]	inhibition rate		
17750	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	SRSF protein kinase 1 [human]	inhibition rate		
17751	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	SRSF protein kinase 2 [human]	inhibition rate		
17752	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Phosphatidylinositol 4-phosphate 5-kinase type-1 beta [human]	inhibition rate		
17753	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Receptor tyrosine-protein kinase erbB-2 [human]	inhibition rate		
17754	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Receptor tyrosine-protein kinase erbB-4 [human]	inhibition rate		
17755	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase Tec [human]	inhibition rate		
17756	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	SNF-related serine/threonine-protein kinase [human]	inhibition rate		
17757	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase ABL1 (H396P) [human]	inhibition rate		
17758	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase ABL1 (M351T) [human]	inhibition rate		
17759	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase ABL1 (Q252H) [human]	inhibition rate		
17760	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase ABL1 (T315I) [human]	inhibition rate		
17761	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase ABL1 (Y253F) [human]	inhibition rate		
17762	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Activated CDC42 kinase 1 [human]	inhibition rate		
17763	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Actin-related protein 2 [human]	inhibition rate		
17764	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	ALK tyrosine kinase receptor [human]	inhibition rate		
17765	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase receptor R3 [human]	inhibition rate		
17766	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Activin receptor type-1 [human]	inhibition rate		
17767	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Activin receptor type-1B [human]	inhibition rate		
17768	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Bone morphogenetic protein receptor type-1B [human]	inhibition rate		
17769	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase ABL2 [human]	inhibition rate		
17770	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	5'-AMP-activated protein kinase catalytic subunit alpha-1 [human]	inhibition rate		
17771	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	5'-AMP-activated protein kinase catalytic subunit alpha-2 [human]	inhibition rate		
17772	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase A-Raf [human]	inhibition rate		
17773	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	NUAK family SNF1-like kinase 1 [human]	inhibition rate		
17774	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Mitogen-activated protein kinase kinase kinase 5 [human]	inhibition rate		
17775	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Aurora kinase A [human]	inhibition rate		
17776	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Aurora kinase B [human]	inhibition rate		
17777	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Aurora kinase C [human]	inhibition rate		
17778	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Receptor tyrosine-protein kinase AXL [human]	inhibition rate		
17779	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase Blk [human]	inhibition rate		
17780	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Bone morphogenetic protein receptor type-2 [human]	inhibition rate		
17781	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Non-receptor tyrosine kinase BMX [human]	inhibition rate		
17782	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Protein-tyrosine kinase 6 [human]	inhibition rate		
17783	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase BRSK1 [human]	inhibition rate		
17784	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase BRSK2 [human]	inhibition rate		
17785	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase BTK [human]	inhibition rate		
17786	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase BTK (R28H) [human]	inhibition rate		
17787	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase B-raf [human]	inhibition rate		
17788	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase B-raf (V599E) [human]	inhibition rate		
17789	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Calcium/calmodulin-dependent protein kinase type 1 [human]	inhibition rate		
17790	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Calcium/calmodulin-dependent protein kinase type 1B [human]	inhibition rate		
17791	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Calcium/calmodulin-dependent protein kinase type 1G [human]	inhibition rate		
17792	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Calcium/calmodulin-dependent protein kinase type II subunit alpha [human]	inhibition rate		
17793	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Calcium/calmodulin-dependent protein kinase type II subunit beta [human]	inhibition rate		
17794	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Calcium/calmodulin-dependent protein kinase type II subunit gamma [human]	inhibition rate		
17795	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Calcium/calmodulin-dependent protein kinase type 1D [human]	inhibition rate		
17796	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Calcium/calmodulin-dependent protein kinase type II delta 2 chain [human]	inhibition rate		
17797	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Calcium/calmodulin-dependent protein kinase type IV [human]	inhibition rate		
17798	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Calcium/calmodulin-dependent protein kinase kinase 1 [human]	inhibition rate		
17799	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Calcium/calmodulin-dependent protein kinase kinase 2 [human]	inhibition rate		
17800	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Cell division control protein 7 [human]; G2/mitotic-specific cyclin-B1 [human]	inhibition rate		
17801	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	G2/mitotic-specific cyclin-B1 [human]; Cyclin-dependent kinase 1 [human]	inhibition rate		
17802	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Cyclin-A2 [human]; Cyclin-dependent kinase 2 [human]	inhibition rate		
17803	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Cyclin-dependent kinase 2 [human]; G1/S-specific cyclin-E [human]	inhibition rate		
17804	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	G1/S-specific cyclin-E [human]; Cyclin-dependent kinase 3 [human]	inhibition rate		
17805	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Cyclin-dependent kinase 4 [human]; Cyclin-D3-1 [human]	inhibition rate		
17806	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Tyrosine-protein kinase ABL1 [human]	inhibition rate		
17807	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2		IC50	100	μM
17808	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2		IC50	100	μM
17809	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase ATM [human]	IC50	100	μM
17810	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase ATM [human]	IC50	100	μM
17811	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase ATM [human]	IC50	100	μM
17812	COC1=CC=C(C=C1Cl)C(=O)NC(=S)NC1=CC=C(C=C1)C1=NC2=C(O1)C=CC=N2	Serine/threonine-protein kinase ATM [human]	IC50	100	μM
17813	CN1CCC(CC1)[C@@](C)(O)C1=CC=C2C=NC(NC3=CC(N4CCN(CC4)C(C)=O)=C(C)C=C3F)=CC2=N1	Cyclin-dependent-like kinase 5;+Cyclin-dependent kinase 5 activator 1, p25	IC50	2.7	nM
17814	CN1CCC(CC1)[C@@](C)(O)C1=CC=C2C=NC(NC3=CC(N4CCN(CC4)C(C)=O)=C(C)C=C3F)=CC2=N1	Cyclin-dependent-like kinase 5 [human];+Cyclin-dependent kinase 5 activator 1, p35 [human]	IC50	3.7	nM
17815	CN1CCC(CC1)[C@@](C)(O)C1=CC=C2C=NC(NC3=CC(N4CCN(CC4)C(C)=O)=C(C)C=C3F)=CC2=N1	CDK-activating kinase assembly factor MAT1;+Cyclin-H1-1;+Cyclin-dependent kinase 7	IC50	78	nM
17816	CN1CCC(CC1)[C@@](C)(O)C1=CC=C2C=NC(NC3=CC(N4CCN(CC4)C(C)=O)=C(C)C=C3F)=CC2=N1	Cyclin-dependent kinase 6;+Cyclin-D3-1	IC50	125	nM
17817	CN1CCC(CC1)[C@@](C)(O)C1=CC=C2C=NC(NC3=CC(N4CCN(CC4)C(C)=O)=C(C)C=C3F)=CC2=N1	Cyclin-dependent kinase 9;+Cyclin-T1	IC50	154	nM
17818	CN1CCC(CC1)[C@@](C)(O)C1=CC=C2C=NC(NC3=CC(N4CCN(CC4)C(C)=O)=C(C)C=C3F)=CC2=N1	Cyclin-dependent kinase 2;+Cyclin-A2	IC50	303	nM
17819	CN1CCC(CC1)[C@@](C)(O)C1=CC=C2C=NC(NC3=CC(N4CCN(CC4)C(C)=O)=C(C)C=C3F)=CC2=N1		IC50	6.4	μM
17820	OCC1=NN(C=C1)C1=CC=C(NC2=CC3=NC(OC4CCNCC4)=CC=C3C=N2)C(F)=C1	Cyclin-dependent-like kinase 5;+Cyclin-dependent kinase 5 activator 1, p25	IC50	16	nM
17821	OCC1=NN(C=C1)C1=CC=C(NC2=CC3=NC(OC4CCNCC4)=CC=C3C=N2)C(F)=C1	CDK-activating kinase assembly factor MAT1;+Cyclin-H1-1;+Cyclin-dependent kinase 7	IC50	87	nM
17822	OCC1=NN(C=C1)C1=CC=C(NC2=CC3=NC(OC4CCNCC4)=CC=C3C=N2)C(F)=C1	Cyclin-dependent kinase 2;+Cyclin-A2	IC50	472	nM
17823	OCC1=NN(C=C1)C1=CC=C(NC2=CC3=NC(OC4CCNCC4)=CC=C3C=N2)C(F)=C1	Cyclin-dependent kinase 6;+Cyclin-D3-1	IC50	1107	nM
17824	OCC1=NN(C=C1)C1=CC=C(NC2=CC3=NC(OC4CCNCC4)=CC=C3C=N2)C(F)=C1	Cyclin-dependent-like kinase 5;+Cyclin-dependent kinase 5 activator 1, p25	IC50	1669	nM
17825	OCC1=NN(C=C1)C1=CC=C(NC2=CC3=NC(OC4CCNCC4)=CC=C3C=N2)C(F)=C1	Cyclin-dependent kinase 9;+Cyclin-T1	IC50	1966	nM
17826	OCC1=NN(C=C1)C1=CC=C(NC2=CC3=NC(OC4CCNCC4)=CC=C3C=N2)C(F)=C1	Cyclin-dependent kinase 2;+Cyclin-A2	IC50	12010	nM
17827	CN1CCC(CC1)[C@@](C)(O)C1=NC2=CC(NC3=CC(N4C[C@@H]5CC[C@H](C4)O5)=C(C=C3F)C#N)=NC=C2C=C1	Cyclin-dependent-like kinase 5;+Cyclin-dependent kinase 5 activator 1, p25	IC50	0.8	nM
17828	CN1CCC(CC1)[C@@](C)(O)C1=NC2=CC(NC3=CC(N4C[C@@H]5CC[C@H](C4)O5)=C(C=C3F)C#N)=NC=C2C=C1	CDK-activating kinase assembly factor MAT1;+Cyclin-H1-1;+Cyclin-dependent kinase 7	IC50	94	nM
17829	CN1CCC(CC1)[C@@](C)(O)C1=NC2=CC(NC3=CC(N4C[C@@H]5CC[C@H](C4)O5)=C(C=C3F)C#N)=NC=C2C=C1	Cyclin-dependent kinase 9;+Cyclin-T1	IC50	127	nM
17830	CN1CCC(CC1)[C@@](C)(O)C1=NC2=CC(NC3=CC(N4C[C@@H]5CC[C@H](C4)O5)=C(C=C3F)C#N)=NC=C2C=C1	Cyclin-dependent kinase 2;+Cyclin-A2	IC50	166	nM
17831	CN1CCC(CC1)[C@@](C)(O)C1=NC2=CC(NC3=CC(N4C[C@@H]5CC[C@H](C4)O5)=C(C=C3F)C#N)=NC=C2C=C1	Cyclin-dependent kinase 6;+Cyclin-D3-1	IC50	201	nM
17832	CC(C)(N)CNC1=NN2C(S1)=NC=C2C1=C(F)C=C(F)C=C1	Serine/threonine-protein kinase haspin	IC50	0.01	μM
17833	CC(C)(N)CNC1=NN2C(S1)=NC=C2C1=C(F)C=C(F)C=C1		EC50	0.025	μM
17834	CC(C)(N)CNC1=NN2C(S1)=NC=C2C1=C(F)C=C(F)C=C1	Receptor-type tyrosine-protein kinase FLT3	IC50	0.1	μM
17835	CC(C)(N)CNC1=NN2C(S1)=NC=C2C1=C(F)C=C(F)C=C1	Serine/threonine-protein kinase pim-3	IC50	0.1	μM
17836	CC(C)(N)CNC1=NN2C(S1)=NC=C2C1=C(F)C=C(F)C=C1	Cyclin-dependent kinase 7	IC50	0.2	μM
17837	CC(C)(N)CNC1=NN2C(S1)=NC=C2C1=C(F)C=C(F)C=C1	Serine/threonine-protein kinase pim-1	IC50	0.2	μM
17838	CC(C)(N)CNC1=NN2C(S1)=NC=C2C1=C(F)C=C(F)C=C1	Serine/threonine-protein kinase pim-2	IC50	0.2	μM
17839	CC(C)(N)CNC1=NN2C(S1)=NC=C2C1=C(F)C=C(F)C=C1	Mast/stem cell growth factor receptor Kit	IC50	1.5	μM
17840	CC(C)(N)CNC1=NN2C(S1)=NC=C2C1=C(F)C=C(F)C=C1	Potassium voltage-gated channel subfamily H member 2	IC50	22	μM
17841	CC(C)(N)CNC1=NN2C(S1)=NC=C2C1=C(F)C=C(F)C=C1		CC50 (cytotoxic concentration)	18	μM
17842	CC(C)(N)CNC1=NN2C(S1)=NC=C2C1=C(F)C=C(F)C=C1		CL (drug clearance)	32	μl/min/mg protein
17843	CC(C)(N)CNC1=NN2C(S1)=NC=C2C1=C(F)C=C(F)C=C1		CL (drug clearance)	25	μl/min/mg protein
17844	CC(C)(N)CNC1=NN2C(S1)=NC=C2C1=C(F)C=C(F)C=C1		CL (drug clearance)	25	μl/min/mg protein
17845	CC(C)(N)CNC1=NN2C(S1)=NC=C2C1=C(F)C=C(F)C=C1		decrease rate	79.4	%
17846	CC(C)(N)CNC1=NN2C(S1)=NC=C2C1=C(F)C=C(F)C=C1		decrease rate	99.9	%
17847	CC(C)(N)CNC1=NN2C(S1)=NC=C2C1=C(F)C=C(F)C=C1		AUC (0-23 h)	57.3	μg/h/ml
17848	CC(C)(N)CNC1=NN2C(S1)=NC=C2C1=C(F)C=C(F)C=C1		AUC (0-23 h)	6.2	μg/h/ml
17849	CC(C)(N)CNC1=NN2C(S1)=NC=C2C1=C(F)C=C(F)C=C1		AUC (0-47 h)	8.4	μg/h/ml
17850	CC(C)(N)CNC1=NN2C(S1)=NC=C2C1=C(F)C=C(F)C=C1		AUC (0-47 h)	87.1	μg/h/ml
17851	CC(C)(N)CNC1=NN2C(S1)=NC=C2C1=C(F)C=C(F)C=C1		Cmax	0.46	μg/ml
17852	CC(C)(N)CNC1=NN2C(S1)=NC=C2C1=C(F)C=C(F)C=C1		Cmax	3.5	μg/ml
17853	COC1=C(C=CC(F)=C1)C1=CN=C2SC(=NN12)N1CCC(C)(N)CC1		EC50	0.017	μM
17854	COC1=C(C=CC(F)=C1)C1=CN=C2SC(=NN12)N1CCC(C)(N)CC1	Receptor-type tyrosine-protein kinase FLT3	IC50	0.6	μM
17855	COC1=C(C=CC(F)=C1)C1=CN=C2SC(=NN12)N1CCC(C)(N)CC1	Serine/threonine-protein kinase haspin	IC50	1.7	μM
17856	COC1=C(C=CC(F)=C1)C1=CN=C2SC(=NN12)N1CCC(C)(N)CC1	Serine/threonine-protein kinase pim-1	IC50	1.8	μM
17857	COC1=C(C=CC(F)=C1)C1=CN=C2SC(=NN12)N1CCC(C)(N)CC1	Mast/stem cell growth factor receptor Kit	IC50	2.4	μM
17858	COC1=C(C=CC(F)=C1)C1=CN=C2SC(=NN12)N1CCC(C)(N)CC1	Potassium voltage-gated channel subfamily H member 2	IC50	2.4	μM
17859	COC1=C(C=CC(F)=C1)C1=CN=C2SC(=NN12)N1CCC(C)(N)CC1	Serine/threonine-protein kinase pim-2	IC50	7.4	μM
17860	COC1=C(C=CC(F)=C1)C1=CN=C2SC(=NN12)N1CCC(C)(N)CC1	Cyclin-dependent kinase 7	IC50	12	μM
17861	COC1=C(C=CC(F)=C1)C1=CN=C2SC(=NN12)N1CCC(C)(N)CC1	Serine/threonine-protein kinase pim-3	IC50	26	μM
17862	COC1=C(C=CC(F)=C1)C1=CN=C2SC(=NN12)N1CCC(C)(N)CC1		CC50 (cytotoxic concentration)	31	μM
17863	COC1=C(C=CC(F)=C1)C1=CN=C2SC(=NN12)N1CCC(C)(N)CC1		CL (drug clearance)	31	μl/min/mg protein
17864	COC1=C(C=CC(F)=C1)C1=CN=C2SC(=NN12)N1CCC(C)(N)CC1		CL (drug clearance)	25	μl/min/mg protein
17865	COC1=C(C=CC(F)=C1)C1=CN=C2SC(=NN12)N1CCC(C)(N)CC1		CL (drug clearance)	38	μl/min/mg protein
17866	CN1CCC[C@H](C1)OC1=NN2C(=CN=C2C(NCC2=CC=CC=C2)=C1)C1CC1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
17867	CN1CC[C@H](C1)OC1=NN2C(=CN=C2C(NCC2=CC=CC=C2)=C1)C1CC1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
17868	Cl[H].COC1=CC(F)=CC=C1CNC1=CC(SC2CCNCC2)=NN2C(=CN=C12)C(C)C	Cyclin-dependent kinase 7	IC50	100	nM
17869	CN1CC[C@H](C1)OC1=NN2C(=CN=C2C(NC2=CC(F)=CC=C2)=C1)C1CC1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
17870	CN1CCC(CC1)OC1=NN2C(=CN=C2C(NC2=CC(F)=CC=C2)=C1)C1CC1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
17871	Cl[H].CC(C)C1=CN=C2N1N=C(NC[C@H]1CCCNC1)C=C2NCC1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
17872	OC=O.COC1=CC=CC=C1CNC1=NC(SC2CCNCC2)=CN2C(=CN=C12)C(C)C	Cyclin-dependent kinase 7	IC50	100	nM
17873	OC=O.COC1=CC=CC=C1CNC1=NC(SC2CCNCC2)=CN2C(=CN=C12)C(C)C	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17874	OC=O.COC1=CC=CC=C1CNC1=NC(SC2CCNCC2)=CN2C(=CN=C12)C(C)C	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17875	OC=O.COC1=CC=CC=C1CNC1=NC(SC2CCNCC2)=CN2C(=CN=C12)C(C)C	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17876	OC=O.COC1=CC=CC=C1CNC1=NC(SC2CCNCC2)=CN2C(=CN=C12)C(C)C	Cyclin-dependent kinase 7 [human]	IC50	5	μM
17877	FC1=CC=CC(NC2=CC(O[C@@H]3CCNC3)=NN3C(=CN=C23)C2CC2)=C1	Cyclin-dependent kinase 7	IC50	100	nM
17878	FC1=CC=CC(NC2=CC(O[C@@H]3CCNC3)=NN3C(=CN=C23)C2CC2)=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17879	FC1=CC=CC(NC2=CC(O[C@@H]3CCNC3)=NN3C(=CN=C23)C2CC2)=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17880	FC1=CC=CC(NC2=CC(O[C@@H]3CCNC3)=NN3C(=CN=C23)C2CC2)=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17881	FC1=CC=CC(NC2=CC(O[C@@H]3CCNC3)=NN3C(=CN=C23)C2CC2)=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
17882	FC(F)(F)C(=O)N1CCC(CC1)SC1=NN2C(=CN=C2C(NCC2=CC=CC=C2)=C1)C1CC1	Cyclin-dependent kinase 7	IC50	1000	nM
17883	Cl[H].FC(F)(F)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
17884	Cl[H].FC(F)(F)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=CC=C1				
17885	C(NC1=CC(O[C@H]2CCNC2)=NN2C(=CN=C12)C1CC1)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
17886	Cl[H].CC(C)C1=CN=C2N1N=C(OC1CCNCC1)C=C2NCC1=CC=CC=C1OC(F)(F)F	Cyclin-dependent kinase 7	IC50	100	nM
17887	Cl[H].CC(C)C1=CN=C2N1N=C(OC1CCNCC1)C=C2NCC1=CC=CC=C1OC(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17888	Cl[H].CC(C)C1=CN=C2N1N=C(OC1CCNCC1)C=C2NCC1=CC=CC=C1OC(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17889	Cl[H].CC(C)C1=CN=C2N1N=C(OC1CCNCC1)C=C2NCC1=CC=CC=C1OC(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17890	Cl[H].CC(C)C1=CN=C2N1N=C(OC1CCNCC1)C=C2NCC1=CC=CC=C1OC(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17891	Cl[H].CC(C)C1=CN=C2N1N=C(OC1CCNCC1)C=C2NCC1=CC=CC=C1OC(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17892	Cl[H].CC(C)C1=CN=C2N1N=C(OC1CCNCC1)C=C2NCC1=CC=CC=C1OC(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17893	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCCNC1)C=C2NCC1=CC=C(F)C=C1C(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
17894	C(NC1=CC(O[C@@H]2CCCNC2)=NN2C(=CN=C12)C1CC1)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
17895	Cl[H].CC(C)C1=CN=C2N1N=C(NC1CCNCC1)C=C2N[C@@H](C)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
17896	C(NC1=CC(OC2CCNCC2)=NN2C(=CN=C12)C1CC1)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
17897	CN1CC[C@@H](C1)OC1=NN2C(=CN=C2C(NC2=CC(F)=CC=C2)=C1)C1CC1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
17898	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCCNC1)C=C2NC1=CC=CC(=C1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
17899	Cl[H].CC(C)C1=CN=C2N1N=C(NC[C@H]1CCNC[C@@H]1O)C=C2NCC1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
17900	Cl[H].CC(C)C1=CN=C2N1N=C(OC1CCNCC1F)C=C2NCC1=CC=CC=C1OC(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
17901	Cl[H].CC(C)C1=CN=C2N1N=C(OC1CCNCC1F)C=C2NCC1=CC=CC=C1OC(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17902	Cl[H].CC(C)C1=CN=C2N1N=C(OC1CCNCC1F)C=C2NCC1=CC=CC=C1OC(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17903	Cl[H].CC(C)C1=CN=C2N1N=C(OC1CCNCC1F)C=C2NCC1=CC=CC=C1OC(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17904	Cl[H].CC(C)C1=CN=C2N1N=C(OC1CCNCC1F)C=C2NCC1=CC=CC=C1OC(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17905	CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=CC=C1OC(F)(F)F	Cyclin-dependent kinase 7	IC50	100	nM
17906	CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=CC=C1OC(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1	μM
17907	CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=CC=C1OC(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17908	CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=CC=C1OC(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1	μM
17909	CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=CC=C1OC(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1	μM
17910	CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=CC=C1OC(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1	μM
17911	CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=CC=C1OC(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17912	CN1CCC(CC1)OC1=NN2C(=CN=C2C(NCC2=CC=CC=C2)=C1)C1CC1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
17913	Cl[H].FC1=CC(NC2=CC(O[C@H]3CCCNC3)=NN3C(=CN=C23)C(F)(F)F)=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
17914	Cl[H].FC1=CC(NC2=CC(O[C@H]3CCCNC3)=NN3C(=CN=C23)C(F)(F)F)=CC=C1				
17915	Cl[H].CC(C)OC1=CC=CC=C1CNC1=CC(SC2CCNCC2)=NN2C(=CN=C12)C(C)C	Cyclin-dependent kinase 7	IC50	100	nM
17916	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=C(F)C=CC=C1F	Cyclin-dependent kinase 7	IC50	100	nM
17917	CN1CCC[C@@H](C1)OC1=NN2C(=CN=C2C(NC2=CC(F)=CC=C2)=C1)C1CC1	Cyclin-dependent kinase 7	IC50	1000	nM
17918	Cl[H].CCOC1=CC=CC=C1CNC1=CC(SC2CCNCC2)=NN2C(=CN=C12)C(C)C	Cyclin-dependent kinase 7	IC50	100	nM
17919	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCCNC1)C=C2NC1=CC=CC(OC(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
17920	CN1CCC[C@@H](C1)OC1=NN2C(=CN=C2C(NCC2=CC=CC=C2)=C1)C1CC1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
17921	Cl[H].CC(C)C1=CN=C2N1N=C(OC1CCNCC1(F)F)C=C2NCC1=CC=CC=C1OC(F)(F)F	Cyclin-dependent kinase 7	IC50	1000	nM
17922	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=CC=C1OC(F)F	Cyclin-dependent kinase 7	IC50	100	nM
17923	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=CC=C1OC(F)F	Cyclin-dependent kinase 7 [human]	IC50	1	μM
17924	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=CC=C1OC(F)F	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17925	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=CC=C1OC(F)F	Cyclin-dependent kinase 7 [human]	IC50	1	μM
17926	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=CC=C1OC(F)F	Cyclin-dependent kinase 7 [human]	IC50	1	μM
17927	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=CC(=C1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100	nM
17928	Cl[H].CC(C)C1=CN=C2N1N=C(NC1CCNCC1)C=C2NC1=CC=CC(F)=C1	Cyclin-dependent kinase 7	IC50	100	nM
17929	Cl[H].CC(C)C1=CN=C2N1N=C(NC1CCNCC1)C=C2NC1=CC=CC(F)=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
17930	Cl[H].CC(C)C1=CN=C2N1N=C(NC1CCNCC1)C=C2NC1=CC=CC(F)=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17931	Cl[H].CC(C)C1=CN=C2N1N=C(NC1CCNCC1)C=C2NC1=CC=CC(F)=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17932	Cl[H].CC(C)C1=CN=C2N1N=C(NC1CCNCC1)C=C2NC1=CC=CC(F)=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17933	Cl[H].CC(C)C1=CN=C2N1N=C(NC1CCNCC1)C=C2NC1=CC=CC(F)=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17934	Cl[H].CC(C)C1=CN=C2N1N=C(NC1CCNCC1)C=C2NC1=CC=CC(F)=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17935	Cl[H].CC(C)C1=CN=C2N1N=C(OC1CCNCC1)C=C2NC1=CC=CC(F)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
17936	CN1CCC[C@H](C1)OC1=NN2C(=CN=C2C(NC2=CC(F)=CC=C2)=C1)C1CC1	Cyclin-dependent kinase 7	IC50	1000	nM
17937	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCCNC1)C=C2NC1=C(F)C=CC=C1F	Cyclin-dependent kinase 7	IC50	100	nM
17938	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NC1=CC=CC(F)=C1	Cyclin-dependent kinase 7	IC50	100	nM
17939	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NC1=CC=CC(F)=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
17940	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NC1=CC=CC(F)=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
17941	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NC1=CC=CC(F)=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
17942	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NC1=CC=CC(F)=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
17943	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NC1=CC=CC(F)=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
17944	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NC1=CC=CC(F)=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
17945	OC=O.C(CC1CNCCO1)NC1=NN2C(=CN=C2C(NCC2=CC=CC=C2)=C1)C1CC1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
17946	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=C(F)C=C1C(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
17947	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=C(F)C=C1F	Cyclin-dependent kinase 7	IC50	100	nM
17948	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=C(F)C=C1F	Cyclin-dependent kinase 7 [human]	IC50	1	μM
17949	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=C(F)C=C1F	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17950	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=C(F)C=C1F	Cyclin-dependent kinase 7 [human]	IC50	1	μM
17951	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=C(F)C=C1F	Cyclin-dependent kinase 7 [human]	IC50	1	μM
17952	Cl[H].C(NC1=CC(SC2CCCNC2)=NN2C(=CN=C12)C1CC1)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
17953	Cl[H].C(NC1=CC(SC2CCCNC2)=NN2C(=CN=C12)C1CC1)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17954	Cl[H].C(NC1=CC(SC2CCCNC2)=NN2C(=CN=C12)C1CC1)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17955	Cl[H].C(NC1=CC(SC2CCCNC2)=NN2C(=CN=C12)C1CC1)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17956	Cl[H].C(NC1=CC(SC2CCCNC2)=NN2C(=CN=C12)C1CC1)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17957	Cl[H].C(NC1=CC(SC2CCCNC2)=NN2C(=CN=C12)C1CC1)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17958	Cl[H].C(NC1=CC(SC2CCCNC2)=NN2C(=CN=C12)C1CC1)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17959	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=CC=C1N(C)C	Cyclin-dependent kinase 7	IC50	100	nM
17960	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=CC=C1N(C)C	Cyclin-dependent kinase 7 [human]	IC50	1	μM
17961	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=CC=C1N(C)C	Cyclin-dependent kinase 7 [human]	IC50	1	μM
17962	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=CC=C1N(C)C	Cyclin-dependent kinase 7 [human]	IC50	1	μM
17963	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=CC=C1N(C)C	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17964	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCCNC1)C=C2NC1=CC=CC=C1C(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
17965	Cl[H].CC(C)C1=CN=C2N1N=C(OC[C@H]1CNCCO1)C=C2NCC1=CC=CC=C1OC(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
17966	Cl[H].CC(C)C1=CN=C2N1C=C(SC1CCCNC1)N=C2N[C@@H](C)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
17967	Cl[H].CC(C)C1=CN=C2N1C=C(SC1CCCNC1)N=C2N[C@@H](C)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17968	Cl[H].CC(C)C1=CN=C2N1C=C(SC1CCCNC1)N=C2N[C@@H](C)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17969	Cl[H].CC(C)C1=CN=C2N1C=C(SC1CCCNC1)N=C2N[C@@H](C)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17970	Cl[H].CC(C)C1=CN=C2N1C=C(SC1CCCNC1)N=C2N[C@@H](C)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17971	Cl[H].CC(C)C1=CN=C2N1C=C(SC1CCCNC1)N=C2N[C@@H](C)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17972	Cl[H].CC(C)C1=CN=C2N1C=C(SC1CCCNC1)N=C2N[C@@H](C)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	5	μM
17973	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCCNC1)C=C2NC1=CC=CC=C1OC(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
17974	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=CC=C1N1C=CC=N1	Cyclin-dependent kinase 7	IC50	100	nM
17975	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=CC=C1N1C=CC=N1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
17976	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=CC=C1N1C=CC=N1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
17977	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=CC=C1N1C=CC=N1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17978	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=CC=C1N1C=CC=N1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17979	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1(F)F)C=C2NCC1=CC=CC=C1OC(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
17980	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1(F)F)C=C2NCC1=CC=CC=C1OC(F)(F)F				
17981	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=CC(OC(F)(F)F)=C1	Cyclin-dependent kinase 7	IC50	100	nM
17982	Cl[H].CC(C)C1=CN=C2N1C=C(SC1CCCNC1)N=C2NCC1=CC=CC=C1N1C=CC=N1	Cyclin-dependent kinase 7	IC50	100	nM
17983	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=CC=C1C(F)(F)F	Cyclin-dependent kinase 7	IC50	100	nM
17984	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=CC=C1C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1	μM
17985	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=CC=C1C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1	μM
17986	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=CC=C1C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1	μM
17987	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2NCC1=CC=CC=C1C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17988	Cl[H].CC(C)C1=CN=C2N1N=C(OC[C@@H]1CNCCO1)C=C2NCC1=CC=CC=C1OC(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
17989	[H]C1(CC1)C1=CN=C2N1N=C(OC1CCN(C)CC1)C=C2NCC1=CC=CC=C1OC	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
17990	Cl[H].CC(C)C1=CN=C2N1C=C(SC1CCNCC1)N=C2N[C@@H](C)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
17991	Cl[H].CC(C)C1=CN=C2N1C=C(SC1CCNCC1)N=C2N[C@@H](C)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17992	Cl[H].CC(C)C1=CN=C2N1C=C(SC1CCNCC1)N=C2N[C@@H](C)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17993	Cl[H].CC(C)C1=CN=C2N1C=C(SC1CCNCC1)N=C2N[C@@H](C)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17994	Cl[H].CC(C)C1=CN=C2N1C=C(SC1CCNCC1)N=C2N[C@@H](C)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17995	Cl[H].CC(C)C1=CN=C2N1C=C(SC1CCNCC1)N=C2N[C@@H](C)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
17996	Cl[H].CC(C)C1=CN=C2N1C=C(SC1CCNCC1)N=C2N[C@@H](C)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	5	μM
17997	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCNCC1F)C=C2NCC1=CC=CC=C1OC(F)(F)F	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
17998	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCCNC1)C=C2NCC1=CC=CC=C1N1C=CC=N1	Cyclin-dependent kinase 7	IC50	100	nM
17999	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCCNC1)C=C2NCC1=CC=CC=C1N1C=CC=N1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
18000	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCCNC1)C=C2NCC1=CC=CC=C1N1C=CC=N1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
18001	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCCNC1)C=C2NCC1=CC=CC=C1N1C=CC=N1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
18002	Cl[H].CC(C)C1=CN=C2N1N=C(SC1CCCNC1)C=C2NCC1=CC=CC=C1N1C=CC=N1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
18003	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	DNA-dependent protein kinase catalytic subunit [human]	IC50	0.34 - 8.2	nM
18004	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	IC50	1820 - 1850	nM
18005	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase ATM [human]	IC50	9153	nM
18006	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase mTOR [human]	IC50	18100 - 44500	nM
18007	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Receptor tyrosine-protein kinase erbB-4 [human]	IC50	100000	nM
18008	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	DNA-dependent protein kinase catalytic subunit [human]	IC50	10	μM
18009	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	DNA-dependent protein kinase catalytic subunit [human]	IC50	10	μM
18010	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1		IC50	10	μM
18011	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	DNA-dependent protein kinase catalytic subunit [human]	number of clonogens per gram of tumor tissue decrease		
18012	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Mitogen-activated protein kinase 15 [human]	inhibition rate	13.84	%
18013	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase/endoribonuclease IRE1 [human]	inhibition rate	12.98	%
18014	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Mitogen-activated protein kinase 1 [human]	inhibition rate	14.06	%
18015	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase A-Raf [human]	inhibition rate	-0.06	%
18016	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	MAP kinase-interacting serine/threonine-protein kinase 1 [human]	inhibition rate	-6.06	%
18017	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase 4 [human]	inhibition rate	-2.25	%
18018	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Casein kinase I isoform gamma-1 [human]	inhibition rate	1.15	%
18019	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Lymphokine-activated killer T-cell-originated protein kinase [human]	inhibition rate	-5.04	%
18020	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	cAMP-dependent protein kinase [human]	inhibition rate	2.41	%
18021	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine kinase NLK [human]	inhibition rate	0.16	%
18022	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Tau-tubulin kinase 1 [human]	inhibition rate	11.87	%
18023	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Dual specificity mitogen-activated protein kinase kinase 5 [human]	inhibition rate	9.23	%
18024	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Mitogen-activated protein kinase 13 [human]	inhibition rate	0.38	%
18025	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase pim-3 [human]	inhibition rate	2.8	%
18026	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Vascular endothelial growth factor receptor 2 [human]	inhibition rate	7.3	%
18027	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	G protein-coupled receptor kinase 5 [human]	inhibition rate	3.66	%
18028	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Misshapen-like kinase 1 [human]	inhibition rate	1.35	%
18029	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase 32C [human]	inhibition rate	19.04	%
18030	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Casein kinase II subunit alpha [human]	inhibition rate	11.32	%
18031	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase MARK2 [human]	inhibition rate	6.37	%
18032	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Mitogen-activated protein kinase 14 [human]	inhibition rate	5.31	%
18033	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Myosin-IIIa [human]	inhibition rate	-15.08	%
18034	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase WNK3 [human]	inhibition rate	9.46	%
18035	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase Nek5 [human]	inhibition rate	10.5	%
18036	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Casein kinase I isoform delta [human]	inhibition rate	-2.73	%
18037	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	MAP kinase-activated protein kinase 5 [human]	inhibition rate	4.22	%
18038	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Dual specificity protein kinase CLK1 [human]	inhibition rate	-3.11	%
18039	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Receptor tyrosine-protein kinase AXL [human]	inhibition rate	14.65	%
18040	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform [human]	inhibition rate	9.96	%
18041	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Tyrosine-protein kinase TXK [human]	inhibition rate	-1.92	%
18042	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Calcium/calmodulin-dependent protein kinase type II subunit alpha [human]	inhibition rate	9.22	%
18043	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase haspin [human]	inhibition rate	11.7	%
18044	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Dual specificity mitogen-activated protein kinase kinase 6 [human]	inhibition rate	-0.79	%
18045	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Casein kinase I isoform delta [human]	inhibition rate	9.37	%
18046	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase PAK 4 [human]	inhibition rate	5.1	%
18047	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase MRCK gamma [human]	inhibition rate	18.02	%
18048	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Tyrosine-protein kinase Fgr [human]	inhibition rate	-1.28	%
18049	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	3-phosphoinositide-dependent protein kinase 1 [human]	inhibition rate	-1.43	%
18050	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial [human]	inhibition rate	1.88	%
18051	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase 32B [human]	inhibition rate	-5.91	%
18052	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase [human]	inhibition rate	-10.89	%
18053	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase TAO1 [human]	inhibition rate	0.4	%
18054	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Mitogen-activated protein kinase kinase kinase 10 [human]	inhibition rate	16.12	%
18055	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Tyrosine-protein kinase Blk [human]	inhibition rate	9.92	%
18056	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase LATS2 [human]	inhibition rate	17.89	%
18057	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Beta-adrenergic receptor kinase 2 [human]	inhibition rate	6.1	%
18058	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	MAP/microtubule affinity-regulating kinase 4 [human]	inhibition rate	3.03	%
18059	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase DCLK2 [human]	inhibition rate	17.41	%
18060	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Ephrin type-B receptor 1 [human]	inhibition rate	-5.73	%
18061	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase VRK2 [human]	inhibition rate	19.56	%
18062	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase 38 [human]	inhibition rate	3.88	%
18063	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase NIM1 [human]	inhibition rate	-3.74	%
18064	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Mitogen-activated protein kinase 11 [human]	inhibition rate	-4.7	%
18065	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Rho-associated protein kinase 1 [human]	inhibition rate	3.6	%
18066	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Ribosomal protein S6 kinase alpha-4 [human]	inhibition rate	3.4	%
18067	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Ephrin type-A receptor 7 [human]	inhibition rate	8.55	%
18068	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase Chk1 [human]	inhibition rate	4.69	%
18069	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Calcium/calmodulin-dependent protein kinase type 1G [human]	inhibition rate	-24.5	%
18070	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase Nek2 [human]	inhibition rate	1.89	%
18071	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Glycogen synthase kinase-3 alpha [human]	inhibition rate	0.13	%
18072	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Dual specificity mitogen-activated protein kinase kinase 4 [human]	inhibition rate	6.69	%
18073	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Interferon-induced, double-stranded RNA-activated protein kinase [human]	inhibition rate	2.28	%
18074	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Interleukin-1 receptor-associated kinase 1 [human]	inhibition rate	-5.32	%
18075	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Protein kinase C, eta [human]	inhibition rate	4.76	%
18076	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Mitogen-activated protein kinase kinase kinase 7 [human]	inhibition rate	-1.58	%
18077	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	eIF-2-alpha kinase Gcn2 [human]	inhibition rate	6.68	%
18078	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Ephrin type-A receptor 6 [human]	inhibition rate	4.86	%
18079	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Calcium/calmodulin-dependent protein kinase type II subunit beta [human]	inhibition rate	-3.82	%
18080	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase tousled-like 1 [human]	inhibition rate	2.05	%
18081	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Cyclin-dependent kinase 7 [human]; Cyclin-H [human]	inhibition rate	-11.91	%
18082	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Dual specificity testis-specific protein kinase 2 [human]	inhibition rate	9.11	%
18083	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Tyrosine-protein kinase Yes [human]	inhibition rate	17.1	%
18084	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	5'-AMP-activated protein kinase catalytic subunit alpha-2 [human];+5'-AMP-activated protein kinase subunit beta-2 [human];+5'-AMP-activated protein kinase subunit gamma-2 [human]	inhibition rate	-7.22	%
18085	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase 26 [human]	inhibition rate	-9.51	%
18086	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Ephrin type-A receptor 5 [human]	inhibition rate	-3.57	%
18087	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Ephrin type-B receptor 2 [human]	inhibition rate	6.38	%
18088	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Myotonin-protein kinase [human]	inhibition rate	-0.3	%
18089	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase MARK3 [human]	inhibition rate	-3.19	%
18090	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Death-associated protein kinase 1 [human]	inhibition rate	3.19	%
18091	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Testis-specific serine/threonine-protein kinase 2 [human]	inhibition rate	10.88	%
18092	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase MAK [human]	inhibition rate	-10.22	%
18093	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase SIK2 [human]	inhibition rate	-6.13	%
18094	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Protein kinase C, delta [human]	inhibition rate	4.65	%
18095	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	5'-AMP-activated protein kinase catalytic subunit alpha-2 [human];+5'-AMP-activated protein kinase subunit gamma-1 [human];+5'-AMP-activated protein kinase subunit beta-2 [human]	inhibition rate	0.93	%
18096	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Cyclin-A1 [human]; Cyclin-dependent kinase 20 [human]	inhibition rate	14.45	%
18097	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase 38-like [human]	inhibition rate	10.04	%
18098	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	cGMP-dependent protein kinase 1 [human]	inhibition rate	9.65	%
18099	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 3 [human]	inhibition rate	-0.44	%
18100	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase B-raf [human]	inhibition rate	24.99	%
18101	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition rate	3.94	%
18102	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial [human]	inhibition rate	22.23	%
18103	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase WNK1 [human]	inhibition rate	10.59	%
18104	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Ephrin type-A receptor 4 [human]	inhibition rate	3.01	%
18105	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Protein kinase C iota type [human]	inhibition rate	-7.97	%
18106	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Macrophage-stimulating protein receptor [human]	inhibition rate	-6.52	%
18107	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	High affinity nerve growth factor receptor [human]	inhibition rate	-5.36	%
18108	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Myosin light chain kinase, smooth muscle [human]	inhibition rate	7.88	%
18109	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Proto-oncogene tyrosine-protein kinase receptor Ret [human]	inhibition rate	3.51	%
18110	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Mitogen-activated protein kinase kinase kinase 19 [human]	inhibition rate	2.13	%
18111	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase Sgk3 [human]	inhibition rate	2.13	%
18112	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Aurora kinase B [human]	inhibition rate	10.46	%
18113	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	serine/threonine-protein kinase pak 5 [human]	inhibition rate	7.35	%
18114	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Cytoplasmic tyrosine-protein kinase BMX [human]	inhibition rate	10.36	%
18115	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Tyrosine-protein kinase Srms [human]	inhibition rate	-15.33	%
18116	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	BDNF/NT-3 growth factors receptor [human]	inhibition rate	4.4	%
18117	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Discoidin domain-containing receptor 2 [human]	inhibition rate	32.53	%
18118	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 2 [human]	inhibition rate	1.34	%
18119	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Mitogen-activated protein kinase 3 [human]	inhibition rate	6.35	%
18120	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Tyrosine-protein kinase, Fes/Fps type [human]	inhibition rate	-4.96	%
18121	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Testis-specific serine/threonine-protein kinase 6 [human]	inhibition rate	26.68	%
18122	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase MARK1 [human]	inhibition rate	4.65	%
18123	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Tyrosine-protein kinase CSK [human]	inhibition rate	1.69	%
18124	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Vascular endothelial growth factor receptor 3 [human]	inhibition rate	1.02	%
18125	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Ribosomal protein S6 kinase alpha-5 [human]	inhibition rate	6.54	%
18126	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	SRSF protein kinase 1 [human]	inhibition rate	-2.54	%
18127	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Mitogen-activated protein kinase kinase kinase 20 [human]	inhibition rate	1.12	%
18128	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Tyrosine-protein kinase Lyn [human]	inhibition rate	-2.82	%
18129	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase OSR1 [human]	inhibition rate	9.78	%
18130	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Mitogen-activated protein kinase kinase kinase 11 [human]	inhibition rate	6.59	%
18131	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Tyrosine-protein kinase Tec [human]	inhibition rate	4.03	%
18132	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Calcium/calmodulin-dependent protein kinase type II delta 2 chain [human]	inhibition rate	8.78	%
18133	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Activin receptor type-1 [human]	inhibition rate	10.07	%
18134	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Proto-oncogene tyrosine-protein kinase ROS [human]	inhibition rate	-5.68	%
18135	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase Chk2 [human]	inhibition rate	3.56	%
18136	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Mitogen-activated protein kinase kinase kinase 8 [human]	inhibition rate	14.55	%
18137	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Calcium/calmodulin-dependent protein kinase type IV [human]	inhibition rate	1.6	%
18138	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase N2 [human]	inhibition rate	6.86	%
18139	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Fibroblast growth factor receptor 2 [human]	inhibition rate	3.43	%
18140	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Protein DBF4 homolog A [human];+Cell division cycle 7-related protein kinase [human]	inhibition rate	-6.73	%
18141	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Fibroblast growth factor receptor 1 [human]	inhibition rate	2.19	%
18142	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Receptor-interacting serine/threonine-protein kinase 4 [human]	inhibition rate	4.01	%
18143	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Mitogen-activated protein kinase kinase kinase kinase 5 [human]	inhibition rate	-2.94	%
18144	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase WNK2 [human]	inhibition rate	9.38	%
18145	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Cyclin-dependent kinase 1 [human]; Cyclin E [human]	inhibition rate	14.24	%
18146	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 1B [human]	inhibition rate	2.16	%
18147	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	SRSF protein kinase 3 [human]	inhibition rate	4.1	%
18148	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	PAS domain-containing serine/threonine-protein kinase [human]	inhibition rate	8.59	%
18149	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	G protein-coupled receptor kinase 6 [human]	inhibition rate	4.97	%
18150	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Epithelial discoidin domain-containing receptor 1 [human]	inhibition rate	12.57	%
18151	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Protein kinase C zeta type [human]	inhibition rate	3.57	%
18152	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Casein kinase I isoform gamma-2 [human]	inhibition rate	-0.37	%
18153	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase SIK1 [human]	inhibition rate	-19.21	%
18154	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Homeodomain-interacting protein kinase 3 [human]	inhibition rate	2	%
18155	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Cyclin-dependent kinase 9 [human]; Cyclin-T1 [human]	inhibition rate	1.55	%
18156	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Insulin receptor [human]	inhibition rate	6	%
18157	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Tyrosine-protein kinase FRK [human]	inhibition rate	-1.22	%
18158	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	serine/threonine-protein kinase sbk1 [human]	inhibition rate	0.31	%
18159	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Aurora kinase A [human]	inhibition rate	-9.16	%
18160	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Tyrosine-protein kinase Fer [human]	inhibition rate	4.29	%
18161	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Non-receptor tyrosine-protein kinase TNK1 [human]	inhibition rate	-1.66	%
18162	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Cyclin-dependent kinase 9 [human]; Cyclin-T2 [human]	inhibition rate	7.49	%
18163	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	MAP kinase-activated protein kinase 2 [human]	inhibition rate	11.3	%
18164	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase pim-2 [human]	inhibition rate	-0.78	%
18165	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Cyclin-dependent kinase 8 [human]; Cyclin-C [human]	inhibition rate	2.63	%
18166	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Cyclin-C [human]; Cyclin-dependent kinase 19 [human]	inhibition rate	1.48	%
18167	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	G1/S-specific cyclin-D3 [human]; Cyclin-dependent kinase 4 [human]	inhibition rate	-6.82	%
18168	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Tyrosine-protein kinase Fyn [human]	inhibition rate	11.14	%
18169	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Dual specificity protein kinase CLK3 [human]	inhibition rate	8.6	%
18170	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Bone morphogenetic protein receptor type-1A [human]	inhibition rate	-1.8	%
18171	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Protein-tyrosine kinase 2-beta [human]	inhibition rate	2.94	%
18172	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Activin receptor type-1B [human]	inhibition rate	14.98	%
18173	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Tyrosine-protein kinase JAK1 [human]	inhibition rate	4.95	%
18174	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	G1/S-specific cyclin-D3 [human]; Cyclin-dependent kinase 6 [human]	inhibition rate	0.78	%
18175	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase Nek3 [human]	inhibition rate	9.14	%
18176	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Casein kinase I isoform gamma-3 [human]	inhibition rate	-7.38	%
18177	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase TAO2 [human]	inhibition rate	2.36	%
18178	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Dual specificity mitogen-activated protein kinase kinase 2 [human]	inhibition rate	3.5	%
18179	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Tyrosine-protein kinase SYK [human]	inhibition rate	-1.54	%
18180	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase 17A [human]	inhibition rate	-16.07	%
18181	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Hepatocyte growth factor receptor [human]	inhibition rate	-4.63	%
18182	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Cyclin-dependent kinase 18 [human]; cyclin-y [human]	inhibition rate	6.39	%
18183	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Receptor tyrosine-protein kinase erbB-2 [human]	inhibition rate	-6.45	%
18184	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Cyclin-dependent kinase 9 [human]; Cyclin-K [human]	inhibition rate	-0.27	%
18185	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Tyrosine-protein kinase JAK3 [human]	inhibition rate	-9.13	%
18186	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase ULK3 [human]	inhibition rate	9.65	%
18187	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Homeodomain-interacting protein kinase 2 [human]	inhibition rate	-12.94	%
18188	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase MRCK beta [human]	inhibition rate	5.16	%
18189	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Tyrosine-protein kinase ABL1 [human]	inhibition rate	2.77	%
18190	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase Sgk2 [human]	inhibition rate	10.96	%
18191	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase PAK 6 [human]	inhibition rate	-5.19	%
18192	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	RAC-alpha serine/threonine-protein kinase [human]	inhibition rate	4.25	%
18193	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase 10 [human]	inhibition rate	-1.3	%
18194	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Death-associated protein kinase 2 [human]	inhibition rate	-5.46	%
18195	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Dual specificity protein kinase CLK4 [human]	inhibition rate	5.97	%
18196	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	G protein-coupled receptor kinase 4 [human]	inhibition rate	3.74	%
18197	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Transient receptor potential cation channel subfamily M member 7 [human]	inhibition rate	5.6	%
18198	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Megakaryocyte-associated tyrosine-protein kinase [human]	inhibition rate	0.47	%
18199	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 4 [human]	inhibition rate	2.29	%
18200	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition rate	2.72	%
18201	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	17.05	%
18202	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	SRSF protein kinase 2 [human]	inhibition rate	6.17	%
18203	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase Nek4 [human]	inhibition rate	1.04	%
18204	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Cyclin-dependent kinase 1 [human]; G2/mitotic-specific cyclin-B1 [human]	inhibition rate	6.77	%
18205	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Casein kinase II subunit alpha' [human]	inhibition rate	2.14	%
18206	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Tyrosine-protein kinase JAK2 [human]	inhibition rate	7.92	%
18207	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase TAO3 [human]	inhibition rate	-12.06	%
18208	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Casein kinase I isoform alpha (isoform CK1A-L) [human]	inhibition rate	-6.08	%
18209	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Fibroblast growth factor receptor 4 [human]	inhibition rate	10.71	%
18210	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Cyclin E [human]; Megakaryocyte-associated tyrosine-protein kinase [human]	inhibition rate	0.97	%
18211	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase Nek6 [human]	inhibition rate	16.75	%
18212	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Mitogen-activated protein kinase kinase kinase 1 [human]	inhibition rate	12.24	%
18213	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Protein kinase C, epsilon [human]	inhibition rate	7.97	%
18214	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Muscle, skeletal receptor tyrosine-protein kinase [human]	inhibition rate	8.08	%
18215	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Beta-adrenergic receptor kinase 1 [human]	inhibition rate	-4.19	%
18216	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Ribosomal protein S6 kinase beta-1 [human]	inhibition rate	0.72	%
18217	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Rhodopsin kinase [human]	inhibition rate	7.06	%
18218	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Mitogen-activated protein kinase 7 [human]	inhibition rate	2.19	%
18219	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Tyrosine-protein kinase Lyn (isoform 2) [human]	inhibition rate	6.66	%
18220	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Platelet-derived growth factor receptor alpha [human]	inhibition rate	-1.82	%
18221	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	RAF proto-oncogene serine/threonine-protein kinase [human]	inhibition rate	-0.47	%
18222	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Tyrosine-protein kinase ZAP-70 [human]	inhibition rate	-2.35	%
18223	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Protein kinase C beta type (isoform Beta-II) [human]	inhibition rate	6.31	%
18224	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Death-associated protein kinase 3 [human]	inhibition rate	-3.51	%
18225	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial [human]	inhibition rate	15.3	%
18226	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase BRSK1 [human]	inhibition rate	4.18	%
18227	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Mitogen-activated protein kinase kinase kinase 21 [human]	inhibition rate	15.39	%
18228	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Homeodomain-interacting protein kinase 1 [human]	inhibition rate	-3	%
18229	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Citron Rho-interacting kinase [human]	inhibition rate	4.11	%
18230	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Dual specificity testis-specific protein kinase 1 [human]	inhibition rate	21.34	%
18231	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	inhibition rate	10.51	%
18232	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Dual specificity mitogen-activated protein kinase kinase 1 [human]	inhibition rate	-13.34	%
18233	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Ephrin type-B receptor 4 [human]	inhibition rate	10.77	%
18234	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	TGF-beta receptor type-2 [human]	inhibition rate	-2.82	%
18235	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Tau-tubulin kinase 2 [human]	inhibition rate	5.7	%
18236	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	cyclin-y [human]; Cyclin-dependent kinase 17 [human]	inhibition rate	3.99	%
18237	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	9.95	%
18238	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase TOUSLED-like 2 [human]	inhibition rate	2.64	%
18239	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Cyclin-dependent kinase 1 [human]; Cyclin-A1 [human]	inhibition rate	3.72	%
18240	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Dual serine/threonine and tyrosine protein kinase [human]	inhibition rate	6.19	%
18241	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Myosin light chain kinase 2, skeletal/cardiac muscle [human]	inhibition rate	22.7	%
18242	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Mitogen-activated protein kinase kinase kinase 5 [human]	inhibition rate	1.12	%
18243	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	LIM domain kinase 2 [human]	inhibition rate	-10.93	%
18244	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Mitogen-activated protein kinase kinase kinase kinase 2 [human]	inhibition rate	9.16	%
18245	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	TGF-beta receptor type-1 [human]	inhibition rate	8.72	%
18246	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial [human]	inhibition rate	16.76	%
18247	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Mitogen-activated protein kinase kinase kinase 3 [human]	inhibition rate	29.67	%
18248	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase Plk3 [human]	inhibition rate	10.07	%
18249	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Myosin light chain kinase 3 [human]	inhibition rate	3.12	%
18250	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase Plk4 [human]	inhibition rate	-0.09	%
18251	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Mitogen-activated protein kinase kinase kinase 9 [human]	inhibition rate	6.79	%
18252	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Vascular endothelial growth factor receptor 1 [human]	inhibition rate	5.38	%
18253	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Cyclin-dependent kinase 4 [human]; G1/S-specific cyclin-D1 [human]	inhibition rate	4.66	%
18254	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	cAMP-dependent protein kinase catalytic subunit PRKX [human]	inhibition rate	-0.94	%
18255	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	cAMP-dependent protein kinase catalytic subunit gamma [human]	inhibition rate	4.5	%
18256	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Dual specificity protein kinase CLK2 [human]	inhibition rate	6.65	%
18257	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	eukaryotic elongation factor 2 kinase [human]	inhibition rate	2.43	%
18258	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Dual specificity mitogen-activated protein kinase kinase 3 [human]	inhibition rate	9.98	%
18259	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase 3 [human]	inhibition rate	13.6	%
18260	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase receptor R3 [human]	inhibition rate	-1.66	%
18261	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Dual specificity mitogen-activated protein kinase kinase 7 [human]	inhibition rate	7.78	%
18262	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	RAC-gamma serine/threonine-protein kinase [human]	inhibition rate	22.48	%
18263	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Ephrin type-A receptor 3 [human]	inhibition rate	17.01	%
18264	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Kinase suppressor of Ras 1 [human]	inhibition rate	-23.33	%
18265	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase SIK3 [human]	inhibition rate	-1.97	%
18266	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	cGMP-dependent protein kinase 2 [human]	inhibition rate	7.88	%
18267	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Wee1-like protein kinase [human]	inhibition rate	30.95	%
18268	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase ICK [human]	inhibition rate	7.9	%
18269	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	LIM domain kinase 1 [human]	inhibition rate	9.54	%
18270	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Fibroblast growth factor receptor 3 [human]	inhibition rate	-1.8	%
18271	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Ribosomal protein S6 kinase alpha-1 [human]	inhibition rate	4.03	%
18272	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	cyclin-y [human]; Cyclin-dependent kinase 14 [human]	inhibition rate	4.8	%
18273	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Tyrosine-protein kinase ABL2 [human]	inhibition rate	5.97	%
18274	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	5'-AMP-activated protein kinase catalytic subunit alpha-1 [human];+5'-AMP-activated protein kinase subunit beta-1 [human];+5'-AMP-activated protein kinase subunit gamma-1 [human]	inhibition rate	1.79	%
18275	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Receptor tyrosine-protein kinase erbB-4 [human]	inhibition rate	0.97	%
18276	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Rho-associated protein kinase 2 [human]	inhibition rate	2.04	%
18277	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	cGMP-dependent protein kinase 1 (isoform Beta) [human]	inhibition rate	-6.04	%
18278	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	5'-AMP-activated protein kinase catalytic subunit alpha-1 [human];+5'-AMP-activated protein kinase subunit beta-1 [human];+5'-AMP-activated protein kinase subunit gamma-3 [human]	inhibition rate	4.12	%
18279	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Protein kinase C beta type (isoform Beta-I) [human]	inhibition rate	-0.03	%
18280	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Homeodomain-interacting protein kinase 4 [human]	inhibition rate	3.2	%
18281	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	5'-AMP-activated protein kinase catalytic subunit alpha-2 [human];+5'-AMP-activated protein kinase subunit beta-1 [human];+5'-AMP-activated protein kinase subunit gamma-1 [human]	inhibition rate	2.82	%
18282	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Bone morphogenetic protein receptor type-1B [human]	inhibition rate	15.53	%
18283	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	5'-AMP-activated protein kinase catalytic subunit alpha-1 [human];+5'-AMP-activated protein kinase subunit beta-1 [human];+5'-AMP-activated protein kinase subunit gamma-1 [human]	inhibition rate	8.77	%
18284	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	cyclin-y [human]; Cyclin-dependent kinase 16 [human]	inhibition rate	10.61	%
18285	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Calcium/calmodulin-dependent protein kinase kinase 1 [human]	inhibition rate	7.52	%
18286	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Platelet-derived growth factor receptor beta [human]	inhibition rate	25.66	%
18287	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human];+Phosphatidylinositol 3-kinase regulatory subunit alpha [human]	inhibition rate	38.78	%
18288	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Phosphatidylinositol 3-kinase regulatory subunit alpha [human];+Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E542K) [human]	inhibition rate	36.74	%
18289	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Phosphatidylinositol 3-kinase regulatory subunit alpha [human];+Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047R) [human]	inhibition rate	34.78	%
18290	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [human];+Phosphatidylinositol 3-kinase regulatory subunit alpha [human]	inhibition rate	28.5	%
18291	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Phosphatidylinositol 3-kinase regulatory subunit alpha (isoform 3) [human];+Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human]	inhibition rate	26.17	%
18292	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Phosphatidylinositol 3-kinase regulatory subunit alpha [human];+Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545K) [human]	inhibition rate	20.96	%
18293	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform [human]	inhibition rate	17.06	%
18294	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [human];+Phosphatidylinositol 3-kinase regulatory subunit alpha [human]	inhibition rate	16.76	%
18295	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Phosphatidylinositol 4-kinase alpha [human]	inhibition rate	16.12	%
18296	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma [human]	inhibition rate	13.52	%
18297	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Ephrin type-B receptor 3 [human]	inhibition rate	13.52	%
18298	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Aurora kinase C [human]	inhibition rate	12.95	%
18299	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Protein kinase C, theta [human]	inhibition rate	12.01	%
18300	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase MRCK alpha [human]	inhibition rate	11.98	%
18301	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase DCLK1 [human]	inhibition rate	10.86	%
18302	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Microtubule-associated serine/threonine-protein kinase 3 [human]	inhibition rate	7.3	%
18303	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Rhodopsin kinase [human]	inhibition rate	5.49	%
18304	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Insulin-like growth factor 1 receptor [human]	inhibition rate	3.65	%
18305	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Tyrosine-protein kinase ITK/TSK [human]	inhibition rate	1.2	%
18306	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	5'-AMP-activated protein kinase catalytic subunit alpha-2 [human];+5'-AMP-activated protein kinase subunit beta-1 [human];+5'-AMP-activated protein kinase subunit gamma-3 [human]	inhibition rate	2.31	%
18307	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Phosphatidylinositol 3-kinase catalytic subunit type 3 [human]	inhibition rate	1.41	%
18308	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	5'-AMP-activated protein kinase catalytic subunit alpha-1 [human];+5'-AMP-activated protein kinase subunit beta-2 [human];+5'-AMP-activated protein kinase subunit gamma-2 [human]	inhibition rate	-1.64	%
18309	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha [human]	inhibition rate	-2.31	%
18310	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	5'-AMP-activated protein kinase catalytic subunit alpha-2 [human];+5'-AMP-activated protein kinase subunit beta-1 [human];+5'-AMP-activated protein kinase subunit gamma-2 [human]	inhibition rate	-3.32	%
18311	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	5-aminosalicylate dioxygenase [human];+5'-AMP-activated protein kinase subunit beta-2 [human];+5'-AMP-activated protein kinase subunit gamma-3 [human]	inhibition rate	-5.7	%
18312	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Ribosomal protein S6 kinase beta-2 [human]	inhibition rate	-6.1	%
18313	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Phosphatidylinositol 4-kinase type 2-alpha [human]	inhibition rate	-6.5	%
18314	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Ephrin type-A receptor 8 [human]	inhibition rate	-8.96	%
18315	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human]	inhibition rate	-0.43	%
18316	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase LATS1 [human]	inhibition rate	6.96	%
18317	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase DCLK1 [human]	inhibition rate	10.86	%
18318	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Sphingosine kinase 1 [human]	inhibition rate	3.31	%
18319	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Phosphatidylinositol 4-kinase beta [human]	inhibition rate	2.16	%
18320	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Sphingosine kinase 2 [human]	inhibition rate	-35.66	%
18321	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human]	inhibition rate	-0.43	%
18322	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	DNA-dependent protein kinase catalytic subunit [human]	S50 (50% inhibition of regrowth fraction)	0.34	μM
18323	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	DNA-dependent protein kinase catalytic subunit [human]	S50 (50% inhibition of regrowth fraction)	0.23	μM
18324	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1		S50 (50% inhibition of regrowth fraction)	10	μM
18325	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	DNA-dependent protein kinase catalytic subunit [human]	number of clonogens per gram of tumor tissue decrease		
18326	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase LATS1 [human]	inhibition rate	6.96	%
18327	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase STK11 [human]	inhibition rate	6.76	%
18328	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase Nek7 [human]	inhibition rate	-4.84	%
18329	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	STE20/SPS1-related proline-alanine-rich protein kinase [human]	inhibition rate	-10.49	%
18330	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Myosin-IIIb [human]	inhibition rate	-11.45	%
18331	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Tyrosine-protein kinase Mer [human]	inhibition rate	1.08	%
18332	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Mitogen-activated protein kinase kinase kinase kinase 4 [human]	inhibition rate	-2.13	%
18333	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	RAC-beta serine/threonine-protein kinase [human]	inhibition rate	14.71	%
18334	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Mitogen-activated protein kinase kinase kinase 6 [human]	inhibition rate	-8.71	%
18335	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	cAMP-dependent protein kinase catalytic subunit beta [human]	inhibition rate	10.24	%
18336	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Mitogen-activated protein kinase 9 [human]	inhibition rate	37.65	%
18337	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Macrophage colony-stimulating factor 1 receptor [human]	inhibition rate	-1.68	%
18338	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase pim-1 [human]	inhibition rate	49.88	%
18339	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Mitogen-activated protein kinase 8 [human]	inhibition rate	25.47	%
18340	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Leucine-rich repeat serine/threonine-protein kinase 2 [human]	inhibition rate	13.46	%
18341	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Tyrosine-protein kinase receptor TYRO3 [human]	inhibition rate	2.27	%
18342	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Traf2 and NCK-interacting protein kinase [human]	inhibition rate	17.95	%
18343	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Maternal embryonic leucine zipper kinase [human]	inhibition rate	-12.6	%
18344	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase PAK 3 [human]	inhibition rate	-5.6	%
18345	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Eukaryotic translation initiation factor 2-alpha kinase 3 [human]	inhibition rate	20.06	%
18346	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Ribosomal protein S6 kinase alpha-6 [human]	inhibition rate	8.98	%
18347	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase 24 [human]	inhibition rate	-11.87	%
18348	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase/endoribonuclease IRE2 [human]	inhibition rate	11.23	%
18349	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase D3 [human]	inhibition rate	10.62	%
18350	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Mitogen-activated protein kinase 12 [human]	inhibition rate	-5.55	%
18351	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase D1 [human]	inhibition rate	2.26	%
18352	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Interleukin-1 receptor-associated kinase 4 [human]	inhibition rate	7.79	%
18353	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Mitogen-activated protein kinase 4 [human]	inhibition rate	2.57	%
18354	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	NUAK family SNF1-like kinase 1 [human]	inhibition rate	2.85	%
18355	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase PLK1 [human]	inhibition rate	5.66	%
18356	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase PLK2 [human]	inhibition rate	-16.13	%
18357	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Casein kinase I isoform epsilon [human]	inhibition rate	-1.74	%
18358	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	glycogen synthase kinase-3 beta [human]	inhibition rate	2.3	%
18359	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase Nek1 [human]	inhibition rate	-14.58	%
18360	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Myosin light chain kinase family member 4 [human]	inhibition rate	3.79	%
18361	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Testis-specific serine/threonine-protein kinase 3 [human]	inhibition rate	10.06	%
18362	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Activated CDC42 kinase 1 [human]	inhibition rate	0.03	%
18363	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase 16 [human]	inhibition rate	9.76	%
18364	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	STE20-like serine/threonine-protein kinase [human]	inhibition rate	7.62	%
18365	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Inhibitor of nuclear factor kappa-B kinase subunit epsilon [human]	inhibition rate	-0.3	%
18366	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	-12.83	%
18367	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Casein kinase I isoform alpha [human]	inhibition rate	-6.97	%
18368	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	MAP kinase-activated protein kinase 3 [human]	inhibition rate	-18.39	%
18369	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Tyrosine-protein kinase HCK [human]	inhibition rate	9.59	%
18370	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase Nek9 [human]	inhibition rate	21.46	%
18371	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	8.16	%
18372	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Mitogen-activated protein kinase 10 [human]	inhibition rate	34.42	%
18373	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Cyclin-dependent kinase 2 [human]; G1/S-specific cyclin-E2 [human]	inhibition rate	14	%
18374	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Proto-oncogene tyrosine-protein kinase LCK [human]	inhibition rate	-1.63	%
18375	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase Nek11 [human]	inhibition rate	12.98	%
18376	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase Sgk1 [human]	inhibition rate	4.12	%
18377	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Calcium/calmodulin-dependent protein kinase type 1 [human]	inhibition rate	-0.41	%
18378	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Insulin receptor-related protein [human]	inhibition rate	5.18	%
18379	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase D2 [human]	inhibition rate	8.65	%
18380	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Tyrosine-protein kinase receptor Tie-2 [human]	inhibition rate	4.75	%
18381	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase PAK 1 [human]	inhibition rate	-5.81	%
18382	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase 25 [human]	inhibition rate	-5.22	%
18383	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Bone morphogenetic protein receptor type-2 [human]	inhibition rate	-10.14	%
18384	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Cyclin-dependent kinase 2 [human]; Cyclin-O [human]	inhibition rate	8.48	%
18385	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Ephrin type-A receptor 1 [human]	inhibition rate	7.68	%
18386	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Calcium/calmodulin-dependent protein kinase type II subunit gamma [human]	inhibition rate	5.22	%
18387	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Receptor-interacting serine/threonine-protein kinase 2 [human]	inhibition rate	-0.38	%
18388	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Cyclin E [human]; Cyclin-dependent kinase 2 [human]	inhibition rate	4.48	%
18389	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase N1 [human]	inhibition rate	41.73	%
18390	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Epidermal growth factor receptor [human]	inhibition rate	2.52	%
18391	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	serine/threonine-protein kinase pak 2 [human]	inhibition rate	7.6	%
18392	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Connector enhancer of kinase suppressor of ras 2 [human]	inhibition rate	-13.24	%
18393	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Cyclin-dependent kinase 5 activator 1, p35 [human]; Cyclin-dependent-like kinase 5 [human]	inhibition rate	9.43	%
18394	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Proto-oncogene tyrosine-protein kinase Src [human]	inhibition rate	9.51	%
18395	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	SNF-related serine/threonine-protein kinase [human]	inhibition rate	13.46	%
18396	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Leukocyte tyrosine kinase receptor [human]	inhibition rate	-6.39	%
18397	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase TBK1 [human]	inhibition rate	3.16	%
18398	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Protein kinase C gamma type [human]	inhibition rate	-0.08	%
18399	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform [human]	inhibition rate	5.7	%
18400	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Mitogen-activated protein kinase kinase kinase kinase 1 [human]	inhibition rate	-5.09	%
18401	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase ULK1 [human]	inhibition rate	3.99	%
18402	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Testis-specific serine/threonine-protein kinase 1 [human]	inhibition rate	-4.44	%
18403	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	5'-AMP-activated protein kinase catalytic subunit alpha-1 [human];+5'-AMP-activated protein kinase subunit gamma-1 [human];+5'-AMP-activated protein kinase subunit beta-2 [human]	inhibition rate	-3.79	%
18404	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase ULK2 [human]	inhibition rate	4.24	%
18405	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Calcium/calmodulin-dependent protein kinase kinase 2 [human]	inhibition rate	10.86	%
18406	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Cyclin-dependent-like kinase 5 [human]; Cyclin-dependent kinase 5 activator 1, p25 [human]	inhibition rate	9.63	%
18407	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase 33 [human]	inhibition rate	7.86	%
18408	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Protein-tyrosine kinase 6 [human]	inhibition rate	-8.53	%
18409	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Cyclin-dependent kinase 6 [human]; G1/S-specific cyclin-D1 [human]	inhibition rate	1.36	%
18410	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	NUAK family SNF1-like kinase 2 [human]	inhibition rate	4.13	%
18411	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Tyrosine-protein kinase BTK [human]	inhibition rate	7.47	%
18412	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	ALK tyrosine kinase receptor [human]	inhibition rate	-27.32	%
18413	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Serine/threonine-protein kinase greatwall [human]	inhibition rate	-7.6	%
18414	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Cyclin-A1 [human]; Cyclin-dependent kinase 2 [human]	inhibition rate	7.44	%
18415	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Eukaryotic translation initiation factor 2-alpha kinase 1 [human]	inhibition rate	27.17	%
18416	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Calcium/calmodulin-dependent protein kinase type 1D [human]	inhibition rate	1.78	%
18417	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	5'-AMP-activated protein kinase catalytic subunit alpha-2 [human];+5'-AMP-activated protein kinase subunit beta-2 [human];+5'-AMP-activated protein kinase subunit gamma-3 [human]	inhibition rate	-8.22	%
18418	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Focal adhesion kinase 1 [human]	inhibition rate	7.3	%
18419	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Calcium/calmodulin-dependent protein kinase type 1B [human]	inhibition rate	11.49	%
18420	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	Inhibitor of nuclear factor kappa-B kinase subunit alpha [human]	inhibition rate	12.6	%
18421	COC1=CC=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCOCC2)C(C)=C1	G1/S-specific cyclin-E2 [human]; Cyclin-dependent kinase 3 [human]	inhibition rate	-26.16	%
18422	CN1CC=CCCOC2=CC=CC(=C2)C2=CC=NC(N2)=NC2=CC(C1)=CC=C2	Cyclin-dependent kinase 2 [human];+Cyclin-dependent kinase 9 [human];+Cyclin-dependent-like kinase 5 [human]; Cyclin-dependent kinase 7 [human]; Cyclin-dependent kinase 1 [human]; Cyclin-dependent kinase 3 [human]; Tyrosine-protein kinase JAK2 [human]; Receptor-type tyrosine-protein kinase FLT3 [human]	IC50	355.6	nM
18423	CN1CC=CCCOC2=CC=CC(=C2)C2=CC=NC(N2)=NC2=CC(C1)=CC=C2	Cyclin-dependent kinase 2 [human];+Cyclin-dependent kinase 9 [human];+Cyclin-dependent-like kinase 5 [human]; Cyclin-dependent kinase 7 [human]; Cyclin-dependent kinase 1 [human]; Cyclin-dependent kinase 3 [human]; Tyrosine-protein kinase JAK2 [human]; Receptor-type tyrosine-protein kinase FLT3 [human]	IC50	422.11	nM
18424	CN1CC=CCCOC2=CC=CC(=C2)C2=CC=NC(N2)=NC2=CC(C1)=CC=C2	Cyclin-dependent kinase 2 [human];+Cyclin-dependent kinase 9 [human];+Cyclin-dependent-like kinase 5 [human]; Cyclin-dependent kinase 7 [human]; Cyclin-dependent kinase 1 [human]; Cyclin-dependent kinase 3 [human]; Tyrosine-protein kinase JAK2 [human]; Receptor-type tyrosine-protein kinase FLT3 [human]	IC50	461.27	nM
18425	CN1CC=CCCOC2=CC=CC(=C2)C2=CC=NC(N2)=NC2=CC(C1)=CC=C2	Cyclin-dependent kinase 2 [human];+Cyclin-dependent kinase 9 [human];+Cyclin-dependent-like kinase 5 [human]; Cyclin-dependent kinase 7 [human]; Cyclin-dependent kinase 1 [human]; Cyclin-dependent kinase 3 [human]; Tyrosine-protein kinase JAK2 [human]; Receptor-type tyrosine-protein kinase FLT3 [human]	induction rate		
18426	CN1CC=CCCOC2=CC=CC(=C2)C2=CC=NC(N2)=NC2=CC(C1)=CC=C2	Cyclin-dependent kinase 2 [human];+Cyclin-dependent kinase 9 [human];+Cyclin-dependent-like kinase 5 [human]; Cyclin-dependent kinase 7 [human]; Cyclin-dependent kinase 1 [human]; Cyclin-dependent kinase 3 [human]; Tyrosine-protein kinase JAK2 [human]; Receptor-type tyrosine-protein kinase FLT3 [human]	induction rate		
18427	CN1CC=CCCOC2=CC=CC(=C2)C2=CC=NC(N2)=NC2=CC(C1)=CC=C2	Cyclin-dependent kinase 2 [human];+Cyclin-dependent kinase 9 [human];+Cyclin-dependent-like kinase 5 [human]; Cyclin-dependent kinase 7 [human]; Cyclin-dependent kinase 1 [human]; Cyclin-dependent kinase 3 [human]; Tyrosine-protein kinase JAK2 [human]; Receptor-type tyrosine-protein kinase FLT3 [human]	induction rate		
18428	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase haspin [human]	IC50	50	nM
18429	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase haspin	IC50	65.8	nM
18430	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase Plk3	IC50	117	nM
18431	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase PLK2	IC50	125	nM
18432	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase PLK1	IC50	294	nM
18433	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Dual specificity protein kinase CLK1 [Mus musculus]	IC50	445	nM
18434	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Death-associated protein kinase 3	IC50	578	nM
18435	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	dual specificity tyrosine-phosphorylation-regulated kinase 1a [rattus norvegicus]	IC50	917	nM
18436	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O		EC50	3.2	μM
18437	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase haspin [human]	EC50	4.4	μM
18438	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase haspin [human]	EC50	5.8	μM
18439	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase haspin [human]	EC50	6.2	μM
18440	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase haspin [human]	EC50	8.5	μM
18441	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin-T [human];+Cyclin-dependent kinase 9 [human]	activity percentage	59	%
18442	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	glycogen synthase kinase-3 beta [human]	activity percentage	76	%
18443	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Casein kinase I isoform epsilon [human]	activity percentage	95	%
18444	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin-dependent-like kinase 5 [human];+Cyclin-dependent kinase 5 activator 1, p25 [human]	activity percentage	100	%
18445	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase pim-1 [human]	activity percentage	100	%
18446	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase ABL1 [human]	activity percentage	82	%
18447	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase JAK3 [human]	activity percentage	95	%
18448	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Epidermal growth factor receptor	inhibition percentage	12	%
18449	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Epidermal growth factor receptor (C797S)	inhibition percentage	15	%
18450	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Epidermal growth factor receptor (G719C)	inhibition percentage	59	%
18451	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Epidermal growth factor receptor (G719S)	inhibition percentage	9	%
18452	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Epidermal growth factor receptor (L858R)	inhibition percentage	10	%
18453	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Epidermal growth factor receptor (L861Q)	inhibition percentage	8	%
18454	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Epidermal growth factor receptor (T790M)	inhibition percentage	43	%
18455	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Epidermal growth factor receptor (T790M, C797S, L858R)	inhibition percentage	18	%
18456	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Epidermal growth factor receptor (T790M, L858R)	inhibition percentage	52	%
18457	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Ephrin type-A receptor 1	inhibition percentage	48	%
18458	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Ephrin type-A receptor 2	inhibition percentage	28	%
18459	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Ephrin type-A receptor 4	inhibition percentage	45	%
18460	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Ephrin type-A receptor 5	inhibition percentage	23	%
18461	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Ephrin type-A receptor 8	inhibition percentage	11	%
18462	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Ephrin type-B receptor 1	inhibition percentage	38	%
18463	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Ephrin type-B receptor 2	inhibition percentage	26	%
18464	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Ephrin type-B receptor 3	inhibition percentage	69	%
18465	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Ephrin type-B receptor 3	inhibition percentage	96	%
18466	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Ephrin type-B receptor 4	inhibition percentage	14	%
18467	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Receptor tyrosine-protein kinase erbB-2	inhibition percentage	16	%
18468	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Receptor tyrosine-protein kinase erbB-4	inhibition percentage	8	%
18469	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase Fer	inhibition percentage	51	%
18470	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase, Fes/Fps type	inhibition percentage	61	%
18471	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Fibroblast growth factor receptor 1	inhibition percentage	39	%
18472	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Fibroblast growth factor receptor 2	inhibition percentage	20	%
18473	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Fibroblast growth factor receptor 2 (N549H)	inhibition percentage	5	%
18474	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Fibroblast growth factor receptor 3	inhibition percentage	5	%
18475	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Fibroblast growth factor receptor 3 (K650E)	inhibition percentage	13	%
18476	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Fibroblast growth factor receptor 3 (K650M)	inhibition percentage	54	%
18477	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Fibroblast growth factor receptor 3 (V555M)	inhibition percentage	6	%
18478	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Fibroblast growth factor receptor 4	inhibition percentage	9	%
18479	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase Fgr	inhibition percentage	47	%
18480	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Vascular endothelial growth factor receptor 1	inhibition percentage	11	%
18481	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Receptor-type tyrosine-protein kinase FLT3	inhibition percentage	60	%
18482	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Receptor-type tyrosine-protein kinase FLT3 (D835Y)	inhibition percentage	79	%
18483	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Vascular endothelial growth factor receptor 3	inhibition percentage	67	%
18484	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase mTOR	inhibition percentage	11	%
18485	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase FRK	inhibition percentage	22	%
18486	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase Fyn	inhibition percentage	23	%
18487	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	G protein-coupled receptor kinase 4	inhibition percentage	30	%
18488	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	G protein-coupled receptor kinase 4	inhibition percentage	80	%
18489	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	G protein-coupled receptor kinase 5	inhibition percentage	61	%
18490	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	G protein-coupled receptor kinase 6	inhibition percentage	24	%
18491	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	G protein-coupled receptor kinase 6	inhibition percentage	80	%
18492	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	rhodopsin kinase	inhibition percentage	51	%
18493	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Glycogen synthase kinase-3 alpha	inhibition percentage	60	%
18494	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Glycogen synthase kinase-3 alpha	inhibition percentage	91	%
18495	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	tau-protein kinase	inhibition percentage	69	%
18496	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	tau-protein kinase	inhibition percentage	92	%
18497	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase HCK	inhibition percentage	17	%
18498	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Homeodomain-interacting protein kinase 1	inhibition percentage	58	%
18499	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Homeodomain-interacting protein kinase 2	inhibition percentage	37	%
18500	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Homeodomain-interacting protein kinase 2	inhibition percentage	80	%
18501	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Homeodomain-interacting protein kinase 3	inhibition percentage	21	%
18502	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Homeodomain-interacting protein kinase 4	inhibition percentage	39	%
18503	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Insulin-like growth factor 1 receptor	inhibition percentage	8	%
18504	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Inhibitor of nuclear factor kappa-B kinase subunit beta	inhibition percentage	40	%
18505	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	inhibition percentage	37	%
18506	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Insulin receptor	inhibition percentage	11	%
18507	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Insulin receptor-related protein	inhibition percentage	13	%
18508	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Interleukin-1 receptor-associated kinase 4	inhibition percentage	15	%
18509	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase ITK/TSK	inhibition percentage	19	%
18510	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase JAK1	inhibition percentage	16	%
18511	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase JAK2	inhibition percentage	11	%
18512	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase JAK2	inhibition percentage	26	%
18513	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase JAK2	inhibition percentage	28	%
18514	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase JAK3	inhibition percentage	3	%
18515	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Vascular endothelial growth factor receptor 2	inhibition percentage	47	%
18516	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Vascular endothelial growth factor receptor 2	inhibition percentage	88	%
18517	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mast/stem cell growth factor receptor Kit	inhibition percentage	66	%
18518	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mast/stem cell growth factor receptor Kit (T670I)	inhibition percentage	66	%
18519	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mast/stem cell growth factor receptor Kit (V559D)	inhibition percentage	52	%
18520	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mast/stem cell growth factor receptor Kit (V559D, V654A)	inhibition percentage	17	%
18521	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mast/stem cell growth factor receptor Kit (V560G)	inhibition percentage	54	%
18522	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Connector enhancer of kinase suppressor of ras 2	inhibition percentage	35	%
18523	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Proto-oncogene tyrosine-protein kinase LCK	inhibition percentage	32	%
18524	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Leukocyte tyrosine kinase receptor	inhibition percentage	21	%
18525	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase Lyn (isoform LYN A)	inhibition percentage	20	%
18526	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase Lyn (isoform LYN B)	inhibition percentage	24	%
18527	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Dual specificity mitogen-activated protein kinase kinase 1	inhibition percentage	57	%
18528	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Dual specificity mitogen-activated protein kinase kinase 2	inhibition percentage	41	%
18529	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Dual specificity mitogen-activated protein kinase kinase 6	inhibition percentage	30	%
18530	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase kinase kinase 19	inhibition percentage	64	%
18531	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase kinase kinase 8	inhibition percentage	41	%
18532	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase kinase kinase 9	inhibition percentage	29	%
18533	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase kinase kinase kinase 2	inhibition percentage	39	%
18534	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase kinase kinase kinase 4	inhibition percentage	69	%
18535	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase kinase kinase kinase 5	inhibition percentage	43	%
18536	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase 1	inhibition percentage	16	%
18537	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase 10	inhibition percentage	17	%
18538	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase 11	inhibition percentage	30	%
18539	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase 12	inhibition percentage	28	%
18540	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase 13	inhibition percentage	23	%
18541	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase 14	inhibition percentage	19	%
18542	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase 14	inhibition percentage	2	%
18543	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase 3	inhibition percentage	21	%
18544	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase 7	inhibition percentage	32	%
18545	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase 8	inhibition percentage	72	%
18546	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase 9	inhibition percentage	46	%
18547	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	MAP kinase-activated protein kinase 2	inhibition percentage	13	%
18548	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	MAP kinase-activated protein kinase 3	inhibition percentage	29	%
18549	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	MAP kinase-activated protein kinase 5	inhibition percentage	40	%
18550	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase MARK1	inhibition percentage	30	%
18551	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase MARK2	inhibition percentage	37	%
18552	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase MARK3	inhibition percentage	42	%
18553	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	MAP/microtubule affinity-regulating kinase 4	inhibition percentage	56	%
18554	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Megakaryocyte-associated tyrosine-protein kinase	inhibition percentage	-1	%
18555	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Maternal embryonic leucine zipper kinase	inhibition percentage	47	%
18556	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Maternal embryonic leucine zipper kinase	inhibition percentage	91	%
18557	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase Mer	inhibition percentage	18	%
18558	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Hepatocyte growth factor receptor	inhibition percentage	13	%
18559	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Hepatocyte growth factor receptor (Y1235D)	inhibition percentage	1	%
18560	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Hepatocyte growth factor receptor (M1250T)	inhibition percentage	22	%
18561	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Misshapen-like kinase 1	inhibition percentage	59	%
18562	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	MAP kinase-interacting serine/threonine-protein kinase 1	inhibition percentage	12	%
18563	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Macrophage-stimulating protein receptor	inhibition percentage	23	%
18564	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase 26	inhibition percentage	33	%
18565	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Muscle, skeletal receptor tyrosine-protein kinase	inhibition percentage	44	%
18566	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	29	%
18567	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase Nek1	inhibition percentage	56	%
18568	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase Nek2	inhibition percentage	78	%
18569	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase Nek4	inhibition percentage	29	%
18570	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase Nek6	inhibition percentage	29	%
18571	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase Nek9	inhibition percentage	5	%
18572	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase NIM1	inhibition percentage	36	%
18573	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	High affinity nerve growth factor receptor	inhibition percentage	30	%
18574	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	BDNF/NT-3 growth factors receptor	inhibition percentage	16	%
18575	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	NT-3 growth factor receptor	inhibition percentage	30	%
18576	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	NUAK family SNF1-like kinase 2	inhibition percentage	22	%
18577	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase PAK 1	inhibition percentage	8	%
18578	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase PAK2	inhibition percentage	1	%
18579	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase PAK 3	inhibition percentage	8	%
18580	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase PAK 4	inhibition percentage	11	%
18581	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase PAK 6	inhibition percentage	13	%
18582	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase PAK5	inhibition percentage	14	%
18583	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	PAS domain-containing serine/threonine-protein kinase	inhibition percentage	59	%
18584	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Platelet-derived growth factor receptor alpha	inhibition percentage	7	%
18585	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Platelet-derived growth factor receptor alpha (D842V)	inhibition percentage	5	%
18586	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Platelet-derived growth factor receptor alpha (V561D)	inhibition percentage	3	%
18587	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Platelet-derived growth factor receptor alpha	inhibition percentage	35	%
18588	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Platelet-derived growth factor receptor beta	inhibition percentage	6	%
18589	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	3-phosphoinositide-dependent protein kinase 1	inhibition percentage	47	%
18590	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	3-phosphoinositide-dependent protein kinase 1	inhibition percentage	14	%
18591	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Inactive tyrosine-protein kinase PEAK1	inhibition percentage	15	%
18592	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase pim-1	inhibition percentage	26	%
18593	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase pim-2	inhibition percentage	13	%
18594	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase pim-3	inhibition percentage	13	%
18595	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase N1	inhibition percentage	23	%
18596	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase N2	inhibition percentage	47	%
18597	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase N2	inhibition percentage	91	%
18598	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase PLK1	inhibition percentage	87	%
18599	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase PLK1	inhibition percentage	97	%
18600	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase PLK2	inhibition percentage	96	%
18601	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase PLK2	inhibition percentage	97	%
18602	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase Plk3	inhibition percentage	85	%
18603	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase Plk3	inhibition percentage	95	%
18604	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	cAMP-dependent protein kinase catalytic subunit alpha	inhibition percentage	68	%
18605	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Protein kinase C alpha type	inhibition percentage	40	%
18606	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Protein kinase C beta type (isoform Beta-I)	inhibition percentage	28	%
18607	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Protein kinase C beta type (isoform Beta-II)	inhibition percentage	30	%
18608	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Protein kinase C, delta	inhibition percentage	19	%
18609	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Protein kinase C, epsilon	inhibition percentage	32	%
18610	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Protein kinase C gamma type	inhibition percentage	21	%
18611	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Protein kinase C, eta	inhibition percentage	32	%
18612	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Protein kinase C iota type	inhibition percentage	22	%
18613	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase D3	inhibition percentage	74	%
18614	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Protein kinase C, theta	inhibition percentage	30	%
18615	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Protein kinase C zeta type	inhibition percentage	5	%
18616	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase D1	inhibition percentage	73	%
18617	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase D2	inhibition percentage	26	%
18618	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase D2	inhibition percentage	84	%
18619	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	cGMP-dependent protein kinase 1	inhibition percentage	55	%
18620	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	cGMP-dependent protein kinase 2	inhibition percentage	70	%
18621	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	cAMP-dependent protein kinase catalytic subunit PRKX	inhibition percentage	79	%
18622	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase PTK2	inhibition percentage	21	%
18623	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Protein-tyrosine kinase 2-beta	inhibition percentage	24	%
18624	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Protein-tyrosine kinase 6	inhibition percentage	34	%
18625	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	RAF proto-oncogene serine/threonine-protein kinase (Y340D, Y341D)	inhibition percentage	47	%
18626	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Proto-oncogene tyrosine-protein kinase receptor Ret	inhibition percentage	52	%
18627	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Proto-oncogene tyrosine-protein kinase receptor Ret (A883F)	inhibition percentage	7	%
18628	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Proto-oncogene tyrosine-protein kinase receptor Ret (S891A)	inhibition percentage	32	%
18629	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Proto-oncogene tyrosine-protein kinase receptor Ret (V804E)	inhibition percentage	6	%
18630	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Proto-oncogene tyrosine-protein kinase receptor Ret (V804L)	inhibition percentage	38	%
18631	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase ABL1 (E255K)	inhibition percentage	20	%
18632	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Proto-oncogene tyrosine-protein kinase receptor Ret (Y791F)	inhibition percentage	42	%
18633	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Rho-associated protein kinase 1	inhibition percentage	29	%
18634	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Rho-associated protein kinase 1	inhibition percentage	84	%
18635	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Rho-associated protein kinase 2	inhibition percentage	69	%
18636	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Proto-oncogene tyrosine-protein kinase ROS	inhibition percentage	48	%
18637	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Proto-oncogene tyrosine-protein kinase ROS	inhibition percentage	89	%
18638	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Ribosomal protein S6 kinase alpha-1	inhibition percentage	27	%
18639	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Ribosomal protein S6 kinase alpha-3	inhibition percentage	14	%
18640	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Ribosomal protein S6 kinase alpha-2	inhibition percentage	49	%
18641	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Ribosomal protein S6 kinase alpha-4	inhibition percentage	50	%
18642	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Ribosomal protein S6 kinase alpha-4	inhibition percentage	88	%
18643	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Ribosomal protein S6 kinase alpha-5	inhibition percentage	58	%
18644	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Ribosomal protein S6 kinase alpha-6	inhibition percentage	41	%
18645	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase ABL1 (F317I)	inhibition percentage	13	%
18646	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Ribosomal protein S6 kinase beta-1	inhibition percentage	75	%
18647	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Ribosomal protein S6 kinase beta-2	inhibition percentage	48	%
18648	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase, Sbk1	inhibition percentage	0	%
18649	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase Sgk1	inhibition percentage	65	%
18650	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase Sgk2	inhibition percentage	51	%
18651	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	58	%
18652	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	AP2-associated protein kinase 1	inhibition percentage	29	%
18653	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Neuronal proto-oncogene tyrosine-protein kinase Src	inhibition percentage	11	%
18654	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	12	%
18655	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase Srms	inhibition percentage	59	%
18656	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase ABL1 (F317L)	inhibition percentage	7	%
18657	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	SRSF protein kinase 1	inhibition percentage	7	%
18658	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	SRSF protein kinase 2	inhibition percentage	1	%
18659	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Testis-specific serine/threonine-protein kinase 2	inhibition percentage	7	%
18660	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Testis-specific serine/threonine-protein kinase 1	inhibition percentage	42	%
18661	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	SRSF protein kinase 3	inhibition percentage	21	%
18662	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase 24	inhibition percentage	41	%
18663	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase 25	inhibition percentage	12	%
18664	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase 3	inhibition percentage	13	%
18665	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase 4	inhibition percentage	11	%
18666	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase SYK	inhibition percentage	47	%
18667	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase ABL1 (G250E)	inhibition percentage	18	%
18668	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase TAO2	inhibition percentage	20	%
18669	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase TBK1	inhibition percentage	42	%
18670	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Angiopoietin-1 receptor	inhibition percentage	15	%
18671	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Non-receptor tyrosine-protein kinase TNK1	inhibition percentage	11	%
18672	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase TXK	inhibition percentage	17	%
18673	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Non-receptor tyrosine-protein kinase TYK2	inhibition percentage	51	%
18674	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase receptor TYRO3	inhibition percentage	29	%
18675	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase yes	inhibition percentage	15	%
18676	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase ZAP-70	inhibition percentage	-2	%
18677	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase ABL1 (H396P)	inhibition percentage	38	%
18678	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase ABL1 (T315I)	inhibition percentage	25	%
18679	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase ABL1 (M351T)	inhibition percentage	12	%
18680	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase ABL1 (Q252H)	inhibition percentage	60	%
18681	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Activin receptor type-1	inhibition percentage	79	%
18682	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Activin receptor type-1 (R206H)	inhibition percentage	80	%
18683	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Activin receptor type-2A	inhibition percentage	56	%
18684	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Activin receptor type-2B	inhibition percentage	59	%
18685	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase receptor R3	inhibition percentage	118	%
18686	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase receptor R3	inhibition percentage	35	%
18687	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Atypical kinase COQ8A, mitochondrial	inhibition percentage	62	%
18688	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	ALK tyrosine kinase receptor (C1156Y)	inhibition percentage	16	%
18689	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	ALK tyrosine kinase receptor (F1174L)	inhibition percentage	35	%
18690	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase Abl (Y253F)	inhibition percentage	25	%
18691	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	ALK tyrosine kinase receptor (L1196M)	inhibition percentage	21	%
18692	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	ALK tyrosine kinase receptor (R1275Q)	inhibition percentage	20	%
18693	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	ALK tyrosine kinase receptor (T1151M, L1152insT)	inhibition percentage	18	%
18694	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	5'-AMP-activated protein kinase catalytic subunit alpha-1;+5'-AMP-activated protein kinase subunit beta-2;+5'-AMP-activated protein kinase subunit gamma-3	inhibition percentage	43	%
18695	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	5'-AMP-activated protein kinase catalytic subunit alpha-2;+5'-AMP-activated protein kinase subunit gamma-1;+5'-AMP-activated protein kinase subunit beta-2	inhibition percentage	36	%
18696	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	5'-AMP-activated protein kinase catalytic subunit alpha-2;+5'-AMP-activated protein kinase subunit beta-2;+5'-AMP-activated protein kinase subunit gamma-2	inhibition percentage	31	%
18697	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	5'-AMP-activated protein kinase catalytic subunit alpha-2;+5'-AMP-activated protein kinase subunit beta-1;+5'-AMP-activated protein kinase subunit gamma-1	inhibition percentage	60	%
18698	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Ankyrin repeat and protein kinase domain-containing protein 1	inhibition percentage	25	%
18699	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Ankyrin repeat and protein kinase domain-containing protein 1	inhibition percentage	88	%
18700	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Receptor tyrosine-protein kinase AXL (R499C)	inhibition percentage	31	%
18701	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Bone morphogenetic protein receptor type-1A	inhibition percentage	61	%
18702	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase ABL2	inhibition percentage	23	%
18703	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Bone morphogenetic protein receptor type-1B	inhibition percentage	61	%
18704	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Bone morphogenetic protein receptor type-1B	inhibition percentage	95	%
18705	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Bone morphogenetic protein receptor type-2	inhibition percentage	119	%
18706	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Bone morphogenetic protein receptor type-2	inhibition percentage	97	%
18707	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase B-raf	inhibition percentage	43	%
18708	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase B-raf (V599E)	inhibition percentage	43	%
18709	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase BRSK1	inhibition percentage	53	%
18710	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase BRSK2	inhibition percentage	40	%
18711	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Calcium/calmodulin-dependent protein kinase type II subunit gamma	inhibition percentage	44	%
18712	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Calcium/calmodulin-dependent protein kinase kinase 1	inhibition percentage	18	%
18713	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Calcium/calmodulin-dependent protein kinase kinase 2	inhibition percentage	31	%
18714	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Peripheral plasma membrane protein CASK	inhibition percentage	42	%
18715	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Activin receptor type-1B	inhibition percentage	4	%
18716	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin-dependent kinase 7; DDK kinase regulatory subunit DBF4	inhibition percentage	63	%
18717	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin-dependent kinase 7; DDK kinase regulatory subunit DBF4	inhibition percentage	95	%
18718	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin-dependent kinase 11	inhibition percentage	25	%
18719	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin-dependent kinase 11	inhibition percentage	81	%
18720	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin-C; Cyclin-dependent kinase 11	inhibition percentage	65	%
18721	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin-C; Cyclin-dependent kinase 11	inhibition percentage	93	%
18722	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin-dependent kinase 13; Cyclin-K	inhibition percentage	51	%
18723	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin-dependent kinase 13; Cyclin-K	inhibition percentage	93	%
18724	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin-dependent kinase 14; Cyclin Y	inhibition percentage	37	%
18725	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin Y; Cyclin-dependent kinase 16	inhibition percentage	37	%
18726	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	G2/mitotic-specific cyclin-A; Cyclin-dependent kinase 2	inhibition percentage	34	%
18727	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin-dependent kinase 2; G2/mitotic-specific cyclin-A	inhibition percentage	77	%
18728	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin-dependent kinase 2; G1/S-specific cyclin-E1	inhibition percentage	75	%
18729	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin-dependent kinase 2; Cyclin-O	inhibition percentage	68	%
18730	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Beta-adrenergic receptor kinase 1	inhibition percentage	16	%
18731	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	G1/S-specific cyclin-E1; Cyclin-dependent kinase 3	inhibition percentage	51	%
18732	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin-dependent-like kinase 5	inhibition percentage	34	%
18733	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin-dependent-like kinase 5; Cyclin-dependent kinase 5 activator 1, p25	inhibition percentage	74	%
18734	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin-dependent-like kinase 5; Cyclin-dependent kinase 5 activator 1, p35	inhibition percentage	72	%
18735	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin-dependent kinase 8; Cyclin-C	inhibition percentage	45	%
18736	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin-dependent kinase 8; Cyclin-C	inhibition percentage	94	%
18737	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin-dependent kinase 9	inhibition percentage	68	%
18738	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin-dependent kinase 9	inhibition percentage	94	%
18739	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin-K; Cyclin-dependent kinase 9	inhibition percentage	76	%
18740	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin-K; Cyclin-dependent kinase 9	inhibition percentage	95	%
18741	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Death-associated protein kinase 2	inhibition percentage	102	%
18742	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Death-associated protein kinase 2	inhibition percentage	118	%
18743	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Epithelial discoidin domain-containing receptor 1	inhibition percentage	9	%
18744	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Discoidin domain-containing receptor 2	inhibition percentage	8	%
18745	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Beta-adrenergic receptor kinase 2	inhibition percentage	22	%
18746	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Discoidin domain-containing receptor 2	inhibition percentage	30	%
18747	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Discoidin domain-containing receptor 2	inhibition percentage	59	%
18748	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Myotonin-protein kinase	inhibition percentage	69	%
18749	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Dual specificity tyrosine-phosphorylation-regulated kinase 2	inhibition percentage	110	%
18750	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Dual specificity tyrosine-phosphorylation-regulated kinase 2	inhibition percentage	85	%
18751	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Epidermal growth factor receptor (d746-750)	inhibition percentage	37	%
18752	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Epidermal growth factor receptor (d747-749, A750P)	inhibition percentage	40	%
18753	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Interferon-induced, double-stranded RNA-activated protein kinase	inhibition percentage	85	%
18754	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Ephrin type-A receptor 3	inhibition percentage	18	%
18755	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Ephrin type-A receptor 6	inhibition percentage	33	%
18756	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Ephrin type-A receptor 7	inhibition percentage	46	%
18757	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	RAC-alpha serine/threonine-protein kinase	inhibition percentage	43	%
18758	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Ethylene-responsive transcription factor ERN1	inhibition percentage	49	%
18759	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Ethylene-responsive transcription factor ERN2	inhibition percentage	39	%
18760	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Fibroblast growth factor receptor 1 (V561M)	inhibition percentage	53	%
18761	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Fibroblast growth factor receptor 3 (G697C)	inhibition percentage	59	%
18762	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Receptor-type tyrosine-protein kinase FLT3 ITD	inhibition percentage	53	%
18763	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase Fyn	inhibition percentage	11	%
18764	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin-G-associated kinase	inhibition percentage	106	%
18765	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin-G-associated kinase	inhibition percentage	68	%
18766	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	rhodopsin kinase	inhibition percentage	42	%
18767	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Hormonally up-regulated neu tumor-associated kinase	inhibition percentage	18	%
18768	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase ICK	inhibition percentage	48	%
18769	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	RAC-beta serine/threonine-protein kinase	inhibition percentage	55	%
18770	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Interleukin-1 receptor-associated kinase 3	inhibition percentage	53	%
18771	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Interleukin-1 receptor-associated kinase 3	inhibition percentage	95	%
18772	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mast/stem cell growth factor receptor Kit (A829P)	inhibition percentage	54	%
18773	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mast/stem cell growth factor receptor Kit (D816H)	inhibition percentage	54	%
18774	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mast/stem cell growth factor receptor Kit (D816V)	inhibition percentage	75	%
18775	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mast/stem cell growth factor receptor Kit (D820E)	inhibition percentage	29	%
18776	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mast/stem cell growth factor receptor Kit (N822K)	inhibition percentage	33	%
18777	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mast/stem cell growth factor receptor Kit (T670E)	inhibition percentage	84	%
18778	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mast/stem cell growth factor receptor Kit (V559D, T670I)	inhibition percentage	33	%
18779	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mast/stem cell growth factor receptor Kit (V654A)	inhibition percentage	41	%
18780	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mast/stem cell growth factor receptor Kit (Y823D)	inhibition percentage	30	%
18781	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	RAC-gamma serine/threonine-protein kinase	inhibition percentage	50	%
18782	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase LATS2	inhibition percentage	50	%
18783	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	LIM domain kinase 1	inhibition percentage	67	%
18784	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	LIM domain kinase 2	inhibition percentage	37	%
18785	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Dual specificity mitogen-activated protein kinase kinase 1	inhibition percentage	66	%
18786	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Dual specificity mitogen-activated protein kinase kinase 1 (S218D, S222D)	inhibition percentage	88	%
18787	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Dual specificity mitogen-activated protein kinase kinase 2	inhibition percentage	62	%
18788	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Dual specificity mitogen-activated protein kinase kinase 4	inhibition percentage	79	%
18789	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Dual specificity mitogen-activated protein kinase kinase 5	inhibition percentage	36	%
18790	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Dual specificity mitogen-activated protein kinase kinase 6	inhibition percentage	78	%
18791	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Dual specificity mitogen-activated protein kinase kinase 6 (S207E, T211E)	inhibition percentage	73	%
18792	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	ALK tyrosine kinase receptor	inhibition percentage	19	%
18793	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase kinase kinase 10	inhibition percentage	55	%
18794	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase kinase kinase 11	inhibition percentage	42	%
18795	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase kinase kinase 14	inhibition percentage	30	%
18796	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase kinase kinase 2	inhibition percentage	-39	%
18797	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase kinase kinase 3	inhibition percentage	1	%
18798	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase kinase kinase 5	inhibition percentage	-9	%
18799	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase kinase kinase 7	inhibition percentage	101	%
18800	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase kinase kinase 7	inhibition percentage	54	%
18801	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase kinase kinase kinase 1	inhibition percentage	51	%
18802	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase kinase kinase kinase 3	inhibition percentage	26	%
18803	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase 10	inhibition percentage	56	%
18804	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	5'-AMP-activated protein kinase catalytic subunit alpha-1;+5'-AMP-activated protein kinase subunit beta-1;+5'-AMP-activated protein kinase subunit gamma-2	inhibition percentage	34	%
18805	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase 15	inhibition percentage	51	%
18806	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase 15	inhibition percentage	85	%
18807	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase 8	inhibition percentage	1	%
18808	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase 9	inhibition percentage	3	%
18809	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase greatwall	inhibition percentage	66	%
18810	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase Mer (A708S)	inhibition percentage	25	%
18811	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Hepatocyte growth factor receptor (D1228H)	inhibition percentage	52	%
18812	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	MAP kinase-interacting serine/threonine-protein kinase 2	inhibition percentage	58	%
18813	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	MAP kinase-interacting serine/threonine-protein kinase 2	inhibition percentage	89	%
18814	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Myosin light chain kinase 3	inhibition percentage	51	%
18815	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase kinase kinase 21	inhibition percentage	23	%
18816	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	myosin light chain kinase	inhibition percentage	16	%
18817	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	5'-AMP-activated protein kinase catalytic subunit alpha-1;+5'-AMP-activated protein kinase subunit beta-1;+5'-AMP-activated protein kinase subunit gamma-3	inhibition percentage	49	%
18818	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Myosin light chain kinase family member 4	inhibition percentage	121	%
18819	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Myosin light chain kinase family member 4	inhibition percentage	42	%
18820	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Myosin-IIIa	inhibition percentage	43	%
18821	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Myosin-IIIb	inhibition percentage	43	%
18822	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase Nek8	inhibition percentage	24	%
18823	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine kinase NLK	inhibition percentage	51	%
18824	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	NUAK family SNF1-like kinase 2	inhibition percentage	87	%
18825	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	inhibition percentage	16	%
18826	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	inhibition percentage	53	%
18827	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Phosphatidylinositol 4-kinase type 2-alpha	inhibition percentage	11	%
18828	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Phosphatidylinositol 4-kinase type 2-beta	inhibition percentage	11	%
18829	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	5'-AMP-activated protein kinase catalytic subunit alpha-1;+5'-AMP-activated protein kinase subunit gamma-1;+5'-AMP-activated protein kinase subunit beta-2 (isoform 1)	inhibition percentage	31	%
18830	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Phosphatidylinositol 4-kinase alpha	inhibition percentage	19	%
18831	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Phosphatidylinositol 4-kinase beta	inhibition percentage	29	%
18832	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	inhibition percentage	24	%
18833	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase Plk4	inhibition percentage	76	%
18834	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	cAMP-dependent protein kinase catalytic subunit beta	inhibition percentage	37	%
18835	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	cAMP-dependent protein kinase catalytic subunit beta	inhibition percentage	83	%
18836	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	cAMP-dependent protein kinase catalytic subunit gamma	inhibition percentage	69	%
18837	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	RAF proto-oncogene serine/threonine-protein kinase (Y340D, Y341D)	inhibition percentage	40	%
18838	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Proto-oncogene tyrosine-protein kinase receptor Ret (G691S)	inhibition percentage	19	%
18839	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Proto-oncogene tyrosine-protein kinase receptor Ret (M918T)	inhibition percentage	9	%
18840	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M)	inhibition percentage	16	%
18841	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	5'-AMP-activated protein kinase catalytic subunit alpha-1;+5'-AMP-activated protein kinase subunit beta-2;+5'-AMP-activated protein kinase subunit gamma-2	inhibition percentage	29	%
18842	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Receptor-interacting serine/threonine-protein kinase 2	inhibition percentage	24	%
18843	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Receptor-interacting serine/threonine-protein kinase 3	inhibition percentage	-2	%
18844	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	LRR receptor-like serine/threonine-protein kinase SIK1	inhibition percentage	10	%
18845	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase SIK3	inhibition percentage	47	%
18846	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	STE20-like serine/threonine-protein kinase	inhibition percentage	47	%
18847	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase 16	inhibition percentage	54	%
18848	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase 17A	inhibition percentage	44	%
18849	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase 17A	inhibition percentage	87	%
18850	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase 17B	inhibition percentage	106	%
18851	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase 17B	inhibition percentage	86	%
18852	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase 32B	inhibition percentage	72	%
18853	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase 32C	inhibition percentage	72	%
18854	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	5'-AMP-activated protein kinase catalytic subunit alpha-2;+5'-AMP-activated protein kinase subunit beta-1;+5'-AMP-activated protein kinase subunit gamma-2	inhibition percentage	45	%
18855	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase 33	inhibition percentage	64	%
18856	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase 38	inhibition percentage	39	%
18857	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase 38-like	inhibition percentage	45	%
18858	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	STE20/SPS1-related proline-alanine-rich protein kinase	inhibition percentage	15	%
18859	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase TAO1	inhibition percentage	71	%
18860	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase TAO3	inhibition percentage	40	%
18861	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase Tec	inhibition percentage	22	%
18862	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase receptor Tie-2 (R849W)	inhibition percentage	9	%
18863	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase receptor Tie-2 (Y1108F)	inhibition percentage	28	%
18864	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase receptor Tie-2 (Y897S)	inhibition percentage	10	%
18865	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	5'-AMP-activated protein kinase catalytic subunit alpha-2;+5'-AMP-activated protein kinase subunit beta-1;+5'-AMP-activated protein kinase subunit gamma-3	inhibition percentage	47	%
18866	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Dual specificity testis-specific protein kinase 1	inhibition percentage	30	%
18867	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Dual specificity testis-specific protein kinase 2	inhibition percentage	19	%
18868	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	TGF-beta receptor type-1	inhibition percentage	38	%
18869	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	TGF-beta receptor type-1	inhibition percentage	84	%
18870	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	TGF-beta receptor type-2	inhibition percentage	107	%
18871	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	TGF-beta receptor type-2	inhibition percentage	123	%
18872	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase tousled-like 1	inhibition percentage	44	%
18873	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase TOUSLED-like 2	inhibition percentage	41	%
18874	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Traf2 and NCK-interacting protein kinase	inhibition percentage	26	%
18875	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Activated CDC42 kinase 1	inhibition percentage	40	%
18876	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Dual specificity protein kinase TTK	inhibition percentage	73	%
18877	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase ULK1	inhibition percentage	45	%
18878	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	5'-AMP-activated protein kinase catalytic subunit alpha-2;+5'-AMP-activated protein kinase subunit beta-2;+5'-AMP-activated protein kinase subunit gamma-3	inhibition percentage	20	%
18879	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase ULK2	inhibition percentage	39	%
18880	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase ULK3	inhibition percentage	37	%
18881	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase VRK2	inhibition percentage	-6	%
18882	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Wee1-like protein kinase	inhibition percentage	38	%
18883	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase WNK1	inhibition percentage	31	%
18884	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase WNK2	inhibition percentage	24	%
18885	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase WNK3	inhibition percentage	16	%
18886	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Mitogen-activated protein kinase kinase kinase 20	inhibition percentage	67	%
18887	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin-dependent kinase 4; Cyclin-D3-1	inhibition percentage	-1	%
18888	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	G1/S-specific cyclin-D1; Cyclin-dependent kinase 6	inhibition percentage	-11	%
18889	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	5'-AMP-activated protein kinase catalytic subunit alpha-1;+5'-AMP-activated protein kinase subunit beta-1;+5'-AMP-activated protein kinase subunit gamma-1	inhibition percentage	36	%
18890	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin-H;+CDK-activating kinase assembly factor MAT1; Cyclin-dependent kinase 7	inhibition percentage	41	%
18891	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin-dependent kinase 9; Cyclin-T1	inhibition percentage	67	%
18892	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Inhibitor of nuclear factor kappa-B kinase subunit alpha	inhibition percentage	49	%
18893	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Death-associated protein kinase 1	inhibition percentage	77	%
18894	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Death-associated protein kinase 1	inhibition percentage	98	%
18895	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase haspin	inhibition percentage	92	%
18896	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase haspin	inhibition percentage	99	%
18897	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Interleukin-1 receptor-associated kinase 1	inhibition percentage	35	%
18898	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Interleukin-1 receptor-associated kinase 1	inhibition percentage	81	%
18899	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Leucine-rich repeat serine/threonine-protein kinase 2	inhibition percentage	47	%
18900	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Leucine-rich repeat serine/threonine-protein kinase 2	inhibition percentage	54	%
18901	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Leucine-rich repeat serine/threonine-protein kinase 2	inhibition percentage	69	%
18902	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Leucine-rich repeat serine/threonine-protein kinase 2 (G2019S)	inhibition percentage	73	%
18903	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Aurora kinase A	inhibition percentage	75	%
18904	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Leucine-rich repeat serine/threonine-protein kinase 2 (I2020T)	inhibition percentage	60	%
18905	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Leucine-rich repeat serine/threonine-protein kinase 2 (R1441C)	inhibition percentage	57	%
18906	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	NUAK family SNF1-like kinase 1	inhibition percentage	28	%
18907	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha	inhibition percentage	6	%
18908	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	inhibition percentage	25	%
18909	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	inhibition percentage	32	%
18910	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Phosphatidylinositol 3-kinase catalytic subunit type 3	inhibition percentage	21	%
18911	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E542K); Phosphatidylinositol 3-kinase regulatory subunit alpha	inhibition percentage	30	%
18912	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Phosphatidylinositol 3-kinase regulatory subunit alpha; Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545K)	inhibition percentage	31	%
18913	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Phosphatidylinositol 3-kinase regulatory subunit alpha; Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition percentage	36	%
18914	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Aurora kinase B	inhibition percentage	45	%
18915	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase ABL1	inhibition percentage	19	%
18916	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform; Phosphatidylinositol 3-kinase regulatory subunit gamma	inhibition percentage	32	%
18917	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Phosphatidylinositol 3-kinase regulatory subunit alpha; Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	inhibition percentage	20	%
18918	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform; Phosphatidylinositol 3-kinase regulatory subunit beta	inhibition percentage	20	%
18919	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Phosphatidylinositol 3-kinase regulatory subunit alpha; Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	inhibition percentage	34	%
18920	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	inhibition percentage	18	%
18921	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	inhibition percentage	12	%
18922	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	inhibition percentage	9	%
18923	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Phosphatidylinositol 4-phosphate 5-kinase type-1 beta	inhibition percentage	12	%
18924	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	inhibition percentage	7	%
18925	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Sphingosine kinase 1	inhibition percentage	24	%
18926	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Aurora kinase C	inhibition percentage	55	%
18927	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Sphingosine kinase 2	inhibition percentage	28	%
18928	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Receptor tyrosine-protein kinase AXL	inhibition percentage	29	%
18929	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase Blk	inhibition percentage	25	%
18930	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cytoplasmic tyrosine-protein kinase BMX	inhibition percentage	25	%
18931	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase B-raf	inhibition percentage	31	%
18932	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase B-raf (V599E)	inhibition percentage	36	%
18933	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase BTK	inhibition percentage	50	%
18934	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Calcium/calmodulin-dependent protein kinase type 1	inhibition percentage	40	%
18935	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Calcium/calmodulin-dependent protein kinase type 1D	inhibition percentage	45	%
18936	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Calcium/calmodulin-dependent protein kinase type 1G	inhibition percentage	29	%
18937	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	AP2-associated protein kinase 1	inhibition percentage	125	%
18938	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	AP2-associated protein kinase 1	inhibition percentage	83	%
18939	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Calcium/calmodulin-dependent protein kinase type II subunit alpha	inhibition percentage	49	%
18940	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Calcium/calmodulin-dependent protein kinase type II subunit beta	inhibition percentage	34	%
18941	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Calcium/calmodulin-dependent protein kinase type II delta 2 chain	inhibition percentage	77	%
18942	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Calcium/calmodulin-dependent protein kinase type IV	inhibition percentage	33	%
18943	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase MRCK alpha	inhibition percentage	-1	%
18944	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase MRCK beta	inhibition percentage	-1	%
18945	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase MRCK gamma	inhibition percentage	33	%
18946	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	G2/mitotic-specific cyclin-B;+Cyclin-dependent kinase 1	inhibition percentage	61	%
18947	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin Y; Cyclin-dependent kinase 17	inhibition percentage	33	%
18948	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin Y; Cyclin-dependent kinase 18	inhibition percentage	70	%
18949	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin-dependent kinase 4; G1/S-specific cyclin-D1	inhibition percentage	3	%
18950	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	G2/mitotic-specific cyclin-A; Cyclin-dependent kinase 2	inhibition percentage	80	%
18951	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin-dependent kinase 9; Cyclin-T1	inhibition percentage	93	%
18952	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Cyclin-dependent kinase-like 5	inhibition percentage	14	%
18953	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase Chk1	inhibition percentage	12	%
18954	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase Chk2	inhibition percentage	74	%
18955	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Dual specificity protein kinase CLK1	inhibition percentage	53	%
18956	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Dual specificity protein kinase CLK1	inhibition percentage	93	%
18957	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Dual specificity protein kinase CLK2	inhibition percentage	57	%
18958	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Dual specificity protein kinase CLK2	inhibition percentage	84	%
18959	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Dual specificity protein kinase CLK3	inhibition percentage	67	%
18960	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Dual specificity protein kinase CLK4	inhibition percentage	98	%
18961	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Dual specificity protein kinase CLK4	inhibition percentage	99	%
18962	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Macrophage colony-stimulating factor 1 receptor	inhibition percentage	68	%
18963	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Macrophage colony-stimulating factor 1 receptor	inhibition percentage	86	%
18964	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Tyrosine-protein kinase CSK	inhibition percentage	14	%
18965	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Casein kinase I isoform alpha	inhibition percentage	20	%
18966	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Casein kinase I isoform alpha-like	inhibition percentage	12	%
18967	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Casein kinase I isoform delta	inhibition percentage	34	%
18968	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Casein kinase I isoform epsilon	inhibition percentage	40	%
18969	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Casein kinase I isoform epsilon	inhibition percentage	84	%
18970	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Casein kinase I isoform epsilon	inhibition percentage	48	%
18971	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Casein kinase I isoform gamma-1	inhibition percentage	18	%
18972	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Casein kinase I isoform gamma-2	inhibition percentage	41	%
18973	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Casein kinase I isoform gamma-3	inhibition percentage	40	%
18974	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Casein kinase II subunit alpha	inhibition percentage	17	%
18975	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Casein kinase II subunit alpha'	inhibition percentage	15	%
18976	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Death-associated protein kinase 3	inhibition percentage	81	%
18977	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Death-associated protein kinase 3	inhibition percentage	94	%
18978	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase DCLK1	inhibition percentage	8	%
18979	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Serine/threonine-protein kinase DCLK2	inhibition percentage	3	%
18980	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	DNA-dependent protein kinase	inhibition percentage	37	%
18981	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Dual specificity tyrosine-phosphorylation-regulated kinase 1A/B	inhibition percentage	50	%
18982	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Dual specificity tyrosine-phosphorylation-regulated kinase 1A/B	inhibition percentage	84	%
18983	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	inhibition percentage	70	%
18984	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	inhibition percentage	93	%
18985	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Dual specificity tyrosine-phosphorylation-regulated kinase 3	inhibition percentage	59	%
18986	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Dual specificity tyrosine-phosphorylation-regulated kinase 3	inhibition percentage	91	%
18987	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	Dual specificity tyrosine-phosphorylation-regulated kinase 4	inhibition percentage	39	%
18988	COC1=NC=C2C=C3C=NC=CC3=C(C2=N1)N(=O)=O	elongation factor-2 kinase	inhibition percentage	21	%
18989	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	DNA-dependent protein kinase catalytic subunit [human]	IC50	7.33 - 7.36	nM
18990	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	IC50	792 - 1390	nM
18991	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase ATM [human]	IC50	4046	nM
18992	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase mTOR [human]	IC50	5830 - 13500	nM
18993	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Receptor tyrosine-protein kinase erbB-4 [human]	IC50	100000	nM
18994	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	DNA-dependent protein kinase catalytic subunit [human]	IC50	10	μM
18995	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	DNA-dependent protein kinase catalytic subunit [human]	IC50	10	μM
18996	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1		IC50	10	μM
18997	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Mitogen-activated protein kinase 15 [human]	inhibition rate	8.2	%
18998	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase/endoribonuclease IRE1 [human]	inhibition rate	7.9	%
18999	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Mitogen-activated protein kinase 1 [human]	inhibition rate	7.8	%
19000	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase A-Raf [human]	inhibition rate	7.8	%
19001	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	MAP kinase-interacting serine/threonine-protein kinase 1 [human]	inhibition rate	7.7	%
19002	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase 4 [human]	inhibition rate	7.7	%
19003	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Casein kinase I isoform gamma-1 [human]	inhibition rate	7.7	%
19004	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Lymphokine-activated killer T-cell-originated protein kinase [human]	inhibition rate	7.6	%
19005	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	cAMP-dependent protein kinase [human]	inhibition rate	7.6	%
19006	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine kinase NLK [human]	inhibition rate	7.5	%
19007	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Tau-tubulin kinase 1 [human]	inhibition rate	7.5	%
19008	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Mitogen-activated protein kinase kinase kinase kinase 3 [human]	inhibition rate	7.4	%
19009	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Dual specificity mitogen-activated protein kinase kinase 5 [human]	inhibition rate	7.4	%
19010	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Ephrin type-A receptor 2 [human]	inhibition rate	7.3	%
19011	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Mitogen-activated protein kinase 13 [human]	inhibition rate	7.2	%
19012	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase pim-3 [human]	inhibition rate	7.2	%
19013	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Vascular endothelial growth factor receptor 2 [human]	inhibition rate	7.2	%
19014	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	G protein-coupled receptor kinase 5 [human]	inhibition rate	7.1	%
19015	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Misshapen-like kinase 1 [human]	inhibition rate	7	%
19016	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase N3 [human]	inhibition rate	6.9	%
19017	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase 32C [human]	inhibition rate	6.9	%
19018	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Casein kinase II subunit alpha [human]	inhibition rate	6.8	%
19019	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase MARK2 [human]	inhibition rate	6.7	%
19020	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	NT-3 growth factor receptor [human]	inhibition rate	6.7	%
19021	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Mitogen-activated protein kinase 14 [human]	inhibition rate	6.6	%
19022	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Myosin-IIIa [human]	inhibition rate	6.6	%
19023	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase WNK3 [human]	inhibition rate	6.4	%
19024	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase Nek5 [human]	inhibition rate	6.2	%
19025	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Casein kinase I isoform delta [human]	inhibition rate	6.1	%
19026	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	MAP kinase-activated protein kinase 5 [human]	inhibition rate	6.1	%
19027	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Dual specificity protein kinase CLK1 [human]	inhibition rate	6	%
19028	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Receptor tyrosine-protein kinase AXL [human]	inhibition rate	6	%
19029	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform [human]	inhibition rate	5.9	%
19030	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Tyrosine-protein kinase TXK [human]	inhibition rate	5.9	%
19031	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Calcium/calmodulin-dependent protein kinase type II subunit alpha [human]	inhibition rate	5.9	%
19032	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase haspin [human]	inhibition rate	5.7	%
19033	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Dual specificity mitogen-activated protein kinase kinase 6 [human]	inhibition rate	5.6	%
19034	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Casein kinase I isoform delta [human]	inhibition rate	5.6	%
19035	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase PAK 4 [human]	inhibition rate	5.5	%
19036	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase MRCK gamma [human]	inhibition rate	5.4	%
19037	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Tyrosine-protein kinase Fgr [human]	inhibition rate	5.4	%
19038	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	3-phosphoinositide-dependent protein kinase 1 [human]	inhibition rate	5.1	%
19039	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial [human]	inhibition rate	5.1	%
19040	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase 32B [human]	inhibition rate	5	%
19041	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase [human]	inhibition rate	4.9	%
19042	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase TAO1 [human]	inhibition rate	4.9	%
19043	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Mitogen-activated protein kinase kinase kinase 10 [human]	inhibition rate	4.9	%
19044	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Tyrosine-protein kinase Blk [human]	inhibition rate	4.7	%
19045	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase LATS2 [human]	inhibition rate	4.7	%
19046	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Beta-adrenergic receptor kinase 2 [human]	inhibition rate	4.7	%
19047	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	MAP/microtubule affinity-regulating kinase 4 [human]	inhibition rate	4.5	%
19048	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase DCLK2 [human]	inhibition rate	4.5	%
19049	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Ephrin type-B receptor 1 [human]	inhibition rate	4.5	%
19050	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase VRK2 [human]	inhibition rate	4.5	%
19051	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase 38 [human]	inhibition rate	4.3	%
19052	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase NIM1 [human]	inhibition rate	4.2	%
19053	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Mitogen-activated protein kinase 11 [human]	inhibition rate	4	%
19054	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Rho-associated protein kinase 1 [human]	inhibition rate	4	%
19055	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Ribosomal protein S6 kinase alpha-4 [human]	inhibition rate	4	%
19056	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Ephrin type-A receptor 7 [human]	inhibition rate	3.8	%
19057	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase Chk1 [human]	inhibition rate	3.6	%
19058	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Calcium/calmodulin-dependent protein kinase type 1G [human]	inhibition rate	3.6	%
19059	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase Nek2 [human]	inhibition rate	3.5	%
19060	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Glycogen synthase kinase-3 alpha [human]	inhibition rate	3.4	%
19061	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Dual specificity mitogen-activated protein kinase kinase 4 [human]	inhibition rate	3.3	%
19062	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Interferon-induced, double-stranded RNA-activated protein kinase [human]	inhibition rate	3.2	%
19063	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Interleukin-1 receptor-associated kinase 1 [human]	inhibition rate	3.2	%
19064	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Protein kinase C, eta [human]	inhibition rate	3.2	%
19065	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Mitogen-activated protein kinase kinase kinase 7 [human]	inhibition rate	3.2	%
19066	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	eIF-2-alpha kinase Gcn2 [human]	inhibition rate	3.2	%
19067	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Ephrin type-A receptor 6 [human]	inhibition rate	3.1	%
19068	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Calcium/calmodulin-dependent protein kinase type II subunit beta [human]	inhibition rate	3.1	%
19069	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase tousled-like 1 [human]	inhibition rate	3.1	%
19070	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Cyclin-dependent kinase 7 [human]; Cyclin-H [human]	inhibition rate	3	%
19071	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Dual specificity testis-specific protein kinase 2 [human]	inhibition rate	2.8	%
19072	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Tyrosine-protein kinase Yes [human]	inhibition rate	2.8	%
19073	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	5'-AMP-activated protein kinase catalytic subunit alpha-2 [human];+5'-AMP-activated protein kinase subunit beta-2 [human];+5'-AMP-activated protein kinase subunit gamma-2 [human]	inhibition rate	2.6	%
19074	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase 26 [human]	inhibition rate	2.6	%
19075	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Ephrin type-A receptor 5 [human]	inhibition rate	4.7	%
19076	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Ephrin type-B receptor 2 [human]	inhibition rate	2.5	%
19077	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Myotonin-protein kinase [human]	inhibition rate	2.5	%
19078	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase MARK3 [human]	inhibition rate	2.5	%
19079	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Death-associated protein kinase 1 [human]	inhibition rate	2.5	%
19080	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Testis-specific serine/threonine-protein kinase 2 [human]	inhibition rate	2.5	%
19081	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase MAK [human]	inhibition rate	2.4	%
19082	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase SIK2 [human]	inhibition rate	2.4	%
19083	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Protein kinase C, delta [human]	inhibition rate	2.3	%
19084	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	5'-AMP-activated protein kinase catalytic subunit alpha-2 [human];+5'-AMP-activated protein kinase subunit gamma-1 [human];+5'-AMP-activated protein kinase subunit beta-2 [human]	inhibition rate	2.3	%
19085	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Cyclin-A1 [human]; Cyclin-dependent kinase 20 [human]	inhibition rate	2.2	%
19086	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase 38-like [human]	inhibition rate	2.1	%
19087	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	cGMP-dependent protein kinase 1 [human]	inhibition rate	2.1	%
19088	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 3 [human]	inhibition rate	2.1	%
19089	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase B-raf [human]	inhibition rate	2.1	%
19090	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition rate	2	%
19091	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial [human]	inhibition rate	2	%
19092	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase WNK1 [human]	inhibition rate	2	%
19093	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Receptor-interacting serine/threonine-protein kinase 3 [human]	inhibition rate	2	%
19094	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Ephrin type-A receptor 4 [human]	inhibition rate	1.9	%
19095	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Protein kinase C iota type [human]	inhibition rate	1.9	%
19096	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Macrophage-stimulating protein receptor [human]	inhibition rate	1.9	%
19097	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	High affinity nerve growth factor receptor [human]	inhibition rate	1.9	%
19098	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Myosin light chain kinase, smooth muscle [human]	inhibition rate	1.9	%
19099	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Proto-oncogene tyrosine-protein kinase receptor Ret [human]	inhibition rate	1.8	%
19100	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Mitogen-activated protein kinase kinase kinase 19 [human]	inhibition rate	1.8	%
19101	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase Sgk3 [human]	inhibition rate	1.7	%
19102	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Aurora kinase B [human]	inhibition rate	1.7	%
19103	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	serine/threonine-protein kinase pak 5 [human]	inhibition rate	1.6	%
19104	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Cytoplasmic tyrosine-protein kinase BMX [human]	inhibition rate	1.4	%
19105	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Tyrosine-protein kinase Srms [human]	inhibition rate	1.4	%
19106	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	BDNF/NT-3 growth factors receptor [human]	inhibition rate	1.4	%
19107	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Discoidin domain-containing receptor 2 [human]	inhibition rate	1.3	%
19108	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 2 [human]	inhibition rate	1.3	%
19109	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Mitogen-activated protein kinase 3 [human]	inhibition rate	1.3	%
19110	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Tyrosine-protein kinase, Fes/Fps type [human]	inhibition rate	1.3	%
19111	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Testis-specific serine/threonine-protein kinase 6 [human]	inhibition rate	1.2	%
19112	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase MARK1 [human]	inhibition rate	1.2	%
19113	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Tyrosine-protein kinase CSK [human]	inhibition rate	1.2	%
19114	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Vascular endothelial growth factor receptor 3 [human]	inhibition rate	1.1	%
19115	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Ribosomal protein S6 kinase alpha-5 [human]	inhibition rate	1.1	%
19116	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	SRSF protein kinase 1 [human]	inhibition rate	1.1	%
19117	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Mitogen-activated protein kinase kinase kinase 20 [human]	inhibition rate	1	%
19118	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Tyrosine-protein kinase Lyn [human]	inhibition rate	1	%
19119	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase OSR1 [human]	inhibition rate	1	%
19120	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Mitogen-activated protein kinase kinase kinase 11 [human]	inhibition rate	1	%
19121	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Tyrosine-protein kinase Tec [human]	inhibition rate	1	%
19122	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Calcium/calmodulin-dependent protein kinase type II delta 2 chain [human]	inhibition rate	1	%
19123	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Ribosomal protein S6 kinase beta-2 [human]	inhibition rate	1	%
19124	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Activin receptor type-1 [human]	inhibition rate	0.9	%
19125	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Proto-oncogene tyrosine-protein kinase ROS [human]	inhibition rate	0.9	%
19126	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase Chk2 [human]	inhibition rate	0.9	%
19127	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Mitogen-activated protein kinase kinase kinase 8 [human]	inhibition rate	0.9	%
19128	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Calcium/calmodulin-dependent protein kinase type IV [human]	inhibition rate	0.8	%
19129	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase N2 [human]	inhibition rate	0.8	%
19130	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Fibroblast growth factor receptor 2 [human]	inhibition rate	0.7	%
19131	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Protein DBF4 homolog A [human];+Cell division cycle 7-related protein kinase [human]	inhibition rate	0.7	%
19132	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Fibroblast growth factor receptor 1 [human]	inhibition rate	0.7	%
19133	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Receptor-interacting serine/threonine-protein kinase 4 [human]	inhibition rate	0.7	%
19134	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Mitogen-activated protein kinase kinase kinase kinase 5 [human]	inhibition rate	0.7	%
19135	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase WNK2 [human]	inhibition rate	0.7	%
19136	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Cyclin-dependent kinase 1 [human]; Cyclin E [human]	inhibition rate	0.6	%
19137	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 1B [human]	inhibition rate	0.6	%
19138	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	SRSF protein kinase 3 [human]	inhibition rate	0.5	%
19139	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	PAS domain-containing serine/threonine-protein kinase [human]	inhibition rate	0.5	%
19140	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	G protein-coupled receptor kinase 6 [human]	inhibition rate	0.4	%
19141	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Epithelial discoidin domain-containing receptor 1 [human]	inhibition rate	0.4	%
19142	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Protein kinase C zeta type [human]	inhibition rate	0.3	%
19143	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Casein kinase I isoform gamma-2 [human]	inhibition rate	0.2	%
19144	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase SIK1 [human]	inhibition rate	0.2	%
19145	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Homeodomain-interacting protein kinase 3 [human]	inhibition rate	0.2	%
19146	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Cyclin-dependent kinase 9 [human]; Cyclin-T1 [human]	inhibition rate	0	%
19147	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Insulin receptor [human]	inhibition rate	0	%
19148	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Cyclin-H [human]; Cyclin-dependent kinase 20 [human]	inhibition rate	-0.1	%
19149	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Tyrosine-protein kinase FRK [human]	inhibition rate	-0.2	%
19150	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	serine/threonine-protein kinase sbk1 [human]	inhibition rate	-0.2	%
19151	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Aurora kinase A [human]	inhibition rate	-0.2	%
19152	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Tyrosine-protein kinase Fer [human]	inhibition rate	-0.2	%
19153	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Non-receptor tyrosine-protein kinase TNK1 [human]	inhibition rate	-0.3	%
19154	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Cyclin-dependent kinase 9 [human]; Cyclin-T2 [human]	inhibition rate	-0.3	%
19155	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	MAP kinase-activated protein kinase 2 [human]	inhibition rate	-0.3	%
19156	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase pim-2 [human]	inhibition rate	-0.4	%
19157	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Cyclin-dependent kinase 8 [human]; Cyclin-C [human]	inhibition rate	-0.4	%
19158	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Cyclin-C [human]; Cyclin-dependent kinase 19 [human]	inhibition rate	-0.5	%
19159	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Protein kinase C alpha type [human]	inhibition rate	-0.6	%
19160	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	G1/S-specific cyclin-D3 [human]; Cyclin-dependent kinase 4 [human]	inhibition rate	-0.6	%
19161	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Tyrosine-protein kinase Fyn [human]	inhibition rate	-0.8	%
19162	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Dual specificity protein kinase CLK3 [human]	inhibition rate	-0.8	%
19163	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Bone morphogenetic protein receptor type-1A [human]	inhibition rate	-0.8	%
19164	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Protein-tyrosine kinase 2-beta [human]	inhibition rate	-0.9	%
19165	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Activin receptor type-1B [human]	inhibition rate	-0.9	%
19166	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Tyrosine-protein kinase JAK1 [human]	inhibition rate	-1	%
19167	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	G1/S-specific cyclin-D3 [human]; Cyclin-dependent kinase 6 [human]	inhibition rate	-1.1	%
19168	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase Nek3 [human]	inhibition rate	-1.2	%
19169	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Casein kinase I isoform gamma-3 [human]	inhibition rate	-1.2	%
19170	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase TAO2 [human]	inhibition rate	-1.3	%
19171	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Dual specificity mitogen-activated protein kinase kinase 2 [human]	inhibition rate	-1.4	%
19172	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Tyrosine-protein kinase SYK [human]	inhibition rate	-1.4	%
19173	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Mitogen-activated protein kinase kinase kinase 2 [human]	inhibition rate	-1.5	%
19174	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase 17A [human]	inhibition rate	-1.5	%
19175	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Hepatocyte growth factor receptor [human]	inhibition rate	-1.5	%
19176	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Cyclin-dependent kinase 18 [human]; cyclin-y [human]	inhibition rate	-1.5	%
19177	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Receptor tyrosine-protein kinase erbB-2 [human]	inhibition rate	-1.5	%
19178	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Cyclin-dependent kinase 9 [human]; Cyclin-K [human]	inhibition rate	-1.6	%
19179	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Tyrosine-protein kinase JAK3 [human]	inhibition rate	-1.6	%
19180	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase ULK3 [human]	inhibition rate	-1.6	%
19181	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Homeodomain-interacting protein kinase 2 [human]	inhibition rate	-1.6	%
19182	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase MRCK beta [human]	inhibition rate	-1.7	%
19183	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Tyrosine-protein kinase ABL1 [human]	inhibition rate	-1.8	%
19184	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase Sgk2 [human]	inhibition rate	-1.9	%
19185	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase PAK 6 [human]	inhibition rate	-2	%
19186	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	RAC-alpha serine/threonine-protein kinase [human]	inhibition rate	-2.1	%
19187	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase 10 [human]	inhibition rate	-2.1	%
19188	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Death-associated protein kinase 2 [human]	inhibition rate	-2.1	%
19189	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Dual specificity protein kinase CLK4 [human]	inhibition rate	-2.2	%
19190	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	G protein-coupled receptor kinase 4 [human]	inhibition rate	-2.3	%
19191	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Transient receptor potential cation channel subfamily M member 7 [human]	inhibition rate	-2.3	%
19192	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Megakaryocyte-associated tyrosine-protein kinase [human]	inhibition rate	-2.5	%
19193	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Dual specificity tyrosine-phosphorylation-regulated kinase 4 [human]	inhibition rate	-2.5	%
19194	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition rate	-2.9	%
19195	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Mast/stem cell growth factor receptor Kit [human]	inhibition rate	-3	%
19196	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	SRSF protein kinase 2 [human]	inhibition rate	-3.2	%
19197	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase Nek4 [human]	inhibition rate	-3.3	%
19198	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Cyclin-dependent kinase 1 [human]; G2/mitotic-specific cyclin-B1 [human]	inhibition rate	-3.4	%
19199	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Casein kinase II subunit alpha' [human]	inhibition rate	-3.5	%
19200	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Tyrosine-protein kinase JAK2 [human]	inhibition rate	-3.5	%
19201	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase TAO3 [human]	inhibition rate	-3.5	%
19202	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Casein kinase I isoform alpha (isoform CK1A-L) [human]	inhibition rate	-3.7	%
19203	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Fibroblast growth factor receptor 4 [human]	inhibition rate	-3.8	%
19204	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Cyclin E [human]; Megakaryocyte-associated tyrosine-protein kinase [human]	inhibition rate	-4.1	%
19205	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase Nek6 [human]	inhibition rate	-4.8	%
19206	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Mitogen-activated protein kinase kinase kinase 1 [human]	inhibition rate	-4.8	%
19207	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Protein kinase C, epsilon [human]	inhibition rate	-4.9	%
19208	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Muscle, skeletal receptor tyrosine-protein kinase [human]	inhibition rate	-5.1	%
19209	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Beta-adrenergic receptor kinase 1 [human]	inhibition rate	-5.1	%
19210	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Ribosomal protein S6 kinase beta-1 [human]	inhibition rate	-5.1	%
19211	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Rhodopsin kinase [human]	inhibition rate	-5.2	%
19212	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Mitogen-activated protein kinase 7 [human]	inhibition rate	-5.3	%
19213	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Tyrosine-protein kinase Lyn (isoform 2) [human]	inhibition rate	-5.3	%
19214	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Platelet-derived growth factor receptor alpha [human]	inhibition rate	-5.3	%
19215	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	RAF proto-oncogene serine/threonine-protein kinase [human]	inhibition rate	-5.4	%
19216	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Tyrosine-protein kinase ZAP-70 [human]	inhibition rate	-5.5	%
19217	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Protein kinase C beta type (isoform Beta-II) [human]	inhibition rate	-5.5	%
19218	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Death-associated protein kinase 3 [human]	inhibition rate	-5.6	%
19219	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial [human]	inhibition rate	-5.6	%
19220	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase BRSK1 [human]	inhibition rate	-5.7	%
19221	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Mitogen-activated protein kinase kinase kinase 21 [human]	inhibition rate	-5.7	%
19222	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Homeodomain-interacting protein kinase 1 [human]	inhibition rate	-5.7	%
19223	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Citron Rho-interacting kinase [human]	inhibition rate	-5.9	%
19224	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Dual specificity testis-specific protein kinase 1 [human]	inhibition rate	-5.9	%
19225	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	inhibition rate	-6.1	%
19226	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Dual specificity mitogen-activated protein kinase kinase 1 [human]	inhibition rate	-6.1	%
19227	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Ephrin type-B receptor 4 [human]	inhibition rate	-6.1	%
19228	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	TGF-beta receptor type-2 [human]	inhibition rate	-6.1	%
19229	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Tau-tubulin kinase 2 [human]	inhibition rate	-4.3	%
19230	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	cyclin-y [human]; Cyclin-dependent kinase 17 [human]	inhibition rate	-6.2	%
19231	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	-6.2	%
19232	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase TOUSLED-like 2 [human]	inhibition rate	-6.4	%
19233	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Cyclin-dependent kinase 1 [human]; Cyclin-A1 [human]	inhibition rate	-6.4	%
19234	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Dual serine/threonine and tyrosine protein kinase [human]	inhibition rate	-6.4	%
19235	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Myosin light chain kinase 2, skeletal/cardiac muscle [human]	inhibition rate	-6.6	%
19236	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Mitogen-activated protein kinase kinase kinase 5 [human]	inhibition rate	-6.6	%
19237	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	LIM domain kinase 2 [human]	inhibition rate	-6.6	%
19238	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Mitogen-activated protein kinase kinase kinase kinase 2 [human]	inhibition rate	-6.7	%
19239	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	TGF-beta receptor type-1 [human]	inhibition rate	-6.7	%
19240	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial [human]	inhibition rate	-6.8	%
19241	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Mitogen-activated protein kinase kinase kinase 3 [human]	inhibition rate	-6.9	%
19242	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase Plk3 [human]	inhibition rate	-7.1	%
19243	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Myosin light chain kinase 3 [human]	inhibition rate	-7.5	%
19244	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase Plk4 [human]	inhibition rate	-7.6	%
19245	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Mitogen-activated protein kinase kinase kinase 9 [human]	inhibition rate	-7.6	%
19246	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Vascular endothelial growth factor receptor 1 [human]	inhibition rate	-7.8	%
19247	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Cyclin-dependent kinase 4 [human]; G1/S-specific cyclin-D1 [human]	inhibition rate	-7.8	%
19248	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	cAMP-dependent protein kinase catalytic subunit PRKX [human]	inhibition rate	-8.1	%
19249	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	cAMP-dependent protein kinase catalytic subunit gamma [human]	inhibition rate	-8.2	%
19250	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Dual specificity protein kinase CLK2 [human]	inhibition rate	-8.2	%
19251	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	eukaryotic elongation factor 2 kinase [human]	inhibition rate	-8.2	%
19252	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Dual specificity mitogen-activated protein kinase kinase 3 [human]	inhibition rate	-8.3	%
19253	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase 3 [human]	inhibition rate	-8.4	%
19254	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase receptor R3 [human]	inhibition rate	-8.8	%
19255	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Dual specificity mitogen-activated protein kinase kinase 7 [human]	inhibition rate	-9.1	%
19256	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Mitogen-activated protein kinase kinase kinase 12 [human]	inhibition rate	-9.2	%
19257	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	RAC-gamma serine/threonine-protein kinase [human]	inhibition rate	-9.6	%
19258	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase MRCK beta [human]	inhibition rate	-9.7	%
19259	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Ephrin type-A receptor 3 [human]	inhibition rate	-10.3	%
19260	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Kinase suppressor of Ras 1 [human]	inhibition rate	-10.3	%
19261	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase SIK3 [human]	inhibition rate	-10.7	%
19262	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	cGMP-dependent protein kinase 2 [human]	inhibition rate	-11	%
19263	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Wee1-like protein kinase [human]	inhibition rate	-11.7	%
19264	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase ICK [human]	inhibition rate	-11.8	%
19265	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	LIM domain kinase 1 [human]	inhibition rate	-12.2	%
19266	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Fibroblast growth factor receptor 3 [human]	inhibition rate	-12.3	%
19267	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Ribosomal protein S6 kinase alpha-1 [human]	inhibition rate	-12.3	%
19268	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	cyclin-y [human]; Cyclin-dependent kinase 14 [human]	inhibition rate	-12.4	%
19269	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Tyrosine-protein kinase ABL2 [human]	inhibition rate	-12.6	%
19270	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	5'-AMP-activated protein kinase catalytic subunit alpha-1 [human];+5'-AMP-activated protein kinase subunit beta-1 [human];+5'-AMP-activated protein kinase subunit gamma-1 [human]	inhibition rate	-13.3	%
19271	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase Nek8 [human]	inhibition rate	-13.4	%
19272	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Receptor tyrosine-protein kinase erbB-4 [human]	inhibition rate	-13.6	%
19273	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Rho-associated protein kinase 2 [human]	inhibition rate	-13.7	%
19274	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	cGMP-dependent protein kinase 1 (isoform Beta) [human]	inhibition rate	-14	%
19275	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	5'-AMP-activated protein kinase catalytic subunit alpha-1 [human];+5'-AMP-activated protein kinase subunit beta-1 [human];+5'-AMP-activated protein kinase subunit gamma-3 [human]	inhibition rate	-14.8	%
19276	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Protein kinase C beta type (isoform Beta-I) [human]	inhibition rate	-15.4	%
19277	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Homeodomain-interacting protein kinase 4 [human]	inhibition rate	-15.6	%
19278	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	5'-AMP-activated protein kinase catalytic subunit alpha-2 [human];+5'-AMP-activated protein kinase subunit beta-1 [human];+5'-AMP-activated protein kinase subunit gamma-1 [human]	inhibition rate	-15.9	%
19279	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Bone morphogenetic protein receptor type-1B [human]	inhibition rate	-16.7	%
19280	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	5'-AMP-activated protein kinase catalytic subunit alpha-1 [human];+5'-AMP-activated protein kinase subunit beta-1 [human];+5'-AMP-activated protein kinase subunit gamma-1 [human]	inhibition rate	-18.1	%
19281	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	cyclin-y [human]; Cyclin-dependent kinase 16 [human]	inhibition rate	-18.4	%
19282	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Calcium/calmodulin-dependent protein kinase kinase 1 [human]	inhibition rate	-22.4	%
19283	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Platelet-derived growth factor receptor beta [human]	inhibition rate	-26.1	%
19284	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Aurora kinase C [human]	inhibition rate	0.5	%
19285	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Protein kinase C, theta [human]	inhibition rate	-2.8	%
19286	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase DCLK1 [human]	inhibition rate	-5.9	%
19287	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Rhodopsin kinase [human]	inhibition rate	-2.7	%
19288	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Insulin-like growth factor 1 receptor [human]	inhibition rate	-5.3	%
19289	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Tyrosine-protein kinase ITK/TSK [human]	inhibition rate	-4.3	%
19290	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Ephrin type-A receptor 8 [human]	inhibition rate	-2.3	%
19291	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase LATS1 [human]	inhibition rate	0.9	%
19292	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	DNA-dependent protein kinase catalytic subunit [human]	S50 (50% inhibition of regrowth fraction)	1.09	μM
19293	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	DNA-dependent protein kinase catalytic subunit [human]	S50 (50% inhibition of regrowth fraction)	2.7	μM
19294	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1		S50 (50% inhibition of regrowth fraction)	10	μM
19295	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase LATS1 [human]	inhibition rate	0.9	%
19296	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase STK11 [human]	inhibition rate	8.7	%
19297	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase Nek7 [human]	inhibition rate	8.6	%
19298	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	STE20/SPS1-related proline-alanine-rich protein kinase [human]	inhibition rate	8.6	%
19299	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Myosin-IIIb [human]	inhibition rate	8.5	%
19300	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Tyrosine-protein kinase Mer [human]	inhibition rate	8.4	%
19301	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Mitogen-activated protein kinase kinase kinase kinase 4 [human]	inhibition rate	8.4	%
19302	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	RAC-beta serine/threonine-protein kinase [human]	inhibition rate	8.3	%
19303	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Mitogen-activated protein kinase kinase kinase 6 [human]	inhibition rate	8.3	%
19304	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase VRK1 [human]	inhibition rate	8.2	%
19305	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	cAMP-dependent protein kinase catalytic subunit beta [human]	inhibition rate	8.2	%
19306	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Mitogen-activated protein kinase 9 [human]	inhibition rate	79.8	%
19307	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Macrophage colony-stimulating factor 1 receptor [human]	inhibition rate	61	%
19308	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase pim-1 [human]	inhibition rate	4.3	%
19309	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Mitogen-activated protein kinase 8 [human]	inhibition rate	57.3	%
19310	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Leucine-rich repeat serine/threonine-protein kinase 2 [human]	inhibition rate	48	%
19311	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Tyrosine-protein kinase receptor TYRO3 [human]	inhibition rate	48	%
19312	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Traf2 and NCK-interacting protein kinase [human]	inhibition rate	46.9	%
19313	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Maternal embryonic leucine zipper kinase [human]	inhibition rate	42.9	%
19314	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase PAK 3 [human]	inhibition rate	42.4	%
19315	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Eukaryotic translation initiation factor 2-alpha kinase 3 [human]	inhibition rate	38.2	%
19316	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Ribosomal protein S6 kinase alpha-6 [human]	inhibition rate	34.2	%
19317	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase 24 [human]	inhibition rate	31.5	%
19318	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase/endoribonuclease IRE2 [human]	inhibition rate	30.9	%
19319	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase D3 [human]	inhibition rate	29.6	%
19320	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Mitogen-activated protein kinase 12 [human]	inhibition rate	29	%
19321	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase D1 [human]	inhibition rate	28.8	%
19322	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Interleukin-1 receptor-associated kinase 4 [human]	inhibition rate	26.6	%
19323	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Mitogen-activated protein kinase 4 [human]	inhibition rate	25.3	%
19324	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	NUAK family SNF1-like kinase 1 [human]	inhibition rate	21.7	%
19325	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase PLK1 [human]	inhibition rate	21.1	%
19326	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase PLK2 [human]	inhibition rate	21	%
19327	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Casein kinase I isoform epsilon [human]	inhibition rate	20	%
19328	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	glycogen synthase kinase-3 beta [human]	inhibition rate	19.9	%
19329	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase Nek1 [human]	inhibition rate	19.7	%
19330	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Cyclin-dependent kinase 20 [human]; Cyclin-T1 [human]	inhibition rate	19.3	%
19331	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Myosin light chain kinase family member 4 [human]	inhibition rate	18.8	%
19332	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Testis-specific serine/threonine-protein kinase 3 [human]	inhibition rate	17.8	%
19333	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Activated CDC42 kinase 1 [human]	inhibition rate	17.3	%
19334	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase 16 [human]	inhibition rate	17.2	%
19335	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	STE20-like serine/threonine-protein kinase [human]	inhibition rate	16.1	%
19336	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Inhibitor of nuclear factor kappa-B kinase subunit epsilon [human]	inhibition rate	15.7	%
19337	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	15.7	%
19338	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Casein kinase I isoform alpha [human]	inhibition rate	15.4	%
19339	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	MAP kinase-activated protein kinase 3 [human]	inhibition rate	15	%
19340	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Tyrosine-protein kinase HCK [human]	inhibition rate	80	%
19341	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase Nek9 [human]	inhibition rate	15	%
19342	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	14.7	%
19343	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Mitogen-activated protein kinase 10 [human]	inhibition rate	80	%
19344	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Cyclin-dependent kinase 2 [human]; G1/S-specific cyclin-E2 [human]	inhibition rate	14.1	%
19345	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Proto-oncogene tyrosine-protein kinase LCK [human]	inhibition rate	13.9	%
19346	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase Nek11 [human]	inhibition rate	13.7	%
19347	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase Sgk1 [human]	inhibition rate	13.5	%
19348	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Calcium/calmodulin-dependent protein kinase type 1 [human]	inhibition rate	13.4	%
19349	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Insulin receptor-related protein [human]	inhibition rate	13.4	%
19350	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase D2 [human]	inhibition rate	13.3	%
19351	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Tyrosine-protein kinase receptor Tie-2 [human]	inhibition rate	13.1	%
19352	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase PAK 1 [human]	inhibition rate	12.8	%
19353	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase 25 [human]	inhibition rate	12.4	%
19354	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Bone morphogenetic protein receptor type-2 [human]	inhibition rate	12.3	%
19355	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Cyclin-dependent kinase 2 [human]; Cyclin-O [human]	inhibition rate	12.3	%
19356	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Ephrin type-A receptor 1 [human]	inhibition rate	12.2	%
19357	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Calcium/calmodulin-dependent protein kinase type II subunit gamma [human]	inhibition rate	12.1	%
19358	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Receptor-interacting serine/threonine-protein kinase 2 [human]	inhibition rate	12	%
19359	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Cyclin E [human]; Cyclin-dependent kinase 2 [human]	inhibition rate	11.9	%
19360	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase N1 [human]	inhibition rate	11.8	%
19361	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Epidermal growth factor receptor [human]	inhibition rate	11.6	%
19362	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	serine/threonine-protein kinase pak 2 [human]	inhibition rate	11.6	%
19363	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Connector enhancer of kinase suppressor of ras 2 [human]	inhibition rate	11.5	%
19364	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Cyclin-dependent kinase 5 activator 1, p35 [human]; Cyclin-dependent-like kinase 5 [human]	inhibition rate	11.4	%
19365	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Proto-oncogene tyrosine-protein kinase Src [human]	inhibition rate	11.3	%
19366	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	SNF-related serine/threonine-protein kinase [human]	inhibition rate	11.3	%
19367	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Leukocyte tyrosine kinase receptor [human]	inhibition rate	11.3	%
19368	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase TBK1 [human]	inhibition rate	11	%
19369	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Protein kinase C gamma type [human]	inhibition rate	11	%
19370	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform [human]	inhibition rate	11	%
19371	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Mitogen-activated protein kinase kinase kinase kinase 1 [human]	inhibition rate	10.9	%
19372	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase ULK1 [human]	inhibition rate	10.8	%
19373	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Testis-specific serine/threonine-protein kinase 1 [human]	inhibition rate	10.8	%
19374	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	5'-AMP-activated protein kinase catalytic subunit alpha-1 [human];+5'-AMP-activated protein kinase subunit gamma-1 [human];+5'-AMP-activated protein kinase subunit beta-2 [human]	inhibition rate	10.5	%
19375	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase ULK2 [human]	inhibition rate	10.3	%
19376	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Calcium/calmodulin-dependent protein kinase kinase 2 [human]	inhibition rate	10.1	%
19377	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Cyclin-dependent-like kinase 5 [human]; Cyclin-dependent kinase 5 activator 1, p25 [human]	inhibition rate	10.1	%
19378	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase 33 [human]	inhibition rate	10.1	%
19379	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Protein-tyrosine kinase 6 [human]	inhibition rate	10	%
19380	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Cyclin-dependent kinase 6 [human]; G1/S-specific cyclin-D1 [human]	inhibition rate	10	%
19381	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Inactive tyrosine-protein kinase PEAK1 [human]	inhibition rate	9.9	%
19382	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	NUAK family SNF1-like kinase 2 [human]	inhibition rate	9.7	%
19383	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Tyrosine-protein kinase BTK [human]	inhibition rate	9.7	%
19384	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	ALK tyrosine kinase receptor [human]	inhibition rate	9.4	%
19385	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Serine/threonine-protein kinase greatwall [human]	inhibition rate	9.4	%
19386	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Cyclin-A1 [human]; Cyclin-dependent kinase 2 [human]	inhibition rate	9.2	%
19387	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Eukaryotic translation initiation factor 2-alpha kinase 1 [human]	inhibition rate	9.2	%
19388	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Calcium/calmodulin-dependent protein kinase type 1D [human]	inhibition rate	9.1	%
19389	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	5'-AMP-activated protein kinase catalytic subunit alpha-2 [human];+5'-AMP-activated protein kinase subunit beta-2 [human];+5'-AMP-activated protein kinase subunit gamma-3 [human]	inhibition rate	9.1	%
19390	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Focal adhesion kinase 1 [human]	inhibition rate	9.1	%
19391	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Calcium/calmodulin-dependent protein kinase type 1B [human]	inhibition rate	9.1	%
19392	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	Inhibitor of nuclear factor kappa-B kinase subunit alpha [human]	inhibition rate	9	%
19393	COC1=CC(C)=C(NC2=CC3=C(C=N2)N(C)C(=O)N3C2CCCC2)C=C1	G1/S-specific cyclin-E2 [human]; Cyclin-dependent kinase 3 [human]	inhibition rate	9	%
19394	C[C@@H]1CC2=C(CN1C(=O)N1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCS(=O)(=O)CC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.8	no unit
19395	C[C@@H]1CC2=C(CN1C(=O)N1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCS(=O)(=O)CC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.55	no unit
19396	C[C@@H]1CC2=C(CN1C(=O)N1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCS(=O)(=O)CC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5.45	no unit
19397	C[C@@H](NC1=NC2=C(C[C@@H](C)N(C2)C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)C=N1)C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.19	no unit
19398	C[C@@H](NC1=NC2=C(C[C@@H](C)N(C2)C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)C=N1)C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19399	C[C@@H](NC1=NC2=C(C[C@@H](C)N(C2)C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)C=N1)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	pIC50	7.85	no unit
19400	CO[C@H]1CC[C@@H](CC1)NC1=NC2=C(C[C@@H](C)N(C2)C(=O)C2CCN(C)CC2C2=CC(C)=NC=C2)C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8	no unit
19401	CO[C@H]1CC[C@@H](CC1)NC1=NC2=C(C[C@@H](C)N(C2)C(=O)C2CCN(C)CC2C2=CC(C)=NC=C2)C=N1	Cyclin-dependent kinase 7 [human]	pIC50	6.39	no unit
19402	CO[C@H]1CC[C@@H](CC1)NC1=NC2=C(C[C@@H](C)N(C2)C(=O)C2CCN(C)CC2C2=CC(C)=NC=C2)C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	5.22	no unit
19403	CC(C)N1CCN([C@H](C1)C1=CC=CC=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NC1CCOCC1)=N2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.19	no unit
19404	CC(C)N1CCN([C@H](C1)C1=CC=CC=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NC1CCOCC1)=N2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.79	no unit
19405	CC(C)N1CCN([C@H](C1)C1=CC=CC=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NC1CCOCC1)=N2	Cyclin-dependent kinase 7 [human]	pIC50	6.63	no unit
19406	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=NN(C)C=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.61	no unit
19407	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=NN(C)C=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19408	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=NN(C)C=C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	7.34	no unit
19409	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1CCS(=O)(=O)C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.2	no unit
19410	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1CCS(=O)(=O)C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	6.62	no unit
19411	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1CCS(=O)(=O)C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5	no unit
19412	C[C@H](NC1=NC2=C(C[C@@H](C)N(C2)C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)C=N1)C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.97	no unit
19413	C[C@H](NC1=NC2=C(C[C@@H](C)N(C2)C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)C=N1)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	pIC50	6.52	no unit
19414	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=C(F)C=C1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.92	no unit
19415	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=C(F)C=C1)N=C(NC1CCOCC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	7.17	no unit
19416	C[C@@H]1CC2=C(CN1C(=O)N1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCN(CC1)S(C)(=O)=O)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.48	no unit
19417	C[C@@H]1CC2=C(CN1C(=O)N1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCN(CC1)S(C)(=O)=O)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.77	no unit
19418	C[C@@H]1CC2=C(CN1C(=O)N1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCN(CC1)S(C)(=O)=O)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.68	no unit
19419	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=CN(C)C=N1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.38	no unit
19420	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=CN(C)C=N1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5	no unit
19421	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=CN(C)C=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.45	no unit
19422	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=CN(C)C=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19423	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=CN(C)C=C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.67	no unit
19424	C[C@@H]1CC2=C(CN1C(=O)N1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCN(CC1)S(=O)(=O)C1CC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.48	no unit
19425	C[C@@H]1CC2=C(CN1C(=O)N1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCN(CC1)S(=O)(=O)C1CC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.7	no unit
19426	C[C@@H]1CC2=C(CN1C(=O)N1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCN(CC1)S(=O)(=O)C1CC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.96	no unit
19427	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC(C)=NC=C1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.71	no unit
19428	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC(C)=NC=C1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.67	no unit
19429	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC(C)=NC=C1)N=C(NC1CCOCC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5.77	no unit
19430	CN1CC[C@@H]([C@H](C1)C1=CC=CC=C1)C(=O)N1CC2=C(C=NC(NC3CCOCC3)=N2)[C@@H]2C[C@H]12	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.27	no unit
19431	CN1CC[C@@H]([C@H](C1)C1=CC=CC=C1)C(=O)N1CC2=C(C=NC(NC3CCOCC3)=N2)[C@@H]2C[C@H]12	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19432	CN1CC[C@@H]([C@H](C1)C1=CC=CC=C1)C(=O)N1CC2=C(C=NC(NC3CCOCC3)=N2)[C@@H]2C[C@H]12	Cyclin-dependent kinase 7 [human]	pIC50	7.23	no unit
19433	CN1CCN([C@H](C1)C1=CC=CC=C1)C(=O)N1CC2=C(CC1(C)C)C=NC(NC1CCOCC1)=N2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.89	no unit
19434	CN1CCN([C@H](C1)C1=CC=CC=C1)C(=O)N1CC2=C(CC1(C)C)C=NC(NC1CCOCC1)=N2	Cyclin-dependent kinase 7 [human]	pIC50	6.29	no unit
19435	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCC(F)(F)CC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19436	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCC(F)(F)CC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.85	no unit
19437	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=CSC=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.92	no unit
19438	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=CSC=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.59	no unit
19439	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=CSC=C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.88	no unit
19440	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=CC=C(C)O1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.05	no unit
19441	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=CC=C(C)O1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.6	no unit
19442	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=CC=C(C)O1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	7.14	no unit
19443	C[C@@H]1CC2=C(CN1C(=O)N1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=NN(C)C=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	6.9	no unit
19444	C[C@@H]1CC2=C(CN1C(=O)N1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=NN(C)C=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	6.8	no unit
19445	C[C@@H]1CC2=C(CN1C(=O)N1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=NN(C)C=C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5.86	no unit
19446	C[C@@H]1CC2=C(CN1C(=O)N1CCNC[C@@H]1C1=CC=CC=C1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.66	no unit
19447	C[C@@H]1CC2=C(CN1C(=O)N1CCNC[C@@H]1C1=CC=CC=C1)N=C(NC1CCOCC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5.91	no unit
19448	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=NN(C)C(C)=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.58	no unit
19449	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=NN(C)C(C)=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.33	no unit
19450	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=NN(C)C(C)=C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5.18	no unit
19451	C[C@@H]1CC2=C(CN1C(=O)N1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.17	no unit
19452	C[C@@H]1CC2=C(CN1C(=O)N1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.81	no unit
19453	C[C@@H]1CC2=C(CN1C(=O)N1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCOCC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.57	no unit
19454	C[C@@H]1CC2=C(CN1C(=O)N1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCN(CC1)S(=O)(=O)N(C)C)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.88	no unit
19455	C[C@@H]1CC2=C(CN1C(=O)N1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCN(CC1)S(=O)(=O)N(C)C)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.7	no unit
19456	C[C@@H]1CC2=C(CN1C(=O)N1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCN(CC1)S(=O)(=O)N(C)C)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.14	no unit
19457	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1CCOC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.85	no unit
19458	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1CCOC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.52	no unit
19459	CN1CC[C@@H]([C@H](C1)C1=CC=CC=C1)C(=O)N1CC2=C(C=NC(NC3CCOCC3)=N2)C(C)(C)C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.05	no unit
19460	CN1CC[C@@H]([C@H](C1)C1=CC=CC=C1)C(=O)N1CC2=C(C=NC(NC3CCOCC3)=N2)C(C)(C)C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	6.75	no unit
19461	CN1CC[C@@H]([C@H](C1)C1=CC=CC=C1)C(=O)N1CC2=C(C=NC(NC3CCOCC3)=N2)C(C)(C)C1	Cyclin-dependent kinase 7 [human]	pIC50	5.44	no unit
19462	C[C@@H](NC1=NC2=C(C[C@@H](C)N(C2)C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)C=N1)C1=CC=CC=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.97	no unit
19463	C[C@@H](NC1=NC2=C(C[C@@H](C)N(C2)C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)C=N1)C1=CC=CC=N1	Cyclin-dependent kinase 7 [human]	pIC50	6.52	no unit
19464	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=NN(C)C(=C1)C(F)F)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.44	no unit
19465	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=NN(C)C(=C1)C(F)F)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	6.85	no unit
19466	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=NN(C)C(=C1)C(F)F)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5.29	no unit
19467	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(N[C@H]1CCC[C@H](O)C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	8.85	no unit
19468	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(N[C@H]1CCC[C@H](O)C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.28	no unit
19469	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(N[C@H]1CCC[C@H](O)C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19470	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=NN(C)C=C1C)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19471	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=NN(C)C=C1C)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.97	no unit
19472	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=NN(C)C=C1C)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.04	no unit
19473	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=CN=C(C)N1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.97	no unit
19474	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=CN=C(C)N1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.9	no unit
19475	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=CN=C(C)N1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5.61	no unit
19476	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=CN(C)N=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.53	no unit
19477	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=CN(C)N=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	6.66	no unit
19478	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=CN(C)N=C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5.53	no unit
19479	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCN(CC1)S(=O)(=O)C1CC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	6.18	no unit
19480	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCN(CC1)S(=O)(=O)C1CC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5	no unit
19481	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Interleukin-1 receptor-associated kinase 4 [human]	pIC50	7.81	no unit
19482	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Interleukin-1 receptor-associated kinase 4 [human]	pIC50	6.3	no unit
19483	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1		CLint (intrinsic clearance)	3	μl/min/mg protein
19484	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Proto-oncogene tyrosine-protein kinase receptor Ret	inhibition rate	36.5	%
19485	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Rho-associated protein kinase 1	inhibition rate	-11.6	%
19486	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Rho-associated protein kinase 2	inhibition rate	4.5	%
19487	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Proto-oncogene tyrosine-protein kinase ROS	inhibition rate	-0.5	%
19488	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Ribosomal protein S6 kinase alpha-1	inhibition rate	10.9	%
19489	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Ribosomal protein S6 kinase alpha-5	inhibition rate	4	%
19490	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Ribosomal protein S6 kinase beta-1	inhibition rate	3.3	%
19491	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Serine/threonine-protein kinase Sgk1	inhibition rate	-1.6	%
19492	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Dual specificity tyrosine-phosphorylation-regulated kinase 2	inhibition rate	3.1	%
19493	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	elongation factor-2 kinase	inhibition rate	-2.6	%
19494	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Tyrosine-protein kinase ABL1	inhibition rate	97.2	%
19495	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Epidermal growth factor receptor	inhibition rate	48.7	%
19496	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Ephrin type-A receptor 5	inhibition rate	30.1	%
19497	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Ephrin type-B receptor 1	inhibition rate	79.2	%
19498	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Ephrin type-B receptor 4	inhibition rate	73.1	%
19499	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Receptor tyrosine-protein kinase erbB-2	inhibition rate	3.1	%
19500	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Receptor tyrosine-protein kinase erbB-4	inhibition rate	62.4	%
19501	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Tyrosine-protein kinase Fer	inhibition rate	7.4	%
19502	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Tyrosine-protein kinase, Fes/Fps type	inhibition rate	-4.2	%
19503	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Fibroblast growth factor receptor 1	inhibition rate	6.5	%
19504	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Fibroblast growth factor receptor 2	inhibition rate	6.4	%
19505	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Tyrosine-protein kinase ABL2	inhibition rate	92.2	%
19506	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Serine/threonine-protein kinase MARK1	inhibition rate	-0.4	%
19507	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Serine/threonine-protein kinase MARK2	inhibition rate	14.5	%
19508	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Tyrosine-protein kinase Mer	inhibition rate	5.7	%
19509	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Hepatocyte growth factor receptor	inhibition rate	19.7	%
19510	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Misshapen-like kinase 1	inhibition rate	-6.4	%
19511	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	MAP kinase-interacting serine/threonine-protein kinase 2	inhibition rate	3.1	%
19512	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Macrophage-stimulating protein receptor	inhibition rate	4.3	%
19513	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Myosin light chain kinase, smooth muscle	inhibition rate	0.3	%
19514	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Serine/threonine-protein kinase Nek2	inhibition rate	14.3	%
19515	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	High affinity nerve growth factor receptor	inhibition rate	78	%
19516	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Activin receptor type-1B	inhibition rate	-15.9	%
19517	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	BDNF/NT-3 growth factors receptor	inhibition rate	77.9	%
19518	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	NT-3 growth factor receptor	inhibition rate	79	%
19519	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Proto-oncogene tyrosine-protein kinase Src	inhibition rate	92.7	%
19520	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	SRSF protein kinase 1	inhibition rate	4.1	%
19521	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Serine/threonine-protein kinase 17A	inhibition rate	5.6	%
19522	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Serine/threonine-protein kinase 4	inhibition rate	0.7	%
19523	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Tyrosine-protein kinase SYK	inhibition rate	15.6	%
19524	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Serine/threonine-protein kinase TBK1	inhibition rate	13.4	%
19525	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	TGF-beta receptor type-1	inhibition rate	21.1	%
19526	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Traf2 and NCK-interacting protein kinase	inhibition rate	5.9	%
19527	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	RAC-alpha serine/threonine-protein kinase	inhibition rate	4.8	%
19528	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Tyrosine-protein kinase receptor TYRO3	inhibition rate	1.5	%
19529	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Serine/threonine-protein kinase ULK2	inhibition rate	-0.7	%
19530	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Tyrosine-protein kinase yes	inhibition rate	91.7	%
19531	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Tyrosine-protein kinase ZAP-70	inhibition rate	-10.6	%
19532	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	RAC-beta serine/threonine-protein kinase	inhibition rate	-2.6	%
19533	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	ALK tyrosine kinase receptor	inhibition rate	4	%
19534	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	AMP-activated protein kinase	inhibition rate	2.7	%
19535	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Aurora kinase B	inhibition rate	-3	%
19536	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Tyrosine-protein kinase receptor UFO	inhibition rate	8.9	%
19537	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Tyrosine-protein kinase Blk	inhibition rate	71.8	%
19538	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Cytoplasmic tyrosine-protein kinase BMX	inhibition rate	72.1	%
19539	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Serine/threonine-protein kinase B-raf	inhibition rate	-21.3	%
19540	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Tyrosine-protein kinase BTK	inhibition rate	103.3	%
19541	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Fibroblast growth factor receptor 3	inhibition rate	1.1	%
19542	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Fibroblast growth factor receptor 4	inhibition rate	-0.2	%
19543	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Vascular endothelial growth factor receptor 1	inhibition rate	-2.2	%
19544	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	25.4	%
19545	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Serine/threonine-protein kinase mTOR	inhibition rate	17.5	%
19546	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Tyrosine-protein kinase Fyn	inhibition rate	87.8	%
19547	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Serine/threonine-protein kinase haspin	inhibition rate	-6.9	%
19548	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Glycogen synthase kinase-3 alpha	inhibition rate	-0.6	%
19549	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	tau-protein kinase	inhibition rate	2.2	%
19550	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Insulin-like growth factor 1 receptor	inhibition rate	-7.3	%
19551	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Inhibitor of nuclear factor kappa-B kinase subunit beta	inhibition rate	-5.3	%
19552	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Insulin receptor	inhibition rate	-0.4	%
19553	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Insulin receptor-related protein	inhibition rate	1.2	%
19554	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Interleukin-1 receptor-associated kinase 1	inhibition rate	70.8	%
19555	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	NUAK family SNF1-like kinase 1	inhibition rate	-4.3	%
19556	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Serine/threonine-protein kinase PAK 1	inhibition rate	9	%
19557	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Serine/threonine-protein kinase PAK2	inhibition rate	1.6	%
19558	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Serine/threonine-protein kinase PAK 4	inhibition rate	7	%
19559	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Serine/threonine-protein kinase PAK5	inhibition rate	1	%
19560	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Platelet-derived growth factor receptor beta	inhibition rate	29.6	%
19561	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	3-phosphoinositide-dependent protein kinase 1	inhibition rate	-1.5	%
19562	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Inactive tyrosine-protein kinase PEAK1	inhibition rate	93.5	%
19563	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Phosphatidylinositol 4-kinase beta	inhibition rate	-9.5	%
19564	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha	inhibition rate	-6.9	%
19565	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Phosphatidylinositol 3-kinase catalytic subunit type 3	inhibition rate	-13.2	%
19566	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform;+Phosphatidylinositol 3-kinase regulatory subunit alpha	inhibition rate	-3.1	%
19567	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	inhibition rate	-2.3	%
19568	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform;+Phosphatidylinositol 3-kinase regulatory subunit alpha	inhibition rate	2.3	%
19569	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Calcium/calmodulin-dependent protein kinase type 1	inhibition rate	-17.3	%
19570	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Calcium/calmodulin-dependent protein kinase type II subunit beta	inhibition rate	5.8	%
19571	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Cyclin-dependent kinase 1;+Cyclin	inhibition rate	0.7	%
19572	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Cyclin-dependent kinase 2;+Cyclin	inhibition rate	7.8	%
19573	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Cyclin-dependent kinase 2;+Cyclin	inhibition rate	8	%
19574	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Cyclin;+Cyclin-dependent kinase 7	inhibition rate	-17.3	%
19575	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Cyclin;+Cyclin-dependent kinase 7	inhibition rate	-0.2	%
19576	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Cyclin-dependent kinase 9;+Cyclin	inhibition rate	-5.5	%
19577	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Serine/threonine-protein kinase Chk1	inhibition rate	-0.6	%
19578	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Dual specificity protein kinase CLK1	inhibition rate	3.9	%
19579	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Dual specificity protein kinase CLK2	inhibition rate	9.3	%
19580	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Dual specificity protein kinase CLK3	inhibition rate	-0.4	%
19581	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Dual specificity protein kinase CLK4	inhibition rate	17.6	%
19582	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Macrophage colony-stimulating factor 1 receptor	inhibition rate	31.1	%
19583	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Casein kinase I isoform gamma-1	inhibition rate	-8.2	%
19584	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Casein kinase II subunit alpha'	inhibition rate	2.4	%
19585	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Discoidin domain-containing receptor 2	inhibition rate	22.6	%
19586	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Myotonin-protein kinase	inhibition rate	2	%
19587	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	DNA-dependent protein kinase catalytic subunit	inhibition rate	-13.3	%
19588	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Interleukin-1 receptor-associated kinase 4	inhibition rate	110.1	%
19589	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Tyrosine-protein kinase JAK1	inhibition rate	-1.1	%
19590	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Tyrosine-protein kinase JAK2	inhibition rate	1.2	%
19591	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Tyrosine-protein kinase JAK3	inhibition rate	-4.3	%
19592	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Vascular endothelial growth factor receptor 2	inhibition rate	-2.1	%
19593	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Mast/stem cell growth factor receptor Kit	inhibition rate	-4.9	%
19594	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Tyrosine-protein kinase Lck	inhibition rate	99.9	%
19595	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Leucine-rich repeat serine/threonine-protein kinase 2	inhibition rate	-2.1	%
19596	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Tyrosine-protein kinase Lyn	inhibition rate	72.6	%
19597	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Dual specificity mitogen-activated protein kinase kinase 1	inhibition rate	-11.8	%
19598	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Mitogen-activated protein kinase kinase kinase 7;+TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	inhibition rate	34	%
19599	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Mitogen-activated protein kinase kinase kinase 9	inhibition rate	3.8	%
19600	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Mitogen-activated protein kinase kinase kinase kinase 1	inhibition rate	3.9	%
19601	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Mitogen-activated protein kinase kinase kinase kinase 3	inhibition rate	10.1	%
19602	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Mitogen-activated protein kinase 1	inhibition rate	0.8	%
19603	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Mitogen-activated protein kinase 14	inhibition rate	-0.8	%
19604	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Mitogen-activated protein kinase 8	inhibition rate	-4.5	%
19605	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	MAP kinase-activated protein kinase 2	inhibition rate	2.3	%
19606	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	MAP kinase-activated protein kinase 5	inhibition rate	1.6	%
19607	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	inhibition rate	0.9	%
19608	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Serine/threonine-protein kinase pim-2	inhibition rate	0.7	%
19609	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Serine/threonine-protein kinase PLK1	inhibition rate	10.6	%
19610	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	cAMP-dependent protein kinase catalytic subunit alpha	inhibition rate	-0.7	%
19611	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Protein kinase C alpha type	inhibition rate	-1	%
19612	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Protein kinase C, epsilon	inhibition rate	2.3	%
19613	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Protein kinase C, theta	inhibition rate	-10.2	%
19614	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	cGMP-dependent protein kinase 1	inhibition rate	5	%
19615	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Serine/threonine-protein kinase PTK2	inhibition rate	-4.9	%
19616	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	Protein-tyrosine kinase 6	inhibition rate	22.8	%
19617	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	RAF proto-oncogene serine/threonine-protein kinase	inhibition rate	-4.7	%
19618	CN1CC2(CC(C2)N2C=C(NC3=NC(NC4(C)CC4)=C4C(=O)N(C=CC4=N3)C3=CN(C)N=N3)C=N2)C1	AP2-associated protein kinase 1	inhibition rate	1.8	%
19619	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Tyrosine-protein phosphatase non-receptor type 11	IC50	4.3	nM
19620	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [human]; G1/S-specific cyclin-D3 [human]	IC50	18.2	nM
19621	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	G1/S-specific cyclin-D3 [human]; Cyclin-dependent kinase 4 [human]	IC50	18.2	nM
19622	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 9 [human];+Cyclin-T1 [human]	IC50	26.4	nM
19623	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	G2/mitotic-specific cyclin-B1 [human];+Cyclin-dependent kinase 1 [human]	IC50	210	nM
19624	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 2 [human];+G1/S-specific cyclin-E2 [human]	IC50	464	nM
19625	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 5 [human];+Cyclin-dependent kinase 5 activator 1, p25 [human]	IC50	540	nM
19626	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	G1/S-specific cyclin-D3 [human]; Cyclin-dependent kinase 6 [human]	IC50	634	nM
19627	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F		IC50	0.64	μM
19628	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 12 [human]; Cyclin-K [human]	IC50	697	nM
19629	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-H [human];+Cyclin-dependent kinase 7 [human]	IC50	968	nM
19630	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [human];+Tyrosine-protein phosphatase non-receptor type 11 [human]	apoptosis rate increase		
19631	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [human];+Tyrosine-protein phosphatase non-receptor type 11 [human]	apoptosis rate increase		
19632	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [mouse];+Tyrosine-protein phosphatase non-receptor type 11 [mouse]	apoptosis rate increase		
19633	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	G1/S-specific cyclin-E [human];+Cyclin-dependent kinase 3 [human]	IC50	1000	nM
19634	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-K [human]; Cyclin-dependent kinase 13 [human]	IC50	1000	nM
19635	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [human];+Tyrosine-protein phosphatase non-receptor type 11 [human]	phosphorylation level decrease		
19636	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [human];+Tyrosine-protein phosphatase non-receptor type 11 [human]	phosphorylation level increase		
19637	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [human];+Tyrosine-protein phosphatase non-receptor type 11 [human]	phosphorylation level decrease		
19638	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F		IC50	1.76	μM
19639	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [mouse];+Tyrosine-protein phosphatase non-receptor type 11 [mouse]	percentage of cells in G0/G1 phase	61.3	%
19640	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [human];+Tyrosine-protein phosphatase non-receptor type 11 [human]	percentage of cells in G0/G1 phase	58.9	%
19641	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [human];+Tyrosine-protein phosphatase non-receptor type 11 [human]	percentage of cells in G0/G1 phase	58.7	%
19642	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [human];+Tyrosine-protein phosphatase non-receptor type 11 [human]	apoptosis rate increase		
19643	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [human];+Tyrosine-protein phosphatase non-receptor type 11 [human]	apoptosis rate increase		
19644	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [mouse];+Tyrosine-protein phosphatase non-receptor type 11 [mouse]	apoptosis rate increase		
19645	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [human];+Tyrosine-protein phosphatase non-receptor type 11 [human]	percentage of cells in S phase	39.6	%
19646	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [human];+Tyrosine-protein phosphatase non-receptor type 11 [human]	percentage of cells in S phase	38.5	%
19647	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [human];+Tyrosine-protein phosphatase non-receptor type 11 [human]	phosphorylation level decrease		
19648	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [human];+Tyrosine-protein phosphatase non-receptor type 11 [human]	phosphorylation level increase		
19649	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [human];+Tyrosine-protein phosphatase non-receptor type 11 [human]	phosphorylation level decrease		
19650	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [mouse];+Tyrosine-protein phosphatase non-receptor type 11 [mouse]	percentage of cells in S phase	36.1	%
19651	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F		IC50	5.57	μM
19652	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [human];+Tyrosine-protein phosphatase non-receptor type 11 [human]	phosphorylation level decrease		
19653	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [human];+Tyrosine-protein phosphatase non-receptor type 11 [human]	phosphorylation level increase		
19654	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [human];+Tyrosine-protein phosphatase non-receptor type 11 [human]	phosphorylation level decrease		
19655	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F		body weight change		
19656	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F		body weight change		
19657	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F		body weight change		
19658	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F		mortality rate		
19659	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F		mortality rate		
19660	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F		mortality rate		
19661	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Tyrosine-protein phosphatase non-receptor type 11	IC50	20000	nM
19662	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Tyrosine-protein phosphatase non-receptor type 6	IC50	20000	nM
19663	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [human];+Tyrosine-protein phosphatase non-receptor type 11 [human]	percentage of cells in G2/M phase	1.59	%
19664	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [human];+Tyrosine-protein phosphatase non-receptor type 11 [human]	percentage of cells in G2/M phase	2.8	%
19665	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [mouse];+Tyrosine-protein phosphatase non-receptor type 11 [mouse]	percentage of cells in G2/M phase	2.6	%
19666	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F		AUC	1202	ng*h/ml
19667	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F		AUC	5506	ng*h/ml
19668	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F		t1/2 (drug half life)	2.11	h
19669	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F		t1/2 (drug half life)	2.94	h
19670	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F		CL (drug clearance)	13.9	ml/min/kg
19671	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F		Vd (volume of distribution)	2.53	l/kg
19672	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F		Cmax	383	ng/ml
19673	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F		Cmax	634	ng/ml
19674	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F		F (drug bioavailability)	45.8	%
19675	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [mouse];+Tyrosine-protein phosphatase non-receptor type 11 [mouse]	TGI (tumor growth inhibition rate)	80	%
19676	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [mouse];+Tyrosine-protein phosphatase non-receptor type 11 [mouse]	TGI (tumor growth inhibition rate)	89	%
19677	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [mouse];+Tyrosine-protein phosphatase non-receptor type 11 [mouse]	phosphorylation level decrease		
19678	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [mouse];+Tyrosine-protein phosphatase non-receptor type 11 [mouse]	phosphorylation level decrease		
19679	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [mouse];+Tyrosine-protein phosphatase non-receptor type 11 [mouse]	phosphorylation level decrease		
19680	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [mouse];+Tyrosine-protein phosphatase non-receptor type 11 [mouse]	phosphorylation level decrease		
19681	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [mouse];+Tyrosine-protein phosphatase non-receptor type 11 [mouse]	phosphorylation level decrease		
19682	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [mouse];+Tyrosine-protein phosphatase non-receptor type 11 [mouse]	phosphorylation level decrease		
19683	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [mouse];+Tyrosine-protein phosphatase non-receptor type 11 [mouse]	decrease rate		
19684	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [mouse];+Tyrosine-protein phosphatase non-receptor type 11 [mouse]	decrease rate		
19685	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [mouse];+Tyrosine-protein phosphatase non-receptor type 11 [mouse]	decrease rate		
19686	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [mouse];+Tyrosine-protein phosphatase non-receptor type 11 [mouse]	CD8+ T cell infiltration increase		
19687	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [mouse];+Tyrosine-protein phosphatase non-receptor type 11 [mouse]	CD8+ T cell infiltration increase		
19688	CC(C)N1C(C)=NC2=C(F)C=C(C=C12)C1=NC(NC2=NC=CC(SC3=CN=C(C=N3)N3CCC4(CO[C@@H](C)[C@H]4N)CC3)=C2Cl)=NC=C1F	Cyclin-dependent kinase 4 [mouse];+Tyrosine-protein phosphatase non-receptor type 11 [mouse]	CD8+ T cell infiltration increase		
19689	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1=CN(CC(C)(C)O)N=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8	no unit
19690	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1=CN(CC(C)(C)O)N=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.72	no unit
19691	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1=CN(CC(C)(C)O)N=C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.75	no unit
19692	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(N[C@H]1CC[C@@H](CC1)OCC1CC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.3	no unit
19693	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(N[C@H]1CC[C@@H](CC1)OCC1CC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19694	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(N[C@H]1CC[C@@H](CC1)OCC1CC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	7.22	no unit
19695	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCN(C)C(=O)C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.67	no unit
19696	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCN(C)C(=O)C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.45	no unit
19697	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCN(C)C(=O)C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5.09	no unit
19698	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCC(=O)N(C)C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.35 - 8.42	no unit
19699	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCC(=O)N(C)C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19700	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCC(=O)N(C)C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.03 - 6.08	no unit
19701	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCOC3(CCC3)C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.21 - 8.57	no unit
19702	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCOC3(CCC3)C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19703	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCOC3(CCC3)C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.51 - 7.16	no unit
19704	CO[C@@]1(C)CC[C@@H](CC1)NC1=NC2=C(C[C@@H](C)N(C2)C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.11	no unit
19705	CO[C@@]1(C)CC[C@@H](CC1)NC1=NC2=C(C[C@@H](C)N(C2)C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19706	CO[C@@]1(C)CC[C@@H](CC1)NC1=NC2=C(C[C@@H](C)N(C2)C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)C=N1	Cyclin-dependent kinase 7 [human]	pIC50	6.8	no unit
19707	CO[C@]1(C)CC[C@@H](CC1)NC1=NC2=C(C[C@@H](C)N(C2)C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.86	no unit
19708	CO[C@]1(C)CC[C@@H](CC1)NC1=NC2=C(C[C@@H](C)N(C2)C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)C=N1	Cyclin-dependent kinase 7 [human]	pIC50	5.87	no unit
19709	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(N[C@H]1CC[C@H](O)CC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.49	no unit
19710	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(N[C@H]1CC[C@H](O)CC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19711	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(N[C@H]1CC[C@H](O)CC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	7.03	no unit
19712	C[C@H]1CC[C@@H](CC1)NC1=NC2=C(C[C@@H](C)N(C2)C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.85	no unit
19713	C[C@H]1CC[C@@H](CC1)NC1=NC2=C(C[C@@H](C)N(C2)C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19714	C[C@H]1CC[C@@H](CC1)NC1=NC2=C(C[C@@H](C)N(C2)C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)C=N1	Cyclin-dependent kinase 7 [human]	pIC50	7.47	no unit
19715	C[C@H]1CC[C@H](CC1)NC1=NC2=C(C[C@@H](C)N(C2)C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.89	no unit
19716	C[C@H]1CC[C@H](CC1)NC1=NC2=C(C[C@@H](C)N(C2)C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)C=N1	Cyclin-dependent kinase 7 [human]	pIC50	6.32	no unit
19717	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCOC3(CCCC3)C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	7.01 - 7.39	no unit
19718	C[C@@H]1CC2=CN=C(NC3COC4=C3C=CC=C4)N=C2CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	pIC50	6.31 - 6.44	no unit
19719	CCO[C@H]1CC[C@@H](CC1)NC1=NC=C2C[C@@H](C)N(CC2=N1)C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	pIC50	7.38	no unit
19720	C[C@H](NC1=NC=C2C[C@@H](C)N(CC2=N1)C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)C1=CC=CC=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.19	no unit
19721	C[C@H](NC1=NC=C2C[C@@H](C)N(CC2=N1)C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)C1=CC=CC=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19722	C[C@H](NC1=NC=C2C[C@@H](C)N(CC2=N1)C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)C1=CC=CC=N1	Cyclin-dependent kinase 7 [human]	pIC50	7.85	no unit
19723	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CC(C)(C)OC(C)(C)C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.96	no unit
19724	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CC(C)(C)OC(C)(C)C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.9	no unit
19725	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCN(CC1)C1COC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.46	no unit
19726	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCN(CC1)C1COC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.11	no unit
19727	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=CC=C(C)N=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.5	no unit
19728	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=CC=C(C)N=C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5.68	no unit
19729	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC(=O)N1CCCCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	6.59	no unit
19730	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC(=O)N1CCCCC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5	no unit
19731	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CC3=C(C1)C=CC=C3)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.55	no unit
19732	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CC3=C(C1)C=CC=C3)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19733	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CC3=C(C1)C=CC=C3)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	7.9	no unit
19734	CC(C)N1C=C(CNC2=NC3=C(C[C@@H](C)N(C3)C(=O)[C@H]3CCN(C)C[C@@H]3C3=CC=CC=C3)C=N2)C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.03	no unit
19735	CC(C)N1C=C(CNC2=NC3=C(C[C@@H](C)N(C3)C(=O)[C@H]3CCN(C)C[C@@H]3C3=CC=CC=C3)C=N2)C=N1	Cyclin-dependent kinase 7 [human]	pIC50	5.41	no unit
19736	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCN(CC1)C(=O)CC1CC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.81	no unit
19737	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCN(CC1)C(=O)CC1CC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	7.16	no unit
19738	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=C(F)C=CC=C1F)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.9	no unit
19739	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=C(F)C=CC=C1F)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.43	no unit
19740	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCN(CC1)C(=O)C1CC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.88	no unit
19741	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCN(CC1)C(=O)C1CC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.79	no unit
19742	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1CC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.94	no unit
19743	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1CC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.56	no unit
19744	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=CC=CC=N1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.78	no unit
19745	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=CC=CC=N1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.7	no unit
19746	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.19	no unit
19747	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1CCOCC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5.62	no unit
19748	CO[C@H]1CC[C@@H](CC1)NC1=NC2=C(C[C@@H](C)N(C2)C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.6	no unit
19749	CO[C@H]1CC[C@@H](CC1)NC1=NC2=C(C[C@@H](C)N(C2)C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19750	CO[C@H]1CC[C@@H](CC1)NC1=NC2=C(C[C@@H](C)N(C2)C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)C=N1	Cyclin-dependent kinase 7 [human]	pIC50	7.47	no unit
19751	CO[C@@H]1CC[C@@H](CC1)NC1=NC2=C(C[C@@H](C)N(C2)C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.46	no unit
19752	CO[C@@H]1CC[C@@H](CC1)NC1=NC2=C(C[C@@H](C)N(C2)C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)C=N1	Cyclin-dependent kinase 7 [human]	pIC50	5.86	no unit
19753	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCOC(C)(C)C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.14 - 8.3	no unit
19754	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCOC(C)(C)C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.7	no unit
19755	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCOC(C)(C)C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.4 - 7.28	no unit
19756	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCN(CC1)C1CC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.39	no unit
19757	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCN(CC1)C1CC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5.86	no unit
19758	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=CC=CC=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.11	no unit
19759	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=CC=CC=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19760	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=CC=CC=C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.97	no unit
19761	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCS(=O)(=O)CC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.04	no unit
19762	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCS(=O)(=O)CC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.7	no unit
19763	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCS(=O)(=O)CC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5.51	no unit
19764	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCN(CC(F)(F)F)CC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.65	no unit
19765	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCN(CC(F)(F)F)CC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.62	no unit
19766	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCN(CC(F)(F)F)CC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.36	no unit
19767	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.3	no unit
19768	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.7	no unit
19769	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCOCC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	7.15	no unit
19770	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=NNC=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.08	no unit
19771	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=NNC=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.29	no unit
19772	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NCC1=NNC=C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5.88	no unit
19773	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC[C@H]1CCOC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.99	no unit
19774	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC[C@H]1CCOC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.39	no unit
19775	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC[C@H]1CCOC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.24	no unit
19776	CC(NC1=NC2=C(C[C@@H](C)N(C2)C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)C=N1)C1=NN(C)C=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.41 - 8.29	no unit
19777	CC(NC1=NC2=C(C[C@@H](C)N(C2)C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)C=N1)C1=NN(C)C=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	6.85 - 7.91	no unit
19778	CC(NC1=NC2=C(C[C@@H](C)N(C2)C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)C=N1)C1=NN(C)C=C1	Cyclin-dependent kinase 7 [human]	pIC50	5.35 - 6.91	no unit
19779	CCN1C=C(CNC2=NC3=C(C[C@@H](C)N(C3)C(=O)[C@H]3CCN(C)C[C@@H]3C3=CC=CC=C3)C=N2)C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.63	no unit
19780	CCN1C=C(CNC2=NC3=C(C[C@@H](C)N(C3)C(=O)[C@H]3CCN(C)C[C@@H]3C3=CC=CC=C3)C=N2)C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19781	CCN1C=C(CNC2=NC3=C(C[C@@H](C)N(C3)C(=O)[C@H]3CCN(C)C[C@@H]3C3=CC=CC=C3)C=N2)C=N1	Cyclin-dependent kinase 7 [human]	pIC50	7.64	no unit
19782	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC[C@@H]1CCOC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.33	no unit
19783	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC[C@@H]1CCOC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19784	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC[C@@H]1CCOC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.21	no unit
19785	CC(C)N1C=CC(CNC2=NC3=C(C[C@@H](C)N(C3)C(=O)[C@H]3CCN(C)C[C@@H]3C3=CC=CC=C3)C=N2)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.56	no unit
19786	CC(C)N1C=CC(CNC2=NC3=C(C[C@@H](C)N(C3)C(=O)[C@H]3CCN(C)C[C@@H]3C3=CC=CC=C3)C=N2)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19787	CC(C)N1C=CC(CNC2=NC3=C(C[C@@H](C)N(C3)C(=O)[C@H]3CCN(C)C[C@@H]3C3=CC=CC=C3)C=N2)=N1	Cyclin-dependent kinase 7 [human]	pIC50	7.55	no unit
19788	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC[C@@H]1CCCO1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19789	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC[C@@H]1CCCO1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.78	no unit
19790	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC[C@@H]1CCCO1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5.88	no unit
19791	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC[C@H]1CCCO1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.84	no unit
19792	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC[C@H]1CCCO1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5.62	no unit
19793	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(N[C@H]1CC[C@@H](CC1)OC(F)F)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.57	no unit
19794	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(N[C@H]1CC[C@@H](CC1)OC(F)F)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19795	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(N[C@H]1CC[C@@H](CC1)OC(F)F)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	7.23	no unit
19796	[2H]C([2H])(NC1=NC2=C(C[C@@H](C)N(C2)C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)C=N1)C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.75	no unit
19797	[2H]C([2H])(NC1=NC2=C(C[C@@H](C)N(C2)C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)C=N1)C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19798	[2H]C([2H])(NC1=NC2=C(C[C@@H](C)N(C2)C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)C=N1)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	pIC50	6.83	no unit
19799	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(N[C@@H](CO)C1=CC=CC=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.54	no unit
19800	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(N[C@@H](CO)C1=CC=CC=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19801	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(N[C@@H](CO)C1=CC=CC=C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.92	no unit
19802	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(N[C@H](CO)C1=CC=CC=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.22	no unit
19803	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(N[C@H](CO)C1=CC=CC=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19804	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(N[C@H](CO)C1=CC=CC=C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.7	no unit
19805	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1=CN(C)N=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.67	no unit
19806	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1=CN(C)N=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19807	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1=CN(C)N=C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	7.33	no unit
19808	CC(C1CC1)N1C=C(NC2=NC3=C(C[C@@H](C)N(C3)C(=O)[C@H]3CCN(C)C[C@@H]3C3=CC=CC=C3)C=N2)C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.24	no unit
19809	CC(C1CC1)N1C=C(NC2=NC3=C(C[C@@H](C)N(C3)C(=O)[C@H]3CCN(C)C[C@@H]3C3=CC=CC=C3)C=N2)C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.44	no unit
19810	CC(C1CC1)N1C=C(NC2=NC3=C(C[C@@H](C)N(C3)C(=O)[C@H]3CCN(C)C[C@@H]3C3=CC=CC=C3)C=N2)C=N1	Cyclin-dependent kinase 7 [human]	pIC50	7.2	no unit
19811	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1=CC=NC(=C1)C(F)F)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.04	no unit
19812	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1=CC=NC(=C1)C(F)F)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.46	no unit
19813	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1=CC=NC(=C1)C(F)F)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	7.24	no unit
19814	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1=CC=NC(=C1)C1CC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	7.48	no unit
19815	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1=C3CCCCN3N=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.88	no unit
19816	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1=C3CCCCN3N=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.53	no unit
19817	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1=C3CCCCN3N=C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.5	no unit
19818	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1=CC=NC(C)=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.37	no unit
19819	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1=CC=NC(C)=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.93	no unit
19820	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1=CC=NC(C)=C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	7.24	no unit
19821	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1=CC=NN1C)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.78	no unit
19822	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1=CC=NN1C)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.37	no unit
19823	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1=CC=NN1C)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5.64	no unit
19824	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1=CN(CC3CC3)N=C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	7.73	no unit
19825	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1=C(C)N(C)N=C1C)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5.87	no unit
19826	CC(C)N1C=C(NC2=NC3=C(C[C@@H](C)N(C3)C(=O)[C@H]3CCN(C)C[C@@H]3C3=CC=CC=C3)C=N2)C=N1	Cyclin-dependent kinase 7 [human]	pIC50	7.15	no unit
19827	CC(C)N1C=C(NC2=NC3=C(C[C@@H](C)N(C3)C(=O)[C@H]3CCN(C)C[C@@H]3C3=CC=CC=C3)C=N2)C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	6.7	no unit
19828	CC(C)N1C=C(NC2=NC3=C(C[C@@H](C)N(C3)C(=O)[C@H]3CCN(C)C[C@@H]3C3=CC=CC=C3)C=N2)C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	6.1	no unit
19829	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1=CN(C)N=C1C(F)(F)F)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5.95	no unit
19830	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1=CN(CC(F)F)N=C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	7.51	no unit
19831	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1=CN(C)N=C1C)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.35	no unit
19832	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1=C(C)N(C)N=C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.18	no unit
19833	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1=CN(N=C1)C1CCCC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	7.54	no unit
19834	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC(C)(C)C1=CN(C)N=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.57	no unit
19835	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC(C)(C)C1=CN(C)N=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.43	no unit
19836	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC(C)(C)C1=CN(C)N=C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5.3	no unit
19837	C[C@@H]1CC2=C(CN1C(=O)[C@@H]1CCN(C)C[C@H]1C1=CC=C(F)C=C1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	5.11	no unit
19838	C[C@@H]1CC2=C(CN1C(=O)[C@@H]1CCN(C)C[C@H]1C1=CC=C(F)C=C1)N=C(NC1CCOCC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5	no unit
19839	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC(C)=CC=C1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.52	no unit
19840	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC(C)=CC=C1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19841	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC(C)=CC=C1)N=C(NC1CCOCC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	7.17	no unit
19842	[2H]C([2H])([2H])C1=CC=CC(=C1)C1CN(C)CCC1C(=O)N1CC2=C(C[C@H]1C)C=NC(NC1=CN(C)N=C1)=N2	Cyclin-dependent kinase 7 [human]	pIC50	6.23 - 7.6	no unit
19843	[2H]C([2H])([2H])C1=CC=CC(=C1)C1CN(C)CCC1C(=O)N1CC2=C(C[C@H]1C)C=NC(NCC1=NN(C)C=C1)=N2	Cyclin-dependent kinase 7 [human]	pIC50	6.22 - 7.58	no unit
19844	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CN=C(C)C=C1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.71	no unit
19845	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CN=C(C)C=C1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	6.98	no unit
19846	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CN=C(C)C=C1)N=C(NC1CCOCC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5.77	no unit
19847	CO[C@H]1CC[C@@H](CC1)NC1=NC2=C(C[C@@H](C)N(C2)C(=O)C2CCN(C)CC2C2=CN=C(C)C=C2)C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.89	no unit
19848	CO[C@H]1CC[C@@H](CC1)NC1=NC2=C(C[C@@H](C)N(C2)C(=O)C2CCN(C)CC2C2=CN=C(C)C=C2)C=N1	Cyclin-dependent kinase 7 [human]	pIC50	6.36	no unit
19849	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1CC1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.1	no unit
19850	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1CC1)N=C(NC1CCOCC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5.76	no unit
19851	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC(Cl)=C(F)C=C1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.96	no unit
19852	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC(Cl)=C(F)C=C1)N=C(NC1CCOCC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	7.25	no unit
19853	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1CCOCC1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	6.92	no unit
19854	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1CCOCC1)N=C(NC1CCOCC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5.2	no unit
19855	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC=NC=C1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.43	no unit
19856	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC=NC=C1)N=C(NC1CCOCC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5.85	no unit
19857	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CN=CC=C1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.79	no unit
19858	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CN=CC=C1)N=C(NC1CCOCC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5	no unit
19859	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC=C(C)C=C1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.93	no unit
19860	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC=C(C)C=C1)N=C(NC1CCOCC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.57	no unit
19861	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC(Cl)=CC=C1)N=C(NC1CCOCC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	7.4	no unit
19862	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC(Cl)=CC=C1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.14	no unit
19863	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC=C(F)C=C1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.92	no unit
19864	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC=C(F)C=C1)N=C(NC1CCOCC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	7.17	no unit
19865	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC(=CC=C1)C1CC1)N=C(NCC1=NN(C)C=C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	8.61	no unit
19866	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC(F)=C(Cl)C=C1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.5	no unit
19867	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC(F)=C(Cl)C=C1)N=C(NC1CCOCC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	7.2	no unit
19868	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC(F)=C(Cl)C=C1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.15	no unit
19869	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC(=CC=C1)C(F)F)N=C(NCC1=NN(C)C=C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5.62 - 7.35	no unit
19870	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC(C)=CC=C1)N=C(NC1=CN(C)N=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.43	no unit
19871	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC(C)=CC=C1)N=C(NC1=CN(C)N=C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.1 - 8.41	no unit
19872	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC(C)=CC=C1)N=C(NC1=CN(C)N=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	6.47 - 7.81	no unit
19873	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC(OC(F)(F)F)=CC=C1)N=C(NCC1=NN(C)C=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.12 - 8.17	no unit
19874	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC(OC(F)(F)F)=CC=C1)N=C(NCC1=NN(C)C=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	6.63 - 7.73	no unit
19875	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC(OC(F)(F)F)=CC=C1)N=C(NCC1=NN(C)C=C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5.82 - 6.99	no unit
19876	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC(=CC=C1)C(F)(F)F)N=C(NCC1=NN(C)C=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.31	no unit
19877	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC(=CC=C1)C(F)(F)F)N=C(NCC1=NN(C)C=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.93	no unit
19878	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC(=CC=C1)C(F)(F)F)N=C(NCC1=NN(C)C=C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	7.38	no unit
19879	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=C(F)C=CC=C1)N=C(NCC1=NN(C)C=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.04 - 8.1	no unit
19880	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=C(F)C=CC=C1)N=C(NCC1=NN(C)C=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.21 - 7.42	no unit
19881	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC=C(Cl)C=C1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.44	no unit
19882	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC=C(Cl)C=C1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8	no unit
19883	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC=C(Cl)C=C1)N=C(NC1CCOCC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	7.09	no unit
19884	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC(F)=CC=C1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.09	no unit
19885	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC(F)=CC=C1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.91	no unit
19886	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC(F)=CC=C1)N=C(NC1CCOCC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	7.01	no unit
19887	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC(C)=CC=C1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.5	no unit
19888	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC(C)=CC=C1)N=C(NC1CCOCC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.02 - 7.17	no unit
19889	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC(C)=CC=C1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	6.34	no unit
19890	C[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC(C)=CC=C1)N=C(NC1=CC(C)=NC=C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	7.69	no unit
19891	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC(C)=CC=C1)N=C(NCC1=NN(C)C=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.94	no unit
19892	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC(C)=CC=C1)N=C(NCC1=NN(C)C=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.8	no unit
19893	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=CC(C)=CC=C1)N=C(NCC1=NN(C)C=C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	7.56	no unit
19894	CC(C)OC1=CC=CC(=C1)C1CN(C)CCC1C(=O)N1CC2=C(C[C@H]1C)C=NC(NCC1=NN(C)C=C1)=N2	Cyclin-dependent kinase 7 [human]	pIC50	6.74	no unit
19895	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=C(C=CC=C1)C(F)F)N=C(NCC1=NN(C)C=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.31	no unit
19896	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=C(C=CC=C1)C(F)F)N=C(NCC1=NN(C)C=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.04	no unit
19897	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C1=C(C=CC=C1)C(F)F)N=C(NCC1=NN(C)C=C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5.9	no unit
19898	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C(F)(F)F)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	5.89	no unit
19899	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C(F)(F)F)N=C(NC1CCOCC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5	no unit
19900	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C(F)(F)F)N=C(NCC1=CC=CC=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.07	no unit
19901	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C(F)(F)F)N=C(NCC1=CC=CC=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	5.53 - 7.4	no unit
19902	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C(F)(F)F)N=C(NCC1=CC=CC=C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5.38	no unit
19903	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C(F)(F)F)N=C(NCC1=NN(C)C=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.05	no unit
19904	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C(F)(F)F)N=C(NCC1=NN(C)C=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19905	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C(F)(F)F)N=C(NCC1=NN(C)C=C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5.59	no unit
19906	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C(F)(F)F)N=C(N[C@H]1CCCNC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19907	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C(F)(F)F)N=C(N[C@H]1CCCNC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8	no unit
19908	C[C@@H]1CC2=C(CN1C(=O)C1CCN(C)CC1C(F)(F)F)N=C(N[C@H]1CCCNC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.12	no unit
19909	CC1CN(C)CCC1C(=O)N1CC2=C(C[C@H]1C)C=NC(NC1CCOCC1)=N2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.17 - 7.94	no unit
19910	CC1CN(C)CCC1C(=O)N1CC2=C(C[C@H]1C)C=NC(NC1CCOCC1)=N2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7 - 7.76	no unit
19911	CC1CN(C)CCC1C(=O)N1CC2=C(C[C@H]1C)C=NC(NC1CCOCC1)=N2	Cyclin-dependent kinase 7 [human]	pIC50	5.53 - 6.16	no unit
19912	CC1CN(C)CCC1C(=O)N1CC2=C(C[C@H]1C)C=NC(NCC1=NN(C)C=C1)=N2	Cyclin-dependent kinase 7 [human]	pIC50	6.09	no unit
19913	CC(C)N1CCC(C(C1)C1=CC(C)=CC=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NC1CCOCC1)=N2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.85	no unit
19914	CC(C)N1CCC(C(C1)C1=CC(C)=CC=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NC1CCOCC1)=N2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.74	no unit
19915	CC(C)N1CCC(C(C1)C1=CC(C)=CC=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NC1CCOCC1)=N2	Cyclin-dependent kinase 7 [human]	pIC50	7.29	no unit
19916	[2H]C([2H])([2H])N1CCC(C(C1)C1=CC(C)=CC=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NCC1=NN(C)C=C1)=N2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.6	no unit
19917	[2H]C([2H])([2H])N1CCC(C(C1)C1=CC(C)=CC=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NCC1=NN(C)C=C1)=N2	Cyclin-dependent kinase 7 [human]	pIC50	5.12 - 5.57	no unit
19918	[2H]C([2H])([2H])N1CCC(C(C1)C1=CC(C)=CC=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NCC1=NN(C)C=C1)=N2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	5.3	no unit
19919	CCN1CCC(C(C1)C1=CC(C)=CC=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NCC1=NN(C)C=C1)=N2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.5	no unit
19920	CCN1CCC(C(C1)C1=CC(C)=CC=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NCC1=NN(C)C=C1)=N2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19921	CCN1CCC(C(C1)C1=CC(C)=CC=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NCC1=NN(C)C=C1)=N2	Cyclin-dependent kinase 7 [human]	pIC50	7.02	no unit
19922	COCCN1CCC(C(C1)C1=CC(C)=CC=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NCC1=NN(C)C=C1)=N2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.2	no unit
19923	COCCN1CCC(C(C1)C1=CC(C)=CC=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NCC1=NN(C)C=C1)=N2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19924	COCCN1CCC(C(C1)C1=CC(C)=CC=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NCC1=NN(C)C=C1)=N2	Cyclin-dependent kinase 7 [human]	pIC50	6.25	no unit
19925	C[C@@H]1CC2=C(CN1C(=O)C1CCN(CCO)CC1C1=CC(C)=CC=C1)N=C(NCC1=CC=CC=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.36	no unit
19926	C[C@@H]1CC2=C(CN1C(=O)C1CCN(CCO)CC1C1=CC(C)=CC=C1)N=C(NCC1=CC=CC=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19927	C[C@@H]1CC2=C(CN1C(=O)C1CCN(CCO)CC1C1=CC(C)=CC=C1)N=C(NCC1=CC=CC=C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.26	no unit
19928	COCCN1CCC(C(C1)C1=CC(C)=CC=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NCC1=CC=CC=C1)=N2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.16	no unit
19929	COCCN1CCC(C(C1)C1=CC(C)=CC=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NCC1=CC=CC=C1)=N2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19930	COCCN1CCC(C(C1)C1=CC(C)=CC=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NCC1=CC=CC=C1)=N2	Cyclin-dependent kinase 7 [human]	pIC50	5.94	no unit
19931	[2H]C([2H])([2H])N1CCC(C(C1)C1=CC=CC=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NCC1=CC=CC=C1)=N2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.6	no unit
19932	[2H]C([2H])([2H])N1CCC(C(C1)C1=CC=CC=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NCC1=CC=CC=C1)=N2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19933	[2H]C([2H])([2H])N1CCC(C(C1)C1=CC=CC=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NCC1=CC=CC=C1)=N2	Cyclin-dependent kinase 7 [human]	pIC50	6.89	no unit
19934	C[C@@H]1CC2=C(CN1C(=O)C1CCN(CC3COC3)CC1C1=CC=CC=C1)N=C(NCC1=CC=CC=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.2	no unit
19935	C[C@@H]1CC2=C(CN1C(=O)C1CCN(CC3COC3)CC1C1=CC=CC=C1)N=C(NCC1=CC=CC=C1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19936	C[C@@H]1CC2=C(CN1C(=O)C1CCN(CC3COC3)CC1C1=CC=CC=C1)N=C(NCC1=CC=CC=C1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.27	no unit
19937	[2H]C([2H])([2H])N1CCC(C(C1)C1=CC=CC=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NC1CCOCC1)=N2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.49	no unit
19938	[2H]C([2H])([2H])N1CCC(C(C1)C1=CC=CC=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NC1CCOCC1)=N2	Cyclin-dependent kinase 7 [human]	pIC50	6.9	no unit
19939	CC(C)N1CCC(C(C1)C1=CC=CC=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NC1CCOCC1)=N2	Cyclin-dependent kinase 7 [human]	pIC50	6.75	no unit
19940	CCN1CCC(C(C1)C1=CC=CC=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NC1CCOCC1)=N2	Cyclin-dependent kinase 7 [human]	pIC50	7.11	no unit
19941	C[C@@H]1CC2=C(CN1C(=O)C1CCN(CC1C1=CC=CC=C1)C1COC1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	6.24	no unit
19942	C[C@@H]1CC2=C(CN1C(=O)C1CCN(CC1C1=CC=CC=C1)C1COC1)N=C(NC1CCOCC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5	no unit
19943	CC(C)N1CCC(C(C1)C1=CC(Cl)=CC=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NC1CCOCC1)=N2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.58	no unit
19944	CC(C)N1CCC(C(C1)C1=CC(Cl)=CC=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NC1CCOCC1)=N2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	6.96	no unit
19945	CC(C)N1CCC(C(C1)C1=CC(Cl)=CC=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NC1CCOCC1)=N2	Cyclin-dependent kinase 7 [human]	pIC50	6.87	no unit
19946	C[C@@H]1CC2=C(CN1C(=O)C1CCN(CC1C1=CC=CC=C1)C1CC1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	6.74	no unit
19947	C[C@@H]1CC2=C(CN1C(=O)C1CCN(CC1C1=CC=CC=C1)C1CC1)N=C(NC1CCOCC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5	no unit
19948	CC(C)N1CCC(C(C1)C1=CC(F)=C(Cl)C=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NC1CCOCC1)=N2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	6.1 - 6.95	no unit
19949	CC(C)N1CCC(C(C1)C1=CC(F)=C(Cl)C=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NC1CCOCC1)=N2	Cyclin-dependent kinase 7 [human]	pIC50	5.49	no unit
19950	CC(C)N1CCC(C(C1)C1=CC(F)=CC=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NC1CCOCC1)=N2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	6.06 - 6.83	no unit
19951	CC(C)N1CCC(C(C1)C1=CC(F)=CC=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NC1CCOCC1)=N2	Cyclin-dependent kinase 7 [human]	pIC50	5.39 - 6.79	no unit
19952	C[C@@H]1CC2=C(CN1C(=O)C1CCC(CN1C1=CC=CC=C1)N(C)C)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	6.95	no unit
19953	C[C@@H]1CC2=C(CN1C(=O)C1CCC(CN1C1=CC=CC=C1)N(C)C)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	5.87 - 6.25	no unit
19954	C[C@@H]1CC2=C(CN1C(=O)C1CCC(CN1C1=CC=CC=C1)N(C)C)N=C(NC1CCOCC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5.24	no unit
19955	C[C@@H]1CC2=C(CN1C(=O)C1CN(C)CC1C1=CC=CC=C1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	6.33	no unit
19956	C[C@@H]1CC2=C(CN1C(=O)C1CN(C)CC1C1=CC=CC=C1)N=C(NC1CCOCC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5	no unit
19957	CC1CC(C(CN1C)C1=CC=CC=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NC1CCOCC1)=N2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	6.1	no unit
19958	CC1CC(C(CN1C)C1=CC=CC=C1)C(=O)N1CC2=C(C[C@H]1C)C=NC(NC1CCOCC1)=N2	Cyclin-dependent kinase 7 [human]	pIC50	5	no unit
19959	C[C@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)C=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.24	no unit
19960	C[C@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)C=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19961	C[C@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)C=C(NC1CCOCC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.54	no unit
19962	CO[C@H]1CC[C@@H](CC1)NC1=CC2=C(CC(C)N(C2)C(=O)C2CCN(C)CC2C2=CC=CC=C2)C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.13	no unit
19963	CO[C@H]1CC[C@@H](CC1)NC1=CC2=C(CC(C)N(C2)C(=O)C2CCN(C)CC2C2=CC=CC=C2)C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8	no unit
19964	CO[C@H]1CC[C@@H](CC1)NC1=CC2=C(CC(C)N(C2)C(=O)C2CCN(C)CC2C2=CC=CC=C2)C=N1	Cyclin-dependent kinase 7 [human]	pIC50	6.73	no unit
19965	C[C@@H]1CC2=CN=C(NCC3=CC=CC=C3)C=C2CN1C(=N)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.78	no unit
19966	C[C@@H]1CC2=CN=C(NCC3=CC=CC=C3)C=C2CN1C(=N)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8	no unit
19967	C[C@@H]1CC2=CN=C(NCC3=CC=CC=C3)C=C2CN1C(=N)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	pIC50	6.99	no unit
19968	C[C@H]1CC2=CN=C(NCC3=NN(C)C=C3)C=C2CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.58	no unit
19969	C[C@H]1CC2=CN=C(NCC3=NN(C)C=C3)C=C2CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.95	no unit
19970	C[C@H]1CC2=CN=C(NCC3=NN(C)C=C3)C=C2CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	pIC50	7.45	no unit
19971	C[C@H]1CC2=CN=C(NC3(COC3)C3=CC=CC=C3)C=C2CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.13	no unit
19972	C[C@H]1CC2=CN=C(NC3(COC3)C3=CC=CC=C3)C=C2CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.52	no unit
19973	C[C@H]1CC2=CN=C(NC3(COC3)C3=CC=CC=C3)C=C2CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	pIC50	6.78	no unit
19974	CC1CC2=CN=C(NC3=CN(C)N=C3)C=C2CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.04	no unit
19975	CC1CC2=CN=C(NC3=CN(C)N=C3)C=C2CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.64	no unit
19976	CC1CC2=CN=C(NC3=CN(C)N=C3)C=C2CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	pIC50	6.42	no unit
19977	CO[C@H]1CC[C@@H](CC1)NC1=NC=C2CC(C)N(CC2=C1)C(=O)C1CCN(C)CC1C1=CC(C)=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.65 - 7.91	no unit
19978	CO[C@H]1CC[C@@H](CC1)NC1=NC=C2CC(C)N(CC2=C1)C(=O)C1CCN(C)CC1C1=CC(C)=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.54	no unit
19979	CO[C@H]1CC[C@@H](CC1)NC1=NC=C2CC(C)N(CC2=C1)C(=O)C1CCN(C)CC1C1=CC(C)=CC=C1	Cyclin-dependent kinase 7 [human]	pIC50	5.23 - 7.01	no unit
19980	[2H]C([2H])([2H])N1CC[C@@H]([C@H](C1)C1=CC=CC=C1)C(=O)N1CC2=CC(NCC3=NN(C)C=C3)=NC=C2C[C@H]1C	Cyclin-dependent kinase 7 [human]	pIC50	5.43	no unit
19981	C[C@@H]1CC2=CN=C(NC3=CN(C)N=C3)C=C2CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC(C)=CC=C1	Cyclin-dependent kinase 7 [human]	pIC50	7.08	no unit
19982	C[C@@H]1CN([C@@H](C)C2=C1C=NC(NC1CCOCC1)=N2)C(=O)[C@@H]1CCN(C)C[C@H]1C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.68	no unit
19983	C[C@@H]1CN([C@@H](C)C2=C1C=NC(NC1CCOCC1)=N2)C(=O)[C@@H]1CCN(C)C[C@H]1C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
19984	C[C@@H]1CN([C@@H](C)C2=C1C=NC(NC1CCOCC1)=N2)C(=O)[C@@H]1CCN(C)C[C@H]1C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	pIC50	7.49	no unit
19985	C[C@@H]1CN([C@@H](C)C2=C1C=NC(NC1CCOCC1)=N2)C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	5.65	no unit
19986	C[C@@H]1CN([C@@H](C)C2=C1C=NC(NC1CCOCC1)=N2)C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	pIC50	5.41	no unit
19987	C[C@H]1CN([C@@H](C)C2=C1C=NC(NC1CCOCC1)=N2)C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	6.98	no unit
19988	C[C@H]1CN([C@@H](C)C2=C1C=NC(NC1CCOCC1)=N2)C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	6.9	no unit
19989	C[C@H]1CN([C@@H](C)C2=C1C=NC(NC1CCOCC1)=N2)C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	pIC50	5.6	no unit
19990	C[C@H]1CN([C@@H](C)C2=C1C=NC(NC1CCOCC1)=N2)C(=O)[C@@H]1CCN(C)C[C@H]1C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	6.14	no unit
19991	C[C@H]1CN([C@@H](C)C2=C1C=NC(NC1CCOCC1)=N2)C(=O)[C@@H]1CCN(C)C[C@H]1C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	pIC50	5.37	no unit
19992	C[C@@H]1N(CCC2=C1N=C(NC1CCOCC1)N=C2)C(=O)[C@@H]1CCN(C)C[C@H]1C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	5	no unit
19993	C[C@@H]1N(CCC2=C1N=C(NC1CCOCC1)N=C2)C(=O)[C@@H]1CCN(C)C[C@H]1C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	pIC50	5	no unit
19994	C[C@@H]1N(CCC2=C1N=C(NC1CCOCC1)N=C2)C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.59	no unit
19995	C[C@@H]1N(CCC2=C1N=C(NC1CCOCC1)N=C2)C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	pIC50	6.27	no unit
19996	CC[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.37	no unit
19997	CC[C@@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCOCC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.14	no unit
19998	CC[C@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	5	no unit
19999	CC[C@H]1CC2=C(CN1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1)N=C(NC1CCOCC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	5	no unit
20000	C[C@H]1CN(CC2=C1C=NC(NC1CCOCC1)=N2)C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	5	no unit
20001	C[C@H]1CN(CC2=C1C=NC(NC1CCOCC1)=N2)C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	pIC50	5	no unit
20002	C[C@@H]1CN(CC2=C1C=NC(NC1CCOCC1)=N2)C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.55	no unit
20003	C[C@@H]1CN(CC2=C1C=NC(NC1CCOCC1)=N2)C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.01	no unit
20004	C[C@@H]1CN(CC2=C1C=NC(NC1CCOCC1)=N2)C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	pIC50	6.98	no unit
20005	CN1CC[C@H]([C@@H](C1)C1=CC=CC=C1)C(=O)N1CC2=C(CC1(C)C)C=NC(NC1CCOCC1)=N2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.75	no unit
20006	CN1CC[C@H]([C@@H](C1)C1=CC=CC=C1)C(=O)N1CC2=C(CC1(C)C)C=NC(NC1CCOCC1)=N2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.65	no unit
20007	CN1CC[C@H]([C@@H](C1)C1=CC=CC=C1)C(=O)N1CC2=C(CC1(C)C)C=NC(NC1CCOCC1)=N2	Cyclin-dependent kinase 7 [human]	pIC50	5.99	no unit
20008	CO[C@H]1CC[C@@H](CC1)NC1=NC2=C(CC(C)(C)N(C2)C(=O)C2CCN(C)CC2C2=CC=CC=C2)C=N1	Cyclin-dependent kinase 7 [human]	pIC50	6.62	no unit
20009	CN1C=CC(CNC2=NC3=C(CC(C)(C)N(C3)C(=O)[C@@H]3CCN(C)C[C@H]3C3=CC=CC=C3)C=N2)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.41	no unit
20010	CN1C=CC(CNC2=NC3=C(CC(C)(C)N(C3)C(=O)[C@@H]3CCN(C)C[C@H]3C3=CC=CC=C3)C=N2)=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	6.53	no unit
20011	CN1C=CC(CNC2=NC3=C(CC(C)(C)N(C3)C(=O)[C@@H]3CCN(C)C[C@H]3C3=CC=CC=C3)C=N2)=N1	Cyclin-dependent kinase 7 [human]	pIC50	5.37	no unit
20012	CO[C@H]1CC[C@@H](CC1)NC1=NC2=C(CC3(CC3)N(C2)C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	6.84	no unit
20013	CO[C@H]1CC[C@@H](CC1)NC1=NC2=C(CC3(CC3)N(C2)C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)C=N1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	6.8	no unit
20014	CO[C@H]1CC[C@@H](CC1)NC1=NC2=C(CC3(CC3)N(C2)C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)C=N1	Cyclin-dependent kinase 7 [human]	pIC50	5.54	no unit
20015	CC1CN(CC2=C1C=NC(NC1=CN(C)N=C1)=N2)C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.21	no unit
20016	CC1CN(CC2=C1C=NC(NC1=CN(C)N=C1)=N2)C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.75	no unit
20017	CC1CN(CC2=C1C=NC(NC1=CN(C)N=C1)=N2)C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	pIC50	6.96	no unit
20018	C[C@@H]1CC2=C(N=C(NC3CCOCC3)N=C2)C(C)N1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.31	no unit
20019	C[C@@H]1CC2=C(N=C(NC3CCOCC3)N=C2)C(C)N1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	pIC50	7.14	no unit
20020	C[C@@H]1CC2=C(N=C(NC3CCOCC3)N=C2)C(C)N1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	5.33	no unit
20021	C[C@H]1CC2=C(N=C(NC3CCOCC3)N=C2)[C@H](C)N1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	pIC50	6.11	no unit
20022	C[C@@H]1CC2=C(N=C(NCC3=NN(C)C=C3)N=C2)C(C)N1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	6.11	no unit
20023	C[C@@H]1CC2=C(N=C(NCC3=NN(C)C=C3)N=C2)C(C)N1C(=O)[C@H]1CCN(C)C[C@@H]1C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	pIC50	5.55	no unit
20024	[H][C@]12C[C@@]1([H])C1=C(CN2C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)N=C(NCC2=NN(C)C=C2)N=C1	Cyclin-dependent kinase 7 [human]	pIC50	6.63	no unit
20025	[H][C@]12C[C@@]1([H])C1=C(CN2C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)N=C(NC2=CN(C)N=C2)N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.77	no unit
20026	[H][C@]12C[C@@]1([H])C1=C(CN2C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)N=C(NC2=CN(C)N=C2)N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.46	no unit
20027	[H][C@]12C[C@@]1([H])C1=C(CN2C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)N=C(NC2=CN(C)N=C2)N=C1	Cyclin-dependent kinase 7 [human]	pIC50	6.49	no unit
20028	[H][C@]12C[C@@]1([H])C1=C(CN2C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)N=C(N[C@H]2CC[C@@H](CC2)OC)N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.16	no unit
20029	[H][C@]12C[C@@]1([H])C1=C(CN2C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)N=C(N[C@H]2CC[C@@H](CC2)OC)N=C1	Cyclin-dependent kinase 7 [human]	pIC50	7.71	no unit
20030	[H][C@]12C[C@@]1([H])C1=C(CN2C(=O)[C@H]2CCN(C)C[C@@H]2C2=CC=CC=C2)N=C(N[C@H]2CC[C@@H](CC2)OC)N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.48	no unit
20031	[H][C@]12C[C@@]1([H])C1=C(CN2C(=O)C2CCN(C)CC2C2=CC(C)=CC=C2)N=C(NC2=CN(C)N=C2)N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.27	no unit
20032	[H][C@]12C[C@@]1([H])C1=C(CN2C(=O)C2CCN(C)CC2C2=CC(C)=CC=C2)N=C(NC2=CN(C)N=C2)N=C1	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	5.63 - 7.77	no unit
20033	[H][C@]12C[C@@]1([H])C1=C(CN2C(=O)C2CCN(C)CC2C2=CC(C)=CC=C2)N=C(NC2=CN(C)N=C2)N=C1	Cyclin-dependent kinase 7 [human]	pIC50	5.16 - 6.83	no unit
20034	C[C@@H]1CC2=C(CN1C(=O)N1CCN(C)C[C@@H]1C1=CC=CC(F)=C1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	8.32	no unit
20035	C[C@@H]1CC2=C(CN1C(=O)N1CCN(C)C[C@@H]1C1=CC=CC(F)=C1)N=C(NC1CCOCC1)N=C2	Cyclin-H [human];+CDK-activating kinase assembly factor MAT1 [human]; Cyclin-dependent kinase 7 [human]	pIC50	7.88	no unit
20036	C[C@@H]1CC2=C(CN1C(=O)N1CCN(C)C[C@@H]1C1=CC=CC(F)=C1)N=C(NC1CCOCC1)N=C2	Cyclin-dependent kinase 7 [human]	pIC50	6.74	no unit
20037	OC=O.CN1CC[C@@H](C1)OC1=NN2C(=CN=C2C(NCC2=CC=CC=C2)=C1)C1CC1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
20038	OC=O.CN1CCC[C@@H](C1)NC1=NN2C(=CN=C2C(NCC2=CC=CC=C2)=C1)C1CC1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
20039	OC=O.C(NC1=NN2C(=CN=C2C(NCC2=CC=CC=C2)=C1)C1CC1)C1CC2(CCNCC2)O1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
20040	Cl.OC=O.C(NC1=CC(SC2CCNCC2)=NN2C(=CN=C12)C1CC1)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
20041	Cl.OC=O.C(NC1=CC(SC2CCCNC2)=NN2C(=CN=C12)C1CC1)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
20042	Cl.OC=O.C(NC1=CC(SC2CCCNC2)=NN2C(=CN=C12)C1CC1)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20043	Cl.OC=O.C(NC1=CC(SC2CCCNC2)=NN2C(=CN=C12)C1CC1)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20044	Cl.OC=O.C(NC1=CC(SC2CCCNC2)=NN2C(=CN=C12)C1CC1)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20045	Cl.OC=O.C(NC1=CC(SC2CCCNC2)=NN2C(=CN=C12)C1CC1)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20046	Cl.OC=O.C(NC1=CC(SC2CCCNC2)=NN2C(=CN=C12)C1CC1)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20047	Cl.OC=O.C(NC1=CC(SC2CCCNC2)=NN2C(=CN=C12)C1CC1)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20048	OC=O.CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2N[C@@H](C)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
20049	OC=O.CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2N[C@@H](C)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20050	OC=O.CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2N[C@@H](C)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20051	OC=O.CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2N[C@@H](C)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
20052	OC=O.CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2N[C@@H](C)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20053	OC=O.CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2N[C@@H](C)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20054	OC=O.CC(C)C1=CN=C2N1N=C(SC1CCNCC1)C=C2N[C@@H](C)C1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20055	Cl.C[C@H](NC1=CC(SC2CCNCC2)=NN2C(=CN=C12)C1CC1)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
20056	Cl.CC(C)C1=CN=C2N1N=C(OC1CCNCC1)C=C2N[C@@H](C)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
20057	Cl.CC(C)C1=CN=C2N1N=C(SC1CCCNC1)C=C2N[C@@H](C)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
20058	Cl.COC(=O)[C@@H](N)CSC1=NN2C(=CN=C2C(NCC2=CC=CC=C2)=C1)C1CC1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
20059	Cl.COC1=C(CNC2=CC(SC3CCNCC3)=NN3C(=CN=C23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
20060	Cl.COC1=C(CNC2=CC(SC3CCNCC3)=NN3C(=CN=C23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
20061	Cl.COC1=C(CNC2=CC(SC3CCNCC3)=NN3C(=CN=C23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20062	Cl.COC1=C(CNC2=CC(SC3CCNCC3)=NN3C(=CN=C23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
20063	Cl.COC1=C(CNC2=CC(SC3CCNCC3)=NN3C(=CN=C23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
20064	Cl.COC1=C(CNC2=CC(SC3CCNCC3)=NN3C(=CN=C23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
20065	Cl.COC1=C(CNC2=CC(SC3CCNCC3)=NN3C(=CN=C23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	5	μM
20066	Cl.COC1=C(CNC2=CC(SC3CCCNC3)=NN3C(=CN=C23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
20067	Cl.COC1=C(CNC2=CC(SC3CCCNC3)=NN3C(=CN=C23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20068	Cl.COC1=C(CNC2=CC(SC3CCCNC3)=NN3C(=CN=C23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20069	Cl.COC1=C(CNC2=CC(SC3CCCNC3)=NN3C(=CN=C23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
20070	Cl.COC1=C(CNC2=CC(SC3CCCNC3)=NN3C(=CN=C23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20071	Cl.COC1=C(CNC2=CC(SC3CCCNC3)=NN3C(=CN=C23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20072	Cl.COC1=C(CNC2=CC(SC3CCCNC3)=NN3C(=CN=C23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20073	Cl.CC(C)C1=CN=C2N1N=C(O[C@H]1CCCNC1)C=C2NC1=CC(F)=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
20074	Cl.CC(C)C1=CN=C2N1N=C(O[C@H]1CCCNC1)C=C2NC1=CC(F)=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20075	Cl.CC(C)C1=CN=C2N1N=C(O[C@H]1CCCNC1)C=C2NC1=CC(F)=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20076	Cl.CC(C)C1=CN=C2N1N=C(O[C@H]1CCCNC1)C=C2NC1=CC(F)=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20077	Cl.CC(C)C1=CN=C2N1N=C(O[C@H]1CCCNC1)C=C2NC1=CC(F)=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20078	Cl.CC(C)C1=CN=C2N1N=C(O[C@H]1CCCNC1)C=C2NC1=CC(F)=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20079	Cl.CC(C)C1=CN=C2N1N=C(O[C@H]1CCCNC1)C=C2NC1=CC(F)=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20080	Cl.COC1=C(CNC2=CC(NC3CCNCC3)=NN3C(=CN=C23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
20081	Cl.COC1=C(CNC2=CC(NC3CCNCC3)=NN3C(=CN=C23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20082	Cl.COC1=C(CNC2=CC(NC3CCNCC3)=NN3C(=CN=C23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20083	Cl.COC1=C(CNC2=CC(NC3CCNCC3)=NN3C(=CN=C23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20084	Cl.COC1=C(CNC2=CC(NC3CCNCC3)=NN3C(=CN=C23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20085	Cl.COC1=C(CNC2=CC(NC3CCNCC3)=NN3C(=CN=C23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20086	Cl.COC1=C(CNC2=CC(NC3CCNCC3)=NN3C(=CN=C23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20087	Cl.CC(C)C1=CN=C2N1N=C(SC1CCCNC1)C=C2NCC1=C(OC(F)(F)F)C=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
20088	Cl.CC(C)C1=CN=C2N1N=C(SC1CCCNC1)C=C2NCC1=C(OC(F)(F)F)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20089	Cl.CC(C)C1=CN=C2N1N=C(SC1CCCNC1)C=C2NCC1=C(OC(F)(F)F)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20090	Cl.CC(C)C1=CN=C2N1N=C(SC1CCCNC1)C=C2NCC1=C(OC(F)(F)F)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20091	Cl.CC(C)C1=CN=C2N1N=C(SC1CCCNC1)C=C2NCC1=C(OC(F)(F)F)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20092	Cl.CC(C)C1=CN=C2N1N=C(SC1CCCNC1)C=C2NCC1=C(OC(F)(F)F)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20093	Cl.CC(C)C1=CN=C2N1N=C(SC1CCCNC1)C=C2NCC1=C(OC(F)(F)F)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20094	Cl.CC(C)C1=CN=C2N1N=C(NC1CCN(CC1)C(=O)OC(C)(C)C)C=C2N(CC1=C(OC(F)(F)F)C=CC=C1)C(=O)OC(C)(C)C	Cyclin-dependent kinase 7	IC50	100	nM
20095	Cl.CC(C)C1=CN=C2N1N=C(NC1CCN(CC1)C(=O)OC(C)(C)C)C=C2N(CC1=C(OC(F)(F)F)C=CC=C1)C(=O)OC(C)(C)C	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20096	Cl.CC(C)C1=CN=C2N1N=C(NC1CCN(CC1)C(=O)OC(C)(C)C)C=C2N(CC1=C(OC(F)(F)F)C=CC=C1)C(=O)OC(C)(C)C	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20097	Cl.CC(C)C1=CN=C2N1N=C(NC1CCN(CC1)C(=O)OC(C)(C)C)C=C2N(CC1=C(OC(F)(F)F)C=CC=C1)C(=O)OC(C)(C)C	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20098	Cl.CC(C)C1=CN=C2N1N=C(NC1CCN(CC1)C(=O)OC(C)(C)C)C=C2N(CC1=C(OC(F)(F)F)C=CC=C1)C(=O)OC(C)(C)C	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20099	Cl.CC(C)C1=CN=C2N1N=C(NC1CCN(CC1)C(=O)OC(C)(C)C)C=C2N(CC1=C(OC(F)(F)F)C=CC=C1)C(=O)OC(C)(C)C	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20100	Cl.CC(C)C1=CN=C2N1N=C(NC1CCN(CC1)C(=O)OC(C)(C)C)C=C2N(CC1=C(OC(F)(F)F)C=CC=C1)C(=O)OC(C)(C)C	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20101	Cl.CC(C)C1=CN=C2N1C=C(SC1CCCNC1)N=C2NCC1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
20102	Cl.CC(C)C1=CN=C2N1C=C(SC1CCCNC1)N=C2NCC1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20103	Cl.CC(C)C1=CN=C2N1C=C(SC1CCCNC1)N=C2NCC1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20104	Cl.CC(C)C1=CN=C2N1C=C(SC1CCCNC1)N=C2NCC1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20105	Cl.CC(C)C1=CN=C2N1C=C(SC1CCCNC1)N=C2NCC1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20106	Cl.CC(C)C1=CN=C2N1C=C(SC1CCCNC1)N=C2NCC1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20107	Cl.CC(C)C1=CN=C2N1N=C(NC[C@H]1CNCCO1)C=C2NCC1=C(OC(F)(F)F)C=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
20108	Cl.CC(C)C1=CN=C2N1N=C(NC[C@H]1CNCCO1)C=C2NCC1=C(OC(F)(F)F)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20109	Cl.CC(C)C1=CN=C2N1N=C(NC[C@H]1CNCCO1)C=C2NCC1=C(OC(F)(F)F)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20110	Cl.CC(C)C1=CN=C2N1N=C(NC[C@H]1CNCCO1)C=C2NCC1=C(OC(F)(F)F)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20111	Cl.CC(C)C1=CN=C2N1N=C(NC[C@H]1CNCCO1)C=C2NCC1=C(OC(F)(F)F)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20112	Cl.CC(C)C1=CN=C2N1N=C(NC[C@H]1CNCCO1)C=C2NCC1=C(OC(F)(F)F)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20113	Cl.CC(C)C1=CN=C2N1N=C(NC[C@H]1CNCCO1)C=C2NCC1=C(OC(F)(F)F)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	5	μM
20114	Cl.CC(C)C1=CN=C2N1N=C(NC[C@@H]1CNCCO1)C=C2NCC1=C(OC(F)(F)F)C=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
20115	Cl.CC(C)C1=CN=C2N1N=C(NC[C@@H]1CNCCO1)C=C2NCC1=C(OC(F)(F)F)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20116	Cl.CC(C)C1=CN=C2N1N=C(NC[C@@H]1CNCCO1)C=C2NCC1=C(OC(F)(F)F)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20117	Cl.CC(C)C1=CN=C2N1N=C(NC[C@@H]1CNCCO1)C=C2NCC1=C(OC(F)(F)F)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20118	Cl.CC(C)C1=CN=C2N1N=C(NC[C@@H]1CNCCO1)C=C2NCC1=C(OC(F)(F)F)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20119	Cl.CC(C)C1=CN=C2N1N=C(NC[C@@H]1CNCCO1)C=C2NCC1=C(OC(F)(F)F)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20120	Cl.CC(C)C1=CN=C2N1N=C(NC[C@@H]1CNCCO1)C=C2NCC1=C(OC(F)(F)F)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	5	μM
20121	OC=O.COC1=C(CNC2=CC(SC3CCCNC3)=NN3C(=CN=C23)C(C)C)C=CC(F)=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
20122	Cl.COC1=C(CNC2=CC(SC3CCNCC3F)=NN3C(=CN=C23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
20123	Cl.COC1=C(CNC2=CC(SC3CCNCC3F)=NN3C(=CN=C23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20124	Cl.COC1=C(CNC2=CC(SC3CCNCC3F)=NN3C(=CN=C23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20125	Cl.COC1=C(CNC2=CC(SC3CCNCC3F)=NN3C(=CN=C23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20126	Cl.COC1=C(CNC2=CC(SC3CCNCC3F)=NN3C(=CN=C23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20127	Cl.CC(C)C1=CN=C2N1N=C(SC1CCNCC1F)C=C2NCC1=C(C=CC=C1)C(F)(F)F	Cyclin-dependent kinase 7	IC50	100	nM
20128	Cl.CC(C)C1=CN=C2N1N=C(SC1CCNCC1F)C=C2NCC1=C(C=CC=C1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20129	Cl.CC(C)C1=CN=C2N1N=C(SC1CCNCC1F)C=C2NCC1=C(C=CC=C1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20130	Cl.CC(C)C1=CN=C2N1N=C(SC1CCNCC1F)C=C2NCC1=C(C=CC=C1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20131	Cl.CC(C)C1=CN=C2N1N=C(SC1CCNCC1F)C=C2NCC1=C(C=CC=C1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20132	Cl.COC1=C(CNC2=CC(SC3CCNCC3(F)F)=NN3C(=CN=C23)C(C)C)C=CC=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
20133	Cl.COC1=C(CNC2=CC(SC3CCNCC3(F)F)=NN3C(=CN=C23)C(C)C)C=CC=C1				
20134	Cl.OC=O.C(NC1=NC(SC2CCNCC2)=CN2C(=CN=C12)C1CC1)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100 - 1000	nM
20135	Cl.OC=O.CC(C)C1=CN=C2N1C=C(SC1CCCNC1)N=C2NCC1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	100	nM
20136	Cl.OC=O.CC(C)C1=CN=C2N1C=C(SC1CCCNC1)N=C2NCC1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20137	Cl.OC=O.CC(C)C1=CN=C2N1C=C(SC1CCCNC1)N=C2NCC1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20138	Cl.OC=O.CC(C)C1=CN=C2N1C=C(SC1CCCNC1)N=C2NCC1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20139	Cl.OC=O.CC(C)C1=CN=C2N1C=C(SC1CCCNC1)N=C2NCC1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20140	Cl.OC=O.CC(C)C1=CN=C2N1C=C(SC1CCCNC1)N=C2NCC1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	5	μM
20141	Cl.OC=O.CC(C)C1=CN=C2N1C=C(SC1CCCNC1)N=C2NCC1=CC=CC=C1	Cyclin-dependent kinase 7 [human]	IC50	5	μM
20142	Cl.C(NC1=NC(NC2CCNCC2)=CN2C(=CN=C12)C1CC1)C1=CC=CC=C1	Cyclin-dependent kinase 7	IC50	1000	nM
20143	Cl.FC1=CC=CC(NC2=CC(O[C@H]3CCCNC3)=NN3C(=CN=C23)C2CC2)=C1	Cyclin-dependent kinase 7	IC50	100	nM
20144	Cl.FC1=CC=CC(NC2=CC(O[C@H]3CCCNC3)=NN3C(=CN=C23)C2CC2)=C1	Cyclin-dependent kinase 7 [human]	IC50	1	μM
20145	Cl.FC1=CC=CC(NC2=CC(O[C@H]3CCCNC3)=NN3C(=CN=C23)C2CC2)=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20146	Cl.FC1=CC=CC(NC2=CC(O[C@H]3CCCNC3)=NN3C(=CN=C23)C2CC2)=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20147	Cl.FC1=CC=CC(NC2=CC(O[C@H]3CCCNC3)=NN3C(=CN=C23)C2CC2)=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20148	Cl.FC1=CC=CC(NC2=CC(O[C@H]3CCCNC3)=NN3C(=CN=C23)C2CC2)=C1	Cyclin-dependent kinase 7 [human]	IC50	1 - 5	μM
20149	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphatidylinositol 3-kinase regulatory subunit alpha	Kd (dissociation constant)	0.099	nM
20150	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	Kd (dissociation constant)	0.71	nM
20151	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphatidylinositol 3-kinase regulatory subunit beta	Kd (dissociation constant)	0.85	nM
20152	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphatidylinositol 3-kinase regulatory subunit gamma	Kd (dissociation constant)	1.6	nM
20153	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphatidylinositol 3-kinase regulatory subunit alpha	Ki (inhibition constant)	2.93	nM
20154	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphatidylinositol 3-kinase regulatory subunit alpha	pKic	8.53	no unit
20155	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase mTOR	Kd (dissociation constant)	32	nM
20156	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphatidylinositol 3-kinase catalytic subunit type 3	Kd (dissociation constant)	54	nM
20157	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C		IC50	82	nM
20158	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C		pIC50	7.09	no unit
20159	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	Kd (dissociation constant)	81	nM
20160	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphatidylinositol 4-kinase beta	Kd (dissociation constant)	30000	nM
20161	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Dual specificity protein kinase CLK3	inhibition rate	3	%
20162	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Dual specificity protein kinase CLK4	inhibition rate	0	%
20163	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Macrophage colony-stimulating factor 1 receptor	inhibition rate	23	%
20164	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Macrophage colony-stimulating factor 1 receptor	inhibition rate	80	%
20165	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase CSK	inhibition rate	0	%
20166	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Casein kinase I isoform alpha	inhibition rate	11	%
20167	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Casein kinase I isoform alpha-like	inhibition rate	0	%
20168	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Casein kinase I isoform delta	inhibition rate	0	%
20169	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Casein kinase I isoform epsilon	inhibition rate	13	%
20170	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Casein kinase I isoform gamma-1	inhibition rate	1	%
20171	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	AP2-associated protein kinase 1	inhibition rate	0	%
20172	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Casein kinase I isoform gamma-2	inhibition rate	0	%
20173	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Casein kinase I isoform gamma-3	inhibition rate	0	%
20174	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Casein kinase II subunit alpha	inhibition rate	25	%
20175	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Casein kinase II subunit alpha'	inhibition rate	0	%
20176	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Megakaryocyte-associated tyrosine-protein kinase	inhibition rate	22	%
20177	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Death-associated protein kinase 1	inhibition rate	4	%
20178	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Death-associated protein kinase 2	inhibition rate	5	%
20179	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Death-associated protein kinase 3	inhibition rate	11	%
20180	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase DCLK1	inhibition rate	41	%
20181	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase DCLK2	inhibition rate	2	%
20182	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase DCLK3	inhibition rate	4	%
20183	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Epithelial discoidin domain-containing receptor 1	inhibition rate	0	%
20184	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Discoidin domain-containing receptor 2	inhibition rate	17	%
20185	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Death-associated protein kinase 3	inhibition rate	3	%
20186	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Myotonin-protein kinase	inhibition rate	13	%
20187	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase MRCK gamma	inhibition rate	0	%
20188	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase 17A	inhibition rate	0	%
20189	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase 17B	inhibition rate	3	%
20190	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Dual specificity tyrosine-phosphorylation-regulated kinase 1A/B	inhibition rate	6	%
20191	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	inhibition rate	2	%
20192	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Dual specificity tyrosine-phosphorylation-regulated kinase 2	inhibition rate	20	%
20193	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	epidermal growth factor-activated receptor	inhibition rate	0	%
20194	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	epidermal growth factor-activated receptor	inhibition rate	5	%
20195	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Epidermal growth factor receptor (G719C)	inhibition rate	13	%
20196	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Epidermal growth factor receptor (G719S)	inhibition rate	3	%
20197	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	epidermal growth factor-activated receptor;+epidermal growth factor-activated receptor	inhibition rate	0	%
20198	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	epidermal growth factor-activated receptor;+epidermal growth factor-activated receptor	inhibition rate	18	%
20199	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	epidermal growth factor-activated receptor Sins;+epidermal growth factor-activated receptor	inhibition rate	2	%
20200	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Epidermal growth factor receptor (L858R)	inhibition rate	0	%
20201	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Epidermal growth factor receptor (L858R);+Epidermal growth factor receptor (T790M)	inhibition rate	3	%
20202	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Epidermal growth factor receptor (L861Q)	inhibition rate	7	%
20203	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	epidermal growth factor-activated receptor	inhibition rate	8	%
20204	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Epidermal growth factor receptor (T790M)	inhibition rate	10	%
20205	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Eukaryotic translation initiation factor 2-alpha kinase 1	inhibition rate	6	%
20206	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Ephrin type-A receptor 1	inhibition rate	0	%
20207	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Ephrin type-A receptor 2	inhibition rate	5	%
20208	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Ephrin type-A receptor 3	inhibition rate	10	%
20209	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Ephrin type-A receptor 4	inhibition rate	6	%
20210	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Ephrin type-A receptor 5	inhibition rate	0	%
20211	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Ephrin type-A receptor 6	inhibition rate	0	%
20212	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase ABL1	inhibition rate	13	%
20213	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Ephrin type-A receptor 7	inhibition rate	0	%
20214	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Ephrin type-A receptor 8	inhibition rate	0	%
20215	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Ephrin type-B receptor 1	inhibition rate	0	%
20216	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Ephrin type-B receptor 2	inhibition rate	5	%
20217	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Ephrin type-B receptor 3	inhibition rate	2	%
20218	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Ephrin type-B receptor 4	inhibition rate	0	%
20219	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Ephrin type-B receptor 6	inhibition rate	35	%
20220	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Receptor tyrosine-protein kinase erbB-2	inhibition rate	30	%
20221	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Receptor tyrosine-protein kinase erbB-3	inhibition rate	16	%
20222	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Receptor tyrosine-protein kinase erbB-4	inhibition rate	0	%
20223	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase ABL1	inhibition rate	0	%
20224	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Extracellular signal-regulated kinase 1	inhibition rate	0	%
20225	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Extracellular signal-regulated kinase 2	inhibition rate	2	%
20226	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mitogen-activated protein kinase 6	inhibition rate	4	%
20227	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mitogen-activated protein kinase 4	inhibition rate	3	%
20228	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mitogen-activated protein kinase 7	inhibition rate	0	%
20229	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mitogen-activated protein kinase 15	inhibition rate	3	%
20230	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Ethylene-responsive transcription factor ERN1	inhibition rate	0	%
20231	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Focal adhesion kinase 1	inhibition rate	0	%
20232	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase Fer	inhibition rate	13	%
20233	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	(-)-endo-fenchol synthase, chloroplastic	inhibition rate	0	%
20234	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase ABL1	inhibition rate	6	%
20235	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Fibroblast growth factor receptor 1	inhibition rate	0	%
20236	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Fibroblast growth factor receptor 2	inhibition rate	11	%
20237	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Fibroblast growth factor receptor 3	inhibition rate	4	%
20238	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Fibroblast growth factor receptor 3	inhibition rate	1	%
20239	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Fibroblast growth factor receptor 4	inhibition rate	0	%
20240	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase Fgr	inhibition rate	3	%
20241	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Vascular endothelial growth factor receptor 1	inhibition rate	1	%
20242	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	9	%
20243	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Receptor-type tyrosine-protein kinase FLT3 (D835H)	inhibition rate	0	%
20244	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Receptor-type tyrosine-protein kinase FLT3 (D835V)	inhibition rate	39	%
20245	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase ABL1	inhibition rate	10	%
20246	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Receptor-type tyrosine-protein kinase FLT3 (D835Y)	inhibition rate	1	%
20247	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Receptor-type tyrosine-protein kinase FLT3 ITD	inhibition rate	3	%
20248	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Receptor-type tyrosine-protein kinase FLT3 (D835V);+Receptor-type tyrosine-protein kinase FLT3 ITD	inhibition rate	13	%
20249	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Receptor-type tyrosine-protein kinase FLT3 ITD;+Receptor-type tyrosine-protein kinase FLT3	inhibition rate	5	%
20250	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	0	%
20251	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	0	%
20252	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	16	%
20253	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	1	%
20254	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Vascular endothelial growth factor receptor 3	inhibition rate	4	%
20255	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase FRK	inhibition rate	0	%
20256	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase ABL1	inhibition rate	0	%
20257	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase Fyn	inhibition rate	0	%
20258	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Cyclin-G-associated kinase	inhibition rate	0	%
20259	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	eIF-2-alpha kinase Gcn2;+eIF-2-alpha kinase Gcn2	inhibition rate	0	%
20260	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	rhodopsin kinase	inhibition rate	33	%
20261	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Beta-adrenergic receptor kinase 1	inhibition rate	0	%
20262	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Beta-adrenergic receptor kinase 2	inhibition rate	0	%
20263	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	G protein-coupled receptor kinase 4	inhibition rate	0	%
20264	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	rhodopsin kinase	inhibition rate	13	%
20265	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Glycogen synthase kinase-3 alpha	inhibition rate	8	%
20266	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	tau-protein kinase	inhibition rate	26	%
20267	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase ABL1	inhibition rate	6	%
20268	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase haspin	inhibition rate	25	%
20269	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase HCK	inhibition rate	14	%
20270	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Homeodomain-interacting protein kinase 1	inhibition rate	3	%
20271	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Homeodomain-interacting protein kinase 2	inhibition rate	17	%
20272	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Homeodomain-interacting protein kinase 3	inhibition rate	0	%
20273	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Homeodomain-interacting protein kinase 4	inhibition rate	0	%
20274	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mitogen-activated protein kinase kinase kinase kinase 1	inhibition rate	0	%
20275	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Hormonally up-regulated neu tumor-associated kinase	inhibition rate	21	%
20276	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase ICK	inhibition rate	5	%
20277	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Insulin-like growth factor 1 receptor	inhibition rate	0	%
20278	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase ABL1	inhibition rate	17	%
20279	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Inhibitor of nuclear factor kappa-B kinase subunit alpha	inhibition rate	29	%
20280	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Inhibitor of nuclear factor kappa-B kinase subunit beta	inhibition rate	27	%
20281	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	inhibition rate	29	%
20282	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Insulin receptor	inhibition rate	1	%
20283	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Insulin receptor-related protein	inhibition rate	4	%
20284	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Interleukin-1 receptor-associated kinase 1	inhibition rate	0	%
20285	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Interleukin-1 receptor-associated kinase 3	inhibition rate	11	%
20286	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Interleukin-1 receptor-associated kinase 4	inhibition rate	5	%
20287	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase ITK/TSK	inhibition rate	1	%
20288	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase JAK1	inhibition rate	0	%
20289	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase ABL1	inhibition rate	1	%
20290	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase JAK1	inhibition rate	68	%
20291	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase JAK2	inhibition rate	12	%
20292	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase JAK3	inhibition rate	12	%
20293	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mitogen-activated protein kinase 8	inhibition rate	7	%
20294	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mitogen-activated protein kinase 9	inhibition rate	11	%
20295	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mitogen-activated protein kinase 10	inhibition rate	0	%
20296	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mast/stem cell growth factor receptor Kit	inhibition rate	7	%
20297	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mast/stem cell growth factor receptor Kit (A829P)	inhibition rate	0	%
20298	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mast/stem cell growth factor receptor Kit (D816H)	inhibition rate	0	%
20299	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mast/stem cell growth factor receptor Kit (D816V)	inhibition rate	21	%
20300	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase ABL1	inhibition rate	6	%
20301	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mast/stem cell growth factor receptor Kit	inhibition rate	47	%
20302	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mast/stem cell growth factor receptor Kit (V559D)	inhibition rate	22	%
20303	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mast/stem cell growth factor receptor Kit (V559D);+Mast/stem cell growth factor receptor Kit	inhibition rate	18	%
20304	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Polyphosphoinositide phosphatase (V654A);+Mast/stem cell growth factor receptor Kit (V559D)	inhibition rate	0	%
20305	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mast/stem cell growth factor receptor Kit	inhibition rate	65	%
20306	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase LATS1	inhibition rate	0	%
20307	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase LATS2	inhibition rate	0	%
20308	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Proto-oncogene tyrosine-protein kinase LCK	inhibition rate	10	%
20309	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	LIM domain kinase 1	inhibition rate	0	%
20310	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	LIM domain kinase 2	inhibition rate	3	%
20311	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase ABL1	inhibition rate	0	%
20312	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase STK11	inhibition rate	0	%
20313	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Ovarian-specific serine/threonine-protein kinase Lok	inhibition rate	5	%
20314	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Leucine-rich repeat serine/threonine-protein kinase 2	inhibition rate	37	%
20315	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Leucine-rich repeat serine/threonine-protein kinase 2 (G2019S)	inhibition rate	21	%
20316	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Leukocyte tyrosine kinase receptor	inhibition rate	0	%
20317	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase Lyn	inhibition rate	0	%
20318	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mitogen-activated protein kinase kinase kinase 13	inhibition rate	0	%
20319	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase MAK	inhibition rate	0	%
20320	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mitogen-activated protein kinase kinase kinase 1	inhibition rate	7	%
20321	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mitogen-activated protein kinase kinase kinase 15	inhibition rate	0	%
20322	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase ABL1	inhibition rate	29	%
20323	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mitogen-activated protein kinase kinase kinase 2	inhibition rate	31	%
20324	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mitogen-activated protein kinase kinase kinase 3	inhibition rate	1	%
20325	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mitogen-activated protein kinase kinase kinase 4	inhibition rate	0	%
20326	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mitogen-activated protein kinase kinase kinase kinase 2	inhibition rate	0	%
20327	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mitogen-activated protein kinase kinase kinase kinase 3	inhibition rate	14	%
20328	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mitogen-activated protein kinase kinase kinase kinase 4	inhibition rate	20	%
20329	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mitogen-activated protein kinase kinase kinase kinase 5	inhibition rate	5	%
20330	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	MAP kinase-activated protein kinase 2	inhibition rate	0	%
20331	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	MAP kinase-activated protein kinase 5	inhibition rate	8	%
20332	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase MARK1	inhibition rate	0	%
20333	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase ABL1	inhibition rate	18	%
20334	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase MARK2	inhibition rate	10	%
20335	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	MAP/microtubule affinity-regulating kinase 3	inhibition rate	35	%
20336	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	MAP/microtubule affinity-regulating kinase 4	inhibition rate	3	%
20337	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	CLIP-associating protein 1	inhibition rate	0	%
20338	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Meiosis-specific serine/threonine-protein kinase MEK1	inhibition rate	31	%
20339	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Dual specificity mitogen-activated protein kinase kinase 2	inhibition rate	41	%
20340	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Dual specificity mitogen-activated protein kinase kinase 3	inhibition rate	41	%
20341	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Dual specificity mitogen-activated protein kinase kinase 4	inhibition rate	0	%
20342	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Dual specificity mitogen-activated protein kinase kinase 5	inhibition rate	23	%
20343	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Dual specificity mitogen-activated protein kinase kinase 6	inhibition rate	0	%
20344	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase ABL1	inhibition rate	10	%
20345	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Maternal embryonic leucine zipper kinase	inhibition rate	0	%
20346	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase Mer	inhibition rate	6	%
20347	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Hepatocyte growth factor receptor	inhibition rate	25	%
20348	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Hepatocyte growth factor receptor (M1250T)	inhibition rate	5	%
20349	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Hepatocyte growth factor receptor	inhibition rate	2	%
20350	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Misshapen-like kinase 1	inhibition rate	1	%
20351	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Dual specificity mitogen-activated protein kinase kinase 7	inhibition rate	2	%
20352	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	MAP kinase-interacting serine/threonine-protein kinase 1	inhibition rate	17	%
20353	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	MAP kinase-interacting serine/threonine-protein kinase 2	inhibition rate	0	%
20354	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Myosin light chain kinase 3	inhibition rate	8	%
20355	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase ABL1	inhibition rate	20	%
20356	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mitogen-activated protein kinase kinase kinase 9	inhibition rate	4	%
20357	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mitogen-activated protein kinase kinase kinase 10	inhibition rate	1	%
20358	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mitogen-activated protein kinase kinase kinase 11	inhibition rate	21	%
20359	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase MRCK alpha	inhibition rate	0	%
20360	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase MRCK beta	inhibition rate	1	%
20361	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Sugar transport protein MST1	inhibition rate	8	%
20362	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Macrophage-stimulating protein receptor	inhibition rate	0	%
20363	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase 3	inhibition rate	3	%
20364	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Sugar transport protein MST3	inhibition rate	2	%
20365	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase 26	inhibition rate	0	%
20366	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase ABL1	inhibition rate	7	%
20367	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase mTOR	inhibition rate	98.8	%
20368	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Muscle, skeletal receptor tyrosine-protein kinase	inhibition rate	21	%
20369	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Myosin light chain kinase, smooth muscle	inhibition rate	39	%
20370	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Myosin light chain kinase 2, skeletal/cardiac muscle	inhibition rate	3	%
20371	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Myosin light chain kinase family member 4	inhibition rate	0	%
20372	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Myosin-IIIa	inhibition rate	0	%
20373	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Myosin-IIIb	inhibition rate	4	%
20374	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase 38	inhibition rate	12	%
20375	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Neurogenic differentiation factor 2	inhibition rate	3	%
20376	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Probable serine/threonine-protein kinase nek1	inhibition rate	4	%
20377	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase ABL2	inhibition rate	9	%
20378	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase Nek10	inhibition rate	24	%
20379	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase Nek11	inhibition rate	31	%
20380	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase Nek2	inhibition rate	5	%
20381	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Probable serine/threonine-protein kinase nek3	inhibition rate	49	%
20382	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase Nek4	inhibition rate	19	%
20383	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase Nek5	inhibition rate	0	%
20384	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase Nek6	inhibition rate	5	%
20385	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase Nek7	inhibition rate	0	%
20386	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase Nek9	inhibition rate	0	%
20387	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mitogen-activated protein kinase kinase kinase 14	inhibition rate	11	%
20388	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Activin receptor type-1	inhibition rate	0	%
20389	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase NIM1	inhibition rate	0	%
20390	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine kinase NLK	inhibition rate	6	%
20391	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase OSR1	inhibition rate	0	%
20392	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mitogen-activated protein kinase 14	inhibition rate	0	%
20393	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mitogen-activated protein kinase 11	inhibition rate	11	%
20394	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mitogen-activated protein kinase 13	inhibition rate	1	%
20395	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mitogen-activated protein kinase 12	inhibition rate	4	%
20396	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Actin-regulating kinase PRK1	inhibition rate	8	%
20397	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase N2	inhibition rate	0	%
20398	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	GTP:AMP phosphotransferase, mitochondrial	inhibition rate	4	%
20399	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Activin receptor type-1B	inhibition rate	18	%
20400	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase PAK 4	inhibition rate	1	%
20401	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase PAK 6	inhibition rate	0	%
20402	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase PAK5	inhibition rate	21	%
20403	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Cyclin-dependent kinase 16	inhibition rate	0	%
20404	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Cyclin-dependent kinase 17	inhibition rate	11	%
20405	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Cyclin-dependent kinase 18	inhibition rate	5	%
20406	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Platelet-derived growth factor receptor alpha	inhibition rate	9	%
20407	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Platelet-derived growth factor receptor beta	inhibition rate	0	%
20408	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	3-phosphoinositide-dependent protein kinase 1	inhibition rate	7	%
20409	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Calcium-dependent protein kinase 1 [Plasmodium falciparum]	inhibition rate	19	%
20410	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Activin receptor type-2A	inhibition rate	14	%
20411	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Cell division control protein 2 homolog [Plasmodium falciparum]	inhibition rate	35	%
20412	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tudor domain-containing protein 7 [Plasmodium falciparum]	inhibition rate	0	%
20413	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Thymidine kinase 1 [Plasmodium falciparum]	inhibition rate	0	%
20414	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	inhibition rate	0	%
20415	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	inhibition rate	11	%
20416	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	inhibition rate	79	%
20417	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	inhibition rate	84	%
20418	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition rate	99.6	%
20419	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (C420R)	inhibition rate	99.4	%
20420	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E542K)	inhibition rate	100	%
20421	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Activin receptor type-2B	inhibition rate	9	%
20422	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545A)	inhibition rate	99.5	%
20423	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (E545K)	inhibition rate	100	%
20424	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047L)	inhibition rate	99.55	%
20425	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (H1047Y)	inhibition rate	94.1	%
20426	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	inhibition rate	100	%
20427	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (M1043I)	inhibition rate	100	%
20428	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (Q546K)	inhibition rate	100	%
20429	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	inhibition rate	99.95	%
20430	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	inhibition rate	81	%
20431	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	inhibition rate	99.9	%
20432	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase receptor R3	inhibition rate	8	%
20433	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphatidylinositol 4-kinase beta	inhibition rate	0	%
20434	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	1-phosphatidylinositol 3-phosphate 5-kinase	inhibition rate	26	%
20435	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase pim-1	inhibition rate	5	%
20436	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase pim-2	inhibition rate	18	%
20437	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase pim-3	inhibition rate	3	%
20438	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	inhibition rate	0	%
20439	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	inhibition rate	15	%
20440	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta	inhibition rate	1	%
20441	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	inhibition rate	5	%
20442	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	cAMP-dependent protein kinase catalytic subunit alpha	inhibition rate	0	%
20443	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Atypical kinase COQ8A, mitochondrial	inhibition rate	22	%
20444	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	cAMP-dependent protein kinase catalytic subunit beta	inhibition rate	10	%
20445	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	inhibition rate	8	%
20446	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase N1	inhibition rate	17	%
20447	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase N2	inhibition rate	16	%
20448	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Probable serine/threonine-protein kinase PknB [Mycobacterium tuberculosis]	inhibition rate	33	%
20449	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase PLK1	inhibition rate	1	%
20450	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase PLK2	inhibition rate	5	%
20451	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase Plk3	inhibition rate	42	%
20452	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase Plk4	inhibition rate	11	%
20453	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Protein kinase C, delta	inhibition rate	0	%
20454	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Atypical kinase COQ8B, mitochondrial	inhibition rate	0	%
20455	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Protein kinase C, epsilon	inhibition rate	21	%
20456	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Protein kinase C, eta	inhibition rate	0	%
20457	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Protein kinase C iota type	inhibition rate	5	%
20458	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Protein kinase C, theta	inhibition rate	17	%
20459	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase D1	inhibition rate	10	%
20460	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase D2	inhibition rate	0	%
20461	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase D3	inhibition rate	7	%
20462	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	cGMP-dependent protein kinase 1	inhibition rate	13	%
20463	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	cGMP-dependent protein kinase 2	inhibition rate	31	%
20464	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Interferon-induced, double-stranded RNA-activated protein kinase	inhibition rate	0	%
20465	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	RAC serine/threonine-protein kinase	inhibition rate	6	%
20466	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	cAMP-dependent protein kinase catalytic subunit PRKX	inhibition rate	0	%
20467	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase prp4	inhibition rate	0	%
20468	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Pyruvate kinase 2	inhibition rate	0	%
20469	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase SIK3	inhibition rate	24	%
20470	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	RAF proto-oncogene serine/threonine-protein kinase	inhibition rate	7	%
20471	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Proto-oncogene tyrosine-protein kinase receptor Ret	inhibition rate	6	%
20472	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Proto-oncogene tyrosine-protein kinase receptor Ret (M918T)	inhibition rate	3	%
20473	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Nucleolar MIF4G domain-containing protein 1 (V804L)	inhibition rate	0	%
20474	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Proto-oncogene tyrosine-protein kinase receptor Ret (V804M)	inhibition rate	0	%
20475	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase Rio1	inhibition rate	2	%
20476	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Abhydrolase domain-containing protein AKT2	inhibition rate	0	%
20477	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase Rio2	inhibition rate	17	%
20478	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase Rio3	inhibition rate	0	%
20479	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Inositol-pentakisphosphate 2-kinase	inhibition rate	0	%
20480	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Receptor-interacting serine/threonine-protein kinase 2	inhibition rate	0	%
20481	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Receptor-interacting serine/threonine-protein kinase 4	inhibition rate	24	%
20482	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Dual serine/threonine and tyrosine protein kinase	inhibition rate	28	%
20483	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Rho-associated protein kinase 1	inhibition rate	0	%
20484	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Rho-associated protein kinase 2	inhibition rate	10	%
20485	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	DNA glycosylase/AP lyase ROS1	inhibition rate	13	%
20486	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Ribosomal protein S6 kinase alpha-4	inhibition rate	18	%
20487	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	RAC-gamma serine/threonine-protein kinase	inhibition rate	0	%
20488	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Ribosomal protein S6 kinase alpha-4	inhibition rate	0	%
20489	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Ribosomal protein S6 kinase alpha-5	inhibition rate	0	%
20490	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Ribosomal protein S6 kinase alpha-5	inhibition rate	0	%
20491	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Ribosomal protein S6 kinase alpha-1	inhibition rate	0	%
20492	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Ribosomal protein S6 kinase alpha-1	inhibition rate	0	%
20493	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Ribosomal protein S6 kinase alpha-2	inhibition rate	15	%
20494	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Ribosomal protein S6 kinase alpha-2	inhibition rate	37	%
20495	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Ribosomal protein S6 kinase alpha-3	inhibition rate	18	%
20496	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Ribosomal protein S6 kinase alpha-3	inhibition rate	7	%
20497	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Ribosomal protein S6 kinase alpha-6	inhibition rate	0	%
20498	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Soluble starch synthase 2-3, chloroplastic/amyloplastic	inhibition rate	29	%
20499	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Ribosomal protein S6 kinase alpha-6	inhibition rate	5	%
20500	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Ribosomal protein S6 kinase beta-1	inhibition rate	44	%
20501	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase, Sbk1	inhibition rate	0	%
20502	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase Sgk1	inhibition rate	15	%
20503	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Uncharacterized serine/threonine-protein kinase SBK3	inhibition rate	13	%
20504	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase Sgk2	inhibition rate	14	%
20505	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase Sgk3	inhibition rate	0	%
20506	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase SIK1	inhibition rate	11	%
20507	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase SIK2	inhibition rate	4	%
20508	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase Fyn	inhibition rate	20	%
20509	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Soluble starch synthase 2-3, chloroplastic/amyloplastic	inhibition rate	9	%
20510	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	NUAK family SNF1-like kinase 2	inhibition rate	0	%
20511	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	SNF-related serine/threonine-protein kinase	inhibition rate	1	%
20512	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Neuronal proto-oncogene tyrosine-protein kinase Src	inhibition rate	9	%
20513	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase Srms	inhibition rate	28	%
20514	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	CBL-interacting serine/threonine-protein kinase 7	inhibition rate	25	%
20515	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	SRSF protein kinase 2	inhibition rate	0	%
20516	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	SRSF protein kinase 3	inhibition rate	1	%
20517	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase 16	inhibition rate	8	%
20518	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase 33	inhibition rate	0	%
20519	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase 35	inhibition rate	7	%
20520	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Soluble starch synthase 2-3, chloroplastic/amyloplastic	inhibition rate	21	%
20521	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase 36	inhibition rate	5	%
20522	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	STE20/SPS1-related proline-alanine-rich protein kinase	inhibition rate	24	%
20523	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase SYK	inhibition rate	14	%
20524	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mitogen-activated protein kinase kinase kinase 7	inhibition rate	0	%
20525	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase TAO1	inhibition rate	20	%
20526	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase TAO2	inhibition rate	28	%
20527	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase TAO3	inhibition rate	23	%
20528	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase TBK1	inhibition rate	9	%
20529	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase Tec	inhibition rate	1	%
20530	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Dual specificity testis-specific protein kinase 1	inhibition rate	0	%
20531	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	5'-AMP-activated protein kinase catalytic subunit alpha-1	inhibition rate	3	%
20532	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	TGF-beta receptor type-1	inhibition rate	0	%
20533	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	TGF-beta receptor type-2	inhibition rate	12	%
20534	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase receptor Tie-1	inhibition rate	0	%
20535	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase receptor Tie-2	inhibition rate	3	%
20536	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase tousled-like 1-B	inhibition rate	1	%
20537	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase TOUSLED-like 2	inhibition rate	0	%
20538	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Traf2 and NCK-interacting protein kinase	inhibition rate	13	%
20539	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Non-receptor tyrosine-protein kinase TNK1	inhibition rate	17	%
20540	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Activated CDC42 kinase 1	inhibition rate	0	%
20541	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase TNNI3K	inhibition rate	0	%
20542	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	5'-AMP-activated protein kinase catalytic subunit alpha-2	inhibition rate	0	%
20543	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Trk system potassium uptake protein TrkA	inhibition rate	19	%
20544	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	BDNF/NT-3 growth factors receptor	inhibition rate	11	%
20545	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	NT-3 growth factor receptor	inhibition rate	14	%
20546	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Transient receptor potential cation channel subfamily M member 6	inhibition rate	29	%
20547	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Testis-specific serine/threonine-protein kinase 1	inhibition rate	5	%
20548	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Testis-specific serine/threonine-protein kinase 3	inhibition rate	0	%
20549	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Dual specificity protein kinase TTK	inhibition rate	8	%
20550	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase TXK	inhibition rate	0	%
20551	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Non-receptor tyrosine-protein kinase TYK2	inhibition rate	8	%
20552	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Non-receptor tyrosine-protein kinase TYK2	inhibition rate	44	%
20553	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Ankyrin repeat and protein kinase domain-containing protein 1	inhibition rate	0	%
20554	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase receptor TYRO3	inhibition rate	0	%
20555	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase ULK1	inhibition rate	15	%
20556	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase ULK2	inhibition rate	4	%
20557	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase ULK3	inhibition rate	19	%
20558	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Vascular endothelial growth factor receptor 2	inhibition rate	19	%
20559	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphatidylinositol 3-kinase, Vps34 type	inhibition rate	95.5	%
20560	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase VRK2	inhibition rate	7	%
20561	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mitosis inhibitor protein kinase wee1	inhibition rate	11	%
20562	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Wee1-like protein kinase 1-A	inhibition rate	0	%
20563	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase WNK1	inhibition rate	1	%
20564	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	NUAK family SNF1-like kinase 1	inhibition rate	1	%
20565	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase WNK2	inhibition rate	8	%
20566	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase WNK3	inhibition rate	4	%
20567	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase WNK4	inhibition rate	8	%
20568	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase 32A	inhibition rate	9	%
20569	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase 32B	inhibition rate	7	%
20570	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase 32C	inhibition rate	1	%
20571	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase yes	inhibition rate	3	%
20572	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase 25	inhibition rate	4	%
20573	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mitogen-activated protein kinase kinase kinase 19	inhibition rate	58	%
20574	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mitogen-activated protein kinase kinase kinase 20	inhibition rate	0	%
20575	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	DASH complex subunit ASK1	inhibition rate	0	%
20576	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase ZAP-70	inhibition rate	0	%
20577	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mitogen-activated protein kinase kinase kinase 6	inhibition rate	0	%
20578	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Aurora kinase A	inhibition rate	4	%
20579	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Aurora kinase B	inhibition rate	44	%
20580	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Aurora kinase C	inhibition rate	0	%
20581	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	NEDD8-activating enzyme E1 regulatory subunit AXL	inhibition rate	3	%
20582	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	BMP-2-inducible protein kinase	inhibition rate	6	%
20583	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase Blk	inhibition rate	0	%
20584	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Bone morphogenetic protein receptor type-1A	inhibition rate	20	%
20585	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Bone morphogenetic protein receptor type-1B	inhibition rate	36	%
20586	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Bone morphogenetic protein receptor type-2	inhibition rate	29	%
20587	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Cytoplasmic tyrosine-protein kinase BMX	inhibition rate	1	%
20588	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase B-raf	inhibition rate	8	%
20589	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase B-raf (V600E)	inhibition rate	11	%
20590	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Bone morphogenetic protein receptor type-2	inhibition rate	0	%
20591	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase BRSK1	inhibition rate	0	%
20592	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase BRSK2	inhibition rate	0	%
20593	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Tyrosine-protein kinase BTK	inhibition rate	34	%
20594	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Mitotic checkpoint serine/threonine-protein kinase BUB1	inhibition rate	23	%
20595	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Calcium/calmodulin-dependent protein kinase type 1	inhibition rate	14	%
20596	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Calcium/calmodulin-dependent protein kinase type 1B	inhibition rate	0	%
20597	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Calcium/calmodulin-dependent protein kinase type 1D	inhibition rate	0	%
20598	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Calcium/calmodulin-dependent protein kinase type 1G	inhibition rate	0	%
20599	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Calcium/calmodulin-dependent protein kinase type II subunit alpha	inhibition rate	4	%
20600	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Calcium/calmodulin-dependent protein kinase type II subunit beta	inhibition rate	0	%
20601	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Calcium/calmodulin-dependent protein kinase type II delta chain	inhibition rate	0	%
20602	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Calcium/calmodulin-dependent protein kinase type II subunit gamma	inhibition rate	0	%
20603	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Calcium/calmodulin-dependent protein kinase type IV	inhibition rate	14	%
20604	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Calcium/calmodulin-dependent protein kinase kinase 1	inhibition rate	4	%
20605	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Calcium/calmodulin-dependent protein kinase kinase 2	inhibition rate	5	%
20606	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Peripheral plasma membrane protein CASK	inhibition rate	31	%
20607	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Cyclin-dependent kinase 11B	inhibition rate	0	%
20608	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Cyclin-dependent kinase 11A	inhibition rate	3	%
20609	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Cyclin-dependent kinase 13	inhibition rate	5	%
20610	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Cyclin-dependent kinase 11	inhibition rate	1	%
20611	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Cyclin-dependent kinase 2	inhibition rate	0	%
20612	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Cyclin-dependent kinase 3	inhibition rate	5	%
20613	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Cyclin-dependent kinase 4	inhibition rate	8	%
20614	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Cyclin-dependent kinase 4;+Cyclin-D1-1	inhibition rate	17	%
20615	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Cyclin-D3-1;+Cyclin-dependent kinase 4	inhibition rate	0	%
20616	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Cyclin-dependent-like kinase 5	inhibition rate	0	%
20617	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Cyclin-dependent kinase 7	inhibition rate	6	%
20618	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Cyclin-dependent kinase 8	inhibition rate	0	%
20619	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Cyclin-dependent kinase 9	inhibition rate	2	%
20620	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Cyclin-dependent kinase-like 1	inhibition rate	10	%
20621	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Cyclin-dependent kinase-like 2	inhibition rate	0	%
20622	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Cyclin-dependent kinase-like 3	inhibition rate	0	%
20623	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Cyclin-dependent kinase-like 5	inhibition rate	0	%
20624	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase Chk1	inhibition rate	12	%
20625	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase Chk2	inhibition rate	12	%
20626	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Citron rho-interacting kinase	inhibition rate	0	%
20627	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Serine/threonine-protein kinase atg1	inhibition rate	7	%
20628	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Dual specificity protein kinase CLK2	inhibition rate	9	%
20629	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C	Phosphatidylinositol 3-kinase regulatory subunit alpha	kinact	120000	s-1
20630	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C		percentage of remaining compound	100	%
20631	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C		percentage of remaining compound	109.7	%
20632	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C		percentage of remaining compound	100	%
20633	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C		percentage of remaining compound	94	%
20634	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C		percentage of remaining compound	93.2	%
20635	NC1=NC(C(F)F)=C(C=N1)C1=NC(=NC(=N1)N1CCOCC1)N1CCN(CC1)C(=O)CNC(=O)C1CCN(CC1)C(=O)C=C		percentage of remaining compound	96.5	%
20636	CCC1=CC=CC=C1NC(=O)C1=CN=CC(=C1)C1=CC=C(C=C1)C(=O)N1CCN(CC1)C(=O)OC(C)(C)C	Cyclin-dependent kinase 11	IC50	316	nM
20637	CCC1=CC=CC=C1NC(=O)C1=CN=CC(=C1)C1=CC=C(C=C1)C(=O)N1CCN(CC1)C(=O)OC(C)(C)C	Cyclin-dependent kinase 7	IC50	538	nM
20638	CCC1=CC=CC=C1NC(=O)C1=CN=CC(=C1)C1=CC=C(C=C1)C(=O)N1CCN(CC1)C(=O)OC(C)(C)C	Cyclin-dependent kinase 6	IC50	1000	nM
20639	CCC1=CC=CC=C1NC(=O)C1=CN=CC(=C1)C1=CC=C(C=C1)C(=O)N1CCN(CC1)C(=O)OC(C)(C)C	Cyclin-dependent kinase 9	IC50	1000	nM
20640	CC1(C)CC[C@H](CN1)NC1=NC(C2=CNC3=C2C=CC(=C3)C#N)=C(C=N1)C(F)(F)F	Cyclin-H; Cyclin-dependent kinase 7	Kd (dissociation constant)	0.45	nM
20641	CC1(C)CC[C@H](CN1)NC1=NC(C2=CNC3=C2C=CC(=C3)C#N)=C(C=N1)C(F)(F)F	Cyclin-T1; Cyclin-dependent kinase 9	Ki (inhibition constant)	130	nM
20642	CC1(C)CC[C@H](CN1)NC1=NC(C2=CNC3=C2C=CC(=C3)C#N)=C(C=N1)C(F)(F)F	Cyclin-K; Cyclin-dependent kinase 12	Ki (inhibition constant)	140	nM
20643	CC1(C)CC[C@H](CN1)NC1=NC(C2=CNC3=C2C=CC(=C3)C#N)=C(C=N1)C(F)(F)F	Cyclin-dependent kinase 7 [human]	EC50	260	nM
20644	CC1(C)CC[C@H](CN1)NC1=NC(C2=CNC3=C2C=CC(=C3)C#N)=C(C=N1)C(F)(F)F	G1/S-specific cyclin-E1; Cyclin-dependent kinase 2	Ki (inhibition constant)	810	nM
20645	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Extracellular signal-regulated kinase 2	IC50	0.045	μM
20646	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Extracellular signal-regulated kinase 2; Extracellular signal-regulated kinase 1	GI50	0.12	μM
20647	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Extracellular signal-regulated kinase 2; Extracellular signal-regulated kinase 1	EC50	0.18	μM
20648	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Extracellular signal-regulated kinase 2; Extracellular signal-regulated kinase 1	inhibition rate		
20649	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Extracellular signal-regulated kinase 2; Extracellular signal-regulated kinase 1	inhibition rate		
20650	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Extracellular signal-regulated kinase 2; Extracellular signal-regulated kinase 1	GI50	10	μM
20651	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Extracellular signal-regulated kinase 2	IC50	10	μM
20652	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Extracellular signal-regulated kinase 2; Extracellular signal-regulated kinase 1	EC50	10	μM
20653	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O		TGI (tumor growth inhibition rate)		
20654	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Extracellular signal-regulated kinase 2; Extracellular signal-regulated kinase 1	inhibition rate	100	%
20655	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Extracellular signal-regulated kinase 1	inhibition rate	10	%
20656	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	tau-protein kinase	inhibition rate	30	%
20657	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Aurora kinase C	inhibition rate	10	%
20658	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Ribosomal protein S6 kinase alpha-1	inhibition rate	10	%
20659	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Aurora kinase B	inhibition rate	10	%
20660	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Cyclin-dependent kinase 7	inhibition rate	10	%
20661	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	RAF proto-oncogene serine/threonine-protein kinase	inhibition rate	10	%
20662	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Calcium/calmodulin-dependent protein kinase type IV	inhibition rate	10	%
20663	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Proto-oncogene tyrosine-protein kinase LCK	inhibition rate	10	%
20664	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Vascular endothelial growth factor receptor 1	inhibition rate	10	%
20665	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Proto-oncogene tyrosine-protein kinase Src	inhibition rate	10	%
20666	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Dual specificity mitogen-activated protein kinase kinase 1	inhibition rate	10	%
20667	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Mitogen-activated protein kinase 10	inhibition rate	10	%
20668	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Serine/threonine-protein kinase Nek2	inhibition rate	10	%
20669	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Tyrosine-protein kinase ABL1	inhibition rate	10	%
20670	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Casein kinase I isoform alpha	inhibition rate	10	%
20671	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Receptor tyrosine-protein kinase erbB-2	inhibition rate	10	%
20672	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Protein kinase C alpha type	inhibition rate	10	%
20673	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Tyrosine-protein kinase ITK/TSK	inhibition rate	10	%
20674	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Mitogen-activated protein kinase kinase kinase 7;+TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	inhibition rate	10	%
20675	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Inhibitor of nuclear factor kappa-B kinase subunit alpha	inhibition rate	10	%
20676	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Mitogen-activated protein kinase kinase kinase 14	inhibition rate	10	%
20677	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Tyrosine-protein kinase JAK3	inhibition rate	10	%
20678	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Serine/threonine-protein kinase Sgk1	inhibition rate	10	%
20679	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Extracellular signal-regulated kinase 2	inhibition rate	10	%
20680	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O		TGI (tumor growth inhibition rate)		
20681	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Extracellular signal-regulated kinase 2; Extracellular signal-regulated kinase 1	phosphorylation level decrease		
20682	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Extracellular signal-regulated kinase 2; Extracellular signal-regulated kinase 1	phosphorylation level decrease		
20683	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Extracellular signal-regulated kinase 2; Extracellular signal-regulated kinase 1	phosphorylation level decrease		
20684	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Extracellular signal-regulated kinase 2; Extracellular signal-regulated kinase 1	phosphorylation level decrease		
20685	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Extracellular signal-regulated kinase 2; Extracellular signal-regulated kinase 1	phosphorylation level decrease		
20686	CC(N(C(=O)C=C)C1=C(NC2=C(C=NC(NC3CCOCC3)=N2)C(F)(F)F)C=CC=C1)C1=C(C=CC=C1)N(=O)=O	Extracellular signal-regulated kinase 2; Extracellular signal-regulated kinase 1	phosphorylation level decrease		
20687	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Cyclin-T1; Cyclin-dependent kinase 9	IC50	2.6	nM
20688	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Cyclin-dependent kinase 9	IC50	7.8	nM
20689	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Cyclin-dependent kinase 9	IC50	9.9	nM
20690	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Cyclin-dependent kinase 9	IC50	11.3	nM
20691	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Cyclin-dependent kinase 9	IC50	15.6	nM
20692	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Cyclin-dependent kinase 9	IC50	0.017	μM
20693	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Cyclin-dependent kinase 9	IC50	27.1	nM
20694	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Cyclin-dependent kinase 9	IC50	28.6	nM
20695	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Cyclin-dependent kinase 9	IC50	29.5	nM
20696	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Cyclin-dependent kinase 12;+Cyclin-K	IC50	42	nM
20697	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Cyclin-dependent kinase 2;+Cyclin-A2	IC50	43	nM
20698	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Cyclin-dependent kinase 8;+Cyclin-C	IC50	44	nM
20699	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Cyclin-H;+Cyclin-dependent kinase 7	IC50	58	nM
20700	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Cyclin-dependent kinase 4; G1/S-specific cyclin-D3	IC50	159	nM
20701	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	G2/mitotic-specific cyclin-B1;+Cyclin-dependent kinase 1	IC50	173	nM
20702	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	G1/S-specific cyclin-D3; Cyclin-dependent kinase 6	IC50	763	nM
20703	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Cyclin-dependent kinase 9	body weight change		
20704	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Cyclin-dependent kinase 9	body weight change		
20705	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	tau-protein kinase	inhibition rate	100.38	%
20706	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	BDNF/NT-3 growth factors receptor	inhibition rate	98.7	%
20707	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Tyrosine-protein kinase JAK3	inhibition rate	97.71	%
20708	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Mitogen-activated protein kinase kinase kinase kinase 4	inhibition rate	90.17	%
20709	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Proto-oncogene tyrosine-protein kinase Src	inhibition rate	89	%
20710	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Mitogen-activated protein kinase kinase kinase kinase 1	inhibition rate	87.81	%
20711	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Tyrosine-protein kinase SYK	inhibition rate	87.45	%
20712	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Cyclin-dependent kinase 16;+Cyclin Y	inhibition rate	82.06	%
20713	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Protein kinase C alpha type	inhibition rate	81.8	%
20714	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Dual specificity protein kinase CLK1	inhibition rate	81.02	%
20715	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Fibroblast growth factor receptor 1	inhibition rate	80.93	%
20716	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Cyclin-dependent kinase 2; G1/S-specific cyclin-E1	inhibition rate	79.26	%
20717	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Proto-oncogene tyrosine-protein kinase LCK	inhibition rate	78.75	%
20718	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	G1/S-specific cyclin-E1; Cyclin-dependent kinase 1	inhibition rate	76.25	%
20719	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Cyclin-dependent-like kinase 5;+Cyclin-dependent kinase 5 activator 1	inhibition rate	68.63	%
20720	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Serine/threonine-protein kinase Nek1	inhibition rate	63.89	%
20721	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Aurora kinase	inhibition rate	61.68	%
20722	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	inhibition rate	56.84	%
20723	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	5'-AMP-activated protein kinase catalytic subunit alpha-1;+5'-AMP-activated protein kinase subunit beta-1;+5'-AMP-activated protein kinase subunit gamma-1	inhibition rate	51.63	%
20724	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Tyrosine-protein kinase ITK/TSK	inhibition rate	45.67	%
20725	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Mitogen-activated protein kinase 9	inhibition rate	43.09	%
20726	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Serine/threonine-protein kinase B-raf	inhibition rate	41.46	%
20727	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Serine/threonine-protein kinase N2	inhibition rate	38.27	%
20728	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Tyrosine-protein kinase ABL1	inhibition rate	33.74	%
20729	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Tyrosine-protein kinase receptor UFO	inhibition rate	32.45	%
20730	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Vascular endothelial growth factor receptor 2	inhibition rate	30.57	%
20731	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	platelet-derived growth factor alpha-receptor	inhibition rate	28.94	%
20732	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Homeodomain-interacting protein kinase 1	inhibition rate	28.08	%
20733	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Serine/threonine-protein kinase Chk2	inhibition rate	27.79	%
20734	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Ephrin type-B receptor 4	inhibition rate	27.7	%
20735	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Mitogen-activated protein kinase 8	inhibition rate	25.11	%
20736	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Ribosomal protein S6 kinase alpha-1	inhibition rate	24.83	%
20737	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Dual specificity mitogen-activated protein kinase kinase 1	inhibition rate	23.56	%
20738	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Probable serine/threonine-protein kinase nek2	inhibition rate	21.85	%
20739	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Activin receptor type-1B	inhibition rate	20.94	%
20740	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Casein kinase I isoform alpha	inhibition rate	15.69	%
20741	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Serine/threonine-protein kinase Chk1	inhibition rate	14.8	%
20742	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Serine/threonine-protein kinase DCLK2	inhibition rate	10.45	%
20743	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Tyrosine-protein kinase receptor Tie-2	inhibition rate	9.43	%
20744	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	MAP kinase-activated protein kinase 2	inhibition rate	9.02	%
20745	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Insulin-like growth factor 1 receptor	inhibition rate	7.67	%
20746	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	RAC-alpha serine/threonine-protein kinase	inhibition rate	7.03	%
20747	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Casein kinase II subunit beta;+Casein kinase II subunit alpha	inhibition rate	6.87	%
20748	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Serine/threonine-protein kinase Sgk1	inhibition rate	6.07	%
20749	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Casein kinase I isoform gamma-2	inhibition rate	4.68	%
20750	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Hepatocyte growth factor receptor	inhibition rate	3.62	%
20751	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	epidermal growth factor-activated receptor	inhibition rate	3.38	%
20752	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Serine/threonine-protein kinase BRSK2	inhibition rate	3.37	%
20753	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Mitogen-activated protein kinase 1	inhibition rate	3.2	%
20754	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	cAMP-dependent protein kinase catalytic subunit alpha	inhibition rate	2.9	%
20755	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Testis-specific serine/threonine-protein kinase 1	inhibition rate	2.81	%
20756	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Serine/threonine-protein kinase D2	inhibition rate	2.16	%
20757	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Mitogen-activated protein kinase 14	inhibition rate	1.58	%
20758	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Serine/threonine-protein kinase PLK1	inhibition rate	-2.62	%
20759	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Death-associated protein kinase 1	inhibition rate	-3.46	%
20760	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Serine/threonine-protein kinase Plk3	inhibition rate	-3.69	%
20761	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Serine/threonine-protein kinase pim-1	inhibition rate	-5.76	%
20762	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Ribosomal protein S6 kinase beta-1	inhibition rate	-6.96	%
20763	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Casein kinase I isoform gamma-3	inhibition rate	-8.61	%
20764	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Inhibitor of nuclear factor kappa-B kinase subunit alpha	inhibition rate	-14.93	%
20765	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O		AUC (0-inf)	336	ng*h/ml
20766	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O		CL (drug clearance)	50.2	ml/min/kg
20767	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O		Vdss	0.922	l/kg
20768	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O		concentration (parameter)	1230	ng/ml
20769	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O		kel (elimination rate constant)	2.5	h-1
20770	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O		t1/2 (drug half life)	0.281	h
20771	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O		MRT (0-t)	0.298	h
20772	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O		MRT (0-inf)	0.309	h
20773	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O		AUC (0-t)	334	ng*h/ml
20774	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Cyclin-dependent kinase 9	TGI (tumor growth inhibition rate)	19.4	%
20775	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Cyclin-dependent kinase 9	TGI (tumor growth inhibition rate)	55.3	%
20776	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Cyclin-dependent kinase 9	TGI (tumor growth inhibition rate)	61	%
20777	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Cyclin-dependent kinase 9	TGI (tumor growth inhibition rate)	71.5	%
20778	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Cyclin-dependent kinase 9	apoptotic cell percentage	15.69	%
20779	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Cyclin-dependent kinase 9	apoptotic cell percentage	22.82	%
20780	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Cyclin-dependent kinase 9	apoptotic cell percentage	25.65	%
20781	CCN1C(=O)COC2=C1C=C(NC1=NC(=C(F)C=N1)C1=C(OC)C=C(F)C=C1)C=C2CN1CCN(CC1)C(C)=O	Cyclin-dependent kinase 9	apoptotic cell percentage	30.25	%
20782	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Fibroblast growth factor receptor 4	IC50	3.7	nM
20783	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Fibroblast growth factor receptor 4	IC50	0.0037	μM
20784	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl		IC50	6.3	nM
20785	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Fibroblast growth factor receptor 4	EC50	9.3	nM
20786	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Fibroblast growth factor receptor 4	EC50	9.3	nM
20787	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Fibroblast growth factor receptor 4	EC50	16	nM
20788	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl		IC50	41	nM
20789	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Fibroblast growth factor receptor 2	IC50	1.3	μM
20790	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Fibroblast growth factor receptor 1	IC50	3.1	μM
20791	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Macrophage colony-stimulating factor 1 receptor	IC50	10	μM
20792	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Tyrosine-protein kinase ABL1	inhibition rate	3	%
20793	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	RAC-alpha serine/threonine-protein kinase	inhibition rate	6	%
20794	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Aurora kinase A	inhibition rate	4	%
20795	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Serine/threonine-protein kinase B-raf	inhibition rate	3	%
20796	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Tyrosine-protein kinase BTK	inhibition rate	2	%
20797	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Cyclin-dependent kinase 2	inhibition rate	2	%
20798	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Cyclin-A2	inhibition rate	2	%
20799	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Cyclin-dependent kinase 7	inhibition rate	1	%
20800	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Cyclin	inhibition rate	1	%
20801	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Macrophage colony-stimulating factor 1 receptor	inhibition rate	47	%
20802	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Epidermal growth factor receptor	inhibition rate	2	%
20803	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Fibroblast growth factor receptor 1	inhibition rate	23	%
20804	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Fibroblast growth factor receptor 2	inhibition rate	41	%
20805	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Fibroblast growth factor receptor 3	inhibition rate	16	%
20806	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Fibroblast growth factor receptor 4	inhibition rate	94	%
20807	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Vascular endothelial growth factor receptor 1	inhibition rate	0	%
20808	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Receptor-type tyrosine-protein kinase FLT3	inhibition rate	8	%
20809	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Tyrosine-protein kinase JAK3	inhibition rate	3	%
20810	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Vascular endothelial growth factor receptor 2	inhibition rate	8	%
20811	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Mast/stem cell growth factor receptor Kit	inhibition rate	1	%
20812	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Mitogen-activated protein kinase kinase kinase kinase 1	inhibition rate	8	%
20813	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Mitogen-activated protein kinase 1	inhibition rate	2	%
20814	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	MAP kinase-activated protein kinase 2	inhibition rate	4	%
20815	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Hepatocyte growth factor receptor	inhibition rate	4	%
20816	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Platelet-derived growth factor receptor alpha	inhibition rate	3	%
20817	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Phosphatidylinositol 4-kinase beta	inhibition rate	9	%
20818	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	inhibition rate	-7	%
20819	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Protein kinase C alpha type	inhibition rate	21	%
20820	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Proto-oncogene tyrosine-protein kinase receptor Ret	inhibition rate	3	%
20821	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Ribosomal protein S6 kinase beta-1	inhibition rate	5	%
20822	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Proto-oncogene tyrosine-protein kinase Src	inhibition rate	5	%
20823	COC1=CC(OC)=C(Cl)C(C(=O)C2=CNC3=NC(NC4=CC=C(C=C4NC(=O)C=C)N4CCOCC4)=CC=C23)=C1Cl	Dual specificity protein kinase TTK	inhibition rate	12	%
20824	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [human]	Kd (dissociation constant)	0.28	nM
20825	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	IC50	0.3	nM
20826	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [human]	IC50	0.6	nM
20827	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	IC50	1.9	nM
20828	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	mRNA expression level decrease		
20829	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2		IC50	12.33	nM
20830	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Epithelial discoidin domain-containing receptor 1 [human]	IC50	15	nM
20831	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Discoidin domain-containing receptor 2 [human]	IC50	15	nM
20832	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Proto-oncogene tyrosine-protein kinase Src [human]	IC50	56	nM
20833	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 3 [human]	Kd (dissociation constant)	74.5	nM
20834	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase SIK1 [human]	IC50	89	nM
20835	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Dual serine/threonine and tyrosine protein kinase [human]	Kd (dissociation constant)	670	nM
20836	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Platelet-derived growth factor receptor beta [human]	IC50	862	nM
20837	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	mRNA expression level decrease		
20838	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	protein expression level decrease		
20839	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	protein expression level decrease		
20840	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Kit ligand [human]	IC50	1509	nM
20841	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 4 [human]	Kd (dissociation constant)	2300	nM
20842	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-type tyrosine-protein kinase FLT3 [human]	IC50	4785	nM
20843	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 1 [human]	Kd (dissociation constant)	9450	nM
20844	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 1 [human]	IC50	30000	nM
20845	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2		cytotoxicity rate		
20846	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	protein expression level change		
20847	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	protein expression level change		
20848	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	protein expression level change		
20849	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	protein expression level change		
20850	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	protein expression level change		
20851	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	protein expression level change		
20852	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	protein expression level change		
20853	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	protein expression level change		
20854	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	protein expression level change		
20855	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	protein expression level change		
20856	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	protein expression level change		
20857	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	protein expression level change		
20858	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	protein expression level change		
20859	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2		cytotoxicity rate		
20860	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	protein expression level change		
20861	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	protein expression level change		
20862	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	protein expression level change		
20863	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	protein expression level change		
20864	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	protein expression level change		
20865	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	protein expression level change		
20866	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	protein expression level change		
20867	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-type tyrosine-protein kinase FLT3 [human]	inhibition rate	18	%
20868	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Histidine protein kinase 1 [human]	inhibition rate	-12	%
20869	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase Chk2 [human]	inhibition rate	29	%
20870	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Casein kinase I isoform gamma-1 [human]	inhibition rate	-7	%
20871	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Casein kinase I isoform gamma-2 [human]	inhibition rate	-13	%
20872	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Casein kinase I isoform gamma-3 [human]	inhibition rate	11	%
20873	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Casein kinase I isoform delta [human]	inhibition rate	68	%
20874	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Casein kinase II subunit alpha [human]	inhibition rate	-3	%
20875	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Casein kinase II subunit alpha-1 [human]	inhibition rate	-12	%
20876	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Kit ligand [human]	inhibition rate	29	%
20877	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Dual specificity protein kinase CLK1 [human]	inhibition rate	28	%
20878	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Dual specificity protein kinase CLK2 [human]	inhibition rate	17	%
20879	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Dual specificity protein kinase CLK3 [human]	inhibition rate	20	%
20880	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Dual specificity protein kinase CLK4 [human]	inhibition rate	20	%
20881	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	RAF proto-oncogene serine/threonine-protein kinase [human]	inhibition rate	13	%
20882	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Chloroplast sensor kinase, chloroplastic [human]	inhibition rate	0	%
20883	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Proto-oncogene tyrosine-protein kinase Src [human]	inhibition rate	92	%
20884	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Death-associated protein kinase 1 [human]	inhibition rate	8	%
20885	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Death-associated protein kinase 2 [human]	inhibition rate	-29	%
20886	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase DCLK1 [human]	inhibition rate	13	%
20887	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase DCLK2 [human]	inhibition rate	-10	%
20888	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase DCLK3 [human]	inhibition rate	53	%
20889	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Epithelial discoidin domain-containing receptor 1 [human]	inhibition rate	98	%
20890	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Discoidin domain-containing receptor 2 [human]	inhibition rate	29	%
20891	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Myotonin-protein kinase [human]	inhibition rate	-5	%
20892	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase 17A [human]	inhibition rate	28	%
20893	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase 17B [human]	inhibition rate	5	%
20894	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	dual specificity tyrosine-phosphorylation-regulated kinase 1a [human]	inhibition rate	-7	%
20895	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Dual specificity tyrosine-phosphorylation-regulated kinase 1B [human]	inhibition rate	-8	%
20896	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Dual specificity tyrosine-phosphorylation-regulated kinase 2 [human]	inhibition rate	19	%
20897	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Dual specificity tyrosine-phosphorylation-regulated kinase 3 [human]	inhibition rate	2	%
20898	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	epidermal growth factor-activated receptor [human]	inhibition rate	22	%
20899	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Ephrin type-A receptor 1 [human]	inhibition rate	97	%
20900	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Ephrin type-A receptor 2 [human]	inhibition rate	79	%
20901	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Ephrin type-A receptor 3 [human]	inhibition rate	36	%
20902	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Ephrin type-A receptor 4 [human]	inhibition rate	41	%
20903	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Ephrin type-A receptor 5 [human]	inhibition rate	61	%
20904	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Ephrin type-A receptor 7 [human]	inhibition rate	16	%
20905	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Ephrin type-A receptor 8 [human]	inhibition rate	84	%
20906	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Ephrin type-B receptor 1 [human]	inhibition rate	75	%
20907	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Ephrin type-B receptor 2 [human]	inhibition rate	83	%
20908	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Ephrin type-B receptor 3 [human]	inhibition rate	7	%
20909	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Ephrin type-B receptor 4 [human]	inhibition rate	86	%
20910	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor tyrosine-protein kinase erbB-2 [human]	inhibition rate	11	%
20911	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor tyrosine-protein kinase erbB-4 [human]	inhibition rate	16	%
20912	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Focal adhesion kinase 1 [human]	inhibition rate	3	%
20913	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Ferredoxin [human]	inhibition rate	17	%
20914	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	AP2-associated protein kinase 1 [human]	inhibition rate	13	%
20915	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Fibroblast growth factor receptor 1 [human]	inhibition rate	76	%
20916	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Fibroblast growth factor receptor 2 [human]	inhibition rate	39	%
20917	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Fibroblast growth factor receptor 3 [human]	inhibition rate	47	%
20918	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Fibroblast growth factor receptor 4 [human]	inhibition rate	23	%
20919	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Betaine aldehyde dehydrogenase 2 [human]	inhibition rate	99	%
20920	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Vascular endothelial growth factor receptor 1 [human]	inhibition rate	57	%
20921	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Vascular endothelial growth factor receptor 3 [human]	inhibition rate	39	%
20922	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Macrophage colony-stimulating factor 1 receptor [human]	inhibition rate	49	%
20923	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Tyrosine-protein kinase Fyn [human]	inhibition rate	94	%
20924	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	D-glycerate 2-kinase [human]	inhibition rate	17	%
20925	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	ABC transporter F family member 2 [human]	inhibition rate	9	%
20926	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Rhodopsin kinase [human]	inhibition rate	0	%
20927	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Beta-adrenergic receptor kinase 1 [human]	inhibition rate	-8	%
20928	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Beta-adrenergic receptor kinase 2 [human]	inhibition rate	-25	%
20929	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	G protein-coupled receptor kinase 5 [human]	inhibition rate	6	%
20930	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	G protein-coupled receptor kinase 6 [human]	inhibition rate	23	%
20931	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Rhodopsin kinase [human]	inhibition rate	-3	%
20932	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Glycogen synthase kinase-3 alpha [human]	inhibition rate	1	%
20933	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	glycogen synthase kinase-3 beta [human]	inhibition rate	-2	%
20934	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Putative serine/threonine-protein kinase haspin homolog [human]	inhibition rate	14	%
20935	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Tyrosine-protein kinase HCK [human]	inhibition rate	94	%
20936	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Homeodomain-interacting protein kinase 1 [human]	inhibition rate	7	%
20937	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Homeodomain-interacting protein kinase 2 [human]	inhibition rate	19	%
20938	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Homeodomain-interacting protein kinase 3 [human]	inhibition rate	17	%
20939	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Homeodomain-interacting protein kinase 4 [human]	inhibition rate	15	%
20940	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Mitogen-activated protein kinase kinase kinase kinase 1 [human]	inhibition rate	21	%
20941	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Eukaryotic translation initiation factor 2-alpha kinase 1 [human]	inhibition rate	15	%
20942	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase ICK [human]	inhibition rate	20	%
20943	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Insulin-like growth factor 1 receptor [human]	inhibition rate	10	%
20944	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Inhibitor of nuclear factor kappa-B kinase subunit alpha [human]	inhibition rate	4	%
20945	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Inhibitor of nuclear factor kappa-B kinase subunit beta [human]	inhibition rate	-25	%
20946	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Inhibitor of nuclear factor kappa-B kinase subunit epsilon [human]	inhibition rate	30	%
20947	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Insulin-like receptor [human]	inhibition rate	14	%
20948	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Interleukin-1 receptor-associated kinase 1 [human]	inhibition rate	1	%
20949	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Interleukin-1 receptor-associated kinase 4 [human]	inhibition rate	21	%
20950	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Probable serine/threonine protein kinase IRE [human]	inhibition rate	-1	%
20951	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Insulin receptor-related protein [human]	inhibition rate	14	%
20952	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Tyrosine-protein kinase ITK/TSK [human]	inhibition rate	-9	%
20953	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Tyrosine-protein kinase JAK1 [human]	inhibition rate	5	%
20954	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Tyrosine-protein kinase JAK2 [human]	inhibition rate	-16	%
20955	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Tyrosine-protein kinase JAK3 [human]	inhibition rate	-9	%
20956	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Mitogen-activated protein kinase 8 (isoform 1) [human]	inhibition rate	-1	%
20957	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Jun Kinase 2 alpha 2 [human]	inhibition rate	-3	%
20958	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Mitogen-activated protein kinase 10 [human]	inhibition rate	-5	%
20959	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Transcription factor PRE6 [human]	inhibition rate	38	%
20960	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Proto-oncogene tyrosine-protein kinase LCK [human]	inhibition rate	95	%
20961	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	LIM domain kinase 1 [human]	inhibition rate	86	%
20962	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	LIM domain kinase 2 [human]	inhibition rate	59	%
20963	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase stk11 homolog [human]	inhibition rate	17	%
20964	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Coiled-coil domain-containing protein 40 [human]	inhibition rate	83	%
20965	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Leucine-rich repeat serine/threonine-protein kinase 2 [human]	inhibition rate	62	%
20966	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Leukocyte tyrosine kinase receptor [human]	inhibition rate	28	%
20967	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	AP2-associated protein kinase 1 [human]	inhibition rate	31	%
20968	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	TBC1 domain family member 1 [human]	inhibition rate	99	%
20969	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Mitogen-activated protein kinase kinase kinase kinase 3 [human]	inhibition rate	41	%
20970	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Mitogen-activated protein kinase kinase kinase kinase 4 [human]	inhibition rate	24	%
20971	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Mitogen-activated protein kinase kinase kinase kinase 5 [human]	inhibition rate	26	%
20972	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	MAP kinase-activated protein kinase 2 [human]	inhibition rate	27	%
20973	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	MAP kinase-activated protein kinase 3 [human]	inhibition rate	1	%
20974	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase MARK1 [human]	inhibition rate	-6	%
20975	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	MAP/microtubule affinity-regulating kinase 3 [human]	inhibition rate	4	%
20976	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	MAP/microtubule affinity-regulating kinase 4 [human]	inhibition rate	21	%
20977	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Dual specificity mitogen-activated protein kinase kinase 1 [human]	inhibition rate	13	%
20978	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Dual specificity mitogen-activated protein kinase kinase 2 [human]	inhibition rate	-3	%
20979	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Mitogen-activated protein kinase kinase kinase 2 [human]	inhibition rate	62	%
20980	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Mitogen-activated protein kinase kinase kinase 3 [human]	inhibition rate	41	%
20981	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Maternal embryonic leucine zipper kinase [human]	inhibition rate	35	%
20982	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Enhancer of rudimentary homolog [human]	inhibition rate	2	%
20983	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase [human]	inhibition rate	13	%
20984	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Misshapen-like kinase 1 [human]	inhibition rate	20	%
20985	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Dual specificity mitogen-activated protein kinase kinase 3 [human]	inhibition rate	57	%
20986	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Dual specificity mitogen-activated protein kinase kinase 6 [human]	inhibition rate	-26	%
20987	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Myosin light chain kinase 3 [human]	inhibition rate	20	%
20988	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Mitogen-activated protein kinase kinase kinase 9 [human]	inhibition rate	11	%
20989	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Mitogen-activated protein kinase kinase kinase 10 [human]	inhibition rate	-20	%
20990	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Mitogen-activated protein kinase kinase kinase 11 [human]	inhibition rate	16	%
20991	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase MRCK alpha [human]	inhibition rate	4	%
20992	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase MRCK beta [human]	inhibition rate	-4	%
20993	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase MRCK gamma [human]	inhibition rate	-5	%
20994	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Lysine-tRNA ligase, mitochondrial [human]	inhibition rate	26	%
20995	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Ribosomal protein S6 kinase alpha-4 [human]	inhibition rate	30	%
20996	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	SRSF protein kinase 3 [human]	inhibition rate	-13	%
20997	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Hepatocyte growth factor-like [human]	inhibition rate	14	%
20998	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Histone acetyltransferase mst2 [human]	inhibition rate	23	%
20999	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase 24 [human]	inhibition rate	20	%
21000	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase 26 [human]	inhibition rate	13	%
21001	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase mTOR [human]	inhibition rate	6	%
21002	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase mTOR [human];+12 kDa FK506-binding protein [human]	inhibition rate	-1	%
21003	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Muscle, skeletal receptor tyrosine-protein kinase [human]	inhibition rate	20	%
21004	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Myosin light chain kinase 2, skeletal/cardiac muscle [human]	inhibition rate	24	%
21005	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Myosin-IIIb [human]	inhibition rate	49	%
21006	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Neurogenic differentiation factor 2 [human]	inhibition rate	17	%
21007	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Probable serine/threonine-protein kinase nek1 [human]	inhibition rate	25	%
21008	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase Nek11 [human]	inhibition rate	13	%
21009	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Probable serine/threonine-protein kinase nek2 [human]	inhibition rate	12	%
21010	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Probable serine/threonine-protein kinase nek3 [human]	inhibition rate	-35	%
21011	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase Nek4 [human]	inhibition rate	5	%
21012	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase Nek6 [human]	inhibition rate	12	%
21013	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase Nek7 [human]	inhibition rate	8	%
21014	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase Nek9 [human]	inhibition rate	13	%
21015	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Mitosis inducer protein kinase cdr1 [human]	inhibition rate	16	%
21016	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	glucose-6-phosphate isomerase [human]	inhibition rate	56	%
21017	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	NUAK family SNF1-like kinase 2 [human]	inhibition rate	29	%
21018	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Ribosomal protein S6 kinase beta-1 [human]	inhibition rate	72	%
21019	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase PAK 1 [human]	inhibition rate	18	%
21020	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	serine/threonine-protein kinase pak 2 [human]	inhibition rate	12	%
21021	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase PAK 3 [human]	inhibition rate	25	%
21022	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase PAK 4 [human]	inhibition rate	15	%
21023	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	serine/threonine-protein kinase pak 5 [human]	inhibition rate	5	%
21024	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase PAK 6 [human]	inhibition rate	-1	%
21025	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Tyrosine-protein kinase Abl [human]	inhibition rate	7	%
21026	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Platelet-derived growth factor receptor alpha [human]	inhibition rate	28	%
21027	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Platelet-derived growth factor receptor beta [human]	inhibition rate	42	%
21028	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial [human]	inhibition rate	27	%
21029	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial [human]	inhibition rate	3	%
21030	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	3-phosphoinositide-dependent protein kinase 1 [human]	inhibition rate	14	%
21031	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	eukaryotic translation initiation factor 2alpha kinase [human]	inhibition rate	1	%
21032	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform [human]	inhibition rate	26	%
21033	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform [human]	inhibition rate	13	%
21034	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [human];+Phosphatidylinositol 3-kinase regulatory subunit alpha (isoform p85-alpha) [human]	inhibition rate	44	%
21035	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [human];+Phosphatidylinositol 3-kinase regulatory subunit alpha (isoform p85-alpha) [human]	inhibition rate	3	%
21036	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [human];+Phosphatidylinositol 3-kinase regulatory subunit alpha (isoform p85-alpha) [human]	inhibition rate	7	%
21037	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform [human]	inhibition rate	3	%
21038	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha [human]	inhibition rate	-7	%
21039	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma [human]	inhibition rate	8	%
21040	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase pim-1 [human]	inhibition rate	-9	%
21041	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase pim-2 [human]	inhibition rate	1	%
21042	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase pim-3 [human]	inhibition rate	0	%
21043	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [human]	inhibition rate	-4	%
21044	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha [human]	inhibition rate	-18	%
21045	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma [human]	inhibition rate	-7	%
21046	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Peptidyl-lysine N-acetyltransferase PatZ [human]	inhibition rate	12	%
21047	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	cAMP-dependent protein kinase catalytic subunit beta [human]	inhibition rate	21	%
21048	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	RAC family serine/threonine-protein kinase homolog [human]	inhibition rate	5	%
21049	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	RAC-beta serine/threonine-protein kinase [human]	inhibition rate	24	%
21050	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	RAC-gamma serine/threonine-protein kinase [human]	inhibition rate	3	%
21051	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Protein kinase C alpha type [human]	inhibition rate	-6	%
21052	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Protein kinase C beta type [human]	inhibition rate	10	%
21053	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Protein kinase C beta type (isoform Beta-II) [human]	inhibition rate	14	%
21054	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Protein kinase C gamma type [human]	inhibition rate	-1	%
21055	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Protein kinase C, delta [human]	inhibition rate	14	%
21056	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Protein kinase C, epsilon [human]	inhibition rate	17	%
21057	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Protein kinase C zeta type [human]	inhibition rate	-14	%
21058	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Protein kinase C, eta [human]	inhibition rate	45	%
21059	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Protein kinase C, theta [human]	inhibition rate	12	%
21060	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Protein kinase C iota type [human]	inhibition rate	20	%
21061	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase D1 [human]	inhibition rate	35	%
21062	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase D2 [human]	inhibition rate	30	%
21063	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase D3 [human]	inhibition rate	42	%
21064	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	cGMP-dependent protein kinase 1 [human]	inhibition rate	3 - 8	%
21065	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Interferon-induced, double-stranded RNA-activated protein kinase [human]	inhibition rate	-1	%
21066	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Phosphatidylinositol 3-kinase 1 [human]	inhibition rate	-2	%
21067	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Phosphatidylinositol 3-kinase 3 [human]	inhibition rate	-5	%
21068	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Phosphatidylinositol 4-kinase [human]	inhibition rate	10	%
21069	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Actin-regulating kinase PRK1 [human]	inhibition rate	14	%
21070	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase N2 [human]	inhibition rate	16	%
21071	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Dual specificity protein kinase splB [human]	inhibition rate	18	%
21072	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Proto-oncogene tyrosine-protein kinase receptor Ret [human]	inhibition rate	78	%
21073	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [human]	inhibition rate	103	%
21074	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Rho-associated protein kinase 1 [human]	inhibition rate	-9	%
21075	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Rho-associated protein kinase 2 [human]	inhibition rate	22	%
21076	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	DNA-directed RNA polymerase subunit beta [human]	inhibition rate	8	%
21077	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Proto-oncogene tyrosine-protein kinase ROS [human]	inhibition rate	3	%
21078	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Tyrosine-protein kinase receptor TYRO3 [human]	inhibition rate	-9	%
21079	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Ribosomal protein S6 kinase alpha-1 [human]	inhibition rate	27	%
21080	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Ribosomal protein S6 kinase alpha-3 [human]	inhibition rate	53	%
21081	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Ribosomal protein S6 kinase alpha-2 [human]	inhibition rate	53	%
21082	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Ribosomal protein S6 kinase alpha-6 [human]	inhibition rate	23	%
21083	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Mitogen-activated protein kinase 14 [human]	inhibition rate	14	%
21084	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Mitogen-activated protein kinase 11 [human]	inhibition rate	20	%
21085	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Mitogen-activated protein kinase 12 [human]	inhibition rate	5	%
21086	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Mitogen-activated protein kinase 13 [human]	inhibition rate	25	%
21087	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	serine/threonine-protein kinase sbk1 [human]	inhibition rate	5	%
21088	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase Sgk1 [human]	inhibition rate	19	%
21089	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase Sgk2 [human]	inhibition rate	4	%
21090	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase Sgk3 [human]	inhibition rate	9	%
21091	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase SIK1 [human]	inhibition rate	91	%
21092	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase SIK2 [human]	inhibition rate	100	%
21093	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase SIK3 [human]	inhibition rate	101	%
21094	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	STE20-like serine/threonine-protein kinase [human]	inhibition rate	79	%
21095	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	SNF-related serine/threonine-protein kinase [human]	inhibition rate	0	%
21096	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Tyrosine-protein kinase Srms [human]	inhibition rate	-7	%
21097	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	SRSF protein kinase 1 [human]	inhibition rate	-10	%
21098	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	SRSF protein kinase 2 [human]	inhibition rate	-14	%
21099	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase 16 [human]	inhibition rate	12	%
21100	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase 33 [human]	inhibition rate	-4	%
21101	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Tyrosine-protein kinase SYK [human]	inhibition rate	9	%
21102	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Mitogen-activated protein kinase kinase kinase 7 [human]	inhibition rate	21	%
21103	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase TAO1 [human]	inhibition rate	10	%
21104	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase TAO2 [human]	inhibition rate	12	%
21105	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase TAO3 [human]	inhibition rate	9	%
21106	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase TBK1 [human]	inhibition rate	14	%
21107	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Tyrosine-protein kinase Tec [human]	inhibition rate	66	%
21108	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	TGF-beta receptor type-1 [human]	inhibition rate	35	%
21109	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	TGF-beta receptor type-2 [human]	inhibition rate	14	%
21110	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Angiopoietin-1 receptor [human]	inhibition rate	27	%
21111	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase tousled-like 1 [human]	inhibition rate	-13	%
21112	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase TOUSLED-like 2 [human]	inhibition rate	0	%
21113	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Traf2 and NCK-interacting protein kinase [human]	inhibition rate	58	%
21114	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	High affinity nerve growth factor receptor [human]	inhibition rate	52	%
21115	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	BDNF/NT-3 growth factors receptor [human]	inhibition rate	48	%
21116	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	NT-3 growth factor receptor [human]	inhibition rate	19	%
21117	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Testis-specific serine/threonine-protein kinase 1 [human]	inhibition rate	20	%
21118	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Testis-specific serine/threonine-protein kinase 2 [human]	inhibition rate	-23	%
21119	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Testis-specific serine/threonine-protein kinase 3 [human]	inhibition rate	11	%
21120	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Testis-specific serine/threonine-protein kinase 4 [human]	inhibition rate	26	%
21121	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Tau-tubulin kinase 1 [human]	inhibition rate	-17	%
21122	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Tau-tubulin kinase 2 [human]	inhibition rate	12	%
21123	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Dual specificity protein kinase TTK [human]	inhibition rate	-5	%
21124	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Tyrosine-protein kinase TXK [human]	inhibition rate	53	%
21125	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Non-receptor tyrosine-protein kinase TYK2 [human]	inhibition rate	0	%
21126	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase ULK1 [human]	inhibition rate	10	%
21127	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase ULK2 [human]	inhibition rate	-2	%
21128	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase ULK3 [human]	inhibition rate	4	%
21129	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase VRK1 [human]	inhibition rate	-3	%
21130	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase VRK2 [human]	inhibition rate	5	%
21131	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Mitosis inhibitor protein kinase wee1 [human]	inhibition rate	-2	%
21132	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Wee1-like protein kinase 2 [human]	inhibition rate	6	%
21133	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Probable serine/threonine-protein kinase WNK1 [human]	inhibition rate	-11	%
21134	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Probable serine/threonine-protein kinase WNK3 [human]	inhibition rate	17	%
21135	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Probable serine/threonine-protein kinase WNK3 [human]	inhibition rate	-17	%
21136	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Probable serine/threonine-protein kinase WNK4 [human]	inhibition rate	1	%
21137	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Tyrosine-protein kinase Yes [human]	inhibition rate	100	%
21138	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Mitogen-activated protein kinase kinase kinase 20 [human]	inhibition rate	19	%
21139	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Tyrosine-protein kinase ZAP-70 [human]	inhibition rate	34	%
21140	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Death-associated protein kinase 3 [human]	inhibition rate	25	%
21141	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Tyrosine-protein kinase Abl [human]	inhibition rate	38	%
21142	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Acetate kinase 1 [human]	inhibition rate	55	%
21143	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Actin-related protein 2 [human]	inhibition rate	36	%
21144	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	ALK tyrosine kinase receptor [human]	inhibition rate	50	%
21145	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase Haspin homolog ALK1 [human]	inhibition rate	65	%
21146	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase Haspin homolog ALK2 [human]	inhibition rate	72	%
21147	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Activin receptor type-1B [human]	inhibition rate	52	%
21148	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Bone morphogenetic protein receptor type-1B [human]	inhibition rate	48	%
21149	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	5'-AMP-activated protein kinase catalytic subunit alpha-1 [human]	inhibition rate	86	%
21150	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	5'-AMP-activated protein kinase catalytic subunit alpha-2 [human]	inhibition rate	92	%
21151	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Arginase [human]	inhibition rate	63	%
21152	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	NUAK family SNF1-like kinase 1 [human]	inhibition rate	92	%
21153	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	DASH complex subunit ASK1 [human]	inhibition rate	4	%
21154	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase ATM [human]	inhibition rate	-3	%
21155	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase ATR [human]	inhibition rate	-6	%
21156	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Aurora kinase A [human]	inhibition rate	-1	%
21157	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Aurora kinase B [human]	inhibition rate	74	%
21158	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Aurora kinase C [human]	inhibition rate	79	%
21159	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Tyrosine-protein kinase receptor UFO [human]	inhibition rate	13	%
21160	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	BMP-2-inducible protein kinase [human]	inhibition rate	-15	%
21161	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Bcl-2-interacting killer [human]	inhibition rate	98	%
21162	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Bone morphogenetic protein receptor type-2 [human]	inhibition rate	-1	%
21163	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Cytoplasmic tyrosine-protein kinase BMX [human]	inhibition rate	70	%
21164	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase B-raf [human]	inhibition rate	10	%
21165	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Protein-tyrosine kinase 6 [human]	inhibition rate	103	%
21166	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase BRSK1 [human]	inhibition rate	63	%
21167	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Serine/threonine-protein kinase BRSK2 [human]	inhibition rate	81	%
21168	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Tyrosine-protein kinase BTK [human]	inhibition rate	36	%
21169	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Calcium/calmodulin-dependent protein kinase type 1 [human]	inhibition rate	22	%
21170	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Calcium/calmodulin-dependent protein kinase type II alpha chain [human]	inhibition rate	29	%
21171	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Calcium/calmodulin-dependent protein kinase type II subunit beta [human]	inhibition rate	10	%
21172	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Calcium/calmodulin-dependent protein kinase type II subunit gamma [human]	inhibition rate	37	%
21173	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Calcium/calmodulin-dependent protein kinase type II delta 2 chain [human]	inhibition rate	41	%
21174	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Calcium/calmodulin-dependent protein kinase type IV [human]	inhibition rate	53	%
21175	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Calcium/calmodulin-dependent protein kinase type 1G [human]	inhibition rate	37	%
21176	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Calcium/calmodulin-dependent protein kinase type 1D [human]	inhibition rate	41	%
21177	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Calcium/calmodulin-dependent protein kinase kinase 1 [human]	inhibition rate	1	%
21178	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Calcium/calmodulin-dependent protein kinase kinase 2 [human]	inhibition rate	19	%
21179	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Cyclin-B1-1 [human];+Cell division control protein 7 [human]	inhibition rate	19	%
21180	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Cyclin-dependent kinase 12 [human];+Cyclin-K [human]	inhibition rate	15	%
21181	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Cyclin-dependent kinase 13 [human];+Cyclin-K [human]	inhibition rate	9	%
21182	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Cyclin-dependent kinase 14 [human];+cyclin-y [human]	inhibition rate	3	%
21183	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Cyclin-dependent kinase 16 [human];+cyclin-y [human]	inhibition rate	1	%
21184	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Cyclin-dependent kinase 17 [human];+cyclin-y [human]	inhibition rate	-2	%
21185	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Cyclin-dependent kinase 18 [human];+cyclin-y [human]	inhibition rate	9	%
21186	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Cyclin-dependent kinase 2 [human];+Cyclin-A1 [human]	inhibition rate	9	%
21187	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Cyclin E [human];+Cyclin-dependent kinase 3 [human]	inhibition rate	-13	%
21188	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Cyclin-dependent kinase 5 homolog [human];+Cyclin-dependent kinase 5 activator 1, p25 [human]	inhibition rate	-16	%
21189	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Cyclin-dependent kinase 6 [human];+Cyclin-D3-1 [human]	inhibition rate	8	%
21190	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Cyclin-H [human];+Acetyl-CoA acetyltransferase, mitochondrial [human];+Cyclin-dependent kinase 7 [human]	inhibition rate	19	%
21191	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Cyclin-dependent kinase 9 [human];+Cyclin-T1 [human]	inhibition rate	-4	%
21192	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Cyclin-dependent kinase-like 1 [human]	inhibition rate	16	%
21193	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Cyclin-dependent kinase-like 3 [human]	inhibition rate	-21	%
21194	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Cyclin-dependent kinase-like 3 [human]	inhibition rate	31	%
21195	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Cyclin-dependent kinase-like 4 [human]	inhibition rate	31	%
21196	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Transient receptor potential cation channel subfamily M member 7 [human]	inhibition rate	6	%
21197	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2		Cmax	68.07	μg/l
21198	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2		Cmax	958.55	μg/l
21199	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2		t1/2 (drug half life)	3.62	h
21200	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2		t1/2 (drug half life)	3.9	h
21201	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2		CL (drug clearance)	67.78	l/h/kg
21202	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2		CL (drug clearance)	9.97	l/h/kg
21203	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2		AUC (0-t)	1002.81	μg/h/l
21204	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2		AUC (0-t)	150.88	μg/h/l
21205	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2		Vz	333.24	l/kg
21206	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2		Vz	43.94	l/kg
21207	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2		F (drug bioavailability)	15.05	%
21208	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	body weight loss decrease		
21209	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	body weight loss decrease		
21210	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	decrease rate		
21211	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	observed parameter		
21212	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	observed parameter		
21213	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	decrease rate		
21214	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	decrease rate		
21215	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 2 [mouse]	decrease rate		
21216	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2		drug concentration	3616	ng/g
21217	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2		drug concentration	9140	ng/g
21218	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2	Receptor-interacting serine/threonine-protein kinase 1 [human]	inhibition rate	6 - 9	%
21219	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2		t1/2 (drug half life)	120	min
21220	CC1=CC(F)=C(C=C1)C1=CN([C@@H]2CC[C@H](N)CC2)C2=C1C(N)=NC=N2		CL (drug clearance)	12	ml/min/g protein
